{"color":"#0066FF","name":"University of Queensland","data":{"source":"NHMRC","name":"University of Queensland","state":"QLD","nla":"http://nla.gov.au/nla.party-460867","type":"University","node_source":"NHMRC","node_type":"Institution"},"children":[{"color":"#FF4D4D","name":"2013 Equipment Grant","data":{"media_summary":"","end_year":2014,"nhmrc_grant_id":9000180,"application_year":2013,"start_year":2013,"scientific_title":"2013 Equipment Grant","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"","for_category":"","cia_name":"Nicole Shively","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/9000180","simplified_title":"2013 Equipment Grant","sub_type":"Equipment Grant","total_budget":"517701.2","source_system":""},"children":[{"color":"#336699","name":"Nicole Shively","data":{"first_name":"Nicole","title":"","dw_individual_id":"DW0038843","middle_name":"","last_name":"Shively","source_individual_id":"5013018","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Nicole Shively"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87065","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76186","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2019,"keywords":["cerebral palsy treatments","brain development","outcomes research","health economics","quality of life"],"nhmrc_grant_id":1077257,"application_year":2013,"health_keywords":["neuroscience","musculoskeletal disorders"],"scientific_title":"","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Health Services Research","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Roslyn Boyd","higher_grant_type":"NHMRC Partnerships","purl":"http://purl.org/au-research/grants/nhmrc/1077257","simplified_title":"PREDICT Outcomes to inform services for children with Cerebral Palsy","sub_type":"Partnership Project for Better Health","total_budget":"774450.3","source_system":"Every 15 hours a new child is born with Cerebral Palsy (CP). CP is due to an early static brain injury however physical problems can progress. Our PREDICT program will examine early measures of brain structure and motor development combined with growth, nutrition, physical activity, cognition, communication, participation, quality of life outcomes at 8 years and relate these to the costs of health care. These prediction models will inform the timing of early interventions, appropriate service provision and projected costs of health care."},"children":[{"color":"#336699","name":"A/Pr Jennifer Whitty","data":{"first_name":"Jennifer","title":"A/Pr","dw_individual_id":"DW0046256","middle_name":"Anne","last_name":"Whitty","source_individual_id":"5029092","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Jennifer Whitty"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88976","size":1},{"color":"#336699","name":"Prof Roslyn Boyd","data":{"first_name":"Roslyn","title":"Prof","dw_individual_id":"DW0041223","middle_name":"N","last_name":"Boyd","source_individual_id":"RMIS1681246","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roslyn Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87689","size":1},{"color":"#336699","name":"Dr Lee Barber","data":{"first_name":"Lee","title":"Dr","dw_individual_id":"DW0040953","middle_name":"Anthony","last_name":"Barber","source_individual_id":"5013324","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Lee Barber"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87627","size":1},{"color":"#336699","name":"Dr Robert Ware","data":{"first_name":"Robert","title":"Dr","dw_individual_id":"DW0040341","middle_name":"S","last_name":"Ware","source_individual_id":"5018199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Robert Ware"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87453","size":1},{"color":"#336699","name":"Prof Jenny Ziviani","data":{"first_name":"Jenny","title":"Prof","dw_individual_id":"DW0029064","middle_name":"M","last_name":"Ziviani","source_individual_id":"5018596","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jenny Ziviani"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84541","size":1},{"color":"#336699","name":"Prof Stewart Trost","data":{"first_name":"Stewart","title":"Prof","dw_individual_id":"DW0028465","middle_name":"Graeme","last_name":"Trost","source_individual_id":"5050183","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stewart Trost"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84362","size":1},{"color":"#336699","name":"Dr Kristie Bell","data":{"first_name":"Kristie","title":"Dr","dw_individual_id":"DW0023569","middle_name":"","last_name":"Bell","source_individual_id":"5013442","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kristie Bell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83059","size":1},{"color":"#336699","name":"Prof Peter Davies","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0018572","middle_name":"Sw","last_name":"Davies","source_individual_id":"5014241","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Davies"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81758","size":1},{"color":"#336699","name":"Dr Koa Whittingham","data":{"first_name":"Koa","title":"Dr","dw_individual_id":"DW0011047","middle_name":"L","last_name":"Whittingham","source_individual_id":"5019383","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Koa Whittingham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79703","size":1},{"color":"#336699","name":"A/Pr Stephen Rose","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0009965","middle_name":"E","last_name":"Rose","source_individual_id":"5017273","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Stephen Rose"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79404","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76155","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2015,"keywords":["diabetes mellitus","pregnancy outcome","hypoglycaemia","insulin sensitivity","breastfeeding"],"nhmrc_grant_id":1076238,"application_year":2013,"start_year":2014,"scientific_title":"","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Naomi Achong","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1076238","simplified_title":"The management of women with type 1 diabetes during pregnancy and breastfeeding.","sub_type":"Medical/Dental Postgraduate Scholarship","total_budget":"50571.48","source_system":"Pregnancy in women with type 1 diabetes is associated with increased risks to the mother and baby and lower rates of breastfeeding. There is a relative paucity of published studies concerning the management of these women particularly in late pregnancy, immediately after delivery and during breastfeeding. Through a series of studies this project aims to address these areas of uncertainty and thereby improve the management of these women during these periods."},"children":[{"color":"#336699","name":"Dr Naomi Achong","data":{"first_name":"Naomi","title":"Dr","dw_individual_id":"5109117","middle_name":"Manik Amoy","last_name":"Achong","source_individual_id":"5109117","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Naomi Achong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76621","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76132","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2016,"keywords":["chronic pain","neuropathic pain","conotoxins","peptide synthesis","peptides"],"nhmrc_grant_id":1076136,"application_year":2013,"health_keywords":["chemistry"],"scientific_title":"","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1076136","simplified_title":"Better treatments for chronic pain","sub_type":"Development Grant","total_budget":"584269.04","source_system":"Chronic pain from damage to the nervous system is extremely debilitating and notoriously difficult to treat. The current drug of choice, gabapentin, has serious side effects and only works in two-thirds of patients.  We have developed a drug, derived from sea snail venom, that exhibits ten times the activity of gabapentin. This proposal seeks to progress our drug to clinical trials and attract a commercial partner for its development into the market."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Dr Richard Clark","data":{"first_name":"Richard","title":"Dr","dw_individual_id":"DW0029966","middle_name":"James","last_name":"Clark","source_individual_id":"5013970","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Richard Clark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84761","size":1},{"color":"#336699","name":"Prof Susan Charman","data":{"first_name":"Susan","title":"Prof","dw_individual_id":"DW0029889","middle_name":"Ann","last_name":"Charman","source_individual_id":"5024479","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Susan Charman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84738","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76128","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2016,"keywords":["dentistry","biomaterials","prosthodontics","inhibition","polymerisation"],"nhmrc_grant_id":1076094,"application_year":2013,"start_year":2014,"scientific_title":"","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dental Materials and Equipment","research_area":"Clinical Medicine and Science","for_category":"DENTISTRY","cia_name":"Dr David Joo","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1076094","simplified_title":"Methods to improve detail reproduction of elastic impression materials","sub_type":"Medical/Dental Postgraduate Scholarship","total_budget":"117368","source_system":"If a dental prosthesis is to fit precisely in the mouth, an accurate impression must be taken of the teeth and surrounding tissues. This research aims to evaluate variable surface conditions which may be taken into consideration to achieve an accurate impression, such as moisture, temperature, and the presence of contaminants. Although any distortions as a result of material interactions would be limited to the surface interface, inaccuracies here may ultimately compromise treatment success."},"children":[{"color":"#336699","name":"Dr David Joo","data":{"first_name":"David","title":"Dr","dw_individual_id":"5104176","middle_name":"","last_name":"Joo","source_individual_id":"5104176","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David Joo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76552","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76124","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2015,"keywords":["asthma","respiratory diseases","medicinal chemistry","drug discovery","drug development"],"nhmrc_grant_id":1075962,"application_year":2013,"start_year":2014,"scientific_title":"","node_source":"NHMRC","node_type":"Grant","field_of_research":"Molecular Medicine","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"A/Pr Mark Smythe","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1075962","simplified_title":"Towards treatment of asthma","sub_type":"Development Grant","total_budget":"334370.28","source_system":"Prostaglandin D2 (PGD2) is a key driver of asthma and allergic rhinitis. We have developed drug-like compounds that block the synthesis of PGD2 by inhibiting the hematopoietic prostaglandin D2 synthase (HPGD2S) enzyme. This project aims to develop these compounds further to ultimately treat a subset of the asthma population that are not well treated, refractory asthmatics."},"children":[{"color":"#336699","name":"A/Pr Mark Smythe","data":{"first_name":"Mark","title":"A/Pr","dw_individual_id":"DW0045518","middle_name":"Leslie","last_name":"Smythe","source_individual_id":"5023110","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Mark Smythe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88779","size":1},{"color":"#336699","name":"Dr Simon Phipps","data":{"first_name":"Simon","title":"Dr","dw_individual_id":"DW0033180","middle_name":"","last_name":"Phipps","source_individual_id":"5016985","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Simon Phipps"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85598","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76114","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2016,"keywords":["skin response","diagnostic test","differential diagnosis","biomedical engineering","clinical trial"],"nhmrc_grant_id":1075739,"application_year":2013,"start_year":2014,"scientific_title":"","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Devices","research_area":"Basic Science","for_category":"BIOMEDICAL ENGINEERING","cia_name":"Prof Mark Kendall","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1075739","simplified_title":"Skin patch technology for fast and simple monitoring of disease","sub_type":"Development Grant","total_budget":"810141.19","source_system":"Micropatch kits will be developed to capture and detect disease-related biomarkers from the skin for diagnostic monitoring, without the need for needles, trained practitioners or expensive laboratory infrastructure"},"children":[{"color":"#336699","name":"Prof Mark Kendall","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0043459","middle_name":"Af","last_name":"Kendall","source_individual_id":"5015660","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Kendall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88269","size":1},{"color":"#336699","name":"Dr Simon Corrie","data":{"first_name":"Simon","title":"Dr","dw_individual_id":"DW0036019","middle_name":"Robert","last_name":"Corrie","source_individual_id":"5038823","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Simon Corrie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86337","size":1},{"color":"#336699","name":"Prof Paul Young","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0005625","middle_name":"R","last_name":"Young","source_individual_id":"RMIS20614","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78234","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76102","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"disability","end_year":2016,"keywords":["cerebral palsy","cerebral palsy treatments","muscle mechanics","muscle function","ultrasound"],"nhmrc_grant_id":1075642,"application_year":2013,"health_keywords":["muscle contracture","muscle strength","training","functional decline","disability"],"scientific_title":"","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Clinical Medicine and Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"Mr Jarred Gillett","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1075642","simplified_title":"The impact of strength training on calf muscle structure and function in youth and adolescents with cerebral palsy","sub_type":"Public Health Postgraduate Scholarship","total_budget":"76517.12","source_system":"Muscle spasticity is a primary cause of disability in individuals with cerebral palsy; however their muscles also do not develop properly: they are weak and resistant to stretch. Strength training causes muscle adaptations that increase strength and decrease stiffness. This study will examine the impact of a strength training intervention on muscle structure and function using innovative imaging techniques, motion analysis and measures of muscle strength and stretch, translating into better conservative intervention planning."},"children":[{"color":"#336699","name":"Mr Jarred Gillett","data":{"first_name":"Jarred","title":"Mr","dw_individual_id":"5105108","middle_name":"","last_name":"Gillett","source_individual_id":"5105108","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Mr Jarred Gillett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76559","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76094","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2015,"keywords":["bronchiectasis","paediatric","chronic suppurative lung disorders","exacerbation","economic analysis"],"nhmrc_grant_id":1075119,"application_year":2013,"health_keywords":["respiratory infection","quality of life","antibiotic resistance"],"scientific_title":"","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics and Reproductive Medicine not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"Dr Vikas Goyal","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1075119","simplified_title":"Advancing the knowledge, understanding and management of respiratory exacerbations in children with bronchiectasis","sub_type":"Medical/Dental Postgraduate Scholarship","total_budget":"67261.97","source_system":"Bronchiectasis is a condition which causes significant morbidity, burden of disease and mortality in children as well as adults. Exacerbations in bronchiectasis influence the decline in lung function and quality of life for patients. Although the importance of treating exacerbations effectively is well accepted, there are no universally accepted guidelines for recognizing and managing an exacerbation of bronchiectasis in children. This study aims to fill this clinical and research gap."},"children":[{"color":"#336699","name":"Dr Vikas Goyal","data":{"first_name":"Vikas","title":"Dr","dw_individual_id":"DW0007563","middle_name":"","last_name":"Goyal","source_individual_id":"5046247","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Vikas Goyal"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78745","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76060","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2016,"keywords":["muscle mechanics","tendon injury","biomechanics","footwear","muscle injury"],"nhmrc_grant_id":1075000,"application_year":2013,"start_year":2014,"scientific_title":"","node_source":"NHMRC","node_type":"Grant","field_of_research":"Podiatry","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Mrs Jayishni Prasad","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1075000","simplified_title":"What is the function of the tibialis posterior muscle and tendon during walking and how does it affect disorders of the foot","sub_type":"Public Health Postgraduate Scholarship","total_budget":"93778.08","source_system":"The tibialis posterior (TP) muscle is important for foot function and is often implicated in foot and ankle problems. We will investigate the function of TP during gait with specific reference to foot posture. In particular we will examine the mechanical function of the muscle and tendon in different foot postures and commonly used treatment modalities such as (footwear and foot orthoses)."},"children":[{"color":"#336699","name":"Mrs Jayishni Prasad","data":{"first_name":"Jayishni","title":"Mrs","dw_individual_id":"5046562","middle_name":"Niharika","last_name":"Prasad","source_individual_id":"5046562","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Mrs Jayishni Prasad"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76256","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76051","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2016,"keywords":["early childhood","epidemiology","respiratory viruses","health economics","community child health"],"nhmrc_grant_id":1074976,"application_year":2013,"health_keywords":["preventive health"],"scientific_title":"","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Ms Mohinder Sarna","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1074976","simplified_title":"Observational research in childhood diseases","sub_type":"Public Health Postgraduate Scholarship","total_budget":"105437.84","source_system":"Respiratory infections are common in children during the first two years of life, where they may experience six to eight infections each year. Complications are common, and between 3-5% of all infants are hospitalised. Available information on children has largely come from hospitalised patients. Information about illness in and cost to the community is scarce. To this aim, a cohort of children will be followed from birth to two. Information about infections and their cost will be recorded and analysed."},"children":[{"color":"#336699","name":"Ms Mohinder Sarna","data":{"first_name":"Mohinder","title":"Ms","dw_individual_id":"5107113","middle_name":"Pal Kaur","last_name":"Sarna","source_individual_id":"5107113","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Mohinder Sarna"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76599","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76047","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2015,"keywords":["vaccine development","Streptococcus pyogenes","rheumatic fever","rheumatic heart disease","pharyngitis"],"nhmrc_grant_id":1074899,"application_year":2013,"start_year":2014,"scientific_title":"","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Mark Walker","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1074899","simplified_title":"Developing a safe vaccine against group A streptococci","sub_type":"Development Grant","total_budget":"765576.24","source_system":"Group A streptococcus causes 520,000 deaths each year. A safe and effective vaccine is not commercially available. We have identified new protective candidate antigens, and we seek to undertake critical non-human primate studies to provide further proof-of-concept data. This work will underpin commercial decisions by our industry partner (Sanofi Pasteur) leading to human trials and the development of a safe group A streptococcal vaccine for human use."},"children":[{"color":"#336699","name":"Prof Istvan Toth","data":{"first_name":"Istvan","title":"Prof","dw_individual_id":"DW0034329","middle_name":"","last_name":"Toth","source_individual_id":"RMIS17214","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Istvan Toth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85883","size":1},{"color":"#336699","name":"Prof Mark Walker","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0010893","middle_name":"J.","last_name":"Walker","source_individual_id":"RMIS127362","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mark Walker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79668","size":1},{"color":"#336699","name":"Dr Peter Moyle","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0009251","middle_name":"Michael","last_name":"Moyle","source_individual_id":"5016594","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Peter Moyle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79217","size":1},{"color":"#336699","name":"Dr Michael Batzloff","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0006004","middle_name":"Raymond","last_name":"Batzloff","source_individual_id":"5011487","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michael Batzloff"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78341","size":1},{"color":"#336699","name":"Prof Victor Nizet","data":{"first_name":"Victor","title":"Prof","dw_individual_id":"DW0003693","middle_name":"","last_name":"Nizet","source_individual_id":"5030735","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Victor Nizet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77687","size":1},{"color":"#336699","name":"Prof Guido Silvestri","data":{"first_name":"Guido","title":"Prof","dw_individual_id":"5104188","middle_name":"","last_name":"Silvestri","source_individual_id":"5104188","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Guido Silvestri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76555","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76044","size":1},{"color":"#FF4D4D","name":"SOLUTIONS for present and future emerging pollutants in land and water resources management","data":{"media_summary":"oxidative stress","end_year":2018,"keywords":["drinking water quality","drinking water","water quality","water supply","environment"],"nhmrc_grant_id":1074775,"application_year":2013,"health_keywords":["environmental monitoring","environmental pollutants","environmental health","in vitro","oxidative stress"],"scientific_title":"SOLUTIONS for present and future emerging pollutants in land and water resources management","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Toxicology (incl. Clinical Toxicology)","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Peta Neale","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/1074775","simplified_title":"SOLUTIONS for present and future emerging pollutants","sub_type":"Aust/EU Collaborative Research Grant","total_budget":"256809.79","source_system":"The European Union project SOLUTIONS will develop a novel conceptual framework to prioritise chemical contaminants for ecological and human health risk assessment of water resources and fish for human consumption. The Australian partner will implement health-relevant bioanalytical endpoints to inform cumulative risk assessment. The developed concepts and tools will be validated using European river case studies, with the knowledge generated to be transferred to the Australian context."},"children":[{"color":"#336699","name":"Prof Beate Escher","data":{"first_name":"Beate","title":"Prof","dw_individual_id":"5107149","middle_name":"Isabella","last_name":"Escher","source_individual_id":"5107149","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Beate Escher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76603","size":1},{"color":"#336699","name":"Dr Peta Neale","data":{"first_name":"Peta","title":"Dr","dw_individual_id":"5104116","middle_name":"Anne","last_name":"Neale","source_individual_id":"5104116","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Peta Neale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76538","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76034","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2016,"keywords":["Aboriginal","critical care","antibiotics","pharmacokinetics","sepsis"],"nhmrc_grant_id":1074523,"application_year":2013,"health_keywords":["infectious diseases","ethnic differences","indigenous health"],"scientific_title":"","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Mr Danny Tsai","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1074523","simplified_title":"Improving Dosing of Common Antibiotics used in Critically Ill Australian Indigenous Patients","sub_type":"Training Scholarship for Aboriginal Health Research","total_budget":"79203.38","source_system":"Optimal antibiotic dosing in patients in the intensive care unit saves lives. However, the way antibiotics move through the body of an intensive care unit patient can be different to other patients. Therefore, research that identifies specific dosing for these patients is essential. Further to this, no research in an Indigenous population is available. The aim of this research is to address this gap by developing optimal antibiotic doses for Indigenous Australians in the intensive care unit."},"children":[{"color":"#336699","name":"Mr Danny Tsai","data":{"first_name":"Danny","title":"Mr","dw_individual_id":"5086121","middle_name":"Yu-Sheng","last_name":"Tsai","source_individual_id":"5086121","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Mr Danny Tsai"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76506","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/76012","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2018,"keywords":["cancer care","health behaviours","health counselling","physical activity","diet"],"nhmrc_grant_id":1074356,"application_year":2013,"health_keywords":["weight control"],"scientific_title":"","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Health and Community Services","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Elizabeth Eakin","higher_grant_type":"NHMRC Partnerships","purl":"http://purl.org/au-research/grants/nhmrc/1074356","simplified_title":"Healthy Living after Cancer","sub_type":"Partnership Project for Better Health","total_budget":"1267110.7","source_system":"A translational initiative investigating the feasibility and outcomes of implementing an evidence-based, broad-reach (telephone-delivered) lifestyle intervention (the Healthy Living after Cancer program) within the Cancer Council Helpline service.  The aim of this work is to inform the widespread uptake of lifestyle interventions into routine cancer care and to improve both quality and quantity of survival for Australian cancer survivors."},"children":[{"color":"#336699","name":"A/Pr Michael Jefford","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0043287","middle_name":"","last_name":"Jefford","source_individual_id":"RMIS1665338","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Michael Jefford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88216","size":1},{"color":"#336699","name":"Prof Gita Mishra","data":{"first_name":"Gita","title":"Prof","dw_individual_id":"DW0038575","middle_name":"Devi","last_name":"Mishra","source_individual_id":"5012169","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gita Mishra"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86995","size":1},{"color":"#336699","name":"Prof Bogda Koczwara","data":{"first_name":"Bogda","title":"Prof","dw_individual_id":"DW0037808","middle_name":"","last_name":"Koczwara","source_individual_id":"5015777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bogda Koczwara"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86791","size":1},{"color":"#336699","name":"Prof Janet Hiller","data":{"first_name":"Janet","title":"Prof","dw_individual_id":"DW0037278","middle_name":"Esther","last_name":"Hiller","source_individual_id":"RMIS14521","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Janet Hiller"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86660","size":1},{"color":"#336699","name":"Prof Elizabeth Eakin","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0036429","middle_name":"G","last_name":"Eakin","source_individual_id":"5014455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Elizabeth Eakin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86445","size":1},{"color":"#336699","name":"A/Pr Janette Vardy","data":{"first_name":"Janette","title":"A/Pr","dw_individual_id":"DW0028558","middle_name":"L","last_name":"Vardy","source_individual_id":"RMIS1975354","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Janette Vardy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84392","size":1},{"color":"#336699","name":"A/Pr Sandra Hayes","data":{"first_name":"Sandra","title":"A/Pr","dw_individual_id":"DW0019524","middle_name":"Christine","last_name":"Hayes","source_individual_id":"5012532","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Sandra Hayes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81970","size":1},{"color":"#336699","name":"Dr Marina Reeves","data":{"first_name":"Marina","title":"Dr","dw_individual_id":"DW0009857","middle_name":"M","last_name":"Reeves","source_individual_id":"5017143","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Marina Reeves"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79376","size":1},{"color":"#336699","name":"Prof Marion Haas","data":{"first_name":"Marion","title":"Prof","dw_individual_id":"DW0007778","middle_name":"Ruth","last_name":"Haas","source_individual_id":"5015140","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Marion Haas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78800","size":1},{"color":"#336699","name":"Prof Frances Boyle","data":{"first_name":"Frances","title":"Prof","dw_individual_id":"DW0000506","middle_name":"Mary","last_name":"Boyle","source_individual_id":"5013576","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frances Boyle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76790","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75997","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2016,"keywords":["vaccine development","vaccine technology","molecular biology","vaccine design","preventive health"],"nhmrc_grant_id":1074296,"application_year":2013,"start_year":2014,"scientific_title":"","node_source":"NHMRC","node_type":"Grant","field_of_research":"Immunology not elsewhere classified","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ben Hankamer","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1074296","simplified_title":"Dengue fever vaccine: Towards low cost production and delivery","sub_type":"Development Grant","total_budget":"601956.21","source_system":"With rising populations and a warming climate mosquito borne viral diseases will become more prevalent and low-cost vaccine production & delivery systems will become increasingly important. Here a microalgae based vaccine production platform will be coupled to proven Nanopatch & low cost oral vaccine delivery. The focus is on a Dengue virus vaccine, as Dengue causes 400 million infections & 100 million symptomatic cases annually."},"children":[{"color":"#336699","name":"Prof Mark Kendall","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0043459","middle_name":"Af","last_name":"Kendall","source_individual_id":"5015660","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Kendall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88269","size":1},{"color":"#336699","name":"Prof Ben Hankamer","data":{"first_name":"Ben","title":"Prof","dw_individual_id":"DW0013481","middle_name":"David","last_name":"Hankamer","source_individual_id":"5015066","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ben Hankamer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80339","size":1},{"color":"#336699","name":"Prof Paul Young","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0005625","middle_name":"R","last_name":"Young","source_individual_id":"RMIS20614","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78234","size":1},{"color":"#336699","name":"Dr Melanie Oey","data":{"first_name":"Melanie","title":"Dr","dw_individual_id":"5046849","middle_name":"","last_name":"Oey","source_individual_id":"5046849","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Melanie Oey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76296","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75994","size":1},{"color":"#FF4D4D","name":"Molecular characteristation of the adiponectin receptors, AdipoR1 and AdipoR2: Identifying strategies to enhance adiponectin sensitivity and reduce cardiometabolic disease.","data":{"media_summary":"cell metabolism","end_year":2017,"keywords":["cardiovascular health","obesity","diabetes","adiponectin","receptor regulation"],"nhmrc_grant_id":1074074,"application_year":2013,"health_keywords":["insulin sensitivity","inflammation","fat metabolism","physiology","cell metabolism"],"scientific_title":"Molecular characteristation of the adiponectin receptors, AdipoR1 and AdipoR2: Identifying strategies to enhance adiponectin sensitivity and reduce cardiometabolic disease.","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Receptors and Membrane Biology","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Miss Hayley O'Neill","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1074074","simplified_title":"Defining how novel hormone receptors work to identify new treatments for heart disease.","sub_type":"Peter Doherty Biomedical ECF","total_budget":"309434.12","source_system":"Obesity and Type 2 diabetes (T2D) increase risk of cardiovascular disease  (CVD), a leading cause of death in Australia. New drugs are required to reduce the health risks and financial burden of these diseases. Targeting hormone receptors to reduce fat storage in liver and skeletal muscle in obesity may improve insulin sensitivity and reduce blood sugar levels and therefore reduce CVD risk. This research will study how these receptors function in order to develop new drugs to reduce CVD risk."},"children":[{"color":"#336699","name":"Miss Hayley O'Neill","data":{"first_name":"Hayley","title":"Miss","dw_individual_id":"5090148","middle_name":"Maree","last_name":"O'Neill","source_individual_id":"5090148","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Miss Hayley O'Neill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76521","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75989","size":1},{"color":"#FF4D4D","name":"Development of an antibody-targeted drug/miRNA/peptide delivery system for effective prevention of restenosis","data":{"media_summary":"artery wall","end_year":2017,"keywords":["biomedical engineering","biomaterials","drug delivery systems","cardiovascular disease prevention","restenosis"],"nhmrc_grant_id":1073591,"application_year":2013,"health_keywords":["gene delivery","RNA interference","in vitro","in vivo","artery wall"],"scientific_title":"Development of an antibody-targeted drug/miRNA/peptide delivery system for effective prevention of restenosis","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biomaterials","research_area":"Basic Science","for_category":"BIOMEDICAL ENGINEERING","cia_name":"Dr Zi Gu","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1073591","simplified_title":"An inexpensive and effective therapeutics to prevent vessel reblocking","sub_type":"Peter Doherty Biomedical ECF","total_budget":"309434.12","source_system":"The re-blocking of vessels after surgery occurs up to 50% of patients, and none of the preventive approaches are cost-effective and safe enough. This project aims to develop a nano-scaled therapeutics delivering combination therapies to effectively prevent the re-blockage after surgery. If successful, this research will present a whole new range of therapeutic agent that prevents the patient from developing clots after surgery, improving the productivity and health of patients with reduced cost."},"children":[{"color":"#336699","name":"Dr Zi Gu","data":{"first_name":"Zi","title":"Dr","dw_individual_id":"5091122","middle_name":"","last_name":"Gu","source_individual_id":"5091122","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Zi Gu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76525","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75978","size":1},{"color":"#FF4D4D","name":"inTOUCH: Tactile assessment in children with Cerebral Palsy","data":{"media_summary":"brain function","end_year":2018,"keywords":["tactile sensation","cerebral palsy","hemiplegia","hand function","child"],"nhmrc_grant_id":1073226,"application_year":2013,"health_keywords":["upper limb function","perception","paediatric","sensation","brain function"],"scientific_title":"inTOUCH: Tactile assessment in children with Cerebral Palsy","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Dr Megan Auld","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1073226","simplified_title":"inTOUCH: Touch assessment in children with Cerebral Palsy","sub_type":"TRIP ECF","total_budget":"170690","source_system":"Recent research finds that over 70% of children with unilateral cerebral palsy have impairments in touch function that affect how well they can use their hands. Until now, the severity and extent of this deficit has been unknown, and so children with cerebral palsy have not been receiving touch assessments. This project aims to increase awareness of touch impairments and achieve integration of touch assessment into routine examaination."},"children":[{"color":"#336699","name":"Dr Megan Auld","data":{"first_name":"Megan","title":"Dr","dw_individual_id":"5086127","middle_name":"Louise","last_name":"Auld","source_individual_id":"5086127","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Megan Auld"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76507","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75956","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"peptides","end_year":2019,"keywords":["pain","pain mechanisms","pain transmission","structure-function","biochemistry"],"nhmrc_grant_id":1072113,"application_year":2013,"health_keywords":["pharmacology","venom","ion channels","proteomics","peptides"],"scientific_title":"","start_year":2015,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Richard Lewis","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/1072113","simplified_title":"Discovery and development of better pain treatments","sub_type":"Program Grant","total_budget":"9209250","source_system":"Many forms of pain remain poorly treated, leading to significant quality of life and economic losses. This Program grant will discover and characterise new peptides from cone snails and spiders that modulate specific channels in nerves that are critical to the transmission of pain signals to the brain. Using advanced chemical and structural approaches, promising leads will be optimised for potency and stability and evaluated in disease and pathway-specific models of pain to establish their clinical potential."},"children":[{"color":"#336699","name":"Prof Macdonald Christie","data":{"first_name":"Macdonald","title":"Prof","dw_individual_id":"DW0035875","middle_name":"James","last_name":"Christie","source_individual_id":"5012593","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Macdonald Christie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86297","size":1},{"color":"#336699","name":"Prof Paul Alewood","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0035049","middle_name":"F","last_name":"Alewood","source_individual_id":"5013158","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Alewood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86082","size":1},{"color":"#336699","name":"Prof Richard Lewis","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0014455","middle_name":"J","last_name":"Lewis","source_individual_id":"5015973","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Lewis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80612","size":1},{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1},{"color":"#336699","name":"Prof David Adams","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0000022","middle_name":"John","last_name":"Adams","source_individual_id":"RMIS8271","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Adams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76652","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75899","size":1},{"color":"#FF4D4D","name":"Contribution of the peri-renal environment to kidney disease","data":{"media_summary":"","end_year":2017,"keywords":["obesity","type 2 diabetes mellitus (non-insulin dependent diabetes mellitus)","nephropathy","molecular biology","endocrinology"],"nhmrc_grant_id":1072086,"application_year":2013,"health_keywords":["hormone receptors","hormone action","glycation"],"scientific_title":"Contribution of the peri-renal environment to kidney disease","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Dr Brooke Harcourt","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1072086","simplified_title":"Contribution of the peri-renal environment to kidney disease","sub_type":"Peter Doherty Biomedical ECF","total_budget":"309434.12","source_system":"This proposal will investigate the peri-renal adipose tissue phenotype and if factors derived from this local adipose tissue depot can influence kidney function"},"children":[{"color":"#336699","name":"Dr Brooke Harcourt","data":{"first_name":"Brooke","title":"Dr","dw_individual_id":"DW0025318","middle_name":"Elyse","last_name":"Harcourt","source_individual_id":"5032461","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brooke Harcourt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83519","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75897","size":1},{"color":"#FF4D4D","name":"Oligomers of the Alzheimer's amyloid-_ peptide: structure, mechanism of toxicity and small molecule interactions","data":{"media_summary":"","end_year":2018,"keywords":["structural biology","biophysics","protein aggregation","amyloid","nuclear magnetic resonance (NMR) spectroscopy"],"nhmrc_grant_id":1071985,"application_year":2013,"health_keywords":["protein function","protein structure","protein folding","protein complexes"],"scientific_title":"Oligomers of the Alzheimer's amyloid-_ peptide: structure, mechanism of toxicity and small molecule interactions","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Structural Biology (incl. Macromolecular Modelling)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Vanessa Morris","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1071985","simplified_title":"Investigating the toxic particles formed by the Alzheimer's disease protein amyloid-beta","sub_type":"CJ Martin Biomedical ECF","total_budget":"338314.12","source_system":"Alzheimers disease is a devastating neurodegenerative disease that currently affects 240 000 Australians. The protein called amyloid-_ is found in deposits in the brains of Alzheimers patients. The toxic form of this protein is thought to be small aggregated particles called oligomers. This work aims to investigate the structure of these particles, the reason why they are toxic, as well as their interaction with the neuroprotective compound EGCG, which is found in green tea."},"children":[{"color":"#336699","name":"Dr Vanessa Morris","data":{"first_name":"Vanessa","title":"Dr","dw_individual_id":"5069107","middle_name":"Kay","last_name":"Morris","source_individual_id":"5069107","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Vanessa Morris"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76496","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75886","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2019,"keywords":["rheumatology","graft versus host disease (GVHD)","skin cancer","microbial ecology","viral immunity"],"nhmrc_grant_id":1071822,"application_year":2013,"start_year":2015,"scientific_title":"","node_source":"NHMRC","node_type":"Grant","field_of_research":"Autoimmunity","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ranjeny Thomas","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/1071822","simplified_title":"Immunoregulation for treatment of disease","sub_type":"Program Grant","total_budget":"11797530","source_system":"Some infections can start inflammation that, while  controlling the infection, can  also attack the  body tissues of genetically susceptible people.  This inflammation can initiate long term problems including arthritis, diabetes and cancer.  Our research program seeks to understand who is genetically at risk of this sort of problem and why, and thus to develop new means to prevent and treat the chronic diseases that are initiated in this way."},"children":[{"color":"#336699","name":"Prof Ranjeny Thomas","data":{"first_name":"Ranjeny","title":"Prof","dw_individual_id":"DW0045826","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS4352","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ranjeny Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88853","size":1},{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1},{"color":"#336699","name":"Prof Mariapia Degli-Esposti","data":{"first_name":"Mariapia","title":"Prof","dw_individual_id":"DW0041983","middle_name":"Alessandra","last_name":"Degli-Esposti","source_individual_id":"5014276","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mariapia Degli-Esposti"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87887","size":1},{"color":"#336699","name":"Prof Philip Hugenholtz","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0019751","middle_name":"","last_name":"Hugenholtz","source_individual_id":"5021803","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Philip Hugenholtz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82032","size":1},{"color":"#336699","name":"Prof Matthew Brown","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0012026","middle_name":"A","last_name":"Brown","source_individual_id":"5012217","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79951","size":1},{"color":"#336699","name":"Prof Geoff Hill","data":{"first_name":"Geoff","title":"Prof","dw_individual_id":"DW0007868","middle_name":"Roger","last_name":"Hill","source_individual_id":"RMIS534437","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Geoff Hill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78822","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75879","size":1},{"color":"#FF4D4D","name":"Bioresponsive nanocarriers for controlled and targeted delivery to efficiently treat Inflammatory Bowel Disease (IBD)","data":{"media_summary":"","end_year":2018,"keywords":["inflammatory bowel disease (IBD)","nanotechnology","formulation optimisation","targeted therapy","drug delivery"],"nhmrc_grant_id":1071796,"application_year":2013,"start_year":2014,"scientific_title":"Bioresponsive nanocarriers for controlled and targeted delivery to efficiently treat Inflammatory Bowel Disease (IBD)","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nanomedicine","research_area":"Basic Science","for_category":"NANOTECHNOLOGY","cia_name":"Dr Amirali Popat","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1071796","simplified_title":"Smart nanoparticles for better treatment of Inflammatory Bowel Disease (IBD)","sub_type":"Peter Doherty Biomedical ECF","total_budget":"309434.12","source_system":"Despite considerable progress in treatment of Inflammatory Bowel Diseases, current treatments suffer from many disadvantages such as side effects, lack of efficacy in many patients, and development of drug dependence. Using state of art nanotechnology, novel nanoparticles will be developed to enhance the delivery to the intestine and efficacy of Budesonide (an anti-inflammatory steroid). This research promises to find safer and more effective ways to treat these diseases."},"children":[{"color":"#336699","name":"Dr Amirali Popat","data":{"first_name":"Amirali","title":"Dr","dw_individual_id":"5059122","middle_name":"","last_name":"Popat","source_individual_id":"5059122","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Amirali Popat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76474","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75877","size":1},{"color":"#FF4D4D","name":"Venoms to drugs: characterizing the molecular interactions between venom peptides and ion channels with a view to rational drug design","data":{"media_summary":"","end_year":2017,"keywords":["structure-activity relationships","computational chemistry","molecular modelling","fluorescence spectroscopy","rational drug design"],"nhmrc_grant_id":1071293,"application_year":2013,"health_keywords":["molecular design"],"scientific_title":"Venoms to drugs: characterizing the molecular interactions between venom peptides and ion channels with a view to rational drug design","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biomolecular Modelling and Design","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Dr Evelyne Deplazes","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1071293","simplified_title":"Venoms to drugs: a novel approach to drug development using venom peptides","sub_type":"Peter Doherty Biomedical ECF","total_budget":"309434.12","source_system":"The conventional approach to drug development is reaching a state of crisis as it is producing fewer new drugs at increasing cost. A promising alternative is to harness the rich and diverse chemistry of venom peptides. This project aims to understand the mechanism by which venom peptides achieve their pharmacological activity. This knowledge is essential for venom-based drug design for treating diseases ranging from nervous systems disorders, stroke, chronic pain and psychiatric illnesses."},"children":[{"color":"#336699","name":"Dr Evelyne Deplazes","data":{"first_name":"Evelyne","title":"Dr","dw_individual_id":"5048139","middle_name":"","last_name":"Deplazes","source_individual_id":"5048139","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Evelyne Deplazes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76322","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75865","size":1},{"color":"#FF4D4D","name":"Investigating the cellular requirement for STIM1 phosphorylation and store-operated calcium entry suppression during mitosis: roles in development and cancer","data":{"media_summary":"","end_year":2018,"keywords":["calcium signalling","calcium channels","cell division","cancer biology","breast cancer"],"nhmrc_grant_id":1071074,"application_year":2013,"health_keywords":["breast development","microenvironment"],"scientific_title":"Investigating the cellular requirement for STIM1 phosphorylation and store-operated calcium entry suppression during mitosis: roles in development and cancer","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Felicity Davis","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1071074","simplified_title":"Calcium signalling in cell division: roles in development and cancer","sub_type":"CJ Martin Biomedical ECF","total_budget":"316676","source_system":"Cells are constantly interacting with and modifying their surrounding environment. The intracellular calcium signal is one mechanism cells use to translate signals from the microenvironment into cellular responses. This proposal seeks to explore why a key calcium signalling pathway, known as store-operated calcium entry, is specifically silenced during cell division, and to determine how reversing this inhibition affects cell division during normal development and in cancer."},"children":[{"color":"#336699","name":"Dr Felicity Davis","data":{"first_name":"Felicity","title":"Dr","dw_individual_id":"DW0012644","middle_name":"M","last_name":"Davis","source_individual_id":"5014234","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Felicity Davis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80126","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75857","size":1},{"color":"#FF4D4D","name":"Efficacy of interventions for equinus gait in children with cerebral palsy","data":{"media_summary":"","end_year":2017,"keywords":["cerebral palsy","muscle contracture","ultrasound","paediatric","muscle mechanics"],"nhmrc_grant_id":1070623,"application_year":2013,"start_year":2014,"scientific_title":"Efficacy of interventions for equinus gait in children with cerebral palsy","node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Clinical Medicine and Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"Dr Lee Barber","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1070623","simplified_title":"The influence of treatment on leg muscle function in children with cerebral palsy","sub_type":"Peter Doherty Biomedical ECF","total_budget":"309434.12","source_system":"Muscle spasticity is a primary cause of disability in children with cerebral palsy; however their muscles also do not develop properly: they are weak and resistant to stretch. This study will examine the precise muscle adaptations that occur due to spasticity using innovative ultrasound techniques and motion analysis. The influence of BOTOX treatment and orthopaedic surgery on muscle structure and function will be evaluated. This research will translate into better intervention planning."},"children":[{"color":"#336699","name":"Dr Lee Barber","data":{"first_name":"Lee","title":"Dr","dw_individual_id":"DW0040953","middle_name":"Anthony","last_name":"Barber","source_individual_id":"5013324","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Lee Barber"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87627","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75835","size":1},{"color":"#FF4D4D","name":"Adult vitamin D deficiency and cognitive dysfunction in a mouse model","data":{"media_summary":"","end_year":2016,"keywords":["animal model","brain function","vitamin D","cognition","attention"],"nhmrc_grant_id":1070081,"application_year":2013,"start_year":2014,"scientific_title":"Adult vitamin D deficiency and cognitive dysfunction in a mouse model","node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychology and Cognitive Sciences not elsewhere classified","research_area":"Basic Science","for_category":"OTHER PSYCHOLOGY AND COGNITIVE SCIENCES","cia_name":"A/Pr Thomas Burne","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1070081","simplified_title":"Low adult vitamin D levels and cognitive dysfunction","sub_type":"Standard Project Grant","total_budget":"412566.39","source_system":"Vitamin D deficiency is common in the Australian adult population. We provide convincing evidence that vitamin D deficiency during adulthood impacts on brain function in a mouse model. If these changes generalize to humans, then this broader program of research could have important public health implications. Vitamin D supplementation is safe and cheap is clearly an attractive candidate for public health intervention."},"children":[{"color":"#336699","name":"A/Pr Thomas Burne","data":{"first_name":"Thomas","title":"A/Pr","dw_individual_id":"DW0023865","middle_name":"Henry Johnston","last_name":"Burne","source_individual_id":"5013713","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thomas Burne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83125","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75821","size":1},{"color":"#FF4D4D","name":"Design and evaluation of inhibitors targeting serine proteases in blood to alleviate systemic inflammatory response to coronary artery bypass graft surgery","data":{"media_summary":"","end_year":2018,"keywords":["biochemistry","computational chemistry","cardiovascular disease","drug design","enzyme inhibitors"],"nhmrc_grant_id":1069819,"application_year":2013,"health_keywords":["enzymology"],"scientific_title":"Design and evaluation of inhibitors targeting serine proteases in blood to alleviate systemic inflammatory response to coronary artery bypass graft surgery","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Bioinformatics","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Joakim Swedberg","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1069819","simplified_title":"Design of therapeutics to alleviate coronary artery bypass graft surgery complications","sub_type":"Peter Doherty Biomedical ECF","total_budget":"309434.12","source_system":"Over 20,000 Australians undergo bypass surgery each year with a 3% mortality rate linked to complications from the procedure. One such common complication is caused by the bodys immune system being activated when the blood comes in contact with the blood bypass pump machine. This project aims to develop new medicines to block this activation of the immune system during bypass surgery to reduce complications and mortality associated with this procedure."},"children":[{"color":"#336699","name":"Dr Joakim Swedberg","data":{"first_name":"Joakim","title":"Dr","dw_individual_id":"DW0022416","middle_name":"Erik","last_name":"Swedberg","source_individual_id":"5043447","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Joakim Swedberg"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82780","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75809","size":1},{"color":"#FF4D4D","name":"Early development, microRNAs, dendritogenesis and cognition","data":{"media_summary":"","end_year":2016,"keywords":["cognition","cortex","behaviour","psychology","mechanisms"],"nhmrc_grant_id":1069570,"application_year":2013,"start_year":2014,"scientific_title":"Early development, microRNAs, dendritogenesis and cognition","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)","research_area":"Basic Science","for_category":"PSYCHOLOGY","cia_name":"Dr Timothy Bredy","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1069570","simplified_title":"How do factors influencing early brain development affect cognitive capacity across the lifespan?","sub_type":"Standard Project Grant","total_budget":"308605.59","source_system":"Neurodevelopmental disorders are characterised by a marked disruption of learning and memory, which is reflected by structural changes in the brains of affected individuals. However, little is known about the underlying mechanisms of this pathology or whether it is directly related to cognitive deficits across the lifespan. How the brain is wired during early development and its relationship to learning and memory in adulthood will therefore be determined."},"children":[{"color":"#336699","name":"Dr Timothy Bredy","data":{"first_name":"Timothy","title":"Dr","dw_individual_id":"DW0017892","middle_name":"William","last_name":"Bredy","source_individual_id":"5019656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Timothy Bredy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81569","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75799","size":1},{"color":"#FF4D4D","name":"Axonal fusion to promote nerve repair: molecules and mechanisms.","data":{"media_summary":"","end_year":2016,"keywords":["cellular nervous system","molecular biology","signalling pathways","apoptosis","axonal transport"],"nhmrc_grant_id":1068871,"application_year":2013,"start_year":2014,"scientific_title":"Axonal fusion to promote nerve repair: molecules and mechanisms.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Massimo Hilliard","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1068871","simplified_title":"Axonal fusion to promote nerve repair: molecules and mechanisms.","sub_type":"Standard Project Grant","total_budget":"448673.97","source_system":"Nerve injuries are in most cases untreatable, leaving patients with high level of disabilities for the rest of their life.  Understanding the molecular mechanism regulating nerve regeneration is critical to develop new drugs and design innovative therapies.  We discovered molecules that mediates axonal repair by favouring the stitching together of the two separated fragments of an axon.   We aim to study how they functions to possibly exploit a similar mechanism of repair for human injuries."},"children":[{"color":"#336699","name":"Dr Massimo Hilliard","data":{"first_name":"Massimo","title":"Dr","dw_individual_id":"DW0025496","middle_name":"A.","last_name":"Hilliard","source_individual_id":"5015251","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Massimo Hilliard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83566","size":1},{"color":"#336699","name":"Prof Ding Xue","data":{"first_name":"Ding","title":"Prof","dw_individual_id":"5061142","middle_name":"","last_name":"Xue","source_individual_id":"5061142","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ding Xue"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76491","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75760","size":1},{"color":"#FF4D4D","name":"Harnessing endogenous L1-mediated mutagenesis to elucidate new candidate genes for liver cancer","data":{"media_summary":"","end_year":2016,"keywords":["transposons","hepatocellular carcinoma","liver cancer","genomics","sequencing"],"nhmrc_grant_id":1068789,"application_year":2013,"start_year":2014,"scientific_title":"Harnessing endogenous L1-mediated mutagenesis to elucidate new candidate genes for liver cancer","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Genetics","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"A/Pr Geoffrey Faulkner","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1068789","simplified_title":"Mobile DNA reveals new liver cancer risk factor genes","sub_type":"Standard Project Grant","total_budget":"622975.56","source_system":"Retrotransposons are mobile genes that copy-and-paste themselves in our genome. Previously thought to represent junk DNA, retrotransposons are increasingly recognised to play major roles in biology. In a recent publication in Cell, we found that retrotransposons were highly active in some types of liver cancer, mutating key genes required to block tumour formation. In the current study, we will determine in greater depth how, and how often, these genes are involved in other types of liver cancer."},"children":[{"color":"#336699","name":"A/Pr Geoffrey Faulkner","data":{"first_name":"Geoffrey","title":"A/Pr","dw_individual_id":"DW0007208","middle_name":"J","last_name":"Faulkner","source_individual_id":"5014580","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Geoffrey Faulkner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78649","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75756","size":1},{"color":"#FF4D4D","name":"A matter of life and death: defining novel interactions between uropathogenic E. coli and macrophages that influence UTI pathology","data":{"media_summary":"","end_year":2016,"keywords":["Escherichia coli","virulence factors","macrophages","urinary tract infection (UTI)","host/pathogen interaction"],"nhmrc_grant_id":1068593,"application_year":2013,"start_year":2014,"scientific_title":"A matter of life and death: defining novel interactions between uropathogenic E. coli and macrophages that influence UTI pathology","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Mark Schembri","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1068593","simplified_title":"Immune cell involvement in urinary tract infections","sub_type":"Standard Project Grant","total_budget":"632466.21","source_system":"Urinary tract infections (UTI) are one of the most common types of infections in humans. Uropathogenic Escherichia coli (UPEC) are the major microbes causing UTI in humans. This project will define novel interactions between UPEC and macrophages, an important immune cell involved in the control of UTI. The outcomes of this project will be a better understanding of how UPEC causes disease, and potentially new treatment regimes for UTI."},"children":[{"color":"#336699","name":"A/Pr Glen Ulett","data":{"first_name":"Glen","title":"A/Pr","dw_individual_id":"DW0045957","middle_name":"C","last_name":"Ulett","source_individual_id":"RMIS495516","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Glen Ulett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88899","size":1},{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1},{"color":"#336699","name":"Prof Mark Schembri","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0016088","middle_name":"A","last_name":"Schembri","source_individual_id":"5017368","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Schembri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81054","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75748","size":1},{"color":"#FF4D4D","name":"Using high-throughput genomics to reveal the deleterious genetic changes that underlie paediatric leukoencephalopathies","data":{"media_summary":"","end_year":2016,"keywords":["genomics","inherited","neurodegenerative disorders","medical genomics","glia"],"nhmrc_grant_id":1068278,"application_year":2013,"start_year":2014,"scientific_title":"Using high-throughput genomics to reveal the deleterious genetic changes that underlie paediatric leukoencephalopathies","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genomics","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Ryan Taft","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1068278","simplified_title":"Using genome sequencing to understand rare inherited childhood brain disorders","sub_type":"Standard Project Grant","total_budget":"988038.9","source_system":"There has been an explosion of high-throughput DNA sequencing technologies in the past five years, which have the potential to completely revolutionise medicine and scientific research. Here we present a series of studies showing the successful application of this technology to children with genetic disorders of the central nervous system. This proposal seeks to expand this study to a large cohort of similarly affected paediatric patients."},"children":[{"color":"#336699","name":"Dr Benjamin Hogan","data":{"first_name":"Benjamin","title":"Dr","dw_individual_id":"DW0043083","middle_name":"M","last_name":"Hogan","source_individual_id":"5015278","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Benjamin Hogan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88165","size":1},{"color":"#336699","name":"Dr Adeline Vanderver","data":{"first_name":"Adeline","title":"Dr","dw_individual_id":"DW0034444","middle_name":"","last_name":"Vanderver","source_individual_id":"5044152","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Adeline Vanderver"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85915","size":1},{"color":"#336699","name":"Dr Richard Leventer","data":{"first_name":"Richard","title":"Dr","dw_individual_id":"DW0032062","middle_name":"Jack","last_name":"Leventer","source_individual_id":"5024074","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Richard Leventer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85295","size":1},{"color":"#336699","name":"Dr Ryan Taft","data":{"first_name":"Ryan","title":"Dr","dw_individual_id":"DW0004931","middle_name":"James","last_name":"Taft","source_individual_id":"5040954","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ryan Taft"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78032","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75735","size":1},{"color":"#FF4D4D","name":"Neurogenesis in the amygdala and hippocampus: a role in learnt fear?","data":{"media_summary":"","end_year":2017,"keywords":["stem cell biology","neuronal development","neuronal plasticity","synapse","learning"],"nhmrc_grant_id":1068227,"application_year":2013,"start_year":2014,"scientific_title":"Neurogenesis in the amygdala and hippocampus: a role in learnt fear?","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Pankaj Sah","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1068227","simplified_title":"Neurogenesis in the amygdala and hippocampus","sub_type":"Standard Project Grant","total_budget":"761928.28","source_system":"It has long been thought that neurons are only born once and then slowly die. Learning and memory formation is thought to occur by changes in the strength of connections between living neurons. However, the hippocampus is now known to produce new neurons throughout life. We have found that neurons are also born in the adult amygdala. In this project we will study how neurogenesis affects learning and memory formation that involve the hippocampus and amygdala."},"children":[{"color":"#336699","name":"Prof Pankaj Sah","data":{"first_name":"Pankaj","title":"Prof","dw_individual_id":"DW0033583","middle_name":"","last_name":"Sah","source_individual_id":"5017304","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Pankaj Sah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85693","size":1},{"color":"#336699","name":"Prof Perry Bartlett","data":{"first_name":"Perry","title":"Prof","dw_individual_id":"DW0011651","middle_name":"Francis","last_name":"Bartlett","source_individual_id":"5013357","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Perry Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79864","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75734","size":1},{"color":"#FF4D4D","name":"A three-tiered strategy to prevent destabilisation of the induced pluripotent stem cell genome by L1 retrotransposition","data":{"media_summary":"","end_year":2016,"keywords":["stem cell biology","sequencing","transposons","epigenetics","genomics"],"nhmrc_grant_id":1067983,"application_year":2013,"start_year":2014,"scientific_title":"A three-tiered strategy to prevent destabilisation of the induced pluripotent stem cell genome by L1 retrotransposition","node_source":"NHMRC","node_type":"Grant","field_of_research":"Regenerative Medicine (incl. Stem Cells and Tissue Engineering)","research_area":"Basic Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"A/Pr Geoffrey Faulkner","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1067983","simplified_title":"Blocking mobile DNA activity in induced pluripotent stem cells","sub_type":"Standard Project Grant","total_budget":"697031.46","source_system":"Retrotransposons are mobile genes that copy-and-paste themselves in our genome. Previously thought to represent junk DNA, retrotransposons are increasingly recognised to play major roles in biology. In recent publications in Cell and Nature, we found that retrotransposons move in mature human cells. In the current study, we will determine whether the same activity occurs when these cells are reprogrammed to become stem cells, possibly impacting stem cell based therapies."},"children":[{"color":"#336699","name":"Prof Ryan Lister","data":{"first_name":"Ryan","title":"Prof","dw_individual_id":"DW0043828","middle_name":"","last_name":"Lister","source_individual_id":"5045661","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ryan Lister"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88359","size":1},{"color":"#336699","name":"A/Pr Geoffrey Faulkner","data":{"first_name":"Geoffrey","title":"A/Pr","dw_individual_id":"DW0007208","middle_name":"J","last_name":"Faulkner","source_individual_id":"5014580","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Geoffrey Faulkner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78649","size":1},{"color":"#336699","name":"Dr Kyle Upton","data":{"first_name":"Kyle","title":"Dr","dw_individual_id":"DW0005162","middle_name":"Ross","last_name":"Upton","source_individual_id":"5043461","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kyle Upton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78104","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75725","size":1},{"color":"#FF4D4D","name":"Developing subtype-selective blockers of acid-sensing ion channels for treating peripheral pain","data":{"media_summary":"","end_year":2016,"keywords":["ion channels","drug discovery","peptides","electrophysiology","pain"],"nhmrc_grant_id":1067940,"application_year":2013,"health_keywords":["pain mechanisms","pharmacokinetics"],"scientific_title":"Developing subtype-selective blockers of acid-sensing ion channels for treating peripheral pain","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Dr Lachlan Rash","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1067940","simplified_title":"ASICs in peripheral pain","sub_type":"Standard Project Grant","total_budget":"630428.13","source_system":"Chronic pain is a huge medical problem that affects 1 in 5 adults. There are few drugs available for treating chronic pain, and many of these have limited efficacy and dose-limiting side-effects. Acid-sensing ion channels are proteins that play an essential role in the specialised nerves that sense pain signals.  The ultimate goal of this project is to engineer highly selective blockers of these channels that can be used to develop effective analgesics for treating patients with chronic pain."},"children":[{"color":"#336699","name":"Dr Lachlan Rash","data":{"first_name":"Lachlan","title":"Dr","dw_individual_id":"DW0027509","middle_name":"D","last_name":"Rash","source_individual_id":"RMIS1373336","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Lachlan Rash"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84101","size":1},{"color":"#336699","name":"Prof Maree Smith","data":{"first_name":"Maree","title":"Prof","dw_individual_id":"DW0022204","middle_name":"T","last_name":"Smith","source_individual_id":"5011570","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Maree Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82728","size":1},{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75724","size":1},{"color":"#FF4D4D","name":"Stimulation of neurogenesis by growth hormone to improve cognition in an aged animal model of dementia","data":{"media_summary":"","end_year":2016,"keywords":["neurogenesis","hippocampus","cognition","growth hormone","dementia"],"nhmrc_grant_id":1067909,"application_year":2013,"health_keywords":["stem cells","old age"],"scientific_title":"Stimulation of neurogenesis by growth hormone to improve cognition in an aged animal model of dementia","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Perry Bartlett","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1067909","simplified_title":"Growth hormone ameliorates ageing dementia","sub_type":"Standard Project Grant","total_budget":"541753.86","source_system":"Production of new neurons in the hippocampus of adult animals plays a role in regulating learning and memory, and this production slows continuously with increasing age. Here we explore ways to activate dormant populations of neurogenic precursor cells in the hippocampus to produce new neurons. Since the precursor cells are still present in the hippocampus of an aged animal these studies will provide unequivocal evidence for their importance in reversing age-related cognitive decline and dementia."},"children":[{"color":"#336699","name":"Dr Daniel Blackmore","data":{"first_name":"Daniel","title":"Dr","dw_individual_id":"DW0017768","middle_name":"G","last_name":"Blackmore","source_individual_id":"5029929","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Daniel Blackmore"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81540","size":1},{"color":"#336699","name":"Prof Perry Bartlett","data":{"first_name":"Perry","title":"Prof","dw_individual_id":"DW0011651","middle_name":"Francis","last_name":"Bartlett","source_individual_id":"5013357","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Perry Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79864","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75723","size":1},{"color":"#FF4D4D","name":"Discovery of novel heart failure therapeutics via development of a next generation therapeutic screening platform: Force-generating human heart tissue micro-arrays","data":{"media_summary":"","end_year":2016,"keywords":["cardiac disease","tissue engineering","drug discovery","disease modelling","stem cells"],"nhmrc_grant_id":1067869,"application_year":2013,"start_year":2014,"scientific_title":"Discovery of novel heart failure therapeutics via development of a next generation therapeutic screening platform: Force-generating human heart tissue micro-arrays","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biotechnology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"Dr James Hudson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1067869","simplified_title":"Discovery of new heart failure therapeutics using human heart micro-tissues","sub_type":"New Investigator Grant","total_budget":"456070.59","source_system":"In this project we will develop a micro scale platform containing 384 miniature human heart muscle strips. The technology we develop will enable us to determine the strength of the contraction of each strip which is a model of heart function. This provides us a platform to better understand heart disease and also to screen for new drugs for heart failure."},"children":[{"color":"#336699","name":"Dr James Hudson","data":{"first_name":"James","title":"Dr","dw_individual_id":"DW0037401","middle_name":"Edward","last_name":"Hudson","source_individual_id":"5026922","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr James Hudson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86691","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75721","size":1},{"color":"#FF4D4D","name":"Genetic analysis of de novo and inherited exome variation in schizophrenia","data":{"media_summary":"","end_year":2016,"keywords":["DNA sequencing","genetic analysis","genetic variation","schizophrenia","de novo mutations"],"nhmrc_grant_id":1067795,"application_year":2013,"start_year":2014,"scientific_title":"Genetic analysis of de novo and inherited exome variation in schizophrenia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Quantitative Genetics (incl. Disease and Trait Mapping Genetics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Bryan Mowry","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1067795","simplified_title":"Genetic analysis of de novo and inherited protein-coding sequence variation in schizophrenia","sub_type":"Standard Project Grant","total_budget":"1341591.83","source_system":"Schizophrenia (SCZ) is a severe mental disorder affecting ~1% of the worlds population. The majority of risk is explained by genetic factors, and thus identifying susceptibility genes may lead to the development of novel therapeutics and personalised treatments. We will join forces with international collaborators to perform the largest DNA sequencing analysis of de novo and inherited protein-coding sequence variation in SCZ to date. We aim to identify key risk genes and genetic pathways."},"children":[{"color":"#336699","name":"Prof Bryan Mowry","data":{"first_name":"Bryan","title":"Prof","dw_individual_id":"DW0044411","middle_name":"J","last_name":"Mowry","source_individual_id":"5016586","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bryan Mowry"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88510","size":1},{"color":"#336699","name":"Dr Rangaswamy Thara","data":{"first_name":"Rangaswamy","title":"Dr","dw_individual_id":"DW0039243","middle_name":"","last_name":"Thara","source_individual_id":"5039188","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Rangaswamy Thara"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87172","size":1},{"color":"#336699","name":"Dr Jacob Gratten","data":{"first_name":"Jacob","title":"Dr","dw_individual_id":"DW0036941","middle_name":"","last_name":"Gratten","source_individual_id":"5025682","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jacob Gratten"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86564","size":1},{"color":"#336699","name":"Prof Peter Visscher","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0005222","middle_name":"M","last_name":"Visscher","source_individual_id":"5018104","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Visscher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78118","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75717","size":1},{"color":"#FF4D4D","name":"Understanding the role of TDP-43 in motor neuron disease.","data":{"media_summary":"","end_year":2016,"keywords":["cellular nervous system","axonal transport","signalling pathways","molecular biology","motor neuron disease (MND)"],"nhmrc_grant_id":1067461,"application_year":2013,"start_year":2014,"scientific_title":"Understanding the role of TDP-43 in motor neuron disease.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Massimo Hilliard","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1067461","simplified_title":"Understanding the role of TDP-43 in motor neuron disease.","sub_type":"Standard Project Grant","total_budget":"643315.56","source_system":"Motor neuron disease (MND) is a fatal neurodegenerative disease with no cure. The cause of MND is poorly understood but new research has shown that defects in TDP-43, an RNA binding protein involved in gene regulation, can lead to the disease. This project is aimed at discovering the molecular mechanisms of TDP-43 function, which will improve the understanding of the disease and aid in the development of new therapies."},"children":[{"color":"#336699","name":"A/Pr Peter Noakes","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0038807","middle_name":"G","last_name":"Noakes","source_individual_id":"5016732","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Noakes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87053","size":1},{"color":"#336699","name":"Dr Massimo Hilliard","data":{"first_name":"Massimo","title":"Dr","dw_individual_id":"DW0025496","middle_name":"A.","last_name":"Hilliard","source_individual_id":"5015251","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Massimo Hilliard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83566","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75700","size":1},{"color":"#FF4D4D","name":"Functional and genomic analysis of the globally disseminated multidrug resistant Escherichia coli ST131 clone","data":{"media_summary":"","end_year":2017,"keywords":["Escherichia coli","functional genomics","bacterial pathogenesis","antibiotic resistance","bacterial virulence factors"],"nhmrc_grant_id":1067455,"application_year":2013,"health_keywords":["urinary tract infection (UTI)"],"scientific_title":"Functional and genomic analysis of the globally disseminated multidrug resistant Escherichia coli ST131 clone","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Mark Schembri","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1067455","simplified_title":"Functional and genomic analysis of E. coli that cause urinary tract infection","sub_type":"Standard Project Grant","total_budget":"806538.97","source_system":"Uropathogenic Escherichia coli (UPEC) is a major cause of urinary tract infections (UTI) and sepsis. Recently, a highly virulent clone of UPEC (E. coli ST131) that is resistant to multiple types of antibiotics has emerged and spread worldwide. This project uses genomic and high-throughput functional analysis methods to understand E. coli ST131 virulence and resistance. The outcomes of the work will be a better understanding of how E. coli ST131 causes disease, and potentially new treatment regimes for UTI."},"children":[{"color":"#336699","name":"Dr Scott Beatson","data":{"first_name":"Scott","title":"Dr","dw_individual_id":"DW0035306","middle_name":"A","last_name":"Beatson","source_individual_id":"5013405","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Scott Beatson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86151","size":1},{"color":"#336699","name":"Prof Mark Schembri","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0016088","middle_name":"A","last_name":"Schembri","source_individual_id":"5017368","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Schembri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81054","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75699","size":1},{"color":"#FF4D4D","name":"(Dys)Regulating junctional tension: a novel mechanism in tumor cell biology","data":{"media_summary":"","end_year":2016,"keywords":["E-cadherin","actin cytoskeleton","myosin","cancer metastasis","cancer cell biology"],"nhmrc_grant_id":1067405,"application_year":2013,"start_year":2014,"scientific_title":"(Dys)Regulating junctional tension: a novel mechanism in tumor cell biology","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Alpha Yap","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1067405","simplified_title":"Cell-cell junction tension and tumor development","sub_type":"Standard Project Grant","total_budget":"720325.86","source_system":"This project will study how cancer cells are forced out of their original tissue of origin. This process, called oncogenic extrusion, is important to allow cancer cells to proliferate and invade their surrounding tissue. We have discovered a new cellular mechanism that causes oncogenic extrusion and aim to understand its molecular basis and test how it contributes to breast cancer."},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1},{"color":"#336699","name":"Dr Peter Simpson","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0033829","middle_name":"T","last_name":"Simpson","source_individual_id":"5017520","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Peter Simpson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85762","size":1},{"color":"#336699","name":"Dr Zoltan Neufeld","data":{"first_name":"Zoltan","title":"Dr","dw_individual_id":"5052177","middle_name":"","last_name":"Neufeld","source_individual_id":"5052177","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Zoltan Neufeld"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76429","size":1},{"color":"#336699","name":"Dr Guillermo Gomez","data":{"first_name":"Guillermo","title":"Dr","dw_individual_id":"5048164","middle_name":"Alberto","last_name":"Gomez","source_individual_id":"5048164","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Guillermo Gomez"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76323","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75697","size":1},{"color":"#FF4D4D","name":"My Baby's Movements: A stepped wedged cluster randomised trial of maternal awareness and reporting of decreased fetal movements to reduce stillbirth","data":{"media_summary":"","end_year":2018,"keywords":["stillbirth","antenatal care","consumer information","preventive health","perinatal"],"nhmrc_grant_id":1067363,"application_year":2013,"health_keywords":["education"],"scientific_title":"My Baby's Movements: A stepped wedged cluster randomised trial of maternal awareness and reporting of decreased fetal movements to reduce stillbirth","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Obstetrics and Gynaecology","research_area":"Health Services Research","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"A/Pr Vicki Flenady","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1067363","simplified_title":"My Baby's Movements","sub_type":"Standard Project Grant","total_budget":"1387466.66","source_system":"Stillbirth is devastating for parents and families. Many stillbirths occur late in pregnancy due to deteriorating health of the baby that can be detected by the mother through a decrease in the babys movements. 'My Baby's Movements is a personalised, user-controlled and interactive mobile phone tool provided as part of routine care to pregnant women to promote general awareness of their babys movements. This trial aims to reduce stillbirth rates by early reporting of decreased movements."},"children":[{"color":"#336699","name":"A/Pr Vicki Flenady","data":{"first_name":"Vicki","title":"A/Pr","dw_individual_id":"DW0042411","middle_name":"Jane","last_name":"Flenady","source_individual_id":"RMIS226011","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Vicki Flenady"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87999","size":1},{"color":"#336699","name":"Prof David Ellwood","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0042261","middle_name":"Alan","last_name":"Ellwood","source_individual_id":"5012080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Ellwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87968","size":1},{"color":"#336699","name":"Dr Glenn Gardener","data":{"first_name":"Glenn","title":"Dr","dw_individual_id":"DW0036771","middle_name":"James","last_name":"Gardener","source_individual_id":"5040156","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Glenn Gardener"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86525","size":1},{"color":"#336699","name":"Ms Philippa Middleton","data":{"first_name":"Philippa","title":"Ms","dw_individual_id":"DW0032597","middle_name":"Fairfax","last_name":"Middleton","source_individual_id":"5012007","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Philippa Middleton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85441","size":1},{"color":"#336699","name":"Prof Jane Norman","data":{"first_name":"Jane","title":"Prof","dw_individual_id":"DW0021175","middle_name":"E","last_name":"Norman","source_individual_id":"5016719","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jane Norman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82426","size":1},{"color":"#336699","name":"Prof Caroline Crowther","data":{"first_name":"Caroline","title":"Prof","dw_individual_id":"DW0018491","middle_name":"Anne","last_name":"Crowther","source_individual_id":"RMIS4107","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Caroline Crowther"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81738","size":1},{"color":"#336699","name":"Prof Christine East","data":{"first_name":"Christine","title":"Prof","dw_individual_id":"DW0012848","middle_name":"Elizabeth","last_name":"East","source_individual_id":"5014470","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Christine East"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80181","size":1},{"color":"#336699","name":"A/Pr Frances Boyle","data":{"first_name":"Frances","title":"A/Pr","dw_individual_id":"DW0011942","middle_name":"Mary","last_name":"Boyle","source_individual_id":"5013593","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Frances Boyle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79938","size":1},{"color":"#336699","name":"A/Pr Michael Coory","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0006712","middle_name":"","last_name":"Coory","source_individual_id":"5012694","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Michael Coory"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78520","size":1},{"color":"#336699","name":"Dr Emily Callander","data":{"first_name":"Emily","title":"Dr","dw_individual_id":"DW0000690","middle_name":"Joy","last_name":"Callander","source_individual_id":"5030659","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Emily Callander"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76854","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75695","size":1},{"color":"#FF4D4D","name":"The dengue virus glycoprotein NS1 binds cholesterol and mediates cellular activation","data":{"media_summary":"","end_year":2016,"keywords":["dengue virus","cell activation","cholesterol","cytokine production","secretory pathway"],"nhmrc_grant_id":1067226,"application_year":2013,"start_year":2014,"scientific_title":"The dengue virus glycoprotein NS1 binds cholesterol and mediates cellular activation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Paul Young","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1067226","simplified_title":"Understanding the basis of disease caused by dengue viruses","sub_type":"Standard Project Grant","total_budget":"621616.83","source_system":"Cholesterol has been shown to play a vital role in the life cycle of many viruses. This project will investigate the basis of dengue virus interaction with this important host molecule and along with investigations of how dengue is able to stimulate host cells, will provide new insights into the way these viruses cause severe disease. Findings from this study will also aid in the development of new drug strategies for dengue and related viruses such as West Nile virus."},"children":[{"color":"#336699","name":"A/Pr Jason Mackenzie","data":{"first_name":"Jason","title":"A/Pr","dw_individual_id":"DW0038214","middle_name":"M","last_name":"Mackenzie","source_individual_id":"RMIS56171","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jason Mackenzie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86904","size":1},{"color":"#336699","name":"Dr Katryn Stacey","data":{"first_name":"Katryn","title":"Dr","dw_individual_id":"DW0028117","middle_name":"Jane","last_name":"Stacey","source_individual_id":"5017656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katryn Stacey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84258","size":1},{"color":"#336699","name":"Prof Paul Young","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0005625","middle_name":"R","last_name":"Young","source_individual_id":"RMIS20614","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78234","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75683","size":1},{"color":"#FF4D4D","name":"Models of Cerebellar Function During Motor Learning","data":{"media_summary":"","end_year":2016,"keywords":["zebrafish","biotechnology","neurobiology","motor learning","behaviour"],"nhmrc_grant_id":1066887,"application_year":2013,"health_keywords":["transgenesis"],"scientific_title":"Models of Cerebellar Function During Motor Learning","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Ethan Scott","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1066887","simplified_title":"The Cerebellum and Motor Learning in Zebrafish","sub_type":"Standard Project Grant","total_budget":"378436.89","source_system":"The cerebellum is responsible for smooth movements and for learning new patterns of motions, but many details of how it works are unclear. We aim to describe neural activity in the cerebellum while motor learning is in progress, and determine exactly what patterns of activity lead to the acquisition of new types of learned movement. The basic knowledge gained will contribute to a better understanding of cerebellar disorders including nystagmus, ataxia, and loss of motor control with ageing."},"children":[{"color":"#336699","name":"Dr Ethan Scott","data":{"first_name":"Ethan","title":"Dr","dw_individual_id":"DW0027841","middle_name":"Kime","last_name":"Scott","source_individual_id":"5017408","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ethan Scott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84182","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75658","size":1},{"color":"#FF4D4D","name":"Modulation of feeding through pharmacological targeting of the relaxin-3 receptor RXFP3","data":{"media_summary":"","end_year":2016,"keywords":["peptides","pharmacology","drug design","obesity","mental health"],"nhmrc_grant_id":1066369,"application_year":2013,"start_year":2014,"scientific_title":"Modulation of feeding through pharmacological targeting of the relaxin-3 receptor RXFP3","node_source":"NHMRC","node_type":"Grant","field_of_research":"Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Dr Karl Johan Rosengren","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1066369","simplified_title":"Novel peptide modulators for the pharmacological manipulation of feeding","sub_type":"Standard Project Grant","total_budget":"575947.45","source_system":"Relaxin-3 is a neuropeptide that regulates a number of physiological processes, including food intake, suggesting that the relaxin-3 receptor RXFP3 may be a new target for treatment of eating disorders such as obesity. This project will develop new selective and high-affinity ligands for RXFP3, which will be critical pharmacological tools for the preclinical studies and evaluation of this system."},"children":[{"color":"#336699","name":"A/Pr Andrew Gundlach","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0042783","middle_name":"L","last_name":"Gundlach","source_individual_id":"5014995","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Andrew Gundlach"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88088","size":1},{"color":"#336699","name":"A/Pr Ross Bathgate","data":{"first_name":"Ross","title":"A/Pr","dw_individual_id":"DW0035287","middle_name":"Ad","last_name":"Bathgate","source_individual_id":"RMIS676878","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Ross Bathgate"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86144","size":1},{"color":"#336699","name":"Dr Karl Johan Rosengren","data":{"first_name":"Karl Johan","title":"Dr","dw_individual_id":"DW0027687","middle_name":"","last_name":"Rosengren","source_individual_id":"5019233","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Karl Johan Rosengren"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84148","size":1},{"color":"#336699","name":"Dr Joseph Nicolazzo","data":{"first_name":"Joseph","title":"Dr","dw_individual_id":"DW0003678","middle_name":"Anthony","last_name":"Nicolazzo","source_individual_id":"5016715","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Joseph Nicolazzo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77683","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75627","size":1},{"color":"#FF4D4D","name":"Molecular dissection of the Munc18c:Syntaxin4 complex required for insulin-regulated exocytosis in adipocytes","data":{"media_summary":"","end_year":2016,"keywords":["vesicle trafficking","membrane trafficking","exocytosis","protein complexes","conformational change"],"nhmrc_grant_id":1066069,"application_year":2013,"start_year":2014,"scientific_title":"Molecular dissection of the Munc18c:Syntaxin4 complex required for insulin-regulated exocytosis in adipocytes","node_source":"NHMRC","node_type":"Grant","field_of_research":"Structural Biology (incl. Macromolecular Modelling)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Martin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1066069","simplified_title":"How fat cells regulate blood glucose uptake","sub_type":"Standard Project Grant","total_budget":"591106.83","source_system":"When blood glucose levels are high, insulin signals to fat and muscle cells to remove glucose from the blood. The uptake of glucose relies on membrane fusion events that deliver a specific glucose transporter protein to the cell surface in response to insulin signals. This process is affected in Type II diabetes. Our research will characterise the regulation of these membrane fusion events and will be important for understanding how insulin signals are communicated in health and disease."},"children":[{"color":"#336699","name":"Dr Andrew Whitten","data":{"first_name":"Andrew","title":"Dr","dw_individual_id":"DW0034688","middle_name":"Edward","last_name":"Whitten","source_individual_id":"5028246","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Andrew Whitten"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85984","size":1},{"color":"#336699","name":"Prof Jennifer Martin","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0008922","middle_name":"Louise","last_name":"Martin","source_individual_id":"5022915","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jennifer Martin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79117","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75611","size":1},{"color":"#FF4D4D","name":"The role of neuronal hyperactivity and neurotrophic factor signalling in synaptogenesis, dendrogenesis and neuron death in motor neuron disease","data":{"media_summary":"","end_year":2016,"keywords":["motor neuron disease (MND)","neurophysiology","neurotrophic factors","synaptic plasticity","Trk B"],"nhmrc_grant_id":1065884,"application_year":2013,"health_keywords":["ephrin"],"scientific_title":"The role of neuronal hyperactivity and neurotrophic factor signalling in synaptogenesis, dendrogenesis and neuron death in motor neuron disease","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Mark Bellingham","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1065884","simplified_title":"Neuronal hyperactivity and neurotrophic factors in motor neuron disease","sub_type":"Standard Project Grant","total_budget":"689135.48","source_system":"Using mice with mutant genes causing amyotrophic lateral sclerosis, we will test whether motor neuron hyper-excitability during early development causes excessive synapse and dendrite formation, ultimately leading to neuronal death. We will also test whether activity-dependent secretion of neurotrophic factors and activation of their receptors plays a role in this disease. This will show whether neuronal hyper-activity and neurotrophic factor signaling plays a causal role in this disease."},"children":[{"color":"#336699","name":"A/Pr Peter Noakes","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0038807","middle_name":"G","last_name":"Noakes","source_individual_id":"5016732","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Noakes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87053","size":1},{"color":"#336699","name":"Dr Mark Bellingham","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0035336","middle_name":"C","last_name":"Bellingham","source_individual_id":"5013441","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mark Bellingham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86159","size":1},{"color":"#336699","name":"A/Pr Ann Turnley","data":{"first_name":"Ann","title":"A/Pr","dw_individual_id":"DW0016752","middle_name":"M","last_name":"Turnley","source_individual_id":"5019345","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ann Turnley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81253","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75596","size":1},{"color":"#FF4D4D","name":"Influence of skin cancer on topical elongate microparticle drug delivery","data":{"media_summary":"","end_year":2016,"keywords":["topical drug delivery","non-melanoma skin cancer","melanoma","drug delivery","transdermal"],"nhmrc_grant_id":1065802,"application_year":2013,"start_year":2014,"scientific_title":"Influence of skin cancer on topical elongate microparticle drug delivery","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Tarl Prow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1065802","simplified_title":"Influence of skin cancer on microparticle drug delivery through the skin","sub_type":"Standard Project Grant","total_budget":"551785.56","source_system":"This project builds on a novel cutaneous delivery method using rod-shaped microparticles we developed in the Dermatology Research Centre. Microparticle administration results in multiple punctures of the skins tough outer layers, increasing permeability. Furthermore, microparticle administration results in a uniform and continuous drug delivery profile within the treatment area, which is an important attribute for the treatment of skin diseases."},"children":[{"color":"#336699","name":"Dr Tarl Prow","data":{"first_name":"Tarl","title":"Dr","dw_individual_id":"DW0039189","middle_name":"","last_name":"Prow","source_individual_id":"5020354","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Tarl Prow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87159","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75591","size":1},{"color":"#FF4D4D","name":"Discovering deep sleep genes and determining their roles for preserving cognitive functions","data":{"media_summary":"","end_year":2016,"keywords":["Drosophila melanogaster","sleep disorders","gene expression","behaviour genetics","cognitive disorders"],"nhmrc_grant_id":1065713,"application_year":2013,"start_year":2014,"scientific_title":"Discovering deep sleep genes and determining their roles for preserving cognitive functions","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Bruno van Swinderen","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1065713","simplified_title":"Discovering deep sleep genes","sub_type":"Standard Project Grant","total_budget":"477145.89","source_system":"Our mental well-being is largely tied to our sleep quality, and most cognitive disorders are also associated with poor sleep processes. Yet, we still do not know how sleep quality safeguards cognitive function. We will uncover genes that play a restorative role during deep sleep, and determine how genetic control of these deep sleep genes modulates selective attention in an animal model. Our results will suggest novel therapies for treating sleep disorders and associated diseases of the brain."},"children":[{"color":"#336699","name":"Dr Enda Byrne","data":{"first_name":"Enda","title":"Dr","dw_individual_id":"DW0012128","middle_name":"Martin","last_name":"Byrne","source_individual_id":"5039577","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Enda Byrne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79977","size":1},{"color":"#336699","name":"A/Pr Bruno Van Swinderen","data":{"first_name":"Bruno","title":"A/Pr","dw_individual_id":"DW0010802","middle_name":"","last_name":"Van Swinderen","source_individual_id":"5020276","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Bruno Van Swinderen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79638","size":1},{"color":"#336699","name":"Dr Qiongyi Zhao","data":{"first_name":"Qiongyi","title":"Dr","dw_individual_id":"5055137","middle_name":"","last_name":"Zhao","source_individual_id":"5055137","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Qiongyi Zhao"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76456","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75584","size":1},{"color":"#FF4D4D","name":"Interactions between host and the gut microbiome in the pathogenesis of ankylosing spondylitis and Crohn's disease","data":{"media_summary":"","end_year":2016,"keywords":["spondyloarthropathy","Crohn's disease","mucosal immunity","sequencing","enteric bacteria"],"nhmrc_grant_id":1065509,"application_year":2013,"start_year":2014,"scientific_title":"Interactions between host and the gut microbiome in the pathogenesis of ankylosing spondylitis and Crohn's disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Matthew Brown","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1065509","simplified_title":"The gut microbiome in ankylosing spondylitis and Crohn's disease","sub_type":"Standard Project Grant","total_budget":"557476.68","source_system":"Ankylosing spondylitis (AS) and Crohn's disease (CD) are common immune-mediated diseases affecting primarily the joints of the spine and the gut respectively.  Genes play a major role in determining the risk of each disease, and it is likely that those genes cause the disease by interaction with some environmental factor, most likely bacteria residing in the gut.  This study aims to test that hypothesis by profiling the bacteria in the gut of patients with the diseases and healthy subjects."},"children":[{"color":"#336699","name":"Prof Mark Morrison","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0044387","middle_name":"","last_name":"Morrison","source_individual_id":"5020653","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Morrison"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88502","size":1},{"color":"#336699","name":"Prof Matthew Brown","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0012026","middle_name":"A","last_name":"Brown","source_individual_id":"5012217","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79951","size":1},{"color":"#336699","name":"A/Pr Graham Radford-Smith","data":{"first_name":"Graham","title":"A/Pr","dw_individual_id":"DW0004114","middle_name":"Lindsay","last_name":"Radford-Smith","source_individual_id":"5017093","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Graham Radford-Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77816","size":1},{"color":"#336699","name":"Dr Francesco Ciccia","data":{"first_name":"Francesco","title":"Dr","dw_individual_id":"5061113","middle_name":"","last_name":"Ciccia","source_individual_id":"5061113","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Francesco Ciccia"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76488","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75571","size":1},{"color":"#FF4D4D","name":"Defining the role of zinc in human macrophage responses to Salmonella","data":{"media_summary":"gene function","end_year":2016,"keywords":["Salmonella typhimurium","bacterial pathogen","macrophages","Toll-like receptors","zinc supplementation"],"nhmrc_grant_id":1065391,"application_year":2013,"health_keywords":["ion transport","bacterial gastroenteritis","zinc deficiency","gene expression","gene function"],"scientific_title":"Defining the role of zinc in human macrophage responses to Salmonella","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Innate Immunity","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"A/Pr Matthew Sweet","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1065391","simplified_title":"How zinc regulates the immune system","sub_type":"Standard Project Grant","total_budget":"582295.56","source_system":"It is estimated that one third of the worlds population is affected by mild to moderate zinc deficiency, and that this predisposes to a range of infectious diseases. The immunomodulatory effects of zinc have been appreciated for many years, and indeed zinc supplementation is used to treat severe diarrhoeal diseases. This project aims to understand the anti-infective mechanisms of zinc by focusing on macrophages, a key cell type involved in killing invading microorganisms."},"children":[{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75557","size":1},{"color":"#FF4D4D","name":"Risk Stratification of Older People in Hospital: Validation and Influence on Clinical Decision Making","data":{"media_summary":"","end_year":2016,"keywords":["frailty","geriatric assessment","acute care","measurement","validation"],"nhmrc_grant_id":1065352,"application_year":2013,"start_year":2014,"scientific_title":"Risk Stratification of Older People in Hospital: Validation and Influence on Clinical Decision Making","node_source":"NHMRC","node_type":"Grant","field_of_research":"Geriatrics and Gerontology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Ruth Hubbard","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1065352","simplified_title":"Stratification of Risk for Older People in Hospital","sub_type":"Standard Project Grant","total_budget":"287314.7","source_system":"Older people in hospital are at high risk of adverse outcomes, a vulnerability commonly referred to as frailty. In community-dwelling older people, frailty status can be measured precisely with a Frailty Index score. This research aims to develop a Frailty Index from a standardised comprehensive geriatric assessment instrument used in the routine care of many patients in hospital. This would assist clinicians to identify vulnerable older inpatients, improving their care in the acute setting."},"children":[{"color":"#336699","name":"Dr Ruth Hubbard","data":{"first_name":"Ruth","title":"Dr","dw_individual_id":"DW0037399","middle_name":"Eleanor","last_name":"Hubbard","source_individual_id":"5042577","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ruth Hubbard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86690","size":1},{"color":"#336699","name":"Prof Len Gray","data":{"first_name":"Len","title":"Prof","dw_individual_id":"DW0007585","middle_name":"Charles","last_name":"Gray","source_individual_id":"5012147","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Len Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78747","size":1},{"color":"#336699","name":"Dr Nancye Peel","data":{"first_name":"Nancye","title":"Dr","dw_individual_id":"DW0003910","middle_name":"M","last_name":"Peel","source_individual_id":"5016909","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nancye Peel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77759","size":1},{"color":"#336699","name":"Prof Arnold Mitnitski","data":{"first_name":"Arnold","title":"Prof","dw_individual_id":"5052118","middle_name":"","last_name":"Mitnitski","source_individual_id":"5052118","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Arnold Mitnitski"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76425","size":1},{"color":"#336699","name":"Prof Kenneth Rockwood","data":{"first_name":"Kenneth","title":"Prof","dw_individual_id":"5049156","middle_name":"John","last_name":"Rockwood","source_individual_id":"5049156","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Kenneth Rockwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76345","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75556","size":1},{"color":"#FF4D4D","name":"Microbial evasion of a novel inflammasome by Salmonella","data":{"media_summary":"","end_year":2016,"keywords":["pattern recognition","signalling pathways","innate immunity","caspases","cytokine production"],"nhmrc_grant_id":1064945,"application_year":2013,"health_keywords":["virulence factors","Salmonella typhimurium","bacterial pathogenicity"],"scientific_title":"Microbial evasion of a novel inflammasome by Salmonella","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Innate Immunity","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Kate Schroder","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1064945","simplified_title":"Mechanisms of immune subversion by Salmonella","sub_type":"Standard Project Grant","total_budget":"478164.93","source_system":"Microbes quickly evolve to evade detection by the innate immune system, the bodys first line of defence against infection. This project investigates the mechanisms by which the immune system recognises bacterial infection, and pathways used by bacteria to avoid these defences. This research will lead to a better understanding of mechanisms underlying resistance and susceptibility to bacterial infection."},"children":[{"color":"#336699","name":"Dr Kate Schroder","data":{"first_name":"Kate","title":"Dr","dw_individual_id":"DW0039577","middle_name":"","last_name":"Schroder","source_individual_id":"5017404","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kate Schroder"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87264","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75536","size":1},{"color":"#FF4D4D","name":"Identifying the mechanism of the G2 phase UV checkpoint and repair response commonly defective in melanoma","data":{"media_summary":"","end_year":2016,"keywords":["melanoma","DNA repair","ultraviolet (UV) irradiation","cell cycle regulation","mutation analysis"],"nhmrc_grant_id":1064807,"application_year":2013,"health_keywords":["skin cancer"],"scientific_title":"Identifying the mechanism of the G2 phase UV checkpoint and repair response commonly defective in melanoma","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Cell Biology","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"A/Pr Brian Gabrielli","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1064807","simplified_title":"Defining a defective UV response in melanoma","sub_type":"Standard Project Grant","total_budget":"558748.95","source_system":"The UV component of sunlight is the major environmental factor driving the development of melanoma.  UV radiation can directly mutate genes resulting in their inability to perform normal functions which may contribute to cancer.   Despite the high number of mutations directly attributable to UV radiation, the mechanisms known to repair these mutations are generally normal in melanoma.  This research will investigate a repair mechanism we have identified that is commonly defective in melanomas."},"children":[{"color":"#336699","name":"Dr Sandra Pavey","data":{"first_name":"Sandra","title":"Dr","dw_individual_id":"DW0044744","middle_name":"Jane","last_name":"Pavey","source_individual_id":"5019165","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sandra Pavey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88571","size":1},{"color":"#336699","name":"A/Pr Brian Gabrielli","data":{"first_name":"Brian","title":"A/Pr","dw_individual_id":"DW0007391","middle_name":"G","last_name":"Gabrielli","source_individual_id":"5014734","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Brian Gabrielli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78693","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75529","size":1},{"color":"#FF4D4D","name":"Exploring a mechanism to underpin a novel colonic therapy for colitis","data":{"media_summary":"","end_year":2016,"keywords":["inflammatory bowel disease (IBD)","treatment strategies","drug metabolism","drug delivery","colon biology"],"nhmrc_grant_id":1064440,"application_year":2013,"start_year":2014,"scientific_title":"Exploring a mechanism to underpin a novel colonic therapy for colitis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology and Pharmaceutical Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Timothy Florin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1064440","simplified_title":"Exploring a mechanism to underpin a novel colonic therapy for colitis","sub_type":"Standard Project Grant","total_budget":"676174.83","source_system":"We have a novel observation that suggests we might be able to avoid serious side-effects of a drug which is used for the treatment of chronic inflammatory diseases.   Our research will underpin the development of safer and more economical treatments for patients with chronic inflammation in their intestines."},"children":[{"color":"#336699","name":"Dr Rohan Lourie","data":{"first_name":"Rohan","title":"Dr","dw_individual_id":"DW0043882","middle_name":"","last_name":"Lourie","source_individual_id":"5024578","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Rohan Lourie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88372","size":1},{"color":"#336699","name":"Prof Timothy Florin","data":{"first_name":"Timothy","title":"Prof","dw_individual_id":"DW0013048","middle_name":"H","last_name":"Florin","source_individual_id":"5014662","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Timothy Florin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80228","size":1},{"color":"#336699","name":"Dr Paraic O Cuiv","data":{"first_name":"Paraic","title":"Dr","dw_individual_id":"DW0009407","middle_name":"","last_name":"O Cuiv","source_individual_id":"5044191","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Paraic O Cuiv"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79255","size":1},{"color":"#336699","name":"Dr John Duley","data":{"first_name":"John","title":"Dr","dw_individual_id":"DW0007066","middle_name":"Alexander","last_name":"Duley","source_individual_id":"5012691","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr John Duley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78611","size":1},{"color":"#336699","name":"A/Pr Ross Norris","data":{"first_name":"Ross","title":"A/Pr","dw_individual_id":"DW0003706","middle_name":"Leslie Greenland","last_name":"Norris","source_individual_id":"5012680","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ross Norris"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77694","size":1},{"color":"#336699","name":"Dr Iulia Oancea","data":{"first_name":"Iulia","title":"Dr","dw_individual_id":"5050304","middle_name":"","last_name":"Oancea","source_individual_id":"5050304","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Iulia Oancea"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76392","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75513","size":1},{"color":"#FF4D4D","name":"Characterisation of the adiponectin receptors - AdipoR1 and AdipoR2","data":{"media_summary":"","end_year":2016,"keywords":["adiponectin","receptors","receptor regulation","cardiovascular","metabolism"],"nhmrc_grant_id":1064353,"application_year":2013,"health_keywords":["receptor dimerisation","receptor trafficking","receptor signalling"],"scientific_title":"Characterisation of the adiponectin receptors - AdipoR1 and AdipoR2","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Receptors and Membrane Biology","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Jonathan Whitehead","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1064353","simplified_title":"Characterisation of novel hormone receptors","sub_type":"Standard Project Grant","total_budget":"437824.59","source_system":"The increasing incidence of cardiometabolic disease highlights an unmet need for novel therapeutic approaches.  Greater understanding of the detail governing cardiometabolic function is required to provide a foundation to construct effective strategies.  We will characterise 2 novel receptors that are important in the regulation and maintenance of cardiometabolic systems, seeking to identify strategies to enhance receptor, improve cardiometabolic function and reduce disease burden."},"children":[{"color":"#336699","name":"A/Pr Jonathan Whitehead","data":{"first_name":"Jonathan","title":"A/Pr","dw_individual_id":"DW0046246","middle_name":"P","last_name":"Whitehead","source_individual_id":"RMIS5218572","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jonathan Whitehead"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88973","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75507","size":1},{"color":"#FF4D4D","name":"Targeting of callosal axons to duplicate cortical areas in the contralateral hemisphere","data":{"media_summary":"","end_year":2017,"keywords":["brain development","cerebral cortex","developmental disorders","molecular neuroscience","brain disorders"],"nhmrc_grant_id":1064174,"application_year":2013,"start_year":2014,"scientific_title":"Targeting of callosal axons to duplicate cortical areas in the contralateral hemisphere","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Linda Richards","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1064174","simplified_title":"Callosal axon targeting in asymmetric brains.","sub_type":"Standard Project Grant","total_budget":"590034.93","source_system":"The two sides of the brain communicate via a large fibre tract called the corpus callosum.  This proposal investigates how the corpus callosum is formed during embryonic and postnatal development.  Specifically, we investigate how the axons that make up the corpus callosum are able to locate their precise target in the contralateral hemisphere so that the brain circuit they form will be functional.  We have developed a new mouse model to discover the fundamental mechanisms regulating how the brain is wired in order to function correctly."},"children":[{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75498","size":1},{"color":"#FF4D4D","name":"Quantifying the ventilatory control contribution to obstructive sleep apnoea using clinical polysomnography","data":{"media_summary":"","end_year":2017,"keywords":["sleep apnoea","sleep disordered breathing","sleep breathing disorders","mathematical modelling","signal processing"],"nhmrc_grant_id":1064163,"application_year":2013,"health_keywords":["control of breathing","respiratory diseases","respiratory physiology"],"scientific_title":"Quantifying the ventilatory control contribution to obstructive sleep apnoea using clinical polysomnography","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Dr Philip Terrill","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1064163","simplified_title":"Measuring breathing control in people with obstructive sleep apnoea.","sub_type":"Standard Project Grant","total_budget":"193923.59","source_system":"Obstructive sleep apnoea is a highly prevalent condition with limited treatment options. New research shows that many patients have sleep apnoea because of a hypersensitive control of breathing (instability). Yet there is no way to measure instability and target it clinically. We aim to refine and apply a powerful new method to measuring breathing instability using a conventional sleep study, to allow treatments for sleep apnoea to be targeted at those patients who will respond most effectively."},"children":[{"color":"#336699","name":"Dr Scott Sands","data":{"first_name":"Scott","title":"Dr","dw_individual_id":"DW0033618","middle_name":"Aaron","last_name":"Sands","source_individual_id":"5041277","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Scott Sands"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85708","size":1},{"color":"#336699","name":"Dr Philip Terrill","data":{"first_name":"Philip","title":"Dr","dw_individual_id":"DW0016606","middle_name":"Ian","last_name":"Terrill","source_individual_id":"RMIS4013862","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Philip Terrill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81214","size":1},{"color":"#336699","name":"Dr Bradley Edwards","data":{"first_name":"Bradley","title":"Dr","dw_individual_id":"DW0012864","middle_name":"Allan","last_name":"Edwards","source_individual_id":"5040875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Bradley Edwards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80182","size":1},{"color":"#336699","name":"Prof Stephen Wilson","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0005484","middle_name":"James","last_name":"Wilson","source_individual_id":"5028658","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stephen Wilson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78193","size":1},{"color":"#336699","name":"Dr David Wellman","data":{"first_name":"David","title":"Dr","dw_individual_id":"5053136","middle_name":"Andrew","last_name":"Wellman","source_individual_id":"5053136","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David Wellman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76438","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75497","size":1},{"color":"#FF4D4D","name":"Immune control of gamma-herpesvirus dissemination","data":{"media_summary":"","end_year":2016,"keywords":["virus pathogenesis","virus eradication","viral immunology","viral vaccines","viral disease"],"nhmrc_grant_id":1064015,"application_year":2013,"health_keywords":["viral persistence"],"scientific_title":"Immune control of gamma-herpesvirus dissemination","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Philip Stevenson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1064015","simplified_title":"Controlling a persistent viral infection","sub_type":"Standard Project Grant","total_budget":"518505.24","source_system":"Human _-herpesviruses persist for life, cause cancers and emerge with particular virulence when the immune system is weak. Vaccination against them is therefore an important health priority. We have shown for a related _-herpesvirus of mice that live vaccines protect. Antibody seems to play a major role. We will test whether safer, recombinant vaccines are also sufficient to elicit protective antibody. Thus we can establish a viable strategy for preventing virus-induced human cancers."},"children":[{"color":"#336699","name":"A/Pr Philip Stevenson","data":{"first_name":"Philip","title":"A/Pr","dw_individual_id":"DW0034054","middle_name":"George","last_name":"Stevenson","source_individual_id":"5019294","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Philip Stevenson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85811","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75493","size":1},{"color":"#FF4D4D","name":"Understanding the regulation of kidney morphogenesis in order to improve renal development","data":{"media_summary":"developmental genetics","end_year":2016,"keywords":["kidney development","imaging","morphogenesis","mathematical modelling","developmental biology"],"nhmrc_grant_id":1063989,"application_year":2013,"health_keywords":["mouse models","signalling pathways","cell proliferation","cell differentiation","developmental genetics"],"scientific_title":"Understanding the regulation of kidney morphogenesis in order to improve renal development","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1063989","simplified_title":"Building a better kidney","sub_type":"Standard Project Grant","total_budget":"671787.48","source_system":"Chronic kidney disease is a growing burden to the health system. The long term health of your kidneys is influenced by the number of functional units, nephrons, present in each kidney, a feature that is determined before birth. If we could influence this number, we may be able to reduce the risk of kidney disease in later life for at risk populations, including the Aboriginal community. This study will investigate the stem cells that form the nephrons, how the process occurs and how it can be influenced."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1},{"color":"#336699","name":"Dr Nicholas Hamilton","data":{"first_name":"Nicholas","title":"Dr","dw_individual_id":"DW0037081","middle_name":"A","last_name":"Hamilton","source_individual_id":"5018862","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nicholas Hamilton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86597","size":1},{"color":"#336699","name":"Prof Andrew Mcmahon","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0020790","middle_name":"Paul","last_name":"Mcmahon","source_individual_id":"5057155","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Andrew Mcmahon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82319","size":1},{"color":"#336699","name":"Prof Raphael Kopan","data":{"first_name":"Raphael","title":"Prof","dw_individual_id":"5052179","middle_name":"","last_name":"Kopan","source_individual_id":"5052179","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Raphael Kopan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76430","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75490","size":1},{"color":"#FF4D4D","name":"Role of oxytocin in chronic visceral pain","data":{"media_summary":"","end_year":2016,"keywords":["drug development","pain mechanisms","gastrointestinal disease","oxytocin","pain minimisation"],"nhmrc_grant_id":1063803,"application_year":2013,"start_year":2014,"scientific_title":"Role of oxytocin in chronic visceral pain","node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Paul Alewood","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1063803","simplified_title":"Stable oxytocin analogues - potential treatment for irritable bowel syndrome","sub_type":"Standard Project Grant","total_budget":"671787.48","source_system":"Irritable Bowel Syndrome (IBS) is one of the leading causes of chronic pain both world-wide and in Australia for which there is a lack of treatments. Chronic pain arises from nerve fibres in the colon wall, which fail to 'reset' back to normal following inflammation.  Targeting these nerve endings with drugs is a key advance in IBS treatment. This project will identify selective oxytocin analogues that act in the colon to lower pain in sensory nerves thus providing efficacious pain relief in IBS."},"children":[{"color":"#336699","name":"Prof Paul Alewood","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0035049","middle_name":"F","last_name":"Alewood","source_individual_id":"5013158","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Alewood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86082","size":1},{"color":"#336699","name":"Dr Stuart Brierley","data":{"first_name":"Stuart","title":"Dr","dw_individual_id":"DW0023778","middle_name":"M","last_name":"Brierley","source_individual_id":"5013610","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Stuart Brierley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83109","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75475","size":1},{"color":"#FF4D4D","name":"Development of selective blockers of acid sensing ion channel 1a for the treatment of stroke","data":{"media_summary":"angiotensin receptor","end_year":2016,"keywords":["stroke","neuronal injury","acidosis","ion channels","peptides"],"nhmrc_grant_id":1063798,"application_year":2013,"health_keywords":["therapeutic agents","drug discovery","therapeutic agents","neuroprotection","angiotensin receptor"],"scientific_title":"Development of selective blockers of acid sensing ion channel 1a for the treatment of stroke","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof Glenn King","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1063798","simplified_title":"Development of novel anti-stroke therapeutics","sub_type":"Standard Project Grant","total_budget":"690768.78","source_system":"Stroke is the second leading cause of death worldwide. In addition, stroke causes an extremely high incidence of disability in surviving victims due to the brain damage suffered during stroke. Unfortunately, no effective neuroprotective therapy is currently available for stroke patients. In this project we plan to develop novel neuroprotective agents that are effective even when used many hours after stroke, thus providing a wide therapeutic time window for treatment of stroke patients."},"children":[{"color":"#336699","name":"Prof Robert Widdop","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0022976","middle_name":"E","last_name":"Widdop","source_individual_id":"5018294","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Widdop"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82922","size":1},{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75473","size":1},{"color":"#FF4D4D","name":"Potent Lipoglycopeptide Antibiotics Against C. Difficile","data":{"media_summary":"","end_year":2016,"keywords":["bacterial infection","antibiotic resistance","drug discovery","mechanism of action","antibiotics"],"nhmrc_grant_id":1063214,"application_year":2013,"health_keywords":["diarrhoea"],"scientific_title":"Potent Lipoglycopeptide Antibiotics Against C. Difficile","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Matthew Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1063214","simplified_title":"New Antibiotics to Treat C. difficile infections","sub_type":"Standard Project Grant","total_budget":"737287.37","source_system":"In some people C. difficile bacteria naturally reside in the gut. Other people accidentally ingest spores of the bacteria while they are patients in a hospital or nursing home.  Sometimes, broad-spectrum antibiotics used to treat an infection also kill healthy gut bacteria.  The gut then becomes overrun with C. difficile, causing diarrhoea and pain, and sometimes death.  We will investigate the use of a new potent antibiotic, vancapticin, to kill C. difficle and prevent relapse of infection."},"children":[{"color":"#336699","name":"Prof Matthew Cooper","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0024249","middle_name":"A","last_name":"Cooper","source_individual_id":"5018347","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83230","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75437","size":1},{"color":"#FF4D4D","name":"Investigation of the functional role of antibodies against myelin proteolipid protein in multiple sclerosis","data":{"media_summary":"","end_year":2016,"keywords":["multiple sclerosis (MS)","antibody","pathogenic mechanisms","demyelinating disease","demyelination"],"nhmrc_grant_id":1063170,"application_year":2013,"health_keywords":["axonal injury","signalling pathways"],"scientific_title":"Investigation of the functional role of antibodies against myelin proteolipid protein in multiple sclerosis","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Judith Greer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1063170","simplified_title":"Do antibodies against myelin proteolipid protein play a role in multiple sclerosis?","sub_type":"Standard Project Grant","total_budget":"615852.48","source_system":"There is a lot of suggestive evidence that molecules called antibodies might cause a faster progression of disease in people with multiple sclerosis (MS), but this remains to be proven. The proposed study will investigate the mechanisms by which antibodies could hasten MS disease progression. Results of this study will help inform treatment options for people with MS and will also help us to better understand the basic pathogenic mechanisms that can cause MS."},"children":[{"color":"#336699","name":"Dr Judith Greer","data":{"first_name":"Judith","title":"Dr","dw_individual_id":"DW0036976","middle_name":"M","last_name":"Greer","source_individual_id":"RMIS24768","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Judith Greer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86571","size":1},{"color":"#336699","name":"Prof Michael Pender","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0009604","middle_name":"P","last_name":"Pender","source_individual_id":"RMIS18293","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Pender"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79308","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75433","size":1},{"color":"#FF4D4D","name":"Understanding the embryonic origins of cortical malformations","data":{"media_summary":"mental retardation","end_year":2016,"keywords":["neural development","neural stem cell","neurobiology","neuronal migration","neurodevelopmental disorders"],"nhmrc_grant_id":1063080,"application_year":2013,"health_keywords":["neurogenesis","neuronal differentiation","cortical development","epilepsy","mental retardation"],"scientific_title":"Understanding the embryonic origins of cortical malformations","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Helen Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1063080","simplified_title":"Embryonic origins of cortical malformations","sub_type":"Standard Project Grant","total_budget":"814183.77","source_system":"Cortical malformation leads to mental retardation and epilepsy. Identification of the aberrant developmental processes contributing to these devastating syndromes is essential for accurate clinical assessment and development of novel therapeutics. Here we investigate a developmentally important receptor, Neogenin, which when mutated, leads to cortical malformations. Determining how Neogenin functions is expected to uncover new signaling pathways contributing to these malformations."},"children":[{"color":"#336699","name":"A/Pr Helen Cooper","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0018393","middle_name":"M","last_name":"Cooper","source_individual_id":"RMIS222363","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Helen Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81710","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75425","size":1},{"color":"#FF4D4D","name":"Wolbachia and West Nile virus in mosquitoes: friends or foes?","data":{"media_summary":"","end_year":2016,"keywords":["flavivirus","microrna","vector-borne disease","mosquito","replication"],"nhmrc_grant_id":1062983,"application_year":2013,"start_year":2014,"scientific_title":"Wolbachia and West Nile virus in mosquitoes: friends or foes?","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Sassan Asgari","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1062983","simplified_title":"Investigating Wolbachia-West Nile virus-mosquito interactions","sub_type":"Standard Project Grant","total_budget":"551785.56","source_system":"Mosquito-borne viruses pose a great risk to human and animal health. Presence of compentent vectors of several viruses in Australia indicates vulnerability of Australias biosecurity. This project will define the mechanisms of inhibition of virus replication in mosquitoes by a symbiotic bacterium which can be utilized in virus inhibition."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1},{"color":"#336699","name":"A/Pr Sassan Asgari","data":{"first_name":"Sassan","title":"A/Pr","dw_individual_id":"DW0035153","middle_name":"","last_name":"Asgari","source_individual_id":"5013231","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Sassan Asgari"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86115","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75414","size":1},{"color":"#FF4D4D","name":"Genetic polymorphisms associated with clinical and dermoscopic naevus signature patterns","data":{"media_summary":"","end_year":2016,"keywords":["melanoma","morphology","genetic epidemiology","naevi","quantitative genetics"],"nhmrc_grant_id":1062935,"application_year":2013,"start_year":2014,"scientific_title":"Genetic polymorphisms associated with clinical and dermoscopic naevus signature patterns","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dermatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof H. Peter Soyer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1062935","simplified_title":"Genotype associations with naevus patterns","sub_type":"Standard Project Grant","total_budget":"828848.9","source_system":"Melanoma is a form of skin cancer that arises from the cells that produce pigment and is a major public health issue in Australia. We will examine the relationship between the form, structure and colour of existing types of moles and their subsequent risk of developing into melanoma. This study will combine dermoscopy, a non-invasive examination technique, with DNA tests of the genes that determine number of naevi, skin, hair and eye colour, aiding in the early prediction and diagnosis of skin cancer."},"children":[{"color":"#336699","name":"A/Pr Richard Sturm","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0045672","middle_name":"Alan","last_name":"Sturm","source_individual_id":"5017777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Sturm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88811","size":1},{"color":"#336699","name":"Prof H. Peter Soyer","data":{"first_name":"H. Peter","title":"Prof","dw_individual_id":"DW0028088","middle_name":"","last_name":"Soyer","source_individual_id":"5019889","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof H. Peter Soyer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84249","size":1},{"color":"#336699","name":"Dr David Duffy","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0012817","middle_name":"Lorenzo","last_name":"Duffy","source_individual_id":"5014423","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David Duffy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80170","size":1},{"color":"#336699","name":"A/Pr Helmut Schaider","data":{"first_name":"Helmut","title":"A/Pr","dw_individual_id":"DW0010104","middle_name":"","last_name":"Schaider","source_individual_id":"5035269","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Helmut Schaider"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79440","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75412","size":1},{"color":"#FF4D4D","name":"Is developmental vitamin D deficiency associated with autism-related phenotypes:  a birth cohort study.","data":{"media_summary":"","end_year":2017,"keywords":["vitamin D","autism spectrum disorders","epidemiology","cohort study","prenatal"],"nhmrc_grant_id":1062846,"application_year":2013,"start_year":2014,"scientific_title":"Is developmental vitamin D deficiency associated with autism-related phenotypes:  a birth cohort study.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof John McGrath","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1062846","simplified_title":"Is developmental vitamin D deficiency associated with autism-related phenotypes?","sub_type":"Standard Project Grant","total_budget":"340284.12","source_system":"There is evidence that low vitamin D before birth may increase the risk of autism. This study will examine this hypothesis based on a Dutch birth cohort. If there is a link between vitami D and autism, then this can be readily addressed with prenatal supplements."},"children":[{"color":"#336699","name":"A/Pr Darryl Eyles","data":{"first_name":"Darryl","title":"A/Pr","dw_individual_id":"DW0042305","middle_name":"W","last_name":"Eyles","source_individual_id":"5014564","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Darryl Eyles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87979","size":1},{"color":"#336699","name":"Prof John Mcgrath","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0009022","middle_name":"Joseph","last_name":"Mcgrath","source_individual_id":"RMIS3680751","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mcgrath"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79147","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75406","size":1},{"color":"#FF4D4D","name":"Elucidation of the gene regulatory networks that cause Alzheimer's disease in Down Syndrome;","data":{"media_summary":"","end_year":2016,"keywords":["Alzheimer disease","Down syndrome","stem cells","gene regulation","neuron-glia interactions"],"nhmrc_grant_id":1062802,"application_year":2013,"health_keywords":["neurodegenerative disorders"],"scientific_title":"Elucidation of the gene regulatory networks that cause Alzheimer's disease in Down Syndrome;","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Ernst Wolvetang","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1062802","simplified_title":"Understanding Alzheimer's disease using Down syndrome as a model","sub_type":"Standard Project Grant","total_budget":"769761.21","source_system":"People with Down syndrome have an extra chromosome 21 and all develop Alzheimer's disease. We are able to delete different parts of chromosome 21 in Down syndrome stem cells and turn these cells into the two main cell types of the brain. By comparing the occurrence of Alzheimer disease with gene expression changes in these gene-edited cell types we can identify the gene-regulatory pathways that cause Alzheimer's disease in Down syndrome and identify novel therapeutic targets for sporadic Alzheimer's disease."},"children":[{"color":"#336699","name":"A/Pr Christine Wells","data":{"first_name":"Christine","title":"A/Pr","dw_individual_id":"DW0040397","middle_name":"Anne","last_name":"Wells","source_individual_id":"5018258","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Christine Wells"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87466","size":1},{"color":"#336699","name":"A/Pr Ernst Wolvetang","data":{"first_name":"Ernst","title":"A/Pr","dw_individual_id":"DW0017193","middle_name":"Jurgen","last_name":"Wolvetang","source_individual_id":"5020397","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ernst Wolvetang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81372","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75402","size":1},{"color":"#FF4D4D","name":"Function and physiological role of inhibitory circuits in the amygdala","data":{"media_summary":"","end_year":2017,"keywords":["neurons","inhibition","synapse","action potential","cortical excitability"],"nhmrc_grant_id":1062183,"application_year":2013,"start_year":2014,"scientific_title":"Function and physiological role of inhibitory circuits in the amygdala","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Pankaj Sah","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1062183","simplified_title":"Inhibitory receptors in the amygdala","sub_type":"Standard Project Grant","total_budget":"723969.76","source_system":"The amygdala is part of the brain that assigns emotional content to our sensory world and dysfunction of the amygdala is responsible for many anxiety-related disorders. Many anxiolytics, like valium, act on receptors in the amygdala. In this project we will study circuits in the amygdala that are modulated by anxiolytics. These studies will provide essential information in the understanding of anxiety disorders and help in developing drugs to treat these disorders."},"children":[{"color":"#336699","name":"Prof Pankaj Sah","data":{"first_name":"Pankaj","title":"Prof","dw_individual_id":"DW0033583","middle_name":"","last_name":"Sah","source_individual_id":"5017304","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Pankaj Sah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85693","size":1},{"color":"#336699","name":"Prof Joseph Lynch","data":{"first_name":"Joseph","title":"Prof","dw_individual_id":"DW0032228","middle_name":"W","last_name":"Lynch","source_individual_id":"5016080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Joseph Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85342","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75347","size":1},{"color":"#FF4D4D","name":"Innovative dosing approaches to maximise bacterial killing and prevent resistance in septic critically ill patients.","data":{"media_summary":"","end_year":2016,"keywords":["antibiotic therapy","pharmacokinetics","sepsis","antibiotic resistance","intensive care medicine"],"nhmrc_grant_id":1062040,"application_year":2013,"start_year":2014,"scientific_title":"Innovative dosing approaches to maximise bacterial killing and prevent resistance in septic critically ill patients.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Jason Roberts","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1062040","simplified_title":"Dosing to maximise bacterial killing and prevent resistance in ICU.","sub_type":"Standard Project Grant","total_budget":"815865.87","source_system":"Patients in the intensive care unit (ICU) frequently die from infection. It remains unknown how important antibiotic dose optimisation is for these patients and whether it may enable more effective treatment. In this project, we propose to compare existing approaches to antibiotic dosing in ICU patients with innovative alternatives. We will determine which dosing approach results in better antibacterial efficacy and reduce the development of antibiotic resistance."},"children":[{"color":"#336699","name":"Prof Jason Roberts","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0033443","middle_name":"A","last_name":"Roberts","source_individual_id":"5017212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jason Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85657","size":1},{"color":"#336699","name":"Prof Jeffrey Lipman","data":{"first_name":"Jeffrey","title":"Prof","dw_individual_id":"DW0032130","middle_name":"","last_name":"Lipman","source_individual_id":"5012259","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jeffrey Lipman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85314","size":1},{"color":"#336699","name":"Dr Cornelia Landersdorfer","data":{"first_name":"Cornelia","title":"Dr","dw_individual_id":"DW0031934","middle_name":"Barbara","last_name":"Landersdorfer","source_individual_id":"5042544","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Cornelia Landersdorfer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85257","size":1},{"color":"#336699","name":"Dr Phillip Bergen","data":{"first_name":"Phillip","title":"Dr","dw_individual_id":"DW0029427","middle_name":"John","last_name":"Bergen","source_individual_id":"5043431","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Phillip Bergen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84629","size":1},{"color":"#336699","name":"Dr Jurgen Bulitta","data":{"first_name":"Jurgen","title":"Dr","dw_individual_id":"DW0017992","middle_name":"Bernd","last_name":"Bulitta","source_individual_id":"5043150","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jurgen Bulitta"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81598","size":1},{"color":"#336699","name":"Prof Carl Kirkpatrick","data":{"first_name":"Carl","title":"Prof","dw_individual_id":"DW0014193","middle_name":"Michael","last_name":"Kirkpatrick","source_individual_id":"5015731","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Carl Kirkpatrick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80526","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75339","size":1},{"color":"#FF4D4D","name":"Public health policies and interventions to reduce tobacco-related harms among socially disadvantaged populations and low probability quitters","data":{"media_summary":"","end_year":2017,"keywords":["harm reduction","tobacco dependence","social disadvantage","smoking","nicotine replacement therapy"],"nhmrc_grant_id":1061978,"application_year":2013,"start_year":2014,"scientific_title":"Public health policies and interventions to reduce tobacco-related harms among socially disadvantaged populations and low probability quitters","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Promotion","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Coral Gartner","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1061978","simplified_title":"Public health policies and interventions to reduce tobacco-related harms among socially disadvantaged populations and low probability quitters","sub_type":"Population Health CDF","total_budget":"411767.04","source_system":"Tobacco continues to be a leading cause of preventable death and disease in Australia. Those who are socially disadvantaged are at higher risk of smoking, which contributes to the health gap between the rich and poor. This research will provide evidence for policy makers on interventions which could reduce smoking among the most disadvantaged in society. It will also examine whether less harmful nicotine products could a reduce health risks in smokers who find quitting difficult."},"children":[{"color":"#336699","name":"Dr Coral Gartner","data":{"first_name":"Coral","title":"Dr","dw_individual_id":"DW0007430","middle_name":"E","last_name":"Gartner","source_individual_id":"5014768","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Coral Gartner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78707","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75332","size":1},{"color":"#FF4D4D","name":"Evaluation of SCID-I in the diagnosis of mental disorders in Indigenous Australians","data":{"media_summary":"","end_year":2017,"keywords":["Aboriginal mental health","indigenous health","guidelines","validation","prevalence"],"nhmrc_grant_id":1061963,"application_year":2013,"health_keywords":["evidence-based health care","culturally appropriate methodology"],"scientific_title":"Evaluation of SCID-I in the diagnosis of mental disorders in Indigenous Australians","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Aboriginal and Torres Strait Islander Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Maree Toombs","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1061963","simplified_title":"Evaluating SCID-I for diagnosing mental disorders in Indigenous Australians","sub_type":"Standard Project Grant","total_budget":"964163.8","source_system":"Current estimates of mental disease among Indigenous Australians are inadequate. This research will examine the use of a structured interview tool that is promoted globally for diagnosing mental disorders, and then use the tool to quantify the burden of mental illness among Indigenous Australians. The findings will provide accurate estimates of occurrence of mental disorders, thereby help inform policy making and planning of services for Indigenous Australians."},"children":[{"color":"#336699","name":"Dr Geetha Ranmuthugala","data":{"first_name":"Geetha","title":"Dr","dw_individual_id":"DW0044999","middle_name":"","last_name":"Ranmuthugala","source_individual_id":"5046837","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Geetha Ranmuthugala"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88651","size":1},{"color":"#336699","name":"Dr Maree Toombs","data":{"first_name":"Maree","title":"Dr","dw_individual_id":"DW0040104","middle_name":"Roslyn","last_name":"Toombs","source_individual_id":"5042556","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Maree Toombs"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87387","size":1},{"color":"#336699","name":"Prof Geoffrey Nicholson","data":{"first_name":"Geoffrey","title":"Prof","dw_individual_id":"DW0009373","middle_name":"Charles","last_name":"Nicholson","source_individual_id":"RMIS3177995","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Geoffrey Nicholson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79246","size":1},{"color":"#336699","name":"Prof Steve Kisely","data":{"first_name":"Steve","title":"Prof","dw_individual_id":"DW0008400","middle_name":"Randolph","last_name":"Kisely","source_individual_id":"5018957","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Steve Kisely"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78971","size":1},{"color":"#336699","name":"A/Pr Deborah Askew","data":{"first_name":"Deborah","title":"A/Pr","dw_individual_id":"DW0005862","middle_name":"Anne","last_name":"Askew","source_individual_id":"5012019","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Deborah Askew"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78299","size":1},{"color":"#336699","name":"A/Pr Srinivas Kondalsamy Chennakesavan","data":{"first_name":"Srinivas","title":"A/Pr","dw_individual_id":"DW0002708","middle_name":"","last_name":"Kondalsamy Chennakesavan","source_individual_id":"5019711","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Srinivas Kondalsamy Chennakesavan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77406","size":1},{"color":"#336699","name":"A/Pr Noel Hayman","data":{"first_name":"Noel","title":"A/Pr","dw_individual_id":"DW0002105","middle_name":"E","last_name":"Hayman","source_individual_id":"5012305","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Noel Hayman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77247","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75330","size":1},{"color":"#FF4D4D","name":"Antiviral defects of the airway epithelium associated with wheeze and atopy in children","data":{"media_summary":"","end_year":2016,"keywords":["asthma","airway epithelium","viral replication","innate immunity","atopy"],"nhmrc_grant_id":1061921,"application_year":2013,"health_keywords":["epithelial cells","paediatric"],"scientific_title":"Antiviral defects of the airway epithelium associated with wheeze and atopy in children","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Dr Kirsten Spann","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1061921","simplified_title":"Immune defects in children at risk of developing asthma","sub_type":"Standard Project Grant","total_budget":"647721.21","source_system":"Asthma affects 10-15% of Australian. Repeated respiratory viral infections increase the risk of developing asthma, and are also the principal cause of asthma attacks. Asthmatics may be more susceptible to respiratory viral infections due to a defect in the innate antiviral response to infection. Here we aim to identify defects in the antiviral response of children who are at risk of developing asthma, and understand how they occur so that future therapies may be developed."},"children":[{"color":"#336699","name":"Dr Emmanuelle Fantino","data":{"first_name":"Emmanuelle","title":"Dr","dw_individual_id":"DW0030616","middle_name":"","last_name":"Fantino","source_individual_id":"5043383","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Emmanuelle Fantino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84954","size":1},{"color":"#336699","name":"Prof Peter Sly","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0028010","middle_name":"David","last_name":"Sly","source_individual_id":"5011929","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Sly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84226","size":1},{"color":"#336699","name":"Dr Peter Collins","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0012412","middle_name":"","last_name":"Collins","source_individual_id":"5051333","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Peter Collins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80059","size":1},{"color":"#336699","name":"Dr Kirsten Spann","data":{"first_name":"Kirsten","title":"Dr","dw_individual_id":"DW0010390","middle_name":"Michelle","last_name":"Spann","source_individual_id":"5017641","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kirsten Spann"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79524","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75326","size":1},{"color":"#FF4D4D","name":"Peripheral membrane proteins in health and disease","data":{"media_summary":"","end_year":2018,"keywords":["X-ray crystallography","endosomes","caveolae","membrane trafficking","membrane signalling"],"nhmrc_grant_id":1061574,"application_year":2013,"health_keywords":["structural biology","cell membrane","molecular basis of disease","molecular neuroscience"],"scientific_title":"Peripheral membrane proteins in health and disease","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Structural Biology (incl. Macromolecular Modelling)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Brett Collins","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1061574","simplified_title":"Peripheral membrane proteins in health and disease","sub_type":"RD Wright Biomedical CDF","total_budget":"455453.28","source_system":"Peripheral membrane proteins are critical for processes such as cell transport, signaling, neurosecretion and development. As such, their dysfunction can lead to many debilitating diseases including cancer, inflammation and neurodegeneration. This project will establish fundamental new knowledge about how peripheral membrane proteins regulate cell function, how their perturbation or mutation results in human disease, and will inform efforts to target them for future therapeutic outcomes."},"children":[{"color":"#336699","name":"Dr Brett Collins","data":{"first_name":"Brett","title":"Dr","dw_individual_id":"DW0041718","middle_name":"Martin","last_name":"Collins","source_individual_id":"5014007","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brett Collins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87821","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75292","size":1},{"color":"#FF4D4D","name":"Dissecting the role of RYK in cortical neuron specification and schizophrenia","data":{"media_summary":"schizophrenia and related disorders","end_year":2016,"keywords":["neural development","neural stem cell","neurobiology","neurodegenerative disorders","neurogenesis"],"nhmrc_grant_id":1061512,"application_year":2013,"health_keywords":["neuronal differentiation","axon guidance","axon growth","cortical development","schizophrenia and related disorders"],"scientific_title":"Dissecting the role of RYK in cortical neuron specification and schizophrenia","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Helen Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1061512","simplified_title":"Ryk, cortical development and schizophrenia","sub_type":"Standard Project Grant","total_budget":"1021223.61","source_system":"Correct production of neuronal subtypes within the neocortex is essential for coordinated brain activity and higher-order functions. Understanding how newborn neurons decide which subtype to adopt is critical as incorrect neuron identity has profound consequences for neocortical function and is associated with schizophrenia and mental disability. We have recently linked one molecule, RYK, to schizophrenia. In this project we will explore how Ryk influences cortical neuron fate."},"children":[{"color":"#336699","name":"Prof Bryan Mowry","data":{"first_name":"Bryan","title":"Prof","dw_individual_id":"DW0044411","middle_name":"J","last_name":"Mowry","source_individual_id":"5016586","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bryan Mowry"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88510","size":1},{"color":"#336699","name":"A/Pr Helen Cooper","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0018393","middle_name":"M","last_name":"Cooper","source_individual_id":"RMIS222363","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Helen Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81710","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75287","size":1},{"color":"#FF4D4D","name":"Combination immunotherapeutic strategies for haematological cancers","data":{"media_summary":"","end_year":2017,"keywords":["cancer immunotherapy","cancer immunology","tumour immunity","immune evasion","cancer vaccine"],"nhmrc_grant_id":1061429,"application_year":2013,"health_keywords":["cellular immunity","innate immunity"],"scientific_title":"Combination immunotherapeutic strategies for haematological cancers","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Tumour Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Stephen Mattarollo","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1061429","simplified_title":"Developing immune-based therapies for blood cancers","sub_type":"RD Wright Biomedical CDF","total_budget":"411767.04","source_system":"Patients with lymphoma cancers initially respond well to treatment, but later relapse with disease. The immune system can be effective at controlling cancer. A potential treatment option is to boost the natural immune response against cancer. This study investigates a novel vaccine that activates a certain immune cell, NKT cells, to fight lymphomas by delivering an NKT cell-activating molecule. Outcomes will allow assessment of combining an NKT-based vaccine with established treatments for lymphoma."},"children":[{"color":"#336699","name":"Dr Stephen Mattarollo","data":{"first_name":"Stephen","title":"Dr","dw_individual_id":"DW0014773","middle_name":"Robert","last_name":"Mattarollo","source_individual_id":"5042373","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Stephen Mattarollo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80699","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75281","size":1},{"color":"#FF4D4D","name":"Targeting the hypoxia sensing pathway to improve hematopoietic stem cell mobilisation and transplantation","data":{"media_summary":"","end_year":2016,"keywords":["haematopoietic stem cell transplantation","haematopoietic stem cells","bone marrow reconstitution","hypoxia","chemotaxis"],"nhmrc_grant_id":1061333,"application_year":2013,"health_keywords":["cell adhesion molecule","cell migration"],"scientific_title":"Targeting the hypoxia sensing pathway to improve hematopoietic stem cell mobilisation and transplantation","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Clinical Medicine and Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Jean-Pierre Levesque","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1061333","simplified_title":"Discovering new drugs to facilitate blood stem cell transplantation in cancer patients","sub_type":"Standard Project Grant","total_budget":"642532.47","source_system":"Transplantation of patients own blood stem cells is used to treat many blood cancers. It increases the chance of cure. However the damage caused by chemotherapies used to combat the cancer can compromise stem cell collection and transplantation. Without transplant, these patients are less likely to survive cancer. This project is to test new drugs that enhance the harvest of blood stem cells for transplantation. These will increase the success rates of transplants and cure in these cancer patients."},"children":[{"color":"#336699","name":"A/Pr Jean-Pierre Levesque","data":{"first_name":"Jean-Pierre","title":"A/Pr","dw_individual_id":"DW0038004","middle_name":"","last_name":"Levesque","source_individual_id":"RMIS7551","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jean-Pierre Levesque"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86847","size":1},{"color":"#336699","name":"Prof Andrew Perkins","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0033140","middle_name":"Charles","last_name":"Perkins","source_individual_id":"RMIS216814","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Andrew Perkins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85587","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75266","size":1},{"color":"#FF4D4D","name":"Burkholderia pseudomallei disulfide-forming proteins: structure, function and inhibition","data":{"media_summary":"","end_year":2016,"keywords":["infection","melioidosis","crystallography","nuclear magnetic resonance (NMR) spectroscopy","bacterial pathogenesis"],"nhmrc_grant_id":1061241,"application_year":2013,"start_year":2014,"scientific_title":"Burkholderia pseudomallei disulfide-forming proteins: structure, function and inhibition","node_source":"NHMRC","node_type":"Grant","field_of_research":"Structural Biology (incl. Macromolecular Modelling)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Martin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1061241","simplified_title":"Towards medicines for melioidosis, a naturally drug-resistant infectious disease endemic in northern Australia","sub_type":"Standard Project Grant","total_budget":"695545.62","source_system":"Our research will lead to a better understanding of melioidosis, a disease endemic to Northern Australia and which impacts indigenous communities at twice the rate of the rest of the population. This project will also aim to generate new compounds with the potential for development as treatments against this devastating disease."},"children":[{"color":"#336699","name":"A/Pr Martin Scanlon","data":{"first_name":"Martin","title":"A/Pr","dw_individual_id":"DW0027806","middle_name":"Joseph","last_name":"Scanlon","source_individual_id":"5017366","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Martin Scanlon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84175","size":1},{"color":"#336699","name":"Prof Bart Currie","data":{"first_name":"Bart","title":"Prof","dw_individual_id":"DW0018509","middle_name":"J","last_name":"Currie","source_individual_id":"RMIS5835","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Bart Currie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81742","size":1},{"color":"#336699","name":"Prof Jennifer Martin","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0008922","middle_name":"Louise","last_name":"Martin","source_individual_id":"5022915","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jennifer Martin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79117","size":1},{"color":"#336699","name":"Dr Mitali Sarkar-Tyson","data":{"first_name":"Mitali","title":"Dr","dw_individual_id":"5051191","middle_name":"","last_name":"Sarkar-Tyson","source_individual_id":"5051191","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mitali Sarkar-Tyson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76405","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75256","size":1},{"color":"#FF4D4D","name":"The Australian Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)","data":{"media_summary":"","end_year":2016,"keywords":["peritoneal dialysis","peritonitis","multicentre","prospective cohort study","survival"],"nhmrc_grant_id":1061235,"application_year":2013,"start_year":2014,"scientific_title":"The Australian Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Johnson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1061235","simplified_title":"Improving peritoneal dialysis practices and outcomes in Australia","sub_type":"Standard Project Grant","total_budget":"481274.91","source_system":"Peritoneal dialysis (PD) is a form of home dialysis that is both substantially cheaper and associated with better early survival than standard hospital-based haemodialysis. Its use in Australia has been severely limited by poor outcomes compared to the rest of the world. This international study aims to identify real world PD centre practices that will lead to better outcomes for Australian patients, greater uptake of home dialysis and health savings of tens of millions of dollars annually."},"children":[{"color":"#336699","name":"Dr Fiona Brown","data":{"first_name":"Fiona","title":"Dr","dw_individual_id":"DW0041303","middle_name":"","last_name":"Brown","source_individual_id":"5039338","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Fiona Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87710","size":1},{"color":"#336699","name":"Dr Sunil Badve","data":{"first_name":"Sunil","title":"Dr","dw_individual_id":"DW0040889","middle_name":"Vasantrao","last_name":"Badve","source_individual_id":"5038644","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sunil Badve"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87605","size":1},{"color":"#336699","name":"Prof Neil Boudville","data":{"first_name":"Neil","title":"Prof","dw_individual_id":"DW0029542","middle_name":"Christopher","last_name":"Boudville","source_individual_id":"5013544","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Neil Boudville"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84653","size":1},{"color":"#336699","name":"Prof Rowan Walker","data":{"first_name":"Rowan","title":"Prof","dw_individual_id":"DW0022792","middle_name":"Graham","last_name":"Walker","source_individual_id":"RMIS224357","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Rowan Walker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82876","size":1},{"color":"#336699","name":"Prof Peter Kerr","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0020086","middle_name":"Gerard","last_name":"Kerr","source_individual_id":"5015679","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Kerr"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82120","size":1},{"color":"#336699","name":"Prof David Johnson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0013969","middle_name":"Wayne","last_name":"Johnson","source_individual_id":"RMIS14680","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Johnson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80471","size":1},{"color":"#336699","name":"Prof Stephen Holt","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0007947","middle_name":"Geoffrey","last_name":"Holt","source_individual_id":"5042777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stephen Holt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78849","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75255","size":1},{"color":"#FF4D4D","name":"The Centre of Excellence in Telehealth","data":{"media_summary":"","end_year":2018,"keywords":["telemedicine","rural and remote health","rural and remote health services","Aboriginal health","rehabilitation services"],"nhmrc_grant_id":1061183,"application_year":2013,"health_keywords":["health policy"],"scientific_title":"The Centre of Excellence in Telehealth","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Health Services Research","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Len Gray","higher_grant_type":"Centre for Research Excellence","purl":"http://purl.org/au-research/grants/nhmrc/1061183","simplified_title":"The Centre of Excellence in Telehealth","sub_type":"Centre for Research Excellence - Health Services","total_budget":"2581351.83","source_system":"The CRE in Telehealth will advance knowledge and research capacity in telehealth to increase the availability of healthcare to all Australians. Modern communication technologies used in telehealth have the potential to revolutionise healthcare delivery.  The CRE will focus on health service settings where access is currently challenging: Small rural hospitals; residential aged care facilities; peoples homes (particularly for disabled and older people); and indigenous communities."},"children":[{"color":"#336699","name":"A/Pr Jennifer Whitty","data":{"first_name":"Jennifer","title":"A/Pr","dw_individual_id":"DW0046256","middle_name":"Anne","last_name":"Whitty","source_individual_id":"5029092","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Jennifer Whitty"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88976","size":1},{"color":"#336699","name":"A/Pr Trevor Russell","data":{"first_name":"Trevor","title":"A/Pr","dw_individual_id":"DW0033555","middle_name":"","last_name":"Russell","source_individual_id":"RMIS3678636","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Trevor Russell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85687","size":1},{"color":"#336699","name":"Prof H. Peter Soyer","data":{"first_name":"H. Peter","title":"Prof","dw_individual_id":"DW0028088","middle_name":"","last_name":"Soyer","source_individual_id":"5019889","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof H. Peter Soyer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84249","size":1},{"color":"#336699","name":"Prof Deborah Theodoros","data":{"first_name":"Deborah","title":"Prof","dw_individual_id":"DW0022512","middle_name":"Gale","last_name":"Theodoros","source_individual_id":"RMIS15273","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Deborah Theodoros"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82794","size":1},{"color":"#336699","name":"A/Pr Anthony Smith","data":{"first_name":"Anthony","title":"A/Pr","dw_individual_id":"DW0016280","middle_name":"Carl","last_name":"Smith","source_individual_id":"5012204","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Anthony Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81117","size":1},{"color":"#336699","name":"Prof Len Gray","data":{"first_name":"Len","title":"Prof","dw_individual_id":"DW0007585","middle_name":"Charles","last_name":"Gray","source_individual_id":"5012147","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Len Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78747","size":1},{"color":"#336699","name":"A/Pr Noel Hayman","data":{"first_name":"Noel","title":"A/Pr","dw_individual_id":"DW0002105","middle_name":"E","last_name":"Hayman","source_individual_id":"5012305","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Noel Hayman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77247","size":1},{"color":"#336699","name":"Dr Nicole Gillespie","data":{"first_name":"Nicole","title":"Dr","dw_individual_id":"5114148","middle_name":"Anne","last_name":"Gillespie","source_individual_id":"5114148","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nicole Gillespie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76637","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75254","size":1},{"color":"#FF4D4D","name":"A novel mechanism for therapeutically modulating neurotransmitter-activated ion channels","data":{"media_summary":"","end_year":2016,"keywords":["glycine receptors","gamma-aminobutyric acid (GABA) receptors","molecular neuroscience","structure-based drug design","electrophysiology"],"nhmrc_grant_id":1060707,"application_year":2013,"health_keywords":["protein biochemistry"],"scientific_title":"A novel mechanism for therapeutically modulating neurotransmitter-activated ion channels","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Joseph Lynch","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1060707","simplified_title":"New ways of treating neurological disorders such pain, epilepsy and anxiety disorders","sub_type":"Standard Project Grant","total_budget":"656532.48","source_system":"GABA-activated chloride channels mediate inhibitory neurotransmission in the brain and are therapeutic targets for many neurological disorders including epilepsy and anxiety disorders. Glycine-activated chloride channels also mediate inhibitory neurotransmission and are emerging as important targets for pain medications. By elucidating the structural basis by which ivermectin binds to and activates both of these receptors, this project will inform the development of improved drugs for a wide variety of neurological disorders."},"children":[{"color":"#336699","name":"Prof Joseph Lynch","data":{"first_name":"Joseph","title":"Prof","dw_individual_id":"DW0032228","middle_name":"W","last_name":"Lynch","source_individual_id":"5016080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Joseph Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85342","size":1},{"color":"#336699","name":"Prof Rob Capon","data":{"first_name":"Rob","title":"Prof","dw_individual_id":"DW0012180","middle_name":"John","last_name":"Capon","source_individual_id":"5011505","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Rob Capon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79993","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75232","size":1},{"color":"#FF4D4D","name":"Cell Surface Mucins in Gastrointestinal Infection, Inflammation and Cancer Development","data":{"media_summary":"","end_year":2016,"keywords":["colorectal cancer","inflammatory bowel disease (IBD)","inflammation","mucins","mucosal inflammation"],"nhmrc_grant_id":1060698,"application_year":2013,"start_year":2014,"scientific_title":"Cell Surface Mucins in Gastrointestinal Infection, Inflammation and Cancer Development","node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis not elsewhere classified","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Prof Michael McGuckin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1060698","simplified_title":"Mucins in Gastrointestinal Disease","sub_type":"Standard Project Grant","total_budget":"461890.89","source_system":"Cell surface mucins are protective molecules that line all the wet surface of the body, including the gastrointestinal tract. Our research has uncovered that mucins regulate cell growth and cell death.  Inappropriate control by the mucins, could lead to chronic inflammation and formation of cancers. We will test how important these molecules are in the development of cancers in the intestine, and further explore the mechanism of action."},"children":[{"color":"#336699","name":"Prof Michael Mcguckin","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0044168","middle_name":"A","last_name":"Mcguckin","source_individual_id":"5016335","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Mcguckin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88447","size":1},{"color":"#336699","name":"Dr Yong Sheng","data":{"first_name":"Yong","title":"Dr","dw_individual_id":"DW0016188","middle_name":"Hua","last_name":"Sheng","source_individual_id":"5038757","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Yong Sheng"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81085","size":1},{"color":"#336699","name":"Prof Timothy Florin","data":{"first_name":"Timothy","title":"Prof","dw_individual_id":"DW0013048","middle_name":"H","last_name":"Florin","source_individual_id":"5014662","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Timothy Florin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80228","size":1},{"color":"#336699","name":"A/Pr Philip Sutton","data":{"first_name":"Philip","title":"A/Pr","dw_individual_id":"DW0010526","middle_name":"","last_name":"Sutton","source_individual_id":"RMIS4463796","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Philip Sutton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79558","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75231","size":1},{"color":"#FF4D4D","name":"Preventing depression and reducing the impact of aphasia in stroke patients and their caregivers a year post onset via a brief early intervention: a cluster randomised control trial of the Action Success Knowledge (ASK) program.","data":{"media_summary":"","end_year":2018,"keywords":["aphasia","stroke rehabilitation","speech pathology","evidence-based clinical practice","service delivery"],"nhmrc_grant_id":1060673,"application_year":2013,"start_year":2014,"scientific_title":"Preventing depression and reducing the impact of aphasia in stroke patients and their caregivers a year post onset via a brief early intervention: a cluster randomised control trial of the Action Success Knowledge (ASK) program.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy (excl. Physiotherapy)","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Linda Worrall","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1060673","simplified_title":"Can a brief early intervention prevent depression and help people live with aphasia a year after stroke?","sub_type":"Standard Project Grant","total_budget":"1291778.15","source_system":"Loss of language after stroke (aphasia) leads to problems with understanding, talking, reading and writing. Aphasia often leads to depression and poorer wellbeing for the person with aphasia and the caregiver. Our research has a) identified what it takes to live successfully with aphasia, b) translated the results to a program called ASK, and c) piloted ASK with promising outcomes in reducing symptoms of depression. We will measure the impact of ASK at 12 month post stroke."},"children":[{"color":"#336699","name":"Prof Linda Worrall","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0046389","middle_name":"Elizabeth","last_name":"Worrall","source_individual_id":"RMIS28004","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Worrall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/89016","size":1},{"color":"#336699","name":"Prof Leanne Togher","data":{"first_name":"Leanne","title":"Prof","dw_individual_id":"DW0028425","middle_name":"M","last_name":"Togher","source_individual_id":"5017950","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Leanne Togher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84351","size":1},{"color":"#336699","name":"Dr Miranda Rose","data":{"first_name":"Miranda","title":"Dr","dw_individual_id":"DW0027680","middle_name":"Lee","last_name":"Rose","source_individual_id":"5029868","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Miranda Rose"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84145","size":1},{"color":"#336699","name":"Dr Emma Power","data":{"first_name":"Emma","title":"Dr","dw_individual_id":"DW0021536","middle_name":"Helen","last_name":"Power","source_individual_id":"5024369","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Emma Power"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82537","size":1},{"color":"#336699","name":"Dr Asad Khan","data":{"first_name":"Asad","title":"Dr","dw_individual_id":"DW0008357","middle_name":"","last_name":"Khan","source_individual_id":"5018956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Asad Khan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78958","size":1},{"color":"#336699","name":"A/Pr Tammy Hoffmann","data":{"first_name":"Tammy","title":"A/Pr","dw_individual_id":"DW0007919","middle_name":"Coral","last_name":"Hoffmann","source_individual_id":"5015292","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Tammy Hoffmann"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78839","size":1},{"color":"#336699","name":"Prof Nina Simmons-Mackie","data":{"first_name":"Nina","title":"Prof","dw_individual_id":"DW0004640","middle_name":"N","last_name":"Simmons-Mackie","source_individual_id":"5019248","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nina Simmons-Mackie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77959","size":1},{"color":"#336699","name":"Dr Ian Kneebone","data":{"first_name":"Ian","title":"Dr","dw_individual_id":"5049259","middle_name":"Indrik","last_name":"Kneebone","source_individual_id":"5049259","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ian Kneebone"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76356","size":1},{"color":"#336699","name":"Dr Kyla Brown","data":{"first_name":"Kyla","title":"Dr","dw_individual_id":"5046988","middle_name":"Maree","last_name":"Brown","source_individual_id":"5046988","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kyla Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76305","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75228","size":1},{"color":"#FF4D4D","name":"Targeting the complement activation fragment C5a to improve the outcome from spinal cord injury","data":{"media_summary":"","end_year":2016,"keywords":["spinal cord injury","spinal cord injury management","neuroinflammation","complement activation","anti-inflammatory agents"],"nhmrc_grant_id":1060538,"application_year":2013,"health_keywords":["neuroprotection","magnetic resonance imaging (MRI)","neuropathology"],"scientific_title":"Targeting the complement activation fragment C5a to improve the outcome from spinal cord injury","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Marc Ruitenberg","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1060538","simplified_title":"A new anti-inflammatory treatment to improve the recovery from spinal cord injury","sub_type":"Standard Project Grant","total_budget":"400135.59","source_system":"This project will focus on the development of a new drug that is designed to attenuate the harmful inflammatory response that follows from spinal cord injury (SCI). The experiments will determine if the therapeutic targeting of an immune receptor molecule, called C5aR, can protect compromised neural tissues after injury against harmful inflammation and degeneration whilst also explore the mechanism behind the therapeutic effect."},"children":[{"color":"#336699","name":"Dr Marc Ruitenberg","data":{"first_name":"Marc","title":"Dr","dw_individual_id":"DW0039444","middle_name":"Jan","last_name":"Ruitenberg","source_individual_id":"5019219","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Marc Ruitenberg"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87228","size":1},{"color":"#336699","name":"Dr Nyoman Kurniawan","data":{"first_name":"Nyoman","title":"Dr","dw_individual_id":"DW0026087","middle_name":"Dana","last_name":"Kurniawan","source_individual_id":"5023196","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nyoman Kurniawan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83741","size":1},{"color":"#336699","name":"Prof Stephen Taylor","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0010587","middle_name":"M","last_name":"Taylor","source_individual_id":"RMIS41211","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79577","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75220","size":1},{"color":"#FF4D4D","name":"Engineering an Osteochondral Tissue for Cartilage Defect Repair","data":{"media_summary":"","end_year":2016,"keywords":["biomedical engineering","stem cells","cartilage","osteoarthritis","tissue engineering"],"nhmrc_grant_id":1060340,"application_year":2013,"start_year":2014,"scientific_title":"Engineering an Osteochondral Tissue for Cartilage Defect Repair","node_source":"NHMRC","node_type":"Grant","field_of_research":"Regenerative Medicine (incl. Stem Cells and Tissue Engineering)","research_area":"Basic Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"Prof Justin Cooper-White","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1060340","simplified_title":"Cartilage Defect Repair","sub_type":"Standard Project Grant","total_budget":"430645.59","source_system":"Osteoarthritis is the leading cause of pain and disability in Australia.  Our team has developed a novel method to make new cartilage tissue from patients' own bone marrow stem cells.  Through NHMRC funding we will optimize this process and test the repair technology in a large animal model."},"children":[{"color":"#336699","name":"Prof Justin Cooper-White","data":{"first_name":"Justin","title":"Prof","dw_individual_id":"DW0036010","middle_name":"J","last_name":"Cooper-White","source_individual_id":"RMIS2454623","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Justin Cooper-White"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86335","size":1},{"color":"#336699","name":"Dr Michael Doran","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0024580","middle_name":"R","last_name":"Doran","source_individual_id":"5014386","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michael Doran"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83305","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75199","size":1},{"color":"#FF4D4D","name":"Development of next generation drugs for chronic myeloid leukaemia","data":{"media_summary":"","end_year":2016,"keywords":["peptides","peptide synthesis","leukaemia","structural biology","structure-based drug design"],"nhmrc_grant_id":1060225,"application_year":2013,"start_year":2014,"scientific_title":"Development of next generation drugs for chronic myeloid leukaemia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Structural Biology (incl. Macromolecular Modelling)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1060225","simplified_title":"New drugs for chronic myeloid leukaemia","sub_type":"Standard Project Grant","total_budget":"622296.21","source_system":"Chronic myeloid leukaemia (CML) is one of the four most common types of leukaemia. With current therapies, 15_20% of patients newly diagnosed for CML will die in the next five years, and it is therefore vitally important to discover new treatments. The aim of this project is to develop a new generation of drugs to treat CML based on new approaches (i.e., different type of molecules and different binding site) that can combat the resistance acquired to the current treatments."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Dr Quentin Kaas","data":{"first_name":"Quentin","title":"Dr","dw_individual_id":"DW0037627","middle_name":"","last_name":"Kaas","source_individual_id":"5043464","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Quentin Kaas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86746","size":1},{"color":"#336699","name":"Dr Sonia Troeira Henriques","data":{"first_name":"Sonia","title":"Dr","dw_individual_id":"5048199","middle_name":"","last_name":"Troeira Henriques","source_individual_id":"5048199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sonia Troeira Henriques"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76327","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75193","size":1},{"color":"#FF4D4D","name":"Vaccination against herpesvirus entry","data":{"media_summary":"","end_year":2016,"keywords":["virus pathogenesis","virus eradication","viral immunology","viral vaccines","viral entry"],"nhmrc_grant_id":1060138,"application_year":2013,"health_keywords":["viral glycoproteins"],"scientific_title":"Vaccination against herpesvirus entry","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Philip Stevenson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1060138","simplified_title":"How to prevent herpesvirus infections","sub_type":"Standard Project Grant","total_budget":"483589.59","source_system":"Herpesviruses infect most Australians and cause recurrent ulcers, birth defects and cancer. Infection lasts lifelong, and spreads to close contacts without obvious clinical signs. Thus disease is hard to prevent. However we can learn much from related animal infections. We have shown that both mouse and human herpesviruses enter mice via cells in the nose. Thus human infections might follow the same route. We will define what body defences work here and whether vaccines can prevent infection."},"children":[{"color":"#336699","name":"A/Pr Philip Stevenson","data":{"first_name":"Philip","title":"A/Pr","dw_individual_id":"DW0034054","middle_name":"George","last_name":"Stevenson","source_individual_id":"5019294","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Philip Stevenson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85811","size":1},{"color":"#336699","name":"A/Pr Nicholas Davis-Poynter","data":{"first_name":"Nicholas","title":"A/Pr","dw_individual_id":"DW0012654","middle_name":"J","last_name":"Davis-Poynter","source_individual_id":"5014228","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nicholas Davis-Poynter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80128","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75184","size":1},{"color":"#FF4D4D","name":"Vesicular trafficking pathways underpinning neuronal secretion and survival","data":{"media_summary":"","end_year":2018,"keywords":["retrograde transport","neurotransmission","exocytosis","endocytosis","neurotoxins"],"nhmrc_grant_id":1060075,"application_year":2013,"start_year":2014,"scientific_title":"Vesicular trafficking pathways underpinning neuronal secretion and survival","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Frederic Meunier","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1060075","simplified_title":"Vesicular trafficking in neurons in health and disease","sub_type":"Research Fellowship","total_budget":"675811.75","source_system":"Plethora of diseases of the nervous system are caused by defects in vesicular trafficking including neurodegenerative diseases such as Alzheimers disease. I will explore the mechanisms underpinning synaptic vesicular trafficking using novel super resolution techniques and reveal the how secretory vesicles traffic to the plasma membrane, undergo exocytosis, and recycle. I will also explain how in the crowded environment of the presynaptic terminals, retrograde cargoes are transported back to the cell body thereby carrying survival signals."},"children":[{"color":"#336699","name":"Prof Frederic Meunier","data":{"first_name":"Frederic","title":"Prof","dw_individual_id":"DW0020864","middle_name":"A","last_name":"Meunier","source_individual_id":"5016455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frederic Meunier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82341","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75181","size":1},{"color":"#FF4D4D","name":"Pathogenic flaviviruses: molecular mechanisms of disease, host response and vaccines","data":{"media_summary":"","end_year":2018,"keywords":["virology","infectious diseases","emerging diseases","vaccines","molecular virology"],"nhmrc_grant_id":1059794,"application_year":2013,"health_keywords":["pathogenesis","cancer therapy"],"scientific_title":"Pathogenic flaviviruses: molecular mechanisms of disease, host response and vaccines","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1059794","simplified_title":"Pathogenic flaviviruses: molecular mechanisms of disease, host response, and vaccines","sub_type":"Research Fellowship","total_budget":"675811.75","source_system":"The application is aimed at advancing our understanding of the viral and host processes determining outcome of infection with pathogenic flaviviruses (i.e. West Nile virus) to the level allowing most comprehensive design of effective vaccines and anti-viral drugs.  One of the aims is also to develop novel viral delivery vectors for cancer therapy based on self-replicating RNA of an attenuated Australian strain of West Nile virus, Kunjin."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75167","size":1},{"color":"#FF4D4D","name":"Inflammasome function in protection against infectious disease and autoimmunity","data":{"media_summary":"","end_year":2018,"keywords":["innate immunity","cell death","autoimmunity","lupus","cancer"],"nhmrc_grant_id":1059729,"application_year":2013,"start_year":2014,"scientific_title":"Inflammasome function in protection against infectious disease and autoimmunity","node_source":"NHMRC","node_type":"Grant","field_of_research":"Innate Immunity","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Katryn Stacey","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1059729","simplified_title":"Response of the body to microbes, and development of autoimmunity","sub_type":"Research Fellowship","total_budget":"611644.15","source_system":"Inflammation, characterised by swelling, heat, pain and redness, is a normal response to injury and infection. Many human diseases such as gout, athersclerosis, diabetes and Alzheimers disease involve some inflammation, mediated through a common pathway termed the inflammasome. This project will investigate the proteins involved in this pathway and how they interact in their normal role of combatting infections, as well as a possible defect in this pathway in autoimmune patients."},"children":[{"color":"#336699","name":"Dr Katryn Stacey","data":{"first_name":"Katryn","title":"Dr","dw_individual_id":"DW0028117","middle_name":"Jane","last_name":"Stacey","source_individual_id":"5017656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katryn Stacey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84258","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75161","size":1},{"color":"#FF4D4D","name":"Understanding and Treating Inflammatory Disease","data":{"media_summary":"","end_year":2018,"keywords":["inflammatory diseases","inflammatory cytokines","inflammatory bowel disease (IBD)","diabetes","respiratory diseases"],"nhmrc_grant_id":1059726,"application_year":2013,"health_keywords":["arthritis","endoplasmic reticulum","infectious diseases"],"scientific_title":"Understanding and Treating Inflammatory Disease","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Immunology not elsewhere classified","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof Michael McGuckin","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1059726","simplified_title":"Understanding and Treating Inflammatory Disease","sub_type":"Research Fellowship","total_budget":"739979.35","source_system":"Prof McGuckin is studying common chronic diseases (gut and respiratory inflammatory diseases, arthritis, and obesity and diabetes) that are major contributors to poor health in the Australian community and are major contributors to healthcare expenditure.  His research includes basic studies elucidating the biological basis of these diseases and then uses this new knowledge to develop new therapeutic approaches to treatment.  The new therapeutic approaches will be tested in model systems as a prelude to clinical trials."},"children":[{"color":"#336699","name":"Prof Michael Mcguckin","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0044168","middle_name":"A","last_name":"Mcguckin","source_individual_id":"5016335","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Mcguckin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88447","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75160","size":1},{"color":"#FF4D4D","name":"Mothers and their Childrens Health study: understanding disparities in health and health service utilisation among Australian families","data":{"media_summary":"longitudinal cohort study","end_year":2017,"keywords":["maternal and child health","family studies","health policy","access to health care","cognition"],"nhmrc_grant_id":1059550,"application_year":2013,"health_keywords":["nutrition","physical activity","social determinants of health","psychology","longitudinal cohort study"],"scientific_title":"Mothers and their Childrens Health study: understanding disparities in health and health service utilisation among Australian families","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Gita Mishra","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1059550","simplified_title":"Mothers' and their Children's Health: understanding disparities in health and health service use among young Australian families","sub_type":"Standard Project Grant","total_budget":"669041.58","source_system":"The Mothers and their Childrens Health study will advance understanding of the risks to child health and development and help guide health policies for families across Australia. It builds on 17 years of data from a leading study of Australian womens health with a new survey on all the children of 4000 mothers from that study. It is uniquely placed to investigate how the history of maternal and family characteristics affects the health and development of all the children in a family."},"children":[{"color":"#336699","name":"Prof Gita Mishra","data":{"first_name":"Gita","title":"Prof","dw_individual_id":"DW0038575","middle_name":"Devi","last_name":"Mishra","source_individual_id":"5012169","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gita Mishra"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86995","size":1},{"color":"#336699","name":"Prof Annette Dobson","data":{"first_name":"Annette","title":"Prof","dw_individual_id":"DW0036318","middle_name":"J","last_name":"Dobson","source_individual_id":"5011952","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Annette Dobson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86411","size":1},{"color":"#336699","name":"Prof Virginia Slaughter","data":{"first_name":"Virginia","title":"Prof","dw_individual_id":"DW0022174","middle_name":"","last_name":"Slaughter","source_individual_id":"5020369","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Virginia Slaughter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82715","size":1},{"color":"#336699","name":"A/Pr Deborah Loxton","data":{"first_name":"Deborah","title":"A/Pr","dw_individual_id":"DW0020495","middle_name":"J","last_name":"Loxton","source_individual_id":"5019044","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Deborah Loxton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82234","size":1},{"color":"#336699","name":"Prof Peter Davies","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0018572","middle_name":"Sw","last_name":"Davies","source_individual_id":"5014241","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Davies"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81758","size":1},{"color":"#336699","name":"Dr Leigh Tooth","data":{"first_name":"Leigh","title":"Dr","dw_individual_id":"DW0010698","middle_name":"Rhonda","last_name":"Tooth","source_individual_id":"RMIS1112435","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Leigh Tooth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79606","size":1},{"color":"#336699","name":"Dr Kylie Hesketh","data":{"first_name":"Kylie","title":"Dr","dw_individual_id":"DW0002169","middle_name":"","last_name":"Hesketh","source_individual_id":"5015211","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kylie Hesketh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77268","size":1},{"color":"#336699","name":"Prof Ilona Koupil","data":{"first_name":"Ilona","title":"Prof","dw_individual_id":"5048294","middle_name":"","last_name":"Koupil","source_individual_id":"5048294","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ilona Koupil"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76334","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75150","size":1},{"color":"#FF4D4D","name":"Polarisation of insulin secretion in beta cells","data":{"media_summary":"","end_year":2016,"keywords":["insulin secretion","cell biology","exocytosis","glucose homeostasis","type 2 diabetes mellitus (non-insulin dependent diabetes mellitus)"],"nhmrc_grant_id":1059426,"application_year":2013,"start_year":2014,"scientific_title":"Polarisation of insulin secretion in beta cells","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof Peter Thorn","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1059426","simplified_title":"How is insulin secretion regulated in health and disease?","sub_type":"Standard Project Grant","total_budget":"693777.06","source_system":"Type 2 diabetes is reaching epidemic proportions across the world and is a huge burden in health care costs. We know it is a multifaceted disease with many symptoms, one of which is a reduction in insulin secretion. This proposal sets out to determine the mechanisms of insulin secretion from healthy tissue and what goes wrong in disease."},"children":[{"color":"#336699","name":"Prof Peter Thorn","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0016656","middle_name":"","last_name":"Thorn","source_individual_id":"5017929","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Thorn"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81226","size":1},{"color":"#336699","name":"Prof Jenny Gunton","data":{"first_name":"Jenny","title":"Prof","dw_individual_id":"DW0001953","middle_name":"E","last_name":"Gunton","source_individual_id":"5014988","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jenny Gunton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77200","size":1},{"color":"#336699","name":"Prof Herbert Gaisano","data":{"first_name":"Herbert","title":"Prof","dw_individual_id":"DW0001696","middle_name":"","last_name":"Gaisano","source_individual_id":"5019985","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Herbert Gaisano"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77133","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75141","size":1},{"color":"#FF4D4D","name":"New antibiotics and treatment methods against drug-resistant bacteria","data":{"media_summary":"","end_year":2018,"keywords":["bacterial infection","antibiotic resistance","drug discovery","mechanism of action","histology"],"nhmrc_grant_id":1059354,"application_year":2013,"start_year":2014,"scientific_title":"New antibiotics and treatment methods against drug-resistant bacteria","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Infection Agents (incl. Prions)","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Matthew Cooper","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1059354","simplified_title":"New drugs against superbugs","sub_type":"Research Fellowship","total_budget":"739979.35","source_system":"Infectious disease is a leading cause of death, and the emergence of \"superbugs\" in the community and hospitals is of grave concern. We are developing new, powerful antibiotics that can kill superbugs using forgotten drugs from the 1970s.  These will combat bacteria that cause pneumonia, skin and urinary track infections; diseases that cause death and discomfort for thousands of Australians today.  We will also develop methods to directly remove bacteria from blood infections."},"children":[{"color":"#336699","name":"Prof Matthew Cooper","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0024249","middle_name":"A","last_name":"Cooper","source_individual_id":"5018347","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83230","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75134","size":1},{"color":"#FF4D4D","name":"Endocrine control of metabolic disease","data":{"media_summary":"","end_year":2018,"keywords":["endocrinology","nuclear receptors","obesity","diabetes","transgenic mouse"],"nhmrc_grant_id":1059341,"application_year":2013,"health_keywords":["metabolism","gene regulation","skeletal muscle"],"scientific_title":"Endocrine control of metabolic disease","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Systems Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1059341","simplified_title":"Hormonal control of metabolism","sub_type":"Research Fellowship","total_budget":"739979.35","source_system":"The nuclear hormone receptors (NRs) translate hormonal, metabolic & pathophysiological signals into gene regulation, and several NRs are very important in human health. NRs are important therapeutics targets in the treatment of dyslipidemia, insulin insensitivity and breast cancer. Our data identifies new and novel NR targets that can be therapeutically/pharmacologically exploited in the context of exercise capacity, metabolic disease and breast cancer."},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75133","size":1},{"color":"#FF4D4D","name":"Determinants of progression of actinic keratoses to squamous cancer","data":{"media_summary":"","end_year":2018,"keywords":["solar keratosis","oncogenesis","tumour immunology","virus pathogenesis","skin cancer"],"nhmrc_grant_id":1059012,"application_year":2013,"start_year":2014,"scientific_title":"Determinants of progression of actinic keratoses to squamous cancer","node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Prof Ian Frazer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1059012","simplified_title":"What makes sunspots become invasive cancers","sub_type":"Standard Project Grant","total_budget":"1149187.62","source_system":"Sunspots can progress to skin cancers, but often go away on their own. Knowing which ones will go away would make management of sun damaged skin easier, and might let us develop new treatments. This grant will examine why some sunspots progress and others don't."},"children":[{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1},{"color":"#336699","name":"Dr Tarl Prow","data":{"first_name":"Tarl","title":"Dr","dw_individual_id":"DW0039189","middle_name":"","last_name":"Prow","source_individual_id":"5020354","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Tarl Prow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87159","size":1},{"color":"#336699","name":"Prof H. Peter Soyer","data":{"first_name":"H. Peter","title":"Prof","dw_individual_id":"DW0028088","middle_name":"","last_name":"Soyer","source_individual_id":"5019889","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof H. Peter Soyer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84249","size":1},{"color":"#336699","name":"Prof Philip Hugenholtz","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0019751","middle_name":"","last_name":"Hugenholtz","source_individual_id":"5021803","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Philip Hugenholtz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82032","size":1},{"color":"#336699","name":"A/Pr E Geoffrey Playford","data":{"first_name":"E Geoffrey","title":"A/Pr","dw_individual_id":"DW0009678","middle_name":"","last_name":"Playford","source_individual_id":"5017017","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr E Geoffrey Playford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79327","size":1},{"color":"#336699","name":"A/Pr Marcel Dinger","data":{"first_name":"Marcel","title":"A/Pr","dw_individual_id":"DW0006980","middle_name":"Eduard","last_name":"Dinger","source_individual_id":"5014341","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Marcel Dinger"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78595","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75103","size":1},{"color":"#FF4D4D","name":"Disorders of gonadal development: Molecular approaches to improved patient care","data":{"media_summary":"","end_year":2018,"keywords":["sexual development","sex reversal","intersexuality","testicular cancer","germ cells"],"nhmrc_grant_id":1059006,"application_year":2013,"health_keywords":["testis development","organogenesis"],"scientific_title":"Disorders of gonadal development: Molecular approaches to improved patient care","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Peter Koopman","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1059006","simplified_title":"Managing intersex disorders and testicular cancer","sub_type":"Research Fellowship","total_budget":"836914.75","source_system":"We will use new genomic technologies to identify the genetic causes of disorders of sex development (DSD), a common and often distressing class of birth defect. Knowing the molecular lesion will take the guesswork out of diagnosis and treatment of DSD children. We will also exploit a new discovery to develop new means of rapid, cost-effective, non-invasive diagnosis and therapy for testicular cancer, the commonest form of cancer in men under 30."},"children":[{"color":"#336699","name":"Prof Peter Koopman","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0043570","middle_name":"A","last_name":"Koopman","source_individual_id":"5015773","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Koopman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88298","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75102","size":1},{"color":"#FF4D4D","name":"Circulating Biomarkers in advanced classical Hodgkin Lymphoma","data":{"media_summary":"","end_year":2016,"keywords":["Hodgkin's disease","lymphoma","biomarkers","microrna","young adults"],"nhmrc_grant_id":1058993,"application_year":2013,"start_year":2014,"scientific_title":"Circulating Biomarkers in advanced classical Hodgkin Lymphoma","node_source":"NHMRC","node_type":"Grant","field_of_research":"Haematological Tumours","research_area":"Clinical Medicine and Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Prof Maher Gandhi","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1058993","simplified_title":"Blood biomarkers in Hodgkin Lymphoma","sub_type":"Standard Project Grant","total_budget":"522175.59","source_system":"Up until now, clinicians have relied on scans to help them judge how well people are responding to chemotherapy. Imaging can be difficult to interpret, and is generally limited to one scan before treatment starts, and another when treatment is finished. This study will attempt to validate novel blood tests to assist Doctors to evaluate patients when scans are not available, and to assist scan interpretation when they are. This will enable patients to have more individually tailored treatment."},"children":[{"color":"#336699","name":"Prof Maher Gandhi","data":{"first_name":"Maher","title":"Prof","dw_individual_id":"DW0042548","middle_name":"","last_name":"Gandhi","source_individual_id":"RMIS3246530","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Maher Gandhi"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88034","size":1},{"color":"#336699","name":"Dr Leanne Berkahn","data":{"first_name":"Leanne","title":"Dr","dw_individual_id":"DW0035356","middle_name":"","last_name":"Berkahn","source_individual_id":"5038593","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Leanne Berkahn"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86163","size":1},{"color":"#336699","name":"Dr Kim-Anh Le Cao","data":{"first_name":"Kim-Anh","title":"Dr","dw_individual_id":"DW0031996","middle_name":"","last_name":"Le Cao","source_individual_id":"5025146","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kim-Anh Le Cao"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85275","size":1},{"color":"#336699","name":"Prof Michael Fulham","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0024962","middle_name":"Joseph","last_name":"Fulham","source_individual_id":"5014731","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Fulham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83418","size":1},{"color":"#336699","name":"A/Pr Judith Trotman","data":{"first_name":"Judith","title":"A/Pr","dw_individual_id":"DW0022620","middle_name":"","last_name":"Trotman","source_individual_id":"5018009","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Judith Trotman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82824","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75101","size":1},{"color":"#FF4D4D","name":"Uncover how Myosin-6 underpins the Ca2+-dependent recruitment of secretory vesicles to the cortical actin network","data":{"media_summary":"","end_year":2016,"keywords":["exocytosis","neurotransmission","myosin","actin cytoskeleton","vesicle trafficking"],"nhmrc_grant_id":1058769,"application_year":2013,"start_year":2014,"scientific_title":"Uncover how Myosin-6 underpins the Ca2+-dependent recruitment of secretory vesicles to the cortical actin network","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Frederic Meunier","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1058769","simplified_title":"Myosin-6 in neuroexocytosis","sub_type":"Standard Project Grant","total_budget":"551066.53","source_system":"Neuronal communication relies on the process of exocytosis by which neurons release a neurotransmitter. Exocytosis underpins processes such as the simplest muscle movement to complex tasks such as learning and memory, and is altered in several neurodegenerative pathologies. We will investigate how the protein Myosin-6 controls exocytosis. This research will be important for understanding how neurons communicate in health and disease and will be relevant to other processes such as insulin release in diabetes."},"children":[{"color":"#336699","name":"Dr Brett Collins","data":{"first_name":"Brett","title":"Dr","dw_individual_id":"DW0041718","middle_name":"Martin","last_name":"Collins","source_individual_id":"5014007","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brett Collins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87821","size":1},{"color":"#336699","name":"Prof Frederic Meunier","data":{"first_name":"Frederic","title":"Prof","dw_individual_id":"DW0020864","middle_name":"A","last_name":"Meunier","source_individual_id":"5016455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frederic Meunier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82341","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75084","size":1},{"color":"#FF4D4D","name":"Endosomal sorting of amyloid precursor protein in Alzheimer's disease","data":{"media_summary":"","end_year":2017,"keywords":["protein trafficking","endosomes","X-ray crystallography","molecular neuroscience","Alzheimer disease"],"nhmrc_grant_id":1058734,"application_year":2013,"health_keywords":["amyloid precursor protein","protein interactions"],"scientific_title":"Endosomal sorting of amyloid precursor protein in Alzheimer's disease","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Trafficking","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Brett Collins","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1058734","simplified_title":"Regulation of amyloid protein in Alzheimer's disease","sub_type":"Standard Project Grant","total_budget":"838203.28","source_system":"Alzheimer's Disease is a progressive neurological disorder and is the most common cause of dementia. Effective treatments are desperately needed, but none are currently available. The toxic amyloid peptide A_ is central to disease pathology and is derived from breakdown of the Alzheimers amyloid precursor protein (APP). In this project we will examine the interactions between APP and the molecular machinery that controls its location in the cell and subsequent degradation."},"children":[{"color":"#336699","name":"Dr Brett Collins","data":{"first_name":"Brett","title":"Dr","dw_individual_id":"DW0041718","middle_name":"Martin","last_name":"Collins","source_individual_id":"5014007","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brett Collins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87821","size":1},{"color":"#336699","name":"A/Pr Rohan Teasdale","data":{"first_name":"Rohan","title":"A/Pr","dw_individual_id":"DW0040022","middle_name":"D","last_name":"Teasdale","source_individual_id":"5017848","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Rohan Teasdale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87368","size":1},{"color":"#336699","name":"Prof Wanjin Hong","data":{"first_name":"Wanjin","title":"Prof","dw_individual_id":"DW0013721","middle_name":"","last_name":"Hong","source_individual_id":"5032649","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Wanjin Hong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80397","size":1},{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1},{"color":"#336699","name":"A/Pr Elizabeth Coulson","data":{"first_name":"Elizabeth","title":"A/Pr","dw_individual_id":"DW0006736","middle_name":"J","last_name":"Coulson","source_individual_id":"5014079","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Elizabeth Coulson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78524","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75081","size":1},{"color":"#FF4D4D","name":"Multiscale analysis of plasma membrane microdomains in health and disease","data":{"media_summary":"","end_year":2018,"keywords":["cell biology","membrane trafficking","caveolae","membrane biology","cell membrane"],"nhmrc_grant_id":1058565,"application_year":2013,"start_year":2014,"scientific_title":"Multiscale analysis of plasma membrane microdomains in health and disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Receptors and Membrane Biology","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1058565","simplified_title":"The plasma membrane in health and disease","sub_type":"Research Fellowship","total_budget":"836914.75","source_system":"The cell surface encloses the cell in a protective barrier but it must also respond to signals coming from outside the cell. To accomplish this, the cell surface is made up of numerous regions each with a specialised role. This proposal aims to examine how lipids and proteins work together to make these specialised regions and aims to understand what goes wrong in diseases such as muscular dystrophy."},"children":[{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75069","size":1},{"color":"#FF4D4D","name":"Inhibitory neurotransmitter receptors as therapeutic targets for chronic pain and anxiety disorders","data":{"media_summary":"","end_year":2018,"keywords":["gamma-aminobutyric acid (GABA) receptors","glycine receptors","chronic pain","anxiety disorders","patch clamp"],"nhmrc_grant_id":1058542,"application_year":2013,"health_keywords":["drug development","structure-based drug design"],"scientific_title":"Inhibitory neurotransmitter receptors as therapeutic targets for chronic pain and anxiety disorders","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Joseph Lynch","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1058542","simplified_title":"Finding new ways to treat pain and anxiety disorders","sub_type":"Research Fellowship","total_budget":"739979.35","source_system":"There are currently few effective long-term treatments for chronic pain and anxiety disorders. Here we propose to develop innovative therapies for both of these debilitating neurological disorders. In addition, we plan to improve our current understanding of how these disorders occur in the first place. This may identify novel potential therapeutic strategies for treating pain, anxiety and a host of other neurological disorders."},"children":[{"color":"#336699","name":"Prof Joseph Lynch","data":{"first_name":"Joseph","title":"Prof","dw_individual_id":"DW0032228","middle_name":"W","last_name":"Lynch","source_individual_id":"5016080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Joseph Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85342","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75065","size":1},{"color":"#FF4D4D","name":"Do the Developmental vitamin D-deficiency and maternal immune activation animal models of schizophrenia have convergent early pathways ?","data":{"media_summary":"","end_year":2016,"keywords":["schizophrenia","vitamin D","dopamine","maternal infection","brain development"],"nhmrc_grant_id":1057883,"application_year":2013,"health_keywords":["ontogeny"],"scientific_title":"Do the Developmental vitamin D-deficiency and maternal immune activation animal models of schizophrenia have convergent early pathways ?","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Darryl Eyles","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1057883","simplified_title":"Convergent pathways in diverse animal modls of schizophrenia","sub_type":"Standard Project Grant","total_budget":"657891.21","source_system":"The etiology of schizophrenia is unknown but it is generally considered to have a neurodevelopmental basis and involve altered dopamine signaling. Using two distinct developmental animal models of schizophrenia we have shown convergent gestational abnormalities in how dopamine systems develop. This is possibly a convergent early etiological mechanism in schizophrenia."},"children":[{"color":"#336699","name":"A/Pr Darryl Eyles","data":{"first_name":"Darryl","title":"A/Pr","dw_individual_id":"DW0042305","middle_name":"W","last_name":"Eyles","source_individual_id":"5014564","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Darryl Eyles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87979","size":1},{"color":"#336699","name":"Dr Urs Meyer","data":{"first_name":"Urs","title":"Dr","dw_individual_id":"5048352","middle_name":"","last_name":"Meyer","source_individual_id":"5048352","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Urs Meyer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76337","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75023","size":1},{"color":"#FF4D4D","name":"The Developmental vitamin D-deficiency animal model of schizophrenia:- Critical window for intervention and optimal dose","data":{"media_summary":"","end_year":2016,"keywords":["schizophrenia","brain development","vitamin D","ontogeny","animal model"],"nhmrc_grant_id":1057882,"application_year":2013,"start_year":2014,"scientific_title":"The Developmental vitamin D-deficiency animal model of schizophrenia:- Critical window for intervention and optimal dose","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Darryl Eyles","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1057882","simplified_title":"What effect does the dose or the timing of vitamin D administration have on brain development in a vitamin D deficient animal","sub_type":"Standard Project Grant","total_budget":"359455.59","source_system":"We have established that low levels of vitamin D at birth increase the risk of children developing schizophrenia in later life. Our studies indicate this risk is dose-dependent and may be enhanced if developmental vitamin D (DVD) deficiency is extended into postnatal life implying there may be an early critical vitamin D threshold and a critical window of exposure required to avert schizophrenia. This project will examine this and the effects of supplements using our DVD-deficiency animal model."},"children":[{"color":"#336699","name":"A/Pr Darryl Eyles","data":{"first_name":"Darryl","title":"A/Pr","dw_individual_id":"DW0042305","middle_name":"W","last_name":"Eyles","source_individual_id":"5014564","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Darryl Eyles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87979","size":1},{"color":"#336699","name":"A/Pr Thomas Burne","data":{"first_name":"Thomas","title":"A/Pr","dw_individual_id":"DW0023865","middle_name":"Henry Johnston","last_name":"Burne","source_individual_id":"5013713","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thomas Burne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83125","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75022","size":1},{"color":"#FF4D4D","name":"The C-type lectin Mincle exemplifies a new mode of sterile inflammation in cardiovascular disease","data":{"media_summary":"","end_year":2016,"keywords":["inflammation","macrophage biology","lectins","neuronal death","cardiac ischaemia"],"nhmrc_grant_id":1057846,"application_year":2013,"health_keywords":["autophagy","gene regulation"],"scientific_title":"The C-type lectin Mincle exemplifies a new mode of sterile inflammation in cardiovascular disease","start_year":2014,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development, Proliferation and Death","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Christine Wells","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1057846","simplified_title":"Mincle has a dual role in tissue loss and inflammation after ischemic injury","sub_type":"Standard Project Grant","total_budget":"596871.21","source_system":"This project investigates two of the life-changing cardiovascular events that most commonly impact on Australians today; Heart attack and Stroke. These diseases often leave individuals debilitated with a long recovery period, and for many people the event is fatal. We have shown that blocking the action of an immune component, \"Mincle\", reduces the inflammation associated with stroke, and improves recovery. This project looks at what Mincle does in brain and heart muscle, and why blocking Mincle protects cells from loss of oxygen."},"children":[{"color":"#336699","name":"A/Pr Christine Wells","data":{"first_name":"Christine","title":"A/Pr","dw_individual_id":"DW0040397","middle_name":"Anne","last_name":"Wells","source_individual_id":"5018258","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Christine Wells"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87466","size":1},{"color":"#336699","name":"A/Pr Thiruma Arumugam","data":{"first_name":"Thiruma","title":"A/Pr","dw_individual_id":"DW0011513","middle_name":"Valavan","last_name":"Arumugam","source_individual_id":"5019753","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thiruma Arumugam"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79828","size":1},{"color":"#336699","name":"Prof Nadia Rosenthal","data":{"first_name":"Nadia","title":"Prof","dw_individual_id":"DW0009972","middle_name":"Alicia","last_name":"Rosenthal","source_individual_id":"5017266","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nadia Rosenthal"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79406","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75019","size":1},{"color":"#FF4D4D","name":"Regulation of neural progenitor cell self-renewal by the RNA-binding protein ZFP36L1 during development and disease","data":{"media_summary":"","end_year":2016,"keywords":["neural stem cell","RNA binding proteins","transcription factor","neural development","cortical development"],"nhmrc_grant_id":1057751,"application_year":2013,"start_year":2014,"scientific_title":"Regulation of neural progenitor cell self-renewal by the RNA-binding protein ZFP36L1 during development and disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Michael Piper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1057751","simplified_title":"Post-translational control of neural stem cell activity in development and disease","sub_type":"Standard Project Grant","total_budget":"339794.97","source_system":"The timely differentiation of neural stem cells is critical during development, and the unrestrained proliferation of neural stem cells in the adult can lead to deadly brain cancers such as glioma. At present our understanding of the key molecules that regulate neural stem cell behaviour during these processes remains limited. In this proposal we will investigate the molecular determinants underpinning neural stem cell biology, both within the developing brain, and within glioma."},"children":[{"color":"#336699","name":"Dr Timothy Bailey","data":{"first_name":"Timothy","title":"Dr","dw_individual_id":"DW0035202","middle_name":"Lawrence","last_name":"Bailey","source_individual_id":"5040904","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Timothy Bailey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86127","size":1},{"color":"#336699","name":"Dr Julian Heng","data":{"first_name":"Julian","title":"Dr","dw_individual_id":"DW0025443","middle_name":"I","last_name":"Heng","source_individual_id":"5015197","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Julian Heng"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83550","size":1},{"color":"#336699","name":"Dr Michael Piper","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0021487","middle_name":"J","last_name":"Piper","source_individual_id":"RMIS3987189","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Michael Piper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82523","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/75011","size":1},{"color":"#FF4D4D","name":"A stratified radomised control trial of an intensive, comprehensive aphasia program to compare patient outcomes post stroke with usual care","data":{"media_summary":"","end_year":2018,"keywords":["aphasia","stroke rehabilitation","speech pathology","translational research","health economics"],"nhmrc_grant_id":1057047,"application_year":2013,"health_keywords":["health education","caregivers","service delivery"],"scientific_title":"A stratified radomised control trial of an intensive, comprehensive aphasia program to compare patient outcomes post stroke with usual care","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy (excl. Physiotherapy)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Linda Worrall","higher_grant_type":"NHMRC Partnerships","purl":"http://purl.org/au-research/grants/nhmrc/1057047","simplified_title":"Can a new intensive model of aphasia rehabilitation achieve better outcomes than usual care?","sub_type":"Partnership Project for Better Health","total_budget":"777188.34","source_system":"Aphasia is a chronic communication disability that affects language processing (talking, understanding, reading & writing) after a brain injury, such as a stroke. Access to rehabilitation services is highly variable, compounding experiences of social isolation, depression & poorer quality of life. Our intensive & comprehensive Aphasia LIFT program has yielded improvements in communication & quality of life, & may provide more cost effective rehabilitation. This study examines whether LIFT is more effective than current models of usual care."},"children":[{"color":"#336699","name":"Prof Linda Worrall","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0046389","middle_name":"Elizabeth","last_name":"Worrall","source_individual_id":"RMIS28004","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Worrall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/89016","size":1},{"color":"#336699","name":"Prof Elizabeth Ward","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0040334","middle_name":"Celeste","last_name":"Ward","source_individual_id":"RMIS15276","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Ward"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87452","size":1},{"color":"#336699","name":"Dr Lennert Veerman","data":{"first_name":"Lennert","title":"Dr","dw_individual_id":"DW0028570","middle_name":"Lennert","last_name":"Veerman","source_individual_id":"5042815","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Lennert Veerman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84394","size":1},{"color":"#336699","name":"Dr Denise O'Connor","data":{"first_name":"Denise","title":"Dr","dw_individual_id":"DW0015319","middle_name":"Ann","last_name":"O'Connor","source_individual_id":"5011904","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Denise O'Connor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80858","size":1},{"color":"#336699","name":"Dr Asad Khan","data":{"first_name":"Asad","title":"Dr","dw_individual_id":"DW0008357","middle_name":"","last_name":"Khan","source_individual_id":"5018956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Asad Khan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78958","size":1},{"color":"#336699","name":"A/Pr David Copland","data":{"first_name":"David","title":"A/Pr","dw_individual_id":"DW0006716","middle_name":"A","last_name":"Copland","source_individual_id":"5014073","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr David Copland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78522","size":1},{"color":"#336699","name":"Ms Melissa Lawrie","data":{"first_name":"Melissa","title":"Ms","dw_individual_id":"5049120","middle_name":"Deleece","last_name":"Lawrie","source_individual_id":"5049120","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Melissa Lawrie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76339","size":1},{"color":"#336699","name":"Dr Moya Pattie","data":{"first_name":"Moya","title":"Dr","dw_individual_id":"5047041","middle_name":"Anne","last_name":"Pattie","source_individual_id":"5047041","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Moya Pattie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76311","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74996","size":1},{"color":"#FF4D4D","name":"2012 Equipment Grant","data":{"media_summary":"","end_year":2013,"nhmrc_grant_id":9000110,"application_year":2012,"start_year":2012,"scientific_title":"2012 Equipment Grant","node_source":"NHMRC","node_type":"Grant","field_of_research":"n-a","research_area":"","for_category":"N-A","cia_name":"Nicole Shively","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/9000110","simplified_title":"2012 Equipment Grant","sub_type":"Equipment Grant","total_budget":"549934.53","source_system":""},"children":[{"color":"#336699","name":"Nicole Shively","data":{"first_name":"Nicole","title":"","dw_individual_id":"DW0038843","middle_name":"","last_name":"Shively","source_individual_id":"5013018","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Nicole Shively"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87065","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74952","size":1},{"color":"#FF4D4D","name":"Modifiable risk factors for Serious Mental Illness - an integrated program of epidemiology, genetics and clinical trials","data":{"media_summary":"","end_year":2018,"keywords":["schizophrenia and related disorders","vitamin D","epidemiology","early psychosis","clinical trial"],"nhmrc_grant_id":1056929,"application_year":2012,"health_keywords":["genetic epidemiology"],"scientific_title":"Modifiable risk factors for Serious Mental Illness - an integrated program of epidemiology, genetics and clinical trials","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Prof John McGrath","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/1056929","simplified_title":"Modifiable risk factors for Serious Mental Illness - an integrated program.","sub_type":"Targeted Call for Research - John Cade Fellowship in Mental Health Research","total_budget":"3750000","source_system":"John McGrath has discovered that vitamin D during brain development is associated with psychosis. Just as the use of folate decreased the incidence of spina bifida, vitamin D supplementation could decrease the incidence of psychosis. Using international samples, McGrath will search for modifiable risk factors for mental illness related to nutrition, infection and stress. He will use the latest methods from genetics to explore modifiable risk factors and undertake clinical trials."},"children":[{"color":"#336699","name":"Prof John Mcgrath","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0009022","middle_name":"Joseph","last_name":"Mcgrath","source_individual_id":"RMIS3680751","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mcgrath"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79147","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74920","size":1},{"color":"#FF4D4D","name":"Assessing vaccine effectiveness of publicly funded vaccination programs in Queensland","data":{"media_summary":"","end_year":2014,"keywords":["vaccine efficacy","vaccine-preventable diseases","epidemiology","data linkage","pertussis"],"nhmrc_grant_id":1056219,"application_year":2012,"health_keywords":["rotavirus"],"scientific_title":"Assessing vaccine effectiveness of publicly funded vaccination programs in Queensland","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Preventive Medicine","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Sarah Sheridan","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1056219","simplified_title":"Assessing vaccine effectiveness of publicly funded vaccination programs in Queensland","sub_type":"Public Health Postgraduate Scholarship","total_budget":"79514.86","source_system":"I will measure how well three vaccines on the national immunisation schedule prevent disease in Queensland. Pertussis (whooping cough), rotavirus, and varicella (chicken-pox) vaccines will be assessed using routinely collected health data, such as disease notifications and hospitalisations, and vaccination data. The findings of this research will contribute to evaluating the effectiveness of these publicly funded vaccination programs and will provide an evidence base for future decision-making."},"children":[{"color":"#336699","name":"Dr Sarah Sheridan","data":{"first_name":"Sarah","title":"Dr","dw_individual_id":"5046596","middle_name":"Louise","last_name":"Sheridan","source_individual_id":"5046596","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sarah Sheridan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76263","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74864","size":1},{"color":"#FF4D4D","name":"Genomic changes in lung malignancy","data":{"media_summary":"epigenetics","end_year":2015,"keywords":["lung cancer","diagnostic marker","cancer detection","cancer prognosis","cancer progression"],"nhmrc_grant_id":1056113,"application_year":2012,"health_keywords":["cancer genetics","cancer cell biology","gene mutations","gene discovery","epigenetics"],"scientific_title":"Genomic changes in lung malignancy","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Genetics","research_area":"Clinical Medicine and Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Dr Marissa Daniels","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1056113","simplified_title":"Biological drivers of lung cancer","sub_type":"Medical/Dental Postgraduate Scholarship","total_budget":"89529.37","source_system":"Lung cancer is a leading cause of cancer death globally. Symptoms may not develop until disease is advanced, so it is often incurable at diagnosis. Scientific developments have greatly improved our ability to test for the changes in DNA structure and function responsible for this deadly disease and its progression. This study examines whole lung cancer genomes then uses these findings to develop safer methods for detection based on changes in DNA sequence."},"children":[{"color":"#336699","name":"Dr Marissa Daniels","data":{"first_name":"Marissa","title":"Dr","dw_individual_id":"5046509","middle_name":"Grace","last_name":"Daniels","source_individual_id":"5046509","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Marissa Daniels"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76251","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74858","size":1},{"color":"#FF4D4D","name":"Determining the genetic basis of skeletal dysplasias using Next Generation Sequencing","data":{"media_summary":"","end_year":2015,"keywords":["skeletal dysplasia","bone biology","sequencing","sequence analysis","osteoclast biology"],"nhmrc_grant_id":1056015,"application_year":2012,"start_year":2013,"scientific_title":"Determining the genetic basis of skeletal dysplasias using Next Generation Sequencing","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Ms Syndia Lazarus","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1056015","simplified_title":"Gene mapping in skeletal dysplasias","sub_type":"Medical/Dental Postgraduate Scholarship","total_budget":"89529.37","source_system":"Osteoporosis is a common condition in Australia, yet treatment options are still limited. Study of rare genetic bone conditions known collectively as skeletal dysplasias have already led to the development of two new osteoporosis drug treatments. My project aims to identify the causative gene for several skeletal dysplasias, and to determine how these genes are involved in the development and maintenance of bone. This knowledge may then translate into new osteoporosis therapies."},"children":[{"color":"#336699","name":"Ms Syndia Lazarus","data":{"first_name":"Syndia","title":"Ms","dw_individual_id":"DW0002855","middle_name":"","last_name":"Lazarus","source_individual_id":"5041678","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Syndia Lazarus"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77455","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74854","size":1},{"color":"#FF4D4D","name":"The impact of infant feeding practices and in utero exposure to bisphenol  A on respiratory health and somatic growth in early childhood","data":{"media_summary":"nutrition","end_year":2015,"keywords":["environmental monitoring","child development","respiratory medicine","obesity","cohort study"],"nhmrc_grant_id":1055634,"application_year":2012,"health_keywords":["in utero growth","immunology","asthma prevalence","infant health","nutrition"],"scientific_title":"The impact of infant feeding practices and in utero exposure to bisphenol  A on respiratory health and somatic growth in early childhood","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Environmental and Occupational Health and Safety","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Bridget Maher","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1055634","simplified_title":"The impact of infant feeding practices and exposure to plastic residues in pregnancy on respiratory health and growth in early childhood","sub_type":"Public Health Postgraduate Scholarship","total_budget":"119572.89","source_system":"Bisphenol A is a chemical often used in making plastic containers, including infant bottles.  It is known to leach from plastic into food in very low doses.  Exposure to high levels of bisphenol A is believed to trigger chemical pathways in the body which increase the risk of obesity and asthma. This project will follow a group of pregnant women and infants to observe the level of exposure to bisphenol A in Australia, and to investigate how exposure to bisphenol A correlates to asthmatic symptoms, growth and fat deposition in early childhood."},"children":[{"color":"#336699","name":"Dr Bridget Maher","data":{"first_name":"Bridget","title":"Dr","dw_individual_id":"DW0043973","middle_name":"Fleur","last_name":"Maher","source_individual_id":"5046434","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Bridget Maher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88393","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74804","size":1},{"color":"#FF4D4D","name":"Cervical auscultation in the diagnosis of aspiration in children","data":{"media_summary":"","end_year":2015,"keywords":["aspiration syndrome","dysphagia","assessment","respiratory","speech pathology"],"nhmrc_grant_id":1055527,"application_year":2012,"health_keywords":["paediatric"],"scientific_title":"Cervical auscultation in the diagnosis of aspiration in children","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Health Services Research","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Mrs Thuy Frakking","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1055527","simplified_title":"Evaluation of swallowing sounds in children with dysphagia","sub_type":"Public Health Postgraduate Scholarship","total_budget":"95741.92","source_system":"Accurate assessment of aspiration risk is critical to prevent respiratory illness & recurrent hospitalisations in children.Current clinical tests have poor reliability in detecting aspiration.Cervical auscultation(CA) is a portable,low-cost instrumental technique that may improve the accuracy of clinical test.This research aims to determine accuracy & reliability of CA in detecting aspiration, compared to objective radiological evaluations.CA may improve aspiration detection & subsequently minimise health system costs."},"children":[{"color":"#336699","name":"Mrs Thuy Frakking","data":{"first_name":"Thuy","title":"Mrs","dw_individual_id":"DW0042461","middle_name":"Thanh","last_name":"Frakking","source_individual_id":"5046245","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Mrs Thuy Frakking"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88011","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74796","size":1},{"color":"#FF4D4D","name":"Potent antibiotics against drug-resistant Tuberculosis","data":{"media_summary":"","end_year":2015,"keywords":["tuberculosis","drug resistance","antibiotic resistance","drug development","drug design"],"nhmrc_grant_id":1055437,"application_year":2012,"start_year":2013,"scientific_title":"Potent antibiotics against drug-resistant Tuberculosis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Matthew Cooper","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1055437","simplified_title":"Drugs against Tuberculosis","sub_type":"Development Grant","total_budget":"528675.94","source_system":"Tuberculosis (TB) is a significant killer and caused 1.7 million deaths in 2009. The disease affects all countries, including Australia, in which the incidence in the indigenous population is 14 times higher than that in the non-indigenous population. We will develop a new anti-TB drug that can replace or enhance the current drugs that are not effective against drug resistant TB."},"children":[{"color":"#336699","name":"Dr Nicholas West","data":{"first_name":"Nicholas","title":"Dr","dw_individual_id":"DW0028762","middle_name":"P","last_name":"West","source_individual_id":"5018276","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nicholas West"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84448","size":1},{"color":"#336699","name":"Prof Matthew Cooper","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0024249","middle_name":"A","last_name":"Cooper","source_individual_id":"5018347","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83230","size":1},{"color":"#336699","name":"Dr Johannes Zuegg","data":{"first_name":"Johannes","title":"Dr","dw_individual_id":"DW0011342","middle_name":"","last_name":"Zuegg","source_individual_id":"5020594","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Johannes Zuegg"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79785","size":1},{"color":"#336699","name":"Dr Tomislav Karoli","data":{"first_name":"Tomislav","title":"Dr","dw_individual_id":"DW0002555","middle_name":"","last_name":"Karoli","source_individual_id":"5041908","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Tomislav Karoli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77365","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74789","size":1},{"color":"#FF4D4D","name":"Optimizing a vaccine for HPV immunotherapy","data":{"media_summary":"","end_year":2014,"keywords":["vaccine technology","cervical cancer","papillomavirus infection","cytotoxic T lymphocytes (CTL)","inflammation"],"nhmrc_grant_id":1055321,"application_year":2012,"start_year":2013,"scientific_title":"Optimizing a vaccine for HPV immunotherapy","node_source":"NHMRC","node_type":"Grant","field_of_research":"Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ian Frazer","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1055321","simplified_title":"HPV therapeutic vaccines","sub_type":"Development Grant","total_budget":"215373.32","source_system":"We will work with Coridon Pty Ltd to optimize the practical administration of a vaccine designed to cure people already infected with cancer-promoting papilloma viruses."},"children":[{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74775","size":1},{"color":"#FF4D4D","name":"Patellofemoral joint osteoarthritis: the effects of foot orthoses","data":{"media_summary":"","end_year":2015,"keywords":["knee osteoarthritis","patellofemoral alignment","pain","biomechanics","clinical trial"],"nhmrc_grant_id":1055276,"application_year":2012,"health_keywords":["muscle function","quality of life"],"scientific_title":"Patellofemoral joint osteoarthritis: the effects of foot orthoses","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Physiotherapy","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Ms Narelle Wyndow","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1055276","simplified_title":"Patellofemoral joint osteoarthritis: the effect of foot orthoses","sub_type":"Primary Health Care Scholarship","total_budget":"104486.94","source_system":"Despite the burden of patellofemoral joint osteoarthritis (PFJ OA), there is a paucity of evidence for conservative treatments. This project aims to determine the functional features of PFJ OA and develop a clinical tool to enable identification of features associated with PFJ OA. A randomised controlled trial will then be conducted utilising a foot orthoses intervention to determine whether foot orthoses improve function and pain in people with PFJ OA."},"children":[{"color":"#336699","name":"Ms Narelle Wyndow","data":{"first_name":"Narelle","title":"Ms","dw_individual_id":"DW0011214","middle_name":"","last_name":"Wyndow","source_individual_id":"5046235","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Narelle Wyndow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79753","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74769","size":1},{"color":"#FF4D4D","name":"Novel methods for debridement of dental implant surfaces contaminated by a dental biofilm","data":{"media_summary":"","end_year":2015,"keywords":["periodontal disease","implants","dental treatments","plaque","novel therapies"],"nhmrc_grant_id":1055172,"application_year":2012,"health_keywords":["dental"],"scientific_title":"Novel methods for debridement of dental implant surfaces contaminated by a dental biofilm","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Dentistry not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"DENTISTRY","cia_name":"Ms Carol Tran","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1055172","simplified_title":"Novel ways for cleaning dental implants with dental plaque","sub_type":"Medical/Dental Postgraduate Scholarship","total_budget":"119572.89","source_system":"Dental implants are becoming more commonly used to replace missing teeth. This process occurs by the bone fusing to the implant. However over time, bone loss and inflammation around a dental implant can occur. This response can occur after some years and can lead to eventual loss of the implant.  The major contributing factors are patient susceptibility and the formation of plaque on the surface of the implant. The aims of this PhD are to understand how plaque grows on the implant surface and how it can be removed."},"children":[{"color":"#336699","name":"Ms Carol Tran","data":{"first_name":"Carol","title":"Ms","dw_individual_id":"DW0022603","middle_name":"","last_name":"Tran","source_individual_id":"5043967","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Carol Tran"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82819","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74758","size":1},{"color":"#FF4D4D","name":"Formulating New Goals for Global Health and proposing new Governance for Global Health that will allow the achievement of these goals","data":{"media_summary":"","end_year":2015,"keywords":["policy development","policy analysis","public health","international comparisons","community development"],"nhmrc_grant_id":1055138,"application_year":2012,"start_year":2013,"scientific_title":"Formulating New Goals for Global Health and proposing new Governance for Global Health that will allow the achievement of these goals","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Peter Hill","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/1055138","simplified_title":"New Goals for Global Health; new Governance to achieve these Goals","sub_type":"Aust/EU Collaborative Research Grant","total_budget":"466266.09","source_system":"The Millennium Development Goals have guided global development since 2000, and are due for evaluation in 2015. Attention is now turning to New Health-Related Goals, with a governance structure to support their implementation. Australian researchers are joining a Go4Health consortium of 13 research institutions to research the development of these goals, examining the input of United Nations agencies and key donors into the process, together with communities, civil society and governments."},"children":[{"color":"#336699","name":"A/Pr Peter Hill","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0013658","middle_name":"Stewart","last_name":"Hill","source_individual_id":"5012306","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Hill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80385","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74756","size":1},{"color":"#FF4D4D","name":"Kidney mesenchymal stem cells in tubular development, repair and turnover","data":{"media_summary":"","end_year":2017,"keywords":["stem cell biology","stem cell therapy","kidney disease","regenerative medicine","cell therapy"],"nhmrc_grant_id":1054985,"application_year":2012,"health_keywords":["cell development"],"scientific_title":"Kidney mesenchymal stem cells in tubular development, repair and turnover","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Regenerative Medicine (incl. Stem Cells and Tissue Engineering)","research_area":"Basic Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/1054985","simplified_title":"Stem cells in the kidney","sub_type":"Aust/EU Collaborative Research Grant","total_budget":"970460.03","source_system":"In Australia, 11.3% of deaths are associated with chronic kidney disease with >$1 billion per annum spent on treating this condition. At present, only dialysis and transplantation are available to treat end stage kidney disease. We have found a kidney stem cell population in both human and mouse that can form new epithelial structures. In this project, we will investigate the normal role played by these kidney stem cells and examine whether they can contribute to kidney regeneration."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74749","size":1},{"color":"#FF4D4D","name":"Investigations of mechanisms underlying autonomic cardiovascular regulation in medial temporal lobe epilepsy.","data":{"media_summary":"","end_year":2016,"keywords":["epilepsy","autonomic dysfunction","cardiac dysfunction","neuroanatomical connections","neuroimaging"],"nhmrc_grant_id":1054862,"application_year":2012,"health_keywords":["stress"],"scientific_title":"Investigations of mechanisms underlying autonomic cardiovascular regulation in medial temporal lobe epilepsy.","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Autonomic Nervous System","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Dr Marcus Gray","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1054862","simplified_title":"Mesial temporal lobe epilepsy; mechanisms of autonomic cardiovascular disturbances","sub_type":"Australian Clincal Research ECF","total_budget":"308224.67","source_system":"People with epilepsy often show disturbed cardiovascular function which may increase mortality risk. This may reflect seizure related disturbances in the autonomic circuitry regulation of the cardiovascular system.  We apply advanced brain imaging analysis of altered neural structure, circuit connectivity and function within medial temporal lobe and mid brain, combined with clinical assessment of autonomic function to provide important new insights into cardiac disturbances in epilepsy."},"children":[{"color":"#336699","name":"Dr Marcus Gray","data":{"first_name":"Marcus","title":"Dr","dw_individual_id":"DW0001892","middle_name":"Andrew","last_name":"Gray","source_individual_id":"5040516","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Marcus Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77183","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74744","size":1},{"color":"#FF4D4D","name":"Early detection of disease using Fluorescence Resonance Energy Transfer (FRET) diagnostics","data":{"media_summary":"","end_year":2018,"keywords":["diagnostic imaging","medical imaging","tumour-specific targeting","polymerisation","biomedical engineering"],"nhmrc_grant_id":1054569,"application_year":2012,"start_year":2014,"scientific_title":"Early detection of disease using Fluorescence Resonance Energy Transfer (FRET) diagnostics","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biotechnology Diagnostics (incl. Biosensors)","research_area":"Basic Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"Dr Craig Bell","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1054569","simplified_title":"Improving methodolgies for the early detection of disease","sub_type":"CJ Martin Biomedical ECF","total_budget":"330172.72","source_system":"Early detection of tumours and diseases is vital for an effective and successful treatment. Current early detection methods are invasive and use toxic or radioactive chemicals. This project focuses on understanding how non-toxic, non-invasive smart polymeric devices would work for early disease detection. It will provide next generation early detection devices which will reduce the cost of treatment, and increase the effectiveness of therapy."},"children":[{"color":"#336699","name":"Dr Craig Bell","data":{"first_name":"Craig","title":"Dr","dw_individual_id":"DW0017669","middle_name":"Andrew","last_name":"Bell","source_individual_id":"5045707","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Craig Bell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81514","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74726","size":1},{"color":"#FF4D4D","name":"Functional organisation of visual inputs to the superior colliculus","data":{"media_summary":"","end_year":2017,"keywords":["visual system","visual pathways","visual cortex","retina","electrophysiology"],"nhmrc_grant_id":1054435,"application_year":2012,"health_keywords":["patch clamp","optical imaging","brain slices"],"scientific_title":"Functional organisation of visual inputs to the superior colliculus","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Benjamin Sivyer","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1054435","simplified_title":"Brain pathways underlying visually guided movments","sub_type":"CJ Martin Biomedical ECF","total_budget":"364016.29","source_system":"The superior colliculus is a brain centre which uses visual information from the eyes and other sensory information, such as sound, to direct the head and eyes towards objects of interest. This project will use current advancements in optogenetics to activate connections to this brain region in order to understand its role in coordinating head and eye movements. This will advance our understanding of how the brain collects and processes visual information to subserve behavioural functions."},"children":[{"color":"#336699","name":"Dr Benjamin Sivyer","data":{"first_name":"Benjamin","title":"Dr","dw_individual_id":"DW0004667","middle_name":"","last_name":"Sivyer","source_individual_id":"5042375","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Benjamin Sivyer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77965","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74715","size":1},{"color":"#FF4D4D","name":"Acquisition and transmission of respiratory pathogens in persons with cystic fibrosis (CF): development and implementation of novel molecular tools","data":{"media_summary":"","end_year":2016,"keywords":["respiratory infection","cystic fibrosis","microbial infections","child health","molecular biology"],"nhmrc_grant_id":1054129,"application_year":2012,"start_year":2013,"scientific_title":"Acquisition and transmission of respiratory pathogens in persons with cystic fibrosis (CF): development and implementation of novel molecular tools","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Microbiology not elsewhere classified","research_area":"Public Health","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr David Whiley","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1054129","simplified_title":"Acquisition and transmission of respiratory pathogens in persons with cystic fibrosis (CF): development and implementation of novel molecular tools","sub_type":"Health Professional Research ECF","total_budget":"154114.42","source_system":"There are a number of significant bacteria that cause infection in children with cystic fibrosis. Early eradication may have a positive impact on clinical outcome.  Molecular biology assists in the rapid identification and characterisation of clinical strains of these bacteria.  This project will develop molecular biology tools and then use them to pimporve detection of these significant bacteria in early childhood of people with CF."},"children":[{"color":"#336699","name":"A/Pr David Whiley","data":{"first_name":"David","title":"A/Pr","dw_individual_id":"DW0046232","middle_name":"Mark","last_name":"Whiley","source_individual_id":"5020798","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr David Whiley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88965","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74694","size":1},{"color":"#FF4D4D","name":"The role of inflammation in viral pathogenesis and exacerbations of asthma","data":{"media_summary":"","end_year":2017,"keywords":["influenza","inflammation","infection","imaging","lung inflammation"],"nhmrc_grant_id":1054081,"application_year":2012,"health_keywords":["asthma exacerbation","asthma","neutrophils"],"scientific_title":"The role of inflammation in viral pathogenesis and exacerbations of asthma","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Ms Kirsty Short","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1054081","simplified_title":"How the immune response can affect influenza virus and asthma","sub_type":"CJ Martin Biomedical ECF","total_budget":"353129.91","source_system":"A strong immune response is essential for protection against viral infections. However, in some circumstances a strong immune response against viruses can actually further aggravate disease. In addition, an anti-viral immune response can trigger asthma attacks in allergic individuals. This research thus seeks to understand and therefore mitigate the potentially detrimental role of inflammation in influenza virus infections and asthma."},"children":[{"color":"#336699","name":"Ms Kirsty Short","data":{"first_name":"Kirsty","title":"Ms","dw_individual_id":"DW0033798","middle_name":"","last_name":"Short","source_individual_id":"5044432","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Kirsty Short"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85752","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74689","size":1},{"color":"#FF4D4D","name":"Co-existent Mental Illness and Chronic Physical Illness in Aboriginal and Torres Strait Islander peoples: Can an Action Research intervention within an Aboriginal Medical Service reduce morbidity?","data":{"media_summary":"","end_year":2017,"keywords":["Aboriginal health","Aboriginal mental health","diabetes prevention","chronic diseases","access to health care"],"nhmrc_grant_id":1053961,"application_year":2012,"start_year":2013,"scientific_title":"Co-existent Mental Illness and Chronic Physical Illness in Aboriginal and Torres Strait Islander peoples: Can an Action Research intervention within an Aboriginal Medical Service reduce morbidity?","node_source":"NHMRC","node_type":"Grant","field_of_research":"Aboriginal and Torres Strait Islander Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Maree Toombs","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1053961","simplified_title":"Co-existent Mental Illness and Chronic Physical Illness in Aboriginal and Torres Strait Islander peoples: Can an Action Research intervention within an Aboriginal Medical Service reduce morbidity?","sub_type":"Australian Training ECF for Aboriginal and Torres Strait Islander Health Research","total_budget":"308224.67","source_system":"This research aims to identify and understand the disparity in health issues that Aboriginal and Torres Strait Islander people face in terms of chronic physical illness and mental health disorders. This research aims to develop a collaborative approach to health care that reduces the potential for silo based care, in favour of a more holistic approach to wellness."},"children":[{"color":"#336699","name":"Dr Maree Toombs","data":{"first_name":"Maree","title":"Dr","dw_individual_id":"DW0040104","middle_name":"Roslyn","last_name":"Toombs","source_individual_id":"5042556","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Maree Toombs"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87387","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74682","size":1},{"color":"#FF4D4D","name":"Using New Genomic Technologies, Statistical and Computational Methods to Uncover The Genetic Aetiology of Complex Traits","data":{"media_summary":"","end_year":2017,"keywords":["biostatistics","sequencing","mental health","complex genetic disease","bioinformatics"],"nhmrc_grant_id":1053639,"application_year":2012,"start_year":2013,"scientific_title":"Using New Genomic Technologies, Statistical and Computational Methods to Uncover The Genetic Aetiology of Complex Traits","node_source":"NHMRC","node_type":"Grant","field_of_research":"Quantitative Genetics (incl. Disease and Trait Mapping Genetics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Enda Byrne","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1053639","simplified_title":"Using New Methods to Unravel the Genetics of Complex Disorders","sub_type":"CJ Martin Biomedical ECF","total_budget":"332060.29","source_system":"Advances in genomics have revolutionised research in the genetics of complex traits, but much of the genetic risk to disease remains unexplained. This project aims to utilise and integrate data from the latest genomic technologies such as next-generation sequencing, methylation arrays and gene expression arrays collected from large cohorts both in the United States and Australia to uncover the biological changes necessary for disease onset."},"children":[{"color":"#336699","name":"Dr Enda Byrne","data":{"first_name":"Enda","title":"Dr","dw_individual_id":"DW0012128","middle_name":"Martin","last_name":"Byrne","source_individual_id":"5039577","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Enda Byrne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79977","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74664","size":1},{"color":"#FF4D4D","name":"The biological impacts of nanoparticle interactions with proteins","data":{"media_summary":"RNA interference","end_year":2017,"keywords":["drug delivery","nanotechnology","cell biology","protein interactions","cancer treatment"],"nhmrc_grant_id":1053124,"application_year":2012,"health_keywords":["molecular mechanisms","proteomics","bioinformatics","biomarkers","RNA interference"],"scientific_title":"The biological impacts of nanoparticle interactions with proteins","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Nanomedicine","research_area":"Basic Science","for_category":"NANOTECHNOLOGY","cia_name":"Dr Zhou Deng","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1053124","simplified_title":"The biological impacts of nanoparticle interactions with proteins","sub_type":"CJ Martin Biomedical ECF","total_budget":"353681.44","source_system":"The proposed research will investigate the molecular basis of how synthetic nano-sized materials interact with the biological system. Using a systematic approach, we aim to establish a novel methodology for better assessing the biological properties of nanoparticles. The outcomes of this study will provide important information for predicting the biosafety of new nanomaterials, as well as for design of safer and more efficient nanoparticles in therapeutic applications."},"children":[{"color":"#336699","name":"Dr Zhou Deng","data":{"first_name":"Zhou","title":"Dr","dw_individual_id":"DW0030349","middle_name":"","last_name":"Deng","source_individual_id":"5037380","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Zhou Deng"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84877","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74636","size":1},{"color":"#FF4D4D","name":"Development of new heart failure therapeutics by analysing signalling in heart failure as a network","data":{"media_summary":"","end_year":2017,"keywords":["tissue engineering","pharmacology","cardiac failure","cardiac hypertrophy","heart development"],"nhmrc_grant_id":1053089,"application_year":2012,"start_year":2013,"scientific_title":"Development of new heart failure therapeutics by analysing signalling in heart failure as a network","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biotechnology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"Dr James Hudson","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1053089","simplified_title":"Development of more effective heart failure treatment","sub_type":"Peter Doherty Biomedical ECF","total_budget":"311329.03","source_system":"After detailed analysis of cell signalling in diseased heart tissue we will facilitate the discovery of new therapeutic drug targets to stop the progression of heart failure in its early stages. It is hoped that the detailed analysis of heart failure signalling as a network rather than as individual pathways will enable the discovery of drugs which are more successful in stopping the progression of heart failure than the currently available drugs."},"children":[{"color":"#336699","name":"Dr James Hudson","data":{"first_name":"James","title":"Dr","dw_individual_id":"DW0037401","middle_name":"Edward","last_name":"Hudson","source_individual_id":"5026922","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr James Hudson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86691","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74635","size":1},{"color":"#FF4D4D","name":"The association of distorted central processing, small axon dysfunction and inflammation in patients with carpal tunnel syndrome","data":{"media_summary":"","end_year":2017,"keywords":["neuropathy","nervous system disorders","musculoskeletal disorders","neuropathic pain","pain mechanisms"],"nhmrc_grant_id":1053058,"application_year":2012,"health_keywords":["inflammation"],"scientific_title":"The association of distorted central processing, small axon dysfunction and inflammation in patients with carpal tunnel syndrome","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Physiotherapy","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Annina Schmid","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1053058","simplified_title":"The role of nerve fibre damage and distorted pain perception in patients with carpal tunnel syndrome","sub_type":"Neil Hamilton Fairley Clinical ECF","total_budget":"356795.34","source_system":"The mechanisms underlying pain in carpal tunnel syndrome (CTS), which results from compression of a nerve at the wrist, are not well understood. In a combination of human and animal studies, we will examine whether the pain involves abnormalities of skin and brain function and whether inflammation in the nervous system may be responsible for such abnormalities. We will test whether surgical outcome can be predicted by these variables.  Accurate predictive tests would avoid unnecessary surgery."},"children":[{"color":"#336699","name":"Dr Annina Schmid","data":{"first_name":"Annina","title":"Dr","dw_individual_id":"DW0004484","middle_name":"Barbara","last_name":"Schmid","source_individual_id":"5042668","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Annina Schmid"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77915","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74632","size":1},{"color":"#FF4D4D","name":"Dissecting genetic variation for human complex diseases and traits","data":{"media_summary":"","end_year":2014,"keywords":["statistical genetics","complex genetic disease","disease association","genetic epidemiology","genetic variation"],"nhmrc_grant_id":1052684,"application_year":2012,"start_year":2013,"scientific_title":"Dissecting genetic variation for human complex diseases and traits","node_source":"NHMRC","node_type":"Grant","field_of_research":"Quantitative Genetics (incl. Disease and Trait Mapping Genetics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Jian Yang","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1052684","simplified_title":"Genetic dissection of complex diseases","sub_type":"RD Wright Biomedical CDF","total_budget":"135821.39","source_system":"Understanding the pattern of inheritance for human common diseases such as cancers, obesity, diabetes and mental illness, is of key importance for disease diagnosis, treatment and prevention. In this project, we will develop statistical methods and software tools to analyse DNA and clinical data to better understand the genetic basis of human common diseases and to predict a persons risk of developing disease."},"children":[{"color":"#336699","name":"Dr Jian Yang","data":{"first_name":"Jian","title":"Dr","dw_individual_id":"DW0011239","middle_name":"","last_name":"Yang","source_individual_id":"5043256","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jian Yang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79758","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74613","size":1},{"color":"#FF4D4D","name":"Uncovering the impact of tandem repeat variation on both common and syndromic forms of paediatric obesity","data":{"media_summary":"","end_year":2015,"keywords":["obesity","genetic disorders","genomics","genetic variation","genetic risk factors"],"nhmrc_grant_id":1052303,"application_year":2012,"health_keywords":["biostatistics"],"scientific_title":"Uncovering the impact of tandem repeat variation on both common and syndromic forms of paediatric obesity","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genomics","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Lachlan Coin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1052303","simplified_title":"Uncovering the impact of tandem repeat variation on both common and syndromic forms of paediatric obesity","sub_type":"Standard Project Grant","total_budget":"615851.52","source_system":"We are currently in the middle of a world-wide obesity epidemic.  While much of the increase in obesity prevalence  is due to diet and a sedentary lifestyle, a significant proportion of risk of childhood obesity is thought to have a genetic basis.  A proportion of our DNA consists of repeated DNA units, like a genetic stutter, and the number of repeats is variable in the population.  We will measure the repeat number at repeats across the genome to search for changes associated with obesity."},"children":[{"color":"#336699","name":"Prof Philippe Froguel","data":{"first_name":"Philippe","title":"Prof","dw_individual_id":"DW0024950","middle_name":"","last_name":"Froguel","source_individual_id":"5044412","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Philippe Froguel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83415","size":1},{"color":"#336699","name":"Dr Lachlan Coin","data":{"first_name":"Lachlan","title":"Dr","dw_individual_id":"DW0024186","middle_name":"James Murray","last_name":"Coin","source_individual_id":"5044275","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Lachlan Coin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83209","size":1},{"color":"#336699","name":"A/Pr Geoffrey Faulkner","data":{"first_name":"Geoffrey","title":"A/Pr","dw_individual_id":"DW0007208","middle_name":"J","last_name":"Faulkner","source_individual_id":"5014580","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Geoffrey Faulkner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78649","size":1},{"color":"#336699","name":"Dr Ryan Taft","data":{"first_name":"Ryan","title":"Dr","dw_individual_id":"DW0004931","middle_name":"James","last_name":"Taft","source_individual_id":"5040954","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ryan Taft"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78032","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74586","size":1},{"color":"#FF4D4D","name":"Genes of Mycobacterium tuberculosis essential for Latent Tuberculosis Infection","data":{"media_summary":"","end_year":2015,"keywords":["tuberculosis","latency","bacterial pathogenesis","host/pathogen interaction","immunity"],"nhmrc_grant_id":1051246,"application_year":2012,"start_year":2013,"scientific_title":"Genes of Mycobacterium tuberculosis essential for Latent Tuberculosis Infection","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Nicholas West","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1051246","simplified_title":"Latent Tuberculosis Infection","sub_type":"Standard Project Grant","total_budget":"586564.48","source_system":"One third of the worlds population is latently infected with M. tuberculosis, the bacteria which causes TB. We have identified key genes in M. tuberculosis that enable the bacterium to shut-down and become latent. This project will investigate these genes, identify their role and yield vital information for a new paradigm of drug and vaccine development. Improved vaccines and drugs which can target and inhibit latency would be of enormous benefit to the global community."},"children":[{"color":"#336699","name":"A/Pr James Triccas","data":{"first_name":"James","title":"A/Pr","dw_individual_id":"DW0034354","middle_name":"A","last_name":"Triccas","source_individual_id":"5017984","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr James Triccas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85898","size":1},{"color":"#336699","name":"Dr Nicholas West","data":{"first_name":"Nicholas","title":"Dr","dw_individual_id":"DW0028762","middle_name":"P","last_name":"West","source_individual_id":"5018276","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nicholas West"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84448","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74527","size":1},{"color":"#FF4D4D","name":"Caspase 8 apoptotic signalling induced by the inflammasome","data":{"media_summary":"","end_year":2015,"keywords":["cell death","death signalling","caspases","pattern recognition","innate immunity"],"nhmrc_grant_id":1050651,"application_year":2012,"health_keywords":["apoptosis","protein-protein interaction"],"scientific_title":"Caspase 8 apoptotic signalling induced by the inflammasome","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development, Proliferation and Death","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Katryn Stacey","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1050651","simplified_title":"A novel pathway for cell death","sub_type":"Standard Project Grant","total_budget":"599539.1","source_system":"The death of cells of our body can be an active and purposeful process. Programmed death occurs in response to infection or as a defence against cancerous changes. If a virally infected cell can die prior to replication of the virus, this will control the infection. We have investigated cell death in response to DNA found in the cytoplasm of cells, which can be an indication of infection. The novel cell death pathway we are characterising is relevant to defence against infection and tumours."},"children":[{"color":"#336699","name":"Dr Kate Schroder","data":{"first_name":"Kate","title":"Dr","dw_individual_id":"DW0039577","middle_name":"","last_name":"Schroder","source_individual_id":"5017404","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kate Schroder"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87264","size":1},{"color":"#336699","name":"Dr Katryn Stacey","data":{"first_name":"Katryn","title":"Dr","dw_individual_id":"DW0028117","middle_name":"Jane","last_name":"Stacey","source_individual_id":"5017656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katryn Stacey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84258","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74486","size":1},{"color":"#FF4D4D","name":"Estimation and partitioning of the still-missing heritability for complex disease","data":{"media_summary":"","end_year":2015,"keywords":["genomics","statistics","complex genetic disease","immune system disorder","inflammatory bowel disease (IBD)"],"nhmrc_grant_id":1050218,"application_year":2012,"start_year":2013,"scientific_title":"Estimation and partitioning of the still-missing heritability for complex disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Quantitative Genetics (incl. Disease and Trait Mapping Genetics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Naomi Wray","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1050218","simplified_title":"Estimation and partitioning of the still-missing heritability for complex disease","sub_type":"Standard Project Grant","total_budget":"290255.25","source_system":"We have pioneered the use of multi-marker statistical genetic methods in human genetics to elucidate the genetic architecture of complex traits, including common diseases. We have shown that between a third and a half of additive genetic variation is captured by common genetic variants, leaving two-thirds to a half truly missing. In this proposal we will test our hypothesis that the still-missing heritability is due to low frequency causal variants. Applications of genomic medicine require this fundamental knowledge to progress fully."},"children":[{"color":"#336699","name":"Dr Jian Yang","data":{"first_name":"Jian","title":"Dr","dw_individual_id":"DW0011239","middle_name":"","last_name":"Yang","source_individual_id":"5043256","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jian Yang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79758","size":1},{"color":"#336699","name":"Prof Naomi Wray","data":{"first_name":"Naomi","title":"Prof","dw_individual_id":"DW0005533","middle_name":"Ruth","last_name":"Wray","source_individual_id":"5018484","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Naomi Wray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78207","size":1},{"color":"#336699","name":"Prof Peter Visscher","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0005222","middle_name":"M","last_name":"Visscher","source_individual_id":"5018104","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Visscher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78118","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74464","size":1},{"color":"#FF4D4D","name":"Modulation of Vegfc/Vegfr3 signaling at the extracellular matrix during embryonic lymphangiogenesis","data":{"media_summary":"","end_year":2015,"keywords":["zebrafish","lymphatics","congenital disorders","vascular development","vascular endothelial growth factor (VEGF)"],"nhmrc_grant_id":1050138,"application_year":2012,"start_year":2013,"scientific_title":"Modulation of Vegfc/Vegfr3 signaling at the extracellular matrix during embryonic lymphangiogenesis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Benjamin Hogan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1050138","simplified_title":"Modulation of Vegfc/Vegfr3 signaling","sub_type":"Standard Project Grant","total_budget":"567504.66","source_system":"Lymphatic vessels play important roles in vascular diseases and cancer. However, we are yet to understand how they form during development and disease.  We recently identified the gene CCBE1, essential for the formation of lymphatic vessels and responsible for lymphatic dysplasia in humans.  This study aims to understand the molecular pathway in which CCBE1 acts. This work aims to characterize new molecular pathways in lymphatic vessels in order to identify new therapeutic targets in lymphatic disease and cancer."},"children":[{"color":"#336699","name":"Dr Benjamin Hogan","data":{"first_name":"Benjamin","title":"Dr","dw_individual_id":"DW0043083","middle_name":"M","last_name":"Hogan","source_individual_id":"5015278","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Benjamin Hogan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88165","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74458","size":1},{"color":"#FF4D4D","name":"Defining the function of two discrete precursor cell populations in the adult hippocampus: Potential for the treatment of cognitive and mood disorders","data":{"media_summary":"","end_year":2015,"keywords":["stem cells","neurogenesis","hippocampus","mood disorders","cognition"],"nhmrc_grant_id":1050019,"application_year":2012,"start_year":2013,"scientific_title":"Defining the function of two discrete precursor cell populations in the adult hippocampus: Potential for the treatment of cognitive and mood disorders","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Perry Bartlett","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1050019","simplified_title":"Activation of functionally discrete precursor cell populations","sub_type":"Standard Project Grant","total_budget":"575513.43","source_system":"Adult hippocampal neurogenesis plays a crucial role in fundamental cognitive processes such as learning and memory formation and mood regulation. Our laboratory has identified two discrete pools of quiescent stem and precursor cells in the adult hippocampus that can be activated by distinct mechanisms. This study will examine the functional properties of new neurons generated from these discrete pools and their role in improving behavioural outcomes associated with cognition and mood regulation"},"children":[{"color":"#336699","name":"Prof Perry Bartlett","data":{"first_name":"Perry","title":"Prof","dw_individual_id":"DW0011651","middle_name":"Francis","last_name":"Bartlett","source_individual_id":"5013357","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Perry Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79864","size":1},{"color":"#336699","name":"Dr Dhanisha Jhaveri","data":{"first_name":"Dhanisha","title":"Dr","dw_individual_id":"DW0002443","middle_name":"","last_name":"Jhaveri","source_individual_id":"5023116","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Dhanisha Jhaveri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77332","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74454","size":1},{"color":"#FF4D4D","name":"Advanced imaging to define hepatic &amp; intestinal drug disposition in aging &amp; liver diseases","data":{"media_summary":"liver transplantation","end_year":2015,"keywords":["pharmacokinetics","drug transport","drug metabolism","pathophysiology","clinical pharmacology"],"nhmrc_grant_id":1049979,"application_year":2012,"health_keywords":["intestinal absorption","drug toxicity","colorectal cancer","liver cancer","liver transplantation"],"scientific_title":"Advanced imaging to define hepatic &amp; intestinal drug disposition in aging &amp; liver diseases","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Darrell Crawford","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1049979","simplified_title":"Advanced imaging to define hepatic &amp; intestinal drug disposition in aging &amp; liver diseases","sub_type":"Standard Project Grant","total_budget":"757553.13","source_system":"Aged people and liver disease patients have impaired drug absorption and elimination functions. Their response to drugs varies widely when given drug dosage regimens recommended for normal patients. This project will explore the possibility of using in vivo imaging techniques to define the gut and liver function and their response to administered drugs. This grant will help the selection of appropriate drugs and doses for aged people and patients with liver diseases, i.e. personalised medicine."},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1},{"color":"#336699","name":"Prof Guy Maddern","data":{"first_name":"Guy","title":"Prof","dw_individual_id":"DW0014626","middle_name":".","last_name":"Maddern","source_individual_id":"5016128","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Guy Maddern"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80659","size":1},{"color":"#336699","name":"Prof Darrell Crawford","data":{"first_name":"Darrell","title":"Prof","dw_individual_id":"DW0006770","middle_name":"Henry Gordon","last_name":"Crawford","source_individual_id":"5012156","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Darrell Crawford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78535","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74450","size":1},{"color":"#FF4D4D","name":"Purine metabolism as an antifungal drug target","data":{"media_summary":"","end_year":2015,"keywords":["cryptococcus","fungal pathogens","antifungal","cryptococcosis","fungal pathogenesis"],"nhmrc_grant_id":1049716,"application_year":2012,"start_year":2013,"scientific_title":"Purine metabolism as an antifungal drug target","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Microbiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr James Fraser","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1049716","simplified_title":"Purine metabolism as an antifungal drug target","sub_type":"Standard Project Grant","total_budget":"699975.24","source_system":"The fungal pathogen Cryptococcus neoformans is responsible for up to a million deaths annually, necessitating the development of novel antifungals. We have characterised the GTP biosynthesis enzyme IMP dehydrogenase, revealing it is critical for infection, and structural and functional analysis reveals routes to inhibitor specificity. In the proposed work will develop novel antifungal compounds that target this enzyme, as well as investigate related enzymes as potential future drug targets."},"children":[{"color":"#336699","name":"Dr Mark Butler","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0018036","middle_name":"Stuart","last_name":"Butler","source_individual_id":"5020282","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mark Butler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81611","size":1},{"color":"#336699","name":"A/Pr James Fraser","data":{"first_name":"James","title":"A/Pr","dw_individual_id":"DW0007343","middle_name":"Anthony","last_name":"Fraser","source_individual_id":"RMIS4444550","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr James Fraser"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78685","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74426","size":1},{"color":"#FF4D4D","name":"Understanding multidrug resistance in cancer: identification of the substrate and inhibitor binding sites in P-glycoprotein","data":{"media_summary":"","end_year":2015,"keywords":["P-glycoprotein","computational chemistry","multidrug resistance","structure-function","drug transport"],"nhmrc_grant_id":1049685,"application_year":2012,"health_keywords":["pharmacokinetics"],"scientific_title":"Understanding multidrug resistance in cancer: identification of the substrate and inhibitor binding sites in P-glycoprotein","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biomolecular Modelling and Design","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Dr Megan O'Mara","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1049685","simplified_title":"Understanding chemotherapy transport in drug resistant cancers","sub_type":"Standard Project Grant","total_budget":"282619.2","source_system":"Cancers expressing the multidrug transporter P-glycoprotein (P-gp) are resistant to chemotherapy.   The clinical impact of P-gp is so large that the National Cancer Institute (USA) profiles all anticancer drugs for transport by P-gp, primarily because the mechanism of drug binding and transport by P-gp is unknown. The aim of this proposal is to understand the molecular details of how drugs bind to and interact with P-gp, a major step in our understanding of P-gp mediated chemotherapy resistance."},"children":[{"color":"#336699","name":"A/Pr Richard Callaghan","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0041426","middle_name":"","last_name":"Callaghan","source_individual_id":"5023641","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Callaghan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87745","size":1},{"color":"#336699","name":"Dr Megan O'Mara","data":{"first_name":"Megan","title":"Dr","dw_individual_id":"DW0032987","middle_name":"L","last_name":"O'Mara","source_individual_id":"5019143","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Megan O'Mara"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85549","size":1},{"color":"#336699","name":"Prof Alan Mark","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0032333","middle_name":"Edward","last_name":"Mark","source_individual_id":"5016199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alan Mark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85371","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74423","size":1},{"color":"#FF4D4D","name":"Tracking epidermal clonal evolution during skin cancer induction and progression","data":{"media_summary":"","end_year":2015,"keywords":["clonal diversity","squamous cell carcinoma","ultraviolet (UV) radiation exposure","solar keratosis","progression"],"nhmrc_grant_id":1049341,"application_year":2012,"start_year":2013,"scientific_title":"Tracking epidermal clonal evolution during skin cancer induction and progression","node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis not elsewhere classified","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"A/Pr Kiarash Khosrotehrani","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1049341","simplified_title":"Evolution of skin cancer cells during progression","sub_type":"Standard Project Grant","total_budget":"554701.85","source_system":"Skin cancer is the most frequent form of cancer in Australia and in many parts of the world. It is strongly connected to ultraviolet radiation from the sun. In this project, we will use our capacity to track individual cells, to observe the heterogeneity of tumours and the lesions that precede them. We will show the importance of this heterogeneity in tumour progression unveiling the limits of current therapies against skin cancer."},"children":[{"color":"#336699","name":"A/Pr James Guy Lyons","data":{"first_name":"James Guy","title":"A/Pr","dw_individual_id":"DW0038196","middle_name":"","last_name":"Lyons","source_individual_id":"5016103","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr James Guy Lyons"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86899","size":1},{"color":"#336699","name":"A/Pr Kiarash Khosrotehrani","data":{"first_name":"Kiarash","title":"A/Pr","dw_individual_id":"DW0037755","middle_name":"","last_name":"Khosrotehrani","source_individual_id":"5015692","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Kiarash Khosrotehrani"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86775","size":1},{"color":"#336699","name":"A/Pr Nicholas Saunders","data":{"first_name":"Nicholas","title":"A/Pr","dw_individual_id":"DW0021953","middle_name":"A","last_name":"Saunders","source_individual_id":"5017363","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nicholas Saunders"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82651","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74395","size":1},{"color":"#FF4D4D","name":"Sleep disturbance and cholinergic degeneration in Alzheimer's disease","data":{"media_summary":"","end_year":2016,"keywords":["neurotrophins","neurodegeneration","Alzheimer disease","cholinesterase inhibitor","sleep disorders"],"nhmrc_grant_id":1049236,"application_year":2012,"health_keywords":["animal model"],"scientific_title":"Sleep disturbance and cholinergic degeneration in Alzheimer's disease","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Elizabeth Coulson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1049236","simplified_title":"Sleep disturbance and degeneration in Alzheimer's disease","sub_type":"Standard Project Grant","total_budget":"850186.92","source_system":"The largest class of drugs given to Alzheimer's disease patients aims to increase the function of cholinergic neurons that degenerate early in the disease.  We will test whether disturbed sleep, which has been linked to Alzheimer's disease and cognitive decline are caused by neurodegeneration of these neurons, and whether early treatment can slow disease progression."},"children":[{"color":"#336699","name":"Dr Mark Bellingham","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0035336","middle_name":"C","last_name":"Bellingham","source_individual_id":"5013441","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mark Bellingham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86159","size":1},{"color":"#336699","name":"A/Pr Elizabeth Coulson","data":{"first_name":"Elizabeth","title":"A/Pr","dw_individual_id":"DW0006736","middle_name":"J","last_name":"Coulson","source_individual_id":"5014079","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Elizabeth Coulson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78524","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74390","size":1},{"color":"#FF4D4D","name":"Characterisation of two novel markers of osteosarcoma metastasis as potential therapeutic targets","data":{"media_summary":"","end_year":2015,"keywords":["osteosarcoma","metastatic disease","therapeutic target","microarray analysis","proteomics"],"nhmrc_grant_id":1049182,"application_year":2012,"start_year":2013,"scientific_title":"Characterisation of two novel markers of osteosarcoma metastasis as potential therapeutic targets","node_source":"NHMRC","node_type":"Grant","field_of_research":"Molecular Targets","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Dr Liliana Endo-Munoz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1049182","simplified_title":"New targets to prevent the spread of osteosarcoma","sub_type":"New Investigator Grant","total_budget":"620937.48","source_system":"Osteosarcoma (OS) is the most common bone tumour in children and adolescents. In spite of aggressive chemotherapy, OS tumours that metastasise to the lungs result in dismal long-term survivals of only 10-20%. For these patients, new treatment options are desperately needed. In this proposal we show compelling data identifying two new markers of OS metastasis. This research aims to validate the suitability of these novel markers as therapeutic targets to prevent OS metastasis."},"children":[{"color":"#336699","name":"A/Pr Nicholas Saunders","data":{"first_name":"Nicholas","title":"A/Pr","dw_individual_id":"DW0021953","middle_name":"A","last_name":"Saunders","source_individual_id":"5017363","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nicholas Saunders"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82651","size":1},{"color":"#336699","name":"Dr Liliana Endo-Munoz","data":{"first_name":"Liliana","title":"Dr","dw_individual_id":"DW0012914","middle_name":"B","last_name":"Endo-Munoz","source_individual_id":"5018791","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Liliana Endo-Munoz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80198","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74383","size":1},{"color":"#FF4D4D","name":"RP105 is a new innate immune receptor for Mycobacterium tuberculosis","data":{"media_summary":"","end_year":2015,"keywords":["Mycobacterium tuberculosis","pattern recognition","macrophage activation","cytokine production","innate immunity"],"nhmrc_grant_id":1049087,"application_year":2012,"start_year":2013,"scientific_title":"RP105 is a new innate immune receptor for Mycobacterium tuberculosis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Antje Blumenthal","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1049087","simplified_title":"A new macrophage sensor for Mycobacterium tuberculosis","sub_type":"New Investigator Grant","total_budget":"521866.76","source_system":"Tuberculosis (TB) is a major global health threat that causes 1.7 million deaths every year. This study will characterise the interactions between the bacteria that cause TB and a new immune sensor. We found that this sensor is involved in controlling TB and this project will determine how it contributes to the immune defence against the infection. Such knowledge will help improve patient management and develop an effective vaccine and better treatments for this devastating disease."},"children":[{"color":"#336699","name":"Dr Antje Blumenthal","data":{"first_name":"Antje","title":"Dr","dw_individual_id":"DW0035431","middle_name":"","last_name":"Blumenthal","source_individual_id":"5038607","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Antje Blumenthal"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86181","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74376","size":1},{"color":"#FF4D4D","name":"Exploiting SNP data in epidemiology and genetics through multivariate analysis of complex traits","data":{"media_summary":"","end_year":2015,"keywords":["epidemiology","genetic epidemiology","health outcomes","genetic markers","genetic susceptibility"],"nhmrc_grant_id":1048853,"application_year":2012,"start_year":2013,"scientific_title":"Exploiting SNP data in epidemiology and genetics through multivariate analysis of complex traits","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Peter Visscher","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1048853","simplified_title":"Exploiting DNA data in epidemiology and genetics by the simultaneous analysis of multiple diseases","sub_type":"Standard Project Grant","total_budget":"474120.49","source_system":"There is overlap in risk factors across multiple diseases, and some of that overlap is due to genetic factors. The availability of genome-wide DNA data on tens of thousands of patients for multiple diseases and healthy controls allows new questions to be asked and answered. For example, what is the overlap due to genes in disease risk for multiple sclerosis and rheumatoid arthritis? This project will develop and statistical genetic methodology to answer such questions and apply those methods to a range of important diseases."},"children":[{"color":"#336699","name":"Prof Peter Visscher","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0005222","middle_name":"M","last_name":"Visscher","source_individual_id":"5018104","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Visscher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78118","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74362","size":1},{"color":"#FF4D4D","name":"Cellular and molecular regulation of interhemispheric fusion","data":{"media_summary":"","end_year":2015,"keywords":["brain development","cerebral cortex","developmental disorders","molecular neuroscience","brain disorders"],"nhmrc_grant_id":1048849,"application_year":2012,"start_year":2013,"scientific_title":"Cellular and molecular regulation of interhemispheric fusion","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Linda Richards","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1048849","simplified_title":"Astrogliogenesis and interhemispheric fusion","sub_type":"Standard Project Grant","total_budget":"446734.07","source_system":"In the developing brain, the two cerebral hemispheres undergo interhemispheric fusion to allow commissural fibres to cross the midline.  Lack of interhemispheric fusion results in agenesis of the corpus callosum and may manifest as an interhemispheric cyst in acallosal patients. This project will investigate the cellular and molecular mechanisms that regulate interhemispheric fusion, including removal of the leptomeninges, astroglial differentiation and the formation of adherens junctions at the interhemispheric fissure to mediate fusion."},"children":[{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74361","size":1},{"color":"#FF4D4D","name":"Antibiotic optimisation for severely ill patients","data":{"media_summary":"","end_year":2017,"keywords":["infection","antibiotic therapy","pharmacokinetics","intensive care medicine","antibiotic resistance"],"nhmrc_grant_id":1048652,"application_year":2012,"start_year":2013,"scientific_title":"Antibiotic optimisation for severely ill patients","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Jason Roberts","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1048652","simplified_title":"Improving antibiotic dosing for patients in the intensive care unit","sub_type":"Clinical CDF","total_budget":"287332.84","source_system":"Ineffective antibiotic therapy is associated with increased mortality in infected patients in the intensive care unit (ICU). Early administration of efficacious antibiotic therapy improves survival substantially. This work seeks to extend upon my previous studies that have described the different concentrations of antibiotics between ICU patients and non-ICU patients. Predicting when to change antibiotic doses in ICU patients is likely to substantially improve patient outcomes."},"children":[{"color":"#336699","name":"Prof Jason Roberts","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0033443","middle_name":"A","last_name":"Roberts","source_individual_id":"5017212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jason Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85657","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74346","size":1},{"color":"#FF4D4D","name":"Uncovering a novel genetic interaction that governs blood vessel development in health and disease","data":{"media_summary":"","end_year":2015,"keywords":["molecular biology","mouse genetics","angiogenesis","vascular endothelial growth factor (VEGF)","vascular endothelium"],"nhmrc_grant_id":1048242,"application_year":2012,"start_year":2013,"scientific_title":"Uncovering a novel genetic interaction that governs blood vessel development in health and disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Mathias Francois","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1048242","simplified_title":"Discovering a new mode for blood vessel formation in health and disease","sub_type":"Standard Project Grant","total_budget":"622769.85","source_system":"Blood vessels are a vital component of the cardiovascular system. Abnormalities in the growth and development of blood vessels are associated with human disorders including cardio-vascular disorders, cancer and inflammatory diseases. The focus of this application is to determine the molecular events that direct the construction of the blood vascular tree, with the aim of identifying targets to which novel therapeutics for the treatment of blood vascular diseases could be generated."},"children":[{"color":"#336699","name":"Dr Benjamin Hogan","data":{"first_name":"Benjamin","title":"Dr","dw_individual_id":"DW0043083","middle_name":"M","last_name":"Hogan","source_individual_id":"5015278","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Benjamin Hogan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88165","size":1},{"color":"#336699","name":"Dr Mathias Francois","data":{"first_name":"Mathias","title":"Dr","dw_individual_id":"DW0013087","middle_name":"F","last_name":"Francois","source_individual_id":"5014705","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mathias Francois"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80238","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74327","size":1},{"color":"#FF4D4D","name":"Telehealth in residential aged care facilities: a pragmatic randomised control trial","data":{"media_summary":"","end_year":2016,"keywords":["geriatrics","nursing care","residential care","telemedicine","nursing homes"],"nhmrc_grant_id":1048098,"application_year":2012,"health_keywords":["assessment"],"scientific_title":"Telehealth in residential aged care facilities: a pragmatic randomised control trial","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Health Services Research","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Len Gray","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1048098","simplified_title":"Telehealth in residential aged care facilities: Improving access to specialist care","sub_type":"Standard Project Grant","total_budget":"1003181","source_system":"People in long term residential care have complex and chronic care issues.  The staff may be able to provide more focused care if they have the support of specialists for advice on the care of residents.  This project considers the value of a geriatric specialist assessment for all new residents via video conferencing, directly to the residential care facility.  This will be supplemented by access to a wide range of other specialists coordinated through a telehealth service model on an \"as needs\" basis."},"children":[{"color":"#336699","name":"Dr Ruth Hubbard","data":{"first_name":"Ruth","title":"Dr","dw_individual_id":"DW0037399","middle_name":"Eleanor","last_name":"Hubbard","source_individual_id":"5042577","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ruth Hubbard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86690","size":1},{"color":"#336699","name":"A/Pr Trevor Russell","data":{"first_name":"Trevor","title":"A/Pr","dw_individual_id":"DW0033555","middle_name":"","last_name":"Russell","source_individual_id":"RMIS3678636","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Trevor Russell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85687","size":1},{"color":"#336699","name":"Dr Melinda Martin-Khan","data":{"first_name":"Melinda","title":"Dr","dw_individual_id":"DW0032375","middle_name":"G","last_name":"Martin-Khan","source_individual_id":"5016241","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Melinda Martin-Khan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85382","size":1},{"color":"#336699","name":"Prof Deborah Theodoros","data":{"first_name":"Deborah","title":"Prof","dw_individual_id":"DW0022512","middle_name":"Gale","last_name":"Theodoros","source_individual_id":"RMIS15273","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Deborah Theodoros"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82794","size":1},{"color":"#336699","name":"A/Pr Ian Scott","data":{"first_name":"Ian","title":"A/Pr","dw_individual_id":"DW0022005","middle_name":"Alexander","last_name":"Scott","source_individual_id":"5012302","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ian Scott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82670","size":1},{"color":"#336699","name":"A/Pr Anthony Smith","data":{"first_name":"Anthony","title":"A/Pr","dw_individual_id":"DW0016280","middle_name":"Carl","last_name":"Smith","source_individual_id":"5012204","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Anthony Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81117","size":1},{"color":"#336699","name":"Prof Elizabeth Beattie","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0011707","middle_name":"Ruby Anne","last_name":"Beattie","source_individual_id":"5013412","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Elizabeth Beattie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79874","size":1},{"color":"#336699","name":"Prof Len Gray","data":{"first_name":"Len","title":"Prof","dw_individual_id":"DW0007585","middle_name":"Charles","last_name":"Gray","source_individual_id":"5012147","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Len Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78747","size":1},{"color":"#336699","name":"Dr Sisira Edirippulige","data":{"first_name":"Sisira","title":"Dr","dw_individual_id":"DW0001422","middle_name":"","last_name":"Edirippulige","source_individual_id":"5043931","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sisira Edirippulige"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77067","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74319","size":1},{"color":"#FF4D4D","name":"Statistical analyses of whole genome genotype data to better understand psychiatric disorders","data":{"media_summary":"","end_year":2015,"keywords":["psychiatric disorders","comorbidity","genetics","rheumatoid arthritis","cancer genetics"],"nhmrc_grant_id":1047956,"application_year":2012,"start_year":2013,"scientific_title":"Statistical analyses of whole genome genotype data to better understand psychiatric disorders","node_source":"NHMRC","node_type":"Grant","field_of_research":"Quantitative Genetics (incl. Disease and Trait Mapping Genetics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Naomi Wray","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1047956","simplified_title":"Analysis of genotype data to better understand psychiatric disorders","sub_type":"Standard Project Grant","total_budget":"540642.83","source_system":"Until now, determining an overlapping genetic aetiology between disorders, required large study cohorts of family records.  Here we will use genome-wide genotypes available on independent case-control samples to estimate a shared genetic aetiology directly from the molecular data. In this way we will explore previously intractable questions, such as the relationship between rheumatoid arthritis in people with schizophrenia, a well-recognised epidemiological puzzle."},"children":[{"color":"#336699","name":"Prof Bryan Mowry","data":{"first_name":"Bryan","title":"Prof","dw_individual_id":"DW0044411","middle_name":"J","last_name":"Mowry","source_individual_id":"5016586","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bryan Mowry"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88510","size":1},{"color":"#336699","name":"Dr Sang Hong Lee","data":{"first_name":"Sang Hong","title":"Dr","dw_individual_id":"DW0020338","middle_name":"","last_name":"Lee","source_individual_id":"5038452","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sang Hong Lee"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82195","size":1},{"color":"#336699","name":"Prof Naomi Wray","data":{"first_name":"Naomi","title":"Prof","dw_individual_id":"DW0005533","middle_name":"Ruth","last_name":"Wray","source_individual_id":"5018484","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Naomi Wray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78207","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74306","size":1},{"color":"#FF4D4D","name":"Inhibitors Of Class II HDACs In Inflammatory And Metabolic Disease","data":{"media_summary":"transgenic mouse","end_year":2015,"keywords":["histone deacetylase","macrophages","medicinal chemistry","inflammation","obesity"],"nhmrc_grant_id":1047921,"application_year":2012,"health_keywords":["rheumatoid arthritis","inflammatory bowel disease (IBD)","Toll-like receptors","drug design","transgenic mouse"],"scientific_title":"Inhibitors Of Class II HDACs In Inflammatory And Metabolic Disease","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Innate Immunity","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"A/Pr Matthew Sweet","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1047921","simplified_title":"New approaches to treat inflammatory, metabolic and obesity diseases","sub_type":"Standard Project Grant","total_budget":"612053.17","source_system":"Inflammatory diseases such as arthritis and inflammatory bowel syndrome are major social and economic burdens on Australian communities. Obesity, diabetes and cardiovascular disease are also now widely viewed as inflammatory diseases. New specialised types of anti-inflammatory drugs are urgently needed to treat such diseases. This project proposes to create new classes of anti-inflammatory drugs by altering anti-cancer drugs called histone deacetylase inhibitors."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1},{"color":"#336699","name":"Dr Abishek Iyer","data":{"first_name":"Abishek","title":"Dr","dw_individual_id":"DW0002389","middle_name":"","last_name":"Iyer","source_individual_id":"5043583","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Abishek Iyer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77322","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74302","size":1},{"color":"#FF4D4D","name":"Understanding the Interplay Between ER Stress and Inflammation","data":{"media_summary":"","end_year":2015,"keywords":["inflammation","inflammatory cytokines","inflammatory bowel disease (IBD)","respiratory diseases","protein folding"],"nhmrc_grant_id":1047905,"application_year":2012,"start_year":2013,"scientific_title":"Understanding the Interplay Between ER Stress and Inflammation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Immunology not elsewhere classified","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof Michael McGuckin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1047905","simplified_title":"ER Stress as a Contributing Factor in Inflammatory Disease","sub_type":"Standard Project Grant","total_budget":"557494.8","source_system":"Chronic inflammatory diseases in the gut and lung affect hundreds of thousands of Australians. We have identified how inflammation causes a type of stress resulting in abnormal protein synthesis in the cells which make the barrier to microbes. Following an infection this process might be the trigger for chronic unresolving inflammatory disease.  The further understanding of this process we seek in this project is likely to lead new approaches to treat common inflammatory diseases."},"children":[{"color":"#336699","name":"Prof Michael Mcguckin","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0044168","middle_name":"A","last_name":"Mcguckin","source_individual_id":"5016335","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Mcguckin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88447","size":1},{"color":"#336699","name":"Dr Simon Phipps","data":{"first_name":"Simon","title":"Dr","dw_individual_id":"DW0033180","middle_name":"","last_name":"Phipps","source_individual_id":"5016985","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Simon Phipps"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85598","size":1},{"color":"#336699","name":"A/Pr David Serisier","data":{"first_name":"David","title":"A/Pr","dw_individual_id":"DW0022029","middle_name":"John","last_name":"Serisier","source_individual_id":"5028360","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr David Serisier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82675","size":1},{"color":"#336699","name":"Prof Timothy Florin","data":{"first_name":"Timothy","title":"Prof","dw_individual_id":"DW0013048","middle_name":"H","last_name":"Florin","source_individual_id":"5014662","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Timothy Florin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80228","size":1},{"color":"#336699","name":"Dr Sumaira Hasnain","data":{"first_name":"Sumaira","title":"Dr","dw_individual_id":"DW0002080","middle_name":"Zia","last_name":"Hasnain","source_individual_id":"5043826","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sumaira Hasnain"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77236","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74299","size":1},{"color":"#FF4D4D","name":"Development of new anticancer drugs using sortase-mediated ligation","data":{"media_summary":"","end_year":2015,"keywords":["cancer treatment","peptide synthesis","nuclear magnetic resonance (NMR) spectroscopy","protein expression","protein oxidation"],"nhmrc_grant_id":1047857,"application_year":2012,"health_keywords":["enzyme mechanism"],"scientific_title":"Development of new anticancer drugs using sortase-mediated ligation","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1047857","simplified_title":"New anticancer drugs","sub_type":"Standard Project Grant","total_budget":"614596.09","source_system":"There is a great need for new cancer treatments. We are developing cyclic peptides as the next generation of safe and effective cancer drugs. Cyclic peptides, unlike their linear counterparts, display high stability and oral bioavailability, as well as high solubility and negligible immune response. One of the hurdles is the cyclisation process and we aim to develop enzyme-mediated cyclisation as a convenient and cost effective method for cyclic peptide production."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Dr Christina Schroeder","data":{"first_name":"Christina","title":"Dr","dw_individual_id":"DW0016110","middle_name":"I","last_name":"Schroeder","source_individual_id":"5017397","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Christina Schroeder"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81060","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74294","size":1},{"color":"#FF4D4D","name":"Capturing New Drugs That Selectively Modulate PAR2 Signaling Pathways","data":{"media_summary":"cardiovascular disease prevention","end_year":2015,"keywords":["protease-activated receptors","protease inhibitors","medicinal chemistry","inflammatory bowel disease (IBD)","inflammation"],"nhmrc_grant_id":1047759,"application_year":2012,"health_keywords":["arthritis","cancer","obesity","fibrosis","cardiovascular disease prevention"],"scientific_title":"Capturing New Drugs That Selectively Modulate PAR2 Signaling Pathways","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biologically Active Molecules","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1047759","simplified_title":"Designing cleaner antiinflammatory and anticancer drugs with fewer side effects","sub_type":"Standard Project Grant","total_budget":"466275.41","source_system":"Infection and tissue damage provoke acute inflammatory responses that sometimes continue unchecked, leading to different kinds of debilitating inflammatory diseases and cancers. We have discovered a new class of drugs that bind to a new target on human cells and block undesirable prolonged inflammatory responses. This project tests a new strategy to produce 'cleaner' drugs that act more selectively with fewer side effects against a new target in the treatment of arthritis and other inflammatory diseases, diet-induced obesity and cancers."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74286","size":1},{"color":"#FF4D4D","name":"Defining a new adipogenic pathway","data":{"media_summary":"","end_year":2015,"keywords":["adipocytes","adipogenesis","obesity","cardiovascular disease","diabetes"],"nhmrc_grant_id":1047625,"application_year":2012,"health_keywords":["obesity","matrix proteins"],"scientific_title":"Defining a new adipogenic pathway","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Jonathan Whitehead","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1047625","simplified_title":"Defining how fat cells are generated","sub_type":"Standard Project Grant","total_budget":"461537.95","source_system":"Obesity increases the risk of developing diseases such as heart disease and type 2 diabetes, however not all obese people develop such diseases. Obese subjects with small fat cells are typically healthier than those with fewer, large fat cells. The applicants have identified a novel pathway that promotes the generation of new fat cells. This project will increase understanding of this pathway and may, ultimately, lead to new therapies that manipulate fat cell number and reduce obesity related disease."},"children":[{"color":"#336699","name":"A/Pr Jonathan Whitehead","data":{"first_name":"Jonathan","title":"A/Pr","dw_individual_id":"DW0046246","middle_name":"P","last_name":"Whitehead","source_individual_id":"RMIS5218572","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jonathan Whitehead"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88973","size":1},{"color":"#336699","name":"Prof Johannes Prins","data":{"first_name":"Johannes","title":"Prof","dw_individual_id":"DW0039181","middle_name":"Bernhard","last_name":"Prins","source_individual_id":"RMIS7041737","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Johannes Prins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87157","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74270","size":1},{"color":"#FF4D4D","name":"IMproving Physical ACtivity with Treadmill training following stroke: the stroke-IMPACT trial","data":{"media_summary":"","end_year":2015,"keywords":["physiotherapy","stroke rehabilitation","physical activity","gait","fitness"],"nhmrc_grant_id":1047426,"application_year":2012,"start_year":2013,"scientific_title":"IMproving Physical ACtivity with Treadmill training following stroke: the stroke-IMPACT trial","node_source":"NHMRC","node_type":"Grant","field_of_research":"Physiotherapy","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Sandra Brauer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1047426","simplified_title":"IMproving Physical ACtivity with Treadmill training following stroke: the stroke-IMPACT trial","sub_type":"Standard Project Grant","total_budget":"732000.89","source_system":"Stroke is a leading cause of disability amongst Australians. After stroke, activity levels are low, with few people able to exercise at an intensity which will reduce the risk of future cardiovascular events. This project examines the effectiveness of combining a high intensity treadmill training program with a self management approach to improve activity levels, mobility, cardiovascular risk profile in stroke survivors, increasing their independence and reducing the burden of care."},"children":[{"color":"#336699","name":"Prof Sandra Brauer","data":{"first_name":"Sandra","title":"Prof","dw_individual_id":"DW0035524","middle_name":"G","last_name":"Brauer","source_individual_id":"5013589","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sandra Brauer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86203","size":1},{"color":"#336699","name":"Dr Suzanne Kuys","data":{"first_name":"Suzanne","title":"Dr","dw_individual_id":"DW0026090","middle_name":"S","last_name":"Kuys","source_individual_id":"RMIS4745356","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Suzanne Kuys"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83742","size":1},{"color":"#336699","name":"Dr Jennifer Paratz","data":{"first_name":"Jennifer","title":"Dr","dw_individual_id":"DW0021337","middle_name":"Davida","last_name":"Paratz","source_individual_id":"5012257","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jennifer Paratz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82479","size":1},{"color":"#336699","name":"Prof Louise Ada","data":{"first_name":"Louise","title":"Prof","dw_individual_id":"DW0011371","middle_name":"M","last_name":"Ada","source_individual_id":"5013117","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Louise Ada"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79790","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74254","size":1},{"color":"#FF4D4D","name":"Endosomal protein trafficking complexes - therapeutic targets for novel antivirals","data":{"media_summary":"","end_year":2015,"keywords":["electron microscopy","structural biology","protein complexes","protein-protein interaction","molecular mechanisms"],"nhmrc_grant_id":1047243,"application_year":2012,"start_year":2013,"scientific_title":"Endosomal protein trafficking complexes - therapeutic targets for novel antivirals","node_source":"NHMRC","node_type":"Grant","field_of_research":"Structural Biology (incl. Macromolecular Modelling)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Michael Landsberg","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1047243","simplified_title":"Endosomal protein trafficking complexes - targets for novel antivirals","sub_type":"New Investigator Grant","total_budget":"540436.72","source_system":"The enzyme Vps4 is a key target for the development of new antiviral drugs targeting a family of enveloped viruses that includes HIV (17,000 cases), Hepatitis B and C (420,000 cases) and Herpes Simplex (type I, II - 1.3 million cases). This project will use high resolution microscopy to investigate the molecular structures that enable infection by these and other Vps4-dependent enveloped viruses."},"children":[{"color":"#336699","name":"Dr Michael Landsberg","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0026132","middle_name":"John","last_name":"Landsberg","source_individual_id":"5020431","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michael Landsberg"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83759","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74238","size":1},{"color":"#FF4D4D","name":"CAGE: Consortium for the Architecture of Gene Expression","data":{"media_summary":"","end_year":2015,"keywords":["control of gene expression","complex genetic disease","genetic analysis","genetic association","genetic mapping"],"nhmrc_grant_id":1046880,"application_year":2012,"start_year":2013,"scientific_title":"CAGE: Consortium for the Architecture of Gene Expression","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression (incl. Microarray and other genome-wide approaches)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Peter Visscher","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1046880","simplified_title":"CAGE: Consortium for the Architecture of Gene Expression","sub_type":"Standard Project Grant","total_budget":"498219.6","source_system":"This research project is about understanding why some people are most susceptible to disease than others, by identifying genetic factors that influence the expression of genes that are important in disease. We will work with leaders in the field in Europe and the USA in an international research consortium to find genetic variants with an effect on gene expression and to link those genetic factors to disease. The project will provide new understanding about the biological basis of common diseases."},"children":[{"color":"#336699","name":"Prof Grant Montgomery","data":{"first_name":"Grant","title":"Prof","dw_individual_id":"DW0020950","middle_name":"W","last_name":"Montgomery","source_individual_id":"RMIS416073","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Grant Montgomery"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82365","size":1},{"color":"#336699","name":"Prof Peter Visscher","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0005222","middle_name":"M","last_name":"Visscher","source_individual_id":"5018104","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Visscher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78118","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74201","size":1},{"color":"#FF4D4D","name":"A longitudinal controlled study to prevent early childhood caries from ages 0-6 years in a disadvantaged community in Queensland","data":{"media_summary":"","end_year":2015,"keywords":["preventive dentistry","dental caries","child health","dental health","dentistry"],"nhmrc_grant_id":1046779,"application_year":2012,"start_year":2013,"scientific_title":"A longitudinal controlled study to prevent early childhood caries from ages 0-6 years in a disadvantaged community in Queensland","node_source":"NHMRC","node_type":"Grant","field_of_research":"Paedodontics","research_area":"Clinical Medicine and Science","for_category":"DENTISTRY","cia_name":"Prof W. Kim Seow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1046779","simplified_title":"A longitudinal controlled study to prevent early childhood caries","sub_type":"Standard Project Grant","total_budget":"691794.64","source_system":"Rampant dental decay in young children is very difficult to prevent. The study will follow a group of high risk children from birth to 6 years of age to test the effectiveness of antibacterial and remineralising agents to prevent dental decay. Our early results showed that these agents have good potential for removing decay-causing bacteria and preventing dental cavities. We expect our long term results will yield valuable information for dental prevention for young children worldwide."},"children":[{"color":"#336699","name":"Prof Laurence Walsh","data":{"first_name":"Laurence","title":"Prof","dw_individual_id":"DW0040305","middle_name":"J","last_name":"Walsh","source_individual_id":"RMIS12116","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Laurence Walsh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87441","size":1},{"color":"#336699","name":"Prof W. Kim Seow","data":{"first_name":"W. Kim","title":"Prof","dw_individual_id":"DW0010175","middle_name":"","last_name":"Seow","source_individual_id":"5019953","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof W. Kim Seow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79460","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74191","size":1},{"color":"#FF4D4D","name":"Anti-viral immunity in asthma: a detailed assessment of TLR7 function and the regulation of interferon _/_ synthesis.","data":{"media_summary":"","end_year":2015,"keywords":["asthma exacerbation","rhinovirus","innate immunity","interferon-alpha (IFN-alpha)","T cell memory"],"nhmrc_grant_id":1046622,"application_year":2012,"start_year":2013,"scientific_title":"Anti-viral immunity in asthma: a detailed assessment of TLR7 function and the regulation of interferon _/_ synthesis.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Prof John Upham","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1046622","simplified_title":"Understanding the mechanisms responsible for abnormal anti-viral immunity in asthma.","sub_type":"Standard Project Grant","total_budget":"514114.58","source_system":"Many people with asthma are unusually vulnerable to viral infections. This study will carefully examine different components of immune function in people with asthma, including the receptors that respond to viral nucleic acids and the reasons why people with asthma do not produce normal quantities of anti-viral interferons. This research may lead to novel methods for prevention and treatment of virus infections in people with asthma."},"children":[{"color":"#336699","name":"Prof John Upham","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0045963","middle_name":"W","last_name":"Upham","source_individual_id":"5018030","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Upham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88900","size":1},{"color":"#336699","name":"A/Pr Ian Mackay","data":{"first_name":"Ian","title":"A/Pr","dw_individual_id":"DW0020546","middle_name":"Maxwell","last_name":"Mackay","source_individual_id":"5016124","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ian Mackay"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82250","size":1},{"color":"#336699","name":"Dr Anthony Bosco","data":{"first_name":"Anthony","title":"Dr","dw_individual_id":"DW0006163","middle_name":"","last_name":"Bosco","source_individual_id":"5023624","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Anthony Bosco"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78377","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74174","size":1},{"color":"#FF4D4D","name":"Do bone marrow macrophages regulate leukaemia stem cells and their response to treatment?","data":{"media_summary":"","end_year":2015,"keywords":["haematopoietic stem cells","haematopoiesis","leukaemia","macrophages","bone marrow stroma"],"nhmrc_grant_id":1046590,"application_year":2012,"start_year":2013,"scientific_title":"Do bone marrow macrophages regulate leukaemia stem cells and their response to treatment?","node_source":"NHMRC","node_type":"Grant","field_of_research":"Haematology","research_area":"Basic Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"A/Pr Jean-Pierre Levesque","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1046590","simplified_title":"Role of bone marrow cells in leukemia progression and resistance to chemotherapy","sub_type":"Standard Project Grant","total_budget":"586564.48","source_system":"This project will investigate the role of population of immune cells called macrophages in promoting resistance of leukaemia cells to chemotherapy treatments. As a high proportion of adult patients with acute leukaemia cannot be cured with current treatments, this project could lead to more efficacious therapies targeting macrophages to sensitise leukaemia cells to chemotherapy treatments."},"children":[{"color":"#336699","name":"A/Pr Jean-Pierre Levesque","data":{"first_name":"Jean-Pierre","title":"A/Pr","dw_individual_id":"DW0038004","middle_name":"","last_name":"Levesque","source_individual_id":"RMIS7551","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jean-Pierre Levesque"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86847","size":1},{"color":"#336699","name":"Dr Ingrid Winkler","data":{"first_name":"Ingrid","title":"Dr","dw_individual_id":"DW0034781","middle_name":"G","last_name":"Winkler","source_individual_id":"5018413","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ingrid Winkler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86008","size":1},{"color":"#336699","name":"Dr Allison Pettit","data":{"first_name":"Allison","title":"Dr","dw_individual_id":"DW0015560","middle_name":"Robyn","last_name":"Pettit","source_individual_id":"5016963","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Allison Pettit"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80923","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74172","size":1},{"color":"#FF4D4D","name":"Innovative diagnosis for and prevention of otitis media in Australian infants","data":{"media_summary":"","end_year":2015,"keywords":["otitis media","risk factors","hearing loss","diagnosis","health services research"],"nhmrc_grant_id":1046477,"application_year":2012,"start_year":2013,"scientific_title":"Innovative diagnosis for and prevention of otitis media in Australian infants","node_source":"NHMRC","node_type":"Grant","field_of_research":"Community Child Health","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Joseph Kei","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1046477","simplified_title":"Prevention of otitis media in infants","sub_type":"Standard Project Grant","total_budget":"436870.2","source_system":"Otitis media (OM) in infants is a major health issue, with the affected infants having high risk of chronic illness, hearing loss and speech and language delay.  Preventing OM in infants requires accurately diagnosing and determining the causes of OM.  This project employs an innovative technology to diagnose OM in infants and determine the risk factors for OM in Australian infants."},"children":[{"color":"#336699","name":"Dr Carlie Driscoll","data":{"first_name":"Carlie","title":"Dr","dw_individual_id":"DW0018770","middle_name":"J","last_name":"Driscoll","source_individual_id":"5014434","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Carlie Driscoll"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81807","size":1},{"color":"#336699","name":"Dr Asad Khan","data":{"first_name":"Asad","title":"Dr","dw_individual_id":"DW0008357","middle_name":"","last_name":"Khan","source_individual_id":"5018956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Asad Khan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78958","size":1},{"color":"#336699","name":"A/Pr Joseph Kei","data":{"first_name":"Joseph","title":"A/Pr","dw_individual_id":"DW0002584","middle_name":"","last_name":"Kei","source_individual_id":"5015638","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Joseph Kei"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77375","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74162","size":1},{"color":"#FF4D4D","name":"The outcomes of adolescents and young adults who experience hallucinations: A birth cohort study","data":{"media_summary":"","end_year":2015,"keywords":["psychotic disorders","psychosis","schizophrenia and related disorders","risk factors","diagnosis"],"nhmrc_grant_id":1046216,"application_year":2012,"start_year":2013,"scientific_title":"The outcomes of adolescents and young adults who experience hallucinations: A birth cohort study","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"A/Pr James Scott","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1046216","simplified_title":"The outcomes of adolescents and young adults who experience hallucinations: A birth cohort study","sub_type":"Standard Project Grant","total_budget":"621303.73","source_system":"A national survey reported that 1 in every 12 Australian adolescents experiences hallucinations. Although hallucinations are relatively common experiences, it remains unclear if hallucinations in adolescence are associated with mental illness, and impairment in social and occupational functioning in later adulthood. This study aims to examine the outcomes at 30 years of age in subjects from an Australian birth cohort study who experienced hallucinations during adolescence and young adulthood."},"children":[{"color":"#336699","name":"A/Pr Alexandra Clavarino","data":{"first_name":"Alexandra","title":"A/Pr","dw_individual_id":"DW0029981","middle_name":"","last_name":"Clavarino","source_individual_id":"RMIS31306","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Alexandra Clavarino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84768","size":1},{"color":"#336699","name":"Prof John Mcgrath","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0009022","middle_name":"Joseph","last_name":"Mcgrath","source_individual_id":"RMIS3680751","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mcgrath"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79147","size":1},{"color":"#336699","name":"A/Pr Rosa Alati","data":{"first_name":"Rosa","title":"A/Pr","dw_individual_id":"DW0005759","middle_name":"","last_name":"Alati","source_individual_id":"RMIS2639340","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Rosa Alati"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78272","size":1},{"color":"#336699","name":"A/Pr James Scott","data":{"first_name":"James","title":"A/Pr","dw_individual_id":"DW0004514","middle_name":"Graham","last_name":"Scott","source_individual_id":"5038796","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr James Scott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77922","size":1},{"color":"#336699","name":"Prof Jackob Najman","data":{"first_name":"Jackob","title":"Prof","dw_individual_id":"DW0003590","middle_name":"Moses","last_name":"Najman","source_individual_id":"5016639","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jackob Najman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77655","size":1},{"color":"#336699","name":"A/Pr Abdullah Mamun","data":{"first_name":"Abdullah","title":"A/Pr","dw_individual_id":"DW0003145","middle_name":"Al","last_name":"Mamun","source_individual_id":"5016160","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Abdullah Mamun"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77536","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74144","size":1},{"color":"#FF4D4D","name":"Periconceptional alcohol exposure: effects on the embryo and fetus and disease risk in adulthood","data":{"media_summary":"","end_year":2015,"keywords":["alcohol consumption","fetal origins of disease","embryo development","pregnancy complications","abnormal development"],"nhmrc_grant_id":1046137,"application_year":2012,"start_year":2013,"scientific_title":"Periconceptional alcohol exposure: effects on the embryo and fetus and disease risk in adulthood","node_source":"NHMRC","node_type":"Grant","field_of_research":"Foetal Development and Medicine","research_area":"Basic Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"A/Pr Karen Moritz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1046137","simplified_title":"Long term effects of alcohol exposure in early development","sub_type":"Standard Project Grant","total_budget":"552447.69","source_system":"It is known that consuming large amounts of alcohol during pregnancy can have deleterious effects on fetal growth and development. Less is known about the effects of consumption of alcohol just around the time of conception. This project will use animal models to explore if alcohol can alter development of the very early embryo and whether this has long term consequences for the health of offspring after birth."},"children":[{"color":"#336699","name":"Prof Mary Wlodek","data":{"first_name":"Mary","title":"Prof","dw_individual_id":"DW0017188","middle_name":"E","last_name":"Wlodek","source_individual_id":"RMIS4562227","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mary Wlodek"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81370","size":1},{"color":"#336699","name":"A/Pr Karen Moritz","data":{"first_name":"Karen","title":"A/Pr","dw_individual_id":"DW0009221","middle_name":"","last_name":"Moritz","source_individual_id":"RMIS1366054","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Karen Moritz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79207","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74136","size":1},{"color":"#FF4D4D","name":"Functional and molecular characterization of a novel regulator of angiogenesis","data":{"media_summary":"","end_year":2015,"keywords":["angiogenesis","cell migration","protein function","zebrafish","mouse"],"nhmrc_grant_id":1046028,"application_year":2012,"start_year":2013,"scientific_title":"Functional and molecular characterization of a novel regulator of angiogenesis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Kelly Smith","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1046028","simplified_title":"Understanding the function of a novel gene required for blood vessel formation","sub_type":"Standard Project Grant","total_budget":"471969.65","source_system":"All cells in the body require blood vessels for the provision of nutrients and waste-removal. A deficiency of vessels prevents proper healing whereas an overabundance is a hallmark of diseases such as cancer and macular degeneration. This research will investigate a novel gene that is essential for new vessel growth. The project aims to understand the mechanism of how this gene functions. Ultimately, the research aims to inform therapeutic development for stimulating or inhibiting vessel growth."},"children":[{"color":"#336699","name":"Dr Benjamin Hogan","data":{"first_name":"Benjamin","title":"Dr","dw_individual_id":"DW0043083","middle_name":"M","last_name":"Hogan","source_individual_id":"5015278","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Benjamin Hogan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88165","size":1},{"color":"#336699","name":"Dr Kelly Smith","data":{"first_name":"Kelly","title":"Dr","dw_individual_id":"DW0022202","middle_name":"Anne","last_name":"Smith","source_individual_id":"5019706","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kelly Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82726","size":1},{"color":"#336699","name":"Dr Mathias Francois","data":{"first_name":"Mathias","title":"Dr","dw_individual_id":"DW0013087","middle_name":"F","last_name":"Francois","source_individual_id":"5014705","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mathias Francois"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80238","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74128","size":1},{"color":"#FF4D4D","name":"Epigenetic regulation of L1 retrotransposition in mouse models of abnormal human neurobiology","data":{"media_summary":"","end_year":2015,"keywords":["Rett syndrome","genomics","neurobiology","knockout mouse","transposons"],"nhmrc_grant_id":1045991,"application_year":2012,"start_year":2013,"scientific_title":"Epigenetic regulation of L1 retrotransposition in mouse models of abnormal human neurobiology","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epigenetics (incl. Genome Methylation and Epigenomics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Geoffrey Faulkner","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1045991","simplified_title":"Genetic consequences of mobile DNA activation in abnormal neurodevelopment","sub_type":"Standard Project Grant","total_budget":"415307.13","source_system":"Retrotransposons are mobile genes that copy-and-paste themselves to spread in DNA. Until very recently, they were thought to only be active in sperm and egg. In our recent work, we demonstrated that they also move in the brain. In the current study, we will use cutting-edge technologies to determine how retrotransposons change the genetic makeup of neurons in neurodevelopmentally impaired mice to predict whether these mutations would also be present in human brain disorders."},"children":[{"color":"#336699","name":"Dr Lucia Clemens-Daxinger","data":{"first_name":"Lucia","title":"Dr","dw_individual_id":"DW0041667","middle_name":"","last_name":"Clemens-Daxinger","source_individual_id":"5043618","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Lucia Clemens-Daxinger"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87811","size":1},{"color":"#336699","name":"A/Pr Geoffrey Faulkner","data":{"first_name":"Geoffrey","title":"A/Pr","dw_individual_id":"DW0007208","middle_name":"J","last_name":"Faulkner","source_individual_id":"5014580","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Geoffrey Faulkner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78649","size":1},{"color":"#336699","name":"Dr Kyle Upton","data":{"first_name":"Kyle","title":"Dr","dw_individual_id":"DW0005162","middle_name":"Ross","last_name":"Upton","source_individual_id":"5043461","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kyle Upton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78104","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74123","size":1},{"color":"#FF4D4D","name":"lncRNAs and mesoderm formation","data":{"media_summary":"","end_year":2015,"keywords":["chromatin","stem cells","RNA binding proteins","developmental genetics","epigenetics"],"nhmrc_grant_id":1045986,"application_year":2012,"start_year":2013,"scientific_title":"lncRNAs and mesoderm formation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Andrew Perkins","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1045986","simplified_title":"Non protein-coding RNA function in mesoderm formation and organogenesis","sub_type":"Standard Project Grant","total_budget":"571507.51","source_system":"Long non-coding RNAs (lncRNAs) were considered to be junk, until recently. They cannot make protein so they were thought to be impotent. Despite this dogma, we studied the function of one lncRNA, in detail. Our data suggests it is a master regulator of mesoderm formation, the precursor of all internal organs. In this grant we will determine how this regulator works in normal development and how we might use this knowledge to design new therapies."},"children":[{"color":"#336699","name":"Prof Andrew Perkins","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0033140","middle_name":"Charles","last_name":"Perkins","source_individual_id":"RMIS216814","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Andrew Perkins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85587","size":1},{"color":"#336699","name":"A/Pr Marcel Dinger","data":{"first_name":"Marcel","title":"A/Pr","dw_individual_id":"DW0006980","middle_name":"Eduard","last_name":"Dinger","source_individual_id":"5014341","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Marcel Dinger"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78595","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74121","size":1},{"color":"#FF4D4D","name":"The role of sodium channels in pain and cold allodynia","data":{"media_summary":"","end_year":2015,"keywords":["pain mechanisms","sodium channel","neuronal response","dorsal root ganglia","allodynia"],"nhmrc_grant_id":1045592,"application_year":2012,"health_keywords":["toxins"],"scientific_title":"The role of sodium channels in pain and cold allodynia","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Irina Vetter","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1045592","simplified_title":"Understanding the role of sodium channels in cold pain","sub_type":"New Investigator Grant","total_budget":"347352.73","source_system":"Many types of chronic pain remain poorly treated and severely impact the quality of life of millions of Australians. Cold allodynia in particular, which occurs in several painful human conditions and leads to severe pain from simply touching a cool surface or item, is poorly understood and thus difficult to treat.  The aim of this project is to determine the pharmacological mechanism of cold allodynia to develop novel treatment approaches."},"children":[{"color":"#336699","name":"Dr Katharina Zimmermann","data":{"first_name":"Katharina","title":"Dr","dw_individual_id":"DW0040703","middle_name":"","last_name":"Zimmermann","source_individual_id":"5039468","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katharina Zimmermann"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87553","size":1},{"color":"#336699","name":"Dr Irina Vetter","data":{"first_name":"Irina","title":"Dr","dw_individual_id":"DW0040232","middle_name":"","last_name":"Vetter","source_individual_id":"RMIS2658802","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Irina Vetter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87422","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74086","size":1},{"color":"#FF4D4D","name":"A novel molecular player in ciliopathy phenotypes","data":{"media_summary":"","end_year":2015,"keywords":["congenital defects","abnormal development","abnormal embryogenesis","craniofacial malformations","limb development"],"nhmrc_grant_id":1045464,"application_year":2012,"start_year":2013,"scientific_title":"A novel molecular player in ciliopathy phenotypes","node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Carol Wicking","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1045464","simplified_title":"A novel mouse mutant that mimics the ciliopathy disorders","sub_type":"Standard Project Grant","total_budget":"640788.48","source_system":"Birth defects can have devastating consequences for individuals and their families, and improving our ability to diagnose and screen for these disorders has implications for treatment and reproductive options. We are using the mouse as a model to discover genes important in a new class of birth defects caused by dysfunction of a hair-like cellular projection known as the cilium."},"children":[{"color":"#336699","name":"A/Pr Carol Wicking","data":{"first_name":"Carol","title":"A/Pr","dw_individual_id":"DW0028805","middle_name":"A","last_name":"Wicking","source_individual_id":"RMIS2473798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Carol Wicking"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84461","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74067","size":1},{"color":"#FF4D4D","name":"Octapeptin-based Antibiotics Against Multi-drug Resistant Gram-negative Bacteria","data":{"media_summary":"","end_year":2015,"keywords":["bacterial infection","antibiotic resistance","drug discovery","mechanism of action","histology"],"nhmrc_grant_id":1045326,"application_year":2012,"start_year":2013,"scientific_title":"Octapeptin-based Antibiotics Against Multi-drug Resistant Gram-negative Bacteria","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Infection Agents (incl. Prions)","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Matthew Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1045326","simplified_title":"Octapeptin derivatives","sub_type":"Standard Project Grant","total_budget":"761614.28","source_system":"Infectious disease is a leading cause of death, and the emergence of \"superbugs\" in the community and hospitals is of grave concern. We have resurrected a forgotten antibiotic from the 1970s that kills superbugs causing pneumonia, skin and urinary track infections; diseases that cause death and discomfort for thousands of Australians today.  We will determine how the original antibiotic works against superbugs, and use this information to design better drugs for the future."},"children":[{"color":"#336699","name":"Dr Bernd Becker","data":{"first_name":"Bernd","title":"Dr","dw_individual_id":"DW0041025","middle_name":"","last_name":"Becker","source_individual_id":"5043050","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Bernd Becker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87640","size":1},{"color":"#336699","name":"Prof Roger Nation","data":{"first_name":"Roger","title":"Prof","dw_individual_id":"DW0038733","middle_name":"L","last_name":"Nation","source_individual_id":"5016666","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Roger Nation"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87031","size":1},{"color":"#336699","name":"Prof Matthew Cooper","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0024249","middle_name":"A","last_name":"Cooper","source_individual_id":"5018347","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83230","size":1},{"color":"#336699","name":"Dr Mark Butler","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0018036","middle_name":"Stuart","last_name":"Butler","source_individual_id":"5020282","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mark Butler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81611","size":1},{"color":"#336699","name":"Dr Craig Muldoon","data":{"first_name":"Craig","title":"Dr","dw_individual_id":"DW0015116","middle_name":"Andrew","last_name":"Muldoon","source_individual_id":"5043348","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Craig Muldoon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80794","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74053","size":1},{"color":"#FF4D4D","name":"L1 retrotransposition in human development and disease","data":{"media_summary":"","end_year":2016,"keywords":["transposons","cancer","neurobiology","genomics","DNA sequencing"],"nhmrc_grant_id":1045237,"application_year":2012,"start_year":2013,"scientific_title":"L1 retrotransposition in human development and disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genome Structure and Regulation","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Geoffrey Faulkner","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1045237","simplified_title":"Mobile DNA in human development and disease","sub_type":"RD Wright Biomedical CDF","total_budget":"410045.29","source_system":"Retrotransposons are mobile genes that copy-and-paste themselves in the human genome. Previously thought to represent junk DNA, retrotransposons are increasingly being found to play important roles in biology. This fellowship will allow Dr Faulkner to research the consequences of retrotransposons being active in the body during development, and in adulthood, as a potential cause of cancer."},"children":[{"color":"#336699","name":"A/Pr Geoffrey Faulkner","data":{"first_name":"Geoffrey","title":"A/Pr","dw_individual_id":"DW0007208","middle_name":"J","last_name":"Faulkner","source_individual_id":"5014580","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Geoffrey Faulkner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78649","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74046","size":1},{"color":"#FF4D4D","name":"Molecular pathogenesis of emerging West Nile viruses","data":{"media_summary":"","end_year":2015,"keywords":["flavivirus encephalitis","virulence factors","host/pathogen interaction","virus pathogenesis","viral infection"],"nhmrc_grant_id":1045188,"application_year":2012,"start_year":2013,"scientific_title":"Molecular pathogenesis of emerging West Nile viruses","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1045188","simplified_title":"Molecular pathogenesis of emerging West Nile viruses","sub_type":"Standard Project Grant","total_budget":"590570.42","source_system":"West Nile virus (WNV) is a mosquito-borne virus that causes potentially fatal encephalitis in humans and horses. This project will investigate the recent emergence of pathogenic for horses WNV in Australia and the potential of this new isolate to cause severe disease in humans. We will define the viral and host factors determining the outcome of WNV infection. This project will provide knowledge on the factors involved in the emergence of virulent WNV strains from attenuated isolates."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1},{"color":"#336699","name":"Prof Roy Hall","data":{"first_name":"Roy","title":"Prof","dw_individual_id":"DW0025278","middle_name":"A","last_name":"Hall","source_individual_id":"RMIS16831","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roy Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83509","size":1},{"color":"#336699","name":"Dr Helle Bielefeldt-Ohmann","data":{"first_name":"Helle","title":"Dr","dw_individual_id":"DW0011797","middle_name":"","last_name":"Bielefeldt-Ohmann","source_individual_id":"5013463","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Helle Bielefeldt-Ohmann"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79892","size":1},{"color":"#336699","name":"A/Pr Mario Lobigs","data":{"first_name":"Mario","title":"A/Pr","dw_individual_id":"DW0008708","middle_name":"","last_name":"Lobigs","source_individual_id":"RMIS218588","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Mario Lobigs"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79059","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74040","size":1},{"color":"#FF4D4D","name":"Molecular Characterisation of Clathrin-independent Endocytosis in Migrating Cells","data":{"media_summary":"","end_year":2015,"keywords":["endocytosis","membrane trafficking","CD44","endosomes","migration"],"nhmrc_grant_id":1045092,"application_year":2012,"start_year":2013,"scientific_title":"Molecular Characterisation of Clathrin-independent Endocytosis in Migrating Cells","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Trafficking","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1045092","simplified_title":"Membrane Remodelling During Cell Migration","sub_type":"Standard Project Grant","total_budget":"865274.66","source_system":"Cell migration is an essential feature of physiological processes involved in embryo development, as well as disease conditions such as cancer metastasis. Cell movement requires extensive changes to the cell surface. We have identified a vital pathway involved in membrane trafficking during cell migration. This proposal aims to identify the cellular components involved in this pathway, screen for new inhibitors, and characterise the role of this pathway in migrating cancer cells."},"children":[{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1},{"color":"#336699","name":"Dr Mark Howes","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0019730","middle_name":"","last_name":"Howes","source_individual_id":"5042549","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mark Howes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82028","size":1},{"color":"#336699","name":"Dr Nicholas Ariotti","data":{"first_name":"Nicholas","title":"Dr","dw_individual_id":"5112147","middle_name":"","last_name":"Ariotti","source_individual_id":"5112147","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nicholas Ariotti"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76630","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74030","size":1},{"color":"#FF4D4D","name":"The role of noncoding subgenomic flavivirus RNA in virus-host interactions","data":{"media_summary":"","end_year":2015,"keywords":["flavivirus encephalitis","viral replication","RNA binding proteins","host/pathogen interaction","virus pathogenesis"],"nhmrc_grant_id":1045080,"application_year":2012,"health_keywords":["RNA metabolism"],"scientific_title":"The role of noncoding subgenomic flavivirus RNA in virus-host interactions","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1045080","simplified_title":"The role of noncoding subgenomic flavivirus RNA in virus-host interactions","sub_type":"Standard Project Grant","total_budget":"620684.38","source_system":"Flaviviruses such as Dengue, Japanese encephalitis , and West Nile are major human pathogens causing more than 50 million infections per year. Elements in viral genome responsible for pathogenesis of these viruses are not well defined. Recently we have identified a unique for these viruses noncoding subgenomic flavivirus RNA (sfRNA) and showed that it is contributing to viral pathogenesis. In this proposal we aim to determine mechanisms by which sfRNA facilitates viral pathogenesis."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74029","size":1},{"color":"#FF4D4D","name":"Trends and determinants of blood pressure in Chinese children and adolescents during the recent obesity epidemic: a repeated cross-sectional study over 25 years","data":{"media_summary":"","end_year":2015,"keywords":["blood pressure","childhood","hypertension","body mass index","obesity"],"nhmrc_grant_id":1045000,"application_year":2012,"start_year":2013,"scientific_title":"Trends and determinants of blood pressure in Chinese children and adolescents during the recent obesity epidemic: a repeated cross-sectional study over 25 years","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Zhiqiang Wang","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1045000","simplified_title":"Trends and determinants of blood pressure in Chinese children during the recent obesity epidemic","sub_type":"Standard Project Grant","total_budget":"347254.75","source_system":"Over the last 25 years, the prevalence of overweight and obesity increased over 9 times among Chinese children and adolescents. The aims of this project are to assess the trends of blood pressure levels in children during the period of obesity epidemic, and to estimate the effects of obesity and other factors on the trends of blood pressure levels. In this repeated cross-sectional study, we will analyse the data of six surveys collected over a period of 25 years with over 1.4 million participants."},"children":[{"color":"#336699","name":"A/Pr Zhiqiang Wang","data":{"first_name":"Zhiqiang","title":"A/Pr","dw_individual_id":"DW0028670","middle_name":"","last_name":"Wang","source_individual_id":"5019801","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Zhiqiang Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84425","size":1},{"color":"#336699","name":"Prof Jun Ma","data":{"first_name":"Jun","title":"Prof","dw_individual_id":"DW0003088","middle_name":"","last_name":"Ma","source_individual_id":"5020481","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jun Ma"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77526","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74025","size":1},{"color":"#FF4D4D","name":"Robust antibiotic dosing for critically ill patients receiving renal replacement therapy","data":{"media_summary":"","end_year":2015,"keywords":["infection","pharmacokinetics","antibiotic therapy","renal dialysis","intensive care medicine"],"nhmrc_grant_id":1044941,"application_year":2012,"start_year":2013,"scientific_title":"Robust antibiotic dosing for critically ill patients receiving renal replacement therapy","node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Jason Roberts","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1044941","simplified_title":"Antibiotic dosing during dialysis in critically ill patients","sub_type":"Standard Project Grant","total_budget":"1064204.44","source_system":"Intensive Care patients more often than not, develop kidney failure requiring dialysis. Unfortunately there is little information available to inform clinicians of appropriate doses for antibiotics in these patients, putting them at an increased risk of death from ineffective treatment. Our project aims to develop dosing guidelines for the many types of dialysis used globally to achieve concentrations in the blood that optimise antibiotic effects in these most critically ill patients."},"children":[{"color":"#336699","name":"Prof John Turnidge","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0045946","middle_name":"Douglas","last_name":"Turnidge","source_individual_id":"5012496","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Turnidge"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88896","size":1},{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1},{"color":"#336699","name":"A/Pr Sandra Peake","data":{"first_name":"Sandra","title":"A/Pr","dw_individual_id":"DW0039011","middle_name":"L","last_name":"Peake","source_individual_id":"5016913","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Sandra Peake"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87108","size":1},{"color":"#336699","name":"Prof Jason Roberts","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0033443","middle_name":"A","last_name":"Roberts","source_individual_id":"5017212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jason Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85657","size":1},{"color":"#336699","name":"Prof Jeffrey Lipman","data":{"first_name":"Jeffrey","title":"Prof","dw_individual_id":"DW0032130","middle_name":"","last_name":"Lipman","source_individual_id":"5012259","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jeffrey Lipman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85314","size":1},{"color":"#336699","name":"Prof Sanjoy Paul","data":{"first_name":"Sanjoy","title":"Prof","dw_individual_id":"DW0003885","middle_name":"Ketan","last_name":"Paul","source_individual_id":"5023146","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sanjoy Paul"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77750","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74017","size":1},{"color":"#FF4D4D","name":"Clinical and psychosocial changes over late childhood and adolescence and early life determinants of long term clinical outcomes in cystic fibrosis","data":{"media_summary":"","end_year":2015,"keywords":["cystic fibrosis","paediatric","adolescence","psychosocial","clinical outcome"],"nhmrc_grant_id":1044829,"application_year":2012,"start_year":2013,"scientific_title":"Clinical and psychosocial changes over late childhood and adolescence and early life determinants of long term clinical outcomes in cystic fibrosis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Claire Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1044829","simplified_title":"Clinical and psychosocial changes over late childhood and adolescence and early life determinants of long term clinical outcomes in cystic fibrosis","sub_type":"Standard Project Grant","total_budget":"1168548.23","source_system":"Cystic fibrosis is the most common life shortening inherited disease in Caucasians. Lung damage starts in infancy and lung function falls most rapidly in adolescence although why and how this happens and early life determinants are not known. This study takes advantage of a previous study that monitored young children from 3 months to 5 years of life and follows them closely through early adolescence to investigate the protective and risk factors for falling lung function."},"children":[{"color":"#336699","name":"Prof Harm Tiddens","data":{"first_name":"Harm","title":"Prof","dw_individual_id":"DW0045861","middle_name":"","last_name":"Tiddens","source_individual_id":"5043668","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Harm Tiddens"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88862","size":1},{"color":"#336699","name":"Ms Suzanna Vidmar","data":{"first_name":"Suzanna","title":"Ms","dw_individual_id":"DW0040241","middle_name":"Ingrid","last_name":"Vidmar","source_individual_id":"5043398","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Suzanna Vidmar"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87423","size":1},{"color":"#336699","name":"Prof Keith Grimwood","data":{"first_name":"Keith","title":"Prof","dw_individual_id":"DW0036997","middle_name":"","last_name":"Grimwood","source_individual_id":"RMIS3130585","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Keith Grimwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86576","size":1},{"color":"#336699","name":"Prof Claire Wainwright","data":{"first_name":"Claire","title":"Prof","dw_individual_id":"DW0028616","middle_name":"Elizabeth","last_name":"Wainwright","source_individual_id":"RMIS6013","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Claire Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84407","size":1},{"color":"#336699","name":"Prof Peter Sly","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0028010","middle_name":"David","last_name":"Sly","source_individual_id":"5011929","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Sly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84226","size":1},{"color":"#336699","name":"A/Pr Richard Massie","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0020670","middle_name":"John","last_name":"Massie","source_individual_id":"5041138","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Massie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82283","size":1},{"color":"#336699","name":"Prof Philip Hugenholtz","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0019751","middle_name":"","last_name":"Hugenholtz","source_individual_id":"5021803","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Philip Hugenholtz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82032","size":1},{"color":"#336699","name":"Dr Peter Cooper","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0018396","middle_name":"John","last_name":"Cooper","source_individual_id":"5025801","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Peter Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81711","size":1},{"color":"#336699","name":"Prof Colin Robertson","data":{"first_name":"Colin","title":"Prof","dw_individual_id":"DW0009926","middle_name":"Frederick","last_name":"Robertson","source_individual_id":"5011931","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Colin Robertson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79394","size":1},{"color":"#336699","name":"Dr Catherine Byrnes","data":{"first_name":"Catherine","title":"Dr","dw_individual_id":"DW0006362","middle_name":"Ann","last_name":"Byrnes","source_individual_id":"5031328","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Catherine Byrnes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78431","size":1},{"color":"#336699","name":"Dr Geraint Rogers","data":{"first_name":"Geraint","title":"Dr","dw_individual_id":"5114108","middle_name":"Berian","last_name":"Rogers","source_individual_id":"5114108","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Geraint Rogers"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76634","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74008","size":1},{"color":"#FF4D4D","name":"A randomized controlled trial of effects of early life exposure to general anaesthesia on  neurobehavioural outcomes in children with cystic fibrosis (CF)","data":{"media_summary":"","end_year":2014,"keywords":["cystic fibrosis","anaesthesia","paediatric","behaviour","outcome evaluation"],"nhmrc_grant_id":1044816,"application_year":2012,"start_year":2013,"scientific_title":"A randomized controlled trial of effects of early life exposure to general anaesthesia on  neurobehavioural outcomes in children with cystic fibrosis (CF)","node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Clinical Medicine and Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"Prof Claire Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1044816","simplified_title":"A randomized controlled trial of effects of early life exposure to general anaesthesia on  neurobehavioural outcomes in children with cystic fibrosis (CF)","sub_type":"Standard Project Grant","total_budget":"587240.78","source_system":"Anaesthesia permits surgeries and other interventional procedures that benefit the health of children to be performed painlessly and non-traumatically. This study will provide critical information about whether the drugs used commonly for general anaesthesia represents a risk to very young children in terms of their neurobehavioural development."},"children":[{"color":"#336699","name":"A/Pr Olivier Salvado","data":{"first_name":"Olivier","title":"A/Pr","dw_individual_id":"DW0045247","middle_name":"","last_name":"Salvado","source_individual_id":"5019230","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Olivier Salvado"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88709","size":1},{"color":"#336699","name":"A/Pr Andrew Davidson","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0030262","middle_name":"John","last_name":"Davidson","source_individual_id":"5014217","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Andrew Davidson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84846","size":1},{"color":"#336699","name":"Prof Claire Wainwright","data":{"first_name":"Claire","title":"Prof","dw_individual_id":"DW0028616","middle_name":"Elizabeth","last_name":"Wainwright","source_individual_id":"RMIS6013","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Claire Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84407","size":1},{"color":"#336699","name":"Prof Floyd Armstrong","data":{"first_name":"Floyd","title":"Prof","dw_individual_id":"DW0023372","middle_name":"Daniel","last_name":"Armstrong","source_individual_id":"5043572","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Floyd Armstrong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83017","size":1},{"color":"#336699","name":"Prof Alexandra Quittner","data":{"first_name":"Alexandra","title":"Prof","dw_individual_id":"DW0021586","middle_name":"L.","last_name":"Quittner","source_individual_id":"5043703","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alexandra Quittner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82554","size":1},{"color":"#336699","name":"Dr Peter Cooper","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0018396","middle_name":"John","last_name":"Cooper","source_individual_id":"5025801","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Peter Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81711","size":1},{"color":"#336699","name":"Prof Colin Robertson","data":{"first_name":"Colin","title":"Prof","dw_individual_id":"DW0009926","middle_name":"Frederick","last_name":"Robertson","source_individual_id":"5011931","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Colin Robertson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79394","size":1},{"color":"#336699","name":"Dr Catherine Byrnes","data":{"first_name":"Catherine","title":"Dr","dw_individual_id":"DW0006362","middle_name":"Ann","last_name":"Byrnes","source_individual_id":"5031328","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Catherine Byrnes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78431","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/74007","size":1},{"color":"#FF4D4D","name":"Defining the role of MMP-9-expressing macrophages in liver injury in chronic liver disease","data":{"media_summary":"","end_year":2015,"keywords":["liver fibrosis","innate immunity","macrophages","progenitor cells","metalloproteinase"],"nhmrc_grant_id":1044650,"application_year":2012,"start_year":2013,"scientific_title":"Defining the role of MMP-9-expressing macrophages in liver injury in chronic liver disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gastroenterology and Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Elizabeth Powell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1044650","simplified_title":"MMP-9-expressing macrophages in liver injury/repair","sub_type":"Standard Project Grant","total_budget":"538777.48","source_system":"Defining pathways that lead to fibrosis in chronic liver disease is an urgent priority and unmet need because cirrhosis remains a major cause of death. We will study the development of an additional fibrogenic pathway involving altered liver repair mechanisms, in order to seek ways to restore liver function. New insights arising from this novel research could significantly advance our understanding of how fibrosis develops and lead to new approaches to treat and prevent advanced liver disease."},"children":[{"color":"#336699","name":"Prof Elizabeth Powell","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0044903","middle_name":"Ellen","last_name":"Powell","source_individual_id":"RMIS13575","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Powell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88622","size":1},{"color":"#336699","name":"Dr Kelli Macdonald","data":{"first_name":"Kelli","title":"Dr","dw_individual_id":"DW0043926","middle_name":"Pa","last_name":"Macdonald","source_individual_id":"5016115","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kelli Macdonald"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88381","size":1},{"color":"#336699","name":"A/Pr Andrew Clouston","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0030002","middle_name":"Donald","last_name":"Clouston","source_individual_id":"RMIS228640","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Andrew Clouston"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84776","size":1},{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1},{"color":"#336699","name":"Dr Katharine Irvine","data":{"first_name":"Katharine","title":"Dr","dw_individual_id":"DW0002371","middle_name":"Margaret","last_name":"Irvine","source_individual_id":"5020576","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katharine Irvine"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77311","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73993","size":1},{"color":"#FF4D4D","name":"Venoms to drugs: translating venom peptides into therapeutics","data":{"media_summary":"venom","end_year":2017,"keywords":["peptides","ion channels","pain","stroke","drug development"],"nhmrc_grant_id":1044414,"application_year":2012,"health_keywords":["sodium channel","channelopathy","protein structure","nuclear magnetic resonance (NMR)","venom"],"scientific_title":"Venoms to drugs: translating venom peptides into therapeutics","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof Glenn King","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1044414","simplified_title":"Venoms to drugs: translating venom peptides into therapeutics","sub_type":"Research Fellowship","total_budget":"737505.92","source_system":"Chronic pain is a major global health problem that currently affects over three million Australians. There are few drugs available for treating chronic pain and many have significant side-effects. Several ion channels are critical for conducting pain signals to the brain. Blocking these channels can provide pain relief and, in some cases, protection from brain injury following stroke. We are producing potent and selective blockers of these ion channels for the treatment of chronic pain and stroke."},"children":[{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73977","size":1},{"color":"#FF4D4D","name":"Therapeutic vaccine against non-Hodgkin's lymphoma targeting the immune adjuvant properties of Natural Killer T cells.","data":{"media_summary":"","end_year":2015,"keywords":["tumour immunity","cancer immunotherapy","cellular immunology","immune regulation","innate immunity"],"nhmrc_grant_id":1044355,"application_year":2012,"start_year":2013,"scientific_title":"Therapeutic vaccine against non-Hodgkin's lymphoma targeting the immune adjuvant properties of Natural Killer T cells.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Tumour Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Stephen Mattarollo","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1044355","simplified_title":"Development of a cell-based vaccine for treatment of lymphoma.","sub_type":"New Investigator Grant","total_budget":"448406.72","source_system":"Patients with lymphoma cancers initially respond well to treatment, but later relapse with disease. The immune system can be effective at controlling cancer. A potential treatment option is to boost the natural immune response against cancer. This study investigates a vaccine that activates a certain immune cell, NKT cells, to fight lymphomas by delivering an NKT cell-activating molecule. Outcomes will allow assessment of combining an NKT-based vaccine with established treatments for lymphoma."},"children":[{"color":"#336699","name":"Dr Stephen Mattarollo","data":{"first_name":"Stephen","title":"Dr","dw_individual_id":"DW0014773","middle_name":"Robert","last_name":"Mattarollo","source_individual_id":"5042373","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Stephen Mattarollo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80699","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73971","size":1},{"color":"#FF4D4D","name":"Selective targeting of microbes by peptides of the innate immune system.","data":{"media_summary":"nosocomial infections","end_year":2015,"keywords":["peptides","computer simulation","membrane lipids","innate immunity","nuclear magnetic resonance (NMR) spectroscopy"],"nhmrc_grant_id":1044327,"application_year":2012,"health_keywords":["antimicrobial resistance","antimicrobial therapy","molecular modelling","membranes","nosocomial infections"],"scientific_title":"Selective targeting of microbes by peptides of the innate immune system.","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Structural Biology (incl. Macromolecular Modelling)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Alan Mark","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1044327","simplified_title":"Targeting the bacterial membrane","sub_type":"Standard Project Grant","total_budget":"623123.31","source_system":"Cytolytic antimicrobial peptides (AMPs) are key components of the innate immune system of many organisms including man. They act by disrupting the outer membranes of bacteria, fungi and enveloped viruses. These simple peptides are highly specific and increasingly seen as a new source of antibiotic agents capable of combating the rising resistance to current drugs. Our aim is to determine the mechanism by which cytolytic AMPs act and to understand the factors that give rise to membrane and cell specificity."},"children":[{"color":"#336699","name":"Prof Alan Mark","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0032333","middle_name":"Edward","last_name":"Mark","source_individual_id":"5016199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alan Mark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85371","size":1},{"color":"#336699","name":"Prof Marie-Isabel Aguilar","data":{"first_name":"Marie-Isabel","title":"Prof","dw_individual_id":"DW0023271","middle_name":"","last_name":"Aguilar","source_individual_id":"RMIS5109331","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Marie-Isabel Aguilar"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82992","size":1},{"color":"#336699","name":"Prof Frances Separovic","data":{"first_name":"Frances","title":"Prof","dw_individual_id":"DW0016152","middle_name":"","last_name":"Separovic","source_individual_id":"5020508","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frances Separovic"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81076","size":1},{"color":"#336699","name":"Dr David Poger","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0009684","middle_name":"Guy","last_name":"Poger","source_individual_id":"5024732","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David Poger"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79328","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73966","size":1},{"color":"#FF4D4D","name":"A randomised, double-blind, placebo-controlled trial to assess the effect of phosphate reduction with lanthanum carbonate on arterial compliance and vascular calcification in patients with chronic kidney disease stages 3-4","data":{"media_summary":"","end_year":2017,"keywords":["cardiovascular hypertrophy","cardiovascular disease prevention","chronic renal failure","arterial stiffness","vascular sclerosis"],"nhmrc_grant_id":1044302,"application_year":2012,"health_keywords":["calcification"],"scientific_title":"A randomised, double-blind, placebo-controlled trial to assess the effect of phosphate reduction with lanthanum carbonate on arterial compliance and vascular calcification in patients with chronic kidney disease stages 3-4","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Carmel Hawley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1044302","simplified_title":"IMPROVE-CKD Study: Impact of a phosphate binder on cardiovascular disease in Chronic Kidney Disease.","sub_type":"Standard Project Grant","total_budget":"1646429.83","source_system":"Chronic kidney disease (CKD) is a significant health problem and is associated with an increased risk of cardiovascular (CV) disease. Vascular calcification and arterial stiffness (stiffening of the blood vessels and arteries) are very common in people with CKD, and are linked to increased death from CV events. This study aims to examine the ways in which treatment with a phosphate binder, Lanthanum Carbonate, may reduce vascular calcification and arterial stiffness to decrease CV events."},"children":[{"color":"#336699","name":"A/Pr Eugenia Pedagogos","data":{"first_name":"Eugenia","title":"A/Pr","dw_individual_id":"DW0044759","middle_name":"","last_name":"Pedagogos","source_individual_id":"5020786","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Eugenia Pedagogos"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88577","size":1},{"color":"#336699","name":"A/Pr Grahame Elder","data":{"first_name":"Grahame","title":"A/Pr","dw_individual_id":"DW0042243","middle_name":"John","last_name":"Elder","source_individual_id":"5025101","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Grahame Elder"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87958","size":1},{"color":"#336699","name":"A/Pr Nigel Toussaint","data":{"first_name":"Nigel","title":"A/Pr","dw_individual_id":"DW0028445","middle_name":"David","last_name":"Toussaint","source_individual_id":"5034735","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nigel Toussaint"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84357","size":1},{"color":"#336699","name":"A/Pr Carmel Hawley","data":{"first_name":"Carmel","title":"A/Pr","dw_individual_id":"DW0025392","middle_name":"Mary","last_name":"Hawley","source_individual_id":"5012539","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Carmel Hawley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83535","size":1},{"color":"#336699","name":"Prof Randall Faull","data":{"first_name":"Randall","title":"Prof","dw_individual_id":"DW0018943","middle_name":"J","last_name":"Faull","source_individual_id":"5014587","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Randall Faull"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81846","size":1},{"color":"#336699","name":"Dr Geoffrey Block","data":{"first_name":"Geoffrey","title":"Dr","dw_individual_id":"DW0017783","middle_name":"Allan","last_name":"Block","source_individual_id":"5043236","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Geoffrey Block"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81544","size":1},{"color":"#336699","name":"Prof Robert Walker","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0016901","middle_name":"","last_name":"Walker","source_individual_id":"5039411","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Walker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81297","size":1},{"color":"#336699","name":"A/Pr Kevan Polkinghorne","data":{"first_name":"Kevan","title":"A/Pr","dw_individual_id":"DW0004014","middle_name":"R","last_name":"Polkinghorne","source_individual_id":"RMIS680853","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Kevan Polkinghorne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77786","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73964","size":1},{"color":"#FF4D4D","name":"Regulation of normal and malignant haematopoiesis by the bone marrow environment","data":{"media_summary":"","end_year":2017,"keywords":["haematopoiesis","haematopoietic stem cells","bone marrow stroma","microenvironment","hypoxia"],"nhmrc_grant_id":1044091,"application_year":2012,"health_keywords":["leukaemia","bone marrow transplantation"],"scientific_title":"Regulation of normal and malignant haematopoiesis by the bone marrow environment","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Haematology","research_area":"Basic Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"A/Pr Jean-Pierre Levesque","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1044091","simplified_title":"How does the bone marrow regulate normal blood formation and leukaemia progression","sub_type":"Research Fellowship","total_budget":"609598.47","source_system":"This project will identify factors within the bone marrow that regulate blood and immune cell formation. These include oxygenation and novel proteins identified in the applicants laboratory. How these factors from the bone marrow influence the behaviour of normal blood forming cells (called haematopoietic stem cells), and the progression of leukaemia and the response of leukaemia to chemotherapy treatments will be investigated. New drugs that interfere with these new factors will be tested for their potential to treat leukaemia."},"children":[{"color":"#336699","name":"A/Pr Jean-Pierre Levesque","data":{"first_name":"Jean-Pierre","title":"A/Pr","dw_individual_id":"DW0038004","middle_name":"","last_name":"Levesque","source_individual_id":"RMIS7551","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jean-Pierre Levesque"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86847","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73946","size":1},{"color":"#FF4D4D","name":"Cadherin Biology in Morphogenesis and Disease","data":{"media_summary":"","end_year":2017,"keywords":["E-cadherin","cytoskeleton","epithelial biology","epithelial morphogenesis","epithelial neoplasms"],"nhmrc_grant_id":1044041,"application_year":2012,"health_keywords":["epithelial-mesenchymal transition (EMT)"],"scientific_title":"Cadherin Biology in Morphogenesis and Disease","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Alpha Yap","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1044041","simplified_title":"Cell-cell interactions in health and disease","sub_type":"Research Fellowship","total_budget":"737505.92","source_system":"This work will analyse how cells, the building blocks of tissues, are organized together to form functioning organs. It focuses on the adhesion molecules that allow cells to recognize one another, which cooperate with the internal skeleton of cells to link them together. We aim to understand how these cellular systems work normally and how they are targeted to disrupt tissue integrity in diseases like cancer and inflammation."},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73942","size":1},{"color":"#FF4D4D","name":"Unravelling Munc18 dual function in exocytosis","data":{"media_summary":"","end_year":2015,"keywords":["exocytosis","vesicle transport","neurotransmission","vesicle trafficking","epilepsy"],"nhmrc_grant_id":1044014,"application_year":2012,"start_year":2013,"scientific_title":"Unravelling Munc18 dual function in exocytosis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Frederic Meunier","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1044014","simplified_title":"Unravelling Munc18 dual function in exocytosis","sub_type":"Standard Project Grant","total_budget":"512425.94","source_system":"Neuronal communication relies on the process of exocytosis by which neurons release a neurotransmitter. Exocytosis is critical for the simplest muscle movement to complex tasks such as learning and memory, and is altered in several neurodegenerative pathologies. We will investigate how the protein Munc18 controls exocytosis. This research will be important for understanding how neurons communicate in health and disease and will be relevant to other processes such as insulin release in diabetes."},"children":[{"color":"#336699","name":"Dr Brett Collins","data":{"first_name":"Brett","title":"Dr","dw_individual_id":"DW0041718","middle_name":"Martin","last_name":"Collins","source_individual_id":"5014007","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brett Collins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87821","size":1},{"color":"#336699","name":"Prof Frederic Meunier","data":{"first_name":"Frederic","title":"Prof","dw_individual_id":"DW0020864","middle_name":"A","last_name":"Meunier","source_individual_id":"5016455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frederic Meunier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82341","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73940","size":1},{"color":"#FF4D4D","name":"Mechanisms of a novel strategy for neuroprotection in experimental models of stroke and epilepsy","data":{"media_summary":"","end_year":2015,"keywords":["stroke","brain metabolism","energy metabolism","seizures","mitochondria"],"nhmrc_grant_id":1044007,"application_year":2012,"health_keywords":["adenosine 5'-triphosphate (ATP)","electron transport"],"scientific_title":"Mechanisms of a novel strategy for neuroprotection in experimental models of stroke and epilepsy","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Metabolic Medicine","research_area":"Basic Science","for_category":"MEDICAL BIOCHEMISTRY AND METABOLOMICS","cia_name":"Dr Karin Borges","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1044007","simplified_title":"Protecting the brain using a new metabolic approach","sub_type":"Standard Project Grant","total_budget":"478981.54","source_system":"Stroke and epilepsy are among the most common neurological disorders affecting many Australians. In both disorders, brain metabolism is disturbed. Dr. Borges has found that an edible oil inhibits seizures in mice and it is now being tested in epilepsy patients. This grant will allow her laboratory to study the effects of this oil against stroke and to investigate how it protects the brain. New knowledge obtained will help to develop new treatments for brain disorders."},"children":[{"color":"#336699","name":"Dr Anita Matthias","data":{"first_name":"Anita","title":"Dr","dw_individual_id":"DW0044085","middle_name":"","last_name":"Matthias","source_individual_id":"5040484","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Anita Matthias"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88426","size":1},{"color":"#336699","name":"Dr Michelle Puchowicz","data":{"first_name":"Michelle","title":"Dr","dw_individual_id":"DW0027440","middle_name":"","last_name":"Puchowicz","source_individual_id":"5039593","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michelle Puchowicz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84082","size":1},{"color":"#336699","name":"Dr Karin Borges","data":{"first_name":"Karin","title":"Dr","dw_individual_id":"DW0011899","middle_name":"","last_name":"Borges","source_individual_id":"5018667","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Karin Borges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79926","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73939","size":1},{"color":"#FF4D4D","name":"Metabolism-driven interactions of non-typeable Haemophilus influenzae and its host: a critical factor in infection?","data":{"media_summary":"","end_year":2015,"keywords":["Haemophilus influenzae","infectious diseases","respiratory infection","metabolism","enzymes"],"nhmrc_grant_id":1043532,"application_year":2012,"health_keywords":["biofilm"],"scientific_title":"Metabolism-driven interactions of non-typeable Haemophilus influenzae and its host: a critical factor in infection?","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Ulrike Kappler","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1043532","simplified_title":"Can Haemophilus influenzae change host cell responses to facilitate infection?","sub_type":"Standard Project Grant","total_budget":"471800.92","source_system":"Non-typeable Haemophilus influenzae (NTHi) is the underlying cause of many severe acute and chronic respiratory infections, which represent a significant burden to the healthcare system. As NTHi is unable to survive outside the human host, it is is highly adapted to survival in the body niches it colonizes. We are investigating how NTHI is able to survive in the presence of tissue inflammation, and whether it contributes to the inflammatory process through some of its metabolic products."},"children":[{"color":"#336699","name":"Dr Ulrike Kappler","data":{"first_name":"Ulrike","title":"Dr","dw_individual_id":"DW0037659","middle_name":"","last_name":"Kappler","source_individual_id":"5020609","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ulrike Kappler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86753","size":1},{"color":"#336699","name":"Prof Alastair Mcewan","data":{"first_name":"Alastair","title":"Prof","dw_individual_id":"DW0014843","middle_name":"G","last_name":"Mcewan","source_individual_id":"5016339","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alastair Mcewan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80715","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73900","size":1},{"color":"#FF4D4D","name":"Reversing autoimmune diabetes by controlling pathogenic effector T-cells","data":{"media_summary":"","end_year":2015,"keywords":["autoimmune disease","type 1 diabetes mellitus (insulin-dependent diabetes mellitus)","gene therapy","tolerance","antigen presenting cells"],"nhmrc_grant_id":1043315,"application_year":2012,"start_year":2013,"scientific_title":"Reversing autoimmune diabetes by controlling pathogenic effector T-cells","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"A/Pr Raymond Steptoe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1043315","simplified_title":"Interrupting the pathogenic immune response to reverse autoimmune diabetes","sub_type":"Standard Project Grant","total_budget":"406211.16","source_system":"Type 1 diabetes (T1D) results from misdirected immune responses that destroy insulin-producing pancreatic cells. The ultimate goal of therapeutic strategies is to remove or inactivate the cells that attack insulin-producing cells, while leaving other cells, for example, those required for protection from infectious diseases and tumours, unaffected.  Here we propose to test a new way of turning off the inappropriate immune reaction with the goal of preventing type 1 diabetes."},"children":[{"color":"#336699","name":"A/Pr Raymond Steptoe","data":{"first_name":"Raymond","title":"A/Pr","dw_individual_id":"DW0028164","middle_name":"J","last_name":"Steptoe","source_individual_id":"5017706","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Raymond Steptoe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84270","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73883","size":1},{"color":"#FF4D4D","name":"A new and effective approach to reversal of allergic airways inflammation by turning off allergic responses","data":{"media_summary":"","end_year":2015,"keywords":["asthma therapy","gene therapy","allergic airways disease","allergy prevention","anaphylaxis"],"nhmrc_grant_id":1043311,"application_year":2012,"start_year":2013,"scientific_title":"A new and effective approach to reversal of allergic airways inflammation by turning off allergic responses","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Basic Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"A/Pr Raymond Steptoe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1043311","simplified_title":"A new and effective approach to reversing allergic airways inflammation","sub_type":"Standard Project Grant","total_budget":"391154.17","source_system":"Inflammatory diseases like asthma develop from misdirected immune responses. The ultimate goal of therapeutic strategies is to remove or inactivate the cells that cause inflammation while leaving other cells, for example, those required for protection from infectious diseases and tumours, unaffected.  Here we propose to test a new way of turning off the inappropriate immune reaction with the goal of preventing or reversing asthma."},"children":[{"color":"#336699","name":"A/Pr Raymond Steptoe","data":{"first_name":"Raymond","title":"A/Pr","dw_individual_id":"DW0028164","middle_name":"J","last_name":"Steptoe","source_individual_id":"5017706","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Raymond Steptoe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84270","size":1},{"color":"#336699","name":"Dr Janet Davies","data":{"first_name":"Janet","title":"Dr","dw_individual_id":"DW0018566","middle_name":"Mary","last_name":"Davies","source_individual_id":"5027738","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Janet Davies"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81756","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73882","size":1},{"color":"#FF4D4D","name":"A mechanism for regulation of oral and gut microflora by interaction of salivary metabolites with breast milk","data":{"media_summary":"","end_year":2015,"keywords":["biochemistry","oral microbiology","neonatology","purines","pyrimidines"],"nhmrc_grant_id":1043282,"application_year":2012,"health_keywords":["microbial pathogenesis","chemistry","pharmacokinetics"],"scientific_title":"A mechanism for regulation of oral and gut microflora by interaction of salivary metabolites with breast milk","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry and Metabolomics not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"MEDICAL BIOCHEMISTRY AND METABOLOMICS","cia_name":"Dr John Duley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1043282","simplified_title":"Why breast is best: A mechanism for regulation of the ecology of the mouth and gut by interaction of salivary metabolites with breast milk.","sub_type":"Standard Project Grant","total_budget":"613759.21","source_system":"Saliva \"lacks the drama of blood, the sincerity of sweat & the emotional appeal of tears\".  But spit has important roles for the mouth & digestion. Now researchers in Brisbane have found baby dribble has natural chemicals that form nucleotides in cells. They are testing the theory that the nucleotides encourage friendly bacteria in the mouth & gut. When baby saliva mixes with breast milk it also makes natural antibiotics called 'oxidative radicals' that stop bad bacteria. This may be part of the mechanism ensuring \"Breast is best\" for babies."},"children":[{"color":"#336699","name":"Dr Christine Knox","data":{"first_name":"Christine","title":"Dr","dw_individual_id":"DW0043550","middle_name":"L","last_name":"Knox","source_individual_id":"RMIS193608","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Christine Knox"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88293","size":1},{"color":"#336699","name":"A/Pr Helen Liley","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0032099","middle_name":"Gwendolin","last_name":"Liley","source_individual_id":"5016001","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Helen Liley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85306","size":1},{"color":"#336699","name":"Prof Paul Shaw","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0016175","middle_name":"Nicholas","last_name":"Shaw","source_individual_id":"5011187","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Shaw"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81082","size":1},{"color":"#336699","name":"Dr John Duley","data":{"first_name":"John","title":"Dr","dw_individual_id":"DW0007066","middle_name":"Alexander","last_name":"Duley","source_individual_id":"5012691","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr John Duley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78611","size":1},{"color":"#336699","name":"A/Pr Bruce Charles","data":{"first_name":"Bruce","title":"A/Pr","dw_individual_id":"DW0000818","middle_name":"","last_name":"Charles","source_individual_id":"RMIS24960","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Bruce Charles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76890","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73878","size":1},{"color":"#FF4D4D","name":"Controlled trial of slowing of Kidney Disease progression From the Inhibition of Xanthine oxidase (CKD-FIX): A double-blind, randomised, placebo-controlled trial","data":{"media_summary":"","end_year":2017,"keywords":["chronic renal failure","kidney disease","kidney failure","renal progression","quality of life"],"nhmrc_grant_id":1043203,"application_year":2012,"health_keywords":["renal function","health economics","renal failure"],"scientific_title":"Controlled trial of slowing of Kidney Disease progression From the Inhibition of Xanthine oxidase (CKD-FIX): A double-blind, randomised, placebo-controlled trial","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Johnson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1043203","simplified_title":"CKD-FIX: a randomised, controlled trial of allopurinol in the slowing of kidney disease progression","sub_type":"Standard Project Grant","total_budget":"1979839.52","source_system":"Chronic kidney disease (CKD) is a major public health problem affecting over 1.5 million Australians and is associated with increased risk of death, heart disease and progression to end-stage kidney disease (ESKD). Current treatments to slow progression to ESKD are limited. The CKD-FIX trial aims to find out whether treatment with allopurinol, a commonly used drug for gout prevention, safely and effectively slows CKD progression. This could lead to significant health and economic benefits."},"children":[{"color":"#336699","name":"Dr Fiona Brown","data":{"first_name":"Fiona","title":"Dr","dw_individual_id":"DW0041303","middle_name":"","last_name":"Brown","source_individual_id":"5039338","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Fiona Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87710","size":1},{"color":"#336699","name":"Dr Sunil Badve","data":{"first_name":"Sunil","title":"Dr","dw_individual_id":"DW0040889","middle_name":"Vasantrao","last_name":"Badve","source_individual_id":"5038644","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sunil Badve"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87605","size":1},{"color":"#336699","name":"A/Pr John Kanellis","data":{"first_name":"John","title":"A/Pr","dw_individual_id":"DW0031667","middle_name":"","last_name":"Kanellis","source_individual_id":"5015602","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr John Kanellis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85198","size":1},{"color":"#336699","name":"Prof Neil Boudville","data":{"first_name":"Neil","title":"Prof","dw_individual_id":"DW0029542","middle_name":"Christopher","last_name":"Boudville","source_individual_id":"5013544","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Neil Boudville"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84653","size":1},{"color":"#336699","name":"A/Pr Gopala Rangan","data":{"first_name":"Gopala","title":"A/Pr","dw_individual_id":"DW0027503","middle_name":"K","last_name":"Rangan","source_individual_id":"5017116","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Gopala Rangan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84098","size":1},{"color":"#336699","name":"Prof Randall Faull","data":{"first_name":"Randall","title":"Prof","dw_individual_id":"DW0018943","middle_name":"J","last_name":"Faull","source_individual_id":"5014587","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Randall Faull"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81846","size":1},{"color":"#336699","name":"Prof Robert Walker","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0016901","middle_name":"","last_name":"Walker","source_individual_id":"5039411","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Walker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81297","size":1},{"color":"#336699","name":"Prof David Johnson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0013969","middle_name":"Wayne","last_name":"Johnson","source_individual_id":"RMIS14680","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Johnson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80471","size":1},{"color":"#336699","name":"Dr Suetonia Palmer","data":{"first_name":"Suetonia","title":"Dr","dw_individual_id":"DW0009515","middle_name":"","last_name":"Palmer","source_individual_id":"5043309","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Suetonia Palmer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79288","size":1},{"color":"#336699","name":"Prof David Harris","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0002049","middle_name":"Charles Hamlyn","last_name":"Harris","source_individual_id":"RMIS3732","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Harris"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77227","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73873","size":1},{"color":"#FF4D4D","name":"Human pigmentation genetics, melanocyte biology and skin cancer","data":{"media_summary":"","end_year":2017,"keywords":["melanoma","melanocyte","pigmentation","skin cancer","gene polymorphisms"],"nhmrc_grant_id":1043187,"application_year":2012,"start_year":2013,"scientific_title":"Human pigmentation genetics, melanocyte biology and skin cancer","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Cell Biology","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"A/Pr Richard Sturm","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1043187","simplified_title":"Genes for skin, hair and eye colour and relation to skin cancer risk","sub_type":"Research Fellowship","total_budget":"673552.15","source_system":"The fellowship application by A/Prof Sturm is to support his research into the biology of human skin, hair and eye colour, and the process of melanoma formation. His pivotal discoveries into the genetic basis of pigmentation and its regulation has provided an understanding of these physical traits and the associated genotypic risk factors for skin cancer development. The genes that determine an individual's skin phototype and the mechanisms involved in the tanning response after UV-exposure of the skin are actively being investigated."},"children":[{"color":"#336699","name":"A/Pr Richard Sturm","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0045672","middle_name":"Alan","last_name":"Sturm","source_individual_id":"5017777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Sturm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88811","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73871","size":1},{"color":"#FF4D4D","name":"Guidance mechanisms regulating the development of axonal projections from the cingulate cortex.","data":{"media_summary":"","end_year":2015,"keywords":["brain development","cerebral cortex","developmental disorders","molecular neuroscience","brain disorders"],"nhmrc_grant_id":1043045,"application_year":2012,"start_year":2013,"scientific_title":"Guidance mechanisms regulating the development of axonal projections from the cingulate cortex.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Linda Richards","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1043045","simplified_title":"Guidance of cingulate callosal axons","sub_type":"Standard Project Grant","total_budget":"481332.38","source_system":"The corpus callosum is the largest fibre tract in the brain and connects neurons in the left and right cerebral hemispheres. A subpopulation of callosal axons arise from neurons in the cingulate cortex and are the first to cross the midline. Defects in activation or wiring of the cingulate cortex are strongly implicated in acute pain, schizophrenia and bipolar disorder.  This proposal investigates how the commissural projections of the cingulate cortex become wired up during development."},"children":[{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73852","size":1},{"color":"#FF4D4D","name":"Combining timelapse imaging and computational modelling to understand the mechanisms of axon guidance in the developing retinotectal system","data":{"media_summary":"","end_year":2015,"keywords":["axon guidance","growth cone","topography","mathematical modelling","developmental biology"],"nhmrc_grant_id":1043044,"application_year":2012,"start_year":2013,"scientific_title":"Combining timelapse imaging and computational modelling to understand the mechanisms of axon guidance in the developing retinotectal system","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Geoffrey Goodhill","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1043044","simplified_title":"Development of connections in the visual system","sub_type":"Standard Project Grant","total_budget":"436161.43","source_system":"Understanding how patterns of brain wiring develop is crucial for understanding many cognitive disorders. One of the commonest types of connection pattern in the brain is a topographic map, where nearby neurons in one structure connect to nearby neurons in another structure. Using the transgenic tools available in the zebrafish as a model system, we will combine novel experiments with computational modelling to understand the rules which govern the formation of topographic maps in the brain."},"children":[{"color":"#336699","name":"Dr Ethan Scott","data":{"first_name":"Ethan","title":"Dr","dw_individual_id":"DW0027841","middle_name":"Kime","last_name":"Scott","source_individual_id":"5017408","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ethan Scott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84182","size":1},{"color":"#336699","name":"Prof Geoffrey Goodhill","data":{"first_name":"Geoffrey","title":"Prof","dw_individual_id":"DW0007543","middle_name":"J","last_name":"Goodhill","source_individual_id":"5014864","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Geoffrey Goodhill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78740","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73851","size":1},{"color":"#FF4D4D","name":"Investigation of processed snoRNAs as cryptic regulators of the imprinted Prader-Willi syndrome locus","data":{"media_summary":"","end_year":2015,"keywords":["developmental disorders","RNA","stem cells","sequencing","genomics"],"nhmrc_grant_id":1043023,"application_year":2012,"health_keywords":["regulation"],"scientific_title":"Investigation of processed snoRNAs as cryptic regulators of the imprinted Prader-Willi syndrome locus","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Ryan Taft","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1043023","simplified_title":"The function of Prader-Willi syndrome associated snoRNAs","sub_type":"Standard Project Grant","total_budget":"670024.96","source_system":"Prader-Willi syndrome (PWS) is a devastating disorder whose symptoms include intellectual disability and compulsive eating. PWS occurs when a piece of the genome is mistakenly deleted, but why this DNA is important is still not understood. Our data indicate that the deleted DNA encodes a suite of previously hidden genetic elements, and here we proposed using the latest high-throughput DNA and RNA sequencing and stem cell technologies to finally unravel this mystery."},"children":[{"color":"#336699","name":"Prof Merlin Butler","data":{"first_name":"Merlin","title":"Prof","dw_individual_id":"DW0023892","middle_name":"Gene","last_name":"Butler","source_individual_id":"5043733","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Merlin Butler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83130","size":1},{"color":"#336699","name":"A/Pr Ernst Wolvetang","data":{"first_name":"Ernst","title":"A/Pr","dw_individual_id":"DW0017193","middle_name":"Jurgen","last_name":"Wolvetang","source_individual_id":"5020397","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ernst Wolvetang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81372","size":1},{"color":"#336699","name":"Dr Ryan Taft","data":{"first_name":"Ryan","title":"Dr","dw_individual_id":"DW0004931","middle_name":"James","last_name":"Taft","source_individual_id":"5040954","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ryan Taft"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78032","size":1},{"color":"#336699","name":"Dr Guy Barry","data":{"first_name":"Guy","title":"Dr","dw_individual_id":"DW0000250","middle_name":"","last_name":"Barry","source_individual_id":"5020175","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Guy Barry"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76725","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73849","size":1},{"color":"#FF4D4D","name":"Role of autotransporter proteins in uropathogenic E. coli infections","data":{"media_summary":"","end_year":2015,"keywords":["bacterial pathogenesis","bacterial virulence","bacterial biofilm","bacterial virulence factors","Escherichia coli"],"nhmrc_grant_id":1042651,"application_year":2012,"health_keywords":["urinary tract infection (UTI)"],"scientific_title":"Role of autotransporter proteins in uropathogenic E. coli infections","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Mark Schembri","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1042651","simplified_title":"Adherence factors of E. coli that cause urinary tract infection","sub_type":"Standard Project Grant","total_budget":"607544.14","source_system":"Urinary tract infections (UTI) are among the most common infectious diseases of humans. Uropathogenic E. coli (UPEC), the primary cause of UTI, utilize a range of adherence mechanisms to colonize the urinary tract. In this project we will characterise the function and mode of secretion for one important class of UPEC adherence factors _ autotransporter proteins. This work may inform new approaches to prevent UTI, an urgent need given the rapid increase in resistance to antibiotics among UPEC."},"children":[{"color":"#336699","name":"Prof Mark Schembri","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0016088","middle_name":"A","last_name":"Schembri","source_individual_id":"5017368","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Schembri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81054","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73819","size":1},{"color":"#FF4D4D","name":"Activity in central cough networks in patients with cough hypersensitivity","data":{"media_summary":"","end_year":2015,"keywords":["functional magnetic resonance imaging (fMRI)","cough","neural pathways","respiratory diseases","sensorimotor control"],"nhmrc_grant_id":1042528,"application_year":2012,"health_keywords":["brain mapping"],"scientific_title":"Activity in central cough networks in patients with cough hypersensitivity","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Stuart Mazzone","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1042528","simplified_title":"Neural dysfunction in chronic cough","sub_type":"Standard Project Grant","total_budget":"456743.94","source_system":"Excessive cough associated with an airways disease represents the most common reason for doctor consultations.  However, the current therapeutic options for relieving excessive cough are limited.  This proposal will provide unprecedented insights into the brain mechanisms that contribute to the development of cough disorders in airways disease."},"children":[{"color":"#336699","name":"Prof Gary Egan","data":{"first_name":"Gary","title":"Prof","dw_individual_id":"DW0018843","middle_name":"F","last_name":"Egan","source_individual_id":"5014499","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gary Egan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81823","size":1},{"color":"#336699","name":"Dr Stuart Mazzone","data":{"first_name":"Stuart","title":"Dr","dw_individual_id":"DW0008967","middle_name":"B","last_name":"Mazzone","source_individual_id":"5016283","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Stuart Mazzone"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79130","size":1},{"color":"#336699","name":"Dr Michael Farrell","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0007204","middle_name":"John","last_name":"Farrell","source_individual_id":"5014579","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michael Farrell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78646","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73795","size":1},{"color":"#FF4D4D","name":"A workplace-based exercise intervention to prevent and reduce the economic and personal burden of non-specific neck pain in the office personnel","data":{"media_summary":"","end_year":2016,"keywords":["exercise training","primary prevention","economic evaluation","musculoskeletal","ergonomics"],"nhmrc_grant_id":1042508,"application_year":2012,"health_keywords":["population health"],"scientific_title":"A workplace-based exercise intervention to prevent and reduce the economic and personal burden of non-specific neck pain in the office personnel","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Promotion","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Venerina Johnston","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1042508","simplified_title":"Workplace interventions to reduce the cost of neck problems in office personnel","sub_type":"Standard Project Grant","total_budget":"680969.06","source_system":"Neck pain in office workers is a major burden in industry in terms of lost productivity and personal suffering. This research will evaluate a novel intervention for the prevention and management of neck pain in computer users. The impact and value of neck specific exercises and best practice office ergonomics will be evaluated from the employers (productivity loss) and workers perspective (severity of neck pain). The findings will directly benefit future management of this significant health issue."},"children":[{"color":"#336699","name":"Prof Leon Straker","data":{"first_name":"Leon","title":"Prof","dw_individual_id":"DW0045660","middle_name":"M","last_name":"Straker","source_individual_id":"5017739","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Leon Straker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88807","size":1},{"color":"#336699","name":"Dr Shaun O'Leary","data":{"first_name":"Shaun","title":"Dr","dw_individual_id":"DW0032976","middle_name":"Patrick","last_name":"O'Leary","source_individual_id":"5016795","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Shaun O'Leary"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85546","size":1},{"color":"#336699","name":"Dr Tracy Comans","data":{"first_name":"Tracy","title":"Dr","dw_individual_id":"DW0024219","middle_name":"Anne","last_name":"Comans","source_individual_id":"5031595","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Tracy Comans"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83219","size":1},{"color":"#336699","name":"Prof Gisela Sjogaard","data":{"first_name":"Gisela","title":"Prof","dw_individual_id":"DW0016255","middle_name":"","last_name":"Sjogaard","source_individual_id":"5041289","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gisela Sjogaard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81106","size":1},{"color":"#336699","name":"A/Pr Markus Melloh","data":{"first_name":"Markus","title":"A/Pr","dw_individual_id":"DW0014942","middle_name":"","last_name":"Melloh","source_individual_id":"5042692","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Markus Melloh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80749","size":1},{"color":"#336699","name":"Dr Venerina Johnston","data":{"first_name":"Venerina","title":"Dr","dw_individual_id":"DW0008209","middle_name":"","last_name":"Johnston","source_individual_id":"5038609","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Venerina Johnston"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78915","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73792","size":1},{"color":"#FF4D4D","name":"Somatic retrotransposition drives neoplastic mutagenesis in glioblastoma multiforme","data":{"media_summary":"","end_year":2015,"keywords":["genomics","DNA sequencing","epigenetics","glioblastoma","somatic mutation"],"nhmrc_grant_id":1042449,"application_year":2012,"start_year":2013,"scientific_title":"Somatic retrotransposition drives neoplastic mutagenesis in glioblastoma multiforme","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Genetics","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"A/Pr Geoffrey Faulkner","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1042449","simplified_title":"Mobile DNA as a contributor to human brain cancer","sub_type":"Standard Project Grant","total_budget":"663464.3","source_system":"Retrotransposons are mobile genes that copy-and-paste themselves in our genome. Previously thought to represent junk DNA, retrotransposons are increasingly found to play major roles in biology. In a recent landmark publication in Nature, we demonstrated that retrotransposons move in the healthy human brain. In the current study, we will use cutting-edge technologies to determine whether brain cancer can occur as a result. This will provide new perspectives of the genetic basis for cancer."},"children":[{"color":"#336699","name":"A/Pr Geoffrey Faulkner","data":{"first_name":"Geoffrey","title":"A/Pr","dw_individual_id":"DW0007208","middle_name":"J","last_name":"Faulkner","source_individual_id":"5014580","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Geoffrey Faulkner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78649","size":1},{"color":"#336699","name":"Dr Ryan Taft","data":{"first_name":"Ryan","title":"Dr","dw_individual_id":"DW0004931","middle_name":"James","last_name":"Taft","source_individual_id":"5040954","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ryan Taft"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78032","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73780","size":1},{"color":"#FF4D4D","name":"Chronic disease epidemiology in different populations: risk factors, detection and prevention","data":{"media_summary":"kidney disease","end_year":2017,"keywords":["Aboriginal health","chronic diseases","epidemiology","risk factors","diabetes"],"nhmrc_grant_id":1042343,"application_year":2012,"health_keywords":["developing countries","cardiovascular disease","early detection","early prevention","kidney disease"],"scientific_title":"Chronic disease epidemiology in different populations: risk factors, detection and prevention","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Zhiqiang Wang","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1042343","simplified_title":"Chronic disease epidemiology","sub_type":"Research Fellowship","total_budget":"609598.47","source_system":"To investigate causes, detection and prevention of diabetes, cardiovascular disease, and kidney disease in Aboriginal and international populations, I will maintain a long-term cohort with a 20-year follow-up in Aboriginal people and to analyse several large repeated cross-sectional data collected over 25 years in China. For the next 5 years, I will continue to to provide critical epidemiological evidence for the development of health policies and clinical guidelines related to chronic diseases in different populations."},"children":[{"color":"#336699","name":"A/Pr Zhiqiang Wang","data":{"first_name":"Zhiqiang","title":"A/Pr","dw_individual_id":"DW0028670","middle_name":"","last_name":"Wang","source_individual_id":"5019801","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Zhiqiang Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84425","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73770","size":1},{"color":"#FF4D4D","name":"Early pharmacological intervention in an animal model of schizophrenia","data":{"media_summary":"","end_year":2015,"keywords":["schizophrenia","animal model","vitamin D","brain development","pharmacological intervention"],"nhmrc_grant_id":1042259,"application_year":2012,"start_year":2013,"scientific_title":"Early pharmacological intervention in an animal model of schizophrenia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Darryl Eyles","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1042259","simplified_title":"Early pharmacological intervention in an animal model of schizophrenia","sub_type":"Standard Project Grant","total_budget":"436555.46","source_system":"The symptoms of schizophrenia do not appear until late adolescence/early adulthood. Some adolescents may be at high risk of progressing to clinical psychosis. There is now intense interest in using antipsychotic drugs (APDs) to delay symptoms in these patients. APD use in adolescents however is controversial. This project seeks to clarify the structural, neurochemical and functional implications of APD use in a well described animal model of schizophrenia, developmental vitamin D deficiency."},"children":[{"color":"#336699","name":"A/Pr Darryl Eyles","data":{"first_name":"Darryl","title":"A/Pr","dw_individual_id":"DW0042305","middle_name":"W","last_name":"Eyles","source_individual_id":"5014564","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Darryl Eyles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87979","size":1},{"color":"#336699","name":"A/Pr Thomas Burne","data":{"first_name":"Thomas","title":"A/Pr","dw_individual_id":"DW0023865","middle_name":"Henry Johnston","last_name":"Burne","source_individual_id":"5013713","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thomas Burne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83125","size":1},{"color":"#336699","name":"Prof John Mcgrath","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0009022","middle_name":"Joseph","last_name":"Mcgrath","source_individual_id":"RMIS3680751","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mcgrath"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79147","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73761","size":1},{"color":"#FF4D4D","name":"Understanding the kidney: from morphogenesis to regeneration","data":{"media_summary":"","end_year":2017,"keywords":["kidney development","kidney disease","developmental biology","stem cell biology","regenerative medicine"],"nhmrc_grant_id":1042093,"application_year":2012,"health_keywords":["morphogenesis","molecular basis of disease","gene expression"],"scientific_title":"Understanding the kidney: from morphogenesis to regeneration","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1042093","simplified_title":"Developing novel treatments for kidney disease","sub_type":"Research Fellowship","total_budget":"834117.55","source_system":"In Australia, 11.3% of deaths are associated with chronic kidney disease with >$1 billion per annum spent on treating this condition. Kidney function throughout life depends upon what happened during your foetal development as all the functional units of the kidney are made prior to birth. In this project, we will use our understanding of normal kidney development to develop new regenerative approaches to the treatment of this condition."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73751","size":1},{"color":"#FF4D4D","name":"Understanding how membrane trafficking controls the levels of Alzheimer's disease causing A_ peptides","data":{"media_summary":"","end_year":2015,"keywords":["protein trafficking","molecular neuroscience","Alzheimer disease","X-ray crystallography","amyloid precursor protein"],"nhmrc_grant_id":1042082,"application_year":2012,"health_keywords":["endosomes","membrane trafficking","neurodegenerative disorders","protein-protein interaction"],"scientific_title":"Understanding how membrane trafficking controls the levels of Alzheimer's disease causing A_ peptides","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Brett Collins","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1042082","simplified_title":"Membrane trafficking in Alzheimer's disease","sub_type":"Standard Project Grant","total_budget":"472254.53","source_system":"Alzheimers disease is a progressive neurological disorder and is the most common cause of dementia. No effective treatments are currently available. The toxic amyloid peptide is central to disease pathology and is derived from breakdown of the Alzheimers amyloid precursor protein (APP). In this project we will examine the interactions between APP and the molecular machinery that controls its location in the cell and subsequent degradation."},"children":[{"color":"#336699","name":"Dr Brett Collins","data":{"first_name":"Brett","title":"Dr","dw_individual_id":"DW0041718","middle_name":"Martin","last_name":"Collins","source_individual_id":"5014007","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brett Collins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87821","size":1},{"color":"#336699","name":"A/Pr Rohan Teasdale","data":{"first_name":"Rohan","title":"A/Pr","dw_individual_id":"DW0040022","middle_name":"D","last_name":"Teasdale","source_individual_id":"5017848","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Rohan Teasdale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87368","size":1},{"color":"#336699","name":"Prof Wanjin Hong","data":{"first_name":"Wanjin","title":"Prof","dw_individual_id":"DW0013721","middle_name":"","last_name":"Hong","source_individual_id":"5032649","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Wanjin Hong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80397","size":1},{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1},{"color":"#336699","name":"A/Pr Elizabeth Coulson","data":{"first_name":"Elizabeth","title":"A/Pr","dw_individual_id":"DW0006736","middle_name":"J","last_name":"Coulson","source_individual_id":"5014079","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Elizabeth Coulson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78524","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73747","size":1},{"color":"#FF4D4D","name":"MicroRNA regulation of fear-related memory","data":{"media_summary":"","end_year":2015,"keywords":["microrna","lentivirus","cell culture","prefrontal cortex","memory"],"nhmrc_grant_id":1042051,"application_year":2012,"start_year":2013,"scientific_title":"MicroRNA regulation of fear-related memory","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Timothy Bredy","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1042051","simplified_title":"Mechanisms of memory stability","sub_type":"Standard Project Grant","total_budget":"487257","source_system":"Emotionally traumatic experiences are well remembered and, in some instances, frequent reminders of these events can lead to the development of fear-related anxiety disorders such as phobia or post-traumatic stress disorder (PTSD). The experiments outlined in this proposal will examine how a novel epigenetic mechanism of gene regulation contributes to the transition from the retrieval of a fear memory to its inhibition through a process called extinction."},"children":[{"color":"#336699","name":"Dr Timothy Bredy","data":{"first_name":"Timothy","title":"Dr","dw_individual_id":"DW0017892","middle_name":"William","last_name":"Bredy","source_individual_id":"5019656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Timothy Bredy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81569","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73744","size":1},{"color":"#FF4D4D","name":"Prevention of asthma in young children via immunostimulation","data":{"media_summary":"","end_year":2016,"keywords":["asthma","mucosal immunology","clinical trial","immunomodulation","primary prevention"],"nhmrc_grant_id":1041983,"application_year":2012,"start_year":2013,"scientific_title":"Prevention of asthma in young children via immunostimulation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Prof Peter Sly","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1041983","simplified_title":"Stop asthma with immunostimulation","sub_type":"Standard Project Grant","total_budget":"671337.67","source_system":"Persistent asthma is a major problem for Australia yet none of the current therapies do more that control the condition. The long-term solution is to prevent asthma from progressing to the persistent form. The major risk factors are: family history, early allergy and recurrent severe lower respiratory infections (sLRI)  in the early life. We will conduct a randomized clinical trial to prevent sLRI using a novel bacterial-derived immunostimulant in infants at high risk of developing asthma."},"children":[{"color":"#336699","name":"Prof Peter Sly","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0028010","middle_name":"David","last_name":"Sly","source_individual_id":"5011929","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Sly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84226","size":1},{"color":"#336699","name":"Dr Deborah Strickland","data":{"first_name":"Deborah","title":"Dr","dw_individual_id":"DW0022374","middle_name":"H","last_name":"Strickland","source_individual_id":"RMIS4352530","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Deborah Strickland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82774","size":1},{"color":"#336699","name":"Prof Patrick Holt","data":{"first_name":"Patrick","title":"Prof","dw_individual_id":"DW0019686","middle_name":"G","last_name":"Holt","source_individual_id":"5015322","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Patrick Holt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82016","size":1},{"color":"#336699","name":"Dr Kathryn Holt","data":{"first_name":"Kathryn","title":"Dr","dw_individual_id":"DW0007945","middle_name":"Elizabeth","last_name":"Holt","source_individual_id":"5018901","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kathryn Holt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78847","size":1},{"color":"#336699","name":"Prof Zoltan Hantos","data":{"first_name":"Zoltan","title":"Prof","dw_individual_id":"DW0002025","middle_name":"","last_name":"Hantos","source_individual_id":"5015077","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Zoltan Hantos"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77217","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73737","size":1},{"color":"#FF4D4D","name":"Endosomal Dynamics and Pathogen Invasion","data":{"media_summary":"","end_year":2017,"keywords":["endocytosis","protein trafficking","host/pathogen interaction","membrane transport","receptor trafficking"],"nhmrc_grant_id":1041929,"application_year":2012,"start_year":2013,"scientific_title":"Endosomal Dynamics and Pathogen Invasion","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Trafficking","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Rohan Teasdale","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1041929","simplified_title":"Cellular Microbiology","sub_type":"Research Fellowship","total_budget":"609598.47","source_system":"Many bacterial pathogens invade host cells to replicate and avoid detection by the host. These pathogens interact with the host and by manipulating it to its benefit they establish an environment to survive in.  A detailed understanding of the targeted hosts pathways and which are essential for pathogen survival is knowledge that will allow future development of therapeutic intervention strategies."},"children":[{"color":"#336699","name":"A/Pr Rohan Teasdale","data":{"first_name":"Rohan","title":"A/Pr","dw_individual_id":"DW0040022","middle_name":"D","last_name":"Teasdale","source_individual_id":"5017848","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Rohan Teasdale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87368","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73732","size":1},{"color":"#FF4D4D","name":"Safety of Hendra virus anti-G glycoprotein monoclonal antibody in humans","data":{"media_summary":"","end_year":2013,"keywords":["infectious diseases","virus","clinical trial","antibody production","antibody therapy"],"nhmrc_grant_id":1041833,"application_year":2012,"start_year":2012,"scientific_title":"Safety of Hendra virus anti-G glycoprotein monoclonal antibody in humans","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Molecular Engineering of Nucleic Acids and Proteins","research_area":"Clinical Medicine and Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"A/Pr E Geoffrey Playford","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/1041833","simplified_title":"Safety assessment of an anti-Hendra virus antibody in humans","sub_type":"Urgent Research - Hendra Virus","total_budget":"400000","source_system":"Hendra virus infection in humans is a serious, and often fatal, disease.  No cure exists for Hendra infection and existing treatments are ineffective.  Recently, a human monoclonal antibody has shown great promise in protecting animals from developing the disease.  This project aims to perform preclinical safety testing and a Phase I clinical trial to establish the safety profile of this antibody such that it can be used to prevent Hendra infection in humans exposed to the disease."},"children":[{"color":"#336699","name":"Dr Deborah Middleton","data":{"first_name":"Deborah","title":"Dr","dw_individual_id":"DW0044267","middle_name":"J","last_name":"Middleton","source_individual_id":"RMIS4224367","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Deborah Middleton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88470","size":1},{"color":"#336699","name":"Dr Trent Munro","data":{"first_name":"Trent","title":"Dr","dw_individual_id":"DW0021027","middle_name":"Phillip","last_name":"Munro","source_individual_id":"5038745","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Trent Munro"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82388","size":1},{"color":"#336699","name":"A/Pr Stephen Mahler","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0020583","middle_name":"Michael","last_name":"Mahler","source_individual_id":"5011435","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Stephen Mahler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82260","size":1},{"color":"#336699","name":"Prof Christopher Broder","data":{"first_name":"Christopher","title":"Prof","dw_individual_id":"DW0011995","middle_name":"C","last_name":"Broder","source_individual_id":"5042562","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Christopher Broder"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79944","size":1},{"color":"#336699","name":"A/Pr E Geoffrey Playford","data":{"first_name":"E Geoffrey","title":"A/Pr","dw_individual_id":"DW0009678","middle_name":"","last_name":"Playford","source_individual_id":"5017017","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr E Geoffrey Playford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79327","size":1},{"color":"#336699","name":"Prof Peter Gray","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0007586","middle_name":"Philip","last_name":"Gray","source_individual_id":"5011274","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78748","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73713","size":1},{"color":"#FF4D4D","name":"Translating health behaviour interventions into Population Health practice: maintenance and dissemination","data":{"media_summary":"","end_year":2017,"keywords":["health promotion","behavioural intervention","cost-effectiveness","health services research","population health"],"nhmrc_grant_id":1041789,"application_year":2012,"health_keywords":["health counselling","health education","chronic diseases"],"scientific_title":"Translating health behaviour interventions into Population Health practice: maintenance and dissemination","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Promotion","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Elizabeth Eakin","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1041789","simplified_title":"Translating health behaviour interventions into Population Health practice","sub_type":"Research Fellowship","total_budget":"609598.47","source_system":"Preventing diabetes, heart disease and cancer is an urgent public health priority. While health organizations conduct programs to encourage people to exercise, eat well and maintain a healthy body weight, little is known about how best to make these programs widely available and effective. This research will test new ways for using telephone counselling and text messaging to help people make feasible and lasting lifestyle changes, to reduce their risk of ill-health and premature death."},"children":[{"color":"#336699","name":"Prof Elizabeth Eakin","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0036429","middle_name":"G","last_name":"Eakin","source_individual_id":"5014455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Elizabeth Eakin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86445","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73702","size":1},{"color":"#FF4D4D","name":"Improving quality of life in high-risk cancer populations: a randomised trial of a structured intervention for head and neck cancer survivors","data":{"media_summary":"","end_year":2015,"keywords":["head and neck cancer","survivorship","patient education","self-management","self-efficacy"],"nhmrc_grant_id":1041640,"application_year":2012,"start_year":2013,"scientific_title":"Improving quality of life in high-risk cancer populations: a randomised trial of a structured intervention for head and neck cancer survivors","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"A/Pr Margaret Turner","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1041640","simplified_title":"Providing tailored support for head and neck cancer survivors","sub_type":"Standard Project Grant","total_budget":"490248.14","source_system":"Patients treated for head and neck cancer commonly experience pain, disfigurement, eating difficulties, depression and fatigue, undermining confidence and quality of life. This study aims to help patients self-manage their ongoing health problems following completion of treatment. This will be achieved through a randomised trial in which patients will be assisted by a trained oncology nurse to develop a tailored survivorship care plan focusing on the patients specific medical and emotional concerns."},"children":[{"color":"#336699","name":"A/Pr Damien Thomson","data":{"first_name":"Damien","title":"A/Pr","dw_individual_id":"DW0045844","middle_name":"Balfour","last_name":"Thomson","source_individual_id":"5017925","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Damien Thomson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88859","size":1},{"color":"#336699","name":"A/Pr Christopher Perry","data":{"first_name":"Christopher","title":"A/Pr","dw_individual_id":"DW0039053","middle_name":"Francis","last_name":"Perry","source_individual_id":"5024238","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Christopher Perry"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87117","size":1},{"color":"#336699","name":"Dr Lizbeth Kenny","data":{"first_name":"Lizbeth","title":"Dr","dw_individual_id":"DW0037733","middle_name":"M","last_name":"Kenny","source_individual_id":"5015684","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Lizbeth Kenny"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86769","size":1},{"color":"#336699","name":"Prof Bryan Burmeister","data":{"first_name":"Bryan","title":"Prof","dw_individual_id":"DW0035641","middle_name":"H","last_name":"Burmeister","source_individual_id":"5013696","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bryan Burmeister"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86230","size":1},{"color":"#336699","name":"A/Pr Margaret Turner","data":{"first_name":"Margaret","title":"A/Pr","dw_individual_id":"DW0028495","middle_name":"Jane","last_name":"Turner","source_individual_id":"5023078","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Margaret Turner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84371","size":1},{"color":"#336699","name":"Dr Louisa Gordon","data":{"first_name":"Louisa","title":"Dr","dw_individual_id":"DW0019278","middle_name":"","last_name":"Gordon","source_individual_id":"5012542","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Louisa Gordon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81914","size":1},{"color":"#336699","name":"Dr Raymond Chan","data":{"first_name":"Raymond","title":"Dr","dw_individual_id":"DW0018164","middle_name":"","last_name":"Chan","source_individual_id":"5043284","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Raymond Chan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81649","size":1},{"color":"#336699","name":"Prof Patsy Yates","data":{"first_name":"Patsy","title":"Prof","dw_individual_id":"DW0005594","middle_name":"","last_name":"Yates","source_individual_id":"RMIS7232","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Patsy Yates"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78222","size":1},{"color":"#336699","name":"Prof Alexandra Mccarthy","data":{"first_name":"Alexandra","title":"Prof","dw_individual_id":"DW0003249","middle_name":"L","last_name":"Mccarthy","source_individual_id":"5016295","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alexandra Mccarthy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77562","size":1},{"color":"#336699","name":"Dr Brett Hughes","data":{"first_name":"Brett","title":"Dr","dw_individual_id":"DW0002316","middle_name":"","last_name":"Hughes","source_individual_id":"5043317","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brett Hughes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77299","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73695","size":1},{"color":"#FF4D4D","name":"Interaction of group A streptococci with intracellular innate immune defence","data":{"media_summary":"","end_year":2016,"keywords":["streptococcal infection","Streptococcus pyogenes","streptococcal disease","streptococcal invasive diseases","streptococcus"],"nhmrc_grant_id":1041294,"application_year":2012,"start_year":2013,"scientific_title":"Interaction of group A streptococci with intracellular innate immune defence","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Mark Walker","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1041294","simplified_title":"Invasion of human cells by group A streptococci","sub_type":"Standard Project Grant","total_budget":"813983.08","source_system":"The pathogenic bacterium group A streptococcus (GAS) is estimated to cause ~700 million cases of self-limited throat or skin infection each year worldwide. GAS infections result in over 600,000 human deaths. This disease burden places GAS in the top 10 causes of human infectious disease deaths worldwide. We have discovered a hitherto unknown mechanism by which GAS subvert the human immune system. An improved understanding of this mechanism will lead to novel ways to combat GAS infections."},"children":[{"color":"#336699","name":"A/Pr Christine Wells","data":{"first_name":"Christine","title":"A/Pr","dw_individual_id":"DW0040397","middle_name":"Anne","last_name":"Wells","source_individual_id":"5018258","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Christine Wells"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87466","size":1},{"color":"#336699","name":"Prof Mark Walker","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0010893","middle_name":"J.","last_name":"Walker","source_individual_id":"RMIS127362","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mark Walker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79668","size":1},{"color":"#336699","name":"Prof Victor Nizet","data":{"first_name":"Victor","title":"Prof","dw_individual_id":"DW0003693","middle_name":"","last_name":"Nizet","source_individual_id":"5030735","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Victor Nizet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77687","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73680","size":1},{"color":"#FF4D4D","name":"Directed differentiation of human embryonic stem cells to kidney progenitors","data":{"media_summary":"","end_year":2015,"keywords":["embryonic stem cells","differentiation","kidney development","kidney disease","pluripotential"],"nhmrc_grant_id":1041277,"application_year":2012,"health_keywords":["nanotechnology","regeneration"],"scientific_title":"Directed differentiation of human embryonic stem cells to kidney progenitors","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Regenerative Medicine (incl. Stem Cells and Tissue Engineering)","research_area":"Basic Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1041277","simplified_title":"Making ES cells into kidney","sub_type":"Standard Project Grant","total_budget":"648715.95","source_system":"In Australia, 11.3% of deaths are associated with chronic kidney disease, costing the health system >$1 billion per annum. No stem cell exists in the adult kidney that can replace damaged kidney filters. We have preliminary results suggesting we may be able to make kidney stem cells from embryonic stem cells or induced pluripotent cells. In this project, we will optimise the conditions required and test the ability of these cells to form new kidney structures."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1},{"color":"#336699","name":"Prof Justin Cooper-White","data":{"first_name":"Justin","title":"Prof","dw_individual_id":"DW0036010","middle_name":"J","last_name":"Cooper-White","source_individual_id":"RMIS2454623","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Justin Cooper-White"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86335","size":1},{"color":"#336699","name":"A/Pr Ernst Wolvetang","data":{"first_name":"Ernst","title":"A/Pr","dw_individual_id":"DW0017193","middle_name":"Jurgen","last_name":"Wolvetang","source_individual_id":"5020397","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ernst Wolvetang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81372","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73679","size":1},{"color":"#FF4D4D","name":"Kidney mesenchymal stem cells in tubular development, repair and turnover.","data":{"media_summary":"","end_year":2015,"keywords":["stem cell biology","stem cell therapy","kidney disease","regenerative medicine","cell therapy"],"nhmrc_grant_id":1041276,"application_year":2012,"health_keywords":["cell development"],"scientific_title":"Kidney mesenchymal stem cells in tubular development, repair and turnover.","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Regenerative Medicine (incl. Stem Cells and Tissue Engineering)","research_area":"Basic Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1041276","simplified_title":"Stem cells in the kidney","sub_type":"Standard Project Grant","total_budget":"0","source_system":"In Australia, 11.3% of deaths are associated with chronic kidney disease with >$1 billion per annum spent on treating this condition. At present, only dialysis and transplantation are available to treat end stage kidney disease. We have found a kidney stem cell population in both human and mouse that can form new epithelial structures. In this project, we will investigate the normal role played by these kidney stem cells and examine whether they can contribute to kidney regeneration."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1},{"color":"#336699","name":"Prof Antonius Rabelink","data":{"first_name":"Antonius","title":"Prof","dw_individual_id":"DW0009777","middle_name":"Johannes","last_name":"Rabelink","source_individual_id":"5042769","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Antonius Rabelink"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79353","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73678","size":1},{"color":"#FF4D4D","name":"Reprogramming to generate new nephron progenitors","data":{"media_summary":"","end_year":2015,"keywords":["stem cells","regeneration","lentiviral vector","gene delivery","gene therapy"],"nhmrc_grant_id":1041275,"application_year":2012,"health_keywords":["kidney development","morphogenesis","transcriptional regulation"],"scientific_title":"Reprogramming to generate new nephron progenitors","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1041275","simplified_title":"Turning adult cells into kidney stem cells","sub_type":"Standard Project Grant","total_budget":"532259.21","source_system":"In Australia, chronic kidney disease costs >$1 billion per annum and can only be treated by dialysis or transplantation. Your kidney function depends upon what happened during your development as all the functional units of the kidney are made prior to birth from a stem cell population that then disappears. We have found a way to recreate these stem cells from adult cells. In this project, we will optimise this process and investigate whether regenerated stem cells can repair an adult kidney."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1},{"color":"#336699","name":"Dr Matthew Wilson","data":{"first_name":"Matthew","title":"Dr","dw_individual_id":"DW0028863","middle_name":"Hunter","last_name":"Wilson","source_individual_id":"5042721","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Matthew Wilson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84480","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73677","size":1},{"color":"#FF4D4D","name":"Evidence-based Mental Health Planning: Translating Evidence into Policy and Services","data":{"media_summary":"","end_year":2017,"keywords":["mental health","mental disorder","substance use disorders","epidemiology","policy analysis"],"nhmrc_grant_id":1041131,"application_year":2012,"start_year":2012,"scientific_title":"Evidence-based Mental Health Planning: Translating Evidence into Policy and Services","node_source":"NHMRC","node_type":"Grant","field_of_research":"Mental Health","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Harvey Whiteford","higher_grant_type":"Centre for Research Excellence","purl":"http://purl.org/au-research/grants/nhmrc/1041131","simplified_title":"Evidence-based Mental Health Planning: Translating Evidence into Policy and Services","sub_type":"Centre for Research Excellence - Health Services","total_budget":"2517984.94","source_system":"The CRE will design a better mental health system for Australia. This service system will include the full range of prevention and treatment interventions using the best available scientific evidence. It will also describe how to ensure that the service system is implemented, by incorporating it into government policy. The work will be carried out across 5 of the best research centres in Australia with expertise in clinical medicine, epidemiology, service planning and implementation science."},"children":[{"color":"#336699","name":"Prof Harvey Whiteford","data":{"first_name":"Harvey","title":"Prof","dw_individual_id":"DW0046245","middle_name":"Alick","last_name":"Whiteford","source_individual_id":"5023501","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Harvey Whiteford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88972","size":1},{"color":"#336699","name":"Prof Brian Head","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0042966","middle_name":"William","last_name":"Head","source_individual_id":"5041372","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Brian Head"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88133","size":1},{"color":"#336699","name":"A/Pr Cathrine Mihalopoulos","data":{"first_name":"Cathrine","title":"A/Pr","dw_individual_id":"DW0038549","middle_name":"","last_name":"Mihalopoulos","source_individual_id":"5016468","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Cathrine Mihalopoulos"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86987","size":1},{"color":"#336699","name":"Prof Professor Louisa Degenhardt","data":{"first_name":"Professor Louisa","title":"Prof","dw_individual_id":"DW0030337","middle_name":"J","last_name":"Degenhardt","source_individual_id":"RMIS572179","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Professor Louisa Degenhardt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84872","size":1},{"color":"#336699","name":"Prof Eric Vos","data":{"first_name":"Eric","title":"Prof","dw_individual_id":"DW0022749","middle_name":"Theo","last_name":"Vos","source_individual_id":"5012185","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Eric Vos"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82861","size":1},{"color":"#336699","name":"Prof Kathy Eagar","data":{"first_name":"Kathy","title":"Prof","dw_individual_id":"DW0018819","middle_name":"","last_name":"Eagar","source_individual_id":"5012479","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Kathy Eagar"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81819","size":1},{"color":"#336699","name":"Prof Jane Pirkis","data":{"first_name":"Jane","title":"Prof","dw_individual_id":"DW0015605","middle_name":"Elizabeth","last_name":"Pirkis","source_individual_id":"5012085","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jane Pirkis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80937","size":1},{"color":"#336699","name":"Prof Gavin Andrews","data":{"first_name":"Gavin","title":"Prof","dw_individual_id":"DW0005813","middle_name":"J","last_name":"Andrews","source_individual_id":"5013220","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gavin Andrews"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78288","size":1},{"color":"#336699","name":"Prof George Patton","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0003882","middle_name":"Christopher","last_name":"Patton","source_individual_id":"RMIS64888","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Patton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77748","size":1},{"color":"#336699","name":"Prof Wayne Hall","data":{"first_name":"Wayne","title":"Prof","dw_individual_id":"DW0001997","middle_name":"Denis","last_name":"Hall","source_individual_id":"5012662","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Wayne Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77211","size":1},{"color":"#336699","name":"Prof Jane Gunn","data":{"first_name":"Jane","title":"Prof","dw_individual_id":"DW0001950","middle_name":"Maree","last_name":"Gunn","source_individual_id":"RMIS223953","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jane Gunn"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77198","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73676","size":1},{"color":"#FF4D4D","name":"Efficacy of a group block versus individualised distributed upper limb rehabilitation in congenital hemiplegia: Motivation and mastery","data":{"media_summary":"","end_year":2014,"keywords":["cerebral palsy","paediatric","upper limb function","rehabilitation","motivation"],"nhmrc_grant_id":1039832,"application_year":2011,"health_keywords":["participation","occupational therapy","intervention"],"scientific_title":"Efficacy of a group block versus individualised distributed upper limb rehabilitation in congenital hemiplegia: Motivation and mastery","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy (excl. Physiotherapy)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Ms Laura Miller","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1039832","simplified_title":"Efficacy of a group block versus individualised distributed upper limb rehabilitation in congenital hemiplegia: Motivation and mastery","sub_type":"Primary Health Care Scholarship","total_budget":"85027.08","source_system":"I am an occupational therapist investigating the contribution of motivation on activity and participation outcomes with children with congenital hemiplegia. This study will compare an intensive block of group based upper limb rehabilitation delivered in such a way as to enhance self-determination with an individualised distributed model of standard care. My research aims to help improve rehabilitation programs for children with hemiplegia, and facilitate effective allocation of resources."},"children":[{"color":"#336699","name":"Ms Laura Miller","data":{"first_name":"Laura","title":"Ms","dw_individual_id":"DW0026757","middle_name":"","last_name":"Miller","source_individual_id":"5041909","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Laura Miller"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83931","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73621","size":1},{"color":"#FF4D4D","name":"Protracted Bacterial Bronchitis(PBB) in Children - natural history, innate immunity and obstructive sleep disorders","data":{"media_summary":"","end_year":2014,"keywords":["bronchitis","paediatric","respiratory diseases","innate immunity","obstructive sleep apnoea"],"nhmrc_grant_id":1039688,"application_year":2011,"start_year":2012,"scientific_title":"Protracted Bacterial Bronchitis(PBB) in Children - natural history, innate immunity and obstructive sleep disorders","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Dr Danielle Wurzel","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1039688","simplified_title":"Protracted Bacterial Bronchitis (PBB) in Children - immunity, sleep and medium term outcome","sub_type":"Medical/Dental Postgraduate Scholarship","total_budget":"97438.13","source_system":"Recurrent episodes of prolonged wet cough in children, termed Protracted Bacterial Bronchitis (PBB), may cause long term lung damage. I am a paediatric respiratory and sleep subspecialist in training. Through our research we will investigate for abnormalities in the immune system of children with recurring episodes of PBB and follow these children over a 2 year period to determine whether they go on to develop lung scarring. We will also be looking for a link between PBB and obstructive sleep problems in children."},"children":[{"color":"#336699","name":"Dr Danielle Wurzel","data":{"first_name":"Danielle","title":"Dr","dw_individual_id":"DW0046414","middle_name":"Fortunee","last_name":"Wurzel","source_individual_id":"5039397","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Danielle Wurzel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/89024","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73612","size":1},{"color":"#FF4D4D","name":"Assessment of calcium signaling in breast cancer cells associated with epithelial-mesenchymal transition","data":{"media_summary":"","end_year":2015,"keywords":["calcium homeostasis","calcium signalling","calcium channels","calcium regulation","molecular pharmacology"],"nhmrc_grant_id":1039358,"application_year":2011,"health_keywords":["breast cancer"],"scientific_title":"Assessment of calcium signaling in breast cancer cells associated with epithelial-mesenchymal transition","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology and Pharmaceutical Sciences not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Miss Teneale Stewart","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1039358","simplified_title":"Calcium signaling in a model for breast cancer metastasis","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"98978.53","source_system":"This research will assess the role of specific proteins that control cell function in a process which is important in the spread of cancer cells throughout the body. The work is aimed at identifying new targets for drugs that may be used to prevent or stop the spread of breast cancer cells to other organs such as the brain and liver."},"children":[{"color":"#336699","name":"Miss Teneale Stewart","data":{"first_name":"Teneale","title":"Miss","dw_individual_id":"DW0004833","middle_name":"Amber","last_name":"Stewart","source_individual_id":"5042115","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Miss Teneale Stewart"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78010","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73586","size":1},{"color":"#FF4D4D","name":"The effect of defective iron handling on immune function and Pseudomonas aeruginosa infection in the cystic fibrosis lung","data":{"media_summary":"iron chelators","end_year":2014,"keywords":["cystic fibrosis","neutrophils","Pseudomonas aeruginosa infection","bronchiectasis","inflammatory mediators"],"nhmrc_grant_id":1039309,"application_year":2011,"health_keywords":["bacterial genetics","bacterial biofilm","bacterial virulence factors","iron metabolism","iron chelators"],"scientific_title":"The effect of defective iron handling on immune function and Pseudomonas aeruginosa infection in the cystic fibrosis lung","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Daniel Smith","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1039309","simplified_title":"The role of iron in the promoting lung infection in people with cystic fibrosis","sub_type":"Medical/Dental Postgraduate Scholarship","total_budget":"97213.77","source_system":"In this research higher degree I will study the effects of iron on airway sepsis in cystic fibrosis (CF), with a particular focus on the major pathogen Pseudomonas aeruginosa.  Increased concentrations of iron have been described in the CF lung, and CF airway epithelial cells display abnormal iron handling which facilitates P. aeruginosa growth. I will explore imposed iron limitation combined with conventional antibiotics as a new therapeutic strategy for treatment of chronic airway infection."},"children":[{"color":"#336699","name":"Dr Daniel Smith","data":{"first_name":"Daniel","title":"Dr","dw_individual_id":"DW0010325","middle_name":"James","last_name":"Smith","source_individual_id":"5028189","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Daniel Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79511","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73581","size":1},{"color":"#FF4D4D","name":"Molecular analysis of endocarditis causing strains of \"Staphylococcus aureus\"","data":{"media_summary":"","end_year":2014,"keywords":["Staphylococcus aureus","endocarditis","bacterial biofilm","bacterial pathogenesis","clinical"],"nhmrc_grant_id":1039296,"application_year":2011,"health_keywords":["infectious diseases"],"scientific_title":"Molecular analysis of endocarditis causing strains of \"Staphylococcus aureus\"","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Miss Cara Nethercott","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1039296","simplified_title":"How \"Golden Staph\" causes endocarditis","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"81263.23","source_system":"Staphylococcus aureus or \"Golden Staph is one of the principal causes of infective endocarditis, the infection of the endocardial surfaces of the heart and heart valves that may result in valvular insufficiency and eventual heart failure. This work will define the molecular mechanisms that allow S. aureus to survive and persist on endocardial surfaces. Such insight may lead to new future treatment regimes for infective endocarditis."},"children":[{"color":"#336699","name":"Miss Cara Nethercott","data":{"first_name":"Cara","title":"Miss","dw_individual_id":"DW0015214","middle_name":"Louise","last_name":"Nethercott","source_individual_id":"5042064","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Miss Cara Nethercott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80828","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73579","size":1},{"color":"#FF4D4D","name":"The development of human hematopoietic prostaglandin D2 synthase inhibitors in allergic asthma and related disorders","data":{"media_summary":"","end_year":2014,"keywords":["asthma","medicinal chemistry","drug discovery","respiratory diseases","chronic obstructive pulmonary disease (COPD)"],"nhmrc_grant_id":1039255,"application_year":2011,"start_year":2012,"scientific_title":"The development of human hematopoietic prostaglandin D2 synthase inhibitors in allergic asthma and related disorders","node_source":"NHMRC","node_type":"Grant","field_of_research":"Molecular Medicine","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"A/Pr Mark Smythe","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1039255","simplified_title":"Towards new thereapeutic treatments for asthma","sub_type":"Development Grant","total_budget":"428071.63","source_system":"Prostaglandin D2 (PGD2) is a key mediator of asthma and allergic rhinitis. We have developed drug-like compounds that block the synthesis of PGD2 by inhibiting the hematopoietic prostaglandin D2 synthase (HPGD2S) enzyme. This project aims to evaluate the potential of these compounds to treat asthma and to further optimize the drug-like characteristics of our lead molecules."},"children":[{"color":"#336699","name":"A/Pr Mark Smythe","data":{"first_name":"Mark","title":"A/Pr","dw_individual_id":"DW0045518","middle_name":"Leslie","last_name":"Smythe","source_individual_id":"5023110","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Mark Smythe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88779","size":1},{"color":"#336699","name":"Dr Simon Phipps","data":{"first_name":"Simon","title":"Dr","dw_individual_id":"DW0033180","middle_name":"","last_name":"Phipps","source_individual_id":"5016985","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Simon Phipps"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85598","size":1},{"color":"#336699","name":"Dr Jack Flanagan","data":{"first_name":"Jack","title":"Dr","dw_individual_id":"DW0030695","middle_name":"Urquhart","last_name":"Flanagan","source_individual_id":"RMIS4453914","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Jack Flanagan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84971","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73578","size":1},{"color":"#FF4D4D","name":"Early pregnancy screening for pre-eclampsia: a proteomic based model for identifying high-risk patients.","data":{"media_summary":"","end_year":2018,"keywords":["pre-eclampsia","screening","early pregnancy","proteomics","risk"],"nhmrc_grant_id":1039119,"application_year":2011,"start_year":2012,"scientific_title":"Early pregnancy screening for pre-eclampsia: a proteomic based model for identifying high-risk patients.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Dr Lisa Harris","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1039119","simplified_title":"Early Pregnancy Screening Project","sub_type":"Medical/Dental Postgraduate Scholarship","total_budget":"119644.64","source_system":"Pre-eclampsia is a serious medical condition affecting 5% of pregnancies and resulting in significant mortality and morbidity for mothers and babies.  As yet there is no acceptable test capable of detecting pre-eclampsia in early pregnancy and diagnosis is made when symptoms and signs are manifest and management options are limited to early delivery.  This project is designed to assess the ability of a blood screening test to detect pre-eclampsia in early pregnancy to enable for early interventions and preventative management to be implemented."},"children":[{"color":"#336699","name":"Dr Lisa Harris","data":{"first_name":"Lisa","title":"Dr","dw_individual_id":"DW0031149","middle_name":"","last_name":"Harris","source_individual_id":"5041664","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Lisa Harris"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85072","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73564","size":1},{"color":"#FF4D4D","name":"Use of snake venom prothrombin activators in blood collection tubes to produce high quality serum to improve patient outcomes","data":{"media_summary":"","end_year":2013,"keywords":["blood","venom","prothrombin","heparin","plasma proteins"],"nhmrc_grant_id":1038834,"application_year":2011,"health_keywords":["blood disorders","blood diseases","haematology"],"scientific_title":"Use of snake venom prothrombin activators in blood collection tubes to produce high quality serum to improve patient outcomes","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biotechnology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1038834","simplified_title":"Generation of high quality serum","sub_type":"Development Grant","total_budget":"284706.16","source_system":"The timely availability of high quality serum and plasma samples are of the utmost importance for accurate biochemical analysis in a clinical setting. This requirement is particularly true for patients on anti-clotting therapeutic agents such as warfarin and heparin. In this study we will employ potent prothrombin activators purified from snake venom to enhance the clotting efficiency of blood for serum preparation for biochemical analysis."},"children":[{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1},{"color":"#336699","name":"Dr Paul Masci","data":{"first_name":"Paul","title":"Dr","dw_individual_id":"DW0020664","middle_name":"Pantaleone","last_name":"Masci","source_individual_id":"5019068","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Paul Masci"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82280","size":1},{"color":"#336699","name":"E/Pr John De Jersey","data":{"first_name":"John","title":"E/Pr","dw_individual_id":"DW0018611","middle_name":"","last_name":"De Jersey","source_individual_id":"5014269","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"E/Pr John De Jersey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81769","size":1},{"color":"#336699","name":"Dr Goce Dimeski","data":{"first_name":"Goce","title":"Dr","dw_individual_id":"DW0001288","middle_name":"","last_name":"Dimeski","source_individual_id":"5024040","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Goce Dimeski"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77027","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73532","size":1},{"color":"#FF4D4D","name":"2011 Equipment Grant","data":{"media_summary":"","end_year":2012,"nhmrc_grant_id":1038551,"application_year":2011,"start_year":2011,"scientific_title":"2011 Equipment Grant","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Not Applicable","for_category":"","cia_name":"Nicole Shively","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/1038551","simplified_title":"2011 Equipment Grant","sub_type":"Equipment Grant","total_budget":"803537","source_system":""},"children":[{"color":"#336699","name":"Nicole Shively","data":{"first_name":"Nicole","title":"","dw_individual_id":"DW0003737","middle_name":"","last_name":"Shively","source_individual_id":"5020468","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Nicole Shively"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77705","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73458","size":1},{"color":"#FF4D4D","name":"Improving pleural procedures: Image analysis and training.","data":{"media_summary":"","end_year":2014,"keywords":["respiratory diseases","ultrasound","cancer","respiratory medicine","training"],"nhmrc_grant_id":1038239,"application_year":2011,"start_year":2012,"scientific_title":"Improving pleural procedures: Image analysis and training.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Dr Matthew Salamonsen","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1038239","simplified_title":"Improving chest procedures","sub_type":"Medical/Dental Postgraduate Scholarship","total_budget":"94468.49","source_system":"Currently, there is little evidence to guide the treatment of pleural disease, with common mismanagement and frequent adverse events. This project will develop image analysis tools, a clinical pathway and training to assist and guide clinicians in managing pleural disease, improving the diagnostic yield of pleural procedures, while reducing complication rates. It will offer a novel contribution to this young but blossoming field of respiratory medicine,  ultimately leading to improved care for people with pleural disease."},"children":[{"color":"#336699","name":"Dr Matthew Salamonsen","data":{"first_name":"Matthew","title":"Dr","dw_individual_id":"DW0045242","middle_name":"Robert","last_name":"Salamonsen","source_individual_id":"5028842","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Matthew Salamonsen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88707","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73436","size":1},{"color":"#FF4D4D","name":"Program in Membrane Interface Biology","data":{"media_summary":"","end_year":2017,"keywords":["membrane biology","membrane signalling","membrane trafficking","membrane protein","cytoskeleton"],"nhmrc_grant_id":1037320,"application_year":2011,"health_keywords":["adhesion mechanisms","caveolae"],"scientific_title":"Program in Membrane Interface Biology","start_year":2013,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/1037320","simplified_title":"The Plasma membrane in health and disease","sub_type":"Program Grant","total_budget":"7326722.34","source_system":"This research program aims to gain a detailed understanding of the organisation of the cell surface at the molecular level. The cell surface is organised into domains with distinct functions. Visualisation of these domains, identifying their important components, and understanding how they form and function will have huge importance for therapeutic strategies aimed at combatting the changes associated with cell transformation in cancer and in other human diseases such as muscular dystrophy."},"children":[{"color":"#336699","name":"Prof Katharina Gaus","data":{"first_name":"Katharina","title":"Prof","dw_individual_id":"DW0036795","middle_name":"","last_name":"Gaus","source_individual_id":"5014795","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Katharina Gaus"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86529","size":1},{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1},{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1},{"color":"#336699","name":"Prof Kirill Alexandrov","data":{"first_name":"Kirill","title":"Prof","dw_individual_id":"DW0005768","middle_name":"","last_name":"Alexandrov","source_individual_id":"5011534","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Kirill Alexandrov"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78275","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73382","size":1},{"color":"#FF4D4D","name":"Bifunctionalised Contrast Nanoparticles for Simultaneous Diagnosis and Treatment of Thrombosis, Vulnerable Plaques and Inflammation","data":{"media_summary":"","end_year":2017,"keywords":["molecular imaging","targeted therapy","cardiovascular disease","pulmonary embolism","atherosclerosis"],"nhmrc_grant_id":1037310,"application_year":2011,"health_keywords":["thrombosis","rheumatoid arthritis","early diagnosis"],"scientific_title":"Bifunctionalised Contrast Nanoparticles for Simultaneous Diagnosis and Treatment of Thrombosis, Vulnerable Plaques and Inflammation","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Dr Hang Ta","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1037310","simplified_title":"Bifunctionalised imaging agents for diagnosis and treatment of cardiovascular and inflammatory diseases","sub_type":"Peter Doherty Biomedical ECF","total_budget":"360741.35","source_system":"The aim of this project is to develop bifunctionalised contrast nanoparticles which selectively target molecular markers of cardiovascular and inflammatory diseases at various states. The nanoparticles would provide an advanced imaging technique for early diagnosis of fatty tissue build up in the vessel wall and for detecting vessel blockages. The nanoparticles would also work as drug carrier that specifically brings curative drugs to the disease site for an acute treatment simultaneously with diagnosis."},"children":[{"color":"#336699","name":"Dr Hang Ta","data":{"first_name":"Hang","title":"Dr","dw_individual_id":"DW0016553","middle_name":"Thu","last_name":"Ta","source_individual_id":"5027317","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Hang Ta"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81197","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73381","size":1},{"color":"#FF4D4D","name":"Australia Fellowship","data":{"media_summary":"","end_year":2016,"keywords":["Bioinformatics","Cancer","Ovarian Cancer","Stem Cells","Mathematical Modelling"],"nhmrc_grant_id":1037235,"application_year":2011,"health_keywords":["Adult Cancer","Ovarian Cancer","Predictive Stem Cell Assay","Cisplatin Resistance"],"scientific_title":"Australia Fellowship","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genomics","research_area":"Basic Science","for_category":"GENETICS","cia_name":"","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1037235","simplified_title":"Australia Fellowship","sub_type":"Australia Fellowship","total_budget":"0","source_system":""},"class":"Grant","self":"http://localhost:7474/db/data/node/73371","size":1},{"color":"#FF4D4D","name":"Neurorestorative rehabilitation in children with cerebral palsy","data":{"media_summary":"physical activity","end_year":2015,"keywords":["cerebral palsy treatments","rehabilitation","neuroscience","brain imaging","plasticity"],"nhmrc_grant_id":1037220,"application_year":2011,"health_keywords":["neurological disability","quality of life","participation","prevention","physical activity"],"scientific_title":"Neurorestorative rehabilitation in children with cerebral palsy","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy (excl. Physiotherapy)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Roslyn Boyd","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1037220","simplified_title":"Can training change the brain in cerebral palsy ?","sub_type":"Clinical CDF","total_budget":"449667.23","source_system":"Cerebral palsy (CP) is the most common physical disability (1 in 500) with life-long impact. The economic burden is AUS$1.47 billion/yr. Children have limitations in function which impacts daily activities and participation. Deficits in visual perception and learning have an impact on vocational aspirations. This program will test novel interventions (Action Observation training, constraint induced movement therapy, multi-modal web training) measuring broad outcomes and mechanisms with Advanced Brain Imaging."},"children":[{"color":"#336699","name":"Prof Roslyn Boyd","data":{"first_name":"Roslyn","title":"Prof","dw_individual_id":"DW0041223","middle_name":"N","last_name":"Boyd","source_individual_id":"RMIS1681246","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roslyn Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87689","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73365","size":1},{"color":"#FF4D4D","name":"The role Survivin and XIAP (X-linked inhibitor of apoptosis protein) as biomarkers and therapeutic targets in paediatric acute myeloid leukaemia.","data":{"media_summary":"","end_year":2016,"keywords":["acute myeloid leukaemia (AML)","cancer biology","paediatric","molecular oncology","cancer chemotherapeutic agents"],"nhmrc_grant_id":1036907,"application_year":2011,"start_year":2012,"scientific_title":"The role Survivin and XIAP (X-linked inhibitor of apoptosis protein) as biomarkers and therapeutic targets in paediatric acute myeloid leukaemia.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Molecular Targets","research_area":"Clinical Medicine and Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Dr Andrew Moore","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1036907","simplified_title":"A study to assess the mechanisms of cell death in acute myeloid leukaemia.","sub_type":"Health Professional Research ECF","total_budget":"292816.71","source_system":"I am a Paediatric Haematologist/Oncologist focussing on new treatments for childhood acute myeloid leukaemia. This study is examining the effects of conventional and novel therapies on two proteins that prevent cell death in acute myeloid leukaemia. The study will also develop clinical trials of new drugs targeting these proteins."},"children":[{"color":"#336699","name":"Dr Andrew Moore","data":{"first_name":"Andrew","title":"Dr","dw_individual_id":"DW0044354","middle_name":"Scott","last_name":"Moore","source_individual_id":"5041371","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Andrew Moore"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88496","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73350","size":1},{"color":"#FF4D4D","name":"Population dynamic modelling of the public health and health care cost implications of intervention to prevent lifestyle-related disease and injury","data":{"media_summary":"","end_year":2016,"keywords":["cost-effectiveness","epidemiology","disease prevention","injury prevention","health inequalities"],"nhmrc_grant_id":1036771,"application_year":2011,"start_year":2012,"scientific_title":"Population dynamic modelling of the public health and health care cost implications of intervention to prevent lifestyle-related disease and injury","node_source":"NHMRC","node_type":"Grant","field_of_research":"Preventive Medicine","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Linda Cobiac","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1036771","simplified_title":"Public health and health care cost implications of disease and injury prevention","sub_type":"Sidney Sax Public Health ECF","total_budget":"373970.35","source_system":"There is growing interest in a more preventive model of health care in Australia. More than a third of poor health is attributable to risky behaviours, such as tobacco and alcohol use, obesity and poor nutrition, with lower socio-economic and Indigenous populations particularly affected. This research will develop new techniques to identify intervention strategies that should be given funding priority to achieve maximum improvement in population health and reduce the health inequalities."},"children":[{"color":"#336699","name":"Dr Linda Cobiac","data":{"first_name":"Linda","title":"Dr","dw_individual_id":"DW0006639","middle_name":"Jane","last_name":"Cobiac","source_individual_id":"5041263","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Linda Cobiac"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78505","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73345","size":1},{"color":"#FF4D4D","name":"Understanding and Preventing Airborne Transmission of Infectious Respiratory Aerosols","data":{"media_summary":"","end_year":2015,"keywords":["aerosol transport and deposition","environmental health","infectious diseases","infection control","cystic fibrosis"],"nhmrc_grant_id":1036620,"application_year":2011,"start_year":2012,"scientific_title":"Understanding and Preventing Airborne Transmission of Infectious Respiratory Aerosols","node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Public Health","for_category":"CLINICAL SCIENCES","cia_name":"Dr Luke Knibbs","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1036620","simplified_title":"Understanding and Preventing Airborne Infections","sub_type":"Public Health (Australia) ECF","total_budget":"345649.9","source_system":"This project aims to significantly advance our understanding of how infectious bacteria are transmitted through the air, and what basic control measures are most effective at preventing this.  This research is focused on persons with cystic fibrosis (CF), as they may be particularly susceptible to such transmission, but our results will also help us better understand how other infections are spread through the air.  This is especially important given the recent global influenza pandemic."},"children":[{"color":"#336699","name":"Dr Luke Knibbs","data":{"first_name":"Luke","title":"Dr","dw_individual_id":"DW0043543","middle_name":"","last_name":"Knibbs","source_individual_id":"5023030","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Luke Knibbs"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88290","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73338","size":1},{"color":"#FF4D4D","name":"Lentiviral infection: intracellular immunity and viral evasion","data":{"media_summary":"host/pathogen interaction","end_year":2018,"keywords":["structural biology","crystallography","structural immunology","biophysics","viral infection"],"nhmrc_grant_id":1036521,"application_year":2011,"health_keywords":["human immunodeficiency virus (HIV)","protein-protein interaction","protein structure","protein function","host/pathogen interaction"],"scientific_title":"Lentiviral infection: intracellular immunity and viral evasion","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Structural Biology (incl. Macromolecular Modelling)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr David Jacques","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1036521","simplified_title":"Proteins involved in HIV infection and host defense","sub_type":"CJ Martin Biomedical ECF","total_budget":"337269.39","source_system":"I am a biochemist focused on answering the question: why is it that humans are susceptible to HIV infection, while certain monkeys are resistant? It is known that these monkeys have evolved proteins which can target and destroy the virus, but the equivalent human proteins dont work against HIV. I intend to compare the monkey and human proteins to understand how the monkeys destroy the virus and why the human protein is defective. These studies will inform the next generation of HIV treatment."},"children":[{"color":"#336699","name":"Dr David Jacques","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0013883","middle_name":"Anthony","last_name":"Jacques","source_individual_id":"5027033","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David Jacques"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80445","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73331","size":1},{"color":"#FF4D4D","name":"From the laboratory to the classroom: Validation of an innovative laboratory model of adolescent impulsivity and alcohol use using a school-based randomised controlled trial","data":{"media_summary":"","end_year":2016,"keywords":["alcohol consumption","adolescence","early intervention","translational research","impulsivity"],"nhmrc_grant_id":1036365,"application_year":2011,"start_year":2012,"scientific_title":"From the laboratory to the classroom: Validation of an innovative laboratory model of adolescent impulsivity and alcohol use using a school-based randomised controlled trial","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health, Clinical and Counselling Psychology","research_area":"Clinical Medicine and Science","for_category":"PSYCHOLOGY","cia_name":"Dr Matthew Gullo","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1036365","simplified_title":"From the laboratory to the classroom: Using basic science to inform novel psychosocial interventions for reducing adolescent alcohol use","sub_type":"Australian Clincal Research ECF","total_budget":"351023","source_system":"I am a psychologist focused on understanding how different psychosocial approaches to reducing adolescent alcohol use actually work. I will achieve this using a new laboratory model I have developed to determine the active ingredients of different interventions. Using a randomised controlled trial, I will then test whether combining these ingredients produces better outcomes in the prevention of teenage drinking."},"children":[{"color":"#336699","name":"Dr Matthew Gullo","data":{"first_name":"Matthew","title":"Dr","dw_individual_id":"DW0031050","middle_name":"John","last_name":"Gullo","source_individual_id":"5038866","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Matthew Gullo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85042","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73326","size":1},{"color":"#FF4D4D","name":"The role of emerging gastrointestinal viruses in the first two years of life: a birth cohort study","data":{"media_summary":"","end_year":2016,"keywords":["gastrointestinal disease","virus detection","paediatric","cohort study","costs"],"nhmrc_grant_id":1036231,"application_year":2011,"start_year":2012,"scientific_title":"The role of emerging gastrointestinal viruses in the first two years of life: a birth cohort study","node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Public Health","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"A/Pr Stephen Lambert","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1036231","simplified_title":"Gastrointestinal viruses in the first two years of life","sub_type":"Public Health (Australia) ECF","total_budget":"389194.29","source_system":"Gastro illnesses are common and potentially serious early in life. We are aiming to find out more about these illnesses by following ~140 children from birth to their second birthday, with parents collecting a dirty nappy swab every week. Our laboratory will test these samples for a wide range of known and new gastro viruses, and we will also be looking for, as yet, undiscovered viruses. This information will allow us to document the burden of these illnesses in young children and their families."},"children":[{"color":"#336699","name":"A/Pr Stephen Lambert","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0026122","middle_name":"B","last_name":"Lambert","source_individual_id":"RMIS682186","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Stephen Lambert"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83757","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73319","size":1},{"color":"#FF4D4D","name":"TRIP Fellowship","data":{"media_summary":"","end_year":2014,"keywords":["cerebral palsy treatments","evidence-based clinical practice","translational research","occupational therapy","physiotherapy"],"nhmrc_grant_id":1036183,"application_year":2011,"health_keywords":["upper limb function","rehabilitation"],"scientific_title":"TRIP Fellowship","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy (excl. Physiotherapy)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Leanne Sakzewski","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1036183","simplified_title":"TRIP Fellowship","sub_type":"TRIP ECF","total_budget":"146247.33","source_system":"Cerebral palsy is the most common physical disability in children. Rehabilitation focuses on improving hand use to enhance daily care, access to education and vocational aspirations. This research aims to change the type of rehabilitation therapists use to treat hand and arm problems and use more current training approaches which have been shown to improve hand and arm skills."},"children":[{"color":"#336699","name":"Dr Leanne Sakzewski","data":{"first_name":"Leanne","title":"Dr","dw_individual_id":"DW0021907","middle_name":"","last_name":"Sakzewski","source_individual_id":"5034282","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Leanne Sakzewski"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82640","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73315","size":1},{"color":"#FF4D4D","name":"Role of Hypoxia Inducible Factor in innate immune function against Gram-positive pathogens","data":{"media_summary":"","end_year":2014,"keywords":["innate immunity","bacterial infection","pathogenic bacteria","antibiotic resistance","infectious diseases"],"nhmrc_grant_id":1035232,"application_year":2011,"health_keywords":["immune response"],"scientific_title":"Role of Hypoxia Inducible Factor in innate immune function against Gram-positive pathogens","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Andrew Hollands","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1035232","simplified_title":"Boosting the human immune response against bacterial infections","sub_type":"CJ Martin Biomedical ECF","total_budget":"241352.02","source_system":"Our society is currently facing the rise of drug-resistant pathogens (\"superbugs\") such as the potentially devastating methicillin-resistant Staphylococcus aureus, or MRSA. Recently, a molecule known as HIF has been shown to control the ability of our white blood cells to kill bacteria. This proposal aims to investigate the use of HIF boosting drugs to treat infections. These novel HIF agonists could be used alongside conventional antibiotics to improve infectious disease."},"children":[{"color":"#336699","name":"Dr Andrew Hollands","data":{"first_name":"Andrew","title":"Dr","dw_individual_id":"DW0007935","middle_name":"","last_name":"Hollands","source_individual_id":"5025495","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Andrew Hollands"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78844","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73269","size":1},{"color":"#FF4D4D","name":"Development of specific modulators of voltage-gated sodium channels","data":{"media_summary":"protein structure","end_year":2015,"keywords":["sodium channel","venom","patch clamp","pain","drug discovery"],"nhmrc_grant_id":1035102,"application_year":2011,"health_keywords":["protein purification","channelopathy","high performance liquid chromatography (HPLC)","peptide synthesis","protein structure"],"scientific_title":"Development of specific modulators of voltage-gated sodium channels","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Linlin Ma","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1035102","simplified_title":"To identify and assess specific modulators of a type of sodium-conducting integral membrane proteins from Australian spider venoms","sub_type":"CJ Martin Biomedical ECF","total_budget":"378084.76","source_system":"This project will identify novel modulators of voltage-gated sodium (NaV) channels, a type of sodium-conducting integral membrane proteins, which play a central role in neuronal, muscular, and cardiac function. These modulators will be characterized in order to understand how they modify channel function and to aid their development as analgesics for the treatment of chronic pain."},"children":[{"color":"#336699","name":"Dr Linlin Ma","data":{"first_name":"Linlin","title":"Dr","dw_individual_id":"DW0003089","middle_name":"","last_name":"Ma","source_individual_id":"5038818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Linlin Ma"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77527","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73261","size":1},{"color":"#FF4D4D","name":"Controlling the development and function of hindbrain commissures in vertebrate animals: the role of Robo3 receptor","data":{"media_summary":"","end_year":2016,"keywords":["neurodevelopment","molecular mechanisms","axon guidance","molecular neuroscience","neurodevelopmental disorders"],"nhmrc_grant_id":1035093,"application_year":2011,"health_keywords":["molecular basis of disease","oculomotor"],"scientific_title":"Controlling the development and function of hindbrain commissures in vertebrate animals: the role of Robo3 receptor","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Peter Kozulin","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1035093","simplified_title":"The development of neuronal axons across the lower brain in vertebrate animals","sub_type":"INSERM Exchange ECF","total_budget":"389932.51","source_system":"Dysfunction in the guidance of developing nerve cells in the lower part of the brain can result in deficits in eye movement and spine formation. This project will investigate the function and mechanisms of action of the molecule Robo3 in the guidance of nerve cell bundles during lower brain development. This project will also offer insight into how mutation of Robo3 can lead to pathological outcomes."},"children":[{"color":"#336699","name":"Dr Peter Kozulin","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0008445","middle_name":"","last_name":"Kozulin","source_individual_id":"5025946","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Peter Kozulin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78984","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73259","size":1},{"color":"#FF4D4D","name":"Rational development of novel analgesics for the treatment of chronic pain","data":{"media_summary":"protein characterisation","end_year":2014,"keywords":["ion channels","peptides","structural biology","chronic pain","nuclear magnetic resonance (NMR) spectroscopy"],"nhmrc_grant_id":1034958,"application_year":2011,"health_keywords":["pain minimisation","analgesia","drug design","protein structure","protein characterisation"],"scientific_title":"Rational development of novel analgesics for the treatment of chronic pain","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biologically Active Molecules","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof Glenn King","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1034958","simplified_title":"Novel analgesics for treating chronic pain","sub_type":"Standard Project Grant","total_budget":"595945.91","source_system":"Chronic pain is a major global health problem that currently affects over three million Australians. There are few drugs available for treatment of chronic pain and most have significant side-effects. Individuals lacking a particular type of ion channel known as Nav1.7 are completely insensitive to pain, but are otherwise normal. Block of this channel therefore appears to be an ideal avenue for pain relief. This project aims to produce selective Nav1.7 blockers that can be used as analgesics for treating chronic pain."},"children":[{"color":"#336699","name":"Dr Mehdi Mobli","data":{"first_name":"Mehdi","title":"Dr","dw_individual_id":"DW0044326","middle_name":"","last_name":"Mobli","source_individual_id":"5039890","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mehdi Mobli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88489","size":1},{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73256","size":1},{"color":"#FF4D4D","name":"Identification of genes causing medulloblastoma by transposon mutagenesis.","data":{"media_summary":"","end_year":2014,"keywords":["medulloblastoma","genetics","transposons","cerebellum","developmental biology"],"nhmrc_grant_id":1034941,"application_year":2011,"health_keywords":["transgenic mouse","transcription factor","knockout mouse","tumour suppressor gene"],"scientific_title":"Identification of genes causing medulloblastoma by transposon mutagenesis.","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Solid Tumours","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1034941","simplified_title":"Novel genes causing brain tumours","sub_type":"Standard Project Grant","total_budget":"621997.5","source_system":"Brain tumours are the most common cause of cancer-related death in children and the tumour medulloblastoma is the most frequent. There is a need to develop new therapeutic approaches to treating medulloblastoma through the development of new drugs to directly target the tumour. This research has identified new genes that are good candidates as drug targets for treating medulloblastoma."},"children":[{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73255","size":1},{"color":"#FF4D4D","name":"Efficacy of prism adaptation for recovery of brain function in unilateral spatial neglect","data":{"media_summary":"","end_year":2014,"keywords":["perception","cognition","cognitive neuroscience","psychology","behavioural intervention"],"nhmrc_grant_id":1034110,"application_year":2011,"start_year":2012,"scientific_title":"Efficacy of prism adaptation for recovery of brain function in unilateral spatial neglect","node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Processes, Perception and Performance","research_area":"Basic Science","for_category":"PSYCHOLOGY","cia_name":"Prof Jason Mattingley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1034110","simplified_title":"Effectiveness of visual retraining for sensory impairments in spatial inattention","sub_type":"Standard Project Grant","total_budget":"531689.97","source_system":"Damage to the brains attention network causes profound impairments of visual and sensory perception. These deficits are frequently long-lasting, and are a major factor in preventing patients from regaining functional independence. This project will use a combination of behavioural and brain imaging techniques to determine whether a promising new treatment involving visual retraining can improve function and reduce perceptual impairments after unilateral brain lesions."},"children":[{"color":"#336699","name":"Dr Pascal Molenberghs","data":{"first_name":"Pascal","title":"Dr","dw_individual_id":"DW0044338","middle_name":"","last_name":"Molenberghs","source_individual_id":"5022886","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Pascal Molenberghs"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88490","size":1},{"color":"#336699","name":"Dr Paul Dux","data":{"first_name":"Paul","title":"Dr","dw_individual_id":"DW0042170","middle_name":"Edmund","last_name":"Dux","source_individual_id":"5020318","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Paul Dux"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87933","size":1},{"color":"#336699","name":"Prof Jason Mattingley","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0020682","middle_name":"Brett","last_name":"Mattingley","source_individual_id":"RMIS123930","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jason Mattingley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82287","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73224","size":1},{"color":"#FF4D4D","name":"Regulation of mammalian heart regeneration by the miR-15 family.","data":{"media_summary":"","end_year":2014,"keywords":["myocardial ischaemia","myocardial infarction","regeneration","tissue regeneration","muscle regeneration"],"nhmrc_grant_id":1033815,"application_year":2011,"health_keywords":["neonatal","cardiac failure"],"scientific_title":"Regulation of mammalian heart regeneration by the miR-15 family.","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Dr Enzo Porrello","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1033815","simplified_title":"Understanding how the newborn heart regenerates following injury.","sub_type":"New Investigator Grant","total_budget":"435859.1","source_system":"The inability of the adult heart to regenerate following a heart attack is a major contributor to the burden of heart disease in the developed world. We have recently discovered that, for a brief period after birth, the newborn heart can completely regenerate itself following injury. Understanding how and why the heart loses this remarkable capacity for regeneration shortly after birth may hold the key for developing cardiac regenerative therapies."},"children":[{"color":"#336699","name":"Dr Enzo Porrello","data":{"first_name":"Enzo","title":"Dr","dw_individual_id":"DW0015643","middle_name":"Roberto","last_name":"Porrello","source_individual_id":"5019186","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Enzo Porrello"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80945","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73216","size":1},{"color":"#FF4D4D","name":"Evolution and pathogenicity of NDM-1 positive Escherichia coli","data":{"media_summary":"","end_year":2014,"keywords":["antibiotic resistance","bacterial pathogenesis","bacterial virulence","bacterial genetics","molecular microbiology"],"nhmrc_grant_id":1033799,"application_year":2011,"start_year":2012,"scientific_title":"Evolution and pathogenicity of NDM-1 positive Escherichia coli","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Mark Schembri","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1033799","simplified_title":"Evolution and pathogenicity of NDM-1 positive bacteria","sub_type":"Standard Project Grant","total_budget":"643275.09","source_system":"Antibiotic resistance (AR), as highlighted by the WHO, is the most pressing medical need of the 21C _ some infections are now untreatable. Our research will focus on the new \"superbug\" NDM-1 positive E. coli. We will correlate AR and pathogenicity and explore the evolution of these \"superbugs\" using state-of-the-art sequencing. This research will benefit Australian medicine by predicting timelines of AR epidemics and by conducting the first analyses on the virulence potential of these strains."},"children":[{"color":"#336699","name":"Dr Scott Beatson","data":{"first_name":"Scott","title":"Dr","dw_individual_id":"DW0035306","middle_name":"A","last_name":"Beatson","source_individual_id":"5013405","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Scott Beatson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86151","size":1},{"color":"#336699","name":"Prof Timothy Walsh","data":{"first_name":"Timothy","title":"Prof","dw_individual_id":"DW0034550","middle_name":"Rutland","last_name":"Walsh","source_individual_id":"5039576","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Timothy Walsh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85952","size":1},{"color":"#336699","name":"Prof Mark Schembri","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0016088","middle_name":"A","last_name":"Schembri","source_individual_id":"5017368","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Schembri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81054","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73213","size":1},{"color":"#FF4D4D","name":"Manipulation of haematopoietic stem cell niches to improve therapeutic outcomes","data":{"media_summary":"","end_year":2015,"keywords":["bone marrow","stem cell biology","microenvironment","haematopoiesis","leukaemia"],"nhmrc_grant_id":1033736,"application_year":2011,"start_year":2012,"scientific_title":"Manipulation of haematopoietic stem cell niches to improve therapeutic outcomes","node_source":"NHMRC","node_type":"Grant","field_of_research":"Haematology","research_area":"Basic Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Dr Ingrid Winkler","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1033736","simplified_title":"How blood and leukaemia stem cells are regulated in the body","sub_type":"Industry CDF","total_budget":"449667.23","source_system":"My aim is to understand how stem cells are naturally regulated by the body. My central hypothesis is that local environment (niche) factors largely govern stem cell behaviour. Identification and manipulation of these factors will offer a novel therapeutic opportunity to improve the clinical use of normal haematopoietic stem cells to improve transplantation success, as well as sensitise leukaemia cells to chemotherapy."},"children":[{"color":"#336699","name":"Dr Ingrid Winkler","data":{"first_name":"Ingrid","title":"Dr","dw_individual_id":"DW0034781","middle_name":"G","last_name":"Winkler","source_individual_id":"5018413","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ingrid Winkler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86008","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73212","size":1},{"color":"#FF4D4D","name":"Characterising the molecular pathogenesis of newly emergent invasive group A Streptococcus M4 serotypes in Australia","data":{"media_summary":"streptococcal infection","end_year":2014,"keywords":["Streptococcus pyogenes","innate immunity","infectious diseases","host/pathogen interaction","streptococcal invasive diseases"],"nhmrc_grant_id":1033258,"application_year":2011,"health_keywords":["necrotising fasciitis","bacterial pathogenesis","group A streptococcal disease","streptococcal disease","streptococcal infection"],"scientific_title":"Characterising the molecular pathogenesis of newly emergent invasive group A Streptococcus M4 serotypes in Australia","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Microbiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Jason Cole","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1033258","simplified_title":"Characterising newly emerged strains of flesh-eating bacteria in Australia","sub_type":"Standard Project Grant","total_budget":"523756.14","source_system":"Group A Streptococcus (GAS) is a human pathogen of global significance, responsible for life-threatening invasive infections such as flesh-eating disease (>650,000 cases per year), with a mortality rate of 25%. A recent outbreak of serotype M4 GAS caused severe invasive infections in Queensland Australia. The aim of this work is to determine how M4 GAS causes invasive disease. Understanding this mechanism will allow the development of new generation therapeutics, treatments and improved health outcomes."},"children":[{"color":"#336699","name":"Dr Jason Cole","data":{"first_name":"Jason","title":"Dr","dw_individual_id":"DW0030026","middle_name":"Nicklaus","last_name":"Cole","source_individual_id":"5014012","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jason Cole"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84783","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73200","size":1},{"color":"#FF4D4D","name":"Secondary stroke prevention: strategies to narrow the gap between evidence and practice","data":{"media_summary":"","end_year":2016,"keywords":["evidence-based clinical practice","stroke prevention","patient education","communication","implementation"],"nhmrc_grant_id":1033038,"application_year":2011,"start_year":2012,"scientific_title":"Secondary stroke prevention: strategies to narrow the gap between evidence and practice","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Tammy Hoffmann","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1033038","simplified_title":"Secondary stroke prevention: strategies to narrow the gap between evidence and practice","sub_type":"Population Health CDF","total_budget":"408290.33","source_system":"People who have had a stroke are at increased risk of having another stroke. Secondary stroke prevention is a neglected area of post-stroke care and the uptake of research evidence is poor. Barriers to evidence integration can include problems with the evidence and difficulties at the health professional and/or consumer level. This research will seek to understand the barriers and develop strategies to reduce the gap between evidence and clinical practice in secondary stroke prevention."},"children":[{"color":"#336699","name":"A/Pr Tammy Hoffmann","data":{"first_name":"Tammy","title":"A/Pr","dw_individual_id":"DW0007919","middle_name":"Coral","last_name":"Hoffmann","source_individual_id":"5015292","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Tammy Hoffmann"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78839","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73191","size":1},{"color":"#FF4D4D","name":"New Approaches for Gene Mapping in Osteoporosis","data":{"media_summary":"","end_year":2014,"keywords":["osteoporosis","fracture risk","bone mineral density","population genetics","sequencing"],"nhmrc_grant_id":1032571,"application_year":2011,"health_keywords":["polymorphism","association studies"],"scientific_title":"New Approaches for Gene Mapping in Osteoporosis","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Quantitative Genetics (incl. Disease and Trait Mapping Genetics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Emma Duncan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1032571","simplified_title":"Finding the genes that cause osteoporosis, to improve preventative and treatment options for this common and disabling disease","sub_type":"New Investigator Grant","total_budget":"893592.49","source_system":"Osteoporosis is the commonest metabolic bone disease worldwide, and costs Australia >1% of GDP.  It is a strongly inherited disease.   We recently completed a genome-wide association study in 2000 postmenopausal women with either very high or very low bone density, and identified many genes contributing to BMD.   The current study aims to use next-generation sequencing to study these women in greater genetic depth, aiming to identify more clearly the exact genetic determinants of bone mass."},"children":[{"color":"#336699","name":"A/Pr Emma Duncan","data":{"first_name":"Emma","title":"A/Pr","dw_individual_id":"DW0018792","middle_name":"Letitia","last_name":"Duncan","source_individual_id":"5014440","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Emma Duncan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81813","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73169","size":1},{"color":"#FF4D4D","name":"Revolutionising alcohol dependence treatment: Targeting individual genetic and psychological risk through Clinical Decision Support Systems","data":{"media_summary":"","end_year":2016,"keywords":["alcohol use disorders","treatment outcomes","clinical decision making","statistics","mental health"],"nhmrc_grant_id":1031909,"application_year":2011,"start_year":2012,"scientific_title":"Revolutionising alcohol dependence treatment: Targeting individual genetic and psychological risk through Clinical Decision Support Systems","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"A/Pr Jason Connor","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1031909","simplified_title":"Revolutionising alcohol dependence treatment: Targeting individual genetic and psychological risk through Clinical Decision Support Systems","sub_type":"Clinical CDF","total_budget":"443105.22","source_system":"Alcohol misuse impacts significantly Australias health. More effective treatments are needed. Computer-based, decision-making tools improve treatment outcomes. Based on genetic and psychological prognostic information provided by these decision-making tools, individual patients strengths and weaknesses can be identified and targeted in treatment. We expect this will significantly improve treatment outcomes in this chronic, relapsing condition."},"children":[{"color":"#336699","name":"A/Pr Jason Connor","data":{"first_name":"Jason","title":"A/Pr","dw_individual_id":"DW0018369","middle_name":"Paul","last_name":"Connor","source_individual_id":"5014050","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Jason Connor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81704","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73142","size":1},{"color":"#FF4D4D","name":"Activation of the Respiratory Syncytial virus fusion protein","data":{"media_summary":"","end_year":2014,"keywords":["respiratory syncytial virus","protease","fusion protein","structure-activity relationships","viral replication"],"nhmrc_grant_id":1031668,"application_year":2011,"start_year":2012,"scientific_title":"Activation of the Respiratory Syncytial virus fusion protein","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Paul Young","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1031668","simplified_title":"Drug targets for childhood respiratory viral infections","sub_type":"Standard Project Grant","total_budget":"582072.03","source_system":"Respiratory Syncytial Virus (RSV) is the most important viral cause of respiratory tract disease in both infants and the elderly. However, there are few available options for control, whether by vaccination or therapeutic intervention. This proposal investigates the way RSV infects cells. A clearer understanding of the molecular basis of this process should provide potential targets for new drugs that can block this process and new insights for the generation of vaccine candidates."},"children":[{"color":"#336699","name":"A/Pr Stuart Kellie","data":{"first_name":"Stuart","title":"A/Pr","dw_individual_id":"DW0025921","middle_name":"","last_name":"Kellie","source_individual_id":"5015653","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Stuart Kellie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83686","size":1},{"color":"#336699","name":"Prof Paul Young","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0005625","middle_name":"R","last_name":"Young","source_individual_id":"RMIS20614","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78234","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73129","size":1},{"color":"#FF4D4D","name":"TRIP Fellowship","data":{"media_summary":"","end_year":2013,"keywords":["gestational diabetes","maternal nutrition","evidence-based health care","dietary intervention","pregnancy"],"nhmrc_grant_id":1031632,"application_year":2011,"start_year":2012,"scientific_title":"TRIP Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical and Sports Nutrition","research_area":"Health Services Research","for_category":"NUTRITION AND DIETICS","cia_name":"Dr Shelley Wilkinson","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1031632","simplified_title":"TRIP Fellowship","sub_type":"TRIP ECF","total_budget":"146247.33","source_system":"Poorly-controlled gestational diabetes mellitus (GDM) can have negative outcomes for mother and baby. Nutrition counselling is the first line strategy to manage GDM and can prevent the need for insulin. No Australian GDM nutrition practice guidelines (NPGs) exist, but better outcomes have been shown in America following a evidence-based schedule of dietary counselling. This project will investigate implementation of American NPGs in an Australian setting, using the latest nutrition advice."},"children":[{"color":"#336699","name":"Dr Shelley Wilkinson","data":{"first_name":"Shelley","title":"Dr","dw_individual_id":"DW0046282","middle_name":"Ann","last_name":"Wilkinson","source_individual_id":"5039202","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Shelley Wilkinson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88985","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73126","size":1},{"color":"#FF4D4D","name":"Phase variable protein glycosylation in bacteria mucosal pathogens and its role in immune evasion","data":{"media_summary":"","end_year":2016,"keywords":["Haemophilus influenzae","Neisseria meningitidis","glycoproteins","phase variation","immune evasion"],"nhmrc_grant_id":1031542,"application_year":2011,"health_keywords":["mass spectrometry","otitis media","chronic obstructive pulmonary disease (COPD)","meningitis"],"scientific_title":"Phase variable protein glycosylation in bacteria mucosal pathogens and its role in immune evasion","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Benjamin Schulz","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1031542","simplified_title":"Sugar-coated bacteria: how and why pathogens decorate themselves with sugars","sub_type":"RD Wright Biomedical CDF","total_budget":"407412.68","source_system":"The bacterium Haemophilus influenzae is a leading cause of ear infections. Hearing loss from these infections can seriously affect literacy and educational performance. As no vaccine is available, we will research how the bacterium makes the HMW protein that is important in infection. We will study how sugars are added to the surface of this protein so that the bacterium can escape the immune system, its role in related bacteria and how it may be used in a vaccine."},"children":[{"color":"#336699","name":"Dr Benjamin Schulz","data":{"first_name":"Benjamin","title":"Dr","dw_individual_id":"DW0039582","middle_name":"L","last_name":"Schulz","source_individual_id":"5019257","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Benjamin Schulz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87266","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73123","size":1},{"color":"#FF4D4D","name":"Defining therapeutic options for brain metastases","data":{"media_summary":"","end_year":2014,"keywords":["brain tumours","metastases","targeted therapy","molecular basis of disease","genomics"],"nhmrc_grant_id":1030751,"application_year":2011,"health_keywords":["breast cancer metastases","lung cancer","melanoma","sequencing"],"scientific_title":"Defining therapeutic options for brain metastases","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Cell Biology","research_area":"Clinical Medicine and Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Prof Sunil Lakhani","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1030751","simplified_title":"Brain Metastases","sub_type":"Standard Project Grant","total_budget":"523139.56","source_system":"It is seldom the initial cancer that kills the patient; most deaths are due to its metastatic spread throughout the body. Survival after the onset of a brain metastasis is dismal. Current understanding of cancer spread to the brain is poor and yet an ability to inhibit this process would save thousands of lives each year. Using rare tissue resources and cutting-edge technologies, this project will elucidate molecular features of brain metastases that can be exploited to generate new treatments."},"children":[{"color":"#336699","name":"Prof Michael Stratton","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0034086","middle_name":"Rudolph","last_name":"Stratton","source_individual_id":"RMIS4440053","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Stratton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85821","size":1},{"color":"#336699","name":"Dr Peter Simpson","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0033829","middle_name":"T","last_name":"Simpson","source_individual_id":"5017520","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Peter Simpson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85762","size":1},{"color":"#336699","name":"Prof Sunil Lakhani","data":{"first_name":"Sunil","title":"Prof","dw_individual_id":"DW0026113","middle_name":"R","last_name":"Lakhani","source_individual_id":"5015822","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sunil Lakhani"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83752","size":1},{"color":"#336699","name":"Dr Nicola Waddell","data":{"first_name":"Nicola","title":"Dr","dw_individual_id":"DW0016876","middle_name":"","last_name":"Waddell","source_individual_id":"5018126","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nicola Waddell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81290","size":1},{"color":"#336699","name":"Dr Leonard Da Silva","data":{"first_name":"Leonard","title":"Dr","dw_individual_id":"DW0012593","middle_name":"","last_name":"Da Silva","source_individual_id":"5020082","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Leonard Da Silva"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80113","size":1},{"color":"#336699","name":"A/Pr Margaret Cummings","data":{"first_name":"Margaret","title":"A/Pr","dw_individual_id":"DW0001124","middle_name":"Cameron","last_name":"Cummings","source_individual_id":"5023200","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Margaret Cummings"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76976","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73083","size":1},{"color":"#FF4D4D","name":"Serial NT-proBNP Monitoring for Predicting Major Cardiovascular Events in the Dialysis Population","data":{"media_summary":"sudden cardiac death","end_year":2014,"keywords":["dialysis","cardiovascular risk","monitoring","natriuretic peptides","biomarkers"],"nhmrc_grant_id":1030584,"application_year":2011,"health_keywords":["biomonitoring","cardiac failure","cardiomyopathy","body composition","sudden cardiac death"],"scientific_title":"Serial NT-proBNP Monitoring for Predicting Major Cardiovascular Events in the Dialysis Population","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Johnson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1030584","simplified_title":"A Study Investigating the Usefulness of Monitoring a Heart Hormone (NT-proBNP) to Predict Heart Related Illness in Dialysis Patients.","sub_type":"Standard Project Grant","total_budget":"288548.07","source_system":"Dialysis patients have a 50-100 fold increased risk of dying from heart disease caused by abnormal heart muscle structure and function. Current tests are unable to accurately identify patients at the highest risk. A test that accurately detects the early stages of heart injury is urgently needed. The aim of our research is to develop a monitoring guide using regular testing of a heart hormone (NT-proBNP) to identify high-risk dialysis patients early allowing treatment before a serious medical complication occurs."},"children":[{"color":"#336699","name":"Prof Andrea Horvath","data":{"first_name":"Andrea","title":"Prof","dw_individual_id":"DW0043136","middle_name":"Rita","last_name":"Horvath","source_individual_id":"5039857","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Andrea Horvath"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88176","size":1},{"color":"#336699","name":"A/Pr Scott Campbell","data":{"first_name":"Scott","title":"A/Pr","dw_individual_id":"DW0035706","middle_name":"Bryan","last_name":"Campbell","source_individual_id":"5038759","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Scott Campbell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86248","size":1},{"color":"#336699","name":"A/Pr Carmel Hawley","data":{"first_name":"Carmel","title":"A/Pr","dw_individual_id":"DW0025392","middle_name":"Mary","last_name":"Hawley","source_individual_id":"5012539","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Carmel Hawley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83535","size":1},{"color":"#336699","name":"A/Pr Richard Troughton","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0022623","middle_name":"William","last_name":"Troughton","source_individual_id":"5040564","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Troughton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82825","size":1},{"color":"#336699","name":"A/Pr Andrew Hayen","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0019520","middle_name":"","last_name":"Hayen","source_individual_id":"5023384","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Andrew Hayen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81969","size":1},{"color":"#336699","name":"Prof David Johnson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0013969","middle_name":"Wayne","last_name":"Johnson","source_individual_id":"RMIS14680","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Johnson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80471","size":1},{"color":"#336699","name":"Dr Magid Fahim","data":{"first_name":"Magid","title":"Dr","dw_individual_id":"DW0001490","middle_name":"Atif","last_name":"Fahim","source_individual_id":"5030623","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Magid Fahim"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77079","size":1},{"color":"#336699","name":"Dr Goce Dimeski","data":{"first_name":"Goce","title":"Dr","dw_individual_id":"DW0001288","middle_name":"","last_name":"Dimeski","source_individual_id":"5024040","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Goce Dimeski"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77027","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73076","size":1},{"color":"#FF4D4D","name":"An Integrated Study of Acyclic Nucleoside Phosphonates as Antimalarial Drugs","data":{"media_summary":"","end_year":2014,"keywords":["enzyme inhibitors","structural biology","malaria therapy","pharmacokinetics","medicinal chemistry"],"nhmrc_grant_id":1030353,"application_year":2011,"health_keywords":["parasitology"],"scientific_title":"An Integrated Study of Acyclic Nucleoside Phosphonates as Antimalarial Drugs","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Structural Biology (incl. Macromolecular Modelling)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Luke Guddat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1030353","simplified_title":"Development of new antimalarial drugs","sub_type":"Standard Project Grant","total_budget":"500544.7","source_system":"Malaria is one of the most serious infectious diseases today. Because of increasing resistance to existing medicines, new drugs are now needed. The therapeutic agents we will develop target the principal species responsible for human malaria are Plasmodium falciparum and vivax. Specifically, the compounds will prevent the parasite from replicating and are related in structure to those compounds in use to treat viral infections including AIDS."},"children":[{"color":"#336699","name":"A/Pr Michael Edstein","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0042215","middle_name":"Douglas","last_name":"Edstein","source_individual_id":"5023004","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Michael Edstein"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87948","size":1},{"color":"#336699","name":"A/Pr Lieve Naesens","data":{"first_name":"Lieve","title":"A/Pr","dw_individual_id":"DW0038705","middle_name":"Marie-Joseph","last_name":"Naesens","source_individual_id":"5016623","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Lieve Naesens"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87027","size":1},{"color":"#336699","name":"A/Pr Luke Guddat","data":{"first_name":"Luke","title":"A/Pr","dw_individual_id":"DW0031041","middle_name":"William","last_name":"Guddat","source_individual_id":"RMIS1125097","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Luke Guddat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85040","size":1},{"color":"#336699","name":"E/Pr John De Jersey","data":{"first_name":"John","title":"E/Pr","dw_individual_id":"DW0018611","middle_name":"","last_name":"De Jersey","source_individual_id":"5014269","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"E/Pr John De Jersey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81769","size":1},{"color":"#336699","name":"Dr Dana Hockova","data":{"first_name":"Dana","title":"Dr","dw_individual_id":"DW0002219","middle_name":"","last_name":"Hockova","source_individual_id":"5041125","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Dana Hockova"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77282","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73060","size":1},{"color":"#FF4D4D","name":"Profiling global inflammatory signatures for GPCRs in human macrophages","data":{"media_summary":"microarrays","end_year":2014,"keywords":["macrophage activation","G protein-coupled receptors","Toll-like receptors","inflammatory mediators","signalling pathways"],"nhmrc_grant_id":1030169,"application_year":2011,"health_keywords":["innate immunity","cytokines","drug discovery","gene expression","microarrays"],"scientific_title":"Profiling global inflammatory signatures for GPCRs in human macrophages","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Matthew Sweet","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1030169","simplified_title":"Understanding how pathogens and drugs regulate inflammatory cells","sub_type":"Standard Project Grant","total_budget":"687770.11","source_system":"Macrophages are important white blood cells of the immune system. They trigger inflammatory responses to infection or injury, but prolonged inflammatory responses can lead to chronic diseases. In this project we aim to better understand how macrophages sense the outside environment, how external signals trigger inflammatory processes, how this leads to diseases such as autoimmune and inflammatory diseases, cancer and cardiovascular diseases, and how to control them with drugs."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73054","size":1},{"color":"#FF4D4D","name":"Nodal signalling in male germ cell development: Balancing fertility and testicular cancer susceptibility","data":{"media_summary":"","end_year":2014,"keywords":["germ cells","embryonic development","testis development","spermatogenesis","mouse models"],"nhmrc_grant_id":1030146,"application_year":2011,"health_keywords":["sexual differentiation","signalling pathways"],"scientific_title":"Nodal signalling in male germ cell development: Balancing fertility and testicular cancer susceptibility","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Josephine Bowles","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1030146","simplified_title":"Genes that control sperm development and testicular cancer","sub_type":"Standard Project Grant","total_budget":"536595.44","source_system":"Testicular cancer is the most common type of cancer in men aged 20-40 years, and its incidence has doubled in the last 30 years. It is sometimes fetal and often results in infertility. We have discovered new genes that regulate testicular cell behaviour in the developing fetus, and here test the concept that defects in these genes might disrupt cell behaviour to the point where cancers form during adult life. Outcomes may lead to new ways to diagnose and treat testicular cancers."},"children":[{"color":"#336699","name":"Prof Peter Koopman","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0043570","middle_name":"A","last_name":"Koopman","source_individual_id":"5015773","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Koopman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88298","size":1},{"color":"#336699","name":"Dr Josephine Bowles","data":{"first_name":"Josephine","title":"Dr","dw_individual_id":"DW0035494","middle_name":"","last_name":"Bowles","source_individual_id":"RMIS30122","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Josephine Bowles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86197","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73049","size":1},{"color":"#FF4D4D","name":"KLF1 regulatory networks in health and disease","data":{"media_summary":"","end_year":2014,"keywords":["erythropoiesis","anaemia","transcription factor","thalassaemia","genomics"],"nhmrc_grant_id":1030143,"application_year":2011,"start_year":2012,"scientific_title":"KLF1 regulatory networks in health and disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Haematology","research_area":"Clinical Medicine and Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Prof Andrew Perkins","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1030143","simplified_title":"Red blood cell production in health and disease","sub_type":"Standard Project Grant","total_budget":"610275.35","source_system":"We will investigate how the master control gene, Kruppel-like factor 1, orchestrates production of red blood cells. We will use genetic and cell biology approaches to determine exactly how this factor interprets the genome blueprint in a cell specific manner. We will also determine how mutations in KLF1 cause human diseases such as congenital dyserythropoietic anemia and hereditary persistence of fetal haemoglobin. This has implications for reactivation of HbF in adults with sickle cell disease."},"children":[{"color":"#336699","name":"Dr Timothy Bailey","data":{"first_name":"Timothy","title":"Dr","dw_individual_id":"DW0035202","middle_name":"Lawrence","last_name":"Bailey","source_individual_id":"5040904","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Timothy Bailey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86127","size":1},{"color":"#336699","name":"Prof Andrew Perkins","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0033140","middle_name":"Charles","last_name":"Perkins","source_individual_id":"RMIS216814","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Andrew Perkins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85587","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73047","size":1},{"color":"#FF4D4D","name":"Molecular and activity dependent mechanisms regulating the targeting of corpus callosum axons in the contralateral hemisphere.","data":{"media_summary":"","end_year":2014,"keywords":["brain development","cerebral cortex","axon guidance","brain disorders","axon growth"],"nhmrc_grant_id":1029975,"application_year":2011,"start_year":2012,"scientific_title":"Molecular and activity dependent mechanisms regulating the targeting of corpus callosum axons in the contralateral hemisphere.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Linda Richards","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1029975","simplified_title":"Callosal axon targeting in the contralateral hemsiphere","sub_type":"Standard Project Grant","total_budget":"413266.5","source_system":"The brain is made up of circuits of neurons that process specific information. For example, the somatosensory cortex receives and sends connections to other somatosensory areas, including the contralateral cortex, but how these systems are wired up is not known. We will investigate whether information about the size and position of the cortical areas and activity-matching of the somatosensory information received by each hemisphere are used to guide callosal axons to their targets."},"children":[{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73038","size":1},{"color":"#FF4D4D","name":"Investigating causes of stillbirths: a prospective cohort study examining use and effectiveness of a comprehensive investigation protocol","data":{"media_summary":"","end_year":2014,"keywords":["stillbirth","cause of death","economic evaluation","pathology","quality of care"],"nhmrc_grant_id":1029613,"application_year":2011,"health_keywords":["pregnancy outcome"],"scientific_title":"Investigating causes of stillbirths: a prospective cohort study examining use and effectiveness of a comprehensive investigation protocol","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Obstetrics and Gynaecology","research_area":"Clinical Medicine and Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"A/Pr Vicki Flenady","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1029613","simplified_title":"Investigating causes of stillbirths","sub_type":"Standard Project Grant","total_budget":"567508.33","source_system":"The effects of stillbirth on women and their families are often devastating and long term. Many stillbirths are not appropriately investigated, resulting in lack of accurate data on causes with one-third classified as unexplained. A major driver for suboptimal investigation is the lack of research to guide which tests should be done. This study aims to accurately identify causes of death in 984 comprehensively investigated stillbirths and determine which tests are needed, with consideration of costs and value."},"children":[{"color":"#336699","name":"A/Pr Vicki Flenady","data":{"first_name":"Vicki","title":"A/Pr","dw_individual_id":"DW0042411","middle_name":"Jane","last_name":"Flenady","source_individual_id":"RMIS226011","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Vicki Flenady"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87999","size":1},{"color":"#336699","name":"Prof David Ellwood","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0042261","middle_name":"Alan","last_name":"Ellwood","source_individual_id":"5012080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Ellwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87968","size":1},{"color":"#336699","name":"Dr Glenn Gardener","data":{"first_name":"Glenn","title":"Dr","dw_individual_id":"DW0036771","middle_name":"James","last_name":"Gardener","source_individual_id":"5040156","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Glenn Gardener"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86525","size":1},{"color":"#336699","name":"Dr Adrienne Gordon","data":{"first_name":"Adrienne","title":"Dr","dw_individual_id":"DW0030946","middle_name":"","last_name":"Gordon","source_individual_id":"RMIS3394767","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Adrienne Gordon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85021","size":1},{"color":"#336699","name":"A/Pr Kassam Mahomed","data":{"first_name":"Kassam","title":"A/Pr","dw_individual_id":"DW0026466","middle_name":"","last_name":"Mahomed","source_individual_id":"5040314","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Kassam Mahomed"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83840","size":1},{"color":"#336699","name":"Prof Teck Khong","data":{"first_name":"Teck","title":"Prof","dw_individual_id":"DW0025968","middle_name":"Yee","last_name":"Khong","source_individual_id":"5032927","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Teck Khong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83702","size":1},{"color":"#336699","name":"Prof Alison Kent","data":{"first_name":"Alison","title":"Prof","dw_individual_id":"DW0025948","middle_name":"","last_name":"Kent","source_individual_id":"5024203","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alison Kent"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83695","size":1},{"color":"#336699","name":"Dr Louisa Gordon","data":{"first_name":"Louisa","title":"Dr","dw_individual_id":"DW0019278","middle_name":"","last_name":"Gordon","source_individual_id":"5012542","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Louisa Gordon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81914","size":1},{"color":"#336699","name":"A/Pr Michael Coory","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0006712","middle_name":"","last_name":"Coory","source_individual_id":"5012694","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Michael Coory"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78520","size":1},{"color":"#336699","name":"Dr Adrian Charles","data":{"first_name":"Adrian","title":"Dr","dw_individual_id":"DW0006515","middle_name":"K","last_name":"Charles","source_individual_id":"5013867","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Adrian Charles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78467","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73012","size":1},{"color":"#FF4D4D","name":"HFE-associated Steatohepatitis: Mechanisms and Therapies","data":{"media_summary":"lipid metabolism","end_year":2014,"keywords":["iron metabolism","iron levels","liver fibrosis","steatosis","fatty liver disease"],"nhmrc_grant_id":1029574,"application_year":2011,"health_keywords":["haemochromatosis","liver cirrhosis","toxic injury mechanisms","cellular mechanisms","lipid metabolism"],"scientific_title":"HFE-associated Steatohepatitis: Mechanisms and Therapies","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gastroenterology and Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Darrell Crawford","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1029574","simplified_title":"Iron and Fat in Liver Disease: Mechanisms and Treatment","sub_type":"Standard Project Grant","total_budget":"650813.46","source_system":"Iron and fat alter normal iron metabolism and cause more severe disease in combination. In this study we will study the relationship between liver disease caused by increased body iron and the consumption of excess fat and the causal mechanisms. We will then examine new therapies for the treatment of iron-associated fatty liver disease."},"children":[{"color":"#336699","name":"A/Pr Graeme Macdonald","data":{"first_name":"Graeme","title":"A/Pr","dw_individual_id":"DW0043925","middle_name":"Alistair","last_name":"Macdonald","source_individual_id":"5016107","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Graeme Macdonald"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88380","size":1},{"color":"#336699","name":"Prof V. Nathan Subramaniam","data":{"first_name":"V. Nathan","title":"Prof","dw_individual_id":"DW0028225","middle_name":"","last_name":"Subramaniam","source_individual_id":"5017768","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof V. Nathan Subramaniam"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84288","size":1},{"color":"#336699","name":"Dr Linda Fletcher","data":{"first_name":"Linda","title":"Dr","dw_individual_id":"DW0013042","middle_name":"M","last_name":"Fletcher","source_individual_id":"5014660","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Linda Fletcher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80225","size":1},{"color":"#336699","name":"Prof Darrell Crawford","data":{"first_name":"Darrell","title":"Prof","dw_individual_id":"DW0006770","middle_name":"Henry Gordon","last_name":"Crawford","source_individual_id":"5012156","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Darrell Crawford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78535","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/73007","size":1},{"color":"#FF4D4D","name":"Synthetic lethality screen targeting a defective checkpoint in melanoma","data":{"media_summary":"","end_year":2014,"keywords":["melanoma","ultraviolet (UV) radiation","cell cycle regulation","DNA repair","targeted therapy"],"nhmrc_grant_id":1029260,"application_year":2011,"health_keywords":["diagnostic marker"],"scientific_title":"Synthetic lethality screen targeting a defective checkpoint in melanoma","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Cell Biology","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"A/Pr Brian Gabrielli","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1029260","simplified_title":"Targeting defective growth controls in cancer","sub_type":"Standard Project Grant","total_budget":"552121.5","source_system":"All cancers have defects in the mechanisms that regulate normal cell growth and division.  These defects provide a growth advantage for the cancer, but can also be an Achilles Heel.  In this project we will investigate targeting a defective control mechanism we found in a high proportion of melanomas.  We will identify genes that when inhibited combine with the defective control to specifically kill tumour cells with this defect.    Normal tissue is protected by its intact regulatory mechanism."},"children":[{"color":"#336699","name":"A/Pr Brian Gabrielli","data":{"first_name":"Brian","title":"A/Pr","dw_individual_id":"DW0007391","middle_name":"G","last_name":"Gabrielli","source_individual_id":"5014734","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Brian Gabrielli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78693","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72992","size":1},{"color":"#FF4D4D","name":"Regulation of growth hormone profile by metabolic balance: neuronal, neuroendocrinal and molecular mechanism","data":{"media_summary":"pituitary gland","end_year":2014,"keywords":["endocrinology","control of homeostasis","energy balance","ghrelin","growth hormone"],"nhmrc_grant_id":1029178,"application_year":2011,"health_keywords":["hormonal regulation","mechanisms","nutritional status","obesity","pituitary gland"],"scientific_title":"Regulation of growth hormone profile by metabolic balance: neuronal, neuroendocrinal and molecular mechanism","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Basic Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Chen Chen","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1029178","simplified_title":"Investigating mechanisms that link the secretion of growth hormone to under and over eating","sub_type":"Standard Project Grant","total_budget":"413257.18","source_system":"Obesity is associated with a reduction in growth hormone secretion. As growth hormone maintains muscle mass at the expense of fat this may further promote the obese condition. This project will determine the physiological role of ghrelin, a hormone that signals hunger, in maintaining growth hormone secretion under normal, fasting and obese conditions. Clarification of the role of ghrelin in regulating growth hormone secretion may aid in the development of pharmacological agents to assist and maintain weight loss."},"children":[{"color":"#336699","name":"Prof Chen Chen","data":{"first_name":"Chen","title":"Prof","dw_individual_id":"DW0024065","middle_name":"","last_name":"Chen","source_individual_id":"RMIS86822","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Chen Chen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83170","size":1},{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72986","size":1},{"color":"#FF4D4D","name":"An integrated approach to inotropic support in preterm neonates","data":{"media_summary":"","end_year":2014,"keywords":["premature birth","neonatal","cardiac output","hypotension","peripheral blood flow"],"nhmrc_grant_id":1028888,"application_year":2011,"start_year":2012,"scientific_title":"An integrated approach to inotropic support in preterm neonates","node_source":"NHMRC","node_type":"Grant","field_of_research":"Foetal Development and Medicine","research_area":"Clinical Medicine and Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"Dr Barbara Lingwood","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1028888","simplified_title":"Supporting heart function in preterm babies","sub_type":"Standard Project Grant","total_budget":"694449.65","source_system":"Poor cardiovascular function in preterm babies can lead to inadequate blood flow to the brain and brain injury. Current treatments to improve heart function are often ineffective. This study will examine the effects of treatment on different parts of the cardiovascular system, and how these effects interact. It will identify reasons for the lack of effectiveness and provide insight which will help to design better treatments for preterm babies."},"children":[{"color":"#336699","name":"Dr Barbara Lingwood","data":{"first_name":"Barbara","title":"Dr","dw_individual_id":"DW0043819","middle_name":"Elizabeth","last_name":"Lingwood","source_individual_id":"5016005","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Barbara Lingwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88355","size":1},{"color":"#336699","name":"Prof Ian Wright","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0034846","middle_name":"Michael","last_name":"Wright","source_individual_id":"5012527","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Wright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86024","size":1},{"color":"#336699","name":"E/Pr Eugenie Lumbers","data":{"first_name":"Eugenie","title":"E/Pr","dw_individual_id":"DW0032221","middle_name":"Ruth","last_name":"Lumbers","source_individual_id":"5016098","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"E/Pr Eugenie Lumbers"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85340","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72981","size":1},{"color":"#FF4D4D","name":"A systems biology approach to defining therapeutic targets in breast cancer","data":{"media_summary":"","end_year":2014,"keywords":["breast cancer","bioinformatics","molecular basis of disease","targeted therapy","BRCA1"],"nhmrc_grant_id":1028742,"application_year":2011,"health_keywords":["gene expression","genomics"],"scientific_title":"A systems biology approach to defining therapeutic targets in breast cancer","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Molecular Targets","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Dr Peter Simpson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1028742","simplified_title":"Targeting the DNA damage response to treat breast cancer.","sub_type":"Standard Project Grant","total_budget":"633112.15","source_system":"Breast cancer is a very complex disease affecting large numbers of women. Current treatment strategies are effective at controlling the disease for patients, however many continue to be burdened by their disease as their tumour either does not respond or develops resistance to the treatment. We will use mathematical approaches to analyse large and complex data sets generated from breast cancers to identify new therapeutic targets and improve patient outcomes."},"children":[{"color":"#336699","name":"Dr Peter Simpson","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0033829","middle_name":"T","last_name":"Simpson","source_individual_id":"5017520","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Peter Simpson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85762","size":1},{"color":"#336699","name":"Prof Mark Ragan","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0009785","middle_name":"Adair","last_name":"Ragan","source_individual_id":"5029000","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Ragan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79355","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72973","size":1},{"color":"#FF4D4D","name":"A randomized controlled trial of probiotics to prevent gestational diabetes.","data":{"media_summary":"","end_year":2014,"keywords":["obesity","gestational diabetes","pregnancy complications","probiotics","maternal and child health"],"nhmrc_grant_id":1028575,"application_year":2011,"start_year":2012,"scientific_title":"A randomized controlled trial of probiotics to prevent gestational diabetes.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Obstetrics and Gynaecology","research_area":"Clinical Medicine and Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"Prof Leonie Callaway","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1028575","simplified_title":"Probiotics and GDM.","sub_type":"Standard Project Grant","total_budget":"857819.11","source_system":"Gestational diabetes mellitus is increasing rapidly in parallel with the rise in overweight and obesity in the obstetric population. Intestinal microbes differ between obese and non-obese people. In the non-pregnant population there is evidence suggesting probiotics supplementation benefits the metabolic and inflammatory milieu of the host.  We propose a randomised placebo controlled trial of probiotics for prevention of gestational diabetes and improve pregnancy outcome for mother and baby."},"children":[{"color":"#336699","name":"Dr Shelley Wilkinson","data":{"first_name":"Shelley","title":"Dr","dw_individual_id":"DW0046282","middle_name":"Ann","last_name":"Wilkinson","source_individual_id":"5039202","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Shelley Wilkinson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88985","size":1},{"color":"#336699","name":"Dr Jacinta Tobin","data":{"first_name":"Jacinta","title":"Dr","dw_individual_id":"DW0040091","middle_name":"M","last_name":"Tobin","source_individual_id":"5017942","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jacinta Tobin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87383","size":1},{"color":"#336699","name":"Prof Harold Mcintyre","data":{"first_name":"Harold","title":"Prof","dw_individual_id":"DW0026640","middle_name":"David","last_name":"Mcintyre","source_individual_id":"5023362","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Harold Mcintyre"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83888","size":1},{"color":"#336699","name":"Dr Chris Mcsweeney","data":{"first_name":"Chris","title":"Dr","dw_individual_id":"DW0020818","middle_name":"Simon","last_name":"Mcsweeney","source_individual_id":"5023377","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Chris Mcsweeney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82327","size":1},{"color":"#336699","name":"Dr Marloes Dekker","data":{"first_name":"Marloes","title":"Dr","dw_individual_id":"DW0018643","middle_name":"Nitert","last_name":"Dekker","source_individual_id":"5040313","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Marloes Dekker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81776","size":1},{"color":"#336699","name":"Prof Leonie Callaway","data":{"first_name":"Leonie","title":"Prof","dw_individual_id":"DW0018070","middle_name":"Kaye","last_name":"Callaway","source_individual_id":"5013749","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Leonie Callaway"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81618","size":1},{"color":"#336699","name":"Prof Peter O'Rourke","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0015374","middle_name":"Kevan","last_name":"O'Rourke","source_individual_id":"5011939","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter O'Rourke"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80877","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72962","size":1},{"color":"#FF4D4D","name":"Cyclic peptide based angiogenic inhibitors.","data":{"media_summary":"","end_year":2014,"keywords":["peptides","drug design","medicinal chemistry","cancer","angiogenesis"],"nhmrc_grant_id":1028509,"application_year":2011,"start_year":2012,"scientific_title":"Cyclic peptide based angiogenic inhibitors.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biomaterials","research_area":"Basic Science","for_category":"BIOMEDICAL ENGINEERING","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1028509","simplified_title":"Cyclic peptide based angiogenic inhibitors.","sub_type":"Standard Project Grant","total_budget":"376258.57","source_system":"This project aims to develop a novel class of drugs with the potential to overcome the stability problems previously associated with protein-based drugs. We will develop novel molecules for the treatment of cancer and cardiovascular disease. This project has the potential to lead to major economic and social benefits to Australia via royalty returns from drug sales and reduced costs for health care for patients with these diseases."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Prof Norelle Daly","data":{"first_name":"Norelle","title":"Prof","dw_individual_id":"DW0012604","middle_name":"L","last_name":"Daly","source_individual_id":"RMIS2275307","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Norelle Daly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80117","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72953","size":1},{"color":"#FF4D4D","name":"Small Molecule Modulators of Complement in Metabolism and Obesity","data":{"media_summary":"","end_year":2014,"keywords":["biochemistry","pharmacology","anti-inflammatory agents","cardiovascular risk factors","obesity"],"nhmrc_grant_id":1028423,"application_year":2011,"health_keywords":["drug design"],"scientific_title":"Small Molecule Modulators of Complement in Metabolism and Obesity","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology and Pharmaceutical Sciences not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1028423","simplified_title":"A New Approach To Preventing and Treating Obesity and Metabolic Disease","sub_type":"Standard Project Grant","total_budget":"682820.65","source_system":"We have discovered that certain inflammatory proteins in the blood that are produced in the immune response to infection are involved in regulating the storage and burn off of fat in adipose tissue in the abdomen. These proteins bind to the surfaces of both fat and immune cells. We will study the effects of new drugs that compete with these blood proteins for the surfaces of these cells, since our experiments indicate that such drugs can potentially prevent and reverse fat deposition in rats fed a high-fat, high-carbohydrate, diet."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"Prof Lindsay Brown","data":{"first_name":"Lindsay","title":"Prof","dw_individual_id":"DW0023816","middle_name":"","last_name":"Brown","source_individual_id":"5013659","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Lindsay Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83114","size":1},{"color":"#336699","name":"Prof Katherine Cianflone","data":{"first_name":"Katherine","title":"Prof","dw_individual_id":"DW0000880","middle_name":"","last_name":"Cianflone","source_individual_id":"5023876","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Katherine Cianflone"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76902","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72948","size":1},{"color":"#FF4D4D","name":"The Role of Attention in Modifying Neural Plasticity in the Adult Human Cortex","data":{"media_summary":"","end_year":2014,"keywords":["attention","selective attention","transcranial magnetic stimulation (TMS)","psychology","cognitive neuroscience"],"nhmrc_grant_id":1028210,"application_year":2011,"start_year":2012,"scientific_title":"The Role of Attention in Modifying Neural Plasticity in the Adult Human Cortex","node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Processes, Perception and Performance","research_area":"Basic Science","for_category":"PSYCHOLOGY","cia_name":"Prof Jason Mattingley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1028210","simplified_title":"The Role of Attention in Brain Plasticity","sub_type":"Standard Project Grant","total_budget":"391242.51","source_system":"The human brain is constantly changing in response to experience. These changes, known as plasticity, are necessary to respond to new environments, to learn new skills and to recover from brain injury. This project will determine how selective attention, a process that filters sensory information in the brain, alters brain plasticity. The outcomes will inform the design of rehabilitation treatments for individuals with a brain injury."},"children":[{"color":"#336699","name":"Dr Martin Sale","data":{"first_name":"Martin","title":"Dr","dw_individual_id":"DW0033591","middle_name":"Victor","last_name":"Sale","source_individual_id":"RMIS3390079","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Martin Sale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85697","size":1},{"color":"#336699","name":"A/Pr Timothy Carroll","data":{"first_name":"Timothy","title":"A/Pr","dw_individual_id":"DW0029812","middle_name":"John","last_name":"Carroll","source_individual_id":"5019678","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Timothy Carroll"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84716","size":1},{"color":"#336699","name":"Dr Marc Kamke","data":{"first_name":"Marc","title":"Dr","dw_individual_id":"DW0025867","middle_name":"","last_name":"Kamke","source_individual_id":"5019885","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Marc Kamke"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83668","size":1},{"color":"#336699","name":"Prof Jason Mattingley","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0020682","middle_name":"Brett","last_name":"Mattingley","source_individual_id":"RMIS123930","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jason Mattingley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82287","size":1},{"color":"#336699","name":"Prof Stephan Riek","data":{"first_name":"Stephan","title":"Prof","dw_individual_id":"DW0015874","middle_name":"","last_name":"Riek","source_individual_id":"5020124","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stephan Riek"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81001","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72929","size":1},{"color":"#FF4D4D","name":"Pathogenesis of a new mouse model of ankylosing spondylitis","data":{"media_summary":"","end_year":2014,"keywords":["autoimmunity initiation","inflammatory arthritis","inflammatory bowel disease (IBD)","fungal pathogenesis","innate immunity"],"nhmrc_grant_id":1027657,"application_year":2011,"start_year":2012,"scientific_title":"Pathogenesis of a new mouse model of ankylosing spondylitis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Autoimmunity","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ranjeny Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1027657","simplified_title":"Pathogenesis of a new mouse model of arthritis and inflammatory bowel disease","sub_type":"Standard Project Grant","total_budget":"682820.65","source_system":"Ankylosing spondylitis and Crohn's disease are autoimmune inflammatory diseases which cause long-term pain and deformity of joints, spine and bowel. Using a new mouse model of both diseases, we will study cells and processes involved in the initiation of disease, in order to discover new targets for prevention and treatment. The work will have importance for design of new therapies for human inflammatory spine and bowel diseases."},"children":[{"color":"#336699","name":"Prof Ranjeny Thomas","data":{"first_name":"Ranjeny","title":"Prof","dw_individual_id":"DW0045826","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS4352","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ranjeny Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88853","size":1},{"color":"#336699","name":"Dr Merja Ruutu","data":{"first_name":"Merja","title":"Dr","dw_individual_id":"DW0045217","middle_name":"","last_name":"Ruutu","source_individual_id":"5039226","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Merja Ruutu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88703","size":1},{"color":"#336699","name":"Prof Michael Mcguckin","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0044168","middle_name":"A","last_name":"Mcguckin","source_individual_id":"5016335","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Mcguckin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88447","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72899","size":1},{"color":"#FF4D4D","name":"Occupational hearing loss induced by solvents and noise: development of new strategies for hearing loss prevention programs in the workplace","data":{"media_summary":"","end_year":2014,"keywords":["auditory dysfunction","hearing loss","occupational disease","prevention","early detection"],"nhmrc_grant_id":1027549,"application_year":2011,"health_keywords":["occupational health and safety","audiology"],"scientific_title":"Occupational hearing loss induced by solvents and noise: development of new strategies for hearing loss prevention programs in the workplace","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Environmental and Occupational Health and Safety","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Louise Hickson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1027549","simplified_title":"Prevention of hearing loss induced by solvents and noise","sub_type":"Standard Project Grant","total_budget":"252088.79","source_system":"There are no guidelines on how to prevent and monitor the effects of solvents on hearing. There is an urgent need of an audiological test battery capable of detecting early signs of occupational solvent-induced hearing loss (OSIHL). It is the aim of this research to  a) investigate the influence of solvent and noise exposure on the function of the auditory system, and b) determine the tests with the highest discriminatory power to detect early signs of OSIHL that can be used in the workplace."},"children":[{"color":"#336699","name":"Dr Adrian Fuente","data":{"first_name":"Adrian","title":"Dr","dw_individual_id":"DW0030782","middle_name":"","last_name":"Fuente","source_individual_id":"5038523","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Adrian Fuente"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84983","size":1},{"color":"#336699","name":"Prof Louise Hickson","data":{"first_name":"Louise","title":"Prof","dw_individual_id":"DW0025478","middle_name":"","last_name":"Hickson","source_individual_id":"5032562","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Louise Hickson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83559","size":1},{"color":"#336699","name":"Dr Warwick Williams","data":{"first_name":"Warwick","title":"Dr","dw_individual_id":"DW0017134","middle_name":"Hamilton","last_name":"Williams","source_individual_id":"5039862","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Warwick Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81350","size":1},{"color":"#336699","name":"Dr Thais Morata","data":{"first_name":"Thais","title":"Dr","dw_individual_id":"DW0009212","middle_name":"Catalani","last_name":"Morata","source_individual_id":"5039868","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Thais Morata"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79203","size":1},{"color":"#336699","name":"Dr Asad Khan","data":{"first_name":"Asad","title":"Dr","dw_individual_id":"DW0008357","middle_name":"","last_name":"Khan","source_individual_id":"5018956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Asad Khan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78958","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72891","size":1},{"color":"#FF4D4D","name":"Retinoic acid receptor-related orphan receptors and the regulation of metabolism:insights into diabetes and obesity","data":{"media_summary":"metabolism","end_year":2014,"keywords":["endocrinology","nuclear receptors","gene regulation","signal transduction","skeletal muscle"],"nhmrc_grant_id":1027484,"application_year":2011,"health_keywords":["adipose tissue","inflammation","expression profiling","bioinformatics","metabolism"],"scientific_title":"Retinoic acid receptor-related orphan receptors and the regulation of metabolism:insights into diabetes and obesity","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1027484","simplified_title":"Receptors Controlling Obesity, Diabetes and Inflammation","sub_type":"Standard Project Grant","total_budget":"760799.65","source_system":"Nuclear receptors (NRs) function as hormone dependent DNA binding proteins important in sustaining human health, highlighted by the array of medicines that target these proteins for human well being.  ROR alpha is one such protein that we have shown regulates fat mass,  obesity, and glucose tolerance.  Obesity and diabetes are often linked with inflammation.  We will examine how ROR controls inflammation during metabolic disease."},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72884","size":1},{"color":"#FF4D4D","name":"Research Fellowship","data":{"media_summary":"","end_year":2016,"keywords":["medicinal chemistry","protease inhibitors","G protein-coupled receptors","drug design","anti-inflammatory agents"],"nhmrc_grant_id":1027369,"application_year":2011,"health_keywords":["antiviral agents","anticancer drug"],"scientific_title":"Research Fellowship","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1027369","simplified_title":"Research Fellowship","sub_type":"Research Fellowship","total_budget":"828406.98","source_system":"This research draws together my expertise in medicinal chemistry, biochemistry, pharmacology and virology to design and develop new compounds that we can use to interrogate and regulate human and viral proteins that cause disease. Protein, cell and animal studies relevant to major 21st century health burdens (such as inflammatory, infectious and metabolic diseases, cancer, pain and viral infections) will provide important new information on mechanisms of disease development and drug action."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72874","size":1},{"color":"#FF4D4D","name":"InterLACE: International collaboration for a Life course Approach to reproductive health and Chronic disease Events","data":{"media_summary":"","end_year":2014,"keywords":["menopause","women's health","cardiovascular disease","epidemiology","chronic diseases"],"nhmrc_grant_id":1027196,"application_year":2011,"start_year":2012,"scientific_title":"InterLACE: International collaboration for a Life course Approach to reproductive health and Chronic disease Events","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Gita Mishra","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1027196","simplified_title":"InterLACE: International collaboration on reproductive health and chronic disease","sub_type":"Standard Project Grant","total_budget":"495965.8","source_system":"Cardiovascular disease and diabetes are major chronic diseases among women. This world-leading research combines data from 7 international and 3 Australian studies of womens health. We will investigate the relationship of reproductive health, from menarche to menopause, with the risk of Type 2 diabetes and cardiovascular disease in later life. Findings will support the development of policies and preventive health strategies to reduce the risk of these chronic diseases."},"children":[{"color":"#336699","name":"Prof Gita Mishra","data":{"first_name":"Gita","title":"Prof","dw_individual_id":"DW0038575","middle_name":"Devi","last_name":"Mishra","source_individual_id":"5012169","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gita Mishra"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86995","size":1},{"color":"#336699","name":"Prof Debra Anderson","data":{"first_name":"Debra","title":"Prof","dw_individual_id":"DW0035093","middle_name":"J","last_name":"Anderson","source_individual_id":"5013217","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Debra Anderson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86095","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72858","size":1},{"color":"#FF4D4D","name":"Role of flavivirus-encoded small regulatory RNAs in virus-mosquito vector interactions","data":{"media_summary":"","end_year":2014,"keywords":["flavivirus","microrna","vector-borne disease","mosquito","replication"],"nhmrc_grant_id":1027110,"application_year":2011,"start_year":2012,"scientific_title":"Role of flavivirus-encoded small regulatory RNAs in virus-mosquito vector interactions","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1027110","simplified_title":"Role of flavivirus-encoded small regulatory RNAs in virus-mosquito vector interactions","sub_type":"Standard Project Grant","total_budget":"547216.03","source_system":"Mosquito-borne diseases are major threats to human health. MicroRNAs are small non-coding ribonucleic acids (RNAs) that play important roles in development, cancer, apoptosis, immunity, longevity, and viral infections. We propose to identify the regulatory microRNAs from flaviviruses and establish their potential function in vector-arboviruses interactions. The project will put Australia at the forefront of research in the most rapidly developing area of microRNA research."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1},{"color":"#336699","name":"A/Pr Sassan Asgari","data":{"first_name":"Sassan","title":"A/Pr","dw_individual_id":"DW0035153","middle_name":"","last_name":"Asgari","source_individual_id":"5013231","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Sassan Asgari"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86115","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72852","size":1},{"color":"#FF4D4D","name":"Structural biology of bacterial lipid II-glycopeptide antibiotic interactions","data":{"media_summary":"","end_year":2014,"keywords":["medicinal chemistry","molecular modelling","structural biology","antibiotic resistance","bacterial infection"],"nhmrc_grant_id":1026922,"application_year":2011,"health_keywords":["drug discovery","structure-based drug design"],"scientific_title":"Structural biology of bacterial lipid II-glycopeptide antibiotic interactions","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biomolecular Modelling and Design","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof Matthew Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1026922","simplified_title":"Understanding how antibiotics work in order to design better ones","sub_type":"Standard Project Grant","total_budget":"605190.35","source_system":"Drug resistant bacteria are threatening our ability to successfully treat serious life-endangering infections, with many common antibiotics no longer effective. We will study in atomic detail how one class of antibiotics interacts with bacteria in order to design new members of this group that can overcome resistance."},"children":[{"color":"#336699","name":"Prof Alan Mark","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0032333","middle_name":"Edward","last_name":"Mark","source_individual_id":"5016199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alan Mark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85371","size":1},{"color":"#336699","name":"Prof Matthew Cooper","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0024249","middle_name":"A","last_name":"Cooper","source_individual_id":"5018347","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83230","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72838","size":1},{"color":"#FF4D4D","name":"Non-Haemolytic Friulimicins for the Treatment of Multi-Drug Resistant Bacteria","data":{"media_summary":"","end_year":2014,"keywords":["pharmacokinetics","microbiology","drug resistance","bacterial infection","antibiotic resistance"],"nhmrc_grant_id":1026921,"application_year":2011,"health_keywords":["drug discovery"],"scientific_title":"Non-Haemolytic Friulimicins for the Treatment of Multi-Drug Resistant Bacteria","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biologically Active Molecules","research_area":"Clinical Medicine and Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof Matthew Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1026921","simplified_title":"A new antibiotic to treat pneumonia","sub_type":"Standard Project Grant","total_budget":"552572.09","source_system":"We are developing a new antibiotic, called friulimicin, to combat the superbugs that cause serious infections in hospitals and the community. We will optimize the drug to target MRSA (methicillin resistant Staphylococcus aureus) VRE (vancomycin resistant enterococci) and DRSP (drug resistant Streptococcus pneumoniae). We will also investigate how the drug can be used for treatment of lung infections such as pneumonia, where the antibiotic can work much better than existing drugs against resistant bacteria."},"children":[{"color":"#336699","name":"Prof Jason Roberts","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0033443","middle_name":"A","last_name":"Roberts","source_individual_id":"5017212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jason Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85657","size":1},{"color":"#336699","name":"Prof Matthew Cooper","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0024249","middle_name":"A","last_name":"Cooper","source_individual_id":"5018347","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83230","size":1},{"color":"#336699","name":"Dr Mark Butler","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0018036","middle_name":"Stuart","last_name":"Butler","source_individual_id":"5020282","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mark Butler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81611","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72837","size":1},{"color":"#FF4D4D","name":"Long term progression and pathways of cardiometabolic risks for mothers and their adult offspring.","data":{"media_summary":"","end_year":2016,"keywords":["obesity","metabolic syndrome","diabetes mellitus","epidemiology","risk factors"],"nhmrc_grant_id":1026598,"application_year":2011,"start_year":2012,"scientific_title":"Long term progression and pathways of cardiometabolic risks for mothers and their adult offspring.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Public Health","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"A/Pr Abdullah Mamun","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1026598","simplified_title":"Progression and pathways of cardiovascular and metabolic risks for mothers and their adult offspring: a 30 year follow-up study","sub_type":"Population Health CDF","total_budget":"450637.96","source_system":"The aim of this research is to investigate long term postnatal outcomes of cardiovascular diseases and mortality throughout the female reproductive life course and beyond, and to study the causes, progression and pathways of metabolic syndrome, diabetes, and obesity from birth to adulthood within adult males and females."},"children":[{"color":"#336699","name":"A/Pr Abdullah Mamun","data":{"first_name":"Abdullah","title":"A/Pr","dw_individual_id":"DW0003145","middle_name":"Al","last_name":"Mamun","source_individual_id":"5016160","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Abdullah Mamun"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77536","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72820","size":1},{"color":"#FF4D4D","name":"Research Fellowship","data":{"media_summary":"","end_year":2017,"keywords":["medicinal chemistry","drug design","protein structure","peptides","nuclear magnetic resonance (NMR)"],"nhmrc_grant_id":1026501,"application_year":2011,"start_year":2012,"scientific_title":"Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1026501","simplified_title":"Research Fellowship","sub_type":"Research Fellowship","total_budget":"829329.67","source_system":"Peptides (mini proteins) have outstanding potential as new drugs for cancer, pain and many other diseases, but their potential has not been realised so far because peptides tend to be unstable in the body. I have discovered a new class of peptides that are ultra-stable and have very favourable pharmaceutical properties. I will use these peptides to develop a new generation of drugs that are more potent and with fewer side effects than traditional drugs."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72812","size":1},{"color":"#FF4D4D","name":"Development of Carbohydrate Based Self-adjuvanting Vaccine Delivery System","data":{"media_summary":"","end_year":2014,"keywords":["vaccine development","peptide synthesis","carbohydrates","lipids","enzymes"],"nhmrc_grant_id":1026488,"application_year":2011,"start_year":2012,"scientific_title":"Development of Carbohydrate Based Self-adjuvanting Vaccine Delivery System","node_source":"NHMRC","node_type":"Grant","field_of_research":"Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Dr Pavla Simerska","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1026488","simplified_title":"Carbohydrate Based Vaccine Delivery System","sub_type":"New Investigator Grant","total_budget":"311647.09","source_system":"The world is in a need for effective vaccines for the treatment/prevention of a range of currently occurring diseases. The aim of this project is to develop sugar/lipid-based delivery systems by revolutionary new chemo-enzymatic technology. Expected outcomes of the project will be numerous biologically active vaccine candidates and novel technologies which will lead to effective therapeutic products."},"children":[{"color":"#336699","name":"Dr Pavla Simerska","data":{"first_name":"Pavla","title":"Dr","dw_individual_id":"DW0010271","middle_name":"","last_name":"Simerska","source_individual_id":"5030723","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Pavla Simerska"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79489","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72810","size":1},{"color":"#FF4D4D","name":"Preventing complications of chronic obstructive pulmonary disease","data":{"media_summary":"","end_year":2016,"keywords":["chronic obstructive pulmonary disease (COPD)","diagnosis","exacerbation","cardiovascular disease","prognosis"],"nhmrc_grant_id":1026215,"application_year":2011,"start_year":2012,"scientific_title":"Preventing complications of chronic obstructive pulmonary disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"A/Pr Ian Yang","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1026215","simplified_title":"Preventing complications of chronic obstructive pulmonary disease","sub_type":"Clinical CDF","total_budget":"309503.84","source_system":"Chronic obstructive pulmonary disease (COPD) is a devastating lung disease that affects smokers. Lung complications and complications in other organs occur commonly. This study will examine factors that lead to exacerbations of COPD, and test the effectiveness of early diagnosis of coronary artery disease using CT scans."},"children":[{"color":"#336699","name":"A/Pr Ian Yang","data":{"first_name":"Ian","title":"A/Pr","dw_individual_id":"DW0028973","middle_name":"Anthony","last_name":"Yang","source_individual_id":"RMIS57007","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Ian Yang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84509","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72787","size":1},{"color":"#FF4D4D","name":"Flaviviral proteases as viable targets for antiinfective drugs","data":{"media_summary":"","end_year":2014,"keywords":["enzymes","protease inhibitors","protease","drug design","dengue virus"],"nhmrc_grant_id":1025883,"application_year":2011,"start_year":2012,"scientific_title":"Flaviviral proteases as viable targets for antiinfective drugs","node_source":"NHMRC","node_type":"Grant","field_of_research":"Enzymes","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1025883","simplified_title":"Viral proteins essential for virus replication are new targets for antiviral drugs","sub_type":"Standard Project Grant","total_budget":"620716.41","source_system":"Viruses hijack the machinery and nutrients of cells they infect in order to reproduce. We will study viral enzymes (proteases) essential for virus replication, use fluorescent probes to learn where the viral enzymes hide and act in infected cells, track the passage of drugs aimed at these enzymes, design drugs to block their actions and stop virus replication, and test antiviral activity against Dengue, West Nile, Japanese Encephalitis and Yellow Fever viruses which infect millions of people."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"Prof Paul Young","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0005625","middle_name":"R","last_name":"Young","source_individual_id":"RMIS20614","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78234","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72770","size":1},{"color":"#FF4D4D","name":"Neural control of airway defense","data":{"media_summary":"","end_year":2016,"keywords":["airways","cough","neural reflexes","respiratory diseases","autonomic nervous system"],"nhmrc_grant_id":1025589,"application_year":2011,"start_year":2012,"scientific_title":"Neural control of airway defense","node_source":"NHMRC","node_type":"Grant","field_of_research":"Systems Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Dr Stuart Mazzone","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1025589","simplified_title":"Neural control of airway defense","sub_type":"RD Wright Biomedical CDF","total_budget":"449667.23","source_system":"Dysfunction of the nervous system plays an important role in the symptoms of many respiratory diseases.  For example, excessive non-productive coughing, elevated mucous secretion, reduced airway patency and hyperreactivity are all characteristic symptoms of diseases such as asthma and all involve over-activity of the nervous system.  This research aims to understand the neural circuitry that is involved in controlling the airways and the mechanisms that underlie how this circuitry can become dysfunctional."},"children":[{"color":"#336699","name":"Dr Stuart Mazzone","data":{"first_name":"Stuart","title":"Dr","dw_individual_id":"DW0008967","middle_name":"B","last_name":"Mazzone","source_individual_id":"5016283","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Stuart Mazzone"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79130","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72750","size":1},{"color":"#FF4D4D","name":"Neisseria gonorrhoeae antmicrobial resistance: detection and propagation","data":{"media_summary":"","end_year":2014,"keywords":["antibiotic resistance","gonorrhoea","molecular epidemiology","Aboriginal health","remote communities"],"nhmrc_grant_id":1025517,"application_year":2011,"start_year":2012,"scientific_title":"Neisseria gonorrhoeae antmicrobial resistance: detection and propagation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Aboriginal and Torres Strait Islander Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr David Whiley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1025517","simplified_title":"Investigating new problems of antibiotic resistance in Neisseria gonorrhoeae","sub_type":"Standard Project Grant","total_budget":"435129.13","source_system":"Neisseria gonorrhoeae, the pathogen that causes gonorrhoea, has developed resistance to multiple classes of antibiotics. The last remaining class of antibiotics that can successfully be used for general treatment of gonorrhoea is extended spectrum cephalosporins (ESCs). However, we are now starting to see Neisseria gonorrhoeae isolates with early signs of ESC resistance. This research will use molecular technology and mathematical modelling to investigate Neisseria gonorrhoeae antimicrobial resistance in Australia."},"children":[{"color":"#336699","name":"marcus chen","data":{"first_name":"marcus","rda":"https://researchdata.ands.org.au/apr-marcus-chen/104261","email":"","social":"","last_name":"chen","node_source":"Web","node_type":"Researcher","full_name":"marcus chen"},"children":[{"color":"#123456","name":"doi:10.5061/dryad.h53v8","data":{"node_source":"Dryad","node_type":"Dataset","doi":"doi:10.5061/dryad.h53v8"},"class":"Dataset","self":"http://localhost:7474/db/data/node/141158","size":1}],"class":"Researcher","self":"http://localhost:7474/db/data/node/141156","size":1},{"color":"#336699","name":"A/Pr David Whiley","data":{"first_name":"David","title":"A/Pr","dw_individual_id":"DW0046232","middle_name":"Mark","last_name":"Whiley","source_individual_id":"5020798","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr David Whiley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88965","size":1},{"color":"#336699","name":"A/Pr Marcus Chen","data":{"first_name":"Marcus","title":"A/Pr","dw_individual_id":"DW0024071","middle_name":"","last_name":"Chen","source_individual_id":"5027974","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Marcus Chen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83172","size":1},{"color":"#336699","name":"Dr David Regan","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0021654","middle_name":"Gabriel","last_name":"Regan","source_individual_id":"5017158","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David Regan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82572","size":1},{"color":"#336699","name":"A/Pr Monica Lahra","data":{"first_name":"Monica","title":"A/Pr","dw_individual_id":"DW0020235","middle_name":"M","last_name":"Lahra","source_individual_id":"RMIS3394705","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Monica Lahra"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82167","size":1},{"color":"#336699","name":"A/Pr Rebecca Guy","data":{"first_name":"Rebecca","title":"A/Pr","dw_individual_id":"DW0019379","middle_name":"J","last_name":"Guy","source_individual_id":"5015012","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Rebecca Guy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81933","size":1},{"color":"#336699","name":"Prof Basil Donovan","data":{"first_name":"Basil","title":"Prof","dw_individual_id":"DW0001330","middle_name":"John","last_name":"Donovan","source_individual_id":"5014375","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Basil Donovan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77045","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72744","size":1},{"color":"#FF4D4D","name":"Research Fellowship","data":{"media_summary":"","end_year":2016,"keywords":["genomics","bioinformatics","mutation detection","systems biology","translational research"],"nhmrc_grant_id":1025427,"application_year":2011,"start_year":2012,"scientific_title":"Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Genetics","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Prof Sean Grimmond","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1025427","simplified_title":"Research Fellowship","sub_type":"Research Fellowship","total_budget":"732456.39","source_system":"We have entered an era where it is now possible to sequence an individual's genetic blueprint. In the case of cancer this can be used to determine the genetic damage that has occurred in cancer cells. This fellowship seeks to carry out large scale sequencing of cancer patient and map out the genetic damage that is common to get a handle on what drives the disease. It will also investigate how personalized mutation detection might improve cancer treatment selection for individual patients."},"children":[{"color":"#336699","name":"Prof Sean Grimmond","data":{"first_name":"Sean","title":"Prof","dw_individual_id":"DW0007616","middle_name":"M","last_name":"Grimmond","source_individual_id":"5014956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sean Grimmond"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78759","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72743","size":1},{"color":"#FF4D4D","name":"Manipulating store-operated Ca2+ entry to improve muscle function in dystrophy","data":{"media_summary":"","end_year":2014,"keywords":["peripheral nervous system (PNS)","skeletal muscle","calcium imaging","dystrophy","excitation-contraction coupling"],"nhmrc_grant_id":1025355,"application_year":2011,"health_keywords":["muscle function","muscle disease","muscular dystrophy"],"scientific_title":"Manipulating store-operated Ca2+ entry to improve muscle function in dystrophy","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Dr Bradley Launikonis","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1025355","simplified_title":"Calcium regulation in healthy and dystrophic skeletal muscle","sub_type":"Standard Project Grant","total_budget":"516163.9","source_system":"Muscle function is regulated in a complex manner by calcium and is impaired in Duchenne muscular dystrophy (DMD). Changes in calcium regulation will be investigated in DMD patients and in an animal model using a novel approach. We will use a combination of novel experimental approaches to manipulate muscles in dystrophic mice and test for improvement in function.  Results will determine the viability of a potential treatment."},"children":[{"color":"#336699","name":"Prof Walter Thomas","data":{"first_name":"Walter","title":"Prof","dw_individual_id":"DW0028371","middle_name":"Glen","last_name":"Thomas","source_individual_id":"RMIS225046","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Walter Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84337","size":1},{"color":"#336699","name":"A/Pr Robyn Murphy","data":{"first_name":"Robyn","title":"A/Pr","dw_individual_id":"DW0021039","middle_name":"M","last_name":"Murphy","source_individual_id":"5016618","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Robyn Murphy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82390","size":1},{"color":"#336699","name":"Dr Bradley Launikonis","data":{"first_name":"Bradley","title":"Dr","dw_individual_id":"DW0014380","middle_name":"S","last_name":"Launikonis","source_individual_id":"5015864","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Bradley Launikonis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80584","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72740","size":1},{"color":"#FF4D4D","name":"Waist circumference and absolute risks of chronic diseases: evidence for establishing waist circumference cutoffs for Aboriginal Australians","data":{"media_summary":"","end_year":2014,"keywords":["Aboriginal health","obesity","cardiovascular risk","diabetes","renal failure"],"nhmrc_grant_id":1025350,"application_year":2011,"health_keywords":["population health","cohort study"],"scientific_title":"Waist circumference and absolute risks of chronic diseases: evidence for establishing waist circumference cutoffs for Aboriginal Australians","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Aboriginal and Torres Strait Islander Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Zhiqiang Wang","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1025350","simplified_title":"Evidence for establishing waist circumference cutoffs for Aboriginal Australians","sub_type":"Standard Project Grant","total_budget":"356978.6","source_system":"The gap in life expectancy between Indigenous and other Australians is unacceptable. Cardiovascular disease, diabetes and kidney failure are major diseases contributing to such a gap. Waist circumference is an important risk marker of those chronic diseases for health promotion and intervention. However, cutoff values for Aboriginal Australians are lacking, which limits its use in this population. In this project, we will provide evidence of multiple sources for establishing appropriate cutoff values for Aboriginal people."},"children":[{"color":"#336699","name":"A/Pr Zhiqiang Wang","data":{"first_name":"Zhiqiang","title":"A/Pr","dw_individual_id":"DW0028670","middle_name":"","last_name":"Wang","source_individual_id":"5019801","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Zhiqiang Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84425","size":1},{"color":"#336699","name":"A/Pr Srinivas Kondalsamy Chennakesavan","data":{"first_name":"Srinivas","title":"A/Pr","dw_individual_id":"DW0002708","middle_name":"","last_name":"Kondalsamy Chennakesavan","source_individual_id":"5019711","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Srinivas Kondalsamy Chennakesavan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77406","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72739","size":1},{"color":"#FF4D4D","name":"Chronic diseases in Aboriginal Australians: a cohort study with 20 years of follow-up in a remote community","data":{"media_summary":"","end_year":2014,"keywords":["Aboriginal health","cardiovascular disease","diabetes","renal failure","risk factors"],"nhmrc_grant_id":1025300,"application_year":2011,"start_year":2012,"scientific_title":"Chronic diseases in Aboriginal Australians: a cohort study with 20 years of follow-up in a remote community","node_source":"NHMRC","node_type":"Grant","field_of_research":"Aboriginal and Torres Strait Islander Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Zhiqiang Wang","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1025300","simplified_title":"Chronic diseases in Aboriginal Australians: a cohort study with 20 years of follow-up","sub_type":"Standard Project Grant","total_budget":"408842.23","source_system":"Our aims are to estimate lifetime risk of cardiovascular disease, diabetes and renal failure, and to assess the long term effects of early life risk factors on those conditions in Aboriginal Australians. Long term follow-up is crucial to investigate the natural history of chronic disease and their early life risk factors. A cohort in a remote Aboriginal community has been established since 1992. To achieve the aims of this project, we propose to extend the follow-up of this cohort to 20 years."},"children":[{"color":"#336699","name":"A/Pr Zhiqiang Wang","data":{"first_name":"Zhiqiang","title":"A/Pr","dw_individual_id":"DW0028670","middle_name":"","last_name":"Wang","source_individual_id":"5019801","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Zhiqiang Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84425","size":1},{"color":"#336699","name":"Prof Wendy Hoy","data":{"first_name":"Wendy","title":"Prof","dw_individual_id":"DW0013767","middle_name":"Elizabeth","last_name":"Hoy","source_individual_id":"RMIS3725","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wendy Hoy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80407","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72736","size":1},{"color":"#FF4D4D","name":"Role of STAT5 in defining lifespan in mouse models","data":{"media_summary":"","end_year":2014,"keywords":["molecular gerontology","healthy ageing","mortality","growth hormone","JAK/STAT pathway"],"nhmrc_grant_id":1025094,"application_year":2011,"health_keywords":["free radical damage","toxins"],"scientific_title":"Role of STAT5 in defining lifespan in mouse models","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Basic Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Michael Waters","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1025094","simplified_title":"Use of transgenic mouse models to elucidate the molecular basis of lifespan","sub_type":"Standard Project Grant","total_budget":"547216.03","source_system":"We seek to elucidate the molecular basis for the extended lifespan seen in the Methuselah mouse, the longest lived mouse model of ageing. This mouse lacks the receptor for growth hormone, and we have identified a major gene-regulating protein activated by the growth hormone receptor as correlating with lifespan. This project seeks to establish if this protein does indeed regulate lifespan, and to determine how it does this, particularly in relation to metabolism of toxins and free radicals."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72716","size":1},{"color":"#FF4D4D","name":"Roles of the nuclear growth hormone receptor in cell proliferation and survival","data":{"media_summary":"","end_year":2014,"keywords":["growth hormone","receptor signalling","proliferation","nuclear transport","splicing"],"nhmrc_grant_id":1025088,"application_year":2011,"health_keywords":["nuclear receptors","cancer cell biology","transcriptional regulation"],"scientific_title":"Roles of the nuclear growth hormone receptor in cell proliferation and survival","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael Waters","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1025088","simplified_title":"Direct actions of the growth hormone receptor in the cell nucleus","sub_type":"Standard Project Grant","total_budget":"429387.56","source_system":"We have discovered that the cell surface receptor for growth hormone travels to the cell nucleus in dividing cells, including cancer cells. Given the role of growth hormone in promoting growth postnatally, we seek to uncover how the nuclear receptor promotes proliferation directly, and by gene splicing. We have identified strong candidates for its direct actions through proteomics, and a DNA binding site for the receptor. Here we will investigate its role in proliferation, gene splicing and DNA strand break repair after cell irradiation."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1},{"color":"#336699","name":"Dr Andrew Brooks","data":{"first_name":"Andrew","title":"Dr","dw_individual_id":"DW0017930","middle_name":"James","last_name":"Brooks","source_individual_id":"5022905","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Andrew Brooks"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81582","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72715","size":1},{"color":"#FF4D4D","name":"Mechanism of activation of JAK2 by a class 1 cytokine receptor","data":{"media_summary":"","end_year":2014,"keywords":["cytokine receptor","cytokine signalling","JAK/STAT pathway","structure-function","growth hormone"],"nhmrc_grant_id":1025082,"application_year":2011,"health_keywords":["conformational change"],"scientific_title":"Mechanism of activation of JAK2 by a class 1 cytokine receptor","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Receptors and Membrane Biology","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Michael Waters","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1025082","simplified_title":"How do cytokine receptors signal ?","sub_type":"Standard Project Grant","total_budget":"562742.09","source_system":"Cytokine receptors regulate key processes such as red/white blood cell formation, stature, adiposity and lactation. They use JAK kinases to signal to regulated genes. Here we will use sophisticated technologies able to observe single molecules and crystallography to uncover the mechanism used by these receptors to signal into the cell using a well characterised, simple cytokine receptor, the growth hormone receptor."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1},{"color":"#336699","name":"Dr Yann Gambin","data":{"first_name":"Yann","title":"Dr","dw_individual_id":"DW0019125","middle_name":"","last_name":"Gambin","source_individual_id":"5039899","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Yann Gambin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81881","size":1},{"color":"#336699","name":"Dr Andrew Brooks","data":{"first_name":"Andrew","title":"Dr","dw_individual_id":"DW0017930","middle_name":"James","last_name":"Brooks","source_individual_id":"5022905","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Andrew Brooks"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81582","size":1},{"color":"#336699","name":"Prof Kirill Alexandrov","data":{"first_name":"Kirill","title":"Prof","dw_individual_id":"DW0005768","middle_name":"","last_name":"Alexandrov","source_individual_id":"5011534","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Kirill Alexandrov"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78275","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72713","size":1},{"color":"#FF4D4D","name":"Research Fellowship","data":{"media_summary":"","end_year":2016,"keywords":["arthritis","genetics","immunogenetics","rheumatoid arthritis","association studies"],"nhmrc_grant_id":1024879,"application_year":2011,"start_year":2012,"scientific_title":"Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Immunology","research_area":"Clinical Medicine and Science","for_category":"GENETICS","cia_name":"Prof Matthew Brown","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1024879","simplified_title":"Research Fellowship","sub_type":"Research Fellowship","total_budget":"828406.98","source_system":"Using cutting edge sequencing and genotyping technology, genes causing common and rare human diseases will be identified, and genetic methods developed to diagnose genetic diseases in both antenatal and postnatal life.  Treatments for common rheumatic diseases affecting tens of thousands of Australians will be developed informed by these genetic findings."},"children":[{"color":"#336699","name":"Prof Matthew Brown","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0012026","middle_name":"A","last_name":"Brown","source_individual_id":"5012217","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79951","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72695","size":1},{"color":"#FF4D4D","name":"Role of the drug metabolising enzyme arylamine N-acetyltransferase 1 in breast cancer","data":{"media_summary":"","end_year":2014,"keywords":["drug metabolism","acetylation","folate metabolism","cell proliferation","breast cancer"],"nhmrc_grant_id":1024769,"application_year":2011,"start_year":2012,"scientific_title":"Role of the drug metabolising enzyme arylamine N-acetyltransferase 1 in breast cancer","node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Rodney Minchin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1024769","simplified_title":"Role of the drug metabolising enzyme arylamine N-acetyltransferase 1 in breast cancer","sub_type":"Standard Project Grant","total_budget":"600196.88","source_system":"The current project will identify the molecular mechanism(s) that underpins the significant changes in phenotype seen in a range of human cancer cells. The expected outcomes will be to demonstrate that NAT1 is critical for the clearance of pABG in cancer cells. The results will be important in the context of understanding this family of intracellular enzymes and will change the current thinking on the function of the arylamine N-acetyltransferase in normal and cancer cells."},"children":[{"color":"#336699","name":"Dr Neville Butcher","data":{"first_name":"Neville","title":"Dr","dw_individual_id":"DW0029714","middle_name":"J","last_name":"Butcher","source_individual_id":"5013724","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Neville Butcher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84690","size":1},{"color":"#336699","name":"Prof Rodney Minchin","data":{"first_name":"Rodney","title":"Prof","dw_individual_id":"DW0026778","middle_name":"F","last_name":"Minchin","source_individual_id":"5016513","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Rodney Minchin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83936","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72684","size":1},{"color":"#FF4D4D","name":"Randomised controlled trial of a telephone-delivered weight loss intervention for overweight and obese women with breast cancer","data":{"media_summary":"","end_year":2015,"keywords":["obesity","weight loss","physical activity","dietary intervention","telephone counselling"],"nhmrc_grant_id":1024739,"application_year":2011,"health_keywords":["breast cancer","chronic diseases"],"scientific_title":"Randomised controlled trial of a telephone-delivered weight loss intervention for overweight and obese women with breast cancer","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Counselling","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Marina Reeves","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1024739","simplified_title":"Using the telephone to promote weight loss following breast cancer","sub_type":"Standard Project Grant","total_budget":"873784.94","source_system":"This will be the first Australian trial and one of a few internationally to evaluate a weight loss intervention, delivered via telephone, for overweight women following treatment for breast cancer. We will recruit 160 women from South-East QLD to assess weight loss outcomes, as well as improvements in quality of life, risk factors for other chronic diseases and cost-effectiveness. Results will inform the integration of weight management as part of follow-up care for women with breast cancer."},"children":[{"color":"#336699","name":"Dr Ingrid Hickman","data":{"first_name":"Ingrid","title":"Dr","dw_individual_id":"DW0043028","middle_name":"J","last_name":"Hickman","source_individual_id":"5015215","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ingrid Hickman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88150","size":1},{"color":"#336699","name":"Prof Elizabeth Eakin","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0036429","middle_name":"G","last_name":"Eakin","source_individual_id":"5014455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Elizabeth Eakin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86445","size":1},{"color":"#336699","name":"Prof Eric Vos","data":{"first_name":"Eric","title":"Prof","dw_individual_id":"DW0022749","middle_name":"Theo","last_name":"Vos","source_individual_id":"5012185","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Eric Vos"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82861","size":1},{"color":"#336699","name":"Dr Marina Reeves","data":{"first_name":"Marina","title":"Dr","dw_individual_id":"DW0009857","middle_name":"M","last_name":"Reeves","source_individual_id":"5017143","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Marina Reeves"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79376","size":1},{"color":"#336699","name":"A/Pr Nicole Mccarthy","data":{"first_name":"Nicole","title":"A/Pr","dw_individual_id":"DW0003252","middle_name":"Jean","last_name":"Mccarthy","source_individual_id":"5016305","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nicole Mccarthy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77565","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72683","size":1},{"color":"#FF4D4D","name":"Mechanism of Epidermal Growth Factor Receptor Transactivation","data":{"media_summary":"","end_year":2014,"keywords":["angiotensin receptor","epidermal growth factor receptor (EGFR)","RNA interference","chemokine receptor","cell signalling"],"nhmrc_grant_id":1024726,"application_year":2011,"start_year":2012,"scientific_title":"Mechanism of Epidermal Growth Factor Receptor Transactivation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Prof Walter Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1024726","simplified_title":"Hijacking growth factor receptors","sub_type":"Standard Project Grant","total_budget":"578268.15","source_system":"This application examines the cellular events that control heart growth in response to angiotensin, a hormone linked to heart failure.  We believe that the same cell processes are also involved in cancer cell growth and by understanding the mechanism by which angiotensin promotes growth, better therapies against human cardiovascular disease and its relationship to uncontrolled growth will evolve."},"children":[{"color":"#336699","name":"Prof Walter Thomas","data":{"first_name":"Walter","title":"Prof","dw_individual_id":"DW0028371","middle_name":"Glen","last_name":"Thomas","source_individual_id":"RMIS225046","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Walter Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84337","size":1},{"color":"#336699","name":"Prof Ross Hannan","data":{"first_name":"Ross","title":"Prof","dw_individual_id":"DW0013491","middle_name":"Duncan","last_name":"Hannan","source_individual_id":"5015053","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ross Hannan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80344","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72682","size":1},{"color":"#FF4D4D","name":"A randomised controlled trial of enhanced parenting capacity to improve developmental outcomes in preterm infants","data":{"media_summary":"","end_year":2016,"keywords":["parenting","premature infant","infant development","mother-infant attachment","parent management strategies"],"nhmrc_grant_id":1024345,"application_year":2011,"start_year":2012,"scientific_title":"A randomised controlled trial of enhanced parenting capacity to improve developmental outcomes in preterm infants","node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Clinical Medicine and Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"Prof Paul Colditz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1024345","simplified_title":"Enhanced parenting capacity to improve developmental outcomes in preterm infants","sub_type":"Standard Project Grant","total_budget":"1037290.44","source_system":"In Australia there are 2, 600 very preterm survivors each year.  50% will have education/behavioural difficulties and 10% major disability.  We aim to optimise the development of infants born very preterm through a tailored Positive Parenting Program.  We predict reductions in child behavioural and emotional problems at 2 years corrected age."},"children":[{"color":"#336699","name":"Dr Margo Pritchard","data":{"first_name":"Margo","title":"Dr","dw_individual_id":"DW0044926","middle_name":"Anne","last_name":"Pritchard","source_individual_id":"5017053","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Margo Pritchard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88629","size":1},{"color":"#336699","name":"A/Pr Michael O'Callaghan","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0044590","middle_name":"James","last_name":"O'Callaghan","source_individual_id":"RMIS1119732","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Michael O'Callaghan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88543","size":1},{"color":"#336699","name":"A/Pr Peter Gray","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0042730","middle_name":"Hamilton","last_name":"Gray","source_individual_id":"5014946","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88078","size":1},{"color":"#336699","name":"Prof Roslyn Boyd","data":{"first_name":"Roslyn","title":"Prof","dw_individual_id":"DW0041223","middle_name":"N","last_name":"Boyd","source_individual_id":"RMIS1681246","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roslyn Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87689","size":1},{"color":"#336699","name":"Prof Matthew Sanders","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0033612","middle_name":"","last_name":"Sanders","source_individual_id":"RMIS15843","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Matthew Sanders"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85704","size":1},{"color":"#336699","name":"Prof Virginia Slaughter","data":{"first_name":"Virginia","title":"Prof","dw_individual_id":"DW0022174","middle_name":"","last_name":"Slaughter","source_individual_id":"5020369","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Virginia Slaughter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82715","size":1},{"color":"#336699","name":"Dr Koa Whittingham","data":{"first_name":"Koa","title":"Dr","dw_individual_id":"DW0011047","middle_name":"L","last_name":"Whittingham","source_individual_id":"5019383","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Koa Whittingham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79703","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72651","size":1},{"color":"#FF4D4D","name":"Developmental vitamin D deficiency and prefrontal cortical dysfunction","data":{"media_summary":"","end_year":2014,"keywords":["vitamin D","brain development","schizophrenia","ontogeny","dopamine"],"nhmrc_grant_id":1024239,"application_year":2011,"start_year":2012,"scientific_title":"Developmental vitamin D deficiency and prefrontal cortical dysfunction","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Darryl Eyles","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1024239","simplified_title":"Developmental vitamin D deficiency and brain impairment","sub_type":"Standard Project Grant","total_budget":"355570.09","source_system":"The cause of schizophrenia is unknown but is believed to be due to abnormal brain development. Dopamine abnormalities are central to schizophrenia. We have developed a model of maternal vitamin D deficiency in rats, based on disease epidemiology that shows individuals that have low levels of vitamin D at birth have an increased risk of developing schizophrenia later in life. We now also show dopamine systems in regions associated with cognition may develop abnormally in our animal model."},"children":[{"color":"#336699","name":"A/Pr Darryl Eyles","data":{"first_name":"Darryl","title":"A/Pr","dw_individual_id":"DW0042305","middle_name":"W","last_name":"Eyles","source_individual_id":"5014564","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Darryl Eyles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87979","size":1},{"color":"#336699","name":"A/Pr Thomas Burne","data":{"first_name":"Thomas","title":"A/Pr","dw_individual_id":"DW0023865","middle_name":"Henry Johnston","last_name":"Burne","source_individual_id":"5013713","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thomas Burne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83125","size":1},{"color":"#336699","name":"Prof John Mcgrath","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0009022","middle_name":"Joseph","last_name":"Mcgrath","source_individual_id":"RMIS3680751","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mcgrath"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79147","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72644","size":1},{"color":"#FF4D4D","name":"Neogenin: a molecular determinant of neural progenitor polarity and function","data":{"media_summary":"","end_year":2014,"keywords":["neural development","cortical development","neurogenesis","neuronal differentiation","neural tube defects"],"nhmrc_grant_id":1024201,"application_year":2011,"health_keywords":["neural stem cell","neurodevelopmental disorders"],"scientific_title":"Neogenin: a molecular determinant of neural progenitor polarity and function","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Helen Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1024201","simplified_title":"Molecular mechanisms building the early vertebrate brain","sub_type":"Standard Project Grant","total_budget":"569296.01","source_system":"The neuroepithelium (NEP) contains the embryonic neural stem cells essential for the production of all neurons in the adult brain. Failure in NEP function leads to devastating neural tube defects and syndromes such as epilepsy, schizophrenia, and mental retardation. This project will identify the molecular mechanisms regulating NEP stem cell activity and the birth of new neurons in the embryonic neocortex."},"children":[{"color":"#336699","name":"A/Pr Helen Cooper","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0018393","middle_name":"M","last_name":"Cooper","source_individual_id":"RMIS222363","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Helen Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81710","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72636","size":1},{"color":"#FF4D4D","name":"Ligand interactions of the MC1R receptor and cellular consequences for melanocyte responses to UV-damage","data":{"media_summary":"","end_year":2014,"keywords":["melanoma","melanocyte","keratinocytes","pigmentation","gene polymorphisms"],"nhmrc_grant_id":1023884,"application_year":2011,"health_keywords":["gene function"],"scientific_title":"Ligand interactions of the MC1R receptor and cellular consequences for melanocyte responses to UV-damage","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Cell Biology","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"A/Pr Richard Sturm","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1023884","simplified_title":"Melanocortin-1 receptor and cellular response to ligand binding and UV-damage","sub_type":"Standard Project Grant","total_budget":"578268.15","source_system":"Although it is evident that fair skin types are more susceptible to sun damage, the relationship between sun exposure, skin colour and skin cancer formation is less clear. The genes and processes that determine an individual's skin phototype and the mechanisms involved in the tanning response after UV-exposure of the skin are the focus of this investigation.  A major regulator of the response to UV radiation in the skin is the melanocortin-1 receptor.  It is essential to understand the complex interactions of this receptor that induce tanning."},"children":[{"color":"#336699","name":"A/Pr Richard Sturm","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0045672","middle_name":"Alan","last_name":"Sturm","source_individual_id":"5017777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Sturm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88811","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72619","size":1},{"color":"#FF4D4D","name":"Defective toll-like receptor 7 signalling in plasmacytoid dendritic cells underlies the inception of virus-associated asthma","data":{"media_summary":"","end_year":2014,"keywords":["asthma","asthma exacerbation","Toll-like receptors","virus detection","lung disease"],"nhmrc_grant_id":1023756,"application_year":2011,"start_year":2012,"scientific_title":"Defective toll-like receptor 7 signalling in plasmacytoid dendritic cells underlies the inception of virus-associated asthma","node_source":"NHMRC","node_type":"Grant","field_of_research":"Allergy","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Simon Phipps","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1023756","simplified_title":"Functional defects in an innate immune receptor underlie the onset of virus-associated asthma","sub_type":"Standard Project Grant","total_budget":"552301.03","source_system":"In genetically susceptible individuals, respiratory virus infections are a risk factor for asthma inception and are the most common cause of acute exacerbations. Using a clinically relevant mouse model of disease, this study will investigate whether the altered expression of toll-like receptor 7, a host protein that senses viral invasion, causes the host to mount an inappropriate pro-allergic immune response to the virus."},"children":[{"color":"#336699","name":"Prof John Upham","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0045963","middle_name":"W","last_name":"Upham","source_individual_id":"5018030","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Upham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88900","size":1},{"color":"#336699","name":"Dr Simon Phipps","data":{"first_name":"Simon","title":"Dr","dw_individual_id":"DW0033180","middle_name":"","last_name":"Phipps","source_individual_id":"5016985","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Simon Phipps"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85598","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72613","size":1},{"color":"#FF4D4D","name":"Apoptosis inducing factor and the progression of diabetic nephropathy","data":{"media_summary":"","end_year":2014,"keywords":["diabetic nephropathy","mitochondrial respiration","kidney disease","mitochondrial function","therapy"],"nhmrc_grant_id":1023664,"application_year":2011,"start_year":2012,"scientific_title":"Apoptosis inducing factor and the progression of diabetic nephropathy","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Basic Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Josephine Forbes","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1023664","simplified_title":"Identification of a novel target for the treatment of diabetic kidney disease","sub_type":"Standard Project Grant","total_budget":"496756.33","source_system":"There has been a dramatic increase in the rates of diabetic kidney disease.  It now affects more than 400,000 Australians and places these individuals at an extremely high risk of death from a heart attack or stroke.  This research is focusing on the powerstations of the cell, the mitochondria, which are responsible for energy production from the food we eat.  We aim to investigate new novel targets to prevent the dysfunction of these power stations, with a view to discovering a new therapy for diabetic kidney disease."},"children":[{"color":"#336699","name":"A/Pr Melinda Coughlan","data":{"first_name":"Melinda","title":"A/Pr","dw_individual_id":"DW0012500","middle_name":"T","last_name":"Coughlan","source_individual_id":"5018740","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Melinda Coughlan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80080","size":1},{"color":"#336699","name":"Prof Josephine Forbes","data":{"first_name":"Josephine","title":"Prof","dw_individual_id":"DW0001615","middle_name":"M","last_name":"Forbes","source_individual_id":"RMIS6864876","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Josephine Forbes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77115","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72605","size":1},{"color":"#FF4D4D","name":"Dietary intake of highly processed foods as a contributor to type 1 diabetes","data":{"media_summary":"","end_year":2014,"keywords":["nutrition","food safety","diabetes prevention","glycation","advanced glycation"],"nhmrc_grant_id":1023661,"application_year":2011,"start_year":2012,"scientific_title":"Dietary intake of highly processed foods as a contributor to type 1 diabetes","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nutritional Physiology","research_area":"Basic Science","for_category":"NUTRITION AND DIETICS","cia_name":"Prof Josephine Forbes","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1023661","simplified_title":"Modern food processing as a contributor to type 1 diabetes","sub_type":"Standard Project Grant","total_budget":"558953.73","source_system":"Modern food processing imparts desirable functional properties such as emulsification and longer shelf life. These biochemical modifications in our food may cause the body to turn on itself and destroy the cells which produce the sugar storage hormone insulin.  This is important for survival and characterizes childhood onset diabetes and can also be seen in type 2 diabetes.  This research will test some dietary and pharmaceutical interventions to slow the development of diabetes."},"children":[{"color":"#336699","name":"A/Pr Robyn Slattery","data":{"first_name":"Robyn","title":"A/Pr","dw_individual_id":"DW0033870","middle_name":"M","last_name":"Slattery","source_individual_id":"5017551","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Robyn Slattery"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85772","size":1},{"color":"#336699","name":"Prof Josephine Forbes","data":{"first_name":"Josephine","title":"Prof","dw_individual_id":"DW0001615","middle_name":"M","last_name":"Forbes","source_individual_id":"RMIS6864876","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Josephine Forbes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77115","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72604","size":1},{"color":"#FF4D4D","name":"Stem and progenitor cell contribution to skin wounds and homeostasis","data":{"media_summary":"","end_year":2015,"keywords":["wound healing","skin ulcer","stem cells","macrophages","mesenchymal signals"],"nhmrc_grant_id":1023371,"application_year":2011,"start_year":2012,"scientific_title":"Stem and progenitor cell contribution to skin wounds and homeostasis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Regenerative Medicine (incl. Stem Cells and Tissue Engineering)","research_area":"Clinical Medicine and Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"A/Pr Kiarash Khosrotehrani","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1023371","simplified_title":"Regenerative medicine in dermatology","sub_type":"Clinical CDF","total_budget":"406535.06","source_system":"Skin wounds represent a major health and economic burden. Although skin stem cells have been used routinely for the treatment of wounds, they cannot reconstitute a fully functional skin given the complexity and the many cell types usually involved in wound healing.  In this project, we intend to evaluate the role of different cell populations on modulating skin wound healing to produce more regeneration and less scaring."},"children":[{"color":"#336699","name":"A/Pr Kiarash Khosrotehrani","data":{"first_name":"Kiarash","title":"A/Pr","dw_individual_id":"DW0037755","middle_name":"","last_name":"Khosrotehrani","source_individual_id":"5015692","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Kiarash Khosrotehrani"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86775","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72582","size":1},{"color":"#FF4D4D","name":"Fetal endothelial progenitors from the placenta as a source for cell therapy","data":{"media_summary":"","end_year":2014,"keywords":["stem cells","placenta","endothelium","blood vessels","ischaemia"],"nhmrc_grant_id":1023368,"application_year":2011,"health_keywords":["wound healing"],"scientific_title":"Fetal endothelial progenitors from the placenta as a source for cell therapy","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Regenerative Medicine (incl. Stem Cells and Tissue Engineering)","research_area":"Clinical Medicine and Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"A/Pr Kiarash Khosrotehrani","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1023368","simplified_title":"Blood vessel generation from placenta","sub_type":"Standard Project Grant","total_budget":"384072.88","source_system":"The recent years have seen a rise in interest in collecting stem cells for future therapies. One example is the commercial offer of banking cord blood stem cells upon birth. In this project, we propose that the placenta, always discarded at the end of pregnancy, is another organ with high numbers of stem cells especially able to make blood vessels. We will examine if these cells can be expanded and used in treatment of situations with a need of increased blood supply such as cardiovascular disorders or skin wounds."},"children":[{"color":"#336699","name":"A/Pr Kiarash Khosrotehrani","data":{"first_name":"Kiarash","title":"A/Pr","dw_individual_id":"DW0037755","middle_name":"","last_name":"Khosrotehrani","source_individual_id":"5015692","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Kiarash Khosrotehrani"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86775","size":1},{"color":"#336699","name":"Prof Nicholas Fisk","data":{"first_name":"Nicholas","title":"Prof","dw_individual_id":"DW0019006","middle_name":"Maxwell","last_name":"Fisk","source_individual_id":"5014632","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nicholas Fisk"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81858","size":1},{"color":"#336699","name":"Dr Jerry Chan","data":{"first_name":"Jerry","title":"Dr","dw_individual_id":"DW0018161","middle_name":"","last_name":"Chan","source_individual_id":"5039809","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jerry Chan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81648","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72581","size":1},{"color":"#FF4D4D","name":"Inflammasome function in neutrophils","data":{"media_summary":"","end_year":2014,"keywords":["innate immunity","neutrophils","caspases","interleukins (IL)","host/pathogen interaction"],"nhmrc_grant_id":1023297,"application_year":2011,"health_keywords":["myelopoiesis","pattern recognition","infection"],"scientific_title":"Inflammasome function in neutrophils","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Innate Immunity","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Kate Schroder","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1023297","simplified_title":"Mechanisms of neutrophil-dependent inflammatory responses","sub_type":"New Investigator Grant","total_budget":"337614.21","source_system":"As the first recruited cells, neutrophils direct protective responses against infection, but can also mediate destructive responses in inflammatory disease. This project will determine mechanisms driving neutrophil-dependent inflammation in both settings, by examining a specific inflammation-promoting molecular pathway (the inflammasome) in neutrophils. This research will lead to a better understanding of inflammation, and may suggest therapeutics for treating inflammatory disease."},"children":[{"color":"#336699","name":"Dr Kate Schroder","data":{"first_name":"Kate","title":"Dr","dw_individual_id":"DW0039577","middle_name":"","last_name":"Schroder","source_individual_id":"5017404","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kate Schroder"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87264","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72577","size":1},{"color":"#FF4D4D","name":"Defining the Myb-p300 dependent transcriptional program in myeloid leukaemia","data":{"media_summary":"","end_year":2014,"keywords":["acute myeloid leukaemia (AML)","gene expression","DNA sequencing","oncogenes","transcriptional regulation"],"nhmrc_grant_id":1023179,"application_year":2011,"health_keywords":["leukaemogenesis","microrna"],"scientific_title":"Defining the Myb-p300 dependent transcriptional program in myeloid leukaemia","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Haematological Tumours","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Prof Thomas Gonda","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1023179","simplified_title":"Identification of genes controlled by the MYB cancer gene that contribute to leukaemia","sub_type":"Standard Project Grant","total_budget":"603631.97","source_system":"MYB is a cancer gene which turns other genes on or off. MYB is needed by leukaemia cells but also for normal blood cell formation. We have found that interaction between the MYB protein and a protein called p300 is more critical for growth of leukaemia cells than for normal cells. Here we aim to identify a set of MYB/p300 co-regulated genes that are needed by leukaemia cells for the continued growth or survival. Some of these genes may be targets for developing new leukaemia drugs."},"children":[{"color":"#336699","name":"Dr Brooke Gardiner","data":{"first_name":"Brooke","title":"Dr","dw_individual_id":"DW0019132","middle_name":"Bridget Ann","last_name":"Gardiner","source_individual_id":"5041737","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brooke Gardiner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81882","size":1},{"color":"#336699","name":"Prof Thomas Gonda","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0007535","middle_name":"John","last_name":"Gonda","source_individual_id":"5014863","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Thomas Gonda"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78737","size":1},{"color":"#336699","name":"Dr Evgeny Glazov","data":{"first_name":"Evgeny","title":"Dr","dw_individual_id":"DW0001814","middle_name":"A","last_name":"Glazov","source_individual_id":"5018846","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Evgeny Glazov"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77165","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72565","size":1},{"color":"#FF4D4D","name":"Targeting of the Myb-p300 Interaction in Myeloid Leukaemogenesis","data":{"media_summary":"","end_year":2014,"keywords":["acute myeloid leukaemia (AML)","oncogenes","transcription factor","drug development","peptide inhibitors"],"nhmrc_grant_id":1023175,"application_year":2011,"health_keywords":["cell transformation","mouse models"],"scientific_title":"Targeting of the Myb-p300 Interaction in Myeloid Leukaemogenesis","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Haematological Tumours","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Prof Thomas Gonda","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1023175","simplified_title":"A new approach to block the MYB cancer gene for treating leukaemia","sub_type":"Standard Project Grant","total_budget":"625980.94","source_system":"MYB is a cancer gene which turns other genes on or off. MYB is needed by leukaemia cells but also for normal blood cell formation. This project aims to show that blocking interaction between the MYB protein and another protein called p300 is a promising strategy for leukaemia treatment, as leukaemia cells are more dependent on this interaction than normal cells. New molecules to block the MYB-p300 interaction will also be designed and tested; these may form a basis for new leukaemia drugs."},"children":[{"color":"#336699","name":"A/Pr Mark Smythe","data":{"first_name":"Mark","title":"A/Pr","dw_individual_id":"DW0045518","middle_name":"Leslie","last_name":"Smythe","source_individual_id":"5023110","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Mark Smythe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88779","size":1},{"color":"#336699","name":"Prof Thomas Gonda","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0007535","middle_name":"John","last_name":"Gonda","source_individual_id":"5014863","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Thomas Gonda"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78737","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72563","size":1},{"color":"#FF4D4D","name":"Exploring DNA methylation as a mechanism for long-term memory for fear extinction","data":{"media_summary":"","end_year":2014,"keywords":["epigenetics","RNA interference","extinction","fear","memory"],"nhmrc_grant_id":1023127,"application_year":2011,"start_year":2012,"scientific_title":"Exploring DNA methylation as a mechanism for long-term memory for fear extinction","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Timothy Bredy","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1023127","simplified_title":"How does the brain inhibit fear?","sub_type":"Standard Project Grant","total_budget":"415322.14","source_system":"Traumatic experiences are well remembered. In some cases, fear-related memories become debilitating and require therapeutic intervention to diminish the impact of these kinds of memories on daily living. Such therapies engage a process of inhibitory learning called fear extinction. Since anxiety disorders are particularly sensitive to relapse even after extensive exposure therapy, a deeper understanding of the extinction process is crucial if we are to develop more effective treatment protocols for a variety of anxiety disorders."},"children":[{"color":"#336699","name":"Dr Timothy Bredy","data":{"first_name":"Timothy","title":"Dr","dw_individual_id":"DW0017892","middle_name":"William","last_name":"Bredy","source_individual_id":"5019656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Timothy Bredy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81569","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72559","size":1},{"color":"#FF4D4D","name":"A phase IIb randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis","data":{"media_summary":"","end_year":2014,"keywords":["antibiotic therapy","bacterial infection","clinical outcome","clinical trial","critical care medicine"],"nhmrc_grant_id":1022460,"application_year":2011,"health_keywords":["infectious diseases","intensive care medicine","sepsis"],"scientific_title":"A phase IIb randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Intensive Care","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Jeffrey Lipman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1022460","simplified_title":"Effectiveness of a continuous infusion intervention versus standard intermittent dosing of beta-lactam antibiotics in the treatment of severe sepsis","sub_type":"Standard Project Grant","total_budget":"947371.74","source_system":"This randomised controlled trial aims to compare, in critically-ill patients with severe sepsis managed in the intensive care unit, whether the administration of beta-lactam antibiotics via continuous infusion improves outcomes for patients compared with standard intermittent dosing. The potential significance of this step-wise research program is that it may lead to a simple and cost-effective intervention to improve ICU-free days, clinical cure and survival for patients with severe infections."},"children":[{"color":"#336699","name":"Dr Joel Dulhunty","data":{"first_name":"Joel","title":"Dr","dw_individual_id":"DW0036392","middle_name":"Marcus","last_name":"Dulhunty","source_individual_id":"5030234","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Joel Dulhunty"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86434","size":1},{"color":"#336699","name":"Prof Jason Roberts","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0033443","middle_name":"A","last_name":"Roberts","source_individual_id":"5017212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jason Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85657","size":1},{"color":"#336699","name":"Prof Jeffrey Lipman","data":{"first_name":"Jeffrey","title":"Prof","dw_individual_id":"DW0032130","middle_name":"","last_name":"Lipman","source_individual_id":"5012259","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jeffrey Lipman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85314","size":1},{"color":"#336699","name":"Prof Steve Webb","data":{"first_name":"Steve","title":"Prof","dw_individual_id":"DW0028726","middle_name":"Anthony Rochford","last_name":"Webb","source_individual_id":"5012066","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Steve Webb"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84436","size":1},{"color":"#336699","name":"Prof Charles Gomersall","data":{"first_name":"Charles","title":"Prof","dw_individual_id":"DW0025116","middle_name":"David","last_name":"Gomersall","source_individual_id":"5024318","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Charles Gomersall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83458","size":1},{"color":"#336699","name":"Dr Joshua Davis","data":{"first_name":"Joshua","title":"Dr","dw_individual_id":"DW0018579","middle_name":"Saul","last_name":"Davis","source_individual_id":"5025809","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Joshua Davis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81760","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72503","size":1},{"color":"#FF4D4D","name":"Nfib regulates glial differentiation during development and disease via repression of the key epigenetic protein, Ezh2","data":{"media_summary":"","end_year":2014,"keywords":["stem cell biology","transcription factor","glia","glioma","brain tumours"],"nhmrc_grant_id":1022308,"application_year":2011,"start_year":2012,"scientific_title":"Nfib regulates glial differentiation during development and disease via repression of the key epigenetic protein, Ezh2","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Michael Piper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1022308","simplified_title":"Nfib regulates glial differentiation via epigenetic chromatin modification","sub_type":"Standard Project Grant","total_budget":"572912.09","source_system":"Glial development is critical during development, and unrestrained proliferation of glial stem cells in the adult can lead to deadly brain cancers such as glioma. At present there is no cure for glioma and current treatments do not significantly delay tumour progression. Nfib is a transcription factor that may prevent tumour growth through cellular differentiation. We will investigate the role of Nfib during development and in the pathogenesis of glioma and its potential as a therapeutic target."},"children":[{"color":"#336699","name":"Dr Timothy Bailey","data":{"first_name":"Timothy","title":"Dr","dw_individual_id":"DW0035202","middle_name":"Lawrence","last_name":"Bailey","source_individual_id":"5040904","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Timothy Bailey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86127","size":1},{"color":"#336699","name":"Prof Andrew Boyd","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0023731","middle_name":"W","last_name":"Boyd","source_individual_id":"RMIS3609","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Andrew Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83095","size":1},{"color":"#336699","name":"Dr Michael Piper","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0021487","middle_name":"J","last_name":"Piper","source_individual_id":"RMIS3987189","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Michael Piper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82523","size":1},{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72492","size":1},{"color":"#FF4D4D","name":"Calcium signaling and epithelial-mesenchymal transition: a new approach to identifying pharmacological targets for metastasis","data":{"media_summary":"","end_year":2015,"keywords":["calcium","calcium signalling","calcium regulation","pharmacology","molecular pharmacology"],"nhmrc_grant_id":1022263,"application_year":2011,"health_keywords":["breast cancer","epithelial-mesenchymal transition (EMT)"],"scientific_title":"Calcium signaling and epithelial-mesenchymal transition: a new approach to identifying pharmacological targets for metastasis","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology and Pharmaceutical Sciences not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Gregory Monteith","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1022263","simplified_title":"Calcium signaling and the development of breast cancer metastasis","sub_type":"Standard Project Grant","total_budget":"561645.61","source_system":"The largest killer of women with breast cancer is disease that has spread e.g. to brain, bones, lungs. Once breast cancer has spread in this way to secondary sites, also known as metastatic disease, then there is limited treatment available and generally therapy is palliative only. Our work describes experiments that will help us understand the process of metastasis and provide new avenues for drug discovery in metastatic disease, thus helping women who have a poor prognosis."},"children":[{"color":"#336699","name":"Prof Erik Thompson","data":{"first_name":"Erik","title":"Prof","dw_individual_id":"DW0045830","middle_name":"W","last_name":"Thompson","source_individual_id":"5017908","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Erik Thompson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88854","size":1},{"color":"#336699","name":"Prof Gregory Monteith","data":{"first_name":"Gregory","title":"Prof","dw_individual_id":"DW0009187","middle_name":"Raymond","last_name":"Monteith","source_individual_id":"RMIS3112522","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gregory Monteith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79194","size":1},{"color":"#336699","name":"Prof Sarah Roberts-Thomson","data":{"first_name":"Sarah","title":"Prof","dw_individual_id":"DW0004272","middle_name":"Jane","last_name":"Roberts-Thomson","source_individual_id":"RMIS5900691","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Sarah Roberts-Thomson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77861","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72491","size":1},{"color":"#FF4D4D","name":"Extracellular acidification and its role in disease","data":{"media_summary":"","end_year":2014,"keywords":["cystic fibrosis","pancreatitis","acid/base balance disturbances","secretion","exocytosis"],"nhmrc_grant_id":1021764,"application_year":2011,"start_year":2012,"scientific_title":"Extracellular acidification and its role in disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Peter Thorn","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1021764","simplified_title":"Does acid play a role in disease?","sub_type":"Standard Project Grant","total_budget":"371529.1","source_system":"This proposal focuses on the diseases cystic fibrosis and acute pancreatitis for which there are currently no treatments. In both diseases the affected organs become strongly acidic. Furthermore, these acid changes can be causal in disease progression. However, the source of this acidification is remains unknown. We will identify the routes of acid secretion, the causal role of acidification in disease progression and the effectiveness of treatments aimed at restoring acid-base balance."},"children":[{"color":"#336699","name":"Prof Peter Thorn","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0016656","middle_name":"","last_name":"Thorn","source_individual_id":"5017929","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Thorn"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81226","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72459","size":1},{"color":"#FF4D4D","name":"The development of innovative Multiplexed Molecular Imaging technology targeting improved diagnostic imaging of Glioblastoma Multiforme","data":{"media_summary":"","end_year":2014,"keywords":["brain tumours","magnetic resonance imaging (MRI)","positron emission tomography (PET)","glioma","imaging"],"nhmrc_grant_id":1021759,"application_year":2011,"start_year":2012,"scientific_title":"The development of innovative Multiplexed Molecular Imaging technology targeting improved diagnostic imaging of Glioblastoma Multiforme","node_source":"NHMRC","node_type":"Grant","field_of_research":"Radiology and Organ Imaging","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Stephen Rose","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1021759","simplified_title":"Improved diagnostic imaging of primary brain tumours","sub_type":"Standard Project Grant","total_budget":"403599.97","source_system":"Glioblastoma Multiforme (GBM) is extremely invasive and the most lethal of all primary brain tumours. To optimise treatment planning, we propose to develop novel Multiplexed Molecular Imaging (MMI) technology employing the latest PET-MRI hybrid imaging technology. Our strategy targets the development of new F19 MRI MI agents for measuring tumour infiltration that can be multiplexed with F18 PET hypoxia tracers. Our MI agents can also act as conjugative vehicles for drug delivery."},"children":[{"color":"#336699","name":"Prof Andrew Whittaker","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0046253","middle_name":"Keith","last_name":"Whittaker","source_individual_id":"5028828","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Andrew Whittaker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88974","size":1},{"color":"#336699","name":"Dr Paul Thomas","data":{"first_name":"Paul","title":"Dr","dw_individual_id":"DW0040054","middle_name":"A","last_name":"Thomas","source_individual_id":"5017905","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Paul Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87378","size":1},{"color":"#336699","name":"Dr Michael Fay","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0030635","middle_name":"Francis","last_name":"Fay","source_individual_id":"5018817","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michael Fay"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84961","size":1},{"color":"#336699","name":"Prof Andrew Boyd","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0023731","middle_name":"W","last_name":"Boyd","source_individual_id":"RMIS3609","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Andrew Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83095","size":1},{"color":"#336699","name":"Prof Nicholas Fisk","data":{"first_name":"Nicholas","title":"Prof","dw_individual_id":"DW0019006","middle_name":"Maxwell","last_name":"Fisk","source_individual_id":"5014632","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nicholas Fisk"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81858","size":1},{"color":"#336699","name":"A/Pr Stephen Rose","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0009965","middle_name":"E","last_name":"Rose","source_individual_id":"5017273","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Stephen Rose"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79404","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72458","size":1},{"color":"#FF4D4D","name":"Melatonin for initial insomnia in stimulant-treated pediatric ADHD","data":{"media_summary":"","end_year":2016,"keywords":["insomnia","attention deficit hyperactivity disorder (ADHD)","melatonin","childhood","clinical trial"],"nhmrc_grant_id":1021478,"application_year":2011,"start_year":2012,"scientific_title":"Melatonin for initial insomnia in stimulant-treated pediatric ADHD","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Jane Nikles","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1021478","simplified_title":"Melatonin for initial insomnia in stimulant-treated pediatric ADHD","sub_type":"Standard Project Grant","total_budget":"613451.17","source_system":"Does melatonin work for children with ADHD and initial insomnia? We will study children with ADHD and initial insomnia using  N-of-1 trials.  This is  a trial in a single person, which  allows them the opportunity to learn if melatonin is effective for them.We will compare  the usual clinical trials  (RCTs, which do not give individual results) with combined results from all the 270 patients who have done N-of-1 trials. Data from the first part of each persons n-of-1 trial will form the RCT."},"children":[{"color":"#336699","name":"Dr Sunita Vohra","data":{"first_name":"Sunita","title":"Dr","dw_individual_id":"DW0046042","middle_name":"","last_name":"Vohra","source_individual_id":"5038949","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sunita Vohra"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88917","size":1},{"color":"#336699","name":"A/Pr Helen Heussler","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0031281","middle_name":"S","last_name":"Heussler","source_individual_id":"5015212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Helen Heussler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85096","size":1},{"color":"#336699","name":"Prof Christopher Schmid","data":{"first_name":"Christopher","title":"Prof","dw_individual_id":"DW0021978","middle_name":"Henry","last_name":"Schmid","source_individual_id":"5039353","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Christopher Schmid"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82663","size":1},{"color":"#336699","name":"Dr Jane Nikles","data":{"first_name":"Jane","title":"Dr","dw_individual_id":"DW0021162","middle_name":"","last_name":"Nikles","source_individual_id":"5023242","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jane Nikles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82422","size":1},{"color":"#336699","name":"Dr Manisha Witmans","data":{"first_name":"Manisha","title":"Dr","dw_individual_id":"DW0005500","middle_name":"Bundheo","last_name":"Witmans","source_individual_id":"5039079","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Manisha Witmans"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78197","size":1},{"color":"#336699","name":"Prof Geoffrey Mitchell","data":{"first_name":"Geoffrey","title":"Prof","dw_individual_id":"DW0003428","middle_name":"Keith","last_name":"Mitchell","source_individual_id":"5012135","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Geoffrey Mitchell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77614","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72437","size":1},{"color":"#FF4D4D","name":"Contribution of Complement C5a to Neuronal Cell Death during Ischemic Stroke","data":{"media_summary":"","end_year":2014,"keywords":["complement C5a","ischaemic stroke","therapeutic target","neuronal cell death","complement activation"],"nhmrc_grant_id":1021413,"application_year":2011,"health_keywords":["neurodegeneration"],"scientific_title":"Contribution of Complement C5a to Neuronal Cell Death during Ischemic Stroke","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology and Pharmaceutical Sciences not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"A/Pr Trent Woodruff","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1021413","simplified_title":"Immune Mediated Neuronal Cell Death Following Stroke","sub_type":"Standard Project Grant","total_budget":"455263.15","source_system":"Ischemic stroke remains the second leading cause of death in Australia. This project aims to understand the role the innate immune system plays in neuronal cell death following ischemic stroke. We will use cellular and animal models of ischemic stroke, as well as examine patients affected by stroke, to explore and inhibit potential damaging immune factors generated by stroke tissue. By exploring these immune pathways, we aim to identify novel therapeutic targets to treat ischemic stroke."},"children":[{"color":"#336699","name":"Dr Sung-Chun Tang","data":{"first_name":"Sung-Chun","title":"Dr","dw_individual_id":"DW0016565","middle_name":"","last_name":"Tang","source_individual_id":"5039243","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sung-Chun Tang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81201","size":1},{"color":"#336699","name":"A/Pr Thiruma Arumugam","data":{"first_name":"Thiruma","title":"A/Pr","dw_individual_id":"DW0011513","middle_name":"Valavan","last_name":"Arumugam","source_individual_id":"5019753","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thiruma Arumugam"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79828","size":1},{"color":"#336699","name":"A/Pr Trent Woodruff","data":{"first_name":"Trent","title":"A/Pr","dw_individual_id":"DW0011172","middle_name":"Martin","last_name":"Woodruff","source_individual_id":"5018447","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Trent Woodruff"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79741","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72432","size":1},{"color":"#FF4D4D","name":"A comprehensive genomic analysis of oesophageal adenocarcinoma: understanding the genetic aetiology of OAC towards biomarkers of progression, prognosis and targeted treatment.","data":{"media_summary":"","end_year":2014,"keywords":["oesophageal cancer","sequencing","microarray analysis","clinical trial","biomarkers"],"nhmrc_grant_id":1021403,"application_year":2011,"health_keywords":["chemotherapy treatment effects","bioinformatics"],"scientific_title":"A comprehensive genomic analysis of oesophageal adenocarcinoma: understanding the genetic aetiology of OAC towards biomarkers of progression, prognosis and targeted treatment.","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Genetics","research_area":"Clinical Medicine and Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"A/Pr Andrew Barbour","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1021403","simplified_title":"A comprehensive genomic analysis of oesophageal adenocarcinoma: understanding the genetic aetiology of OAC towards biomarkers of progression, prognosis and targeted treatment.","sub_type":"Standard Project Grant","total_budget":"987906.96","source_system":"Oesophageal cancer (OAC) continues to have poor survival despite surgery, chemotherapy and radiotherapy. Selecting patients for the most appropriate therapies and improving survival remain unmet research needs. We propose to undertake a detailed genetic study of OAC, including next generation sequencing, in order to catalogue the genetic changes in the disease. This information forms an essential basis for identifying genetic signatures of OAC progression, prognosis and treatment response."},"children":[{"color":"#336699","name":"Dr Lutz Krause","data":{"first_name":"Lutz","title":"Dr","dw_individual_id":"DW0043604","middle_name":"","last_name":"Krause","source_individual_id":"5024792","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Lutz Krause"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88305","size":1},{"color":"#336699","name":"A/Pr Andrew Barbour","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0035251","middle_name":"Paul","last_name":"Barbour","source_individual_id":"RMIS705983","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Andrew Barbour"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86137","size":1},{"color":"#336699","name":"Dr Damian Hussey","data":{"first_name":"Damian","title":"Dr","dw_individual_id":"DW0031459","middle_name":"James","last_name":"Hussey","source_individual_id":"5015391","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Damian Hussey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85144","size":1},{"color":"#336699","name":"Dr Derek Nancarrow","data":{"first_name":"Derek","title":"Dr","dw_individual_id":"DW0026955","middle_name":"J","last_name":"Nancarrow","source_individual_id":"RMIS7763","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Derek Nancarrow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83977","size":1},{"color":"#336699","name":"Prof David Watson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0022872","middle_name":"Ian","last_name":"Watson","source_individual_id":"RMIS12562","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Watson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82898","size":1},{"color":"#336699","name":"Dr Nicola Waddell","data":{"first_name":"Nicola","title":"Dr","dw_individual_id":"DW0016876","middle_name":"","last_name":"Waddell","source_individual_id":"5018126","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nicola Waddell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81290","size":1},{"color":"#336699","name":"Prof Reginald Lord","data":{"first_name":"Reginald","title":"Prof","dw_individual_id":"DW0014543","middle_name":"V N","last_name":"Lord","source_individual_id":"5016066","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Reginald Lord"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80634","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72430","size":1},{"color":"#FF4D4D","name":"A novel role for the IL-2 pathway in type-1-diabetes.","data":{"media_summary":"","end_year":2015,"keywords":["antigen presenting cells","tolerance","genetic susceptibility","diabetes mellitus","autoimmune disease"],"nhmrc_grant_id":1021324,"application_year":2011,"health_keywords":["T cell response"],"scientific_title":"A novel role for the IL-2 pathway in type-1-diabetes.","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Autoimmunity","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Emma Hamilton-Williams","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1021324","simplified_title":"A novel role for the IL-2 pathway in type-1-diabetes.","sub_type":"New Investigator Grant","total_budget":"546842.71","source_system":"Genes encoding IL-2 and its receptor are strongly linked to susceptibility to multiple autoimmune diseases, including type-1-diabetes. Despite the importance of this pathway in the immune system, it is not yet understood how the associated genes affect disease. In this study, a novel function for IL-2 expression by dendritic cells in normal self-tolerance is investigated. The impacts of dendritic cell produced IL-2 expression and linkage to autoimmunity will be elucidated in both mouse and man."},"children":[{"color":"#336699","name":"Dr Emma Hamilton-Williams","data":{"first_name":"Emma","title":"Dr","dw_individual_id":"DW0037082","middle_name":"Estelle","last_name":"Hamilton-Williams","source_individual_id":"5025386","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Emma Hamilton-Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86598","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72423","size":1},{"color":"#FF4D4D","name":"Winter-only treatment with omalizumab to prevent asthma exacerbations in children.","data":{"media_summary":"","end_year":2014,"keywords":["asthma exacerbation","allergy","clinical trial","respiratory viruses","immunoglobulin E (IgE)"],"nhmrc_grant_id":1021316,"application_year":2011,"start_year":2012,"scientific_title":"Winter-only treatment with omalizumab to prevent asthma exacerbations in children.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Prof Peter Sly","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1021316","simplified_title":"Omalizumab to prevent asthma exacerbations in children","sub_type":"Standard Project Grant","total_budget":"738855","source_system":"Acute exacerbations of asthma add considerably to the economic and social burden imposed by asthma. Current asthma treatment frequently controls underlying asthma but does not prevent acute exacerbations in exacerbation-prone asthmatics. This trial, based on our asthma research, provides new hope that acute asthma can be prevented."},"children":[{"color":"#336699","name":"Prof Peter Sly","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0028010","middle_name":"David","last_name":"Sly","source_individual_id":"5011929","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Sly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84226","size":1},{"color":"#336699","name":"Prof Patrick Holt","data":{"first_name":"Patrick","title":"Prof","dw_individual_id":"DW0019686","middle_name":"G","last_name":"Holt","source_individual_id":"5015322","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Patrick Holt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82016","size":1},{"color":"#336699","name":"Prof Mimi Tang","data":{"first_name":"Mimi","title":"Prof","dw_individual_id":"DW0004940","middle_name":"Lai-Kuan","last_name":"Tang","source_individual_id":"RMIS5862038","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mimi Tang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78037","size":1},{"color":"#336699","name":"Prof Peter Le Souef","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0002865","middle_name":"Neils","last_name":"Le Souef","source_individual_id":"RMIS170200","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Peter Le Souef"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77460","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72421","size":1},{"color":"#FF4D4D","name":"Identifying mechanisms that increase the pool of brain wiring proteins","data":{"media_summary":"","end_year":2014,"keywords":["neurogenetics","cell-cell communication","molecular mechanisms","neural development","Drosophila melanogaster"],"nhmrc_grant_id":1021006,"application_year":2011,"health_keywords":["Down syndrome"],"scientific_title":"Identifying mechanisms that increase the pool of brain wiring proteins","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr S. Sean Millard","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1021006","simplified_title":"Increasing the pool of proteins that wire the brain","sub_type":"New Investigator Grant","total_budget":"445093.15","source_system":"The computational power of the brain is driven by its interconnected nerve cells. Defects in these connections can lead to neurological disease. This proposal seeks to identify new mechanisms for generating specific connections between nerve cells and thus establishing the proper neural circuitry in a healthy brain."},"children":[{"color":"#336699","name":"Dr S. Sean Millard","data":{"first_name":"S. Sean","title":"Dr","dw_individual_id":"DW0003404","middle_name":"","last_name":"Millard","source_individual_id":"5038651","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr S. Sean Millard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77607","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72396","size":1},{"color":"#FF4D4D","name":"Reprogramming of Ataxia Telangiectasia fibroblasts to generate iPS cells","data":{"media_summary":"","end_year":2014,"keywords":["ataxia telangiectasia","genetics","neuroscience","stem cells","cell biology"],"nhmrc_grant_id":1021005,"application_year":2011,"health_keywords":["DNA damage","signal transduction"],"scientific_title":"Reprogramming of Ataxia Telangiectasia fibroblasts to generate iPS cells","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurogenetics","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1021005","simplified_title":"Generating adult stem cells for a genetic disorder","sub_type":"Standard Project Grant","total_budget":"601386.44","source_system":"Ataxia telangiectasia (A-T) is a human genetic disorder characterised by immunodeficiency, cancer predisposition and neurodegeneration. The aim of this project is to generate adult stem cells from A-T patient  as a model system to investigate the nature of the nervous system defect in this disorder. These adult stem cells will be employed to produce neuronal cells which will be a resource for screening for therapeutic compounds to treat A-T patients."},"children":[{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1},{"color":"#336699","name":"A/Pr Ernst Wolvetang","data":{"first_name":"Ernst","title":"A/Pr","dw_individual_id":"DW0017193","middle_name":"Jurgen","last_name":"Wolvetang","source_individual_id":"5020397","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ernst Wolvetang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81372","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72395","size":1},{"color":"#FF4D4D","name":"Research Fellowship","data":{"media_summary":"","end_year":2016,"keywords":["growth hormone","receptor signalling","stem cells","cancer therapy","cancer biology"],"nhmrc_grant_id":1020317,"application_year":2011,"health_keywords":["longevity"],"scientific_title":"Research Fellowship","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Receptors and Membrane Biology","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Michael Waters","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1020317","simplified_title":"Research Fellowship","sub_type":"Research Fellowship","total_budget":"828406.98","source_system":"I study hormone action at the molecular level, particularly that of growth hormone action. I focus on the mechanism of activation of its receptor, notably as a target for cancer therapy, since growth hormone is necessary for the progression of many types of cancer. The ability of growth hormone to activate neural stem cells for a prolonged period in response to voluntary exercise is also a key interest. So too is the 40% extension of lifespan in mice after genetically deleting the growth hormone receptor."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72330","size":1},{"color":"#FF4D4D","name":"Practitioner Fellowship","data":{"media_summary":"","end_year":2016,"keywords":["dermatology","telemedicine","melanoma","squamous cell carcinoma","confocal scanning laser microscopy"],"nhmrc_grant_id":1020148,"application_year":2011,"start_year":2012,"scientific_title":"Practitioner Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dermatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof H. Peter Soyer","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1020148","simplified_title":"Practitioner Fellowship","sub_type":"Practitioner Fellowship","total_budget":"545828.78","source_system":"The University of Queensland Dermatology Research Centre are committed to conducting and promoting high quality clinical research into skin disease, particularly skin cancer, aimed at improved patient outcomes. Telemedicine and cutting edge imaging technologies are employed with a view towards their implementation into clinical practise to potentially overcome geographical inadequacies of health care in Qld. We expect the research will impact on Australian policies and guidelines in the field of telemedicine and skin cancer management."},"children":[{"color":"#336699","name":"Prof H. Peter Soyer","data":{"first_name":"H. Peter","title":"Prof","dw_individual_id":"DW0028088","middle_name":"","last_name":"Soyer","source_individual_id":"5019889","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof H. Peter Soyer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84249","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72318","size":1},{"color":"#FF4D4D","name":"An open-label randomised pragmatic policy trial of nicotine products for short-term cessation assistance or long-term substitution in smokers.","data":{"media_summary":"","end_year":2015,"keywords":["cigarette smoking","harm reduction","nicotine replacement therapy","smoking cessation","tobacco control"],"nhmrc_grant_id":1020123,"application_year":2011,"health_keywords":["smoking intervention","tobacco use","nicotine dependence"],"scientific_title":"An open-label randomised pragmatic policy trial of nicotine products for short-term cessation assistance or long-term substitution in smokers.","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Preventive Medicine","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Coral Gartner","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1020123","simplified_title":"Can using nicotine as a long-term substitute enhance smoking cessation over using it only as a cessation aid?","sub_type":"Standard Project Grant","total_budget":"1053140.94","source_system":"Many smokers who try to quit fail in their attempt. Medicinal nicotine is currently only used as a short-term quit aid. This trial will test if offering smokers the option of using these products as long-term substitutes for cigarettes will help more smokers to successfully quit. We will also determine if offering smokers low toxicity smokeless tobacco and electronic nicotine devices in addition to medicinal nicotine products further increases the number of smokers who quit successfully."},"children":[{"color":"#336699","name":"Prof Ron Borland","data":{"first_name":"Ron","title":"Prof","dw_individual_id":"DW0011902","middle_name":"","last_name":"Borland","source_individual_id":"RMIS999210","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ron Borland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79927","size":1},{"color":"#336699","name":"Dr Coral Gartner","data":{"first_name":"Coral","title":"Dr","dw_individual_id":"DW0007430","middle_name":"E","last_name":"Gartner","source_individual_id":"5014768","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Coral Gartner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78707","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72316","size":1},{"color":"#FF4D4D","name":"Research Fellowship","data":{"media_summary":"therapeutics","end_year":2016,"keywords":["ataxia telangiectasia","genetics","neuroscience","signal transduction","cell biology"],"nhmrc_grant_id":1020028,"application_year":2011,"health_keywords":["stem cells","DNA damage","prostate cancer","venom","therapeutics"],"scientific_title":"Research Fellowship","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1020028","simplified_title":"Research Fellowship","sub_type":"Research Fellowship","total_budget":"903406.98","source_system":"The overall goal of the program is to develop novel approaches to slow the progress or prevent neurodegeneration in patients with rare human genetic disorders. The second program is designed to develop novel therapeutics from snake venom proteins.  These include proteins with anti-bleeding activity and those with application in wound healing. The third program involves the development of novel biomarkers for the early detection and prognosis in prostate cancer."},"children":[{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72309","size":1},{"color":"#FF4D4D","name":"Role of oxidative stress in activating ATM to protect against neurodegeneration","data":{"media_summary":"","end_year":2014,"keywords":["ataxia telangiectasia","phosphorylation","DNA damage","signal transduction","oxidative stress"],"nhmrc_grant_id":1019996,"application_year":2011,"health_keywords":["genetics","neuronal degeneration"],"scientific_title":"Role of oxidative stress in activating ATM to protect against neurodegeneration","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1019996","simplified_title":"Role of oxidative stress in the human genetic disorder ataxia telangiectasia","sub_type":"Standard Project Grant","total_budget":"570334.32","source_system":"ATM is the protein defective in the human genetic disorder ataxia-telangiectasia (A-T). This project is designed to investigate how this protein is activated by oxidative stress. The study is largely a mechanistic one, to investigate changes occurring in ATM as part of the activation process. There is evidence that ATM exists in the cytoplasm in neuronal cells and understanding its function in these cells may assist in understanding the basis for neurodegeneration in A-T."},"children":[{"color":"#336699","name":"Dr Sergei Kozlov","data":{"first_name":"Sergei","title":"Dr","dw_individual_id":"DW0031855","middle_name":"","last_name":"Kozlov","source_individual_id":"5015768","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sergei Kozlov"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85243","size":1},{"color":"#336699","name":"Dr Mark Graham","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0030979","middle_name":"Evan","last_name":"Graham","source_individual_id":"5014904","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mark Graham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85030","size":1},{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72308","size":1},{"color":"#FF4D4D","name":"A multi-centre, double-blind, randomised controlled trial to evaluate the efficacy of 10 valent-pneumococcal-Protein D conjugate vaccine in reducing respiratory exacerbations in children aged _ 18 months with suppurative lung disease","data":{"media_summary":"","end_year":2014,"keywords":["Haemophilus influenzae","paediatric","chronic suppurative lung disorders","vaccine efficacy","immune protection"],"nhmrc_grant_id":1019904,"application_year":2011,"start_year":2012,"scientific_title":"A multi-centre, double-blind, randomised controlled trial to evaluate the efficacy of 10 valent-pneumococcal-Protein D conjugate vaccine in reducing respiratory exacerbations in children aged _ 18 months with suppurative lung disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Clinical Medicine and Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"Dr Kerry-Ann O'Grady","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1019904","simplified_title":"Reducing respiratory exacerbations in children with suppurative lung disease by vaccination against Haemophilus influenzae","sub_type":"Standard Project Grant","total_budget":"1160660.35","source_system":"Chronic suppurative (ie infected) lung diseases in children are major causes of poor health and deaths worldwide. Repeated childhood infections contribute to poor lung health in adults. The most common organism causing infection is non-typeable Haemophilus influenzae (NTHi). This study aims to determine whether a vaccine against NTHi can reduce repeated respiratory infections in children. If so, vaccination may lead to substantial improvements in current/ future lung health, and considerable direct and indirect cost of disease savings."},"children":[{"color":"#336699","name":"Ms Amber Revell","data":{"first_name":"Amber","title":"Ms","dw_individual_id":"DW0045055","middle_name":"","last_name":"Revell","source_individual_id":"5039235","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Amber Revell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88665","size":1},{"color":"#336699","name":"Prof Paul Torzillo","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0040107","middle_name":"John","last_name":"Torzillo","source_individual_id":"5012586","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Torzillo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87388","size":1},{"color":"#336699","name":"Prof Keith Grimwood","data":{"first_name":"Keith","title":"Prof","dw_individual_id":"DW0036997","middle_name":"","last_name":"Grimwood","source_individual_id":"RMIS3130585","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Keith Grimwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86576","size":1},{"color":"#336699","name":"Dr Kerry-Ann O'Grady","data":{"first_name":"Kerry-Ann","title":"Dr","dw_individual_id":"DW0032957","middle_name":"F","last_name":"O'Grady","source_individual_id":"5016768","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kerry-Ann O'Grady"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85541","size":1},{"color":"#336699","name":"Prof Edward Mulholland","data":{"first_name":"Edward","title":"Prof","dw_individual_id":"DW0032730","middle_name":"Kim","last_name":"Mulholland","source_individual_id":"5012030","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Edward Mulholland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85478","size":1},{"color":"#336699","name":"Prof Anne Chang","data":{"first_name":"Anne","title":"Prof","dw_individual_id":"DW0018172","middle_name":"Bernadette","last_name":"Chang","source_individual_id":"5011865","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Anne Chang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81651","size":1},{"color":"#336699","name":"Dr Heidi Smith-Vaughan","data":{"first_name":"Heidi","title":"Dr","dw_individual_id":"DW0016317","middle_name":"C","last_name":"Smith-Vaughan","source_individual_id":"5017589","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Heidi Smith-Vaughan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81130","size":1},{"color":"#336699","name":"Prof Allan Cripps","data":{"first_name":"Allan","title":"Prof","dw_individual_id":"DW0012543","middle_name":"William","last_name":"Cripps","source_individual_id":"5014137","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Allan Cripps"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80094","size":1},{"color":"#336699","name":"Dr Nicholas Wood","data":{"first_name":"Nicholas","title":"Dr","dw_individual_id":"DW0011160","middle_name":"James","last_name":"Wood","source_individual_id":"RMIS3799821","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Nicholas Wood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79735","size":1},{"color":"#336699","name":"Prof Peter Morris","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0003494","middle_name":"S","last_name":"Morris","source_individual_id":"RMIS5912132","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Peter Morris"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77636","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72301","size":1},{"color":"#FF4D4D","name":"Practitioner Fellowship","data":{"media_summary":"","end_year":2017,"keywords":["lung cancer","chronic obstructive pulmonary disease (COPD)","computed tomography","screening","risk prediction"],"nhmrc_grant_id":1019891,"application_year":2011,"start_year":2012,"scientific_title":"Practitioner Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Prof Kwun Fong","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1019891","simplified_title":"Practitioner Fellowship","sub_type":"Practitioner Fellowship","total_budget":"455282.51","source_system":"This Practitioner Fellowship will aim to improve outcomes in people with lung cancer.    The clinical studies will focus on:  1. Using low dose CT scans to detect lung cancer at a very early stage.  2. Molecular tests to diagnose lung cancer earlier, and provide information that will be useful for deciding treatment  3. Using advanced techniques to diagnose small opacities in the lung"},"children":[{"color":"#336699","name":"Prof Kwun Fong","data":{"first_name":"Kwun","title":"Prof","dw_individual_id":"DW0007308","middle_name":"M","last_name":"Fong","source_individual_id":"5011833","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Kwun Fong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78670","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72300","size":1},{"color":"#FF4D4D","name":"Research Fellowship","data":{"media_summary":"","end_year":2016,"keywords":["adrenoceptors","allodynia","pain","peptides","transporters"],"nhmrc_grant_id":1019761,"application_year":2011,"health_keywords":["channelopathy","calcium channels","sodium channel","nicotinic receptors"],"scientific_title":"Research Fellowship","start_year":2012,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Richard Lewis","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1019761","simplified_title":"Research Fellowship","sub_type":"Research Fellowship","total_budget":"732456.39","source_system":"Professor Lewis is a molecular pharmacologist interested in discovering new venom peptides and ciguatoxins and determining how they interact with the membrane proteins they target using advanced biochemical and spectroscopic methods. Peptides of interest are then modified to improve potency and selectivity. Those with appropriate properties are patented and developed for clinical applications using approaches successfully applied to Xen2174, a conopeptide analogue I co-discovered that is now in Phase II clinical trials for severe pain."},"children":[{"color":"#336699","name":"Prof Richard Lewis","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0014455","middle_name":"J","last_name":"Lewis","source_individual_id":"5015973","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Lewis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80612","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72292","size":1},{"color":"#FF4D4D","name":"NHMRC Standard Equipment Grant _ 2010","data":{"media_summary":"","end_year":2011,"nhmrc_grant_id":9000029,"application_year":2010,"start_year":2010,"scientific_title":"NHMRC Standard Equipment Grant _ 2010","node_source":"NHMRC","node_type":"Grant","field_of_research":"n-a","research_area":"Not Applicable","for_category":"N-A","cia_name":"Ms Janine  Richards","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/9000029","simplified_title":"NHMRC Standard Equipment Grant _ 2010","sub_type":"Equipment Grant","total_budget":"792983","source_system":""},"children":[{"color":"#336699","name":"Ms Janine  Richards","data":{"first_name":"Janine ","title":"Ms","dw_individual_id":"DW0039316","middle_name":"D","last_name":"Richards","source_individual_id":"RMIS6469880","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Janine  Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87190","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72236","size":1},{"color":"#FF4D4D","name":"Relationship between Oral Motor Skills, Gross Motor Attainment and Nutrition in Preschool Children with Cerebral Palsy","data":{"media_summary":"","end_year":2014,"keywords":["cerebral palsy","paediatric","feeding and nutrition","growth failure","motor function"],"nhmrc_grant_id":1018264,"application_year":2010,"health_keywords":["cerebral palsy","dysphagia","nutritional status","feeding and nutrition"],"scientific_title":"Relationship between Oral Motor Skills, Gross Motor Attainment and Nutrition in Preschool Children with Cerebral Palsy","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy (excl. Physiotherapy)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Ms Katherine Benfer","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1018264","simplified_title":"Oral Motor and Feeding Skills, Gross Motor Function and Nutrition in Preschool Children with Cerebral Palsy","sub_type":"Medical Postgraduate Scholarship","total_budget":"99074.02","source_system":"Cerebral Palsy (CP) is the most common cause of physical disability in childhood, present in approximately 2/1000 live births. Just as movement of the larger muscles may be altered, the brain lesion can also affect the oral muscles associated with eating. This study will explore oral motor and feeding skills in a population-based sample of children with CP at two ages, 18-24 and 30-36 months (corrected ages) and relationships with gross motor skills (movement and posture) and nutrition."},"children":[{"color":"#336699","name":"Ms Katherine Benfer","data":{"first_name":"Katherine","title":"Ms","dw_individual_id":"DW0029404","middle_name":"Adele","last_name":"Benfer","source_individual_id":"5029771","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Katherine Benfer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84625","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72197","size":1},{"color":"#FF4D4D","name":"Identification of key enzymes required for efficient post-translational modification and multimerisation of adiponectin","data":{"media_summary":"","end_year":2014,"keywords":["obesity","diabetes prevention","diabetes","cardiovascular disease","metabolic syndrome"],"nhmrc_grant_id":1017781,"application_year":2010,"health_keywords":["diabetes prevention","cardiovascular disease prevention","metabolic syndrome"],"scientific_title":"Identification of key enzymes required for efficient post-translational modification and multimerisation of adiponectin","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Metabolism","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Ms Julie Webster","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1017781","simplified_title":"Investigation into a key hormone involved in obesity related diabetes","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"92364.03","source_system":"Obesity is a major national and global health issue, with 62% of adult Australians being overweight/obese, associated with a number of diseases such as type 2 diabetes and cardiovascular disease. Fat tissue secretes hormones and dysregulation of these hormones contributes to the development of obesity-associated disease. This project aims to define processes governing the secretion of one key hormone and ultimately to identify targets for the treatment of obesity-associated complications."},"children":[{"color":"#336699","name":"Ms Julie Webster","data":{"first_name":"Julie","title":"Ms","dw_individual_id":"DW0028733","middle_name":"Ann","last_name":"Webster","source_individual_id":"5028405","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Julie Webster"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84438","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/72141","size":1},{"color":"#FF4D4D","name":"GENETIC AND FUNCTIONAL CHARACTERISATION OF ERAP1 VARIANTS ASSOCIATED WITH ANKYLOSING SPONDYLITIS.","data":{"media_summary":"","end_year":2014,"keywords":["arthritis","sequencing","functional genomics","genetics"],"nhmrc_grant_id":1017662,"application_year":2010,"health_keywords":["arthritis","uveitis","genetics"],"scientific_title":"GENETIC AND FUNCTIONAL CHARACTERISATION OF ERAP1 VARIANTS ASSOCIATED WITH ANKYLOSING SPONDYLITIS.","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression (incl. Microarray and other genome-wide approaches)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Philip Robinson","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1017662","simplified_title":"Assessment of genetic variants associated with Ankylosing Spondylitis","sub_type":"Medical Postgraduate Scholarship","total_budget":"133351.81","source_system":"Ankylosing Spondylitis is a progressive arthritis which affects the back and causes the back joints to fuse. The project seeks to investigate the role of the ERAP1 protein and the gene which is the blueprint for the ERAP1 protein in causing Ankylosing Spondylitis. This will be through resequencing the gene, investigating the action of the different ERAP1 proteins and the effect of ERAP1 deficiency in mice."},"children":[{"color":"#336699","name":"Dr Philip Robinson","data":{"first_name":"Philip","title":"Dr","dw_individual_id":"DW0015923","middle_name":"Cameron","last_name":"Robinson","source_individual_id":"5028241","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Philip Robinson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81014","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/67087","size":1},{"color":"#FF4D4D","name":"Genomic adaptation of Pseudomonas aeruginosa in the cystic fibrosis airway","data":{"media_summary":"phenotype-genotype correlation","end_year":2014,"keywords":["cystic fibrosis","Pseudomonas aeruginosa infection","antibiotic resistance","bioinformatics","phenotype-genotype correlation"],"nhmrc_grant_id":1017517,"application_year":2010,"health_keywords":["cystic fibrosis","Pseudomonas aeruginosa infection","antibiotic resistance","bioinformatics","phenotype-genotype correlation"],"scientific_title":"Genomic adaptation of Pseudomonas aeruginosa in the cystic fibrosis airway","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Dr Sze Tai","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1017517","simplified_title":"Genomic adaptation of Pseudomonas aeruginosa in the cystic fibrosis airway","sub_type":"Medical Postgraduate Scholarship","total_budget":"133351.09","source_system":"Pseudomonas aeruginosa (Pa) is an important respiratory pathogen in Cystic Fibrosis (CF) which causes substantial morbidity and mortality. Its genetic versatility enables it to thrive in a wide diversity of environment.  This study aims to assess the genomic adaptation of the common Pa strains among the Australian CF patients during chronic infection and during intravenous antibiotics therapy. The study results can lead to development of novel treatment options for Pa infection in CF."},"children":[{"color":"#336699","name":"Dr Sze Tai","data":{"first_name":"Sze","title":"Dr","dw_individual_id":"DW0039978","middle_name":"Anna","last_name":"Tai","source_individual_id":"5028839","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sze Tai"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87358","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/67071","size":1},{"color":"#FF4D4D","name":"Development of an in vitro immunodiagnostic test for serum IgE specific to the major pollen allergen, Pas n 1, of the subtropical Bahia grass","data":{"media_summary":"","end_year":2014,"keywords":["allergy testing","antibody","allergen","diagnosis","asthma prevalence"],"nhmrc_grant_id":1017441,"application_year":2010,"health_keywords":["allergy","allergic rhinitis","asthma"],"scientific_title":"Development of an in vitro immunodiagnostic test for serum IgE specific to the major pollen allergen, Pas n 1, of the subtropical Bahia grass","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Allergy","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Dr Janet Davies","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1017441","simplified_title":"Development of an allergen-specific blood test for Bahia grass pollen allergy","sub_type":"Development Grant","total_budget":"349435.21","source_system":"Treatment of grass pollen allergy by immunotherapy reduces the risk of asthma but most reagents for diagnosis and treatment are based on cool climate grasses. We will develop a more specific diagnostic blood test for people with hay fever and allergic asthma triggered by subtropical Bahia grass pollen. This test based on the major allergen of Bahia grass pollen, Pas n 1, will help people who need improved accuracy of diagnosis and more effective treatment outcomes for hay fever and allergic asthma."},"children":[{"color":"#336699","name":"Prof John Upham","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0045963","middle_name":"W","last_name":"Upham","source_individual_id":"5018030","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Upham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88900","size":1},{"color":"#336699","name":"Dr Janet Davies","data":{"first_name":"Janet","title":"Dr","dw_individual_id":"DW0018566","middle_name":"Mary","last_name":"Davies","source_individual_id":"5027738","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Janet Davies"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81756","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/67063","size":1},{"color":"#FF4D4D","name":"The development of store operated calcium channel monoclonal antibody inhibitors as a therapeutic option for breast cancer treatment","data":{"media_summary":"","end_year":2013,"keywords":["calcium channels","breast cancer","antibody cancer therapy","screening","monoclonal antibody"],"nhmrc_grant_id":1017311,"application_year":2010,"health_keywords":["cancer immunotherapy","breast cancer","monoclonal antibody"],"scientific_title":"The development of store operated calcium channel monoclonal antibody inhibitors as a therapeutic option for breast cancer treatment","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology and Pharmaceutical Sciences not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Gregory Monteith","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1017311","simplified_title":"Antibody inhibitors against a calcium channel as a treatment for breast cancer","sub_type":"Development Grant","total_budget":"230753.75","source_system":"Despite recent advances in the treatment of breast cancer, a significant proportion of women with this disease receive little benefit from currently available treatments and die from breast cancer. Hence, new therapies for the breast cancers with the poorest prognosis are needed. This grant exploits our earlier finding that a specific calcium channel is a likely therapeutic target for breast cancer. Funding from this grant will be used to develop an inhibitory monoclonal antibody to this target."},"children":[{"color":"#336699","name":"Prof Ross Barnard","data":{"first_name":"Ross","title":"Prof","dw_individual_id":"DW0011623","middle_name":"Thomas","last_name":"Barnard","source_individual_id":"5011324","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ross Barnard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79855","size":1},{"color":"#336699","name":"Prof Gregory Monteith","data":{"first_name":"Gregory","title":"Prof","dw_individual_id":"DW0009187","middle_name":"Raymond","last_name":"Monteith","source_individual_id":"RMIS3112522","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gregory Monteith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79194","size":1},{"color":"#336699","name":"Prof Sarah Roberts-Thomson","data":{"first_name":"Sarah","title":"Prof","dw_individual_id":"DW0004272","middle_name":"Jane","last_name":"Roberts-Thomson","source_individual_id":"RMIS5900691","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Sarah Roberts-Thomson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77861","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/67049","size":1},{"color":"#FF4D4D","name":"Therapeutic development of a novel EphA4 antagonist for spinal cord injuries","data":{"media_summary":"","end_year":2014,"keywords":["neuronal repair","neuronal regeneration","spinal cord damage","spinal cord injury management","spinal cord injury"],"nhmrc_grant_id":1017308,"application_year":2010,"health_keywords":["spinal cord injury management","spinal cord injury","neuronal regeneration","neuronal repair"],"scientific_title":"Therapeutic development of a novel EphA4 antagonist for spinal cord injuries","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Perry Bartlett","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1017308","simplified_title":"Therapeutic development of a novel drug for spinal cord injuries","sub_type":"Development Grant","total_budget":"687105.65","source_system":"Spinal cord injuries impose a significant burden on patients and their carers. At present, there are no treatments for spinal cord injury that provide functional improvement. This research program will develop a novel therapeutic molecule, EphA4-Fc, which promotes axonal regeneration and delivers significant functional improvement. We will determine the most effective protocol for EphA4-Fc administration and the physiological and functional outcomes of these treatment regimes."},"children":[{"color":"#336699","name":"Prof Andrew Boyd","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0023731","middle_name":"W","last_name":"Boyd","source_individual_id":"RMIS3609","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Andrew Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83095","size":1},{"color":"#336699","name":"Prof Perry Bartlett","data":{"first_name":"Perry","title":"Prof","dw_individual_id":"DW0011651","middle_name":"Francis","last_name":"Bartlett","source_individual_id":"5013357","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Perry Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79864","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/67048","size":1},{"color":"#FF4D4D","name":"Maternal Lipids in Pregnancy","data":{"media_summary":"","end_year":2015,"keywords":["pregnancy complications","lipid metabolism","obesity","diabetes"],"nhmrc_grant_id":1017172,"application_year":2010,"health_keywords":["pregnancy complications","lipid metabolism","obesity","diabetes"],"scientific_title":"Maternal Lipids in Pregnancy","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Dr Helen Barrett","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/1017172","simplified_title":"Maternal Lipids in Pregnancy","sub_type":"Medical Postgraduate Scholarship","total_budget":"115112.72","source_system":"There is a link between maternal lipids and newborn weight as well as other adverse pregnancy outcomes. Maternal lipids _ serum level, dietary intake and change in maternal lipids during pregnancy may be important in determining not only immediate pregnancy and newborn outcomes but also longer term problems for mother and child. As yet, we do not know whether altering maternal lipids will change outcomes or how to influence lipid levels in practice or how best to approach this."},"children":[{"color":"#336699","name":"Dr Helen Barrett","data":{"first_name":"Helen","title":"Dr","dw_individual_id":"DW0023507","middle_name":"Lorraine","last_name":"Barrett","source_individual_id":"5027913","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Helen Barrett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83043","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/67032","size":1},{"color":"#FF4D4D","name":"Public attitudes towards using pharmaceuticals for neuroenhancement.","data":{"media_summary":"","end_year":2014,"keywords":["addiction","bioethics","qualitative research","public health policy"],"nhmrc_grant_id":1013528,"application_year":2010,"health_keywords":["addiction","public health policy","pharmaceutical treatment","ethical guidelines"],"scientific_title":"Public attitudes towards using pharmaceuticals for neuroenhancement.","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Bradley Partridge","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1013528","simplified_title":"Smart drugs: What do members of the public think about using prescription drugs to improve cognitive performance?","sub_type":"Public Health (Australia) ECF","total_budget":"343888.31","source_system":"Neuroenhancement is the use of pharmaceuticals and other substances by healthy people to improve their normal cognitive abilities - for example by improving their attention span, memory or mood.  By conducting in-depth interviews with community members this project will explore understandings of, and attitudes towards, neuroenhancement among Australian adults.   This information is essential to inform policies, and medical practice, in the use of pharmaceuticals for neuroenhancement purposes."},"children":[{"color":"#336699","name":"Dr Bradley Partridge","data":{"first_name":"Bradley","title":"Dr","dw_individual_id":"DW0038984","middle_name":"John","last_name":"Partridge","source_individual_id":"5023572","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Bradley Partridge"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87097","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66922","size":1},{"color":"#FF4D4D","name":"Mechanisms of rapid memory CD8+ T-cell inactivation","data":{"media_summary":"","end_year":2013,"keywords":["tolerance","T cells","T cell memory","antigen presenting cells"],"nhmrc_grant_id":1013066,"application_year":2010,"health_keywords":["tolerance","autoimmunity","immunotherapy"],"scientific_title":"Mechanisms of rapid memory CD8+ T-cell inactivation","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"A/Pr Raymond Steptoe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1013066","simplified_title":"Optimising reversal of pathogenic CD8+ T-cell responses","sub_type":"Standard Project Grant","total_budget":"318517.71","source_system":"Type 1 diabetes (T1D) and other autoimmune diseases results from misdirected immune responses that destroy normal body tissues. The ultimate goal of therapeutic strategies is to remove or inactivate the immune cells that attack normal tissues, while leaving other immune cells, for example, those required for protection from infectious diseases and tumours, unaffected.  Here we propose to test a new way of turning off inappropriate immune reactions."},"children":[{"color":"#336699","name":"A/Pr Raymond Steptoe","data":{"first_name":"Raymond","title":"A/Pr","dw_individual_id":"DW0028164","middle_name":"J","last_name":"Steptoe","source_individual_id":"5017706","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Raymond Steptoe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84270","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66894","size":1},{"color":"#FF4D4D","name":"Determining the bacterial contributions to tuberculosis and identification of drug targets","data":{"media_summary":"","end_year":2014,"keywords":["tuberculosis","bacterial pathogenesis","bacterial genetics","virulence factors","drug discovery"],"nhmrc_grant_id":1012865,"application_year":2010,"health_keywords":["tuberculosis","chronic infection","respiratory diseases","drug development"],"scientific_title":"Determining the bacterial contributions to tuberculosis and identification of drug targets","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Nicholas West","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1012865","simplified_title":"Tuberculosis: genes to drugs","sub_type":"RD Wright Biomedical CDF","total_budget":"443946.44","source_system":"Serious issues of drug resistance have emerged in tuberculosis prevention and are placing enormous pressure on global health systems. We have identified an enzyme of M. tuberculosis that is essential for its survival. This project will develop potent inhibitory compounds for this enzyme. Further, we will identify new drug targets through a screen to specifically identify the genes of the organism essential for its survival in the body. This information will be used to develop new TB drugs."},"children":[{"color":"#336699","name":"Dr Nicholas West","data":{"first_name":"Nicholas","title":"Dr","dw_individual_id":"DW0028762","middle_name":"P","last_name":"West","source_individual_id":"5018276","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nicholas West"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84448","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66885","size":1},{"color":"#FF4D4D","name":"Genes, biology and environment in the development of substance use and mental health disorders","data":{"media_summary":"","end_year":2015,"keywords":["mental health","alcohol use disorders","longitudinal cohort study"],"nhmrc_grant_id":1012485,"application_year":2010,"health_keywords":["mental health","alcohol use disorders","genetic epidemiology"],"scientific_title":"Genes, biology and environment in the development of substance use and mental health disorders","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Rosa Alati","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1012485","simplified_title":"Genes, biology and environment in the development of substance use and mental health disorders","sub_type":"Population Health CDF","total_budget":"474867.46","source_system":"Substance use and mental health disorders are major public health problems which cause long-term disabilities, poor health and early mortality. Addressing these problems requires a better understanding of the genetic, biological and environmental factors leading to these disorders. This research program represents a unique opportunity to increase our knowledge  of the origins and mechanisms behind these disorders and significantly contribute to improved substance use and mental health prevention policies and programs."},"children":[{"color":"#336699","name":"A/Pr Rosa Alati","data":{"first_name":"Rosa","title":"A/Pr","dw_individual_id":"DW0005759","middle_name":"","last_name":"Alati","source_individual_id":"RMIS2639340","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Rosa Alati"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78272","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66864","size":1},{"color":"#FF4D4D","name":"Development of potent and selective blockers of acid sensing ion channels for the treatment of pain","data":{"media_summary":"ischaemic injury","end_year":2013,"keywords":["pain management","ion channels","drug design","drug development","chronic pain"],"nhmrc_grant_id":1012338,"application_year":2010,"health_keywords":["pain management","chronic pain","chronic back pain","chronic inflammatory disease","ischaemic injury"],"scientific_title":"Development of potent and selective blockers of acid sensing ion channels for the treatment of pain","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biologically Active Molecules","research_area":"Clinical Medicine and Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof Glenn King","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1012338","simplified_title":"Development of new analgesics for the treatment of chronic pain","sub_type":"Standard Project Grant","total_budget":"578704.76","source_system":"More than three million Australians suffer from chronic pain, and there are few effective drugs available for treating this condition. A 2007 Access Economics Report estimated the economic burden of chronic pain in Australia at $34.3 billion. Acid-sensing ion channels (ASICs) are a recently discovered family of proteins that play a key role in sensing pain. The goal of this project is to develop potent blockers of these channels that can be used to treat patients suffering from persistent pain."},"children":[{"color":"#336699","name":"Prof Paul Alewood","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0035049","middle_name":"F","last_name":"Alewood","source_individual_id":"5013158","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Alewood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86082","size":1},{"color":"#336699","name":"Prof Alan Mark","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0032333","middle_name":"Edward","last_name":"Mark","source_individual_id":"5016199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alan Mark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85371","size":1},{"color":"#336699","name":"Dr Lachlan Rash","data":{"first_name":"Lachlan","title":"Dr","dw_individual_id":"DW0027509","middle_name":"D","last_name":"Rash","source_individual_id":"RMIS1373336","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Lachlan Rash"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84101","size":1},{"color":"#336699","name":"Prof Matthew Cooper","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0024249","middle_name":"A","last_name":"Cooper","source_individual_id":"5018347","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83230","size":1},{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66849","size":1},{"color":"#FF4D4D","name":"Investigation of the effect of prism therapy on attention dysfunction in right-parietal lobe damaged stroke patients with spatial neglect.","data":{"media_summary":"","end_year":2015,"keywords":["attention deficits","spatial neglect","functional magnetic resonance imaging (fMRI)","transcranial magnetic stimulation (TMS)"],"nhmrc_grant_id":1012153,"application_year":2010,"health_keywords":["spatial neglect","stroke","attention deficits"],"scientific_title":"Investigation of the effect of prism therapy on attention dysfunction in right-parietal lobe damaged stroke patients with spatial neglect.","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Processes, Perception and Performance","research_area":"Basic Science","for_category":"PSYCHOLOGY","cia_name":"Dr Martin Sale","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1012153","simplified_title":"Rewiring brains to improve attention dysfunction following stroke.","sub_type":"Peter Doherty Biomedical ECF","total_budget":"343888.31","source_system":"A strong predictor of a bad outcome after stroke is spatial neglect. This condition is due to a deficit in attention. With attention shifted towards the undamaged side, the victim ignores their damaged side. A new therapy improves neglect, yet little is known about how brain circuits are altered with therapy. We will identify brain areas critical in restoring normal attention, and will investigate for the first time whether repeated therapy sessions improve treatment effectiveness."},"children":[{"color":"#336699","name":"Dr Martin Sale","data":{"first_name":"Martin","title":"Dr","dw_individual_id":"DW0033591","middle_name":"Victor","last_name":"Sale","source_individual_id":"RMIS3390079","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Martin Sale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85697","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66835","size":1},{"color":"#FF4D4D","name":"Escherichia coli ST131: an emerging pathogen","data":{"media_summary":"","end_year":2013,"keywords":["Escherichia coli","bacterial pathogenesis","urinary tract infection (UTI)","bacterial biofilm"],"nhmrc_grant_id":1012076,"application_year":2010,"health_keywords":["infectious diseases","bacterial pathogenesis","urinary tract infection (UTI)"],"scientific_title":"Escherichia coli ST131: an emerging pathogen","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Mark Schembri","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1012076","simplified_title":"E. coli ST131: an emerging pathogen","sub_type":"Standard Project Grant","total_budget":"574171.69","source_system":"Uropathogenic Escherichia coli (UPEC) are a major cause of urinary tract infections (UTI) and sepsis. Recently, a highly virulent clone of UPEC (E. coli ST131) that is resistant to multiple types of antibiotics has emerged worldwide. This project addresses the mechanisms by which E. coli ST131 can colonise the urinary tract and cause disease. The outcomes of this project will be a better understanding of how E. coli ST131 causes disease, and potentially new treatment regimes for UTI."},"children":[{"color":"#336699","name":"Dr Scott Beatson","data":{"first_name":"Scott","title":"Dr","dw_individual_id":"DW0035306","middle_name":"A","last_name":"Beatson","source_individual_id":"5013405","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Scott Beatson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86151","size":1},{"color":"#336699","name":"Prof Mark Schembri","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0016088","middle_name":"A","last_name":"Schembri","source_individual_id":"5017368","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Schembri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81054","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66832","size":1},{"color":"#FF4D4D","name":"The physiology of Brown Adipose Tissue in Adult Humans","data":{"media_summary":"cardiovascular disease prevention","end_year":2014,"keywords":["obesity","diabetes mellitus","energy metabolism","fat metabolism"],"nhmrc_grant_id":1011531,"application_year":2010,"health_keywords":["obesity","metabolism","energy expenditure","diabetes prevention","cardiovascular disease prevention"],"scientific_title":"The physiology of Brown Adipose Tissue in Adult Humans","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Ken Ho","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1011531","simplified_title":"Brown Fat in Adult Humans","sub_type":"Standard Project Grant","total_budget":"620026.47","source_system":"Brown fat, unlike ordinary fat generates heat by burning calories to maintain body temperature.  Originally thought to disappear after birth, recent research including our own have shown that brown fat exists in adult humans in varying amounts.  Our aim is to find ways of turning on peoples brown fat allowing them to lose weight by burning more calories."},"children":[{"color":"#336699","name":"Dr Jing Ting Zhao","data":{"first_name":"Jing Ting","title":"Dr","dw_individual_id":"DW0034957","middle_name":"","last_name":"Zhao","source_individual_id":"5024619","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jing Ting Zhao"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86064","size":1},{"color":"#336699","name":"Prof Ken Ho","data":{"first_name":"Ken","title":"Prof","dw_individual_id":"DW0025511","middle_name":"","last_name":"Ho","source_individual_id":"5015301","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ken Ho"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83572","size":1},{"color":"#336699","name":"Dr Paul Lee","data":{"first_name":"Paul","title":"Dr","dw_individual_id":"DW0020336","middle_name":"Cheuk Ying","last_name":"Lee","source_individual_id":"5015923","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Paul Lee"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82193","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66798","size":1},{"color":"#FF4D4D","name":"Better Methods for Individual Risk Prediction of Complex Traits in Human Populations","data":{"media_summary":"","end_year":2014,"keywords":["risk prediction","genetic risk factors","statistical genetics"],"nhmrc_grant_id":1011506,"application_year":2010,"health_keywords":["preventive screening","genetic risk factors","genetic susceptibility"],"scientific_title":"Better Methods for Individual Risk Prediction of Complex Traits in Human Populations","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Quantitative Genetics (incl. Disease and Trait Mapping Genetics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Naomi Wray","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1011506","simplified_title":"Better Methods for Individual Risk Prediction of Complex Traits in Human Populations","sub_type":"Standard Project Grant","total_budget":"748609.88","source_system":"A genetic contribution to many common diseases is shown by an increased risk of disease in family members of diseased individuals. However, for each disease there are likely to be many hundreds of DNA variants each conferring a small increase in risk.   This proposal is about the development of better statistical methods to predict disease from genome-wide genetic marker data. Individual risk prediction for disease  is likely to become an integral part of Genomic Medicine in Australia."},"children":[{"color":"#336699","name":"Prof Naomi Wray","data":{"first_name":"Naomi","title":"Prof","dw_individual_id":"DW0005533","middle_name":"Ruth","last_name":"Wray","source_individual_id":"5018484","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Naomi Wray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78207","size":1},{"color":"#336699","name":"Prof Peter Visscher","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0005222","middle_name":"M","last_name":"Visscher","source_individual_id":"5018104","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Visscher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78118","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66795","size":1},{"color":"#FF4D4D","name":"Design, development and analysis of new tuberculosis drugs","data":{"media_summary":"","end_year":2014,"keywords":["tuberculosis","antibiotics","microbial pathogenesis","genetic screening","structure-based drug design"],"nhmrc_grant_id":1011266,"application_year":2010,"health_keywords":["tuberculosis","drug development","respiratory diseases"],"scientific_title":"Design, development and analysis of new tuberculosis drugs","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Nicholas West","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1011266","simplified_title":"Genes to drugs for TB","sub_type":"Standard Project Grant","total_budget":"736628.1","source_system":"Serious issues of drug resistance have emerged in tuberculosis prevention and are placing enormous pressure on global health systems. We have identified an enzyme of M. tuberculosis that is essential for its survival. This project will develop potent inhibitory compounds for this enzyme. Further, we will identify new drug targets through a screen to specifically identify the genes of the organism essential for its survival in the body. This information will be used to develop new TB drugs."},"children":[{"color":"#336699","name":"Prof Warwick Britton","data":{"first_name":"Warwick","title":"Prof","dw_individual_id":"DW0041287","middle_name":"John","last_name":"Britton","source_individual_id":"5012794","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Warwick Britton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87705","size":1},{"color":"#336699","name":"A/Pr Richard Payne","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0039008","middle_name":"J","last_name":"Payne","source_individual_id":"5019173","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Payne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87106","size":1},{"color":"#336699","name":"Dr Nicholas West","data":{"first_name":"Nicholas","title":"Dr","dw_individual_id":"DW0028762","middle_name":"P","last_name":"West","source_individual_id":"5018276","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nicholas West"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84448","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66765","size":1},{"color":"#FF4D4D","name":"Lymphangiogenesis from development to disease:  Analysis of SOX18 function in the control of lymphatic remodeling","data":{"media_summary":"","end_year":2014,"keywords":["molecular genetics","developmental genetics","transcription factor","mouse models","gene expression"],"nhmrc_grant_id":1011242,"application_year":2010,"health_keywords":["metastasis suppressor","cancer metastasis","lymphatics"],"scientific_title":"Lymphangiogenesis from development to disease:  Analysis of SOX18 function in the control of lymphatic remodeling","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Mathias Francois","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1011242","simplified_title":"How lymphatic vessels develop and their role in diseases","sub_type":"RD Wright Biomedical CDF","total_budget":"401361.34","source_system":"Cancers are lethal mainly because they spread (metastasise) to other parts of the body via blood vessels and lymphatic ducts. Pilot studies suggest that suppressing the function of a gene, SOX18, reduces tumour metastasis. We now propose to confirm these findings and study this effect in detail, with the ultimate aim of developing new therapies able to complement already existing anti-cancer treatments."},"children":[{"color":"#336699","name":"Dr Mathias Francois","data":{"first_name":"Mathias","title":"Dr","dw_individual_id":"DW0013087","middle_name":"F","last_name":"Francois","source_individual_id":"5014705","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mathias Francois"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80238","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66763","size":1},{"color":"#FF4D4D","name":"The mechanism of cell death in response to cytoplasmic DNA, and its role in tumour suppression","data":{"media_summary":"","end_year":2014,"keywords":["cell death","cancer cell biology","endogenous retroviruses","innate immunity"],"nhmrc_grant_id":1010887,"application_year":2010,"health_keywords":["cancer cell biology","infectious diseases","viral immunology","gene therapy"],"scientific_title":"The mechanism of cell death in response to cytoplasmic DNA, and its role in tumour suppression","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development, Proliferation and Death","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Katryn Stacey","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1010887","simplified_title":"Cell death in response to stray DNA, and its relevance to cancers","sub_type":"Standard Project Grant","total_budget":"517897.37","source_system":"DNA in mammalian cells is in a structure known as the nucleus. Retroviruses such as HIV generate DNA outside the nucleus in the cytoplasm, and detection of DNA in the cytoplasm can lead to cell death, as a defence. All cells carry the remnants of ancient retroviruses in their nuclear DNA. These are normally inactive but may contribute to cancer when activated. This project investigates how normal cells die with cytoplasmic DNA, and whether a defect in this process promotes development of cancer."},"children":[{"color":"#336699","name":"Dr Katryn Stacey","data":{"first_name":"Katryn","title":"Dr","dw_individual_id":"DW0028117","middle_name":"Jane","last_name":"Stacey","source_individual_id":"5017656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katryn Stacey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84258","size":1},{"color":"#336699","name":"Dr Tara Roberts","data":{"first_name":"Tara","title":"Dr","dw_individual_id":"DW0015901","middle_name":"L","last_name":"Roberts","source_individual_id":"5017199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Tara Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81007","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66736","size":1},{"color":"#FF4D4D","name":"Developing inhibitors of an essential histidine kinase in Staphylococcus aureus","data":{"media_summary":"antibiotics","end_year":2013,"keywords":["drug discovery","drug development","kinase inhibitors","structural biology","organic chemistry"],"nhmrc_grant_id":1010776,"application_year":2010,"health_keywords":["infectious diseases","bacterial infection","Staphylococcus aureus","antibiotic resistance","antibiotics"],"scientific_title":"Developing inhibitors of an essential histidine kinase in Staphylococcus aureus","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biologically Active Molecules","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof Glenn King","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1010776","simplified_title":"Development of new antibiotics to treat Golden Staph infections","sub_type":"Standard Project Grant","total_budget":"578351.99","source_system":"Staphylococcus aureus (Golden staph) has been termed a \"superbug\" because of its persistent ability to acquire resistance to a wide range of antibiotics. Once considered primarily a hospital-acquired pathogen, many patients are now being infected with antibiotic-resistant Golden staph outside of hospitals. The primary aim of this research program is to develop new antibiotics to treat antibiotic-resistant strains of Staphylococcus aureus and related pathogens."},"children":[{"color":"#336699","name":"Prof Rob Capon","data":{"first_name":"Rob","title":"Prof","dw_individual_id":"DW0012180","middle_name":"John","last_name":"Capon","source_individual_id":"5011505","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Rob Capon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79993","size":1},{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66728","size":1},{"color":"#FF4D4D","name":"Neogenin: a regulator of neuronal differentiation and migration in the adult brain","data":{"media_summary":"neurological disorders","end_year":2013,"keywords":["neural stem cell","neural regeneration","neurobiology","neurogenesis","neuronal migration"],"nhmrc_grant_id":1010723,"application_year":2010,"health_keywords":["neural regeneration","neural stem cell","neural transplantation","neurogenesis","neurological disorders"],"scientific_title":"Neogenin: a regulator of neuronal differentiation and migration in the adult brain","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Helen Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1010723","simplified_title":"Neogenin and the production of new neurons in the adult brain","sub_type":"Standard Project Grant","total_budget":"334053.95","source_system":"Conditions such as Alzheimers and Huntingtons diseases, as well as stroke, represent a major burden of disease in Australia. One goal of modern neurobiology is to harness the brain's ability to make new neurons so that we can replace those damaged by disease or injury. We will investigate how an important developmental molecule, Neogenin, promotes the production of new neurons in the adult brain. A second goal is to show that Neogenin can be activated to promote the repair of the damaged brain."},"children":[{"color":"#336699","name":"A/Pr Helen Cooper","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0018393","middle_name":"M","last_name":"Cooper","source_individual_id":"RMIS222363","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Helen Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81710","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66718","size":1},{"color":"#FF4D4D","name":"Development of a scorpion toxin for tumour imaging","data":{"media_summary":"","end_year":2013,"keywords":["brain imaging","medulloblastoma","peptides","toxins","neuroscience"],"nhmrc_grant_id":1010552,"application_year":2010,"health_keywords":["brain tumours","cancer","medulloblastoma"],"scientific_title":"Development of a scorpion toxin for tumour imaging","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1010552","simplified_title":"Development of a scorpion toxin for the treatment of cancer","sub_type":"Standard Project Grant","total_budget":"529577.49","source_system":"The aim of this project is to develop a tool for visualising tumours during surgery. Surgical removal of tumours remains the foundation of cancer treatment, but the ability to distinguish the margin between cancerous and healthy cells is imprecise. We will explore the potential of a scorpion toxin that selectively targets cancer cells, as a tumour imaging agent. This project has the potential to dramatically enhance patient survival as a result of improving treatments for cancer."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Prof Norelle Daly","data":{"first_name":"Norelle","title":"Prof","dw_individual_id":"DW0012604","middle_name":"L","last_name":"Daly","source_individual_id":"RMIS2275307","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Norelle Daly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80117","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66702","size":1},{"color":"#FF4D4D","name":"Uptake of evidence to policy: the Indigenous Burden of Disease case study","data":{"media_summary":"evidence-based","end_year":2014,"keywords":["indigenous Australians","policy analysis","burden of disease","evidence-based","resource allocation"],"nhmrc_grant_id":1010534,"application_year":2010,"health_keywords":["indigenous Australians","policy development","burden of disease","priority setting","evidence-based"],"scientific_title":"Uptake of evidence to policy: the Indigenous Burden of Disease case study","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Aboriginal and Torres Strait Islander Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Peter Hill","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1010534","simplified_title":"How has the Indigenous Burden of Disease case study influenced policy?","sub_type":"Standard Project Grant","total_budget":"439210.59","source_system":"Burden of Disease (BOD) methods were designed with the intention of assisting health policy makers in decision making. Using a unit called the Disability Adjusted Life Year, the process measures both death and disability caused by disease or illness, allowing the burden of differing diseases to be compared, and priorities clarified. This research will improve communication between researchers, community and policy makers by showing how the Indigenous BOD study has been used in policy processes."},"children":[{"color":"#336699","name":"Prof Cindy Shannon","data":{"first_name":"Cindy","title":"Prof","dw_individual_id":"DW0033749","middle_name":"Anne-Maree","last_name":"Shannon","source_individual_id":"RMIS383276","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Cindy Shannon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85739","size":1},{"color":"#336699","name":"Prof Philip Davies","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0030277","middle_name":"","last_name":"Davies","source_individual_id":"5012370","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Philip Davies"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84851","size":1},{"color":"#336699","name":"A/Pr Peter Hill","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0013658","middle_name":"Stewart","last_name":"Hill","source_individual_id":"5012306","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Hill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80385","size":1},{"color":"#336699","name":"Prof Anthony Zwi","data":{"first_name":"Anthony","title":"Prof","dw_individual_id":"DW0005685","middle_name":"B","last_name":"Zwi","source_individual_id":"5018598","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Anthony Zwi"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78253","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66698","size":1},{"color":"#FF4D4D","name":"Cortactin: integrating cadherin signalling for junctional integrity","data":{"media_summary":"","end_year":2013,"keywords":["cell biology","cell adhesion","E-cadherin","cytoskeleton","signalling"],"nhmrc_grant_id":1010489,"application_year":2010,"health_keywords":["cancer cell biology","epithelial biology","invasion"],"scientific_title":"Cortactin: integrating cadherin signalling for junctional integrity","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Alpha Yap","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1010489","simplified_title":"Cortactin and cadherin adhesion","sub_type":"Standard Project Grant","total_budget":"593888.23","source_system":"Adhesion between cells holds the human body together and affects many aspects of our health, including normal tissue and organ function. Importantly, loss of normal cell-cell adhesion contributes to many diseases, including cancer and inflammation. One key adhesion molecule, E-cadherin, is necessary for many epithelial tissues and its function is perturbed in disease. This research project addresses how E-cadherin signals into cells to control cell-to-cell interactions."},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1},{"color":"#336699","name":"Dr Guillermo Gomez","data":{"first_name":"Guillermo","title":"Dr","dw_individual_id":"5048164","middle_name":"Alberto","last_name":"Gomez","source_individual_id":"5048164","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Guillermo Gomez"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76323","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66695","size":1},{"color":"#FF4D4D","name":"Neurodevelopmental role of susceptibility genes for Autism spectrum disorders: from genes to behaviour","data":{"media_summary":"","end_year":2013,"keywords":["brain disorders","brain development","synapse"],"nhmrc_grant_id":1010427,"application_year":2010,"health_keywords":["brain disorders","brain development","brain function"],"scientific_title":"Neurodevelopmental role of susceptibility genes for Autism spectrum disorders: from genes to behaviour","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Brian Key","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1010427","simplified_title":"Neurodevelopmental role of susceptibility genes for Autism spectrum disorders","sub_type":"Standard Project Grant","total_budget":"482968.78","source_system":"Autism is a developmental neuropsychiatric syndrome characterised by impairments in three principal domains: social interaction, language and behavioural inflexibility. Autism spectrum disorder (ASD) refers to a group of neurodevelopmental syndromes with the common feature of dysfunctional reciprocal social interaction.  In this project we will investigate the role of genes that increase the risk of ASD in the development of behaviours using an animal model.  This work will lead to a better understanding of the genetic basis of ASD."},"children":[{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66690","size":1},{"color":"#FF4D4D","name":"Inheritance of DNA methylation state in humans","data":{"media_summary":"","end_year":2014,"keywords":["inheritance","methylation","quantitative genetics","microarrays","genetic mapping"],"nhmrc_grant_id":1010374,"application_year":2010,"health_keywords":["genetic variation","twin studies","population genetics","genetic association"],"scientific_title":"Inheritance of DNA methylation state in humans","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Epigenetics (incl. Genome Methylation and Epigenomics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Allan McRae","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1010374","simplified_title":"Inheritance of DNA methylation","sub_type":"New Investigator Grant","total_budget":"722423.14","source_system":"In the study of common disease, it is becoming apparent that it is not only an individual's DNA sequence that can encode susceptibility to disease, but also chemical modifications to that sequence.  Despite the importance of these chemical modifications in the development of disease, there has been no comprehensive survey of the extent which they are transmitted across generations in humans. This proposal will investigate how one of those modifications, DNA methylation, is inherited."},"children":[{"color":"#336699","name":"Dr Allan Mcrae","data":{"first_name":"Allan","title":"Dr","dw_individual_id":"DW0044224","middle_name":"F","last_name":"Mcrae","source_individual_id":"5016413","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Allan Mcrae"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88460","size":1},{"color":"#336699","name":"Dr Jodie Painter","data":{"first_name":"Jodie","title":"Dr","dw_individual_id":"DW0033041","middle_name":"Nicole","last_name":"Painter","source_individual_id":"5024313","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jodie Painter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85561","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66684","size":1},{"color":"#FF4D4D","name":"Viral factors contributing to flavivirus-induced cell death and pathogenicity","data":{"media_summary":"","end_year":2013,"keywords":["flavivirus","flavivirus encephalitis","virus pathogenesis","host/pathogen interaction","cell death"],"nhmrc_grant_id":1009874,"application_year":2010,"health_keywords":["encephalitis","flavivirus","arbovirus diseases","microbiology"],"scientific_title":"Viral factors contributing to flavivirus-induced cell death and pathogenicity","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1009874","simplified_title":"Viral factors contributing to flavivirus-induced cell death and pathogenicity","sub_type":"Standard Project Grant","total_budget":"612885.92","source_system":"West Nile virus is a mosquito-transmitted pathogen that causes severe and fatal neurological   disease in humans. There are currently no effective treatments or vaccines for this disease. In this project, we will investigate how West Nile virus and other viruses of the same group use a novel translational regulatory mechanism to modulate the host antiviral response and facilitate viral pathogenicity. This will provide valuable information for the development of effective treatments against this medically important group of viral pathogens."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1},{"color":"#336699","name":"Dr Anneke Funk","data":{"first_name":"Anneke","title":"Dr","dw_individual_id":"DW0030790","middle_name":"","last_name":"Funk","source_individual_id":"5018815","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Anneke Funk"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84987","size":1},{"color":"#336699","name":"Prof Roy Hall","data":{"first_name":"Roy","title":"Prof","dw_individual_id":"DW0025278","middle_name":"A","last_name":"Hall","source_individual_id":"RMIS16831","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roy Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83509","size":1},{"color":"#336699","name":"Dr Ezequiel Balmori Melian","data":{"first_name":"Ezequiel","title":"Dr","dw_individual_id":"DW0005932","middle_name":"Na","last_name":"Balmori Melian","source_individual_id":"5020409","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ezequiel Balmori Melian"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78320","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66635","size":1},{"color":"#FF4D4D","name":"Genetic and Environmental Contributions to the Life Course of the Common Mental Disorders","data":{"media_summary":"depression","end_year":2014,"keywords":["mental health","psychiatry","social determinants of health","genetic susceptibility","social epidemiology"],"nhmrc_grant_id":1009469,"application_year":2010,"health_keywords":["population health","mental disorder","genetic susceptibility","substance use disorders","depression"],"scientific_title":"Genetic and Environmental Contributions to the Life Course of the Common Mental Disorders","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Mental Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Jackob Najman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1009469","simplified_title":"Gene x environmental interactions and the common mental disorders","sub_type":"Standard Project Grant","total_budget":"1529567.39","source_system":"The common mental disorders (anxiety, depression, substance use) constitute a major disease burden and cost on the health system. Little is known about their causes and patterns of occurrence over the life span. This study follows a sample of 4000 persons from birth to 30 years of age to determine the environmental and genetic factors that lead to the onset and recurrence of the common mental disorders. It will provide important information to influence the treatment and prevention of these disorders."},"children":[{"color":"#336699","name":"A/Pr Michael O'Callaghan","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0044590","middle_name":"James","last_name":"O'Callaghan","source_individual_id":"RMIS1119732","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Michael O'Callaghan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88543","size":1},{"color":"#336699","name":"A/Pr Alexandra Clavarino","data":{"first_name":"Alexandra","title":"A/Pr","dw_individual_id":"DW0029981","middle_name":"","last_name":"Clavarino","source_individual_id":"RMIS31306","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Alexandra Clavarino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84768","size":1},{"color":"#336699","name":"Dr Gerome Breen","data":{"first_name":"Gerome","title":"Dr","dw_individual_id":"DW0023763","middle_name":"Daniel","last_name":"Breen","source_individual_id":"5024490","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Gerome Breen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83101","size":1},{"color":"#336699","name":"Prof Gail Williams","data":{"first_name":"Gail","title":"Prof","dw_individual_id":"DW0017119","middle_name":"Marilyn","last_name":"Williams","source_individual_id":"RMIS28497","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gail Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81346","size":1},{"color":"#336699","name":"Dr Deon Venter","data":{"first_name":"Deon","title":"Dr","dw_individual_id":"DW0010829","middle_name":"Jacobus","last_name":"Venter","source_individual_id":"5023610","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Deon Venter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79644","size":1},{"color":"#336699","name":"Dr William Bor","data":{"first_name":"William","title":"Dr","dw_individual_id":"DW0006156","middle_name":"","last_name":"Bor","source_individual_id":"RMIS1099638","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr William Bor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78373","size":1},{"color":"#336699","name":"A/Pr Rosa Alati","data":{"first_name":"Rosa","title":"A/Pr","dw_individual_id":"DW0005759","middle_name":"","last_name":"Alati","source_individual_id":"RMIS2639340","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Rosa Alati"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78272","size":1},{"color":"#336699","name":"Prof Naomi Wray","data":{"first_name":"Naomi","title":"Prof","dw_individual_id":"DW0005533","middle_name":"Ruth","last_name":"Wray","source_individual_id":"5018484","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Naomi Wray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78207","size":1},{"color":"#336699","name":"Prof Jackob Najman","data":{"first_name":"Jackob","title":"Prof","dw_individual_id":"DW0003590","middle_name":"Moses","last_name":"Najman","source_individual_id":"5016639","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jackob Najman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77655","size":1},{"color":"#336699","name":"A/Pr Abdullah Mamun","data":{"first_name":"Abdullah","title":"A/Pr","dw_individual_id":"DW0003145","middle_name":"Al","last_name":"Mamun","source_individual_id":"5016160","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Abdullah Mamun"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77536","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66615","size":1},{"color":"#FF4D4D","name":"The aetiology of alcohol use disorders in adulthood: a generational perspective","data":{"media_summary":"","end_year":2014,"keywords":["alcohol dependence","fetal origins of disease","genetic risk factors","environmental risk factors","cohort study"],"nhmrc_grant_id":1009460,"application_year":2010,"health_keywords":["alcohol use disorders","longitudinal cohort study","genetic influences"],"scientific_title":"The aetiology of alcohol use disorders in adulthood: a generational perspective","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry (incl. Psychotherapy)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Rosa Alati","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1009460","simplified_title":"The aetiology of alcohol use disorders in adulthood","sub_type":"Standard Project Grant","total_budget":"630927.84","source_system":"This study aims to investigate the causes of alcohol problems in adult Australians. We will follow-up participants from a birth cohort study who are now in their thirties. We will assess long term outcomes from in-utero exposure to alcohol and biological, developmental and genetic predictors of alcohol disorders in adulthood. This study also aims to study genetic factors which may be important in the development of alcohol abuse and dependence."},"children":[{"color":"#336699","name":"Dr Penelope Lind","data":{"first_name":"Penelope","title":"Dr","dw_individual_id":"DW0032113","middle_name":"Alathea","last_name":"Lind","source_individual_id":"5015990","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Penelope Lind"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85311","size":1},{"color":"#336699","name":"A/Pr Alexandra Clavarino","data":{"first_name":"Alexandra","title":"A/Pr","dw_individual_id":"DW0029981","middle_name":"","last_name":"Clavarino","source_individual_id":"RMIS31306","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Alexandra Clavarino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84768","size":1},{"color":"#336699","name":"Prof Gail Williams","data":{"first_name":"Gail","title":"Prof","dw_individual_id":"DW0017119","middle_name":"Marilyn","last_name":"Williams","source_individual_id":"RMIS28497","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gail Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81346","size":1},{"color":"#336699","name":"Dr William Bor","data":{"first_name":"William","title":"Dr","dw_individual_id":"DW0006156","middle_name":"","last_name":"Bor","source_individual_id":"RMIS1099638","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr William Bor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78373","size":1},{"color":"#336699","name":"A/Pr Rosa Alati","data":{"first_name":"Rosa","title":"A/Pr","dw_individual_id":"DW0005759","middle_name":"","last_name":"Alati","source_individual_id":"RMIS2639340","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Rosa Alati"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78272","size":1},{"color":"#336699","name":"Prof Naomi Wray","data":{"first_name":"Naomi","title":"Prof","dw_individual_id":"DW0005533","middle_name":"Ruth","last_name":"Wray","source_individual_id":"5018484","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Naomi Wray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78207","size":1},{"color":"#336699","name":"Dr John Whitfield","data":{"first_name":"John","title":"Dr","dw_individual_id":"DW0005416","middle_name":"B","last_name":"Whitfield","source_individual_id":"5018300","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr John Whitfield"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78178","size":1},{"color":"#336699","name":"Prof Jackob Najman","data":{"first_name":"Jackob","title":"Prof","dw_individual_id":"DW0003590","middle_name":"Moses","last_name":"Najman","source_individual_id":"5016639","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jackob Najman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77655","size":1},{"color":"#336699","name":"A/Pr Abdullah Mamun","data":{"first_name":"Abdullah","title":"A/Pr","dw_individual_id":"DW0003145","middle_name":"Al","last_name":"Mamun","source_individual_id":"5016160","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Abdullah Mamun"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77536","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66614","size":1},{"color":"#FF4D4D","name":"Reconsideration of the mechanisms underlying movement changes with pain","data":{"media_summary":"","end_year":2014,"keywords":["motor control","motor unit","pain mechanisms"],"nhmrc_grant_id":1009410,"application_year":2010,"health_keywords":["movement control","rehabilitation","muscle function","pain"],"scientific_title":"Reconsideration of the mechanisms underlying movement changes with pain","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Peripheral Nervous System","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Dr Kylie Tucker","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1009410","simplified_title":"How does pain change the way we move?","sub_type":"RD Wright Biomedical CDF","total_budget":"401361.34","source_system":"Pain changes the way we move. Although undisputed, there is a surprising lack of agreement regarding the underlying mechanisms. This project involves an innovative mix of neurophysiological methods to investigate how the drive to muscle cells from the nervous system is altered during pain. We aim to resolve the perplexing problem of how pain changes our ability to activate muscle. Our findings are likely to provide a clear understanding of the underlying mechanisms and guide rehabilitation."},"children":[{"color":"#336699","name":"Dr Kylie Tucker","data":{"first_name":"Kylie","title":"Dr","dw_individual_id":"DW0016734","middle_name":"J","last_name":"Tucker","source_individual_id":"5017997","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kylie Tucker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81245","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66606","size":1},{"color":"#FF4D4D","name":"The role of hypoxia in the developmental programming of the kidney","data":{"media_summary":"","end_year":2013,"keywords":["kidney development","fetal origins of disease","hypoxia","fetal programming"],"nhmrc_grant_id":1009338,"application_year":2010,"health_keywords":["kidney disease","hypertension","abnormal development"],"scientific_title":"The role of hypoxia in the developmental programming of the kidney","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Foetal Development and Medicine","research_area":"Basic Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"A/Pr Karen Moritz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1009338","simplified_title":"The effect of hypoxia before birth on kidney development","sub_type":"Standard Project Grant","total_budget":"651275.97","source_system":"We aim to understand how inadequate oxygen supply to the fetus during pregnancy can affect development of the kidney. Many babies do not get enough oxygen whilst developing in the womb. This can be due to a poorly formed placenta or the mother smoking. This can interfere with normal growth and formation of the kidney. Our knowledge may help babies get the best start to life."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1},{"color":"#336699","name":"Prof Sally Dunwoodie","data":{"first_name":"Sally","title":"Prof","dw_individual_id":"DW0024651","middle_name":"Lewers","last_name":"Dunwoodie","source_individual_id":"5012582","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sally Dunwoodie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83328","size":1},{"color":"#336699","name":"Dr Lorine Wilkinson","data":{"first_name":"Lorine","title":"Dr","dw_individual_id":"DW0017106","middle_name":"Joy","last_name":"Wilkinson","source_individual_id":"5020278","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Lorine Wilkinson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81341","size":1},{"color":"#336699","name":"A/Pr Karen Moritz","data":{"first_name":"Karen","title":"A/Pr","dw_individual_id":"DW0009221","middle_name":"","last_name":"Moritz","source_individual_id":"RMIS1366054","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Karen Moritz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79207","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66596","size":1},{"color":"#FF4D4D","name":"Harnessing plants to produce peptide drugs","data":{"media_summary":"","end_year":2013,"keywords":["peptide processing","drug design","peptide synthesis","transgenic model","gene cloning"],"nhmrc_grant_id":1009267,"application_year":2010,"health_keywords":["prostate cancer","neuropathic pain","compliance"],"scientific_title":"Harnessing plants to produce peptide drugs","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Molecular Engineering of Nucleic Acids and Proteins","research_area":"Basic Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1009267","simplified_title":"Drugs in plants","sub_type":"Standard Project Grant","total_budget":"380662.66","source_system":"This project will unleash the potential of peptide drugs by overcoming their final barrier to widespread use, their synthesis. Plants naturally produce ultra-stable cyclic peptides. We will co-opt their machinery to produce in seeds, two drug leads that have potential as treatments for prostate cancer and chronic neuropathic pain. As an organic drug source, seeds have the potential to improve patient compliance and low-tech production systems will allow technology transfer to third-world nations."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"A/Pr Joshua Mylne","data":{"first_name":"Joshua","title":"A/Pr","dw_individual_id":"DW0009309","middle_name":"Scott","last_name":"Mylne","source_individual_id":"5020288","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Joshua Mylne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79233","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66587","size":1},{"color":"#FF4D4D","name":"Human dendritic cell subsets and their application for immunotherapy","data":{"media_summary":"","end_year":2014,"keywords":["dendritic cell","cancer immunotherapy","antigen presentation","infectious diseases","vaccine development"],"nhmrc_grant_id":1008986,"application_year":2010,"health_keywords":["cancer immunology","immunotherapy","vaccine development","virus"],"scientific_title":"Human dendritic cell subsets and their application for immunotherapy","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"A/Pr Kristen Radford","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1008986","simplified_title":"Understanding human dendritic cells","sub_type":"RD Wright Biomedical CDF","total_budget":"443946.44","source_system":"Immunotherapy is a promising non-toxic strategy for the treatment of many cancers, viruses and other diseases. It works by teaching the patient's own immune system to recognize and destroy the cancer. Specialized blood cells called dendritic cells are essential to this process but they are poorly understood in humans. I aim to investigate the function these cells and use this information to develop new treatments for cancer and viruses."},"children":[{"color":"#336699","name":"A/Pr Kristen Radford","data":{"first_name":"Kristen","title":"A/Pr","dw_individual_id":"DW0009781","middle_name":"Jane","last_name":"Radford","source_individual_id":"5017071","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Kristen Radford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79354","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66562","size":1},{"color":"#FF4D4D","name":"Targeted redox therapy for photoageing prevention and treatment","data":{"media_summary":"","end_year":2013,"keywords":["drug delivery systems","antioxidant therapy","collagen"],"nhmrc_grant_id":1008739,"application_year":2010,"health_keywords":["photoageing","skin ageing","skin cancer","skin immunology"],"scientific_title":"Targeted redox therapy for photoageing prevention and treatment","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Complementary and Alternative Medicine not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"COMPLEMENTARY/ALTERNATIVE MEDICINE","cia_name":"Dr Tarl Prow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1008739","simplified_title":"Targeted metabolic therapy for sun damaged skin","sub_type":"Standard Project Grant","total_budget":"562815.75","source_system":"Our goal is to target natural reduction/oxidation (redox) modifiers, i.e. niacin and sulforaphane, to the skin deeper layers to treat photoageing. Both drugs have been separately shown to prevent UV induced skin cancer.  The outcomes of this project will be safer and more effective prevention and treatment of sun damaged skin. This project can provide health benefits to Australians from improved treatment of sun damage, and economic benefits to the nation."},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1},{"color":"#336699","name":"Dr Tarl Prow","data":{"first_name":"Tarl","title":"Dr","dw_individual_id":"DW0039189","middle_name":"","last_name":"Prow","source_individual_id":"5020354","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Tarl Prow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87159","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66536","size":1},{"color":"#FF4D4D","name":"Targeting acetohydroxyacid synthase to discover new antifungal agents.","data":{"media_summary":"","end_year":2014,"keywords":["structural biology","fungal infection","drug discovery","medicinal chemistry","X-ray crystallography"],"nhmrc_grant_id":1008736,"application_year":2010,"health_keywords":["antifungal","candida","cryptococcus","drug discovery"],"scientific_title":"Targeting acetohydroxyacid synthase to discover new antifungal agents.","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Enzymes","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Luke Guddat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1008736","simplified_title":"Discovery of new antifungal agents.","sub_type":"Standard Project Grant","total_budget":"481135.86","source_system":"Invasive fungal infections are increasingly being recognized as a major life threatening risk to hospitalized patients. The efficacy of the current medications is sub-optimal due to the emergence of resistance and the high dosage regimes that are required to treat these infections. We propose to develop a new class of antifungal agent that target an enzyme, acetohydroxyacid synthase, whose activity is required for the survival of pathogenic fungi in mammals."},"children":[{"color":"#336699","name":"A/Pr Luke Guddat","data":{"first_name":"Luke","title":"A/Pr","dw_individual_id":"DW0031041","middle_name":"William","last_name":"Guddat","source_individual_id":"RMIS1125097","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Luke Guddat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85040","size":1},{"color":"#336699","name":"A/Pr Jian-Guo Wang","data":{"first_name":"Jian-Guo","title":"A/Pr","dw_individual_id":"DW0016933","middle_name":"","last_name":"Wang","source_individual_id":"5025109","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Jian-Guo Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81305","size":1},{"color":"#336699","name":"A/Pr James Fraser","data":{"first_name":"James","title":"A/Pr","dw_individual_id":"DW0007343","middle_name":"Anthony","last_name":"Fraser","source_individual_id":"RMIS4444550","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr James Fraser"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78685","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66535","size":1},{"color":"#FF4D4D","name":"A randomised, placebo-controlled trial of Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia in chronic kidney disease","data":{"media_summary":"erythropoietin","end_year":2014,"keywords":["nephrology","anaemia","pharmacokinetics","oxidative stress","inflammation"],"nhmrc_grant_id":1008604,"application_year":2010,"health_keywords":["anaemia","pharmacokinetics","oxidative stress","nephrology","erythropoietin"],"scientific_title":"A randomised, placebo-controlled trial of Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia in chronic kidney disease","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Johnson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1008604","simplified_title":"The HERO trial is a clinical trial designed to test the safety, effectiveness and cost benefits of a drug Oxypentifylline, in treating chronic kidney disease (CKD) patients with anaemia that is unresponsive to red blood cell stimulating treatments.","sub_type":"Standard Project Grant","total_budget":"345189.49","source_system":"Anaemia in chronic kidney disease (CKD) is linked to poor health outcomes, increased death rates and high health care costs.  Drugs that stimulate red blood cell production are routinely used to treat CKD patients with anaemia, however some patients do not respond to these drugs.  The HERO trial is a clinical trial designed to test the safety, effectiveness and cost benefits of a drug Oxypentifylline, in treating CKD patients with anaemia that is unresponsive to red blood cell stimulating treatments."},"children":[{"color":"#336699","name":"A/Pr Eugenia Pedagogos","data":{"first_name":"Eugenia","title":"A/Pr","dw_individual_id":"DW0044759","middle_name":"","last_name":"Pedagogos","source_individual_id":"5020786","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Eugenia Pedagogos"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88577","size":1},{"color":"#336699","name":"Prof Stephen Mcdonald","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0044145","middle_name":"Peter","last_name":"Mcdonald","source_individual_id":"5016329","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stephen Mcdonald"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88437","size":1},{"color":"#336699","name":"Prof Robert Fassett","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0036561","middle_name":"Gordon","last_name":"Fassett","source_individual_id":"5012207","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Fassett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86481","size":1},{"color":"#336699","name":"Prof Philip Clarke","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0018296","middle_name":"M","last_name":"Clarke","source_individual_id":"5013977","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Philip Clarke"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81686","size":1},{"color":"#336699","name":"Prof David Johnson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0013969","middle_name":"Wayne","last_name":"Johnson","source_individual_id":"RMIS14680","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Johnson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80471","size":1},{"color":"#336699","name":"Prof Paolo Ferrari","data":{"first_name":"Paolo","title":"Prof","dw_individual_id":"DW0007249","middle_name":"","last_name":"Ferrari","source_individual_id":"5022851","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paolo Ferrari"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78656","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66526","size":1},{"color":"#FF4D4D","name":"Characterisation of conserved Sox18-dependent genes in lymphatic vascular development","data":{"media_summary":"","end_year":2013,"keywords":["lymphatics","lymphatic disease","vascular biology","zebrafish","SOX genes"],"nhmrc_grant_id":1008586,"application_year":2010,"health_keywords":["lymphoedema","vascular development","cancer metastasis"],"scientific_title":"Characterisation of conserved Sox18-dependent genes in lymphatic vascular development","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Benjamin Hogan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1008586","simplified_title":"Analysis of conserved regulators of lymphatic development","sub_type":"Standard Project Grant","total_budget":"401355.5","source_system":"Lymphatic vessels are important in a number of diseases including lymphoedema and cancer. There is a significant gap in our basic understanding of how lymphatic vessels form. We have identified a series of genes that are regulated downstream of the lymphatic master gene Sox18 in mouse lymphatic vessels. This study aims to characterise these genes using complementary model systems.  The genes and pathways identified will represent potential therapeutic targets in a number of disease contexts."},"children":[{"color":"#336699","name":"Dr Benjamin Hogan","data":{"first_name":"Benjamin","title":"Dr","dw_individual_id":"DW0043083","middle_name":"M","last_name":"Hogan","source_individual_id":"5015278","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Benjamin Hogan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88165","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66525","size":1},{"color":"#FF4D4D","name":"Neurexin and Neuroligin: A Code for Synaptic Development","data":{"media_summary":"","end_year":2013,"keywords":["synaptic mechanisms","synaptic plasticity","molecular neuroscience"],"nhmrc_grant_id":1008125,"application_year":2010,"health_keywords":["molecular basis of disease","autism spectrum disorders","schizophrenia"],"scientific_title":"Neurexin and Neuroligin: A Code for Synaptic Development","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Charles Claudianos","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1008125","simplified_title":"Molecular mechanisms of synaptic development","sub_type":"Standard Project Grant","total_budget":"349590.19","source_system":"As soon as we are born, we interpret our world through our senses, learn new information and lay down memory. These processes require molecules that connect neurons together. Mutations in genes encoding these molecules result in incorrect wiring of the brain and lead to mental disorders such as autism and schizophrenia. Using simple insect models, our project aims to unravel the fundamental mechanisms of how these molecules function in the brain and how their interaction controls behaviour."},"children":[{"color":"#336699","name":"A/Pr Charles Claudianos","data":{"first_name":"Charles","title":"A/Pr","dw_individual_id":"DW0041660","middle_name":"","last_name":"Claudianos","source_individual_id":"5013978","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Charles Claudianos"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87809","size":1},{"color":"#336699","name":"Dr Judith Reinhard","data":{"first_name":"Judith","title":"Dr","dw_individual_id":"DW0021671","middle_name":"","last_name":"Reinhard","source_individual_id":"5022900","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Judith Reinhard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82575","size":1},{"color":"#336699","name":"A/Pr Bruno Van Swinderen","data":{"first_name":"Bruno","title":"A/Pr","dw_individual_id":"DW0010802","middle_name":"","last_name":"Van Swinderen","source_individual_id":"5020276","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Bruno Van Swinderen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79638","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66481","size":1},{"color":"#FF4D4D","name":"Gamma-Secretase inhibitors as novel pharmacological agents to target stroke-induced brain injury","data":{"media_summary":"","end_year":2013,"keywords":["pharmacology","neuronal cell death","ischaemic stroke"],"nhmrc_grant_id":1008048,"application_year":2010,"health_keywords":["stroke","brain injury","protection"],"scientific_title":"Gamma-Secretase inhibitors as novel pharmacological agents to target stroke-induced brain injury","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology and Pharmaceutical Sciences not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"A/Pr Thiruma Arumugam","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1008048","simplified_title":"Gamma-Secretase inhibitors to target stroke-induced brain injury","sub_type":"Standard Project Grant","total_budget":"441511.92","source_system":"Stroke is the worlds 2nd leading cause of death. In Australia, stroke is the leading cause of serious, long-term disability. Alarmingly, there is a looming stroke epidemic in Australia. There is an urgent need for novel therapies capable of reducing mortality and long-term disability in victims of stroke. We have recently identified gamma-secretase inhibitors (GSIs) as a potent stroke therapy. This project will investigate how GSIs protect against ischaemic stroke at the molecular level."},"children":[{"color":"#336699","name":"A/Pr Christopher Sobey","data":{"first_name":"Christopher","title":"A/Pr","dw_individual_id":"DW0016332","middle_name":"Graeme","last_name":"Sobey","source_individual_id":"5017621","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Christopher Sobey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81135","size":1},{"color":"#336699","name":"Dr Bradley Launikonis","data":{"first_name":"Bradley","title":"Dr","dw_individual_id":"DW0014380","middle_name":"S","last_name":"Launikonis","source_individual_id":"5015864","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Bradley Launikonis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80584","size":1},{"color":"#336699","name":"A/Pr Thiruma Arumugam","data":{"first_name":"Thiruma","title":"A/Pr","dw_individual_id":"DW0011513","middle_name":"Valavan","last_name":"Arumugam","source_individual_id":"5019753","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thiruma Arumugam"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79828","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66470","size":1},{"color":"#FF4D4D","name":"Promoting activity for frail aged in post-acute hospital settings: a randomised controlled trial of accelerometry","data":{"media_summary":"quality improvement","end_year":2014,"keywords":["rehabilitation","geriatrics","monitoring","exercise","clinical decision making"],"nhmrc_grant_id":1007886,"application_year":2010,"health_keywords":["aged care","rehabilitation","exercise","health promotion","quality improvement"],"scientific_title":"Promoting activity for frail aged in post-acute hospital settings: a randomised controlled trial of accelerometry","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Geriatrics and Gerontology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Len Gray","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1007886","simplified_title":"Improving activity level of older patients in rehabilitation settings","sub_type":"Standard Project Grant","total_budget":"542119.48","source_system":"Keeping older people in hospital actively mobile is a vital objective of high quality aged care. Using accelerometers, the Centre for Research in Geriatric Medicine at the University of Queensland, and its partner, the CSIRO e-health Research Centre, are trialing a method of promoting activity in older rehabilitation patients. Potentially, a system of activity management could solve an age old problem in hospital care of older people."},"children":[{"color":"#336699","name":"Prof Susan Kurrle","data":{"first_name":"Susan","title":"Prof","dw_individual_id":"DW0020216","middle_name":"Elizabeth","last_name":"Kurrle","source_individual_id":"5015799","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Susan Kurrle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82159","size":1},{"color":"#336699","name":"Prof Maria Crotty","data":{"first_name":"Maria","title":"Prof","dw_individual_id":"DW0018484","middle_name":"","last_name":"Crotty","source_individual_id":"RMIS499869","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Maria Crotty"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81736","size":1},{"color":"#336699","name":"Prof Ian Cameron","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0018077","middle_name":"Douglas","last_name":"Cameron","source_individual_id":"5012435","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Cameron"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81622","size":1},{"color":"#336699","name":"Dr Mohanraj Karunanithi","data":{"first_name":"Mohanraj","title":"Dr","dw_individual_id":"DW0014072","middle_name":"Krishnamoorthy","last_name":"Karunanithi","source_individual_id":"5023537","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mohanraj Karunanithi"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80494","size":1},{"color":"#336699","name":"Prof Len Gray","data":{"first_name":"Len","title":"Prof","dw_individual_id":"DW0007585","middle_name":"Charles","last_name":"Gray","source_individual_id":"5012147","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Len Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78747","size":1},{"color":"#336699","name":"Dr Nancye Peel","data":{"first_name":"Nancye","title":"Dr","dw_individual_id":"DW0003910","middle_name":"M","last_name":"Peel","source_individual_id":"5016909","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nancye Peel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77759","size":1},{"color":"#336699","name":"Prof Sanjoy Paul","data":{"first_name":"Sanjoy","title":"Prof","dw_individual_id":"DW0003885","middle_name":"Ketan","last_name":"Paul","source_individual_id":"5023146","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sanjoy Paul"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77750","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66452","size":1},{"color":"#FF4D4D","name":"Neonatal vitamin D status and risk of schizophrenia: a replication in two independent samples","data":{"media_summary":"","end_year":2013,"keywords":["schizophrenia","vitamin D","prevention"],"nhmrc_grant_id":1007677,"application_year":2010,"health_keywords":["prevention","vitamin D","schizophrenia"],"scientific_title":"Neonatal vitamin D status and risk of schizophrenia: a replication in two independent samples","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry (incl. Psychotherapy)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof John McGrath","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1007677","simplified_title":"Vitamin D and Schizophrenia","sub_type":"Standard Project Grant","total_budget":"346399.73","source_system":"Our group have discovered that low vitamin D (the sunshine hormone) during early life alters brain development. Recently we completed the first study to examine vitamin D in stored blood samples from new born babies and examined their risk of later schizophrenia. This study, based on Danish samples, confirmed a significant relationship between vitamin D levels and risk of later schizophrenia. The current study will examine new samples from Denmark and Scotland in order to replicate this association."},"children":[{"color":"#336699","name":"A/Pr Darryl Eyles","data":{"first_name":"Darryl","title":"A/Pr","dw_individual_id":"DW0042305","middle_name":"W","last_name":"Eyles","source_individual_id":"5014564","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Darryl Eyles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87979","size":1},{"color":"#336699","name":"Dr Carsten Pedersen","data":{"first_name":"Carsten","title":"Dr","dw_individual_id":"DW0033115","middle_name":"Bocker","last_name":"Pedersen","source_individual_id":"5022928","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Carsten Pedersen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85581","size":1},{"color":"#336699","name":"Dr Preben Mortensen","data":{"first_name":"Preben","title":"Dr","dw_individual_id":"DW0026883","middle_name":"Bo","last_name":"Mortensen","source_individual_id":"5020603","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Preben Mortensen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83960","size":1},{"color":"#336699","name":"A/Pr Thomas Burne","data":{"first_name":"Thomas","title":"A/Pr","dw_individual_id":"DW0023865","middle_name":"Henry Johnston","last_name":"Burne","source_individual_id":"5013713","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thomas Burne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83125","size":1},{"color":"#336699","name":"Dr David St Clair","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0022280","middle_name":"Malcolm","last_name":"St Clair","source_individual_id":"5020602","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David St Clair"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82750","size":1},{"color":"#336699","name":"Prof John Mcgrath","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0009022","middle_name":"Joseph","last_name":"Mcgrath","source_individual_id":"RMIS3680751","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mcgrath"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79147","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66437","size":1},{"color":"#FF4D4D","name":"Prospective methylation biomarker validation study in lung cancer","data":{"media_summary":"","end_year":2014,"keywords":["lung","genetics","early detection"],"nhmrc_grant_id":1006695,"application_year":2010,"health_keywords":["lung","genetics","early detection"],"scientific_title":"Prospective methylation biomarker validation study in lung cancer","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","cia_name":"Prof Kwun Fong","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1006695","simplified_title":"Methylation biomarkers in lung cancer","sub_type":"Standard Project Grant","total_budget":"528281.8","source_system":"Lung cancer is a major public health burden with increasing incidence every year. Despite advances, the biology of lung cancer associated with its recurrence either local or distant, with non-smoking lung cancer subtypes and asbestos-related lung cancer remains unexplored."},"children":[{"color":"#336699","name":"Dr Edwina Duhig","data":{"first_name":"Edwina","title":"Dr","dw_individual_id":"DW0024634","middle_name":"","last_name":"Duhig","source_individual_id":"5012556","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Edwina Duhig"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83323","size":1},{"color":"#336699","name":"Prof Kwun Fong","data":{"first_name":"Kwun","title":"Prof","dw_individual_id":"DW0007308","middle_name":"M","last_name":"Fong","source_individual_id":"5011833","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Kwun Fong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78670","size":1},{"color":"#336699","name":"A/Pr Alexander Dobrovic","data":{"first_name":"Alexander","title":"A/Pr","dw_individual_id":"DW0006998","middle_name":"","last_name":"Dobrovic","source_individual_id":"RMIS17767","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Alexander Dobrovic"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78599","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66406","size":1},{"color":"#FF4D4D","name":"A Self-assembling and Self-adjuvanting Nanoparticular Therapeutic Vaccine Against Cervical Cancer","data":{"media_summary":"nanotechnology","end_year":2014,"keywords":["cancer immunotherapy","peptide synthesis","nanotechnology","vaccine strategy","drug delivery systems"],"nhmrc_grant_id":1006454,"application_year":2010,"health_keywords":["cancer immunotherapy","cancer vaccine","cervical cancer","adjuvant","nanotechnology"],"scientific_title":"A Self-assembling and Self-adjuvanting Nanoparticular Therapeutic Vaccine Against Cervical Cancer","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Nanomedicine","research_area":"Basic Science","for_category":"NANOTECHNOLOGY","cia_name":"Dr Mariusz Skwarczynski","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1006454","simplified_title":"Nanoparticles as Pathogen-like Bullets for Development of Anticancer Vaccine","sub_type":"New Investigator Grant","total_budget":"387858.51","source_system":"One in every three Australians will be diagnosed with cancer in their lifetime according to the Australia Cancer Foundation. The proposed project aims to develop pathogen-like bullets based on self-organized nanoparticles which would become a strong weapon against cervical cancer."},"children":[{"color":"#336699","name":"Dr Mariusz Skwarczynski","data":{"first_name":"Mariusz","title":"Dr","dw_individual_id":"DW0022171","middle_name":"","last_name":"Skwarczynski","source_individual_id":"5020333","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mariusz Skwarczynski"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82714","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66379","size":1},{"color":"#FF4D4D","name":"Novel treatment approaches to prevent joint fusion in ankylosing spondylitis","data":{"media_summary":"","end_year":2014,"keywords":["bone formation","spondyloarthropathy","mouse models","osteoblast","bone disease"],"nhmrc_grant_id":1006450,"application_year":2010,"health_keywords":["bone disease","spondyloarthropathy","joint disease","arthritis"],"scientific_title":"Novel treatment approaches to prevent joint fusion in ankylosing spondylitis","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Dr Gethin Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1006450","simplified_title":"Novel treatments for ankylosing spondylitis","sub_type":"Standard Project Grant","total_budget":"477440.03","source_system":"Ankylosing spondylitis (AS) is a form of arthritis targeting the spine and pelvis that causes uncontrolled bone formation resulting in complete joint fusion, severe disability and even death for which no therapies are currently available. Using a mouse model that closely replicates the human disease we will characterise the changes causing this joint fusion and identify possible new targets to develop novel treatments."},"children":[{"color":"#336699","name":"Dr Gethin Thomas","data":{"first_name":"Gethin","title":"Dr","dw_individual_id":"DW0022525","middle_name":"Penar","last_name":"Thomas","source_individual_id":"5017886","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Gethin Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82800","size":1},{"color":"#336699","name":"Dr Allison Pettit","data":{"first_name":"Allison","title":"Dr","dw_individual_id":"DW0015560","middle_name":"Robyn","last_name":"Pettit","source_individual_id":"5016963","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Allison Pettit"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80923","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66377","size":1},{"color":"#FF4D4D","name":"Understanding the structure/function relationships of the iron regulatory peptide hepcidin","data":{"media_summary":"","end_year":2014,"keywords":["regulatory peptides","iron metabolism","drug design","haemochromatosis"],"nhmrc_grant_id":1006423,"application_year":2010,"health_keywords":["haemochromatosis","therapeutics","drug design","iron metabolism"],"scientific_title":"Understanding the structure/function relationships of the iron regulatory peptide hepcidin","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Dr Richard Clark","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1006423","simplified_title":"Structure/function studies of hepcidin","sub_type":"Standard Project Grant","total_budget":"365126.43","source_system":"This project seeks to understand the interactions between the peptide hormone hepcidin and its receptor and use this information to develop new drugs. Hepcidin is the major iron-regulatory hormone in humans and a range of iron-related diseases are caused by incorrect levels of this hormone. Many Australians are affected by these diseases so the development of hepcidin-based treatments has the potential to have significant impact on the overall health of the community."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Dr Richard Clark","data":{"first_name":"Richard","title":"Dr","dw_individual_id":"DW0029966","middle_name":"James","last_name":"Clark","source_individual_id":"5013970","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Richard Clark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84761","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66373","size":1},{"color":"#FF4D4D","name":"Neural correlates of fear conditioning and extinction","data":{"media_summary":"","end_year":2015,"keywords":["amygdala","learning","sensory systems","electrophysiology"],"nhmrc_grant_id":1006316,"application_year":2010,"health_keywords":["anxiety disorders","memory related disorders","phobias"],"scientific_title":"Neural correlates of fear conditioning and extinction","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Pankaj Sah","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1006316","simplified_title":"Memory formation and erasure","sub_type":"Standard Project Grant","total_budget":"898597.6","source_system":"The amygdala is a part of the brain that processes emotional information.  Disorders of amygdala function lead to a host of anxiety-related disorders such as phobias and post-traumatic stress disorder.  In this grant we will study how the amygdala processes sensory information from the environment and forms memories of salient events. These findings will tell us how memories are formed, stored and retrieved. In the long term it will provide targets for the development of new anxiolytic agents"},"children":[{"color":"#336699","name":"Prof Pankaj Sah","data":{"first_name":"Pankaj","title":"Prof","dw_individual_id":"DW0033583","middle_name":"","last_name":"Sah","source_individual_id":"5017304","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Pankaj Sah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85693","size":1},{"color":"#336699","name":"Dr Francois Windels","data":{"first_name":"Francois","title":"Dr","dw_individual_id":"DW0005486","middle_name":"","last_name":"Windels","source_individual_id":"5020061","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Francois Windels"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78194","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66364","size":1},{"color":"#FF4D4D","name":"From maps to efficient multi-parasite control in the Philippines","data":{"media_summary":"","end_year":2013,"keywords":["epidemiology","disease modelling","disease transmission","mathematical modelling","parasitology"],"nhmrc_grant_id":1006254,"application_year":2010,"health_keywords":["schistosomiasis","helminth infection","health economics"],"scientific_title":"From maps to efficient multi-parasite control in the Philippines","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Archie Clements","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1006254","simplified_title":"Mapping parasites in the Philippines","sub_type":"New Investigator Grant","total_budget":"358121.72","source_system":"Schistosomiasis and soil-transmitted helminths are major parasitic infections in Asia, causing anaemia, poor growth and poor school performance and death in some chronic schistosomiasis cases. We will use maps to demonstrate the geographic distribution of these parasites in the Philippines. We will estimate the impact and costs and benefits of parasite control programmes. This research will help plan more efficient parasite control and reduce the impact of these infections in the Philippines."},"children":[{"color":"#336699","name":"Dr Darren Gray","data":{"first_name":"Darren","title":"Dr","dw_individual_id":"DW0025164","middle_name":"James","last_name":"Gray","source_individual_id":"5020033","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Darren Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83474","size":1},{"color":"#336699","name":"Prof Archie Clements","data":{"first_name":"Archie","title":"Prof","dw_individual_id":"DW0024164","middle_name":"Campbell Adair","last_name":"Clements","source_individual_id":"5012114","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Archie Clements"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83203","size":1},{"color":"#336699","name":"Dr Kate Halton","data":{"first_name":"Kate","title":"Dr","dw_individual_id":"DW0019418","middle_name":"","last_name":"Halton","source_individual_id":"5020316","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kate Halton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81941","size":1},{"color":"#336699","name":"Dr Juan Antonio Solon","data":{"first_name":"Juan Antonio","title":"Dr","dw_individual_id":"DW0010372","middle_name":"Aseniero","last_name":"Solon","source_individual_id":"5024276","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Juan Antonio Solon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79519","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66360","size":1},{"color":"#FF4D4D","name":"TNF traffic and secretion in astrocytes and microglial cells: unveilling new targets for ischemic stroke","data":{"media_summary":"","end_year":2013,"keywords":["trafficking","microglia","exocytosis","anti-inflammatory","Golgi"],"nhmrc_grant_id":1005964,"application_year":2010,"health_keywords":["acute stroke","anti-inflammatory","Alzheimer disease","multiple sclerosis (MS)"],"scientific_title":"TNF traffic and secretion in astrocytes and microglial cells: unveilling new targets for ischemic stroke","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Frederic Meunier","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1005964","simplified_title":"Traffic and secretion of TNF in glial cells in health and disease","sub_type":"Standard Project Grant","total_budget":"585070.52","source_system":"Neurodegenerative disorders share a similar pathway to disastrous neurotoxicity, which occurs through the release of cytokines such as tumour necrosis factor-_ (TNF) from glial cells. TNF controls inflammation but its excessive secretion in the brain is highly detrimental. The mechanism of TNF secretion is unknown but strategies aimed at reducing it have therapeutic potential. This grant proposes to study TNF discharge to find new ways to reduce secretion and confer protection in a stroke model."},"children":[{"color":"#336699","name":"Prof Frederic Meunier","data":{"first_name":"Frederic","title":"Prof","dw_individual_id":"DW0020864","middle_name":"A","last_name":"Meunier","source_individual_id":"5016455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frederic Meunier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82341","size":1},{"color":"#336699","name":"A/Pr Thiruma Arumugam","data":{"first_name":"Thiruma","title":"A/Pr","dw_individual_id":"DW0011513","middle_name":"Valavan","last_name":"Arumugam","source_individual_id":"5019753","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thiruma Arumugam"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79828","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66327","size":1},{"color":"#FF4D4D","name":"The putative drug metabolising enzyme SULT4A1 is a sulfotransferase inhibitor","data":{"media_summary":"","end_year":2013,"keywords":["metabolism","sulfotransferase","binding protein"],"nhmrc_grant_id":1005899,"application_year":2010,"health_keywords":["metabolism","sulfotransferase","binding protein"],"scientific_title":"The putative drug metabolising enzyme SULT4A1 is a sulfotransferase inhibitor","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Rodney Minchin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1005899","simplified_title":"A novel approach to controlling drug metabolism by sulfation","sub_type":"Standard Project Grant","total_budget":"467851.91","source_system":"The sulfotransferase SULT4A1 is a novel protein found predominantly in neurons but its function is unknown. This project will investigate the mechanisms that the body uses to regulate the levels of this protein and how it may interfere with other enzymes essential for metabolising hormones and neurotransmitters."},"children":[{"color":"#336699","name":"Prof Rodney Minchin","data":{"first_name":"Rodney","title":"Prof","dw_individual_id":"DW0026778","middle_name":"F","last_name":"Minchin","source_individual_id":"5016513","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Rodney Minchin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83936","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66322","size":1},{"color":"#FF4D4D","name":"Development of the cerebral cortex","data":{"media_summary":"","end_year":2015,"keywords":["axon guidance","cerebral cortex","brain development"],"nhmrc_grant_id":1005751,"application_year":2010,"health_keywords":["mental retardation","brain abnormalities","brain pathways"],"scientific_title":"Development of the cerebral cortex","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Linda Richards","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1005751","simplified_title":"Development of the cerebral cortex","sub_type":"Research Fellowship","total_budget":"724883.6","source_system":"The mammalian cerebral cortex is an area of the brain responsible for all higher order cognitive processes. I investigate how connections from between the two cerebral hemispheres during embryonic and foetal development, thus enabling the brain to coordinate information from the two sides of the body.  Malformations of these connections cause mental retardation and sensory and motor deficits.  I want to understand how these brain defects occur and how best to treat them."},"children":[{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66310","size":1},{"color":"#FF4D4D","name":"Development of Novel Hybrid Antibiotics for the Treatment of Hospital and Community Acquired Drug Resistant Gram-Negative and Gram-Postitive Bacterial Infections","data":{"media_summary":"","end_year":2014,"keywords":["medicinal chemistry","microbiology","drug resistance"],"nhmrc_grant_id":1005350,"application_year":2010,"health_keywords":["bacterial infection","antibiotic resistance","drug discovery"],"scientific_title":"Development of Novel Hybrid Antibiotics for the Treatment of Hospital and Community Acquired Drug Resistant Gram-Negative and Gram-Postitive Bacterial Infections","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Infection Agents (incl. Prions)","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Matthew Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1005350","simplified_title":"Membrane Targeted  Antibiotics Against Resistant Bacteria","sub_type":"Standard Project Grant","total_budget":"715076.81","source_system":"Drug resistant bacteria now pose a serious and growing threat to human health.  Many bacteria have developed new resistance mechanisms such that most common antibiotics no longer can protect patients from serious, life-threatening infection.  We will modify two existing antibiotics, colistin and carbapenem (a penicillin), to convert it into a more powerful antibiotic that targets resistant bacteria."},"children":[{"color":"#336699","name":"Prof David Paterson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0027242","middle_name":"Leslie","last_name":"Paterson","source_individual_id":"5012495","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Paterson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84040","size":1},{"color":"#336699","name":"Prof Matthew Cooper","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0024249","middle_name":"A","last_name":"Cooper","source_individual_id":"5018347","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83230","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66297","size":1},{"color":"#FF4D4D","name":"Role of macrophages in uropathogenic E. coli infections","data":{"media_summary":"","end_year":2014,"keywords":["Escherichia coli","urinary tract infection (UTI)","macrophages"],"nhmrc_grant_id":1005315,"application_year":2010,"health_keywords":["urinary tract infection (UTI)","infectious diseases","macrophages"],"scientific_title":"Role of macrophages in uropathogenic E. coli infections","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Mark Schembri","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1005315","simplified_title":"The role of immune cells in urinary tract infections","sub_type":"Standard Project Grant","total_budget":"574890.52","source_system":"Urinary tract infections (UTI) are one of the most common types of infections in humans. They are also a major cause of septic shock, a condition with high fatality rates. Uropathogenic Escherichia coli (UPEC) are the major microbes causing UTI in humans. This project addresses the role of an immune cell type, the macrophage, in UPEC-mediated disease. The outcomes of this project will be a better understanding of how UPEC causes disease, and potentially new treatment regimes for UTI."},"children":[{"color":"#336699","name":"A/Pr Glen Ulett","data":{"first_name":"Glen","title":"A/Pr","dw_individual_id":"DW0045957","middle_name":"C","last_name":"Ulett","source_individual_id":"RMIS495516","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Glen Ulett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88899","size":1},{"color":"#336699","name":"A/Pr Timothy Ravasi","data":{"first_name":"Timothy","title":"A/Pr","dw_individual_id":"DW0033345","middle_name":"","last_name":"Ravasi","source_individual_id":"5023765","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Timothy Ravasi"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85634","size":1},{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1},{"color":"#336699","name":"Prof Mark Schembri","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0016088","middle_name":"A","last_name":"Schembri","source_individual_id":"5017368","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Schembri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81054","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66290","size":1},{"color":"#FF4D4D","name":"Effects of nevogenesis susceptibility genes and phenotypic correlation with dermoscopic characteristics of nevi","data":{"media_summary":"skin cancer","end_year":2013,"keywords":["melanoma","morphology","genetic epidemiology","naevi","quantitative genetics"],"nhmrc_grant_id":1004999,"application_year":2010,"health_keywords":["malignant skin melanoma","melanoma","cancer biology","skin colour","skin cancer"],"scientific_title":"Effects of nevogenesis susceptibility genes and phenotypic correlation with dermoscopic characteristics of nevi","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Dermatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof H. Peter Soyer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1004999","simplified_title":"Genotypic, phenotypic and dermoscopic characteristics of nevi","sub_type":"Standard Project Grant","total_budget":"554099.57","source_system":"Melanoma is a form of skin cancer that arises from the cells that produce pigment and is a major public health issue in Australia. We will examine the relationship between the form, structure and colour of existing types of moles and their subsequent risk of developing into melanoma. This will be the first study to combine dermoscopy, a non-invasive examination technique, with DNA tests of the genes that determine skin, hair and eye colour, aiding in the early prediction and diagnosis of skin cancer."},"children":[{"color":"#336699","name":"A/Pr Richard Sturm","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0045672","middle_name":"Alan","last_name":"Sturm","source_individual_id":"5017777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Sturm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88811","size":1},{"color":"#336699","name":"Prof Bernard Smithers","data":{"first_name":"Bernard","title":"Prof","dw_individual_id":"DW0039773","middle_name":"Mark","last_name":"Smithers","source_individual_id":"5019539","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bernard Smithers"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87308","size":1},{"color":"#336699","name":"Prof H. Peter Soyer","data":{"first_name":"H. Peter","title":"Prof","dw_individual_id":"DW0028088","middle_name":"","last_name":"Soyer","source_individual_id":"5019889","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof H. Peter Soyer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84249","size":1},{"color":"#336699","name":"Dr David Duffy","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0012817","middle_name":"Lorenzo","last_name":"Duffy","source_individual_id":"5014423","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David Duffy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80170","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66282","size":1},{"color":"#FF4D4D","name":"Role of extracellular surface residues in agonist activation of the alpha1 adrenoceptor","data":{"media_summary":"G protein-coupled receptors","end_year":2013,"keywords":["G protein-coupled receptors","noradrenaline","structure-function","adrenoceptors","angiotensin receptor"],"nhmrc_grant_id":1004602,"application_year":2010,"health_keywords":["cardiovascular pharmacology","noradrenaline","angiotensin receptor","structure-function","G protein-coupled receptors"],"scientific_title":"Role of extracellular surface residues in agonist activation of the alpha1 adrenoceptor","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Richard Lewis","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1004602","simplified_title":"A new approach to understanding how to design better drugs","sub_type":"Standard Project Grant","total_budget":"414786.47","source_system":"Most modern drugs act on a class of cellular proteins known as GPCRs. Despite their importance, little is known about how agonists acting from the outside of cells produce a change in GPCR structure allowing signalling to the cell's interior. We have identified new residues on the extracellular surface of the alpha1 adrenoceptor that dramatically affect agonist responses, opening the door to understanding the molecular process of GPCR activation and the development of drugs that can target different GPCR conformations."},"children":[{"color":"#336699","name":"Prof Walter Thomas","data":{"first_name":"Walter","title":"Prof","dw_individual_id":"DW0028371","middle_name":"Glen","last_name":"Thomas","source_individual_id":"RMIS225046","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Walter Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84337","size":1},{"color":"#336699","name":"Prof Richard Lewis","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0014455","middle_name":"J","last_name":"Lewis","source_individual_id":"5015973","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Lewis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80612","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66251","size":1},{"color":"#FF4D4D","name":"Celluar basis of cortico-cortical integration","data":{"media_summary":"","end_year":2013,"keywords":["synaptic transmission","neocortex","dendrites","sensorimotor cortex","ion channels"],"nhmrc_grant_id":1004575,"application_year":2010,"health_keywords":["mental disease","schizophrenia and related disorders","mental retardation"],"scientific_title":"Celluar basis of cortico-cortical integration","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Stephen Williams","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1004575","simplified_title":"How do areas of the neocortex communicate?","sub_type":"New Investigator Grant","total_budget":"349590.19","source_system":"The neocortex is the region of the brain that underlies all cognitive functions. Mental disorders, such as schizophrenia, occur when the communication between nerve cells in the neocortex breaks down. We propose to make electrical measurements from the thin processes of neurons that receive input from widely separated neocortical areas to understand how areas of the neocortex are functionally interlinked, with the ultimate aim to identify how these processes are disturbed in mental disorders."},"children":[{"color":"#336699","name":"Prof Stephen Williams","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0046308","middle_name":"Richard","last_name":"Williams","source_individual_id":"5020043","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stephen Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88993","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66247","size":1},{"color":"#FF4D4D","name":"Targeting the Pathophysiology and Therapy of Liver Fibrosis","data":{"media_summary":"","end_year":2013,"keywords":["fibrosis","hepatic fibrosis","hepatic stellate cells"],"nhmrc_grant_id":1004517,"application_year":2010,"health_keywords":["liver fibrosis","cholestasis","liver cirrhosis"],"scientific_title":"Targeting the Pathophysiology and Therapy of Liver Fibrosis","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Darrell Crawford","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1004517","simplified_title":"Pathophysiology of Liver Fibrosis","sub_type":"Standard Project Grant","total_budget":"484006.63","source_system":"Hepatic fibrosis, or scarring of the liver, is a serious condition which can lead to liver cancer or death. Treatment of liver scarring is currently not effective once the scarring is well developed. This project aims to examine agents which may act to halt liver scarring once it has already developed. Outcomes from this project may help provide potential treatments to reduce the need for liver transplantation or to reduce patient deaths."},"children":[{"color":"#336699","name":"Dr Kim Bridle","data":{"first_name":"Kim","title":"Dr","dw_individual_id":"DW0017903","middle_name":"R","last_name":"Bridle","source_individual_id":"RMIS2353158","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Kim Bridle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81571","size":1},{"color":"#336699","name":"Prof Darrell Crawford","data":{"first_name":"Darrell","title":"Prof","dw_individual_id":"DW0006770","middle_name":"Henry Gordon","last_name":"Crawford","source_individual_id":"5012156","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Darrell Crawford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78535","size":1},{"color":"#336699","name":"A/Pr Julie Jonsson","data":{"first_name":"Julie","title":"A/Pr","dw_individual_id":"DW0002506","middle_name":"R","last_name":"Jonsson","source_individual_id":"5015557","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Julie Jonsson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77348","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66241","size":1},{"color":"#FF4D4D","name":"Delineating the role of advanced glycation in diabetes and nephropathy","data":{"media_summary":"kidney disease","end_year":2015,"keywords":["diabetic nephropathy","advanced glycation","mitochondria","kidney disease","insulin secretion"],"nhmrc_grant_id":1004503,"application_year":2010,"health_keywords":["diabetic nephropathy","diabetes mellitus","nephrology","insulin secretion","kidney disease"],"scientific_title":"Delineating the role of advanced glycation in diabetes and nephropathy","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Basic Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Josephine Forbes","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1004503","simplified_title":"Pathways of damage in diabetes and kidney disease","sub_type":"Research Fellowship","total_budget":"628821.4","source_system":"Type 1 diabetes affects more than 140,000 Australians and up to 40% of children and adolescents with the disease develop complications including kidney disease. Excess blood sugar as the result of diabetes can accelerate a biochemical process called advanced glycation, which permanently alters proteins affecting their structure and function, which I have previously shown as contributors to kidney damage in diabetes.  Recently, however, I have discovered that this biochemical process is also involved in the development of type 1 diabetes itself."},"children":[{"color":"#336699","name":"Prof Josephine Forbes","data":{"first_name":"Josephine","title":"Prof","dw_individual_id":"DW0001615","middle_name":"M","last_name":"Forbes","source_individual_id":"RMIS6864876","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Josephine Forbes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77115","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66240","size":1},{"color":"#FF4D4D","name":"Therapeutic Targeting of Complement C5a Receptors in Huntingtons Disease","data":{"media_summary":"","end_year":2013,"keywords":["Huntington's disease","complement C5a","therapeutic target","neuroinflammation"],"nhmrc_grant_id":1004455,"application_year":2010,"health_keywords":["Huntington's disease","neurodegeneration","therapeutic target","complement C5a"],"scientific_title":"Therapeutic Targeting of Complement C5a Receptors in Huntingtons Disease","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology and Pharmaceutical Sciences not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"A/Pr Trent Woodruff","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1004455","simplified_title":"Targeting Inflammation in Huntingtons Disease","sub_type":"Standard Project Grant","total_budget":"468312.58","source_system":"Huntingtons disease is a genetic neurodegenerative condition leading to progressive cognitive and motor deficits and eventual death. This research aims to explore the role of immune and inflammatory pathways in the progression of disease in patients suffering Huntingtons disease, as well as in an animal model of this condition. By exploring these immune and inflammatory pathways, we aim to identify novel therapeutic targets to treat Huntingtons disease."},"children":[{"color":"#336699","name":"A/Pr Peter Noakes","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0038807","middle_name":"G","last_name":"Noakes","source_individual_id":"5016732","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Noakes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87053","size":1},{"color":"#336699","name":"A/Pr Trent Woodruff","data":{"first_name":"Trent","title":"A/Pr","dw_individual_id":"DW0011172","middle_name":"Martin","last_name":"Woodruff","source_individual_id":"5018447","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Trent Woodruff"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79741","size":1},{"color":"#336699","name":"Prof Stephen Taylor","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0010587","middle_name":"M","last_name":"Taylor","source_individual_id":"RMIS41211","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79577","size":1},{"color":"#336699","name":"A/Pr John O'Sullivan","data":{"first_name":"John","title":"A/Pr","dw_individual_id":"DW0003804","middle_name":"Daniel","last_name":"O'Sullivan","source_individual_id":"5024118","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr John O'Sullivan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77724","size":1},{"color":"#336699","name":"Dr Estifanos Ghebremedhin","data":{"first_name":"Estifanos","title":"Dr","dw_individual_id":"DW0001756","middle_name":"","last_name":"Ghebremedhin","source_individual_id":"5022930","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Estifanos Ghebremedhin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77151","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66234","size":1},{"color":"#FF4D4D","name":"The role of obesity, insulin resistance and fatty liver (steatosis) in human disease and strategies to monitor and improve patient outcomes","data":{"media_summary":"","end_year":2015,"keywords":["liver","hepatitis C infection","lifestyle factors","metabolic syndrome","fatty liver disease"],"nhmrc_grant_id":1004242,"application_year":2010,"health_keywords":["hepatitis C virus","fatty liver disease","fibrosis","lifestyle factors"],"scientific_title":"The role of obesity, insulin resistance and fatty liver (steatosis) in human disease and strategies to monitor and improve patient outcomes","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Elizabeth Powell","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1004242","simplified_title":"The role of obesity, insulin resistance and fatty liver (steatosis) in human disease and strategies to monitor and improve patient outcomes","sub_type":"Practitioner Fellowship","total_budget":"321710.87","source_system":"The overall objective of my research activity is to examine in human subjects, the mechanisms by which obesity and fatty liver impair the response of the liver to injury and inflammation from multiple causes and to develop specific strategies to monitor and improve the outcome of treatment in overweight patients with liver disease."},"children":[{"color":"#336699","name":"Prof Elizabeth Powell","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0044903","middle_name":"Ellen","last_name":"Powell","source_individual_id":"RMIS13575","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Powell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88622","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66220","size":1},{"color":"#FF4D4D","name":"COMBIT: Randomised Controlled Trial of Novel Upper Neurorehabilitation for Congenital Hemiplegia","data":{"media_summary":"participation","end_year":2013,"keywords":["cerebral palsy treatments","neuroscience","magnetic resonance imaging (MRI)","rehabilitation"],"nhmrc_grant_id":1003887,"application_year":2010,"health_keywords":["cerebral palsy","cerebral cortex","rehabilitation","quality of life","participation"],"scientific_title":"COMBIT: Randomised Controlled Trial of Novel Upper Neurorehabilitation for Congenital Hemiplegia","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Prof Roslyn Boyd","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1003887","simplified_title":"Novel Rehabilitation for Hemiplegia","sub_type":"Standard Project Grant","total_budget":"486588.72","source_system":"Cerebral palsy is the most common disability in children - there are over one million children with the hemiplegic form in the industrialised world. Rehabilitation to improve hand use impacts on daily care, access to education and vocational aspirations, and consumes a great deal of time and money. Our team wishes to test a novel COMbined Constraint and BImanual Training study (COMBIT) in a randomized controlled trial investigating upper limb function, participation and mechanisms of action of the intervention."},"children":[{"color":"#336699","name":"Prof Roslyn Boyd","data":{"first_name":"Roslyn","title":"Prof","dw_individual_id":"DW0041223","middle_name":"N","last_name":"Boyd","source_individual_id":"RMIS1681246","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roslyn Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87689","size":1},{"color":"#336699","name":"Prof Richard Macdonell","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0038206","middle_name":"Alan","last_name":"Macdonell","source_individual_id":"5024033","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Macdonell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86902","size":1},{"color":"#336699","name":"Prof Jenny Ziviani","data":{"first_name":"Jenny","title":"Prof","dw_individual_id":"DW0029064","middle_name":"M","last_name":"Ziviani","source_individual_id":"5018596","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jenny Ziviani"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84541","size":1},{"color":"#336699","name":"Dr David Abbott","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0011354","middle_name":"F","last_name":"Abbott","source_individual_id":"RMIS460186","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr David Abbott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79786","size":1},{"color":"#336699","name":"A/Pr Stephen Rose","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0009965","middle_name":"E","last_name":"Rose","source_individual_id":"5017273","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Stephen Rose"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79404","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66175","size":1},{"color":"#FF4D4D","name":"Real-time Imaging of cell cycle progression in melanoma","data":{"media_summary":"targeted therapy","end_year":2014,"keywords":["melanoma","cell cycle","microenvironment","targeted therapy","imaging"],"nhmrc_grant_id":1003637,"application_year":2010,"health_keywords":["melanoma","cancer metastasis","anticancer drug action","drug resistance","targeted therapy"],"scientific_title":"Real-time Imaging of cell cycle progression in melanoma","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Cell Biology","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"A/Pr Nikolas Haass","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1003637","simplified_title":"Real-time cell cycle analysis of melanoma","sub_type":"Standard Project Grant","total_budget":"526911.46","source_system":"Melanoma is the most aggressive skin cancer and is highly therapy resistant, reasons of which are poorly understood. Here we hypothesise that differences in the growth capacity of melanoma cells in different tumour regions contribute to therapy resistance. We will use a novel microscopic system that allows us to visualise division of individual melanoma cells in intact tumours in real time. Using this system, we will test the effects of targeted therapies on melanoma cell growth and survival."},"children":[{"color":"#336699","name":"Prof Wolfgang Weninger","data":{"first_name":"Wolfgang","title":"Prof","dw_individual_id":"DW0040399","middle_name":"","last_name":"Weninger","source_individual_id":"5019396","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Wolfgang Weninger"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87467","size":1},{"color":"#336699","name":"A/Pr Nikolas Haass","data":{"first_name":"Nikolas","title":"A/Pr","dw_individual_id":"DW0013416","middle_name":"K","last_name":"Haass","source_individual_id":"5015005","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nikolas Haass"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80324","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66154","size":1},{"color":"#FF4D4D","name":"Toll-like receptors and innate immunity: genes and pathways regulating infectious and inflammatory diseases","data":{"media_summary":"salmonellosis","end_year":2015,"keywords":["Toll-like receptors","macrophage activation","inflammation","histone deacetylase","Salmonella typhimurium"],"nhmrc_grant_id":1003470,"application_year":2010,"health_keywords":["inflammatory mediators","inflammatory diseases","infectious diseases","rheumatoid arthritis","salmonellosis"],"scientific_title":"Toll-like receptors and innate immunity: genes and pathways regulating infectious and inflammatory diseases","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Innate Immunity","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"A/Pr Matthew Sweet","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1003470","simplified_title":"Innate immunity in infectious and inflammatory diseases","sub_type":"Research Fellowship","total_budget":"122329.06","source_system":"The innate immune system is the first line of defence against infectious diseases, but also contributes to the pathology of inflammatory diseases (e.g. rheumatoid arthritis). I study specific genes and pathways used by the innate immune system to (1) understand how the innate immune system prevents infections and how microorganisms overcome these defences, and (2) develop approaches to block inflammation. Outcomes may include new therapies for inflammatory and infectious diseases."},"children":[{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66134","size":1},{"color":"#FF4D4D","name":"Investigation of the role of Nfix in adult neurogenesis","data":{"media_summary":"","end_year":2013,"keywords":["stem cell biology","neurogenesis","transcription factor"],"nhmrc_grant_id":1003462,"application_year":2010,"health_keywords":["stem cell biology","neurogenesis","neurodegeneration"],"scientific_title":"Investigation of the role of Nfix in adult neurogenesis","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Michael Piper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1003462","simplified_title":"Molecular regulation of adult neurogenesis","sub_type":"New Investigator Grant","total_budget":"349590.19","source_system":"This project will identify key components of the molecular roadmap that  mediates adult neurogenesis. Elucidating the genes involved in this process will represent a major advance in our understanding of how neurogenesis within the adult brain is orchestrated, and will provide molecular targets for practical applications aimed at harnessing adult neurogenesis for replacement therapies."},"children":[{"color":"#336699","name":"Dr Michael Piper","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0021487","middle_name":"J","last_name":"Piper","source_individual_id":"RMIS3987189","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Michael Piper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82523","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66133","size":1},{"color":"#FF4D4D","name":"Molecular and structural basis of signalling by TIR domain-containing adaptors in TLR pathways","data":{"media_summary":"","end_year":2014,"keywords":["Toll-like receptors","structural biology","protein-protein interaction","structural immunology","innate immunity"],"nhmrc_grant_id":1003326,"application_year":2010,"health_keywords":["innate immunity","inflammatory diseases","peptide inhibitors"],"scientific_title":"Molecular and structural basis of signalling by TIR domain-containing adaptors in TLR pathways","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Structural Biology (incl. Macromolecular Modelling)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Bostjan Kobe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1003326","simplified_title":"Understanding the molecular mechanisms of signalling in innate immunity signalling pathways","sub_type":"Standard Project Grant","total_budget":"666417.59","source_system":"Humans first detect the presence of pathogens and respond to them through specific pathways termed innate immune pathways. The proposed research will study proteins that participate in these pathways, in particular their three-dimensional structures and how they interact with each other, to understand how they work together to mount an immune response, and to find ways to modulate this response in infectious diseases as well as chronic inflammatory diseases."},"children":[{"color":"#336699","name":"Prof Nick Gay","data":{"first_name":"Nick","title":"Prof","dw_individual_id":"DW0036797","middle_name":"","last_name":"Gay","source_individual_id":"5023061","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nick Gay"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86530","size":1},{"color":"#336699","name":"Prof Bostjan Kobe","data":{"first_name":"Bostjan","title":"Prof","dw_individual_id":"DW0031827","middle_name":"","last_name":"Kobe","source_individual_id":"5011436","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bostjan Kobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85237","size":1},{"color":"#336699","name":"Dr Ashley Mansell","data":{"first_name":"Ashley","title":"Dr","dw_individual_id":"DW0026490","middle_name":"","last_name":"Mansell","source_individual_id":"RMIS2022114","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Ashley Mansell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83847","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66116","size":1},{"color":"#FF4D4D","name":"Structural biology of infection and immunity","data":{"media_summary":"","end_year":2015,"keywords":["protein structure","protein-protein interaction","bioinformatics","bacterial pathogenesis","immunity"],"nhmrc_grant_id":1003325,"application_year":2010,"health_keywords":["bacterial infection","innate immunity","inflammation"],"scientific_title":"Structural biology of infection and immunity","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Structural Biology (incl. Macromolecular Modelling)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Bostjan Kobe","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1003325","simplified_title":"Structural biology of infection and immunity","sub_type":"Research Fellowship","total_budget":"662151.88","source_system":"I am a biochemist focussed on understanding how the structures of proteins determine their functions. I intend to apply this understanding to medically relevant questions by working collaboratively and using a range of complementary structural, computational and cell biology techniques. In particular, I will focus on proteins involved in infection and immunity, to understand how they work, and contribute to the development of drugs and vaccines."},"children":[{"color":"#336699","name":"Prof Bostjan Kobe","data":{"first_name":"Bostjan","title":"Prof","dw_individual_id":"DW0031827","middle_name":"","last_name":"Kobe","source_individual_id":"5011436","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bostjan Kobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85237","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66115","size":1},{"color":"#FF4D4D","name":"SELECTIVE VULNERABILITY IN ALZHEIMERS DISEASE AND RELATED DISORDERS: MECHANISM OF TAU PATHOLOGY","data":{"media_summary":"","end_year":2014,"keywords":["Alzheimer disease","genomics","transgenesis","Parkinson disease","frontotemporal dementia"],"nhmrc_grant_id":1003150,"application_year":2010,"health_keywords":["Alzheimer disease","Parkinson disease","frontotemporal dementia","ageing"],"scientific_title":"SELECTIVE VULNERABILITY IN ALZHEIMERS DISEASE AND RELATED DISORDERS: MECHANISM OF TAU PATHOLOGY","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Jurgen Gotz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1003150","simplified_title":"SELECTIVE VULNERABILITY IN ALZHEIMERS DISEASE AND RELATED DISORDERS","sub_type":"Standard Project Grant","total_budget":"1072324.55","source_system":"Alzheimers disease and related dementias affect 230,000 people in Australia, with numbers expected to grow to 730,000 by 2050. The direct costs for health and residential care alone exceed $6.6 billion per annum. By identifying genes that protect degenerating neurons in the Alzheimer brain, a deeper understanding of the underlying processes will be gained and therapeutic targets will be defined that will assist in developing a therapy for a yet uncurable disease."},"children":[{"color":"#336699","name":"Prof Lars Ittner","data":{"first_name":"Lars","title":"Prof","dw_individual_id":"DW0031512","middle_name":"Matthias","last_name":"Ittner","source_individual_id":"5015435","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Lars Ittner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85158","size":1},{"color":"#336699","name":"Prof Jurgen Gotz","data":{"first_name":"Jurgen","title":"Prof","dw_individual_id":"DW0019243","middle_name":"","last_name":"Gotz","source_individual_id":"5014902","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jurgen Gotz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81906","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66102","size":1},{"color":"#FF4D4D","name":"Monocytes/macrophages in chronic liver diseases: cross-talk with hepatocytes and nonparenchymal cells and role in progressive liver injury","data":{"media_summary":"hepatitis","end_year":2013,"keywords":["hepatic fibrosis","monocyte/macrophage","hepatic steatosis","obesity","insulin resistance"],"nhmrc_grant_id":1003108,"application_year":2010,"health_keywords":["hepatic fibrosis","obesity","nonalcoholic steatohepatitis","chronic inflammation","hepatitis"],"scientific_title":"Monocytes/macrophages in chronic liver diseases: cross-talk with hepatocytes and nonparenchymal cells and role in progressive liver injury","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gastroenterology and Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Elizabeth Powell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1003108","simplified_title":"Communication between cells of the liver: role in progressive liver injury","sub_type":"Standard Project Grant","total_budget":"598645.42","source_system":"More than 170 million people world-wide are chronically infected with the hepatitis C virus. Approximately 10-15% of chronically infected subjects develop cirrhosis with its attendant risks of liver failure and hepatocellular carcinoma. The objective of this important project is to examine the mechanisms by which monocytes and macrophages (cells of the immune system) enhance or impair the progression of liver disease and response to antiviral treatment in patients with chronic hepatitis C."},"children":[{"color":"#336699","name":"Prof Elizabeth Powell","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0044903","middle_name":"Ellen","last_name":"Powell","source_individual_id":"RMIS13575","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Powell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88622","size":1},{"color":"#336699","name":"A/Pr Andrew Clouston","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0030002","middle_name":"Donald","last_name":"Clouston","source_individual_id":"RMIS228640","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Andrew Clouston"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84776","size":1},{"color":"#336699","name":"A/Pr Julie Jonsson","data":{"first_name":"Julie","title":"A/Pr","dw_individual_id":"DW0002506","middle_name":"R","last_name":"Jonsson","source_individual_id":"5015557","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Julie Jonsson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77348","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66096","size":1},{"color":"#FF4D4D","name":"Epigenetic and neurobehavioural changes in a new mouse model of foetal alcohol spectrum disorders.","data":{"media_summary":"","end_year":2014,"keywords":["epigenetics","alcohol","brain development","mouse models"],"nhmrc_grant_id":1003038,"application_year":2010,"health_keywords":["prenatal programming","neurodevelopmental disorders","behaviour disorders"],"scientific_title":"Epigenetic and neurobehavioural changes in a new mouse model of foetal alcohol spectrum disorders.","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Epigenetics (incl. Genome Methylation and Epigenomics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Suyinn Chong","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1003038","simplified_title":"A study of the molecular, morphological and behavioural changes associated with prenatal alcohol exposure in the mouse.","sub_type":"Standard Project Grant","total_budget":"949466.23","source_system":"Prenatal alcohol exposure can result in foetal alcohol syndrome (FAS) which involves growth restriction, changes to skull morphology, central nervous system defects and intellectual disabilities. At present, diagnosis is difficult and under-reporting is suspected. We are using a mouse model to study the underlying causes of FAS, focussing on changes in brain structure and function. Hopefully we will identify markers that can be used for the early diagnosis of FAS in the future."},"children":[{"color":"#336699","name":"Prof Graham Galloway","data":{"first_name":"Graham","title":"Prof","dw_individual_id":"DW0036756","middle_name":"J","last_name":"Galloway","source_individual_id":"5014770","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Graham Galloway"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86521","size":1},{"color":"#336699","name":"Dr Nyoman Kurniawan","data":{"first_name":"Nyoman","title":"Dr","dw_individual_id":"DW0026087","middle_name":"Dana","last_name":"Kurniawan","source_individual_id":"5023196","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nyoman Kurniawan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83741","size":1},{"color":"#336699","name":"Dr Nina Kaminen-Ahola","data":{"first_name":"Nina","title":"Dr","dw_individual_id":"DW0025866","middle_name":"","last_name":"Kaminen-Ahola","source_individual_id":"5024604","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nina Kaminen-Ahola"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83667","size":1},{"color":"#336699","name":"Dr Suyinn Chong","data":{"first_name":"Suyinn","title":"Dr","dw_individual_id":"DW0012308","middle_name":"","last_name":"Chong","source_individual_id":"5013904","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Suyinn Chong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80030","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66086","size":1},{"color":"#FF4D4D","name":"Protein trafficking in inflammation and disease","data":{"media_summary":"","end_year":2015,"keywords":["protein trafficking","cytokine secretion","cell polarity","host/pathogen interaction"],"nhmrc_grant_id":1003021,"application_year":2010,"health_keywords":["inflammation","cancer cell biology","chronic diseases","infectious diseases"],"scientific_title":"Protein trafficking in inflammation and disease","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Trafficking","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1003021","simplified_title":"Protein trafficking in human disease","sub_type":"Research Fellowship","total_budget":"725021.67","source_system":"Understanding the basic biology of cells will allow us to pinpoint key mechanisms and molecules that underpin multiple diseases and are targets for treatments. The broad aims of this research program include the development of new therapies for chronic inflammatory diseases, understanding how proteins are sorted and trafficked inside cells in processes that are essential to immunity and cancer biology, and identifying new intracellular targets to block bacterial invasion and infectious diseases."},"children":[{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66083","size":1},{"color":"#FF4D4D","name":"Constitutive activation of the growth hormone receptor","data":{"media_summary":"cardiovascular disease","end_year":2013,"keywords":["growth hormone","growth disorders","receptor dimerisation","JAK/STAT pathway","Src-family tyrosine kinases"],"nhmrc_grant_id":1002893,"application_year":2010,"health_keywords":["growth control","diabetes mellitus","muscular dystrophy","cancer biology","cardiovascular disease"],"scientific_title":"Constitutive activation of the growth hormone receptor","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael Waters","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1002893","simplified_title":"Means and significance of activating the growth hormone receptor without hormone","sub_type":"Standard Project Grant","total_budget":"566277.2","source_system":"Growth hormone regulates growth, metabolism, bone, stem cells and longevity, and cancer. These actions are mediated by the GH receptor, and here we seek to understand how it is activated by the hormone through receptor constructs which are active without hormone, to different degrees. We will use these to elucidate its signaling properties, its ability to promote cancer, to grow muscle, and whether cases of giantism and cancer are a consequence of the activating mutations we have identified."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1},{"color":"#336699","name":"Dr Andrew Brooks","data":{"first_name":"Andrew","title":"Dr","dw_individual_id":"DW0017930","middle_name":"James","last_name":"Brooks","source_individual_id":"5022905","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Andrew Brooks"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81582","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66071","size":1},{"color":"#FF4D4D","name":"Identification and characterisation of genes required for cardiac morphogenesis","data":{"media_summary":"","end_year":2014,"keywords":["organogenesis","developmental biology","zebrafish","heart development"],"nhmrc_grant_id":1002884,"application_year":2010,"health_keywords":["heart development","birth defect","organogenesis"],"scientific_title":"Identification and characterisation of genes required for cardiac morphogenesis","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Kelly Smith","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1002884","simplified_title":"Understanding embryonic cardiac development","sub_type":"New Investigator Grant","total_budget":"434706.86","source_system":"The heart is the first organ to become functional as an embryo forms, reflecting its critical role in sustaining life. Mistakes that occur as the heart develops have devastating consequences for an individuals survival and health. We have identified two zebrafish mutants with heart defects and, using sophisticated imaging and genetic studies, will investigate these defects and identify the genes responsible. This research will improve our understanding of correct and diseased heart formation."},"children":[{"color":"#336699","name":"Dr Kelly Smith","data":{"first_name":"Kelly","title":"Dr","dw_individual_id":"DW0022202","middle_name":"Anne","last_name":"Smith","source_individual_id":"5019706","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kelly Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82726","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66068","size":1},{"color":"#FF4D4D","name":"Modelling the regulation of nephron number by the renal stem cell niche.","data":{"media_summary":"Aboriginal health","end_year":2013,"keywords":["kidney development","stem cell biology","mathematical modelling","nephron endowment","cell proliferation"],"nhmrc_grant_id":1002748,"application_year":2010,"health_keywords":["chronic renal failure","nephrogenesis","intrauterine growth retardation","renal dysplasia","Aboriginal health"],"scientific_title":"Modelling the regulation of nephron number by the renal stem cell niche.","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1002748","simplified_title":"How kidney stem cells make nephrons","sub_type":"Standard Project Grant","total_budget":"715935","source_system":"Chronic kidney disease is a growing burden to the health system. The long term health of your kidneys is influenced by the number of functional units, nephrons, present in each kidney, a feature that is determined before birth. If we could influence this number, we may be able to reduce the risk of kidney disease in later life for at risk populations, including the Aboriginal community. This study will investigate the stem cells that form the nephrons, how the process occurs and how it can be influenced."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1},{"color":"#336699","name":"Dr Nicholas Hamilton","data":{"first_name":"Nicholas","title":"Dr","dw_individual_id":"DW0037081","middle_name":"A","last_name":"Hamilton","source_individual_id":"5018862","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nicholas Hamilton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86597","size":1},{"color":"#336699","name":"A/Pr Karen Moritz","data":{"first_name":"Karen","title":"A/Pr","dw_individual_id":"DW0009221","middle_name":"","last_name":"Moritz","source_individual_id":"RMIS1366054","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Karen Moritz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79207","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66057","size":1},{"color":"#FF4D4D","name":"How do p75 and sortilin facilitate TrkA-mediated survival signalling?","data":{"media_summary":"","end_year":2013,"keywords":["neurotrophins","receptor signalling","receptor trafficking","receptor dimerisation","apoptosis of neurons"],"nhmrc_grant_id":1002610,"application_year":2010,"health_keywords":["neurodegeneration","developmental biology","disease mechanisms"],"scientific_title":"How do p75 and sortilin facilitate TrkA-mediated survival signalling?","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Elizabeth Coulson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1002610","simplified_title":"How do neurotrophin receptors signal neuronal survival?","sub_type":"Standard Project Grant","total_budget":"559354.28","source_system":"Neurotrophins are the classical growth factors that regulate neuronal survival and death throughout the nervous system in both the developing and adult animal. These factors signal through one of three receptors, but precisely how the receptors interact to propagate cell survival is unclear. The goal of this grant is to unravel the molecular basis underpinning this life and death signalling decision so that we can then devise ways to promote cell survival in neurodegenerative conditions"},"children":[{"color":"#336699","name":"A/Pr Elizabeth Coulson","data":{"first_name":"Elizabeth","title":"A/Pr","dw_individual_id":"DW0006736","middle_name":"J","last_name":"Coulson","source_individual_id":"5014079","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Elizabeth Coulson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78524","size":1},{"color":"#336699","name":"Prof Anders Nykjr","data":{"first_name":"Anders","title":"Prof","dw_individual_id":"DW0003724","middle_name":"","last_name":"Nykjr","source_individual_id":"5019983","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Anders Nykjr"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77700","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66035","size":1},{"color":"#FF4D4D","name":"Development of early warning systems for dengue fever based on socio-ecological factors","data":{"media_summary":"","end_year":2014,"keywords":["mosquito-borne disease","prediction","climate variability"],"nhmrc_grant_id":1002608,"application_year":2010,"health_keywords":["vector-borne disease","prediction","climate variability"],"scientific_title":"Development of early warning systems for dengue fever based on socio-ecological factors","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Wenbiao Hu","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1002608","simplified_title":"Develop an early warning system for dengue fever","sub_type":"New Investigator Grant","total_budget":"327402.02","source_system":"Global climate change has potentially serious effects on the transmission of dengue. An early warning system (EWS) based on socio-ecological factors will be developed to examine where and when outbreaks of dengue are likely to occur and how the future dengue control strategies and prevention efforts need to be applied and strengthened in Australia. This project will provide a platform for future research on developing and implementing an EWS for dengue in the Asia-Pacific region."},"children":[{"color":"#336699","name":"Prof Archie Clements","data":{"first_name":"Archie","title":"Prof","dw_individual_id":"DW0024164","middle_name":"Campbell Adair","last_name":"Clements","source_individual_id":"5012114","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Archie Clements"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83203","size":1},{"color":"#336699","name":"Prof Weizhong Yang","data":{"first_name":"Weizhong","title":"Prof","dw_individual_id":"DW0017256","middle_name":"","last_name":"Yang","source_individual_id":"5020771","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Weizhong Yang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81395","size":1},{"color":"#336699","name":"Dr Wenbiao Hu","data":{"first_name":"Wenbiao","title":"Dr","dw_individual_id":"DW0002298","middle_name":"","last_name":"Hu","source_individual_id":"5019952","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Wenbiao Hu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77295","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66034","size":1},{"color":"#FF4D4D","name":"Control of insulin secretion in beta cells","data":{"media_summary":"","end_year":2014,"keywords":["endocrinology","hormone deficiency","diabetes"],"nhmrc_grant_id":1002520,"application_year":2010,"health_keywords":["diabetes","insulin secretion","secretion"],"scientific_title":"Control of insulin secretion in beta cells","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof Peter Thorn","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1002520","simplified_title":"Control of insulin secretion","sub_type":"Standard Project Grant","total_budget":"593888.23","source_system":"Secretion is an essential step in memory and learning, control of metabolism and reproduction and the functioning of most organs. Secretory dysfunction also underlies many diseases including type 2 diabetes. We plan experiments to test for a new model of control of insulin secretion."},"children":[{"color":"#336699","name":"Prof Peter Thorn","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0016656","middle_name":"","last_name":"Thorn","source_individual_id":"5017929","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Thorn"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81226","size":1},{"color":"#336699","name":"Prof Herbert Gaisano","data":{"first_name":"Herbert","title":"Prof","dw_individual_id":"DW0001696","middle_name":"","last_name":"Gaisano","source_individual_id":"5019985","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Herbert Gaisano"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77133","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66023","size":1},{"color":"#FF4D4D","name":"Use of innovative mobile telehealth technology to enable a new service delivery solution for dysphagia management","data":{"media_summary":"","end_year":2013,"keywords":["speech pathology","telemedicine","dysphagia","assessment","health service accessibility"],"nhmrc_grant_id":1002472,"application_year":2010,"health_keywords":["dysphagia","speech pathology","health service accessibility","diagnosis"],"scientific_title":"Use of innovative mobile telehealth technology to enable a new service delivery solution for dysphagia management","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Health Services Research","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Elizabeth Ward","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1002472","simplified_title":"A mobile telehealth system for dysphagia management","sub_type":"Standard Project Grant","total_budget":"207231.38","source_system":"Dysphagia, the term used to describe a swallowing difficulty, affects up to 30% of people over 65 years of age. Speech pathologists are responsible for diagnosing and managing dysphagia, however there is a shortfall between the number of clinicians available and the large number of individuals with this condition. The study aims to validate a way to assess dysphagia using telehealth, to increase access to speech pathology services particularly for patients in rural health settings."},"children":[{"color":"#336699","name":"Prof Elizabeth Ward","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0040334","middle_name":"Celeste","last_name":"Ward","source_individual_id":"RMIS15276","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Ward"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87452","size":1},{"color":"#336699","name":"A/Pr Trevor Russell","data":{"first_name":"Trevor","title":"A/Pr","dw_individual_id":"DW0033555","middle_name":"","last_name":"Russell","source_individual_id":"RMIS3678636","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Trevor Russell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85687","size":1},{"color":"#336699","name":"Prof Deborah Theodoros","data":{"first_name":"Deborah","title":"Prof","dw_individual_id":"DW0022512","middle_name":"Gale","last_name":"Theodoros","source_individual_id":"RMIS15273","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Deborah Theodoros"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82794","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/66014","size":1},{"color":"#FF4D4D","name":"Physiology and pathophysiology of disorders of the musculoskelatal system","data":{"media_summary":"","end_year":2015,"keywords":["physiotherapy","motor control","pain","rehabilitation","electromyography"],"nhmrc_grant_id":1002190,"application_year":2010,"health_keywords":["low back pain","musculoskeletal disorders","incontinence","osteoarthritis"],"scientific_title":"Physiology and pathophysiology of disorders of the musculoskelatal system","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Paul Hodges","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1002190","simplified_title":"Disorders of the musculoskeletal system: Understanding the mechanisms and the efficacy of treatments","sub_type":"Research Fellowship","total_budget":"894995.88","source_system":"I am a neuroscientist and physiotherapist focussed on the conservative management of disorders of the musculoskeletal system. My research aims to uncover the mechanisms underlying musculoskeletal pain and other disorders such as incontinence, to develop and refine treatments for these conditions, and to understand the mechanism for efficacy of these treatments."},"children":[{"color":"#336699","name":"Prof Paul Hodges","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0043077","middle_name":"W","last_name":"Hodges","source_individual_id":"RMIS222953","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Hodges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88164","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65984","size":1},{"color":"#FF4D4D","name":"Attentional processing in developmentally vitamin D deficient rats: Modelling the cognitive symptoms of schizophrenia","data":{"media_summary":"","end_year":2014,"keywords":["psychiatry","behavioural science","animal model"],"nhmrc_grant_id":1002118,"application_year":2010,"health_keywords":["schizophrenia","vitamin D","brain development"],"scientific_title":"Attentional processing in developmentally vitamin D deficient rats: Modelling the cognitive symptoms of schizophrenia","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)","research_area":"Clinical Medicine and Science","for_category":"PSYCHOLOGY","cia_name":"A/Pr Thomas Burne","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/1002118","simplified_title":"Modelling cognitive symptoms in a rodent model of schizophrenia","sub_type":"Standard Project Grant","total_budget":"252911.29","source_system":"Schizophrenia is a poorly understood but very disabling group of brain disorders. There is an urgent need for animal models of cognitive impairments in schizophrenia. Based on clues from epidemiology, we have proposed that low prenatal vitamin D may be a risk factor for later development of schizophrenia. We propose to use a rat model with prenatal vitamin D deficiency to explore the neurobiological correlates of impaired cognition and as a platform to screen novel drugs to improve cognition."},"children":[{"color":"#336699","name":"A/Pr Darryl Eyles","data":{"first_name":"Darryl","title":"A/Pr","dw_individual_id":"DW0042305","middle_name":"W","last_name":"Eyles","source_individual_id":"5014564","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Darryl Eyles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87979","size":1},{"color":"#336699","name":"A/Pr Thomas Burne","data":{"first_name":"Thomas","title":"A/Pr","dw_individual_id":"DW0023865","middle_name":"Henry Johnston","last_name":"Burne","source_individual_id":"5013713","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thomas Burne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83125","size":1},{"color":"#336699","name":"Prof John Mcgrath","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0009022","middle_name":"Joseph","last_name":"Mcgrath","source_individual_id":"RMIS3680751","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mcgrath"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79147","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65974","size":1},{"color":"#FF4D4D","name":"Inflammatory airway diseases in children: mechanisms underlying and preventative strategies","data":{"media_summary":"","end_year":2015,"keywords":["asthma","cystic fibrosis","environmental health","respiratory physiology"],"nhmrc_grant_id":1002035,"application_year":2010,"health_keywords":["asthma","cystic fibrosis","infectious diseases","public health"],"scientific_title":"Inflammatory airway diseases in children: mechanisms underlying and preventative strategies","start_year":2011,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Clinical Medicine and Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"Prof Peter Sly","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/1002035","simplified_title":"Understanding why children get airway diseases and how to prevent them","sub_type":"Research Fellowship","total_budget":"819995.88","source_system":"Professor Slys research concentrates on understanding why some children develop chronic lung disease and on finding ways to prevent this from happening."},"children":[{"color":"#336699","name":"Prof Peter Sly","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0028010","middle_name":"David","last_name":"Sly","source_individual_id":"5011929","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Sly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84226","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65964","size":1},{"color":"#FF4D4D","name":"Improving quality and safety of health care delivery at the interface between the primary and acute care sectors","data":{"media_summary":"","end_year":2015,"keywords":["primary care","health services research","translational research"],"nhmrc_grant_id":1001157,"application_year":2009,"health_keywords":["heart failure","palliative care","primary care","hospitals"],"scientific_title":"Improving quality and safety of health care delivery at the interface between the primary and acute care sectors","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Primary Health Care","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Claire Jackson","higher_grant_type":"Centre for Research Excellence","purl":"http://purl.org/au-research/grants/nhmrc/1001157","simplified_title":"Quality and safety at the interface","sub_type":"Centre for Research Excellence - Health Services","total_budget":"2521498.06","source_system":""},"children":[{"color":"#336699","name":"Prof Philip Davies","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0030277","middle_name":"","last_name":"Davies","source_individual_id":"5012370","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Philip Davies"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84851","size":1},{"color":"#336699","name":"Prof Luke Connelly","data":{"first_name":"Luke","title":"Prof","dw_individual_id":"DW0030066","middle_name":"Brian","last_name":"Connelly","source_individual_id":"5012629","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Luke Connelly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84790","size":1},{"color":"#336699","name":"A/Pr Ian Scott","data":{"first_name":"Ian","title":"A/Pr","dw_individual_id":"DW0022005","middle_name":"Alexander","last_name":"Scott","source_individual_id":"5012302","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ian Scott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82670","size":1},{"color":"#336699","name":"Dr Samantha Hollingworth","data":{"first_name":"Samantha","title":"Dr","dw_individual_id":"DW0013711","middle_name":"","last_name":"Hollingworth","source_individual_id":"5012445","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Samantha Hollingworth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80394","size":1},{"color":"#336699","name":"A/Pr Michele Foster","data":{"first_name":"Michele","title":"A/Pr","dw_individual_id":"DW0013072","middle_name":"Maree","last_name":"Foster","source_individual_id":"RMIS1697875","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Michele Foster"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80236","size":1},{"color":"#336699","name":"A/Pr Anthony Russell","data":{"first_name":"Anthony","title":"A/Pr","dw_individual_id":"DW0010015","middle_name":"William","last_name":"Russell","source_individual_id":"5017298","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Anthony Russell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79417","size":1},{"color":"#336699","name":"Prof Claire Jackson","data":{"first_name":"Claire","title":"Prof","dw_individual_id":"DW0008114","middle_name":"Louise","last_name":"Jackson","source_individual_id":"RMIS229437","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Claire Jackson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78891","size":1},{"color":"#336699","name":"A/Pr Deborah Askew","data":{"first_name":"Deborah","title":"A/Pr","dw_individual_id":"DW0005862","middle_name":"Anne","last_name":"Askew","source_individual_id":"5012019","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Deborah Askew"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78299","size":1},{"color":"#336699","name":"Prof Geoffrey Mitchell","data":{"first_name":"Geoffrey","title":"Prof","dw_individual_id":"DW0003428","middle_name":"Keith","last_name":"Mitchell","source_individual_id":"5012135","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Geoffrey Mitchell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77614","size":1},{"color":"#336699","name":"A/Pr Jared Dart","data":{"first_name":"Jared","title":"A/Pr","dw_individual_id":"DW0001175","middle_name":"","last_name":"Dart","source_individual_id":"RMIS1366780","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jared Dart"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76988","size":1},{"color":"#336699","name":"Prof Philip Davies","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"5114147","middle_name":"","last_name":"Davies","source_individual_id":"5114147","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Philip Davies"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76636","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65956","size":1},{"color":"#FF4D4D","name":"Centre of Research Excellence in Women's Health in the 21st Century","data":{"media_summary":"women's health","end_year":2015,"keywords":["health services research","epidemiology","data linkage","longitudinal cohort study","health inequalities"],"nhmrc_grant_id":1000986,"application_year":2009,"health_keywords":["reproductive health","musculoskeletal","mental health","cardiovascular health","women's health"],"scientific_title":"Centre of Research Excellence in Women's Health in the 21st Century","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Annette Dobson","higher_grant_type":"Centre for Research Excellence","purl":"http://purl.org/au-research/grants/nhmrc/1000986","simplified_title":"CREWH21","sub_type":"Centre for Research Excellence - Health Services","total_budget":"2291168.51","source_system":""},"children":[{"color":"#336699","name":"Prof Christina Lee","data":{"first_name":"Christina","title":"Prof","dw_individual_id":"DW0043712","middle_name":"","last_name":"Lee","source_individual_id":"5012167","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Christina Lee"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88330","size":1},{"color":"#336699","name":"Prof Gita Mishra","data":{"first_name":"Gita","title":"Prof","dw_individual_id":"DW0038575","middle_name":"Devi","last_name":"Mishra","source_individual_id":"5012169","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gita Mishra"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86995","size":1},{"color":"#336699","name":"Prof Annette Dobson","data":{"first_name":"Annette","title":"Prof","dw_individual_id":"DW0036318","middle_name":"J","last_name":"Dobson","source_individual_id":"5011952","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Annette Dobson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86411","size":1},{"color":"#336699","name":"Prof Wendy Brown","data":{"first_name":"Wendy","title":"Prof","dw_individual_id":"DW0023824","middle_name":"J","last_name":"Brown","source_individual_id":"RMIS1714084","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wendy Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83116","size":1},{"color":"#336699","name":"Prof Julie Byles","data":{"first_name":"Julie","title":"Prof","dw_individual_id":"DW0018047","middle_name":"Ellen","last_name":"Byles","source_individual_id":"5012165","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Julie Byles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81614","size":1},{"color":"#336699","name":"Prof Nancy Pachana","data":{"first_name":"Nancy","title":"Prof","dw_individual_id":"DW0003819","middle_name":"Ann","last_name":"Pachana","source_individual_id":"RMIS1713128","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Nancy Pachana"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77727","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65949","size":1},{"color":"#FF4D4D","name":"Protease Activated Receptor 2 Antagonist In Inflammatory Disease","data":{"media_summary":"","end_year":2012,"keywords":["inflammation","arthritis","protease inhibitors","protease-activated receptors"],"nhmrc_grant_id":1000745,"application_year":2009,"health_keywords":["inflammatory diseases","inflammatory mediators","inflammatory bowel disease (IBD)","arthritis"],"scientific_title":"Protease Activated Receptor 2 Antagonist In Inflammatory Disease","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Molecular Medicine","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1000745","simplified_title":"A New Drug That Binds Cell Surfaces And Blocks Inflammation","sub_type":"Development Grant","total_budget":"621347.77","source_system":""},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65940","size":1},{"color":"#FF4D4D","name":"Preclinical studies of group A streptococcal vaccine candidates","data":{"media_summary":"","end_year":2012,"keywords":["vaccines","vaccine-preventable diseases","Streptococcus pyogenes","streptococcal disease"],"nhmrc_grant_id":1000512,"application_year":2009,"health_keywords":["vaccines","vaccine-preventable diseases","Streptococcus pyogenes","streptococcal disease"],"scientific_title":"Preclinical studies of group A streptococcal vaccine candidates","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Mark Walker","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/1000512","simplified_title":"Developing a safe group A streptococcal vaccine","sub_type":"Development Grant","total_budget":"532492.93","source_system":""},"children":[{"color":"#336699","name":"Prof Bostjan Kobe","data":{"first_name":"Bostjan","title":"Prof","dw_individual_id":"DW0031827","middle_name":"","last_name":"Kobe","source_individual_id":"5011436","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bostjan Kobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85237","size":1},{"color":"#336699","name":"Prof Mark Walker","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0010893","middle_name":"J.","last_name":"Walker","source_individual_id":"RMIS127362","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mark Walker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79668","size":1},{"color":"#336699","name":"Dr Michael Batzloff","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0006004","middle_name":"Raymond","last_name":"Batzloff","source_individual_id":"5011487","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michael Batzloff"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78341","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65927","size":1},{"color":"#FF4D4D","name":"Control of cardiac growth and development by miR-195.","data":{"media_summary":"","end_year":2014,"keywords":["cardiac failure","cell cycle","cell death-apoptosis","development","microRNA"],"nhmrc_grant_id":635530,"application_year":2009,"start_year":2010,"scientific_title":"Control of cardiac growth and development by miR-195.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMOTOLOGY","cia_name":"Dr Enzo Porrello","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/635530","simplified_title":"Targeting RNA in congenital and adult heart disease.","sub_type":"CJ Martin Biomedical ECF","total_budget":"355082.76","source_system":""},"children":[{"color":"#336699","name":"Dr Enzo Porrello","data":{"first_name":"Enzo","title":"Dr","dw_individual_id":"DW0015643","middle_name":"Roberto","last_name":"Porrello","source_individual_id":"5019186","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Enzo Porrello"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80945","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65877","size":1},{"color":"#FF4D4D","name":"Defining the emergence, initiation, and evolution of invasive Streptococcal infections","data":{"media_summary":"","end_year":2014,"keywords":["bacterial genetics","bacterial pathogen","bacteriophage"],"nhmrc_grant_id":635250,"application_year":2009,"start_year":2010,"scientific_title":"Defining the emergence, initiation, and evolution of invasive Streptococcal infections","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genomics","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Mark Davies","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/635250","simplified_title":"Evolution of invasive Streptococcal infections","sub_type":"CJ Martin Biomedical ECF","total_budget":"377458.24","source_system":""},"children":[{"color":"#336699","name":"Dr Mark Davies","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0041927","middle_name":"R","last_name":"Davies","source_individual_id":"RMIS1976108","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Mark Davies"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87876","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65869","size":1},{"color":"#FF4D4D","name":"Australasian Kidney Trials (AKT) Network","data":{"media_summary":"","end_year":2015,"keywords":["Chronic renal diseade","Clinical trial","Nephrology"],"nhmrc_grant_id":631731,"application_year":2009,"start_year":2010,"scientific_title":"Australasian Kidney Trials (AKT) Network","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Carmel Hawley","higher_grant_type":"NHMRC Enabling Grants","purl":"http://purl.org/au-research/grants/nhmrc/631731","simplified_title":"Australasian Kidney Trials (AKT) Network","sub_type":"Enabling Grant","total_budget":"2086014.1","source_system":""},"children":[{"color":"#336699","name":"A/Pr Carmel Hawley","data":{"first_name":"Carmel","title":"A/Pr","dw_individual_id":"DW0025392","middle_name":"Mary","last_name":"Hawley","source_individual_id":"5012539","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Carmel Hawley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83535","size":1},{"color":"#336699","name":"Prof Vlado Perkovic","data":{"first_name":"Vlado","title":"Prof","dw_individual_id":"DW0021428","middle_name":"","last_name":"Perkovic","source_individual_id":"5019167","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Vlado Perkovic"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82504","size":1},{"color":"#336699","name":"Prof David Johnson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0013969","middle_name":"Wayne","last_name":"Johnson","source_individual_id":"RMIS14680","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Johnson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80471","size":1},{"color":"#336699","name":"Prof Wendy Hoy","data":{"first_name":"Wendy","title":"Prof","dw_individual_id":"DW0013767","middle_name":"Elizabeth","last_name":"Hoy","source_individual_id":"RMIS3725","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wendy Hoy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80407","size":1},{"color":"#336699","name":"Prof Alan Cass","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0006447","middle_name":"","last_name":"Cass","source_individual_id":"5013822","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alan Cass"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78452","size":1},{"color":"#336699","name":"Prof Jonathan Craig","data":{"first_name":"Jonathan","title":"Prof","dw_individual_id":"DW0001065","middle_name":"C","last_name":"Craig","source_individual_id":"5011289","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jonathan Craig"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76962","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65650","size":1},{"color":"#FF4D4D","name":"Muscularskeletal pain, injury and health: Improving outcomes through conservative management","data":{"media_summary":"","end_year":2015,"keywords":["Biomechanics","Motor control","Musculosceletal pain","Neck and Back pain-injuries","Physiotherapy management"],"nhmrc_grant_id":631717,"application_year":2009,"start_year":2010,"scientific_title":"Muscularskeletal pain, injury and health: Improving outcomes through conservative management","node_source":"NHMRC","node_type":"Grant","field_of_research":"Physiotherapy","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Paul Hodges","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/631717","simplified_title":"Muscularskeletal pain, injury and health: Improving outcomes through conservative management","sub_type":"Program Grant","total_budget":"8093790.3","source_system":""},"children":[{"color":"#336699","name":"Prof Guglielmo Vicenzino","data":{"first_name":"Guglielmo","title":"Prof","dw_individual_id":"DW0046019","middle_name":"Tarcisio","last_name":"Vicenzino","source_individual_id":"5018115","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Guglielmo Vicenzino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88911","size":1},{"color":"#336699","name":"Prof Paul Hodges","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0043077","middle_name":"W","last_name":"Hodges","source_individual_id":"RMIS222953","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Hodges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88164","size":1},{"color":"#336699","name":"E/Pr Gwendolen Jull","data":{"first_name":"Gwendolen","title":"E/Pr","dw_individual_id":"DW0019981","middle_name":"A","last_name":"Jull","source_individual_id":"RMIS5215","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"E/Pr Gwendolen Jull"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82087","size":1},{"color":"#336699","name":"Prof David Hunter","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0002333","middle_name":"J","last_name":"Hunter","source_individual_id":"RMIS1093243","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Hunter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77303","size":1},{"color":"#336699","name":"Prof Kim Bennell","data":{"first_name":"Kim","title":"Prof","dw_individual_id":"DW0000329","middle_name":"Louise","last_name":"Bennell","source_individual_id":"RMIS97963","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Kim Bennell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76743","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65649","size":1},{"color":"#FF4D4D","name":"Optimising outcomes for Cerebral Palsy: RCT of a Parenting Intervention","data":{"media_summary":"","end_year":2017,"keywords":["cerebral palsy","neurodevelopmental disorders","parenting"],"nhmrc_grant_id":631712,"application_year":2009,"start_year":2010,"scientific_title":"Optimising outcomes for Cerebral Palsy: RCT of a Parenting Intervention","node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Clinical Medicine and Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"Dr Koa Whittingham","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631712","simplified_title":"Optimising outcomes for Cerebral Palsy: a Parenting Intervention","sub_type":"Health Professional Research ECF","total_budget":"247105.05","source_system":""},"children":[{"color":"#336699","name":"Dr Koa Whittingham","data":{"first_name":"Koa","title":"Dr","dw_individual_id":"DW0011047","middle_name":"L","last_name":"Whittingham","source_individual_id":"5019383","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Koa Whittingham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79703","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65648","size":1},{"color":"#FF4D4D","name":"Australia Fellowship","data":{"media_summary":"","end_year":2015,"keywords":["CNS Function","genetics","motor control","spinal injuries","transgenic mice"],"nhmrc_grant_id":631709,"application_year":2009,"start_year":2010,"scientific_title":"Australia Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Martyn Goulding","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631709","simplified_title":"Australia Fellowship","sub_type":"Australia Fellowship","total_budget":"0","source_system":""},"children":[{"color":"#336699","name":"Martyn Goulding","data":{"first_name":"Martyn","title":"","dw_individual_id":"DW0030961","middle_name":"","last_name":"Goulding","source_individual_id":"5023039","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Martyn Goulding"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85025","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65647","size":1},{"color":"#FF4D4D","name":"Understanding signaling in bacteria: structure and mechanism of an essential membrane bound histidine kinase","data":{"media_summary":"","end_year":2013,"keywords":["Antibiotics","Bacterial cell signaling","Membrane protein crystallography","Staphylococcus","Two-component signal transduction"],"nhmrc_grant_id":631704,"application_year":2009,"start_year":2010,"scientific_title":"Understanding signaling in bacteria: structure and mechanism of an essential membrane bound histidine kinase","node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Rikki Hvorup","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631704","simplified_title":"Probing the structure of an antimicrobial target in Golden Staph","sub_type":"Peter Doherty Biomedical ECF","total_budget":"286045.84","source_system":""},"children":[{"color":"#336699","name":"Dr Rikki Hvorup","data":{"first_name":"Rikki","title":"Dr","dw_individual_id":"DW0025674","middle_name":"","last_name":"Hvorup","source_individual_id":"5018921","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Rikki Hvorup"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83612","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65646","size":1},{"color":"#FF4D4D","name":"Epidemiological investigation of environmental determinants of health using spatial and temporal statistical methods","data":{"media_summary":"","end_year":2014,"keywords":["Cancer epidemiology","Environmental health","Epidemiological research method","Infectious disease","Spatio-temporal modelling"],"nhmrc_grant_id":631691,"application_year":2009,"start_year":2010,"scientific_title":"Epidemiological investigation of environmental determinants of health using spatial and temporal statistical methods","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Nirmala Pandeya","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631691","simplified_title":"Spatial modelling of environmental determinants of health","sub_type":"Public Health (Australia) ECF","total_budget":"338859.98","source_system":""},"children":[{"color":"#336699","name":"Dr Nirmala Pandeya","data":{"first_name":"Nirmala","title":"Dr","dw_individual_id":"DW0003838","middle_name":"","last_name":"Pandeya","source_individual_id":"RMIS3113591","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Nirmala Pandeya"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77735","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65645","size":1},{"color":"#FF4D4D","name":"Characterizing memory impairments in temporal lobe epilepsy with functional and structural brain imaging","data":{"media_summary":"","end_year":2013,"keywords":["Cognitive impairment","Functional magnetic resonance imaging","Language","Memory","Temporal lobe epilepsy"],"nhmrc_grant_id":631679,"application_year":2009,"start_year":2010,"scientific_title":"Characterizing memory impairments in temporal lobe epilepsy with functional and structural brain imaging","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Dr Julia Hocking","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631679","simplified_title":"Brain imaging of memory in epilepsy patients","sub_type":"Australian Clincal Research ECF","total_budget":"338859.98","source_system":""},"children":[{"color":"#336699","name":"Dr Julia Hocking","data":{"first_name":"Julia","title":"Dr","dw_individual_id":"DW0013680","middle_name":"","last_name":"Hocking","source_individual_id":"5019492","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Julia Hocking"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80389","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65644","size":1},{"color":"#FF4D4D","name":"Identifying eQTLs and endophenotyping known CNVs in a large Australian schizophrenia sample","data":{"media_summary":"","end_year":2013,"keywords":["Schizophrenia","case control study","gene expression","mental health","molecular genetics"],"nhmrc_grant_id":631671,"application_year":2009,"health_keywords":["gene expression","molecular basis of disease","schizophrenia - aetiology","schizophrenia - genetics"],"scientific_title":"Identifying eQTLs and endophenotyping known CNVs in a large Australian schizophrenia sample","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry (incl. Psychotherapy)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Bryan Mowry","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631671","simplified_title":"Identifying genetic variation underlying gene expression in schizophrenia","sub_type":"Standard Project Grant","total_budget":"902472.8","source_system":"This study hopes to identify genetic code variations associated with an increased risk of schizophrenia . We will study variation in gene expression levels in patients and healthy controls to identify underlying changes in the genetic code responsible. In a subset of patients with schizophrenia and known rare copy number variations (CNVs) in the genetic code we will conduct brain scans and psychological tests to characterize the effect of CNVs on brain structure and function in schizophrenia."},"children":[{"color":"#336699","name":"Prof Bryan Mowry","data":{"first_name":"Bryan","title":"Prof","dw_individual_id":"DW0044411","middle_name":"J","last_name":"Mowry","source_individual_id":"5016586","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bryan Mowry"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88510","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65643","size":1},{"color":"#FF4D4D","name":"The Role of Crim1 in Cardiovascular Development","data":{"media_summary":"fetal development","end_year":2013,"keywords":["embryo development","growth factors","heart","morphogenesis","vascular development"],"nhmrc_grant_id":631658,"application_year":2009,"health_keywords":["birth defects","cardiovascular disease","congenital heart disease","congestive heart failure","fetal development"],"scientific_title":"The Role of Crim1 in Cardiovascular Development","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiovascular medicine and Haemotology nec","research_area":"Basic Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMOTOLOGY","cia_name":"Dr David Pennisi","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631658","simplified_title":"Crim1 in heart and blood vessel development","sub_type":"New Investigator Grant","total_budget":"648634.5","source_system":"Coronary artery disease is the largest single cause of death in Australia, and commonly manifests as heart attack and angina. Congenital heart disease is the most common birth defect. We have identified a gene, Crim1, that is important for heart and coronary artery development. Investigating how this gene functions will lead to a greater understanding of congenital heart disease and may lay the foundation for therapeutics to regenerate damaged hear tissue."},"children":[{"color":"#336699","name":"Dr David Pennisi","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0027296","middle_name":"J","last_name":"Pennisi","source_individual_id":"5019159","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David Pennisi"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84053","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65641","size":1},{"color":"#FF4D4D","name":"The mechanism of ccbe1 function during lymphangiogenesis","data":{"media_summary":"lymphatic disease","end_year":2012,"keywords":["Development","Lymphatic","Model organism","Vascular biology","Zebrafish"],"nhmrc_grant_id":631657,"application_year":2009,"health_keywords":["Inflammation","Lymphoedema","Metastasis","Obesity","lymphatic disease"],"scientific_title":"The mechanism of ccbe1 function during lymphangiogenesis","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Benjamin Hogan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631657","simplified_title":"Ccbe1 in lymphatic development","sub_type":"New Investigator Grant","total_budget":"502437.97","source_system":"Tumours induce the regional growth of lymphatic vessels (in a process termed lymphangiogenesis) and then spread (a process termed metastasis) via lymphatic vessels and lymph nodes. Inhibiting lymphangiogenesis can inhibit metastasis. We have identified a gene called ccbe1 that is essential for lymphangiogenesis during development. We aim to understand how this potential therapeutic target functions at the molecular level during lymphangiogenesis."},"children":[{"color":"#336699","name":"Dr Benjamin Hogan","data":{"first_name":"Benjamin","title":"Dr","dw_individual_id":"DW0043083","middle_name":"M","last_name":"Hogan","source_individual_id":"5015278","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Benjamin Hogan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88165","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65640","size":1},{"color":"#FF4D4D","name":"Adhesins of uropathogenic Escherichia coli","data":{"media_summary":"","end_year":2013,"keywords":["Bacterial genetics","Bacterial pathogen","Biofilm","Infectious diseases","Virulence"],"nhmrc_grant_id":631654,"application_year":2009,"health_keywords":["Bacterial infection","Microbiology - pathogenesis","Urinary tract infection"],"scientific_title":"Adhesins of uropathogenic Escherichia coli","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Mark Schembri","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631654","simplified_title":"Adhesins of uropathogenic Escherichia coli","sub_type":"Standard Project Grant","total_budget":"405594.25","source_system":"Urinary tract infections (UTI) are among the most common infectious diseases of humans and a major cause of morbidity and mortality. In the USA, UTI accounts for >$1.6 billion in medical expenses each year. It is estimated that 50% of women will develop a UTI in their lifetime. This research aims to understand the processes by which bacteria colonize the human bladder. The work has implications for the development of new approaches to prevent and treat UTI."},"children":[{"color":"#336699","name":"Prof Mark Schembri","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0016088","middle_name":"A","last_name":"Schembri","source_individual_id":"5017368","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Schembri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81054","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65639","size":1},{"color":"#FF4D4D","name":"The intersection between hedgehog and notch signalling in medulloblastoma.","data":{"media_summary":"","end_year":2012,"keywords":["cancer","cerebellum","mouse genetics","murine models","notch signalling pathway"],"nhmrc_grant_id":631650,"application_year":2009,"health_keywords":["cancer biology","chemotherapy","genetic disease","medulloblastoma"],"scientific_title":"The intersection between hedgehog and notch signalling in medulloblastoma.","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Genetics","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631650","simplified_title":"Genetic pathways controlling medulloblastoma growth","sub_type":"Standard Project Grant","total_budget":"620647.81","source_system":"Brain tumours are the second most common malignancy of childhood and the leading cause of cancer related death and disability in children. Medulloblastoma is the most frequent malignant childhood brain tumour, arising in the cerebellum. This application looks at the relationship between two genetic pathways responsible for medulloblastoma which are also drug targets. Understanding this interaction will lead to better treatment options for the disease."},"children":[{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65638","size":1},{"color":"#FF4D4D","name":"Preclinical optimisation of intrauterine transplantation of fetal mesenchymal stem cells for osteogenesis imperfecta.","data":{"media_summary":"Stem cell therapy","end_year":2013,"keywords":["Birth defects","Fetal therapy","Osteogenesis","Stem cells","Transplantation"],"nhmrc_grant_id":631641,"application_year":2009,"health_keywords":["Bone growth and fracture healing","Congenital skeletal defects","Fetal medicine","Osteogenesis imperfecta","Stem cell therapy"],"scientific_title":"Preclinical optimisation of intrauterine transplantation of fetal mesenchymal stem cells for osteogenesis imperfecta.","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Foetal Development and Medicine","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Nicholas Fisk","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631641","simplified_title":"Fetal stem cell therapy for Osteogenesis Imperfecta","sub_type":"Standard Project Grant","total_budget":"600932.15","source_system":"Osteogenesis imperfecta is a genetic disorder causing brittle bones and fractures. Currently there is no good treatment. Transplanting stem cells before birth should allow them to build healthy bones early in life. Despite promising effects in animals, stem cell uptake is too low to prevent all fractures and ameliorate pain and deformity. We are studying how to improve the uptake of stem cells given to the fetus and neonate, in order to develop a treatment suitable for eventual use in humans."},"children":[{"color":"#336699","name":"A/Pr Kiarash Khosrotehrani","data":{"first_name":"Kiarash","title":"A/Pr","dw_individual_id":"DW0037755","middle_name":"","last_name":"Khosrotehrani","source_individual_id":"5015692","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Kiarash Khosrotehrani"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86775","size":1},{"color":"#336699","name":"Prof Nicholas Fisk","data":{"first_name":"Nicholas","title":"Prof","dw_individual_id":"DW0019006","middle_name":"Maxwell","last_name":"Fisk","source_individual_id":"5014632","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nicholas Fisk"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81858","size":1},{"color":"#336699","name":"Dr Liza Raggatt","data":{"first_name":"Liza","title":"Dr","dw_individual_id":"DW0015741","middle_name":"J","last_name":"Raggatt","source_individual_id":"RMIS4437738","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Liza Raggatt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80966","size":1},{"color":"#336699","name":"Dr Allison Pettit","data":{"first_name":"Allison","title":"Dr","dw_individual_id":"DW0015560","middle_name":"Robyn","last_name":"Pettit","source_individual_id":"5016963","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Allison Pettit"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80923","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65636","size":1},{"color":"#FF4D4D","name":"Membrane fusion in axonal regeneration: molecules and mechanisms","data":{"media_summary":"Nervous system development","end_year":2012,"keywords":["Axon growth","Axon regeneration","Molecular neuroscience","Nerve regeneration","Spinal cord injury"],"nhmrc_grant_id":631634,"application_year":2009,"health_keywords":["Axonal injury","Axonal reconnection","Nerve injury","Nerve regeneration","Nervous system development"],"scientific_title":"Membrane fusion in axonal regeneration: molecules and mechanisms","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Massimo Hilliard","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631634","simplified_title":"Nerve regeneration in a simple animal model system (C. elegans).","sub_type":"Standard Project Grant","total_budget":"461597.97","source_system":"Limited nerve regeneration is the main obstacle for recovery from spinal cord and brain injuries. Understanding the cellular and molecular mechanisms underlying axonal regeneration is an essential step toward the development of novel effective therapies to enhance this process. In this proposal, we use the powerful molecular and genetic tools available for the small nematode worm C. elegans to identify and study axonal regeneration and discover the key molecules involved."},"children":[{"color":"#336699","name":"Dr Massimo Hilliard","data":{"first_name":"Massimo","title":"Dr","dw_individual_id":"DW0025496","middle_name":"A.","last_name":"Hilliard","source_individual_id":"5015251","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Massimo Hilliard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83566","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65635","size":1},{"color":"#FF4D4D","name":"Vancomycin derivatives active against resistant bacterial nosocomial infections","data":{"media_summary":"","end_year":2012,"keywords":["bioluminescent imaging","medicinal chemistry","microbiology"],"nhmrc_grant_id":631632,"application_year":2009,"health_keywords":["antibiotic resistance","bacterial infection","drug discovery"],"scientific_title":"Vancomycin derivatives active against resistant bacterial nosocomial infections","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Infection Agents (incl. Prions)","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Matthew Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631632","simplified_title":"Vancomycin Derived Drugs","sub_type":"Standard Project Grant","total_budget":"760763.22","source_system":"Bacterial infection is a leading cause of death worldwide and the emergence of superbugs that are resistant to multiple treatments is becoming a major global concern. Vancomycin is the drug of last resort for the treatment of hospital-acquired Gram -positive bacterial infections. We will synthetically modify vancomycin by incorporating naturally occurring membrane-associative peptides to produce novel antibiotics with multiple modes of action to avoid existing bacterial resistance mechanisms."},"children":[{"color":"#336699","name":"Prof David Paterson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0027242","middle_name":"Leslie","last_name":"Paterson","source_individual_id":"5012495","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Paterson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84040","size":1},{"color":"#336699","name":"Prof Matthew Cooper","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0024249","middle_name":"A","last_name":"Cooper","source_individual_id":"5018347","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83230","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65634","size":1},{"color":"#FF4D4D","name":"TAKING THE LIMP OUT OF CARTILAGE REPAIR","data":{"media_summary":"osteoarthritis","end_year":2011,"keywords":["cartilage","hypoxia","osteoarthritis","stem cells","tissue regeneration"],"nhmrc_grant_id":631629,"application_year":2009,"health_keywords":["PGP5","arthritis and cartilage degradation","cartilage damage","degenerative joint disease","osteoarthritis"],"scientific_title":"TAKING THE LIMP OUT OF CARTILAGE REPAIR","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Regenerative Medicine (incl. Stem Cells and Tissue Engineering)","research_area":"Clinical Medicine and Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"Prof Justin Cooper-White","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631629","simplified_title":"TAKING THE LIMP OUT OF CARTILAGE REPAIR","sub_type":"Standard Project Grant","total_budget":"296866.72","source_system":"In Australia osteoarthritis is the leading cause of pain and disability with the majority of individuals displaying radiographic evidence of this condition by age 65. We are developing two novel technologies which use patients' own stem cells to repair damaged cartilage. This project involves both the advancement of these technologies as well as their evaluation using a sheep cartilage repair model. These technologies offer significant promise for those suffering joint pain."},"children":[{"color":"#336699","name":"Prof Dietmar Hutmacher","data":{"first_name":"Dietmar","title":"Prof","dw_individual_id":"DW0043211","middle_name":"W","last_name":"Hutmacher","source_individual_id":"5015392","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Dietmar Hutmacher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88195","size":1},{"color":"#336699","name":"Prof Justin Cooper-White","data":{"first_name":"Justin","title":"Prof","dw_individual_id":"DW0036010","middle_name":"J","last_name":"Cooper-White","source_individual_id":"RMIS2454623","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Justin Cooper-White"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86335","size":1},{"color":"#336699","name":"Dr Michael Doran","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0024580","middle_name":"R","last_name":"Doran","source_individual_id":"5014386","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michael Doran"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83305","size":1},{"color":"#336699","name":"Dr Gary Brooke","data":{"first_name":"Gary","title":"Dr","dw_individual_id":"DW0006249","middle_name":"P","last_name":"Brooke","source_individual_id":"5011318","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Gary Brooke"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78400","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65633","size":1},{"color":"#FF4D4D","name":"Regulating the secretion of inflammatory cytokines","data":{"media_summary":"","end_year":2013,"keywords":["cytokine secretion","golgi complex","macrophage","transgenesis","vesicle trafficking"],"nhmrc_grant_id":631621,"application_year":2009,"health_keywords":["inflammation","inflammatory bowel disease","rheumatoid arthritis"],"scientific_title":"Regulating the secretion of inflammatory cytokines","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Amanda Stanley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631621","simplified_title":"Regulating the secretion of inflammatory cytokines","sub_type":"Standard Project Grant","total_budget":"558441.69","source_system":"Cytokines or chemical messengers released by cells are essential for controlling immune responses but, in excess, they cause Crohn's disease and arthritis. Our research aims to block cytokine release as a novel way to ameliorate disease. We have identified specific cellular proteins, called golgins, that can be targeted to reduce cytokines. Here, characterization of golgin mediated cytokine transport in cells and in a mouse disease model is necessary to translate these findings for human benefit"},"children":[{"color":"#336699","name":"Dr Markus Kerr","data":{"first_name":"Markus","title":"Dr","dw_individual_id":"DW0025954","middle_name":"C","last_name":"Kerr","source_individual_id":"5015672","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Markus Kerr"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83697","size":1},{"color":"#336699","name":"Prof Paul Gleeson","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0013254","middle_name":"A","last_name":"Gleeson","source_individual_id":"RMIS1013566","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Gleeson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80283","size":1},{"color":"#336699","name":"Dr Amanda Stanley","data":{"first_name":"Amanda","title":"Dr","dw_individual_id":"DW0010421","middle_name":"C","last_name":"Stanley","source_individual_id":"5019300","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Amanda Stanley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79533","size":1},{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65632","size":1},{"color":"#FF4D4D","name":"Spatial risk assessment of emerging infectious diseases in Australia","data":{"media_summary":"","end_year":2014,"keywords":["Genetic epidemiology","Geographic variations","Mathematical modelling","Risk assessment"],"nhmrc_grant_id":631619,"application_year":2009,"start_year":2010,"scientific_title":"Spatial risk assessment of emerging infectious diseases in Australia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Archie Clements","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631619","simplified_title":"Mapping approaches to assist surveillance and control of infectious disease threats to Australia","sub_type":"Population Health CDF","total_budget":"423213.84","source_system":""},"children":[{"color":"#336699","name":"Prof Archie Clements","data":{"first_name":"Archie","title":"Prof","dw_individual_id":"DW0024164","middle_name":"Campbell Adair","last_name":"Clements","source_individual_id":"5012114","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Archie Clements"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83203","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65631","size":1},{"color":"#FF4D4D","name":"N-glycosylation in health and disease: A key role for Ost3p and Ost6p in regulation of substrate specificity.","data":{"media_summary":"","end_year":2013,"keywords":["Brain development","Cancer","Endoplasmic reticulum","Enzyme-protein interactions","Glycoproteins"],"nhmrc_grant_id":631615,"application_year":2009,"health_keywords":["Brain development","Ovarian cancer","Prostate cancer","virus"],"scientific_title":"N-glycosylation in health and disease: A key role for Ost3p and Ost6p in regulation of substrate specificity.","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Benjamin Schulz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631615","simplified_title":"Regulation of N-glycosylation in health and disease","sub_type":"New Investigator Grant","total_budget":"523084.5","source_system":"Protein glycosylation is the addition of complex sugar chains to specific proteins. Proteins on the surface of cells are often glycosylated, and this is important for controlling the interactions between cells that occur in development, cancer and infection. Glycosylation can be regulated, and our research will characterize the mechanisms of this regulation. This will help us understand exactly how glycosylation is important in cancer and development."},"children":[{"color":"#336699","name":"Dr Benjamin Schulz","data":{"first_name":"Benjamin","title":"Dr","dw_individual_id":"DW0039582","middle_name":"L","last_name":"Schulz","source_individual_id":"5019257","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Benjamin Schulz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87266","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65630","size":1},{"color":"#FF4D4D","name":"Discovering molecules and mechanisms regulating dendrite formation","data":{"media_summary":"Sensory Function","end_year":2012,"keywords":["Dendrites","Developmental Neurobiology","Molecular Neuroscience","Neural Development","Neurite Outgrowth"],"nhmrc_grant_id":631605,"application_year":2009,"health_keywords":["Developmental Disorders","Mental Retardation","Nervous System Disorders","Nervous system development","Sensory Function"],"scientific_title":"Discovering molecules and mechanisms regulating dendrite formation","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Massimo Hilliard","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631605","simplified_title":"Discovering molecules and mechanisms regulating the development of neuronal processes","sub_type":"Standard Project Grant","total_budget":"517989.5","source_system":"Dendrites are neuronal projections necessary to receive stimuli from other neurons or the external environment. Abnormalities in dendrite development associate with mental retardation and other human conditions such as Down syndrome, Rett syndrome and Fragile-X syndrome. The studies presented in this proposal, using the powerful genetic and molecular tools available for the nematode C. elegans, will provide new insight into the cellular and molecular mechanisms regulating dendrite development."},"children":[{"color":"#336699","name":"Dr Massimo Hilliard","data":{"first_name":"Massimo","title":"Dr","dw_individual_id":"DW0025496","middle_name":"A.","last_name":"Hilliard","source_individual_id":"5015251","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Massimo Hilliard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83566","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65628","size":1},{"color":"#FF4D4D","name":"Molecular and cellular mechanisms of vertebrate brain development","data":{"media_summary":"nervous system repair","end_year":2012,"keywords":["axon guidance","brain development","neuronal differentiation"],"nhmrc_grant_id":631598,"application_year":2009,"health_keywords":["nerve damage","nerve injury","nerve regeneration","nervous system development","nervous system repair"],"scientific_title":"Molecular and cellular mechanisms of vertebrate brain development","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Brian Key","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631598","simplified_title":"How the brain develops.","sub_type":"Standard Project Grant","total_budget":"586428.38","source_system":"The essential steps in forming a normal functioning brain occur during life as an embryo. If these processes go haywire, there can be serious repercussions for life after birth. This project seeks to understand how the brain forms during embryonic stages so that better treatments and procedures can be developed to deal with developmental problems."},"children":[{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65627","size":1},{"color":"#FF4D4D","name":"Membrane Fusion in Macrophage Function","data":{"media_summary":"","end_year":2013,"keywords":["SNARE proteins","lysosomes","macrophage","protein trafficking","secretion"],"nhmrc_grant_id":631584,"application_year":2009,"health_keywords":["bacterial infection","inflammation","macrophage activation"],"scientific_title":"Membrane Fusion in Macrophage Function","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Trafficking","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Nicholas Hamilton","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631584","simplified_title":"Membrane Fusion in Macrophage Function","sub_type":"Standard Project Grant","total_budget":"542800.16","source_system":"Macrophages are important cells at the front-line of immunity where one of their main roles is to release anti-bacterial proteins. We will study the macrophage molecules, subcellular organelles and pathways that help to release these proteins to kill bacteria and fight infection. Our studies will identify new cellular targets for boosting immunity and treating inherited diseases with defective macrophage function."},"children":[{"color":"#336699","name":"A/Pr Rohan Teasdale","data":{"first_name":"Rohan","title":"A/Pr","dw_individual_id":"DW0040022","middle_name":"D","last_name":"Teasdale","source_individual_id":"5017848","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Rohan Teasdale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87368","size":1},{"color":"#336699","name":"Dr Nicholas Hamilton","data":{"first_name":"Nicholas","title":"Dr","dw_individual_id":"DW0037081","middle_name":"A","last_name":"Hamilton","source_individual_id":"5018862","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nicholas Hamilton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86597","size":1},{"color":"#336699","name":"Dr Tomohiko Taguchi","data":{"first_name":"Tomohiko","title":"Dr","dw_individual_id":"DW0022430","middle_name":"","last_name":"Taguchi","source_individual_id":"5019314","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Tomohiko Taguchi"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82782","size":1},{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65626","size":1},{"color":"#FF4D4D","name":"Elucidating genetic mechanisms responsible for familial hyperaldosteronism type II","data":{"media_summary":"","end_year":2013,"keywords":["genetic variations","hyperaldosteronaemia","hypertension"],"nhmrc_grant_id":631580,"application_year":2009,"health_keywords":["endocrine disorder","genetics","hyperaldosteronaemia","hypertension"],"scientific_title":"Elucidating genetic mechanisms responsible for familial hyperaldosteronism type II","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael Stowasser","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631580","simplified_title":"Searching for genes causing a curable form of hypertension","sub_type":"Standard Project Grant","total_budget":"424812.89","source_system":"Primary aldosteronism (PAL) is the commonest specifically treatable and potentially curable form of hypertension (high blood pressure), a common disease, expensive to treat, with serious morbidity and mortality. This project will use cutting edge technology to gain new knowledge concerning how genes regulate the body's production of aldosterone (salt hormone), which will help us understand how PAL develops and how common it is, and could lead to better approaches to diagnosis and treatment."},"children":[{"color":"#336699","name":"Dr Paul Leo","data":{"first_name":"Paul","title":"Dr","dw_individual_id":"DW0037994","middle_name":"J","last_name":"Leo","source_individual_id":"5019017","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Paul Leo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86844","size":1},{"color":"#336699","name":"E/Pr Richard Gordon","data":{"first_name":"Richard","title":"E/Pr","dw_individual_id":"DW0025132","middle_name":"D","last_name":"Gordon","source_individual_id":"RMIS41928","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"E/Pr Richard Gordon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83460","size":1},{"color":"#336699","name":"Prof Michael Stowasser","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022365","middle_name":"","last_name":"Stowasser","source_individual_id":"5017746","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Stowasser"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82770","size":1},{"color":"#336699","name":"Dr David Duffy","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0012817","middle_name":"Lorenzo","last_name":"Duffy","source_individual_id":"5014423","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David Duffy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80170","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65625","size":1},{"color":"#FF4D4D","name":"Enhancing erythropoietin therapy in ischaemia-reperfusion injury of heart and kidney","data":{"media_summary":"Oxidative stress","end_year":2013,"keywords":["Apoptosis","Cardiac failure","Cardiovascular pharmacology","Pathophysiology","Renal failure"],"nhmrc_grant_id":631576,"application_year":2009,"health_keywords":["Cardiovascular diseases","Ischaemia-reperfusion","Ischaemic acute renal failure","Myocardial infarction","Oxidative stress"],"scientific_title":"Enhancing erythropoietin therapy in ischaemia-reperfusion injury of heart and kidney","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMOTOLOGY","cia_name":"Prof David Johnson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631576","simplified_title":"Investigating how Epo therapy can be improved to provide best protection for heart and kidney after ischaemic injury","sub_type":"Standard Project Grant","total_budget":"361021.75","source_system":"Heart attacks and kidney disease from a lack of blood flow are common causes of morbidity and have poor treatment options. Erythropoietin (epo) is a useful new treatment, but there remain some caveats to its use in humans: eg. it may cause excessive scarring during repair. Use of epo with an anti-inflammatory drug may decrease scarring and provide benefit to long-term health. We plan to carefully define the biomolecular pathways of injury and repair, to better plan this therapy for human use."},"children":[{"color":"#336699","name":"A/Pr Glenda Gobe","data":{"first_name":"Glenda","title":"A/Pr","dw_individual_id":"DW0042655","middle_name":"Carolyn","last_name":"Gobe","source_individual_id":"5012448","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Glenda Gobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88060","size":1},{"color":"#336699","name":"Dr David Vesey","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0034467","middle_name":"Alan","last_name":"Vesey","source_individual_id":"RMIS387799","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr David Vesey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85922","size":1},{"color":"#336699","name":"Prof Lindsay Brown","data":{"first_name":"Lindsay","title":"Prof","dw_individual_id":"DW0023816","middle_name":"","last_name":"Brown","source_individual_id":"5013659","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Lindsay Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83114","size":1},{"color":"#336699","name":"Prof David Johnson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0013969","middle_name":"Wayne","last_name":"Johnson","source_individual_id":"RMIS14680","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Johnson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80471","size":1},{"color":"#336699","name":"Prof Malcolm West","data":{"first_name":"Malcolm","title":"Prof","dw_individual_id":"DW0005385","middle_name":"J","last_name":"West","source_individual_id":"5018261","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Malcolm West"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78171","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65624","size":1},{"color":"#FF4D4D","name":"Modulating neuronal secretion by the PI3-kinase pathway","data":{"media_summary":"","end_year":2012,"keywords":["Exocytosis","Phosphoinositides","SNARE proteins","lipid biochemistry","membrane fusion"],"nhmrc_grant_id":631568,"application_year":2009,"health_keywords":["diabetes","endocrinology","neurodegenerative disease"],"scientific_title":"Modulating neuronal secretion by the PI3-kinase pathway","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Frederic Meunier","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631568","simplified_title":"Phosphoinositide control of neuronal communication","sub_type":"Standard Project Grant","total_budget":"516855.19","source_system":"Neuronal communication relies on the process of exocytosis by which neurons release neurotransmitter. Exocytosis is critical for the simplest reflex movement to complex tasks such as learning and memory, and is altered in several neurodegenerative pathologies. We will investigate how certain lipids control exocytosis. This research is important for understanding how neurons communicate in health and disease and is relevant to other processes such as insulin release in diabetes."},"children":[{"color":"#336699","name":"Prof Frederic Meunier","data":{"first_name":"Frederic","title":"Prof","dw_individual_id":"DW0020864","middle_name":"A","last_name":"Meunier","source_individual_id":"5016455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frederic Meunier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82341","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65623","size":1},{"color":"#FF4D4D","name":"Improving the Assessment of Brain Tumour Treatment Outcome using 18F-FDOPA PET-MRI Fusion","data":{"media_summary":"","end_year":2014,"keywords":["Brain tumours","Magnetic Resonance Imaging","Positron Emission Tomography"],"nhmrc_grant_id":631567,"application_year":2009,"health_keywords":["brain tumour","magnetic resonance imaging","positron emission tomography"],"scientific_title":"Improving the Assessment of Brain Tumour Treatment Outcome using 18F-FDOPA PET-MRI Fusion","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Radiology and Organ Imaging","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Stephen Rose","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631567","simplified_title":"Improved diagnostic imaging of brain tumours","sub_type":"Standard Project Grant","total_budget":"660666.68","source_system":"The mortality rate within the first year of diagnosis for high-grade brain tumours is approximately 80%. A major factor contributing to poor outcome measures is the limitation of current neuroimaging techniques. In a novel approach we propose to combine the information available from MRI and PET images to better define the extent of the tumour and provide markers of early treatment response. This improved diagnostic information should improve survival rates."},"children":[{"color":"#336699","name":"A/Pr Olivier Salvado","data":{"first_name":"Olivier","title":"A/Pr","dw_individual_id":"DW0045247","middle_name":"","last_name":"Salvado","source_individual_id":"5019230","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Olivier Salvado"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88709","size":1},{"color":"#336699","name":"Dr Paul Thomas","data":{"first_name":"Paul","title":"Dr","dw_individual_id":"DW0040054","middle_name":"A","last_name":"Thomas","source_individual_id":"5017905","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Paul Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87378","size":1},{"color":"#336699","name":"Dr Michael Fay","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0030635","middle_name":"Francis","last_name":"Fay","source_individual_id":"5018817","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michael Fay"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84961","size":1},{"color":"#336699","name":"Prof Stuart Crozier","data":{"first_name":"Stuart","title":"Prof","dw_individual_id":"DW0024340","middle_name":"","last_name":"Crozier","source_individual_id":"5012384","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stuart Crozier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83245","size":1},{"color":"#336699","name":"A/Pr Stephen Rose","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0009965","middle_name":"E","last_name":"Rose","source_individual_id":"5017273","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Stephen Rose"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79404","size":1},{"color":"#336699","name":"Prof Alan Coulthard","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0001046","middle_name":"","last_name":"Coulthard","source_individual_id":"5014087","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alan Coulthard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76953","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65622","size":1},{"color":"#FF4D4D","name":"Fibroblast growth factors in the development of forebrain commissures","data":{"media_summary":"midline brain disorders","end_year":2012,"keywords":["axon guidance","brain development","fibroblast growth factors","magnetic resonance imaging","neurobiology"],"nhmrc_grant_id":631552,"application_year":2009,"health_keywords":["autism spectrun disorders","brain development","congenital brain defects","learning and cognitive deficits","midline brain disorders"],"scientific_title":"Fibroblast growth factors in the development of forebrain commissures","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Linda Richards","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631552","simplified_title":"Formation of connections between the cortical hemispheres of the brain","sub_type":"Standard Project Grant","total_budget":"497796.03","source_system":"In order to function correctly the two hemispheres of the brain must communicate information. This communication occurs across large fibre tracts called commissures. There are three commissural projections in the forebrain; the corpus callosum, the hippocampal commissure and the anterior commissure. Here we investigate the development of these commissures and provide a comprehensive analysis of the role of several secreted, fibroblast growth factor proteins, in their development."},"children":[{"color":"#336699","name":"Prof John Rubenstein","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0027714","middle_name":"L.R.","last_name":"Rubenstein","source_individual_id":"5019212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Rubenstein"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84157","size":1},{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65620","size":1},{"color":"#FF4D4D","name":"The contribution of upstream open reading frames to the eukaryotic proteome","data":{"media_summary":"","end_year":2012,"keywords":["bioinformatics","polycistronic mRNAs","proteomics","regulatory peptides","upstream open reading frames"],"nhmrc_grant_id":631551,"application_year":2009,"health_keywords":["biochemistry - protein peptide","gene expression","genetic disease","post-transcriptional regulation of gene expression"],"scientific_title":"The contribution of upstream open reading frames to the eukaryotic proteome","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"A/Pr Joseph Rothnagel","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631551","simplified_title":"Functional peptides from upstream open reading frames","sub_type":"Standard Project Grant","total_budget":"197911.14","source_system":"This project will investigate the novel idea that genomes of complex organisms (including human) 'double-dip' with many genes containing information for more than one protein. It will also examine if these small supernumary proteins have cell regulatory functions. If proved, it would significantly alter current views on the information content of higher vertebrate genomes. An understanding of the roles of these novel protein sequences may result in the development of new drugs."},"children":[{"color":"#336699","name":"Prof Ross Smith","data":{"first_name":"Ross","title":"Prof","dw_individual_id":"DW0045515","middle_name":"William","last_name":"Smith","source_individual_id":"RMIS6441","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ross Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88776","size":1},{"color":"#336699","name":"A/Pr Thomas Huber","data":{"first_name":"Thomas","title":"A/Pr","dw_individual_id":"DW0043169","middle_name":"","last_name":"Huber","source_individual_id":"5015365","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thomas Huber"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88186","size":1},{"color":"#336699","name":"A/Pr Joseph Rothnagel","data":{"first_name":"Joseph","title":"A/Pr","dw_individual_id":"DW0009982","middle_name":"A","last_name":"Rothnagel","source_individual_id":"5017267","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Joseph Rothnagel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79410","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65619","size":1},{"color":"#FF4D4D","name":"Inhibitors of Secretory Phospholipases in Diet Induced Obese Rats","data":{"media_summary":"obesity","end_year":2012,"keywords":["abdominal obesity","anti-inflammatory","biochemistry","cardiovascular and diabetes type II risk factors","enzyme inhibition"],"nhmrc_grant_id":631534,"application_year":2009,"health_keywords":["cardiovascular disease","diabetes","inflammation","metabolic syndrome","obesity"],"scientific_title":"Inhibitors of Secretory Phospholipases in Diet Induced Obese Rats","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631534","simplified_title":"Investigating a new treatment for obesity induced diseases","sub_type":"Standard Project Grant","total_budget":"581051.65","source_system":"A new drug given to rats fed a high fat-carbohydrate diet shows very promising effects in preventing and treating abdominal obesity, insulin resistance, glucose intolerance, and other risk factors for diabetes and cardiovascular disease. This project will profile biochemical and pharmacological properties of the drug in more detail in order to track down molecular mechanisms of its action and potential therapeutic benefits, guided by studies on rats, biochemical markers, rat and human fat cells."},"children":[{"color":"#336699","name":"A/Pr Jonathan Whitehead","data":{"first_name":"Jonathan","title":"A/Pr","dw_individual_id":"DW0046246","middle_name":"P","last_name":"Whitehead","source_individual_id":"RMIS5218572","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jonathan Whitehead"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88973","size":1},{"color":"#336699","name":"Prof Johannes Prins","data":{"first_name":"Johannes","title":"Prof","dw_individual_id":"DW0039181","middle_name":"Bernhard","last_name":"Prins","source_individual_id":"RMIS7041737","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Johannes Prins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87157","size":1},{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"Prof Lindsay Brown","data":{"first_name":"Lindsay","title":"Prof","dw_individual_id":"DW0023816","middle_name":"","last_name":"Brown","source_individual_id":"5013659","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Lindsay Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83114","size":1},{"color":"#336699","name":"Dr Robert Reid","data":{"first_name":"Robert","title":"Dr","dw_individual_id":"DW0009865","middle_name":"C","last_name":"Reid","source_individual_id":"RMIS4598791","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Robert Reid"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79380","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65617","size":1},{"color":"#FF4D4D","name":"Cyclic-nucleotide-dependent regulation of axon guidance sensitivity","data":{"media_summary":"","end_year":2012,"keywords":["Axon guidance","Computational modelling","Growth cone chemotaxis"],"nhmrc_grant_id":631532,"application_year":2009,"health_keywords":["Brain abnormalities","Nervous system development","Spinal cord injury"],"scientific_title":"Cyclic-nucleotide-dependent regulation of axon guidance sensitivity","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Geoffrey Goodhill","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631532","simplified_title":"Modelling how the brain becomes wired up during development","sub_type":"Standard Project Grant","total_budget":"527338.63","source_system":"Problems in wiring up the brain underlie several nervous system disorders. The goal of this project is to understand better how this wiring normally forms. This will ultimately lead to a better understanding of what can go wrong with brain wiring, and how to fix such problems. It will also lead to a better understanding of how to make axons regenerate after injury."},"children":[{"color":"#336699","name":"Prof Geoffrey Goodhill","data":{"first_name":"Geoffrey","title":"Prof","dw_individual_id":"DW0007543","middle_name":"J","last_name":"Goodhill","source_individual_id":"5014864","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Geoffrey Goodhill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78740","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65616","size":1},{"color":"#FF4D4D","name":"Characterization of human-specific anti-microbial pathways","data":{"media_summary":"tuberculosis","end_year":2012,"keywords":["Mycobacterium tuberculosis","Salmonella typhimurium","host-pathogen interaction","innate immunity","macrophage"],"nhmrc_grant_id":631531,"application_year":2009,"health_keywords":["infectious diseases","inflammation","intracellular bacterial infections","salmonellosis","tuberculosis"],"scientific_title":"Characterization of human-specific anti-microbial pathways","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Innate Immunity","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"A/Pr Matthew Sweet","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631531","simplified_title":"How immune cells kill invading microbes","sub_type":"Standard Project Grant","total_budget":"586428.38","source_system":"The immune system protects us against infectious disease by killing invading microbes or pathogens. Macrophages are white blood cells that are important for the recognition and destruction of pathogens. This project aims to investigate the role of certain genes, which are turned on in macrophages when they sense invading pathogens, in protecting us against infectious diseases such as tuberculosis and gastroenteritis."},"children":[{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1},{"color":"#336699","name":"Dr Katryn Stacey","data":{"first_name":"Katryn","title":"Dr","dw_individual_id":"DW0028117","middle_name":"Jane","last_name":"Stacey","source_individual_id":"5017656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katryn Stacey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84258","size":1},{"color":"#336699","name":"Dr Bernadette Saunders","data":{"first_name":"Bernadette","title":"Dr","dw_individual_id":"DW0010087","middle_name":"M","last_name":"Saunders","source_individual_id":"RMIS84552","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Bernadette Saunders"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79437","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65615","size":1},{"color":"#FF4D4D","name":"A functional interaction between domains of the flavivirus NS5 protein presents a new target for antiviral therapy","data":{"media_summary":"","end_year":2012,"keywords":["drug targeting","flavivirus","protein structure","protein-protein interaction"],"nhmrc_grant_id":631520,"application_year":2009,"health_keywords":["arbovirus diseases","flavivirus encephalitis","flavivirus infections"],"scientific_title":"A functional interaction between domains of the flavivirus NS5 protein presents a new target for antiviral therapy","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICINAL AND BIOMOLECULAR CHEMISTRY","cia_name":"Prof Roy Hall","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631520","simplified_title":"Understanding the structures and functions of viral proteins to design drugs","sub_type":"Standard Project Grant","total_budget":"502891.03","source_system":"Mosquito-transmitted flaviviruses such as dengue, yellow fever, Japanese encephalitis and West Nile infect hundreds of millions of people and cause debilitating and fatal diseases. Developing anti-viral treatments against these diseases is a high priority. Our strategy is to develop small molecules that can bind to specific sites on viral proteins and prevent the virus from replicating and causing disease."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1},{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"Prof Roy Hall","data":{"first_name":"Roy","title":"Prof","dw_individual_id":"DW0025278","middle_name":"A","last_name":"Hall","source_individual_id":"RMIS16831","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roy Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83509","size":1},{"color":"#336699","name":"Prof Bruno Carnard","data":{"first_name":"Bruno","title":"Prof","dw_individual_id":"DW0006422","middle_name":"","last_name":"Carnard","source_individual_id":"5018716","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bruno Carnard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78441","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65614","size":1},{"color":"#FF4D4D","name":"Home-based speech treatment for Parkinsons Disease via telerehabilitation : clinical and economic outcomes.","data":{"media_summary":"","end_year":2014,"keywords":["Parkinson's Disease","Rehabilitation","Rural health","Speech pathology","Telerehabilitation"],"nhmrc_grant_id":631514,"application_year":2009,"health_keywords":["Motor speech disorders","Parkinson's Disease","Rehabilitation","Rural and remote health"],"scientific_title":"Home-based speech treatment for Parkinsons Disease via telerehabilitation : clinical and economic outcomes.","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy (excl. Physiotherapy)","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Deborah Theodoros","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631514","simplified_title":"Treating disordered speech in Parkinsons Disease in the home via the Internet","sub_type":"Standard Project Grant","total_budget":"485793.12","source_system":"Parkinson's Disease affects a person's ability to speak clearly. Speech pathologists can provide effective treatment for this speech disorder. Access to a speech pathologist, however, is difficult for many people with Parkinson's Disease due to their physical difficulties and the limited availability of speech pathology services in rural areas. This study demonstrates the use of telerehabilitation to deliver speech treatment to people with Parkinson's Disease in their own homes via the Internet."},"children":[{"color":"#336699","name":"A/Pr Trevor Russell","data":{"first_name":"Trevor","title":"A/Pr","dw_individual_id":"DW0033555","middle_name":"","last_name":"Russell","source_individual_id":"RMIS3678636","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Trevor Russell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85687","size":1},{"color":"#336699","name":"Prof Deborah Theodoros","data":{"first_name":"Deborah","title":"Prof","dw_individual_id":"DW0022512","middle_name":"Gale","last_name":"Theodoros","source_individual_id":"RMIS15273","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Deborah Theodoros"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82794","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65613","size":1},{"color":"#FF4D4D","name":"Investigating the role of the NR4A nuclear receptor family in melanocyte function and tumorigenesis","data":{"media_summary":"ultraviolet radiation exposure","end_year":2012,"keywords":["DNA repair","gene expression","melanocyte","melanoma","nuclear receptor"],"nhmrc_grant_id":631510,"application_year":2009,"health_keywords":["cancer predisposition","cancer-melanoma","cancer: mechanisms of growth, invasion, metastases","gene expression","ultraviolet radiation exposure"],"scientific_title":"Investigating the role of the NR4A nuclear receptor family in melanocyte function and tumorigenesis","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression (incl. Microarray and other genome-wide approaches)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Aaron Smith","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631510","simplified_title":"Understanding NR4A gene function in melanocyte and melanoma cells","sub_type":"Standard Project Grant","total_budget":"555325.32","source_system":"Individuals with red hair and fair skin have a considerably greater risk of developing melanoma and non-melanoma skin cancer. Understanding the relationship that genes such as MC1R and NR4As have to skin functions such as tanning and protection from UV damage, will provide a greater insight into melanoma susceptibility and progression. Furthermore, understanding the role that abnormal NR4A regulation plays in melanoma formation will aid in the identification of new therapeutic targets."},"children":[{"color":"#336699","name":"A/Pr Richard Sturm","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0045672","middle_name":"Alan","last_name":"Sturm","source_individual_id":"5017777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Sturm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88811","size":1},{"color":"#336699","name":"Dr Aaron Smith","data":{"first_name":"Aaron","title":"Dr","dw_individual_id":"DW0033883","middle_name":"G","last_name":"Smith","source_individual_id":"5017576","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Aaron Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85775","size":1},{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65612","size":1},{"color":"#FF4D4D","name":"Early origins, progression and aetiology of obesity, metabolic syndrome and diabetes: a 30 years follow-up study","data":{"media_summary":"METABOLISM","end_year":2013,"keywords":["DEVELOPMENTAL OUTCOMES","DIABETES","METABOLIC SYNDROME","OBESITY"],"nhmrc_grant_id":631507,"application_year":2009,"health_keywords":["CHILDHOOD OBESITY","DIABETES","FOETAL GROWTH AND DEVELOPMENT","INSULIN RESISTANCE","METABOLISM"],"scientific_title":"Early origins, progression and aetiology of obesity, metabolic syndrome and diabetes: a 30 years follow-up study","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Public Health","for_category":"CARDIOVASCULAR MEDICINE AND HAEMOTOLOGY","cia_name":"A/Pr Abdullah Mamun","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631507","simplified_title":"Early origins, progression and aetiology of obesity, metabolic syndrome and diabetes","sub_type":"Standard Project Grant","total_budget":"1194979.04","source_system":"This research proposal aims to use the unique existing Mater University Study of Pregnancy (MUSP) and its offspring data and conduct a 30-year follow-up of MUSP children to investigate the early origins, progression and causal pathways of obesity, metabolic syndrome and diabetes for young Australian. Findings of this study will extend our understanding of the factors driving these health problems with the ultimate aim of being able to reverse the obesity epidemic and improve public health."},"children":[{"color":"#336699","name":"A/Pr Michael O'Callaghan","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0044590","middle_name":"James","last_name":"O'Callaghan","source_individual_id":"RMIS1119732","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Michael O'Callaghan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88543","size":1},{"color":"#336699","name":"A/Pr Alexandra Clavarino","data":{"first_name":"Alexandra","title":"A/Pr","dw_individual_id":"DW0029981","middle_name":"","last_name":"Clavarino","source_individual_id":"RMIS31306","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Alexandra Clavarino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84768","size":1},{"color":"#336699","name":"Prof Gail Williams","data":{"first_name":"Gail","title":"Prof","dw_individual_id":"DW0017119","middle_name":"Marilyn","last_name":"Williams","source_individual_id":"RMIS28497","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gail Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81346","size":1},{"color":"#336699","name":"A/Pr Rosa Alati","data":{"first_name":"Rosa","title":"A/Pr","dw_individual_id":"DW0005759","middle_name":"","last_name":"Alati","source_individual_id":"RMIS2639340","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Rosa Alati"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78272","size":1},{"color":"#336699","name":"Prof Jackob Najman","data":{"first_name":"Jackob","title":"Prof","dw_individual_id":"DW0003590","middle_name":"Moses","last_name":"Najman","source_individual_id":"5016639","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jackob Najman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77655","size":1},{"color":"#336699","name":"A/Pr Abdullah Mamun","data":{"first_name":"Abdullah","title":"A/Pr","dw_individual_id":"DW0003145","middle_name":"Al","last_name":"Mamun","source_individual_id":"5016160","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Abdullah Mamun"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77536","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65611","size":1},{"color":"#FF4D4D","name":"Improving methods to measure comparable mortality by cause","data":{"media_summary":"","end_year":2014,"keywords":["burden of disease","demography","diagnosis","mortality","public health"],"nhmrc_grant_id":631494,"application_year":2009,"health_keywords":["PGP3","epidemiology","mortality","population health"],"scientific_title":"Improving methods to measure comparable mortality by cause","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Information Systems (incl. Surveillance)","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Alan Lopez","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631494","simplified_title":"Improving methods to estimate causes of death in developing countries","sub_type":"Standard Project Grant","total_budget":"1972470.85","source_system":"Understanding the leading causes of death (COD) in a population is critical to guide health priorities. In many developing countries, information on COD is not available for the entire population, or is of poor quality. New methods are required to generate reliable COD data at low cost with minimal involvement of physicians. This project will develop and validate methods to reliably diagnose COD and to estimate national mortality patterns from biased hospital statistics."},"children":[{"color":"#336699","name":"Prof Christopher Murray","data":{"first_name":"Christopher","title":"Prof","dw_individual_id":"DW0032763","middle_name":"J L","last_name":"Murray","source_individual_id":"5019088","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Christopher Murray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85483","size":1},{"color":"#336699","name":"Prof Alan Lopez","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0026372","middle_name":"Donald","last_name":"Lopez","source_individual_id":"5012116","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alan Lopez"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83819","size":1},{"color":"#336699","name":"Prof Rafael Lozano","data":{"first_name":"Rafael","title":"Prof","dw_individual_id":"DW0020497","middle_name":"","last_name":"Lozano","source_individual_id":"5019022","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Rafael Lozano"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82236","size":1},{"color":"#336699","name":"E/Pr Ian Riley","data":{"first_name":"Ian","title":"E/Pr","dw_individual_id":"DW0015879","middle_name":"Douglas","last_name":"Riley","source_individual_id":"5030617","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"E/Pr Ian Riley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81003","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65610","size":1},{"color":"#FF4D4D","name":"The primary cilium in hedgehog signalling and disease","data":{"media_summary":"","end_year":2013,"keywords":["abnormal embryogenesis","ciliopathies","hedgehog signalling","limb development"],"nhmrc_grant_id":631493,"application_year":2009,"health_keywords":["congenital defects","defects in embryonic development","inherited disorders"],"scientific_title":"The primary cilium in hedgehog signalling and disease","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Carol Wicking","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631493","simplified_title":"The primary cilium in hedgehog signalling and disease","sub_type":"Standard Project Grant","total_budget":"583312","source_system":"Every mammalian cell has a single protrusion called the primary cilium. Recent studies in mice and humans have highlighted the importance of the primary cilium in disease states affecting the limb, kidney, skeleton, brain, eyes, ears and lungs, as well as obesity and diabetes. We have isolated a novel mouse with a defect in the machinery required for correct functioning of the primary cilium. This mouse has widespread abnormalities and will be used to elucidate the role of cilia in disease."},"children":[{"color":"#336699","name":"A/Pr Carol Wicking","data":{"first_name":"Carol","title":"A/Pr","dw_individual_id":"DW0028805","middle_name":"A","last_name":"Wicking","source_individual_id":"RMIS2473798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Carol Wicking"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84461","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65609","size":1},{"color":"#FF4D4D","name":"Regulation of Bone Dynamics by Osteal Tissue Macrophages (Osteomacs)","data":{"media_summary":"Skeletal disease","end_year":2013,"keywords":["Macrophage","Osteoblast","Osteoclast","bone remodelling and osteogenesis","osteoimmunology"],"nhmrc_grant_id":631484,"application_year":2009,"health_keywords":["Ageing","Bone growth and fracture healing","Bone loss","Osteoporosis","Skeletal disease"],"scientific_title":"Regulation of Bone Dynamics by Osteal Tissue Macrophages (Osteomacs)","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Orthopaedics","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Allison Pettit","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631484","simplified_title":"Rebuilding bone through macrophages","sub_type":"Standard Project Grant","total_budget":"741095.48","source_system":"There is a high demand for effective treatments to rebuild and replace lost bone in fracture repair and osteoporosis. We have described a discrete population of macrophages (classically immune defense cells) within the specialized tissues that line bones. We have shown that these bone tissue macrophages have a novel role in promoting the formation of new bone. This project grant will extend these observations and identify the clinical potential of bone tissue macrophages to treat bone disease."},"children":[{"color":"#336699","name":"Dr Liza Raggatt","data":{"first_name":"Liza","title":"Dr","dw_individual_id":"DW0015741","middle_name":"J","last_name":"Raggatt","source_individual_id":"RMIS4437738","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Liza Raggatt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80966","size":1},{"color":"#336699","name":"Dr Allison Pettit","data":{"first_name":"Allison","title":"Dr","dw_individual_id":"DW0015560","middle_name":"Robyn","last_name":"Pettit","source_individual_id":"5016963","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Allison Pettit"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80923","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65608","size":1},{"color":"#FF4D4D","name":"Nuclear Receptor 4A3 signalling in skeletal muscle","data":{"media_summary":"Obesity","end_year":2012,"keywords":["Diabetes and Obesity","Gene Regulation","Metabolism","Skeletal Muscle","Steroid Hormone Receptors"],"nhmrc_grant_id":631480,"application_year":2009,"health_keywords":["Biological Sciences","Diabetes","Dyslipidaemia","Metabolic Disorders","Obesity"],"scientific_title":"Nuclear Receptor 4A3 signalling in skeletal muscle","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631480","simplified_title":"Regulation of oxidative metabolism in muscle","sub_type":"Standard Project Grant","total_budget":"475745.22","source_system":"Nuclear receptors regulate hormonal control of reproduction, endocrine physiology, and metabolism, and are very important in human health. NR4A3 function in peripheral tissues remains illusive. However, it is expressed in skeletal muscle, a tissue that (i) modulates blood lipids, insulin sensitivity and energy balance, and (ii) has an imortant role in diabetes and obesity. Understanding NR4A3 function in metabolism provides a potential platform for therapeutic intervention."},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65607","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2014,"keywords":["gastroenterology","pathophysiology","physiology","renal","transporters"],"nhmrc_grant_id":631475,"application_year":2009,"start_year":2010,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof Daniel Markovich","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631475","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"591080.99","source_system":""},"children":[{"color":"#336699","name":"Prof Daniel Markovich","data":{"first_name":"Daniel","title":"Prof","dw_individual_id":"DW0038289","middle_name":"","last_name":"Markovich","source_individual_id":"5016201","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Daniel Markovich"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86917","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65606","size":1},{"color":"#FF4D4D","name":"Cytoplasmic DNA as a danger signal for mammalian cells","data":{"media_summary":"viral infection","end_year":2012,"keywords":["cell death-apoptosis","host-pathogen interaction","innate immunity","systemic lupus erythematosus","viral immunology"],"nhmrc_grant_id":631472,"application_year":2009,"health_keywords":["cancer biology","gene therapy","infectious disease","systemic lupus erythematosus","viral infection"],"scientific_title":"Cytoplasmic DNA as a danger signal for mammalian cells","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Innate Immunity","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Katryn Stacey","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631472","simplified_title":"Stray DNA in mammalian cells signals an infection","sub_type":"Standard Project Grant","total_budget":"592661.13","source_system":"DNA in mammalian cells is contained within a structure known as the nucleus. The presence of DNA outside the nucleus in the cytoplasm of the cell is a sure sign that something is wrong, and may indicate the presence of a viral invader. In this case, the cell initiates anti-viral responses, including production of anti-viral proteins and death of the infected cell to stop replication of the virus. Lack of proper control of these responses may contibute to the autoimmune disease lupus."},"children":[{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1},{"color":"#336699","name":"Dr Katryn Stacey","data":{"first_name":"Katryn","title":"Dr","dw_individual_id":"DW0028117","middle_name":"Jane","last_name":"Stacey","source_individual_id":"5017656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katryn Stacey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84258","size":1},{"color":"#336699","name":"Dr Tara Roberts","data":{"first_name":"Tara","title":"Dr","dw_individual_id":"DW0015901","middle_name":"L","last_name":"Roberts","source_individual_id":"5017199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Tara Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81007","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65605","size":1},{"color":"#FF4D4D","name":"DCC-Robo interactions cooperate to regulate callosal axon guidance","data":{"media_summary":"","end_year":2012,"keywords":["Axon guidance","Brain development","Neurobiology","corpus callosum","transmembrane receptors"],"nhmrc_grant_id":631466,"application_year":2009,"health_keywords":["autistic spectrum disorder","congenital brain defects","developmental brain disorders"],"scientific_title":"DCC-Robo interactions cooperate to regulate callosal axon guidance","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Linda Richards","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631466","simplified_title":"Molecular regulation of corpus callosum formation","sub_type":"Standard Project Grant","total_budget":"383422.18","source_system":"In order for the brain to function, the correct connections between neurons must be formed during development. These connections, formed by the axonal processes of neurons, are able to find their synaptic targets by sensing molecular cues within the brain that guide them, by attraction or repulsion, to their target. This proposal investigates how attractive and repulsive signals are received and integrated in neurons to enable axons to find their targets in the brain."},"children":[{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65604","size":1},{"color":"#FF4D4D","name":"Determinants of successfully living with aphasia after stroke: a prospective cohort mixed methods study","data":{"media_summary":"stroke rehabilitation","end_year":2014,"keywords":["aphasia","longitudinal study","qualitative research","rehabilitation","speech pathology"],"nhmrc_grant_id":631464,"application_year":2009,"health_keywords":["aphasia","neurogenic communication disorder","neurological disability","patient related health outcomes","stroke rehabilitation"],"scientific_title":"Determinants of successfully living with aphasia after stroke: a prospective cohort mixed methods study","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy (excl. Physiotherapy)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Linda Worrall","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631464","simplified_title":"Successfully living with aphasia: What does it take?","sub_type":"Standard Project Grant","total_budget":"469003.23","source_system":"People with the communication disability of aphasia following stroke are critical of rehabilitation services. This project seeks to determine what it takes to live successfully with aphasia so that aphasia rehabilitation can be improved. Participants will be interviewed over the first 12 months following the stroke. The most important factors contributing to success will be identified and barriers and facilitators described. The most important factors can then be targeted in rehabilitation."},"children":[{"color":"#336699","name":"Prof Linda Worrall","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0046389","middle_name":"Elizabeth","last_name":"Worrall","source_individual_id":"RMIS28004","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Worrall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/89016","size":1},{"color":"#336699","name":"Dr Asad Khan","data":{"first_name":"Asad","title":"Dr","dw_individual_id":"DW0008357","middle_name":"","last_name":"Khan","source_individual_id":"5018956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Asad Khan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78958","size":1},{"color":"#336699","name":"Prof Nina Simmons-Mackie","data":{"first_name":"Nina","title":"Prof","dw_individual_id":"DW0004640","middle_name":"N","last_name":"Simmons-Mackie","source_individual_id":"5019248","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nina Simmons-Mackie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77959","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65603","size":1},{"color":"#FF4D4D","name":"MicroRNA regulation of sex determination and gonad development.","data":{"media_summary":"sexual differentiation","end_year":2012,"keywords":["microRNAs","sex determination","testis differentiation"],"nhmrc_grant_id":631460,"application_year":2009,"health_keywords":["Infertility","congenital anomaly of sexual development","molecular basis of disease","sex determination","sexual differentiation"],"scientific_title":"MicroRNA regulation of sex determination and gonad development.","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Dagmar Wilhelm","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631460","simplified_title":"MicroRNAs in sex determination.","sub_type":"Standard Project Grant","total_budget":"518076.03","source_system":"Sex determination, the decision to develop into either boy or girl, influences most aspects of our lives. Consequently, disorders of sexual development (~1% of births), resulting in genital abnormalities, infertility and often cancer, are extremely traumatic for the individual. The molecular basis of these disorders is not well understood. This project will identify new factors important for sex determination and therefore will improve diagnosis and clinical care for the patients."},"children":[{"color":"#336699","name":"A/Pr Dagmar Wilhelm","data":{"first_name":"Dagmar","title":"A/Pr","dw_individual_id":"DW0046276","middle_name":"","last_name":"Wilhelm","source_individual_id":"5018314","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Dagmar Wilhelm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88981","size":1},{"color":"#336699","name":"Dr Charles Bailey","data":{"first_name":"Charles","title":"Dr","dw_individual_id":"DW0029261","middle_name":"G","last_name":"Bailey","source_individual_id":"5018616","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Charles Bailey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84588","size":1},{"color":"#336699","name":"A/Pr Marcel Dinger","data":{"first_name":"Marcel","title":"A/Pr","dw_individual_id":"DW0006980","middle_name":"Eduard","last_name":"Dinger","source_individual_id":"5014341","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Marcel Dinger"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78595","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65602","size":1},{"color":"#FF4D4D","name":"New peptide-based drugs for the treatment of neuropathic pain","data":{"media_summary":"","end_year":2012,"keywords":["Chronic pain","Drug design","Neuropathic pain","Therapeutics","conotoxins"],"nhmrc_grant_id":631457,"application_year":2009,"health_keywords":["Biochemistry-protein peptide","Chronic pain and analgesia","Neuropathic pain","Novel therapeutic"],"scientific_title":"New peptide-based drugs for the treatment of neuropathic pain","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides (incl. Medical Proteomics)","research_area":"Basic Science","for_category":"MEDICAL BIOCHEMISTRY AND METABOLOMICS","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631457","simplified_title":"A treatment for neuropathic pain","sub_type":"Standard Project Grant","total_budget":"527171.83","source_system":"Chronic pain affects 1 in 5 Australians and neuropathic pain is among the most severe forms of chronic pain. Peptides from cone snail venoms have attracted recent attention as potential therapeutic agents for the treatment of neuropathic pain. Unfortunately, these peptides suffer from the disadvantage of short biological half-lives and poor activity when taken orally. We have developed a new approach to solve these problems that we will apply to develop new drugs for the treatment of pain."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Dr Richard Clark","data":{"first_name":"Richard","title":"Dr","dw_individual_id":"DW0029966","middle_name":"James","last_name":"Clark","source_individual_id":"5013970","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Richard Clark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84761","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65601","size":1},{"color":"#FF4D4D","name":"Complement activation in experimental epilepsy: role of C5a receptors","data":{"media_summary":"traumatic brain injury","end_year":2012,"keywords":["complement C5a","inflammatory mediators","neuroimmunology","neuronal injury","seizures"],"nhmrc_grant_id":631451,"application_year":2009,"health_keywords":["ageing","epilepsy","seizures","stroke","traumatic brain injury"],"scientific_title":"Complement activation in experimental epilepsy: role of C5a receptors","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Karin Borges","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631451","simplified_title":"How epilepsy develops and how it can be prevented","sub_type":"Standard Project Grant","total_budget":"314716.75","source_system":"400,000 patients in Australia suffer from epilepsy and 45% of them suffer from uncontrolled seizures. Epilepsy often develops after head injury or stroke, but no treatments are available to prevent this process. Inflammatory processes seem to be involved in epilepsy. We will investigate if the inflammatory complement factor C5a plays a role in epilepsy and if we can prevent development of seizures in mice. If successful our data will be a prerequisite for later clinical trials."},"children":[{"color":"#336699","name":"Dr Karin Borges","data":{"first_name":"Karin","title":"Dr","dw_individual_id":"DW0011899","middle_name":"","last_name":"Borges","source_individual_id":"5018667","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Karin Borges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79926","size":1},{"color":"#336699","name":"Prof Stephen Taylor","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0010587","middle_name":"M","last_name":"Taylor","source_individual_id":"RMIS41211","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79577","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65600","size":1},{"color":"#FF4D4D","name":"Developing novel selective glycine receptor potentiators as a means to control pain.","data":{"media_summary":"","end_year":2013,"keywords":["ligand-gated ion channel function","medicinal chemistry","molecular biology","neuropharmacology","structure -activity relationships"],"nhmrc_grant_id":631448,"application_year":2009,"health_keywords":["chronic pain","inflammatory arthritis","neuropathic pain"],"scientific_title":"Developing novel selective glycine receptor potentiators as a means to control pain.","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Rob Capon","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631448","simplified_title":"New molecules to control chronic inflammatory pain","sub_type":"Standard Project Grant","total_budget":"552647.42","source_system":"It has been estimated that >3M Australians suffer from pain at a cost to the economy of >$34B, with chronic pain (persisting beyond 1-6 mths) accounting for ~half this burden. There is an urgent and compelling social and economic case for the development of safer and more effective pain therapeutics. This project takes inspiration from a new class of Australian marine natural products that selectively regulate a key pain pathway, and will optimize and develop these as a new class of pain drug."},"children":[{"color":"#336699","name":"Prof Joseph Lynch","data":{"first_name":"Joseph","title":"Prof","dw_individual_id":"DW0032228","middle_name":"W","last_name":"Lynch","source_individual_id":"5016080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Joseph Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85342","size":1},{"color":"#336699","name":"Prof Rob Capon","data":{"first_name":"Rob","title":"Prof","dw_individual_id":"DW0012180","middle_name":"John","last_name":"Capon","source_individual_id":"5011505","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Rob Capon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79993","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65599","size":1},{"color":"#FF4D4D","name":"Molecular regulation of angiotensin receptors","data":{"media_summary":"","end_year":2012,"keywords":["G protein-coupled receptor","angiotensin","arrestin","cell surface receptor","molecular pharmacology"],"nhmrc_grant_id":631443,"application_year":2009,"health_keywords":["blood pressure regulation","cardiovascular disease and hypertension","drug discovery"],"scientific_title":"Molecular regulation of angiotensin receptors","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology and Pharmaceutical Sciences not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Walter Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631443","simplified_title":"receptors for the hormone angiotensin","sub_type":"Standard Project Grant","total_budget":"636199.34","source_system":"The hormone angiotensin II affect our heart and blood vessels by switching-on receptors that are then switched-off to prevent over-stimulation. This application continues our investigations into how angiotensin II receptors are switched-on and -off. We apply new technologies to identify and study receptor modulating proteins and the pairing receptors into dimers. Results will further our understanding of angiotensin receptors and cardiovascular control."},"children":[{"color":"#336699","name":"Prof Walter Thomas","data":{"first_name":"Walter","title":"Prof","dw_individual_id":"DW0028371","middle_name":"Glen","last_name":"Thomas","source_individual_id":"RMIS225046","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Walter Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84337","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65598","size":1},{"color":"#FF4D4D","name":"Metallo-beta-lactamases: predicting and combating antibiotic resistance","data":{"media_summary":"Urinary tract infection","end_year":2013,"keywords":["Antibiotics","Enzyme inhibition","NMR spectroscopy","Rational drug design","X-ray crystallography"],"nhmrc_grant_id":631433,"application_year":2009,"health_keywords":["Antibiotic resistance","Bacterial infection","Bacterial pathogen","Drug resistant bacteria","Urinary tract infection"],"scientific_title":"Metallo-beta-lactamases: predicting and combating antibiotic resistance","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides (incl. Medical Proteomics)","research_area":"Public Health","for_category":"MEDICAL BIOCHEMISTRY AND METABOLOMICS","cia_name":"A/Pr Gerhard Schenk","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631433","simplified_title":"Combating antibiotic resistance","sub_type":"Standard Project Grant","total_budget":"530424.63","source_system":"The increase of drug-resistant bacterial pathogens has become a major global health concern. Many pathogens employ a special enzyme, named metallo-beta-lactamase (MBL), to degrade antibiotics such as penicillin. No clinically useful inhibitors of this enzyme are available. We will use sophisticated techniques to predict and combat drug resistance of the MBL from Klebsiella pneumoniae, a pathogen associated in particular with hospital-acquired infections such as urinary tract infections."},"children":[{"color":"#336699","name":"A/Pr Gerhard Schenk","data":{"first_name":"Gerhard","title":"A/Pr","dw_individual_id":"DW0033669","middle_name":"","last_name":"Schenk","source_individual_id":"5017375","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Gerhard Schenk"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85717","size":1},{"color":"#336699","name":"Prof David Ollis","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0027122","middle_name":"L","last_name":"Ollis","source_individual_id":"5016797","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Ollis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84011","size":1},{"color":"#336699","name":"A/Pr Ross Mcgeary","data":{"first_name":"Ross","title":"A/Pr","dw_individual_id":"DW0003289","middle_name":"P","last_name":"Mcgeary","source_individual_id":"RMIS3165807","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Ross Mcgeary"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77578","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65597","size":1},{"color":"#FF4D4D","name":"Rad50 protects the integrity of the genome to minimise disease risk","data":{"media_summary":"","end_year":2012,"keywords":["Cancer","DNA Damage","Genetic Disease","Neurodegeneration","Signal Transduction"],"nhmrc_grant_id":631425,"application_year":2009,"health_keywords":["Ataxia","Genetic Disorders","Neurodegeneration"],"scientific_title":"Rad50 protects the integrity of the genome to minimise disease risk","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cancer Cell Biology","research_area":"Basic Science","for_category":"ONCOLOGY AND CARCINOGENESIS","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631425","simplified_title":"Rad50 protects the genome","sub_type":"Standard Project Grant","total_budget":"524222.26","source_system":"Exposure to both endogenous products of metabolism as well as a variety of exogenous agents (UV, X-rays) increases the risk of cancer and other diseases. This project is designed to further investigate a novel defect in the Rad50 gene that predisposes to genetic instability and cancer. In short we have described for the first time a patient with a defect in the Rad50 gene. This information will assist in understanding our defence systems against oxidative stress to reduce the risk of disease."},"children":[{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1},{"color":"#336699","name":"Dr Thilo Dork","data":{"first_name":"Thilo","title":"Dr","dw_individual_id":"DW0018737","middle_name":"","last_name":"Dork","source_individual_id":"5014401","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Thilo Dork"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81800","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65596","size":1},{"color":"#FF4D4D","name":"Structure-based design of therapeutics targeting relaxin family peptide receptors","data":{"media_summary":"","end_year":2014,"keywords":["G-protein coupled receptors","NMR spectroscopy","hormone signalling","structure-activity relationships"],"nhmrc_grant_id":631420,"application_year":2009,"start_year":2010,"scientific_title":"Structure-based design of therapeutics targeting relaxin family peptide receptors","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides (incl. Medical Proteomics)","research_area":"Basic Science","for_category":"MEDICAL BIOCHEMISTRY AND METABOLOMICS","cia_name":"Dr Karl Johan Rosengren","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631420","simplified_title":"Molecular mechanism and modulation of relaxin family peptide receptors","sub_type":"RD Wright Biomedical CDF","total_budget":"394460.05","source_system":""},"children":[{"color":"#336699","name":"Dr Karl Johan Rosengren","data":{"first_name":"Karl Johan","title":"Dr","dw_individual_id":"DW0027687","middle_name":"","last_name":"Rosengren","source_individual_id":"5019233","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Karl Johan Rosengren"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84148","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65595","size":1},{"color":"#FF4D4D","name":"The neuronal PIKfyve complex regulates neurotransmission and neurodegeneration","data":{"media_summary":"","end_year":2013,"keywords":["autophagy","molecular neuroscience","neurodegeneration","phosphoinositides","synaptic transmission"],"nhmrc_grant_id":631418,"application_year":2009,"health_keywords":["Alzheimer Disease","Amyotrophic Lateral Sclerosis","Neurodegeneration"],"scientific_title":"The neuronal PIKfyve complex regulates neurotransmission and neurodegeneration","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Shona Osborne","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631418","simplified_title":"Lipid regulation of neuronal communication and degeneration","sub_type":"New Investigator Grant","total_budget":"372965.65","source_system":"Neuronal communication is essential for the functioning of our bodies and mind. We have identified a novel pathway for the regulation of this process involving a little studied lipid, PI3,5P2. This lipid also appears to be important for neuronal survival. We will investigate the regulation and function of this lipid in neurons. The outcomes of this proposal will be an important step closer to understanding the processes underlying neuronal communication and neurodegeneration."},"children":[{"color":"#336699","name":"Dr Shona Osborne","data":{"first_name":"Shona","title":"Dr","dw_individual_id":"DW0038912","middle_name":"L","last_name":"Osborne","source_individual_id":"5016827","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Shona Osborne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87084","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65594","size":1},{"color":"#FF4D4D","name":"Astrocyte Regulation of Ammonia and Glutamate in Neonatal Hypoxia-Ischaemia","data":{"media_summary":"","end_year":2012,"keywords":["excitotoxicity","glia","glutamine","hypoxia","neonatal"],"nhmrc_grant_id":631414,"application_year":2009,"health_keywords":["brain asphyxia","hypoxia and malnutrition during pregnancy","hypoxic-ischaemic encephalopathy","neuronal cell death"],"scientific_title":"Astrocyte Regulation of Ammonia and Glutamate in Neonatal Hypoxia-Ischaemia","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof David Pow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631414","simplified_title":"A novel marker and mediator of brain damage in brains subjected to a lack of oxygen","sub_type":"Standard Project Grant","total_budget":"523804.09","source_system":"Lack of oxygen is a common problem for newborn infants, ocurring during events such as a difficult labour, and can lead to brain damage. We have discovered that a protein in the brain which normally removes ammonia (a toxic product of metabolism) is rapidly lost after a brief period of low oxygen. We propose that a build up of ammonia in the brain may be a key damaging event in hypoxia-related brain injury, and that it will be ameniable to therapeutic intervention."},"children":[{"color":"#336699","name":"Dr Barbara Lingwood","data":{"first_name":"Barbara","title":"Dr","dw_individual_id":"DW0043819","middle_name":"Elizabeth","last_name":"Lingwood","source_individual_id":"5016005","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Barbara Lingwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88355","size":1},{"color":"#336699","name":"Prof David Pow","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0021533","middle_name":"Vaughan","last_name":"Pow","source_individual_id":"RMIS4392155","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Pow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82534","size":1},{"color":"#336699","name":"A/Pr Nigel Barnett","data":{"first_name":"Nigel","title":"A/Pr","dw_individual_id":"DW0011632","middle_name":"L","last_name":"Barnett","source_individual_id":"5013343","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nigel Barnett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79858","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1},{"color":"#336699","name":"Dr Kathryn Buller","data":{"first_name":"Kathryn","title":"Dr","dw_individual_id":"DW0006311","middle_name":"Marie","last_name":"Buller","source_individual_id":"5013676","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kathryn Buller"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78421","size":1},{"color":"#336699","name":"Dr Stella Bjorkman","data":{"first_name":"Stella","title":"Dr","dw_individual_id":"DW0000420","middle_name":"Tracey","last_name":"Bjorkman","source_individual_id":"5013484","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Stella Bjorkman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76767","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65593","size":1},{"color":"#FF4D4D","name":"Role of Senataxin in protecting against neurodegeneration","data":{"media_summary":"","end_year":2012,"keywords":["Cell Biology","Mouse model","Neurodegeneration","Senataxin","Transcription"],"nhmrc_grant_id":631407,"application_year":2009,"health_keywords":["Ataxia","Degeneration disorders","Gene Expression","Genetic Disease"],"scientific_title":"Role of Senataxin in protecting against neurodegeneration","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631407","simplified_title":"Senataxin protects against neurodegeneration","sub_type":"Standard Project Grant","total_budget":"539773.79","source_system":"A number of rare autosomal recessive ataxias have been described that overlap in their clinical phenotype. A subgroup of these have in common a reduced capacity to deal with damage to the genome which is associated with neurodegeneration. We are characterising the protein (senataxin) defective in one of these syndromes, ataxia oculomotor apraxia type 2 (AOA2). We have generated a mouse model of setx the gene coding for senataxin which will assist in our understanding of this disease."},"children":[{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65592","size":1},{"color":"#FF4D4D","name":"Studying the molecular basis of schizophrenia in a large, globally competitive Indian sample","data":{"media_summary":"","end_year":2014,"keywords":["Schizophrenia","case control study","diagnostic criteria","mental health","molecular genetics"],"nhmrc_grant_id":631406,"application_year":2009,"health_keywords":["Mental Health","PGP3","Psychiatric Disorders","Schizophrenia"],"scientific_title":"Studying the molecular basis of schizophrenia in a large, globally competitive Indian sample","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry (incl. Psychotherapy)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Bryan Mowry","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631406","simplified_title":"A genetic study of schizophrenia in a large Indian sample","sub_type":"Standard Project Grant","total_budget":"998040.05","source_system":"This study will attempt to identify genetic factors contributing to the development of schizophrenia, a severe mental illness which causes an immense burden on families. In India, there are 7-8 million sufferers, with approximately 30-40% untreated, especially in rural areas. We aim to recruit over 2000 people with and 3000 without schizophrenia, and analyse DNA to identify schizophrenia susceptibility genes. This may lead to better treatments and earlier diagnosis."},"children":[{"color":"#336699","name":"A/Pr Dale Nyholt","data":{"first_name":"Dale","title":"A/Pr","dw_individual_id":"DW0044574","middle_name":"R","last_name":"Nyholt","source_individual_id":"RMIS679856","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Dale Nyholt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88539","size":1},{"color":"#336699","name":"Prof Bryan Mowry","data":{"first_name":"Bryan","title":"Prof","dw_individual_id":"DW0044411","middle_name":"J","last_name":"Mowry","source_individual_id":"5016586","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bryan Mowry"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88510","size":1},{"color":"#336699","name":"Dr Rangaswamy Thara","data":{"first_name":"Rangaswamy","title":"Dr","dw_individual_id":"DW0028354","middle_name":"","last_name":"Thara","source_individual_id":"RMIS51648","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Rangaswamy Thara"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84327","size":1},{"color":"#336699","name":"Prof Lynn Jorde","data":{"first_name":"Lynn","title":"Prof","dw_individual_id":"DW0025836","middle_name":"B","last_name":"Jorde","source_individual_id":"RMIS2356432","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Lynn Jorde"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83657","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65591","size":1},{"color":"#FF4D4D","name":"Functions of viral chemokine receptor homologues important for cytomegalovirus pathogenesis and latency","data":{"media_summary":"viral persistence","end_year":2013,"keywords":["cytomegalovirus","host-pathogen interaction","viral chemokine receptor homologue","virus persistence and latency"],"nhmrc_grant_id":631401,"application_year":2009,"health_keywords":["cytomegalovirus","infectious disease","microbiology-virology","understanding virus-host interactions","viral persistence"],"scientific_title":"Functions of viral chemokine receptor homologues important for cytomegalovirus pathogenesis and latency","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Nicholas Davis-Poynter","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631401","simplified_title":"Herpesvirus proteins that modify activities of the cell to promote virus infection and persistence. How do they work ?","sub_type":"Standard Project Grant","total_budget":"461597.97","source_system":"Cytomegalovirus (CMV) causes life-threatening disease in babies, transplant recipients and HIV-AIDS patients. We will focus on a CMV gene that has been 'hijacked' from the host cell and enables the virus to switch on signalling molecules within infected cells. We will determine how these signals enable CMV to infect sites of the body that are critical for virus transmission and contribute to long-term virus persistence. Our results will provide new strategies for drugs against CMV."},"children":[{"color":"#336699","name":"Dr Helen Farrell","data":{"first_name":"Helen","title":"Dr","dw_individual_id":"DW0030627","middle_name":"Elizabeth","last_name":"Farrell","source_individual_id":"5014571","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Helen Farrell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84957","size":1},{"color":"#336699","name":"A/Pr Nicholas Davis-Poynter","data":{"first_name":"Nicholas","title":"A/Pr","dw_individual_id":"DW0012654","middle_name":"J","last_name":"Davis-Poynter","source_individual_id":"5014228","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nicholas Davis-Poynter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80128","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65589","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2014,"keywords":["infectious disease","streptococcal disease","streptococcal infection","streptococcal invasive diseases","vaccines"],"nhmrc_grant_id":631386,"application_year":2009,"start_year":2010,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Mark Walker","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631386","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"715099.88","source_system":""},"children":[{"color":"#336699","name":"Prof Mark Walker","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0010893","middle_name":"J.","last_name":"Walker","source_individual_id":"RMIS127362","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mark Walker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79668","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65588","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2014,"keywords":["cell cycle","melanoma","mitosis","molecular mechanisms"],"nhmrc_grant_id":631384,"application_year":2009,"start_year":2010,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development, Proliferation and Death","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Brian Gabrielli","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631384","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"591080.99","source_system":""},"children":[{"color":"#336699","name":"A/Pr Brian Gabrielli","data":{"first_name":"Brian","title":"A/Pr","dw_individual_id":"DW0007391","middle_name":"G","last_name":"Gabrielli","source_individual_id":"5014734","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Brian Gabrielli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78693","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65587","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2012,"keywords":["adhesion mechanisms","cytoskeleton","signalling"],"nhmrc_grant_id":631383,"application_year":2009,"start_year":2010,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Alpha Yap","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631383","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"385024.94","source_system":""},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65586","size":1},{"color":"#FF4D4D","name":"Myosin VI: a novel molecular apparatus for epithelial cohesion","data":{"media_summary":"","end_year":2012,"keywords":["Cell Adhesion","Cell Biology","Cytoskeleton","Epithelial Biology"],"nhmrc_grant_id":631377,"application_year":2009,"health_keywords":["Cancer Biology","Invasion","Metastasis"],"scientific_title":"Myosin VI: a novel molecular apparatus for epithelial cohesion","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Alpha Yap","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631377","simplified_title":"Myosin VI and epithelial integrity","sub_type":"Standard Project Grant","total_budget":"605096.28","source_system":"Adhesion between cells holds the human body together and affects many aspects of our health including normal tissue and organ function. Conversely, loss of normal cell-cell adhesion contributes to major diseases, including cancer and inflammation. One key molecule, E-cadherin, is necessary for many epithelial organs and its function is perturbed in disease. This research project addresses how E-cadherin works with a cellular motor, Myosin VI, to maintain the integrity of epithelial tissues."},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65584","size":1},{"color":"#FF4D4D","name":"MOLECULAR CELL BIOLOGICAL ANALYSIS OF CAVEOLIN SECRETION","data":{"media_summary":"","end_year":2012,"keywords":["cell biology","endocytosis","exocytosis","membrane transport"],"nhmrc_grant_id":631371,"application_year":2009,"health_keywords":["cell signalling","cellular transformation","prostate cancer","secretory pathway as drug target"],"scientific_title":"MOLECULAR CELL BIOLOGICAL ANALYSIS OF CAVEOLIN SECRETION","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Trafficking","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631371","simplified_title":"CAVEOLIN SECRETION","sub_type":"Standard Project Grant","total_budget":"536657.41","source_system":"Aggressive forms of prostate cancer are associated with the release of a protein, called caveolin, from the cancerous cells. Caveolin is normally embedded in the cell surface and drives the formation of microscopic pits termed caveolae. In this proposal we will investigate how caveolin is secreted with a long-term goal of preventing the secretion, or the action, of caveolin."},"children":[{"color":"#336699","name":"Susan Nixon","data":{"first_name":"Susan","title":"","dw_individual_id":"DW0038806","middle_name":"","last_name":"Nixon","source_individual_id":"5030353","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Susan Nixon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87052","size":1},{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65583","size":1},{"color":"#FF4D4D","name":"Why do people keep hurting their back: A longitudinal study of biological, psychological and social predictors","data":{"media_summary":"Motor control","end_year":2014,"keywords":["Biomechanics","Chronic disease","Longitudinal study","Low back pain","Pain"],"nhmrc_grant_id":631369,"application_year":2009,"health_keywords":["Chronic low back pain","Inflammation","Intrinsic pain control system","Low back pain","Motor control"],"scientific_title":"Why do people keep hurting their back: A longitudinal study of biological, psychological and social predictors","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Physiotherapy","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Paul Hodges","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631369","simplified_title":"Why do people keep hurting their back?","sub_type":"Standard Project Grant","total_budget":"739946.29","source_system":"We aim to identify why people continue to suffer episodes of back pain. If we can identify factors that predict the course of back pain we can target treatments to the right people to reduce the burden of this common condition. We will follow people for a year after an acute episode. We will measure novel issues like control of trunk muscles, inflammatory response, and how the nervous system deals with pain. We will also investigate how these factors interact with social and psychological issues"},"children":[{"color":"#336699","name":"Prof Paul Hodges","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0043077","middle_name":"W","last_name":"Hodges","source_individual_id":"RMIS222953","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Hodges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88164","size":1},{"color":"#336699","name":"Prof Michael Nicholas","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0038783","middle_name":"K","last_name":"Nicholas","source_individual_id":"5011212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Nicholas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87045","size":1},{"color":"#336699","name":"Prof Jacek Cholewicki","data":{"first_name":"Jacek","title":"Prof","dw_individual_id":"DW0035863","middle_name":"","last_name":"Cholewicki","source_individual_id":"RMIS3161648","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jacek Cholewicki"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86290","size":1},{"color":"#336699","name":"Dr Mary Barbe","data":{"first_name":"Mary","title":"Dr","dw_individual_id":"DW0035248","middle_name":"F","last_name":"Barbe","source_individual_id":"5018649","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mary Barbe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86136","size":1},{"color":"#336699","name":"Prof Michele Sterling","data":{"first_name":"Michele","title":"Prof","dw_individual_id":"DW0028165","middle_name":"","last_name":"Sterling","source_individual_id":"5017714","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michele Sterling"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84271","size":1},{"color":"#336699","name":"Prof G. Lorimer Moseley","data":{"first_name":"G. Lorimer","title":"Prof","dw_individual_id":"DW0009239","middle_name":"","last_name":"Moseley","source_individual_id":"5016567","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof G. Lorimer Moseley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79214","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65582","size":1},{"color":"#FF4D4D","name":"The role of subgenomic non-coding viral RNA in flavivirus pathogenicity","data":{"media_summary":"","end_year":2013,"keywords":["Flavivirus","RNA structure and degradation","host response","host-pathogen interaction","virus replication"],"nhmrc_grant_id":631365,"application_year":2009,"health_keywords":["Australian encephalitis and related flavivirus infections","Microbiology - Virology","arbovirus diseases","flavivirus encephalitis"],"scientific_title":"The role of subgenomic non-coding viral RNA in flavivirus pathogenicity","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631365","simplified_title":"The role of subgenomic non-coding viral RNA in flavivirus pathogenicity","sub_type":"Standard Project Grant","total_budget":"555325.32","source_system":"Flaviviruses are transmitted by insects and pose a serious health threat to the Australian population. They can cause fever syndromes, encephalitis and death. We aim at better understanding of how these viruses cause disease. We are particularly interested in elucidating the role of small non-coding nucleic acid produced by flaviviruses in the viral pathogenicity. Ultimately, this deeper understanding should lead to the development of effective vaccines and antiviral therapies."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1},{"color":"#336699","name":"Dr Anneke Funk","data":{"first_name":"Anneke","title":"Dr","dw_individual_id":"DW0030790","middle_name":"","last_name":"Funk","source_individual_id":"5018815","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Anneke Funk"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84987","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65581","size":1},{"color":"#FF4D4D","name":"Regulatory RNAs Underlying Genetic Associations With Ankylosing Spondylitis","data":{"media_summary":"spondyloarthropathy","end_year":2013,"keywords":["bioinformatics","gene regulation","genetic polymorphisms","molecular genetics","molecular markers"],"nhmrc_grant_id":631363,"application_year":2009,"health_keywords":["arthritis and back pain","autoimmune disease","chronic inflammatory disease","molecular diagnostics","spondyloarthropathy"],"scientific_title":"Regulatory RNAs Underlying Genetic Associations With Ankylosing Spondylitis","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genomics","research_area":"Clinical Medicine and Science","for_category":"GENETICS","cia_name":"Dr Gethin Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631363","simplified_title":"Regulatory RNAs in Ankylosing spondylitis","sub_type":"New Investigator Grant","total_budget":"431201.42","source_system":"Ankylosing spondylitis is a chronic inflammatory disease affecting the spine and causing back pain. The diagnosis of the disease is delayed by up to 10 years due to lack of accurate tests. We aim to identify molecular signatures of the disease that might be used to distinguish inflammatory processes typical of the disease and other causes of back pain. This would allow earlier and more accurate diagnosis of the disease and result earlier patient treatment and better health outcomes."},"children":[{"color":"#336699","name":"Dr Michael Pheasant","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0039071","middle_name":"J","last_name":"Pheasant","source_individual_id":"5019160","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michael Pheasant"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87126","size":1},{"color":"#336699","name":"Dr Gethin Thomas","data":{"first_name":"Gethin","title":"Dr","dw_individual_id":"DW0022525","middle_name":"Penar","last_name":"Thomas","source_individual_id":"5017886","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Gethin Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82800","size":1},{"color":"#336699","name":"Dr Brooke Gardiner","data":{"first_name":"Brooke","title":"Dr","dw_individual_id":"DW0019132","middle_name":"Bridget Ann","last_name":"Gardiner","source_individual_id":"5041737","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brooke Gardiner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81882","size":1},{"color":"#336699","name":"A/Pr Marcel Dinger","data":{"first_name":"Marcel","title":"A/Pr","dw_individual_id":"DW0006980","middle_name":"Eduard","last_name":"Dinger","source_individual_id":"5014341","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Marcel Dinger"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78595","size":1},{"color":"#336699","name":"Dr Evgeny Glazov","data":{"first_name":"Evgeny","title":"Dr","dw_individual_id":"DW0001814","middle_name":"A","last_name":"Glazov","source_individual_id":"5018846","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Evgeny Glazov"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77165","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65580","size":1},{"color":"#FF4D4D","name":"Reprogramming the renal epithelium to reinitiate nephrogenesis","data":{"media_summary":"tissue repair","end_year":2012,"keywords":["developmental genes","gene delivery","kidney","lentiviral vector","organ growth and development"],"nhmrc_grant_id":631362,"application_year":2009,"health_keywords":["chronic renal disease","nephrology","nephron endowment","tissue regeneration","tissue repair"],"scientific_title":"Reprogramming the renal epithelium to reinitiate nephrogenesis","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Regenerative Medicine (incl. Stem Cells and Tissue Engineering)","research_area":"Basic Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631362","simplified_title":"Growing new nephrons in an adult kidney","sub_type":"Standard Project Grant","total_budget":"636199.34","source_system":"It has been shown that a mature cell type can be reprogrammed to a different type of cell in vivo via the introduction of genes critical during an earlier stage of organ development. In this way, new beta-islet cells in the pancreas can be made. In this study, we will use our understanding of kidney development to redirect the cells of the kidney tubules to dedifferentiate and form new nephrons. This may ultimately result in a regenerative strategy to treat chronic renal disease."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65579","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2014,"keywords":["developmental outcomes","fetal origins of adult disease","hypertension","kidney","renal growth factors"],"nhmrc_grant_id":631361,"application_year":2009,"start_year":2010,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Systems Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"A/Pr Karen Moritz","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631361","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"591080.99","source_system":""},"children":[{"color":"#336699","name":"A/Pr Karen Moritz","data":{"first_name":"Karen","title":"A/Pr","dw_individual_id":"DW0009221","middle_name":"","last_name":"Moritz","source_individual_id":"RMIS1366054","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Karen Moritz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79207","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65578","size":1},{"color":"#FF4D4D","name":"Practitioner Fellowship","data":{"media_summary":"","end_year":2014,"keywords":["hippocampus","magnetic rosanance imaging","temporal lobe epilepsy"],"nhmrc_grant_id":631352,"application_year":2009,"start_year":2010,"scientific_title":"Practitioner Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Prof David Reutens","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631352","simplified_title":"Practitioner Fellowship","sub_type":"Practitioner Fellowship","total_budget":"532893.74","source_system":""},"children":[{"color":"#336699","name":"Prof David Reutens","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0045054","middle_name":"C","last_name":"Reutens","source_individual_id":"RMIS86404","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Reutens"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88664","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65577","size":1},{"color":"#FF4D4D","name":"Control of neurosecretion by Munc18","data":{"media_summary":"","end_year":2012,"keywords":["Exocytosis","Neurotransmitter release","SNARE proteins","Secretory granules"],"nhmrc_grant_id":631349,"application_year":2009,"health_keywords":["Epilepsy","diabetes","neurodegenerative disease"],"scientific_title":"Control of neurosecretion by Munc18","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Frederic Meunier","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631349","simplified_title":"Mechanism controlling neuronal communication","sub_type":"Standard Project Grant","total_budget":"492701.03","source_system":"Neuronal communication relies on the process of exocytosis by which neurons release a neurotransmitter. Exocytosis is critical for the simplest muscle movement to complex tasks such as learning and memory, and is altered in several neurodegenerative pathologies. We will investigate how the protein Munc18 controls exocytosis. This research will be important for understanding how neurons communicate in health and disease and will be relevant to other processes such as insulin release in diabetes."},"children":[{"color":"#336699","name":"Dr Brett Collins","data":{"first_name":"Brett","title":"Dr","dw_individual_id":"DW0041718","middle_name":"Martin","last_name":"Collins","source_individual_id":"5014007","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brett Collins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87821","size":1},{"color":"#336699","name":"Prof Frederic Meunier","data":{"first_name":"Frederic","title":"Prof","dw_individual_id":"DW0020864","middle_name":"A","last_name":"Meunier","source_individual_id":"5016455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frederic Meunier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82341","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65576","size":1},{"color":"#FF4D4D","name":"Two recently identified calcium transporters in lactation and during mammary epithelial cell apoptosis.","data":{"media_summary":"","end_year":2013,"keywords":["breast cancer","calcium","calcium channels","calcium imaging","molecular pharmacology"],"nhmrc_grant_id":631347,"application_year":2009,"health_keywords":["breast cancer","breastmilk","calcium","gene structure protein function novel drug therapies"],"scientific_title":"Two recently identified calcium transporters in lactation and during mammary epithelial cell apoptosis.","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology and Pharmaceutical Sciences not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Gregory Monteith","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631347","simplified_title":"How does the mammary gland transport calcium during lactation and what does it mean for pharmaceutical science?","sub_type":"Standard Project Grant","total_budget":"465115.63","source_system":"The transport of calcium into milk is a key event in human health. In addition to its importance in neonatal nutrition, the way breast cells regulate calcium also has implications in breast cancer, as well as the modification of proteins important in immunity, and the activity of biopharmaceuticals. This grant will determine how two specific calcium transporters regulate calcium levels in the breast and their respective roles in cellular processes important in normal function and in disease."},"children":[{"color":"#336699","name":"Dr John Holland","data":{"first_name":"John","title":"Dr","dw_individual_id":"DW0013703","middle_name":"William","last_name":"Holland","source_individual_id":"5018915","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr John Holland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80393","size":1},{"color":"#336699","name":"Prof Gregory Monteith","data":{"first_name":"Gregory","title":"Prof","dw_individual_id":"DW0009187","middle_name":"Raymond","last_name":"Monteith","source_individual_id":"RMIS3112522","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gregory Monteith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79194","size":1},{"color":"#336699","name":"Prof Sarah Roberts-Thomson","data":{"first_name":"Sarah","title":"Prof","dw_individual_id":"DW0004272","middle_name":"Jane","last_name":"Roberts-Thomson","source_individual_id":"RMIS5900691","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Sarah Roberts-Thomson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77861","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65575","size":1},{"color":"#FF4D4D","name":"Practitioner Fellowship","data":{"media_summary":"","end_year":2014,"keywords":["antibiotic resistance","antibiotics","molecular epidemiology"],"nhmrc_grant_id":631342,"application_year":2009,"start_year":2010,"scientific_title":"Practitioner Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Paterson","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/631342","simplified_title":"Practitioner Fellowship","sub_type":"Practitioner Fellowship","total_budget":"317308.31","source_system":""},"children":[{"color":"#336699","name":"Prof David Paterson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0027242","middle_name":"Leslie","last_name":"Paterson","source_individual_id":"5012495","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Paterson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84040","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65574","size":1},{"color":"#FF4D4D","name":"the clinical utility of b-type natruretic peptides in the management of patients with chronic kidney disease","data":{"media_summary":"","end_year":2012,"keywords":["Cardiovascular disease","dialysis modality choice","dialysis prescription","renal dialysis"],"nhmrc_grant_id":631324,"application_year":2009,"start_year":2010,"scientific_title":"the clinical utility of b-type natruretic peptides in the management of patients with chronic kidney disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Magid Fahim","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/631324","simplified_title":"a study investigating the role of cardiac hormones in managing patients with chronic kidney disease","sub_type":"Medical Postgraduate Scholarship","total_budget":"110115.37","source_system":""},"children":[{"color":"#336699","name":"Dr Magid Fahim","data":{"first_name":"Magid","title":"Dr","dw_individual_id":"DW0001490","middle_name":"Atif","last_name":"Fahim","source_individual_id":"5030623","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Magid Fahim"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77079","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65573","size":1},{"color":"#FF4D4D","name":"genetic variation in IL23R, and its role in ankylosing spondlysis","data":{"media_summary":"","end_year":2011,"keywords":["arthritis","genetic disease","genotyping","immunogenetics"],"nhmrc_grant_id":631320,"application_year":2009,"start_year":2010,"scientific_title":"genetic variation in IL23R, and its role in ankylosing spondlysis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Immunogenetics (incl. Genetic Immunology)","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Mr Stuart Davidson","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/631320","simplified_title":"the role of IL23R in ankylosing spondylisis","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"44440.14","source_system":""},"children":[{"color":"#336699","name":"Mr Stuart Davidson","data":{"first_name":"Stuart","title":"Mr","dw_individual_id":"DW0018564","middle_name":"I","last_name":"Davidson","source_individual_id":"5030547","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Mr Stuart Davidson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81755","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65572","size":1},{"color":"#FF4D4D","name":"Investigating the genetic aetiology of Aicardi syndrome","data":{"media_summary":"","end_year":2011,"keywords":["Abnormal embryogenesis","Central nervous system","Genetic diseases"],"nhmrc_grant_id":631318,"application_year":2009,"start_year":2010,"scientific_title":"Investigating the genetic aetiology of Aicardi syndrome","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Genetics (excl. Cancer Genetics)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Benjamin Kamien","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/631318","simplified_title":"Investigating the genetic cause of Aicardi syndrome","sub_type":"Medical Postgraduate Scholarship","total_budget":"21743.83","source_system":""},"children":[{"color":"#336699","name":"Dr Benjamin Kamien","data":{"first_name":"Benjamin","title":"Dr","dw_individual_id":"DW0008275","middle_name":"A","last_name":"Kamien","source_individual_id":"5030492","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Benjamin Kamien"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78932","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65571","size":1},{"color":"#FF4D4D","name":"The role of microRNA regulation in the development of the fetal gonad.","data":{"media_summary":"","end_year":2014,"keywords":["conditional gene targeting","control of gene expression","gonadal development"],"nhmrc_grant_id":631317,"application_year":2009,"start_year":2010,"scientific_title":"The role of microRNA regulation in the development of the fetal gonad.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Genetics (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Ms Elanor Wainwright","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/631317","simplified_title":"MicroRNAs in gonad development","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"90867.23","source_system":""},"children":[{"color":"#336699","name":"Ms Elanor Wainwright","data":{"first_name":"Elanor","title":"Ms","dw_individual_id":"DW0010877","middle_name":"N","last_name":"Wainwright","source_individual_id":"5030383","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Elanor Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79663","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65570","size":1},{"color":"#FF4D4D","name":"Free muscle flap vascularity and neovascularisation - implications for future surgery and trauma management","data":{"media_summary":"","end_year":2012,"keywords":["microsurgery","neovascularization","reconstructive surgery","wound healing"],"nhmrc_grant_id":631315,"application_year":2009,"start_year":2010,"scientific_title":"Free muscle flap vascularity and neovascularisation - implications for future surgery and trauma management","node_source":"NHMRC","node_type":"Grant","field_of_research":"Surgery","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Michael Wagels","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/631315","simplified_title":"Reconstruction of broken legs using transplanted muscle - how safe is it?","sub_type":"Medical Postgraduate Scholarship","total_budget":"81905.06","source_system":""},"children":[{"color":"#336699","name":"Dr Michael Wagels","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0022770","middle_name":"","last_name":"Wagels","source_individual_id":"5030602","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michael Wagels"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82866","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65569","size":1},{"color":"#FF4D4D","name":"The neural basis of the partial reinforcement extinction effect","data":{"media_summary":"","end_year":2012,"keywords":["brain imaging","extinction","partial reinforcement"],"nhmrc_grant_id":631311,"application_year":2009,"start_year":2010,"scientific_title":"The neural basis of the partial reinforcement extinction effect","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr John Morris","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/631311","simplified_title":"The neural basis of the partial reinforcement extinction effect","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"70235.94","source_system":""},"children":[{"color":"#336699","name":"Dr John Morris","data":{"first_name":"John","title":"Dr","dw_individual_id":"DW0003490","middle_name":"S","last_name":"Morris","source_individual_id":"5030479","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr John Morris"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77634","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65568","size":1},{"color":"#FF4D4D","name":"Mechanisms of retinotectal map development","data":{"media_summary":"","end_year":2011,"keywords":["Axon guidance","CNS development","Mathematical modelling","Nerve regeneration","eph-class system"],"nhmrc_grant_id":631310,"application_year":2009,"start_year":2010,"scientific_title":"Mechanisms of retinotectal map development","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Hugh Simpson","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/631310","simplified_title":"wiring up the visual brain","sub_type":"Medical Postgraduate Scholarship","total_budget":"45577.94","source_system":""},"children":[{"color":"#336699","name":"Dr Hugh Simpson","data":{"first_name":"Hugh","title":"Dr","dw_individual_id":"DW0022136","middle_name":"D","last_name":"Simpson","source_individual_id":"5030700","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Hugh Simpson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82700","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65567","size":1},{"color":"#FF4D4D","name":"Low-dose computerised tomography screening for lung cancer in Queensland","data":{"media_summary":"","end_year":2013,"keywords":["Lung cancer","computer tomography","cost effectiveness","population screening","smoking cessation"],"nhmrc_grant_id":631306,"application_year":2009,"start_year":2010,"scientific_title":"Low-dose computerised tomography screening for lung cancer in Queensland","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMOTOLOGY","cia_name":"Dr Henry Marshall","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/631306","simplified_title":"Using a body scanner to screen lung cancer","sub_type":"Medical Postgraduate Scholarship","total_budget":"111718.37","source_system":""},"children":[{"color":"#336699","name":"Dr Henry Marshall","data":{"first_name":"Henry","title":"Dr","dw_individual_id":"DW0003195","middle_name":"M","last_name":"Marshall","source_individual_id":"5030514","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Henry Marshall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77551","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65566","size":1},{"color":"#FF4D4D","name":"Setting Priorities for tobacco control in Australia for the total population and Indigenous Australians","data":{"media_summary":"","end_year":2012,"keywords":["Cost effectiveness","Priority Setting","indigenous health","mathematical modelling","tobacco"],"nhmrc_grant_id":631305,"application_year":2009,"start_year":2010,"scientific_title":"Setting Priorities for tobacco control in Australia for the total population and Indigenous Australians","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Ms Angela Wallace","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/631305","simplified_title":"Setting priorities for Tobacco control in Australia","sub_type":"Public Health Postgraduate Scholarship","total_budget":"62533.66","source_system":""},"children":[{"color":"#336699","name":"Ms Angela Wallace","data":{"first_name":"Angela","title":"Ms","dw_individual_id":"DW0022798","middle_name":"L","last_name":"Wallace","source_individual_id":"5030782","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Angela Wallace"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82877","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65565","size":1},{"color":"#FF4D4D","name":"Investigating the use of pharmacotherapy in adolescents for weight loss maintenance","data":{"media_summary":"","end_year":2014,"keywords":["Adolescents","appetite","cardiovascular risk","intervention study","obesity"],"nhmrc_grant_id":631303,"application_year":2009,"start_year":2010,"scientific_title":"Investigating the use of pharmacotherapy in adolescents for weight loss maintenance","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Diane Jensen","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/631303","simplified_title":"Eat smart for success","sub_type":"Medical Postgraduate Scholarship","total_budget":"134148.17","source_system":""},"children":[{"color":"#336699","name":"Dr Diane Jensen","data":{"first_name":"Diane","title":"Dr","dw_individual_id":"DW0019909","middle_name":"Emily","last_name":"Jensen","source_individual_id":"5030484","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Diane Jensen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82067","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65564","size":1},{"color":"#FF4D4D","name":"The pathogenesis of distinct endophenotypes of asthma is underpinned by the collaborative activation of specific PRRs.","data":{"media_summary":"Obstructive airways disease","end_year":2012,"keywords":["Asthma","Eosinophils","Innate immunity","Interleukins","Neutrophils"],"nhmrc_grant_id":631020,"application_year":2009,"health_keywords":["Acute inflammation","Asthma and respiratory diseases","Asthma disease induction and prevention","Eosinophils and neutrophils","Obstructive airways disease"],"scientific_title":"The pathogenesis of distinct endophenotypes of asthma is underpinned by the collaborative activation of specific PRRs.","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Basic Science","for_category":"CARDIOVASCULAR MEDICINE AND HAEMOTOLOGY","cia_name":"Dr Simon Phipps","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/631020","simplified_title":"PRR activation and neutrophilic asthma","sub_type":"Standard Project Grant","total_budget":"678754.88","source_system":"Asthma is a chronic airway disease caused by inflammation. Although asthmatics can be sub-typed based on the type of inflammatory cells present in the lungs, medication specific for the treatment of these sub-types is not yet available. In this grant we will investigate the immune processes that orchestrate the development of the distinct inflammatory sub-types of asthma. This information will help us develop new therapies that will be tailored to target the appropriate type of inflammation."},"children":[{"color":"#336699","name":"Dr Simon Phipps","data":{"first_name":"Simon","title":"Dr","dw_individual_id":"DW0033180","middle_name":"","last_name":"Phipps","source_individual_id":"5016985","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Simon Phipps"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85598","size":1},{"color":"#336699","name":"A/Pr Jodie Simpson","data":{"first_name":"Jodie","title":"A/Pr","dw_individual_id":"DW0027964","middle_name":"L","last_name":"Simpson","source_individual_id":"5017527","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Jodie Simpson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84216","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65549","size":1},{"color":"#FF4D4D","name":"Translating addiction neuroscience into effective treatment and public policy","data":{"media_summary":"","end_year":2014,"keywords":["Addiction","Neurobiology","Neurocognitive Assessment","Policy and Ethical Analysis","Public Health"],"nhmrc_grant_id":628935,"application_year":2009,"start_year":2010,"scientific_title":"Translating addiction neuroscience into effective treatment and public policy","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Adrian Carter","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/628935","simplified_title":"How will neuroscience and genetic research affect how we think about and treat addiction and those that suffer from it?","sub_type":"Public Health (Australia) ECF","total_budget":"331046.28","source_system":""},"children":[{"color":"#336699","name":"Dr Adrian Carter","data":{"first_name":"Adrian","title":"Dr","dw_individual_id":"DW0041491","middle_name":"Nicholas","last_name":"Carter","source_individual_id":"5018709","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Adrian Carter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87762","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65444","size":1},{"color":"#FF4D4D","name":"Burden of respiratory infection in the first 2 years of life: a birth cohort study of emerging respiratory pathogens.","data":{"media_summary":"viral infection","end_year":2014,"keywords":["community child health","molecular epidemiology","prospective cohort","respiratory infection","virus detection"],"nhmrc_grant_id":615700,"application_year":2009,"health_keywords":["emerging respiratory pathogens","infant, newborn diseases","population health","respiratory tract infection","viral infection"],"scientific_title":"Burden of respiratory infection in the first 2 years of life: a birth cohort study of emerging respiratory pathogens.","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Public Health","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Keith Grimwood","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/615700","simplified_title":"Respiratory infections in infants under two years of age","sub_type":"Standard Project Grant","total_budget":"1168963.01","source_system":"Respiratory illnesses are extremely common, but there is little information about patterns of infection in the community using modern diagnostic tests. Children have the highest rates of infection and transmit to all other age groups. We intend to recruit 138 newborns to monitor respiratory symptoms and collect specimens for testing in the first two years of life. This will allow us to document illnesses due to known and newly identified respiratory pathogens."},"children":[{"color":"#336699","name":"Dr Robert Ware","data":{"first_name":"Robert","title":"Dr","dw_individual_id":"DW0040341","middle_name":"S","last_name":"Ware","source_individual_id":"5018199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Robert Ware"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87453","size":1},{"color":"#336699","name":"Dr David Wang","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0040312","middle_name":"","last_name":"Wang","source_individual_id":"5018201","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87443","size":1},{"color":"#336699","name":"Prof Keith Grimwood","data":{"first_name":"Keith","title":"Prof","dw_individual_id":"DW0036997","middle_name":"","last_name":"Grimwood","source_individual_id":"RMIS3130585","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Keith Grimwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86576","size":1},{"color":"#336699","name":"A/Pr Stephen Lambert","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0026122","middle_name":"B","last_name":"Lambert","source_individual_id":"RMIS682186","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Stephen Lambert"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83757","size":1},{"color":"#336699","name":"Prof Theo Sloots","data":{"first_name":"Theo","title":"Prof","dw_individual_id":"DW0016277","middle_name":"Pieter","last_name":"Sloots","source_individual_id":"5017574","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Theo Sloots"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81115","size":1},{"color":"#336699","name":"A/Pr Michael Nissen","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0009388","middle_name":"Desmond","last_name":"Nissen","source_individual_id":"5016723","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Michael Nissen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79252","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65214","size":1},{"color":"#FF4D4D","name":"Explaining the Dark Matter of Genome-wide Association Studies for Complex Disease","data":{"media_summary":"","end_year":2012,"keywords":["Estimating genetic variance from population data","Maker based relationship matrix","Whole genome association analysis"],"nhmrc_grant_id":613672,"application_year":2009,"health_keywords":["Melanoma","Schizophrenia","Type 2 diabetes"],"scientific_title":"Explaining the Dark Matter of Genome-wide Association Studies for Complex Disease","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Quantitative Genetics (incl. Disease and Trait Mapping Genetics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Peter Visscher","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/613672","simplified_title":"Why have large genome scans of common variation not explained more of the familial risk for diseases?","sub_type":"Standard Project Grant","total_budget":"453098.74","source_system":"Common diseases, such as psychiatric disorders and cardiovascular disease, are caused by the interplay of genetic and envirionmental factors. In the last 4 years, very large studies have been conducted to associate genetic factors with risk of disease, but these studies have not accounted for known familial risk. We aim to use data on very distant relatives to explain why. Understanding the genetic basis of common disease is crucial to guide future experiments and for developing new treatments."},"children":[{"color":"#336699","name":"Prof Michael Goddard","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0030923","middle_name":"E","last_name":"Goddard","source_individual_id":"5018831","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Goddard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85016","size":1},{"color":"#336699","name":"Prof Peter Visscher","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0005222","middle_name":"M","last_name":"Visscher","source_individual_id":"5018104","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Visscher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78118","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65195","size":1},{"color":"#FF4D4D","name":"Towards an etiological understanding of the comorbidity of psychiatric disorders","data":{"media_summary":"Psychiatric disorders","end_year":2013,"keywords":["Anxiety disorders","Comorbidity","Genetic polymorphisms","Major depression","Psychiatric disorders"],"nhmrc_grant_id":613608,"application_year":2009,"health_keywords":["Anxiety disorders","Comorbidity","Genetic Susceptibility","Genetics, polygenic inheritance","Psychiatric disorders"],"scientific_title":"Towards an etiological understanding of the comorbidity of psychiatric disorders","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry (incl. Psychotherapy)","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Naomi Wray","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/613608","simplified_title":"Towards an understanding of the causes of comorbidity of psychiatric disorders","sub_type":"Standard Project Grant","total_budget":"997883.27","source_system":"Pyschiatric disorders are common disorders with both genetic and environmental etilogy. The disorders are characterised both by significant overlap of symptoms and by significant heterogenity of symptoms within disorders. The availability of genome-wide genotypes allows us, for the first time, to investigate co-morbidity directly at the molecular level. Understanding the nature of co-morbidity between disorders nay be an important key to effective treatment."},"children":[{"color":"#336699","name":"Prof Robert Krueger","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0037852","middle_name":"Frank","last_name":"Krueger","source_individual_id":"5018994","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Krueger"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86809","size":1},{"color":"#336699","name":"Nelson Freimer","data":{"first_name":"Nelson","title":"","dw_individual_id":"DW0024932","middle_name":"","last_name":"Freimer","source_individual_id":"5030369","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Nelson Freimer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83408","size":1},{"color":"#336699","name":"Prof Grant Montgomery","data":{"first_name":"Grant","title":"Prof","dw_individual_id":"DW0020950","middle_name":"W","last_name":"Montgomery","source_individual_id":"RMIS416073","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Grant Montgomery"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82365","size":1},{"color":"#336699","name":"Prof Nicholas Martin","data":{"first_name":"Nicholas","title":"Prof","dw_individual_id":"DW0014736","middle_name":"G","last_name":"Martin","source_individual_id":"RMIS2356999","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Nicholas Martin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80688","size":1},{"color":"#336699","name":"Prof Naomi Wray","data":{"first_name":"Naomi","title":"Prof","dw_individual_id":"DW0005533","middle_name":"Ruth","last_name":"Wray","source_individual_id":"5018484","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Naomi Wray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78207","size":1},{"color":"#336699","name":"Dr Christel Middeldorp","data":{"first_name":"Christel","title":"Dr","dw_individual_id":"DW0003394","middle_name":"M","last_name":"Middeldorp","source_individual_id":"5019107","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Christel Middeldorp"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77603","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65178","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2014,"keywords":["Bioinformatics","Gene mapping","Genetic epidemiology","Genetics","Quantitative genetics"],"nhmrc_grant_id":613602,"application_year":2009,"start_year":2010,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Quantitative Genetics (incl. Disease and Trait Mapping Genetics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Naomi Wray","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/613602","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"226067.19","source_system":""},"children":[{"color":"#336699","name":"Prof Naomi Wray","data":{"first_name":"Naomi","title":"Prof","dw_individual_id":"DW0005533","middle_name":"Ruth","last_name":"Wray","source_individual_id":"5018484","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Naomi Wray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78207","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65177","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2014,"keywords":["Bioinformatics","Gene mapping","Genetic epidemiology","Genetics","Quantitative genetics"],"nhmrc_grant_id":613601,"application_year":2009,"start_year":2010,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Quantitative Genetics (incl. Disease and Trait Mapping Genetics)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Peter Visscher","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/613601","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"858774.38","source_system":""},"children":[{"color":"#336699","name":"Prof Peter Visscher","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0005222","middle_name":"M","last_name":"Visscher","source_individual_id":"5018104","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Visscher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78118","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65176","size":1},{"color":"#FF4D4D","name":"Structural Investigation of Pathogenic Bacteria Pili and Secreted Toxins","data":{"media_summary":"","end_year":2014,"keywords":["Bacterial Pathogen","Protein Structure","Stapylococcus","Streptococcus","X-ray Crystallography"],"nhmrc_grant_id":606728,"application_year":2009,"start_year":2010,"scientific_title":"Structural Investigation of Pathogenic Bacteria Pili and Secreted Toxins","node_source":"NHMRC","node_type":"Grant","field_of_research":"Structural Biology (incl. Macromolecular Modelling)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Ms Julia Archbold","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/606728","simplified_title":"Molecular Mechanisms of Pathogenic Bacterial Infection","sub_type":"CJ Martin Biomedical ECF","total_budget":"380786.42","source_system":""},"children":[{"color":"#336699","name":"Ms Julia Archbold","data":{"first_name":"Julia","title":"Ms","dw_individual_id":"DW0017473","middle_name":"K","last_name":"Archbold","source_individual_id":"RMIS4011379","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Julia Archbold"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81458","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/65079","size":1},{"color":"#FF4D4D","name":"Strategies to enhance the migratory and therapeutic potential of mesenchymal stem cells for myocardial repair","data":{"media_summary":"","end_year":2015,"keywords":["cell migration","cytokines and chemokines","murine models","myocardial infarction","stem cells"],"nhmrc_grant_id":604311,"application_year":2009,"start_year":2010,"scientific_title":"Strategies to enhance the migratory and therapeutic potential of mesenchymal stem cells for myocardial repair","node_source":"NHMRC","node_type":"Grant","field_of_research":"Regenerative Medicine (incl. Stem Cells and Tissue Engineering)","research_area":"Basic Science","for_category":"MEDICAL BIOTECHNOLOGY","cia_name":"Dr Rebecca Pelekanos","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/604311","simplified_title":"Enhancing adult stem cells for heart repair","sub_type":"Peter Doherty Biomedical ECF","total_budget":"369311.34","source_system":""},"children":[{"color":"#336699","name":"Dr Rebecca Pelekanos","data":{"first_name":"Rebecca","title":"Dr","dw_individual_id":"DW0009600","middle_name":"A","last_name":"Pelekanos","source_individual_id":"5019174","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Rebecca Pelekanos"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79306","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64981","size":1},{"color":"#FF4D4D","name":"Genomic characterisation of novel inflammatory regulators in a mouse model of disseminated Candidiasis","data":{"media_summary":"","end_year":2012,"keywords":["Toll-like receptor signalling","alternate splicing","genetic immunology","genome structure","regulation of gene expression"],"nhmrc_grant_id":597452,"application_year":2009,"health_keywords":["Disseminated candidiasis","Susceptibility to fungal infection","infection and inflammation"],"scientific_title":"Genomic characterisation of novel inflammatory regulators in a mouse model of disseminated Candidiasis","start_year":2010,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression (incl. Microarray and other genome-wide approaches)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Christine Wells","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/597452","simplified_title":"Understanding susceptibility to fungal infection","sub_type":"Standard Project Grant","total_budget":"581427.84","source_system":"Genome biology offers great promise for the study of immune function, but new approaches are needed to build insights between data and disease. This project looks at the gene products used by mice susceptible to yeast infection and asks if the information is used differently in resistant animals. Blood-borne fungal infections are increasing in hospitals; we want to discover new immune gene products and understand how they contribute, so we can better predict the outcome of an infection."},"children":[{"color":"#336699","name":"A/Pr Christine Wells","data":{"first_name":"Christine","title":"A/Pr","dw_individual_id":"DW0040397","middle_name":"Anne","last_name":"Wells","source_individual_id":"5018258","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Christine Wells"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87466","size":1},{"color":"#336699","name":"A/Pr Robert Ashman","data":{"first_name":"Robert","title":"A/Pr","dw_individual_id":"DW0029217","middle_name":"Brian","last_name":"Ashman","source_individual_id":"5013239","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Robert Ashman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84574","size":1},{"color":"#336699","name":"Prof Vicky Avery","data":{"first_name":"Vicky","title":"Prof","dw_individual_id":"DW0011541","middle_name":"M","last_name":"Avery","source_individual_id":"5018622","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Vicky Avery"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79833","size":1},{"color":"#336699","name":"Prof Sean Grimmond","data":{"first_name":"Sean","title":"Prof","dw_individual_id":"DW0007616","middle_name":"M","last_name":"Grimmond","source_individual_id":"5014956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sean Grimmond"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78759","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64936","size":1},{"color":"#FF4D4D","name":"Research Fellowship","data":{"media_summary":"","end_year":2014,"keywords":["Cardiovascular system and diseases","Diagnostic Applications","Fetal Development and Medicine","Preventive Medicine","Reproduction"],"nhmrc_grant_id":586651,"application_year":2009,"start_year":2010,"scientific_title":"Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Systems Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof Greg Rice","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/586651","simplified_title":"Research Fellowship","sub_type":"Research Fellowship","total_budget":"749617.88","source_system":""},"children":[{"color":"#336699","name":"Prof Greg Rice","data":{"first_name":"Greg","title":"Prof","dw_individual_id":"DW0009889","middle_name":"Edward","last_name":"Rice","source_individual_id":"RMIS2438912","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Greg Rice"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79384","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64859","size":1},{"color":"#FF4D4D","name":"Equipment Grant","data":{"media_summary":"","end_year":2009,"keywords":["Equipment Grant"],"nhmrc_grant_id":640303,"application_year":2008,"start_year":2009,"scientific_title":"Equipment Grant","node_source":"NHMRC","node_type":"Grant","field_of_research":"n-a","research_area":"Not Applicable","for_category":"N-A","cia_name":"Ms Janine Richards","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/640303","simplified_title":"Equipment Grant","sub_type":"Equipment Grant","total_budget":"737555","source_system":""},"children":[{"color":"#336699","name":"Ms Janine  Richards","data":{"first_name":"Janine ","title":"Ms","dw_individual_id":"DW0039316","middle_name":"D","last_name":"Richards","source_individual_id":"RMIS6469880","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Janine  Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87190","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64765","size":1},{"color":"#FF4D4D","name":"H1N1 Nanopatch immunisation against pandemic Novel A (H1N1) influenza virus 09: potent immunity at a reduced dose","data":{"media_summary":"","end_year":2011,"keywords":["H1N1"],"nhmrc_grant_id":631720,"application_year":2008,"start_year":2009,"scientific_title":"H1N1 Nanopatch immunisation against pandemic Novel A (H1N1) influenza virus 09: potent immunity at a reduced dose","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Mark Kendall","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/631720","simplified_title":"H1N1 Nanopatch immunisation against pandemic Novel A (H1N1) influenza virus 09: potent immunity at a reduced dose","sub_type":"Urgent Research - Pandemic Influenza - H1N1 ","total_budget":"183061.44","source_system":""},"children":[{"color":"#336699","name":"Dr Deborah Middleton","data":{"first_name":"Deborah","title":"Dr","dw_individual_id":"DW0044267","middle_name":"J","last_name":"Middleton","source_individual_id":"RMIS4224367","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Deborah Middleton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88470","size":1},{"color":"#336699","name":"Prof Mark Kendall","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0043459","middle_name":"Af","last_name":"Kendall","source_individual_id":"5015660","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Kendall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88269","size":1},{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1},{"color":"#336699","name":"Dr Germain Fernando","data":{"first_name":"Germain","title":"Dr","dw_individual_id":"DW0030659","middle_name":"J","last_name":"Fernando","source_individual_id":"5014600","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Germain Fernando"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84967","size":1},{"color":"#336699","name":"Prof Lorena Brown","data":{"first_name":"Lorena","title":"Prof","dw_individual_id":"DW0029635","middle_name":"E","last_name":"Brown","source_individual_id":"RMIS41665","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Lorena Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84675","size":1},{"color":"#336699","name":"Stirling Edwards","data":{"first_name":"Stirling","title":"","dw_individual_id":"DW0007114","middle_name":"","last_name":"Edwards","source_individual_id":"5030640","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Stirling Edwards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78623","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64758","size":1},{"color":"#FF4D4D","name":"International Cancer Genome Consortium","data":{"media_summary":"","end_year":2014,"keywords":["Cancer Genome","Ovarian Cancer","Pancreatic Cancer"],"nhmrc_grant_id":631701,"application_year":2008,"start_year":2009,"scientific_title":"International Cancer Genome Consortium","node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/631701","simplified_title":"International Cancer Genome Consortium","sub_type":"Medical Bioinformatics,Genomics & Proteomics Grant","total_budget":"28308229.84","source_system":""},"children":[{"color":"#336699","name":"Prof David Bowtell","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0029554","middle_name":"Dl","last_name":"Bowtell","source_individual_id":"RMIS183458","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Bowtell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84658","size":1},{"color":"#336699","name":"Prof Andrew Biankin","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0029456","middle_name":"V","last_name":"Biankin","source_individual_id":"5013455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Andrew Biankin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84635","size":1},{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1},{"color":"#336699","name":"Prof Sean Grimmond","data":{"first_name":"Sean","title":"Prof","dw_individual_id":"DW0007616","middle_name":"M","last_name":"Grimmond","source_individual_id":"5014956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sean Grimmond"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78759","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64757","size":1},{"color":"#FF4D4D","name":"Role of bacteriophage-encoded streptodornase in invasive disease caused by diverse group A streptococcal M serotypes.","data":{"media_summary":"toxic shock syndrome","end_year":2012,"keywords":["bacterial genetics","bacterial pathogen","plasminogen","streptococcus","streptodornase"],"nhmrc_grant_id":573401,"application_year":2008,"health_keywords":["necrotising fasciitis","streptococcal disease","streptococcal infection","streptococcal invasive diseases","toxic shock syndrome"],"scientific_title":"Role of bacteriophage-encoded streptodornase in invasive disease caused by diverse group A streptococcal M serotypes.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Mark Walker","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/573401","simplified_title":"Does viral reprogramming cause group A streptococcal invasive disease?","sub_type":"Standard Project Grant","total_budget":"832544.65","source_system":"Streptococcus pyogenes (group A streptococcus, GAS) is estimated to cause ~700 million cases of self-limited throat or skin infection each year worldwide. Invasive GAS disease occurs in approximately 1-1000 cases, with associated mortality of 25%. We have recently discovered that a viral infection can reprogram GAS for invasive disease propensity. We will investigate whether this phenomenon is widespread, in order to understand this process and develop future therapeutics."},"children":[{"color":"#336699","name":"Prof Mark Walker","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0010893","middle_name":"J.","last_name":"Walker","source_individual_id":"RMIS127362","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mark Walker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79668","size":1},{"color":"#336699","name":"Prof Victor Nizet","data":{"first_name":"Victor","title":"Prof","dw_individual_id":"DW0003693","middle_name":"","last_name":"Nizet","source_individual_id":"5030735","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Victor Nizet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77687","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64652","size":1},{"color":"#FF4D4D","name":"Systematic diabetic retinopathy screening and monitoring of early stage disease in general practice","data":{"media_summary":"","end_year":2014,"keywords":["Aboriginal","access to health care","diabetes mellitus","health economics","screening"],"nhmrc_grant_id":569944,"application_year":2008,"start_year":2010,"scientific_title":"Systematic diabetic retinopathy screening and monitoring of early stage disease in general practice","node_source":"NHMRC","node_type":"Grant","field_of_research":"Primary Health Care","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Claire Jackson","higher_grant_type":"NHMRC Partnerships","purl":"http://purl.org/au-research/grants/nhmrc/569944","simplified_title":"Diabetic Retinopathy Screening and Monitoring in General Practice","sub_type":"Partnership Project for Better Health","total_budget":"260569.13","source_system":"The project will assess the accuracy, acceptability and relative cost effectiveness of general practice based diabetic retinopathy (DR) screening and monitoring, with ophthalmic support and education via videoconferencing. Accredited GPs will screen for DR using non-mydriatic cameras as part of the Diabetes Annual Cycle of Care and monitor patients with minimal to moderate levels of DR but no sight threatening signs, with virtual ophthalmology support. Positive project outcomes have the capacity to effect policy"},"children":[{"color":"#336699","name":"Prof Paul Mitchell","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0026794","middle_name":"","last_name":"Mitchell","source_individual_id":"5016494","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Mitchell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83940","size":1},{"color":"#336699","name":"Prof Claire Jackson","data":{"first_name":"Claire","title":"Prof","dw_individual_id":"DW0008114","middle_name":"Louise","last_name":"Jackson","source_individual_id":"RMIS229437","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Claire Jackson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78891","size":1},{"color":"#336699","name":"A/Pr Deborah Askew","data":{"first_name":"Deborah","title":"A/Pr","dw_individual_id":"DW0005862","middle_name":"Anne","last_name":"Askew","source_individual_id":"5012019","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Deborah Askew"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78299","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64420","size":1},{"color":"#FF4D4D","name":"Immunological therapies for cancer, chronic infection and autoimmunity","data":{"media_summary":"","end_year":2014,"keywords":["Chronic infections","Genetics","Immune-mediated inflammation","Immunoregulation","Immunotherapy"],"nhmrc_grant_id":569938,"application_year":2008,"start_year":2009,"scientific_title":"Immunological therapies for cancer, chronic infection and autoimmunity","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ranjeny Thomas","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/569938","simplified_title":"Utilising immunoregulation for treatment of disease","sub_type":"Program Grant","total_budget":"10891788.21","source_system":"The team comprises five leading scientists with a history of successful investigation into the role of the immune system in cancers, chronic viral infections, and autoimmune diseases. There is a large unmet need for effective solutions with fewer side effects in these diseases which cause a high disease burden in our society. In this program, we particularly seek to develop novel vaccines for chronic infections and autoimmune diseases, and to improve the safety of bone marrow transplantation."},"children":[{"color":"#336699","name":"Prof Ranjeny Thomas","data":{"first_name":"Ranjeny","title":"Prof","dw_individual_id":"DW0045826","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS4352","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ranjeny Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88853","size":1},{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1},{"color":"#336699","name":"Prof Mariapia Degli-Esposti","data":{"first_name":"Mariapia","title":"Prof","dw_individual_id":"DW0041983","middle_name":"Alessandra","last_name":"Degli-Esposti","source_individual_id":"5014276","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mariapia Degli-Esposti"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87887","size":1},{"color":"#336699","name":"Prof Matthew Brown","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0012026","middle_name":"A","last_name":"Brown","source_individual_id":"5012217","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79951","size":1},{"color":"#336699","name":"Prof Geoff Hill","data":{"first_name":"Geoff","title":"Prof","dw_individual_id":"DW0007868","middle_name":"Roger","last_name":"Hill","source_individual_id":"RMIS534437","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Geoff Hill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78822","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64418","size":1},{"color":"#FF4D4D","name":"CCRE in Aphasia Rehabilitation","data":{"media_summary":"","end_year":2014,"keywords":["Aphasia","Chronic stroke patients","Health Services","Health consumers information and decision-making","Neurogenic communication disorder"],"nhmrc_grant_id":569935,"application_year":2008,"start_year":2009,"scientific_title":"CCRE in Aphasia Rehabilitation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Sciences not elsewhere classified","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Linda Worrall","higher_grant_type":"Centre for Research Excellence","purl":"http://purl.org/au-research/grants/nhmrc/569935","simplified_title":"CCRE in Aphasia Rehabilitation","sub_type":"Centre of Clinical Research Excellence","total_budget":"2548720.8","source_system":"This national research centre uniquely combines two recent advances in rehabilitation, applies them to rehabilitation of acquired communication disorder (aphasia) and translates them into a clear pathway for clinical management of people with aphasia. This cell to society research program integrates a consumer's perspective into research in the relearning of lost skills after injury. The resulting Australian Aphasia Clinical Pathway will enable and ensure best practice in aphasia services."},"children":[{"color":"#336699","name":"Prof Linda Worrall","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0046389","middle_name":"Elizabeth","last_name":"Worrall","source_individual_id":"RMIS28004","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Worrall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/89016","size":1},{"color":"#336699","name":"Prof Jacinta Douglas","data":{"first_name":"Jacinta","title":"Prof","dw_individual_id":"DW0036348","middle_name":"Mary","last_name":"Douglas","source_individual_id":"5014395","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jacinta Douglas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86416","size":1},{"color":"#336699","name":"Prof Alison Ferguson","data":{"first_name":"Alison","title":"Prof","dw_individual_id":"DW0030657","middle_name":"Jean","last_name":"Ferguson","source_individual_id":"RMIS3674577","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alison Ferguson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84966","size":1},{"color":"#336699","name":"Prof Leanne Togher","data":{"first_name":"Leanne","title":"Prof","dw_individual_id":"DW0028425","middle_name":"M","last_name":"Togher","source_individual_id":"5017950","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Leanne Togher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84351","size":1},{"color":"#336699","name":"Prof Lyndsey Nickels","data":{"first_name":"Lyndsey","title":"Prof","dw_individual_id":"DW0027042","middle_name":"A","last_name":"Nickels","source_individual_id":"5016714","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Lyndsey Nickels"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83997","size":1},{"color":"#336699","name":"A/Pr David Copland","data":{"first_name":"David","title":"A/Pr","dw_individual_id":"DW0006716","middle_name":"A","last_name":"Copland","source_individual_id":"5014073","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr David Copland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78522","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64417","size":1},{"color":"#FF4D4D","name":"Venom peptide modulators of pain pathways","data":{"media_summary":"","end_year":2014,"keywords":["Ligand-gated ion channels","Neuropathic pain","Neuropharmacology","Structure-activity relationships","Venoms"],"nhmrc_grant_id":569927,"application_year":2008,"start_year":2009,"scientific_title":"Venom peptide modulators of pain pathways","node_source":"NHMRC","node_type":"Grant","field_of_research":"Peripheral Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Richard Lewis","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/569927","simplified_title":"Improving our understanding and treatment of chronic pain using venom-derived peptides","sub_type":"Program Grant","total_budget":"6838279.66","source_system":"The goal of the proposed Program is to improve treatments forpain, especially persistent pain, which remains a poorly managed global health burden. Our pre-eminent team integrates a unique set of complementary research skills in using peptides derived from venomous invertebrates to dissect the pharmacology of pain pathways in persistent pain states, and develop these novel peptides to the point where they can be considered for pre-clinical development in collaboration with commercial partners."},"children":[{"color":"#336699","name":"Prof Macdonald Christie","data":{"first_name":"Macdonald","title":"Prof","dw_individual_id":"DW0035875","middle_name":"James","last_name":"Christie","source_individual_id":"5012593","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Macdonald Christie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86297","size":1},{"color":"#336699","name":"Prof Paul Alewood","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0035049","middle_name":"F","last_name":"Alewood","source_individual_id":"5013158","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Alewood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86082","size":1},{"color":"#336699","name":"Prof Richard Lewis","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0014455","middle_name":"J","last_name":"Lewis","source_individual_id":"5015973","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Lewis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80612","size":1},{"color":"#336699","name":"Prof David Adams","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0000022","middle_name":"John","last_name":"Adams","source_individual_id":"RMIS8271","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Adams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76652","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64416","size":1},{"color":"#FF4D4D","name":"Enhancing teamwork for prevention and management of chronic illness in indegenous community health centres","data":{"media_summary":"","end_year":2011,"keywords":["Chronic Disease","Indigenous Health","Primary Health Care","Quality Improvement","Teamwork"],"nhmrc_grant_id":569919,"application_year":2008,"start_year":2009,"scientific_title":"Enhancing teamwork for prevention and management of chronic illness in indegenous community health centres","node_source":"NHMRC","node_type":"Grant","field_of_research":"Primary Health Care","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Damin Si","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569919","simplified_title":"Enhancing teamwork for chronic illness care in indegenous community health centres","sub_type":"Peter Doherty Biomedical ECF","total_budget":"126586.29","source_system":"Not Available - Grant Title - Enhancing teamwork for prevention and management of chronic illness in Indigenous community health centres"},"children":[{"color":"#336699","name":"Dr Damin Si","data":{"first_name":"Damin","title":"Dr","dw_individual_id":"DW0033803","middle_name":"","last_name":"Si","source_individual_id":"5017503","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Damin Si"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85754","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64415","size":1},{"color":"#FF4D4D","name":"Identification and Characterization of Novel Bioactive Peptides from Australian Conesnails targeting Pain Pathways","data":{"media_summary":"","end_year":2012,"keywords":["chronic pain","dorsal root ganglia","neuropathy","neuropharmacology","venom"],"nhmrc_grant_id":569918,"application_year":2008,"start_year":2009,"scientific_title":"Identification and Characterization of Novel Bioactive Peptides from Australian Conesnails targeting Pain Pathways","node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Irina Vetter","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569918","simplified_title":"Using conesnail venom to better understand chronic pain","sub_type":"Peter Doherty Biomedical ECF","total_budget":"320803.44","source_system":"In recent years, significant advances have been made in the identification of new targets in the central or peripheral nervous systems which may be used to develop new pain killers. However, molecules specifically targeting these receptors and channels are lacking to date. This project will use novel cell-based approaches to find new molecules from conesnails which specifically target receptors involved in pain. These will be useful to increase our understanding of the mechanisms of pain."},"children":[{"color":"#336699","name":"Dr Irina Vetter","data":{"first_name":"Irina","title":"Dr","dw_individual_id":"DW0040232","middle_name":"","last_name":"Vetter","source_individual_id":"RMIS2658802","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Irina Vetter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87422","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64414","size":1},{"color":"#FF4D4D","name":"Investigating the utility of therapeutic drug monitoring of beta-lactam antibiotics in hospitalised patients","data":{"media_summary":"","end_year":2013,"keywords":["antibiotics","beta-lactam antibiotics","patient management","therapeutic drug monitoring"],"nhmrc_grant_id":569917,"application_year":2008,"start_year":2009,"scientific_title":"Investigating the utility of therapeutic drug monitoring of beta-lactam antibiotics in hospitalised patients","node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Jason Roberts","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569917","simplified_title":"Investigating the utility of therapeutic drug monitoring of beta-lactam antibiotics in hospitalised patients","sub_type":"Health Professional Research ECF","total_budget":"215887.38","source_system":"The appropriate dosing of antibiotics for patients admitted to hospital is based on broad guidelines derived from studies in healthy volunteers or in patients that may have different types of infections. Minor changes in the clinical state of the patients can require significant dosing adjustments. The best way to guarantee appropriate antibiotic therapy is to individualize doses based on blood concentration data. We aim to determine the utility of dose adjustment in hospitalized patients."},"children":[{"color":"#336699","name":"Prof Jason Roberts","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0033443","middle_name":"A","last_name":"Roberts","source_individual_id":"5017212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jason Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85657","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64413","size":1},{"color":"#FF4D4D","name":"Vascular Smooth Muscle Cell Senescence and the Effects of Oestrogen","data":{"media_summary":"","end_year":2011,"keywords":["Atherosclerosis","Cell senescence","Oestrogen","Smooth muscle"],"nhmrc_grant_id":569911,"application_year":2008,"start_year":2009,"scientific_title":"Vascular Smooth Muscle Cell Senescence and the Effects of Oestrogen","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Bei Cheng","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569911","simplified_title":"How does oestrogen affect blood vessels?","sub_type":"Australia-China Exchange ECF","total_budget":"191370.36","source_system":"The incidence of cardiovascular diseases is much lower in women before menopause, and this is thought to be due to a beneficial effect of oestrogen on the cardiovascular system. However the mechanisms of the hormones cardiovascular-protective actions are still not clear. The proposed project will determine whether oestrogen acts by slowing the natural ageing process of cells."},"children":[{"color":"#336699","name":"Dr Bei Cheng","data":{"first_name":"Bei","title":"Dr","dw_individual_id":"DW0024079","middle_name":"","last_name":"Cheng","source_individual_id":"5013877","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Bei Cheng"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83175","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64411","size":1},{"color":"#FF4D4D","name":"Studying the function and mechanism of histone ADP-ribosylation; (ii) Lipo-peptide--protein vaccine development","data":{"media_summary":"","end_year":2013,"keywords":["Chromatin","Histone Code","Immunisation","Molecular Markers","Vaccine Development"],"nhmrc_grant_id":569869,"application_year":2008,"start_year":2009,"scientific_title":"Studying the function and mechanism of histone ADP-ribosylation; (ii) Lipo-peptide--protein vaccine development","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Peter Moyle","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569869","simplified_title":"Studying factors that affect gene regulation and disease, and the development of improved vaccine technologies","sub_type":"CJ Martin Biomedical ECF","total_budget":"496076.01","source_system":"(i) Histones, which act as DNA supports, are subject to modifications, which may be associated with disease (e.g. cancers). A better understanding of these modifications will provide access to new medicines (ii) The production of new vaccines requires new vaccine development tools. We propose to use fats to produce vaccines which can be delivered via the mouth or nose rather than by injection."},"children":[{"color":"#336699","name":"Dr Peter Moyle","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0009251","middle_name":"Michael","last_name":"Moyle","source_individual_id":"5016594","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Peter Moyle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79217","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64409","size":1},{"color":"#FF4D4D","name":"Using astrocytes to protect the brain from injury: Investigating mechanisms and therapeutic strategies.","data":{"media_summary":"","end_year":2015,"keywords":["Astrocytes","Cytoskeleton","Glia-neuron relationship","Hypoxia","Perinatal brain damage"],"nhmrc_grant_id":569868,"application_year":2008,"start_year":2009,"scientific_title":"Using astrocytes to protect the brain from injury: Investigating mechanisms and therapeutic strategies.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Susan Sullivan","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569868","simplified_title":"Astrocytes: A possible target to treat hypoxic brain damage.","sub_type":"Peter Doherty Biomedical ECF","total_budget":"373937.16","source_system":"Brain damage caused by hypoxia (lack of oxygen) is a common problem in babies and can lead to outcomes ranging from cerebral palsy to death. We have a limited understanding of the mechanisms that cause damage, and thus very limited treatments. This project will investigate the role of cells called astrocytes in brain injury and identify novel therapeutic strategies to prevent or reverse brain damage. The outcomes of this research will ultimately lead to new treatments for hypoxic brain injury."},"children":[{"color":"#336699","name":"Susan Sullivan","data":{"first_name":"Susan","title":"","dw_individual_id":"DW0016508","middle_name":"M","last_name":"Sullivan","source_individual_id":"5017781","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Susan Sullivan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81184","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64408","size":1},{"color":"#FF4D4D","name":"Structural characterisation of SNARE protein complexes involved in insulin-regulated glucose transport","data":{"media_summary":"","end_year":2012,"keywords":["Munc18","Protein structure","Protein-Protein interaction","SAXS-SANS","SNARE proteins"],"nhmrc_grant_id":569864,"application_year":2008,"start_year":2009,"scientific_title":"Structural characterisation of SNARE protein complexes involved in insulin-regulated glucose transport","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Andrew Whitten","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569864","simplified_title":"How SNARE proteins regulate glucose transport","sub_type":"Peter Doherty Biomedical ECF","total_budget":"320803.44","source_system":"Insulin-regulated glucose transportation is defective in type 2 diabetes, a disease that is a major health problem worldwide and in some cases can lead to death. The aim of this work is to investigate the molecular structure and function of proteins critical to the transportation and delivery of glucose to muscle and fat cells, which will lead to the validation of new therapeutic targets and the development of new treatments for diabetes."},"children":[{"color":"#336699","name":"Dr Andrew Whitten","data":{"first_name":"Andrew","title":"Dr","dw_individual_id":"DW0034688","middle_name":"Edward","last_name":"Whitten","source_individual_id":"5028246","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Andrew Whitten"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85984","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64406","size":1},{"color":"#FF4D4D","name":"Is sedentary behaviour (too much sitting) a distinct risk for cardiovascular disease?","data":{"media_summary":"","end_year":2013,"keywords":["Behavioural intervention","Epidemiology","Inactivity physiology","Sedentary Behaviour"],"nhmrc_grant_id":569861,"application_year":2008,"start_year":2009,"scientific_title":"Is sedentary behaviour (too much sitting) a distinct risk for cardiovascular disease?","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Genevieve Healy","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569861","simplified_title":"Prolonged sitting and cardiovascular disease","sub_type":"Public Health (Australia) ECF","total_budget":"342666.38","source_system":"Cardiovascular disease and type 2 diabetes are significant and prevalent public health problems. Physical activity can decrease the risk for these conditions. However, reducing prolonged sitting may also be important. This research will add crucial new evidence on the role of sitting time in type 2 diabetes and heart disease, and will help with future decisions about whether reducing prolonged sitting at home and at work should be taken as seriously as promoting exercise for good health."},"children":[{"color":"#336699","name":"Dr Genevieve Healy","data":{"first_name":"Genevieve","title":"Dr","dw_individual_id":"DW0019538","middle_name":"N","last_name":"Healy","source_individual_id":"5015159","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Genevieve Healy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64405","size":1},{"color":"#FF4D4D","name":"Neuropathic pain drugs based on the endogenous opioid peptide Endomorphin 1.","data":{"media_summary":"","end_year":2010,"keywords":["Nerve injury","Neuropathic pain","Neuropeptides","Opioid receptors","Preclinical drug development"],"nhmrc_grant_id":569855,"application_year":2008,"health_keywords":["Diabetic neuropathy","Nerve injury","Neuropathic pain","Neuropeptides"],"scientific_title":"Neuropathic pain drugs based on the endogenous opioid peptide Endomorphin 1.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmaceutical Sciences and Pharmacy","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Istvan Toth","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/569855","simplified_title":"New neuropathic pain drugs","sub_type":"Development Grant","total_budget":"209470.5","source_system":"We have developed a new pain drug based on the natural pain killing opioid peptide, Endomorhin 1. The new drug exhibits activity similar to morphine and gabapentin against neuropathic pain in animals but seems to act through a different mechanism. We will complete our preclinical investigation of this compound by assessing its side effect profile and tolerence inducing properties in animals. We will also continue our development of an orally active analogue of this important peptide."},"children":[{"color":"#336699","name":"Prof Istvan Toth","data":{"first_name":"Istvan","title":"Prof","dw_individual_id":"DW0034329","middle_name":"","last_name":"Toth","source_individual_id":"RMIS17214","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Istvan Toth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85883","size":1},{"color":"#336699","name":"Dr Joanne Blanchfield","data":{"first_name":"Joanne","title":"Dr","dw_individual_id":"DW0029492","middle_name":"T","last_name":"Blanchfield","source_individual_id":"5011312","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Joanne Blanchfield"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84646","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64404","size":1},{"color":"#FF4D4D","name":"Combined dry-needling, advice and graded exercise: a randomized controlled trial in chronic whiplash","data":{"media_summary":"","end_year":2012,"keywords":["acupuncture","clinical trial","exercise","whiplash injuries"],"nhmrc_grant_id":569832,"application_year":2008,"health_keywords":["alternative intervention","injury rehabilitation and management","whiplash related disorders"],"scientific_title":"Combined dry-needling, advice and graded exercise: a randomized controlled trial in chronic whiplash","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Complementary-Alternative Medicine not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"COMPLEMENTARY-ALTERNATIVE MEDICINE","cia_name":"Prof Michele Sterling","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569832","simplified_title":"Dry-needling, advice and graded exercise for chronic whiplash","sub_type":"Standard Project Grant","total_budget":"309339.64","source_system":"Central hyperexcitability is a feature of chronic whiplash and may be one reason for the poor response of this condition to standard treatment approaches such as exercise. Complementary and Alternative Medicine (CAM) treatment of dry-needling has shown potential to decrease this hypersensitivity in other musculoskeletal conditions. This study will investigate the effects of dry-needling combined with an orthodox treatment of advice and graded exercise on pain and disability in chronic whiplash."},"children":[{"color":"#336699","name":"Prof Guglielmo Vicenzino","data":{"first_name":"Guglielmo","title":"Prof","dw_individual_id":"DW0046019","middle_name":"Tarcisio","last_name":"Vicenzino","source_individual_id":"5018115","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Guglielmo Vicenzino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88911","size":1},{"color":"#336699","name":"Prof Luke Connelly","data":{"first_name":"Luke","title":"Prof","dw_individual_id":"DW0030066","middle_name":"Brian","last_name":"Connelly","source_individual_id":"5012629","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Luke Connelly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84790","size":1},{"color":"#336699","name":"Prof Michele Sterling","data":{"first_name":"Michele","title":"Prof","dw_individual_id":"DW0028165","middle_name":"","last_name":"Sterling","source_individual_id":"5017714","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michele Sterling"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84271","size":1},{"color":"#336699","name":"Dr Tina Souvlis","data":{"first_name":"Tina","title":"Dr","dw_individual_id":"DW0022251","middle_name":"","last_name":"Souvlis","source_individual_id":"5017638","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Tina Souvlis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82740","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64403","size":1},{"color":"#FF4D4D","name":"The immunogenetics of ankylosing spondylitis: a genetic and functional investigation of IL23R and related genes","data":{"media_summary":"","end_year":2011,"keywords":["arthritis","gene mapping","genetic predisposition","immunogenetics"],"nhmrc_grant_id":569830,"application_year":2008,"health_keywords":["MHC associated genetic diseases","genetic predisposition to disease","spondyloarthropathy"],"scientific_title":"The immunogenetics of ankylosing spondylitis: a genetic and functional investigation of IL23R and related genes","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Immunogenetics","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Dr Gethin Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569830","simplified_title":"IL23R and Ankylosing Spondylitis","sub_type":"Standard Project Grant","total_budget":"536679.79","source_system":"Ankylosing spondylitis (AS) is a common inflammatory arthritis which causes primarily back pain and stiffness, and affects 1-250 individuals. Our group identified association between tagging genetic markers in the gene IL23R and AS, and our preliminary data suggests some related genes are involved as well. This study aims to identify the key genetic variants involved and determine the mechanism by which they cause AS."},"children":[{"color":"#336699","name":"Dr Gethin Thomas","data":{"first_name":"Gethin","title":"Dr","dw_individual_id":"DW0022525","middle_name":"Penar","last_name":"Thomas","source_individual_id":"5017886","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Gethin Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82800","size":1},{"color":"#336699","name":"Prof Matthew Brown","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0012026","middle_name":"A","last_name":"Brown","source_individual_id":"5012217","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79951","size":1},{"color":"#336699","name":"Prof Huji Xu","data":{"first_name":"Huji","title":"Prof","dw_individual_id":"DW0005567","middle_name":"","last_name":"Xu","source_individual_id":"RMIS5935581","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Huji Xu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78213","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64402","size":1},{"color":"#FF4D4D","name":"Major Histocompatibility Complex (MHC) Genetics of Ankylosing Spondylitis","data":{"media_summary":"","end_year":2011,"keywords":["arthritis","gene mapping","genetic predisposition","immunogenetics"],"nhmrc_grant_id":569829,"application_year":2008,"health_keywords":["MHC associated genetic diseases","genetic predisposition to disease","spondyloarthropathy"],"scientific_title":"Major Histocompatibility Complex (MHC) Genetics of Ankylosing Spondylitis","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Immunogenetics","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Prof Matthew Brown","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569829","simplified_title":"MHC Genetics of AS","sub_type":"Standard Project Grant","total_budget":"568612.08","source_system":"Ankylosing spondylitis (AS) is the prototypic condition of a group of types of inflammatory arthritis called 'seronegative spondyloarthropathies'. These conditions are the most common form of inflammatory arthritis in white populations and occur worldwide. One third of the risk of developing AS is determined by genes within a region called the 'major histocompatibility complex' (MHC), in addition to the gene HLA-B27, the main gene causing AS. We aim to identify the remaining MHC genes."},"children":[{"color":"#336699","name":"Prof David Evans","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0042292","middle_name":"Meurig","last_name":"Evans","source_individual_id":"RMIS5230747","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Evans"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87975","size":1},{"color":"#336699","name":"Prof Matthew Brown","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0012026","middle_name":"A","last_name":"Brown","source_individual_id":"5012217","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79951","size":1},{"color":"#336699","name":"Prof Huji Xu","data":{"first_name":"Huji","title":"Prof","dw_individual_id":"DW0005567","middle_name":"","last_name":"Xu","source_individual_id":"RMIS5935581","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Huji Xu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78213","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64401","size":1},{"color":"#FF4D4D","name":"The role of neuronal hyper-excitability in an animal model of motor neuron disease","data":{"media_summary":"","end_year":2011,"keywords":["Corticospinal","Electrophysiology","Motor neuron disease","RNA interference","Sodium channel"],"nhmrc_grant_id":569827,"application_year":2008,"health_keywords":["Ageing","Motor neuron disease","Neurodegenerative disease"],"scientific_title":"The role of neuronal hyper-excitability in an animal model of motor neuron disease","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Mark Bellingham","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569827","simplified_title":"Hyper-excitability in motor neuron disease","sub_type":"Standard Project Grant","total_budget":"558170.74","source_system":"Every day at least one person in Australia dies of the fatal and untreatable adult neurodegenerative disease of amyotrophic lateral sclerosis (motor neuron disease). This research examines the factors driving early increases in neural activity which may lead to the loss of upper and lower motor neurons in adulthood. The use of new methods to suppress production of specific proteins causing increased neural activity may lead to novel treatments for this disease."},"children":[{"color":"#336699","name":"A/Pr Peter Noakes","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0038807","middle_name":"G","last_name":"Noakes","source_individual_id":"5016732","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Noakes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87053","size":1},{"color":"#336699","name":"Dr Mark Bellingham","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0035336","middle_name":"C","last_name":"Bellingham","source_individual_id":"5013441","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mark Bellingham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86159","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64400","size":1},{"color":"#FF4D4D","name":"GABA excitotoxicity, neuroprotection and the perinatal brain","data":{"media_summary":"","end_year":2011,"keywords":["brain development","excitotoxicity","hypoxia","neuroprotection","newborn"],"nhmrc_grant_id":569826,"application_year":2008,"health_keywords":["cerebral palsy","hypoxia ischemic encephalopathy","neonatal brain injury","perinatal hypoxia"],"scientific_title":"GABA excitotoxicity, neuroprotection and the perinatal brain","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Stella Bjorkman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569826","simplified_title":"Pathways to injury and protection in the developing brain","sub_type":"New Investigator Grant","total_budget":"547970.74","source_system":"Approximately 3.5% of babies die each year from brain damage due to perinatal asphyxia, a shortage of oxygen to the developing brain. Babies that survive face lifelong neurological disabilities, placing enormous burden on health, social and economic resources. Current treatments are inadequate. We will examine what occurs when there is a shortage of oxygen to the developing brain and investigate pathways to hypoxic brain injury that offer opportunities for therapeutic intervention."},"children":[{"color":"#336699","name":"Dr Stella Bjorkman","data":{"first_name":"Stella","title":"Dr","dw_individual_id":"DW0000420","middle_name":"Tracey","last_name":"Bjorkman","source_individual_id":"5013484","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Stella Bjorkman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76767","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64399","size":1},{"color":"#FF4D4D","name":"Functional contribution of fetal microchimeric cells in transgenic models of maternal tissue repair in and after pregnancy","data":{"media_summary":"Women's health","end_year":2012,"keywords":["Fetomaternal cell trafficking","Fetomaternal microchimerism","Stem cells","Tissue regeneration","Women's health"],"nhmrc_grant_id":569822,"application_year":2008,"health_keywords":["Osteogenesis imperfecta","Pregnancy complications","Stem cell therapy","Termination of pregnancy","Women's health"],"scientific_title":"Functional contribution of fetal microchimeric cells in transgenic models of maternal tissue repair in and after pregnancy","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Foetal Development and Medicine","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Nicholas Fisk","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569822","simplified_title":"How fetal cells that persist after pregnancy repair damaged tissues in women.","sub_type":"Standard Project Grant","total_budget":"542462.24","source_system":"Fetal stem cells cross into the mother during pregnancy and persist lifelong in her tissues. To determine whether helpful or harmful, we will study how these cells contribute to healing both after acute injury and in chronic genetic models like brittle-bone disease and muscular dystrophy. This research will inform long-term consequences of pregnancy, important for women's health and longevity, and help develop a promising form of stem cell therapy."},"children":[{"color":"#336699","name":"A/Pr Kiarash Khosrotehrani","data":{"first_name":"Kiarash","title":"A/Pr","dw_individual_id":"DW0037755","middle_name":"","last_name":"Khosrotehrani","source_individual_id":"5015692","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Kiarash Khosrotehrani"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86775","size":1},{"color":"#336699","name":"A/Pr George Bou-Gharios","data":{"first_name":"George","title":"A/Pr","dw_individual_id":"DW0035480","middle_name":"","last_name":"Bou-Gharios","source_individual_id":"5013554","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr George Bou-Gharios"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86192","size":1},{"color":"#336699","name":"Prof Nicholas Fisk","data":{"first_name":"Nicholas","title":"Prof","dw_individual_id":"DW0019006","middle_name":"Maxwell","last_name":"Fisk","source_individual_id":"5014632","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nicholas Fisk"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81858","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64398","size":1},{"color":"#FF4D4D","name":"Genetic Determinants of Bone Mass","data":{"media_summary":"","end_year":2010,"keywords":["Fractures","Gene Mapping","Osteoporosis","Quantitative Genetics","Susceptibility Genes"],"nhmrc_grant_id":569807,"application_year":2008,"start_year":2009,"scientific_title":"Genetic Determinants of Bone Mass","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"GENETICS","cia_name":"A/Pr Emma Duncan","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569807","simplified_title":"Genetics of Osteoporosis","sub_type":"Clinical CDF","total_budget":"107366.09","source_system":"I am a clinician-scientist and endocrinologist most interested in clinical problems associated with bone, in particular the highly heritable disease of osteoporosis. I hope by studying genetic determinants of bone mass to determine the key genes involved, with the long term aim of informing the development of novel therapies for this common, painful and disabling disease."},"children":[{"color":"#336699","name":"A/Pr Emma Duncan","data":{"first_name":"Emma","title":"A/Pr","dw_individual_id":"DW0018792","middle_name":"Letitia","last_name":"Duncan","source_individual_id":"5014440","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Emma Duncan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81813","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64397","size":1},{"color":"#FF4D4D","name":"Promoting physical activity participation among adolescents with cerebral palsy - a randomised clinical trial.","data":{"media_summary":"","end_year":2010,"keywords":["Cerebral Palsy","Health Promotion","Physical Activity"],"nhmrc_grant_id":569789,"application_year":2008,"start_year":2009,"scientific_title":"Promoting physical activity participation among adolescents with cerebral palsy - a randomised clinical trial.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Exercise Physiology","research_area":"Clinical Medicine and Science","for_category":"HUMAN MOVEMENT AND SPORTS SCIENCE","cia_name":"Ms Kelly Clanchy","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/569789","simplified_title":"Motivating adolescents with cerebral palsy to be physically active.","sub_type":"Medical Postgraduate Scholarship","total_budget":"44276.81","source_system":"Adolescents with cerebral palsy (CP) are amongst the least active members of society. These decreased activity levels places them at high risk of additional disability and disease. This program of study focuses on (i) validation of an objective community based measure of Habitual Physical Activity (HPA) and (ii) a community based randomised clinical trial comparing a novel approach motivational training with a standard care intervention to enhance HPA in adolescents with CP."},"children":[{"color":"#336699","name":"Ms Kelly Clanchy","data":{"first_name":"Kelly","title":"Ms","dw_individual_id":"DW0006601","middle_name":"M","last_name":"Clanchy","source_individual_id":"5030469","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Kelly Clanchy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78494","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64396","size":1},{"color":"#FF4D4D","name":"Investigation of the low dose UV G2 phase checkpoint and its potential exploitation in the treatment of melanoma","data":{"media_summary":"","end_year":2010,"keywords":["Cancer therapy","Cell cycle control","Melanoma"],"nhmrc_grant_id":569787,"application_year":2008,"start_year":2009,"scientific_title":"Investigation of the low dose UV G2 phase checkpoint and its potential exploitation in the treatment of melanoma","node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Mr Matthew Wigan","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/569787","simplified_title":"Identification of novel therapeutic targets in the development and treatment of melanoma","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"35085.9","source_system":"The research aims to indentify the role UV exposure contributes to the development of melanoma and if this knowledge can be used to develop new methods in the prevention and treatment of this disease"},"children":[{"color":"#336699","name":"Mr Matthew Wigan","data":{"first_name":"Matthew","title":"Mr","dw_individual_id":"DW0028810","middle_name":"P","last_name":"Wigan","source_individual_id":"5030545","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Mr Matthew Wigan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84462","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64395","size":1},{"color":"#FF4D4D","name":"Individualisation of immunosuppressant therapy in renal transplant recipients.","data":{"media_summary":"","end_year":2012,"keywords":["Genetic polymorphisms","Immunosuppression","Kidney","Pharmacokinetics","Transplanation"],"nhmrc_grant_id":569784,"application_year":2008,"start_year":2009,"scientific_title":"Individualisation of immunosuppressant therapy in renal transplant recipients.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Katherine Barraclough","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/569784","simplified_title":"Individualisation of immunosuppressant therapy.","sub_type":"Medical Postgraduate Scholarship","total_budget":"113496","source_system":"People who undergo kidney transplantation require potent anti-rejection medications. Dosing is difficult. Two people given the same drug dose can have markedly different blood drug concentrations. If drug concentrations too low, there is an increased risk of rejection. If too high, there is an increased risk of drug side effects, infections and cancer. This study aims to find out why different people need different doses and to improve dosing methods, thereby improving patient outcomes."},"children":[{"color":"#336699","name":"Dr Katherine Barraclough","data":{"first_name":"Katherine","title":"Dr","dw_individual_id":"DW0005960","middle_name":"A","last_name":"Barraclough","source_individual_id":"5013336","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katherine Barraclough"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78328","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64394","size":1},{"color":"#FF4D4D","name":"Examining the interface between complementary and alternative medicine use and provision and rural general practice.","data":{"media_summary":"","end_year":2011,"keywords":["complementary medicine","health services research","primary health care","qualitative research","rural health"],"nhmrc_grant_id":569782,"application_year":2008,"start_year":2009,"scientific_title":"Examining the interface between complementary and alternative medicine use and provision and rural general practice.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Complementary-Alternative Medicine not elsewhere classified","research_area":"Public Health","for_category":"COMPLEMENTARY-ALTERNATIVE MEDICINE","cia_name":"Dr Jonathan Wardle","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/569782","simplified_title":"Examining the interface between complementary and alternative medicine use and provision and rural general practice.","sub_type":"Public Health Postgraduate Scholarship","total_budget":"85580.45","source_system":"The project aims to improve rural health outcomes by investigating practices and perspectives of rural general practitioners (GPs) regarding complementary medicine (CAM). CAM use is highest in rural areas and this could have potential safety issues when combined with conventional healthcare. The results will better equip rural health providers coordinate and manage healthcare for their patients, avoid potential complications and give rural GPs a perspective on managing challenges posed by CAM."},"children":[{"color":"#336699","name":"Dr Jonathan Wardle","data":{"first_name":"Jonathan","title":"Dr","dw_individual_id":"DW0022851","middle_name":"Lee","last_name":"Wardle","source_individual_id":"5018205","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jonathan Wardle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82891","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64393","size":1},{"color":"#FF4D4D","name":"Molecular Characterisation of Adiponectin Receptors: implications for adiponectin action and resistance","data":{"media_summary":"","end_year":2014,"keywords":["Adiponectin Receptors","Insulin Resistance","Metabolic Syndrome"],"nhmrc_grant_id":569775,"application_year":2008,"start_year":2009,"scientific_title":"Molecular Characterisation of Adiponectin Receptors: implications for adiponectin action and resistance","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Ms Felicity Rose","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/569775","simplified_title":"Characterisation of Adiponectin Receptors","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"95137.37","source_system":"Adiponectin is a hormone secreted by fat cells with anti-inflammatory, anti-atherogenic and insulin sensitising properties. Adiponectin levels and actions are compromised in obesity and type 2 diabetes. Adponectin mediates its effects via two receptors but the mechanisms are poorly understood. This proposal aims to define the underlying mechanisms with the ultimate goal of identifying novel therapeutic strategies to improve adiponectin's actions."},"children":[{"color":"#336699","name":"Ms Felicity Rose","data":{"first_name":"Felicity","title":"Ms","dw_individual_id":"DW0015947","middle_name":"J","last_name":"Rose","source_individual_id":"5017232","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Felicity Rose"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81018","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64392","size":1},{"color":"#FF4D4D","name":"Regulation of macrophage gene expression and function by histone deacetylases","data":{"media_summary":"","end_year":2010,"keywords":["Cardiovascular risk","Histone deacetylase","Macrophage activation","Rheumatoid arthritis"],"nhmrc_grant_id":569774,"application_year":2008,"start_year":2009,"scientific_title":"Regulation of macrophage gene expression and function by histone deacetylases","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Miss Melanie Andrews","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/569774","simplified_title":"Treating inflammatory disease by targeting immune cell function","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"35909.6","source_system":"Macrophages are white blood cells that play a major role in the development of inflammatory diseases such as rheumatoid arthritis and atherosclerosis, diseases that are a major burden to Australian society. This project aims to characterise the effects of a novel class of potential anti-inflammatory agents on macrophages. Defining how these drugs modify macrophages in disease models will allow design of therapeutics with minimal side effects."},"children":[{"color":"#336699","name":"Miss Melanie Andrews","data":{"first_name":"Melanie","title":"Miss","dw_individual_id":"DW0023343","middle_name":"R","last_name":"Andrews","source_individual_id":"5013204","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Miss Melanie Andrews"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83008","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64391","size":1},{"color":"#FF4D4D","name":"The burden and epidemiology of low back pain: comparisons between low, middle, and high-income countries.","data":{"media_summary":"","end_year":2011,"keywords":["Epidemiology","International comparisons","Low back pain","Musculoskeletal disability","Priority setting and planning"],"nhmrc_grant_id":569772,"application_year":2008,"start_year":2009,"scientific_title":"The burden and epidemiology of low back pain: comparisons between low, middle, and high-income countries.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rheumatology and Arthritis","research_area":"Public Health","for_category":"CLINICAL SCIENCES","cia_name":"Dr Damian Hoy","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/569772","simplified_title":"The burden of low back pain: comparisons between the rich and the poor.","sub_type":"Public Health Postgraduate Scholarship","total_budget":"75951.71","source_system":"Low back pain is one of the most common, debilitating and costly health problems. This project will estimate the global burden of low back pain through a variety of epidemiological and statistical methods, and draw comparisons between different cultures and countries to help improve our understanding of low back pain. By improving our understanding, policy and programs will become more effective in reducing the burden of low back pain."},"children":[{"color":"#336699","name":"Dr Damian Hoy","data":{"first_name":"Damian","title":"Dr","dw_individual_id":"DW0007999","middle_name":"G","last_name":"Hoy","source_individual_id":"5015340","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Damian Hoy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78866","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64390","size":1},{"color":"#FF4D4D","name":"Pulsed Laser Ablation of Smear Layers in Root Canals","data":{"media_summary":"","end_year":2009,"keywords":["Dental Lasers","Dental Technology","Dental Therapy"],"nhmrc_grant_id":569771,"application_year":2008,"start_year":2009,"scientific_title":"Pulsed Laser Ablation of Smear Layers in Root Canals","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dentistry not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"DENTISTRY","cia_name":"Dr Raghad Hmud","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/569771","simplified_title":"Cleaning debris from the root canals of teeth using pulsed lasers as part of endodontic treatment.","sub_type":"Medical Postgraduate Scholarship","total_budget":"32628","source_system":"The project is in the general field of clinical dentistry, and in the speciality area of endodontics (root canal treatment). It examines the ability of several novel laser systems to remove bacteria and soft tissue debris from the root canals of teeth, building on recent developments in optical fiber technology and in antimicrobial therapy."},"children":[{"color":"#336699","name":"Raghad Hmud","data":{"first_name":"Raghad","title":"","dw_individual_id":"DW0019638","middle_name":"","last_name":"Hmud","source_individual_id":"RMIS4753360","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Raghad Hmud"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82004","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64389","size":1},{"color":"#FF4D4D","name":"Neurological manifestations of experimental neuronal voltage-gated potassium channel autoimmunity.","data":{"media_summary":"","end_year":2011,"keywords":["Autoantibodies","Autoimmune Encephalopathy","Epilepsy","Paraneoplastic Neurological Disorders","Voltage-gated Potassium Channels"],"nhmrc_grant_id":569767,"application_year":2008,"start_year":2009,"scientific_title":"Neurological manifestations of experimental neuronal voltage-gated potassium channel autoimmunity.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Autoimmunity","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Dr Kee Meng Tan","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/569767","simplified_title":"Autoimmune epilepsy.","sub_type":"Medical Postgraduate Scholarship","total_budget":"65148.41","source_system":"Antibodies against neuronal voltage-gated potassium channels (VGKC) are seen in various neurological illnesses, most commonly epilepsy and memory loss. The role of VGKC antibodies in the development of brain disease will be studied by immunizing rabbits against VGKC and transferring these antibodies to mice."},"children":[{"color":"#336699","name":"Dr Kee Meng Tan","data":{"first_name":"Kee Meng","title":"Dr","dw_individual_id":"DW0010558","middle_name":"","last_name":"Tan","source_individual_id":"5017822","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kee Meng Tan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79567","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64388","size":1},{"color":"#FF4D4D","name":"Association of Retinal Vascular Calibre with Physical Activity and Sedentary Behaviour in Adults","data":{"media_summary":"","end_year":2011,"keywords":["behavioural intervention","ophthalmology","population health"],"nhmrc_grant_id":569764,"application_year":2008,"start_year":2009,"scientific_title":"Association of Retinal Vascular Calibre with Physical Activity and Sedentary Behaviour in Adults","node_source":"NHMRC","node_type":"Grant","field_of_research":"Opthalmology and Vision Science","research_area":"Public Health","for_category":"CLINICAL SCIENCES","cia_name":"Dr Satyamurthy Anuradha","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/569764","simplified_title":"Physical Activity, sitting time and adults eye health","sub_type":"Public Health Postgraduate Scholarship","total_budget":"104664","source_system":"The back of the eye provides a unique window to the health of the body's veins and arteries. The diameter of its blood vessels can be measured using photographs. Studies have shown that these measurements can help identify a person's risk of high blood pressure, diabetes or stroke. This project aims to see if the state of health of these blood vessels are related to a person's level of physical activity and television viewing time using data from a large-scale Australian study."},"children":[{"color":"#336699","name":"Dr Satyamurthy Anuradha","data":{"first_name":"Satyamurthy","title":"Dr","dw_individual_id":"DW0040829","middle_name":"","last_name":"Anuradha","source_individual_id":"5013207","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Satyamurthy Anuradha"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87590","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64387","size":1},{"color":"#FF4D4D","name":"Identification, validation and functional analysis of genes and miRNAs involved in recurrent non-small cell lung cancer.","data":{"media_summary":"","end_year":2011,"keywords":["Genetics","Lung Cancer","Recurrence"],"nhmrc_grant_id":569762,"application_year":2008,"start_year":2009,"scientific_title":"Identification, validation and functional analysis of genes and miRNAs involved in recurrent non-small cell lung cancer.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Bajee Krishna Sriram","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/569762","simplified_title":"Discovery and analysis of genes involved in the recurrence of lung cancer.","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"104664","source_system":"Recurrence of lung cancer after treatment affects 20-85% of patients. Current prognostication tools are inaccurate and thus patients receive generic treatments. Our intention is to identify genes involved in recurrence of lung cancer. We foresee that this will translate to earlier identification of at-risk patients enabling individualised less toxic and more successful treatments. We also hope to better understand biology of lung cancer recurrence and discover new targets for treatment."},"children":[{"color":"#336699","name":"Dr Bajee Krishna Sriram","data":{"first_name":"Bajee Krishna","title":"Dr","dw_individual_id":"DW0039826","middle_name":"B","last_name":"Sriram","source_individual_id":"5017662","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Bajee Krishna Sriram"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87321","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64386","size":1},{"color":"#FF4D4D","name":"Conversion and function of regulatory T cells in the periphery: the role of the RelB transcription factor","data":{"media_summary":"","end_year":2011,"keywords":["Dendritic cells","Immunological tolerance","T cell immunity","Transcription factor"],"nhmrc_grant_id":569755,"application_year":2008,"health_keywords":["autoimmune disease","immune regulation","immunity, cellular","inflammation"],"scientific_title":"Conversion and function of regulatory T cells in the periphery: the role of the RelB transcription factor","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Autoimmunity","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ranjeny Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569755","simplified_title":"Understanding the control of immune regulation to improve treatment of autoimmune disease","sub_type":"Standard Project Grant","total_budget":"526878.44","source_system":"There is limited understanding of the molecular mechanisms regulating immune tolerance, or protection from autoimmune diseases, like childhood diabetes. This proposal studies RelB-deficient mice. They present a novel opportunity to study tolerance and autoimmune disease development, as we have discovered that autoimmunity in these mice is correctable by treatment with dendritic cells expressing RelB. This may be relevant to treatment of patients with certain forms of autoimmune disease."},"children":[{"color":"#336699","name":"Prof Ranjeny Thomas","data":{"first_name":"Ranjeny","title":"Prof","dw_individual_id":"DW0045826","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS4352","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ranjeny Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88853","size":1},{"color":"#336699","name":"Dr Dennis Dowhan","data":{"first_name":"Dennis","title":"Dr","dw_individual_id":"DW0024590","middle_name":"H","last_name":"Dowhan","source_individual_id":"5014382","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Dennis Dowhan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83309","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64385","size":1},{"color":"#FF4D4D","name":"Reconsideration of the motor adaptation to pain","data":{"media_summary":"rehabilitation of motor function","end_year":2012,"keywords":["experimental pain","motor control","muscle contraction","musculoskeletal Pain","physiotherapy"],"nhmrc_grant_id":569744,"application_year":2008,"health_keywords":["motor control","muscle function deficits - loss of motor control","musculoskeletal physiology","pain","rehabilitation of motor function"],"scientific_title":"Reconsideration of the motor adaptation to pain","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Kylie Tucker","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569744","simplified_title":"Why do we move differently in pain?","sub_type":"Standard Project Grant","total_budget":"417881.84","source_system":"Pain changes movement. Although undisputed, there is a surprising lack of agreement regarding the underlying mechanisms. This project involves an innovative mix of neurophysiological methods to investigate the drive to muscle cells from the nervous system and changes in the mechanics of contraction. These studies will resolve the perplexing problem of how pain changes our ability to activate muscle. Clear understanding of the underlying mechanisms can guide rehabilitation."},"children":[{"color":"#336699","name":"Prof Paul Hodges","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0043077","middle_name":"W","last_name":"Hodges","source_individual_id":"RMIS222953","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Hodges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88164","size":1},{"color":"#336699","name":"Prof Andrew Cresswell","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0018461","middle_name":"G","last_name":"Cresswell","source_individual_id":"5014129","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Andrew Cresswell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81727","size":1},{"color":"#336699","name":"Dr Kylie Tucker","data":{"first_name":"Kylie","title":"Dr","dw_individual_id":"DW0016734","middle_name":"J","last_name":"Tucker","source_individual_id":"5017997","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kylie Tucker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81245","size":1},{"color":"#336699","name":"Prof S Garland","data":{"first_name":"S","title":"Prof","dw_individual_id":"DW0007424","middle_name":"Jayne","last_name":"Garland","source_individual_id":"5014774","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof S Garland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78705","size":1},{"color":"#336699","name":"A/Pr Jane Butler","data":{"first_name":"Jane","title":"A/Pr","dw_individual_id":"DW0000667","middle_name":"E","last_name":"Butler","source_individual_id":"RMIS706035","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jane Butler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76844","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64384","size":1},{"color":"#FF4D4D","name":"Understanding the physiological role of COUP-TF orphan nuclear receptors in skeletal muscle.","data":{"media_summary":"gene expression","end_year":2012,"keywords":["Gene Regulation","Gene expression","Steroid Hormone Receptors","skeletal muscle","transgenic animals"],"nhmrc_grant_id":569742,"application_year":2008,"health_keywords":["Biochemistry and Molecular Biology","Biological Sciences","Diabetes","Obesity","gene expression"],"scientific_title":"Understanding the physiological role of COUP-TF orphan nuclear receptors in skeletal muscle.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569742","simplified_title":"Regulation of metabolism in skeletal muscle.","sub_type":"Standard Project Grant","total_budget":"454923.09","source_system":"COUP-TF is a protein expressed in skeletal muscle, a tissue that accounts for ~40% of the body mass and energy expenditure, and is a major site of nutrient metabolism. COUP-TF is a member of the nuclear hormone receptor (NR) superfamily. These proteins respond to physiological signals, and are targets of pharmaceuticals for the treatment of inflammation, metabolic and endorcrine disorders. Our project is directed toward understanding the role of COUP-TF in the context of metabolism and obesity."},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64383","size":1},{"color":"#FF4D4D","name":"NR1F (ROR) nuclear hormone receptors and metabolism: insights into the control of lipid homeostasis.","data":{"media_summary":"Obesity","end_year":2012,"keywords":["Gene Regulation","Metabolism","Skeletal Muscle","Steroid Hormone Receptors","Transcription"],"nhmrc_grant_id":569741,"application_year":2008,"health_keywords":["Biological Sciences","Diabetes","Dyslipidaemia","Metabolic Disorders","Obesity"],"scientific_title":"NR1F (ROR) nuclear hormone receptors and metabolism: insights into the control of lipid homeostasis.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569741","simplified_title":"Regulation of metabolism..","sub_type":"Standard Project Grant","total_budget":"581892.59","source_system":"ROR is a member of a gene family, that regulates reproduction, endocrine physiology, and metabolism, and are important in human health. ROR function remains illusive. However, it is expressed in liver, fat and muscle, tissues that (i) modulate blood lipids, insulin sensitivity and energy balance, and (ii) have an important role in diabetes and obesity. Understanding ROR function in metabolism provides the opportunity for the discovery of new pathways that ameliorate metabolic disease."},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64382","size":1},{"color":"#FF4D4D","name":"Australia Fellowship","data":{"media_summary":"","end_year":2014,"keywords":["Addiction treatment, Addiction prevention","Drug abuse, Drug addiction","Policy and interventions","Policy development","Policy making, Public health policy"],"nhmrc_grant_id":569738,"application_year":2008,"start_year":2009,"scientific_title":"Australia Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Wayne Hall","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569738","simplified_title":"Australia Fellowship","sub_type":"Australia Fellowship","total_budget":"4000000","source_system":"Prof Hall is a population health researcher investigating the public health and public policy implications of neurobiological and genetic research on alcohol and other drug use and addiction. My research includes: the social and health system implications of new pharmacological treatments for addiction arising from neurobiological and genetic research; new approaches suggested for the prevention of drug use and addiction (for example, genetic screening and vaccination); and the impact of neurobiological and genetic research findings on public understanding of, attitudes towards, and support for, different social policies that aim to deal with drug use and addiction."},"children":[{"color":"#336699","name":"Prof Wayne Hall","data":{"first_name":"Wayne","title":"Prof","dw_individual_id":"DW0001997","middle_name":"Denis","last_name":"Hall","source_individual_id":"5012662","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Wayne Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77211","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64381","size":1},{"color":"#FF4D4D","name":"Towards selective targeting of HDACs for anti-inflammatory applications","data":{"media_summary":"thrombosis","end_year":2011,"keywords":["anti-inflammatory","histone deacetylase","inflammatory mediators","macrophage activation","thrombosis"],"nhmrc_grant_id":569735,"application_year":2008,"health_keywords":["cardiovascular complications","chronic inflammatory diseases","inflammatory diseases","rheumatoid arthritis","thrombosis"],"scientific_title":"Towards selective targeting of HDACs for anti-inflammatory applications","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"A/Pr Matthew Sweet","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569735","simplified_title":"Using anti-cancer drugs to treat inflammatory disease","sub_type":"Standard Project Grant","total_budget":"581892.59","source_system":"HDAC inhibitors are anti-cancer drugs that kill rapidly growing cells (like cancer cells). These drugs also have anti-inflammatory properties and so may be beneficial in chronic inflammatory diseases such as as Rheumatoid Arthritis. However, it is unknown how they reduce inflammation. In this project we aim to understand how HDAC inhibitors act as anti-inflammatory agents and to design new HDAC inhibitors with reduced side effects for the treatment of inflammatory diseases."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64379","size":1},{"color":"#FF4D4D","name":"The roles of ion transporters in sulfate homeostasis","data":{"media_summary":"disease models, animal","end_year":2012,"keywords":["Homeostasis","Kidney","Polymorphism","Transporters","proximal tubule kidney"],"nhmrc_grant_id":569734,"application_year":2008,"health_keywords":["Ageing","Hyposulphataemia","Kidney","Renal reabsorption disorder","disease models, animal"],"scientific_title":"The roles of ion transporters in sulfate homeostasis","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Systems Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof Daniel Markovich","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569734","simplified_title":"Control of sulfate levels in the body","sub_type":"Standard Project Grant","total_budget":"443450.93","source_system":"Sulfate is an essential nutrient for life. Individuals with autism, Alzheimers, Parkinsons and motor neurone disease have low blood sulfate levels. In this project, we plan to study several genes as candidates in controlling blood sulfate levels. We also plan to determine the role blood sulfate levels play in longevity. Our findings will make an important link between dietary nutritional intake, genes, blood sulfate levels and longevity."},"children":[{"color":"#336699","name":"Prof Daniel Markovich","data":{"first_name":"Daniel","title":"Prof","dw_individual_id":"DW0038289","middle_name":"","last_name":"Markovich","source_individual_id":"5016201","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Daniel Markovich"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86917","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64378","size":1},{"color":"#FF4D4D","name":"Nanopatch immunisation against pandemic influenza: improved immune responses at a reduced dose.","data":{"media_summary":"Influenza","end_year":2012,"keywords":["Immunisation","Influenza","Skin Immunology","Topical drug delivery","Vaccine Development"],"nhmrc_grant_id":569726,"application_year":2008,"health_keywords":["Alternative Vaccination Strategies","Drug delivery","Immune Responses","Improvement of Vaccine Efficacy","Influenza"],"scientific_title":"Nanopatch immunisation against pandemic influenza: improved immune responses at a reduced dose.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Humoral Immunology and Immunochemistry","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof Mark Kendall","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569726","simplified_title":"Nanopatch immunisation against influenza","sub_type":"Standard Project Grant","total_budget":"511294.64","source_system":"Development of a new way to vaccinate against influenza that will make standard vaccines 100 times more potent than conventional syringe injection. The Nanopatch is made from a silicon wafer, bristling with micro-nanoscale spikes. It painlessly deposits vaccine under the skin surface. Experiments in mice show that even a small vaccine payload delivered to the skin generates good immune responses. The Nanopatch vaccination system is expected to be ready for clinical trials within a few years."},"children":[{"color":"#336699","name":"Prof Mark Kendall","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0043459","middle_name":"Af","last_name":"Kendall","source_individual_id":"5015660","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Kendall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88269","size":1},{"color":"#336699","name":"Dr Germain Fernando","data":{"first_name":"Germain","title":"Dr","dw_individual_id":"DW0030659","middle_name":"J","last_name":"Fernando","source_individual_id":"5014600","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Germain Fernando"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84967","size":1},{"color":"#336699","name":"Prof Lorena Brown","data":{"first_name":"Lorena","title":"Prof","dw_individual_id":"DW0029635","middle_name":"E","last_name":"Brown","source_individual_id":"RMIS41665","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Lorena Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84675","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64375","size":1},{"color":"#FF4D4D","name":"The molecular physiology of Streptococcus pneumoniae during sepsis","data":{"media_summary":"","end_year":2009,"keywords":["Bacterial pathogenesis","Sepsis","Streptococcus pneumoniae","Virulence"],"nhmrc_grant_id":569720,"application_year":2008,"health_keywords":["Bacterial infection","Innate Immunity","Pneumonia","Septicaemia"],"scientific_title":"The molecular physiology of Streptococcus pneumoniae during sepsis","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Alastair McEwan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569720","simplified_title":"How pneumococcus causes blood poisoning","sub_type":"Standard Project Grant","total_budget":"232504.8","source_system":"The project will determine the way in which pneumococcus changes its properties when it invades the bloodstream of the human host. Since these changes are linked to sepsis then this new understanding will provide information that can be used to manage and control acute pneumococcal infection."},"children":[{"color":"#336699","name":"Prof James Paton","data":{"first_name":"James","title":"Prof","dw_individual_id":"DW0027246","middle_name":"C","last_name":"Paton","source_individual_id":"RMIS7494","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof James Paton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84042","size":1},{"color":"#336699","name":"Prof Michael Jennings","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0025768","middle_name":"P","last_name":"Jennings","source_individual_id":"RMIS449244","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Jennings"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83637","size":1},{"color":"#336699","name":"Prof Alastair Mcewan","data":{"first_name":"Alastair","title":"Prof","dw_individual_id":"DW0014843","middle_name":"G","last_name":"Mcewan","source_individual_id":"5016339","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alastair Mcewan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80715","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64374","size":1},{"color":"#FF4D4D","name":"Dissecting the role of hedgehog signalling in chondrogenesis and skeletal disease","data":{"media_summary":"skeletal disease","end_year":2012,"keywords":["cartilage","craniofacial development","embryo development","limb development","skeletal dysplasia"],"nhmrc_grant_id":569713,"application_year":2008,"health_keywords":["bone development","congenital defects","congenital limb defects","craniofacial development","skeletal disease"],"scientific_title":"Dissecting the role of hedgehog signalling in chondrogenesis and skeletal disease","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Carol Wicking","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569713","simplified_title":"Analysis of mouse models of limb and face skeletogenesis","sub_type":"Standard Project Grant","total_budget":"408739.29","source_system":"There are close to 400 inherited disorders that affect how the skeleton develops, as well as a range of injury and age-related skeletal defects. There is much interest in treating such abnormalities with artificial bone grown outside the body. In order to achieve this aim we must understand all of the processes involved in producing and maintaining bone within the body. We are using both mouse and cell culture models of skeletal development to increase our understanding of these processes."},"children":[{"color":"#336699","name":"A/Pr Carol Wicking","data":{"first_name":"Carol","title":"A/Pr","dw_individual_id":"DW0028805","middle_name":"A","last_name":"Wicking","source_individual_id":"RMIS2473798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Carol Wicking"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84461","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64373","size":1},{"color":"#FF4D4D","name":"Pharmacodynamics in Liver Disease and in Liver Surgery","data":{"media_summary":"optimum treatment","end_year":2012,"keywords":["antioxidant","fibrosis","liver","pharmacodynamics","pharmacokinetics"],"nhmrc_grant_id":569710,"application_year":2008,"health_keywords":["liver cirrhosis","liver disease","liver transplantation","minimising adverse incidents","optimum treatment"],"scientific_title":"Pharmacodynamics in Liver Disease and in Liver Surgery","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Michael Roberts","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569710","simplified_title":"Pharmacodynamics in Liver Disease and in Liver Surgery","sub_type":"Standard Project Grant","total_budget":"899646.18","source_system":"The liver is the main organ in the body for drug metabolism and detoxification. This work seeks to address the poorly understood question: what is the in vivo disposition and response in liver of the drugs for treatment of liver diseases? The results of this work will help us better design new drugs and choose the most effective drugs for liver disease. The research may also help us find a better strategy for liver transplantation and thus improve success rates."},"children":[{"color":"#336699","name":"A/Pr Graeme Macdonald","data":{"first_name":"Graeme","title":"A/Pr","dw_individual_id":"DW0043925","middle_name":"Alistair","last_name":"Macdonald","source_individual_id":"5016107","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Graeme Macdonald"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88380","size":1},{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1},{"color":"#336699","name":"Prof Michael Weiss","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0028752","middle_name":"","last_name":"Weiss","source_individual_id":"5018257","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Weiss"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84444","size":1},{"color":"#336699","name":"A/Pr Luis Vitetta","data":{"first_name":"Luis","title":"A/Pr","dw_individual_id":"DW0028601","middle_name":"","last_name":"Vitetta","source_individual_id":"5018122","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Luis Vitetta"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84406","size":1},{"color":"#336699","name":"Prof Jonathan Fawcett","data":{"first_name":"Jonathan","title":"Prof","dw_individual_id":"DW0018949","middle_name":"","last_name":"Fawcett","source_individual_id":"RMIS4512205","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jonathan Fawcett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81850","size":1},{"color":"#336699","name":"Dr Linda Fletcher","data":{"first_name":"Linda","title":"Dr","dw_individual_id":"DW0013042","middle_name":"M","last_name":"Fletcher","source_individual_id":"5014660","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Linda Fletcher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80225","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64372","size":1},{"color":"#FF4D4D","name":"Development of purine nucleoside phosphonates as anti-malarial drugs targeting nuceloside synthesis in Plasmodium","data":{"media_summary":"","end_year":2012,"keywords":["Drug design","Enzyme inhibition","Protein crystallography","medicinal chemistry","parasitology"],"nhmrc_grant_id":569703,"application_year":2008,"health_keywords":["Infection control","Malaria","Parasitic disease"],"scientific_title":"Development of purine nucleoside phosphonates as anti-malarial drugs targeting nuceloside synthesis in Plasmodium","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Enzymes","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Luke Guddat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569703","simplified_title":"Discovery of new anti-malarial drugs","sub_type":"Standard Project Grant","total_budget":"428917.1","source_system":"Malaria is one of the most serious infectious diseases today. Because of its location in a malaria endemic region, the tropical regions (above 19 S in latitude) of Australia face an emerging threat. The causative agent of the disease is the parasite, Plasmodium. Because of increasing resistance to existing medicines, new drugs are now needed. The drugs we will develop target the parasites replication cycle and are related in structure to those in use to treat viral infections including AIDS."},"children":[{"color":"#336699","name":"Dr Tina Skinner-Adams","data":{"first_name":"Tina","title":"Dr","dw_individual_id":"DW0039729","middle_name":"S","last_name":"Skinner-Adams","source_individual_id":"5017563","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Tina Skinner-Adams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87303","size":1},{"color":"#336699","name":"A/Pr Lieve Naesens","data":{"first_name":"Lieve","title":"A/Pr","dw_individual_id":"DW0038705","middle_name":"Marie-Joseph","last_name":"Naesens","source_individual_id":"5016623","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Lieve Naesens"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87027","size":1},{"color":"#336699","name":"Prof Antonin Holy","data":{"first_name":"Antonin","title":"Prof","dw_individual_id":"DW0037346","middle_name":"","last_name":"Holy","source_individual_id":"5015308","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Antonin Holy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86676","size":1},{"color":"#336699","name":"A/Pr Luke Guddat","data":{"first_name":"Luke","title":"A/Pr","dw_individual_id":"DW0031041","middle_name":"William","last_name":"Guddat","source_individual_id":"RMIS1125097","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Luke Guddat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85040","size":1},{"color":"#336699","name":"Prof Ian Brereton","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0029590","middle_name":"","last_name":"Brereton","source_individual_id":"5011611","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Brereton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84666","size":1},{"color":"#336699","name":"E/Pr John De Jersey","data":{"first_name":"John","title":"E/Pr","dw_individual_id":"DW0018611","middle_name":"","last_name":"De Jersey","source_individual_id":"5014269","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"E/Pr John De Jersey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64371","size":1},{"color":"#FF4D4D","name":"Development of a new method of motor unit number estimation for use in motor neurone disease","data":{"media_summary":"","end_year":2012,"keywords":["biological markers","motor neuron disease","nerve excitability","neurophysiology"],"nhmrc_grant_id":569698,"application_year":2008,"health_keywords":["amyotrophic lateral sclerosis","motor neuron disease","neurological disease","neuronal degeneration"],"scientific_title":"Development of a new method of motor unit number estimation for use in motor neurone disease","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Pamela McCombe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569698","simplified_title":"Assessment of disease progression in MND","sub_type":"Standard Project Grant","total_budget":"480127.04","source_system":"This project aims to help understand motor neurone disease, which is a severe disease that leads to paralysis and death. In motor neurone disease there is of death of the nerve cells that maks muscles move. We have developed a new method of measuring the number of motor nerve cells. We will use this to study the different types of motor neurone disease."},"children":[{"color":"#336699","name":"Dr Mark Bellingham","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0035336","middle_name":"C","last_name":"Bellingham","source_individual_id":"5013441","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mark Bellingham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86159","size":1},{"color":"#336699","name":"Prof Pamela Mccombe","data":{"first_name":"Pamela","title":"Prof","dw_individual_id":"DW0032439","middle_name":"Ann","last_name":"Mccombe","source_individual_id":"RMIS5883","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Pamela Mccombe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85397","size":1},{"color":"#336699","name":"Dr Robert Henderson","data":{"first_name":"Robert","title":"Dr","dw_individual_id":"DW0019568","middle_name":"D","last_name":"Henderson","source_individual_id":"5015182","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Robert Henderson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81982","size":1},{"color":"#336699","name":"Dr Gareth Ridall","data":{"first_name":"Gareth","title":"Dr","dw_individual_id":"DW0015867","middle_name":"R","last_name":"Ridall","source_individual_id":"5017201","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Gareth Ridall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80997","size":1},{"color":"#336699","name":"Prof Tony Pettitt","data":{"first_name":"Tony","title":"Prof","dw_individual_id":"DW0003952","middle_name":"","last_name":"Pettitt","source_individual_id":"5012571","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Tony Pettitt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77771","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64370","size":1},{"color":"#FF4D4D","name":"Pharmacological Targeting of Arylamine N-Acetyltransferase I","data":{"media_summary":"","end_year":2012,"keywords":["Drug targeting","E-cadherin","Gene regulation","Pharmacology"],"nhmrc_grant_id":569695,"application_year":2008,"health_keywords":["Cancer","Drug development","Growth"],"scientific_title":"Pharmacological Targeting of Arylamine N-Acetyltransferase I","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Rodney Minchin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569695","simplified_title":"Novel target for new cancer treatemnt","sub_type":"Standard Project Grant","total_budget":"474653.24","source_system":"This project will investigate a novel approach to controlling how cancer cells grow and spread. It plans to study whether a protein termed N-acetyltransferase is a key to determining whether cancer cells can change thier characteristics, allowing them to invade other tissues. In addition, novel approaches to target this protein are proposed. If successful, the work outlined in this project will open new avenues to understanding and trerating cancers."},"children":[{"color":"#336699","name":"Dr Neville Butcher","data":{"first_name":"Neville","title":"Dr","dw_individual_id":"DW0029714","middle_name":"J","last_name":"Butcher","source_individual_id":"5013724","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Neville Butcher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84690","size":1},{"color":"#336699","name":"Prof Rodney Minchin","data":{"first_name":"Rodney","title":"Prof","dw_individual_id":"DW0026778","middle_name":"F","last_name":"Minchin","source_individual_id":"5016513","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Rodney Minchin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83936","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64369","size":1},{"color":"#FF4D4D","name":"The Toxicology of Nanomaterials","data":{"media_summary":"","end_year":2014,"keywords":["Pharmacokinetics","Pharmacology - toxicology","Toxicology"],"nhmrc_grant_id":569694,"application_year":2008,"health_keywords":["pharmacokinetics","pharmacology - toxicology","toxicity"],"scientific_title":"The Toxicology of Nanomaterials","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Toxicology (incl. Clinical Toxicology)","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Rodney Minchin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569694","simplified_title":"Toxicology of Nanomaterials","sub_type":"Standard Project Grant","total_budget":"1907006.04","source_system":"This application will investigate the potential for nanomaterials to have adverse effects on human health and to formulate approaches to screen nanomaterials for potential health risks, particularly those with a high likelihood for human exposure in Australia. Understanding how existing nanomaterials interact with biological systems will help determine the risk of adverse effects in the human population and identify those nanoparticles with little or no risk."},"children":[{"color":"#336699","name":"Prof Darren Martin","data":{"first_name":"Darren","title":"Prof","dw_individual_id":"DW0044044","middle_name":"J","last_name":"Martin","source_individual_id":"5016215","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Darren Martin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88414","size":1},{"color":"#336699","name":"A/Pr Lawrence Gahan","data":{"first_name":"Lawrence","title":"A/Pr","dw_individual_id":"DW0042526","middle_name":"R","last_name":"Gahan","source_individual_id":"5014758","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Lawrence Gahan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88027","size":1},{"color":"#336699","name":"Dr Suzanne Smith","data":{"first_name":"Suzanne","title":"Dr","dw_individual_id":"DW0039770","middle_name":"Virginia","last_name":"Smith","source_individual_id":"5011641","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Suzanne Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87307","size":1},{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1},{"color":"#336699","name":"Prof Rodney Minchin","data":{"first_name":"Rodney","title":"Prof","dw_individual_id":"DW0026778","middle_name":"F","last_name":"Minchin","source_individual_id":"5016513","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Rodney Minchin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83936","size":1},{"color":"#336699","name":"Prof Michael Monteiro","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0003460","middle_name":"J","last_name":"Monteiro","source_individual_id":"5016546","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Monteiro"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77625","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64368","size":1},{"color":"#FF4D4D","name":"Complement C5a Receptors , Placental Inflammation and Reproductive Impairment.","data":{"media_summary":"spontaneous abortion","end_year":2013,"keywords":["complement C5a antagonists","folic acid","inflammation","placenta","pre-eclampsia"],"nhmrc_grant_id":569693,"application_year":2008,"health_keywords":["autoimmune disease","foetal growth and development","intrauterine growth retardation","pre-eclampsia","spontaneous abortion"],"scientific_title":"Complement C5a Receptors , Placental Inflammation and Reproductive Impairment.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Stephen Taylor","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569693","simplified_title":"Inflammation of the womb during pregnancy and reproductive consequences","sub_type":"Standard Project Grant","total_budget":"1025229.02","source_system":"We are investigating how mothers may have health difficulties during pregnancy, such as high blood pressure, and how this can affect their fetuses' health. There is emerging evidence that an unhealthy placenta during pregnancy can greatly affect fetal development, and it seems that inflammation in the placenta during pregnancy may be a key factor in reducing fetal growth, resulting in low birth weight infants. Our studies are aimed at developing new treatments for this."},"children":[{"color":"#336699","name":"Prof Richard Finnell","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0024820","middle_name":"H","last_name":"Finnell","source_individual_id":"5014630","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Finnell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83380","size":1},{"color":"#336699","name":"Prof Leonie Callaway","data":{"first_name":"Leonie","title":"Prof","dw_individual_id":"DW0018070","middle_name":"Kaye","last_name":"Callaway","source_individual_id":"5013749","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Leonie Callaway"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81618","size":1},{"color":"#336699","name":"A/Pr Trent Woodruff","data":{"first_name":"Trent","title":"A/Pr","dw_individual_id":"DW0011172","middle_name":"Martin","last_name":"Woodruff","source_individual_id":"5018447","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Trent Woodruff"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79741","size":1},{"color":"#336699","name":"Prof Stephen Taylor","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0010587","middle_name":"M","last_name":"Taylor","source_individual_id":"RMIS41211","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79577","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64367","size":1},{"color":"#FF4D4D","name":"A novel tumour suppressor function of E2F7 in squamous cell carcinoma formation","data":{"media_summary":"","end_year":2011,"keywords":["carcinogenesis","epidermis","keratinocyte","squamous cell carcinoma"],"nhmrc_grant_id":569689,"application_year":2008,"health_keywords":["non-melanoma skin cancer","squamous cell carcinoma","squamous cell carcinoma of the head and neck"],"scientific_title":"A novel tumour suppressor function of E2F7 in squamous cell carcinoma formation","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Nicholas Saunders","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569689","simplified_title":"how squamous cancers form","sub_type":"Standard Project Grant","total_budget":"524124.18","source_system":"squamous cell carcinomas of the skin are the second most common skin cancer. In this proposal we present data showing that a new gene, E2F7, may play an important role in the development of squamous cell carcinoma. If true, these studies will identify a new therapeutic target that could be exploited in developing novel anticancer therapies."},"children":[{"color":"#336699","name":"A/Pr Nicholas Saunders","data":{"first_name":"Nicholas","title":"A/Pr","dw_individual_id":"DW0021953","middle_name":"A","last_name":"Saunders","source_individual_id":"5017363","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nicholas Saunders"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82651","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64366","size":1},{"color":"#FF4D4D","name":"Reliability of an Online Geriatric Assessment Procedure","data":{"media_summary":"residential care","end_year":2011,"keywords":["computer-based decision support","early diagnosis","electronic record linkage","geriatrics","telemedicine"],"nhmrc_grant_id":569688,"application_year":2008,"health_keywords":["acute care hospital","age-related diseases","frailty","rehabilitation","residential care"],"scientific_title":"Reliability of an Online Geriatric Assessment Procedure","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Geriatrics and Gerontology","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Len Gray","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569688","simplified_title":"Online Geriatric Assessment","sub_type":"Standard Project Grant","total_budget":"343822.76","source_system":"This study will examine the reliability, safety and cost of a novel new method of providing geriatrician assessment to older people in hospital. Nurses consult with the patient and enter their findings on a web-based software system that enables the geriatrician to review, report and make recommendations over the internet."},"children":[{"color":"#336699","name":"Prof Helen Edwards","data":{"first_name":"Helen","title":"Prof","dw_individual_id":"DW0042220","middle_name":"E","last_name":"Edwards","source_individual_id":"RMIS7227","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Helen Edwards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87949","size":1},{"color":"#336699","name":"Dr Melinda Martin-Khan","data":{"first_name":"Melinda","title":"Dr","dw_individual_id":"DW0032375","middle_name":"G","last_name":"Martin-Khan","source_individual_id":"5016241","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Melinda Martin-Khan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85382","size":1},{"color":"#336699","name":"Prof Peteris Darzins","data":{"first_name":"Peteris","title":"Prof","dw_individual_id":"DW0030254","middle_name":"","last_name":"Darzins","source_individual_id":"RMIS221263","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Peteris Darzins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84844","size":1},{"color":"#336699","name":"Prof Steven Counsell","data":{"first_name":"Steven","title":"Prof","dw_individual_id":"DW0030124","middle_name":"R","last_name":"Counsell","source_individual_id":"5014089","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Steven Counsell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84807","size":1},{"color":"#336699","name":"Prof Richard Wootton","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0023093","middle_name":"","last_name":"Wootton","source_individual_id":"5018481","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Wootton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82948","size":1},{"color":"#336699","name":"Prof Len Gray","data":{"first_name":"Len","title":"Prof","dw_individual_id":"DW0007585","middle_name":"Charles","last_name":"Gray","source_individual_id":"5012147","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Len Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78747","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64365","size":1},{"color":"#FF4D4D","name":"Development of Quality Indicators for the frail elderly in acute care","data":{"media_summary":"Quality of care","end_year":2010,"keywords":["Aged care","Frail elderly","Health services research","Outcome measurement"],"nhmrc_grant_id":569682,"application_year":2008,"health_keywords":["Acute care","Health outcomes","Health status","Prevention","Quality of care"],"scientific_title":"Development of Quality Indicators for the frail elderly in acute care","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Geriatrics and Gerontology","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Len Gray","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569682","simplified_title":"Development of Quality Indicators for the frail elderly in acute care","sub_type":"Standard Project Grant","total_budget":"372311.4","source_system":"Frail older people are particularly vulnerable to a range of mishaps while in hospital. Good care can reduce the frequency and extent of these problems. Quality indicators (QIs) assist hospitals, and clinical service units within them, to appraise their performance, and to compare it to other hospitals. QIs for the measurement of outcomes for the frail aged in the acute care setting do not exist in Australia or overseas. We aim to develop these indicators during this study."},"children":[{"color":"#336699","name":"Dr Richard Jones","data":{"first_name":"Richard","title":"Dr","dw_individual_id":"DW0043357","middle_name":"N","last_name":"Jones","source_individual_id":"5015548","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Richard Jones"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88234","size":1},{"color":"#336699","name":"Prof John Morris","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0032697","middle_name":"","last_name":"Morris","source_individual_id":"5016556","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Morris"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85471","size":1},{"color":"#336699","name":"Dr Olivia Wright","data":{"first_name":"Olivia","title":"Dr","dw_individual_id":"DW0028944","middle_name":"Renee","last_name":"Wright","source_individual_id":"5018501","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Olivia Wright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84504","size":1},{"color":"#336699","name":"Dr Caroline Brand","data":{"first_name":"Caroline","title":"Dr","dw_individual_id":"DW0017882","middle_name":"A","last_name":"Brand","source_individual_id":"5012635","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Caroline Brand"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81563","size":1},{"color":"#336699","name":"Prof Len Gray","data":{"first_name":"Len","title":"Prof","dw_individual_id":"DW0007585","middle_name":"Charles","last_name":"Gray","source_individual_id":"5012147","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Len Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78747","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64364","size":1},{"color":"#FF4D4D","name":"Molecular mechanisms that help organise effective synaptic transmission.","data":{"media_summary":"sarcopenia","end_year":2012,"keywords":["calcium channels","molecular neuroscience","nerve terminals","neuromuscular junction","synaptic transmission"],"nhmrc_grant_id":569680,"application_year":2008,"health_keywords":["motor neuron disease","muscle function deficits - loss of motor control","muscular dystrophy","neuromuscular diseases","sarcopenia"],"scientific_title":"Molecular mechanisms that help organise effective synaptic transmission.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Peter Noakes","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569680","simplified_title":"The role of laminins in the organization of nerve muscle contacts","sub_type":"Standard Project Grant","total_budget":"555824.99","source_system":"This study will test the idea that adhesion molecules alpha4- and beta2-laminin are needed for proper development and function of motor nerve - muscle connections. This study will provide insights into how such molecules control effective nerve-muscle communication, in both health and disease. We also believe that our results will provide the basic knowledge needed for identifying pharmacological targets that could improve such connections, and to promote reconnections between nerve and muscle."},"children":[{"color":"#336699","name":"A/Pr Peter Noakes","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0038807","middle_name":"G","last_name":"Noakes","source_individual_id":"5016732","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Noakes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87053","size":1},{"color":"#336699","name":"Dr Nickolas Lavidis","data":{"first_name":"Nickolas","title":"Dr","dw_individual_id":"DW0020288","middle_name":"Anastasios","last_name":"Lavidis","source_individual_id":"5015890","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nickolas Lavidis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82178","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64363","size":1},{"color":"#FF4D4D","name":"Molecular basis of asymptomatic colonization of the human urinary tract","data":{"media_summary":"","end_year":2012,"keywords":["Bacterial genetics","Bacterial pathogen","Biofilm","Infectious diseases","Virulence"],"nhmrc_grant_id":569676,"application_year":2008,"health_keywords":["Bacterial infection","Biofilm contamination on instruments and implants","Microbiology - pathogenesis","Urinary tract infection"],"scientific_title":"Molecular basis of asymptomatic colonization of the human urinary tract","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Mark Schembri","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569676","simplified_title":"Urinary tract infections caused by Escherichia coli","sub_type":"Standard Project Grant","total_budget":"461894.4","source_system":"Urinary tract infections (UTI) are among the most common infectious diseases of humans and a major cause of morbidity and mortality. In the USA, UTI accounts for >$1.6 billion in medical expenses each year. It is estimated that 50% of women will develop a UTI in their lifetime. This research aims to understand the processes by which bacteria colonize the human bladder and the surface of urinary catheters. The work has implications for the development of new approaches to prevent and treat UTI."},"children":[{"color":"#336699","name":"Prof Per Klemm","data":{"first_name":"Per","title":"Prof","dw_individual_id":"DW0031803","middle_name":"","last_name":"Klemm","source_individual_id":"5015726","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Per Klemm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85231","size":1},{"color":"#336699","name":"Prof Mark Schembri","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0016088","middle_name":"A","last_name":"Schembri","source_individual_id":"5017368","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Schembri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81054","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64362","size":1},{"color":"#FF4D4D","name":"Evolutionary events shaping the genome of Cryptococcus neoformans and their effects on pathogenesis","data":{"media_summary":"","end_year":2012,"keywords":["HIV-AIDS","evolution","fungal pathogens","infectious diseases","pathogenesis"],"nhmrc_grant_id":569673,"application_year":2008,"start_year":2009,"scientific_title":"Evolutionary events shaping the genome of Cryptococcus neoformans and their effects on pathogenesis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Mycology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr James Fraser","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569673","simplified_title":"Evolution of virulence in a pathogenic fungus","sub_type":"RD Wright Biomedical CDF","total_budget":"387489.51","source_system":"Recurring infection in patients with fungal meningitis caused by Cryptococcus neoformans is typically caused by persistence of the original infection rather than reinfection with a new strain. Our analysis of relapse strains shows that small-scale alterations frequently occur at the chromosome ends - regions containing important pathogenesis-related genes in other pathogens. We seek to characterise this microevolution further to understand how it contributes to the success of this pathogen."},"children":[{"color":"#336699","name":"A/Pr James Fraser","data":{"first_name":"James","title":"A/Pr","dw_individual_id":"DW0007343","middle_name":"Anthony","last_name":"Fraser","source_individual_id":"RMIS4444550","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr James Fraser"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78685","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64360","size":1},{"color":"#FF4D4D","name":"Value of central Blood Pressure for GUIDing managEment of hypertension (BP GUIDE Study)","data":{"media_summary":"","end_year":2012,"keywords":["Blood pressure","Hypertension","Therapy","Ventricular hypertrophy"],"nhmrc_grant_id":569669,"application_year":2008,"health_keywords":["Cardiovascular disease","Hypertension","Left ventricular hypertrophy"],"scientific_title":"Value of central Blood Pressure for GUIDing managEment of hypertension (BP GUIDE Study)","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr James Sharman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569669","simplified_title":"A study to determine the clinical value of measuring central blood pressure in patients with hypertension","sub_type":"Standard Project Grant","total_budget":"339553","source_system":"A pressure pulse may be felt at the wrist with every heart beat. New technology allows the analysis of this pulse and measurement of blood pressure (BP) at the heart (central BP) . This information may help doctors improve the decision making process regarding a patient's risk related to BP as well as the effect of drug treatment. The study aims to test this theory. It is expected that the new technology will improve the way people with high BP are identified and treated."},"children":[{"color":"#336699","name":"Prof Michael Stowasser","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022365","middle_name":"","last_name":"Stowasser","source_individual_id":"5017746","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Stowasser"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82770","size":1},{"color":"#336699","name":"A/Pr James Sharman","data":{"first_name":"James","title":"A/Pr","dw_individual_id":"DW0010203","middle_name":"E","last_name":"Sharman","source_individual_id":"5019538","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr James Sharman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79465","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64359","size":1},{"color":"#FF4D4D","name":"A novel marker of distressed neurons in the hypoxic brain: Regulation, function and potential clinical utility.","data":{"media_summary":"stroke-cerebral ischaemia","end_year":2011,"keywords":["NMDA","amino acid transport","hypoxia-ischaemia-reperfusion injury to the brain","neonatal","neuronal injury"],"nhmrc_grant_id":569666,"application_year":2008,"health_keywords":["brain ischaemia and traumatic injury","hypoxic-ischaemic encephalopathy","neonatal brain injury","neonatal seizures","stroke-cerebral ischaemia"],"scientific_title":"A novel marker of distressed neurons in the hypoxic brain: Regulation, function and potential clinical utility.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Prof David Pow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569666","simplified_title":"Investigating a protein that allows identification of distressed nerve cells in the brain","sub_type":"Standard Project Grant","total_budget":"526878.44","source_system":"The brain is easily damaged by lack of oxygen (hypoxia). We have recently identified a novel protein called GLAST1b which is expressed in distressed neurons. This protein is a glutamate transporter. Glutamate is implicated as a toxic agent hypoxia. This study will investigate what regulates the expression of GLAST1b, what the consequences of expression are, and whether this marker can be developed as a diagnostic tool for identifying the presence of, and distribution of brain damage."},"children":[{"color":"#336699","name":"Prof David Pow","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0021533","middle_name":"Vaughan","last_name":"Pow","source_individual_id":"RMIS4392155","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Pow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82534","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1},{"color":"#336699","name":"Prof Philip Poronnik","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0004031","middle_name":"","last_name":"Poronnik","source_individual_id":"RMIS7101816","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Philip Poronnik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77792","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64358","size":1},{"color":"#FF4D4D","name":"Characterizing novel therapeutic interventions in a new model of focal retinopathy","data":{"media_summary":"","end_year":2011,"keywords":["Macular degeneration","inflammation","macrophage","microhaemorrhage","neovascularisation"],"nhmrc_grant_id":569665,"application_year":2008,"health_keywords":["Age-related macular degeneration","diabetic retinopathy","retinal haemorrhage"],"scientific_title":"Characterizing novel therapeutic interventions in a new model of focal retinopathy","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Opthalmology and Vision Science","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Pow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569665","simplified_title":"Using a unique model of human retinal disease to test novel therapies","sub_type":"Standard Project Grant","total_budget":"536794.64","source_system":"Focal retinopathies such as age-related macular degeneration pose an immense burden on our society, both socially and economically. We have recently developed an animal model that allows us to investigate for the first time, drugs and therapies that might be used to treat AMD both after its onset, and more significantly, in at-risk populations before onset of the disease."},"children":[{"color":"#336699","name":"Prof Jan Provis","data":{"first_name":"Jan","title":"Prof","dw_individual_id":"DW0044936","middle_name":"M","last_name":"Provis","source_individual_id":"RMIS124997","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jan Provis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88635","size":1},{"color":"#336699","name":"Prof David Pow","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0021533","middle_name":"Vaughan","last_name":"Pow","source_individual_id":"RMIS4392155","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Pow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82534","size":1},{"color":"#336699","name":"A/Pr Anthony Kwan","data":{"first_name":"Anthony","title":"A/Pr","dw_individual_id":"DW0014304","middle_name":"","last_name":"Kwan","source_individual_id":"5015815","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Anthony Kwan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80563","size":1},{"color":"#336699","name":"A/Pr Nigel Barnett","data":{"first_name":"Nigel","title":"A/Pr","dw_individual_id":"DW0011632","middle_name":"L","last_name":"Barnett","source_individual_id":"5013343","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nigel Barnett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79858","size":1},{"color":"#336699","name":"A/Pr Trent Woodruff","data":{"first_name":"Trent","title":"A/Pr","dw_individual_id":"DW0011172","middle_name":"Martin","last_name":"Woodruff","source_individual_id":"5018447","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Trent Woodruff"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79741","size":1},{"color":"#336699","name":"Prof Stephen Taylor","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0010587","middle_name":"M","last_name":"Taylor","source_individual_id":"RMIS41211","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79577","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64357","size":1},{"color":"#FF4D4D","name":"The role of tumour-initiating cells in glioma","data":{"media_summary":"","end_year":2012,"keywords":["brain","cancer","cell cycle","neural stem cell"],"nhmrc_grant_id":569662,"application_year":2008,"health_keywords":["brain tumour","cancer biology","glioblastoma","glioma"],"scientific_title":"The role of tumour-initiating cells in glioma","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Angus Harding","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569662","simplified_title":"Brain Cancer Stem Cells","sub_type":"Standard Project Grant","total_budget":"363827.65","source_system":"The overall incidence of primary brain tumours in the Western world is 10 per 100,000 people. Unlike many other tumours, these occur in patients of all ages and comprise the second most common tumour type among children and young adults. Most brain tumours remain incurable. We are using our expertise in the field of neural stem cell research to characterise tumour cells responsible for resistance to treatment, with the final goal of identifying new targets for therapeutic intervention."},"children":[{"color":"#336699","name":"Dr Angus Harding","data":{"first_name":"Angus","title":"Dr","dw_individual_id":"DW0037105","middle_name":"S","last_name":"Harding","source_individual_id":"5015071","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Angus Harding"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86603","size":1},{"color":"#336699","name":"Prof Brent Reynolds","data":{"first_name":"Brent","title":"Prof","dw_individual_id":"DW0027570","middle_name":"A","last_name":"Reynolds","source_individual_id":"RMIS4373598","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brent Reynolds"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84115","size":1},{"color":"#336699","name":"A/Pr Brian Gabrielli","data":{"first_name":"Brian","title":"A/Pr","dw_individual_id":"DW0007391","middle_name":"G","last_name":"Gabrielli","source_individual_id":"5014734","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Brian Gabrielli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78693","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64356","size":1},{"color":"#FF4D4D","name":"Comparison of cognitive-behavioural treatments for children with PTSD following an accidental injury: A multi-site RCT.","data":{"media_summary":"Post traumatic stress disorder","end_year":2012,"keywords":["Child health","Cognitive behaviour","Mental health","Post traumatic stress disorder","Randomised control trial"],"nhmrc_grant_id":569660,"application_year":2008,"health_keywords":["Accidental injury","Child health","Family-centered intervention","Mental health, quality of life","Post traumatic stress disorder"],"scientific_title":"Comparison of cognitive-behavioural treatments for children with PTSD following an accidental injury: A multi-site RCT.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Health, Clinical and Counselling Psychology","research_area":"Public Health","for_category":"PSYCHOLOGY","cia_name":"Prof Justin Kenardy","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569660","simplified_title":"Treating children with PTSD following an accidental injury: A multi-site RCT.","sub_type":"Standard Project Grant","total_budget":"359111.93","source_system":"Children who experience a traumatic event are at increased risk of developing Post traumatic stress disorder (PTSD). Despite the significant consequences, and the poor prognosis of this disorder, few evaluations of interventions for PTSD in children exist. This project will compare two active treatments (child vs. family-focused cognitive behaviour therapy) for children experiencing PTSD following an accidental injury (the most common category of traumatic events experienced by children)."},"children":[{"color":"#336699","name":"A/Pr Reginald Nixon","data":{"first_name":"Reginald","title":"A/Pr","dw_individual_id":"DW0038805","middle_name":"Dv","last_name":"Nixon","source_individual_id":"5016717","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Reginald Nixon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87051","size":1},{"color":"#336699","name":"Prof Justin Kenardy","data":{"first_name":"Justin","title":"Prof","dw_individual_id":"DW0037727","middle_name":"Alastair","last_name":"Kenardy","source_individual_id":"RMIS53308","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Justin Kenardy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86768","size":1},{"color":"#336699","name":"A/Pr Brett Mcdermott","data":{"first_name":"Brett","title":"A/Pr","dw_individual_id":"DW0008994","middle_name":"Michael","last_name":"Mcdermott","source_individual_id":"5016302","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Brett Mcdermott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79138","size":1},{"color":"#336699","name":"Dr Vanessa Cobham","data":{"first_name":"Vanessa","title":"Dr","dw_individual_id":"DW0006638","middle_name":"","last_name":"Cobham","source_individual_id":"5020176","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Vanessa Cobham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78504","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64355","size":1},{"color":"#FF4D4D","name":"Understanding changes in the mammalian prenylome induced by statins and prenyltransferase inhibitors","data":{"media_summary":"vision disorders, blindness","end_year":2011,"keywords":["GTP-binding protein","isoprenoids","membrane signaling","protein prenyltransferases","signal transduction"],"nhmrc_grant_id":569652,"application_year":2008,"health_keywords":["anticancer drug action","coronary artery disease","immune-mediated inflammation","inhibition of osteoclastogenesis","vision disorders, blindness"],"scientific_title":"Understanding changes in the mammalian prenylome induced by statins and prenyltransferase inhibitors","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Kirill Alexandrov","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569652","simplified_title":"Understanding drug induced changes in protein prenylation","sub_type":"Standard Project Grant","total_budget":"566308.79","source_system":"Prenylation, the covalent attachment of isoprenoid lipids to proteins, is widespread in mammalian cells. Essential for a protein's normal function, it contributes to the progression of cancer and inflammation. We have developed a novel technology to identify all prenylated proteins in the cell. Aided by this method, we will analyse the effect of statins and anti-cancer drugs on protein prenylation. This will provide guidance in identifying a more effective clinical use for them."},"children":[{"color":"#336699","name":"Daniel Abankwa","data":{"first_name":"Daniel","title":"","dw_individual_id":"DW0040716","middle_name":"","last_name":"Abankwa","source_individual_id":"5011535","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Daniel Abankwa"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87557","size":1},{"color":"#336699","name":"Prof Kirill Alexandrov","data":{"first_name":"Kirill","title":"Prof","dw_individual_id":"DW0005768","middle_name":"","last_name":"Alexandrov","source_individual_id":"5011534","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Kirill Alexandrov"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78275","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64354","size":1},{"color":"#FF4D4D","name":"Modulation of endosomes for pathogen invasion","data":{"media_summary":"","end_year":2011,"keywords":["Endocytosis","Endosomes","Phospholipids","Protein Trafficking"],"nhmrc_grant_id":569648,"application_year":2008,"health_keywords":["Bacterial Pathogen","Infectious Diseases","Salmonellosis"],"scientific_title":"Modulation of endosomes for pathogen invasion","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Rohan Teasdale","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569648","simplified_title":"Host pathogen interactions","sub_type":"Standard Project Grant","total_budget":"490610.84","source_system":"Infectious pathogens invade cells by hijacking cellular pathways, termed endocytosis, that normally internalise material from outside the cell. We will identify the molecular details of these pathways and how they are modulated in response to infection with Salmonella, a leading cause of human gastroenteritis. Such studies are necessary in order to understand host-pathogen interactions so that treatments can be developed targeting the symptoms of infection"},"children":[{"color":"#336699","name":"A/Pr Rohan Teasdale","data":{"first_name":"Rohan","title":"A/Pr","dw_individual_id":"DW0040022","middle_name":"D","last_name":"Teasdale","source_individual_id":"5017848","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Rohan Teasdale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87368","size":1},{"color":"#336699","name":"Dr Markus Kerr","data":{"first_name":"Markus","title":"Dr","dw_individual_id":"DW0025954","middle_name":"C","last_name":"Kerr","source_individual_id":"5015672","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Markus Kerr"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83697","size":1},{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64353","size":1},{"color":"#FF4D4D","name":"Calcium Influx Pathways and Breast Cancer","data":{"media_summary":"","end_year":2012,"keywords":["breast cancer","calcium channels","calcium imaging","calcium signaling","molecular pharmacology"],"nhmrc_grant_id":569645,"application_year":2008,"health_keywords":["breast cancer","calcium","cancer","drug target"],"scientific_title":"Calcium Influx Pathways and Breast Cancer","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Gregory Monteith","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569645","simplified_title":"Exploiting the way in which calcium enters the breast cancer cell as a potential cancer therapy","sub_type":"Standard Project Grant","total_budget":"398352.39","source_system":"Calcium acts as a signal to control cell processes important in cancer. The entry of calcium into the cell is regulated by calcium channels and we have found some channels are over-expressed in breast cancer. Altering the expression and activity of these calcium channels is a possible therapeutic approach for cancer. We will determine the reasons and consequences of alterations of calcium channels in breast cancer and whether they are viable anti-cancer therapies and biomarkers."},"children":[{"color":"#336699","name":"Dr Marie-Odile Parat","data":{"first_name":"Marie-Odile","title":"Dr","dw_individual_id":"DW0044700","middle_name":"","last_name":"Parat","source_individual_id":"5016847","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Marie-Odile Parat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88561","size":1},{"color":"#336699","name":"Dr Peter Simpson","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0033829","middle_name":"T","last_name":"Simpson","source_individual_id":"5017520","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Peter Simpson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85762","size":1},{"color":"#336699","name":"Prof Gregory Monteith","data":{"first_name":"Gregory","title":"Prof","dw_individual_id":"DW0009187","middle_name":"Raymond","last_name":"Monteith","source_individual_id":"RMIS3112522","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gregory Monteith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79194","size":1},{"color":"#336699","name":"Prof Sarah Roberts-Thomson","data":{"first_name":"Sarah","title":"Prof","dw_individual_id":"DW0004272","middle_name":"Jane","last_name":"Roberts-Thomson","source_individual_id":"RMIS5900691","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Sarah Roberts-Thomson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77861","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64352","size":1},{"color":"#FF4D4D","name":"A comprehensive analysis of Myb target genes involved in myelopoiesis and myeloid transformation","data":{"media_summary":"","end_year":2011,"keywords":["Myb oncogene","gene regulation","micro RNA","microarray","myelopoiesis"],"nhmrc_grant_id":569639,"application_year":2008,"health_keywords":["breast cancer","colon cancer","leukaemia"],"scientific_title":"A comprehensive analysis of Myb target genes involved in myelopoiesis and myeloid transformation","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Thomas Gonda","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569639","simplified_title":"Understanding how the Myb cancer gene acts in blood cell formation and leukaemia","sub_type":"Standard Project Grant","total_budget":"511294.64","source_system":"The MYB gene is essential for both normal blood cell formation and the growth of leukaemia cells. It acts by switching other genes (target genes) on and off. This project aims to advance our understanding of how MYB functions, by carrying out a comprehensive search for MYB target genes. In particular it will focus on target genes that help explain MYB's ability to control cellular growth and maturation. Some of these target genes may provide leads for future anti-cancer drug development."},"children":[{"color":"#336699","name":"Prof Thomas Gonda","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0007535","middle_name":"John","last_name":"Gonda","source_individual_id":"5014863","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Thomas Gonda"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78737","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64351","size":1},{"color":"#FF4D4D","name":"Neogenin regulates progenitor division and interneuron migration in the developing forebrain","data":{"media_summary":"","end_year":2011,"keywords":["cell division","developmental neurobiology","molecular neuroscience","neural migration","neurogenesis"],"nhmrc_grant_id":569638,"application_year":2008,"health_keywords":["brain development","cell signalling","mental retardation","neuron pathfinding-fasciculation"],"scientific_title":"Neogenin regulates progenitor division and interneuron migration in the developing forebrain","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Helen Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569638","simplified_title":"Neogenin controls development of the embryonic brain","sub_type":"Standard Project Grant","total_budget":"526878.44","source_system":"In humans, mutations in genes controlling the production of new neurons in the embryonic brain result in severe disruption of the adult cortex. This project tests the hypothesis that one cell surface molecule, Neogenin, regulates the birth of new neurons and their subsequent travels through the developing brain to form the neocortex. The outcome of these studies will provide fundamental insights into the aberrant processes that underlie human mental retardation, epilepsy, dyslexia and autism."},"children":[{"color":"#336699","name":"Prof Brent Reynolds","data":{"first_name":"Brent","title":"Prof","dw_individual_id":"DW0027570","middle_name":"A","last_name":"Reynolds","source_individual_id":"RMIS4373598","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brent Reynolds"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84115","size":1},{"color":"#336699","name":"A/Pr Helen Cooper","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0018393","middle_name":"M","last_name":"Cooper","source_individual_id":"RMIS222363","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Helen Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81710","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64350","size":1},{"color":"#FF4D4D","name":"The genetics of cognitive deficits in attention deficit hyperactivity disorder (ADHD)","data":{"media_summary":"","end_year":2011,"keywords":["attention deficit hyperactivity disorder (ADHD)","attention deficits","cognitive impairment","inattention"],"nhmrc_grant_id":569636,"application_year":2008,"health_keywords":["Attention Deficit Hyperactivity Disorder (ADHD)","attention deficits","cognitive deficits","neuropsychological impairments"],"scientific_title":"The genetics of cognitive deficits in attention deficit hyperactivity disorder (ADHD)","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biological Psychology (Neuropsychology, Psychopharmacology, Physiological **Psychology)","research_area":"Basic Science","for_category":"PSYCHOLOGY","cia_name":"Prof Mark Bellgrove","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569636","simplified_title":"The genetics of cognition in ADHD","sub_type":"Standard Project Grant","total_budget":"675512.73","source_system":"Attention deficit hyperactivity disorder (ADHD) is a common psychiatric disorder of childhood that is marked by age-inappropriate levels of inattention and-or hyperactivity-impulsivity. The disorder appears genetic with a number of different genes likely contributing risk for ADHD. This project takes an innovative approach by asking whether there are different genetic profiles associated with children with ADHD who do or do not have neurocognitive deficits."},"children":[{"color":"#336699","name":"Prof David Hay","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0042955","middle_name":"Alexander","last_name":"Hay","source_individual_id":"5015154","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Hay"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88129","size":1},{"color":"#336699","name":"A/Pr Helen Heussler","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0031281","middle_name":"S","last_name":"Heussler","source_individual_id":"5015212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Helen Heussler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85096","size":1},{"color":"#336699","name":"A/Pr Alasdair Vance","data":{"first_name":"Alasdair","title":"A/Pr","dw_individual_id":"DW0028549","middle_name":"L","last_name":"Vance","source_individual_id":"5018058","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Alasdair Vance"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84388","size":1},{"color":"#336699","name":"Prof Jason Mattingley","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0020682","middle_name":"Brett","last_name":"Mattingley","source_individual_id":"RMIS123930","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jason Mattingley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82287","size":1},{"color":"#336699","name":"Dr Robyn Wallace","data":{"first_name":"Robyn","title":"Dr","dw_individual_id":"DW0016908","middle_name":"H","last_name":"Wallace","source_individual_id":"5018180","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Robyn Wallace"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81301","size":1},{"color":"#336699","name":"Prof Mark Bellgrove","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0000316","middle_name":"Andrew","last_name":"Bellgrove","source_individual_id":"5013434","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Bellgrove"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76741","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64349","size":1},{"color":"#FF4D4D","name":"Improving Outcomes for Premature Infants Through Effective Maintenance of Systemic Blood Flow","data":{"media_summary":"","end_year":2012,"keywords":["blood flow","blood pressure","endocrine factors","neonatal","premature birth"],"nhmrc_grant_id":569635,"application_year":2008,"health_keywords":["hypotension","infant, premature","low cardiac output","neurodevelopmental impairment, cerebral palsy"],"scientific_title":"Improving Outcomes for Premature Infants Through Effective Maintenance of Systemic Blood Flow","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Foetal Development and Medicine","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Barbara Lingwood","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569635","simplified_title":"Low systemic blood flow in preterm infants","sub_type":"Standard Project Grant","total_budget":"789383.74","source_system":"Survival rates for preterm babies are increasing, but the rate of disability is still high. Preterm babies may experience inadequate blood flow to the brain, leading to longterm disability. The causes of low blood flow are not known and current treatments are ineffective in nearly half of cases. This study will confirm that low blood flow is the result of immaturity of the structure and-or control of the heart, and will test new treatments targeted to these systems in the baby."},"children":[{"color":"#336699","name":"Dr Barbara Lingwood","data":{"first_name":"Barbara","title":"Dr","dw_individual_id":"DW0043819","middle_name":"Elizabeth","last_name":"Lingwood","source_individual_id":"5016005","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Barbara Lingwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88355","size":1},{"color":"#336699","name":"A/Pr David Osborn","data":{"first_name":"David","title":"A/Pr","dw_individual_id":"DW0038907","middle_name":"A","last_name":"Osborn","source_individual_id":"5016826","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr David Osborn"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87083","size":1},{"color":"#336699","name":"E/Pr Eugenie Lumbers","data":{"first_name":"Eugenie","title":"E/Pr","dw_individual_id":"DW0032221","middle_name":"Ruth","last_name":"Lumbers","source_individual_id":"5016098","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"E/Pr Eugenie Lumbers"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85340","size":1},{"color":"#336699","name":"A/Pr Nicholas Evans","data":{"first_name":"Nicholas","title":"A/Pr","dw_individual_id":"DW0007178","middle_name":"J","last_name":"Evans","source_individual_id":"RMIS218851","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Nicholas Evans"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78635","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64348","size":1},{"color":"#FF4D4D","name":"Interstitially Invasive Trophoblast of the Murine Placenta: Developmental Origins, Functions and Gene Expression.","data":{"media_summary":"pregnancy complications","end_year":2012,"keywords":["invasion and metastases","mother-infant interaction","placenta","transgenic animals","trophoblast"],"nhmrc_grant_id":569618,"application_year":2008,"health_keywords":["invasion","maternal and child health","placental implantation","placentation","pregnancy complications"],"scientific_title":"Interstitially Invasive Trophoblast of the Murine Placenta: Developmental Origins, Functions and Gene Expression.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Reproduction","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr David Simmons","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569618","simplified_title":"Understanding trophoblast invasion in mice: modeling human placental development and disease","sub_type":"New Investigator Grant","total_budget":"369717.44","source_system":"Due to the obvious limitations to studying human pregnancy, the mouse has become a valuable model. However, invasion of the placenta into the uterine wall and vasculature, critical for successful pregnancy, is poorly understood in the mouse. The aims of the proposal are designed to gain a better understanding of these processes in mice and will provide a more accurate model system to study serious pregnancy complications resulting from abnormal placental invasion, such as preeclampsia."},"children":[{"color":"#336699","name":"Dr David Simmons","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0022129","middle_name":"G","last_name":"Simmons","source_individual_id":"5017525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David Simmons"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82698","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64346","size":1},{"color":"#FF4D4D","name":"An oral loading test to predict susceptibility to fluoropyrimidine drug toxicity","data":{"media_summary":"side-effects","end_year":2011,"keywords":["drug metabolism","drug toxicity","genetic polymorphisms","pharmacokinetics","screening"],"nhmrc_grant_id":569611,"application_year":2008,"health_keywords":["breast cancer","cancer chemotherapy","colorectal cancer","gynaecological cancers","side-effects"],"scientific_title":"An oral loading test to predict susceptibility to fluoropyrimidine drug toxicity","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr John Duley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569611","simplified_title":"Predicting drug toxicity","sub_type":"Standard Project Grant","total_budget":"225525.5","source_system":"Side-effects from anticancer drugs can be unpleasant, but may be deadly if a patient's genes are wrong for the drugs. A common chemotherapy drug, fluorouracil, can be very dangerous, but there's no simple way to predict this. We developed a simple test in which a small amount of a natural chemical is swallowed before chemotherapy. The results should allow the doctor to predict if a patient will suffer serious side effects on fluorouracil, so the dose can be reduced, or another drug tried."},"children":[{"color":"#336699","name":"Prof Peter George","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0036810","middle_name":"M","last_name":"George","source_individual_id":"5014807","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter George"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86535","size":1},{"color":"#336699","name":"Dr Catherine Shannon","data":{"first_name":"Catherine","title":"Dr","dw_individual_id":"DW0022054","middle_name":"M","last_name":"Shannon","source_individual_id":"5017467","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Catherine Shannon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82683","size":1},{"color":"#336699","name":"A/Pr Leslie Sheffield","data":{"first_name":"Leslie","title":"A/Pr","dw_individual_id":"DW0010213","middle_name":"Jon","last_name":"Sheffield","source_individual_id":"5017464","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Leslie Sheffield"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79467","size":1},{"color":"#336699","name":"Dr John Duley","data":{"first_name":"John","title":"Dr","dw_individual_id":"DW0007066","middle_name":"Alexander","last_name":"Duley","source_individual_id":"5012691","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr John Duley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78611","size":1},{"color":"#336699","name":"A/Pr Ross Norris","data":{"first_name":"Ross","title":"A/Pr","dw_individual_id":"DW0003706","middle_name":"Leslie Greenland","last_name":"Norris","source_individual_id":"5012680","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ross Norris"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77694","size":1},{"color":"#336699","name":"A/Pr Bruce Charles","data":{"first_name":"Bruce","title":"A/Pr","dw_individual_id":"DW0000818","middle_name":"","last_name":"Charles","source_individual_id":"RMIS24960","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Bruce Charles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76890","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64345","size":1},{"color":"#FF4D4D","name":"Longitudinal growth, nutrition and physical activity in young children with Cerebral Palsy","data":{"media_summary":"","end_year":2015,"keywords":["Child Nutrition and Growth","Natural History","Neurodevelopmental impairment, Cerebral Palsy","Nutrition Status","Physical Activity"],"nhmrc_grant_id":569605,"application_year":2008,"health_keywords":["Cerebral Palsy","Improving the Physical health of those with a disability","Nutrition Status","Relation between nutrition and disease"],"scientific_title":"Longitudinal growth, nutrition and physical activity in young children with Cerebral Palsy","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Prof Peter Davies","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569605","simplified_title":"Longitudinal growth and physical activity in Cerebral Palsy","sub_type":"Standard Project Grant","total_budget":"686147.89","source_system":"Cerebral palsy is the most common type of physical disability impacting on 1 in 500 children, with lifetime costs of $2m and up to 40% may have restricted growth and nutrition. We aim to follow a cohort of 240 young children with Cerebral Palsy from 18 mths to 5 years to monitor their growth, nutrition, habitual activity, body composition and relate this to comprehensive health outcomes and costs. Better knowledge of these factors will enable nutritional and medical care to be better focused."},"children":[{"color":"#336699","name":"Dr Sean Tweedy","data":{"first_name":"Sean","title":"Dr","dw_individual_id":"DW0045948","middle_name":"M","last_name":"Tweedy","source_individual_id":"5018024","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sean Tweedy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88898","size":1},{"color":"#336699","name":"Prof Roslyn Boyd","data":{"first_name":"Roslyn","title":"Prof","dw_individual_id":"DW0041223","middle_name":"N","last_name":"Boyd","source_individual_id":"RMIS1681246","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roslyn Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87689","size":1},{"color":"#336699","name":"Dr Kristie Bell","data":{"first_name":"Kristie","title":"Dr","dw_individual_id":"DW0023569","middle_name":"","last_name":"Bell","source_individual_id":"5013442","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kristie Bell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83059","size":1},{"color":"#336699","name":"Prof Peter Davies","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0018572","middle_name":"Sw","last_name":"Davies","source_individual_id":"5014241","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Davies"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81758","size":1},{"color":"#336699","name":"Prof Richard Stevenson","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0016437","middle_name":"D","last_name":"Stevenson","source_individual_id":"5017708","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Stevenson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81165","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64344","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2012,"keywords":["Anti-tumour drugs, Basic science","Biochemistry protein peptide, Medicinal chemistr","Cancer chemotherapeutic agents","Drug Design, Protein structure","Nuclear magnetic resonance (NMR)"],"nhmrc_grant_id":569603,"application_year":2008,"start_year":2009,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569603","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"414596.77","source_system":"I am a structural biologist specialising in nuclear magnetic resonance spectroscopy who is primarily studying the properties and applications of proteins and peptides in drug design."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64343","size":1},{"color":"#FF4D4D","name":"Molecular mechanisms of neuronal survival","data":{"media_summary":"","end_year":2013,"keywords":["molecular mechanisms","neurodegeneration","neurotransmission","neurotrophic factor"],"nhmrc_grant_id":569601,"application_year":2008,"start_year":2009,"scientific_title":"Molecular mechanisms of neuronal survival","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Elizabeth Coulson","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569601","simplified_title":"Mechanisms of neuronal survival","sub_type":"RD Wright Biomedical CDF","total_budget":"428602.7","source_system":"Nerve cell survival is dependent on both growth-promoting factors and factors released by neurotransmission, which can promote recovery in neurodegenerative conditions by overriding cell death pathways. The molecule responsible for activating death pathways in the nervous system is called p75. This project will investigate how p75 results in cell death, how synaptic signals can prevent the activation of the p75 death pathway and whether blocking p75 function can limit neurodegeneration."},"children":[{"color":"#336699","name":"A/Pr Elizabeth Coulson","data":{"first_name":"Elizabeth","title":"A/Pr","dw_individual_id":"DW0006736","middle_name":"J","last_name":"Coulson","source_individual_id":"5014079","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Elizabeth Coulson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78524","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64342","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2013,"keywords":["Alzheimer's disease and normal ageing","Neurodegenerative disease, neurotransmission","SNARE proteins, lipid","Vesicle trafficking, membrane fusion, exocytosis","gene therapy, motor neuron disease"],"nhmrc_grant_id":569596,"application_year":2008,"start_year":2009,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Neurochemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Frederic Meunier","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569596","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"580751.93","source_system":"I am a neuroscientist-cell biologist determining the dynamics of molecular events underlying vesicular exocytosis during synaptic transmission."},"children":[{"color":"#336699","name":"Prof Frederic Meunier","data":{"first_name":"Frederic","title":"Prof","dw_individual_id":"DW0020864","middle_name":"A","last_name":"Meunier","source_individual_id":"5016455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frederic Meunier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82341","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64341","size":1},{"color":"#FF4D4D","name":"Protease Activated Receptor 2 : A New Drug Target For Inflammatory Diseases and Cancer","data":{"media_summary":"","end_year":2012,"keywords":["Agonist and Antagonist","Molecular pharmacology","Peptide mimics","Protease Activated Receptor","Proteins and Enzymes"],"nhmrc_grant_id":569595,"application_year":2008,"health_keywords":["arthritis","cancers","inflammatory diseases"],"scientific_title":"Protease Activated Receptor 2 : A New Drug Target For Inflammatory Diseases and Cancer","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569595","simplified_title":"Finding new antiinflammatory and anticancer drugs that bind to the surfaces of human cells","sub_type":"Standard Project Grant","total_budget":"739434.88","source_system":"A new class of proteins (Protease Activated Receptors) has been found on the surfaces of many different types of cells. They are believed to be natural sensors that respond to traces of degradative enzymes called proteases. This project will create and evaluate new drugs for one of these receptors thought to regulate inflammatory diseases (e.g. arthritis, inflammatory bowel disease, asthma, pancreatitis) and cancers, while providing a better understanding of a new mechanism of immune defence."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64340","size":1},{"color":"#FF4D4D","name":"ATM Activation and its functional Importance in DNA damage response","data":{"media_summary":"Genetic Defect","end_year":2011,"keywords":["Cancer and Related Disorders","Cre-lox knockin mice","DNA damage","Phosphorylation","Radiation Biology"],"nhmrc_grant_id":569591,"application_year":2008,"health_keywords":["Ataxia telangiectasia","Biochemistry and molecular biology","Cerebellar disorder","Chromosomal Disorders","Genetic Defect"],"scientific_title":"ATM Activation and its functional Importance in DNA damage response","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569591","simplified_title":"Activation of the protein kinase ATM","sub_type":"Standard Project Grant","total_budget":"555541.19","source_system":"ATM is the protein deficient in the human genetic disorder ataxia-telangiectasia (A-T). This syndrome is characterised by neurodegeneration and increased risk of cancer. ATM recognises damage in DNA and facilitates its repair to minimize the risk of genetic defects. The project is designed to investigate the mechanism of activation of ATM. This information is important to understand the role of ATM in preventing cancer."},"children":[{"color":"#336699","name":"Dr Sergei Kozlov","data":{"first_name":"Sergei","title":"Dr","dw_individual_id":"DW0031855","middle_name":"","last_name":"Kozlov","source_individual_id":"5015768","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sergei Kozlov"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85243","size":1},{"color":"#336699","name":"Dr Mark Graham","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0030979","middle_name":"Evan","last_name":"Graham","source_individual_id":"5014904","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mark Graham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85030","size":1},{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64339","size":1},{"color":"#FF4D4D","name":"Development and refinement of neural connections in the adult brain in health and disease","data":{"media_summary":"","end_year":2013,"keywords":["molecular neuroscience, neurogenesis","nervous system disorders, neurotransmission","neural plasticity, learning and memory, mental health","neuronal degeneration and loss of brain function","transgenic animals, neuronal regeneration"],"nhmrc_grant_id":569575,"application_year":2008,"start_year":2009,"scientific_title":"Development and refinement of neural connections in the adult brain in health and disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Perry Bartlett","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/569575","simplified_title":"Regeneration and repair of the adult brain","sub_type":"Program Grant","total_budget":"8061595.75","source_system":"Our group will use innovative approaches such as advanced imaging and cell-sorting and development of animal models to determine how new neurons are generated, how they travel to different parts of the brain and how they integrate into the existing brain circuitry. These discoveries will point to new ways in which to treat brain damage both during ageing and during pathology. Since team members have previously been involved in progressing molecular discovery to clinical trials, we are also in a good position to exploit these discoveries in partnership with the biopharmaceutical industry."},"children":[{"color":"#336699","name":"Prof Pankaj Sah","data":{"first_name":"Pankaj","title":"Prof","dw_individual_id":"DW0033583","middle_name":"","last_name":"Sah","source_individual_id":"5017304","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Pankaj Sah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85693","size":1},{"color":"#336699","name":"Prof Seong-Seng Tan","data":{"first_name":"Seong-Seng","title":"Prof","dw_individual_id":"DW0028290","middle_name":"","last_name":"Tan","source_individual_id":"5017816","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Seong-Seng Tan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84311","size":1},{"color":"#336699","name":"Prof Trevor Kilpatrick","data":{"first_name":"Trevor","title":"Prof","dw_individual_id":"DW0025980","middle_name":"John","last_name":"Kilpatrick","source_individual_id":"5012199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Trevor Kilpatrick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83706","size":1},{"color":"#336699","name":"Prof Perry Bartlett","data":{"first_name":"Perry","title":"Prof","dw_individual_id":"DW0011651","middle_name":"Francis","last_name":"Bartlett","source_individual_id":"5013357","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Perry Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79864","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64338","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2013,"keywords":["Ion channels, synaptic transmission","Movement disorders","chronic back pain","molecular pharmacology, drug discovery","pain transmission"],"nhmrc_grant_id":569570,"application_year":2008,"start_year":2009,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Joseph Lynch","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569570","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"641678.02","source_system":"I am a molecular physiologist investigating the structure and function of the inhibitory neurotransmitter glycine receptor (GlyR) and GABA type- A receptor (GABAAR) chloride channels. We are interested in understanding how these receptors open and close"},"children":[{"color":"#336699","name":"Prof Joseph Lynch","data":{"first_name":"Joseph","title":"Prof","dw_individual_id":"DW0032228","middle_name":"W","last_name":"Lynch","source_individual_id":"5016080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Joseph Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85342","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64337","size":1},{"color":"#FF4D4D","name":"Modulation of Calcium Signalling by Acetylcholine in the Basolateral Amygdala","data":{"media_summary":"post-traumatic stress disorder (PTSD)","end_year":2011,"keywords":["acetylcholine","amygdala","calcium signalling","neurophysiology","synaptic plasticity"],"nhmrc_grant_id":569564,"application_year":2008,"health_keywords":["Alzheimer's disease","addiction","anxiety","phobias","post-traumatic stress disorder (PTSD)"],"scientific_title":"Modulation of Calcium Signalling by Acetylcholine in the Basolateral Amygdala","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr John Power","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569564","simplified_title":"How Acetylcholine Affects the Signalling Molecule Calcium in the Amygdala: Implications for Anxiety Disorders","sub_type":"New Investigator Grant","total_budget":"266748.1","source_system":"The amygdala is an area of the brain involved in assigning emotional significance to sensory stimuli. This grant examines the cellular processes involved in making these associations. Specifically, it studies the relationship between two signalling molecules implicated in association learning, acetylcholine and calcium. This research will test hypotheses of memory formation and provide insight into disorders linked to detrimental emotional associations, such as anxiety and addiction."},"children":[{"color":"#336699","name":"Dr John Power","data":{"first_name":"John","title":"Dr","dw_individual_id":"DW0004060","middle_name":"M","last_name":"Power","source_individual_id":"5017024","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr John Power"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77801","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64336","size":1},{"color":"#FF4D4D","name":"Practitioner Fellowship","data":{"media_summary":"","end_year":2013,"keywords":["Disease aetiology","Endoplasmic reticulum, Biochemical pharmacology","Greater chance of benefiting from treatment","Inflammatory bowel disease, Enteric infections","Ulcerative colitis, Enteric bacteria, Mucins"],"nhmrc_grant_id":569562,"application_year":2008,"start_year":2009,"scientific_title":"Practitioner Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gastroenterology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Timothy Florin","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569562","simplified_title":"Practitioner Fellowship","sub_type":"Practitioner Fellowship","total_budget":"311763.75","source_system":"I am a gastroenterologist working in the area of IBD. My novel research looks at disease aetiology and better treatment outcomes for IBD patients"},"children":[{"color":"#336699","name":"Prof Timothy Florin","data":{"first_name":"Timothy","title":"Prof","dw_individual_id":"DW0013048","middle_name":"H","last_name":"Florin","source_individual_id":"5014662","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Timothy Florin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80228","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64335","size":1},{"color":"#FF4D4D","name":"Recycling endosomes governing cell polarity and cytokine secretion.","data":{"media_summary":"","end_year":2014,"keywords":["cytokine secretion","endosomes","epithelial cells","macrophage","protein trafficking"],"nhmrc_grant_id":569543,"application_year":2008,"health_keywords":["arthritis, rheumatoid","inflammation","inflammatory bowel disease"],"scientific_title":"Recycling endosomes governing cell polarity and cytokine secretion.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569543","simplified_title":"Polarized cytokine secretion","sub_type":"Standard Project Grant","total_budget":"958412.53","source_system":"Cytokines are chemical messengers released by cells to mount inflammatory responses to fight infections. The timing and direction of cytokine release must be tightly regulated. We investigate the cellular compartments and molecules that control cytokine secretion using sophisticated live cell imaging. Uncontrolled cytokine release is the main cause of ongoing inflammation in arthritis and inflammatory bowel disease and our studies aim to identify cellular targets for new drug development."},"children":[{"color":"#336699","name":"Dr Amanda Stanley","data":{"first_name":"Amanda","title":"Dr","dw_individual_id":"DW0010421","middle_name":"C","last_name":"Stanley","source_individual_id":"5019300","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Amanda Stanley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79533","size":1},{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64334","size":1},{"color":"#FF4D4D","name":"Australia Fellowship","data":{"media_summary":"","end_year":2013,"keywords":["cell biology","drug delivery","membrane transport","plasma membrane","protein trafficking"],"nhmrc_grant_id":569542,"application_year":2008,"start_year":2009,"scientific_title":"Australia Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569542","simplified_title":"Australia Fellowship","sub_type":"Australia Fellowship","total_budget":"4000000","source_system":"Prof Parton is a cell biologist studying how the plasma membrane functions in health and in disease. These studies have provided new insights into potential vehicles that can be used to introduce therapeutic agents into cells."},"children":[{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64333","size":1},{"color":"#FF4D4D","name":"A new approach to curbing risky trajectories of adolescent alcohol-tobacco use: A tailored brief program for parents.","data":{"media_summary":"smoking-related diseases","end_year":2012,"keywords":["adolescents","alcohol","parent management strategies","prevention","smoking"],"nhmrc_grant_id":569539,"application_year":2008,"health_keywords":["adolescent health and well-being","alcohol and behaviour","brief alcohol-tobacco interventions","parenting","smoking-related diseases"],"scientific_title":"A new approach to curbing risky trajectories of adolescent alcohol-tobacco use: A tailored brief program for parents.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Health, Clinical and Counselling Psychology","research_area":"Public Health","for_category":"PSYCHOLOGY","cia_name":"A/Pr Adrian Kelly","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569539","simplified_title":"Helping parents of teenagers at risk of alcohol-tobacco-related harm: A brief prevention program.","sub_type":"Standard Project Grant","total_budget":"320271.39","source_system":"Parent-adolescent interactions predict adolescent involvement in alcohol and tobacco use, and parent-oriented programs reduce conduct problems. Nevertheless, parent training is a rare alcohol-tobacco-related prevention strategy. This research will evaluate a brief parent program for adolescents at risk of escalating alcohol-tobacco problems. The technology should be cost-effective and readily complement existing school prevention strategies."},"children":[{"color":"#336699","name":"A/Pr Adrian Kelly","data":{"first_name":"Adrian","title":"A/Pr","dw_individual_id":"DW0037701","middle_name":"B","last_name":"Kelly","source_individual_id":"RMIS1090709","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Adrian Kelly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86764","size":1},{"color":"#336699","name":"Dr Michele Haynes","data":{"first_name":"Michele","title":"Dr","dw_individual_id":"DW0013586","middle_name":"","last_name":"Haynes","source_individual_id":"5015171","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michele Haynes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80363","size":1},{"color":"#336699","name":"Prof Robert Mcmahon","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0009063","middle_name":"J","last_name":"Mcmahon","source_individual_id":"5016383","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Mcmahon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79160","size":1},{"color":"#336699","name":"A/Pr Annemaree Carroll","data":{"first_name":"Annemaree","title":"A/Pr","dw_individual_id":"DW0006429","middle_name":"","last_name":"Carroll","source_individual_id":"5013818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Annemaree Carroll"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78445","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64332","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2013,"keywords":["Australian encephalitis and related flavivirus inf","Infectious diseases","Understanding virus-host interactions","Vaccines, Microbiology-virology","Virus replication, Viral infections, Flavivirus"],"nhmrc_grant_id":569537,"application_year":2008,"start_year":2009,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569537","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"580751.93","source_system":"I am a molecular virologist studying the events of virus replication and virus-host interactions with the ultimate goal to understand the mechanisms determining viral pathogenesis and develop safe and effective vaccines."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64331","size":1},{"color":"#FF4D4D","name":"Correlative structure-function studies of cis- and trans-Golgi membrane traffic in mammalian cells","data":{"media_summary":"","end_year":2013,"keywords":["cell biology","electron microscopy","insulin secretion","membrane transport","protein trafficking"],"nhmrc_grant_id":569535,"application_year":2008,"health_keywords":["mis-targeting of proteins to organelles","type 1 diabetes","type 2 diabetes"],"scientific_title":"Correlative structure-function studies of cis- and trans-Golgi membrane traffic in mammalian cells","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Metabolism","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Brad Marsh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569535","simplified_title":"Correlative studies of Golgi membrane traffic in mammalian cells","sub_type":"Standard Project Grant","total_budget":"649531.32","source_system":"This project combines imaging by light and electron microscopy with additional techniques for studying protein function at the molecular level, to elucidate how changes in the 3D organisation of cellular machinery can lead to fundamental changes in the function and health of mammalian cells. Although this work includes detailed investigation of the 'insulin factory', it has the potential to modify established concepts on membrane traffic and protein secretion well beyond the field of diabetes."},"children":[{"color":"#336699","name":"Prof Brian Storrie","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0034079","middle_name":"","last_name":"Storrie","source_individual_id":"5017745","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Brian Storrie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85817","size":1},{"color":"#336699","name":"Dr Brad Marsh","data":{"first_name":"Brad","title":"Dr","dw_individual_id":"DW0026517","middle_name":"J","last_name":"Marsh","source_individual_id":"5016204","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brad Marsh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83855","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64330","size":1},{"color":"#FF4D4D","name":"Imaging genetics of attention deficit hyperactivity disorder (ADHD)","data":{"media_summary":"neuropsychological impairments","end_year":2011,"keywords":["attention deficit hyperactivity disorder (ADHD)","attention deficits","cognitive impairment","functional magnetic resonance imaging","mental health"],"nhmrc_grant_id":569533,"application_year":2008,"health_keywords":["Attention Deficit Hyperactivity Disorder (ADHD)","attention deficits","cognitive deficits","mental health","neuropsychological impairments"],"scientific_title":"Imaging genetics of attention deficit hyperactivity disorder (ADHD)","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Learning, Memory, Cognition and Language","research_area":"Basic Science","for_category":"PSYCHOLOGY","cia_name":"Prof Mark Bellgrove","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569533","simplified_title":"Imaging genetics of ADHD","sub_type":"Standard Project Grant","total_budget":"321767.74","source_system":"Attention deficit hyperactivity disorder (ADHD) is a common psychiatric disorder of childhood that is marked by age-inappropriate levels of inattention and-or hyperactivity-impulsivity. The disorder appears genetic with a number of different genes likely contributing risk for ADHD. This project takes an innovative approach by asking how risk genes for ADHD influence the brain activity of children with ADHD when they pay attention"},"children":[{"color":"#336699","name":"A/Pr Ross Cunnington","data":{"first_name":"Ross","title":"A/Pr","dw_individual_id":"DW0036113","middle_name":"","last_name":"Cunnington","source_individual_id":"5014154","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ross Cunnington"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86356","size":1},{"color":"#336699","name":"A/Pr Helen Heussler","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0031281","middle_name":"S","last_name":"Heussler","source_individual_id":"5015212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Helen Heussler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85096","size":1},{"color":"#336699","name":"A/Pr Alasdair Vance","data":{"first_name":"Alasdair","title":"A/Pr","dw_individual_id":"DW0028549","middle_name":"L","last_name":"Vance","source_individual_id":"5018058","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Alasdair Vance"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84388","size":1},{"color":"#336699","name":"Prof Mark Bellgrove","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0000316","middle_name":"Andrew","last_name":"Bellgrove","source_individual_id":"5013434","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Bellgrove"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76741","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64329","size":1},{"color":"#FF4D4D","name":"Physiological and neurochemical mechanisms of executive control","data":{"media_summary":"","end_year":2011,"keywords":["brain imaging","cognition","event related potentials","executive control","functional magnetic resonance imagin g"],"nhmrc_grant_id":569532,"application_year":2008,"health_keywords":["cognitive deficits","cognitive disorders","mental health","neuropsychological impairments"],"scientific_title":"Physiological and neurochemical mechanisms of executive control","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Learning, Memory, Cognition and Language","research_area":"Basic Science","for_category":"PSYCHOLOGY","cia_name":"Prof Mark Bellgrove","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569532","simplified_title":"Neural bases of executive control","sub_type":"Standard Project Grant","total_budget":"285500.14","source_system":"This study will examine how manipulating brain chemistry influences our ability to inhibit behaviour and monitor our own performance errors. We will determine the response of the brain using the physiological techniques of event-related potentials (ERPs) and functional magnetic resonance imaging (fMRI). The first technique allows us to determine how drugs influence the timing of neural events, while the second technique allows us to determine where in the brain these drugs act."},"children":[{"color":"#336699","name":"A/Pr Robert Hester","data":{"first_name":"Robert","title":"A/Pr","dw_individual_id":"DW0031279","middle_name":"L","last_name":"Hester","source_individual_id":"5015226","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Robert Hester"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85095","size":1},{"color":"#336699","name":"Prof Jason Mattingley","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0020682","middle_name":"Brett","last_name":"Mattingley","source_individual_id":"RMIS123930","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jason Mattingley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82287","size":1},{"color":"#336699","name":"Prof Pradeep Nathan","data":{"first_name":"Pradeep","title":"Prof","dw_individual_id":"DW0015192","middle_name":"","last_name":"Nathan","source_individual_id":"5016651","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Pradeep Nathan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80821","size":1},{"color":"#336699","name":"Prof Mark Bellgrove","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0000316","middle_name":"Andrew","last_name":"Bellgrove","source_individual_id":"5013434","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Bellgrove"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76741","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64328","size":1},{"color":"#FF4D4D","name":"Advanced paternal age: behavioural, neuroanatomical and genomic correlates in the offspring of older fathers","data":{"media_summary":"","end_year":2012,"keywords":["Animal models","Behavioural neuroscience","Psychiatry"],"nhmrc_grant_id":569528,"application_year":2008,"health_keywords":["Autism spectrum disorders","neuropsychiatric disorders","schizophrenia - aetiology"],"scientific_title":"Advanced paternal age: behavioural, neuroanatomical and genomic correlates in the offspring of older fathers","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof John McGrath","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569528","simplified_title":"How does having an older father alter brain development?","sub_type":"Standard Project Grant","total_budget":"501565.34","source_system":"The offspring of older fathers have an increased risk of developing disorders such as autism and schizophrenia. This is thought to be due to mutations in the developing sperm. Our group has shown in a mouse model that the offspring of older fathers have changes in brain shape and in behaviour, similar to some findings in autism. In this grant we will refine this animal model and explore the brain, behavioural and genetic correlates of advanced paternal age."},"children":[{"color":"#336699","name":"A/Pr Darryl Eyles","data":{"first_name":"Darryl","title":"A/Pr","dw_individual_id":"DW0042305","middle_name":"W","last_name":"Eyles","source_individual_id":"5014564","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Darryl Eyles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87979","size":1},{"color":"#336699","name":"A/Pr Thomas Burne","data":{"first_name":"Thomas","title":"A/Pr","dw_individual_id":"DW0023865","middle_name":"Henry Johnston","last_name":"Burne","source_individual_id":"5013713","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thomas Burne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83125","size":1},{"color":"#336699","name":"Prof John Mcgrath","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0009022","middle_name":"Joseph","last_name":"Mcgrath","source_individual_id":"RMIS3680751","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mcgrath"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79147","size":1},{"color":"#336699","name":"Prof Emma Whitelaw","data":{"first_name":"Emma","title":"Prof","dw_individual_id":"DW0005414","middle_name":"","last_name":"Whitelaw","source_individual_id":"5018282","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Emma Whitelaw"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78177","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64327","size":1},{"color":"#FF4D4D","name":"Antibody-directed delivery of anti-restenotic agents using inorganic nanoparticles","data":{"media_summary":"targeted therapy","end_year":2012,"keywords":["anti-restenosis therapy","cardiovascular disease","drug delivery","drug targeting","nanotechnology"],"nhmrc_grant_id":569525,"application_year":2008,"health_keywords":["atherosclerosis","drug delivery systems","restenosis","restenosis after angioplasty","targeted therapy"],"scientific_title":"Antibody-directed delivery of anti-restenotic agents using inorganic nanoparticles","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Julie Campbell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569525","simplified_title":"Targeted delivery of anti-restenotic agents using antibodies and novel inorganic nanoparticles","sub_type":"Standard Project Grant","total_budget":"327151.54","source_system":"Arteries that have been surgically treated to remove fatty lesions that block blood flow frequently become re-blocked (restenosed), and drugs to prevent this re-blockage often have bad side-effects. We propose to prevent these complications by target-delivering the drugs directly and only to the required site using a single injection at the time of surgery. This will limit systemic side-effects, treatment costs and incidence of reblocking and bleeding complications."},"children":[{"color":"#336699","name":"Prof Max Lu","data":{"first_name":"Max","title":"Prof","dw_individual_id":"DW0038155","middle_name":"Gq","last_name":"Lu","source_individual_id":"5016090","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Max Lu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86888","size":1},{"color":"#336699","name":"Dr Anita Thomas","data":{"first_name":"Anita","title":"Dr","dw_individual_id":"DW0034250","middle_name":"C","last_name":"Thomas","source_individual_id":"RMIS1952190","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Anita Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85865","size":1},{"color":"#336699","name":"A/Pr Zhiping Xu","data":{"first_name":"Zhiping","title":"A/Pr","dw_individual_id":"DW0005569","middle_name":"Gordon","last_name":"Xu","source_individual_id":"5018507","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Zhiping Xu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78215","size":1},{"color":"#336699","name":"Prof Julie Campbell","data":{"first_name":"Julie","title":"Prof","dw_individual_id":"DW0000708","middle_name":"H","last_name":"Campbell","source_individual_id":"RMIS330901","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Julie Campbell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76860","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64326","size":1},{"color":"#FF4D4D","name":"Molecular mechanisms underlying the positive associations between male gender and leptin with Barretts oesophagus","data":{"media_summary":"","end_year":2012,"keywords":["Barrett's oesophagus","leptin","obesity","proteomics","sex hormones"],"nhmrc_grant_id":569512,"application_year":2008,"start_year":2009,"scientific_title":"Molecular mechanisms underlying the positive associations between male gender and leptin with Barretts oesophagus","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gastroenterology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Michelle Hill","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569512","simplified_title":"Investigation into the link between gender, obesity and cancer of the lower oesophagus","sub_type":"RD Wright Biomedical CDF","total_budget":"387489.51","source_system":"Barrett's oesophagus is a disease of the gullet that can lead to the development of oesophageal cancer, which has a very poor outcome. We have shown that the risk of Barrett's oesophagus is greatest in obese males with a high blood level of leptin, a hormone made in fat tissue. The aim of this study is to examine how leptin causes this increased cancer risk, so that new treatments or tests for Barrett's and oesophageal cancer can be developed."},"children":[{"color":"#336699","name":"Dr Michelle Hill","data":{"first_name":"Michelle","title":"Dr","dw_individual_id":"DW0007874","middle_name":"M","last_name":"Hill","source_individual_id":"5015259","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michelle Hill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78825","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64324","size":1},{"color":"#FF4D4D","name":"A -induced cell death signalling by the p75 neurotrophin receptor.","data":{"media_summary":"","end_year":2011,"keywords":["Cholinergic neurons","molecular mechanisms","molecular neuroscience","neurodegeneration","neurotrophic factor"],"nhmrc_grant_id":569507,"application_year":2008,"health_keywords":["Alzheimer's disease and normal aging","mechanisms of neuronal degeneration and the role of p75NTR","neuronal cell death"],"scientific_title":"A -induced cell death signalling by the p75 neurotrophin receptor.","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Elizabeth Coulson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569507","simplified_title":"Mechanisms of Alzheimers disease degeneration","sub_type":"Standard Project Grant","total_budget":"546382.69","source_system":"The amyloid peptide A is central to the cause of Alzheimer's disease. We have recently found that A can activate the cell death receptor p75NTR which is found in the nerve cells that die in Alzheimer's disease. This project will study whether this death pathway underpins the neuronal death associated with Alzheimer's disease. It will also determine the mechanism by which A activates p75NTR death signalling, and identify biochemical ways to prevent this from occurring."},"children":[{"color":"#336699","name":"A/Pr Elizabeth Coulson","data":{"first_name":"Elizabeth","title":"A/Pr","dw_individual_id":"DW0006736","middle_name":"J","last_name":"Coulson","source_individual_id":"5014079","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Elizabeth Coulson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78524","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64323","size":1},{"color":"#FF4D4D","name":"Nuclear Factor One genes regulate multiple aspects of cerebral cortex development","data":{"media_summary":"","end_year":2011,"keywords":["axon guidance","cortical development","molecular neuroscience","neuronal migration"],"nhmrc_grant_id":569504,"application_year":2008,"health_keywords":["brain development","mental retardation","neurological disorders"],"scientific_title":"Nuclear Factor One genes regulate multiple aspects of cerebral cortex development","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Linda Richards","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569504","simplified_title":"Development of the cerebral cortex","sub_type":"Standard Project Grant","total_budget":"526878.44","source_system":"To function, the brain must be formed correctly during embryonic development. We are investigating the embryonic development of the cerebral cortex, an area involved in high-order cognitive processing. Recently, we discovered that an important group of genes regulates cortical development, making it possible to study the underlying molecular mechanisms. The results will impact the prognosis and treatment of developmental brain disorders."},"children":[{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64322","size":1},{"color":"#FF4D4D","name":"Nfi genes regulate the switch between neurogenesis and gliogenesis during cortical development","data":{"media_summary":"","end_year":2012,"keywords":["Brain development","Cell differentiation","Developmental genes","Radial glial cells","Transcription factor"],"nhmrc_grant_id":569502,"application_year":2008,"start_year":2009,"scientific_title":"Nfi genes regulate the switch between neurogenesis and gliogenesis during cortical development","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Michael Piper","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/569502","simplified_title":"Nfi genes regulate cortical gliogenesis","sub_type":"RD Wright Biomedical CDF","total_budget":"387489.51","source_system":"Cells within the brain fall into two categories; neurons or glia. Importantly, both derive from a common progenitor population, the radial glia, during development. Early in development radial glia produce neurons, while later they generate glia. The genes which control the switch from neuron production to glia production remain poorly defined. I propose to investigate how this switch is controlled in radial glia, focussing on a family of proteins known to regulate gene transcription."},"children":[{"color":"#336699","name":"Dr Michael Piper","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0021487","middle_name":"J","last_name":"Piper","source_individual_id":"RMIS3987189","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Michael Piper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82523","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64321","size":1},{"color":"#FF4D4D","name":"Axonal degeneration in C. elegans neurons","data":{"media_summary":"Peripheral neuropathy","end_year":2011,"keywords":["Axon degeneration","Axon growth","Molecular neuroscience","Neurodegeneration","Neuronal development"],"nhmrc_grant_id":569500,"application_year":2008,"health_keywords":["Axonal injury","Nervous system development","Neurodegenerative disease","Neuronal degeneration","Peripheral neuropathy"],"scientific_title":"Axonal degeneration in C. elegans neurons","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Massimo Hilliard","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/569500","simplified_title":"Discovery of nerve degeneration genes using a simple animal model system (C. elegans)","sub_type":"Standard Project Grant","total_budget":"511294.64","source_system":"Understanding the biological mechanisms of nerve degeneration is an essential step toward the development of novel therapies for human neurodegenerative conditions such as Parkinson's, Alzheimer's and Huntington's diseases, and for spinal cord injuries. The studies presented in this proposal, using the powerful molecular and genetic tools available for the small nematode worm C. elegans, will provide new insights into the cellular and molecular mechanisms responsible for nerve degeneration."},"children":[{"color":"#336699","name":"Dr Massimo Hilliard","data":{"first_name":"Massimo","title":"Dr","dw_individual_id":"DW0025496","middle_name":"A.","last_name":"Hilliard","source_individual_id":"5015251","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Massimo Hilliard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83566","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64320","size":1},{"color":"#FF4D4D","name":"Identification of brain regions involved in the regulation of coughing","data":{"media_summary":"","end_year":2012,"keywords":["Cough","Supramedullary control of the cough reflex","Urge-to-cough","magnetic resonance imaging","neuroanatomy"],"nhmrc_grant_id":566734,"application_year":2008,"health_keywords":["Asthma","Cough","Obstructive Airways Disease"],"scientific_title":"Identification of brain regions involved in the regulation of coughing","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Stuart Mazzone","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/566734","simplified_title":"How the brain controls coughing","sub_type":"Standard Project Grant","total_budget":"431146.37","source_system":"Cough is a symptom of more than 100 clinical conditions of the respiratory system, and is the most common reason that people seek medical advice. However, currently available cough suppresant drugs are at best only modestly effective at treating cough disorders. In this study we aim to better understand how the brain regulates coughing in the hope to identify new therapeutic targets for relieving cough."},"children":[{"color":"#336699","name":"Prof Gary Egan","data":{"first_name":"Gary","title":"Prof","dw_individual_id":"DW0018843","middle_name":"F","last_name":"Egan","source_individual_id":"5014499","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gary Egan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81823","size":1},{"color":"#336699","name":"Dr Stuart Mazzone","data":{"first_name":"Stuart","title":"Dr","dw_individual_id":"DW0008967","middle_name":"B","last_name":"Mazzone","source_individual_id":"5016283","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Stuart Mazzone"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79130","size":1},{"color":"#336699","name":"Dr Michael Farrell","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0007204","middle_name":"John","last_name":"Farrell","source_individual_id":"5014579","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michael Farrell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78646","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/64088","size":1},{"color":"#FF4D4D","name":"Genome-wide association studies of biomedical traits and endophenotypes for complex disease","data":{"media_summary":"","end_year":2012,"keywords":["gene expression","gene mapping","genetic epidemiology","genetics","statistical genetics"],"nhmrc_grant_id":552498,"application_year":2008,"start_year":2009,"scientific_title":"Genome-wide association studies of biomedical traits and endophenotypes for complex disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"GENETICS","cia_name":"Dr Beben Benyamin","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/552498","simplified_title":"Genetics and prediction of complex disease risk","sub_type":"Peter Doherty Biomedical ECF","total_budget":"295804.35","source_system":"The burden of common complex diseases, such as cardiovascular disease is substantial to the health care system. These diseases are caused by genes and environments as well as their interactions. The proposed project will identify genes affecting the susceptibility of individuals to complex diseases. Discovery of such genes will be important for their diagnosis, prevention and treatment and may serve as an important resource for future personalized medicine."},"children":[{"color":"#336699","name":"Dr Beben Benyamin","data":{"first_name":"Beben","title":"Dr","dw_individual_id":"DW0006073","middle_name":"","last_name":"Benyamin","source_individual_id":"5013439","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Beben Benyamin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78352","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63904","size":1},{"color":"#FF4D4D","name":"Enhancing quality in primary health care services through better use of data and information systems","data":{"media_summary":"","end_year":2013,"keywords":["Health Services Management","Indigenous Health","Information Systems-Decision Support Systems - Cli","Primary Health Care","Quality Assurance"],"nhmrc_grant_id":545248,"application_year":2008,"start_year":2009,"scientific_title":"Enhancing quality in primary health care services through better use of data and information systems","node_source":"NHMRC","node_type":"Grant","field_of_research":"Primary Health Care","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Sanchia Shibasaki","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/545248","simplified_title":"Enhancing quality in primary health care services through better use of data and information systems","sub_type":"Australian Training ECF for Aboriginal and Torres Strait Islander Health Research","total_budget":"143758","source_system":"The performance of PHC services has increasingly been scrutinized due to the rise in prevalence of chronic diseases, growing demand for care, rising health care costs, and evidence of unexplained variations in clinical practice. The use of performance monitoring frameworks has increased and it is anticipated this process will become a regular activity. A key element to ensuring the successful engagement in performance monitoring activities is the effective management of information systems."},"children":[{"color":"#336699","name":"Dr Sanchia Shibasaki","data":{"first_name":"Sanchia","title":"Dr","dw_individual_id":"DW0004598","middle_name":"","last_name":"Shibasaki","source_individual_id":"RMIS681889","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Sanchia Shibasaki"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77945","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63734","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2013,"keywords":["inflammatory bowel disease, infection-acute inflam","mucins, epithelial biology","mucosal immunity, cancer biology","mucosal inflammation, ulcerative colitis","oncogenesis"],"nhmrc_grant_id":543712,"application_year":2008,"start_year":2009,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gastroenterology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael McGuckin","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/543712","simplified_title":"Uncoupled Research Felloship","sub_type":"Research Fellowship","total_budget":"641678.02","source_system":"My basic science and translational research centres around elucidation of the function of the mucosal barrier in preventing infection, inflammation and development of cancers, and how defects in this barrier lead to these diseases."},"children":[{"color":"#336699","name":"Prof Michael Mcguckin","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0044168","middle_name":"A","last_name":"Mcguckin","source_individual_id":"5016335","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Mcguckin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88447","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63702","size":1},{"color":"#FF4D4D","name":"Improving the bioavailability of peptide-based therapeutics for the treatment of Multiple Sclerosis","data":{"media_summary":"","end_year":2013,"keywords":["Biochemistry and protein structure","Molecular mechanisms of deafness and blindness","NMR spectroscopy","X-ray crystallography","computer simulation"],"nhmrc_grant_id":536578,"application_year":2008,"start_year":2009,"scientific_title":"Improving the bioavailability of peptide-based therapeutics for the treatment of Multiple Sclerosis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Conan Wang","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/536578","simplified_title":"Improving the bioavailability of peptide-based therapeutics for the treatment of Multiple Sclerosis","sub_type":"Australia-China Exchange ECF","total_budget":"341123.15","source_system":"Many diseases are controlled at the molecular level by proteins and their interactions with other proteins. Harmonin is a key protein in Usher syndrome, the most common form of deaf-blindness in humans, and harmonin has similarities to some proteins involved in Alzheimers disease. We seek to understand how harmonin works. The findings of this study may lead to new treatments for deaf-blindness and Alzheimers disease."},"children":[{"color":"#336699","name":"Dr Conan Wang","data":{"first_name":"Conan","title":"Dr","dw_individual_id":"DW0010926","middle_name":"Kuan-Lun","last_name":"Wang","source_individual_id":"5018184","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Conan Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79677","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63642","size":1},{"color":"#FF4D4D","name":"Molecular Mechanisms Regulating Spontaneous Onset of Human Labour","data":{"media_summary":"","end_year":2011,"keywords":["birth","labour","pregnancy"],"nhmrc_grant_id":526686,"application_year":2008,"health_keywords":["Complicaitons of labour","Placental Function","Preterm birth"],"scientific_title":"Molecular Mechanisms Regulating Spontaneous Onset of Human Labour","start_year":2009,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Reproduction","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Greg Rice","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/526686","simplified_title":"Understanding what triggers birth","sub_type":"Standard Project Grant","total_budget":"481156.76","source_system":"The single most important complication contributing to poor pregnancy and neonatal outcome is premature birth. If we are to provide the best possible start to life, improve perinatal health and reduce the risk of developing adult disease . A better understanding of labour is requisite to improving health care delivery during pregnancy and outcomes for both mother and baby. This reserach project will investigate the how labour-associated events are reguluated by nuclear proteins."},"children":[{"color":"#336699","name":"A/Pr Martha Lappas","data":{"first_name":"Martha","title":"A/Pr","dw_individual_id":"DW0020269","middle_name":"","last_name":"Lappas","source_individual_id":"5015875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Martha Lappas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82173","size":1},{"color":"#336699","name":"Prof Greg Rice","data":{"first_name":"Greg","title":"Prof","dw_individual_id":"DW0009889","middle_name":"Edward","last_name":"Rice","source_individual_id":"RMIS2438912","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Greg Rice"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79384","size":1},{"color":"#336699","name":"Prof Michael Permezel","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0003935","middle_name":"","last_name":"Permezel","source_individual_id":"5016938","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Permezel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77765","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63559","size":1},{"color":"#FF4D4D","name":"equipment grant","data":{"media_summary":"","end_year":2008,"nhmrc_grant_id":580004,"application_year":2007,"start_year":2008,"scientific_title":"equipment grant","node_source":"NHMRC","node_type":"Grant","field_of_research":"n-a","research_area":"Not Applicable","for_category":"N-A","cia_name":"Ms Janine Richards","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/580004","simplified_title":"equipment grant","sub_type":"Equipment Grant","total_budget":"717032","source_system":""},"children":[{"color":"#336699","name":"Ms Janine  Richards","data":{"first_name":"Janine ","title":"Ms","dw_individual_id":"DW0039316","middle_name":"D","last_name":"Richards","source_individual_id":"RMIS6469880","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Janine  Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87190","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63444","size":1},{"color":"#FF4D4D","name":"T cell trafficking and effective immunotherapy for cancer","data":{"media_summary":"","end_year":2012,"keywords":["Immunotherapy","Tumour immunology"],"nhmrc_grant_id":519839,"application_year":2007,"start_year":2008,"scientific_title":"T cell trafficking and effective immunotherapy for cancer","node_source":"NHMRC","node_type":"Grant","field_of_research":"Tumour Immunology","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Dr Shanling Liu","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519839","simplified_title":"Better cancer treatment using the bodys defences against infection","sub_type":"Australia-China Exchange ECF","total_budget":"218807.99","source_system":"Cancer is the major cause of death in Australia in 2007. New forms of treatment are needed. The bodys defences against infection can be harnessed to fight some cancers. This project will examine how we can do this better using the signals that tell the bodys killer cells where to go and what to do when they get there."},"children":[{"color":"#336699","name":"Dr Shanling Liu","data":{"first_name":"Shanling","title":"Dr","dw_individual_id":"DW0008698","middle_name":"","last_name":"Liu","source_individual_id":"5016036","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Shanling Liu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79058","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63389","size":1},{"color":"#FF4D4D","name":"Development of a novel orally active peptide for the treatment of pain","data":{"media_summary":"","end_year":2010,"keywords":["Chronic pain","Drug design","Neuropathic pain","Therapeutics"],"nhmrc_grant_id":519822,"application_year":2007,"health_keywords":["Biochemistry-protein peptide","Chronic pain and analgesia","Neuropathic pain"],"scientific_title":"Development of a novel orally active peptide for the treatment of pain","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/519822","simplified_title":"A new drug for pain treatment","sub_type":"Development Grant","total_budget":"402145.85","source_system":"Chronic pain from damage to the nervous system is difficult to treat. A new type of drug has recently been developed from sea snail venom to treat chronic pain but is given by injection, which limits its use. Our research has developed a stable molecule that has analgesic activity when ingested. This proposal focuses on further testing to fully establish this molecule's therapeutic potential. This information can then attract a commercial partner to bring the new drug into general use."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Dr Richard Clark","data":{"first_name":"Richard","title":"Dr","dw_individual_id":"DW0029966","middle_name":"James","last_name":"Clark","source_individual_id":"5013970","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Richard Clark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84761","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63388","size":1},{"color":"#FF4D4D","name":"indigenous health","data":{"media_summary":"","end_year":2008,"keywords":["body mass index","cardiovascular disease","indigenous health"],"nhmrc_grant_id":519817,"application_year":2007,"start_year":2008,"scientific_title":"indigenous health","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Zaimin Wang","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519817","simplified_title":"indigenous health","sub_type":"Traveling Award for ECF","total_budget":"4000","source_system":""},"children":[{"color":"#336699","name":"Dr Zaimin Wang","data":{"first_name":"Zaimin","title":"Dr","dw_individual_id":"DW0005299","middle_name":"","last_name":"Wang","source_individual_id":"RMIS3989308","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Zaimin Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78144","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63387","size":1},{"color":"#FF4D4D","name":"MicroRNA analysis of cervical cancer HeLa cells resistant to gene silencing of human papillomavirus (HPV) E6 and E7 onco","data":{"media_summary":"","end_year":2008,"keywords":["HPV"],"nhmrc_grant_id":519809,"application_year":2007,"start_year":2008,"scientific_title":"MicroRNA analysis of cervical cancer HeLa cells resistant to gene silencing of human papillomavirus (HPV) E6 and E7 onco","node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Wenyi Gu","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519809","simplified_title":"MicroRNA analysis of cervical cancer HeLa cells resistant to gene silencing of human papillomavirus (HPV) E6 and E7 onco","sub_type":"Traveling Award for ECF","total_budget":"10833","source_system":""},"children":[{"color":"#336699","name":"Dr Wenyi Gu","data":{"first_name":"Wenyi","title":"Dr","dw_individual_id":"DW0042774","middle_name":"","last_name":"Gu","source_individual_id":"RMIS5507911","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Wenyi Gu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88086","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63386","size":1},{"color":"#FF4D4D","name":"Evidence for psychological and-or educational interventions for cancer-related fatigue: A systematic review","data":{"media_summary":"","end_year":2013,"keywords":["Cancer and related diseases","Palliative Care","Psychology","evidence based practice","fatigue"],"nhmrc_grant_id":519793,"application_year":2007,"start_year":2008,"scientific_title":"Evidence for psychological and-or educational interventions for cancer-related fatigue: A systematic review","node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Sally Bennett","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/519793","simplified_title":"Evidence for psychological and educational interventions for cancer-related fatigue","sub_type":"Palliative Care Research","total_budget":"28283","source_system":"Potential benefits to the community: Fatigue is one of the most common and distressing symptoms experienced by people with cancer and can exacerbate the experience of other symptoms, negatively affect mood, and impact on function and quality of life. Understanding which interventions are effective in helping people cope with cancer-related fatigue is important to inform decision-making by consumers, clinicians working in palliative care and policy makers. Objectives: This study aims to systematically review the evidence for psychological and-or educational interventions for managing cancer-related fatigue. Methods: This study will use the Cochrane Collaborations methodology to search, critically appraise, and analyse randomised controlled trials of psychological and-or educational interventions. This will involve collaboration with consumers and with the Cochrane Pain, Palliative Care, and Supportive Care Collaborative Review Group. This review will inform decision-making at all levels, assist in research translation and identify further gaps in the research regarding this distressing symptom."},"children":[{"color":"#336699","name":"Dr Pamela Meredith","data":{"first_name":"Pamela","title":"Dr","dw_individual_id":"DW0020851","middle_name":"Joy","last_name":"Meredith","source_individual_id":"5016430","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Pamela Meredith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82336","size":1},{"color":"#336699","name":"Dr Sally Bennett","data":{"first_name":"Sally","title":"Dr","dw_individual_id":"DW0017689","middle_name":"","last_name":"Bennett","source_individual_id":"5013438","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sally Bennett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81520","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63383","size":1},{"color":"#FF4D4D","name":"Using n-of-1 trials to determine effectiveness of paracetamol in advanced cancer patients on opioids","data":{"media_summary":"","end_year":2009,"keywords":["Cancer","End of life","Pain","Palliative care","terminal illness"],"nhmrc_grant_id":519791,"application_year":2007,"start_year":2009,"scientific_title":"Using n-of-1 trials to determine effectiveness of paracetamol in advanced cancer patients on opioids","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmaceutical Sciences and Pharmacy","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Jane Nikles","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/519791","simplified_title":"Comparing the effectiveness of paracetamol and placebo in advanced cancer patients opioids","sub_type":"Palliative Care Research","total_budget":"49996","source_system":"In advanced cancer, the prevalence of pain is very high (70-90%). Chronic pain is the most feared symptom and is not controlled in a large proportion of cancer patients. The impact on function (physical, mental, social and spiritual) and quality of life (QOL) is very significant. The role of paracetamol in the management of pain in patients with advanced cancer on opioids needs to be defined. Managing pain with treatment supported by the best possible evidence for individual patients and producing any improvement in pain will improve patients functional status, and will greatly improve QOL for patients and carers. N-of-1 trials are randomized, double-blind cross-over comparisons of active drug with placebo or another drug. The patient is their own control. N-of-1 trials provide objective means of testing effectiveness of medicines in individuals, providing evidence stronger than randomised controlled trial evidence for the efficacy of that drug in that individual. We will pilot N-of-1 trials of paracetamol for pain in 10 patients. If feasible, this will be a new method of obtaining strong evidence in a difficult to research population: palliative care patients."},"children":[{"color":"#336699","name":"Prof Christopher Del Mar","data":{"first_name":"Christopher","title":"Prof","dw_individual_id":"DW0041984","middle_name":"B","last_name":"Del Mar","source_individual_id":"RMIS2365573","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Christopher Del Mar"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87888","size":1},{"color":"#336699","name":"A/Pr Michael Yelland","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0040629","middle_name":"J","last_name":"Yelland","source_individual_id":"RMIS4535118","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Michael Yelland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87528","size":1},{"color":"#336699","name":"Prof Philip Schluter","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0039558","middle_name":"John","last_name":"Schluter","source_individual_id":"RMIS1697880","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Philip Schluter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87260","size":1},{"color":"#336699","name":"Prof Janet Hardy","data":{"first_name":"Janet","title":"Prof","dw_individual_id":"DW0037109","middle_name":"R","last_name":"Hardy","source_individual_id":"RMIS3148016","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Janet Hardy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86605","size":1},{"color":"#336699","name":"Dr Rohan Vora","data":{"first_name":"Rohan","title":"Dr","dw_individual_id":"DW0022747","middle_name":"R","last_name":"Vora","source_individual_id":"RMIS7171136","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Rohan Vora"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82860","size":1},{"color":"#336699","name":"Dr Jane Nikles","data":{"first_name":"Jane","title":"Dr","dw_individual_id":"DW0021162","middle_name":"","last_name":"Nikles","source_individual_id":"5023242","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jane Nikles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82422","size":1},{"color":"#336699","name":"Prof David Currow","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0012584","middle_name":"Christopher","last_name":"Currow","source_individual_id":"5011920","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Currow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80107","size":1},{"color":"#336699","name":"Prof Geoffrey Mitchell","data":{"first_name":"Geoffrey","title":"Prof","dw_individual_id":"DW0003428","middle_name":"Keith","last_name":"Mitchell","source_individual_id":"5012135","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Geoffrey Mitchell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77614","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63382","size":1},{"color":"#FF4D4D","name":"Assessing the impact of climate change on the transmission of mosquito-borne diseases in Australia","data":{"media_summary":"","end_year":2012,"keywords":["Climate Change","Early warning system","Mosquito transmission"],"nhmrc_grant_id":519788,"application_year":2007,"start_year":2008,"scientific_title":"Assessing the impact of climate change on the transmission of mosquito-borne diseases in Australia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Wenbiao Hu","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519788","simplified_title":"Climate change and mosquito-borne diseases","sub_type":"Public Health (Australia) ECF","total_budget":"346689.5","source_system":"Global climate change has potentially serious effects on the transmission of mosquito-borne diseases (MBDs). Bayesian spatiotemporal models will be developed to explore the underlying mechanisms of the current distribution of MBDs and to forecast future changes in pattern of these diseases. The model will be useful in examining where and when MBDs are likely to occur and how the future MBDs control strategies and prevention efforts need to be applied and strengthened in Australia."},"children":[{"color":"#336699","name":"Dr Wenbiao Hu","data":{"first_name":"Wenbiao","title":"Dr","dw_individual_id":"DW0002298","middle_name":"","last_name":"Hu","source_individual_id":"5019952","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Wenbiao Hu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77295","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63381","size":1},{"color":"#FF4D4D","name":"Evaluating the effectiveness of future tobacco control strategies","data":{"media_summary":"","end_year":2013,"keywords":["Drug addiction","Smoking","Tobacco","drug dependence","policy and interventions"],"nhmrc_grant_id":519783,"application_year":2007,"start_year":2008,"scientific_title":"Evaluating the effectiveness of future tobacco control strategies","node_source":"NHMRC","node_type":"Grant","field_of_research":"Preventive Medicine","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Coral Gartner","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519783","simplified_title":"Effectiveness of future tobacco control strategies","sub_type":"Public Health (Australia) ECF","total_budget":"368112.96","source_system":"This research will evaluate promising new strategies to reduce the harm caused by tobacco, the leading preventable cause of premature death in Australia. This includes evaluation of general population-based strategies, such as public smoking bans, and interventions to help smokers quit smoking, such as new cessation aids and long-term maintenance on pharmaceutical nicotine or low-nitrosamine smokeless tobacco."},"children":[{"color":"#336699","name":"Dr Coral Gartner","data":{"first_name":"Coral","title":"Dr","dw_individual_id":"DW0007430","middle_name":"E","last_name":"Gartner","source_individual_id":"5014768","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Coral Gartner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78707","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63380","size":1},{"color":"#FF4D4D","name":"The classification of motor function impairment in chronic neck pain","data":{"media_summary":"","end_year":2010,"keywords":["differential diagnosis","exercise testing and rehabilitation","motor control","musculoskeletal pain","physiotherapy"],"nhmrc_grant_id":519781,"application_year":2007,"start_year":2008,"scientific_title":"The classification of motor function impairment in chronic neck pain","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Shaun O'Leary","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519781","simplified_title":"Identifying movement and muscle function problems in neck pain sufferers","sub_type":"Health Professional Research ECF","total_budget":"117228.6","source_system":"Disability due to painful neck disorders is a serious health issue. Changes in control of neck movement and muscle function are known problems in neck pain sufferers yet management of these issues remains poorly understood. This project aims to develop classifications that better identify movement and muscle problems in the neck with the goal to facilitate better rehabilitation. This project is likely to significantly improve the management of neck pain in the community."},"children":[{"color":"#336699","name":"Dr Shaun O'Leary","data":{"first_name":"Shaun","title":"Dr","dw_individual_id":"DW0032976","middle_name":"Patrick","last_name":"O'Leary","source_individual_id":"5016795","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Shaun O'Leary"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85546","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63379","size":1},{"color":"#FF4D4D","name":"Genetic Factors for Osteoporosis","data":{"media_summary":"","end_year":2012,"keywords":["Bone","Fracture","Genetics","Genetics of the skeleton","Osteoporosis"],"nhmrc_grant_id":519776,"application_year":2007,"start_year":2009,"scientific_title":"Genetic Factors for Osteoporosis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Geriatrics and Gerontology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Matthew Brown","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/519776","simplified_title":"Genetic Factors for Osteoporosis","sub_type":"Aust/EU Collaborative Research Grant","total_budget":"810661.2","source_system":"Osteoporosis is a common condition in which bone strength is reduced due to reduced amount and quality of bone. Reduced bone strength means an increased risk of fracture. Osteoporotic fractures occur in 1 in 2 women and 1 in 3 men in their lifetime, and the likelihood of suffering osteoporotic fracture increases with age. Most of the risk of developing osteoporosis is genetic, but few of the genes involved have been identified. Our goal is to identify those genes. We will complete recruitment and assessment of a cohort of 1500 postmenopausal women with either low or high bone mineral density from pre-existing population cohorts in Australia. A genomewide association study will then be performed on these cases. Associated genes in different datasets will then be investigated further in our cohort, and high-density SNP mapping performed to identify true associated variants. These studies should identify most genetic variants associated with BMD variation and low trauma fracture in the general community, allowing development of diagnostic-disease predictive genetic tests, and informing development of novel therapeutic agents for osteoporosis."},"children":[{"color":"#336699","name":"Prof Matthew Brown","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0012026","middle_name":"A","last_name":"Brown","source_individual_id":"5012217","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79951","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63377","size":1},{"color":"#FF4D4D","name":"Whiplash injury: Classification, prediction and directives for improved management strategies.","data":{"media_summary":"","end_year":2011,"keywords":["musculoskeletal disorders","pain","whiplash injuries"],"nhmrc_grant_id":519771,"application_year":2007,"start_year":2008,"scientific_title":"Whiplash injury: Classification, prediction and directives for improved management strategies.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michele Sterling","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519771","simplified_title":"Whiplash injury: Classification, prediction and directives for improved management strategies.","sub_type":"RD Wright Biomedical CDF","total_budget":"331674.36","source_system":"Whiplash is a costly condition with many people developing chronic symptoms. This research aims to improve the diagnosis and classification of the condition from the time of injury until either recovery or the development of persistent pain. This will facilitate the early identification of those at risk of poor recovery and will lay the foundations for the development of improved early management, particularly in primary care."},"children":[{"color":"#336699","name":"Prof Michele Sterling","data":{"first_name":"Michele","title":"Prof","dw_individual_id":"DW0028165","middle_name":"","last_name":"Sterling","source_individual_id":"5017714","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michele Sterling"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84271","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63376","size":1},{"color":"#FF4D4D","name":"Tolerance induction by antigen-presenting cell-targeted antigen","data":{"media_summary":"","end_year":2011,"keywords":["autoimmunity","immune regulation","immunotherapy"],"nhmrc_grant_id":519768,"application_year":2007,"start_year":2008,"scientific_title":"Tolerance induction by antigen-presenting cell-targeted antigen","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"A/Pr Raymond Steptoe","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519768","simplified_title":"Targeting antigens for tolerance","sub_type":"RD Wright Biomedical CDF","total_budget":"420872.14","source_system":"We have found that by targeting antigen to the cells that train the immune system we have been able to prevent the development of autoimmune disease. In the research proposed here we aim to develop new ways in which antigens can be targeted to these cells so that this approach can be applied clinically. The proposed studies will also determine how antigens targeted in this way restore self-tolerance and prevent autoimmune disease."},"children":[{"color":"#336699","name":"A/Pr Raymond Steptoe","data":{"first_name":"Raymond","title":"A/Pr","dw_individual_id":"DW0028164","middle_name":"J","last_name":"Steptoe","source_individual_id":"5017706","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Raymond Steptoe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84270","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63375","size":1},{"color":"#FF4D4D","name":"Developmental stages of cardiovascular risk factors and their public health impact: a life course perspective","data":{"media_summary":"","end_year":2012,"keywords":["cardiovascular disease prevention","cardiovascular risk factors","fetal origins of adult disease","longitudinal","mental health"],"nhmrc_grant_id":519756,"application_year":2007,"start_year":2008,"scientific_title":"Developmental stages of cardiovascular risk factors and their public health impact: a life course perspective","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Abdullah Mamun","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519756","simplified_title":"Developmental stages of cardiovascular risk factors","sub_type":"Population Health CDF","total_budget":"380558.72","source_system":"Using a life course approach, the aims of this study are to (a) investigate the developmental stages (pre-natal, childhood and adolescence) of cardiovascular (CVD) risk factors in young adulthood; (b) identify what is influencing these developmental stages either directly or indirectly and (c) quantify the public health burden of these stages and individual factors. Findings will enhance our understanding of the developmental stages of CVD and their public health burden."},"children":[{"color":"#336699","name":"A/Pr Abdullah Mamun","data":{"first_name":"Abdullah","title":"A/Pr","dw_individual_id":"DW0003145","middle_name":"Al","last_name":"Mamun","source_individual_id":"5016160","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Abdullah Mamun"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77536","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63374","size":1},{"color":"#FF4D4D","name":"Patched gene family control of epidermal development and cancer","data":{"media_summary":"","end_year":2010,"keywords":["cancer","conditional gene targeting","developmental genes","mouse genetics"],"nhmrc_grant_id":519748,"application_year":2007,"health_keywords":["epidermal development","genetic disease","skin tumours","stem cells"],"scientific_title":"Patched gene family control of epidermal development and cancer","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/519748","simplified_title":"The molecular basis of skin development and cancer","sub_type":"Standard Project Grant","total_budget":"521961.08","source_system":"The skin is the largest organ in the body and functions as a barrier against infection and dehydration. From a clinical perspective we need to know how to regenerate skin for better wound healing and the treatment of burns. We have identified a genetic pathway that regulates the stem cells of the skin and this research will show us the mechanism whereby the skin develops and regenerates, as well as the possible manipulations we can use to increase healing in the clinic."},"children":[{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1},{"color":"#336699","name":"A/Pr Pritinder Kaur","data":{"first_name":"Pritinder","title":"A/Pr","dw_individual_id":"DW0002563","middle_name":"","last_name":"Kaur","source_individual_id":"RMIS222159","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Pritinder Kaur"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77368","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63373","size":1},{"color":"#FF4D4D","name":"Osteal macrophages: novel regulators of osteoblast function and the endosteal stem cell niche","data":{"media_summary":"","end_year":2013,"keywords":["Age related skeletal disorders","Bone formation","Bone growth and fracture healing","Haemopoietic stem cell mobilization"],"nhmrc_grant_id":519744,"application_year":2007,"start_year":2008,"scientific_title":"Osteal macrophages: novel regulators of osteoblast function and the endosteal stem cell niche","node_source":"NHMRC","node_type":"Grant","field_of_research":"Orthopaedics","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Allison Pettit","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519744","simplified_title":"A new role for macrophages in bone and stem cell biology: is this the key to curing bone disease?","sub_type":"RD Wright Biomedical CDF","total_budget":"406125.15","source_system":"Bone diseases are a major health problem and current treatments are inadequate. We are investigating a novel role for macrophages (cells important in tissue maintenance and immune responses) in bone growth, repair and disease. Greater understanding of this will provide new ways to treat bone disease. We will also determine if these macrophages help support stem cells that reside near bone surfaces, which may provide new treatment strategies to improve bone marrow transplantation in cancer."},"children":[{"color":"#336699","name":"Dr Allison Pettit","data":{"first_name":"Allison","title":"Dr","dw_individual_id":"DW0015560","middle_name":"Robyn","last_name":"Pettit","source_individual_id":"5016963","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Allison Pettit"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80923","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63372","size":1},{"color":"#FF4D4D","name":"Development of effective peptide-based drugs","data":{"media_summary":"","end_year":2011,"keywords":["antibiotics","chronic pain and analgesia","hemochromatosis"],"nhmrc_grant_id":519739,"application_year":2007,"start_year":2008,"scientific_title":"Development of effective peptide-based drugs","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Dr Richard Clark","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519739","simplified_title":"Effective peptide drugs","sub_type":"RD Wright Biomedical CDF","total_budget":"307232.18","source_system":"There is huge interest in the development of bioactive peptides and proteins for the treatment of a wide range of diseases. However, the biggest challenge in the development of peptide and protein drugs is overcoming their poor stability in the human body. The aim of my research is to develop novel methods that provide therapeutically promising peptides and proteins the ability to resist the bodys natural degradation pathways so they can reach their biological target and act as effective drugs."},"children":[{"color":"#336699","name":"Dr Richard Clark","data":{"first_name":"Richard","title":"Dr","dw_individual_id":"DW0029966","middle_name":"James","last_name":"Clark","source_individual_id":"5013970","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Richard Clark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84761","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63371","size":1},{"color":"#FF4D4D","name":"The role of non-coding RNAs in development and disease.","data":{"media_summary":"","end_year":2012,"keywords":["Cancer","Congenital diseases","Disorders of sexual development"],"nhmrc_grant_id":519737,"application_year":2007,"start_year":2008,"scientific_title":"The role of non-coding RNAs in development and disease.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Clinical Medicine and Science","for_category":"GENETICS","cia_name":"A/Pr Dagmar Wilhelm","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519737","simplified_title":"A new aspect of gene regulation involved in development and disease.","sub_type":"RD Wright Biomedical CDF","total_budget":"420872.14","source_system":"We have discovered a new mechanism by which genome activity is regulated. This project will test the hypothesis that this mechanism is critical for cell growth and embryonic development. It has the potential to identify new causes of birth defects and may also be relevant to understanding the etiology of other diseases such as cancer, resulting in improvements in diagnosis and management of disorders that present a major health care burden."},"children":[{"color":"#336699","name":"A/Pr Dagmar Wilhelm","data":{"first_name":"Dagmar","title":"A/Pr","dw_individual_id":"DW0046276","middle_name":"","last_name":"Wilhelm","source_individual_id":"5018314","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Dagmar Wilhelm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88981","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63370","size":1},{"color":"#FF4D4D","name":"Neurorehabilitation of aphasia","data":{"media_summary":"","end_year":2011,"keywords":["cardiovascular disease","cortical reorganisation","stroke rehabilitation"],"nhmrc_grant_id":519736,"application_year":2007,"start_year":2008,"scientific_title":"Neurorehabilitation of aphasia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Hearing and Speech","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr David Copland","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519736","simplified_title":"Language treatment and recovery after stroke","sub_type":"Clinical CDF","total_budget":"420872.14","source_system":"Word finding difficulties are the most common type of language impairment following stroke, causing considerable frustration and distress for the individual and their family and friends. Current available language therapies are not always effective. This project aims to (1) develop and test new language treatments for stroke sufferers, and (2) find out how language therapy works in the brain. Outcomes will include improved treatment of communication disorders after stroke."},"children":[{"color":"#336699","name":"A/Pr David Copland","data":{"first_name":"David","title":"A/Pr","dw_individual_id":"DW0006716","middle_name":"A","last_name":"Copland","source_individual_id":"5014073","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr David Copland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78522","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63369","size":1},{"color":"#FF4D4D","name":"Dissecting the divisome: development of antibacterial agents that inhibit bacterial cytokinesis","data":{"media_summary":"infectious disease","end_year":2010,"keywords":["NMR spectroscopy","antibiotics","infectious disease","protein structure","structure-activity relationships"],"nhmrc_grant_id":519735,"application_year":2007,"health_keywords":["antibiotic resistance","bacterial infections","biochemistry - protein peptide","drug development","infectious disease"],"scientific_title":"Dissecting the divisome: development of antibacterial agents that inhibit bacterial cytokinesis","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Glenn King","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/519735","simplified_title":"Development of antibacterial agents that inhibit bacterial cell division","sub_type":"Standard Project Grant","total_budget":"504097.08","source_system":"Infectious diseases accounted for 25-30% of the estimated 54 million deaths worldwide in 1998. Unfortunately, the recent spread of antibiotic resistant bacteria from hospitals into the community has coincided with a marked downturn in the rate of development of new antibiotics. Thus, there is an urgent need to develop new antimicrobial agents. The aim of this project is to provide essential groundwork for the development of new antimicrobials that inhibit bacterial cell division."},"children":[{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63368","size":1},{"color":"#FF4D4D","name":"Development of Novel antibacterial compounds from subtilosin A","data":{"media_summary":"Microbiological safety","end_year":2011,"keywords":["Antibiotics","Antimicrobial therapy","Drug Design","Food technology","Structure-Activity Relationships"],"nhmrc_grant_id":519734,"application_year":2007,"health_keywords":["Antimicrobial resistance","Bacterial Pathogens","Food borne infections","Microbial infections","Microbiological safety"],"scientific_title":"Development of Novel antibacterial compounds from subtilosin A","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/519734","simplified_title":"Development of Novel antibacterial compounds","sub_type":"Standard Project Grant","total_budget":"490724.81","source_system":"We aim to overcome a problem that is not being addressed by pharmaceutical companies- i.e., there is an urgent need to develop new classes of antibacterial drugs because of the increasing prevalence of drug resistant bacteria. We will combine genetics, structural biology and chemistry to develop a new class of anti-bacterial drug based on a naturally occurring microbial molecule that is novel in structure and very stable- attributes that make it very different to existing therapeutic approaches."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63367","size":1},{"color":"#FF4D4D","name":"Protecting Newborn Brains via Innovative Monitoring Technology","data":{"media_summary":"","end_year":2014,"keywords":["hypoxic-ischaemic encephalopathy","perinatal hypoxia","premature birth","preterm birth"],"nhmrc_grant_id":519727,"application_year":2007,"start_year":2008,"scientific_title":"Protecting Newborn Brains via Innovative Monitoring Technology","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biotechnology","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Dr Simon Finnigan","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519727","simplified_title":"Protecting Newborn Brains via Innovative Monitoring Technology","sub_type":"Industry CDF","total_budget":"394460.05","source_system":"This project aims to develop innovative brain monitoring technology which could help minimise brain damage in newborn babies with brain injuries, thereby delivering a healthier start to life. Such novel technology may automatically analyse babies brain activity and deliver instant detection of critical abnormalities, which could enable more effective treatment of brain injuries. Babies with reduced oxygen or blood supply to the brain and premature babies could benefit from such innovations."},"children":[{"color":"#336699","name":"Dr Simon Finnigan","data":{"first_name":"Simon","title":"Dr","dw_individual_id":"DW0036617","middle_name":"","last_name":"Finnigan","source_individual_id":"5014608","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Simon Finnigan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86496","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63365","size":1},{"color":"#FF4D4D","name":"Copper and its antibacterial action: an emerging aspect of host defence against bacterial pathogens","data":{"media_summary":"Sepsis","end_year":2011,"keywords":["Bacterial pathogen","Copper transport","Salmonella typhimurium","Sepsis","Virulence"],"nhmrc_grant_id":519722,"application_year":2007,"health_keywords":["Innate Immunity","Microbial infections","Microbiology - pathogenesis","Nosocomial infections","Sepsis"],"scientific_title":"Copper and its antibacterial action: an emerging aspect of host defence against bacterial pathogens","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Alastair McEwan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/519722","simplified_title":"How copper is used by the host to kill bacteria","sub_type":"Standard Project Grant","total_budget":"454858.08","source_system":"This project will determine the way in which copper is used as an antimicrobial agent to kill Salmonella that reside inside the macrophage (white blood cell) of the host and also determine how Salmonella defends against copper-dependent killing. It will also determine the role of copper in the killing of extra-intestinal pathogens during sepsis. These results will provide information that can be used to manage and control infections intracellular and extracellular bacterial pathogens."},"children":[{"color":"#336699","name":"Prof Mark Schembri","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0016088","middle_name":"A","last_name":"Schembri","source_individual_id":"5017368","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Schembri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81054","size":1},{"color":"#336699","name":"Prof Alastair Mcewan","data":{"first_name":"Alastair","title":"Prof","dw_individual_id":"DW0014843","middle_name":"G","last_name":"Mcewan","source_individual_id":"5016339","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alastair Mcewan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80715","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63364","size":1},{"color":"#FF4D4D","name":"Progressing life course research in psychiatric epidemiology","data":{"media_summary":"","end_year":2011,"keywords":["Alcohol use disorders","substance abuse and dependence","fetal programming","mental health"],"nhmrc_grant_id":519721,"application_year":2007,"start_year":2008,"scientific_title":"Progressing life course research in psychiatric epidemiology","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Rosa Alati","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519721","simplified_title":"Life course research in psychiatric epidemiology","sub_type":"Population Health CDF","total_budget":"331674.36","source_system":"Mental health and alcohol disorders are major public health problems which cause long-term disabilities, poor health and early mortality. Addressing these problems requires a better understanding of the early factors leading to these disorders. This research program represents a unique opportunity to increase our knowledge of the origins of these disorders and significantly contribute to improved mental health and alcohol prevention policies and programs."},"children":[{"color":"#336699","name":"A/Pr Rosa Alati","data":{"first_name":"Rosa","title":"A/Pr","dw_individual_id":"DW0005759","middle_name":"","last_name":"Alati","source_individual_id":"RMIS2639340","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Rosa Alati"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78272","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63363","size":1},{"color":"#FF4D4D","name":"The assessment of clinical and molecular adjunctive tools for the early detection of oral mucosal neoplasia","data":{"media_summary":"prevention of cancer progression","end_year":2010,"keywords":["cancer","diagnosis","differential gene expression","oral pathology","squamous cell carcinoma"],"nhmrc_grant_id":519717,"application_year":2007,"health_keywords":["cancer detection, therapy and prevention","diagnostic test","head and neck cancer","oral health","prevention of cancer progression"],"scientific_title":"The assessment of clinical and molecular adjunctive tools for the early detection of oral mucosal neoplasia","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Camile Farah","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/519717","simplified_title":"Clinical and molecular diagnostic aids for the early detection of oral cancer.","sub_type":"New Investigator Grant","total_budget":"454383.54","source_system":"It is anticipated that this research will make a significant contribution to our understanding of the natural development of oral cancer and will thus have a direct benefit to patients. The proposed research will enable high quality genetic analysis of individual mutations of relevance to oral cancer via a rapid, reliable, economic, and sensitive screening assay for the assessment of a large number of suspicious oral mucosal lesions."},"children":[{"color":"#336699","name":"A/Pr Camile Farah","data":{"first_name":"Camile","title":"A/Pr","dw_individual_id":"DW0030619","middle_name":"S","last_name":"Farah","source_individual_id":"RMIS706067","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Camile Farah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84955","size":1},{"color":"#336699","name":"Prof Michael Mccullough","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0008992","middle_name":"J","last_name":"Mccullough","source_individual_id":"5016316","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Mccullough"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79137","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63362","size":1},{"color":"#FF4D4D","name":"Hyperpolarized Helium MRI to quantify regional lung damage and ventilation for improvement of recruitment strategy.","data":{"media_summary":"magnetic resonance imaging techniques","end_year":2010,"keywords":["electrical impedance tomography","lung function","magnetic resonance imaging","respiratory distress syndrome","respiratory mechanics"],"nhmrc_grant_id":519716,"application_year":2007,"health_keywords":["acute lung injury","acute respiratory distress syndrome","burn injury","lung function assessment","magnetic resonance imaging techniques"],"scientific_title":"Hyperpolarized Helium MRI to quantify regional lung damage and ventilation for improvement of recruitment strategy.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Systems Physiology","research_area":"Clinical Medicine and Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof John Fraser","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/519716","simplified_title":"Improvement of recruitment strategies for acute lung injury using novel imaging technqiues","sub_type":"Standard Project Grant","total_budget":"455160.27","source_system":"Many lung injuries need mechanical ventilation to reopen collapsed lung airspaces and supply oxygen to the patient. This study uses two methods to monitor the lungs during ventilation: Hyperpolarised helium MRI to image the airspace, and electrical impedance tomography to measure lung volume. This information will allow adjustment of ventilator pressure to maximize oxygen transfer without increasing lung damage. Quicker repair of lung damage and patient recovery are the benefits of this study."},"children":[{"color":"#336699","name":"Dr Gary Cowin","data":{"first_name":"Gary","title":"Dr","dw_individual_id":"DW0041797","middle_name":"John","last_name":"Cowin","source_individual_id":"5011610","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Gary Cowin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87847","size":1},{"color":"#336699","name":"A/Pr Andreas Schibler","data":{"first_name":"Andreas","title":"A/Pr","dw_individual_id":"DW0039550","middle_name":"","last_name":"Schibler","source_individual_id":"5012068","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Andreas Schibler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87258","size":1},{"color":"#336699","name":"Prof Graham Galloway","data":{"first_name":"Graham","title":"Prof","dw_individual_id":"DW0036756","middle_name":"J","last_name":"Galloway","source_individual_id":"5014770","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Graham Galloway"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86521","size":1},{"color":"#336699","name":"Dr Marlies Friese","data":{"first_name":"Marlies","title":"Dr","dw_individual_id":"DW0030772","middle_name":"Elly Joy","last_name":"Friese","source_individual_id":"5011609","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Marlies Friese"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84982","size":1},{"color":"#336699","name":"Dr Deming Wang","data":{"first_name":"Deming","title":"Dr","dw_individual_id":"DW0028655","middle_name":"D","last_name":"Wang","source_individual_id":"5018194","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Deming Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84421","size":1},{"color":"#336699","name":"Prof John Fraser","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0007344","middle_name":"Francis","last_name":"Fraser","source_individual_id":"5011410","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Fraser"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78686","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63361","size":1},{"color":"#FF4D4D","name":"Molecular characterization of dengue virus fusion and antiviral inhibitors.","data":{"media_summary":"","end_year":2010,"keywords":["antiviral","dengue","membrane fusion","protein structure"],"nhmrc_grant_id":519709,"application_year":2007,"health_keywords":["antiviral drug","dengue fever","drug discovery"],"scientific_title":"Molecular characterization of dengue virus fusion and antiviral inhibitors.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Paul Young","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/519709","simplified_title":"Understanding how dengue virus enters cells and how to prevent it.","sub_type":"Standard Project Grant","total_budget":"573557.21","source_system":"Dengue viruses are transmitted by mosquitoes and cause major epidemics in more than 100 countries around the world, including Australia. Infection with dengue viruses cause severe and sometimes fatal disease. This proposal focuses on the way dengue virus enters cells and the development of drugs that will prevent virus entry. We have already identified compounds that inhibit the entry process of dengue into cells and this project will significantly build on these early findings."},"children":[{"color":"#336699","name":"A/Pr Paul Young","data":{"first_name":"Paul","title":"A/Pr","dw_individual_id":"DW0046476","middle_name":"Michael","last_name":"Young","source_individual_id":"5018539","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/89039","size":1},{"color":"#336699","name":"Prof Alan Mark","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0032333","middle_name":"Edward","last_name":"Mark","source_individual_id":"5016199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alan Mark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85371","size":1},{"color":"#336699","name":"Prof Bostjan Kobe","data":{"first_name":"Bostjan","title":"Prof","dw_individual_id":"DW0031827","middle_name":"","last_name":"Kobe","source_individual_id":"5011436","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bostjan Kobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85237","size":1},{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63360","size":1},{"color":"#FF4D4D","name":"Targeted delivery by topical application","data":{"media_summary":"toxicity","end_year":2010,"keywords":["dermatology","drug delivery","pharmaceutics","pharmacokinetics","toxicology"],"nhmrc_grant_id":519703,"application_year":2007,"health_keywords":["dermatology","pharmaceutical treatment","pharmacokinetics","psoriasis","toxicity"],"scientific_title":"Targeted delivery by topical application","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Michael Roberts","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/519703","simplified_title":"Topical Drug Delivery","sub_type":"Standard Project Grant","total_budget":"631052.78","source_system":"Many products are applied to the skin to prevent skin cancer or to treat skin diseases. This project seeks to better understand how we can make such products more affective, safer and appropriate for conditions such as psoriasis. One major component of the grant is concerned with the evaluation of nanotechnology products applied to the skin."},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63358","size":1},{"color":"#FF4D4D","name":"Antibiotic dosing in the","data":{"media_summary":"traumatic head injury","end_year":2011,"keywords":["antibiotics","critical care medicine","dosing","pharmacodynamics","pharmacokinetics"],"nhmrc_grant_id":519702,"application_year":2007,"health_keywords":["burn injury","infection-acute inflammation","sepsis","trauma","traumatic head injury"],"scientific_title":"Antibiotic dosing in the","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Intensive Care","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Jeffrey Lipman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/519702","simplified_title":"Antibiotics in the critically ill","sub_type":"Standard Project Grant","total_budget":"612859.04","source_system":"The appropriate dosing of antibiotics for patient admitted to ICU after a traumatic injury is poorly defined and based on intuition rather than evidence. Doctors need to predict which patients may develop very high antibiotic clearances and dose accordingly so that potentially life-threatening infections do not occur. Given these patients are unknown, this research seeks to identify such patients and recommend which antibiotic and which dose is appropriate to ensure adequate treatment."},"children":[{"color":"#336699","name":"A/Pr Peter Kruger","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0043614","middle_name":"S","last_name":"Kruger","source_individual_id":"RMIS3702501","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Kruger"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88308","size":1},{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1},{"color":"#336699","name":"Prof Jason Roberts","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0033443","middle_name":"A","last_name":"Roberts","source_individual_id":"5017212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jason Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85657","size":1},{"color":"#336699","name":"Prof Jeffrey Lipman","data":{"first_name":"Jeffrey","title":"Prof","dw_individual_id":"DW0032130","middle_name":"","last_name":"Lipman","source_individual_id":"5012259","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jeffrey Lipman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85314","size":1},{"color":"#336699","name":"Prof David Paterson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0027242","middle_name":"Leslie","last_name":"Paterson","source_individual_id":"5012495","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Paterson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84040","size":1},{"color":"#336699","name":"Prof Carl Kirkpatrick","data":{"first_name":"Carl","title":"Prof","dw_individual_id":"DW0014193","middle_name":"Michael","last_name":"Kirkpatrick","source_individual_id":"5015731","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Carl Kirkpatrick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80526","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63357","size":1},{"color":"#FF4D4D","name":"The Role of the Complement System in Neurodegeneration and the Therapeutic Potential of Complement Inhibition","data":{"media_summary":"","end_year":2011,"keywords":["Huntington's disease","Parkinson's disease","motor neuron disease","neurodegenerative and age-related diseases","neuroinflammatory disease"],"nhmrc_grant_id":519700,"application_year":2007,"start_year":2008,"scientific_title":"The Role of the Complement System in Neurodegeneration and the Therapeutic Potential of Complement Inhibition","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Trent Woodruff","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/519700","simplified_title":"The Role of Inflammation and the Potential for Therapeutic Strategies in Neurodegenerative Diseases","sub_type":"RD Wright Biomedical CDF","total_budget":"380558.72","source_system":"This project aims to identify the role of immune and inflammatory components in the pathology of neurodegenerative disease. Additionally, this research will determine whether a new class of novel anti-inflammatory drugs can alter the neurodegenerative process. This will allow for an increased understanding of the biology of neurodegenerative disease, and also may lead to the development of new treatments for conditions such as Parkinsons disease, Huntingtons disease and motor neuron disease."},"children":[{"color":"#336699","name":"A/Pr Trent Woodruff","data":{"first_name":"Trent","title":"A/Pr","dw_individual_id":"DW0011172","middle_name":"Martin","last_name":"Woodruff","source_individual_id":"5018447","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Trent Woodruff"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79741","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63356","size":1},{"color":"#FF4D4D","name":"Defining the mechanism of invasive disease caused by diverse group A streptococcal M serotypes","data":{"media_summary":"","end_year":2011,"keywords":["Bacterial genetics","Bacterial pathogen","Plasminogen","Streptococcus","Streptodornase"],"nhmrc_grant_id":514639,"application_year":2007,"start_year":2008,"scientific_title":"Defining the mechanism of invasive disease caused by diverse group A streptococcal M serotypes","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Microbiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Jason Cole","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/514639","simplified_title":"Defining the mechanism of group A streptococcal flesh-eating invasive disease","sub_type":"CJ Martin Biomedical ECF","total_budget":"393061.22","source_system":"Streptococcus pyogenes (group A Streptococcus; GAS) causes life-threatening invasive infections including flesh-eating disease and toxic shock syndrome (>600,000 cases and 163,000 deaths per year). We recently discovered the trigger for invasive disease in a globally disseminated GAS strain. The aim of this work is to determine whether this trigger applies to other strains associated with GAS invasive disease. These studies will allow the development of new therapeutics and treatments."},"children":[{"color":"#336699","name":"Dr Jason Cole","data":{"first_name":"Jason","title":"Dr","dw_individual_id":"DW0030026","middle_name":"Nicklaus","last_name":"Cole","source_individual_id":"5014012","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jason Cole"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84783","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63236","size":1},{"color":"#FF4D4D","name":"Molecular pathways mediating quiescence and resistance in leukaemia stem cells in acute myeloid leukaemia.","data":{"media_summary":"","end_year":2011,"keywords":["Acute myeloid leukaemia","Leukaemia stem cells","Oxidative stress"],"nhmrc_grant_id":511275,"application_year":2007,"start_year":2008,"scientific_title":"Molecular pathways mediating quiescence and resistance in leukaemia stem cells in acute myeloid leukaemia.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Haematology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Steven Lane","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/511275","simplified_title":"Targeting leukaemia stem cells in acute myeloid leukaemia","sub_type":"Medical Postgraduate Scholarship","total_budget":"100381","source_system":"Acute myeloid leukaemia (AML) is a devastating cancer of the blood and bone marrow which is rapidly fatal unless effectively treated with chemotherapy. AML is caused by genetic events that alter normal blood stem cells to give them a growth and survival advantage and also may confer resistance to chemotherapy in some cases. We will evaluate and target the mechanism of this resistance in laboratory models. This information can then be used to design new treatments to improve outcomes in AML."},"children":[{"color":"#336699","name":"Dr Steven Lane","data":{"first_name":"Steven","title":"Dr","dw_individual_id":"DW0026136","middle_name":"W","last_name":"Lane","source_individual_id":"5015873","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Steven Lane"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83761","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63021","size":1},{"color":"#FF4D4D","name":"Cognitive dysfunction in multiple sclerosis and its relationship to mood disturbance and fatigue","data":{"media_summary":"","end_year":2010,"keywords":["Cognitive dysfunction","Fatigue","Mood disturbance","Multiple Sclerosis","Neurological rehabilitation"],"nhmrc_grant_id":511270,"application_year":2007,"start_year":2008,"scientific_title":"Cognitive dysfunction in multiple sclerosis and its relationship to mood disturbance and fatigue","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Ms Hannah Gill","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/511270","simplified_title":"Cognitive dysfunction in multiple sclerosis and its relationship to mood disturbance and fatigue","sub_type":"Public Health Postgraduate Scholarship","total_budget":"57342.9","source_system":"This research aims to test a hypothesized model addressing the interplay between cognitive dysfunction, mood disturbance, and fatigue in people with multiple sclerosis as well as determine the associated impact on daily functioning and quality of life. The importance of background factors, disease factors and psychosocial factors in predicting cognitive dysfunction will also be investigated. Recommendations for new rehabilitation approaches will be developed in light of our findings."},"children":[{"color":"#336699","name":"Ms Hannah Gill","data":{"first_name":"Hannah","title":"Ms","dw_individual_id":"DW0036839","middle_name":"L","last_name":"Gill","source_individual_id":"5030392","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Hannah Gill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86544","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63020","size":1},{"color":"#FF4D4D","name":"EFFECT OF LIPOXIN A4 AND PROSTAGLANDIN E2 IN ASSISSTED BONE HEALING","data":{"media_summary":"","end_year":2011,"keywords":["Angiogenesis","Animal Model","Bone","Matrix Proteins","Oral biology"],"nhmrc_grant_id":511268,"application_year":2007,"start_year":2008,"scientific_title":"EFFECT OF LIPOXIN A4 AND PROSTAGLANDIN E2 IN ASSISSTED BONE HEALING","node_source":"NHMRC","node_type":"Grant","field_of_research":"Immunology not elsewhere classified","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Srinivas Varanasi","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/511268","simplified_title":"Effect of Lipoxin A4 or Prostaglandin E2 and polymer foam scaffolds on healing of surgical defect in rat mandible.","sub_type":"Dental Postgraduate Research Scholarship","total_budget":"118796.29","source_system":"Bone healing and repair following trauma involves a complex series of events at both the cellular and molecular levels. This study aims to determine that local application of optimal dose of lipoxin A4 (promote resolution of inflammation) and prostaglandin E2 (low dosage stimulating localised bone formation) will promote healing following the placement of polymer foam in the defect, there by develop a therapy where bone deposition is accelerated and healing is enhanced."},"children":[{"color":"#336699","name":"Srinivas Varanasi","data":{"first_name":"Srinivas","title":"","dw_individual_id":"DW0022704","middle_name":"","last_name":"Varanasi","source_individual_id":"5018085","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Srinivas Varanasi"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82848","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63019","size":1},{"color":"#FF4D4D","name":"Clinical utility of new non-invasive assessments of left ventricular function.","data":{"media_summary":"","end_year":2009,"keywords":["Cardiovascular disease and hypertension","Echocardiography","Left ventricular function","Test-retest reproducibility"],"nhmrc_grant_id":511266,"application_year":2007,"start_year":2008,"scientific_title":"Clinical utility of new non-invasive assessments of left ventricular function.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr James Hare","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/511266","simplified_title":"Assessment of the clinical application of new techniques to non-invasively assess left heart function.","sub_type":"Medical Postgraduate Scholarship","total_budget":"48361.69","source_system":"This project involves a series of studies that investigate the use of new ultrasound measurements of heart function in order to assess whether or nor they make a meaningful contribution to patient management, both in terms of diagnosis and monitoring of treatments. Major studies include: 1) Detection and prevention of early heart disease in patients who are undergoing toxic chemotherapy for cancer; and 2) Investigation and treatment of patients with a high blood pressure response to exercise."},"children":[{"color":"#336699","name":"Dr James Hare","data":{"first_name":"James","title":"Dr","dw_individual_id":"DW0002035","middle_name":"Linley","last_name":"Hare","source_individual_id":"RMIS4744497","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr James Hare"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77222","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63018","size":1},{"color":"#FF4D4D","name":"Transient receptor potential calcium channels in breast cancer cell proliferation, apoptosis and invasiveness","data":{"media_summary":"","end_year":2011,"keywords":["Breast cancer","Calcium signalling","Molecular pharmacology"],"nhmrc_grant_id":511262,"application_year":2007,"start_year":2008,"scientific_title":"Transient receptor potential calcium channels in breast cancer cell proliferation, apoptosis and invasiveness","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Felicity Davis","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/511262","simplified_title":"The role of the TRP calcium channels in breast cancer","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"104018.71","source_system":"Calcium is a highly regulated signal used by cells to control processes such as growth and division, cell death and motility. Calcium channels let calcium into the cells, and specific calcium channel types are overexpressed in cancers, including those of the prostate and breast. In this research, we will assess the role of specific calcium permeable channels known as TRPs in breast cancer and the consequences of their inhibition on breast cancer cell growth and survival."},"children":[{"color":"#336699","name":"Dr Felicity Davis","data":{"first_name":"Felicity","title":"Dr","dw_individual_id":"DW0012644","middle_name":"M","last_name":"Davis","source_individual_id":"5014234","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Felicity Davis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80126","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63017","size":1},{"color":"#FF4D4D","name":"Evaluation of anterior hip muscle function in the presence of osteoarthritis","data":{"media_summary":"","end_year":2012,"keywords":["hip joint","magnetic resonance imaging","muscle","osteoarthritis","rehabilitation"],"nhmrc_grant_id":511258,"application_year":2007,"start_year":2008,"scientific_title":"Evaluation of anterior hip muscle function in the presence of osteoarthritis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Mrs Marianne Mendis","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/511258","simplified_title":"A study of the anterior hip muscles in the presence of osteoarthritis","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"88237.35","source_system":"Hip osteoarthritis is a disease with significant costs to the individual, the community and the healthcare system. This research study aims to investigate muscle function at the front of the hip joint in healthy and osteoarthritic hips. Expected outcomes are the identification of muscle imbalances and weakness due to osteoarthritis. This information will help to design effective physiotherapy treatment for this population so that further degeneration may be prevented."},"children":[{"color":"#336699","name":"Dr Marianne Mendis","data":{"first_name":"Marianne","title":"Dr","dw_individual_id":"DW0020840","middle_name":"Dilani","last_name":"Mendis","source_individual_id":"5016436","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Marianne Mendis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82331","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63015","size":1},{"color":"#FF4D4D","name":"Genomic characterisation of Asbestos Related Lung Cancer","data":{"media_summary":"","end_year":2011,"keywords":["ArrayCGH","Gene expression","Gene regulation","Microarrays"],"nhmrc_grant_id":511255,"application_year":2007,"start_year":2008,"scientific_title":"Genomic characterisation of Asbestos Related Lung Cancer","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Clinical Medicine and Science","for_category":"GENETICS","cia_name":"Dr Casey Wright","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/511255","simplified_title":"Gene abnormalities in lung cancers related to asbestos","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"88099.29","source_system":"Lung cancer causes more deaths in Australia than any other cancer. Smoking is the main cause, but people exposed to asbestos are also at risk, and it can be difficult to know whether a case is due to tobacco, asbestos or both. We will study lung cancer genes in people with asbestos exposure to find whether asbestos lung cancer has a specific pattern of abnormal genes (signature). If so, this could help people entitled to compensation, and also point to new treatments for asbestos lung cancer"},"children":[{"color":"#336699","name":"Dr Casey Wright","data":{"first_name":"Casey","title":"Dr","dw_individual_id":"DW0028940","middle_name":"Maree","last_name":"Wright","source_individual_id":"5018591","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Casey Wright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84503","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63014","size":1},{"color":"#FF4D4D","name":"the molecular basis for the initiation of squamous differentiation and how it is disrupted in oral cancers","data":{"media_summary":"","end_year":2009,"keywords":["epithelium","keratinocyte","squamous cell carcinoma","squamous differentiation"],"nhmrc_grant_id":511250,"application_year":2007,"start_year":2008,"scientific_title":"the molecular basis for the initiation of squamous differentiation and how it is disrupted in oral cancers","node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Orla Gannon","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/511250","simplified_title":"how do mouth cancers form","sub_type":"Dental Postgraduate Research Scholarship","total_budget":"64631","source_system":"Squamous cancers of the mouth, nose and throat occur due to defects in the cells that line these regions. We have shown that a major defect is that the lining cells are unable to stop growing and mature into cells that provide a barrier against the environment. In this proposal we will undertake studies to identify why these cancers cells do not mature properly. In doing so we will be able to identify new strategies that may be used to treat patients with this frequently deadly cancer."},"children":[{"color":"#336699","name":"Orla Gannon","data":{"first_name":"Orla","title":"","dw_individual_id":"DW0042551","middle_name":"","last_name":"Gannon","source_individual_id":"RMIS5553750","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Orla Gannon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88035","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63013","size":1},{"color":"#FF4D4D","name":"Multidimensional Coding of Visual Information in the Retina","data":{"media_summary":"","end_year":2010,"keywords":["central nervous system","neuroanatomy","neurophysiology","retina","vision"],"nhmrc_grant_id":511242,"application_year":2007,"health_keywords":["eyes and vision","retinal function","visual function"],"scientific_title":"Multidimensional Coding of Visual Information in the Retina","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof David Vaney","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511242","simplified_title":"Parallel Processing in the Retina","sub_type":"Standard Project Grant","total_budget":"359431.08","source_system":"Although both the retina and visual cortex are part of the central nervous system, the coding of visual information in the two laminar structures differs markedly in that all three dimensions of the cortical sheet are used to code multiple response axes but only one dimension of the retinal sheet. This project examines how visual response properties are mapped through the depth of the retina and this will provide a comparatively simple paradigm of complex information processing in the brain."},"children":[{"color":"#336699","name":"Prof David Vaney","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0028555","middle_name":"I","last_name":"Vaney","source_individual_id":"RMIS52594","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Vaney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84390","size":1},{"color":"#336699","name":"A/Pr Nathan Hart","data":{"first_name":"Nathan","title":"A/Pr","dw_individual_id":"DW0019488","middle_name":"S","last_name":"Hart","source_individual_id":"5015121","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nathan Hart"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81963","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63012","size":1},{"color":"#FF4D4D","name":"The efficacy of novel, non-robotic devices to train reaching post stroke","data":{"media_summary":"upper limb hemiplegia","end_year":2013,"keywords":["motor control","physical impairment","physiotherapy","rehabilitation","stroke"],"nhmrc_grant_id":511241,"application_year":2007,"health_keywords":["motor recovery","rehabilitation of motor function","stroke rehabilitation","treatment strategies","upper limb hemiplegia"],"scientific_title":"The efficacy of novel, non-robotic devices to train reaching post stroke","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Sandra Brauer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511241","simplified_title":"Training reaching post stroke","sub_type":"Standard Project Grant","total_budget":"491605.42","source_system":"Up to 50% of stroke survivors are left with upper limb disability that limits their daily activities and their paralysis is so severe that it excludes them from training with the most effective methods. This study is a clinical trial of innovative new techniques to assist people with severe upper limb paralysis to reach following stroke. Positive results are likely to reduce disability in a large number of stroke survivors and has the potential to be used by other patients with paralysis."},"children":[{"color":"#336699","name":"Prof Richard Carson","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0041489","middle_name":"G","last_name":"Carson","source_individual_id":"5013819","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Carson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87761","size":1},{"color":"#336699","name":"Prof Sandra Brauer","data":{"first_name":"Sandra","title":"Prof","dw_individual_id":"DW0035524","middle_name":"G","last_name":"Brauer","source_individual_id":"5013589","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sandra Brauer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86203","size":1},{"color":"#336699","name":"Dr Ruth Barker","data":{"first_name":"Ruth","title":"Dr","dw_individual_id":"DW0035256","middle_name":"N","last_name":"Barker","source_individual_id":"5013333","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ruth Barker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86139","size":1},{"color":"#336699","name":"Prof Andrew Cresswell","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0018461","middle_name":"G","last_name":"Cresswell","source_individual_id":"5014129","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Andrew Cresswell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81727","size":1},{"color":"#336699","name":"Prof Stephen Wilson","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0005484","middle_name":"James","last_name":"Wilson","source_individual_id":"5028658","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stephen Wilson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78193","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63011","size":1},{"color":"#FF4D4D","name":"Optimising corticosteroid injection for lateral epicondylalgia with physiotherapy: a randomised placebo control trial.","data":{"media_summary":"long term treatment outcome","end_year":2012,"keywords":["clinical trial","muscle tendon","musculoskeletal pain","physiotherapy","primary health care"],"nhmrc_grant_id":511238,"application_year":2007,"health_keywords":["corticosteroids","iatrogenic","injury rehabilitation and management","lateral epicondylalgia (tennis elbow)","long term treatment outcome"],"scientific_title":"Optimising corticosteroid injection for lateral epicondylalgia with physiotherapy: a randomised placebo control trial.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Guglielmo Vicenzino","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511238","simplified_title":"Can steroid injections for tennis elbow be improved by adding physiotherapy and are they any better than placebo?","sub_type":"Standard Project Grant","total_budget":"373393.83","source_system":"Tennis elbow affects just under 1% of patients seeing a doctor and on average 10-30% need to take 12 weeks off work. Two popular treatments are physiotherapy and corticosteroid injections. We have recently shown that whilst injection is superior in the short term (3 weeks) compared to physiotherapy, it is responsible for 9 times more recurrences. We seek a solution for the downside to steroid injections, by studying the effects of adding physiotherapy; as such it will address a major problem."},"children":[{"color":"#336699","name":"Prof Guglielmo Vicenzino","data":{"first_name":"Guglielmo","title":"Prof","dw_individual_id":"DW0046019","middle_name":"Tarcisio","last_name":"Vicenzino","source_individual_id":"5018115","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Guglielmo Vicenzino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88911","size":1},{"color":"#336699","name":"Prof Peter Brooks","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0035559","middle_name":"M","last_name":"Brooks","source_individual_id":"5013624","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Brooks"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86210","size":1},{"color":"#336699","name":"Dr Leanne Bisset","data":{"first_name":"Leanne","title":"Dr","dw_individual_id":"DW0035399","middle_name":"Margaret","last_name":"Bisset","source_individual_id":"5013491","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Leanne Bisset"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86173","size":1},{"color":"#336699","name":"Prof Luke Connelly","data":{"first_name":"Luke","title":"Prof","dw_individual_id":"DW0030066","middle_name":"Brian","last_name":"Connelly","source_individual_id":"5012629","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Luke Connelly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84790","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63010","size":1},{"color":"#FF4D4D","name":"Regulation of caspase-1 activation and inflammation by PYD and CARD proteins","data":{"media_summary":"rheumatoid arthritis","end_year":2011,"keywords":["NMR spectroscopy","biochemistry","protein structure","protein-protein interaction"],"nhmrc_grant_id":511227,"application_year":2007,"health_keywords":["familial Mediterranean fever","infection-acute inflammation","inflammatory diseases","innate immunity","rheumatoid arthritis"],"scientific_title":"Regulation of caspase-1 activation and inflammation by PYD and CARD proteins","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Justine Hill","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511227","simplified_title":"Regulation of caspase-1 activation and inflammation","sub_type":"Standard Project Grant","total_budget":"364549.81","source_system":"Inflammatory diseases such as rheumatoid arthritis are among the largest contributors to health expenditure in Australia, and the impact of these diseases will increase dramatically over the next 15-20 years as the population ages. This research will reveal new insights into the regulation of caspase-1 activation and secretion of interleukin-1b, the primary cause of chronic and acute inflammation, and will enhance future approaches for development of treatments for inflammatory disease."},"children":[{"color":"#336699","name":"Dr Justine Hill","data":{"first_name":"Justine","title":"Dr","dw_individual_id":"DW0013656","middle_name":"Maria","last_name":"Hill","source_individual_id":"RMIS706133","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Justine Hill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80384","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63009","size":1},{"color":"#FF4D4D","name":"Pathogenomics: new ways to exploit genome sequence data from pathogenic bacteria.","data":{"media_summary":"Urinary tract infection","end_year":2011,"keywords":["Bacterial genetics","Bacterial pathogen","Bioinformatics","Enteric infections","Host-pathogen interaction"],"nhmrc_grant_id":511224,"application_year":2007,"health_keywords":["Bacterial pathogenicity","Enteric infection","Genomics","Pseudomonas aeruginosa","Urinary tract infection"],"scientific_title":"Pathogenomics: new ways to exploit genome sequence data from pathogenic bacteria.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Scott Beatson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511224","simplified_title":"Pathogenomics: new ways to exploit genome sequence data from pathogenic bacteria.","sub_type":"New Investigator Grant","total_budget":"547372.81","source_system":"Bacterial pathogens are locked in an evolutionary battle of survival with their eukaryote hosts. The rapidly evolving genes of medically-important pathogens are generally those required for adaptation to the human host. This project aims to exploit the abundance of available bacterial genome sequences to predict rapid evolution in bacterial pathogens using computational methods. The protein products of such genes offer novel targets for therapeutic intervention."},"children":[{"color":"#336699","name":"Dr Scott Beatson","data":{"first_name":"Scott","title":"Dr","dw_individual_id":"DW0035306","middle_name":"A","last_name":"Beatson","source_individual_id":"5013405","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Scott Beatson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86151","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63008","size":1},{"color":"#FF4D4D","name":"Obesity-related inflammation and insulin resistance in chronic liver disease: Exercise and diet as treatment options","data":{"media_summary":"obesity-metabolism","end_year":2012,"keywords":["Cytokine","Insulin resistance","Lifestyle factors","Liver","Obesity"],"nhmrc_grant_id":511219,"application_year":2007,"health_keywords":["Hepatic insulin resistance","Hepatitis C","exercise training","fatty liver disease","obesity-metabolism"],"scientific_title":"Obesity-related inflammation and insulin resistance in chronic liver disease: Exercise and diet as treatment options","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Ingrid Hickman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511219","simplified_title":"Obesity and liver disease: Contributors to liver injury and the role or exercise and weight loss as treatment options","sub_type":"New Investigator Grant","total_budget":"540509.58","source_system":"The two most common types of liver disease in Australia are chronic hepatitis C (Hep C) and fatty liver disease and both result in more severe liver injury when the person is overweight. We propose to test if weight loss through lifestyle changes such as improving diet or increasing exercise are suitable treatment alternatives for people living with liver disease. This will help doctors better advise patients as to what they can do themselves to improve the health of their liver."},"children":[{"color":"#336699","name":"Dr Ingrid Hickman","data":{"first_name":"Ingrid","title":"Dr","dw_individual_id":"DW0043028","middle_name":"J","last_name":"Hickman","source_individual_id":"5015215","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ingrid Hickman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88150","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63007","size":1},{"color":"#FF4D4D","name":"The use of soluble antagonists of EphA4 in spinal cord injuries","data":{"media_summary":"spinal cord injury","end_year":2010,"keywords":["Eph-ephrin signalling","movement dysfunction","neural regeneration","neurite outgrowth","spinal cord injury"],"nhmrc_grant_id":511212,"application_year":2007,"health_keywords":["motor recovery","nerve damage","nerve regeneration","nerve repair","spinal cord injury"],"scientific_title":"The use of soluble antagonists of EphA4 in spinal cord injuries","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Perry Bartlett","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511212","simplified_title":"Is recovery from spinal cord injuries improved if we neutralise EphA4","sub_type":"Standard Project Grant","total_budget":"622361.35","source_system":"Permanent and limited recovery of function following spinal cord injury is a direct result of the lack of nerve regrowth through the injury. Our preliminary data suggest that antagonising the effects of EphA4, a protein involved in brain development, leads to substantial functional recovery simultaneous with nerve regrowth. In addition to designing new, more effective blockers of EphA4, we will study the signalling pathways that EphA4 activates to inhibit nerve regrowth."},"children":[{"color":"#336699","name":"Prof Dimitar Nikolov","data":{"first_name":"Dimitar","title":"Prof","dw_individual_id":"DW0038795","middle_name":"B","last_name":"Nikolov","source_individual_id":"RMIS5240556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Dimitar Nikolov"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87046","size":1},{"color":"#336699","name":"Prof Andrew Boyd","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0023731","middle_name":"W","last_name":"Boyd","source_individual_id":"RMIS3609","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Andrew Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83095","size":1},{"color":"#336699","name":"A/Pr Ann Turnley","data":{"first_name":"Ann","title":"A/Pr","dw_individual_id":"DW0016752","middle_name":"M","last_name":"Turnley","source_individual_id":"5019345","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ann Turnley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81253","size":1},{"color":"#336699","name":"Prof Perry Bartlett","data":{"first_name":"Perry","title":"Prof","dw_individual_id":"DW0011651","middle_name":"Francis","last_name":"Bartlett","source_individual_id":"5013357","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Perry Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79864","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63004","size":1},{"color":"#FF4D4D","name":"An efficacy study of a cognitive-communicative intervention to improve transition to residential care in dementia","data":{"media_summary":"","end_year":2012,"keywords":["Behavioural intervention","Cognitive impairment","Community geriatrics","Dementia","Memory"],"nhmrc_grant_id":511208,"application_year":2007,"start_year":2008,"scientific_title":"An efficacy study of a cognitive-communicative intervention to improve transition to residential care in dementia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Residential Client Care","research_area":"Clinical Medicine and Science","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Helen Chenery","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/511208","simplified_title":"Training caregivers to improve the transition from home to residential care in dementia","sub_type":"Dementia Research Grants Program","total_budget":"681083.38","source_system":"The transition from home to a residential aged care facility (RACF) is a potentially traumatic process that has a negative impact on the health and well-being of both people with dementia and their caregivers. This project will develop an intervention program for people with dementia that maximizes their ability to learn and retain functional skills and that enhances the communicative competence of both people with dementia and their carergivers. This will serve to minimize the stress and disorientation, as well as accompanying increased risk of illness, of entering residential care. We will investigate whether this intervention program has good outcomes both for the people with dementia as well as their caregivers. The research will develop guidelines for the development of best-practice policies for service providers and the government, which will assist both health workers and homebased caregivers to better manage the transition of people with dementia from home to the RACF environment."},"children":[{"color":"#336699","name":"Dr Anthony Angwin","data":{"first_name":"Anthony","title":"Dr","dw_individual_id":"DW0029171","middle_name":"J","last_name":"Angwin","source_individual_id":"5013213","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Anthony Angwin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84566","size":1},{"color":"#336699","name":"Prof Desley Hegney","data":{"first_name":"Desley","title":"Prof","dw_individual_id":"DW0025422","middle_name":"Gail","last_name":"Hegney","source_individual_id":"5015186","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Desley Hegney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83545","size":1},{"color":"#336699","name":"Prof Gerard Byrne","data":{"first_name":"Gerard","title":"Prof","dw_individual_id":"DW0023904","middle_name":"James","last_name":"Byrne","source_individual_id":"5013745","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gerard Byrne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83133","size":1},{"color":"#336699","name":"Prof Helen Chenery","data":{"first_name":"Helen","title":"Prof","dw_individual_id":"DW0018206","middle_name":"J","last_name":"Chenery","source_individual_id":"5013884","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Helen Chenery"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81660","size":1},{"color":"#336699","name":"E/Pr Cindy Gallois","data":{"first_name":"Cindy","title":"E/Pr","dw_individual_id":"DW0013152","middle_name":"","last_name":"Gallois","source_individual_id":"5014762","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"E/Pr Cindy Gallois"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80253","size":1},{"color":"#336699","name":"Prof Michael Humphreys","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0008036","middle_name":"S","last_name":"Humphreys","source_individual_id":"RMIS1713125","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Humphreys"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78874","size":1},{"color":"#336699","name":"Prof Nancy Pachana","data":{"first_name":"Nancy","title":"Prof","dw_individual_id":"DW0003819","middle_name":"Ann","last_name":"Pachana","source_individual_id":"RMIS1713128","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Nancy Pachana"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77727","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63003","size":1},{"color":"#FF4D4D","name":"Inhibition of histidine kinase signal sensing: a novel paradigm for antimicrobial development","data":{"media_summary":"nosocomial infections","end_year":2010,"keywords":["X-ray crystallography","nuclear magnetic resonance (NMR)","protein structure","staphylococcus","two-component signal transduction"],"nhmrc_grant_id":511206,"application_year":2007,"health_keywords":["Staphylococcus aureus","antibiotics","infectious disease","multiply-resistant staphylococci","nosocomial infections"],"scientific_title":"Inhibition of histidine kinase signal sensing: a novel paradigm for antimicrobial development","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Glenn King","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511206","simplified_title":"Development of antibiotics for treatment of infections caused by Golden Staph and other bacteria","sub_type":"Standard Project Grant","total_budget":"464144.68","source_system":"Staphylococcus aureus (Golden staph) has been termed a superbug because of its remarkable ability to acquire resistance to virtually all antibiotics. Until recently, Golden Staph infections were almost always acquired in hospitals, but the increasing incidence of community-acquired S. aureus infections has rendered it a major public health threat in Australia. The aim of this research is to develop antimicrobial agents to combat antibiotic-resistant strains of Staphylococcus aureus."},"children":[{"color":"#336699","name":"Prof Jill Trewhella","data":{"first_name":"Jill","title":"Prof","dw_individual_id":"DW0045912","middle_name":"","last_name":"Trewhella","source_individual_id":"5017991","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jill Trewhella"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88883","size":1},{"color":"#336699","name":"Prof Graeme Nimmo","data":{"first_name":"Graeme","title":"Prof","dw_individual_id":"DW0038799","middle_name":"Robert","last_name":"Nimmo","source_individual_id":"5012699","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Graeme Nimmo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87047","size":1},{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1},{"color":"#336699","name":"E/Pr Jules Guss","data":{"first_name":"Jules","title":"E/Pr","dw_individual_id":"DW0001959","middle_name":"M","last_name":"Guss","source_individual_id":"5018883","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"E/Pr Jules Guss"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77203","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63002","size":1},{"color":"#FF4D4D","name":"ASSESSMENT OF ENDOPLASMIC RETICULUM STRESS AND MUTATIONS IN MUCIN OLIGOMERIZATION DOMAINS IN ULCERATIVE COLITIS","data":{"media_summary":"","end_year":2010,"keywords":["endoplasmic reticulum stress disease","genetic polymorphisms","mucins, IBD","pathophysiology","ulcerative colitis"],"nhmrc_grant_id":511204,"application_year":2007,"health_keywords":["gastrointestinal disease","pathogenic mechanisms","ulcerative colitis"],"scientific_title":"ASSESSMENT OF ENDOPLASMIC RETICULUM STRESS AND MUTATIONS IN MUCIN OLIGOMERIZATION DOMAINS IN ULCERATIVE COLITIS","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gastroenterology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Timothy Florin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511204","simplified_title":"MUCIN MISFOLDING AND ER STRESS IN ULCERATIVE COLITIS","sub_type":"Standard Project Grant","total_budget":"292216.81","source_system":"Ulcerative colitis affects 0.2% of Australians causing chronic or recurrent health morbidity and affecting employment. In severe cases it is life threatening. Its pathogenesis remains poorly understood. We have exciting and novel preliminary data from humans and informed by our unique animal models that make us propose that the disease is caused by Endoplasmic Reticulum Stress due to misfolding of mucin. We have designed fully powered prospective clinical and lab studies to test this hypothesis."},"children":[{"color":"#336699","name":"Prof Michael Mcguckin","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0044168","middle_name":"A","last_name":"Mcguckin","source_individual_id":"5016335","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Mcguckin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88447","size":1},{"color":"#336699","name":"Dr Rajaraman Eri","data":{"first_name":"Rajaraman","title":"Dr","dw_individual_id":"DW0042281","middle_name":"D","last_name":"Eri","source_individual_id":"5014527","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Rajaraman Eri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87973","size":1},{"color":"#336699","name":"Prof Timothy Florin","data":{"first_name":"Timothy","title":"Prof","dw_individual_id":"DW0013048","middle_name":"H","last_name":"Florin","source_individual_id":"5014662","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Timothy Florin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80228","size":1},{"color":"#336699","name":"Dr Elizabeth Fowler","data":{"first_name":"Elizabeth","title":"Dr","dw_individual_id":"DW0007333","middle_name":"V","last_name":"Fowler","source_individual_id":"5014686","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Elizabeth Fowler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78682","size":1},{"color":"#336699","name":"A/Pr Graham Radford-Smith","data":{"first_name":"Graham","title":"A/Pr","dw_individual_id":"DW0004114","middle_name":"Lindsay","last_name":"Radford-Smith","source_individual_id":"5017093","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Graham Radford-Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77816","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63001","size":1},{"color":"#FF4D4D","name":"Role of obesity in impaired treatment response in chronic hepatitis C: mechanisms and therapeutic strategies","data":{"media_summary":"","end_year":2010,"keywords":["antiviral therapy","hepatitis c","insulin resistance","interferon signaling","obesity"],"nhmrc_grant_id":511201,"application_year":2007,"health_keywords":["hepatitis c","insulin resistance","interferon - ribavirin treatment","obesity"],"scientific_title":"Role of obesity in impaired treatment response in chronic hepatitis C: mechanisms and therapeutic strategies","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Elizabeth Powell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511201","simplified_title":"Role of obesity in impaired treatment response in chronic hepatitis C: mechanisms and therapeutic strategies","sub_type":"Standard Project Grant","total_budget":"540075.08","source_system":"The overall objective of this Research Project is to examine the mechanisms by which obesity and fatty liver impair the response to antiviral treatment in patients with chronic hepatitis C and to develop specific strategies to monitor and improve the outcome of treatment. In addition, the development of non-invasive strategies and surrogate cell culture systems for the assessment and serial monitoring of the antiviral response will be of substantial benefit."},"children":[{"color":"#336699","name":"Prof Elizabeth Powell","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0044903","middle_name":"Ellen","last_name":"Powell","source_individual_id":"RMIS13575","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Powell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88622","size":1},{"color":"#336699","name":"A/Pr Andrew Clouston","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0030002","middle_name":"Donald","last_name":"Clouston","source_individual_id":"RMIS228640","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Andrew Clouston"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84776","size":1},{"color":"#336699","name":"Dr Scott Ward","data":{"first_name":"Scott","title":"Dr","dw_individual_id":"DW0016960","middle_name":"M","last_name":"Ward","source_individual_id":"5018192","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Scott Ward"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81314","size":1},{"color":"#336699","name":"A/Pr Julie Jonsson","data":{"first_name":"Julie","title":"A/Pr","dw_individual_id":"DW0002506","middle_name":"R","last_name":"Jonsson","source_individual_id":"5015557","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Julie Jonsson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77348","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/63000","size":1},{"color":"#FF4D4D","name":"Characterisation of neural stem cells in the ageing mammalian brain","data":{"media_summary":"neurodegeneration","end_year":2009,"keywords":["Neural stem cell","ageing","cell proliferation","neurobiology","regeneration"],"nhmrc_grant_id":511200,"application_year":2007,"health_keywords":["Nervous system repair","ageing","brain cell culture","mental health","neurodegeneration"],"scientific_title":"Characterisation of neural stem cells in the ageing mammalian brain","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Rodney Rietze","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511200","simplified_title":"Neural stem cells in the ageing brain","sub_type":"Standard Project Grant","total_budget":"182411.5","source_system":"Due to their relatively recent discovery, little is known about how stem cells in the brain are affected by age. This work will initially focus on understanding how age affects the number of stem cells found in the brain, and how their normal function and regenerative capacity are compromised with increasing age. The second phase of this study will examine how we can slow or even reverse these age-related changes on stem cells by environmental manipulation."},"children":[{"color":"#336699","name":"Rodney Rietze","data":{"first_name":"Rodney","title":"","dw_individual_id":"DW0004241","middle_name":"","last_name":"Rietze","source_individual_id":"RMIS1220749","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Rodney Rietze"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77852","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62999","size":1},{"color":"#FF4D4D","name":"Investigating A Novel Generic Approach To Anti-Infective Agents","data":{"media_summary":"","end_year":2010,"keywords":["bacteria","helix","protein","structure","virus"],"nhmrc_grant_id":511194,"application_year":2007,"health_keywords":["antibacterial","antiviral","diagnostic","infectious disease"],"scientific_title":"Investigating A Novel Generic Approach To Anti-Infective Agents","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511194","simplified_title":"Testing A Rational Approach To Blocking Infection","sub_type":"Standard Project Grant","total_budget":"636833.21","source_system":"Alpha helical regions of proteins mediate infection by viruses and bacteria. Short peptides corresponding to these helical segments are unstructured in water. We will (a) test new technology for its generic capacity to stabilize 1-4 turns of alpha helical viral and bacterial peptides, (b) test small molecules for helical structure, and (c) test for antiviral, antibacterial or immunogenicity activity in cell assays. Proof of the technology may benefit many fields of medicine and health prevention."},"children":[{"color":"#336699","name":"A/Pr Paul Young","data":{"first_name":"Paul","title":"A/Pr","dw_individual_id":"DW0046476","middle_name":"Michael","last_name":"Young","source_individual_id":"5018539","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/89039","size":1},{"color":"#336699","name":"A/Pr Gilda Tachedjian","data":{"first_name":"Gilda","title":"A/Pr","dw_individual_id":"DW0045726","middle_name":"","last_name":"Tachedjian","source_individual_id":"RMIS676851","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Gilda Tachedjian"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88828","size":1},{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62998","size":1},{"color":"#FF4D4D","name":"MC1R polymorphisms associated with skin cancer risk phenotypes","data":{"media_summary":"population variation in cancer risk","end_year":2010,"keywords":["keratinocyte","melanocortin-1 receptor","melanocyte","pigmentation","polymorphism"],"nhmrc_grant_id":511191,"application_year":2007,"health_keywords":["cancer-melanoma","cell signalling","gene expression","genetic predisposition to disease","population variation in cancer risk"],"scientific_title":"MC1R polymorphisms associated with skin cancer risk phenotypes","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Richard Sturm","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511191","simplified_title":"MC1R in skin cancer risk phenotypes","sub_type":"Standard Project Grant","total_budget":"519715.21","source_system":"Sunsmart campaigns are a unifying element in the lives of many Australians who wish to ensure protection against the damaging effects of UV rays in sunlight. Although it is evident that lighter skin colours are more susceptible to sun damage, the relationship between sun exposure, skin type and melanoma formation is less clear. It is essential to understand the complex interactions that give rise to melanoma and to identify the genes in individuals that are responsible for this increased risk."},"children":[{"color":"#336699","name":"A/Pr Richard Sturm","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0045672","middle_name":"Alan","last_name":"Sturm","source_individual_id":"5017777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Sturm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88811","size":1},{"color":"#336699","name":"Dr J. Helen Leonard","data":{"first_name":"J. Helen","title":"Dr","dw_individual_id":"DW0032048","middle_name":"","last_name":"Leonard","source_individual_id":"5015934","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr J. Helen Leonard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85289","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62997","size":1},{"color":"#FF4D4D","name":"Mechanisms contributing to long-term neuronal loss after hypoxia-ischemia in the premature neonate brain.","data":{"media_summary":"prematurity","end_year":2011,"keywords":["hypoxia-ischaemia-reperfusion injury to the brain","neurodegeneration","perinatal brain damage","prematurity"],"nhmrc_grant_id":511189,"application_year":2007,"health_keywords":["hypoxic-ischaemic encephalopathy","neonatal brain injury","neuroanatomical connections","neuronal degeneration and loss of brain function","prematurity"],"scientific_title":"Mechanisms contributing to long-term neuronal loss after hypoxia-ischemia in the premature neonate brain.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Kathryn Buller","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511189","simplified_title":"Characterising on-going brain injury from preterm birth to adulthood.","sub_type":"Standard Project Grant","total_budget":"432535.81","source_system":"A lack of oxygen (hypoxia) and blood flow to the brain (ischemia) around the time of birth can cause brain injury that perists into adulthood. The burdens on financial, educational and healthcare resources are enormous. We will improve our understanding of what parts of the brain are injured and the mechanisms contributing to on-going brain injury after hypoxia-ischemia.This is important to devise treatments and to provide a healthy start to life for neonates."},"children":[{"color":"#336699","name":"A/Pr Glenda Gobe","data":{"first_name":"Glenda","title":"A/Pr","dw_individual_id":"DW0042655","middle_name":"Carolyn","last_name":"Gobe","source_individual_id":"5012448","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Glenda Gobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88060","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1},{"color":"#336699","name":"Dr Kathryn Buller","data":{"first_name":"Kathryn","title":"Dr","dw_individual_id":"DW0006311","middle_name":"Marie","last_name":"Buller","source_individual_id":"5013676","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kathryn Buller"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78421","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62996","size":1},{"color":"#FF4D4D","name":"CAM use among mid-age women: a national mixed-methods study across the urban-rural divide","data":{"media_summary":"","end_year":2012,"keywords":["Chronic disease","Complementary medicine","Geographic variations","Women s health"],"nhmrc_grant_id":511181,"application_year":2007,"start_year":2008,"scientific_title":"CAM use among mid-age women: a national mixed-methods study across the urban-rural divide","node_source":"NHMRC","node_type":"Grant","field_of_research":"Complementary-Alternative Medicine not elsewhere classified","research_area":"Health Services Research","for_category":"COMPLEMENTARY-ALTERNATIVE MEDICINE","cia_name":"Prof Jonathan Adams","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/511181","simplified_title":"CAM use among mid-age women","sub_type":"Complimentary and Alternative Medicines","total_budget":"452251.09","source_system":"The aim of this project is to understand and explain why higher proportions of mid-age women in regional areas use complementary and alternative medicine (CAM) than those in urban areas of Australia. Such work will provide an evidence-base for policy and practice on this topic and the project findings will help develop CAM initiatives and programs for womens health that are sensitive to geographical variations in community health, health practice and provision. Women are significantly more likely to utilise CAM treatments than males and mid-age women have been found to be the highest CAM user group amongst Australian women. Researchers and practitioners have identified treatments from within CAM as potentially well-suited to dealing with a range of health problems and associated symptoms prevalent amongst mid-age women including the onset of cancer, arthritis, diabetes and asthma as well as menopause. Our previous pilot work found that mid-age women in regional areas are significantly more likely to use CAM than those in urban areas. A number of explanations as to why this is so can be or have been proposed. These include: limited access to conventional health care services in regional areas; closer working ties between non-urban general practitioners and CAM provision; dissatisfaction with conventional health care services in regional areas and stronger informal community networks in nonurban areas. Our proposed project, drawing upon a national representative sample of mid-age women will test such hypotheses and will provide findings of benefit and interest to policy makers, practitioners, consumers and all involved in womens health and health care across urban and regional Australia."},"children":[{"color":"#336699","name":"Prof Jonathan Adams","data":{"first_name":"Jonathan","title":"Prof","dw_individual_id":"DW0040733","middle_name":"","last_name":"Adams","source_individual_id":"RMIS1688445","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jonathan Adams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87562","size":1},{"color":"#336699","name":"E/Pr John Humphreys","data":{"first_name":"John","title":"E/Pr","dw_individual_id":"DW0031447","middle_name":"Stirling","last_name":"Humphreys","source_individual_id":"5015394","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"E/Pr John Humphreys"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85141","size":1},{"color":"#336699","name":"Prof Marc Cohen","data":{"first_name":"Marc","title":"Prof","dw_individual_id":"DW0030019","middle_name":"Maurice","last_name":"Cohen","source_individual_id":"5012666","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Marc Cohen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84781","size":1},{"color":"#336699","name":"A/Pr Marie Pirotta","data":{"first_name":"Marie","title":"A/Pr","dw_individual_id":"DW0027365","middle_name":"Vera","last_name":"Pirotta","source_individual_id":"RMIS999986","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Marie Pirotta"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84069","size":1},{"color":"#336699","name":"A/Pr Alexander Broom","data":{"first_name":"Alexander","title":"A/Pr","dw_individual_id":"DW0023800","middle_name":"F","last_name":"Broom","source_individual_id":"5013649","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Alexander Broom"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83113","size":1},{"color":"#336699","name":"A/Pr Deborah Loxton","data":{"first_name":"Deborah","title":"A/Pr","dw_individual_id":"DW0020495","middle_name":"J","last_name":"Loxton","source_individual_id":"5019044","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Deborah Loxton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82234","size":1},{"color":"#336699","name":"Prof David Sibbritt","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0010254","middle_name":"W","last_name":"Sibbritt","source_individual_id":"5017488","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Sibbritt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79484","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62994","size":1},{"color":"#FF4D4D","name":"Family care-giving for CALD people living with dementia: the perspectives of family carers and health service providers","data":{"media_summary":"","end_year":2011,"keywords":["Carers","Dementia","Qualitative research"],"nhmrc_grant_id":511180,"application_year":2007,"start_year":2008,"scientific_title":"Family care-giving for CALD people living with dementia: the perspectives of family carers and health service providers","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Jonathan Adams","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/511180","simplified_title":"Family care-giving for CALD people living with dementia","sub_type":"Dementia Research Grants Program","total_budget":"456278.9","source_system":""},"children":[{"color":"#336699","name":"Prof Jonathan Adams","data":{"first_name":"Jonathan","title":"Prof","dw_individual_id":"DW0040733","middle_name":"","last_name":"Adams","source_individual_id":"RMIS1688445","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jonathan Adams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87562","size":1},{"color":"#336699","name":"Ms Helen Kyriazopoulos","data":{"first_name":"Helen","title":"Ms","dw_individual_id":"DW0026093","middle_name":"","last_name":"Kyriazopoulos","source_individual_id":"5015826","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Helen Kyriazopoulos"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83744","size":1},{"color":"#336699","name":"Dr Christopher Shanley","data":{"first_name":"Christopher","title":"Dr","dw_individual_id":"DW0022052","middle_name":"Gerard","last_name":"Shanley","source_individual_id":"5017460","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Christopher Shanley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82682","size":1},{"color":"#336699","name":"Prof Constance Pond","data":{"first_name":"Constance","title":"Prof","dw_individual_id":"DW0009691","middle_name":"Dimity","last_name":"Pond","source_individual_id":"5017013","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Constance Pond"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79331","size":1},{"color":"#336699","name":"Dr Jeffrey Rowland","data":{"first_name":"Jeffrey","title":"Dr","dw_individual_id":"DW0004351","middle_name":"T","last_name":"Rowland","source_individual_id":"5017262","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jeffrey Rowland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77882","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62993","size":1},{"color":"#FF4D4D","name":"Beyond motherhood: a 27-year follow-up of the mental health of mid-age women.","data":{"media_summary":"women's mental health","end_year":2011,"keywords":["anxiety disorders","comorbidity","environmental influences","longitudinal","maternal mental health"],"nhmrc_grant_id":511177,"application_year":2007,"health_keywords":["ageing","anxiety, depression","menopause","substance-related disorders","women's mental health"],"scientific_title":"Beyond motherhood: a 27-year follow-up of the mental health of mid-age women.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Mental Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Alexandra Clavarino","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511177","simplified_title":"A 27 year follow-up of the mental health of middle age women.","sub_type":"Standard Project Grant","total_budget":"1755651.84","source_system":"There have been few studies of the causes and consequences of anxiety disorders yet they are disabiling, chronic and impair life prospects particularly for women. Environmental factors hold the greatest promise to understanding their natural history and for mitigating their effects. This proposal is for a 27 year follow up of women participating in the Mater University Study of Pregnancy to understand the development of anxiety disorders and comorbid depression and substance use."},"children":[{"color":"#336699","name":"A/Pr Alexandra Clavarino","data":{"first_name":"Alexandra","title":"A/Pr","dw_individual_id":"DW0029981","middle_name":"","last_name":"Clavarino","source_individual_id":"RMIS31306","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Alexandra Clavarino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84768","size":1},{"color":"#336699","name":"Prof Gail Williams","data":{"first_name":"Gail","title":"Prof","dw_individual_id":"DW0017119","middle_name":"Marilyn","last_name":"Williams","source_individual_id":"RMIS28497","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gail Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81346","size":1},{"color":"#336699","name":"Dr William Bor","data":{"first_name":"William","title":"Dr","dw_individual_id":"DW0006156","middle_name":"","last_name":"Bor","source_individual_id":"RMIS1099638","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr William Bor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78373","size":1},{"color":"#336699","name":"A/Pr Rosa Alati","data":{"first_name":"Rosa","title":"A/Pr","dw_individual_id":"DW0005759","middle_name":"","last_name":"Alati","source_individual_id":"RMIS2639340","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Rosa Alati"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78272","size":1},{"color":"#336699","name":"Prof Jackob Najman","data":{"first_name":"Jackob","title":"Prof","dw_individual_id":"DW0003590","middle_name":"Moses","last_name":"Najman","source_individual_id":"5016639","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jackob Najman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77655","size":1},{"color":"#336699","name":"A/Pr Abdullah Mamun","data":{"first_name":"Abdullah","title":"A/Pr","dw_individual_id":"DW0003145","middle_name":"Al","last_name":"Mamun","source_individual_id":"5016160","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Abdullah Mamun"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77536","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62992","size":1},{"color":"#FF4D4D","name":"Function of sulfotransferase SULT4A1 - transcriptional and post-transcriptional regulation","data":{"media_summary":"","end_year":2011,"keywords":["Drug metabolism","Gene regulaton","Phosphorylation","Sulfotransferase"],"nhmrc_grant_id":511175,"application_year":2007,"health_keywords":["Metabolism","carcinogenesis","sulfation"],"scientific_title":"Function of sulfotransferase SULT4A1 - transcriptional and post-transcriptional regulation","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Rodney Minchin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511175","simplified_title":"Regulation of sulfotransferase SULT4A1","sub_type":"Standard Project Grant","total_budget":"302063.54","source_system":"Our understanding of how important proteins work is critical to devising modern approaches for disease treatment. This project looks specifically at a protein sulfotransferase 4A1 linked with schizophrenia, and may be involved in other neuronal disorders. The plan is to characterise how the protein functions and what might be the implications of abnormal regulation. Through a series of intricate experiments, the molecular and cellular properties of the protein will be more clearly defined."},"children":[{"color":"#336699","name":"Prof Rodney Minchin","data":{"first_name":"Rodney","title":"Prof","dw_individual_id":"DW0026778","middle_name":"F","last_name":"Minchin","source_individual_id":"5016513","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Rodney Minchin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83936","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62991","size":1},{"color":"#FF4D4D","name":"Training dual task performance during gait in Parkinson disease","data":{"media_summary":"Treatment strategies","end_year":2012,"keywords":["Attention deficits","Gait","Parkinson's Disease","Physiotherapy","Rehabilitation"],"nhmrc_grant_id":511170,"application_year":2007,"health_keywords":["Attention deficits","Gait disorders","Parkinson's Disease","Rehabilitation","Treatment strategies"],"scientific_title":"Training dual task performance during gait in Parkinson disease","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Sandra Brauer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511170","simplified_title":"Training dual tasking in Parkinson Disease","sub_type":"Standard Project Grant","total_budget":"386980.11","source_system":"Difficulty performing more than one task at a time is a common and disabling problem experienced by people with Parkinson's Disease (PD), a progressive neurological condition that affects the ability of people to perform well-learned movements like walking with normal speed and size. This research will investigate how to best train people with PD to dual-task when walking. Teaching people with PD how to dual task will enhance their everyday activities and has potential to reduce falls incidence."},"children":[{"color":"#336699","name":"Prof Meg Morris","data":{"first_name":"Meg","title":"Prof","dw_individual_id":"DW0044381","middle_name":"E","last_name":"Morris","source_individual_id":"5016579","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Meg Morris"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88500","size":1},{"color":"#336699","name":"Prof Marjorie Woollacott","data":{"first_name":"Marjorie","title":"Prof","dw_individual_id":"DW0040569","middle_name":"H","last_name":"Woollacott","source_individual_id":"5018473","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Marjorie Woollacott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87511","size":1},{"color":"#336699","name":"Prof Sandra Brauer","data":{"first_name":"Sandra","title":"Prof","dw_individual_id":"DW0035524","middle_name":"G","last_name":"Brauer","source_individual_id":"5013589","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sandra Brauer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86203","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62990","size":1},{"color":"#FF4D4D","name":"Identification of novel therapeutic binding sites on glycine receptors by high throughput screening","data":{"media_summary":"","end_year":2010,"keywords":["high throughput screening","ion channels","molecular biology","pain","patch clamping"],"nhmrc_grant_id":511169,"application_year":2007,"health_keywords":["ligand gated ion channel function - ion channel diseases","neuropharmacology","pain"],"scientific_title":"Identification of novel therapeutic binding sites on glycine receptors by high throughput screening","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Joseph Lynch","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511169","simplified_title":"Discovering new binding sites for analgesic and anti-spasticity drugs","sub_type":"Standard Project Grant","total_budget":"542017.81","source_system":"Glycine receptors mediate inhibitory neurotransmission in the nervous system. They provide fresh therapeutic targets for chronic inflammatory pain and muscle spasticity. Here we identify 5 compounds that may be appropriate as leads for discovering novel therapies for these disorders. We will use automated high throughput screening methods to discover how these drugs interact with the receptor. This will narrow down the search for the next generation of analgesic and muscle relaxant drugs."},"children":[{"color":"#336699","name":"Prof Joseph Lynch","data":{"first_name":"Joseph","title":"Prof","dw_individual_id":"DW0032228","middle_name":"W","last_name":"Lynch","source_individual_id":"5016080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Joseph Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85342","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62989","size":1},{"color":"#FF4D4D","name":"Can the needs caregivers of patients with advanced cancer be met using a GP Caregive Needs Toolkit?","data":{"media_summary":"","end_year":2012,"keywords":["Improving quality of life","Palliative car","Quality of care","a healthy start to live","ageing well"],"nhmrc_grant_id":511168,"application_year":2007,"start_year":2008,"scientific_title":"Can the needs caregivers of patients with advanced cancer be met using a GP Caregive Needs Toolkit?","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Geoffrey Mitchell","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/511168","simplified_title":"Meeting the needs of caregivers of patients with advanced cancer in General Practice","sub_type":"General Practice Clinical Research Grant","total_budget":"584815.86","source_system":""},"children":[{"color":"#336699","name":"Prof Moyaz Jiwa","data":{"first_name":"Moyaz","title":"Prof","dw_individual_id":"DW0043308","middle_name":"","last_name":"Jiwa","source_individual_id":"5015509","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Moyaz Jiwa"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88220","size":1},{"color":"#336699","name":"Prof Afaf Girgis","data":{"first_name":"Afaf","title":"Prof","dw_individual_id":"DW0013247","middle_name":"","last_name":"Girgis","source_individual_id":"RMIS59748","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Afaf Girgis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80279","size":1},{"color":"#336699","name":"Prof David Sibbritt","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0010254","middle_name":"W","last_name":"Sibbritt","source_individual_id":"5017488","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Sibbritt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79484","size":1},{"color":"#336699","name":"Prof Geoffrey Mitchell","data":{"first_name":"Geoffrey","title":"Prof","dw_individual_id":"DW0003428","middle_name":"Keith","last_name":"Mitchell","source_individual_id":"5012135","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Geoffrey Mitchell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77614","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62988","size":1},{"color":"#FF4D4D","name":"Effects of prenatal alcohol exposure on the developing kidney","data":{"media_summary":"","end_year":2010,"keywords":["abnormal development","alcohol","developmental outcomes","hypertension","renal"],"nhmrc_grant_id":511162,"application_year":2007,"health_keywords":["fetal alcohol syndrome","hypertension","renal development and renal disease and hypertension as adults","renal diseases"],"scientific_title":"Effects of prenatal alcohol exposure on the developing kidney","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Karen Moritz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511162","simplified_title":"How does prenatal exposure to alcohol affect the developing kidney?","sub_type":"Standard Project Grant","total_budget":"602636.21","source_system":"Almost 50% of Australian women consume alcohol when they are pregnant. Although it is generally thought that low levels of consumption (one-two standard drinks per day) are not harmful to the fetus, no study has examined the effect of this level of alcohol consumption on the development of the kidney and the long term renal and cardiovascular function of the offspring. We shall identify if low levels of exposure to ethanol can alter kidney development and impact on long-term health."},"children":[{"color":"#336699","name":"A/Pr Karen Moritz","data":{"first_name":"Karen","title":"A/Pr","dw_individual_id":"DW0009221","middle_name":"","last_name":"Moritz","source_individual_id":"RMIS1366054","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Karen Moritz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79207","size":1},{"color":"#336699","name":"Prof John Bertram","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0000365","middle_name":"Frederick","last_name":"Bertram","source_individual_id":"5011614","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Bertram"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76752","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62987","size":1},{"color":"#FF4D4D","name":"Clinical efficacy and physiological mechanisms of nerve and tendon gliding exercises for carpal tunnel syndrome","data":{"media_summary":"","end_year":2011,"keywords":["Hand function","Musculoskeletal pain","Physiotherapy","Randomised controlled trial"],"nhmrc_grant_id":511161,"application_year":2007,"health_keywords":["Musculoskeletal injury (overuse)","Rehabilitation services, exercise therapy","Work related musculoskeletal disorders"],"scientific_title":"Clinical efficacy and physiological mechanisms of nerve and tendon gliding exercises for carpal tunnel syndrome","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Michel Coppieters","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511161","simplified_title":"The effect and underlying mechanisms of nerve and tendon gliding exercises for carpal tunnel syndrome","sub_type":"Standard Project Grant","total_budget":"370068.6","source_system":"Compression of one of the major nerves at the wrist (carpal tunnel syndrome) is a very common condition that significantly impacts on the well-being of the patient. To date, there is no good evidence that traditionally advocated interventions are effective in the long term. This project will evaluate the effects of a novel, active treatment strategy and will investigate the underlying mechanisms that may be associated with exercises that aim to mobilise the nerve and tendons at the wrist."},"children":[{"color":"#336699","name":"Prof Guglielmo Vicenzino","data":{"first_name":"Guglielmo","title":"Prof","dw_individual_id":"DW0046019","middle_name":"Tarcisio","last_name":"Vicenzino","source_individual_id":"5018115","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Guglielmo Vicenzino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88911","size":1},{"color":"#336699","name":"Dr Nicola Massy-Westropp","data":{"first_name":"Nicola","title":"Dr","dw_individual_id":"DW0044066","middle_name":"","last_name":"Massy-Westropp","source_individual_id":"5016237","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nicola Massy-Westropp"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88421","size":1},{"color":"#336699","name":"A/Pr Michel Coppieters","data":{"first_name":"Michel","title":"A/Pr","dw_individual_id":"DW0018401","middle_name":"W","last_name":"Coppieters","source_individual_id":"5014067","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Michel Coppieters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81713","size":1},{"color":"#336699","name":"Dr Andrew Dilley","data":{"first_name":"Andrew","title":"Dr","dw_individual_id":"DW0001285","middle_name":"","last_name":"Dilley","source_individual_id":"5014340","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Andrew Dilley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77025","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62986","size":1},{"color":"#FF4D4D","name":"Preserving barriers: how cadherin signaling coordinates dynamic adhesion and tight junction assembly in epithelial cell.","data":{"media_summary":"","end_year":2010,"keywords":["Cell Adhesion","Cell Biology","Cell signaling","Cytoskeleton","Epithelial Biology"],"nhmrc_grant_id":511156,"application_year":2007,"health_keywords":["Cancer Biology","Invasion","Metastasis"],"scientific_title":"Preserving barriers: how cadherin signaling coordinates dynamic adhesion and tight junction assembly in epithelial cell.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Alpha Yap","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511156","simplified_title":"Preserving epithelial cell-cell barriers.","sub_type":"Standard Project Grant","total_budget":"557939.08","source_system":"Epithelia protect the body from its environment. Breakdown of the epithelial barrier in tissues such as the skin and intestine, as occurs in burns and inflammation, leads to invasion of bacteria and severe metabolic disturbances. In this project we study the cell signaling mechanisms that maintain epithelial barriers in healthy tissues that undergo turnover and remodelling. Understanding these signaling pathways provides a foundation to understand how they are perturbed in disease."},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62985","size":1},{"color":"#FF4D4D","name":"Regulation of Myosin II by E-cadherin adhesion.","data":{"media_summary":"","end_year":2010,"keywords":["Cell Adhesion","Cell Biology","Cell signaling","Cytoskeleton","Epithelial Biology"],"nhmrc_grant_id":511155,"application_year":2007,"health_keywords":["Cancer Biology","Invasion","Metastasis"],"scientific_title":"Regulation of Myosin II by E-cadherin adhesion.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Alpha Yap","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511155","simplified_title":"Myosin and cadherin adhesion.","sub_type":"Standard Project Grant","total_budget":"573557.21","source_system":"Adhesion between cells is important during health and disease. Cell-cell interactions are necessary both as the embryo forms and to preserve tissues and organs in later life. Important disease states arise when cell-cell adhesion is broken. Only by understanding the molecular mechanisms that hold cells together can we analyse how they are perturbed to cause diseases such as cancer and inflammation."},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62984","size":1},{"color":"#FF4D4D","name":"Investigation into the alternative splicing of steroid hormone regulated genes in breast cancer.","data":{"media_summary":"steroid hormone action","end_year":2010,"keywords":["Control of gene Expression","Molecular Mechanisms","RNA binding proteins","RNA processing","Steroid hormone receptors"],"nhmrc_grant_id":511153,"application_year":2007,"health_keywords":["Biochemistry and molecular biology","Cancer biology","Gene expression","post-transcriptional regulation of gene expression","steroid hormone action"],"scientific_title":"Investigation into the alternative splicing of steroid hormone regulated genes in breast cancer.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Dennis Dowhan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511153","simplified_title":"To understand how and why steroid hormones are able to make different proteins from a single gene in breast cancer cells","sub_type":"New Investigator Grant","total_budget":"292216.81","source_system":"Steroid hormones have imortant roles in breast tissue growth and differentiation. We have identified several proteins called PRMT6 and CAPER's , that are involved in steroid hormone signaling and control the alternative splicing of RNA, the process in which several different proteins can be produced from a single gene. Our aim is to study these proteins in an effort to understand how they influence alternative splicing and to identify genes they control in relation to breast cancer."},"children":[{"color":"#336699","name":"Dr Dennis Dowhan","data":{"first_name":"Dennis","title":"Dr","dw_individual_id":"DW0024590","middle_name":"H","last_name":"Dowhan","source_individual_id":"5014382","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Dennis Dowhan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83309","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62983","size":1},{"color":"#FF4D4D","name":"Selective attention and the processing of observed actions.","data":{"media_summary":"Social and Behavioural Research","end_year":2011,"keywords":["Action Recognition","Cognitive Behaviour","Selective Attention","Social Cognition"],"nhmrc_grant_id":511148,"application_year":2007,"health_keywords":["Autistic Spectum Disorder","Cognition","Cognitive Deficits","Neuropsychological Impairments","Social and Behavioural Research"],"scientific_title":"Selective attention and the processing of observed actions.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)","research_area":"Basic Science","for_category":"PSYCHOLOGY","cia_name":"A/Pr Ross Cunnington","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511148","simplified_title":"The role of attention in human action recognition","sub_type":"Standard Project Grant","total_budget":"343812.94","source_system":"Our ability to understand the hand and face gestures of others is a crucial part of social interaction. Deficits in the ability to perceive others' actions are associated with clinical disorders such as autism and apraxia. We will examine how specific regions of the brain operate to process and recognise actions that we observe. This is a crucial first-step toward understanding and redefining clinical disorders such as apraxia that involve deficits in the perception of actions and gestures."},"children":[{"color":"#336699","name":"A/Pr Ross Cunnington","data":{"first_name":"Ross","title":"A/Pr","dw_individual_id":"DW0036113","middle_name":"","last_name":"Cunnington","source_individual_id":"5014154","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ross Cunnington"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86356","size":1},{"color":"#336699","name":"A/Pr Mark Williams","data":{"first_name":"Mark","title":"A/Pr","dw_individual_id":"DW0023011","middle_name":"Alexander","last_name":"Williams","source_individual_id":"RMIS3185167","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Mark Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82930","size":1},{"color":"#336699","name":"Prof Jason Mattingley","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0020682","middle_name":"Brett","last_name":"Mattingley","source_individual_id":"RMIS123930","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jason Mattingley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82287","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62982","size":1},{"color":"#FF4D4D","name":"West Nile virus replication and host response","data":{"media_summary":"","end_year":2011,"keywords":["Flavivirus","Interferon","host antiviral response","signal transduction","virus-host interactions"],"nhmrc_grant_id":511129,"application_year":2007,"health_keywords":["Australian encephalitis and related flavivirus infections","flavivirus infections","understanding virus-host interactions"],"scientific_title":"West Nile virus replication and host response","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511129","simplified_title":"West Nile virus replication and host response","sub_type":"Standard Project Grant","total_budget":"560434.94","source_system":"We seek to gain a detailed understanding of how interactions between the West Nile virus proteins and host factors involved in the IFN response determine the outcome of virus infection. Better understanding of the mechanisms employed by this highly pathogenic virus to disable the mammalian host's IFN response will have wider implications for our understanding of other human diseases such as cancer, autoimmunity and provide new avenues for design of efficient antiviral and anticancer therapies."},"children":[{"color":"#336699","name":"Dr Wenjun Liu","data":{"first_name":"Wenjun","title":"Dr","dw_individual_id":"DW0043838","middle_name":"","last_name":"Liu","source_individual_id":"RMIS2346721","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Wenjun Liu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88361","size":1},{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1},{"color":"#336699","name":"Prof Roy Hall","data":{"first_name":"Roy","title":"Prof","dw_individual_id":"DW0025278","middle_name":"A","last_name":"Hall","source_individual_id":"RMIS16831","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roy Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83509","size":1},{"color":"#336699","name":"Prof Shizuo Akira","data":{"first_name":"Shizuo","title":"Prof","dw_individual_id":"DW0000059","middle_name":"","last_name":"Akira","source_individual_id":"5013149","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Shizuo Akira"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76662","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62980","size":1},{"color":"#FF4D4D","name":"Clinical outcomes, staff and carer perceptions of acute hospitalisation of patients with dementia","data":{"media_summary":"","end_year":2010,"keywords":["Acute care","Carer and staff perceptions","Cognition","Dementia","Structured screening and assessment"],"nhmrc_grant_id":511125,"application_year":2007,"start_year":2008,"scientific_title":"Clinical outcomes, staff and carer perceptions of acute hospitalisation of patients with dementia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Geriatrics and Gerontology","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Len Gray","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/511125","simplified_title":"Pathways in hospital for patients aged 70 years or older with dementia","sub_type":"Dementia Research Grants Program","total_budget":"541745.71","source_system":""},"children":[{"color":"#336699","name":"Prof Gerard Byrne","data":{"first_name":"Gerard","title":"Prof","dw_individual_id":"DW0023904","middle_name":"James","last_name":"Byrne","source_individual_id":"5013745","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gerard Byrne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83133","size":1},{"color":"#336699","name":"Prof Len Gray","data":{"first_name":"Len","title":"Prof","dw_individual_id":"DW0007585","middle_name":"Charles","last_name":"Gray","source_individual_id":"5012147","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Len Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78747","size":1},{"color":"#336699","name":"Prof Nancy Pachana","data":{"first_name":"Nancy","title":"Prof","dw_individual_id":"DW0003819","middle_name":"Ann","last_name":"Pachana","source_individual_id":"RMIS1713128","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Nancy Pachana"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77727","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62979","size":1},{"color":"#FF4D4D","name":"The mechanism of growth hormone receptor activation","data":{"media_summary":"Obesity prevention","end_year":2010,"keywords":["Endocrine therapy","Growth hormone","Hormone signalling","Tyrosine kinase receptor"],"nhmrc_grant_id":511120,"application_year":2007,"health_keywords":["Cancer therapy","Cardiovascular disease","Diabetic retinopathy","Growth hormone deficiency","Obesity prevention"],"scientific_title":"The mechanism of growth hormone receptor activation","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael Waters","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511120","simplified_title":"How does growth hormone work ?","sub_type":"Standard Project Grant","total_budget":"679500.67","source_system":"Growth hormone GH excess or deficit results in considerably shortened lifespan. While cardiovascular disease is a major element in this mortality, GH status has also been linked to kidney disease and diabetic retinopathy. Importantly, GH produced locally in breast cells and prostate cells transform s these cells, creating cancers. We aim to define how GH activates its receptor, to facilitate a GH antagonist which results from understanding how GH activates its cell surface receptor."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1},{"color":"#336699","name":"Dr Michael Gorman","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0007550","middle_name":"A","last_name":"Gorman","source_individual_id":"5014914","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Michael Gorman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78741","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62977","size":1},{"color":"#FF4D4D","name":"Validation of a competency assessment method for persons with dementia","data":{"media_summary":"","end_year":2012,"keywords":["Competence","Dementia","Financial management","Geriatric assessment","Legal quardians"],"nhmrc_grant_id":511119,"application_year":2007,"start_year":2008,"scientific_title":"Validation of a competency assessment method for persons with dementia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Nancy Pachana","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/511119","simplified_title":"Testing a better process to dementia if a person with dementia can manage their own financial affairs","sub_type":"Dementia Research Grants Program","total_budget":"580451.57","source_system":"Deciding what if any aspects of their financial affairs a person with dementia or suspected dementia can responsibly manage is a difficult process for health and legal professionals as well as for guardianship boards and tribunals. This process is often stressful for the older person, and families can find deciding when to take over stressful. Also, having family members manage the older persons assets may result in family conflict. There is a small amount of overseas research examining this issue. However, no comprehensive and validated method exists internationally or in Australia to determine competency in this context. We will test a methodology for assessing the capacity of individuals to manage their own financial affairs where dementia is an issue. This method involves the use of a number of reliable and well-validated instruments measuring the older persons mental state, anxiety levels, depression, and social vulnerability combined with an interview exploring the personal circumstances of the older adult in relation to their financial affairs. We will work with the Office of the Adult Guardian in Queensland to recruit participants and to verify both the utility and usability of our methodology with stakeholders (e.g. solicitors, the Office of the Adult Guardian). A comparison will be made between the results obtained in approximately 200 financial competency cases with the competency opinions independently arrived at by the Office of the Adult Guardian in Queensland. As a result of this research, we will be able to ascertain the viability and utility of this assessment method, improve the method as per the data gathered, and ultimately seek future funding to trial the methods across multiple jurisdictions (e.g. other states) and contexts (e.g. various cultural contexts)."},"children":[{"color":"#336699","name":"Prof Gill Wilson","data":{"first_name":"Gill","title":"Prof","dw_individual_id":"DW0034764","middle_name":"","last_name":"Wilson","source_individual_id":"5018384","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gill Wilson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86002","size":1},{"color":"#336699","name":"Prof Gerard Byrne","data":{"first_name":"Gerard","title":"Prof","dw_individual_id":"DW0023904","middle_name":"James","last_name":"Byrne","source_individual_id":"5013745","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gerard Byrne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83133","size":1},{"color":"#336699","name":"Dr Cheryl Tilse","data":{"first_name":"Cheryl","title":"Dr","dw_individual_id":"DW0016671","middle_name":"","last_name":"Tilse","source_individual_id":"5017947","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Cheryl Tilse"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81230","size":1},{"color":"#336699","name":"Prof Nancy Pachana","data":{"first_name":"Nancy","title":"Prof","dw_individual_id":"DW0003819","middle_name":"Ann","last_name":"Pachana","source_individual_id":"RMIS1713128","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Nancy Pachana"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77727","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62976","size":1},{"color":"#FF4D4D","name":"Practitioner Fellowship","data":{"media_summary":"","end_year":2012,"keywords":["Hypoxia ischaemia peperfusion injury to the brain","Infant newborn","Neurodevelopmental disorders, Perinatal hypoxia","Perinatalasphyxia, Perinatal physiology","low birth weight, neonatal seizures"],"nhmrc_grant_id":511117,"application_year":2007,"start_year":2008,"scientific_title":"Practitioner Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Paul Colditz","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/511117","simplified_title":"Practitioner Fellowship","sub_type":"Practitioner Fellowship","total_budget":"514013.81","source_system":"I am a perinatal paediatrician undertaking clinically-focussed research on brain development, brain disorders, brain therapies, neurodevelopmental outcomes and the development, application and evaluation of new technology to clinical problems."},"children":[{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62975","size":1},{"color":"#FF4D4D","name":"Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs","data":{"media_summary":"","end_year":2011,"keywords":["Computer-based decision support","Mycophenolate mofetil","Organ transplatation","Pharmacodynamics","Tacrolimus"],"nhmrc_grant_id":511109,"application_year":2007,"health_keywords":["Dose individualisation","Drug efficacy","Health services","Organ transplantation"],"scientific_title":"Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Christine Staatz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511109","simplified_title":"Tailoring doses of the newer immunosuppressant drugs","sub_type":"Standard Project Grant","total_budget":"486206.94","source_system":"After organ transplantation, recipients need to take medicines continually to stop their immune system from rejecting their new organ. This treatment with immunosuppressant drugs is vital for long-term success of their graft. However, too many people are losing their transplant or are experiencing drug toxicity or infection due to poorly managed immunosuppression. The project aims to accurately define the best way to dose newer immunosuppressant drugs in Australian transplant populations."},"children":[{"color":"#336699","name":"Prof Susan Tett","data":{"first_name":"Susan","title":"Prof","dw_individual_id":"DW0040037","middle_name":"Elizabeth","last_name":"Tett","source_individual_id":"5011655","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Susan Tett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87372","size":1},{"color":"#336699","name":"Dr Christine Staatz","data":{"first_name":"Christine","title":"Dr","dw_individual_id":"DW0028116","middle_name":"E","last_name":"Staatz","source_individual_id":"RMIS680289","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Christine Staatz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84257","size":1},{"color":"#336699","name":"Mr Paul Taylor","data":{"first_name":"Paul","title":"Mr","dw_individual_id":"DW0022474","middle_name":"James","last_name":"Taylor","source_individual_id":"5017860","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Mr Paul Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82790","size":1},{"color":"#336699","name":"Prof Stephen Lynch","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0014580","middle_name":"V","last_name":"Lynch","source_individual_id":"RMIS5846","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80640","size":1},{"color":"#336699","name":"Prof David Johnson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0013969","middle_name":"Wayne","last_name":"Johnson","source_individual_id":"RMIS14680","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Johnson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80471","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62974","size":1},{"color":"#FF4D4D","name":"Regulation of p75 death signalling: How neurotransmitter- and neurotrophic- signals determine cell survival","data":{"media_summary":"neurotransmission","end_year":2011,"keywords":["G-protein coupled receptors","neuronal death","p75 neurotrophin receptor","phospholipids (PIP2)","potassium channels"],"nhmrc_grant_id":511107,"application_year":2007,"health_keywords":["cell signalling","cell survival","nervous system development","neuronal cell death","neurotransmission"],"scientific_title":"Regulation of p75 death signalling: How neurotransmitter- and neurotrophic- signals determine cell survival","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Elizabeth Coulson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511107","simplified_title":"Synaptic activity and neuronal survival","sub_type":"Standard Project Grant","total_budget":"292216.81","source_system":"Nerve cell survival is dependent on trophic support in the form of growth factors and synaptic input, both of which promote recovery after nerve injury. The survival pathways activated by growth factors are generally well characterised, whereas survival signals activated by synaptic activity are largely unexplored. This proposal aims to discover how synaptic activity prevents nerve cell death by looking at how synaptic activity inhibits the processes active in dying nerve cells."},"children":[{"color":"#336699","name":"A/Pr Elizabeth Coulson","data":{"first_name":"Elizabeth","title":"A/Pr","dw_individual_id":"DW0006736","middle_name":"J","last_name":"Coulson","source_individual_id":"5014079","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Elizabeth Coulson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78524","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62973","size":1},{"color":"#FF4D4D","name":"Discovery and exploitation of novel biophysical methods for charcterising molecular pathways invld in disease progression","data":{"media_summary":"","end_year":2014,"keywords":["Antibiotic resistance","Bacterial pathogen","Cell death-apoptosis","Multidisciplinary","Screeneing"],"nhmrc_grant_id":511105,"application_year":2007,"start_year":2008,"scientific_title":"Discovery and exploitation of novel biophysical methods for charcterising molecular pathways invld in disease progression","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biotechnology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"BIOTECHNOLOGY","cia_name":"Prof Matthew Cooper","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/511105","simplified_title":"Discovery and exploitation of novel biophysical methods for charcterising molecular pathways invld in disease progression","sub_type":"Australia Fellowship","total_budget":"4000000","source_system":"Dr Cooper has conducted groundbreaking research into the progression and spread of antibiotic-resistant bacterial pathogens. Utilising a strongly multidisciplinary approach, he will use his Fellowship to expand upon this research in the area of antibiotic resistance and will supplement this focus with research into biofilms formed by bacterial pathogens on medical implants, cannulas and catheters. Dr Coopers Australia Fellowship will also assist his research into the changes that occur in cells during the initiation and evolution of cancer."},"children":[{"color":"#336699","name":"Prof Matthew Cooper","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0024249","middle_name":"A","last_name":"Cooper","source_individual_id":"5018347","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83230","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62972","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2013,"keywords":["Health issue-Disease-Clinical condition:","Insulin Resistance,Diabetes(type 2),Adiposity and","Obesity. Endocrine factors, Signalling Pathways","Protein Characterisation"],"nhmrc_grant_id":511104,"application_year":2007,"start_year":2008,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Jonathan Whitehead","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/511104","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"812138.51","source_system":"I am a biochemist - cell biologist investigating the molecular coordination of cellular processes that regulate metabolism. My research aim is to identify and validate novel therapeutic targets - strategies that will ameliorate the metabolic complications"},"children":[{"color":"#336699","name":"A/Pr Jonathan Whitehead","data":{"first_name":"Jonathan","title":"A/Pr","dw_individual_id":"DW0046246","middle_name":"P","last_name":"Whitehead","source_individual_id":"RMIS5218572","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jonathan Whitehead"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88973","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62971","size":1},{"color":"#FF4D4D","name":"Transplanted metanephroi as functional kidneys","data":{"media_summary":"","end_year":2010,"keywords":["Growth factor","Kidney","Renal growth factors","Transplantation"],"nhmrc_grant_id":511094,"application_year":2007,"health_keywords":["End stage renal disease","Kidney failure","Kidney transplantation"],"scientific_title":"Transplanted metanephroi as functional kidneys","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Julie Campbell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511094","simplified_title":"Transplanting kidneys","sub_type":"Standard Project Grant","total_budget":"307834.94","source_system":"To investigate alternative strategies to treat end stage renal disease we have transplanted embryonic kidneys into the wall of the abdominal cavity of adult hosts where they become vascularised and undergo continued but limited development. Strategies to enhance their growth-development and decrease immunogenicity-rejection will now be determined, and the origin of a 'ureter-like' tube of tissue that grows to connect the transplanted embryonic kidney with the recipient bladder investigated."},"children":[{"color":"#336699","name":"A/Pr Sharon Ricardo","data":{"first_name":"Sharon","title":"A/Pr","dw_individual_id":"DW0033403","middle_name":"Denise","last_name":"Ricardo","source_individual_id":"5011613","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Sharon Ricardo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85647","size":1},{"color":"#336699","name":"Prof Julie Campbell","data":{"first_name":"Julie","title":"Prof","dw_individual_id":"DW0000708","middle_name":"H","last_name":"Campbell","source_individual_id":"RMIS330901","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Julie Campbell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76860","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62970","size":1},{"color":"#FF4D4D","name":"Clinical trial of respiratory sonification","data":{"media_summary":"Monitoring vital signs","end_year":2009,"keywords":["Anaesthesia","Ergonomics","Multidisciplinary","Safety"],"nhmrc_grant_id":511088,"application_year":2007,"health_keywords":["Anaesthesia","Information science/medical informatics","Maintenance of anaesthesia","Management of human performance","Monitoring vital signs"],"scientific_title":"Clinical trial of respiratory sonification","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Anaesthesiology","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Penelope Sanderson","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/511088","simplified_title":"Clinical trial of respiratory sonification","sub_type":"Development Grant","total_budget":"100951.95","source_system":"We will conduct a clinical trial of the effectiveness of a continuous auditory display of an anesthetized patient's respiratory status. Expired carbon dioxide monitoring has helped reduce respiratory incidents since its widespread introduction in the late 1980s, but a continuous auditory display of respiratory status may reduce incidents further. We will conduct a clinical trial with 10 anaesthetists of continuous auditory respiratory monitoring. Successful outcome may lead to commercial uptake."},"children":[{"color":"#336699","name":"Dr W. John Russell","data":{"first_name":"W. John","title":"Dr","dw_individual_id":"DW0039461","middle_name":"","last_name":"Russell","source_individual_id":"RMIS3119189","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr W. John Russell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87235","size":1},{"color":"#336699","name":"Dr Kersi Taraporewalla","data":{"first_name":"Kersi","title":"Dr","dw_individual_id":"DW0034188","middle_name":"J","last_name":"Taraporewalla","source_individual_id":"RMIS3119194","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Kersi Taraporewalla"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85849","size":1},{"color":"#336699","name":"Prof Penelope Sanderson","data":{"first_name":"Penelope","title":"Prof","dw_individual_id":"DW0027783","middle_name":"M","last_name":"Sanderson","source_individual_id":"RMIS3119186","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Penelope Sanderson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84172","size":1},{"color":"#336699","name":"Dr Richard Morris","data":{"first_name":"Richard","title":"Dr","dw_individual_id":"DW0026871","middle_name":"W","last_name":"Morris","source_individual_id":"5028854","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Richard Morris"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83956","size":1},{"color":"#336699","name":"Dr Simon Jenkins","data":{"first_name":"Simon","title":"Dr","dw_individual_id":"DW0019906","middle_name":"A","last_name":"Jenkins","source_individual_id":"RMIS5047496","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Simon Jenkins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82065","size":1},{"color":"#336699","name":"Marcus Watson","data":{"first_name":"Marcus","title":"","dw_individual_id":"DW0016985","middle_name":"","last_name":"Watson","source_individual_id":"RMIS2979823","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Marcus Watson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81319","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62968","size":1},{"color":"#FF4D4D","name":"Chronic disease in high risk populations","data":{"media_summary":"","end_year":2013,"keywords":["Chronic renal disease","Diabetes","Hypertnsion","Kidney"],"nhmrc_grant_id":511081,"application_year":2007,"start_year":2008,"scientific_title":"Chronic disease in high risk populations","node_source":"NHMRC","node_type":"Grant","field_of_research":"Indigenous Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Wendy Hoy","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/511081","simplified_title":"Chronic disease in high risk populationsq","sub_type":"Australia Fellowship","total_budget":"4000000","source_system":"Professor Hoy has conducted precedent-setting research into chronic disease, especially in high risk populations, with a focus in Australia on Indigenous health. She is a role model for work amongst Indigenous people, specifically among Aboriginal people, and her work has been very influential, particularly in the training of staff. Professor Hoys Australia Fellowship will be used for an expanded multidisciplinary research program targeting the prevention and management of chronic diseases in the Aboriginal population, and focusing on hypertension, kidney disease, type 2 diabetes and cardiovascular disease."},"children":[{"color":"#336699","name":"Prof Wendy Hoy","data":{"first_name":"Wendy","title":"Prof","dw_individual_id":"DW0013767","middle_name":"Elizabeth","last_name":"Hoy","source_individual_id":"RMIS3725","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wendy Hoy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80407","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62967","size":1},{"color":"#FF4D4D","name":"Retromer based Endosome Trafficking","data":{"media_summary":"","end_year":2010,"keywords":["Endocytosis","Endosomes","Receptor trafficking"],"nhmrc_grant_id":511072,"application_year":2007,"health_keywords":["cancer biology","cancer metastasis","growth factors-receptors"],"scientific_title":"Retromer based Endosome Trafficking","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Rohan Teasdale","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511072","simplified_title":"Endosome Trafficking","sub_type":"Standard Project Grant","total_budget":"490724.81","source_system":"The regulated movement of membrane receptors and ligands between the cell surface and intracellular compartments is vital to many cellular operations, including communication between cells and their environment. However, the molecular details of these sorting events remain poorly defined. Determination of the mechanisms that control the cellular distribution of receptors is critical for understanding normal cellular processes and in pathological processes like tumorigenesis."},"children":[{"color":"#336699","name":"Dr Brett Collins","data":{"first_name":"Brett","title":"Dr","dw_individual_id":"DW0041718","middle_name":"Martin","last_name":"Collins","source_individual_id":"5014007","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brett Collins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87821","size":1},{"color":"#336699","name":"A/Pr Rohan Teasdale","data":{"first_name":"Rohan","title":"A/Pr","dw_individual_id":"DW0040022","middle_name":"D","last_name":"Teasdale","source_individual_id":"5017848","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Rohan Teasdale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87368","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62966","size":1},{"color":"#FF4D4D","name":"Modulation and trafficking of SK channels in the lateral amygdala","data":{"media_summary":"post-traumatic stress disorder (PTSD)","end_year":2010,"keywords":["amygdala","neuromodulation","synaptic plasticity","synaptic transmission","trafficking"],"nhmrc_grant_id":511069,"application_year":2007,"health_keywords":["anxiety","depression","panic disorder","phobias","post-traumatic stress disorder (PTSD)"],"scientific_title":"Modulation and trafficking of SK channels in the lateral amygdala","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Elizabeth Louise Faber","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511069","simplified_title":"Synaptic transmission in the amygdala","sub_type":"Standard Project Grant","total_budget":"260980.54","source_system":"The amygdala is a brain structure that underlies emotional processing. Malfunctions in emotional processing are thought to be the cause of anxiety disorders. Understanding amygdala physiology is thus vital for developing therapies to treat these disorders. We have recently found a novel role for an ion channel in controlling amygdala excitability. In this grant we will investigate how this ion channel is modulated, which will elucidate a novel way in which activity in the amygdala is regulated."},"children":[{"color":"#336699","name":"Dr Elizabeth Louise Faber","data":{"first_name":"Elizabeth Louise","title":"Dr","dw_individual_id":"DW0030604","middle_name":"Sophie","last_name":"Faber","source_individual_id":"RMIS3123369","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Elizabeth Louise Faber"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84950","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62965","size":1},{"color":"#FF4D4D","name":"Examining the role of ASIC channels in pain through the development of subtype-specific ASIC channel modulators.","data":{"media_summary":"","end_year":2010,"keywords":["ligand-gated ion channels","molecular pharmacology","pain management","sensory neurons","structure-activity relationships"],"nhmrc_grant_id":511067,"application_year":2007,"health_keywords":["Pharmacology","ligand gated ion channel function - ion channel diseases","mechanisms of pain","neuroprotective drugs to minimise neural death after stroke"],"scientific_title":"Examining the role of ASIC channels in pain through the development of subtype-specific ASIC channel modulators.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Lachlan Rash","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511067","simplified_title":"Developing selective tools to study the involvement of acid sensors in pain.","sub_type":"Standard Project Grant","total_budget":"617256.35","source_system":"Acid sensing ion channels (ASICs) sense changes in acidity in the body. They are found throughout the body and may underlie nerve damage in stroke and some types of pain. ASICs also have many as yet unknown functions. A lack of selective tools to study ASICs is a major barrier to a complete understanding of what they do. This proposal aims to modify three animal toxins which block these receptors to make useful tools to study their function, in particular their role in sensing pain."},"children":[{"color":"#336699","name":"Prof Paul Alewood","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0035049","middle_name":"F","last_name":"Alewood","source_individual_id":"5013158","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Alewood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86082","size":1},{"color":"#336699","name":"Dr Lachlan Rash","data":{"first_name":"Lachlan","title":"Dr","dw_individual_id":"DW0027509","middle_name":"D","last_name":"Rash","source_individual_id":"RMIS1373336","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Lachlan Rash"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84101","size":1},{"color":"#336699","name":"Prof Glenn King","data":{"first_name":"Glenn","title":"Prof","dw_individual_id":"DW0008383","middle_name":"Frederick","last_name":"King","source_individual_id":"RMIS2989417","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glenn King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78967","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62964","size":1},{"color":"#FF4D4D","name":"Social behaviour in rats developmentally deficient in Vitamin D: Modelling the negative symptoms of schizophrenia","data":{"media_summary":"Vitamin D deficiency","end_year":2012,"keywords":["Animal Model","Behaviour","Neurochemistry","Schizophrenia","Vitamin D"],"nhmrc_grant_id":511066,"application_year":2007,"health_keywords":["Brain development","Developmental Manipulation","Negative symptoms","Schizophrenia","Vitamin D deficiency"],"scientific_title":"Social behaviour in rats developmentally deficient in Vitamin D: Modelling the negative symptoms of schizophrenia","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Thomas Burne","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511066","simplified_title":"An animal model of the negative symptoms of schizophrenia","sub_type":"Standard Project Grant","total_budget":"360927.14","source_system":"We are exploring low maternal vitamin D as a biological explanation for a 7-10% increase in the incidence of patients born with schizophrenia in the colder months of the year world wide. Developmental vitamin D (DVD) deficiency in rats leads to long term changes in brain development and behaviour. The aim of this research is to examine social behaviour in DVD deficient rats as a model of negative symptoms of schizophrenia and establish the neurochemical basis for this altered behaviour"},"children":[{"color":"#336699","name":"A/Pr Darryl Eyles","data":{"first_name":"Darryl","title":"A/Pr","dw_individual_id":"DW0042305","middle_name":"W","last_name":"Eyles","source_individual_id":"5014564","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Darryl Eyles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87979","size":1},{"color":"#336699","name":"A/Pr Thomas Burne","data":{"first_name":"Thomas","title":"A/Pr","dw_individual_id":"DW0023865","middle_name":"Henry Johnston","last_name":"Burne","source_individual_id":"5013713","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thomas Burne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83125","size":1},{"color":"#336699","name":"Prof John Mcgrath","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0009022","middle_name":"Joseph","last_name":"Mcgrath","source_individual_id":"RMIS3680751","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mcgrath"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79147","size":1},{"color":"#336699","name":"Prof Alan Mackay-Sim","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0003102","middle_name":"","last_name":"Mackay-Sim","source_individual_id":"RMIS222290","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alan Mackay-Sim"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77528","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62963","size":1},{"color":"#FF4D4D","name":"NMDA receptor function in the amygdala","data":{"media_summary":"","end_year":2010,"keywords":["Ion Channels","Learning","Synapses","anxiety"],"nhmrc_grant_id":511052,"application_year":2007,"health_keywords":["amygdala","learning","memory","neurological disorders"],"scientific_title":"NMDA receptor function in the amygdala","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Pankaj Sah","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511052","simplified_title":"Function of glutamate receptors in the amygdala","sub_type":"Standard Project Grant","total_budget":"359431.08","source_system":"The amygdala is an area of the brain that is involved in assigning emotional content to sensory information. Disorders of the amygdala lead to a variety of anxiety-related mental disorders such as panic attacks and post-traumatic stress. This grant will study how the NMDA receptor, which plays a central role in memory formation, works in the amygdala. We will determine the functional role of this receptor in the amygdala and how it may be modified by experience."},"children":[{"color":"#336699","name":"Prof Pankaj Sah","data":{"first_name":"Pankaj","title":"Prof","dw_individual_id":"DW0033583","middle_name":"","last_name":"Sah","source_individual_id":"5017304","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Pankaj Sah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85693","size":1},{"color":"#336699","name":"Dr Andrew Delaney","data":{"first_name":"Andrew","title":"Dr","dw_individual_id":"DW0012705","middle_name":"James","last_name":"Delaney","source_individual_id":"5014278","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Andrew Delaney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80142","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62962","size":1},{"color":"#FF4D4D","name":"Molecular Regulation of Metabolism and Body Composition by Ski via crosstalk with Nuclear Hormone Receptor Signalling.","data":{"media_summary":"","end_year":2010,"keywords":["Adipogenesis","Hormone signalling","Nuclear hormone receptors","Skeletal muscle","Transforming growth factor"],"nhmrc_grant_id":511044,"application_year":2007,"health_keywords":["Biological sciences","Glucocorticoids","Metabolism","Obesity"],"scientific_title":"Molecular Regulation of Metabolism and Body Composition by Ski via crosstalk with Nuclear Hormone Receptor Signalling.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Gary Leong","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511044","simplified_title":"Ski regulation of metabolism and fat development","sub_type":"Standard Project Grant","total_budget":"558441.08","source_system":"Obesity is a common and burdensome health problem in the community which leads to diabetes and heart disease. A number of factors, including hormones play important roles in determing risk of obesity. This study proposes to investigate whether the Ski gene which is a regulatory factor for many hormones affects metabolism in transgenic mouse models of altered Ski function. The proposed studies may identify Ski as a target for therapy for obesity and improvement in sketal muscle metabolism."},"children":[{"color":"#336699","name":"Dr Anthony Kee","data":{"first_name":"Anthony","title":"Dr","dw_individual_id":"DW0031700","middle_name":"John","last_name":"Kee","source_individual_id":"5015651","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Anthony Kee"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85208","size":1},{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1},{"color":"#336699","name":"Dr Gary Leong","data":{"first_name":"Gary","title":"Dr","dw_individual_id":"DW0020356","middle_name":"Martin","last_name":"Leong","source_individual_id":"RMIS1096296","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Gary Leong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82200","size":1},{"color":"#336699","name":"Prof Edna Hardeman","data":{"first_name":"Edna","title":"Prof","dw_individual_id":"DW0007725","middle_name":"Christine","last_name":"Hardeman","source_individual_id":"5015078","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Edna Hardeman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78790","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62961","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2012,"keywords":["Receptor trafficking, endocytosis, endosomes","cell-cell communication, cell adhesion molecule","transmembrane protein, cancer biology"],"nhmrc_grant_id":511042,"application_year":2007,"start_year":2008,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Rohan Teasdale","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/511042","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"570217.7","source_system":"I am a cell biologist-computational biologist determining the molecular mechanisms of protein subcellular localisation."},"children":[{"color":"#336699","name":"A/Pr Rohan Teasdale","data":{"first_name":"Rohan","title":"A/Pr","dw_individual_id":"DW0040022","middle_name":"D","last_name":"Teasdale","source_individual_id":"5017848","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Rohan Teasdale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87368","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62960","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2012,"keywords":["Regeneration","kidney, Devopmental genetics","microarray","renal failure"],"nhmrc_grant_id":511032,"application_year":2007,"start_year":2008,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/511032","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"557082.17","source_system":""},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62959","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2012,"keywords":["Genetics,melanoma,skin cancer, skin colour","melanocortin-1,melanocyte,melanoma","pigmentation, skin cancer","sunburn"],"nhmrc_grant_id":511029,"application_year":2007,"start_year":2008,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Richard Sturm","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/511029","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"630274.94","source_system":"My work on human pigmentation genetics has provided a framework to understand normal variation in this physical trait and the associated genotypic risk factors for skin cancer development. The genes that determine an individual's skin phototype and the ce"},"children":[{"color":"#336699","name":"A/Pr Richard Sturm","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0045672","middle_name":"Alan","last_name":"Sturm","source_individual_id":"5017777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Sturm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88811","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62958","size":1},{"color":"#FF4D4D","name":"The immunoregulatory domains and binding interactions of human respiratory syncytial virus non-structural proteins","data":{"media_summary":"viral bronchiolitis","end_year":2010,"keywords":["antiviral","molecular biology","protein-protein interactions","proteomics","respiratory syncytial virus"],"nhmrc_grant_id":511020,"application_year":2007,"health_keywords":["antiviral therapy","immunocompromised patients","microbiology-virology","respiratory diseases in children","viral bronchiolitis"],"scientific_title":"The immunoregulatory domains and binding interactions of human respiratory syncytial virus non-structural proteins","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Kirsten Spann","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511020","simplified_title":"Regulation of immune response by RSV proteins","sub_type":"Standard Project Grant","total_budget":"484051.08","source_system":"Human respiratory syncytial virus (HRSV) is the leading cause of lower respiratory tract disease in infants and yet there are no vaccines available. HRSV exacerbates disease by interfering with the innate immune response. We aim to establish the mechanism by which this occurs by identifying the cellular-viral protein interactions involved, and by identifying the specific regions of the viral proteins responsible. This information will allow targeted vaccines and antivirals to be developed."},"children":[{"color":"#336699","name":"Prof Jeffrey Gorman","data":{"first_name":"Jeffrey","title":"Prof","dw_individual_id":"DW0025137","middle_name":"J.","last_name":"Gorman","source_individual_id":"RMIS80042","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jeffrey Gorman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83462","size":1},{"color":"#336699","name":"Dr Kirsten Spann","data":{"first_name":"Kirsten","title":"Dr","dw_individual_id":"DW0010390","middle_name":"Michelle","last_name":"Spann","source_individual_id":"5017641","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kirsten Spann"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79524","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62957","size":1},{"color":"#FF4D4D","name":"Practitioner Fellowship","data":{"media_summary":"","end_year":2012,"keywords":["Dendritic cell","Respiratory Allergy","Respiratory Virus"],"nhmrc_grant_id":511019,"application_year":2007,"start_year":2008,"scientific_title":"Practitioner Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof John Upham","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/511019","simplified_title":"Practitioner Fellowship","sub_type":"Practitioner Fellowship","total_budget":"514013.81","source_system":"I am a respiratory physician studying mechanisms of respiratory allergy and host defence against respiratory viruses. My research aims to develop new ways of treating airway inflammation in asthma and COPD."},"children":[{"color":"#336699","name":"Prof John Upham","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0045963","middle_name":"W","last_name":"Upham","source_individual_id":"5018030","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Upham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88900","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62956","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2012,"keywords":["Aboriginal health,diabetes(type 2),cardiovascular","Aboriginal,Risk factors,Biostatistical methods","Cardiovascular disease,Diabetes mellitus","among indigenous populations","disease,multiple risk factors, chronic disease"],"nhmrc_grant_id":511013,"application_year":2007,"start_year":2008,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Indigenous Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Zhiqiang Wang","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/511013","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"570217.7","source_system":"With particular interest in developing data analysis techniques, I am an epidemiologist assessing risk factors and developing risk calculators for non-communicable diseases, such as cardiovascular disease and diabetes, in Aboriginal people."},"children":[{"color":"#336699","name":"A/Pr Zhiqiang Wang","data":{"first_name":"Zhiqiang","title":"A/Pr","dw_individual_id":"DW0028670","middle_name":"","last_name":"Wang","source_individual_id":"5019801","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Zhiqiang Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84425","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62955","size":1},{"color":"#FF4D4D","name":"Store operated Ca2+ entry in skeletal fibres from normal and dystrophin-deficient muscle.","data":{"media_summary":"","end_year":2011,"keywords":["calcium imaging","mechanically skinned fibres","muscle","physiology"],"nhmrc_grant_id":511011,"application_year":2007,"health_keywords":["muscle","muscular dystrophy","musculoskeletal physiology"],"scientific_title":"Store operated Ca2+ entry in skeletal fibres from normal and dystrophin-deficient muscle.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Dr Bradley Launikonis","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511011","simplified_title":"Regulation of calcium entry in healthy and dystrophic muscle","sub_type":"Standard Project Grant","total_budget":"351790.81","source_system":"Skeletal muscle, the most abundant tissue in the body, is essential for life and movement. Muscle function is regulated in a complex manner by calcium and is severely impaired in patients with Duchenne muscular dystrophy. Changes in calcium regulation, known to occur in dystrophic muscle, will be investigated in an animal model using a novel, single cell approach. Results obtained will contribute to understanding better muscular dystrophy and help provide therapeutic targets for treatment."},"children":[{"color":"#336699","name":"Prof D. George Stephenson","data":{"first_name":"D. George","title":"Prof","dw_individual_id":"DW0022315","middle_name":"","last_name":"Stephenson","source_individual_id":"5017705","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof D. George Stephenson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82758","size":1},{"color":"#336699","name":"Dr Bradley Launikonis","data":{"first_name":"Bradley","title":"Dr","dw_individual_id":"DW0014380","middle_name":"S","last_name":"Launikonis","source_individual_id":"5015864","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Bradley Launikonis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80584","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62954","size":1},{"color":"#FF4D4D","name":"Molecular and Functional Characterisation of Cell Surface Microdomains","data":{"media_summary":"","end_year":2013,"keywords":["Anti-cancer Drugs","Endocytosis","Muscular Dystrophy","Plasma Membrane","Ras Protein"],"nhmrc_grant_id":511005,"application_year":2007,"start_year":2008,"scientific_title":"Molecular and Functional Characterisation of Cell Surface Microdomains","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/511005","simplified_title":"The Cell Surface in Health and Disease","sub_type":"Program Grant","total_budget":"4803731.36","source_system":"This research program aims to gain a detailed understanding of the organisation of the cell surface at the molecular level. The cell surface is organised into domains with distinct functions. Visualisation of these domains, identifying their important components, and understanding how they form and function will have huge importance for therapeutic strategies aimed at combating the changes associated with cell transformation in cancer and in other human diseases such as muscular dystrophy."},"children":[{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1},{"color":"#336699","name":"Prof Kirill Alexandrov","data":{"first_name":"Kirill","title":"Prof","dw_individual_id":"DW0005768","middle_name":"","last_name":"Alexandrov","source_individual_id":"5011534","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Kirill Alexandrov"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78275","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62952","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2012,"keywords":["Behavioural intervention;effectiveness study;","Physical activity;diet;cancer;types 2 diabetes;","cardiovascular disease","chronic disease;older people;preventive medicine;"],"nhmrc_grant_id":511001,"application_year":2007,"start_year":2008,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Promotion","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Elizabeth Eakin","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/511001","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"617878.82","source_system":"I am a behavioural scientist whose research focuses on development of the evidence base for health behaviour interventions. Specifically, my focus is on physical activity, diet and weight control interventions that have broad population reach and are appl"},"children":[{"color":"#336699","name":"Prof Elizabeth Eakin","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0036429","middle_name":"G","last_name":"Eakin","source_individual_id":"5014455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Elizabeth Eakin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86445","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62951","size":1},{"color":"#FF4D4D","name":"TELEPHONE COUNSELLING FOR MAINTENANCE OF PHYSICAL ACTIVITY, WEIGHT LOSS and GLYCAEMIC CONTROL IN TYPE 2 DIABETES","data":{"media_summary":"","end_year":2013,"keywords":["Behavioural Intervention","Diet","Physical Activity","Telephone Counselling","Weight Loss"],"nhmrc_grant_id":511000,"application_year":2007,"health_keywords":["Glycaemic Control","Type 2 Diabetes","Weight Loss"],"scientific_title":"TELEPHONE COUNSELLING FOR MAINTENANCE OF PHYSICAL ACTIVITY, WEIGHT LOSS and GLYCAEMIC CONTROL IN TYPE 2 DIABETES","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Promotion","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Elizabeth Eakin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/511000","simplified_title":"A POPULATION HEALTH APPROACH TO THE LIFESTYLE MANAGEMENT OF TYPE 2 DIABETES","sub_type":"Standard Project Grant","total_budget":"1285894.37","source_system":"Regular exercise, a healthy diet and weight loss are key to managing type 2 diabetes, yet these are major challenges for most people with diabetes. This study will evaluate the impact of a telephone counselling program to assist people with type 2 diabetes to exercise, eat a healthy diet and lose weight, with the goal of helping them to sustain these changes over the long-term. It is expected that these lifestyle changes will also result in improved blood glucose control and quality of life."},"children":[{"color":"#336699","name":"A/Pr David Dunstan","data":{"first_name":"David","title":"A/Pr","dw_individual_id":"DW0042157","middle_name":"Wayne","last_name":"Dunstan","source_individual_id":"5012550","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr David Dunstan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87930","size":1},{"color":"#336699","name":"Prof Elizabeth Eakin","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0036429","middle_name":"G","last_name":"Eakin","source_individual_id":"5014455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Elizabeth Eakin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86445","size":1},{"color":"#336699","name":"Prof Nicholas Graves","data":{"first_name":"Nicholas","title":"Prof","dw_individual_id":"DW0025161","middle_name":"","last_name":"Graves","source_individual_id":"5012570","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nicholas Graves"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83472","size":1},{"color":"#336699","name":"Dr Marina Reeves","data":{"first_name":"Marina","title":"Dr","dw_individual_id":"DW0009857","middle_name":"M","last_name":"Reeves","source_individual_id":"5017143","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Marina Reeves"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79376","size":1},{"color":"#336699","name":"A/Pr Alison Marshall","data":{"first_name":"Alison","title":"A/Pr","dw_individual_id":"DW0003192","middle_name":"L","last_name":"Marshall","source_individual_id":"5016226","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Alison Marshall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77550","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62950","size":1},{"color":"#FF4D4D","name":"Pneumovirus infection in infancy affects the development of life-long adaptive immunity.","data":{"media_summary":"Viral bronchiolitis","end_year":2011,"keywords":["Airway inflammation","Innate immunity","Neutrophils","Respiratory diseases","Respiratory syncytial virus"],"nhmrc_grant_id":510718,"application_year":2007,"health_keywords":["Acute and chronic lung infections","Asthma and COPD","Neonatal-pediatric respiratory diseases","Respiratory syncytial virus","Viral bronchiolitis"],"scientific_title":"Pneumovirus infection in infancy affects the development of life-long adaptive immunity.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Simon Phipps","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/510718","simplified_title":"Immune mechanisms in early life that promote protective immunity to infection","sub_type":"New Investigator Grant","total_budget":"408469.04","source_system":"Respiratory syncytial virus is the most important cause of acute lower respiratory tract infection (RTI) in young children worldwide. Hospital admission rates in Western societies for RTIs are around 3% for children younger than 1 year. A vaccine to RSV is not yet available and repeat infections occur thoughout life, suggesting that the immune response does not develop correctly. In this project we are exploring the mechanisms that underpin disease development and promote incomplete immunity."},"children":[{"color":"#336699","name":"Dr Simon Phipps","data":{"first_name":"Simon","title":"Dr","dw_individual_id":"DW0033180","middle_name":"","last_name":"Phipps","source_individual_id":"5016985","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Simon Phipps"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85598","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62934","size":1},{"color":"#FF4D4D","name":"Reducing alcohol-related harm in rural Aboriginal communities: integrating clinical care and community development.","data":{"media_summary":"","end_year":2012,"keywords":["Indigenous Health","Indigenous community-controlled health services","alcohol","intervention study"],"nhmrc_grant_id":510431,"application_year":2007,"start_year":2008,"scientific_title":"Reducing alcohol-related harm in rural Aboriginal communities: integrating clinical care and community development.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Indigenous Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Anton Clifford","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/510431","simplified_title":"Working with rural Aboriginal communities to reduce harm from alcohol","sub_type":"Australian Training ECF for Aboriginal and Torres Strait Islander Health Research","total_budget":"316165.24","source_system":"This project involves working with rural Aboriginal communities to reduce harms from alcohol. Two programs will be implemented in Aboriginal communities: a clinical care program to improve the prevention, management and treatment of alcohol problems in Aboriginal people, and a community development program to help Aboriginal communities find solutions to alcohol problems."},"children":[{"color":"#336699","name":"Dr Anton Clifford","data":{"first_name":"Anton","title":"Dr","dw_individual_id":"DW0029998","middle_name":"Christopher","last_name":"Clifford","source_individual_id":"RMIS3386554","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Anton Clifford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84774","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62921","size":1},{"color":"#FF4D4D","name":"Linkage and association studies of schizophrenia in an isolated population.","data":{"media_summary":"","end_year":2012,"keywords":["Diagnostic criteria","Gene Mapping","Linkage analysis","Psychiatry","Schizophrenia"],"nhmrc_grant_id":496698,"application_year":2007,"health_keywords":["Mental Health","Psychiatric disorders","Schizophrenia"],"scientific_title":"Linkage and association studies of schizophrenia in an isolated population.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Bryan Mowry","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/496698","simplified_title":"A genetic study of schizophrenia in an isolated population.","sub_type":"Standard Project Grant","total_budget":"693726.6","source_system":"The cause of schizophrenia is unknown, but there is good evidence that genes play a role. Geneticists do not fully understand how the disease is inherited, but it is very complex, and several interacting genes as well as environmental factors are likely involved. To address this complexity, we have recruited large schizophrenia pedigrees from the Iban of Sarawak, a geographically and genetically isolated population. This sample will help clarify the genetics of this devastating illness."},"children":[{"color":"#336699","name":"Prof Bryan Mowry","data":{"first_name":"Bryan","title":"Prof","dw_individual_id":"DW0044411","middle_name":"J","last_name":"Mowry","source_individual_id":"5016586","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bryan Mowry"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88510","size":1},{"color":"#336699","name":"Prof Lynn Jorde","data":{"first_name":"Lynn","title":"Prof","dw_individual_id":"DW0025836","middle_name":"B","last_name":"Jorde","source_individual_id":"RMIS2356432","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Lynn Jorde"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83657","size":1},{"color":"#336699","name":"A/Pr Stuart Macgregor","data":{"first_name":"Stuart","title":"A/Pr","dw_individual_id":"DW0014597","middle_name":"","last_name":"Macgregor","source_individual_id":"5016108","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Stuart Macgregor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80649","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62609","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2013,"keywords":["Calcium signalling","Endocrinology","Growth hormone","Insulin secretion","Ion channels"],"nhmrc_grant_id":494825,"application_year":2007,"start_year":2008,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Chen Chen","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/494825","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"902104.09","source_system":"I am a cellular physiologist investigating the role of ion channels, receptors and intracellular signalling systems in the control of hormone secretion from endocrine cells, contraction of cardiac myocytes and to a lesser extent, growth of endometrium can"},"children":[{"color":"#336699","name":"Prof Chen Chen","data":{"first_name":"Chen","title":"Prof","dw_individual_id":"DW0024065","middle_name":"","last_name":"Chen","source_individual_id":"RMIS86822","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Chen Chen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83170","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62579","size":1},{"color":"#FF4D4D","name":"Inflammasome function in gastrointestinal immunity and inflammation","data":{"media_summary":"","end_year":2012,"keywords":["caspases","infection","inflammation","innate immunity","interleukins"],"nhmrc_grant_id":490993,"application_year":2007,"start_year":2008,"scientific_title":"Inflammasome function in gastrointestinal immunity and inflammation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Kate Schroder","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/490993","simplified_title":"Identification of novel pathways mediating immunity and inflammation in the gut","sub_type":"CJ Martin Biomedical ECF","total_budget":"421116.22","source_system":"The immune system in the gut provides a vital defence against microbes. If these defences are ineffective we become infected leading to gastroenteritis, a major cause of death in the third world and hospitalisation in developed countries. Conversely, excessive or inappropriate activation of these defences can cause inflammatory disease. This project will investigate microbial detection in the gut, and aims to discover new, more effective ways to treat gastrointestinal infection and inflammation."},"children":[{"color":"#336699","name":"Dr Kate Schroder","data":{"first_name":"Kate","title":"Dr","dw_individual_id":"DW0039577","middle_name":"","last_name":"Schroder","source_individual_id":"5017404","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kate Schroder"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87264","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62479","size":1},{"color":"#FF4D4D","name":"The aetiology and prevention of pneumonia of Indigenous children in Northern Australia","data":{"media_summary":"","end_year":2012,"keywords":["Aboriginal and Torres Strait Islander health","Aetiology","Child health","Pneumonia","Prevention"],"nhmrc_grant_id":490338,"application_year":2007,"start_year":2008,"scientific_title":"The aetiology and prevention of pneumonia of Indigenous children in Northern Australia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Kerry-Ann O'Grady","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/490338","simplified_title":"Pneumonia and its prevention in Indigenous children","sub_type":"Australian Training ECF for Aboriginal and Torres Strait Islander Health Research","total_budget":"344258.11","source_system":"This research aims to identify the causes of pneumonia in Indigenous children and to find out whether new and existing vaccines can reduce the amount of infections and their complications."},"children":[{"color":"#336699","name":"Dr Kerry-Ann O'Grady","data":{"first_name":"Kerry-Ann","title":"Dr","dw_individual_id":"DW0032957","middle_name":"F","last_name":"O'Grady","source_individual_id":"5016768","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kerry-Ann O'Grady"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85541","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62450","size":1},{"color":"#FF4D4D","name":"Characterisation of the genetic networks underlying macrophage differentiation and the resolution of inflammation","data":{"media_summary":"","end_year":2012,"keywords":["Infectious diseases","Inflammation","Innate immunity"],"nhmrc_grant_id":481945,"application_year":2007,"start_year":2008,"scientific_title":"Characterisation of the genetic networks underlying macrophage differentiation and the resolution of inflammation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Immunology","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Christine Wells","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/481945","simplified_title":"Identification of novel repressors of inflammation","sub_type":"RD Wright Biomedical CDF","total_budget":"405000.9","source_system":"Chronic inflammation is a central player in many common diseases, impacting on the health and well being of millions of Australians. By using innovative genomic approaches to build a map of all of the gene products involved in the inflammatory process, this project aims to identify which are the critical molecules that normally switch off inflammation. Our ultimate aim is to develop new approaches to treating inflammatory disease."},"children":[{"color":"#336699","name":"A/Pr Christine Wells","data":{"first_name":"Christine","title":"A/Pr","dw_individual_id":"DW0040397","middle_name":"Anne","last_name":"Wells","source_individual_id":"5018258","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Christine Wells"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87466","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62372","size":1},{"color":"#FF4D4D","name":"The role of stargazin and TARP phosphorylation in synaptic plasticity","data":{"media_summary":"","end_year":2014,"keywords":["glutamate receptors","molecular neuroscience","phosphoprotein","receptor trafficking","synaptic plasticity"],"nhmrc_grant_id":477108,"application_year":2007,"start_year":2008,"scientific_title":"The role of stargazin and TARP phosphorylation in synaptic plasticity","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Neurochemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Victor Anggono","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/477108","simplified_title":"Molecular mechanisms of synaptic plasticity","sub_type":"CJ Martin Biomedical ECF","total_budget":"423305.02","source_system":"A constant change in the strength of synaptic communication between neurons is critical for higher brain functions such as learning and memory. Synaptic strength is determined in part by the number of receptor ion channels at the synapse. This project will characterise how key interacting proteins regulate the synaptic targeting of these receptors in vivo. This research aims to understand the mechanisms of synaptic plasticity that may ultimately lead to new therapies for various brain disorders."},"children":[{"color":"#336699","name":"Dr Victor Anggono","data":{"first_name":"Victor","title":"Dr","dw_individual_id":"DW0040823","middle_name":"","last_name":"Anggono","source_individual_id":"5028226","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Victor Anggono"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87589","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62299","size":1},{"color":"#FF4D4D","name":"Neuro restorative rehabilitation in children with Cerebral Palsy","data":{"media_summary":"","end_year":2012,"keywords":["Cerebral Palsy","Cortical Reorganisation","Neurological Disability","Population Health","Rehabilitation of Motor Function"],"nhmrc_grant_id":473840,"application_year":2007,"start_year":2009,"scientific_title":"Neuro restorative rehabilitation in children with Cerebral Palsy","node_source":"NHMRC","node_type":"Grant","field_of_research":"Care for Disabled","research_area":"Clinical Medicine and Science","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Roslyn Boyd","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/473840","simplified_title":"Cerebral Palsy Health and Neurorehabilitation","sub_type":"Clinical CDF","total_budget":"380558.72","source_system":""},"children":[{"color":"#336699","name":"Prof Roslyn Boyd","data":{"first_name":"Roslyn","title":"Prof","dw_individual_id":"DW0041223","middle_name":"N","last_name":"Boyd","source_individual_id":"RMIS1681246","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roslyn Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87689","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62281","size":1},{"color":"#FF4D4D","name":"EGFR transactivation in cardiac hypertrophy","data":{"media_summary":"","end_year":2010,"keywords":["EGF receptor transactivation","G-protein coupled receptors","angiotensin II receptors","cardiac hypertrophy","molecular mechanisms"],"nhmrc_grant_id":472640,"application_year":2007,"health_keywords":["cardiac hypertrophy","cardiovascular disease and hypertension","cell signalling","heart disease"],"scientific_title":"EGFR transactivation in cardiac hypertrophy","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Walter Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/472640","simplified_title":"EGFR transactivation in cardiac hypertrophy","sub_type":"Standard Project Grant","total_budget":"589175.35","source_system":"Muscle cells that constitute the bulk of the human heart do not divide but enlarge as we grow. Accelerated heart cell growth, as a consequence of heart damage or other factors, is a predictor of heart failure and early death. This application examines the cellular events that control heart growth in response to angiotensin, a hormone linked to heart failure. By understanding the mechanism by which angiotensin promotes growth, better therapies against human cardiovascular disease will evolve."},"children":[{"color":"#336699","name":"Prof Walter Thomas","data":{"first_name":"Walter","title":"Prof","dw_individual_id":"DW0028371","middle_name":"Glen","last_name":"Thomas","source_individual_id":"RMIS225046","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Walter Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84337","size":1},{"color":"#336699","name":"Prof Ross Hannan","data":{"first_name":"Ross","title":"Prof","dw_individual_id":"DW0013491","middle_name":"Duncan","last_name":"Hannan","source_individual_id":"5015053","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ross Hannan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80344","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62255","size":1},{"color":"#FF4D4D","name":"Endosomal tubule formation in health and disease","data":{"media_summary":"","end_year":2012,"keywords":["Disease","Health","Proteins"],"nhmrc_grant_id":546155,"application_year":2006,"start_year":2007,"scientific_title":"Endosomal tubule formation in health and disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Fiona Simpson","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/546155","simplified_title":"Endosomal tubule formation in health and disease","sub_type":"RD Wright Biomedical CDF","total_budget":"471058.72","source_system":""},"children":[{"color":"#336699","name":"Dr Fiona Simpson","data":{"first_name":"Fiona","title":"Dr","dw_individual_id":"DW0010280","middle_name":"","last_name":"Simpson","source_individual_id":"5017533","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Fiona Simpson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79493","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62203","size":1},{"color":"#FF4D4D","name":"Equipment Grant","data":{"media_summary":"","end_year":2008,"keywords":["Equipment"],"nhmrc_grant_id":520952,"application_year":2006,"start_year":2008,"scientific_title":"Equipment Grant","node_source":"NHMRC","node_type":"Grant","field_of_research":"n-a","research_area":"Not Applicable","for_category":"N-A","cia_name":"Mr Michael Tse","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/520952","simplified_title":"Equipment Grant","sub_type":"Equipment Grant","total_budget":"724298","source_system":""},"children":[{"color":"#336699","name":"Mr Michael Tse","data":{"first_name":"Michael","title":"Mr","dw_individual_id":"DW0016724","middle_name":"","last_name":"Tse","source_individual_id":"RMIS4747161","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mr Michael Tse"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81243","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62194","size":1},{"color":"#FF4D4D","name":"Androgen Status in Obese men","data":{"media_summary":"","end_year":2012,"keywords":["Androgen Deficiency","Obese Men","Prevalence","Risk Factors"],"nhmrc_grant_id":465317,"application_year":2006,"start_year":2007,"scientific_title":"Androgen Status in Obese men","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Cynthia Ong","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/465317","simplified_title":"Androgen Status in Obese men","sub_type":"Medical Postgraduate Scholarship","total_budget":"125555.94","source_system":""},"children":[{"color":"#336699","name":"Dr Cynthia Ong","data":{"first_name":"Cynthia","title":"Dr","dw_individual_id":"DW0009460","middle_name":"T R Y","last_name":"Ong","source_individual_id":"5016800","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Cynthia Ong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79269","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62074","size":1},{"color":"#FF4D4D","name":"VicCPchild- prospective cohort study of children with cerebral palsy","data":{"media_summary":"Population based research","end_year":2010,"keywords":["Brain structure in cerebral palsy","Cerebral Palsy","Child Health","Gross motor development","Population based health"],"nhmrc_grant_id":465128,"application_year":2006,"health_keywords":["Brain injury classification","Cerebral Palsy","Gross motor development","Motor development","Population based research"],"scientific_title":"VicCPchild- prospective cohort study of children with cerebral palsy","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Care for Disabled","research_area":"Clinical Medicine and Science","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Roslyn Boyd","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/465128","simplified_title":"VicCPchild - study of children with cerebral palsy - the class of 2004 and 2005","sub_type":"Standard Project Grant","total_budget":"613587.43","source_system":"Cerebral palsy is the most common cause of physical disability in children affecting 1 in 500 young Australians. While the brain lesion is static, the musculoskeletal problems are progressive and require lifelong management (cost of US$946,000 over life per person). Only large prospective population-based studies give a true indication of the incidence of physical problems, determine the pathway(s) to outcome and determine the best pathways to successful treatment and efficient resource allocation. The broad aim of this project is: This population based cohort study (n - 240) aims to determine the pathway to motor outcome from diagnosis at 18 months to 5 years based on the nature of the brain injury at 24 months (structural MRI of the nature, location and timing of the brain lesion). Secondary Aims: Determine the rate of musculoskeletal deformity (hip displacement, spasticity, muscle contracture). Potential impact of medical co-morbidities (nutrition, epilepsy, respiratory problems) Patterns of participation and HRQOL. Patterns of medical resource use: treatment costs and outcomes. This study will: Allow clinicians to better the likely functional outcomes of children with CP from an earlier age based on the rate and limit of gross motor development and nature and severity of the brain lesion, determine the nature and timing of physical deformities to aid prevention and treatment; provide information on resource use for future planning and organisation of medical and therapy services. This in turn will give more accurate prognostic counseling as well as target areas for early therapy. Our multidisciplinary research group is uniquely placed to conduct this world-first study with access to two entire birth years of children linked to our Victorian Cerebral Palsy Register. Recruitment is conducted at both the Royal Children's Hospital and the Monash Medical centre in order to ensure state wide referral and easy access for families."},"children":[{"color":"#336699","name":"Prof Roslyn Boyd","data":{"first_name":"Roslyn","title":"Prof","dw_individual_id":"DW0041223","middle_name":"N","last_name":"Boyd","source_individual_id":"RMIS1681246","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roslyn Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87689","size":1},{"color":"#336699","name":"A/Pr Barry Rawicki","data":{"first_name":"Barry","title":"A/Pr","dw_individual_id":"DW0027520","middle_name":"H","last_name":"Rawicki","source_individual_id":"5017128","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Barry Rawicki"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84105","size":1},{"color":"#336699","name":"Prof Ingeborg Krageloh Mann","data":{"first_name":"Ingeborg","title":"Prof","dw_individual_id":"DW0026066","middle_name":"F","last_name":"Krageloh Mann","source_individual_id":"5015783","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ingeborg Krageloh Mann"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83734","size":1},{"color":"#336699","name":"A/Pr Michael Fahey","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0001489","middle_name":"C","last_name":"Fahey","source_individual_id":"RMIS2659810","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Michael Fahey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77078","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/62056","size":1},{"color":"#FF4D4D","name":"Empowerment of consumers, carers & communities to support people with mental illness in remote Indigenous C.Y. communit","data":{"media_summary":"","end_year":2008,"keywords":["indigenouse health","indigenouse wellbeing","mantal health"],"nhmrc_grant_id":456339,"application_year":2006,"start_year":2007,"scientific_title":"Empowerment of consumers, carers & communities to support people with mental illness in remote Indigenous C.Y. communit","node_source":"NHMRC","node_type":"Grant","field_of_research":"Indigenous Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Miss Brenda Hall","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/456339","simplified_title":"Empowerment of consumers, carers & communities to support people with mental illness in remote Indigenous C.Y. communit","sub_type":"Training Scholarship for Aboriginal Health Research","total_budget":"44123","source_system":""},"children":[{"color":"#336699","name":"Brenda Hall","data":{"first_name":"Brenda","title":"","dw_individual_id":"DW0019402","middle_name":"","last_name":"Hall","source_individual_id":"RMIS4745744","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Brenda Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81938","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61775","size":1},{"color":"#FF4D4D","name":"Detection of subgingival calculus using laser flourescence and differential reflectometry","data":{"media_summary":"","end_year":2010,"keywords":["clinical research","differential reflectometry","laser flourescence","optical methods","subgingival calculus"],"nhmrc_grant_id":456337,"application_year":2006,"start_year":2007,"scientific_title":"Detection of subgingival calculus using laser flourescence and differential reflectometry","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dentistry not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"DENTISTRY","cia_name":"Dr Fardad Shakibaie","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/456337","simplified_title":"Detection of subgingival calculus using laser flourescence and differential reflectometry","sub_type":"Dental Postgraduate Research Scholarship","total_budget":"113976.97","source_system":""},"children":[{"color":"#336699","name":"Dr Fardad Shakibaie","data":{"first_name":"Fardad","title":"Dr","dw_individual_id":"DW0010188","middle_name":"","last_name":"Shakibaie","source_individual_id":"5030741","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Fardad Shakibaie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79462","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61774","size":1},{"color":"#FF4D4D","name":"The ethical implications of neuroscience research on depression, anxiety and addiction","data":{"media_summary":"","end_year":2008,"keywords":["brain","ethics","mind","policy"],"nhmrc_grant_id":456331,"application_year":2006,"start_year":2007,"scientific_title":"The ethical implications of neuroscience research on depression, anxiety and addiction","node_source":"NHMRC","node_type":"Grant","field_of_research":"Human Bioethics","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Adrian Carter","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/456331","simplified_title":"The ethical implications of neuroscience research on depression, anxiety and addiction","sub_type":"Public Health Postgraduate Scholarship","total_budget":"33024.99","source_system":""},"children":[{"color":"#336699","name":"Dr Adrian Carter","data":{"first_name":"Adrian","title":"Dr","dw_individual_id":"DW0041491","middle_name":"Nicholas","last_name":"Carter","source_individual_id":"5018709","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Adrian Carter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87762","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61773","size":1},{"color":"#FF4D4D","name":"promotion of 'prudent' lifestyle: a factorial randomised trial","data":{"media_summary":"","end_year":2008,"keywords":["population based randomised trial","preventive medicine","prudent lifestyle","public health"],"nhmrc_grant_id":456330,"application_year":2006,"start_year":2007,"scientific_title":"promotion of 'prudent' lifestyle: a factorial randomised trial","node_source":"NHMRC","node_type":"Grant","field_of_research":"Preventive Medicine","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Sanjoti Parekh","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/456330","simplified_title":"promotion of 'prudent' lifestyle: a factorial randomised trial","sub_type":"Public Health Postgraduate Scholarship","total_budget":"44123","source_system":""},"children":[{"color":"#336699","name":"Dr Sanjoti Parekh","data":{"first_name":"Sanjoti","title":"Dr","dw_individual_id":"DW0044704","middle_name":"","last_name":"Parekh","source_individual_id":"RMIS4743988","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Sanjoti Parekh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88562","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61772","size":1},{"color":"#FF4D4D","name":"The morphology and behaviour of the lumbar paraspinal muscles in chronic low back pain","data":{"media_summary":"","end_year":2009,"keywords":["Back muscles","Chronic low back pain","Electromyography","Physiotherapy"],"nhmrc_grant_id":456328,"application_year":2006,"start_year":2007,"scientific_title":"The morphology and behaviour of the lumbar paraspinal muscles in chronic low back pain","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Mr David MacDonald","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/456328","simplified_title":"The morphology and behaviour of the lumbar paraspinal muscles in chronic low back pain","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"69973.69","source_system":""},"children":[{"color":"#336699","name":"David Macdonald","data":{"first_name":"David","title":"","dw_individual_id":"DW0020536","middle_name":"","last_name":"Macdonald","source_individual_id":"RMIS4745607","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Macdonald"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82246","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61771","size":1},{"color":"#FF4D4D","name":"The Pharmacoepidemiology of Complementary and alternative medicine (CAM) use","data":{"media_summary":"","end_year":2010,"keywords":["complimentary medicines","drug interactions","pharmacoepidemiology","quality use of medicine"],"nhmrc_grant_id":456322,"application_year":2006,"start_year":2007,"scientific_title":"The Pharmacoepidemiology of Complementary and alternative medicine (CAM) use","node_source":"NHMRC","node_type":"Grant","field_of_research":"Complementary-Alternative Medicine not elsewhere classified","research_area":"Public Health","for_category":"COMPLEMENTARY-ALTERNATIVE MEDICINE","cia_name":"Peter Coxeter","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/456322","simplified_title":"The Pharmacoepidemiology of Complementary and alternative medicine (CAM) use","sub_type":"Public Health Postgraduate Scholarship","total_budget":"55492.56","source_system":""},"children":[{"color":"#336699","name":"Peter Coxeter","data":{"first_name":"Peter","title":"","dw_individual_id":"DW0024286","middle_name":"D","last_name":"Coxeter","source_individual_id":"5014107","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Peter Coxeter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83237","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61770","size":1},{"color":"#FF4D4D","name":"Physical activity in the lives of Indigenous young people","data":{"media_summary":"","end_year":2010,"keywords":["indigenous","physical activity","young people"],"nhmrc_grant_id":456319,"application_year":2006,"start_year":2007,"scientific_title":"Physical activity in the lives of Indigenous young people","node_source":"NHMRC","node_type":"Grant","field_of_research":"Indigenous Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Alison Nelson","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/456319","simplified_title":"Physical activity in the lives of Indigenous young people","sub_type":"Training Scholarship for Aboriginal Health Research","total_budget":"69934.5","source_system":""},"children":[{"color":"#336699","name":"Dr Alison Nelson","data":{"first_name":"Alison","title":"Dr","dw_individual_id":"DW0038747","middle_name":"L","last_name":"Nelson","source_individual_id":"5030494","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Alison Nelson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87034","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61769","size":1},{"color":"#FF4D4D","name":"Peripheral mechanisms of analgesia and the involvement of cell adhesion","data":{"media_summary":"","end_year":2009,"keywords":["Antinociception","Cell adhesion","Inflammation","Liposomes","Pain"],"nhmrc_grant_id":456314,"application_year":2006,"start_year":2007,"scientific_title":"Peripheral mechanisms of analgesia and the involvement of cell adhesion","node_source":"NHMRC","node_type":"Grant","field_of_research":"Peripheral Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Miss Susan HUA","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/456314","simplified_title":"Peripheral mechanisms of analgesia and the involvement of cell adhesion","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"69973.69","source_system":""},"children":[{"color":"#336699","name":"Dr Susan Hua","data":{"first_name":"Susan","title":"Dr","dw_individual_id":"DW0019740","middle_name":"","last_name":"Hua","source_individual_id":"5027793","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Susan Hua"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82030","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61768","size":1},{"color":"#FF4D4D","name":"Adiponectin: linking obesity and cardiovascular disease","data":{"media_summary":"","end_year":2010,"keywords":["Adipokine","Cardiovascular disease","Obesity","Thrombosis"],"nhmrc_grant_id":456313,"application_year":2006,"start_year":2007,"scientific_title":"Adiponectin: linking obesity and cardiovascular disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Liza Phillips","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/456313","simplified_title":"Adiponectin: linking obesity and cardiovascular disease","sub_type":"John Shaw Biomedical Postgraduate Scholarship","total_budget":"117361.81","source_system":""},"children":[{"color":"#336699","name":"Dr Liza Phillips","data":{"first_name":"Liza","title":"Dr","dw_individual_id":"DW0003962","middle_name":"Kirsty","last_name":"Phillips","source_individual_id":"5016959","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Liza Phillips"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77774","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61767","size":1},{"color":"#FF4D4D","name":"Structured treadmill walking for stroke patients: the impact on cardiovascular demand, gait speed and gait quality","data":{"media_summary":"","end_year":2008,"keywords":["physiotherapy","rehabilitation","stroke"],"nhmrc_grant_id":456308,"application_year":2006,"start_year":2007,"scientific_title":"Structured treadmill walking for stroke patients: the impact on cardiovascular demand, gait speed and gait quality","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Mrs Suzanne Kuys","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/456308","simplified_title":"Structured treadmill walking for stroke patients: the impact on cardiovascular demand, gait speed and gait quality","sub_type":"Public Health Postgraduate Scholarship","total_budget":"41634.95","source_system":""},"children":[{"color":"#336699","name":"Dr Suzanne Kuys","data":{"first_name":"Suzanne","title":"Dr","dw_individual_id":"DW0026090","middle_name":"S","last_name":"Kuys","source_individual_id":"RMIS4745356","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Suzanne Kuys"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83742","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61766","size":1},{"color":"#FF4D4D","name":"Are head and neck cancer stem cells resistant to cytotoxic therapies?","data":{"media_summary":"","end_year":2009,"keywords":["Tumour stem cells","head and neck cancer","minimal residual disease","squamous cell carcinoma"],"nhmrc_grant_id":456300,"application_year":2006,"start_year":2007,"scientific_title":"Are head and neck cancer stem cells resistant to cytotoxic therapies?","node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Miss Kim Hanchard","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/456300","simplified_title":"Are head and neck cancer stem cells resistant to cytotoxic therapies?","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"66800","source_system":""},"children":[{"color":"#336699","name":"Kim Hanchard","data":{"first_name":"Kim","title":"","dw_individual_id":"DW0019440","middle_name":"","last_name":"Hanchard","source_individual_id":"RMIS4745464","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Kim Hanchard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81948","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61765","size":1},{"color":"#FF4D4D","name":"Development of a palliative care in residential care outcome scale (PARCOS)","data":{"media_summary":"","end_year":2009,"keywords":["ageing and dementia","outcome assessment","palliative care","residential care"],"nhmrc_grant_id":456232,"application_year":2006,"start_year":2008,"scientific_title":"Development of a palliative care in residential care outcome scale (PARCOS)","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nursing not elsewhere classified","research_area":"Health Services Research","for_category":"NURSING","cia_name":"Ms Deborah Parker","higher_grant_type":"SRDC - People","purl":"http://purl.org/au-research/grants/nhmrc/456232","simplified_title":"A palliative care outcome scale for residents in aged care facilities","sub_type":"Palliative Care Research Fellowship","total_budget":"137000","source_system":"The project seeks to develop and undertake psychometric testing of a scale suitable to measure outcomes for residents in residential aged care facilities for whom a palliative approach is appropriate. The project will include a Joanna Briggs Institute systematic review of existing outcome measures in palliative care with emphasis on their use in residential aged care facilities."},"children":[{"color":"#336699","name":"A/Pr Deborah Parker","data":{"first_name":"Deborah","title":"A/Pr","dw_individual_id":"DW0003853","middle_name":"","last_name":"Parker","source_individual_id":"RMIS1361072","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Deborah Parker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77742","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61764","size":1},{"color":"#FF4D4D","name":"Using Single Patient Trials to determine the effectiveness of psychostimulants in fatigue in advanced cancer patients","data":{"media_summary":"","end_year":2012,"keywords":["Cancer","Fatigue","Terminal illness"],"nhmrc_grant_id":456223,"application_year":2006,"start_year":2007,"scientific_title":"Using Single Patient Trials to determine the effectiveness of psychostimulants in fatigue in advanced cancer patients","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Geoffrey Mitchell","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/456223","simplified_title":"Using Single Patient Trials to determine the effectiveness of psychostimulants in fatigue in advanced cancer patients","sub_type":"Palliative Care Research","total_budget":"162563","source_system":"The lack of good evidence in palliative care (PC) is widely acknowledged but research in PC is difficult. Methodological barriers include: difficulties in recruitment, high rates of attrition, problems with maintaining distinct and sustainable intervention strategies, poorly chosen outcomes and opposition to randomization. Organizational barriers include: lack of research infrastructure, few trained clinical researchers, prioritisation of clinical responsibilities and funding difficulties. The hierarchy of evidence rates RCTs as the gold standard. An alternative is the n-of-1 trial: a randomized, double-blind cross-over comparison of active drug with placebo or another drug. The patient is in effect their own control. N-of-1 trials provide an objective means of testing the effectiveness of medicines in individual patients, providing evidence stronger than RCT evidence for the efficacy of that drug in that particular individual. If multiple n-of-1 trials are conducted, the resultant data amounts to RCT evidence for that treatment in a population. We propose n-of-1 trials as a workable option for researching the benefit of drugs and other therapies in PC patients. If successful, this model could be accepted internationally as the gold standard for research in this difficult population group. This would be a world first and of great national and international significance. In advanced cancer, the prevalence of fatigue is very high at 60-90% and can be related to the treatment or the disease itself. The impact of fatigue on function (physical, mental, social and spiritual) and hence quality of life (QOL) is very significant for many palliative patients as well as their families-carers. The role of pyschostimulants in the management of fatigue in patients with advanced cancer and life limiting disease needs to be defined. We will conduct n-of-1 trials of psychostimulants (i.e. methylphenidate) for fatigue in a group of 40 patients, recruited from 5 sites around Australia through a national clinical trial network recently set up for palliative care research. Managing fatigue with treatment supported by the best possible evidence for individual patients and producing any improvement in fatigue will improve patients functional status, and will greatly improve QOL for patients and carers."},"children":[{"color":"#336699","name":"A/Pr Michael Yelland","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0040629","middle_name":"J","last_name":"Yelland","source_individual_id":"RMIS4535118","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Michael Yelland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87528","size":1},{"color":"#336699","name":"Prof Philip Schluter","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0039558","middle_name":"John","last_name":"Schluter","source_individual_id":"RMIS1697880","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Philip Schluter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87260","size":1},{"color":"#336699","name":"Prof Janet Hardy","data":{"first_name":"Janet","title":"Prof","dw_individual_id":"DW0037109","middle_name":"R","last_name":"Hardy","source_individual_id":"RMIS3148016","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Janet Hardy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86605","size":1},{"color":"#336699","name":"Dr Rohan Vora","data":{"first_name":"Rohan","title":"Dr","dw_individual_id":"DW0022747","middle_name":"R","last_name":"Vora","source_individual_id":"RMIS7171136","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Rohan Vora"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82860","size":1},{"color":"#336699","name":"Dr Jane Nikles","data":{"first_name":"Jane","title":"Dr","dw_individual_id":"DW0021162","middle_name":"","last_name":"Nikles","source_individual_id":"5023242","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jane Nikles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82422","size":1},{"color":"#336699","name":"Prof David Currow","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0012584","middle_name":"Christopher","last_name":"Currow","source_individual_id":"5011920","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Currow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80107","size":1},{"color":"#336699","name":"Prof Geoffrey Mitchell","data":{"first_name":"Geoffrey","title":"Prof","dw_individual_id":"DW0003428","middle_name":"Keith","last_name":"Mitchell","source_individual_id":"5012135","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Geoffrey Mitchell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77614","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61763","size":1},{"color":"#FF4D4D","name":"Mechanisms regulating cell cycle progression in response to UV radiation","data":{"media_summary":"","end_year":2012,"keywords":["Copper","Ion Transporters","Menkes disease","Wilson disease"],"nhmrc_grant_id":456193,"application_year":2006,"start_year":2007,"scientific_title":"Mechanisms regulating cell cycle progression in response to UV radiation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Won Jae Lee","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/456193","simplified_title":"Mechanisms regulating cell cycle progression in response to UV radiation","sub_type":"CJ Martin Biomedical ECF","total_budget":"339489.47","source_system":""},"children":[{"color":"#336699","name":"Dr Won Jae Lee","data":{"first_name":"Won Jae","title":"Dr","dw_individual_id":"DW0032026","middle_name":"","last_name":"Lee","source_individual_id":"5030421","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Won Jae Lee"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85284","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61762","size":1},{"color":"#FF4D4D","name":"The role of RelB in Atopic Asthma","data":{"media_summary":"","end_year":2011,"keywords":["Asthma","Dendritic cells","RelB","Th2"],"nhmrc_grant_id":456187,"application_year":2006,"start_year":2007,"scientific_title":"The role of RelB in Atopic Asthma","node_source":"NHMRC","node_type":"Grant","field_of_research":"Allergy","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Shayna Street","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/456187","simplified_title":"The role of RelB in Atopic Asthma","sub_type":"Peter Doherty Biomedical ECF","total_budget":"309133","source_system":""},"children":[{"color":"#336699","name":"Dr Shayna Street","data":{"first_name":"Shayna","title":"Dr","dw_individual_id":"DW0039914","middle_name":"Ea","last_name":"Street","source_individual_id":"RMIS682569","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Shayna Street"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87342","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61760","size":1},{"color":"#FF4D4D","name":"Prospective study of the emergence of syndromal and sub syndromal anxiety and depression during cognitive decline.","data":{"media_summary":"","end_year":2011,"keywords":["anxiety","cognitive impairment","depression","epidemiology","older people"],"nhmrc_grant_id":456182,"application_year":2006,"start_year":2007,"scientific_title":"Prospective study of the emergence of syndromal and sub syndromal anxiety and depression during cognitive decline.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Gerard Byrne","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/456182","simplified_title":"In order people do depression and anxiety lead to dementia or vice versa?","sub_type":"Dementia Research Grants Program","total_budget":"555696.89","source_system":"In older people it is well known that memory impairment and cognitive decline are associated with depression and anxiety. However, it is remains quite uncertain which comes first. For a long time it had been thought that deteriorating brain function associated with ageing and the development of dementia is also the cause of new symptoms of depression and anxiety found in older people. Recently, some evidence has emerged to challenge this hypothesis. So we plan to study this question in detail with data from an existing longitudinal study of ageing women."},"children":[{"color":"#336699","name":"Prof Gerard Byrne","data":{"first_name":"Gerard","title":"Prof","dw_individual_id":"DW0023904","middle_name":"James","last_name":"Byrne","source_individual_id":"5013745","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gerard Byrne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83133","size":1},{"color":"#336699","name":"Prof Robert King","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0020120","middle_name":"J","last_name":"King","source_individual_id":"5015719","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82135","size":1},{"color":"#336699","name":"Prof Soo Keat Khoo","data":{"first_name":"Soo Keat","title":"Prof","dw_individual_id":"DW0008364","middle_name":"","last_name":"Khoo","source_individual_id":"5015714","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Soo Keat Khoo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78960","size":1},{"color":"#336699","name":"Prof Nancy Pachana","data":{"first_name":"Nancy","title":"Prof","dw_individual_id":"DW0003819","middle_name":"Ann","last_name":"Pachana","source_individual_id":"RMIS1713128","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Nancy Pachana"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77727","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61759","size":1},{"color":"#FF4D4D","name":"Nurses and midwives e-cohort.","data":{"media_summary":"","end_year":2011,"keywords":["nursing recruitment and retention","rural and remote communities"],"nhmrc_grant_id":456163,"application_year":2006,"start_year":2007,"scientific_title":"Nurses and midwives e-cohort.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Catherine Turner","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/456163","simplified_title":"Nurses and midwives e-cohort.","sub_type":"Population Health CDF","total_budget":"471058.72","source_system":""},"children":[{"color":"#336699","name":"Prof Catherine Turner","data":{"first_name":"Catherine","title":"Prof","dw_individual_id":"DW0010740","middle_name":"T","last_name":"Turner","source_individual_id":"5018000","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Catherine Turner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79616","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61758","size":1},{"color":"#FF4D4D","name":"Preventing progression of COPD","data":{"media_summary":"","end_year":2011,"keywords":["Respiratory"],"nhmrc_grant_id":456158,"application_year":2006,"start_year":2007,"scientific_title":"Preventing progression of COPD","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Ian Yang","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/456158","simplified_title":"Preventing progression of COPD","sub_type":"Clinical CDF","total_budget":"329741.1","source_system":""},"children":[{"color":"#336699","name":"A/Pr Ian Yang","data":{"first_name":"Ian","title":"A/Pr","dw_individual_id":"DW0028973","middle_name":"Anthony","last_name":"Yang","source_individual_id":"RMIS57007","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Ian Yang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84509","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61757","size":1},{"color":"#FF4D4D","name":"MPM non-invasive imaging of biological interactions following drug delivery with micro-nanoprojection patches.","data":{"media_summary":"","end_year":2009,"keywords":["Epidermis","Immunoregulation","Non-invasive imaging","Skin cell immunogy","Topical Drug Delivery"],"nhmrc_grant_id":456150,"application_year":2006,"health_keywords":["Drug Delivery","Immunoregulation","Non-invasive imaging","Skin cell immunology"],"scientific_title":"MPM non-invasive imaging of biological interactions following drug delivery with micro-nanoprojection patches.","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof Mark Kendall","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456150","simplified_title":"MPM non-invasive imaging of biological interactions following drug delivery with micro-nanoprojection patches.","sub_type":"Standard Project Grant","total_budget":"403612.13","source_system":"The overarching aim of my research is to develop and evaluate effective, practical and reproducible physical methods for delivering genes and drugs to specific immunologically-sensitive cells in the skin to ultimately treat and vaccinate against human diseases. I recently patented a method using arrays of nano-scale projections on a patch to accurately, efficiently and safely deliver biomolecules not just to specific skin cells, but also to organelles within them. Conceptually, the delivery device is a set of microscopic nanoneedles coated with drug substance and applied to the skin as a small patch. The device is practical, needle-free and pain-free. The aim of this current project is to use the micro-nanoprojection array patches-configured to uniquely deliver biomolecules to cells within given strata-to find: 1) what delivery sites of antigen-expression plasmid- toll like receptor (TLR) agonist lead to strong humoral immune responses in the intact animal. 2) whether delivery of different TLR agonists have different effects on the maturation and migration of the different professional antigen presenting cells (APCs) in the skin, as visualised locally by Multi-Photon Microscopy (MPM). 3) whether differences in APC maturation and migration are associated with different systemic antibody responses. We will identify optimal delivery sites of drugs-vaccines to the skin (layer, cells targeted, duration of delivery) with MPM for desired systemic immune responses. This will have important contributions towards improving immunotherapeutics of major diseases via skin targeting with micro-nanoprojection array patch technologies (and other methods)."},"children":[{"color":"#336699","name":"Prof Mark Kendall","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0043459","middle_name":"Af","last_name":"Kendall","source_individual_id":"5015660","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Kendall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88269","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61755","size":1},{"color":"#FF4D4D","name":"Transcriptional complexity of cell cycle regulated genes during cell division and tumorigenesis","data":{"media_summary":"","end_year":2009,"keywords":["cell cycle regulation","kinases","melanoma","phosphatase","transcriptomics"],"nhmrc_grant_id":456140,"application_year":2006,"health_keywords":["DNA damage","melanoma","tumorigenesis"],"scientific_title":"Transcriptional complexity of cell cycle regulated genes during cell division and tumorigenesis","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Sean Grimmond","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456140","simplified_title":"Transcriptional complexity of cell cycle regulated genes during cell division and tumorigenesis","sub_type":"Standard Project Grant","total_budget":"491703.23","source_system":"Massive scale transcriptome and genome annotation efforts have recently identified all genes encoding the cellular machinery of protein phosphorylation. The size of the molecular network of kinases and phosphatses has been found to be far more complex in mammals than previously reported, with many kinase and phosphatase loci generating, on average, more than 4 transcripts per gene. This grant is aimed at addressing the role of transcriptional complexity in the control of normal cell division and tumorigenesis using a systems wide approach. Rather than relying on the locus based study, this proposal seeks to take a systems biology approach, addressing the functional diversity of the expanded human phosphoregulator proteome, identifying all components of the network that are actively and dynamically expressed in the normal cell cycle and-or tumour progression, and then screening selected novel components for an ability regulate the cell cycle. Such studies will advance our understanding the involvements of the protein phosphorylation machinery in regulating cell division, highlight novel components potentially relevant tumorigenesis and potentially identify new chemotherapeutic targets."},"children":[{"color":"#336699","name":"Prof Sean Grimmond","data":{"first_name":"Sean","title":"Prof","dw_individual_id":"DW0007616","middle_name":"M","last_name":"Grimmond","source_individual_id":"5014956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sean Grimmond"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78759","size":1},{"color":"#336699","name":"A/Pr Brian Gabrielli","data":{"first_name":"Brian","title":"A/Pr","dw_individual_id":"DW0007391","middle_name":"G","last_name":"Gabrielli","source_individual_id":"5014734","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Brian Gabrielli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78693","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61754","size":1},{"color":"#FF4D4D","name":"Exertional dyspnoea with increased filling pressure - Mechanisms and treatment strategies","data":{"media_summary":"","end_year":2009,"keywords":["echocardiography","exercise intolerance","myocardial dysfunction","vascular disease"],"nhmrc_grant_id":456139,"application_year":2006,"health_keywords":["diastolic dysfunction","exercise","myocardial dysfunction","vascular dysfunction"],"scientific_title":"Exertional dyspnoea with increased filling pressure - Mechanisms and treatment strategies","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Thomas Marwick","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456139","simplified_title":"Exertional dyspnoea with increased filling pressure","sub_type":"Standard Project Grant","total_budget":"387793.34","source_system":"Patients with early heart disease often present with shortness of breath with exercise, as myocardial reserve at that stage is usually sufficient to maintain normal function at rest . Indeed, much myocardial dysfunction may originate from the modern lifestyle, including inactivity, obesity, the metabolic syndrome and type II diabetes. The potential benefits of making a definitive early diagnosis are large, because it seems more likely that an impact can be made on the disease process (and therefore, outcome) than with late stage disease. Current treatment strategies are expensive and because they are directed at end-organ damage (heart failure, heart attacks etc), rather ineffective. This multispecialty, multidisciplinary group will undertake a series of unique studies aimed at identifying early cardiovascular disease. The strategy will involve detection of abnormal filling behaviour at stress echocardiography, with randomization into longterm and short-term trials to examine various therapeutic strategies. Sensitive new cardiovascular imaging techniques will be used to detect preclinical abnormalities in the structure and function of the heart and vasculature, facilitating a mechanistic understanding of the process of increasing filling pressure with exercise."},"children":[{"color":"#336699","name":"Prof Thomas Marwick","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0032377","middle_name":"Hugh","last_name":"Marwick","source_individual_id":"RMIS108223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Marwick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85383","size":1},{"color":"#336699","name":"Prof Jeff Coombes","data":{"first_name":"Jeff","title":"Prof","dw_individual_id":"DW0018387","middle_name":"Scott","last_name":"Coombes","source_individual_id":"RMIS159442","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jeff Coombes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81708","size":1},{"color":"#336699","name":"A/Pr James Sharman","data":{"first_name":"James","title":"A/Pr","dw_individual_id":"DW0010203","middle_name":"E","last_name":"Sharman","source_individual_id":"5019538","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr James Sharman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79465","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61753","size":1},{"color":"#FF4D4D","name":"Determination of the mechanisms of action of a cytomegalovirus chemokine receptor homologue in pathogenesis","data":{"media_summary":"","end_year":2009,"keywords":["G protein-coupled receptor","chemokine receptor","cytomegalovirus","host/pathogen interaction"],"nhmrc_grant_id":456137,"application_year":2006,"health_keywords":["herpesvirus disease (cytomegalovirus)","microbiology-virology","targets for design of antiviral research","understanding virus-host interactions"],"scientific_title":"Determination of the mechanisms of action of a cytomegalovirus chemokine receptor homologue in pathogenesis","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Nicholas Davis-Poynter","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456137","simplified_title":"Cytomegalovirus chemokine receptor function","sub_type":"Standard Project Grant","total_budget":"251341.71","source_system":"A number of herpesviruses encode proteins that are similar to proteins of our immune system. These pirated proteins are exploited by the virus to enable it to replicate and persist in the infected individual, usually by evading or gaining advantage from the normal immune response. This project will investigate the role of one such protein found in both human and animal herpesviruses (specifically cytomegaloviruses (CMV)) that is conserved with cellular cell surface proteins (receptors) that bind immune signaling molecules (chemokines). Chemokines are important proteins in the early response to infection. Binding of chemokines to their receptors initiates a cascade of signals within the cell that has profound effects on cellular responses to environmental stimuli. Thus, it is believed that herpesviruses have acquired chemokine receptors to modify or react to the immune response, causing infected cells to behave abnormally either despite or in response to chemokine signals. This project will determine how this CMV specific protein affects the function of cells that CMV infects and how this may promote virus replication, dissemination and persistence in infected hosts. We will also engineer CMVs where the activity of the target protein can be inhibited by administration of prototype antiviral drugs. If inhibition of the activity of the protein is found to reduce virus replication, dissemination or persistence, then this will demonstrate that this type of protein would be a suitable target for the development of novel drugs active against CMV infections. CMV can cause serious (potentially life threatening) disease in newborn children (following infection in the uterus) and immunosuppressed people (eg. organ transplant recipients and people with HIV-AIDS). Our studies will improve our understanding of the contribution of a specific CMV protein to disease, thereby assisting efforts to reduce the impact of CMV infections."},"children":[{"color":"#336699","name":"Dr Helen Farrell","data":{"first_name":"Helen","title":"Dr","dw_individual_id":"DW0030627","middle_name":"Elizabeth","last_name":"Farrell","source_individual_id":"5014571","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Helen Farrell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84957","size":1},{"color":"#336699","name":"A/Pr Nicholas Davis-Poynter","data":{"first_name":"Nicholas","title":"A/Pr","dw_individual_id":"DW0012654","middle_name":"J","last_name":"Davis-Poynter","source_individual_id":"5014228","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nicholas Davis-Poynter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80128","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61752","size":1},{"color":"#FF4D4D","name":"Validation of Cognitive Assessments using Telecommunication","data":{"media_summary":"","end_year":2008,"keywords":["Cognition","Dementia","Multicentre","Telegeriatrics","Telemedicine"],"nhmrc_grant_id":456135,"application_year":2006,"health_keywords":["Ageing and dementia","Alzheimer Disease","Cognitive assessment","Rural and remote health"],"scientific_title":"Validation of Cognitive Assessments using Telecommunication","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Geriatrics and Gerontology","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Leonard Gray","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456135","simplified_title":"Validation of Cognitive Assessments using Telecommunication","sub_type":"Standard Project Grant","total_budget":"257261","source_system":"This project will assess the use of video conferencing to enable geriatricians to assess and diagnose memory problems including dementia. Establishing the reliability of diagnosis and other related assessments, and identifying which functions can confidently be carried out via video conferencing, is one step towards extending the availability of this service to rural and remote communities. Access to accurate diagnosis and assessment of cognitive impairment is an important step in the management of dementia, Alzheimer's disease and other associated disorders. High level expertise, such as that offered by a specialist Memory Disorder Clinic, is particularly important if there is uncertainty about the diagnosis, or if the prescription of cholinesterase inhibitors and associated medications are being considered. It was estimated that in 2005 there were 52,000 people diagnosed with dementia in Australia and by 2050 there will be an additional 175,000 cases each year. For the vast number of people who will be affected by dementia, early detection and intervention will play an important role in their healthy ageing experience. Access to accurate diagnosis and advice as a function of detection and intervention is often not as freely available to people in rural areas. The experience of travelling long distances for assessment can be detrimental to the emotional well being of people who may have dementia. Access to geriatrician services in a local rural area is an important element to maintaining their sense of well being. Geriatricians are not commonly available in rural areas which means current access to specialist diagnosis and assessment is either a missed opportunity or involves extensive travel. Internationally, there are many individuals living in remote regions with no access to geriatrician services, or reliable cognitive assessment. This study will inform similar experiments in other cultural settings."},"children":[{"color":"#336699","name":"Prof Helen Edwards","data":{"first_name":"Helen","title":"Prof","dw_individual_id":"DW0042220","middle_name":"E","last_name":"Edwards","source_individual_id":"RMIS7227","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Helen Edwards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87949","size":1},{"color":"#336699","name":"A/Pr Poh-Kooi Loh","data":{"first_name":"Poh-Kooi","title":"A/Pr","dw_individual_id":"DW0038118","middle_name":"","last_name":"Loh","source_individual_id":"RMIS2321548","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Poh-Kooi Loh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86876","size":1},{"color":"#336699","name":"Dr Melinda Martin-Khan","data":{"first_name":"Melinda","title":"Dr","dw_individual_id":"DW0032375","middle_name":"G","last_name":"Martin-Khan","source_individual_id":"5016241","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Melinda Martin-Khan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85382","size":1},{"color":"#336699","name":"Prof Richard Wootton","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0023093","middle_name":"","last_name":"Wootton","source_individual_id":"5018481","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Wootton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82948","size":1},{"color":"#336699","name":"Prof Leon Flicker","data":{"first_name":"Leon","title":"Prof","dw_individual_id":"DW0013045","middle_name":"","last_name":"Flicker","source_individual_id":"RMIS145624","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Leon Flicker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80226","size":1},{"color":"#336699","name":"Prof Len Gray","data":{"first_name":"Len","title":"Prof","dw_individual_id":"DW0007585","middle_name":"Charles","last_name":"Gray","source_individual_id":"5012147","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Len Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78747","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61751","size":1},{"color":"#FF4D4D","name":"Virulence determinants of encephalitic flaviviruses","data":{"media_summary":"vaccine development","end_year":2009,"keywords":["encephalomyelitis","flavivirus","molecular cloning","vaccine development","virulence"],"nhmrc_grant_id":456126,"application_year":2006,"health_keywords":["arbovirus diseases","flavivirus encephalitis","immunisation","infectious diseases","vaccine development"],"scientific_title":"Virulence determinants of encephalitic flaviviruses","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Roy Hall","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456126","simplified_title":"Identifying the virulence factors of flaviviruses that cause encephalitis","sub_type":"Standard Project Grant","total_budget":"455670.1","source_system":"Murray Valley encephalitis, Japanese enecephaltis virus and West Nile virus are mosquito transmitted pathogens that cause severe and fatal neurological diseases in man and animals. Currenly, it is not clear why these viruses produce such severe diseases and therefore they are difficult to treat and prevent. In this project we will indentify the components of the viruses that allow them to invade the central nervous sytem and cause neurological symptoms. This will provide valuable information on critical elements of these pathogenic viruses that contribute to their virulence and will identify new candidate vaccines for prevention of the encephalitic diseases they cause."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1},{"color":"#336699","name":"Prof Roy Hall","data":{"first_name":"Roy","title":"Prof","dw_individual_id":"DW0025278","middle_name":"A","last_name":"Hall","source_individual_id":"RMIS16831","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roy Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83509","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61750","size":1},{"color":"#FF4D4D","name":"Senataxin, a novel protein involved in the DNA damage response","data":{"media_summary":"Neurodegeneration","end_year":2009,"keywords":["Biological Sciences","Inherited Diseases","Neurodegeneration"],"nhmrc_grant_id":456118,"application_year":2006,"health_keywords":["Biochemistry","DNA damage","Genetic disease","Molecular biology","Neurodegeneration"],"scientific_title":"Senataxin, a novel protein involved in the DNA damage response","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456118","simplified_title":"Study of a DNA repair protein","sub_type":"Standard Project Grant","total_budget":"500460.05","source_system":"The human genome is constantly exposed to agents-chemicals that cause DNA damage. Some of these are generated during normal metabolism and are referred to as reactive oxygen species while others comprise damaging sunlight, radiation and a variety of chemical agents. These agents can lead to cancer and a range of pathologies to different tissues including deterioration of brain function. This project is designed to investigate these processes using a specific genetic disorder as a model system. This disorder is called ataxia with oculomotor apraxia type 2 or AOA2. This condition develops in the teenage to early twenties and as the name suggests is characterised by loss of control of gait together with difficulties of eye movement. It is due to reduced function of a particular region of the brain called the cerebellum responsible for controlling movement. We have initial data suggesting that cells from these patients are very sensitive to environmental chemicals and their capacity to carry out repair of damage to DNA is compromised. We will investigate the nature of the defect at the molecular level and establish the function of the protein defective in this syndrome. This information will be important to determining specific therapies for AOA2 patients and may also have relevance to other neurodegenerative disorders."},"children":[{"color":"#336699","name":"A/Pr Nuri Gueven","data":{"first_name":"Nuri","title":"A/Pr","dw_individual_id":"DW0037013","middle_name":"","last_name":"Gueven","source_individual_id":"RMIS3058711","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Nuri Gueven"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86581","size":1},{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61749","size":1},{"color":"#FF4D4D","name":"Total Laparoscopic Hysterectomy (TLH) vs. Total Abdominal Hysterectomy (TAH) for the Treatment of Endometrial Cancer","data":{"media_summary":"Treatment of Cancer","end_year":2009,"keywords":["Cancer","Laparoscopic Surgery","Quality of Life","Survival","Uterus"],"nhmrc_grant_id":456110,"application_year":2006,"health_keywords":["Endometrial Cancer","Laparoscopic Surgery","Quality of Life","Survival","Treatment of Cancer"],"scientific_title":"Total Laparoscopic Hysterectomy (TLH) vs. Total Abdominal Hysterectomy (TAH) for the Treatment of Endometrial Cancer","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Andreas Obermair","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456110","simplified_title":"LACE Laparascopic Approach to Carcinoma of the Endometrium","sub_type":"Standard Project Grant","total_budget":"809860.84","source_system":"The LACE study is a clinical trial comparing two types of surgery for women with early-stage cancer of the inner lining of the uterus, known as endometrial cancer. Treatment for endometrial cancer involves removal of the uterus, tubes, ovaries and lymph nodes. Traditionally this has been performed by open surgery via an abdominal incision. Open surgery is effective for endometrial cancer, but it is highly invasive, resulting in visible scarring, tissue damage, blood loss and a fairly high risk of complications. Laparoscopic surgery, commonly referred to as keyhole surgery, is a new approach to removing the uterus, tubes, ovaries and lymph nodes. Preliminary results from this less invasive surgery have been extremely encouraging. Laparoscopic surgery is practical and safe in treating endometrial cancer, while also resulting in less tissue damage, lower blood loss, less pain and a shorter recovery period in hospital. The LACE study aims to give definitive answers about the results offered by laparoscopic surgery in treating women with early stage endometrial cancer. The primary aim is to investigate whether the treatment of endometrial cancer using laparoscopic surgery is as good as that using open surgery. Secondary aims look at whether laparoscopic surgery provides more benefits compared to open surgery for endometrial cancer, such as: - improvements in the quality of life post-surgery, - reduced number of early and late surgery-related complications, - shorter stays in hospital, - fewer blood transfusions required, - less pain post-surgery, and hence fewer pain-killers. The LACE study is already under way, with recruitment on target for Stage 1. This application seeks funding for Stage 2, to expand recruitment from 2007. The outcomes of the trial will have a significant bearing on the future choice of treatment for endometrial cancer. Therefore the study will impact many patients around the world, including ~2000 women every year in Australia."},"children":[{"color":"#336699","name":"Dr Thomas Manolitsas","data":{"first_name":"Thomas","title":"Dr","dw_individual_id":"DW0044006","middle_name":"P","last_name":"Manolitsas","source_individual_id":"RMIS3825591","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Thomas Manolitsas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88401","size":1},{"color":"#336699","name":"Dr Russell Hogg","data":{"first_name":"Russell","title":"Dr","dw_individual_id":"DW0037318","middle_name":"J","last_name":"Hogg","source_individual_id":"RMIS4437555","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Russell Hogg"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86669","size":1},{"color":"#336699","name":"Dr Anthony Mccartney","data":{"first_name":"Anthony","title":"Dr","dw_individual_id":"DW0020711","middle_name":"J","last_name":"Mccartney","source_individual_id":"RMIS3825588","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Anthony Mccartney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82295","size":1},{"color":"#336699","name":"A/Pr Monika Janda","data":{"first_name":"Monika","title":"A/Pr","dw_individual_id":"DW0008143","middle_name":"","last_name":"Janda","source_individual_id":"RMIS3098491","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Monika Janda"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78898","size":1},{"color":"#336699","name":"Prof Andreas Obermair","data":{"first_name":"Andreas","title":"Prof","dw_individual_id":"DW0003729","middle_name":"","last_name":"Obermair","source_individual_id":"RMIS2355527","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Andreas Obermair"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77704","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61748","size":1},{"color":"#FF4D4D","name":"First aid for burns: the use of ice water and ice?","data":{"media_summary":"inflammation: wound healing","end_year":2009,"keywords":["burn wound healing","cell death-apoptosis","re-epithelialisation"],"nhmrc_grant_id":456106,"application_year":2006,"health_keywords":["burn injury","cell survival","cooling burn wound","first aid","inflammation: wound healing"],"scientific_title":"First aid for burns: the use of ice water and ice?","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Surgery","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Roy Kimble","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456106","simplified_title":"Ice water for burn first aid?","sub_type":"Standard Project Grant","total_budget":"209668.78","source_system":"Millions of people worldwide receive burn injuries every year and last year the Royal Children's Hospital in Brisbane alone treated more than 500 children with new burn injuries. Many of these children with burn injuries will heal burn wounds with unsightly scars and impaired skin function. Cooling burns as first aid has been used since ancient time and is proved to be the most effective way to reduce skin temperature, lessen pain, minimize the depth of injury, and ultimately improve wound healing outcome. However, despite the evidence that cooling burns using ice water <4 C may be beneficial to burns, current first aid recommend to only use cold water 8-25 C and the use of ice-ice water is strongly discouraged for fear of the potential to cause hypothermia and deepen the existing burn injury. In this application we will examine the effect of ice-ice water 2 C on wound healing outcome compared to 15 C water as first aid, in an in vivo model. The wound healing will be clinically assessed by experienced clinicians weekly for six weeks, and then will also be assessed histologically and mechanically at week six. We will also determine the optimal cooling temperature and duration for injured tissue in burn wounds to recover and the conduction of cold through skin. With the coming new knowledge we wish to design an optimal cooling burn treatment which will maximize the beneficial of cooling to the burns but avoid adverse effect of excessive cooling. The success of this project will advance our knowledge on first aid treatment or burn cooling treatment and also wound healing process. It will enable us to offer better first aid treatment which may lead to wound healing with less scars, otherwise can not achieved by other current available treatments. The better healing of burn wounds will significantly improve burn patients' lives, particularly children with burn injuries. It will also release the burden on much needed health funds."},"children":[{"color":"#336699","name":"Prof Roy Kimble","data":{"first_name":"Roy","title":"Prof","dw_individual_id":"DW0037763","middle_name":"Mark","last_name":"Kimble","source_individual_id":"RMIS1123549","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roy Kimble"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86776","size":1},{"color":"#336699","name":"Dr Xue-Qing Wang","data":{"first_name":"Xue-Qing","title":"Dr","dw_individual_id":"DW0005296","middle_name":"","last_name":"Wang","source_individual_id":"5019783","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Xue-Qing Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78142","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61746","size":1},{"color":"#FF4D4D","name":"SNARE-mediated protein trafficking in macrophages","data":{"media_summary":"","end_year":2009,"keywords":["cytokine secretion","macrophage","membrane fusion","vesicle associated proteins","vesicle trafficking"],"nhmrc_grant_id":456095,"application_year":2006,"health_keywords":["inflammatory mediators","innate immunity","macrophage activation","major histocompatibility complex"],"scientific_title":"SNARE-mediated protein trafficking in macrophages","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456095","simplified_title":"Protein trafficking in macrophages","sub_type":"Standard Project Grant","total_budget":"784371.26","source_system":"Macrophages are white blood cells that provide front line defence against infection by initiating inflammatory responses by ingesting or phagocytosing microbes and by releasing soluble messengers (cytokines) to recruit other immune cells. These defensive functions require extensive trafficking of proteins within the macrophages. Protein trafficking is orchestrated in part by a family of membrane fusion proteins called SNAREs. By defining the relevant SNAREs, we have recently discovered a much acclaimed and novel pathway that allows efficient, combined cytokine secretion and phagocytosis in macrophages. Our studies proposed here will now expand on this discovery by comparing the phagocytic process, in terms of SNARE-mediated membrane and cytokine trafficking, for a wide range of microbes, highlighting differences that could provide new avenues for drug development. Moreover, since our strategy of using SNAREs to investigate and map trafficking pathways has proven so successful, we will now launch a major large-scale initiative to study ALL SNARE-mediated trafficking pathways in macrophages using a discovery pipeline of assays, including live cell imaging, we have developed. This will provide valuable information on many SNAREs including those associated with disease, and will elucidate trafficking pathways governing all macrophage actions in immunity, including cytokine secretion and antigen presentation. All of these pathways are highly relevant to current drug targets being used clinically or studied in inflammatory disease and for the development of vaccines."},"children":[{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61744","size":1},{"color":"#FF4D4D","name":"Molecular Profiling of Breast Tumour Stem/Progenitor Cells","data":{"media_summary":"","end_year":2009,"keywords":["breast cancer","epigenetics","microarray","molecular genetics","stem cells"],"nhmrc_grant_id":456084,"application_year":2006,"health_keywords":["breast cancer","cell growth/differentiation","genomics","molecular basis of disease"],"scientific_title":"Molecular Profiling of Breast Tumour Stem/Progenitor Cells","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Sunil Lakhani","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456084","simplified_title":"Understanding breast tumour stem cells","sub_type":"Standard Project Grant","total_budget":"308824.25","source_system":"Breast cancer is the commonest cancer in women in many countries including Australia, the USA and the UK. The incidence of breast cancer has been increasing over the last decade however mortality from breast cancer has declined. Although there is debate as to the exact reasons for this decline in mortality, it is clear that the introduction of the screening program as well as improvements in treatment have played a significant role. Nevertheless, a proportion of patients will have disseminated disease at presentation and may not fully respond to treatment. In addition a number of patients will go on to form apparent recurrence of the primary tumour and- or distant metastases following what appears to be complete clearance of a tumour. In recent years a new concept has been put forward that might account for some of these recurrences. It is thought that the cells in a tumour do not all divide at the same rate. Instead some cells only divide rarely, and then give rise to other cells which divide rapidly and form the bulk of the tumour. Since these 'tumour stem cells' are slow cycling they will be resistant to existing chemotherapy because this affects rapidly dividing cells. These resistant cells may then go on to form another tumour. We intend to study these 'tumour stem cells' using a range of techniques that will show us how they differ from both the rest of the tumour cells and the different types of normal cells in the breast. By identifying molecules that are different in the tumour stem cells we will then have new targets for therapies that are designed to target these chemotherapy-resistant cells. Such therapies could be used in the future in conjunction with existing therapies to achieve a greater eradication of breast tumours."},"children":[{"color":"#336699","name":"Prof Michael Stratton","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0034086","middle_name":"Rudolph","last_name":"Stratton","source_individual_id":"RMIS4440053","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Stratton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85821","size":1},{"color":"#336699","name":"Dr Peter Simpson","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0033829","middle_name":"T","last_name":"Simpson","source_individual_id":"5017520","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Peter Simpson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85762","size":1},{"color":"#336699","name":"Prof Sunil Lakhani","data":{"first_name":"Sunil","title":"Prof","dw_individual_id":"DW0026113","middle_name":"R","last_name":"Lakhani","source_individual_id":"5015822","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sunil Lakhani"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83752","size":1},{"color":"#336699","name":"Dr Catherine Clarke","data":{"first_name":"Catherine","title":"Dr","dw_individual_id":"DW0012352","middle_name":"L","last_name":"Clarke","source_individual_id":"RMIS3660947","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Catherine Clarke"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80043","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61743","size":1},{"color":"#FF4D4D","name":"Noncoding RNAs as prognostic markers and therapeutic targets in breast cancer","data":{"media_summary":"cancer staging","end_year":2009,"keywords":["breast cancer","cell differentiation","differential gene expression","microarray"],"nhmrc_grant_id":456080,"application_year":2006,"health_keywords":["breast cancer","breast cancer diagnosis","breast development","cancer biology","cancer staging"],"scientific_title":"Noncoding RNAs as prognostic markers and therapeutic targets in breast cancer","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof John Mattick","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456080","simplified_title":"Noncoding RNAs as predictive markers and therapeutic targets in breast cancer","sub_type":"Standard Project Grant","total_budget":"550283.42","source_system":"Normal human development involves a symphony of genetic changes that control the growth and differentiation of different types of cells during embryogenesis. For many years it has been assumed that most genetic information is transacted by proteins, and that the remaining 98% of the human genome that does not encode proteins was (apart from a limited amount of associated regulatory elements) largely non-functional evolutionary junk. However, this may not be the case. Recent results from our laboratory and others have shown that most of our genome and that of other mammals is actually expressed as noncoding RNA, which appears to be developmentally regulated. These RNAs (of which there appear to be tens of thousands, well outnumbering the protein-coding mRNAs) have been referred to as the hidden layer or dark matter of our genome, as they have barely been studied, but appear to play a central role in both normal and abnormal development in humans. There is now increasing evidence that many noncoding RNAs, including small regulatory RNAs called microRNAs, are perturbed in cancer and that these perturbations may be directly involved in, and be an accurate indicator of, cancer state and the direction of cancer progression. If this is true we need to understand the expression and functions of these RNAs in order to develop better diagnostics and perhaps powerful new therapeutics for cancer, based on RNA technology and generic delivery systems. This project will explore the patterns of noncoding RNA expression in normal breast development and in breast cancer, to identify those RNAs that direct or accompany the differentiation of these tissues, and to test the effects of interfering with their expression on these processes. These foundation studies lie at the leading edge of a new understanding of human genetics and cancer, and will provide a platform for future applications in medicine that utilize this information and understanding."},"children":[{"color":"#336699","name":"Prof Melissa Brown","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0041312","middle_name":"A","last_name":"Brown","source_individual_id":"RMIS511711","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Melissa Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87712","size":1},{"color":"#336699","name":"Prof John Mattick","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0014777","middle_name":"Stanley","last_name":"Mattick","source_individual_id":"5016273","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Mattick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80700","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61742","size":1},{"color":"#FF4D4D","name":"Novel peptides for the treatment of pain","data":{"media_summary":"","end_year":2009,"keywords":["Chronic pain","Drug design","Neuropathic pain","Therapeutics"],"nhmrc_grant_id":456074,"application_year":2006,"health_keywords":["Biochemistry-protein peptide","Chronic pain and analgesia","Neuropathic pain","Novel therapeutic"],"scientific_title":"Novel peptides for the treatment of pain","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmaceutical Sciences and Pharmacy","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456074","simplified_title":"New drugs for pain treatment","sub_type":"Standard Project Grant","total_budget":"303828.39","source_system":"Chronic pain affects 1 in 5 Australians and neuropathic pain is among the most severe forms of chronic pain. Several peptides derived from cone snail venoms have attracted recent attention as potential therapeutic agents for the treatment of neuropathic pain. One of these, conotoxin MVIIA, has recently been approved in the US and Europe and others, including CVID and ACVI, are in various stages of clinical investigation. These small disulfide rich peptides share the attractive features of peptides in general of having exquisite selectivity for particular receptors, but also share the general disadvantages of peptides of short biological half-lives and poor bioavailablility. Stabilisation of these conotoxins has the potential to substantially increase their therapeutic potential. In preliminary studies we have shown that by introducing a circular petide backbone into a conotoxin using a linker sequence we can increase its stability and resistance to enzymatic degradation. We therefore propose that it will be possible to cyclise a wide range of conotoxin molecules and thereby improve their drug like properties. In this project we will use our cyclisation approach to develop new potential treatments for pain from two classes of conotoxins. One of the lead molecules shows oral bioavailability in an animal pain model and potentially represents a major breakthrough in the field of peptide drug delivery."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Dr Richard Clark","data":{"first_name":"Richard","title":"Dr","dw_individual_id":"DW0029966","middle_name":"James","last_name":"Clark","source_individual_id":"5013970","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Richard Clark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84761","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61741","size":1},{"color":"#FF4D4D","name":"Development of a generic strategy for the stabilisation of peptide-based therapeutics","data":{"media_summary":"","end_year":2009,"keywords":["Drug delivery","haemochromatosis","rational drug design","regulatory peptides"],"nhmrc_grant_id":456073,"application_year":2006,"health_keywords":["haemochromatosis","new approaches to drug design","therapeutics"],"scientific_title":"Development of a generic strategy for the stabilisation of peptide-based therapeutics","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Therapies and Therapeutic Technology","research_area":"Basic Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Dr Richard Clark","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456073","simplified_title":"Stable peptide-based therapeutics","sub_type":"Standard Project Grant","total_budget":"443196.74","source_system":"There is huge interest in the development of bioactive peptides and proteins for the treatment of a wide range of diseases. However, there are still a number of hurdles that need to be overcome before this source of promising pharmaceuticals can fulfil their vast potential. One of the biggest challenges in the development of peptides and proteins as drugs is overcoming their poor stability in the human body. The broad aim of this research proposal is to develop a novel strategy that provides therapeutically promising peptides and proteins the ability to resist the body s natural degradation pathways so they are able to reach their biological target. To develop this strategy we will use the recently discovered peptide hepcidin as a model system. Hepcidin is the major iron-regulatory hormone in the human body and incorrect levels of this hormone result in either iron overload (haemochromatosis), when there is not enough hepcidin produced by the body, or anemia of inflammation when there is too much hepcidin. The development of hepcidin-based therapeutic agents to treat these conditions has the potential to have significant impact as it has been estimated that up to 1 in 300 Australians are affected by haemochromatosis during their lifetimes. Unfortunately, unmodified peptides, like hepcidin, are of limited therapeutic value due to their poor stability within the human body. This research proposal describes the development of stabilised hepcidin analogues with the potential of being useful drug leads for the treatment of haemochromatosis."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Dr Richard Clark","data":{"first_name":"Richard","title":"Dr","dw_individual_id":"DW0029966","middle_name":"James","last_name":"Clark","source_individual_id":"5013970","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Richard Clark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84761","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61740","size":1},{"color":"#FF4D4D","name":"Inhibitors Of West Nile Virus Protease As Antiviral Drugs","data":{"media_summary":"","end_year":2009,"keywords":["enzyme inhibition","flavivirus","protease inhibitors","virus replication"],"nhmrc_grant_id":456061,"application_year":2006,"health_keywords":["drug discovery","drug target","protease","viral infection"],"scientific_title":"Inhibitors Of West Nile Virus Protease As Antiviral Drugs","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456061","simplified_title":"Studying ways to block a viral enzyme to treat a viral infection spread by migratory birds","sub_type":"Standard Project Grant","total_budget":"590740.52","source_system":"The West Nile Virus (WNV) was first isolated from a woman in the West Nile region of Uganda in 1937. It is one of ~70 known flaviviruses (e.g. Dengue fever, Yellow fever, West Nile, Kunjun, Japanese encephalitis, St. Louis encephalitis, tick-borne encephalitis, Australian encephalitis and the related hepatitis C virus) which annually infect hundreds of millions of people worldwide, particularly in tropical and sub-tropical areas, and cause major public health problems. WNV is endemic in people in the Middle East, parts of Africa and Europe, but recent epidemics in Israel (1998), Romania (1996), United States (1999), and UK (2003), that have been traced to migratory birds, were characterized by severe symptoms , severe neurological pathology, and fatalities. In the USA alone there were 4,156 infections and 284 deaths in 2002, 9122 infections and 223 deaths in 2003, and this mosquito borne virus has quickly spread since 1999 through all USA states and into Canada and Mexico (http:--www.cdc.gov-ncidod-dvbid- westnile-index.htm). No treatments or vaccines are available. This project focuses on a viral enzyme, known as the West Nile Virus NS3 protease, that is essential for replication of the virus. By studying the enzyme in the laboratory we can design small molecules that block its function and these are potential leads for developing drug treatments for people infected, not only by this virus but potentially also other flaviviruses. A precedent is the success of inhibitors of HIV-1 protease that are the most effective treatment for humans with HIV-infections, and other viral proteases are now becoming recognized as viable antiviral targets for pharmaceutical development. The project involves experts on small molecule protease inhibitor design and development, proteases, and virology including West Nile virology. We expect to generate new information at the cutting edge of West Nile Virus and flavivirus research and promising new antiviral drug candidates."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"Prof Paul Young","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0005625","middle_name":"R","last_name":"Young","source_individual_id":"RMIS20614","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78234","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61739","size":1},{"color":"#FF4D4D","name":"Targeting A Complement Receptor That Regulates Inflammatory Disease","data":{"media_summary":"","end_year":2009,"keywords":["Complement C5a","G-protein coupled receptors","inflammation","medicinal chemistry","molecular pharmacology"],"nhmrc_grant_id":456060,"application_year":2006,"health_keywords":["chronic infammatory disease","complement activation","drug design","inflammation"],"scientific_title":"Targeting A Complement Receptor That Regulates Inflammatory Disease","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456060","simplified_title":"Finding out how drugs bind in the cell membrane to improve their antinflammatory activity and drug-like properties","sub_type":"Standard Project Grant","total_budget":"566946.74","source_system":"There are over 100 inflammatory diseases, such as arthritis, inflammatory bowel diseases, sepsis, shock, heart disease, ischemia-reperfusion injury, atherosclerosis, multiple sclerosis, etc. Current antiinflammatory drugs are either not very effective or are compromised by high costs, safety concerns, or reduced effectiveness over time. Complement proteins are natural substances in human blood that protect against infection and injury by causing inflammation which is a desirable component of the immune response. One of these complement factors known as C5a is now thought to be a pivotal component of the complement system of human blood proteins that are synthesized during immune defence against infection. However when C5a is overexpressed or left unregulated it can lead to inflammatory diseases and is now throught to be a key factor in disease progression. In other work, we have been investigating the blockade of various human complement proteins (C5a, C3a, MAC), resulting in a number of new small molecules that can selectively affect, and allow us to probe their specific importance in, the human immune response. This project seeks to develop new compounds (suitable for development into drugs) that can block the binding of C5a to its receptor on the surface of immune cells, thereby preventing the pro-inflammatory actions of C5a. Such compounds have the potential to be new classes of antiinflammatory drugs that treat disease progression rather than just the symptoms of disease. We have previously created the first small molecule antagonists that helped to establish the importance of human C5a in inflammatory disease. We now need to find out how small molecules bind to the receptor for C5a, in order to more effectively block its action in vivo and develop improved antiinflammatory drugs for man."},"children":[{"color":"#336699","name":"A/Pr Peter Monk","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0044344","middle_name":"N","last_name":"Monk","source_individual_id":"RMIS4444069","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Monk"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88493","size":1},{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"Dr Joel Tyndall","data":{"first_name":"Joel","title":"Dr","dw_individual_id":"DW0028508","middle_name":"David Alan","last_name":"Tyndall","source_individual_id":"RMIS1832631","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Joel Tyndall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84375","size":1},{"color":"#336699","name":"Dr Robert Reid","data":{"first_name":"Robert","title":"Dr","dw_individual_id":"DW0009865","middle_name":"C","last_name":"Reid","source_individual_id":"RMIS4598791","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Robert Reid"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79380","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61738","size":1},{"color":"#FF4D4D","name":"Wnt-Ryk signaling in the establishment of major axon tracts in the embryonic mouse brain","data":{"media_summary":"","end_year":2009,"keywords":["axon guidance","developmental neurobiology","molecular neuroscience","signalling pathways"],"nhmrc_grant_id":456040,"application_year":2006,"health_keywords":["brain development","cell signalling","injury and repair to nerves in spinal cord and brain","neuron pathfinding/fasciculation"],"scientific_title":"Wnt-Ryk signaling in the establishment of major axon tracts in the embryonic mouse brain","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Helen Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456040","simplified_title":"Ryk receptor signaling regulates axon guidance","sub_type":"Standard Project Grant","total_budget":"513946.74","source_system":"The corpus callosum is the major interhemispheric commissure in the human brain, comprising approximately 3 million myelinated fibers which connect homologous regions in the neocortex. To date more than 50 different human congenital syndromes have been described in which the corpus callosum does not form leading to epilepsy and mental retardation. We have identified a new guidance molecule (Ryk) which is crucial for corpus callosum formation. This project aims to dissect that molecular mechanisms controlling Ryk signaling during corpus callosum development. Our analysis of Ryk function will advance our understanding of the molecular mechanisms underlying the formation of this important commissure."},"children":[{"color":"#336699","name":"A/Pr Helen Cooper","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0018393","middle_name":"M","last_name":"Cooper","source_individual_id":"RMIS222363","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Helen Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81710","size":1},{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61736","size":1},{"color":"#FF4D4D","name":"Mechanisms of tolerance in memory T cells","data":{"media_summary":"","end_year":2009,"keywords":["dendritic cells","immunology","immunoregulation","memory T cells"],"nhmrc_grant_id":456028,"application_year":2006,"health_keywords":["T cell immunity","dendritic cell","immune regulation","tolerance"],"scientific_title":"Mechanisms of tolerance in memory T cells","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Raymond Steptoe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456028","simplified_title":"Tolerance in memory T cells","sub_type":"Standard Project Grant","total_budget":"335065.08","source_system":"Autoimmune diseases constitute a significant medical problem in the developed world and are increasing in incidence. Many control mechanisms exist in the body, but in people with genetic susceptibility to autoimmune disease, the mechanisms fail and the body's immune system attacks normal tissues or organs. We have developed a new approach, using the cells which train the immune system, to re-educate the cells that would otherwise attack normal healthy tissues in autoimmune-prone individuals. These cells (dendritic cells) are genetically modified to express the molecular targets of the autoimmune response. This in turn switches off the response to these targets. In this project, we will explore how these cells can be used to turn off the harmful cells present in the immune system."},"children":[{"color":"#336699","name":"A/Pr Raymond Steptoe","data":{"first_name":"Raymond","title":"A/Pr","dw_individual_id":"DW0028164","middle_name":"J","last_name":"Steptoe","source_individual_id":"5017706","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Raymond Steptoe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84270","size":1},{"color":"#336699","name":"Dr Tony Kenna","data":{"first_name":"Tony","title":"Dr","dw_individual_id":"DW0025943","middle_name":"John","last_name":"Kenna","source_individual_id":"RMIS4441078","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Tony Kenna"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83692","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61735","size":1},{"color":"#FF4D4D","name":"Development of the commissural plate and its role in forebrain commissure development","data":{"media_summary":"neurodevelopmental disorders","end_year":2009,"keywords":["abnormal embryogenesis","brain development","human foetuses","magnetic resonance imaging","neuroanatomy"],"nhmrc_grant_id":456027,"application_year":2006,"health_keywords":["birth defects","clinical embryology","developmental brain disorders","mental retardation","neurodevelopmental disorders"],"scientific_title":"Development of the commissural plate and its role in forebrain commissure development","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Foetal Development and Medicine","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Linda Richards","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456027","simplified_title":"Midline brain development","sub_type":"Standard Project Grant","total_budget":"529565.08","source_system":"During development, neurons in one hemisphere of the brain connect and communicate with neurons in the opposite hemisphere. Such neural connections between the two hemispheres are called commissures, which are large bundles of axons (neural-wires) that cross the midline of the brain. There are three commissures in the forebrain: the corpus callosum, the hippocampal commissure and the anterior commissure. This wiring of the brain is essential to its proper function. When these connections don't form, the brain cannot integrate and process information in fundamental ways. Over 50 different human congenital disorders are associated with the malformation of one or more of these forebrain commissures. This proposal investigates the hypothesis that a midline structure, called the commissural plate (CP), regulates the development of all forebrain commissures. The CP was first described anatomically at the turn of the 20th century in a number of different species, and in humans in 1968. However, since this time, no papers have been published on the CP. Experiments in this proposal will use modern neuroanatomical techniques, particularly magnetic resonance imaging, molecular and mouse mutagenesis techniques, and axon guidance assays, to study the CP. We will test the hypothesis that there is something fundamentally unique about the CP as the midline crossing point for all commissural axons. We generate mouse mutants that disrupt only dorsal CP formation and then determine whether the subsequent development of the dorsal commissures occurs. We also perform molecular expression, and imaging analyses on human foetal brains. Our goal is to provide an understanding of what developmental events are disrupted in human congential disorders resulting in midline brain malformations and agenesis of the forebrain commissures. Understanding the basis of these disorders will lead to more accurate diagnoses and potentially their prevention through genetic counseling."},"children":[{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61734","size":1},{"color":"#FF4D4D","name":"The role of Netrin-DCC in the development of the corpus callosum","data":{"media_summary":"neurogenetics","end_year":2009,"keywords":["Axon guidance","Molecular neuroscience","Neural development","Neuron-glia interactions"],"nhmrc_grant_id":456026,"application_year":2006,"health_keywords":["brain development","embryonic development","genetic defect","neurodevelopmental disorders","neurogenetics"],"scientific_title":"The role of Netrin-DCC in the development of the corpus callosum","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Linda Richards","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456026","simplified_title":"Molecular mechanisms regulating brain wiring","sub_type":"Standard Project Grant","total_budget":"512065.08","source_system":"During embryonic development neurons send out axons that connect to other target neurons within the brain. The proper connectivity of these axons is vital to brain function. The largest axon tract in the brain is called the corpus callosum and connects neurons in the left and right cerebral hemispheres. When the corpus callosum does not form, significant cognitive, motor and sensory deficits occur in patients. This condition, known as agenesis of the corpus callosum (ACC), is associated with over 50 different human congenital syndromes. Thus understanding how the genes and molecules involved in the formation of the corpus callosum function in normal development can provide the basis for our understanding of what goes wrong in ACC. In this proposal we will investigate the role of the axon guidance molecule Netrin1, and its receptor DCC, in development of the corpus callosum in both a mouse model and in humans with malformations of the corpus callosum. Although Netrin1-DCC signalling has traditionally been associated with mechanisms of axon guidance, we hypothesize that these molecules may play a different role, specifically in cellular adhesion and ultimately in the fusion of the two cerebral hemispheres, in a manner that allows the corpus callosum to form. A second role for Netrin1-DCC signalling may be in the guidance of these axons once the midline has fused correctly and we investigate this in Aim 2 of the proposal. Finally, we are collaborating with a paediatric neurologist at UCSF, who has identified several mutations in the DCC gene in patients with ACC. In Aim 3 we test whether these mutations disrupt the function of DCC in callosal axon pathfinding. Understanding how these genes function during development of the brain and how their function may be altered in ACC is crucial to providing a proper diagnosis and prognosis for these patients. Ultimately, understanding more about how these genes function could also lead to prevention of these disorders."},"children":[{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61733","size":1},{"color":"#FF4D4D","name":"The contribution of dopamine to regulation of orofacial, limb and trunk control: System or function specific effects?","data":{"media_summary":"","end_year":2009,"keywords":["Parkinson's disease","motor control","movement disorders","physiotherapy","speech pathology"],"nhmrc_grant_id":456017,"application_year":2006,"health_keywords":["Parkinson's disease","motor speech disorders","movement disorders","physiotherapy"],"scientific_title":"The contribution of dopamine to regulation of orofacial, limb and trunk control: System or function specific effects?","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Hearing and Speech","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Bruce Murdoch","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456017","simplified_title":"Regulation of orofacial, trunk and limb muscle systems","sub_type":"Standard Project Grant","total_budget":"493124.25","source_system":"Treatment for Parkinson's disease, including dopamine replacement therapy and deep brain stimulation, fail to produce the same beneficial effects on all movement systems. Whereas limb function is the primary beneficiary of these treatments, other functions such as speech and postural control are less responsive. Critical to the research is the postulate that such differences may have arisen due to the fact that previous studies of dopamine and movement control have investigated distinct motor systems via the assessment of distinct movement constructs, making cross system comparisons an impossible task. The proposed research will assess the effect of Parkinson's disease, deep brain stimulation and dopamine on identical muscle functions within the orofacial, trunk and limb muscle systems. To this end, the results generated from this resarch have the potential to reconceptualise working models of brain-muscle relationships. Further the research will provide guidance for future studies that aim to eradicate trade-off effects (e.g. limb function improved but not speech) relating to symptom relief for people with Parkinson's disease."},"children":[{"color":"#336699","name":"Prof Paul Hodges","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0043077","middle_name":"W","last_name":"Hodges","source_individual_id":"RMIS222953","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Hodges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88164","size":1},{"color":"#336699","name":"Prof Sandra Brauer","data":{"first_name":"Sandra","title":"Prof","dw_individual_id":"DW0035524","middle_name":"G","last_name":"Brauer","source_individual_id":"5013589","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sandra Brauer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86203","size":1},{"color":"#336699","name":"Brooke-Mai Whelan","data":{"first_name":"Brooke-Mai","title":"","dw_individual_id":"DW0028773","middle_name":"","last_name":"Whelan","source_individual_id":"RMIS3117654","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Brooke-Mai Whelan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84450","size":1},{"color":"#336699","name":"Dr Justine Goozee","data":{"first_name":"Justine","title":"Dr","dw_individual_id":"DW0019273","middle_name":"V","last_name":"Goozee","source_individual_id":"RMIS1113109","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Justine Goozee"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81911","size":1},{"color":"#336699","name":"Prof Bruce Murdoch","data":{"first_name":"Bruce","title":"Prof","dw_individual_id":"DW0015136","middle_name":"Ernest","last_name":"Murdoch","source_individual_id":"RMIS15270","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Bruce Murdoch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80802","size":1},{"color":"#336699","name":"Prof Fay Horak","data":{"first_name":"Fay","title":"Prof","dw_individual_id":"DW0013734","middle_name":"","last_name":"Horak","source_individual_id":"RMIS4447742","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Fay Horak"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80400","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61732","size":1},{"color":"#FF4D4D","name":"The dynamics of gradient sensing by growth cones: timelapse imaging and mathematical modelling","data":{"media_summary":"","end_year":2009,"keywords":["axon guidance","growth cone","mathematical modelling"],"nhmrc_grant_id":456003,"application_year":2006,"health_keywords":["injury and repair to nerves in spinal cord and brain","nervous system development","neurodevelopmental disorders","neuron pathfinding/fasciculation"],"scientific_title":"The dynamics of gradient sensing by growth cones: timelapse imaging and mathematical modelling","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biophysics","research_area":"Basic Science","for_category":"OTHER PHYSICAL SCIENCES","cia_name":"A/Pr Geoffrey Goodhill","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/456003","simplified_title":"Modelling how the brain becomes wired up during development","sub_type":"Standard Project Grant","total_budget":"493305.01","source_system":"Problems in the wiring up of the brain underlie several nervous system disorders. The goal of this project is to understand better how this wiring normally forms. This will ultimately lead to a better understanding of what can go wrong with brain wiring, and how to fix such problems. It will also lead to a better understanding of how to make axons regenerate after injury. Our approach is to use a combination of timelapse imaging of neurons in culture, and mathematical modelling, to understand how the tips of the wires growing between neurons sense their environment. By comparing our experimental measurements with our theoretical results we will arrive at a detailed and accurate model of this sensing process. This will allow us to make predictions about how these developmental events normally occur in vivo, and what can go wrong."},"children":[{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1},{"color":"#336699","name":"Prof Geoffrey Goodhill","data":{"first_name":"Geoffrey","title":"Prof","dw_individual_id":"DW0007543","middle_name":"J","last_name":"Goodhill","source_individual_id":"5014864","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Geoffrey Goodhill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78740","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61731","size":1},{"color":"#FF4D4D","name":"Molecular and cellular mechanisms of axon guidance in the vertebrate nervous system","data":{"media_summary":"","end_year":2009,"keywords":["axon growth","axon guidance","brain development"],"nhmrc_grant_id":455993,"application_year":2006,"health_keywords":["brain disorders originating during pregnancy","brain growth","nervous system disorders"],"scientific_title":"Molecular and cellular mechanisms of axon guidance in the vertebrate nervous system","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Brian Key","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455993","simplified_title":"Axon navigation during development","sub_type":"Standard Project Grant","total_budget":"330735.05","source_system":"There are, at least, two major obstacles that have to be overcome in the design of therapies to assist the repair of injured brain tissue. First, the nerve cells that are damaged have to be encouraged to regrow - typically this regrowth is inhibited in the brain; and second, this regrowth has to be directed so that the correct connections are re-established. This project will begin to unravel some of the mechanisms that nerve cells use to wire up together during development. This information can be used to assist in trying to modulate and facilitate directed regrowth following injury."},"children":[{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61729","size":1},{"color":"#FF4D4D","name":"Hepatocyte replicative arrest, hepatic progenitor cells and the ductular reaction in hepatic fibrogenesis","data":{"media_summary":"hepatitis C","end_year":2009,"keywords":["ductular reaction","hepatic fibrosis","hepatic progenitor cells"],"nhmrc_grant_id":455985,"application_year":2006,"health_keywords":["chronic liver disease","fatty liver disease","hemochromatosis","hepatic insulin resistance","hepatitis C"],"scientific_title":"Hepatocyte replicative arrest, hepatic progenitor cells and the ductular reaction in hepatic fibrogenesis","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Julie Jonsson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455985","simplified_title":"A new model for fibrosis in chronic liver disease","sub_type":"Standard Project Grant","total_budget":"527683.42","source_system":"Chronic liver diseases such as hepatitis C and obesity-related fatty liver can be associated with scarring that eventually results in cirrhosis and liver failure. We are unsure why this scarring occurs, but as hepatitis and fatty liver are becoming more common it is necessary to understand this process so that effective therapies can be developed. This study looks at one possible mechanism to explain the development of liver scarring. We believe that the normal repair mechanisms of the liver lead to the production of liver cells to replace those that have died, but in some circumstances also produce small bile ducts that drain bile from the hepatocytes. These small bile ducts may have a previously unsuspected role in stimulating the scar formation. The study will see if the small bile ducts are produced in a range of liver diseases in humans, and will use rodent models to find the factors responsible for stimulating the scarring. When the process is understood more clearly, it could lead to the development of new or more effective therapies to reduce or even reverse liver scarring."},"children":[{"color":"#336699","name":"Prof Elizabeth Powell","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0044903","middle_name":"Ellen","last_name":"Powell","source_individual_id":"RMIS13575","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Powell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88622","size":1},{"color":"#336699","name":"A/Pr Andrew Clouston","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0030002","middle_name":"Donald","last_name":"Clouston","source_individual_id":"RMIS228640","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Andrew Clouston"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84776","size":1},{"color":"#336699","name":"Prof John Olynyk","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0021252","middle_name":"Kevin","last_name":"Olynyk","source_individual_id":"RMIS126729","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Olynyk"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82452","size":1},{"color":"#336699","name":"Dr Belinda Knight","data":{"first_name":"Belinda","title":"Dr","dw_individual_id":"DW0020145","middle_name":"","last_name":"Knight","source_individual_id":"5015728","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Belinda Knight"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82144","size":1},{"color":"#336699","name":"A/Pr Julie Jonsson","data":{"first_name":"Julie","title":"A/Pr","dw_individual_id":"DW0002506","middle_name":"R","last_name":"Jonsson","source_individual_id":"5015557","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Julie Jonsson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77348","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61728","size":1},{"color":"#FF4D4D","name":"Transposable element mobility and chromosomal rearrangement in the fungal pathogen Cryptococcus during human infection","data":{"media_summary":"mycoses","end_year":2009,"keywords":["HIV/AIDS","diagnostic techniques","fungal pathogens","infectious diseases","pathogenesis"],"nhmrc_grant_id":455980,"application_year":2006,"health_keywords":["evolution of virulence","fungal pathogenesis, Cryptococcus neoformans","meningitis","microbiology - pathogenesis","mycoses"],"scientific_title":"Transposable element mobility and chromosomal rearrangement in the fungal pathogen Cryptococcus during human infection","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Mycology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr James Fraser","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455980","simplified_title":"Microevolution of the fungal pathogen Cryptococcus during human infection","sub_type":"New Investigator Grant","total_budget":"322028.39","source_system":"Pathogenic fungi present in the environment have emerged as an increasingly common threat to human health. Cryptococcus neoformans and the closely related species Cryptococcus gattii are the leading causes of life-threatening fungal meningitis, and Australia is one of the few countries where both species are prevalent. Although C. neoformans is an increasingly common cause of infection in immunocompromised patients such as those suffering from AIDS, approximately one in four infected individuals has no apparent immune system defect. For patients with AIDS, in the absence of antiretroviral therapy cryptococcal infection is incurable and requires lifelong treatment with antifungal medication to keep the infection in check. During infection, Cryptococcus is under tremendous stress enforced not only by the immune system and the presence of antifungals, but also by the high temperature, nutrient limiting environment encountered in the host. The proposed research will reveal how Cryptococcus evolves in this environment to enable persistence of infection despite medical intervention. I propose that naturally occurring mobile genetic elements present in the Cryptococcus genome cause chromosomal rearrangements during long term infection to produce gene deletions and duplications that facilitate survival. By characterising these changes and the genes associated with them, the research will identify novel genes involved in pathogenesis and will increase our understanding of the infection process. The expected outcome of this project is a detailed understanding of the roles mobile element movement and chromosomal rearrangement play in Cryptococcus during infection, and how these affect genes that contribute to the pathogenic process. The fundamental knowledge gained from this study will facilitate studies designed to combat infections in the clinical setting, provide new drug targets and help foster the development of more effective therapies."},"children":[{"color":"#336699","name":"A/Pr James Fraser","data":{"first_name":"James","title":"A/Pr","dw_individual_id":"DW0007343","middle_name":"Anthony","last_name":"Fraser","source_individual_id":"RMIS4444550","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr James Fraser"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78685","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61727","size":1},{"color":"#FF4D4D","name":"CDK4 activity in S/G2 phases influences mitotic fidelity","data":{"media_summary":"","end_year":2009,"keywords":["UV radiation","cell cycle","melanoma","mitosis","transcriptional regulation"],"nhmrc_grant_id":455977,"application_year":2006,"health_keywords":["melanoma","skin cancer","sunlight exposure"],"scientific_title":"CDK4 activity in S/G2 phases influences mitotic fidelity","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Brian Gabrielli","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455977","simplified_title":"CDK4 activity influences mitotic fidelity","sub_type":"Standard Project Grant","total_budget":"531696.74","source_system":"The ultraviolet radiation component of the sunlight is a major environmental factor in the development of skin cancers, including melanomas. Over the past 10 years a genetic factors have also been identified that predispose towards developing melanoma, although the connection between ultraviolet radiation and the genetic factors has remained elusive. In this study we will investigate a cellular mechanism that potentially explains the link between sunlight exposure and one of the genetic risk factors. We will also examine whether targeting the pathway this genetic factor normally operates in can deliver increased therapeutic benefit to an existing chemotherapeutic treatment."},"children":[{"color":"#336699","name":"Prof Sean Grimmond","data":{"first_name":"Sean","title":"Prof","dw_individual_id":"DW0007616","middle_name":"M","last_name":"Grimmond","source_individual_id":"5014956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sean Grimmond"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78759","size":1},{"color":"#336699","name":"A/Pr Brian Gabrielli","data":{"first_name":"Brian","title":"A/Pr","dw_individual_id":"DW0007391","middle_name":"G","last_name":"Gabrielli","source_individual_id":"5014734","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Brian Gabrielli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78693","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61726","size":1},{"color":"#FF4D4D","name":"The role of Crim1 in growth factor activity and cell motility/adhesion.","data":{"media_summary":"vascular diseases","end_year":2009,"keywords":["angiogenesis","cell biology","cell morphology","developmental genetics","kidney"],"nhmrc_grant_id":455972,"application_year":2006,"health_keywords":["ischaemia","regulation of tumour progression","renal dysplasia","tissue remodelling","vascular diseases"],"scientific_title":"The role of Crim1 in growth factor activity and cell motility/adhesion.","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455972","simplified_title":"The role of a novel protein, Crim1, in development and disease","sub_type":"Standard Project Grant","total_budget":"600065.08","source_system":"Crim1 is a novel protein which appears to regulate the activity of growth factors and therefore affects the normal development of a number of organs. It is particulrly involved in normal development of blood vessels. A greater understanding of how growth factor activity is modulated by Crim1 will have significance to almost every developmental and disease state involving such growth factors. The potential for Crim1 to link the activity of several distinct growth factor pathways may explain tissue specific differences in growth factor responses. These basic advances in understanding will have implications for many disease states, including renal disease, vascular disease and cancer."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61725","size":1},{"color":"#FF4D4D","name":"Viral factors involved in flavivirus replication and virus-host interactions","data":{"media_summary":"virus replication","end_year":2009,"keywords":["flavivirus","infections","understanding virus-host interactions","viral persistence","virus replication"],"nhmrc_grant_id":455954,"application_year":2006,"health_keywords":["flavivirus","viral infections","virology","virus pathogenesis","virus replication"],"scientific_title":"Viral factors involved in flavivirus replication and virus-host interactions","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455954","simplified_title":"Viral factors involved in pathogenesis of encephalitic flaviviruses","sub_type":"Standard Project Grant","total_budget":"743696.74","source_system":"With our increased understanding of virus-host interactions it has become apparent that small, non-structural proteins and small RNAs of most viruses are vital for numerous, often multiple, functions in the viral life cycle. In the proposed project, we seek to gain a detailed understanding of the functions of small nonstructural protein NS2A and small abundant viral RNAs of medicaly important encephalitic flaviviruses, which have remained so far elusive and are at the cutting-edge in the research field. We anticipate that with a better understanding of the roles of these factors in flaviviral replication and pathogenesis, novel targets for antiviral therapies and-or molecular determinants for inclusion in candidate vaccines will be identified."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1},{"color":"#336699","name":"Dr Gorben Pijlman","data":{"first_name":"Gorben","title":"Dr","dw_individual_id":"DW0027355","middle_name":"P","last_name":"Pijlman","source_individual_id":"RMIS4452077","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Gorben Pijlman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84066","size":1},{"color":"#336699","name":"Prof Roy Hall","data":{"first_name":"Roy","title":"Prof","dw_individual_id":"DW0025278","middle_name":"A","last_name":"Hall","source_individual_id":"RMIS16831","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roy Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83509","size":1},{"color":"#336699","name":"A/Pr Mario Lobigs","data":{"first_name":"Mario","title":"A/Pr","dw_individual_id":"DW0008708","middle_name":"","last_name":"Lobigs","source_individual_id":"RMIS218588","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Mario Lobigs"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79059","size":1},{"color":"#336699","name":"Prof Paul Young","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0005625","middle_name":"R","last_name":"Young","source_individual_id":"RMIS20614","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78234","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61723","size":1},{"color":"#FF4D4D","name":"Design and use of human hematopoietic prostaglandin D2 synthase inhibitors in allergic asthma and bone diseases","data":{"media_summary":"pharmacology","end_year":2009,"keywords":["Biochemical pharmacology","Enzyme inhibition","NSAIDs","Prostaglandins","Rational drug design"],"nhmrc_grant_id":455949,"application_year":2006,"health_keywords":["Acute and chronic asthma","Drug design","Enzyme inhibitors as pharmacological agents","Glutathione S-transferases","pharmacology"],"scientific_title":"Design and use of human hematopoietic prostaglandin D2 synthase inhibitors in allergic asthma and bone diseases","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Jack Flanagan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455949","simplified_title":"Developing inhibitors for enzymes involved in inflammation","sub_type":"New Investigator Grant","total_budget":"517960.05","source_system":"Many currently used non-steroidal anti-inflammatory drugs are burdened by side effects such as gastrointestinal bleeding or increased risk of heart attack. This is because they ablate the production of a class of molecules called prostaglandins. We believe it is possible to fine tune the action of these drugs and reduce the side effect risk. There is evidence to suggest that only some prostaglandins are involved in inflammation, so the risk of side effect can be reduced by blocking the production of only a small set. One prostaglandin, prostaglandin D2, is known to cause many characteristics of allergic asthma and may also contribute to osteoarthritis, although the evidence for this is contradictory. We will determine any therapeutic benefit to blocking the production of prostaglandin D2 in these diseases by developing compounds that only inhibit the enzyme responsible for its production."},"children":[{"color":"#336699","name":"Dr Jack Flanagan","data":{"first_name":"Jack","title":"Dr","dw_individual_id":"DW0030695","middle_name":"Urquhart","last_name":"Flanagan","source_individual_id":"RMIS4453914","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Jack Flanagan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84971","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61722","size":1},{"color":"#FF4D4D","name":"The c-type lectin, Mincle, is a macrophage receptor for Candida albicans.","data":{"media_summary":"","end_year":2009,"keywords":["TNF-alpha","cell-surface receptor","macrophage activation","phagocytosis","signalling pathways"],"nhmrc_grant_id":455947,"application_year":2006,"health_keywords":["cell signalling","infectiocute inflammation","inflamamtory mediators","macrophage activation"],"scientific_title":"The c-type lectin, Mincle, is a macrophage receptor for Candida albicans.","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Robert Ashman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455947","simplified_title":"How phagocytic cells recognise yeast","sub_type":"Standard Project Grant","total_budget":"465210.05","source_system":"The yeast Candida albicans is an important opportunistic infection that causes both mucosal and disseminated disease in patients whose innate or adaptive immune responses are impaired Infection and proliferation results in fungal colonisation of the tissues, and a variable degree of tissue damage. The latter is determined both by the virulence properties of the organism and by the genetic makeup of the host. This large, extracellular pathogen is eradicated from the body predominantly by acavenger (phagocytic) cells, which are also important in determining the severity of the associated tissue lesions. A phagocytic cell that is central to both innate and adaptive immune responses is the macrophage, which not only takes up and kills the yeast, but also is capable of of killing and digesting it, and presenting the components to cells of the adaptive immune system. This project is based on the postulate that the outcome and severity of infection is determined, at least in part, by the early functional response of the macrophage to the overall virulence properties of the yeast. The response is initiated by interactions with cell-surface receptors, and this study will show that a novel macrophage receptor, Mincle, is an important part of the innate immune response to fungal infections. We have shown that it is associated with differences in susceptibility to yeast infections in inbred mouse strains; it can discriminate between different isolates of the yeast; and it initiates the inflammatory signalling cascade. Our project will define the specific role of this receptor in fungal infection. The results will be important in understanding the basic biology of host resistance, and will offer new opportunities for therapeutic intervention by selectively blocking or modifying different activation pathways."},"children":[{"color":"#336699","name":"A/Pr Christine Wells","data":{"first_name":"Christine","title":"A/Pr","dw_individual_id":"DW0040397","middle_name":"Anne","last_name":"Wells","source_individual_id":"5018258","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Christine Wells"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87466","size":1},{"color":"#336699","name":"A/Pr Robert Ashman","data":{"first_name":"Robert","title":"A/Pr","dw_individual_id":"DW0029217","middle_name":"Brian","last_name":"Ashman","source_individual_id":"5013239","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Robert Ashman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84574","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61721","size":1},{"color":"#FF4D4D","name":"Role of bone-associated macrophages in bone remodelling and bone disease","data":{"media_summary":"osteoporosis","end_year":2009,"keywords":["bone","immunopathology","monocyte/macrophage differentiation","osteoblast","osteoclast"],"nhmrc_grant_id":455941,"application_year":2006,"health_keywords":["bone formation","bone growth and fracture healing","bone resorption","macrophage activation","osteoporosis"],"scientific_title":"Role of bone-associated macrophages in bone remodelling and bone disease","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Orthopaedics","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Allison Pettit","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455941","simplified_title":"Bone macrophages contribute to bone remodelling and disease","sub_type":"Standard Project Grant","total_budget":"564963.89","source_system":"Musculoskeletal diseases, including osteoporosis and osteoarthritis, are a national and international health and research priorities. Over 3 million Australians suffer from arthritis and musculoskeletal conditions and their social and economic impact is expected to dramatically increase in the next 20 years as a result of the aging population. Early diagnosis, prevention and treatment of many musculoskeletal diseases are currently inadequate. Consequently, there is a high demand for effective treatment options. This project grant application proposes a novel line of scientific investigation that will provide greater understanding of the contribution of macrophages (a cell type that has important roles in normal tissue maintenance and defense against infection) in bone remodelling and disease. Bone is continuously remodelled and replaced to maintain skeletal strength and mineral metabolism. We have shown that a population of macrophages is intimately associated with bone and propose that these cells play an important part in regulating bone remodelling. Macrophages have been implicated in many diseases that have damaging consequences on bone, including osteoporosis and several forms of arthritis, linking aberrant macrophage function to disease-associated bone damage. This project aims to characterize this population of bone-associated macrophages and determine their ability to influence the function of other cells integrally involved in bone remodelling. We will also undertake studies in animal models to determine whether these cells are required for bone remodelling and-or damage. Detailed description of the novel role of macrophages in bone biology will facilitate the development of superior therapeutics, preventatives and cures for bone diseases."},"children":[{"color":"#336699","name":"Dr Liza Raggatt","data":{"first_name":"Liza","title":"Dr","dw_individual_id":"DW0015741","middle_name":"J","last_name":"Raggatt","source_individual_id":"RMIS4437738","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Liza Raggatt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80966","size":1},{"color":"#336699","name":"Dr Allison Pettit","data":{"first_name":"Allison","title":"Dr","dw_individual_id":"DW0015560","middle_name":"Robyn","last_name":"Pettit","source_individual_id":"5016963","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Allison Pettit"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80923","size":1},{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61720","size":1},{"color":"#FF4D4D","name":"Ambulatory fetal activity monitoring predicts clinical outcome","data":{"media_summary":"pregnancy","end_year":2009,"keywords":["fetal development","fetal growth","obstetrics","pregnancy"],"nhmrc_grant_id":455935,"application_year":2006,"health_keywords":["fetal health","fetal mortality","fetal well-being","mortality","pregnancy"],"scientific_title":"Ambulatory fetal activity monitoring predicts clinical outcome","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Obstetrics and Gynaecology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Paul Colditz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455935","simplified_title":"Detection of fetal activity","sub_type":"Standard Project Grant","total_budget":"397236.68","source_system":"A small number of babies die unexpectedly while still in the womb: the numbers are much higher than those dying from Sudden Infant Death Syndrome (SIDS). Some of these babies slow their movements down in the days before death. It would be very helpful to be able to accurately monitor babies' movements in the womb so that we could help the few babies who need it, and so prevent poor outcomes. Mothers feel their babies moving, but it's often hard for them to pick up all the movements that do occur. The best way of measuring babies' movements is during an ultrasound. However, that's expensive and means that the pregnant mother needs to lie still for about half an hour to have this testing done. We are developing a way of recording babies' movements, which still lets the pregnant woman continue with her normal activities. We will do this using an AMBULATORY FETAL ACTIVITY MONITOR, which is an accelerometer, like an advanced pedometer. The ambulatory fetal activity monitor will measure the activity of the unborn baby during pregnancy, looking at the number of times s-he moves and how simple or complex the movements are. We expect that the unborn baby who is not getting enough nutrition during the pregnancy will have fewer movements than other unborn babies. This project involves checking that movements picked up by the ambulatory fetal activity monitor are the same as movements seen on an ultrasound. We will then monitor a large number of pregnant women with healthy and possibly unhealthy babies, to help identify the babies who need help. Once we have this information, we will be able to use it in the future to possibly prevent poor outcomes in those babies who do need help."},"children":[{"color":"#336699","name":"Prof Stuart Crozier","data":{"first_name":"Stuart","title":"Prof","dw_individual_id":"DW0024340","middle_name":"","last_name":"Crozier","source_individual_id":"5012384","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stuart Crozier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83245","size":1},{"color":"#336699","name":"Prof Shaun Brennecke","data":{"first_name":"Shaun","title":"Prof","dw_individual_id":"DW0023770","middle_name":"P","last_name":"Brennecke","source_individual_id":"RMIS3360","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Shaun Brennecke"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83105","size":1},{"color":"#336699","name":"Prof Christine East","data":{"first_name":"Christine","title":"Prof","dw_individual_id":"DW0012848","middle_name":"Elizabeth","last_name":"East","source_individual_id":"5014470","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Christine East"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80181","size":1},{"color":"#336699","name":"Prof Colin Sullivan","data":{"first_name":"Colin","title":"Prof","dw_individual_id":"DW0010497","middle_name":"Edward","last_name":"Sullivan","source_individual_id":"RMIS81110","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Colin Sullivan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79552","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1},{"color":"#336699","name":"Prof Stephen Wilson","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0005484","middle_name":"James","last_name":"Wilson","source_individual_id":"5028658","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stephen Wilson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78193","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61719","size":1},{"color":"#FF4D4D","name":"Therapeutic potential of glycine receptors in pain sensory pathways","data":{"media_summary":"","end_year":2009,"keywords":["ion channels","molecular biology","pain","patch clamping","synaptic transmission"],"nhmrc_grant_id":455931,"application_year":2006,"health_keywords":["brain function","ligand gated ion channel family - ion channel diseases","neuropharmacology","pain"],"scientific_title":"Therapeutic potential of glycine receptors in pain sensory pathways","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Joseph Lynch","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455931","simplified_title":"Are spinal cord glycine receptors a promising target for analgesic drugs?","sub_type":"Standard Project Grant","total_budget":"292223.37","source_system":"Inflammation caused by infection or injury leads to a heightened sensation of pain and can convert non-painful stimuli (e.g., touch) into painful stimuli. This effect is mediated by the production of prostaglandins both in peripheral tissues and in the spinal cord. Prostaglandins have recently been shown to decrease the magnitude of the inhibitory neurotransmission that normally occurs onto pain sensing neurons in the spinal cord. This has the effect of raising the excitability of these neurons, thereby making it easier for weak pain stimuli to be relayed to the brain. Inhibitory neurotransmission onto pain sensing neurons is largely mediated by the alpha3 glycine receptor subunit that is not found anywhere else in the body. Very little is known about the physiological and pharmacological properties of these receptors. We hypothesise that drugs that increase the activation of alpha3 glycine receptors may provide a novel treatment for pain. This project will firstly identify new drugs that can increase the activation of these receptors. It will then test whether these drugs are likely to work in vivo. The project will also establish why these receptors are found only on pain neurons. Together, this information will establish whether alpha3 glycine receptors represent a promising new therapeutic target for inflammatory pain, and will place us in an excellent position to begin the next step of identifying novel therapeutic lead compounds."},"children":[{"color":"#336699","name":"Prof Joseph Lynch","data":{"first_name":"Joseph","title":"Prof","dw_individual_id":"DW0032228","middle_name":"W","last_name":"Lynch","source_individual_id":"5016080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Joseph Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85342","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61718","size":1},{"color":"#FF4D4D","name":"identification of clinically significant subtypes of head and neck cancer cells","data":{"media_summary":"","end_year":2009,"keywords":["keratinocytes","squamous cell carcinoma","tumour stem cells","tumourogenesis"],"nhmrc_grant_id":455929,"application_year":2006,"health_keywords":["head and neck cancer","minimal residual disease","squamous cell carcinoma"],"scientific_title":"identification of clinically significant subtypes of head and neck cancer cells","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Nicholas Saunders","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455929","simplified_title":"Do head and neck cancers contain cancer cells that behave differently","sub_type":"Standard Project Grant","total_budget":"469122.18","source_system":"Squamous cell carcinoma of the head and neck region (HNSCC) is amongst the top 10 most prevalent cancers. It is a life threatening cancer that is associated with a mortality rate of approximately 40%. Whilst most patients are treated with a combination of surgery, radiation and chemotherapy a significant fraction of patients relapse and eventually succumb to the cancer. The molecular basis for relapse in these patients is still unknown. One possible explanation for treatment failure is the notion that the cancer contains biologically distinct subtypes of cancer cells. Some these cells may respond to therapy whilst a small fraction of cells may not. If this small fraction of resistant cells were able to divide and repopulate the tissue then this would provide an explanation for relapse in these patients. However, as yet no such data has been available to support this argument. Most recently, studies with another cancer called acute myelocytic leukaemia has shown that they do contain a small subtype of cancer cells that are resistant to therapy and can regenerate the disease in patients. These cells have been called tumour initiating cells (TIC). In this application we will use patient tumour samples to try to isolate TICs from HNSCC. We will first determine whether these TICs exist and whether they express markers of normal human stem cells. We will also test whether these TICs are more resistant to chemotherapeutics or radiation than the rest of the tumour cells. In addition we will enrich for these TICs and identify new protein markers that could be used to test patient samples before or after treatment. This would be of considerable assistance in making decisions about treatment choice or prognosis. Since TICs have not been reported in HNSCC previously their identification would lead to a considerable advance in our undesratnding of how these tumours form."},"children":[{"color":"#336699","name":"A/Pr Nicholas Saunders","data":{"first_name":"Nicholas","title":"A/Pr","dw_individual_id":"DW0021953","middle_name":"A","last_name":"Saunders","source_individual_id":"5017363","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nicholas Saunders"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82651","size":1},{"color":"#336699","name":"A/Pr Pritinder Kaur","data":{"first_name":"Pritinder","title":"A/Pr","dw_individual_id":"DW0002563","middle_name":"","last_name":"Kaur","source_individual_id":"RMIS222159","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Pritinder Kaur"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77368","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61717","size":1},{"color":"#FF4D4D","name":"Evaluation of factor Va from the venom of the Australian Brown snake as a topical and systemic anti-bleeding agent","data":{"media_summary":"Traumatic injury","end_year":2008,"keywords":["Biochemical pharmacology","Coagulation protein","Drug development","Protein characterization","Venom"],"nhmrc_grant_id":455925,"application_year":2006,"health_keywords":["Biochemistry protein and peptide","Coagulation","Drug discovery","Haemostasis","Traumatic injury"],"scientific_title":"Evaluation of factor Va from the venom of the Australian Brown snake as a topical and systemic anti-bleeding agent","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides","research_area":"Clinical Medicine and Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/455925","simplified_title":"An anti-bleeding agent from snake venom","sub_type":"Development Grant","total_budget":"113742.6","source_system":"Anti-bleeding agents are important pharmaceuticals for use in truama, surgery and several medical conditions to reduce blood loss and the need for blood transfusion. Some Australian snakes contain in their venom a powerful blood clotting agent. This agent mimics the human clotting machinery. In this project, we plan to test purified components of snake venom for an ability to clot human blood. We will undertake laboratory test-tube experiments as well as using an animal model after ethical approval. This project seeks to capture some of the genetic blueprint of an Australian snake, for human benefit by developing a new therapeutic agent based on a venom component. If the experiments are successful, the next stage will be further testing of efficacy and toxicity before seeking approval for clinical trials. The research is supported by the Australian pharmaceutical company QRx Pharma Pty Ltd who will work with Uniquest Pty Ltd to protect intellectual property generated in the project."},"children":[{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1},{"color":"#336699","name":"Dr Paul Masci","data":{"first_name":"Paul","title":"Dr","dw_individual_id":"DW0020664","middle_name":"Pantaleone","last_name":"Masci","source_individual_id":"5019068","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Paul Masci"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82280","size":1},{"color":"#336699","name":"E/Pr John De Jersey","data":{"first_name":"John","title":"E/Pr","dw_individual_id":"DW0018611","middle_name":"","last_name":"De Jersey","source_individual_id":"5014269","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"E/Pr John De Jersey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61715","size":1},{"color":"#FF4D4D","name":"Improved support for regional and remote paediatric oncology families: a randomised controlled trial of videotelephony","data":{"media_summary":"Rural health","end_year":2009,"keywords":["Family-centered intervention","Paediatric oncology","Randomised controlled trial","Rural health","Telemedicine"],"nhmrc_grant_id":455922,"application_year":2006,"health_keywords":["Family needs and support","Family-centered intervention","Health service","Paediatric oncology","Rural health"],"scientific_title":"Improved support for regional and remote paediatric oncology families: a randomised controlled trial of videotelephony","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Health Services Research","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Dr Andrew Hallahan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455922","simplified_title":"Improving the support provided to regional and remote paediatric oncology families using videotelephones","sub_type":"Standard Project Grant","total_budget":"304843.34","source_system":"Childhood cancer presents a major life stressor for the entire family. Significant changes to the everyday lives of families, practically, socially and emotionally cause major disruption. There is evidence that this disruption results in isolation and poor communication between family members, anxiety, low self-esteem and school problems for siblings and anxiety, post-traumatic stress symptoms and risk of depression for parents. Providing ongoing support to these families is an essential part of care. The Royal Children's Hospital (RCH) Paediatric Oncology Service in Brisbane is the major tertiary paediatric referral centre for Queensland, northern New South Wales and the southwest Pacific. A multidisciplinary team of medical, nursing, and allied health professionals provides care and support to children with cancer, as well as their families. Each year around 100 newly diagnosed patients are cared for. Around 60% of the families cared for by the service live in regional and remote areas. There are a number of challenges which inhibit the equitable provision of specialist health services to these areas including availability of health care professionals and accessibility due to distance, time, cost and transport. For paediatric oncology families, opportunities to receive support are limited. One possible solution is the use of online support mechanisms, such as videotelephony, to facilitate the provision of much needed support to patients, parents, siblings and the family as a whole. The objective of this research is to see if videotelephony can be used to support regional and remote families of the Royal Children's Hospital Paediatric Oncology Service providing indizidualised communication, education, counselling and monitoring. This will present a new and innovative use of videophone technology as well as a new method for supporting regional and remote oncology patients and their families."},"children":[{"color":"#336699","name":"A/Pr Trevor Russell","data":{"first_name":"Trevor","title":"A/Pr","dw_individual_id":"DW0033555","middle_name":"","last_name":"Russell","source_individual_id":"RMIS3678636","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Trevor Russell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85687","size":1},{"color":"#336699","name":"A/Pr Andrew Hallahan","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0025279","middle_name":"R","last_name":"Hallahan","source_individual_id":"RMIS4434868","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Andrew Hallahan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83510","size":1},{"color":"#336699","name":"Prof Richard Wootton","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0023093","middle_name":"","last_name":"Wootton","source_individual_id":"5018481","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Wootton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82948","size":1},{"color":"#336699","name":"Prof Deborah Theodoros","data":{"first_name":"Deborah","title":"Prof","dw_individual_id":"DW0022512","middle_name":"Gale","last_name":"Theodoros","source_individual_id":"RMIS15273","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Deborah Theodoros"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82794","size":1},{"color":"#336699","name":"Dr Helen Irving","data":{"first_name":"Helen","title":"Dr","dw_individual_id":"DW0002372","middle_name":"","last_name":"Irving","source_individual_id":"RMIS3678642","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Helen Irving"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77312","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61714","size":1},{"color":"#FF4D4D","name":"Cellular Activation and Apoptosis in Response to Foreign Cytoplasmic DNA","data":{"media_summary":"","end_year":2009,"keywords":["cell death/apoptosis","innate immunity","interferon","transfection"],"nhmrc_grant_id":455920,"application_year":2006,"health_keywords":["gene therapy","infectious diseases","systemic lupus erythematosus","viral infection"],"scientific_title":"Cellular Activation and Apoptosis in Response to Foreign Cytoplasmic DNA","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Katryn Stacey","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455920","simplified_title":"A novel pathway for detection of viral DNA","sub_type":"Standard Project Grant","total_budget":"496446.74","source_system":"Viruses are simple organisms. They grow within cells, needing host cell proteins for their replication. Viruses have only a few proteins of their own, and evolve rapidly to change these. It is therefore challenging for the immune system to identify viral infections. Recently it has been recognised that the genetic material of viruses (DNA or RNA) is detected by the immune system. A novel pathway for recognition of viral double stranded DNA is emerging. The genetic material of mammalian cells (DNA) is found within the membrane-bound nucleus of the cell. The presence of DNA outside the nucleus in the cytoplasm is abnormal, and is detected as an indication of viral infection. This causes either death of the cell, or activation to produce anti-viral molecules. We have identified a protein from the cytoplasm of cells which binds specifically to DNA. This protein, X is found in association with foreign DNA within 5 minutes of it being introduced into the cell. In this project we propose to confirm that X recognises foreign DNA and initiates cellular activation or death. Other molecules to which X binds during this process will be identified. This project is relevant to a number of problems in health and disease as well as biotechnology. In both gene therapy and biotechnology, DNA is introduced into cells in order to allow those cells to make specific proteins. The cell sees the introduced DNA as a potential viral infection, and it responds in ways which limit the production of the desired proteins. Lupus is an autoimmune disease with high levels of DNA in circulation. X is proposed as a protein involved lupus in mouse models. We suggest that DNA taken up by cells is recognised by X and this contributes to the disease. Understanding the means by which DNA is recognised in the cytoplasm may allow the development of much more efficient processes for gene therapy and protein production in biotechnology, and more effective lupus and antiviral therapies."},"children":[{"color":"#336699","name":"Dr Katryn Stacey","data":{"first_name":"Katryn","title":"Dr","dw_individual_id":"DW0028117","middle_name":"Jane","last_name":"Stacey","source_individual_id":"5017656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katryn Stacey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84258","size":1},{"color":"#336699","name":"Dr Tara Roberts","data":{"first_name":"Tara","title":"Dr","dw_individual_id":"DW0015901","middle_name":"L","last_name":"Roberts","source_individual_id":"5017199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Tara Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81007","size":1},{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61713","size":1},{"color":"#FF4D4D","name":"Clinical impact of clonal Pseudomonas aeruginosa in cystic fibrosis","data":{"media_summary":"spread of infection","end_year":2009,"keywords":["Pseudomonas aeruginosa infection","cross-infection","cystic fibrosis","epidemiology","respiratory infection"],"nhmrc_grant_id":455919,"application_year":2006,"health_keywords":["Pseudomonas aeruginosa infection","cystic fibrosis","epidemiological monitoring of pathogens","respiratory infections","spread of infection"],"scientific_title":"Clinical impact of clonal Pseudomonas aeruginosa in cystic fibrosis","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Scott Bell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455919","simplified_title":"Epidemic Pseudomonas infection in patients with cystic fibrosis","sub_type":"Standard Project Grant","total_budget":"547238.45","source_system":"In patients with cystic fibrosis (CF), the normal defence mechanisms are compromised by an inherent genetic fault which results in an extremely sticky and dehydrated mucus. The respiratory system is unable to eradicate microbes (infection) from the lungs of patients with CF which begin to multiply and cause infection and inflammation. Recurring infections are treated with multiple courses of antibiotics and frequent hospitalisation and eventually result in premature death. This study focuses on the major bacterial problem, Pseudomonas aeruginosa. Several studies from Australia and the UK, including our own have shown that about 30% to 45% of patients share the same strain of Pseudomonas aeruginosa within a centre. We know that two dominant strains of Pseudomonas aeruginosa are found in CF centres on the eastern board of Australia. This is unexpected as this bacterium is usually acquired from the environment. The emergence of these clonal strains is causing increasing anxiety in the CF community. This study is designed to provide vitally needed information on the clinical implications of being infected by an clonal strain of Pseudomonas aeruginosa and the risk factors for the acquisition of an clonal strain. This new information will provide a rationale basis for the need for changes to infection control policies (including patient segregation), better outcome predictors for patients infected with clonal strain of Pseudomonas aeruginosa."},"children":[{"color":"#336699","name":"Prof Peter Bye","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0041404","middle_name":"Thomas Patrick","last_name":"Bye","source_individual_id":"5013727","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Bye"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87738","size":1},{"color":"#336699","name":"Prof Scott Bell","data":{"first_name":"Scott","title":"Prof","dw_individual_id":"DW0029395","middle_name":"C","last_name":"Bell","source_individual_id":"RMIS15775","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Scott Bell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84618","size":1},{"color":"#336699","name":"A/Pr Philip Robinson","data":{"first_name":"Philip","title":"A/Pr","dw_individual_id":"DW0021767","middle_name":"","last_name":"Robinson","source_individual_id":"5011983","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Philip Robinson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82599","size":1},{"color":"#336699","name":"Prof Guy Marks","data":{"first_name":"Guy","title":"Prof","dw_individual_id":"DW0014706","middle_name":"Barrington","last_name":"Marks","source_individual_id":"RMIS5596","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Guy Marks"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80679","size":1},{"color":"#336699","name":"Barbara Rose","data":{"first_name":"Barbara","title":"","dw_individual_id":"DW0009963","middle_name":"","last_name":"Rose","source_individual_id":"RMIS3083058","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Barbara Rose"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79403","size":1},{"color":"#336699","name":"A/Pr Colin Harbour","data":{"first_name":"Colin","title":"A/Pr","dw_individual_id":"DW0007722","middle_name":"","last_name":"Harbour","source_individual_id":"5015070","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Colin Harbour"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78789","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61712","size":1},{"color":"#FF4D4D","name":"Molecular Characterization of E. coli that cause Urinary Tract Infection","data":{"media_summary":"","end_year":2009,"keywords":["adhesion mechanisms","bacterial pathogen","virulence"],"nhmrc_grant_id":455914,"application_year":2006,"health_keywords":["bacterial virulence factors","biofilm","microbiology - pathogenesis","urinary tract infection"],"scientific_title":"Molecular Characterization of E. coli that cause Urinary Tract Infection","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Mark Schembri","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455914","simplified_title":"Molecular Characterization of E. coli that cause Urinary Tract Infection","sub_type":"Standard Project Grant","total_budget":"387114.92","source_system":"The long term goals of the proposed research are to understand the processes by which uropathogenic Escherichia coli (UPEC) cause acute, recurrent and chronic infections and to identify new UPEC targets for therapeutic intervention. Urinary tract infections (UTI) are among the most common infectious diseases of humans and a major cause of morbidity and mortality. In the USA, UTI accounts for more than 1 million hospitalizations and $1.6 billion in medical expenditures each year. It is estimated that one in four women and one in twenty men will develop a UTI in their lifetime. The recurrence rate is high and no treatment other than antibiotics (often inefficient) is currently available. UPEC are the primary cause of UTI. In the last grant period, we focused on the molecular interplay that exists between different surface adhesins of UPEC. We succeeded in demonstrating functional interference between adhesins, motility organelles, aggregation factors and the capsule. We also discovered and partially characterized several novel UPEC adhesins that may play a role in pathogenesis. We established two novel technology sets: a mouse model of ascending UTI and the flow chamber biofilm model. In the next grant period, we will build on these concepts and experimental systems to gain a deeper understanding of the molecular mechanisms underlying UPEC virulence. We will characterize the role of several novel UPEC surface proteins in cell adhesin, aggregation, biofilm formation and colonization of the mouse urinary tract. We will employ an integrated approach that combines a powerful bacterial genetic system, a biofilm model, a mouse UTI model, microscopy and tissue culture systems to reveal the cellular, molecular, and structural basis for the pathogenesis of UTI. The work will facilitate the development of new vaccine approaches to prevent UTI, such as novel mechanisms for strain attenuation and vaccine design. The burden of UTI disease demands such research endeavours."},"children":[{"color":"#336699","name":"Prof Mark Schembri","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0016088","middle_name":"A","last_name":"Schembri","source_individual_id":"5017368","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Schembri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81054","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61711","size":1},{"color":"#FF4D4D","name":"Interaction between PTH and Y2 bone anabolic pathways","data":{"media_summary":"","end_year":2009,"keywords":["bone","neuropeptide Y","osteoblast","osteoporosis","parathyroid hormone"],"nhmrc_grant_id":455907,"application_year":2006,"health_keywords":["bone formation","osteopenia","osteoporosis","preventing age-related bone loss"],"scientific_title":"Interaction between PTH and Y2 bone anabolic pathways","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Jonathan Whitehead","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455907","simplified_title":"Neural and hormonal control of bone formation","sub_type":"Standard Project Grant","total_budget":"731311.9","source_system":"Osteoporosis is a costly condition that affects more than 150 million people worldwide and fills more hospital beds than any other disease*. People who have osteoporotic fractures experience a diminished quality of life and a reduced life expectancy. Although there are currently a number of therapies in use to reduce further loss of bone in osteoporotic patients, there is only one to replace lost bone, parathyroid hormone. For clinical and economic reasons, there is a need for additional bone-building therapies. Like all tissues, the nervous system affects skeletal function. We recently discovered a powerful control pathway by which the nervous system regulates bone formation. This project will test whether altering the function of this neural pathway can increase bone formation and whether it can work together with parathyroid hormone therapy to produce an enhanced bone formation response greater than either therapy alone. This research is important because of the need for new osteoporosis therapies to repair weakened bones. The knowledge gained from this study has the potential to provide a very important and useful contribution to skeletal health and thus aged health worldwide. *The Burden of Brittle Bones: Costing Osteoporosis in Australia. A report prepared by Access Economics Pty. Ltd. September 2001"},"children":[{"color":"#336699","name":"A/Pr Jonathan Whitehead","data":{"first_name":"Jonathan","title":"A/Pr","dw_individual_id":"DW0046246","middle_name":"P","last_name":"Whitehead","source_individual_id":"RMIS5218572","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jonathan Whitehead"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88973","size":1},{"color":"#336699","name":"A/Pr Edith Gardiner","data":{"first_name":"Edith","title":"A/Pr","dw_individual_id":"DW0013168","middle_name":"M","last_name":"Gardiner","source_individual_id":"RMIS218068","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Edith Gardiner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80255","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61710","size":1},{"color":"#FF4D4D","name":"CHARACTERISATION OF NOVEL PICORNAVIRUS-LIKE VIRUSES IDENTIFIED FROM PATIENTS WITH ACUTE RESPIRATORY INFECTIONS.","data":{"media_summary":"Viral respiratory disease","end_year":2009,"keywords":["Molecular epidemiology","Respiratory diseases","Viral detection","Viral infections","Virology"],"nhmrc_grant_id":455905,"application_year":2006,"health_keywords":["Diagnosis","Emerging/reemerging infectious disease","Lower respiratory tract disease","Respiratory virus infection/common cold","Viral respiratory disease"],"scientific_title":"CHARACTERISATION OF NOVEL PICORNAVIRUS-LIKE VIRUSES IDENTIFIED FROM PATIENTS WITH ACUTE RESPIRATORY INFECTIONS.","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Public Health","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Ian Mackay","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455905","simplified_title":"A NEW VIRUS FOUND IN CHILDREN WITH SERIOUS RESPIRATORY ILLNESS.","sub_type":"Standard Project Grant","total_budget":"366998.5","source_system":"The common cold and serious chest colds are usually due to viral infections, and mostly occur in children. Unfortunately we can only be certain of the virus causing this illness in as little as 15% of cases. We intend to address this lack of research by examining, in detail, a new virus we recently identified in a child with serious respiratory illness that required admission to hospital. Testing by our laboratory suggests that the new virus is related to picornaviruses (which cause some common colds) but seems to be present in children with far more serious illness. Our study plans to more completely identify the new picornavirus-like virus (PLV) using the tools of molecular biology and the expertise of a senior team of Australian scientists and clinicians who have recently made several virus discoveries in Australia, demonstrating that Australian virus research is capable of achieving highly competitive results that benefit our hospitals and especially their young patients. Our studies will develop extremely sensitive tests which rely on the detection of very small amounts of the viral genome. We can use these tests to determine what the whole virus looks like, when it might occur during the year and whether the PLV are found worldwide. Our studies will also produce viral proteins in the laboratory and use these to make new tests for stored blood samples. If a blood sample comes from a patient who has previously been infected by PLV, their blood will contain specific antibodies which we will then be able to detect. We also intend to determine whether some strains of PLV are more or less likely to cause serious illness than others. Improved understanding of these and other viruses minimises the chance of illness spreading within a hospital, helps scientists to decide against which viruses to design vaccines and drugs and aids medical doctors to better identify what once went undiagnosed."},"children":[{"color":"#336699","name":"A/Pr Stephen Lambert","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0026122","middle_name":"B","last_name":"Lambert","source_individual_id":"RMIS682186","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Stephen Lambert"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83757","size":1},{"color":"#336699","name":"A/Pr Ian Mackay","data":{"first_name":"Ian","title":"A/Pr","dw_individual_id":"DW0020546","middle_name":"Maxwell","last_name":"Mackay","source_individual_id":"5016124","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ian Mackay"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82250","size":1},{"color":"#336699","name":"Prof Theo Sloots","data":{"first_name":"Theo","title":"Prof","dw_individual_id":"DW0016277","middle_name":"Pieter","last_name":"Sloots","source_individual_id":"5017574","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Theo Sloots"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81115","size":1},{"color":"#336699","name":"A/Pr Michael Nissen","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0009388","middle_name":"Desmond","last_name":"Nissen","source_individual_id":"5016723","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Michael Nissen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79252","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61709","size":1},{"color":"#FF4D4D","name":"Gene therapy to cure botulinum toxin intoxication and new motoneuron delivery system","data":{"media_summary":"synaptic mechanisms","end_year":2009,"keywords":["Gene therapy","motor function","nerve regeneration","nervous system repair","neuromuscular diseases"],"nhmrc_grant_id":455903,"application_year":2006,"health_keywords":["SNARE proteins","botulinum toxin","gene therapy","neuromuscular junction","synaptic mechanisms"],"scientific_title":"Gene therapy to cure botulinum toxin intoxication and new motoneuron delivery system","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biotechnology not elsewhere classified","research_area":"Public Health","for_category":"BIOTECHNOLOGY","cia_name":"A/Pr Frederic Meunier","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455903","simplified_title":"Gene therapy for treatment of botulism","sub_type":"Standard Project Grant","total_budget":"390321.74","source_system":"The aim of the project is to establish two biotechnological strategies to help curing motoneuronal diseases. Botulinum neurotoxins (BoNTs) are the deadliest toxins known. They provoke profound flaccid neuromuscular paralysis that leads to death due to respiratory failure. There are no current therapies available and affected patients require respiratory assistance for up to 7 months with sophisticated respirators. BoNT is therefore an acquired motoneuronal disease and a well-known biological weapon which is also easy to produce in large quantities. It is therefore important to provide a quick and efficient way of overriding BoNT-induced paralysis other than very costly mechanical respirators. Our first strategy aims at designing a gene therapy against botulism. BoNTs promote muscular paralysis by cleaving molecules implicated in the mechanism of neuronal communication (SNARE proteins). Our aim is to deliver genetically modified uncleavable forms of SNAREs to rescue neuronal communication and prevent botulism. BoNT are comprised of two chains: a toxic light chain and a non toxic heavy chain which is responsible for the extreme selectivity of BoNT for motoneurons and for delivering the light chain in the motoneuronal cytosol by a mechanism named translocation. Our second aim is to use the BoNTs atoxic heavy chain to engineer a selective motoneuronal delivery system. This could be useful in the future to deliver molecules of interest in diseased motoneurons."},"children":[{"color":"#336699","name":"Prof Frederic Meunier","data":{"first_name":"Frederic","title":"Prof","dw_individual_id":"DW0020864","middle_name":"A","last_name":"Meunier","source_individual_id":"5016455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frederic Meunier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82341","size":1},{"color":"#336699","name":"Dr Nickolas Lavidis","data":{"first_name":"Nickolas","title":"Dr","dw_individual_id":"DW0020288","middle_name":"Anastasios","last_name":"Lavidis","source_individual_id":"5015890","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nickolas Lavidis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82178","size":1},{"color":"#336699","name":"Prof Ming Wei","data":{"first_name":"Ming","title":"Prof","dw_individual_id":"DW0019989","middle_name":"Q","last_name":"Wei","source_individual_id":"RMIS6079851","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ming Wei"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82090","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61708","size":1},{"color":"#FF4D4D","name":"Cellular and molecular regulation of fetal ovarian development","data":{"media_summary":"organogenesis","end_year":2009,"keywords":["cell differentiation","molecular markers","mouse genetics","organ growth and development","sex determination"],"nhmrc_grant_id":455902,"application_year":2006,"health_keywords":["cell growth/differentiation","developmental abnormalities","embryogenesis","gene expression","organogenesis"],"scientific_title":"Cellular and molecular regulation of fetal ovarian development","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Peter Koopman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455902","simplified_title":"Understanding ovarian development and disease","sub_type":"Standard Project Grant","total_budget":"547315.08","source_system":"Normal development of the ovaries is critical for women's health and reproduction. Recent studies have shown that even the very earliest steps in ovarian development, occurring during fetal growth, can play a major part in predisposing to some of the most common and debilitating reproductive and endocrine disorders affecting Australian women. In this project we will take a systematic and comprehensive approach to exploring the mysteries of fetal ovary development, discovering what genes need to be activated and what cellular processes are required for normal ovary development and hence may play a part in ovarian diseases that manifest in later life. This work will offer new avenues for the prevention, diagnosis and treatment of ovarian disease and female infertility."},"children":[{"color":"#336699","name":"A/Pr Dagmar Wilhelm","data":{"first_name":"Dagmar","title":"A/Pr","dw_individual_id":"DW0046276","middle_name":"","last_name":"Wilhelm","source_individual_id":"5018314","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Dagmar Wilhelm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88981","size":1},{"color":"#336699","name":"Prof Peter Koopman","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0043570","middle_name":"A","last_name":"Koopman","source_individual_id":"5015773","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Koopman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88298","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61707","size":1},{"color":"#FF4D4D","name":"Mechanisms of lesion localization in multiple sclerosis","data":{"media_summary":"","end_year":2009,"keywords":["brainstem","cerebellum","demyelinating disease","humoral and cellular immunity","neuroimmunology"],"nhmrc_grant_id":455895,"application_year":2006,"health_keywords":["brain lesion","central nervous system demyelination and inflammation","multiple sclerosis","protein expression - immunohistochemistry"],"scientific_title":"Mechanisms of lesion localization in multiple sclerosis","start_year":2008,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Judith Greer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455895","simplified_title":"Why do lesions occur where they do in MS?","sub_type":"Standard Project Grant","total_budget":"411228.68","source_system":"Multiple sclerosis (MS) is a chronic disease that affects all areas of the brain and spinal cord (central nervous system or CNS), leading to a huge variety of clinical symptoms and signs, depending upon which parts of the CNS are affected. MS affects about 2 million people worldwide, with the onset of disease often between 20-40 years of age, at a time when family and work commitments are often at their peak. There is no cure for MS, and most people who develop this disease become more and more disabled over their lifetime. MS is an autoimmune disease, i.e. one's own immune system starts to see the CNS as something foreign that needs to be targetted and eliminated. Previously, it has been considered that there are no particular reasons why people with MS develop lesions in the specific parts of the CNS that they do, i.e. it has been thought to be a fairly random event. However, we have recently shown that there are clear correlations between the development of lesions in some parts of the CNS, the particular molecules within the CNS that are being targetted by the immune system, and some genes that control the immune system that are carried by people with MS. The aim of the current study is to work out the mechanism(s) by which autoimmune reactivity targets lesions to different parts of the CNS. We will focus on one target molecule known as myelin proteolipid protein or PLP. People with MS who carry certain immune-related genes are more likely to have immune cells that target PLP, and our work strongly suggests that this subsequently leads to the development of lesions in the brainstem or cerebellum. This work has implications for disease pathogenesis, prognostication and therapy for MS, as a knowledge of patterns of autoimmune reactivity that lead to particular clinical outcomes will improve our ability to give people with MS an idea of they symptoms they might experience and allow specific therapies to be given to patients who will benefit most from them."},"children":[{"color":"#336699","name":"Dr Judith Greer","data":{"first_name":"Judith","title":"Dr","dw_individual_id":"DW0036976","middle_name":"M","last_name":"Greer","source_individual_id":"RMIS24768","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Judith Greer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86571","size":1},{"color":"#336699","name":"Prof Michael Pender","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0009604","middle_name":"P","last_name":"Pender","source_individual_id":"RMIS18293","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Pender"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79308","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61705","size":1},{"color":"#FF4D4D","name":"Non-viral vectors for targeted delivery of RNAi nucleotides to cervical cancers","data":{"media_summary":"","end_year":2009,"keywords":["Cancer","RNA interference","cervical cancer","gene delivery","nanoparticles"],"nhmrc_grant_id":455890,"application_year":2006,"health_keywords":["anti-tumour agents","cervical cancer","genetic therapy","human papilloma virus/cervical carcinoma"],"scientific_title":"Non-viral vectors for targeted delivery of RNAi nucleotides to cervical cancers","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Nigel McMillan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455890","simplified_title":"Delivery of gene-silencing nucleotides","sub_type":"Standard Project Grant","total_budget":"415738.45","source_system":"RNA interference (or gene silencing) is a new technique whereby we are able to turn off the expression of a particular gene either temporarily or permanently. Cancer is basically a genetic disease where certain protective genes are lost or cancer-causing genes expressed. Gene silencing holds great promise in the treatment of genetic disorders, infectious diseases and cancer. Cervical cancer is caused by infection with the human papillomavirus and the expression of two cancer-causing genes. Using RNA interference we can turn off the expression of these two genes which results in the death of the cancer cell. We are also able to cure mice of tumours derived from human cervical cancer. The major issue with gene silencing is how to deliver it effectively to patients. Here we are investigating novel nanoparticulate systems to deliver this new gene-inhibiting drugs preferentially to the tumour site."},"children":[{"color":"#336699","name":"Dr Harendra Parekh","data":{"first_name":"Harendra","title":"Dr","dw_individual_id":"DW0038962","middle_name":"Shantilal","last_name":"Parekh","source_individual_id":"RMIS4456172","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Harendra Parekh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87092","size":1},{"color":"#336699","name":"Prof Nigel Mcmillan","data":{"first_name":"Nigel","title":"Prof","dw_individual_id":"DW0032535","middle_name":"Alan John","last_name":"Mcmillan","source_individual_id":"5016394","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nigel Mcmillan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85423","size":1},{"color":"#336699","name":"A/Pr Ross Mcgeary","data":{"first_name":"Ross","title":"A/Pr","dw_individual_id":"DW0003289","middle_name":"P","last_name":"Mcgeary","source_individual_id":"RMIS3165807","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Ross Mcgeary"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77578","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61704","size":1},{"color":"#FF4D4D","name":"The Developmental vitamin D model (DVD) as an animal model for schizophrenia","data":{"media_summary":"","end_year":2009,"keywords":["Animal model","Behaviour","Neurochemistry","Schizophrenia","Vitamin D"],"nhmrc_grant_id":455884,"application_year":2006,"health_keywords":["Brain Development","Developmental Manipulation","Schizophrenia","Vitamin D deficiency"],"scientific_title":"The Developmental vitamin D model (DVD) as an animal model for schizophrenia","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Darryl Eyles","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455884","simplified_title":"Vitamin D and the developing brain","sub_type":"Standard Project Grant","total_budget":"258075.84","source_system":"Most Australians have the opportunity to enjoy the natural benefits of sunlight, however many Australians lack vitamin D. We have shown that even in Queensland, the so-called Sunshine State, vitamin D levels in the middle of winter are below World Health Organisation recommended levels. We are exploring low maternal vitamin D as a biological explanation for the universal phenomena worldwide of a 7-10% increase in the incidence of patients born with schizophrenia in the colder months of the year. Schizophrenia is a developmental disease that presents in adolescence and affects about 1% of the world's population. To date we have shown increased amounts of schizophrenia in offspring from mothers that had low blood vitamin D levels during pregnancy or who had inadequate vitamin D intake. Early signs therefore appear promising but obviously more research is required to confirm this idea. Our studies in animals have revealed that by restricting vitamin D intake in pregnant rats, newborns have brains that develop differently. Most notably lateral ventricle volume is increased, a key anatomical finding in patients with schizophrenia. When these animals become adults the increase in lateral ventricles persists. Also when we explore the behaviour of these animals we find a deficit in learning and memory similar to that seen in many schizophrenic patients. Furthermore when we expose these animals to agents that induce psychosis or agents that block psychosis in patients we see a heightened sensitivity in animals that were deprived of this vitamin in utero particularly in locomotion. These behavioural findings are consistent with the best animal models for schizophrenia. At a mechanistic level they indicate an abnormality in the two major neurotransmitters in the brain that have been consistently linked with this disease, dopamine and glutamate. The experiments outlined in this application will attempt to establish the neurochemical basis for these altered behaviours."},"children":[{"color":"#336699","name":"A/Pr Darryl Eyles","data":{"first_name":"Darryl","title":"A/Pr","dw_individual_id":"DW0042305","middle_name":"W","last_name":"Eyles","source_individual_id":"5014564","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Darryl Eyles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87979","size":1},{"color":"#336699","name":"A/Pr Thomas Burne","data":{"first_name":"Thomas","title":"A/Pr","dw_individual_id":"DW0023865","middle_name":"Henry Johnston","last_name":"Burne","source_individual_id":"5013713","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Thomas Burne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83125","size":1},{"color":"#336699","name":"Prof John Mcgrath","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0009022","middle_name":"Joseph","last_name":"Mcgrath","source_individual_id":"RMIS3680751","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mcgrath"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79147","size":1},{"color":"#336699","name":"Prof Alan Mackay-Sim","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0003102","middle_name":"","last_name":"Mackay-Sim","source_individual_id":"RMIS222290","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alan Mackay-Sim"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77528","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61703","size":1},{"color":"#FF4D4D","name":"Regulation and Function of TLR9","data":{"media_summary":"","end_year":2009,"keywords":["cell surface receptor","innate immunity","macrophage activation","toll-like receptor"],"nhmrc_grant_id":455882,"application_year":2006,"health_keywords":["infectious diseases","systemic lupus erythematosus","vaccination"],"scientific_title":"Regulation and Function of TLR9","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Katryn Stacey","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455882","simplified_title":"How cells recognise bacterial DNA","sub_type":"Standard Project Grant","total_budget":"256973.37","source_system":"Cells of the immune system need to recognise characteristic viral and bacterial molecules, in order to identify infection. Some immune cells can detect the presence of viral and bacterial DNA. The cells respond by making a number of anti-viral or anti-bacterial molecules, as well as activating other cells to fight the infection. The effect of bacterial DNA can be mimicked by certain short synthetic pieces of DNA. The potent activity of this synthetic DNA (termed CpG DNA ) is being exploited in a number of clinical trials for treatment of cancer and allergy, as well as to improve vaccinations. Despite the rapid advance towards clinical application, there is still much basic information to learn about how CpG DNA acts on cells. The molecule to which DNA binds in order to activate the cells is called TLR9. TLR9 is not on the surface of cells, but within cells. In a bacterial infection, cells called macrophages engulf and digest bacteria and release the bacterial DNA within the cell, where it binds to TLR9. In other cases, including when CpG DNA is used therapeutically, the DNA needs to be taken up into the cell. Evidence shows that there is a receptor on the cell surface which binds DNA, and takes it into the cell. In this project we propose to identify this DNA uptake receptor. Apart from the use of CpG DNA, there are a number of other proposals for the therapeutic use of DNA. Although it is known that DNA enters into cells, the route for this has not been established. Whilst CpG DNA can activate immune cells, some other distinct DNA molecules can prevent the activation. We will examine whether these inhibitory DNA molecules bind more effectively to TLR9 than the CpG DNA, but do not activate the cell. These inhibitory molecules are proposed as a therapy for the autoimmune disease lupus, which involves inappropriate responses to DNA, and is thought to involve TLR9. In order to develop therapies, a detailed knowledge of how they work is essential."},"children":[{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1},{"color":"#336699","name":"Dr Katryn Stacey","data":{"first_name":"Katryn","title":"Dr","dw_individual_id":"DW0028117","middle_name":"Jane","last_name":"Stacey","source_individual_id":"5017656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katryn Stacey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84258","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61702","size":1},{"color":"#FF4D4D","name":"Neonatal vitamin D status and risk of schizophrenia: a study using Danish dried bloods spots","data":{"media_summary":"","end_year":2008,"keywords":["brain development","schizophrenia","vitamin D"],"nhmrc_grant_id":455879,"application_year":2006,"health_keywords":["hypoxia and malnutrition during pregnancy","schizophrenia aetiology","vitamin D deficiency"],"scientific_title":"Neonatal vitamin D status and risk of schizophrenia: a study using Danish dried bloods spots","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof John McGrath","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455879","simplified_title":"Neonatal vitamin D status and risk of schizophrenia","sub_type":"Standard Project Grant","total_budget":"164980.2","source_system":"There is increasing evidence that low levels of vitamin D (i.e. the 'sunshine hormone') during early development can alter brain development. In particular, it has been proposed that low vitamin D during development (e.g. prenatal and in early life), increases the risk of developing schizophrenia during adulthood. A previous study based on stored third trimester blood samples from US women suggested that very low levels of maternal vitamin D may be associated with an increased risk of schizophrenia in the offspring. We have the opportunity to explore this hypothesis using a large, well-described Danish 'bio-bank'. Since 1981, blood samples from newborn babies have been kept by a central agency in Denmark. In collaboration with senior Danish medical researchers, 900 blood samples of babies who have subsequently developed schizophrenia and 1800 from matched healthy individuals have been identified. We will measure vitamin D levels in these blood samples. We predict that babies with low levels of vitamin D will have an increased risk of developing schizophrenia. If low prenatal vitamin D does increase the risk of schizophrenia, this finding will have important implications from a public health perspective. Just as the number of infants affected by spina bifida has been reduced by adding folate supplements to foods, optimizing maternal vitamin D levels may lead to a reduction in the incidence of schizophrenia."},"children":[{"color":"#336699","name":"A/Pr Darryl Eyles","data":{"first_name":"Darryl","title":"A/Pr","dw_individual_id":"DW0042305","middle_name":"W","last_name":"Eyles","source_individual_id":"5014564","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Darryl Eyles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87979","size":1},{"color":"#336699","name":"Dr Preben Mortensen","data":{"first_name":"Preben","title":"Dr","dw_individual_id":"DW0026883","middle_name":"Bo","last_name":"Mortensen","source_individual_id":"5020603","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Preben Mortensen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83960","size":1},{"color":"#336699","name":"Prof John Mcgrath","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0009022","middle_name":"Joseph","last_name":"Mcgrath","source_individual_id":"RMIS3680751","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mcgrath"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79147","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61701","size":1},{"color":"#FF4D4D","name":"Evaluation of a group intervention to promote older people's adjustment to driving cessation","data":{"media_summary":"","end_year":2009,"keywords":["Ageing","Community participation","Driving cessation","Older people","Transport"],"nhmrc_grant_id":455876,"application_year":2006,"health_keywords":["Ageing","Chronic disease","Older people","Transport"],"scientific_title":"Evaluation of a group intervention to promote older people's adjustment to driving cessation","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Geriatrics and Gerontology","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Dr Louise Gustafsson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455876","simplified_title":"Helping older people give up driving","sub_type":"Standard Project Grant","total_budget":"350755.03","source_system":"As a result of age-related changes, chronic medical conditions, the side-effects of medication or a combination of these, many older people decide or are required to give up driving. Driving is a highly valued role, associated with freedom, independence and convenience. Because of this, the transition to driving cessation can be traumatic and associated with depression, social isolation and compromised well-being. Despite the frequent reporting of poor outcomes for older people after driving cessation, limited attention has been given to developing and evaluating methods to help older people prepare for and cope with this transition. This study will evaluate the effect of a group intervention on older people's episodes away from home, use of alternative transport modes, life satisfaction, depression, and self-rated performance of and satisfaction with up to five lifestyle goals related to transport. This study will contribute to evidence for the effectiveness of a group intervention versus usual practice (which is to say, no intervention) to help older people maintain their well-being and stay engaged in valued roles, activities and the community after retiring from driving. It will also contribute to the theoretical underpinnings of adjustment after undergoing the transition to retired driver."},"children":[{"color":"#336699","name":"Dr Kryss Mckenna","data":{"first_name":"Kryss","title":"Dr","dw_individual_id":"DW0038431","middle_name":"T","last_name":"Mckenna","source_individual_id":"RMIS1112438","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Kryss Mckenna"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86956","size":1},{"color":"#336699","name":"Dr Louise Gustafsson","data":{"first_name":"Louise","title":"Dr","dw_individual_id":"DW0013404","middle_name":"","last_name":"Gustafsson","source_individual_id":"RMIS7489502","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Louise Gustafsson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80322","size":1},{"color":"#336699","name":"Prof Nancy Pachana","data":{"first_name":"Nancy","title":"Prof","dw_individual_id":"DW0003819","middle_name":"Ann","last_name":"Pachana","source_individual_id":"RMIS1713128","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Nancy Pachana"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77727","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61700","size":1},{"color":"#FF4D4D","name":"Australian Zebrafish Phenomics Facility","data":{"media_summary":"neurological disorders","end_year":2012,"keywords":["development and morphogenesis","neuronal differentiation","organ growth and development","zebrafish"],"nhmrc_grant_id":455871,"application_year":2006,"health_keywords":["ageing","blood disorders","cancer: mechanisms of growth","muscular dystrophy","neurological disorders"],"scientific_title":"Australian Zebrafish Phenomics Facility","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Enabling Grants","purl":"http://purl.org/au-research/grants/nhmrc/455871","simplified_title":"Building national infrastructure for zebrafish functional genomics","sub_type":"Enabling Grant","total_budget":"1584445.61","source_system":"Globally, zebrafish are making a very significant impact on biomedical research. Zebrafish have a number of attributes that make them ideal models for the study of development and disease, including: - adults are relatively small, so housing is cheap - eggs are transparent, so early developmental processes can be visualized easily - development is rapid - organs are made in 1-7 days - zebrafish are vertebrates and thus have a gene complement very similar to humans - large numbers of eggs are produced each week from a single mother, aiding experimentation - ENU mutagenesis screens have generated thousands of useful mutants, including an increasing number that accurately model human genetic diseases - high-resolution imaging of RNA and protein expression in whole embryos is easy - drugs and chemicals can be easily tested for activities in zebrafish by adding them to the water Becuase of these attributes, zebrafish are becoming the model organism of choice for the study to human development and disease - indeed, the zebrafish field is growing at three times the rate of the mouse field. The international biomedical community has invested very heavily in infrastructure to aid the zebrafish community in realising the potential of this model. In Australia we have very strong basic research teams whom have embraced zebrafish mdoels. However, we lag behind other parts of the world in that, as yet, we have not had much specific funding allocated to animal model infrastructure. This Enabling Grant will build unique infrastructure by bringing together the zebrafish community with two areas in which Australia is very strong - genomics and biodiversity. This will result in a greatly enhanced ability to determine how genes work, and a pipeline for screening Australia's rich source of natural products and chemical libraries for activites against common human diseases such as cancer, dementia, and muscle diseases using zebrafish models."},"children":[{"color":"#336699","name":"Prof Paul Alewood","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0035049","middle_name":"F","last_name":"Alewood","source_individual_id":"5013158","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Alewood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86082","size":1},{"color":"#336699","name":"Prof Andrew Perkins","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0033140","middle_name":"Charles","last_name":"Perkins","source_individual_id":"RMIS216814","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Andrew Perkins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85587","size":1},{"color":"#336699","name":"Dr Michael Lardelli","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0031951","middle_name":"Trent","last_name":"Lardelli","source_individual_id":"RMIS12265","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Michael Lardelli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85262","size":1},{"color":"#336699","name":"Dr Ethan Scott","data":{"first_name":"Ethan","title":"Dr","dw_individual_id":"DW0027841","middle_name":"Kime","last_name":"Scott","source_individual_id":"5017408","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ethan Scott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84182","size":1},{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1},{"color":"#336699","name":"Prof Andrew Boyd","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0023731","middle_name":"W","last_name":"Boyd","source_individual_id":"RMIS3609","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Andrew Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83095","size":1},{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1},{"color":"#336699","name":"Prof Alister Ward","data":{"first_name":"Alister","title":"Prof","dw_individual_id":"DW0010935","middle_name":"C","last_name":"Ward","source_individual_id":"5018196","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alister Ward"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79682","size":1},{"color":"#336699","name":"A/Pr Joseph Rothnagel","data":{"first_name":"Joseph","title":"A/Pr","dw_individual_id":"DW0009982","middle_name":"A","last_name":"Rothnagel","source_individual_id":"5017267","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Joseph Rothnagel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79410","size":1},{"color":"#336699","name":"Prof Sean Grimmond","data":{"first_name":"Sean","title":"Prof","dw_individual_id":"DW0007616","middle_name":"M","last_name":"Grimmond","source_individual_id":"5014956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sean Grimmond"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78759","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61699","size":1},{"color":"#FF4D4D","name":"Molecular Characterisation of Lipid Droplet Function","data":{"media_summary":"","end_year":2009,"keywords":["Cell Biology","Cholesterol","Endocytosis","Molecular Mechanisms","Protein Trafficking"],"nhmrc_grant_id":455865,"application_year":2006,"health_keywords":["Biochemistry and Molecular Biology","Diabetes","Lipids","Obesity"],"scientific_title":"Molecular Characterisation of Lipid Droplet Function","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455865","simplified_title":"Lipid Storage in Fat Cells","sub_type":"Standard Project Grant","total_budget":"496446.74","source_system":"Fat is stored inside cells in spherical structures called lipid droplets. The accumulation of fat within lipid droplets underlies obesity. This project aims to understand how fat is stored within lipid droplets and how it is released when energy is required. In particular, we will look at two types of protein which move to lipid droplets under certain energy conditions and attempt to unravel how these proteins control fat storage and release. The first protein we will study, caveolin, normally associates with regions of the cell surface but moves to lipid droplets when cells are fed lipids. Mice which lack this protein eat more food but remain leaner than normal mice. Understanding how caveolin moves to lipid droplets and how it controls fat accumulation will therefore provide new insights into obesity and conditions associated with obesity, such as diabetes. The second protein to be studied, Rab18, is a member of a protein family which controls membrane movement within cells. Rab18 moves to lipid droplets when lipid release is stimulated. Therefore studies of Rab18 can provide new insights into the way lipids are released from fat tissue under conditions of starvation. The project will provide fundamental new insights into the basic mechanisms by which we store energy and the energy imbalances which cause obesity and related diseases."},"children":[{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1},{"color":"#336699","name":"Dr Sally Martin","data":{"first_name":"Sally","title":"Dr","dw_individual_id":"DW0003208","middle_name":"","last_name":"Martin","source_individual_id":"RMIS6515","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Sally Martin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77555","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61698","size":1},{"color":"#FF4D4D","name":"The nuclear growth hormone receptor- its actions and mechanism of nuclear translocation","data":{"media_summary":"","end_year":2009,"keywords":["apoptosis","growth hormone","proteomics","receptors","transport"],"nhmrc_grant_id":455864,"application_year":2006,"health_keywords":["cancer and related disorders","growth disorders","retinopathy"],"scientific_title":"The nuclear growth hormone receptor- its actions and mechanism of nuclear translocation","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael WATERS","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455864","simplified_title":"Role of the growth hormone receptor in the cell nucleus and how it gets there.","sub_type":"Standard Project Grant","total_budget":"531696.74","source_system":"We and others have found that cell surface receptors for growth factors such as EGF, FGF and growth hormone can be found in the nucleus of proliferating cells. We have shown that many cancers have elevated nuclear GH receptor including leukemia, breast and colon cancer. If we artificially target the GH receptor to the nucleus, the resulting cells are tumorigenic when injected into immunocompromised mice, rapidly form ing metastasising tumours. To create more effective inhibitors of this tumourogenesis, and to define the physiological roles of nuclear GH receptor, we will define the transport process which carries the receptor to the nucleus and block it. We will also seek to define how the receptor in the nucleus interacts directly with DNA to inhibit programmed cell death. To carry out these projects we will use sophisticated proteomics -mass spectrometry to identify the proteins interacting with the receptor in the transport and gene activation processes. The role of candidates will be tested by preventing their expression or by direct inhibition of their action using drugs or dominant negative versions. These approaches will provide leads to new anti-cancer therapeutics, and therapies for blocking diabetic blindness and kidney failure."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61697","size":1},{"color":"#FF4D4D","name":"CCRE in Spinal Pain, Injury and Health","data":{"media_summary":"Whiplash Associated Disorders","end_year":2012,"keywords":["Motor control","Pain science","Prevention","Rehabilitation technology","Spinal pain"],"nhmrc_grant_id":455863,"application_year":2006,"health_keywords":["Back injury","Headache","Low back pain","Neck pain","Whiplash Associated Disorders"],"scientific_title":"CCRE in Spinal Pain, Injury and Health","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Paul Hodges","higher_grant_type":"Centre for Research Excellence","purl":"http://purl.org/au-research/grants/nhmrc/455863","simplified_title":"CCRE in Spinal Pain, Injury and Health","sub_type":"Centre of Clinical Research Excellence","total_budget":"2007200","source_system":"Spinal complaints present the greatest social and economic burden of musculoskeletal conditions in Australia. This reflects current realities: the cause remains unknown; 80% of the population is affected; and isolated professions perform a staggering array of interventions. The CCRE aims to target these realities and improve Australia's capacity to prevent and manage spinal disorders by supporting innovative interdisciplinary research and training. This community- and university-based centre will align highly successful clinical and basic researchers in collaboration with a national network of spine scientists to foster interdisciplinary clinical researcher training, develop new diagnostics and therapeutics, and translate findings to the community. Through clinical research the centre aims to: (i) Advance understanding of physiology and pathophysiology of spinal pain (ii) Translate findings from basic research to clinical practice (iii) Establish coordinated multidisciplinary research to reduce the burden of spinal pain (iv) Predict and prevent the transition from acute to chronic states (v) Train a new generation of transdisciplinary clinical scientists (vi) Rapidly assess new treatment possibilities in pre-clinical studies (vii) Develop innovative technologies for diagnostics and therapeutics (viii) Encourage Australian commercialisation opportunities for new discoveries (ix) Encourage community-user participation in direction of research programs (x) Disseminate new findings and information of evidence-based practice to patients, clinicians, insurers, government and the scientific and wider community"},"children":[{"color":"#336699","name":"Prof Guglielmo Vicenzino","data":{"first_name":"Guglielmo","title":"Prof","dw_individual_id":"DW0046019","middle_name":"Tarcisio","last_name":"Vicenzino","source_individual_id":"5018115","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Guglielmo Vicenzino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88911","size":1},{"color":"#336699","name":"Prof Paul Hodges","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0043077","middle_name":"W","last_name":"Hodges","source_individual_id":"RMIS222953","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Hodges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88164","size":1},{"color":"#336699","name":"Prof Justin Kenardy","data":{"first_name":"Justin","title":"Prof","dw_individual_id":"DW0037727","middle_name":"Alastair","last_name":"Kenardy","source_individual_id":"RMIS53308","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Justin Kenardy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86768","size":1},{"color":"#336699","name":"Prof Michele Sterling","data":{"first_name":"Michele","title":"Prof","dw_individual_id":"DW0028165","middle_name":"","last_name":"Sterling","source_individual_id":"5017714","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michele Sterling"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84271","size":1},{"color":"#336699","name":"E/Pr Gwendolen Jull","data":{"first_name":"Gwendolen","title":"E/Pr","dw_individual_id":"DW0019981","middle_name":"A","last_name":"Jull","source_individual_id":"RMIS5215","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"E/Pr Gwendolen Jull"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82087","size":1},{"color":"#336699","name":"Prof Wayne Gibbon","data":{"first_name":"Wayne","title":"Prof","dw_individual_id":"DW0019190","middle_name":"W","last_name":"Gibbon","source_individual_id":"5030616","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Wayne Gibbon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81892","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61696","size":1},{"color":"#FF4D4D","name":"DsbA inhibitors as potential antimicrobials","data":{"media_summary":"","end_year":2009,"keywords":["NMR spectroscopy","crystallography","enzyme inhibition"],"nhmrc_grant_id":455860,"application_year":2006,"health_keywords":["bacterial infection","bacterial virulence factors","drug discovery"],"scientific_title":"DsbA inhibitors as potential antimicrobials","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Martin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455860","simplified_title":"Developing novel anti-bacterial agents","sub_type":"Standard Project Grant","total_budget":"565026.32","source_system":"Infectious diseases are one of the leading causes of death and morbidity worldwide. In the last two decades the incidence of diseases caused by bacteria has increased dramatically with old pathogens re-emerging, often in a more virulent form, and new infectious agents appearing. Many pathogenic microbes are becoming increasingly resistant to antibiotics so that the need for new therapeutic targets is urgent. We will develop new antimicrobial chemotherapies by targeting DsbA, a specific factor involved in the generation of bacterial virulence. This protein is found in most bacteria and contributes to pathogenicity by promoting the formation of toxins and virulence factors. We will design specific inhibitors of DsbA by using a structure-based approach, implementing the leading edge technologies of fragment-based lead discovery by crystallography and NMR. We will then optimise the fragments to develop lead compounds and evaluate their suitability as DsbA inhibitors by in vitro and in vivo assays."},"children":[{"color":"#336699","name":"A/Pr Martin Scanlon","data":{"first_name":"Martin","title":"A/Pr","dw_individual_id":"DW0027806","middle_name":"Joseph","last_name":"Scanlon","source_individual_id":"5017366","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Martin Scanlon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84175","size":1},{"color":"#336699","name":"Dr Robert Reid","data":{"first_name":"Robert","title":"Dr","dw_individual_id":"DW0009865","middle_name":"C","last_name":"Reid","source_individual_id":"RMIS4598791","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Robert Reid"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79380","size":1},{"color":"#336699","name":"Prof Jennifer Martin","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0008922","middle_name":"Louise","last_name":"Martin","source_individual_id":"5022915","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jennifer Martin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79117","size":1},{"color":"#336699","name":"Prof William Charman","data":{"first_name":"William","title":"Prof","dw_individual_id":"DW0006520","middle_name":"N","last_name":"Charman","source_individual_id":"RMIS47162","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof William Charman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78470","size":1},{"color":"#336699","name":"Dr Begona Heras","data":{"first_name":"Begona","title":"Dr","dw_individual_id":"DW0002158","middle_name":"","last_name":"Heras","source_individual_id":"RMIS4598788","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Begona Heras"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77263","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61695","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2011,"keywords":["Breast neoplasms-pathology-therapy","Cancer and related disorders; growth hormone","Colorectal cancer; short stature; obesity-metaboli","Endocrinology","Metabolic syndrome"],"nhmrc_grant_id":455858,"application_year":2006,"start_year":2007,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael Waters","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/455858","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"765882.9","source_system":"I am a molecular endocrinologist studying the mode of action and physiological consequences of growth hormone action."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61694","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2011,"keywords":["Bioinformatics","Microarray","Organ growth and development","Stem cells","Tissue regeneration"],"nhmrc_grant_id":455857,"application_year":2006,"start_year":2007,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Sean Grimmond","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/455857","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"559560.3","source_system":"I am a Genomics Scientist focusing on studying the mammalian transcriptome and its role in cell differentiation, organogenesis and tumorigenesis."},"children":[{"color":"#336699","name":"Prof Sean Grimmond","data":{"first_name":"Sean","title":"Prof","dw_individual_id":"DW0007616","middle_name":"M","last_name":"Grimmond","source_individual_id":"5014956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sean Grimmond"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78759","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61693","size":1},{"color":"#FF4D4D","name":"Evaluation of orally active anti-inflammatory C5a receptor antagonists in a transgenic rat motor neurone disease model","data":{"media_summary":"","end_year":2009,"keywords":["anti-inflammatory","complement C5a receptor","drug development","neurodegeneration"],"nhmrc_grant_id":455856,"application_year":2006,"health_keywords":["complement activation","inflammatory disease","motor neurone disease","neurodegeneration"],"scientific_title":"Evaluation of orally active anti-inflammatory C5a receptor antagonists in a transgenic rat motor neurone disease model","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Stephen Taylor","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455856","simplified_title":"A new drug treatment approach for motor neurone disease","sub_type":"Standard Project Grant","total_budget":"533578.39","source_system":"Motor neurone disease is a rapidly progressive and incurable disease, usually ending in death within 3-5 years of diagnosis. The disease usually arrives without warning, and results in a progressive loss of muscle control. There is no effective treatment, and available drugs increase life span by a few weeks at best. There is evidence that the disease involves an inflammatory component, but available anti-inflammatory drugs are ineffective. We have developed a new class of anti-inflammatory drugs, known as C5a antagonists, and in preliminary experiments have shown they are therapeutically effective in a transgenic rat model of motor neurone disease. We propose to investigate in more detail how these drugs work in the rat model, and demonstrate that a specific inflammatory pathway, which we can now block, is responsible for some of the disease's progression. This work may lead to an entirely new class of drugs being used to treat patients with this drastic disease."},"children":[{"color":"#336699","name":"A/Pr Peter Noakes","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0038807","middle_name":"G","last_name":"Noakes","source_individual_id":"5016732","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Noakes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87053","size":1},{"color":"#336699","name":"Prof Stephen Taylor","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0010587","middle_name":"M","last_name":"Taylor","source_individual_id":"RMIS41211","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79577","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61692","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2011,"keywords":["Biological sciences, mechanisms of pain","multidisciplinary","neurological disorders, neuropharmacology","novel therapeutic, membrane protein","venom"],"nhmrc_grant_id":455840,"application_year":2006,"start_year":2007,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Prof Richard Lewis","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/455840","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"618721.82","source_system":"I am a biochemist and molecular pharmacologist discovering and determining the mode and site of action of bioactive peptides from cone snails. I guide the assay and chemical detection of new bioactives which are isolate to purity, sequenced and their stru"},"children":[{"color":"#336699","name":"Prof Richard Lewis","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0014455","middle_name":"J","last_name":"Lewis","source_individual_id":"5015973","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Lewis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80612","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61691","size":1},{"color":"#FF4D4D","name":"NR4A orphan nuclear receptor signalling in skeletal muscle: evidence for crosstalk with the beta-adrenergic pathway.","data":{"media_summary":"Obesity","end_year":2009,"keywords":["Gene Regulation","Metabolism","Skeletal Muscle","Steroid Hormone Receptors","Transcription"],"nhmrc_grant_id":455839,"application_year":2006,"health_keywords":["Biological Sciences","Diabetes","Dyslipidaemia","Metabolic Disorders","Obesity"],"scientific_title":"NR4A orphan nuclear receptor signalling in skeletal muscle: evidence for crosstalk with the beta-adrenergic pathway.","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455839","simplified_title":"Regulation of metabolism in skeletal muscle","sub_type":"Standard Project Grant","total_budget":"323749.69","source_system":"The NR4A subgroup of are 'orphan' members of the nuclear hormone receptor (NR) superfamily (that are all implicated in human disease). NRs are hormone-dependent DNA binding proteins that translate nutritional and pathophysiological signals into gene regulation. The importance of this 'drugable' gene family in the context of promoting and maintaining human health is underscored by the diversity of medicinals associated with dysfunctional hormone signalling, in the context of inflammation, diabetes, dyslipidemia, and endocrine disorders (e.g ~15% of the top selling therapeutic compounds target NRs). The NR4A subgroup are stress response genes which are induced by a wide range of physiological stimuli and have been implicated in the response to energy excess (over-eating) and diet induced obesity. The NR4A subgroup are expressed in skeletal muscle, a major mass peripheral tissue that accounts for ~40% of the body mass and energy expenditure. This lean tissue is a major site of fat oxidation, insulin-stimulated glucose utilization and cholesterol metabolism. Therefore this tissue plays a notable role in insulin sensitivity, the blood lipid profile, and energy balance. Accordingly, muscle has a significant role in the progression of dyslipidemia, diabetes and obesity. Surprisingly, the function of the NR4A subgroup in skeletal muscle metabolism has not been examined. Nevertheless, given the data on NR4A mediated gene regulation, and the potential therapeutic utility for the treatment of metabolic disease, the contribution of skeletal muscle to NR4A action must be defined. Correspondingly, the objective of this proposal is to examine the role of the NR4A subgroup and is relevant to understanding the basis of dyslipidemia and obesity."},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61690","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellows","data":{"media_summary":"","end_year":2011,"keywords":["Genetics of complex diseases; Genetics","Inflammatory arthritis","Osteoporosis; chondrocalcinosis","Susceptibility genes; Arthritis; Osteoporosis","spondyloarthropathy"],"nhmrc_grant_id":455836,"application_year":2006,"start_year":2007,"scientific_title":"Uncoupled Research Fellows","node_source":"NHMRC","node_type":"Grant","field_of_research":"Quantitative Genetics","research_area":"Clinical Medicine and Science","for_category":"GENETICS","cia_name":"Prof Matthew Brown","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/455836","simplified_title":"Uncoupled Research Fellows","sub_type":"Research Fellowship","total_budget":"677383.33","source_system":"I am a clinican-scientist and rheumatologist studying genetic determinants of common chronic human musculoskeletal diseases. My research aims are to define for key genes how specific genotypes promote diease phenotypes, using in vitro and in vivo approac"},"children":[{"color":"#336699","name":"Prof Matthew Brown","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0012026","middle_name":"A","last_name":"Brown","source_individual_id":"5012217","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Matthew Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79951","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61689","size":1},{"color":"#FF4D4D","name":"CCRE in Cardiovascular and Metabolic Diseases","data":{"media_summary":"renal failure","end_year":2011,"keywords":["cardiovascular disease","exercise training","lifestyle factors","obesity","renal failure"],"nhmrc_grant_id":455832,"application_year":2006,"health_keywords":["cardiovascular and other disease prevention","exercise training","lifestyle","obesity","renal failure"],"scientific_title":"CCRE in Cardiovascular and Metabolic Diseases","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Thomas Marwick","higher_grant_type":"Centre for Research Excellence","purl":"http://purl.org/au-research/grants/nhmrc/455832","simplified_title":"CCRE in Cardiovascular and Metabolic Diseases","sub_type":"Centre of Clinical Research Excellence","total_budget":"2007200","source_system":"Metabolic disorders related to the modern lifestyle, including inactivity, obesity, the metabolic syndrome and type II diabetes, are responsible for a major proportion of the disease burden in Australia. Current treatment strategies are expensive and because they are directed at end-organ damage (heart failure, heart attacks etc), rather ineffective. This multispecialty, multidisciplinary group will undertake a series of unique studies aimed at understanding and preventing early cardiovascular complications of these metabolic conditions. Sensitive new cardiovascular imaging techniques will be used to detect preclinical abnormalities in the structure, function and metabolism of the heart and vasculature, facilitating the development of new strategies of exercise and lifestyle intervention to prevent these complications. While built on the successful current CCRE in Cardiovascular and Metabolic Disease, including multidisciplinary clinical research training, the new application involves major new directions in the interface between the liver and metabolic syndrome, and strategies for community-based prevention programs. The nursing intervention model, which will focus on workforce models of care, is especially important. The results of this study will provide information to address the need for different nursing models sought by the recent Productivity Commission Report."},"children":[{"color":"#336699","name":"A/Pr Graeme Macdonald","data":{"first_name":"Graeme","title":"A/Pr","dw_individual_id":"DW0043925","middle_name":"Alistair","last_name":"Macdonald","source_individual_id":"5016107","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Graeme Macdonald"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88380","size":1},{"color":"#336699","name":"Prof Johannes Prins","data":{"first_name":"Johannes","title":"Prof","dw_individual_id":"DW0039181","middle_name":"Bernhard","last_name":"Prins","source_individual_id":"RMIS7041737","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Johannes Prins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87157","size":1},{"color":"#336699","name":"A/Pr Nicole Isbel","data":{"first_name":"Nicole","title":"A/Pr","dw_individual_id":"DW0037471","middle_name":"Maree","last_name":"Isbel","source_individual_id":"5015434","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nicole Isbel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86705","size":1},{"color":"#336699","name":"Prof Thomas Marwick","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0032377","middle_name":"Hugh","last_name":"Marwick","source_individual_id":"RMIS108223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Marwick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85383","size":1},{"color":"#336699","name":"Prof Desley Hegney","data":{"first_name":"Desley","title":"Prof","dw_individual_id":"DW0025422","middle_name":"Gail","last_name":"Hegney","source_individual_id":"5015186","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Desley Hegney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83545","size":1},{"color":"#336699","name":"Prof Michael Stowasser","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022365","middle_name":"","last_name":"Stowasser","source_individual_id":"5017746","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Stowasser"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82770","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61688","size":1},{"color":"#FF4D4D","name":"","data":{"media_summary":"","end_year":2011,"keywords":["Bacterial virulence factors","Biochemistry and Molecular biology","Diabetes mellitus","Protein structure; enzyme inhibition","Protein-protein interactions"],"nhmrc_grant_id":455829,"application_year":2006,"start_year":2007,"scientific_title":"","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Martin","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/455829","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"370200","source_system":"I am a structural biologist with a background in pharmacy. My research focuses on dissecting the molecular mechanisms of disease-causing proteins to underpin the development of new and improved therapeutics"},"children":[{"color":"#336699","name":"Prof Jennifer Martin","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0008922","middle_name":"Louise","last_name":"Martin","source_individual_id":"5022915","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jennifer Martin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79117","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61687","size":1},{"color":"#FF4D4D","name":"Regulation of dynamic cell-cell adhesions by coordinated action of lipid kinases and phosphatases","data":{"media_summary":"","end_year":2009,"keywords":["Cell Adhesion","Cell Biology","Cytoskeleton","Epithelial biology","Signaling pathways"],"nhmrc_grant_id":455824,"application_year":2006,"health_keywords":["Cancer biology","Invasion","Metastasis"],"scientific_title":"Regulation of dynamic cell-cell adhesions by coordinated action of lipid kinases and phosphatases","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Alpha Yap","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/455824","simplified_title":"PIP3 signaling and E-cadherin","sub_type":"Standard Project Grant","total_budget":"529565.08","source_system":"This research project studies the molecular mechanisms that allow cells to attach to, and recognize, one another. Such cell-to-cell adhesion is mediated by the cadherin family of molecules, which reside on the surfaces of cells. Cadherins allow cells to recognize one another and, upon recognition, to adhere to each other. By this means, populations of individual cells can be linked together into cohesive populations - i.e. the tissues and organs of the body. The importance of cadherin adhesion is exemplified by the fact that disruption of cadherin adhesion contributes to many important diseases, especially inflammation and cancer. Thus understanding how cadherins hold cells together is necessary for us to understand the molecular basis of common diseases. In this project we study how cadherins signal to regulate cellular behaviour. We build on our recent discovery that E-cadherin can activate a lipid in the cell membrane, PIP3, that is known to be a key regulator of many cellular activities. We aim to understand how this signal is generated in response to E-cadherin adhesion and how it elicits normal cellular responses to cadherin adhesion."},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61686","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2012,"keywords":["Developmental Genes;","cancer","craniofacial development","limb development","murine models"],"nhmrc_grant_id":455823,"application_year":2006,"start_year":2007,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Carol Wicking","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/455823","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"749274.94","source_system":"My background is in the study of human molecular genetic disease, and my interest has evolved to the analysis of embryonic development using the mouse as a model system. My particular interest is in the molecular mechanisms governing limb and craniofacial"},"children":[{"color":"#336699","name":"A/Pr Carol Wicking","data":{"first_name":"Carol","title":"A/Pr","dw_individual_id":"DW0028805","middle_name":"A","last_name":"Wicking","source_individual_id":"RMIS2473798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Carol Wicking"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84461","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61685","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2011,"keywords":["Cancer","Genetic Disease","Neurodegeneration","Radiosensitivity","signal transduction"],"nhmrc_grant_id":455818,"application_year":2006,"start_year":2007,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/455818","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"765882.9","source_system":"I am a molecular biologist with research interests in cancer genetics, neurodegenerative disorders and development of novel therapeutics. My major focus is on the cellular response to different stresses and the consequences thereof."},"children":[{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61684","size":1},{"color":"#FF4D4D","name":"Regulation of Airway Defensive Reflexes","data":{"media_summary":"","end_year":2011,"keywords":["Airways","Asthma","Disease","treatment"],"nhmrc_grant_id":454776,"application_year":2006,"start_year":2007,"scientific_title":"Regulation of Airway Defensive Reflexes","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Stuart Mazzone","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/454776","simplified_title":"Regulation of Airway Defensive Reflexes","sub_type":"RD Wright Biomedical CDF","total_budget":"490129","source_system":""},"children":[{"color":"#336699","name":"Dr Stuart Mazzone","data":{"first_name":"Stuart","title":"Dr","dw_individual_id":"DW0008967","middle_name":"B","last_name":"Mazzone","source_individual_id":"5016283","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Stuart Mazzone"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79130","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61568","size":1},{"color":"#FF4D4D","name":"Effects of prism adaptation on space perception following chronic and reversible cortical lesions","data":{"media_summary":"Stroke Rehabilitation","end_year":2009,"keywords":["Cognitive Impairment","Parietal Cortex","Rehabilitation","Selective attention","Transcranial Magnetic Stimulation"],"nhmrc_grant_id":454446,"application_year":2006,"health_keywords":["Attention Deficits","Diseases of Ageing","Neuropsychological Impairment","Spatial Neglect","Stroke Rehabilitation"],"scientific_title":"Effects of prism adaptation on space perception following chronic and reversible cortical lesions","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)","research_area":"Basic Science","for_category":"PSYCHOLOGY","cia_name":"Prof Jason Mattingley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/454446","simplified_title":"Neural basis of visual and auditory space perception in the parietal lobe of the brain","sub_type":"Standard Project Grant","total_budget":"319336.68","source_system":"Damage to one side of the brain following a stroke often produces a debilitating disorder called spatial neglect. Affected patients persistently ignore objects, sounds or touches on the side of space opposite their brain injury. This disorder occurs despite normal sensory function, and reflects damage to the brain's internal representations of one side of space, causing patients to behave as if that side of space no longer exists. Spatial neglect is difficult to rehabilitate and is a major predictor of poor functional recovery after stroke, but there are no effective treatments for it. A promising new treatment for spatial neglect has been recently discovered, which involves patients practicing pointing to a visual target while wearing spectacle-mounted prism lenses that systematically correct for their altered view of the world. Following a brief period of this training, patients' show increased ability to perceive visual objects presented to the previously neglected side of space. Studies have shown that the prism treatment can have long-term benefits for many neglect sufferers. However, it is not known what the brain mechanisms underlying the treatment effects are, and to what degree the effects generalize to all affected senses. The proposed project aims to investigate whether prism treatment ameliorates spatial neglect of sounds as well as visual objects in a group of stroke patients. The project will also systematically examine which part of the brain is critical for the beneficial effects of prism treatment by using focal magnetic stimulation to create reversible, virtual lesions in the brains of healthy participants. Addressing these issues has clear implications for identifying suitable candidates for the treatment, and for understanding how the sensory world is represented in the human brain."},"children":[{"color":"#336699","name":"Prof Dexter Irvine","data":{"first_name":"Dexter","title":"Prof","dw_individual_id":"DW0025708","middle_name":"Robert","last_name":"Irvine","source_individual_id":"RMIS8519","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Dexter Irvine"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83618","size":1},{"color":"#336699","name":"Prof Jason Mattingley","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0020682","middle_name":"Brett","last_name":"Mattingley","source_individual_id":"RMIS123930","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jason Mattingley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82287","size":1},{"color":"#336699","name":"Dr Ranmalee Eramudugolla","data":{"first_name":"Ranmalee","title":"Dr","dw_individual_id":"DW0012918","middle_name":"","last_name":"Eramudugolla","source_individual_id":"RMIS4488926","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Ranmalee Eramudugolla"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80201","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61495","size":1},{"color":"#FF4D4D","name":"Anti-apoptotic, anti-fibrotic, and positive inotropic effects of ghrelin and GHRP on rat and mouse cardiac myocytes","data":{"media_summary":"","end_year":2009,"keywords":["Apoptosis","Calcium","Fibroblast proliferation","Ion channels","Signal transduction"],"nhmrc_grant_id":441113,"application_year":2006,"health_keywords":["Cardiac fibrosis","Cardiac hypertrophy","Heart failure","Myocardial infarction"],"scientific_title":"Anti-apoptotic, anti-fibrotic, and positive inotropic effects of ghrelin and GHRP on rat and mouse cardiac myocytes","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Chen Chen","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/441113","simplified_title":"Protective effects of growth hormone releasing peptides on chronic heart failure and myocardial infarction","sub_type":"Standard Project Grant","total_budget":"442530.75","source_system":"Growth hormone (GH) is a protein hormone secreted from an endocrine organ, the pituitary gland, below the brain. Synthetic GH-releasing peptides (GHRPs) and endogenous GHRP (ghrelin) possess many other physiological functions in addition to the release of GH. GHRPs have been shown to affect cardiac function in animals and humans through their specific receptors. We recently demonstrated at single cell level that GHRPs increased contraction of cardiac muscle cells and protected them from the programmed cell death which occurs in heart failure and myocardial infarction. We also demonstrated that GHRPs protected the heart in chronic heart failure and alleviated functional loss of the heart in experimental heart failure models. Preliminary results now indicate that GHRPs prevent cardiac fibrosis, which accounts for cardiac dysfunction after heart failure and infarction. It is proposed in this project to clarify the mechanism underlying the action of GHRPs in (1) cardiac functional enhancing; (2) anti-cell death; (3) anti-fibrosis effects, in primary cultured rat myocytes in vitro and in cardiac diseased mouse models in vivo. By completing this project, we will be able to (1) better understand the physiological role of ghrelin in the regulation of cardiac function; and (2) clarify the potential for therapeutic use of GHRPs in the treatment of chronic heart failure, a disease affecting 1-2% of the population of Australia, with 5 year mortality rates about 65%."},"children":[{"color":"#336699","name":"Dr Morag Young","data":{"first_name":"Morag","title":"Dr","dw_individual_id":"DW0040647","middle_name":"Jennifer","last_name":"Young","source_individual_id":"5018554","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Morag Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87533","size":1},{"color":"#336699","name":"Prof Chen Chen","data":{"first_name":"Chen","title":"Prof","dw_individual_id":"DW0024065","middle_name":"","last_name":"Chen","source_individual_id":"RMIS86822","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Chen Chen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83170","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61326","size":1},{"color":"#FF4D4D","name":"Australian Mouse Brain Mapping Consortium","data":{"media_summary":"neurological diseases","end_year":2012,"keywords":["brain imaging","immunohistochemistry","magnetic resonance imaging","neuroanatomy","transgenic animals"],"nhmrc_grant_id":436673,"application_year":2006,"health_keywords":["brain disease","mental illness","mental retardation","neurodegenerative disorders","neurological diseases"],"scientific_title":"Australian Mouse Brain Mapping Consortium","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof David Reutens","higher_grant_type":"NHMRC Enabling Grants","purl":"http://purl.org/au-research/grants/nhmrc/436673","simplified_title":"Australian Mouse Brain Mapping Consortium","sub_type":"Enabling Grant","total_budget":"2009462.12","source_system":"We propose to establish the Australian Mouse Brain Mapping Consortium which is a national network of facilities allowing Australian researchers to better characterise mouse models of neurological diseases such as Alzheimer's Disease and stroke. Just as accurate maps were key to the voyages of geographic discovery in the 17th and 18th century, improved methods of mapping structural and functional changes in the brain of mouse models of neurological disease will be key to discovery in the neurosciences in the 21st century . For the Consortium the cartographic tools will be magnetic resonance imaging (MRI), microscopy and sophisticated computational methods of mapping brain structure and function. Participants in the Consortium are internationally recognised leaders in brain imaging based at Monash University, the Howard Florey Institute, the Prince of Wales Medical Research Institute and the Centre for Magnetic Resonance and the Queensland Brain Institute, University of Queensland."},"children":[{"color":"#336699","name":"Prof David Reutens","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0045054","middle_name":"C","last_name":"Reutens","source_individual_id":"RMIS86404","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Reutens"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88664","size":1},{"color":"#336699","name":"Prof Graham Galloway","data":{"first_name":"Graham","title":"Prof","dw_individual_id":"DW0036756","middle_name":"J","last_name":"Galloway","source_individual_id":"5014770","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Graham Galloway"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86521","size":1},{"color":"#336699","name":"A/Pr Steven Petrou","data":{"first_name":"Steven","title":"A/Pr","dw_individual_id":"DW0033153","middle_name":"","last_name":"Petrou","source_individual_id":"5016955","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Steven Petrou"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85591","size":1},{"color":"#336699","name":"Prof George Paxinos","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0027259","middle_name":"","last_name":"Paxinos","source_individual_id":"5016895","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof George Paxinos"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84046","size":1},{"color":"#336699","name":"Prof Gary Egan","data":{"first_name":"Gary","title":"Prof","dw_individual_id":"DW0018843","middle_name":"F","last_name":"Egan","source_individual_id":"5014499","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gary Egan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81823","size":1},{"color":"#336699","name":"Prof Perry Bartlett","data":{"first_name":"Perry","title":"Prof","dw_individual_id":"DW0011651","middle_name":"Francis","last_name":"Bartlett","source_individual_id":"5013357","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Perry Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79864","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61236","size":1},{"color":"#FF4D4D","name":"Genetic control of embryonic lymphangiogenesis","data":{"media_summary":"","end_year":2011,"keywords":["Gene Discovery","Gene Function","Lymphangiogenesis","Model Organism","Molecular Regulation"],"nhmrc_grant_id":433628,"application_year":2006,"start_year":2007,"scientific_title":"Genetic control of embryonic lymphangiogenesis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Benjamin Hogan","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/433628","simplified_title":"Genetic control of embryonic lymphangiogenesis","sub_type":"CJ Martin Biomedical ECF","total_budget":"390250.08","source_system":""},"children":[{"color":"#336699","name":"Dr Benjamin Hogan","data":{"first_name":"Benjamin","title":"Dr","dw_individual_id":"DW0043083","middle_name":"M","last_name":"Hogan","source_individual_id":"5015278","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Benjamin Hogan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88165","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61158","size":1},{"color":"#FF4D4D","name":"Energetics of skeletal muscle working in series with compliant tendon","data":{"media_summary":"","end_year":2010,"keywords":["Ageing","Compliance","Energy","Muscle","Tendon"],"nhmrc_grant_id":428259,"application_year":2006,"start_year":2007,"scientific_title":"Energetics of skeletal muscle working in series with compliant tendon","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biomechanics","research_area":"Basic Science","for_category":"HUMAN MOVEMENT AND SPORTS SCIENCE","cia_name":"Dr Glen Lichtwark","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/428259","simplified_title":"Energetics of skeletal muscle working in series with compliant tendon","sub_type":"Peter Doherty Biomedical ECF","total_budget":"282258","source_system":""},"children":[{"color":"#336699","name":"Dr Glen Lichtwark","data":{"first_name":"Glen","title":"Dr","dw_individual_id":"DW0032092","middle_name":"Anthony","last_name":"Lichtwark","source_individual_id":"5015952","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Glen Lichtwark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85301","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61112","size":1},{"color":"#FF4D4D","name":"Molecular regulation of the type 1 angiotensin receptor","data":{"media_summary":"","end_year":2009,"keywords":["G protein-coupled receptors","angiotensin","arrestin","molecular pharmacology","receptor trafficking"],"nhmrc_grant_id":418921,"application_year":2006,"health_keywords":["blood pressure regulation","cardiovascular disease and hypertension","molecular basis of disease","pharmacology"],"scientific_title":"Molecular regulation of the type 1 angiotensin receptor","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Walter Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/418921","simplified_title":"Function of angiotensin receptors","sub_type":"Standard Project Grant","total_budget":"695440.08","source_system":"Angiotensin II is a hormone made in our bodies in response to a decrease in blood pressure (or salt in our bloodstream). It causes our blood vessels to constrict, makes us thirsty, and induces salt and fluid retention via an effect on the kidneys, thereby increasing blood pressure. In some cardiovascular diseases, the generation of angiotensin II or our sensitivity to this hormone is elevated. It is therefore crucial that we understand how angiotensin II works and how its actions in the body are mediated. For angiotensin II to act it must first bind to a receptor. Receptors are proteins and behave like locks that are opened by the hormone keys. Thus, cellular receptors for angiotensin II are engaged and activated by increases in angiotensin II in our blood. These receptors then produce signals which initiate a response (e.g. constriction of a blood vessel). Subsequently, the receptors are switched-off to prevent over-stimulation. The experiments proposed in this application continue our investigations into how angiotensin II receptors are switched-on and -off. A major way for receptors to be turned on is for them to interact with other cellular proteins, although we know only some of these interactions for the angiotensin receptor. Receptors are turned off by being ear-marked by a modification known as phosphorylation; these modified receptors are then bound by proteins termed arrestins, which as indicated by their name, play a role in preventing further receptor signalling. These arrestins also help to remove activated receptors from the cell surface to the inside of the cell. This application proposes new technologies to investigate the spectrum of proteins recruited to the angiotensin receptor and the role of arrestins in switching receptors on and off. Results from these studies will further our understanding of angiotensin II receptors and their role in cardiovascular control."},"children":[{"color":"#336699","name":"Prof Walter Thomas","data":{"first_name":"Walter","title":"Prof","dw_individual_id":"DW0028371","middle_name":"Glen","last_name":"Thomas","source_individual_id":"RMIS225046","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Walter Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84337","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/61007","size":1},{"color":"#FF4D4D","name":"Equipment Grant","data":{"media_summary":"","end_year":2007,"keywords":["Equipment"],"nhmrc_grant_id":467203,"application_year":2005,"start_year":2007,"scientific_title":"Equipment Grant","node_source":"NHMRC","node_type":"Grant","field_of_research":"n-a","research_area":"Not Applicable","for_category":"N-A","cia_name":"Mr Michael Tse","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/467203","simplified_title":"Equipment Grant","sub_type":"Equipment Grant","total_budget":"669769","source_system":""},"children":[{"color":"#336699","name":"Mr Michael Tse","data":{"first_name":"Michael","title":"Mr","dw_individual_id":"DW0016724","middle_name":"","last_name":"Tse","source_individual_id":"RMIS4747161","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mr Michael Tse"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81243","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60907","size":1},{"color":"#FF4D4D","name":"Assessment to Service Outcomes - Care pathways for older Australians with Dementia, CVD and Arthritis","data":{"media_summary":"","end_year":2009,"keywords":["CVD system and diseases","Health policy evaluation","Health related to ageing","Nervous system and disorders","Skeletal system and disorders"],"nhmrc_grant_id":410002,"application_year":2005,"start_year":2006,"scientific_title":"Assessment to Service Outcomes - Care pathways for older Australians with Dementia, CVD and Arthritis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Economics","research_area":"Health Services Research","for_category":"ECONOMICS","cia_name":"Prof Stephen Duckett","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/410002","simplified_title":"Care Pathways for Older Australians","sub_type":"Health Services Research","total_budget":"656029.2","source_system":"The project aims to use existing data source to answer questions similar to What happens to people after they have been assessed and recommended for aged care? in respect of service delivery for people with one of the three chronic conditions dementia, arthritis or cardiovascular disease. The project is to provide information about issues such as bed blockers and determine if the outcomes are different for people who have been assessed for aged care while they are in hospital. It is to chart changes in service use over time and examine factors that affect the type of care used by older people."},"children":[{"color":"#336699","name":"Stephen Duckett","data":{"first_name":"Stephen","title":"","dw_individual_id":"DW0024623","middle_name":"","last_name":"Duckett","source_individual_id":"RMIS119057","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Stephen Duckett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83318","size":1},{"color":"#336699","name":"Prof Diane Gibson","data":{"first_name":"Diane","title":"Prof","dw_individual_id":"DW0007470","middle_name":"M","last_name":"Gibson","source_individual_id":"RMIS613397","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Diane Gibson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78719","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60873","size":1},{"color":"#FF4D4D","name":"Simplified Process Methods for Mass Vaccine Manufacture","data":{"media_summary":"","end_year":2007,"keywords":["Biomanufacturing","Biomolecular Products","Influenza","Vaccination","Virus-like particle"],"nhmrc_grant_id":409976,"application_year":2005,"start_year":2006,"scientific_title":"Simplified Process Methods for Mass Vaccine Manufacture","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Basic Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Anton Middelberg","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/409976","simplified_title":"Simplified Vaccine Manufacture","sub_type":"Urgent Research - Pandemic Influenza - H5N1","total_budget":"158393.8","source_system":""},"children":[{"color":"#336699","name":"Dr Marcus Niebert","data":{"first_name":"Marcus","title":"Dr","dw_individual_id":"DW0032876","middle_name":"","last_name":"Niebert","source_individual_id":"RMIS4224713","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Marcus Niebert"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85518","size":1},{"color":"#336699","name":"Prof Anton Middelberg","data":{"first_name":"Anton","title":"Prof","dw_individual_id":"DW0026739","middle_name":"Peter Jacob","last_name":"Middelberg","source_individual_id":"RMIS4224699","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Anton Middelberg"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83925","size":1},{"color":"#336699","name":"Dr Linda Lua","data":{"first_name":"Linda","title":"Dr","dw_individual_id":"DW0003057","middle_name":"Hwee-Lin","last_name":"Lua","source_individual_id":"RMIS4224717","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Linda Lua"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77515","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60872","size":1},{"color":"#FF4D4D","name":"Avian Influenza - National perception of risks to paramedics and innovative ambulance service population-based models of","data":{"media_summary":"","end_year":2007,"keywords":["Behavioural epidemiology","Emergency medical services","Influenza","Predicting outbreak of disease","Risk assessment and management"],"nhmrc_grant_id":409973,"application_year":2005,"start_year":2006,"scientific_title":"Avian Influenza - National perception of risks to paramedics and innovative ambulance service population-based models of","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Public Health","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Ms Vivienne Tippett","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/409973","simplified_title":"Avian influenza - risk perception, triage and surveillance in the emergency prehospital sector","sub_type":"Urgent Research - Pandemic Influenza - H5N1","total_budget":"297909.8","source_system":""},"children":[{"color":"#336699","name":"A/Pr Frank Archer","data":{"first_name":"Frank","title":"A/Pr","dw_individual_id":"DW0040836","middle_name":"L","last_name":"Archer","source_individual_id":"RMIS4225487","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Frank Archer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87594","size":1},{"color":"#336699","name":"Prof Konrad Jamrozik","data":{"first_name":"Konrad","title":"Prof","dw_individual_id":"DW0031545","middle_name":"","last_name":"Jamrozik","source_individual_id":"RMIS112179","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Konrad Jamrozik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85166","size":1},{"color":"#336699","name":"Prof Frederick Burkle","data":{"first_name":"Frederick","title":"Prof","dw_individual_id":"DW0029693","middle_name":"M","last_name":"Burkle","source_individual_id":"RMIS4225532","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Frederick Burkle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84688","size":1},{"color":"#336699","name":"Vivienne Tippett","data":{"first_name":"Vivienne","title":"","dw_individual_id":"DW0022570","middle_name":"","last_name":"Tippett","source_individual_id":"RMIS4225479","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Vivienne Tippett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82807","size":1},{"color":"#336699","name":"Prof Heath Kelly","data":{"first_name":"Heath","title":"Prof","dw_individual_id":"DW0020053","middle_name":"A","last_name":"Kelly","source_individual_id":"RMIS1020487","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Heath Kelly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82111","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60871","size":1},{"color":"#FF4D4D","name":"Men, Women and Ageing: Predictors of Ageing Well in the Australian Longitudinal Study on Womens Health and the Perth He","data":{"media_summary":"","end_year":2012,"keywords":["Behavioural Epidemiology","Cardiovascular risk","Lifestlye and social determinants of health","Longitudinal Study","Morbidity"],"nhmrc_grant_id":409953,"application_year":2005,"start_year":2006,"scientific_title":"Men, Women and Ageing: Predictors of Ageing Well in the Australian Longitudinal Study on Womens Health and the Perth He","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Annette Dobson","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/409953","simplified_title":"Men, Women and Ageing: Predictors of Ageing Well in the Australian Longitudinal Study on Womens Health and the Perth He","sub_type":"ARC/NHMRC Ageing Well - Ageing Productively","total_budget":"1935634.81","source_system":"Maintaining health and independent living are high priorities for Australias rapidly expanding older population. This project capitalizes on two existing large-scale studies, to increase our scientific understanding of strategies for maintaining the health and wellbeing of older people living in the community. Two separate longitudinal research projects, the Australian Longitudinal Study on Womens Health involving over 12,000 older women selected from every part of Australia, and the Health in Men Study involving over 12,000 older men from Perth, Western Australia, have been following older Australians in order to determine what contributes to older peoples health and quality of life. The new project will combine data from these two studies. The two projects contain a breadth of data and can address the following questions: What health-related, personal, lifestyle and social factors predict survival and healthy non-disabled life in men and women aged 70-90 years? Do changes in lifestyle in older age (eg smoking cessation) affect length and quality of life? Who makes greatest use of health services, and who least, and how does this relate to health outcomes?How are health and lifestyle factors related to social connectedness and independent living in older age? What health and lifestyle factors predict positive mental health in older age? How are older mens and womens lifestyles and health status different, and how are they the same? Should health promotion programs in old age target men and women separately, or not?"},"children":[{"color":"#336699","name":"Prof Jonathan Adams","data":{"first_name":"Jonathan","title":"Prof","dw_individual_id":"DW0040733","middle_name":"","last_name":"Adams","source_individual_id":"RMIS1688445","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jonathan Adams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87562","size":1},{"color":"#336699","name":"Prof Annette Dobson","data":{"first_name":"Annette","title":"Prof","dw_individual_id":"DW0036318","middle_name":"J","last_name":"Dobson","source_individual_id":"5011952","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Annette Dobson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86411","size":1},{"color":"#336699","name":"Prof Paul Norman","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0032902","middle_name":"Edward","last_name":"Norman","source_individual_id":"5011883","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Norman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85524","size":1},{"color":"#336699","name":"Prof Konrad Jamrozik","data":{"first_name":"Konrad","title":"Prof","dw_individual_id":"DW0031545","middle_name":"","last_name":"Jamrozik","source_individual_id":"RMIS112179","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Konrad Jamrozik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85166","size":1},{"color":"#336699","name":"Prof Wendy Brown","data":{"first_name":"Wendy","title":"Prof","dw_individual_id":"DW0023824","middle_name":"J","last_name":"Brown","source_individual_id":"RMIS1714084","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wendy Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83116","size":1},{"color":"#336699","name":"Prof Osvaldo Almeida","data":{"first_name":"Osvaldo","title":"Prof","dw_individual_id":"DW0023309","middle_name":"P","last_name":"Almeida","source_individual_id":"RMIS145627","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Osvaldo Almeida"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83000","size":1},{"color":"#336699","name":"Prof Julie Byles","data":{"first_name":"Julie","title":"Prof","dw_individual_id":"DW0018047","middle_name":"Ellen","last_name":"Byles","source_individual_id":"5012165","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Julie Byles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81614","size":1},{"color":"#336699","name":"Prof Leon Flicker","data":{"first_name":"Leon","title":"Prof","dw_individual_id":"DW0013045","middle_name":"","last_name":"Flicker","source_individual_id":"RMIS145624","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Leon Flicker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80226","size":1},{"color":"#336699","name":"Prof Nancy Pachana","data":{"first_name":"Nancy","title":"Prof","dw_individual_id":"DW0003819","middle_name":"Ann","last_name":"Pachana","source_individual_id":"RMIS1713128","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Nancy Pachana"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77727","size":1},{"color":"#336699","name":"Prof Graeme Hankey","data":{"first_name":"Graeme","title":"Prof","dw_individual_id":"DW0002016","middle_name":"John","last_name":"Hankey","source_individual_id":"5012086","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Graeme Hankey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77214","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60869","size":1},{"color":"#FF4D4D","name":"Clinical application of arterial pressure waveform analyses: Role of exercise central blood pressure","data":{"media_summary":"","end_year":2009,"keywords":["Exercise","Hypertension","Myocardium","Vasculature"],"nhmrc_grant_id":409940,"application_year":2005,"start_year":2006,"scientific_title":"Clinical application of arterial pressure waveform analyses: Role of exercise central blood pressure","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr James Sharman","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/409940","simplified_title":"Clinical application of arterial pressure waveform analyses: Role of exercise central blood pressure","sub_type":"Australian Clincal Research ECF","total_budget":"276750","source_system":""},"children":[{"color":"#336699","name":"A/Pr James Sharman","data":{"first_name":"James","title":"A/Pr","dw_individual_id":"DW0010203","middle_name":"E","last_name":"Sharman","source_individual_id":"5019538","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr James Sharman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79465","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60868","size":1},{"color":"#FF4D4D","name":"Investigating paediatric respiratory control disorders using non-linear analysis","data":{"media_summary":"","end_year":2009,"keywords":["Chaos","non-linear","peadiatric","respiratory control","sleep disorders"],"nhmrc_grant_id":409938,"application_year":2005,"start_year":2006,"scientific_title":"Investigating paediatric respiratory control disorders using non-linear analysis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Instruments and Techniques","research_area":"Clinical Medicine and Science","for_category":"OTHER PHYSICAL SCIENCES","cia_name":"Mr Phillip Terrill","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409938","simplified_title":"Investigating paediatric respiratory control disorders using non-linear analysis","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"69912.44","source_system":""},"children":[{"color":"#336699","name":"Dr Philip Terrill","data":{"first_name":"Philip","title":"Dr","dw_individual_id":"DW0016606","middle_name":"Ian","last_name":"Terrill","source_individual_id":"RMIS4013862","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Philip Terrill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81214","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60867","size":1},{"color":"#FF4D4D","name":"Investigation of Adiponectin Receptor Structure and Function","data":{"media_summary":"","end_year":2007,"keywords":["AdipoR1","AdipoR2","Adiponectin","Insulin resistance","Metabolic"],"nhmrc_grant_id":409937,"application_year":2005,"start_year":2006,"scientific_title":"Investigation of Adiponectin Receptor Structure and Function","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Ms Hayley Charlton","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409937","simplified_title":"Investigation of Adiponectin Receptor Structure and Function","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"43097","source_system":""},"children":[{"color":"#336699","name":"Hayley Charlton","data":{"first_name":"Hayley","title":"","dw_individual_id":"DW0029887","middle_name":"","last_name":"Charlton","source_individual_id":"RMIS4013853","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Hayley Charlton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84737","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60866","size":1},{"color":"#FF4D4D","name":"Angiogenesis: Towards a cure for Coronary Artery Disease and Ischaemic Heart Failure","data":{"media_summary":"","end_year":2009,"keywords":["Angiogenesis","Coronary Artery Disease","Heart Failure","Preventive Medicine"],"nhmrc_grant_id":409936,"application_year":2005,"start_year":2006,"scientific_title":"Angiogenesis: Towards a cure for Coronary Artery Disease and Ischaemic Heart Failure","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Michael Hoenig","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409936","simplified_title":"Angiogenesis: Towards a cure for Coronary Artery Disease and Ischaemic Heart Failure","sub_type":"Medical Postgraduate Scholarship","total_budget":"110383.69","source_system":""},"children":[{"color":"#336699","name":"Dr Michael Hoenig","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0025528","middle_name":"","last_name":"Hoenig","source_individual_id":"RMIS3924608","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Michael Hoenig"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83576","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60865","size":1},{"color":"#FF4D4D","name":"Optimising immunotherapy for chrinic viral infection","data":{"media_summary":"","end_year":2008,"keywords":["Human papilloma virus","Immunology","Vaccine"],"nhmrc_grant_id":409935,"application_year":2005,"start_year":2006,"scientific_title":"Optimising immunotherapy for chrinic viral infection","node_source":"NHMRC","node_type":"Grant","field_of_research":"Tumour Immunology","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Dr Jennifer broom","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409935","simplified_title":"Optimising immunotherapy for chrinic viral infection","sub_type":"Medical Postgraduate Scholarship","total_budget":"94025","source_system":""},"children":[{"color":"#336699","name":"Jennifer Broom","data":{"first_name":"Jennifer","title":"","dw_individual_id":"DW0017940","middle_name":"","last_name":"Broom","source_individual_id":"RMIS4013825","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Jennifer Broom"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81587","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60864","size":1},{"color":"#FF4D4D","name":"An Investigation of pharmacokinetic/pharmacodynamic characheristics of various betalactam antibotics in parents with sep","data":{"media_summary":"","end_year":2008,"keywords":["Beta-Lactam Antibiotics","Microdialysis","Pharmacokinetics","Sepsis"],"nhmrc_grant_id":409931,"application_year":2005,"start_year":2006,"scientific_title":"An Investigation of pharmacokinetic/pharmacodynamic characheristics of various betalactam antibotics in parents with sep","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Mr Jason Roberts","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409931","simplified_title":"An Investigation of pharmacokinetic/pharmacodynamic characheristics of various betalactam antibotics in parents with sep","sub_type":"Public Health Postgraduate Scholarship","total_budget":"68451.95","source_system":""},"children":[{"color":"#336699","name":"Prof Jason Roberts","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0033443","middle_name":"A","last_name":"Roberts","source_individual_id":"5017212","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jason Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85657","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60863","size":1},{"color":"#FF4D4D","name":"Neuromuscular effects and adaptions to anti-pronation taping: A neurophysiological approach to anti-pronation taping and","data":{"media_summary":"","end_year":2009,"keywords":["Musculoskeletal Pain Injury","Neuromuscular","Neurophysiological","Physical Therapy","Tape and Foot Orthoses"],"nhmrc_grant_id":409925,"application_year":2005,"start_year":2006,"scientific_title":"Neuromuscular effects and adaptions to anti-pronation taping: A neurophysiological approach to anti-pronation taping and","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Miss Melinda FRANETTOVICH","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409925","simplified_title":"Neuromuscular effects and adaptions to anti-pronation taping: A neurophysiological approach to anti-pronation taping and","sub_type":"Public Health Postgraduate Scholarship","total_budget":"97688.09","source_system":""},"children":[{"color":"#336699","name":"Melinda Franettovich","data":{"first_name":"Melinda","title":"","dw_individual_id":"DW0036691","middle_name":"","last_name":"Franettovich","source_individual_id":"RMIS4013757","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Melinda Franettovich"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86507","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60862","size":1},{"color":"#FF4D4D","name":"G-Protein coupled receptor-medicated Ca2+ sigalling and plasma membrane Ca2+ ATpase: molecular basis for regulation of C","data":{"media_summary":"","end_year":2007,"keywords":["Ca2+ sigalling","G-Protein coupled receptors","PDZ","PMCA"],"nhmrc_grant_id":409922,"application_year":2005,"start_year":2006,"scientific_title":"G-Protein coupled receptor-medicated Ca2+ sigalling and plasma membrane Ca2+ ATpase: molecular basis for regulation of C","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Mr Wade Kruger","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409922","simplified_title":"G-Protein coupled receptor-medicated Ca2+ sigalling and plasma membrane Ca2+ ATpase: molecular basis for regulation of C","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"32193.95","source_system":""},"children":[{"color":"#336699","name":"Mr Wade Kruger","data":{"first_name":"Wade","title":"Mr","dw_individual_id":"DW0014279","middle_name":"Andrew","last_name":"Kruger","source_individual_id":"RMIS4013705","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mr Wade Kruger"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80555","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60861","size":1},{"color":"#FF4D4D","name":"Targeting the cortex via physiotherapy for complex regional pain syndrome and stroke","data":{"media_summary":"","end_year":2006,"keywords":["CRPS","Central nervous system","Chronic Pain","Rehabilitation","Stroke"],"nhmrc_grant_id":409919,"application_year":2005,"start_year":2006,"scientific_title":"Targeting the cortex via physiotherapy for complex regional pain syndrome and stroke","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Ms Nicole Acerra","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409919","simplified_title":"Targeting the cortex via physiotherapy for complex regional pain syndrome and stroke","sub_type":"Public Health Postgraduate Scholarship","total_budget":"26817","source_system":""},"children":[{"color":"#336699","name":"Nicole Acerra","data":{"first_name":"Nicole","title":"","dw_individual_id":"DW0011369","middle_name":"","last_name":"Acerra","source_individual_id":"RMIS4013563","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Nicole Acerra"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79789","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60860","size":1},{"color":"#FF4D4D","name":"Liposomal delivery of RNA inhibitory nucleotides for treatment of cervical cancer","data":{"media_summary":"","end_year":2009,"keywords":["Cervical Cancer","Delivery of siRNA","Gene delivery","Liposome","RNA interference"],"nhmrc_grant_id":409918,"application_year":2005,"start_year":2006,"scientific_title":"Liposomal delivery of RNA inhibitory nucleotides for treatment of cervical cancer","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmaceutical Sciences and Pharmacy","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"A/Pr Sherry WU","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409918","simplified_title":"Liposomal delivery of RNA inhibitory nucleotides for treatment of cervical cancer","sub_type":"Public Health Postgraduate Scholarship","total_budget":"96790.69","source_system":""},"children":[{"color":"#336699","name":"Sherry Wu","data":{"first_name":"Sherry","title":"","dw_individual_id":"DW0046410","middle_name":"","last_name":"Wu","source_individual_id":"RMIS4013503","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Sherry Wu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/89023","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60859","size":1},{"color":"#FF4D4D","name":"Regulation of cadherin function by PTEN and c-Src","data":{"media_summary":"","end_year":2008,"keywords":["Cell Adhesion","E-caderin","Metastasis","PTEN","Src"],"nhmrc_grant_id":409915,"application_year":2005,"start_year":2006,"scientific_title":"Regulation of cadherin function by PTEN and c-Src","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Ms Angela JEANES","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409915","simplified_title":"Regulation of cadherin function by PTEN and c-Src","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"54255.99","source_system":""},"children":[{"color":"#336699","name":"Dr Angela Jeanes","data":{"first_name":"Angela","title":"Dr","dw_individual_id":"DW0008155","middle_name":"","last_name":"Jeanes","source_individual_id":"RMIS4013350","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Angela Jeanes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78901","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60858","size":1},{"color":"#FF4D4D","name":"Characterisation of RANKL gene regulation in T cells and its role in bone erosion","data":{"media_summary":"","end_year":2009,"keywords":["NFAT","RA","RANKL","T Cells"],"nhmrc_grant_id":409914,"application_year":2005,"start_year":2006,"scientific_title":"Characterisation of RANKL gene regulation in T cells and its role in bone erosion","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rheumatology and Arthritis","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Miss Kylie Alexander","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409914","simplified_title":"Characterisation of RANKL gene regulation in T cells and its role in bone erosion","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"76723.56","source_system":""},"children":[{"color":"#336699","name":"Dr Kylie Alexander","data":{"first_name":"Kylie","title":"Dr","dw_individual_id":"DW0005766","middle_name":"Anne","last_name":"Alexander","source_individual_id":"RMIS4013275","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Kylie Alexander"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78274","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60857","size":1},{"color":"#FF4D4D","name":"Role of Macrophages residing on the bone surface in bone renodelling and repair","data":{"media_summary":"","end_year":2009,"keywords":["Bone","Macrophage","Repair"],"nhmrc_grant_id":409913,"application_year":2005,"start_year":2006,"scientific_title":"Role of Macrophages residing on the bone surface in bone renodelling and repair","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Miss Ming-Kang CHANG","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409913","simplified_title":"Role of Macrophages residing on the bone surface in bone renodelling and repair","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"54466.56","source_system":"To determine if the F4-80+ macrophages that reside on the bone surface, bone lining macrophages (BLMs) are responsible for the detection of apoptotic osteocyte cells and subsequently initiate bone remodelling in response to bone damage."},"children":[{"color":"#336699","name":"Ming-Kang Chang","data":{"first_name":"Ming-Kang","title":"","dw_individual_id":"DW0006496","middle_name":"","last_name":"Chang","source_individual_id":"RMIS4013261","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ming-Kang Chang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78462","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60856","size":1},{"color":"#FF4D4D","name":"Drug design and development using cyclic cystine knots","data":{"media_summary":"","end_year":2007,"keywords":["Cyclotide","Design","Development","Drug","Peptide"],"nhmrc_grant_id":409903,"application_year":2005,"start_year":2006,"scientific_title":"Drug design and development using cyclic cystine knots","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides","research_area":"Clinical Medicine and Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Mr David Ireland","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409903","simplified_title":"Drug design and development using cyclic cystine knots","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"32193.95","source_system":""},"children":[{"color":"#336699","name":"David Ireland","data":{"first_name":"David","title":"","dw_individual_id":"DW0031498","middle_name":"","last_name":"Ireland","source_individual_id":"RMIS4012753","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Ireland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85156","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60854","size":1},{"color":"#FF4D4D","name":"Treating Burn injuries: First-aid and alternative therapies","data":{"media_summary":"","end_year":2009,"keywords":["Burn","First-aid","Scar","Wound Healing"],"nhmrc_grant_id":409902,"application_year":2005,"start_year":2006,"scientific_title":"Treating Burn injuries: First-aid and alternative therapies","node_source":"NHMRC","node_type":"Grant","field_of_research":"Surgery","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Ms Leila Cuttle","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409902","simplified_title":"Treating Burn injuries: First-aid and alternative therapies","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"76661.44","source_system":""},"children":[{"color":"#336699","name":"Dr Leila Cuttle","data":{"first_name":"Leila","title":"Dr","dw_individual_id":"DW0041866","middle_name":"","last_name":"Cuttle","source_individual_id":"RMIS4012745","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Leila Cuttle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87861","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60853","size":1},{"color":"#FF4D4D","name":"The Role of patched-1 in Epithelia","data":{"media_summary":"","end_year":2007,"keywords":["Cancer","Growth","Hedgehog","Homeostasis","Skin"],"nhmrc_grant_id":409901,"application_year":2005,"start_year":2006,"scientific_title":"The Role of patched-1 in Epithelia","node_source":"NHMRC","node_type":"Grant","field_of_research":"n-a","research_area":"Basic Science","for_category":"N-A","cia_name":"Miss Rehan Villani","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/409901","simplified_title":"The Role of patched-1 in Epithelia","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"43097","source_system":""},"children":[{"color":"#336699","name":"Miss Rehan Villani","data":{"first_name":"Rehan","title":"Miss","dw_individual_id":"DW0040248","middle_name":"M","last_name":"Villani","source_individual_id":"RMIS4012718","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Miss Rehan Villani"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87426","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60852","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2010,"keywords":["Asthma Mechanics","Asthma Prevention","Children's Environmental Health","Cystic Fibrosis","Respiratory Physiology"],"nhmrc_grant_id":403911,"application_year":2005,"start_year":2006,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Sciences not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Peter Sly","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/403911","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"751161","source_system":""},"children":[{"color":"#336699","name":"Prof Peter Sly","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0028010","middle_name":"David","last_name":"Sly","source_individual_id":"5011929","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Sly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84226","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60742","size":1},{"color":"#FF4D4D","name":"The public health significance of echinococcosis: disease burden & new strategies impacting on control.","data":{"media_summary":"","end_year":2009,"keywords":["Burden of disease","Echinococcosis","Epidemiology","Mathematic models","Population health"],"nhmrc_grant_id":401795,"application_year":2005,"start_year":2006,"scientific_title":"The public health significance of echinococcosis: disease burden & new strategies impacting on control.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Yu Yang","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401795","simplified_title":"The public health significance of echinococcosis: disease burden & new strategies impacting on control.","sub_type":"Public Health (Australia) ECF","total_budget":"304250","source_system":""},"children":[{"color":"#336699","name":"Dr Yurong Yang","data":{"first_name":"Yurong","title":"Dr","dw_individual_id":"DW0023131","middle_name":"","last_name":"Yang","source_individual_id":"5019942","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Yurong Yang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82960","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60603","size":1},{"color":"#FF4D4D","name":"A proteomic approach to the identification of novel virulence factors in Neisseria meningitidis and Neisseria gonorrhoeae.","data":{"media_summary":"","end_year":2010,"keywords":["gene regulation","oxidative stress","pathogenic neisseria","pathogenicity","proteomics"],"nhmrc_grant_id":401794,"application_year":2005,"start_year":2006,"scientific_title":"A proteomic approach to the identification of novel virulence factors in Neisseria meningitidis and Neisseria gonorrhoeae.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Hilda Wu","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401794","simplified_title":"A proteomic approach to the identification of novel virulence factors in Neisseria meningitidis and Neisseria gonorrhoeae.","sub_type":"CJ Martin Biomedical ECF","total_budget":"234502","source_system":""},"children":[{"color":"#336699","name":"Dr Hilda Wu","data":{"first_name":"Hilda","title":"Dr","dw_individual_id":"DW0034858","middle_name":"H-J","last_name":"Wu","source_individual_id":"5018494","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Hilda Wu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86028","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60602","size":1},{"color":"#FF4D4D","name":"The Role of a Conserved Polarity Complex in Tubulogenesis.","data":{"media_summary":"","end_year":2012,"keywords":["Cyst polarity","EMT","Par3-Par6-aPKC","epithelial polarity","tubulogenesis"],"nhmrc_grant_id":401782,"application_year":2005,"start_year":2006,"scientific_title":"The Role of a Conserved Polarity Complex in Tubulogenesis.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Annette Shewan","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401782","simplified_title":"The Role of a Conserved Polarity Complex in Tubulogenesis.","sub_type":"CJ Martin Biomedical ECF","total_budget":"344460.26","source_system":""},"children":[{"color":"#336699","name":"Dr Annette Shewan","data":{"first_name":"Annette","title":"Dr","dw_individual_id":"DW0045407","middle_name":"M","last_name":"Shewan","source_individual_id":"5017492","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Annette Shewan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88743","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60601","size":1},{"color":"#FF4D4D","name":"Impact of prenatal growth on nitric oxide-regulation of cerbrovascular function, sensitivity hypoxic/ischemic brain inju","data":{"media_summary":"","end_year":2008,"keywords":["Cerebrovascular","Intrauterine growth restriction","Nitric Oxide","Perinatal brain injury","Piglet"],"nhmrc_grant_id":401781,"application_year":2005,"start_year":2006,"scientific_title":"Impact of prenatal growth on nitric oxide-regulation of cerbrovascular function, sensitivity hypoxic/ischemic brain inju","node_source":"NHMRC","node_type":"Grant","field_of_research":"Systems Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Ms Sarah Williams","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401781","simplified_title":"Impact of prenatal growth on nitric oxide-regulation of cerbrovascular function, sensitivity hypoxic/ischemic brain inj","sub_type":"Peter Doherty Biomedical ECF","total_budget":"170000","source_system":""},"children":[{"color":"#336699","name":"Ms Sarah Williams","data":{"first_name":"Sarah","title":"Ms","dw_individual_id":"DW0011095","middle_name":"J","last_name":"Williams","source_individual_id":"RMIS3987235","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Sarah Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79718","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60600","size":1},{"color":"#FF4D4D","name":"What is the place of IMETs in difficult to research clinical conditions: palliative care as a case study","data":{"media_summary":"","end_year":2011,"keywords":["Clinical decision making","Pain and symptom control","Palliative care","Single patient trials","n-of-1 trials"],"nhmrc_grant_id":401780,"application_year":2005,"start_year":2007,"scientific_title":"What is the place of IMETs in difficult to research clinical conditions: palliative care as a case study","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Jane Nikles","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401780","simplified_title":"What is the place of IMETs in difficult to research clinical conditions: palliative care as a case study","sub_type":"Australian Clincal Research ECF","total_budget":"378009.86","source_system":""},"children":[{"color":"#336699","name":"Dr Jane Nikles","data":{"first_name":"Jane","title":"Dr","dw_individual_id":"DW0021162","middle_name":"","last_name":"Nikles","source_individual_id":"5023242","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jane Nikles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82422","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60599","size":1},{"color":"#FF4D4D","name":"Improving immunotherapy by inhibiting Il-10 mediated immune deviation","data":{"media_summary":"","end_year":2006,"keywords":["Cytokines","Immunotherapy","Vaccines"],"nhmrc_grant_id":401779,"application_year":2005,"start_year":2006,"scientific_title":"Improving immunotherapy by inhibiting Il-10 mediated immune deviation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Ian Frazer","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/401779","simplified_title":"Better therapeutic vaccines using IL-10 inhibitors","sub_type":"Development Grant","total_budget":"90500","source_system":""},"children":[{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1},{"color":"#336699","name":"Dr Xiaosong Liu","data":{"first_name":"Xiaosong","title":"Dr","dw_individual_id":"DW0038100","middle_name":"","last_name":"Liu","source_individual_id":"RMIS4445093","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Xiaosong Liu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86872","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60598","size":1},{"color":"#FF4D4D","name":"Sensitise cervical cancer cells to shRNA-mediated gene silence","data":{"media_summary":"","end_year":2009,"keywords":["Apoptosis","Cervical cancer","HPV E6/E7","Lentiviral","RNA interference"],"nhmrc_grant_id":401773,"application_year":2005,"start_year":2006,"scientific_title":"Sensitise cervical cancer cells to shRNA-mediated gene silence","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Therapy","research_area":"Basic Science","for_category":"BIOTECHNOLOGY","cia_name":"Dr Wenyi Gu","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401773","simplified_title":"Sensitise cervical cancer cells to shRNA-mediated gene silence","sub_type":"Peter Doherty Biomedical ECF","total_budget":"274250","source_system":""},"children":[{"color":"#336699","name":"Dr Wenyi Gu","data":{"first_name":"Wenyi","title":"Dr","dw_individual_id":"DW0042774","middle_name":"","last_name":"Gu","source_individual_id":"RMIS5507911","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Wenyi Gu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88086","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60597","size":1},{"color":"#FF4D4D","name":"The characterisation of Ras signalling and ageing mechanisms using the C.elegans and mammalian model systems.","data":{"media_summary":"","end_year":2010,"keywords":["C.elegans","Ras","ageing","cancer","scaffold proteins"],"nhmrc_grant_id":401765,"application_year":2005,"start_year":2006,"scientific_title":"The characterisation of Ras signalling and ageing mechanisms using the C.elegans and mammalian model systems.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Other","research_area":"Clinical Medicine and Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Dr Angus Harding","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401765","simplified_title":"The characterisation of Ras signalling and ageing mechanisms using the C.elegans and mammalian model systems.","sub_type":"CJ Martin Biomedical ECF","total_budget":"297308.66","source_system":""},"children":[{"color":"#336699","name":"Dr Angus Harding","data":{"first_name":"Angus","title":"Dr","dw_individual_id":"DW0037105","middle_name":"S","last_name":"Harding","source_individual_id":"5015071","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Angus Harding"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86603","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60596","size":1},{"color":"#FF4D4D","name":"The role of Nfi genes in development of the corpus callosum.","data":{"media_summary":"","end_year":2008,"keywords":["Nfi genes","axon guidance","brain development","corpus callosum","cortical development"],"nhmrc_grant_id":401760,"application_year":2005,"start_year":2006,"scientific_title":"The role of Nfi genes in development of the corpus callosum.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Michael Piper","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401760","simplified_title":"The role of Nfi genes in development of the corpus callosum.","sub_type":"Howard Florey Centenary ECF","total_budget":"173875","source_system":""},"children":[{"color":"#336699","name":"Dr Michael Piper","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0021487","middle_name":"J","last_name":"Piper","source_individual_id":"RMIS3987189","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Michael Piper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82523","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60594","size":1},{"color":"#FF4D4D","name":"A life course approach to depression, psychological distress and substance misuse","data":{"media_summary":"","end_year":2006,"keywords":["depression","psychological","substance abuse"],"nhmrc_grant_id":401759,"application_year":2005,"start_year":2006,"scientific_title":"A life course approach to depression, psychological distress and substance misuse","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Rosa Alati","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401759","simplified_title":"A life course approach to depression, psychological distress and substance misuse","sub_type":"Traveling Award for ECF","total_budget":"13700.6","source_system":""},"children":[{"color":"#336699","name":"A/Pr Rosa Alati","data":{"first_name":"Rosa","title":"A/Pr","dw_individual_id":"DW0005759","middle_name":"","last_name":"Alati","source_individual_id":"RMIS2639340","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Rosa Alati"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78272","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60593","size":1},{"color":"#FF4D4D","name":"Nur77 and skeltal muscle: new targets in metabolic disease","data":{"media_summary":"","end_year":2008,"keywords":["Biological sciences","Cardiovascular diseas","Dyslipidemia","Endocrine diseases and diabetes","Obesity"],"nhmrc_grant_id":401757,"application_year":2005,"start_year":2007,"scientific_title":"Nur77 and skeltal muscle: new targets in metabolic disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Sciences not elsewhere classified","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Megan Maxwell","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401757","simplified_title":"Nur77 and skeltal muscle: new targets in metabolic disease","sub_type":"Peter Doherty Biomedical ECF","total_budget":"119562.5","source_system":""},"children":[{"color":"#336699","name":"Dr Megan Maxwell","data":{"first_name":"Megan","title":"Dr","dw_individual_id":"DW0008957","middle_name":"A","last_name":"Maxwell","source_individual_id":"RMIS3987103","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Megan Maxwell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79126","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60592","size":1},{"color":"#FF4D4D","name":"Activation and regulation of pro-inflammotory caspases","data":{"media_summary":"","end_year":2010,"keywords":["Cancer","Proteins"],"nhmrc_grant_id":401748,"application_year":2005,"start_year":2006,"scientific_title":"Activation and regulation of pro-inflammotory caspases","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Dr Justine Hill","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401748","simplified_title":"Activation and regulation of pro-inflammotory caspases","sub_type":"RD Wright Biomedical CDF","total_budget":"462290","source_system":""},"children":[{"color":"#336699","name":"Dr Justine Hill","data":{"first_name":"Justine","title":"Dr","dw_individual_id":"DW0013656","middle_name":"Maria","last_name":"Hill","source_individual_id":"RMIS706133","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Justine Hill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80384","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60591","size":1},{"color":"#FF4D4D","name":"Excitatory synaptic transmission and plasticity in the amygdala","data":{"media_summary":"","end_year":2010,"keywords":["Neurological Disorders"],"nhmrc_grant_id":401739,"application_year":2005,"start_year":2006,"scientific_title":"Excitatory synaptic transmission and plasticity in the amygdala","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Elizabeth Louise Faber","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401739","simplified_title":"Excitatory synaptic transmission and plasticity in the amygdala","sub_type":"RD Wright Biomedical CDF","total_budget":"462290","source_system":""},"children":[{"color":"#336699","name":"Dr Elizabeth Louise Faber","data":{"first_name":"Elizabeth Louise","title":"Dr","dw_individual_id":"DW0030604","middle_name":"Sophie","last_name":"Faber","source_individual_id":"RMIS3123369","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Elizabeth Louise Faber"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84950","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60589","size":1},{"color":"#FF4D4D","name":"Molecular mechanisms of Glucocorticoid control of baby growth and development","data":{"media_summary":"","end_year":2011,"keywords":["baby growth and development","glucocorticoid control","molecular mechanisms"],"nhmrc_grant_id":401738,"application_year":2005,"start_year":2006,"scientific_title":"Molecular mechanisms of Glucocorticoid control of baby growth and development","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Gary Leong","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401738","simplified_title":"Molecular mechanisms of Glucocorticoid control of baby growth and development","sub_type":"Clinical CDF","total_budget":"234424.36","source_system":""},"children":[{"color":"#336699","name":"Dr Gary Leong","data":{"first_name":"Gary","title":"Dr","dw_individual_id":"DW0020356","middle_name":"Martin","last_name":"Leong","source_individual_id":"RMIS1096296","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Gary Leong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82200","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60588","size":1},{"color":"#FF4D4D","name":"ERRgamma and skeletal muscle: insights into lipid utilization and catabolism","data":{"media_summary":"Obesity","end_year":2008,"keywords":["Fatty Acid and Lipid Metabolism","Gene Regulation","Skeletal Muscle","Steroid (and Nuclear) Hormone Receptors","Transcription"],"nhmrc_grant_id":401734,"application_year":2005,"health_keywords":["Biological Sciences","Cardiovascular Disease","Diabetes","Dyslipidaemia","Obesity"],"scientific_title":"ERRgamma and skeletal muscle: insights into lipid utilization and catabolism","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401734","simplified_title":"Regulation of fat and energy metabolism in muscle","sub_type":"Standard Project Grant","total_budget":"357936.08","source_system":"The significance of Nuclear hormone receptors (NRs) in disease is underscored by the range of pharmacopoeia for the treatment of NR-associated disorders (e.g 16% of the top 100 drugs target NRs). ERRgamma receptors are abundantly expressed in skeletal muscle, a major mass periperal tissue that acconts for ~40% of total body weight, and energy expenditure. Muscle is the major site of glucose metabolism and, fatty acid oxidation. Consequently, it has a significant role in insulin sensitivity, the blood lipid profile, lipid metabolism and obesity. Understanding the functional role of the orphan ERR receptors in skeletal muscle in the context of inflammation, lipid and energy homeostasis is of paramount importance in further understanding the mechanistic basis of dyslipidemia, chronic inflammation, insulin sensitivity, diabetes and obesity. Identification of novel ERRgamma targets that regulate metabolism in a major mass peripheral tissue, and positively influence the risk factors for cardiovascular disease, provides platforms for potential therapeutic intervention. Cardiovascular disease is the foremost cause of global mortality, and was responsible for >15 million deaths in 2003."},"children":[{"color":"#336699","name":"Dr Shu Ching Wang","data":{"first_name":"Shu Ching","title":"Dr","dw_individual_id":"DW0040321","middle_name":"M","last_name":"Wang","source_individual_id":"RMIS3709673","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Shu Ching Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87445","size":1},{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60587","size":1},{"color":"#FF4D4D","name":"Molecular genetics of the host response defect in cystic fibrosis","data":{"media_summary":"","end_year":2008,"keywords":["airway diseases","conditional gene targeting","developmental genes","molecular genetics","mouse genetics"],"nhmrc_grant_id":401724,"application_year":2005,"health_keywords":["cystic fibrosis","genetic disease","inflammation"],"scientific_title":"Molecular genetics of the host response defect in cystic fibrosis","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401724","simplified_title":"Genes which alter the lung disease in cystic fibrosis","sub_type":"Standard Project Grant","total_budget":"564690.64","source_system":"Cystic fibrosis is the most common lethal genetic disease in Caucasian populations. Affected individuals suffer from a number of symptoms but the most serious is a chronic infect with the bacterial pathogen Pseudomonas aeruginosa. The sustained lung inflammation caused by infection with Pseudomonas aeruginosa ultimately destroys the structure of the lung to the point where it can no longer function. Gene therapy has been suggested as a possible treatment for the disease but another approach is to identify the CF specific aspects of the inflammatory response and target those for therapeutic development. In our previous work we have identified several strong candidates for the inflammatory molecules in the CF lung and in this application we will test those candidates to see whether they play a major role in CF lung disease."},"children":[{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1},{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60586","size":1},{"color":"#FF4D4D","name":"Urinary tract E. coli: the good guys versus the bad guys","data":{"media_summary":"","end_year":2008,"keywords":["biofilm","gene regulation","pathogenesis","urinary bladder","vaccine development"],"nhmrc_grant_id":401714,"application_year":2005,"health_keywords":["bacterial pathogenicity","bacterial virulence factors","biofilm contamination on instruments and implants","urinary tract infection"],"scientific_title":"Urinary tract E. coli: the good guys versus the bad guys","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Mark Schembri","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401714","simplified_title":"Urinary tract E. coli: the good guys versus the bad guys","sub_type":"Standard Project Grant","total_budget":"296150.52","source_system":"Escherichia coli is the primary cause of urinary tract infection (UTI) in the developed world. In Australia alone, E. coli affects more than 250,000 yearly to the extent where they require medical intervention. It is estimated that one in four women and one in twenty men will develop a UTI in their lifetime and in the USA UTIs result in $1.6 billion in medical expenses each year. Uropathogenic E. coli (UPEC) strains readily form biofilms on indwelling catheters and recent evidence suggests that they also form biofilm-like aggregates in the bladder. No treatment other than antibiotics (often inefficient due to resistance) is currently available. E. coli is also the most frequent cause of asymptomatic bacteriuria (ABU). ABU occurs in up to 6% of healthy individuals and affects high risk groups such as the elderly and diabetics. In general, most patients with ABU do not need treatment and in many cases the colonizing organism actually helps to prevent infection by other more virulent bacteria. The aim of this project is to compare UPEC and ABU E. coli for differences associated with virulence and biofilm growth. The project will generate a comprehensive and defined strain bank relative to E. coli that cause UTI. Understanding biofilm growth by this organism may lead to the development of improved and-or novel treatments. Furthermore, increased knowledge of ABU E. coli is essential if we are to fully explore the possibility of employing these organisms as probiotic agents to prevent infection by other pathogens in specific high risk patient groups."},"children":[{"color":"#336699","name":"Prof Per Klemm","data":{"first_name":"Per","title":"Prof","dw_individual_id":"DW0031803","middle_name":"","last_name":"Klemm","source_individual_id":"5015726","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Per Klemm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85231","size":1},{"color":"#336699","name":"Prof Mark Schembri","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0016088","middle_name":"A","last_name":"Schembri","source_individual_id":"5017368","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Schembri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81054","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60585","size":1},{"color":"#FF4D4D","name":"Altered hepatic pharmacokinetics as a consequence of drug- and disease-induced changes in hepatic vascularity.","data":{"media_summary":"Non-alcoholic steatohepatitis","end_year":2008,"keywords":["Cardiovascular disease","Liver disease","Modelling","Pharmacokinetics","Vasoactive drugs"],"nhmrc_grant_id":401702,"application_year":2005,"health_keywords":["Atherosclerosis","Heart failure","Hypertension","Liver cirrhosis","Non-alcoholic steatohepatitis"],"scientific_title":"Altered hepatic pharmacokinetics as a consequence of drug- and disease-induced changes in hepatic vascularity.","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmaceutical Sciences and Pharmacy","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Michael Roberts","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401702","simplified_title":"Pharmacokinetics and liver vascularity.","sub_type":"Standard Project Grant","total_budget":"498088.1","source_system":"Many drugs are broken down by the liver or are removed from the liver out into the intestine by the bile, as well as being removed by the kidney and other organs. The effectiveness of the breakdown and removal by the liver depends both on whether the drug can get into the liver cells and on how well the enzymes in the liver are working. Cardiovascular and liver diseases and certain drugs can affect both of these processes. This work is concentrating on those processes which mainly affect the uptake process. The diseases of most interest are liver cirrhosis, fatty liver disease, atherosclerosis and chronic heart failure, all of which together are leading causes of death in Western countries. They are also associated with liver dysfunction due to effects on liver vessels. We have a poor understanding of how the effects of these diseases and a number of drugs on liver vessels affect the functioning of the liver, especially in terms of how they affect drug breakdown or removal of drugs. This project seeks to understand these effects and proposes a number of animal studies as well as human studies to provide insight. The drugs to be studied are those most commonly used in patients with cardiovascular and liver diseases, as one of our main goals is to provide better therapeutic management in these patients."},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1},{"color":"#336699","name":"Dr Daniel Hung","data":{"first_name":"Daniel","title":"Dr","dw_individual_id":"DW0025646","middle_name":"Y","last_name":"Hung","source_individual_id":"RMIS3182892","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Daniel Hung"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83604","size":1},{"color":"#336699","name":"Prof Darrell Crawford","data":{"first_name":"Darrell","title":"Prof","dw_individual_id":"DW0006770","middle_name":"Henry Gordon","last_name":"Crawford","source_individual_id":"5012156","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Darrell Crawford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78535","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60584","size":1},{"color":"#FF4D4D","name":"Phenotypic studies of the NaSi-1 transporter knock-out   mouse","data":{"media_summary":"","end_year":2008,"keywords":["membrane transport","murine model","pathophysiology","sulfate homeostasis","sulfate reabsorption"],"nhmrc_grant_id":401687,"application_year":2005,"health_keywords":["hyposulphataemia","ion transport defect","sulfate metabolism disorder","sulfation"],"scientific_title":"Phenotypic studies of the NaSi-1 transporter knock-out   mouse","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"A/Pr Daniel Markovich","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401687","simplified_title":"Studies of a mouse with low blood sulfate levels","sub_type":"Standard Project Grant","total_budget":"268264.67","source_system":"Sulfate is an essential nutrient for cell growth and survival. Despite this, sulfate levels are rarely measured clinically and very little is known about the consequences of disturbed blood sulfate levels.The human kidneys regulate sulfate levels in the body, by mechanisms that are not fully characterised. Our laboratory has isolated a gene (Nas1) from humans and mice, which encodes a protein involved in sulfate absorption from the diet. Nas1 also controls sulfate excretion into the urine, by regulating kidney reabsorption. Normally, very little sulfate is lost in the urine. However, individuals with autism, Alzheimers, Parkinsons, motor neurone disease and liver cirrhosis, have been reported to have reduced blood sulfate levels. The mechanisms underlying the low blood sulfate levels in these disorders, have not been characterised. Recently, we generated a mouse lacking the Nas1 gene. This mouse has very low blood sulfate levels and suffers from growth retardation, reduced fertility and displays seizures. In this study, we plan to investigate these phenomena in the Nas1 knock out mouse and determine the role of low blood sulfate levels on these conditions. We also plan to characterise the role of low blood sulfate levels on the expression of genes in various body organs, using a gene array approach. In addition, we plan to study wound repair and the detoxification process in our Nas1 knock out mouse, which we expect to be affected due to low blood sulfate levels. These studies will establish the roles sulfate plays in mammalian physiology and will provide a foundation for studying diseases that are associated with changes in blood sulfate levels."},"children":[{"color":"#336699","name":"Prof Daniel Markovich","data":{"first_name":"Daniel","title":"Prof","dw_individual_id":"DW0038289","middle_name":"","last_name":"Markovich","source_individual_id":"5016201","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Daniel Markovich"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86917","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60583","size":1},{"color":"#FF4D4D","name":"Hedgehog signalling in limb and craniofacial development and disease","data":{"media_summary":"","end_year":2008,"keywords":["abnormal embryogenesis","craniofacial development","developmental genes","limb development","murine models"],"nhmrc_grant_id":401683,"application_year":2005,"health_keywords":["defects in embryonic development","facial dysmorphology","limb deformity","organogenesis"],"scientific_title":"Hedgehog signalling in limb and craniofacial development and disease","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Carol Wicking","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401683","simplified_title":"Analysis of genes involved in embryonic development and disease","sub_type":"Standard Project Grant","total_budget":"494544.75","source_system":"Anomalies of the face and limbs are amongst the most common features of human birth defects, and their frequent association suggests that the same genes are involved in governing the development of the limbs and face during embryogenesis. We have used a genomics-based approach to identify genes involved in limb development based on their alteration in a mouse model which develops extra fingers and toes. Defects in this mouse result from changes in Gli3, a gene which is known to be important in both limb and face development. Based on the organs in which our genes of interest are active, we believe that they will also play key roles in embryonic development of the limbs, face and other organs. We now plan to investigate the regulation of a subset of these genes based on analysis in mouse models of limb and face development. In addition, we have chosen to further analyse the function of a completely novel gene we have identified which our preliminary studies suggest may play a role in the normal development of the lip and palate. These studies have the potential to shed light on the processes governing how organs develop, as well as on the molecular basis of common birth defects such as polydactyly (extra fingers and toes) and cleft palate."},"children":[{"color":"#336699","name":"Dr Joy Richman","data":{"first_name":"Joy","title":"Dr","dw_individual_id":"DW0045076","middle_name":"M","last_name":"Richman","source_individual_id":"RMIS3702106","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Joy Richman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88672","size":1},{"color":"#336699","name":"A/Pr Carol Wicking","data":{"first_name":"Carol","title":"A/Pr","dw_individual_id":"DW0028805","middle_name":"A","last_name":"Wicking","source_individual_id":"RMIS2473798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Carol Wicking"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84461","size":1},{"color":"#336699","name":"Dr Fiona Simpson","data":{"first_name":"Fiona","title":"Dr","dw_individual_id":"DW0010280","middle_name":"","last_name":"Simpson","source_individual_id":"5017533","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Fiona Simpson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79493","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60582","size":1},{"color":"#FF4D4D","name":"IMPDH and lipid accumulation","data":{"media_summary":"","end_year":2008,"keywords":["Cell differentiation","Lipid","Metabolism","Phosphoprotein","Purine nucleotide biosynthesis"],"nhmrc_grant_id":401677,"application_year":2005,"health_keywords":["Insulin resistance","Metabolic syndrome","Obesity","Type 2 diabetes"],"scientific_title":"IMPDH and lipid accumulation","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Jonathan Whitehead","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401677","simplified_title":"IMPDH, an enzyme involved in fat accumulation","sub_type":"Standard Project Grant","total_budget":"478844.91","source_system":"Inosine-5' Monophosphate Dehydrogenase (IMPDH) is an enzyme responsible for providing a form of energy to cells, so that they may undertake their correct functions. Recently, we have demonstrated that IMPDH also has a role in the formation of fat droplets within cells, when they are exposed to excessive nutrients. In mammals, excess consumed energy is stored as fat droplets within all cells. In fat cells, the energy is stored in very large droplets, and we see this as extra body fat. This is sometimes associated with an alteration in the hormone production of the cells, leading to problems such as diabetes. In other cells, the excess energy is stored as tiny fat droplets (lipid bodies) that can adversely affect the function of the cell. We have shown that blocking the action of IMPDH can interfere with the accumulation of fat in both fat cells and other types of cell. This suggests that IMPDH has an important role in the development of obesity and associated problems such as diabetes. In this study we aim to investigate in detail the role of IMPDH in the accumulation of fat droplets in cells. We will do this by looking at the effects of different forms of IMPDH in different cell types, including human fat cells. We will also study cells and animals with increased or decreased amounts of IMPDH, and investigate the effects of this on the development of increased fat stores and insulin resistance. These studies will increase our understanding of the role of IMPDH in the development of obesity, and may lead to identification of new avenues of treatment for obesity and type 2 diabetes."},"children":[{"color":"#336699","name":"A/Pr Jonathan Whitehead","data":{"first_name":"Jonathan","title":"A/Pr","dw_individual_id":"DW0046246","middle_name":"P","last_name":"Whitehead","source_individual_id":"RMIS5218572","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jonathan Whitehead"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88973","size":1},{"color":"#336699","name":"Prof Johannes Prins","data":{"first_name":"Johannes","title":"Prof","dw_individual_id":"DW0039181","middle_name":"Bernhard","last_name":"Prins","source_individual_id":"RMIS7041737","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Johannes Prins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87157","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60581","size":1},{"color":"#FF4D4D","name":"STAT5 as an anti-obesity agent","data":{"media_summary":"","end_year":2008,"keywords":["JAK-STAT pathway","gene knockout","growth hormone","leptin","obesity"],"nhmrc_grant_id":401668,"application_year":2005,"health_keywords":["cardiovascular disease and hypertension","coronary heart disease prevention","diabetes (type 2)","obesity prevention"],"scientific_title":"STAT5 as an anti-obesity agent","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael WATERS","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401668","simplified_title":"Transcription factor STAT5 controls obesity","sub_type":"Standard Project Grant","total_budget":"505523.48","source_system":"An obesity epidemic is evident in first world countries including Australia. Twenty seven percent of men aged 55-64 in this country are obese. Obesity results in increased mortality and morbidity from type 2 diabetes, cardiovascular disease, renal disease and endometrial cancer, among others. Given our flaccid lifestyles, it is imperative that the metabolic processes underlying obesity be fully understood, to allow development of suitable treatment modalities. This proposal seeks to establish an important new element in our understanding of the development of obesity, the transcription factor STAT5. With previous NHMRC support, we developed sophisticated genetically modified mice which lack defined signalling processes initiated by growth hormone, an anti-obesity agent. These studies showed a strong correlation between ability to activate STAT5 and resistance to obesity. There is fragmentary literature evidence to support our hypothesis, which could also explain some of leptins anti-obesity actions. Using mice which lack STAT5, we shall establish a role for STAT5 as an antiobesity agent. The actions of STAT5 are normally blocked by feedback inhibitors referred to as SOCS, discovered by Australians. We shall define which SOCS is the feedback regulator for obesity control, allowing us to develop specific anti-SOCS agents which will act as novel anti-obesity agents."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60580","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2010,"keywords":["Axon guidance","Commissure","Corpus callosum","Cortical development","Glial development"],"nhmrc_grant_id":401658,"application_year":2005,"start_year":2006,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Linda Richards","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401658","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"607101","source_system":""},"children":[{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60579","size":1},{"color":"#FF4D4D","name":"Identification of new mutations that contribute to breast   cancer","data":{"media_summary":"","end_year":2008,"keywords":["BRCA1","Gene regulation","Genetic predisposition","Mutation screening"],"nhmrc_grant_id":401651,"application_year":2005,"health_keywords":["Breast cancer","Familial cancer","Genetic testing","Therapeutic target"],"scientific_title":"Identification of new mutations that contribute to breast   cancer","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genome Structure","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Melissa Brown","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401651","simplified_title":"Understanding the genetic abnormalities that cause breast cancer","sub_type":"Standard Project Grant","total_budget":"323825.75","source_system":"Breast cancer affects approximately one in ten women and is therefore a major health problem. In order to improve the diagnosis, treatment and prognosis of this disease, it is critical to understand the genetic defects that contribute to disease initiation and progression. Although a number of breast cancer susceptibility genes have been identified, the contribution each of these genes makes to breast cancer susceptibility is currently unclear. This is partly due to limitations in current diagnostic processes and an incomplete understanding of all of the genetic elements for which disruption can lead to loss of gene function. This proposal aims to identify regulatory pathways that are critical for the expression of an important breast cancer gene called BRCA1. Furthermore, it aims to determine the status of these pathways in breast cancer patients, thus expanding our knowledge of the actual contribution that disruption of this gene makes to this disease. It also aims to determine the potential for trans-acting factors to regulate the expression of BRCA1 and thus activity of the BRCA1 pathway. The predicted outcome of this research is an improved ability to perform presymptomatic diagnostic testing for breast cancer and the ultimately the development of more effective drugs to treat certain breast tumours."},"children":[{"color":"#336699","name":"Prof Melissa Brown","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0041312","middle_name":"A","last_name":"Brown","source_individual_id":"RMIS511711","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Melissa Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87712","size":1},{"color":"#336699","name":"Prof Melissa Southey","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0039798","middle_name":"","last_name":"Southey","source_individual_id":"5012491","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Southey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87312","size":1},{"color":"#336699","name":"Dr Sean Tavtigian","data":{"first_name":"Sean","title":"Dr","dw_individual_id":"DW0022461","middle_name":"V","last_name":"Tavtigian","source_individual_id":"5017835","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Sean Tavtigian"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82788","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60578","size":1},{"color":"#FF4D4D","name":"RCT of an Intervention to Improve the Health of Adolescents with Intellectual Disability.","data":{"media_summary":"Population screening","end_year":2011,"keywords":["Adolescent health","Health Screening and Promotion","Intellectual Disability","Primary Health Care"],"nhmrc_grant_id":401647,"application_year":2005,"health_keywords":["Developmental disabilities","Health inequalities","Health promotion","Intellectual disability","Population screening"],"scientific_title":"RCT of an Intervention to Improve the Health of Adolescents with Intellectual Disability.","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Care for Disabled","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Nicholas Lennox","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401647","simplified_title":"The Health of Adolescents with Intellectual Disability Study","sub_type":"Standard Project Grant","total_budget":"803146.25","source_system":"A high number of people with intellectual disability die at a younger age than the general population - 5 to 20 years younger. The standard of their health is low compared with others. They experience high levels of unrecognised disease and do not receive health promotion or health screening. As they comprise 2.7% of our population (502,000 Australians) - this situation is unjust and should be rectified. The barriers to good health for them include communication difficulties, impaired recall of significant health information, negative social attitudes and inadequate training about disability for health service providers. This project is an attempt to minimise some of these barriers by examining the use of a Health Intervention Package. We want to give young people with intellectual disabilty the chance of similar health standards to the rest of the population. This package includes a comprehensive health review, a diary for collecting and storing health information, and advocacy training. We specifically want to examine if adolescents with intellectual disabilty using this package will receive better healthcare and improved health outcomes. We envisage that if successful, the intervention will establish good health practices for the rest of the young person's life. This group of young people is particularly at risk as they move from care provided by specialist paediatricians to accessing General Practitioners' services. To achieve this, the study will seek to recruit 1000 young people (and their parents and teachers) in Special Schools in Queensland. We have already shown that the comprehensive health review does improve health outcomes adults with intellectual disabilty, and the health information and advocacy training has received very positive evaluation. We now need to investigate the effect of both these processes in adolscence and establish if evidence exists to support wider implementation throughout the sector."},"children":[{"color":"#336699","name":"A/Pr Michael O'Callaghan","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0044590","middle_name":"James","last_name":"O'Callaghan","source_individual_id":"RMIS1119732","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Michael O'Callaghan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88543","size":1},{"color":"#336699","name":"Prof Nicholas Lennox","data":{"first_name":"Nicholas","title":"Prof","dw_individual_id":"DW0032044","middle_name":"Gordon","last_name":"Lennox","source_individual_id":"5015941","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nicholas Lennox"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85287","size":1},{"color":"#336699","name":"Dr Suzanne Carrington","data":{"first_name":"Suzanne","title":"Dr","dw_individual_id":"DW0029805","middle_name":"B","last_name":"Carrington","source_individual_id":"5013800","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Suzanne Carrington"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84714","size":1},{"color":"#336699","name":"Prof Gail Williams","data":{"first_name":"Gail","title":"Prof","dw_individual_id":"DW0017119","middle_name":"Marilyn","last_name":"Williams","source_individual_id":"RMIS28497","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gail Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81346","size":1},{"color":"#336699","name":"Dr Chris Bain","data":{"first_name":"Chris","title":"Dr","dw_individual_id":"DW0000195","middle_name":"J","last_name":"Bain","source_individual_id":"5013299","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Chris Bain"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76709","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60577","size":1},{"color":"#FF4D4D","name":"Deciphering the molecular basis of SM regulation of exocytosis","data":{"media_summary":"","end_year":2008,"keywords":["Munc18","SNARE proteins","molecular biology","protein structure","protein-protein interactions"],"nhmrc_grant_id":401643,"application_year":2005,"health_keywords":["diabetes mellitus","insulin resistance","neurological disease"],"scientific_title":"Deciphering the molecular basis of SM regulation of exocytosis","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Martin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401643","simplified_title":"Understanding how cells regulate the uptake of glucose & the release of neurotransmitters","sub_type":"Standard Project Grant","total_budget":"515564.54","source_system":"Diabetes, obesity, heart disease and physical inactivity are major and escalating health problems within western societies. These problems are all linked to, or aggravate, the condition known as insulin resistance. Insulin resistance occurs when normal levels of insulin are insufficient to remove glucose from the blood. In the normal situation, insulin regulates glucose uptake into muscle and fat cells by stimulating the movement of a glucose transport protein from inside the cell to the cell surface. The trafficking of this protein is somehow disrupted in insulin resistance. The purpose of this research is to follow up our exciting preliminary results on this system to shed light on the molecular processes that regulate the trafficking of the glucose transporter. Information resulting from our studies will lead to a better understanding of insulin-stimulated glucose transport and may also unravel the details of a related cellular secretion system that regulates neurotransmission. Our hope is that by understanding at the molecular level how cells regulate secretion, we can in the future develop therapeutics to counteract many of today s major health problems."},"children":[{"color":"#336699","name":"Prof Frederic Meunier","data":{"first_name":"Frederic","title":"Prof","dw_individual_id":"DW0020864","middle_name":"A","last_name":"Meunier","source_individual_id":"5016455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frederic Meunier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82341","size":1},{"color":"#336699","name":"Prof David James","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0019872","middle_name":"E","last_name":"James","source_individual_id":"RMIS8321","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David James"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82057","size":1},{"color":"#336699","name":"Prof Jennifer Martin","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0008922","middle_name":"Louise","last_name":"Martin","source_individual_id":"5022915","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jennifer Martin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79117","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60576","size":1},{"color":"#FF4D4D","name":"E-Cadherin endocytosis in morphogenesis: recycling and growth factor induced uptake.","data":{"media_summary":"","end_year":2008,"keywords":["adhesion molecules","endocytosis","epithelial cells","growth factors","protein trafficking"],"nhmrc_grant_id":401642,"application_year":2005,"health_keywords":["cancer biology","development","metastasis"],"scientific_title":"E-Cadherin endocytosis in morphogenesis: recycling and growth factor induced uptake.","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401642","simplified_title":"E-Cadherin endocytosis in morphogenesis","sub_type":"Standard Project Grant","total_budget":"498088.1","source_system":"E-cadherin is a cell-cell adhesion protein expressed in all epithelia with essential roles in establishing cell polarity and in tissue patterning during development. In the adult, E-cadherin functions to maintain epithelial integrity. E-cadherin is also a vital tumour suppressor, protecting cells against metastatic transformation. Our earlier studies showed that E-cadherin is constantly moved, or trafficked, to and from the surface of epithelial cells. The endocytosis or internalisation of cell surface E-cadherin serves to regulate its role in adhesion. More recently, we and others have shown that E-cadherin is endocytosed in response to growth factors, in conjunction with the activated growth factor receptors themselves. E-cadherin can influence the trafficking and signaling of these receptor tyrosine kinases. This joint endocytosis is an elegant mechanism for the simultaneous downregulation of cell adhesion and activation of signaling for cell growth and motility. The growth and differentiation of epithelial cells during tissue patterning or morphogenesis relies critically on these endocytic pathways. Our research is aimed at defining the endosomes and cellular machinery involved in E-cadherin-receptor endocytosis, moreover we will pursue initial findings suggesting that there are different pathways and fates for E-cadherin endocytosed at the behest of different growth factors. We will study endocytosis during the processes of epithelial cyst formation and tubulation of cysts as an in vitro model for mammalian morphogenesis. These studies will provide important and novel information for understanding the roles of E-cadherin in adhesion and in growth factor signaling during epithelial morphogenesis. Ultimately these findings will be of relevance to epithelial development and the prevention of cancer."},"children":[{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60575","size":1},{"color":"#FF4D4D","name":"Structural biology of endosomal membrane trafficking","data":{"media_summary":"","end_year":2010,"keywords":["membrane trafficking","protein complexes","structural biology","x-ray crystallography"],"nhmrc_grant_id":401626,"application_year":2005,"start_year":2006,"scientific_title":"Structural biology of endosomal membrane trafficking","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Brett Collins","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401626","simplified_title":"Structural biology of endosomal membrane trafficking","sub_type":"RD Wright Biomedical CDF","total_budget":"462290","source_system":""},"children":[{"color":"#336699","name":"Dr Brett Collins","data":{"first_name":"Brett","title":"Dr","dw_individual_id":"DW0041718","middle_name":"Martin","last_name":"Collins","source_individual_id":"5014007","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brett Collins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87821","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60574","size":1},{"color":"#FF4D4D","name":"Mechanisms of dendritic cell-induced T-cell tolerance","data":{"media_summary":"tolerance","end_year":2008,"keywords":["cellular immunology","dendritic cell","immune regulation","tolerance"],"nhmrc_grant_id":401620,"application_year":2005,"health_keywords":["autoimmune disease","cellular immunity","dendritic cells","immune regulation","tolerance"],"scientific_title":"Mechanisms of dendritic cell-induced T-cell tolerance","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Raymond Steptoe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401620","simplified_title":"Mechanisms of dendritic cell-induced tolerance","sub_type":"Standard Project Grant","total_budget":"314773.48","source_system":"Autoimmune diseases constitute a significant medical problem in the developed world and are increasing in incidence. Many control mechanisms exist in the body, but in people with genetic suceptibility to autoimmune disease, the mechanisms fail and the body's immune sytem attacks normal tissues or organs. We have developed a new approach to using the cells which train the immune system to re-educate the cells that would otherwise attack normal healthy tissues in autoimmune-prone individuals. These cells (dendritic cells) are genetically modified to express the molecular targets of the autoimmune response. This in turn switches off the response to these targets. In this project we will explore how these cells can be used to turn off cells of the immune system and if cells of the immune system in turn control the dendritic cell's ability to do this."},"children":[{"color":"#336699","name":"A/Pr Raymond Steptoe","data":{"first_name":"Raymond","title":"A/Pr","dw_individual_id":"DW0028164","middle_name":"J","last_name":"Steptoe","source_individual_id":"5017706","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Raymond Steptoe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84270","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60573","size":1},{"color":"#FF4D4D","name":"Regulation of cortical development by Nfi genes.","data":{"media_summary":"Schizophrenia and related disorders","end_year":2008,"keywords":["Axon guidance","Cell migration","Cerebral cortex","Developmental neurobiology","Midline formation"],"nhmrc_grant_id":401616,"application_year":2005,"health_keywords":["Attention Deficit Hyperactivity Disorder (ADHD)","Autistic spectrum disorder","Embryonic development","Mental retardation","Schizophrenia and related disorders"],"scientific_title":"Regulation of cortical development by Nfi genes.","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurogenetics","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Linda Richards","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401616","simplified_title":"How the transcription factor family of Nuclear factor 1 genes regulates development of the cerebral cortex in mouse.","sub_type":"Standard Project Grant","total_budget":"472267.61","source_system":"Neurons in the two hemispheres of the brain make connections with each other via a large fibre tract called the corpus callosum. In over fifty different human congenital syndromes the corpus callosum fails to form properly. Such syndromes, which include Aicardi syndrome, Andermann syndrome, Shapiro syndrome and Acrocallosal syndrome, can result in mental retardation, seizures, lack of motor coordination and ocular abnormalities in children. Our data on both mouse and human brain development show that the mouse is an excellent model system for understanding how the brain becomes wired up during development and what may go wrong in these disorders. Here we investigate the role of a family of genes called nuclear factor one (Nfi) genes in brain development. When mutated in mice, members of this gene family, principally Nfia and Nfib, cause severe malformations of the brain. The phenotype inlcudes a failure to form some midline glial populations, the expansion of the cingulate cortex and loss of the corpus callosum. The propoer formation of midline glial populations and the cingulate cortex are essential to callosal fomration and correct brain wiring. Defects in brain wiring in the cingulate cortex during development may underlie disorders such as schizophrenia, bipolar disorder and depression. In this project we will address the mechanism of function underlying the control of brain development by the Nfi genes. The expected outcomes of this research are to identify new mechanisms and genetic pathways critical to the formation of connections between the two sides of the brain and proper formation of the cingulate cortex. These results will improve our understanding of how the brain forms and what mechanisms may be disrupted during development that result in neurological and cognitive deficits in children and adults."},"children":[{"color":"#336699","name":"Prof Linda Richards","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0015855","middle_name":"Jane","last_name":"Richards","source_individual_id":"RMIS3266050","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Richards"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80994","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60572","size":1},{"color":"#FF4D4D","name":"Adiponectin - Multimerization, Secretion and Action","data":{"media_summary":"Type 2 Diabetes","end_year":2008,"keywords":["Biochemistry","Cell biology","Cell surface receptor","Glycoproteins","Hormone signalling"],"nhmrc_grant_id":401612,"application_year":2005,"health_keywords":["Insulin Resistance","Liver","Metabolic syndrome","Obesity","Type 2 Diabetes"],"scientific_title":"Adiponectin - Multimerization, Secretion and Action","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Jonathan Whitehead","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401612","simplified_title":"Secretion and Action of Adiponectin","sub_type":"Standard Project Grant","total_budget":"478844.91","source_system":"Adiponectin is a hormone produced by fat tissue. It functions to control blood glucose levels and acts to prevent damage to blood vessels associated with heart disease and stroke. Adiponectin levels in the blood are low in subjects with obesity, diabetes and heart disease, and in animals with these conditions, additional adiponectin is of benefit. It has recently been recognised that adiponectin is produced in different forms - a low weight form made up of a small number of adiponectin molecules and a higher weight form (HMW adiponectin) made up of large numbers of adiponectin molecules complexed together. We and others have shown that the HMW adiponectin is particularly beneficial. This projects aims to understand the processes regulating the production of differing types of adiponectin by fat cells. It will also examine how the different types of adiponectin have their effects in different tissues such as liver and muscle. The information gained will increase our understanding of how illnesses such as diabetes are associated with obesity. It may also lead to the development of treatments aimed at increasing adiponectin levels - particulalry HMW adiponectin - which may be of benefit in patients with diabetes and cardiovascular disease."},"children":[{"color":"#336699","name":"A/Pr Jonathan Whitehead","data":{"first_name":"Jonathan","title":"A/Pr","dw_individual_id":"DW0046246","middle_name":"P","last_name":"Whitehead","source_individual_id":"RMIS5218572","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jonathan Whitehead"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88973","size":1},{"color":"#336699","name":"A/Pr Graeme Macdonald","data":{"first_name":"Graeme","title":"A/Pr","dw_individual_id":"DW0043925","middle_name":"Alistair","last_name":"Macdonald","source_individual_id":"5016107","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Graeme Macdonald"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88380","size":1},{"color":"#336699","name":"Prof Johannes Prins","data":{"first_name":"Johannes","title":"Prof","dw_individual_id":"DW0039181","middle_name":"Bernhard","last_name":"Prins","source_individual_id":"RMIS7041737","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Johannes Prins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87157","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60571","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2010,"keywords":["Cell adhesion","Cytokines","Endocytosis","Protein trafficking","Secretion"],"nhmrc_grant_id":401609,"application_year":2005,"start_year":2006,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401609","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"664574","source_system":""},"children":[{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60570","size":1},{"color":"#FF4D4D","name":"Retroviral Expression Cloning Using an Arrayed Full Length cDNA Gene Set","data":{"media_summary":"","end_year":2010,"keywords":["biological process","establish an arrayed retroviral library","human genome, sloning system, identify genes."],"nhmrc_grant_id":401608,"application_year":2005,"start_year":2006,"scientific_title":"Retroviral Expression Cloning Using an Arrayed Full Length cDNA Gene Set","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genome Structure","research_area":"Clinical Medicine and Science","for_category":"GENETICS","cia_name":"Prof Thomas Gonda","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/401608","simplified_title":"Retroviral Expression Cloning Using an Arrayed Full Length cDNA Gene Set","sub_type":"Medical Bioinformatics,Genomics & Proteomics Grant","total_budget":"1841500","source_system":"The sequencing of the human genome has revealed the blueprint for life, but the identities and-or functions of the majority of genes remain unknown. Here we propose to establish a radically modified retroviral expression cloning system that will, in principle, allow identification of all genes that confer a particular dominant phenotype. To do this we will establish an arrayed retroviral library of sequence-verified genes covering the entire human transcriptome. This technology will be used to identify genes involved in a wide range of medically-important biological processes."},"children":[{"color":"#336699","name":"Prof Thomas Gonda","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0007535","middle_name":"John","last_name":"Gonda","source_individual_id":"5014863","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Thomas Gonda"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78737","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60569","size":1},{"color":"#FF4D4D","name":"Telerehabilitation: Assessing acquired neurogenic communication disorders online.","data":{"media_summary":"","end_year":2007,"keywords":["Access to health care","Aphasia","Dysarthria","Speech Pathology","Telemedicine"],"nhmrc_grant_id":401604,"application_year":2005,"health_keywords":["Brain damage","Health service accessibility","Rehabilitation","Rural and remote health"],"scientific_title":"Telerehabilitation: Assessing acquired neurogenic communication disorders online.","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Hearing and Speech","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Deborah Theodoros","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401604","simplified_title":"Assessing speech and language disorders following brain damage across the Internet","sub_type":"Standard Project Grant","total_budget":"172446.9","source_system":"People who suffer brain damage as a result of a stroke, head injury, or a disorder such as Parkinson's disease frequently develop difficulty in either speaking, writing, reading, or understanding the spoken language. As a result, the person's ability to communicate with his or her family and friends, and the community in general is seriously affected. Individuals who experience these speech and language disorders are treated by a speech pathologist who focuses on improving the person's ability to communicate. The treatment of these disorders is frequently long-term requiring speech pathology management beyond existing hospital care. For many people with these communication disorders, accessing speech pathology services after their discharge from hospital may be very difficult due to their physical difficulties, the distances they are required to travel, and the limited availability of speech pathologists in their local community. This project aims to overcome these access issues through the development of a telerehabilitation system that will enable speech pathologists to assess people with these speech and language difficulties across the Internet using videoconferencing. It is intended that this research will ultimately enable people with these types of communication difficulties to be assessed and treated within their own home or local community."},"children":[{"color":"#336699","name":"Prof Elizabeth Ward","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0040334","middle_name":"Celeste","last_name":"Ward","source_individual_id":"RMIS15276","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Ward"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87452","size":1},{"color":"#336699","name":"A/Pr Trevor Russell","data":{"first_name":"Trevor","title":"A/Pr","dw_individual_id":"DW0033555","middle_name":"","last_name":"Russell","source_individual_id":"RMIS3678636","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Trevor Russell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85687","size":1},{"color":"#336699","name":"Prof Richard Wootton","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0023093","middle_name":"","last_name":"Wootton","source_individual_id":"5018481","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Wootton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82948","size":1},{"color":"#336699","name":"Prof Deborah Theodoros","data":{"first_name":"Deborah","title":"Prof","dw_individual_id":"DW0022512","middle_name":"Gale","last_name":"Theodoros","source_individual_id":"RMIS15273","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Deborah Theodoros"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82794","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60568","size":1},{"color":"#FF4D4D","name":"Bioengineering of Cyclotides with Angiogenic Properties","data":{"media_summary":"","end_year":2008,"keywords":["Angiogenesis","Drug Design","Protein Chemistry"],"nhmrc_grant_id":401600,"application_year":2005,"health_keywords":["Cardiovascular and Peripheral Vascular Disease","Neovascularization","Novel Therapeutics"],"scientific_title":"Bioengineering of Cyclotides with Angiogenic Properties","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401600","simplified_title":"Novel Angiogenic Agents","sub_type":"Standard Project Grant","total_budget":"488273.48","source_system":"Atherosclerosis, a gradual clogging of the arteries, is the single leading cause of death in Australia, Europe, the USA and Japan. Coronary heart disease (CHD; clogging of the coronary arteries), while secondary to atherosclerosis in most of the world, accounts for nearly 2 million deaths per year in Europe alone. In Australia CHD is the single leading cause of death. This project is aimed at developing lead molecules for the development of therapeutics capable of stimulating revascularization (that is, opening up blocked vessels to improve blood flow) of tissues with slow or retarded circulation. Such therapeutics would improve the treatment of atherosclerosis and CHD. Peptides, small proteins, are generally not stable enough to be used as drugs. In this project we plan to engineer protein molecules based on an unusually stable family of proteins, known as the cyclotides. We will chemically synthesise analogues of cyclotides that have been altered to incorporate the activities of less stable small peptides that are able to induce therapeutic angiogenesis. Given the prevalence of CHD, the development of effective therapeutics could have a profound impact on the economic cost of the disease, which in the USA amounts to US$133.2 billion per year. This project involves collaboration between researchers from the Institute for Molecular Bioscience, who have expertise in drug design and protein chemistry, and researchers from the Centre for Research in Vascular Biology, who have expertise in vascular biology and vessel engineering. Both of these institutes are part of the University of Queensland."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Prof Julie Campbell","data":{"first_name":"Julie","title":"Prof","dw_individual_id":"DW0000708","middle_name":"H","last_name":"Campbell","source_individual_id":"RMIS330901","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Julie Campbell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76860","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60567","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2010,"keywords":["Low back pain","Motor control","Musculoskeletal pain","Pain and movement","Therapeutic intervention"],"nhmrc_grant_id":401599,"application_year":2005,"start_year":2006,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Paul Hodges","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401599","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"664574","source_system":""},"children":[{"color":"#336699","name":"Prof Paul Hodges","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0043077","middle_name":"W","last_name":"Hodges","source_individual_id":"RMIS222953","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Hodges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88164","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60566","size":1},{"color":"#FF4D4D","name":"Pain and trunk muscle control: Effects, mechanisms and consequences","data":{"media_summary":"","end_year":2008,"keywords":["experimental muscle pain","low back pain","motor control","physiotherapy","sensorimotor physiology"],"nhmrc_grant_id":401598,"application_year":2005,"health_keywords":["acute pain","injury prevention","low back pain","motor control"],"scientific_title":"Pain and trunk muscle control: Effects, mechanisms and consequences","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Paul Hodges","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401598","simplified_title":"Trunk muscle conrol in low back pain: short-term benefit with long-term consequences?","sub_type":"Standard Project Grant","total_budget":"296452.77","source_system":"Twenty-one percent of Australians report long-term back problems. This makes back pain the most common chronic pain in Australia and most prevalent disorder among the National Health Priority Areas. For the majority with recurrent and chronic problems, the cause is unknown but changes in control of the spine are thought to be important. It is well accepted that pain and injury to the low back affect the way that we control the back muscles and this leads to changes in spinal function. However, despite considerable investigation of this problem, there is a distinct lack of consensus for how the control of movement is changed during pain, why it changes, and whether these changes lead to further problems in the long term. The objective of this series of studies is to determine how the adaptation to pain changes the control of the spine. We will use a range of techniques that include tests of the strategies used by the brain to control the spine and mathematical models to estimate the effect that these changes have on the spine when people are given back pain by injecting sterile salty water into the back muscles. These studies will be backed up by measures of mechanical properties of the spine and by comparison to people with clinical pain. This combination of methods has not been used previously and is likely to help resolve the problem of how muscle control is chaged in back pain. We will also test a range of hypotheses regarding how pain has its effect on muscle activity. A final series of studies aims to determine whether the failure of these changes in muscle control to resolve after an epiosde of back pain leads to increased recurrence of pain in the long-term. The importance of this project is highlighted by the significance of back pain as a major health issue, the lack of consensus regarding the effect and mechanisms of pain on trunk muscle control (despite extensive investigation), and the potential for the findings to guide rehabilitation and management."},"children":[{"color":"#336699","name":"Prof Paul Hodges","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0043077","middle_name":"W","last_name":"Hodges","source_individual_id":"RMIS222953","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Hodges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88164","size":1},{"color":"#336699","name":"Prof Jacek Cholewicki","data":{"first_name":"Jacek","title":"Prof","dw_individual_id":"DW0035863","middle_name":"","last_name":"Cholewicki","source_individual_id":"RMIS3161648","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jacek Cholewicki"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86290","size":1},{"color":"#336699","name":"Prof Rob Herbert","data":{"first_name":"Rob","title":"Prof","dw_individual_id":"DW0031266","middle_name":"","last_name":"Herbert","source_individual_id":"RMIS5768596","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Rob Herbert"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85093","size":1},{"color":"#336699","name":"Prof Thomas Graven-Nielsen","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0013316","middle_name":"","last_name":"Graven-Nielsen","source_individual_id":"5028243","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Thomas Graven-Nielsen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80299","size":1},{"color":"#336699","name":"Prof G. Lorimer Moseley","data":{"first_name":"G. Lorimer","title":"Prof","dw_individual_id":"DW0009239","middle_name":"","last_name":"Moseley","source_individual_id":"5016567","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof G. Lorimer Moseley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79214","size":1},{"color":"#336699","name":"Prof Jaap Van Dieen","data":{"first_name":"Jaap","title":"Prof","dw_individual_id":"DW0005185","middle_name":"H","last_name":"Van Dieen","source_individual_id":"RMIS3161651","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jaap Van Dieen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78108","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60565","size":1},{"color":"#FF4D4D","name":"Polarized trafficking of E-cadherin in epithelial cells.","data":{"media_summary":"","end_year":2008,"keywords":["adhesion molecules","epithelial cells","exocytosis","protein localisation","protein trafficking"],"nhmrc_grant_id":401592,"application_year":2005,"health_keywords":["cancer biology","cell adhesion molecule","mechanisms inhibiting cancer cell growth","metastasis"],"scientific_title":"Polarized trafficking of E-cadherin in epithelial cells.","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401592","simplified_title":"E-cadherin trafficking.","sub_type":"Standard Project Grant","total_budget":"515564.54","source_system":"The cell adhesion protein E-cadherin is expressed in all epithelial tissues of the body where it has essential functions during development and in the adult in establishing and maintaining polarized cell monolayers. E-cadherin is also a vital tumour suppressor, its normal function guarantees that cells or even early tumours cannot metastasise; in contrast E-cadherin is always lost or malfunctions in malignant tumours. Earlier studies showed that E-cadherin is constantly moved, or trafficked, to and from the surface of epithelial cells. This trafficking has dual roles, firstly in delivering newly-made E-cadherin to the surface where it functions and secondly, in regulating its adhesive function. Our research in this project is focussed on the molecules and intracellular compartments that control the delivery of E-cadherin to the cell surface. E-cadherin must be sorted in order to be delivered to the correct side of the cell. Having previously discovered the sorting signal in E-cadherin, we will now identify the cognate adaptor protein(s) that accomplish this sorting. New imaging techniques allow us to study protein trafficking inside live cells. Such studies have recently revealed that E-cadherin passes through a recycling endosome compartment on its way to the cell surface. This unexpected route, and the structure and role of the recycling endosome will now be studied in detail in live cells. Finally we will compare the sorting and trafficking of E-cadherin with the closely-related N-cadherin protein, to determine whether there are inherent differences in their trafficking that could explain their opposite roles in tumour cells, where N-cadherin is substituted for E-cadherin and allows metastatic behaviour. These studies will provide important information for understanding the adhesive and tumour suppressive roles of E-cadherin. In addition our findings will generate information fundamental to our understanding of cell polarity and protein sorting."},"children":[{"color":"#336699","name":"A/Pr Rohan Teasdale","data":{"first_name":"Rohan","title":"A/Pr","dw_individual_id":"DW0040022","middle_name":"D","last_name":"Teasdale","source_individual_id":"5017848","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Rohan Teasdale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87368","size":1},{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60564","size":1},{"color":"#FF4D4D","name":"The role of central and peripheral synaptic activity in the developmental death of motoneurons.","data":{"media_summary":"Neuronal cell death","end_year":2008,"keywords":["Developmental motoneuron death","Glycinergic , GABAergic transmission","Neural Development","Neuromuscular junction","Neuronal death"],"nhmrc_grant_id":401579,"application_year":2005,"health_keywords":["Motor neuron disease","Nervous system development","Nervous system disorders","Neuromuscular diseases","Neuronal cell death"],"scientific_title":"The role of central and peripheral synaptic activity in the developmental death of motoneurons.","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Peter Noakes","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401579","simplified_title":"How synaptic connections made onto motoneurons regulate motoneuron death during embryonic development.","sub_type":"Standard Project Grant","total_budget":"463145.08","source_system":"Information processing in the nervous system relies on the effective communication between neurons and their target cells which make up our neuronal circuitry. At the centre of all this is the synapse, the specialized contact between a neuron and its target cell, be it another neuron in the brain or a target organ such as skeletal muscle. Our primary goal is to determine how the formation of synaptic connections during development regulates neuronal survival. In this proposal we have focussed on the neuromotor system as it is a well characterised part of the nervous system. During development, 50% of motoneurons die at a time when they are making contact with skeletal muscle, and when contacts onto motoneurons by other neurons are being established. We believe that the formation of effective synaptic contacts onto motoneurons, as well as connections by motoneurons onto muscle are the key regulators of motoneuron survival. We are in a position to be able to address what regulates motoneuron death; as we have a number of mice which lack key molecules needed for the formation of specialisations that allow neuronal contacts to be made between motor neurons and their muscle, and with other neurons within the spinal cord. By examining the function of motoneurons, counting them and screening for molecular changes in these mice, we will be able to dissect out the mechanism of how a motoneurons' fate is determined during developmental motoneuron death. This research could help in developing strategies aimed at improving neuronal connections to improve neuronal viability. Our research will have important implications for our understanding about the basis of adult neuro-degenerative diseases, such as motor neuron disease and Alzheimer's, which are in part characterised by a molecular breakdown in neuronal connections that ultimately result in neuronal death."},"children":[{"color":"#336699","name":"A/Pr Peter Noakes","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0038807","middle_name":"G","last_name":"Noakes","source_individual_id":"5016732","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Noakes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87053","size":1},{"color":"#336699","name":"Dr Mark Bellingham","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0035336","middle_name":"C","last_name":"Bellingham","source_individual_id":"5013441","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mark Bellingham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86159","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60563","size":1},{"color":"#FF4D4D","name":"NR1 nuclear hormone receptors, and skeletal muscle metabolism: insights into dyslipidemia and metabolic disease.","data":{"media_summary":"obesity","end_year":2008,"keywords":["Fatty Acid and Lipid Metabolism","Gene Regulation","Skeletal Muscle","Steroid (and Nuclear) Hormone Receptors","Transcription"],"nhmrc_grant_id":401573,"application_year":2005,"health_keywords":["biological Sciences","cardiovascular diseases","dyslipidaemia","endocrine Disease","obesity"],"scientific_title":"NR1 nuclear hormone receptors, and skeletal muscle metabolism: insights into dyslipidemia and metabolic disease.","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401573","simplified_title":"Hormonal regulation of fat metabolism in muscle","sub_type":"Standard Project Grant","total_budget":"582547","source_system":"The significance of Nuclear hormone receptors (NRs) in disease is underscored by the range of pharmacopoeia for the treatment of NR-associated disorders (e.g 16% of the top 100 drugs target NRs). Orphan NR1 receptors are abundantly expressed in skeletal muscle, a major mass peripheral tissue that accounts for ~40% of total body weight, and energy expenditure. Muscle is the major site of glucose metabolism and, fatty acid oxidation. Furthermore, it is an important regulator of cholesterol homeostasis and HDL levels. Consequently, it has a significant role in insulin sensitivity, the blood lipid profile, lipid metabolism and obesity. Understanding the functional role of the orphan NR1 receptors in skeletal muscle in the context of inflammation, lipid and energy homeostasis is of paramount importance in further understanding the mechanistic basis of dyslipidemia, chronic inflammation, insulin sensitivity, diabetes and obesity. Identification of novel NR1 targets that regulate metabolism in a major mass peripheral tissue, and positively influence the risk factors for cardiovascular disease, provides platforms for potential therapeutic intervention. Cardiovascular disease is the foremost cause of global mortality, and was responsible for >15 million deaths in 2003."},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60562","size":1},{"color":"#FF4D4D","name":"Cytoprotection by erythropoietin in hypoxia-ischaemia of the kidney and brain","data":{"media_summary":"Kidney failure","end_year":2008,"keywords":["Molecular biology","Neonatology","Nephrology","Neurology","Pathology"],"nhmrc_grant_id":401568,"application_year":2005,"health_keywords":["Brain pathology","Drug therapy","Infant premature","Ischaemia-reperfusion injury","Kidney failure"],"scientific_title":"Cytoprotection by erythropoietin in hypoxia-ischaemia of the kidney and brain","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof David Johnson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401568","simplified_title":"Identification and characterisation of the way erythropoietin protects tissue from oxygen stress","sub_type":"Standard Project Grant","total_budget":"477661.41","source_system":"We aim to make a significant research impact by describing the complex mechanisms responsible for protecting kidney and brain cells from stress caused by a lack of oxygen. In particular we will establish whether the compound erythropoietin (Epo), which occurs naturally in the human body but its human recombinant form can also be used as a treatment, may be useful in protecting cells from death following a shortage of oxygen. . We have already described how Epo can protect the kidney, but no one has yet described its action on kidney cell differentiation or its effect on structural and vascular support in the injured kidney. When might Epo treatment be effective? Could it protect against chronic renal disease? Likewise, whilst more very pre-term babies survive, this is a crucial period when they are at heightened sensitivity to lack of oxygen and they are at risk of brain damage and poor development because of lack of maturation of key structural cells in the brain. The role of Epo in aiding brain cell maturation and on blood vessel formation and function in this faulty development period is not known. Both of these health problems are major issues causing huge costs to society both financial and emotional. Despite the early evidence of a useful role for Epo in human disease treatment, current experimental and clinical data demonstrate the importance of further thorough investigation of mechanisms and cellular pathways that will underpin improvements in clinical outcomes. A particular strength of our project is that by comparing similarities and differences in the kidney and brain, we will be able to elucidate the mechanisms of action of Epo and its analogues."},"children":[{"color":"#336699","name":"Prof Michael Goligorsky","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0042674","middle_name":"S","last_name":"Goligorsky","source_individual_id":"RMIS3679063","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Goligorsky"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88065","size":1},{"color":"#336699","name":"A/Pr Glenda Gobe","data":{"first_name":"Glenda","title":"A/Pr","dw_individual_id":"DW0042655","middle_name":"Carolyn","last_name":"Gobe","source_individual_id":"5012448","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Glenda Gobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88060","size":1},{"color":"#336699","name":"Prof David Johnson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0013969","middle_name":"Wayne","last_name":"Johnson","source_individual_id":"RMIS14680","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Johnson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80471","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60561","size":1},{"color":"#FF4D4D","name":"Deciphering the mechanisms for constructing the olfactory system","data":{"media_summary":"","end_year":2008,"keywords":["axon guidance","development","olfactory"],"nhmrc_grant_id":401565,"application_year":2005,"health_keywords":["brain damage","brain development","brain growth","peripheral nerve injury"],"scientific_title":"Deciphering the mechanisms for constructing the olfactory system","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Brian Key","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401565","simplified_title":"Guiding olfactory axons to their targets","sub_type":"Standard Project Grant","total_budget":"496321.34","source_system":"The olfactory (smell) system is a unique part of the nervous system; nerve cells are generated throughout life and it can regenerate even after injury. It therefore provides an excellent model for examining the growth, development and maintenance of nerve cells. This project will examine the effects on the organisation of the olfactory system when some guidance signals are altered. Information we obtain about how this system develops and regenerates may be useful in treating brain disorders and spinal injuries The results of these experiments will provide important information on the the initial growth and targeting of these nerve cells which may have implications for regeneration of these as well as other nerve cells."},"children":[{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60560","size":1},{"color":"#FF4D4D","name":"Regulation of human arylamine N-acetyltransferase transcription, translation and protein stability","data":{"media_summary":"","end_year":2008,"keywords":["Drug metabolism","acetyltransferase","polyubiquitination","regulation of expression"],"nhmrc_grant_id":401563,"application_year":2005,"health_keywords":["adverse drug reaction","environmental effects on drug response","variation in drug metabolism"],"scientific_title":"Regulation of human arylamine N-acetyltransferase transcription, translation and protein stability","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Rod Minchin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401563","simplified_title":"The control of human drug metabolising enzymes","sub_type":"Standard Project Grant","total_budget":"470958.64","source_system":"Individuals respond very differently to many drugs and other chemicals in the diet and workplace. This variation can be a significant complication in treating patients and in attempting to determine risk with exposure to toxins. Genetic differences between individuals are a common reason for this variation. However, many enzymes and other proteins in humans are controlled by environmental factors that can either increase their activity or inhibit it. In this study, we will investigate how the activity of an important family of enzymes (the acetyltransferases) varies between individuals as a result of environmental factors. We will look at the genes for each of the enzymes and learn about this control mechanism. We will also look careful at the structure of the proteins and determine how this may change when challenged with external stimuli. The expected outcome will be a better understanding of these important enzymes that are involved in the metabolism of many drugs, and also provide a means of determining how different individuals may respond to foreign chemicals and drugs that use these enzymes in the body for metabolism."},"children":[{"color":"#336699","name":"Prof Rodney Minchin","data":{"first_name":"Rodney","title":"Prof","dw_individual_id":"DW0026778","middle_name":"F","last_name":"Minchin","source_individual_id":"5016513","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Rodney Minchin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83936","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60559","size":1},{"color":"#FF4D4D","name":"The future of tobacco control: exploring the feasibility, acceptability and cost-effectiveness of new policy directions","data":{"media_summary":"","end_year":2008,"keywords":["Bioethics","Genetics polygenic inheritance","Nicotine dependence","Public health policy","Tobacco control"],"nhmrc_grant_id":401558,"application_year":2005,"health_keywords":["Cancer prevention","Cardiovascular disease prevention","Nicotine dependence","Prevention of tobacco-related disease"],"scientific_title":"The future of tobacco control: exploring the feasibility, acceptability and cost-effectiveness of new policy directions","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Preventive Medicine","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Wayne Hall","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401558","simplified_title":"The future of tobacco control","sub_type":"Standard Project Grant","total_budget":"495752.93","source_system":"We will examine the practical feasibility, ethical and public acceptability, and likely cost effectiveness of a number of different ways of reducing tobacco smoking and the harm caused by smoking in Australia. These policy options will include: (1) more restrictive policies towards tobacco products (such as prohibiting tobacco smoking and creating a government monopoly on the manufacture and supply of tobacco); (2) encouraging smokers to switch from smoking cigarettes to less harmful ways of using nicotine, such as using nicotine patches or gum ; (3) using new biotechnologies to improve smokers chances of quitting (e.g. genetic screening of smokers to select the most effective way of helping them to stop smoking and vaccinating ex-smokers against the effects of nicotine); and (4) new biotechnologies that may prevent nonsmokers from beginning to smoke (e.g. vaccinating nonsmokers against the effects of nicotine) or reduce the chances of their developing tobacco-related diseases (e.g. screening the population for genes that predict an increased susceptibility to nicotine dependence and tobacco-related diseases). The project will provide important information that will assist government in formulating policies to reduce the rate of cigarette smoking in the Australian population below current levels."},"children":[{"color":"#336699","name":"Prof Simon Chapman","data":{"first_name":"Simon","title":"Prof","dw_individual_id":"DW0029883","middle_name":"","last_name":"Chapman","source_individual_id":"5012067","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Simon Chapman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84736","size":1},{"color":"#336699","name":"Prof Wayne Hall","data":{"first_name":"Wayne","title":"Prof","dw_individual_id":"DW0001997","middle_name":"Denis","last_name":"Hall","source_individual_id":"5012662","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Wayne Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77211","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60558","size":1},{"color":"#FF4D4D","name":"Molecular and histopathological investigation of stress fracture healing and effects of anti-inflammatory drugs.","data":{"media_summary":"tissue remodelling","end_year":2008,"keywords":["animal model","anti-inflammatory","fractures","histopathology","osteogenesis"],"nhmrc_grant_id":401553,"application_year":2005,"health_keywords":["anti-inflammatory agents, non steroidal","bone resorption","fracture repair","musculoskeletal injury, overuse","tissue remodelling"],"scientific_title":"Molecular and histopathological investigation of stress fracture healing and effects of anti-inflammatory drugs.","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Orthopaedics","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Mark Forwood","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401553","simplified_title":"Influence of anti-inflammatory treatments on healing of stress fractures","sub_type":"Standard Project Grant","total_budget":"412652.93","source_system":"Stress fractures are debilitating injuries affecting children, adolescents and adults in sport, and army recruits. They also occur in horse and greyhound racing, often resulting in euthanasia of the animals involved. They incur considerable costs in medical expenses, time lost from sport and interruption to military training. But, there is almost no information on the mechanism of healing of these fractures. Non-steroidal anti-inflammatory drugs (NSAIDs) are still the most widely used medication in management of musculoskeletal injuries, yet their effect on healing of stress fractures is unknown. NSAIDs delay fracture healing, but until recently there has been no standardised way of studying stress fractures. We have created, for the first time, a well-characterised, non-invasive model of stress fractures in the forearm of rats that closely resembles the clinical situation. This provides a novel and unique opportunity to determine the histological and molecular mechanism of stress fracture healing, and to investigate effects of antiinflammatory-analgesic medications on this process. Rats will have an experimental stress fracture produced in one forelimb, and its healing will be examined up to ten weeks using microscopic investigation and analysis of the genes that are turned off or on to initiate the process. Groups of rats will also be treated with antiinflammatory drugs such as ibuprofen, specific COX-2 inhibitors and a new class of drugs that target early immune responses called C5a receptor antagonists. The analgesic Paracetamol will also be investigated as an alternative to the NSAIDs described above. There is widespread use of anti-inflammatory agents in managing stress fractures, so it is vital that their effects on stress fracture healing be examined. This project has enormous significance for optimising approaches for clinical management of stress fractures and for understanding the interaction of anti-inflammatory or analgesic agents in that process."},"children":[{"color":"#336699","name":"Dr Julia Kuliwaba","data":{"first_name":"Julia","title":"Dr","dw_individual_id":"DW0014287","middle_name":"Suzanne","last_name":"Kuliwaba","source_individual_id":"5015797","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Julia Kuliwaba"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80557","size":1},{"color":"#336699","name":"Prof Mark Forwood","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0007324","middle_name":"R","last_name":"Forwood","source_individual_id":"RMIS18701","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mark Forwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78676","size":1},{"color":"#336699","name":"Prof Nicola (Nick) Fazzalari","data":{"first_name":"Nicola (Nick)","title":"Prof","dw_individual_id":"DW0007214","middle_name":"L","last_name":"Fazzalari","source_individual_id":"RMIS5831069","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Nicola (Nick) Fazzalari"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78651","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60557","size":1},{"color":"#FF4D4D","name":"Excitotoxic Mechanisms in Alcoholic Brain Damage","data":{"media_summary":"","end_year":2008,"keywords":["Gene Expression","Glutamate Receptors and Transporters","Human Brain Damage","Neurotransmission","Pathogenesis"],"nhmrc_grant_id":401551,"application_year":2005,"health_keywords":["Alcohol Abuse and Dependence","Liver Cirrhosis","Neuropathology"],"scientific_title":"Excitotoxic Mechanisms in Alcoholic Brain Damage","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Peter Dodd","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401551","simplified_title":"How Alcohol Misuse Damages the Human Brain","sub_type":"Standard Project Grant","total_budget":"387892.61","source_system":"Brain damage resulting from long-term alcohol abuse is localized to discrete regions of the brain and selectively impairs key neuropsychological functions. Alcohol misuse affects processes that control excitability in the brain, leading to the over-stimulation of brain cells. When this continues for long periods the cells are likely to die and most alcoholics misuse alcohol for most of their adult lives. We will study the human brain s capacity to use and respond to glutamate, its major natural excitant, in the regions that are selectively damaged by alcoholism. How these capacities are affected by heredity, and by diseases commonly associated with alcoholism such as cirrhosis of the liver, will also be explored. If we can understand how selective brain damage occurs in alcoholics we will be better able to devise new drug therapies to combat and prevent it. As well, localized brain damage is a feature of many neurological diseases, so the study will provide a general model of disease mechanisms."},"children":[{"color":"#336699","name":"Dr David Innes","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0031494","middle_name":"J","last_name":"Innes","source_individual_id":"RMIS3676731","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr David Innes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85154","size":1},{"color":"#336699","name":"A/Pr Peter Dodd","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0001312","middle_name":"R","last_name":"Dodd","source_individual_id":"RMIS34635","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Dodd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77036","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60556","size":1},{"color":"#FF4D4D","name":"What people with aphasia want: towards person-centred goal-setting in aphasia rehabilitation","data":{"media_summary":"patient/professional communication","end_year":2008,"keywords":["aphasia","rehabilitation","speech pathology"],"nhmrc_grant_id":401532,"application_year":2005,"health_keywords":["aphasia","collaboration","disabled person","patient preference","patient/professional communication"],"scientific_title":"What people with aphasia want: towards person-centred goal-setting in aphasia rehabilitation","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Hearing and Speech","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Linda Worrall","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401532","simplified_title":"What people with aphasia want: towards person-centred goal-setting in aphasia rehabilitation","sub_type":"Standard Project Grant","total_budget":"427702.77","source_system":"Consumers of health services expect their concerns and priorities to form part of their health care. People with aphasia have difficulty communicating their needs and speech pathologists are challenged to plan therapy to meet aphasic clients' needs. Family members of people with aphasia also have unrecognised concerns. The first aim of this study is to determine the goals of people with aphasia and their families and to gain their perspective of whether these goals were addressed in speech therapy. The study will then seek the perspective of their treating speech pathologists about the goals of therapy and the challenges that speech pathologists face in practising person-centered goal setting. This study will not only provide a framework for aphasia services in Australia but also provide data that will inform professional educational programs about person-centered practice for speech pathologists and other health professionals. It will also contribute to current theories on collaborative goal setting in a rehabilitation context."},"children":[{"color":"#336699","name":"Prof Linda Worrall","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0046389","middle_name":"Elizabeth","last_name":"Worrall","source_individual_id":"RMIS28004","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Worrall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/89016","size":1},{"color":"#336699","name":"Prof Alison Ferguson","data":{"first_name":"Alison","title":"Prof","dw_individual_id":"DW0030657","middle_name":"Jean","last_name":"Ferguson","source_individual_id":"RMIS3674577","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alison Ferguson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84966","size":1},{"color":"#336699","name":"Dr Bronwyn Davidson","data":{"first_name":"Bronwyn","title":"Dr","dw_individual_id":"DW0030263","middle_name":"","last_name":"Davidson","source_individual_id":"RMIS3674571","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Bronwyn Davidson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84847","size":1},{"color":"#336699","name":"Dr Deborah Hersh","data":{"first_name":"Deborah","title":"Dr","dw_individual_id":"DW0025467","middle_name":"Jane","last_name":"Hersh","source_individual_id":"5041805","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Deborah Hersh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83554","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60554","size":1},{"color":"#FF4D4D","name":"Neuroprotection in a model of chronic ocular hypertension","data":{"media_summary":"Vision loss","end_year":2008,"keywords":["Glutamate","Neurodegeneration","Neuroprotection","Retina","Transporters"],"nhmrc_grant_id":401529,"application_year":2005,"health_keywords":["Eye disease","Glaucoma","Neurodegeneration","Retinal ganglion cell death","Vision loss"],"scientific_title":"Neuroprotection in a model of chronic ocular hypertension","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Ophthalmology and Vision Science","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Nigel Barnett","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401529","simplified_title":"Neuroprotection in a model of chronic ocular hypertension","sub_type":"Standard Project Grant","total_budget":"264221.74","source_system":"Damage can occur to nervous tissues like the retina and brain when there is a reduction in the blood supply. This can occur in the eye disease, glaucoma, in which the pressure inside the eye is elevated. This serious condition often results in blindness. Much of the neuronal damage is thought to be due to the release of an excess of glutamate. Glutamate is a chemical (neurotransmitter) that nerves use to communicate with each other, but it is toxic to nerves when present at high concentrations. This project will utilise a new model of glaucoma to investigate the mechanisms that regulate the concentration of glutamate in the retina. If these mechanisms could be made to work more efficiently, they may prevent the build-up of the glutamate and therefore prevent damage to the nerve cells. Understanding these mechanisms will aid in the development of an effective treatment to prevent visual loss in the 150,000 Australians who suffer from glaucoma."},"children":[{"color":"#336699","name":"Prof Glen Gole","data":{"first_name":"Glen","title":"Prof","dw_individual_id":"DW0042673","middle_name":"Anthony","last_name":"Gole","source_individual_id":"RMIS3093523","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Glen Gole"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88064","size":1},{"color":"#336699","name":"A/Pr Nigel Barnett","data":{"first_name":"Nigel","title":"A/Pr","dw_individual_id":"DW0011632","middle_name":"L","last_name":"Barnett","source_individual_id":"5013343","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nigel Barnett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79858","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60553","size":1},{"color":"#FF4D4D","name":"FGF-1 in human adipogenesis","data":{"media_summary":"type 2 diabetes","end_year":2008,"keywords":["FGF receptors","adipogenesis","biochemistry","fibroblast growth factors","obesity"],"nhmrc_grant_id":401528,"application_year":2005,"health_keywords":["cardiovascular disease","insulin resistance","obesity","syndrome X","type 2 diabetes"],"scientific_title":"FGF-1 in human adipogenesis","start_year":2007,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Louise Hutley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401528","simplified_title":"FGF-1 in development of human obesity","sub_type":"New Investigator Grant","total_budget":"438077.01","source_system":"Obesity is becoming more common in Australian adults and children, and is a major contributor to a number of diseases including type 2 diabetes, cardiovascular disease and some cancers. Current weight loss strategies using either lifestyle modification (diet and exercise) or drugs are relatively ineffective in the majority of obese individuals. This is partly due to the fact that we have an incomplete knowledge of the factors that regulate weight in humans. In laboratory studies we have shown that human fat cell development can be dramatically accelerated by fibroblast growth factor-1 (FGF-1). This growth factor is produced by human endothelial cells, which are cells that line the blood vessels in fat tissue. When human fat cell precursors (preadipocytes) are cultured in the presence of FGF-1 the preadipocytes divide much more rapidly than normal and, additionally, then develop into mature fat cells much more rapidly than normal. These processes involved in development of new fat cells form the basis of fat tissue expansion in the body. The effect of FGF-1 on human fat cell development is far greater in magnitude than that of other known factors that promote fat cell growth. The aim of this project is to determine the actual biochemical pathways that mediate the effect of FGF-1 in promoting fat cell growth and development. Results obtained will provide insight into the cellular and molecular mechanisms regulating expansion of fat tissue mass in humans. Research aimed at identifying these underlying mechanisms, or at potentially contributing or exacerbating factors, is critically important in development of novel and more effective approaches to prevention and treatment of obesity."},"children":[{"color":"#336699","name":"Dr Louise Hutley","data":{"first_name":"Louise","title":"Dr","dw_individual_id":"DW0037436","middle_name":"J","last_name":"Hutley","source_individual_id":"RMIS2594062","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Louise Hutley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86697","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60552","size":1},{"color":"#FF4D4D","name":"Development of Hepatitis B surface antigen as a generic vector for the delivery of foreign CTL epitopes.","data":{"media_summary":"vaccine vectors","end_year":2008,"keywords":["hepatitis B","immunotherapy","vaccine development","virology","virus-like particle"],"nhmrc_grant_id":401526,"application_year":2005,"health_keywords":["DNA and VLP Vaccine","hepatitis B surface antigen","immunity-cellular","immunotherapy","vaccine vectors"],"scientific_title":"Development of Hepatitis B surface antigen as a generic vector for the delivery of foreign CTL epitopes.","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof ROBERT TINDLE","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401526","simplified_title":"HBsAg as a generic vaccine vector","sub_type":"Standard Project Grant","total_budget":"439642.61","source_system":"Many kinds of cancer and infections display unique proteins which the body's immune system can recognise as ' foreign', and mount an immune response which, if correctly harnessed, will kill the cancer or infected cells . A way to harness the immune response is to vaccinate with these unique proteins. However, new ways need to be found to deliver the unique proteins to produce the maximal possible anti- cancer or pathogen response, and one that is long lived. In particular one needs to stimulate the cellular arm of the immune response to produce killer cells named CTLs which specifically kill cancer or infected cells. In this project we plan to use an already-licensed human vaccine - the Hepatitis B surface antigen vaccine , or HBsAG, - and genetically modify it to contain important regions of cancer or pathogen proteins termed 'epitopes'. We surmise that immunisation with these modified HBsAg will elicit powerful CTL responses which will killer cancer or infected cells."},"children":[{"color":"#336699","name":"Prof Eric Gowans","data":{"first_name":"Eric","title":"Prof","dw_individual_id":"DW0030966","middle_name":"J","last_name":"Gowans","source_individual_id":"RMIS24406","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Eric Gowans"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85026","size":1},{"color":"#336699","name":"Prof Robert Tindle","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0028412","middle_name":"W","last_name":"Tindle","source_individual_id":"RMIS388145","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Robert Tindle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84347","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60551","size":1},{"color":"#FF4D4D","name":"Practitioner Fellowship","data":{"media_summary":"","end_year":2010,"keywords":["Hepatitis C","Liver disease","Metabolic syndrome","Obesity","Steatosis"],"nhmrc_grant_id":401522,"application_year":2005,"start_year":2006,"scientific_title":"Practitioner Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Elizabeth Powell","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401522","simplified_title":"Practitioner Fellowship","sub_type":"Practitioner Fellowship","total_budget":"296892","source_system":""},"children":[{"color":"#336699","name":"Prof Elizabeth Powell","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0044903","middle_name":"Ellen","last_name":"Powell","source_individual_id":"RMIS13575","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Powell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88622","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60550","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2010,"keywords":["Atherosclerosis","Myofibroblasts","Restenosis","Smooth muscle biology","Tissue engineering"],"nhmrc_grant_id":401511,"application_year":2005,"start_year":2006,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biotechnology not elsewhere classified","research_area":"Basic Science","for_category":"BIOTECHNOLOGY","cia_name":"Prof Julie Campbell","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401511","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"751161","source_system":""},"children":[{"color":"#336699","name":"Prof Julie Campbell","data":{"first_name":"Julie","title":"Prof","dw_individual_id":"DW0000708","middle_name":"H","last_name":"Campbell","source_individual_id":"RMIS330901","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Julie Campbell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76860","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60549","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2011,"keywords":["Biological sciences","Cardiovascular disease","Dyslipidemia","Endocrine diseases and diabetes","Obesity"],"nhmrc_grant_id":401504,"application_year":2005,"start_year":2006,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Sciences not elsewhere classified","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401504","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"805133.33","source_system":""},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60547","size":1},{"color":"#FF4D4D","name":"The role of innate immunity genes in COPD","data":{"media_summary":"","end_year":2008,"keywords":["gene expression","innate immunity","molecular genetics"],"nhmrc_grant_id":401500,"application_year":2005,"health_keywords":["COPD","COPD exacerbation","chronic bronchitis"],"scientific_title":"The role of innate immunity genes in COPD","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Ian Yang","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/401500","simplified_title":"Genes that defend the lungs against infection","sub_type":"Standard Project Grant","total_budget":"353136.74","source_system":"Chronic obstructive pulmonary disease (COPD) is a smoking-induced lung disease that is the fourth leading cause of death in Australia. The immune system is highly likely to play an important role in the progression of this condition, because of the frequency of respiratory infections that occur. We will examine in detail the immune response of COPD patients, examining specific genes and proteins that are important in the defence against bacteria. Blood samples will be obtained from people with COPD who are stable. We will then obtain further blood samples when there is a flare-up of the lung condition, and during recovery. We will compare the results from the blood samples, with variations in the genes that people carry. Information about individual differences in the body's response to infection would help us to better understand how COPD develops, and to initiate research on new methods of diagnosis and treatment of COPD."},"children":[{"color":"#336699","name":"A/Pr Paul Zimmerman","data":{"first_name":"Paul","title":"A/Pr","dw_individual_id":"DW0034971","middle_name":"V","last_name":"Zimmerman","source_individual_id":"RMIS45736","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Paul Zimmerman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86068","size":1},{"color":"#336699","name":"A/Pr Ian Yang","data":{"first_name":"Ian","title":"A/Pr","dw_individual_id":"DW0028973","middle_name":"Anthony","last_name":"Yang","source_individual_id":"RMIS57007","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Ian Yang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84509","size":1},{"color":"#336699","name":"Dr Maria Nataatmadja","data":{"first_name":"Maria","title":"Dr","dw_individual_id":"DW0015191","middle_name":"Inawati","last_name":"Nataatmadja","source_individual_id":"RMIS56558","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Maria Nataatmadja"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80820","size":1},{"color":"#336699","name":"Prof Kwun Fong","data":{"first_name":"Kwun","title":"Prof","dw_individual_id":"DW0007308","middle_name":"M","last_name":"Fong","source_individual_id":"5011833","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Kwun Fong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78670","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60546","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2011,"keywords":["Excitotoxicity","Glia","Glutamate","NMDA","Schizophrenia"],"nhmrc_grant_id":401229,"application_year":2005,"start_year":2006,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof David Pow","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/401229","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"735471.82","source_system":""},"children":[{"color":"#336699","name":"Prof David Pow","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0021533","middle_name":"Vaughan","last_name":"Pow","source_individual_id":"RMIS4392155","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Pow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82534","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60532","size":1},{"color":"#FF4D4D","name":"Identifying healthy BMI, WC, WHR ranges and predicting CVD risk in Indigenous and non Indigenous Australians","data":{"media_summary":"","end_year":2009,"keywords":["Body Mass Index","Cardiovascular disease","Indigenous"],"nhmrc_grant_id":400408,"application_year":2005,"start_year":2006,"scientific_title":"Identifying healthy BMI, WC, WHR ranges and predicting CVD risk in Indigenous and non Indigenous Australians","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Zaimin Wang","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/400408","simplified_title":"Identifying healthy BMI, WC, WHR ranges and predicting CVD risk in Indigenous and non Indigenous Australians","sub_type":"Australian Training ECF for Aboriginal and Torres Strait Islander Health Research","total_budget":"306750","source_system":""},"children":[{"color":"#336699","name":"Dr Zaimin Wang","data":{"first_name":"Zaimin","title":"Dr","dw_individual_id":"DW0005299","middle_name":"","last_name":"Wang","source_individual_id":"RMIS3989308","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Zaimin Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78144","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60434","size":1},{"color":"#FF4D4D","name":"Mechanism of activation of ATM by DNA double strand breaks and other stimuli","data":{"media_summary":"Genetic Defect","end_year":2009,"keywords":["DNA damage","Genetic Disease","Phosphorylation","Radiation Biology","Signal Transduction"],"nhmrc_grant_id":389877,"application_year":2005,"health_keywords":["Ataxia telangiectasia","Biochemistry and molecular biology","Chromosomal Disorders","Gene Expression","Genetic Defect"],"scientific_title":"Mechanism of activation of ATM by DNA double strand breaks and other stimuli","start_year":2006,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/389877","simplified_title":"ATM Activation","sub_type":"Standard Project Grant","total_budget":"517751.61","source_system":"The human genetic disorder ataxia-telangiectasia is a rare human disease characterised by cancer predisposition and neuronal degeneration. The gene defective in this disorder, ATM, plays a central role in recognising damage to the genetic material and activates a number of different cellular pathways designed to maintain stability of genome and minimise the risk of cancer and other pathologies. In this project we are investigating how the protein is activated from a dormant state to phosphorylate a series of substrates involved in cellular signaling. Information in this process is very significant since the genetic lesion that activates ATM is a double strand break in DNA which not only is a potentially lethal lesion to the cell but has also the capacity to destabilize the genetic material. Information on this mechanism will also be useful for the design of small molecules that might interfere with ATM activation and in this way make tumour cells more susceptible to radiotherapy."},"children":[{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60237","size":1},{"color":"#FF4D4D","name":"Population Health Approaches to Dietary Behaviour and Cancer Control","data":{"media_summary":"","end_year":2011,"keywords":["Cancer survivors","dietary behaviour","dietary measurement","quality of life"],"nhmrc_grant_id":389500,"application_year":2005,"start_year":2007,"scientific_title":"Population Health Approaches to Dietary Behaviour and Cancer Control","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nutrition and Dietetics","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Marina Reeves","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/389500","simplified_title":"Population Health Approaches to Dietary Behaviour and Cancer Control","sub_type":"Public Health (Australia) ECF","total_budget":"297752.56","source_system":""},"children":[{"color":"#336699","name":"Dr Marina Reeves","data":{"first_name":"Marina","title":"Dr","dw_individual_id":"DW0009857","middle_name":"M","last_name":"Reeves","source_individual_id":"5017143","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Marina Reeves"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79376","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60218","size":1},{"color":"#FF4D4D","name":"The role of the kidney in the developmental preogramming of adult disease","data":{"media_summary":"","end_year":2010,"keywords":["Advancement of knowledge","Health and Medical Sciences"],"nhmrc_grant_id":384279,"application_year":2005,"start_year":2006,"scientific_title":"The role of the kidney in the developmental preogramming of adult disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"A/Pr Karen Moritz","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/384279","simplified_title":"The role of the kidney in the developmental preogramming of adult disease","sub_type":"RD Wright Biomedical CDF","total_budget":"433124.17","source_system":""},"children":[{"color":"#336699","name":"A/Pr Karen Moritz","data":{"first_name":"Karen","title":"A/Pr","dw_individual_id":"DW0009221","middle_name":"","last_name":"Moritz","source_individual_id":"RMIS1366054","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Karen Moritz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79207","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/60137","size":1},{"color":"#FF4D4D","name":"Equipment Grant","data":{"media_summary":"","end_year":2005,"keywords":["Equipment"],"nhmrc_grant_id":361651,"application_year":2004,"start_year":2005,"scientific_title":"Equipment Grant","node_source":"NHMRC","node_type":"Grant","field_of_research":"n-a","research_area":"Not Applicable","for_category":"N-A","cia_name":"Mrs Deb Ford","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/361651","simplified_title":"Equipment Grant","sub_type":"Equipment Grant","total_budget":"698941","source_system":""},"children":[{"color":"#336699","name":"Mrs Deb Ford","data":{"first_name":"Deb","title":"Mrs","dw_individual_id":"DW0042438","middle_name":"","last_name":"Ford","source_individual_id":"RMIS2960571","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mrs Deb Ford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88007","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6738","size":1},{"color":"#FF4D4D","name":"Detection and management of depression in general practice patients with chronic manifestations of ischaemic heart disea","data":{"media_summary":"","end_year":2008,"keywords":["Angina pectoris","Comorbid depression","General practice","Heart disease","Heart failure"],"nhmrc_grant_id":361324,"application_year":2004,"start_year":2006,"scientific_title":"Detection and management of depression in general practice patients with chronic manifestations of ischaemic heart disea","node_source":"NHMRC","node_type":"Grant","field_of_research":"Primary Health Care","research_area":"Clinical Medicine and Science","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Deborah Askew","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/361324","simplified_title":"Detection and management of depression in general practice patients with chronic manifestations of ischaemic heart disea","sub_type":"General Practice Clinical Research Grant","total_budget":"499797.8","source_system":"This research will investigate the impact of ischemic heart disease on the prevalence and severity of patients with depression. This will be done via a 12 month general practice based program of 1) systematic screening for depression 2) informing general practitioners of best-practice guidelines for management of depression in these patients, and 3) providing the treating general practitioner with patient-specific, psychiatric advice."},"children":[{"color":"#336699","name":"Dr Marie-Louise Dick","data":{"first_name":"Marie-Louise","title":"Dr","dw_individual_id":"DW0036289","middle_name":"B","last_name":"Dick","source_individual_id":"RMIS24318","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Marie-Louise Dick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86405","size":1},{"color":"#336699","name":"Prof Paul Scuffham","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0033702","middle_name":"Anthony","last_name":"Scuffham","source_individual_id":"5011938","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Scuffham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85726","size":1},{"color":"#336699","name":"Prof Thomas Marwick","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0032377","middle_name":"Hugh","last_name":"Marwick","source_individual_id":"RMIS108223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Marwick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85383","size":1},{"color":"#336699","name":"Dr Geoff Schrader","data":{"first_name":"Geoff","title":"Dr","dw_individual_id":"DW0027827","middle_name":"David","last_name":"Schrader","source_individual_id":"RMIS11808","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Geoff Schrader"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84179","size":1},{"color":"#336699","name":"Prof Simon Stewart","data":{"first_name":"Simon","title":"Prof","dw_individual_id":"DW0016448","middle_name":"","last_name":"Stewart","source_individual_id":"RMIS1638564","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Simon Stewart"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81167","size":1},{"color":"#336699","name":"David Wilkinson","data":{"first_name":"David","title":"","dw_individual_id":"DW0011071","middle_name":"","last_name":"Wilkinson","source_individual_id":"RMIS3133085","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Wilkinson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79710","size":1},{"color":"#336699","name":"Prof Alexander Mcfarlane","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0009011","middle_name":"Cowell","last_name":"Mcfarlane","source_individual_id":"RMIS2293440","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Mcfarlane"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79146","size":1},{"color":"#336699","name":"Prof Claire Jackson","data":{"first_name":"Claire","title":"Prof","dw_individual_id":"DW0008114","middle_name":"Louise","last_name":"Jackson","source_individual_id":"RMIS229437","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Claire Jackson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78891","size":1},{"color":"#336699","name":"A/Pr Deborah Askew","data":{"first_name":"Deborah","title":"A/Pr","dw_individual_id":"DW0005862","middle_name":"Anne","last_name":"Askew","source_individual_id":"5012019","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Deborah Askew"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78299","size":1},{"color":"#336699","name":"Mr Tony Wade","data":{"first_name":"Tony","title":"Mr","dw_individual_id":"DW0005238","middle_name":"","last_name":"Wade","source_individual_id":"RMIS3902826","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mr Tony Wade"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78123","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6712","size":1},{"color":"#FF4D4D","name":"Control of blood vessel development by Sox7 transcription factor","data":{"media_summary":"","end_year":2007,"keywords":["Sox7","blood vessels","transcription factors"],"nhmrc_grant_id":361322,"application_year":2004,"start_year":2007,"scientific_title":"Control of blood vessel development by Sox7 transcription factor","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Mathias Francois","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/361322","simplified_title":"Control of blood vessel development by Sox7 transcription factor","sub_type":"INSERM Exchange ECF","total_budget":"71251","source_system":""},"children":[{"color":"#336699","name":"Dr Mathias Francois","data":{"first_name":"Mathias","title":"Dr","dw_individual_id":"DW0019064","middle_name":"","last_name":"Francois","source_individual_id":"RMIS3397245","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Mathias Francois"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81869","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6711","size":1},{"color":"#FF4D4D","name":"Mapping of Susceptibility Genes for Schizophrenia","data":{"media_summary":"","end_year":2006,"keywords":["Genetics","Heterogeneity","Phenotype","Schizophrenia","linkage"],"nhmrc_grant_id":361314,"application_year":2004,"start_year":2005,"scientific_title":"Mapping of Susceptibility Genes for Schizophrenia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Public Health","for_category":"GENETICS","cia_name":"Dr Elizabeth Holliday","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/361314","simplified_title":"Mapping of Susceptibility Genes for Schizophrenia","sub_type":"Public Health Postgraduate Scholarship","total_budget":"42068","source_system":""},"children":[{"color":"#336699","name":"Dr Elizabeth Holliday","data":{"first_name":"Elizabeth","title":"Dr","dw_individual_id":"DW0031363","middle_name":"G","last_name":"Holliday","source_individual_id":"5018893","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Elizabeth Holliday"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85119","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6710","size":1},{"color":"#FF4D4D","name":"The role of 11B HSD Type 1 Activity in Obesity & the Metabolic Syndrome","data":{"media_summary":"","end_year":2008,"keywords":["Glucocorticoids","Metabolic Syndrome","Obesity","Type 2 diabetes"],"nhmrc_grant_id":361313,"application_year":2004,"start_year":2005,"scientific_title":"The role of 11B HSD Type 1 Activity in Obesity & the Metabolic Syndrome","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Janelle Nisbet","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/361313","simplified_title":"The role of 11B HSD Type 1 Activity in Obesity & the Metabolic Syndrome","sub_type":"Medical Postgraduate Scholarship","total_budget":"92684.61","source_system":""},"children":[{"color":"#336699","name":"Janelle Nisbet","data":{"first_name":"Janelle","title":"","dw_individual_id":"DW0038800","middle_name":"","last_name":"Nisbet","source_individual_id":"RMIS3392117","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Janelle Nisbet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87048","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6709","size":1},{"color":"#FF4D4D","name":"Malaria in pregnancy in Solomon Islands","data":{"media_summary":"","end_year":2011,"keywords":["Health Service","Malaria","Pregnancy"],"nhmrc_grant_id":361312,"application_year":2004,"start_year":2005,"scientific_title":"Malaria in pregnancy in Solomon Islands","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Ms Bridget Appleyard","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/361312","simplified_title":"Malaria in pregnancy in Solomon Islands","sub_type":"Public Health Postgraduate Scholarship","total_budget":"87144.92","source_system":""},"children":[{"color":"#336699","name":"Ms Bridget Appleyard","data":{"first_name":"Bridget","title":"Ms","dw_individual_id":"DW0040832","middle_name":"M","last_name":"Appleyard","source_individual_id":"5030606","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Ms Bridget Appleyard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87593","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6708","size":1},{"color":"#FF4D4D","name":"Investigation into role of Inosine-5' Monophosphate Dehydrogenase in lipid accumulation & adipogenesis","data":{"media_summary":"","end_year":2008,"keywords":["Adipogenesis","Enzyme","Lipid","Obesity","Signalling"],"nhmrc_grant_id":361310,"application_year":2004,"start_year":2005,"scientific_title":"Investigation into role of Inosine-5' Monophosphate Dehydrogenase in lipid accumulation & adipogenesis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Metabolism","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Miss Elaine Thomas","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/361310","simplified_title":"Investigation into role of Inosine-5' Monophosphate Dehydrogenase in lipid accumulation & adipogenesis","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"75092.99","source_system":""},"children":[{"color":"#336699","name":"Elaine Thomas","data":{"first_name":"Elaine","title":"","dw_individual_id":"DW0045817","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS3392108","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Elaine Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88849","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6707","size":1},{"color":"#FF4D4D","name":"The role of Novel genes in LImb & Craniofacial development & disease","data":{"media_summary":"","end_year":2007,"keywords":["Craniofacial","Embryonic","Gli3","Limb","Polydactyly"],"nhmrc_grant_id":361308,"application_year":2004,"start_year":2005,"scientific_title":"The role of Novel genes in LImb & Craniofacial development & disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Mr Liam Town","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/361308","simplified_title":"The role of Novel genes in LImb & Craniofacial development & disease","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"53030.95","source_system":""},"children":[{"color":"#336699","name":"Liam Town","data":{"first_name":"Liam","title":"","dw_individual_id":"DW0040112","middle_name":"","last_name":"Town","source_individual_id":"RMIS3392099","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Liam Town"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87390","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6706","size":1},{"color":"#FF4D4D","name":"Clinical application of contrast agents with Echocardiography:Heart disease diagnosis and treatment","data":{"media_summary":"","end_year":2006,"keywords":["contrast","coronary artery disease","echocardiography","health"],"nhmrc_grant_id":361307,"application_year":2004,"start_year":2005,"scientific_title":"Clinical application of contrast agents with Echocardiography:Heart disease diagnosis and treatment","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr William Moir","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/361307","simplified_title":"Clinical application of contrast agents with Echocardiography:Heart disease diagnosis and treatment","sub_type":"Medical Postgraduate Scholarship","total_budget":"53464","source_system":""},"children":[{"color":"#336699","name":"William Moir","data":{"first_name":"William","title":"","dw_individual_id":"DW0020933","middle_name":"","last_name":"Moir","source_individual_id":"RMIS3392235","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"William Moir"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82359","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6705","size":1},{"color":"#FF4D4D","name":"Derivation and application of strain rate imaging to echocardiographic assessments of mycardial function","data":{"media_summary":"","end_year":2006,"keywords":["Coronary artery disease","Mitral regurgitation","Strain rate imaging","Stress echocardiography"],"nhmrc_grant_id":361306,"application_year":2004,"start_year":2005,"scientific_title":"Derivation and application of strain rate imaging to echocardiographic assessments of mycardial function","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Lizelle Hanekom","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/361306","simplified_title":"Derivation and application of strain rate imaging to echocardiographic assessments of mycardial function","sub_type":"Medical Postgraduate Scholarship","total_budget":"60614","source_system":""},"children":[{"color":"#336699","name":"Lizelle Hanekom","data":{"first_name":"Lizelle","title":"","dw_individual_id":"DW0013480","middle_name":"","last_name":"Hanekom","source_individual_id":"RMIS3392226","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Lizelle Hanekom"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80338","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6704","size":1},{"color":"#FF4D4D","name":"Influence of Nerve Injury on the Antinociceptive Effects of Oxycodone & Morphine in rats","data":{"media_summary":"","end_year":2009,"keywords":["Neuropathic pain","Opioid receptors","Oxycodone","antinociception","morphine"],"nhmrc_grant_id":361305,"application_year":2004,"start_year":2005,"scientific_title":"Influence of Nerve Injury on the Antinociceptive Effects of Oxycodone & Morphine in rats","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Miss Lillian Huang","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/361305","simplified_title":"Influence of Nerve Injury on the Antinociceptive Effects of Oxycodone & Morphine in rats","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"95950.14","source_system":""},"children":[{"color":"#336699","name":"Lillian Huang","data":{"first_name":"Lillian","title":"","dw_individual_id":"DW0037395","middle_name":"","last_name":"Huang","source_individual_id":"RMIS3392090","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Lillian Huang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86687","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6703","size":1},{"color":"#FF4D4D","name":"Detection and treatment of early cardiovascular changes in obesity and metabolic syndrome","data":{"media_summary":"","end_year":2006,"keywords":["Health","cardiovascular","obesity","sleep apnea"],"nhmrc_grant_id":361304,"application_year":2004,"start_year":2005,"scientific_title":"Detection and treatment of early cardiovascular changes in obesity and metabolic syndrome","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Chiew Wong","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/361304","simplified_title":"Detection and treatment of early cardiovascular changes in obesity and metabolic syndrome","sub_type":"Medical Postgraduate Scholarship","total_budget":"60614","source_system":""},"children":[{"color":"#336699","name":"A/Pr Chiew Wong","data":{"first_name":"Chiew","title":"A/Pr","dw_individual_id":"DW0028894","middle_name":"Ying","last_name":"Wong","source_individual_id":"5018457","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Chiew Wong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84488","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6702","size":1},{"color":"#FF4D4D","name":"Role and modulation of oxidative stress in age-associated renal pathologies","data":{"media_summary":"","end_year":2008,"keywords":["Ageing","Apoptosis","Caloric Restriction","Kidney disease","Oxidative stress"],"nhmrc_grant_id":361303,"application_year":2004,"start_year":2005,"scientific_title":"Role and modulation of oxidative stress in age-associated renal pathologies","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Miss Christine Percy","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/361303","simplified_title":"Role and modulation of oxidative stress in age-associated renal pathologies","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"75092.99","source_system":""},"children":[{"color":"#336699","name":"Dr Christine Percy","data":{"first_name":"Christine","title":"Dr","dw_individual_id":"DW0044779","middle_name":"Jane","last_name":"Percy","source_individual_id":"RMIS3392081","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Christine Percy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88587","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6701","size":1},{"color":"#FF4D4D","name":"Bacterial mechanosensitive channels as novel targets for antibacterial agents","data":{"media_summary":"pathogenic bacterial infection","end_year":2007,"keywords":["antibiotic development","computational chemistry","drug design","ion channels, patch clamp","structural biology, electron spin resonance, crystallography"],"nhmrc_grant_id":353619,"application_year":2004,"health_keywords":["Clostridium perfrigens (wound infections, food poisoning)","H. infuenzae (otitis media, meningitis, septic arthritis)","Mycobacterium tuberculosis (tuberculosis)","antibiotic resistance","pathogenic bacterial infection"],"scientific_title":"Bacterial mechanosensitive channels as novel targets for antibacterial agents","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Therapies and Therapeutic Technology","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Boris Martinac","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/353619","simplified_title":"Towards the development of a new class of antibacterial drugs","sub_type":"Standard Project Grant","total_budget":"424500","source_system":"The focus of this research is the development of new antibiotics to combat bacterial antibiotic resistance. Since their discovery antibiotics have had a profound effect on the health and well being of mankind, providing ready effective treatment for otherwise intractable infections. Although pencillin was initially effective against a large range of infections by the 1950s it was apparent that some bacterial strains had become resistant to this antibiotic. Partially in response to this resistance new antibiotics such as streptomycin, chloramphenicol and tetracycline were developed. These new drugs were potent against both Gram-positive and Gram-negative bacteria. However, there were early signs that resistance to these drugs was also emerging. For example, in 1953, during a Shigella outbreak in Japan, a strain of the dysentery bacillus was isolated which was multi-drug resistant, exhibiting resistance to chloramphenicol, tetracycline, streptomycin and the sulfanilamides. Multidrug-resistance in pathogenic strains of bacteria has in the last decade presented an increasing problem in treatment of bacterial infections and diseases. In 1994 a Melbourne public hospital reported a new antibiotic resistant strain of bacteria. This bacterium was resistant to vancomycin (the antibiotic used when all others have failed) and is known as VRE or vancomycin resistant enterococcus. Now strains of golden staph resistant to all antibiotics have appeared. The re-emergence of tuberculosis (TB), which kills more than 3 million people annually and which is spreading rapidly throughout the world, is also a serious threat, particularly as many strains are now multi-drug resistant. New antibiotics are needed that overcome bacterial drug resistance. It is anticipated that this research will lead to new antibiotics by exploiting molecular components of bacteria that have only recently been identified."},"children":[{"color":"#336699","name":"Prof Thomas Riley","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0045089","middle_name":"Victor","last_name":"Riley","source_individual_id":"RMIS6184054","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Riley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88676","size":1},{"color":"#336699","name":"Prof Matthew Wilce","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0034708","middle_name":"Charles James","last_name":"Wilce","source_individual_id":"RMIS182462","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Matthew Wilce"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85991","size":1},{"color":"#336699","name":"Prof Allan Mckinley","data":{"first_name":"Allan","title":"Prof","dw_individual_id":"DW0032509","middle_name":"James","last_name":"Mckinley","source_individual_id":"RMIS1647700","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Allan Mckinley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85417","size":1},{"color":"#336699","name":"Prof Boris Martinac","data":{"first_name":"Boris","title":"Prof","dw_individual_id":"DW0020659","middle_name":"","last_name":"Martinac","source_individual_id":"5012362","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Boris Martinac"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82276","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6495","size":1},{"color":"#FF4D4D","name":"Bacterial Pathogenesis: a genomic approach","data":{"media_summary":"","end_year":2007,"keywords":["evolution","genomics","mutation","pseudomonas"],"nhmrc_grant_id":351697,"application_year":2004,"start_year":2005,"scientific_title":"Bacterial Pathogenesis: a genomic approach","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Scott Beatson","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/351697","simplified_title":"Bacterial Pathogenesis: a genomic approach","sub_type":"Howard Florey Centenary ECF","total_budget":"175686.94","source_system":""},"children":[{"color":"#336699","name":"Dr Scott Beatson","data":{"first_name":"Scott","title":"Dr","dw_individual_id":"DW0035306","middle_name":"A","last_name":"Beatson","source_individual_id":"5013405","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Scott Beatson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86151","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6426","size":1},{"color":"#FF4D4D","name":"Identification of secreted that maintain metanephric mesenchyme using kidney explant cultures and transplantation assays.","data":{"media_summary":"","end_year":2011,"keywords":["Kidney disease"],"nhmrc_grant_id":351696,"application_year":2004,"start_year":2005,"scientific_title":"Identification of secreted that maintain metanephric mesenchyme using kidney explant cultures and transplantation assays.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Fiona Rae","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/351696","simplified_title":"Screening for novel renal growth factors for use in development of therapies for kidney disease.","sub_type":"Industry ECF","total_budget":"379859.22","source_system":""},"children":[{"color":"#336699","name":"Dr Fiona Rae","data":{"first_name":"Fiona","title":"Dr","dw_individual_id":"DW0044970","middle_name":"K","last_name":"Rae","source_individual_id":"5017086","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Fiona Rae"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88642","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6425","size":1},{"color":"#FF4D4D","name":"Development Of Novel And Selective Anticancer Drugs Derived From Cysteine.","data":{"media_summary":"","end_year":2006,"keywords":["anticancer drugs","cancer chemotherapy","cell cycle","drug design","melanoma"],"nhmrc_grant_id":351688,"application_year":2004,"start_year":2005,"scientific_title":"Development Of Novel And Selective Anticancer Drugs Derived From Cysteine.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/351688","simplified_title":"Selective Anticancer Drugs.","sub_type":"Development Grant","total_budget":"264250","source_system":"In the next few years cancer is projected to become the leading cause of death in industrialised countries. Cancer chemotherapy currently relies on destruction of tumours by toxic drugs that indiscriminately kill all cell types, resulting in side effects that limit treatment. In the 21st century new cancer drugs will more effectively destroy malignant tumour cells without damaging normal cells. The R and D herein will value-add to our discovery of a new class of potent and orally active anti-tumour drugs that possess unusually high selectivity in acting on cancer cells without killing normal human cells. Our current proof of concept will be turned into a drug development candidate that will improve our negotiating position with commercial partners."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6424","size":1},{"color":"#FF4D4D","name":"Automated seizure detection in the newborn.","data":{"media_summary":"","end_year":2006,"keywords":["brain development","fetal hypoxia and birth trauma","infant, newborn diseases","newborn infant","perinatal asphyxia"],"nhmrc_grant_id":351682,"application_year":2004,"start_year":2005,"scientific_title":"Automated seizure detection in the newborn.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Prof Paul Colditz","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/351682","simplified_title":"Automated seizure detection in the newborn","sub_type":"Development Grant","total_budget":"243750","source_system":"Newborn babies are at risk of becoming short of oxygen during delivery and sustaining brain damage. Seizures may cause further damage to the brain because they release damaging chemicals or make extra energy demands on the brain that cannot be met. To detect seizures, it is necessary to measure the EEG, the tiny electrical signals from the brain. We are proposing to automatically detect and count seizures, building upon 8 years of fundamental EEG signal processing research work we have undertaken. We anticipate that the product will be of major commercial interest. We will further explore what is a rapidly expanding marketplace and ensure we maximize the commercial return on this product."},"children":[{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1},{"color":"#336699","name":"Prof Boualem Boashash","data":{"first_name":"Boualem","title":"Prof","dw_individual_id":"DW0000451","middle_name":"","last_name":"Boashash","source_individual_id":"RMIS477867","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Boualem Boashash"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76779","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6423","size":1},{"color":"#FF4D4D","name":"An investigation of the mechanisms of cervical muscle impairment in people with chronic neck pain.","data":{"media_summary":"","end_year":2008,"keywords":["experimental pain","motor control","muscle physiology","neck pain"],"nhmrc_grant_id":351678,"application_year":2004,"start_year":2005,"scientific_title":"An investigation of the mechanisms of cervical muscle impairment in people with chronic neck pain.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Deborah Falla","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/351678","simplified_title":"An investigation of the mechanisms of cervical muscle impairment in people with chronic neck pain.","sub_type":"CJ Martin Biomedical ECF","total_budget":"280741.63","source_system":""},"children":[{"color":"#336699","name":"Deborah Falla","data":{"first_name":"Deborah","title":"","dw_individual_id":"DW0001496","middle_name":"","last_name":"Falla","source_individual_id":"RMIS2639378","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Deborah Falla"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77080","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6422","size":1},{"color":"#FF4D4D","name":"Characterisation of the Chfr mediated mitotic checkpoint arrest.","data":{"media_summary":"","end_year":2010,"keywords":["Chfr","arrest","cancer","mitosis"],"nhmrc_grant_id":351675,"application_year":2004,"start_year":2005,"scientific_title":"Characterisation of the Chfr mediated mitotic checkpoint arrest.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Andrew Burgess","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/351675","simplified_title":"Characterisation of the Chfr mediated mitotic checkpoint arrest.","sub_type":"INSERM Exchange ECF","total_budget":"315033.18","source_system":""},"children":[{"color":"#336699","name":"Dr Andrew Burgess","data":{"first_name":"Andrew","title":"Dr","dw_individual_id":"DW0012078","middle_name":"J","last_name":"Burgess","source_individual_id":"5013686","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Andrew Burgess"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79968","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6421","size":1},{"color":"#FF4D4D","name":"Type 2 diabetes and chronic liver disease: An emerging relationship between co-morbid diseases of obesity.","data":{"media_summary":"","end_year":2009,"keywords":["Diabetes","Fatty liver","Insulin resistance","Obesity","Weight loss outcomes"],"nhmrc_grant_id":351669,"application_year":2004,"start_year":2005,"scientific_title":"Type 2 diabetes and chronic liver disease: An emerging relationship between co-morbid diseases of obesity.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Ingrid Hickman","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/351669","simplified_title":"Type 2 diabetes and chronic liver disease: An emerging relationship between co-morbid diseases of obesity.","sub_type":"Australian Clincal Research ECF","total_budget":"272812.5","source_system":""},"children":[{"color":"#336699","name":"Dr Ingrid Hickman","data":{"first_name":"Ingrid","title":"Dr","dw_individual_id":"DW0043028","middle_name":"J","last_name":"Hickman","source_individual_id":"5015215","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ingrid Hickman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88150","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6420","size":1},{"color":"#FF4D4D","name":"Exploiting DNA repair defects in breast cancer as a novel chemotherapeutic strategy.","data":{"media_summary":"","end_year":2011,"keywords":["BRCA1 and BRCA2","Chemotherapeutics","DNA repair","breast cancer"],"nhmrc_grant_id":351667,"application_year":2004,"start_year":2005,"scientific_title":"Exploiting DNA repair defects in breast cancer as a novel chemotherapeutic strategy.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Stacey Wardrop","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/351667","simplified_title":"Exploiting DNA repair defects in breast cancer as a novel chemotherapeutic strategy.","sub_type":"CJ Martin Biomedical ECF","total_budget":"409810.28","source_system":""},"children":[{"color":"#336699","name":"Stacey Wardrop","data":{"first_name":"Stacey","title":"","dw_individual_id":"DW0034580","middle_name":"","last_name":"Wardrop","source_individual_id":"5030632","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Stacey Wardrop"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85962","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6419","size":1},{"color":"#FF4D4D","name":"Effect of conflicting respiratory,continence,and postural demands on postural control of the trunk","data":{"media_summary":"","end_year":2006,"keywords":["Back pain","Motor control","Respiratory Disease","Urinary incontinence"],"nhmrc_grant_id":351664,"application_year":2004,"start_year":2005,"scientific_title":"Effect of conflicting respiratory,continence,and postural demands on postural control of the trunk","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Michelle Smith","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351664","simplified_title":"Effect of conflicting respiratory,continence,and postural demands on postural control of the trunk","sub_type":"Public Health Postgraduate Scholarship","total_budget":"50848.38","source_system":""},"children":[{"color":"#336699","name":"Dr Michelle Smith","data":{"first_name":"Michelle","title":"Dr","dw_individual_id":"DW0045508","middle_name":"D","last_name":"Smith","source_individual_id":"RMIS3392203","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Michelle Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88773","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6418","size":1},{"color":"#FF4D4D","name":"Foot orthotics in the treatment of patellofemoral pain syndrome; A RCT in primary care","data":{"media_summary":"","end_year":2007,"keywords":["Exercise","Foot orthotics","Injury","Musculoskeletal pain","Physical activity"],"nhmrc_grant_id":351663,"application_year":2004,"start_year":2005,"scientific_title":"Foot orthotics in the treatment of patellofemoral pain syndrome; A RCT in primary care","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Miss Natalie Collins","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351663","simplified_title":"Foot orthotics in the treatment of patellofemoral pain syndrome; A RCT in primary care","sub_type":"Public Health Postgraduate Scholarship","total_budget":"66945.26","source_system":""},"children":[{"color":"#336699","name":"Dr Natalie Collins","data":{"first_name":"Natalie","title":"Dr","dw_individual_id":"DW0035967","middle_name":"J","last_name":"Collins","source_individual_id":"5018746","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Natalie Collins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86325","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6417","size":1},{"color":"#FF4D4D","name":"To investage into the role of protein tyrosine phosphatase dep-1 in macrophages","data":{"media_summary":"","end_year":2006,"keywords":["Dep-1","Macrophage","Regulation"],"nhmrc_grant_id":351661,"application_year":2004,"start_year":2005,"scientific_title":"To investage into the role of protein tyrosine phosphatase dep-1 in macrophages","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Mrs Richa Dave","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351661","simplified_title":"To investage into the role of protein tyrosine phosphatase dep-1 in macrophages","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"42068","source_system":""},"children":[{"color":"#336699","name":"Richa Dave","data":{"first_name":"Richa","title":"","dw_individual_id":"DW0041907","middle_name":"","last_name":"Dave","source_individual_id":"RMIS3392057","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Richa Dave"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87871","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6416","size":1},{"color":"#FF4D4D","name":"Cadherin-Microtubule Cooperativity: Implications of Cell-Cell Recognition","data":{"media_summary":"","end_year":2007,"keywords":["Adhesion","Cadherin","Cancer","Microtubules","Morphogenesis"],"nhmrc_grant_id":351660,"application_year":2004,"start_year":2005,"scientific_title":"Cadherin-Microtubule Cooperativity: Implications of Cell-Cell Recognition","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Miss Samantha Stehbens","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351660","simplified_title":"Cadherin-Microtubule Cooperativity: Implications of Cell-Cell Recognition","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"53031.95","source_system":""},"children":[{"color":"#336699","name":"Dr Samantha Stehbens","data":{"first_name":"Samantha","title":"Dr","dw_individual_id":"DW0039857","middle_name":"","last_name":"Stehbens","source_individual_id":"RMIS3392031","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Samantha Stehbens"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87330","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6415","size":1},{"color":"#FF4D4D","name":"Molecular Genetics of Innate Immunity in Lung diseases","data":{"media_summary":"","end_year":2007,"keywords":["COPD asthma","Innate immunity","bronchiectasis","molecular genetics"],"nhmrc_grant_id":351657,"application_year":2004,"start_year":2005,"scientific_title":"Molecular Genetics of Innate Immunity in Lung diseases","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Ms Santiyagu Savarimuthu Francis","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351657","simplified_title":"Molecular Genetics of Innate Immunity in Lung diseases","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"63935","source_system":""},"children":[{"color":"#336699","name":"Ms Santiyagu Savarimuthu Francis","data":{"first_name":"Santiyagu","title":"Ms","dw_individual_id":"DW0004458","middle_name":"M","last_name":"Savarimuthu Francis","source_individual_id":"RMIS3392024","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Santiyagu Savarimuthu Francis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77906","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6413","size":1},{"color":"#FF4D4D","name":"Cortical motor topography of the abdominal muscles in people with & without chronic low back pain","data":{"media_summary":"","end_year":2007,"keywords":["Motor control","Motor cortex plaxticity","Motor learning","low back pain"],"nhmrc_grant_id":351656,"application_year":2004,"start_year":2005,"scientific_title":"Cortical motor topography of the abdominal muscles in people with & without chronic low back pain","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Hearing and Speech","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Henry Tsao","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351656","simplified_title":"Cortical motor topography of the abdominal muscles in people with & without chronic low back pain","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"80690","source_system":""},"children":[{"color":"#336699","name":"Dr Henry Tsao","data":{"first_name":"Henry","title":"Dr","dw_individual_id":"DW0016722","middle_name":"","last_name":"Tsao","source_individual_id":"RMIS3392185","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Henry Tsao"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81242","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6412","size":1},{"color":"#FF4D4D","name":"Myocardial Structure & Metabolism in Viable Myocardium: Therapeutic Implicaitons for Functional Recovery & Remodelling","data":{"media_summary":"","end_year":2008,"keywords":["MRI","echo","remodelling","viability"],"nhmrc_grant_id":351655,"application_year":2004,"start_year":2005,"scientific_title":"Myocardial Structure & Metabolism in Viable Myocardium: Therapeutic Implicaitons for Functional Recovery & Remodelling","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Jonathon Chan","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351655","simplified_title":"Myocardial Structure & Metabolism in Viable Myocardium: Therapeutic Implicaitons for Functional Recovery & Remodelling","sub_type":"Medical Postgraduate Scholarship","total_budget":"62017","source_system":""},"children":[{"color":"#336699","name":"Jonathon Chan","data":{"first_name":"Jonathon","title":"","dw_individual_id":"DW0000793","middle_name":"","last_name":"Chan","source_individual_id":"RMIS3392170","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Jonathon Chan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76883","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6411","size":1},{"color":"#FF4D4D","name":"Lifetime risk fators & casual pathways for common mental disorders in young adults to 21 years","data":{"media_summary":"","end_year":2007,"keywords":["Life course epidemiology","Longitudinal study","Mental health disorders & symptoms","Risk pathways","Young adults"],"nhmrc_grant_id":351654,"application_year":2004,"start_year":2005,"scientific_title":"Lifetime risk fators & casual pathways for common mental disorders in young adults to 21 years","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Ms Kaeleen Dingle","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351654","simplified_title":"Lifetime risk fators & casual pathways for common mental disorders in young adults to 21 years","sub_type":"Public Health Postgraduate Scholarship","total_budget":"80689","source_system":""},"children":[{"color":"#336699","name":"Dr Kaeleen Dingle","data":{"first_name":"Kaeleen","title":"Dr","dw_individual_id":"DW0042040","middle_name":"Deanne","last_name":"Dingle","source_individual_id":"RMIS3392255","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Kaeleen Dingle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87899","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6410","size":1},{"color":"#FF4D4D","name":"B-Arrestin Function in Macrophages","data":{"media_summary":"","end_year":2008,"keywords":["B-Arrestin","G-protein coupled receptor","Macrophage"],"nhmrc_grant_id":351651,"application_year":2004,"start_year":2005,"scientific_title":"B-Arrestin Function in Macrophages","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Ms Jane Lattin","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351651","simplified_title":"B-Arrestin Function in Macrophages","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"75089.91","source_system":""},"children":[{"color":"#336699","name":"Ms Jane Lattin","data":{"first_name":"Jane","title":"Ms","dw_individual_id":"DW0008538","middle_name":"","last_name":"Lattin","source_individual_id":"RMIS3391920","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Jane Lattin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79013","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6409","size":1},{"color":"#FF4D4D","name":"Assessing acquired neurogenic communication disorders online: a telerehabilitation application","data":{"media_summary":"","end_year":2007,"keywords":["Assessment","Communication disorders","Internet","Speech-=Language Pathology","Telerehabilitation"],"nhmrc_grant_id":351649,"application_year":2004,"start_year":2005,"scientific_title":"Assessing acquired neurogenic communication disorders online: a telerehabilitation application","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Hearing and Speech","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Ms Anne Hill","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351649","simplified_title":"Assessing acquired neurogenic communication disorders online: a telerehabilitation application","sub_type":"Public Health Postgraduate Scholarship","total_budget":"80689","source_system":""},"children":[{"color":"#336699","name":"Anne Hill","data":{"first_name":"Anne","title":"","dw_individual_id":"DW0043040","middle_name":"","last_name":"Hill","source_individual_id":"RMIS3392142","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Anne Hill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88153","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6408","size":1},{"color":"#FF4D4D","name":"Gene expression profiles in Chronic Periodontitis patients with Type-2 Diabetes","data":{"media_summary":"","end_year":2008,"keywords":["Gene arrays","Host modulation","Immonology","Periodontal disease","Type-2 Diabetes"],"nhmrc_grant_id":351647,"application_year":2004,"start_year":2005,"scientific_title":"Gene expression profiles in Chronic Periodontitis patients with Type-2 Diabetes","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dentistry not elsewhere classified","research_area":"Basic Science","for_category":"DENTISTRY","cia_name":"Dr Marie Matias","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351647","simplified_title":"Gene expression profiles in Chronic Periodontitis patients with Type-2 Diabetes","sub_type":"Dental Postgraduate Research Scholarship","total_budget":"108081.34","source_system":""},"children":[{"color":"#336699","name":"Marie Matias","data":{"first_name":"Marie","title":"","dw_individual_id":"DW0032395","middle_name":"","last_name":"Matias","source_individual_id":"RMIS3391875","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Marie Matias"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85386","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6407","size":1},{"color":"#FF4D4D","name":"Investigation of the mechanisms by which steatosis contributes to hepatic fibrogenesis","data":{"media_summary":"","end_year":2008,"keywords":["apoptosis","hepatic fibrosis","hepatic steatosis","hepatitis C","hepatocyte proliferation"],"nhmrc_grant_id":351642,"application_year":2004,"start_year":2005,"scientific_title":"Investigation of the mechanisms by which steatosis contributes to hepatic fibrogenesis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Miss Meagan Walsh","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351642","simplified_title":"Investigation of the mechanisms by which steatosis contributes to hepatic fibrogenesis","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"53708.31","source_system":""},"children":[{"color":"#336699","name":"Meagan Walsh","data":{"first_name":"Meagan","title":"","dw_individual_id":"DW0005273","middle_name":"","last_name":"Walsh","source_individual_id":"RMIS3391821","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Meagan Walsh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78130","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6406","size":1},{"color":"#FF4D4D","name":"The detection & prevention of adverse events in acute gastroenterology hospital patients","data":{"media_summary":"","end_year":2007,"keywords":["Adverse events","Gastroenterology","Health care teams","Medical education","Simulation"],"nhmrc_grant_id":351641,"application_year":2004,"start_year":2005,"scientific_title":"The detection & prevention of adverse events in acute gastroenterology hospital patients","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Information Systems (incl. Surveillance)","research_area":"Clinical Medicine and Science","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr David Hewett","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/351641","simplified_title":"The detection & prevention of adverse events in acute gastroenterology hospital patients","sub_type":"Medical Postgraduate Scholarship","total_budget":"92037","source_system":""},"children":[{"color":"#336699","name":"A/Pr David Hewett","data":{"first_name":"David","title":"A/Pr","dw_individual_id":"DW0031284","middle_name":"George","last_name":"Hewett","source_individual_id":"RMIS3392133","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr David Hewett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85098","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6405","size":1},{"color":"#FF4D4D","name":"Early detection of hearing damage in children receiving anticancer chemotherapy","data":{"media_summary":"","end_year":2008,"keywords":["Audiology","Child health","Drug toxicity","Hearing","Ototoxicity"],"nhmrc_grant_id":351595,"application_year":2004,"health_keywords":["Auditory dysfunction in oncology patients","Hearing loss, sensorineural","Ototoxicity in children receiving chemotherapy","Pharmacology-toxicology"],"scientific_title":"Early detection of hearing damage in children receiving anticancer chemotherapy","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Hearing and Speech","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Dr Joseph Kei","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351595","simplified_title":"Early detection of hearing damage in children with cancer","sub_type":"Standard Project Grant","total_budget":"197500","source_system":"Children surviving cancer are often left with a severe permanent hearing loss. However, very little progress has been made to minimize hearing damage in this special population. Early detection of hearing damage is not possible using traditional assessment tools. The present research seeks to investigate the use of innovative testing techniques to identify hearing damage in the early stages of the disease with high accuracy. If successful, the research will alter standard audiometric practice in hospital clinics around Australia, hence improving the standard of hearing health care for this group. The early diagnosis of hearing impairment will not only provide a chance for doctors to balance the therapeutic effects of anticancer drugs against the danger of a permanent hearing loss, but also enable allied health professionals and educational specialist to provide timely management strategies. The determination of the rate and extent of hearing dysfunction progression in children receiving chemotherapy, as proposed in this research, enables the ototoxic effects of existing drugs to be compared. With this approach, the ototoxic side effects of new drugs can also be evaluated. In summary, the proposed study will improve the quality and efficiency of audiological service delivery to young children undergoing chemotherapy in Australia and overseas."},"children":[{"color":"#336699","name":"A/Pr Joseph Kei","data":{"first_name":"Joseph","title":"A/Pr","dw_individual_id":"DW0002584","middle_name":"","last_name":"Kei","source_individual_id":"5015638","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Joseph Kei"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77375","size":1},{"color":"#336699","name":"A/Pr Bruce Charles","data":{"first_name":"Bruce","title":"A/Pr","dw_individual_id":"DW0000818","middle_name":"","last_name":"Charles","source_individual_id":"RMIS24960","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Bruce Charles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76890","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6403","size":1},{"color":"#FF4D4D","name":"The West Nile viral protease, NS3: a target for antiviral drug and vaccine design","data":{"media_summary":"","end_year":2005,"keywords":["Drug Design","Enzyme","Inhibitor","Protease","West Nile Virus"],"nhmrc_grant_id":351594,"application_year":2004,"health_keywords":["infectious disease","vaccine strategy","viral inhibitor"],"scientific_title":"The West Nile viral protease, NS3: a target for antiviral drug and vaccine design","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Enzymes","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351594","simplified_title":"West Nile virus drug and vaccine development","sub_type":"Standard Project Grant","total_budget":"230500","source_system":"The West Nile Virus (WNV) was first isolated from a woman in the West Nile region of Uganda in 1937. It is one of ~70 known flaviviruses (e.g. Dengue fever, Yellow fever, West Nile, Kunjun, Japanese encephalitis, St. Louis encephalitis, tick-borne encephalitis, Australian encephalitis and the related hepatitis C virus) which annually infect hundreds of millions of people worldwide, particularly in tropical and sub-tropical areas, and cause major public health problems. WNV is endemic in the Middle East, parts of Africa and Europe, but recent epidemics in Israel (1998), Romania (1996), United States (1999), and UK (2003) have been characterized by severe symptoms , severe neurological pathology, and fatalities. In the USA alone there were 4,156 infections and 284 deaths in 2002, 9122 infections and 223 deaths in 2003, and this mosquito borne virus has quickly spread since 1999 through all USA states and into Canada and Mexico (http:--www.cdc.gov-ncidod-dvbid-westnile-index.htm). No treatments or vaccines are available. This project focuses on an enzyme, known as the West Nile Virus NS3 protease, that is essential for replication of the virus. By studying the enzyme in the laboratory we can design small molecules that can block its function and these have real potential as leads for development of drug treatments for people infected by this virus. A precedent is the success of inhibitors of HIV-1 protease that are the most effective treatment for humans with HIV-infections. Our studies will also be used to develop potential vaccines. The science involves experts on protease enzymes, drug design and development, virology including West Nile virology, and vaccine development. We expect to generate drug and vaccine candidates and new information for their development that is at the cutting edge of West Nile Virus research."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1},{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"Prof Roy Hall","data":{"first_name":"Roy","title":"Prof","dw_individual_id":"DW0025278","middle_name":"A","last_name":"Hall","source_individual_id":"RMIS16831","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roy Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83509","size":1},{"color":"#336699","name":"Prof Paul Young","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0005625","middle_name":"R","last_name":"Young","source_individual_id":"RMIS20614","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78234","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6402","size":1},{"color":"#FF4D4D","name":"New leads for Anti-Cancer Drug Development","data":{"media_summary":"","end_year":2007,"keywords":["Anti-cancer drugs","Drug Design","Protein Chemistry"],"nhmrc_grant_id":351590,"application_year":2004,"health_keywords":["Anti cancer Development","Anti-tumor drugs","Novel therapeutics"],"scientific_title":"New leads for Anti-Cancer Drug Development","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351590","simplified_title":"Novel Anti-cancer agents","sub_type":"Standard Project Grant","total_budget":"326250","source_system":"There is an ongoing need for the development of new anticancer drugs, particularly those directed against solid tumours. In the past plants have been an extremely valuable source of anticancer agents, including the world s best selling anticancer drug, Taxol, isolated from the Pacific Yew tree. However, such molecules are typically complex and often very expensive to manufacture or extract from natural sources. So far very little attention has been paid to protein-based molecules from plants as potential anticancer agents because pharmaceutical companies have focused on organic molecules. In principle protein-based molecules could be produced much more cheaply and thus made available more widely to patients than existing drugs. All that is required are the lead molecules, or proteins that display sufficient anticancer activity to be used as the basis for further optimization. We have discovered a family of plant proteins called the cyclotides that have recently been shown to have considerable promise as anticancer agents. In the current project we will use synthetic chemistry to modify selected amino acids on the surface of this new family of proteins to determine which parts of the molecules are responsible for their activity. We will use this information to design improved analogues. The project is a collaboration between researchers at the Institute for Molecular Bioscience, University of Queensland, who have expertise in the required peptide chemistry and researchers and clinicians at Uppsala University, Sweden who have a range of assays and clinical expertise to test the new molecules. Both groups have been centrally involved in the discovery of the cyclotide family of plant proteins and are committed to developing them as exciting new anticancer agents."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6401","size":1},{"color":"#FF4D4D","name":"Validating a new model for growth hormone receptor activation","data":{"media_summary":"obesity prevention","end_year":2007,"keywords":["endocrine therapy","growth hormone","hormone signalling","tyrosine kinase receptor"],"nhmrc_grant_id":351584,"application_year":2004,"health_keywords":["cancer therapy","cardiovascular disease","diabetic retinopathy","growth hormone deficiency","obesity prevention"],"scientific_title":"Validating a new model for growth hormone receptor activation","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael WATERS","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351584","simplified_title":"A new paradigm for activation of the body growth receptor","sub_type":"Standard Project Grant","total_budget":"472500","source_system":"Growth hormone is an important hormone therapeutic for treating dwarfism. Recently, many new therapeutic applications for growth hormone have been discovered, particularly in relation to its anabolic actions. These include post surgery recovery, enhanced bone fracture healing, Crohns disease, dilated cardiomyopathy, infertility and ageing. The hormone exerts these actions through its receptor, which is a class1 cytokine receptor, similar to many receptors important in regulating immunity, inflammation, metabolism and cancers. In principle, if we can find out how the GH receptor works, this information would help in designing drugs to treat many immune and inflammatory disorders. With current NHMRC support we have developed a model which describes how GH activates the receptor at a molecular level. The model involves two pre-associated receptors at the cell surface binding to the hormone, with the result that the receptors are rotated relative to each other, and this brings the two JAK2 signalling units attached tothe receptor inside the cell into alignment, so they can activate each other. We can activate the receptor without hormone by artificially rotating it. This model is a prediction based on several techniques, but lacks proof of rotation. There are also a number of issues relating to the need for rigidity in the receptors, so the torque can be transmitted into the cell, since many believe there is no rigidity just above the membrane. We predict there is , but need to prove this. This information is vital for designing small orally active mimics of growth hormone, and for developing GH antagonists, likely to be useful for breast and colon cancer. Finally, we have evidence that the specificity of receptor signalling can be changed by mutating the outer part of the receptor (novel). We believe this can be used to change the activity spectrum of GH, hence decrease side effects, by developing analogs which activate one pathway or the other."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6400","size":1},{"color":"#FF4D4D","name":"Empowerment as a strategy for wellbeing in Indigenous settings: developing tools to systematically evaluate outcomes","data":{"media_summary":"healthier environments","end_year":2006,"keywords":["Empowerment research","Health Outcomes research","Indigenous health","Individual, group and community capacity"],"nhmrc_grant_id":351582,"application_year":2004,"health_keywords":["Improved self worth","Mastery and control","Social and emotional health","Stronger social networks","healthier environments"],"scientific_title":"Empowerment as a strategy for wellbeing in Indigenous settings: developing tools to systematically evaluate outcomes","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Social and Community Psychology","research_area":"Public Health","for_category":"PSYCHOLOGY","cia_name":"Dr Melissa Haswell-Elkins","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351582","simplified_title":"Empowerment as a strategy for wellbeing in Indigenous settings: developing tools to systematically evaluate outcomes","sub_type":"Standard Project Grant","total_budget":"403100","source_system":"This project will add significant strength to one of Australia's key initiatives in the promotion of health and well-being, namely the Family Well Being Program . This program was developed by a group of Aboriginal people based in Adelaide in order to specifically address the effects of colonisation on the emotional health and wellbeing of Indigenous Australians. It is a nationally accredited course and has been delivered in a wide variety of settings and participating groups. Previous evaluation using in-depth interviews, focus groups and course evaluation forms have revealed long lasting increases in participants' life skills and problem-solving capacity, thereby making them better able to help themselves and the young people around them to deal with emotions and life's challenges. Changes are particularly profound among individuals who have completed the full Four Stage Program (40 week course) and their families and communities. Up to now, the impact and outcome of the Family Well Being Program has not had a way of being objectively measured in the way that other health promotion programs have. This is partly due to the complexity of its aims; empowering people to take control of their lives, as opposed to trying to directly change behaviours that place them at risk of illness. It is also because the definition, pathway and results of becoming an empowered person, group and community are not completely understood and are likely to be expressed differently from one social and cultural group to another. This current project aims to gain a clearer understanding of the meaning, experience, outcomes and values people attach to empowerment; then use this information to design tools to help assess the effectiveness of programs that seek to stimulate empowerment. Activities will include further analysis of existing qualitative data, workshop discussions, piloting tools and implementing them within communities with ongoing Family Well Being programs."},"children":[{"color":"#336699","name":"Prof Komla Tsey","data":{"first_name":"Komla","title":"Prof","dw_individual_id":"DW0045925","middle_name":"","last_name":"Tsey","source_individual_id":"RMIS1122536","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Komla Tsey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88886","size":1},{"color":"#336699","name":"Prof Christopher Doran","data":{"first_name":"Christopher","title":"Prof","dw_individual_id":"DW0042089","middle_name":"Mark","last_name":"Doran","source_individual_id":"5014376","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Christopher Doran"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87913","size":1},{"color":"#336699","name":"Prof Ernest Hunter","data":{"first_name":"Ernest","title":"Prof","dw_individual_id":"DW0025657","middle_name":"","last_name":"Hunter","source_individual_id":"RMIS226584","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ernest Hunter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83608","size":1},{"color":"#336699","name":"A/Pr Melissa Haswell-Elkins","data":{"first_name":"Melissa","title":"A/Pr","dw_individual_id":"DW0019509","middle_name":"Ruth","last_name":"Haswell-Elkins","source_individual_id":"RMIS1289414","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Melissa Haswell-Elkins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81966","size":1},{"color":"#336699","name":"Prof Yvonne Cadet-James","data":{"first_name":"Yvonne","title":"Prof","dw_individual_id":"DW0018055","middle_name":"Lorraine","last_name":"Cadet-James","source_individual_id":"RMIS682305","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Yvonne Cadet-James"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81616","size":1},{"color":"#336699","name":"Prof Andrew Wilson","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0011115","middle_name":"Andrew","last_name":"Wilson","source_individual_id":"5018407","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Andrew Wilson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79722","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6399","size":1},{"color":"#FF4D4D","name":"The role of steatosis in promoting cellular injury and fibrogenesis in human liver disease","data":{"media_summary":"","end_year":2007,"keywords":["apoptosis","hepatic fibrosis","hepatic steatosis","hepatocyte proliferation"],"nhmrc_grant_id":351579,"application_year":2004,"health_keywords":["NAFLD","hepatitis C","nonalcoholic steatohepatitis","obesity"],"scientific_title":"The role of steatosis in promoting cellular injury and fibrogenesis in human liver disease","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gastroenterology and Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Elizabeth Powell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351579","simplified_title":"How fatty liver causes fibrosis","sub_type":"Standard Project Grant","total_budget":"414375","source_system":"Lay Description Fatty liver (steatosis) is important because it increases the vulnerability of the liver to factors that trigger inflammation and fibrosis. Patients with steatosis may develop steatohepatitis spontaneously and this increases the risk and rate of progression to cirrhosis, with consequent liver-related morbidity and mortality. In addition, steatosis significantly potentiates the severity of liver damage that is caused by other agents such as drugs or infections. To improve the prognosis of patients with fatty livers, it is important to understand why hepatic steatosis increases the risk for more serious liver disease. To date, much of our understanding of mechanisms of liver injury in fatty liver disease comes from animal models, and these findings have not been systematically evaluated in the human disease. Apart from optimizing body weight, there is no established treatment of fatty liver disease. Delineation of the mechanisms involved in liver injury will allow the development of specific protective strategies for steatotic livers."},"children":[{"color":"#336699","name":"Prof Elizabeth Powell","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0044903","middle_name":"Ellen","last_name":"Powell","source_individual_id":"RMIS13575","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Powell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88622","size":1},{"color":"#336699","name":"A/Pr Andrew Clouston","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0030002","middle_name":"Donald","last_name":"Clouston","source_individual_id":"RMIS228640","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Andrew Clouston"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84776","size":1},{"color":"#336699","name":"A/Pr Julie Jonsson","data":{"first_name":"Julie","title":"A/Pr","dw_individual_id":"DW0002506","middle_name":"R","last_name":"Jonsson","source_individual_id":"5015557","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Julie Jonsson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77348","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6398","size":1},{"color":"#FF4D4D","name":"Exposure and risks from persistent organic pollutants through consumption of traditional seafood","data":{"media_summary":"Risk assessment","end_year":2007,"keywords":["Bioaccumulation","Dietary intake","Dioxin-like compounds","Environmental Health","Persistent organic pollutants"],"nhmrc_grant_id":351572,"application_year":2004,"health_keywords":["Chronic disease","Dietary lifestyle","Environmental pollutants","Indigenous health","Risk assessment"],"scientific_title":"Exposure and risks from persistent organic pollutants through consumption of traditional seafood","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Indigenous Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Caroline Gaus","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351572","simplified_title":"Contaminants in traditional seafood","sub_type":"Standard Project Grant","total_budget":"322042.5","source_system":"For many coastal Aboriginal and Torres Strait Islander people, local marine resources provide an important and integral aspect of the communities' diet, culture and traditions. The health benefits associated with seafood consumption have been well documented. On the other hand, many environmental contaminants accumulate in the marine environment. In particular persistent organic pollutants (POPs) have the potential to accumulate to elevated levels in the marine food chain, including humans. Consumption of food contaminated with POPs can pose a risk of causing adverse health effects, including cancer, endocrine disruption, developmental and immunotoxic responses. Recent studies in Queensland have shown elevated concentrations of POPs, specifically dioxins, in the near shore marine environment. Concentrations present in dugong and turtle tissues were found to be among the highest reported compared to other marine biota worldwide. These species represent an integral part of the traditions and diet for many coastal Aboriginal and Torres Strait Islander communities. However, to date no information on exposure to these compounds from locally sourced seafood exists in Australia. The proposed study will redress this lack of information and provide an understanding of the risks associated with the consumption of traditional seafood from local contaminated areas. In collaboration with the Quandamooka community, Moreton Bay in South East Queensland this will provide a case study with the objectives of: 1. Assessing the qualitative and quantitative risks associated with consumption of traditional and contemporary seafood sourced from local contaminated areas. 2. Providing communities with a thorough understanding of food contamination and building internationally competitive capacity in Australian Indigenous researchers. 3. Develop risk management options that allow informed decisions making on POP exposure and are acceptable to the community."},"children":[{"color":"#336699","name":"Dr Caroline Gaus","data":{"first_name":"Caroline","title":"Dr","dw_individual_id":"DW0030847","middle_name":"","last_name":"Gaus","source_individual_id":"RMIS3205782","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Caroline Gaus"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84999","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6397","size":1},{"color":"#FF4D4D","name":"Elucidation of the molecular requirements of the low affinity 'state' of the beta1-adrenoceptor","data":{"media_summary":"","end_year":2007,"keywords":["beta-adrenoceptor subtypes","membrane signaling","molecular pharmacology"],"nhmrc_grant_id":351569,"application_year":2004,"health_keywords":["cardiovascular disease","cardiovascular disease prevention","pharmacology"],"scientific_title":"Elucidation of the molecular requirements of the low affinity 'state' of the beta1-adrenoceptor","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Peter Molenaar","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351569","simplified_title":"Investigation of different beta1-adrenoceptor 'states'","sub_type":"Standard Project Grant","total_budget":"535500","source_system":"Beta-blockers are used for the management of cardiovascular diseases including heart failure, ischaemic heart disease and high blood pressure. Beta-blockers mostly work by blocking the effects of a naturally occuring chemical called noradrenaline. Beta-blockers can be used to prevent noradrenaline induced increases in the rate and force of human heart contraction. We have discovered that one group of beta-blockers exemplified by CGP 12177 has the remarkable property of not only being able to block beta-receptors but they can also stimulate them at higher concentrations. Thus low concentrations block the effects of noradrenaline, but higher concentrations stimulate the receptor. More puzzling is that the stimulant effects of this group of beta-blockers cannot be easily blocked. To explain this we hypothesize that human beta-receptors can exist in two different 'states'. One 'state' can be stimulated by noradrenaline and blocked by low concentrations of beta-blockers such as propranolol and CGP 12177. Another 'state' of the same receptor is resistant to blockade by beta-blockers such as propranolol but can be stimulated by beta-blockers such as CGP 12177. This project seeks to investigate the molecular basis of the beta-adrenoceptor that is responsible for stimulant effects of beta-blockers. Specifically it explores the components of the beta-adrenoceptor that are critically and uniquely important for interacting with the stimulant beta-blockers. This project is an important increment in our laboratories research program to increase our understanding of the effects of beta-blockers. Our long term goal is to be able to develop beta-blockers that can block both states of the beta-adrenoceptor to provide a more effective block of the receptor and in particular for the improved management of heart failure."},"children":[{"color":"#336699","name":"A/Pr Peter Molenaar","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0020938","middle_name":"","last_name":"Molenaar","source_individual_id":"RMIS221171","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Molenaar"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82361","size":1},{"color":"#336699","name":"Prof Ming Wei","data":{"first_name":"Ming","title":"Prof","dw_individual_id":"DW0019989","middle_name":"Q","last_name":"Wei","source_individual_id":"RMIS6079851","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ming Wei"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82090","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6396","size":1},{"color":"#FF4D4D","name":"Transcription control of the c-fms gene","data":{"media_summary":"","end_year":2007,"keywords":["epigenetics","macrophage","transcription","transgenics","tumour progression"],"nhmrc_grant_id":351559,"application_year":2004,"health_keywords":["Cancer","Infectious Disease","Inflammation"],"scientific_title":"Transcription control of the c-fms gene","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof David Hume","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351559","simplified_title":"Relationships between production of white blood cells and cancer progression","sub_type":"Standard Project Grant","total_budget":"666000","source_system":"This project concerns the basic biology of large white blood cells called macrophages. Macrophages are required for the immediate defence against infection, wound repair and normal turnover of tissues, but they can also produce toxic products that cause illness, especially in inflammatory diseases and cancer. We are studying a gene that is normally only produced in macrophages, but appears abnormally in many cancer cells. Our aim is to understand at a molecular level exactly how the gene is controlled, and why it appears in tumours."},"children":[{"color":"#336699","name":"Prof Susan Clark","data":{"first_name":"Susan","title":"Prof","dw_individual_id":"DW0024144","middle_name":"Joy","last_name":"Clark","source_individual_id":"5013985","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Susan Clark"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83199","size":1},{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6395","size":1},{"color":"#FF4D4D","name":"Guiding intervention choices to reduce health costs, health inequalities, and improve the health of Australians","data":{"media_summary":"","end_year":2010,"keywords":["Indigenous Australians","cost effectivness","non communicable diseases","prevention","priority setting"],"nhmrc_grant_id":351558,"application_year":2004,"start_year":2005,"scientific_title":"Guiding intervention choices to reduce health costs, health inequalities, and improve the health of Australians","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Economics","research_area":"Health Services Research","for_category":"ECONOMICS","cia_name":"Prof Eric Vos","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/351558","simplified_title":"Prioritising prevention of non communicable diseases in Australia","sub_type":"Health Services Research","total_budget":"3200000","source_system":"As health care costs rise, governments increasingly will need objective evidence on the benefits and costs of health intervention options, whilst taking into account the need for greater health equity, transparency of decision making and stakeholder acceptability. This project will provide the health intelligence to guide such health priority setting in Australia, with a focus on prevention of non-communicable diseases, the implications for Indigenous Australians and the most efficient ways of implementing priority interventions in primary care."},"children":[{"color":"#336699","name":"Prof Christopher Doran","data":{"first_name":"Christopher","title":"Prof","dw_individual_id":"DW0042089","middle_name":"Mark","last_name":"Doran","source_individual_id":"5014376","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Christopher Doran"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87913","size":1},{"color":"#336699","name":"Prof Ian Anderson","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0040809","middle_name":"Philip Smith","last_name":"Anderson","source_individual_id":"RMIS3927","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ian Anderson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87583","size":1},{"color":"#336699","name":"Prof Alan Lopez","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0026372","middle_name":"Donald","last_name":"Lopez","source_individual_id":"5012116","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alan Lopez"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83819","size":1},{"color":"#336699","name":"Prof Robert Carter","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0023991","middle_name":"Charles","last_name":"Carter","source_individual_id":"5012404","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Carter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83156","size":1},{"color":"#336699","name":"Prof Eric Vos","data":{"first_name":"Eric","title":"Prof","dw_individual_id":"DW0022749","middle_name":"Theo","last_name":"Vos","source_individual_id":"5012185","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Eric Vos"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82861","size":1},{"color":"#336699","name":"Prof Andrew Wilson","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0011115","middle_name":"Andrew","last_name":"Wilson","source_individual_id":"5018407","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Andrew Wilson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79722","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6394","size":1},{"color":"#FF4D4D","name":"Co-administration of DNA encoding co-stimulatory molecules enhances the efficacy of immune response to foreign antigen","data":{"media_summary":"vaccine vectors","end_year":2006,"keywords":["Cytotoxic T cell","DNA vaccine","costimulatory molecule","dendritic cell"],"nhmrc_grant_id":351556,"application_year":2004,"health_keywords":["HPV","dendritic cells","immune protection","immunity cellular","vaccine vectors"],"scientific_title":"Co-administration of DNA encoding co-stimulatory molecules enhances the efficacy of immune response to foreign antigen","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof ROBERT TINDLE","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351556","simplified_title":"Improving the efficiency of DNA vaccines","sub_type":"Standard Project Grant","total_budget":"182000","source_system":"Vaccines to prevent or treat infectious diseases and some cancers are urgently needed. Infected cells and some cancer cells display unique proteins which the body's immune system can recognises as 'foreign'. The body will then mount an immune response, which, if successful, will eradicate the infected or cancerous cells. Dendritic cells (DCs) initiate the body's immune response by instructing other immune cells to mount a response. For a vaccine to be successful it is important that the vaccine activates the DCs in the right way. We propose to activate DCs by vaccinating with DNA encoding recently identified costimulatory molecules, as well as DNA encoding the foreign antigen. Our earlier work leads us to believe that this will enhance the immune response, and lead to a more effective state of immunity"},"children":[{"color":"#336699","name":"Prof Robert Tindle","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0028412","middle_name":"W","last_name":"Tindle","source_individual_id":"RMIS388145","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Robert Tindle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84347","size":1},{"color":"#336699","name":"Dr Carsten Wiethe","data":{"first_name":"Carsten","title":"Dr","dw_individual_id":"DW0005436","middle_name":"","last_name":"Wiethe","source_individual_id":"RMIS3138029","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Carsten Wiethe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78181","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6393","size":1},{"color":"#FF4D4D","name":"A multi-centre, randomised, controlled trial of BAL directed therapy in young children with cystic fibrosis.","data":{"media_summary":"longitudinal","end_year":2009,"keywords":["children","economic evaluation","infection and inflammation","multicenter","randomised controlled trial"],"nhmrc_grant_id":351541,"application_year":2004,"health_keywords":["computed tomography","cystic fibrosis","flexible bronchoscopy and bronchoalveolar lavage","long term treatment outcome","longitudinal"],"scientific_title":"A multi-centre, randomised, controlled trial of BAL directed therapy in young children with cystic fibrosis.","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Claire Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351541","simplified_title":"A new approach to management of young children with cystic fibrosis to improve clinical outcomes","sub_type":"Standard Project Grant","total_budget":"571750","source_system":"The management of children with cystic fibrosis (CF) aims to delay the inevitable progression of lung disease that results from chronic lower respiratory tract infection (LRTI) and inflammation. Flexible bronchoscopy (FB) and bronchoalveolar lavage (BAL) are increasingly used as research and clinical tools in the management of LRTI in CF infants and are integral to the monitoring of future drug trials and gene therapy. Early LRTI particularly with Pseudomonas aeruginosa (Pa) in CF is associated with a decline in pulmonary function and an increase in morbidity and mortality. Many CF centres internationally now treat young children with CF using aggressive antibiotic protocols in an attempt to eradicate infection. Most centres use oropharyngeal specimens to diagnose LRTI with a sensitivity of around 45% and specificity of around 90%. Thus many children miss out on treatment or are exposed unnecessarily to antibiotics. The use of antibiotics themselves may increase the risk of infection with resistant organisms thus complicating the design of drug trials in young children as monitoring for the emergence of resistant new organisms requires BAL. It is thus of key importance that the safety and value of FB and BAL is examined and long term outcomes are obtained. The financial costs of managing patients with CF in Australia may be estimated at more than $85 million-annum. Early intervention strategies may reduce health costs because of improved morbidity or may increase costs due to the intervention. This will be the first time an economic evaluation of early management and the cost effectiveness of an intervention in children with CF has been undertaken which will enable responsible health care planning for this important group of patients. This trial provides a unique opportunity to study the relationship between LRTI and inflammation and long term outcomes such as lung function and radiological scores and will provide key evidence for designing future trials."},"children":[{"color":"#336699","name":"Prof Keith Grimwood","data":{"first_name":"Keith","title":"Prof","dw_individual_id":"DW0036997","middle_name":"","last_name":"Grimwood","source_individual_id":"RMIS3130585","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Keith Grimwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86576","size":1},{"color":"#336699","name":"Prof John Carlin","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0035730","middle_name":"B","last_name":"Carlin","source_individual_id":"RMIS193048","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Carlin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86257","size":1},{"color":"#336699","name":"A/Pr David Armstrong","data":{"first_name":"David","title":"A/Pr","dw_individual_id":"DW0035140","middle_name":"","last_name":"Armstrong","source_individual_id":"RMIS3130589","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr David Armstrong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86110","size":1},{"color":"#336699","name":"Prof Claire Wainwright","data":{"first_name":"Claire","title":"Prof","dw_individual_id":"DW0028616","middle_name":"Elizabeth","last_name":"Wainwright","source_individual_id":"RMIS6013","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Claire Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84407","size":1},{"color":"#336699","name":"Prof Robert Carter","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0023991","middle_name":"Charles","last_name":"Carter","source_individual_id":"5012404","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Carter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83156","size":1},{"color":"#336699","name":"Prof Colin Robertson","data":{"first_name":"Colin","title":"Prof","dw_individual_id":"DW0009926","middle_name":"Frederick","last_name":"Robertson","source_individual_id":"5011931","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Colin Robertson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79394","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6392","size":1},{"color":"#FF4D4D","name":"Generation of Complex Responses in Retinal Ganglion Cells","data":{"media_summary":"","end_year":2007,"keywords":["central nervous system","neuroanatomy","neurophysiology","retina"],"nhmrc_grant_id":351538,"application_year":2004,"health_keywords":["CNS function","neuroanatomical connections","neurotransmission","retinal function"],"scientific_title":"Generation of Complex Responses in Retinal Ganglion Cells","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof David Vaney","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351538","simplified_title":"Neuronal Complexity in the Retina","sub_type":"Standard Project Grant","total_budget":"490500","source_system":"The retinal ganglion cells, whose axons form the optic nerve, comprise numerous distinct types, which respond to visual stimuli in either a simple or complex manner. The project will investigate how the complex responses of the direction-selective ganglion cells (DSGCs) and the local-edge-detector ganglion cells (LEDs) are generated. It appears that the retinal neurons providing inhibitory input to DSGCs and LEDs use different neurotransmitters, and the project will investigate how this shapes the response properties of the ganglion cells. This will be done both by recording the visually evoked responses of the ganglion cells in an isolated preparation of the retina and by using two-photon laser-scanning microscopy to functionally image the neuronal interactions between the neurons that inhibit the DSGCs."},"children":[{"color":"#336699","name":"Prof David Vaney","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0028555","middle_name":"I","last_name":"Vaney","source_individual_id":"RMIS52594","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Vaney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84390","size":1},{"color":"#336699","name":"A/Pr Nathan Hart","data":{"first_name":"Nathan","title":"A/Pr","dw_individual_id":"DW0019488","middle_name":"S","last_name":"Hart","source_individual_id":"5015121","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nathan Hart"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81963","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6391","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2009,"keywords":["neuronal circuitry","neurotransmitter","retina"],"nhmrc_grant_id":351537,"application_year":2004,"start_year":2005,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof David Vaney","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/351537","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"651750","source_system":""},"children":[{"color":"#336699","name":"Prof David Vaney","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0028555","middle_name":"I","last_name":"Vaney","source_individual_id":"RMIS52594","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Vaney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84390","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6390","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2009,"keywords":["Cell cycle checkpoints","Chromatin acetylation","Mitosis","cell signalling"],"nhmrc_grant_id":351522,"application_year":2004,"start_year":2005,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Brian Gabrielli","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/351522","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"538250","source_system":""},"children":[{"color":"#336699","name":"A/Pr Brian Gabrielli","data":{"first_name":"Brian","title":"A/Pr","dw_individual_id":"DW0007391","middle_name":"G","last_name":"Gabrielli","source_individual_id":"5014734","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Brian Gabrielli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78693","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6389","size":1},{"color":"#FF4D4D","name":"Management of burn injury: Fluid dynamics and antibiotic pharmacokinetics","data":{"media_summary":"","end_year":2007,"keywords":["Antibiotic pharmacokinetics","Antibiotic tissue penetration","Burn injury and infection","Protein extravasation","Wound fluid dynamics"],"nhmrc_grant_id":351519,"application_year":2004,"health_keywords":["Burn injury management","Burn resuscitation therapy","Infection management"],"scientific_title":"Management of burn injury: Fluid dynamics and antibiotic pharmacokinetics","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Intensive Care","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Sheree Cross","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351519","simplified_title":"Burns and antibiotic pharmacokinetics","sub_type":"Standard Project Grant","total_budget":"342375","source_system":"It is well known that major burns, as well as being relatively common injuries, are notoriously difficult to manage. Patients exhibit significant variability due to a combination of anatomic, physiologic, hormonal and immunologic alterations occurring both at the wound site and, more importantly, in other body compartments and vital organ systems. Skin burn injury results in the release of multiple inflammatory mediators in addition to significant fluid loss. The distribution of inflammatory mediators and wound bacteria to central organs can cause complex physiological changes that may lead to multiple organ failure, with serious infections occurring in around 50% of patients with serious burns. Antibiotic distribution kinetics, such as bioavailability, clearance, volume of distribution, elimination half-life and unbound fraction in plasma can be significantly altered in burn patients. Without detailed knowledge of changes and relationships between factors such as wound pH, tissue oxygenation, protein concentrations of fluid leaked from the local wound microvasculature, tissue binding, oedema and changes in burned and non-burned tissue induced by resuscitation therapies, the optimisation of both local and systemic infection contriol therapies can hardly be expected to advance. This project aims to determine how changes the physiology of burn patients, in particular in the burn wound environment, affect antibiotic penetration and distribution into tissues. We also believe that these changes will vary between patients and are aiming to determine whether certain parameters can be used to give an indication of the best antibiotic dosing regimens for individual patients."},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1},{"color":"#336699","name":"Prof Jeffrey Lipman","data":{"first_name":"Jeffrey","title":"Prof","dw_individual_id":"DW0032130","middle_name":"","last_name":"Lipman","source_individual_id":"5012259","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jeffrey Lipman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85314","size":1},{"color":"#336699","name":"Prof Bala Venkatesh","data":{"first_name":"Bala","title":"Prof","dw_individual_id":"DW0016832","middle_name":"","last_name":"Venkatesh","source_individual_id":"RMIS5223868","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Bala Venkatesh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81276","size":1},{"color":"#336699","name":"Sheree Cross","data":{"first_name":"Sheree","title":"","dw_individual_id":"DW0001098","middle_name":"","last_name":"Cross","source_individual_id":"RMIS40999","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Sheree Cross"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76971","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6388","size":1},{"color":"#FF4D4D","name":"Microtubule capture by E-cadherin: a novel mechanism for dynamic cell-cell adhesion.","data":{"media_summary":"","end_year":2007,"keywords":["Cadherin adhesion molecules","Epithelial morphogenesis","Microtubule cytoskeleton"],"nhmrc_grant_id":351506,"application_year":2004,"health_keywords":["Cancer","Epithelial inflammation","Gastrointestinal disease","Kidney disease"],"scientific_title":"Microtubule capture by E-cadherin: a novel mechanism for dynamic cell-cell adhesion.","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Alpha Yap","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351506","simplified_title":"Microtubule cytoskeleton and cadherin adhesion.","sub_type":"Standard Project Grant","total_budget":"439500","source_system":"This project studies the molecular mechanisms responsible for holding cells together in normal tissues. Such cell-to-cell adhesion is mediated by the cadherin family of molecules, which reside at the surfaces of cells. Cadherins allow cells to recognize one another and, upon recognition, adhere to one another. By this means populations of individual cells can be linked together into cohesive populations (i.e. the tissues or organs of the body). The importance of cadherin adhesion is exemplified by the well-documented observation that disruption of cadherin adhesion contributes to many important diseases, including inflammation of epithelia and cancers. Thus understanding the mechanisms by which cadherins hold cells together is necessary for us to understand the molecular basis of commondisease. It has long been known that cadherins work in cooperation with elements within the cell, called the cytoskeleton. My lab has recently made the novel discovery that microtubules, specific components of the cytoskeleton, can regulate the functionof cadherin adhesion molecules. Inparticular, microtubules appear to affect how cadherins can participate in dynamic cell processes necessary for cells to be properly organized in tissues. In this project we will probe the molecular mechanisms responsible for this effect of microtubules. The information obtained will provide important new insights into how dynamic cadherin adhesion is controlled, to help our understanding of the cellular mechanisms that couple cells into tissues, and how they may be disrupted in diesase."},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6387","size":1},{"color":"#FF4D4D","name":"Mechanisms of death receptor-mediated apoptosis","data":{"media_summary":"","end_year":2007,"keywords":["NMR spectroscopy","biochemistry","protein structure","protein-protein interaction"],"nhmrc_grant_id":351503,"application_year":2004,"health_keywords":["autoimmune disease","biological sciences","cell death"],"scientific_title":"Mechanisms of death receptor-mediated apoptosis","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Justine Hill","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351503","simplified_title":"Death receptors and apoptosis","sub_type":"New Investigator Grant","total_budget":"472500","source_system":"The balance between cell division and programmed cell death is crucial for normal development, maintenance of homeostasis, and immune system function. Inappropriately regulated cell death contributes to the pathogenesis of a wide variety of human diseases including neurodegenerative disorders, autoimmune syndromes and several forms of cancer. Death receptors such as Fas and TNFR1 are cell-surface sensors that trigger cellular destruction by apoptosis in response to specific extracellular death signals. Recent studies have demonstrated that the mechanisms of signal transduction through Fas and TNFR1 differ significantly, however, they both require the adaptor protein FADD to induce apoptosis. In this study we will elucidate the molecular basis of the interactions between FADD and its binding partners using biochemical and biophysical studies. This research will improve our understanding of death receptor-induced apoptosis and the differences in signalling mechanisms. A detailed knowledge of these aspects of death receptor signalling is of significance because they represent critical regulatory steps that could be useful for targeted interventions."},"children":[{"color":"#336699","name":"Dr Justine Hill","data":{"first_name":"Justine","title":"Dr","dw_individual_id":"DW0013656","middle_name":"Maria","last_name":"Hill","source_individual_id":"RMIS706133","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Justine Hill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80384","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6386","size":1},{"color":"#FF4D4D","name":"Seizure detection in the newborn","data":{"media_summary":"","end_year":2007,"keywords":["EEG","Hypoxia-ischaemia-reperfusion injury to the brain","Newborn infant","Paediatric","Perinatal physiology"],"nhmrc_grant_id":351501,"application_year":2004,"health_keywords":["Hypoxic-ischaemic encephalopathy","Neonatal seizures","Perinatal hypoxia"],"scientific_title":"Seizure detection in the newborn","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Paul Colditz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351501","simplified_title":"Seizures in the newborn","sub_type":"Standard Project Grant","total_budget":"728250","source_system":"Newborn babies are at risk of becoming short of oxygen during delivery. Death or brain damage may result. In the days after birth, when the brain is attempting to recover from the lack of oxygen, seizures (also called fits) are common. Seizures may cause further damage to the brain because they release damaging chemicals such as glutamate or because they make extra energy demands on the brain that cannot be met. It is difficult to be certain whether unusual movements or twitches are seizures or not. To detect seizures, it is necessary to measure the EEG, the tiny electrical signals from the brain that can be measured from the scalp using small stick on electrodes. It is difficult to measure EEG, particularly for longer periods, because the electrodes may fall off, the baby may move excessively or electrical interference may ruin the recording. We are proposing to measure EEG for 48 hours in babies who have suffered a lack of oxygen during delivery. We will develop, optimise and implement a new method of automatically detecting seizures, building upon 6 years of fundamental signal processing research work that we have done in the newborn. We will test this system against the 'gold standard' to determine how accurate it will be in detecting seizures. We will also try to find out whether damage in particular areas of the brain or in particular cell types within the brain is most likely to be associated with seizures. The anticipated outcome is that we will be able to accurately identify seizures. This is a major step on the path to being able to prevent injury to the brain and to monitor the effectiveness of new experimental treatments."},"children":[{"color":"#336699","name":"Dr Barbara Lingwood","data":{"first_name":"Barbara","title":"Dr","dw_individual_id":"DW0043819","middle_name":"Elizabeth","last_name":"Lingwood","source_individual_id":"5016005","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Barbara Lingwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88355","size":1},{"color":"#336699","name":"Dr Christopher Burke","data":{"first_name":"Christopher","title":"Dr","dw_individual_id":"DW0018010","middle_name":"","last_name":"Burke","source_individual_id":"RMIS67619","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Christopher Burke"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81604","size":1},{"color":"#336699","name":"A/Pr Stephen Rose","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0009965","middle_name":"E","last_name":"Rose","source_individual_id":"5017273","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Stephen Rose"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79404","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1},{"color":"#336699","name":"Prof Boualem Boashash","data":{"first_name":"Boualem","title":"Prof","dw_individual_id":"DW0000451","middle_name":"","last_name":"Boashash","source_individual_id":"RMIS477867","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Boualem Boashash"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76779","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6385","size":1},{"color":"#FF4D4D","name":"Physiological and neurophysiological assessment of lip and tongue function for speech in multiple sclerosis","data":{"media_summary":"","end_year":2007,"keywords":["dysarthria","motor control","multiple sclerosis","neurophysiology","pathophysiology"],"nhmrc_grant_id":351490,"application_year":2004,"health_keywords":["improving the quality of life of those with a disability","motor speech disorders","multiple sclerosis","neuropathology"],"scientific_title":"Physiological and neurophysiological assessment of lip and tongue function for speech in multiple sclerosis","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Hearing and Speech","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Bruce Murdoch","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351490","simplified_title":"Assessment of lip and tongue movements and neural control for speech in multiple sclerosis","sub_type":"Standard Project Grant","total_budget":"356250","source_system":"Speech difficulties are commonly experienced by people with multiple sclerosis (MS) and can have a devastating, restrictive effect on social interactions, work and education opportunities, ultimately reducing quality of life. Research has shown that a major factor underlying impaired speech in MS is disturbed functioning of the structures that articulate speech, particularly the tongue and lips. In order to effectively treat these speech disturbances, it is imperative that the nature and severity of the tongue and lip impairments be identified, so that specific treatment methods can be employed to directly target those impairments. The present project will use state-of-the-art technology to track and record movements of the tongue and lips during speech and to investigate how well the neural command pathways leading from the brain to the lip and tongue muscles are functioning in persons with MS. The results of the study will direct the development of more specific and effective speech therapy procedures that will empower persons with MS with intelligible speech."},"children":[{"color":"#336699","name":"Prof Richard Carson","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0041489","middle_name":"G","last_name":"Carson","source_individual_id":"5013819","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Carson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87761","size":1},{"color":"#336699","name":"Brooke-Mai Whelan","data":{"first_name":"Brooke-Mai","title":"","dw_individual_id":"DW0028773","middle_name":"","last_name":"Whelan","source_individual_id":"RMIS3117654","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Brooke-Mai Whelan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84450","size":1},{"color":"#336699","name":"Dr Justine Goozee","data":{"first_name":"Justine","title":"Dr","dw_individual_id":"DW0019273","middle_name":"V","last_name":"Goozee","source_individual_id":"RMIS1113109","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Justine Goozee"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81911","size":1},{"color":"#336699","name":"Prof Bruce Murdoch","data":{"first_name":"Bruce","title":"Prof","dw_individual_id":"DW0015136","middle_name":"Ernest","last_name":"Murdoch","source_individual_id":"RMIS15270","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Bruce Murdoch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80802","size":1},{"color":"#336699","name":"Deborah Falla","data":{"first_name":"Deborah","title":"","dw_individual_id":"DW0001496","middle_name":"","last_name":"Falla","source_individual_id":"RMIS2639378","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Deborah Falla"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77080","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6383","size":1},{"color":"#FF4D4D","name":"Excitatory synaptic circuitry and plasticity in the amygdala.","data":{"media_summary":"","end_year":2007,"keywords":["amygdala","anxiety","long term potentiation","neurotransmission","synaptic plasticity"],"nhmrc_grant_id":351481,"application_year":2004,"health_keywords":["anxiety","depression","phobias","post traumatic stress disorder"],"scientific_title":"Excitatory synaptic circuitry and plasticity in the amygdala.","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Andrew Delaney","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351481","simplified_title":"Synaptic plasticity in the amygdala","sub_type":"Standard Project Grant","total_budget":"405750","source_system":"The amygdala is a key structure in the neuronal circuitry that underlies the analysis of emotional information. In particular this structure plays a major role in the processing of fear-related information. Disorders of the processing and storage of such information are thought to be the major underlying cause of mental disorders such as panic attacks, anxiety and post traumatic stress disorder. Understanding the physiology of this structure and the ways in which this can change in response to various stimuli is necessary for the development of rational therapies that target the amygdala."},"children":[{"color":"#336699","name":"Prof Pankaj Sah","data":{"first_name":"Pankaj","title":"Prof","dw_individual_id":"DW0033583","middle_name":"","last_name":"Sah","source_individual_id":"5017304","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Pankaj Sah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85693","size":1},{"color":"#336699","name":"Dr Elizabeth Louise Faber","data":{"first_name":"Elizabeth Louise","title":"Dr","dw_individual_id":"DW0030604","middle_name":"Sophie","last_name":"Faber","source_individual_id":"RMIS3123369","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Elizabeth Louise Faber"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84950","size":1},{"color":"#336699","name":"Dr Andrew Delaney","data":{"first_name":"Andrew","title":"Dr","dw_individual_id":"DW0012705","middle_name":"James","last_name":"Delaney","source_individual_id":"5014278","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Andrew Delaney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80142","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6382","size":1},{"color":"#FF4D4D","name":"Genetics of Primary Aldosteronism","data":{"media_summary":"","end_year":2007,"keywords":["Familial hyperaldosteronism","Human hypertension","Linkage studies","Primary aldosteronism","Sequencing"],"nhmrc_grant_id":351480,"application_year":2004,"health_keywords":["Familial hyperaldosteronism","Human hypertension","Primary aldosteronism","Secondary hypertension"],"scientific_title":"Genetics of Primary Aldosteronism","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael Stowasser","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351480","simplified_title":"Looking for defective genes that cause high blood pressure in families","sub_type":"Standard Project Grant","total_budget":"268000","source_system":"Hypertension (high blood pressure) is the commonest chronic condition in western societies, and can lead to strokes, heart attacks and kidney failure. In a disease known as primary aldosteronism (PAL), hypertension results from the excessive production of the salt-retaining hormone, aldosterone, by the the body's adrenal glands. In some patients, this is due to the growth of an aldosterone-producing adrenal tumour. Recent work performed within the Hypertension Unit at Greenslopes Hospital and continued by these investigators within the Hypertension Unit at Princess Alexandra Hospital has shown that PAL is the commonest potentially curable form of hypertension, accounting for at least 5% and possibly 10% of patients. Several lines of evidence accumulated by these investigators, including the detection of a new familial variety of PAL (Familial Hyperaldosteronism Type II or FH-II), suggest that PAL is a genetic disorder. The study sets out to locate the genetic defect causing PAL by comparing genetic material collected from affected members of these families with that from non-affected members, and by comparing genes from patients with PAL with those of unrelated, unaffected individuals. Once the genetics of this condition is understood, affected persons can be detected early in life, and even at birth, and the ill-effects of their developing conditions prevented."},"children":[{"color":"#336699","name":"E/Pr Richard Gordon","data":{"first_name":"Richard","title":"E/Pr","dw_individual_id":"DW0025132","middle_name":"D","last_name":"Gordon","source_individual_id":"RMIS41928","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"E/Pr Richard Gordon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83460","size":1},{"color":"#336699","name":"Prof Michael Stowasser","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022365","middle_name":"","last_name":"Stowasser","source_individual_id":"5017746","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Stowasser"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82770","size":1},{"color":"#336699","name":"Dr David Duffy","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0012817","middle_name":"Lorenzo","last_name":"Duffy","source_individual_id":"5014423","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr David Duffy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80170","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6381","size":1},{"color":"#FF4D4D","name":"Is EphA4 the major molecular regulator of axonal regeneration?","data":{"media_summary":"","end_year":2007,"keywords":["EphA4","Motor function","Neural regeneration","Neurite outgrowth","Spinal cord injury"],"nhmrc_grant_id":351479,"application_year":2004,"health_keywords":["Astrocyte gliosis","Movement dysfunction","Neural regeneration","Spinal cord injury"],"scientific_title":"Is EphA4 the major molecular regulator of axonal regeneration?","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Andrew Boyd","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351479","simplified_title":"Is EphA4 the major molecular regulator of spinal cord repair?","sub_type":"Standard Project Grant","total_budget":"491000","source_system":"Spinal cord injury affects a substantial number of Australians each year. Around half the number of spinal cord injury cases result in quadriplegia, with loss of function to a varying degree in the upper as well as the lower limbs. The limited degree of repair of spinal axons following injury means that such paralysis is usually permanent. Although the inability to walk is a serious issue, the limited function of the arms and hands results in a loss of independence which is a major factor contribuing to the enormous personal, financial, and community costs of this problem, estimated to cost the Australian community $200 million a year. In recent years advanced anatomical and molecular approaches to the problem of repair of the central nervous system have provided great insights into the neuronal and glial reactions to neural damage that appear to govern the success or failure of neural regeneration. Our preliminary data indicate that a receptor tyrosine kinase, EphA4, which is important for axonal pathfinding in the developing nervous system, is a potent inhibitor of neural regeneration following spinal cord injury. In this project we will determine the mechanisms by which EphA4 exerts its inhibitory effects, and examine the effect of neutralizing EphA4 signalling on neural regeneration. Success in achieving this result will lead to the development of a therapeutic intervention that we will test in mouse models."},"children":[{"color":"#336699","name":"Prof Andrew Boyd","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0023731","middle_name":"W","last_name":"Boyd","source_individual_id":"RMIS3609","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Andrew Boyd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83095","size":1},{"color":"#336699","name":"Prof Mary Galea","data":{"first_name":"Mary","title":"Prof","dw_individual_id":"DW0019118","middle_name":"P","last_name":"Galea","source_individual_id":"5014751","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mary Galea"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81880","size":1},{"color":"#336699","name":"A/Pr Ann Turnley","data":{"first_name":"Ann","title":"A/Pr","dw_individual_id":"DW0016752","middle_name":"M","last_name":"Turnley","source_individual_id":"5019345","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Ann Turnley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81253","size":1},{"color":"#336699","name":"Prof Perry Bartlett","data":{"first_name":"Perry","title":"Prof","dw_individual_id":"DW0011651","middle_name":"Francis","last_name":"Bartlett","source_individual_id":"5013357","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Perry Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79864","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6380","size":1},{"color":"#FF4D4D","name":"Origin of cells in the 'artificial' artery grown in the peritoneal cavity","data":{"media_summary":"","end_year":2007,"keywords":["Cell Biology","Monocyte/macrophage differentiation","Myofibroblast","Plasticity","Smooth Muscle"],"nhmrc_grant_id":351476,"application_year":2004,"health_keywords":["Artery bypass graft","Cardiovascular and peripheral vascular disease","Cell growth/differentiation","Urogenital disorders"],"scientific_title":"Origin of cells in the 'artificial' artery grown in the peritoneal cavity","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof Julie Campbell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351476","simplified_title":"Can macrophages trans-differentiate into smooth muscle?","sub_type":"Standard Project Grant","total_budget":"489000","source_system":"Implantation of a foreign object (such as a sterile, flexible plastic tube) into the abdominal cavity of animals induces cells floating in the peritoneal fluid to form a capsule around the object. Over the next 2-3 weeks, the cells differentiate into fibroblasts then myofibroblasts. When this capsule of living tissue (in the appropriate moulded shape) is subsequently grafted into smooth muscle-rich organs such as artery, bladder, uterus or vas deferens to replace excised segments, it gains the structure of the surrounding tissue and the myofibroblasts differentiate further into functional smooth muscle. This raises the question: what is the origin of the cells of the capsule? Our previous studies suggested that monocyte-macrophages stimulated to enter the abdominal cavity in response to the sterile foreign body might be the source of the cells. In the current study we will use transgenic (c-fms EGFP and c-fms Cre Z-AP) mice in which cells of monocyte-macrophage lineage are genetically labelled. These cells can be clearly distinguished from all other cells of the body, and analysis of capsules formed around foreign bodies will give us a definitive answer. We will using micro-array analysis, determine which growth factors-cytokines are important in regulating differentiation of the cells, and the role of physical factors (eg pulsatile stretching). Finally, we will determine whether these cells stimulated to enter the abdominal cavity are capable of differentiating along alternative pathways, such as cardiac muscle or liver cells. Knowledge gained will further the use of the abdominal cavity as a bioreactor in which to engineer tissues for organ replacement therapies. Identification of the mechanisms regulating the (trans)differentiation and biology of the cells may also assist in wound repair strategies to prevent pathologies caused by excessive myofibroblast accumulation and fibrosis."},"children":[{"color":"#336699","name":"Dr Barbara Rolfe","data":{"first_name":"Barbara","title":"Dr","dw_individual_id":"DW0004314","middle_name":"E","last_name":"Rolfe","source_individual_id":"RMIS19792","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Barbara Rolfe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77870","size":1},{"color":"#336699","name":"Prof Julie Campbell","data":{"first_name":"Julie","title":"Prof","dw_individual_id":"DW0000708","middle_name":"H","last_name":"Campbell","source_individual_id":"RMIS330901","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Julie Campbell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76860","size":1},{"color":"#336699","name":"Gordon Campbell","data":{"first_name":"Gordon","title":"","dw_individual_id":"DW0000705","middle_name":"","last_name":"Campbell","source_individual_id":"RMIS14178","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Gordon Campbell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76859","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6379","size":1},{"color":"#FF4D4D","name":"STudy of Risk Assessment To reduce complications In patients Following noncardiac surgerY (STRATIFY)","data":{"media_summary":"","end_year":2007,"keywords":["Anesthesia","Cardiac complications","Dobutamine echocardiography","Prognosis"],"nhmrc_grant_id":351475,"application_year":2004,"health_keywords":["Coronary artery disease","Echocardography","Major noncardiac surgery","Myocardial ischemia"],"scientific_title":"STudy of Risk Assessment To reduce complications In patients Following noncardiac surgerY (STRATIFY)","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Thomas Marwick","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351475","simplified_title":"Reduction of cardiac complications of noncardiac surgery","sub_type":"Standard Project Grant","total_budget":"436000","source_system":"Cardiac problems account for many complications in patients undergoing major non-cardiac surgery, and even apparently minor cardiac damage is a marker of high risk for subsequent adverse events. Unfortunately, while money and effort is expended on identifying patients at risk, the appropriate response to this risk is quite unclear. The performance of bypass surgery or balloon angioplasty in order to treat the underlying coronary disease of at-risk patients is used in other situations, and reduces longterm risk. However, in many patients undergoing major noncardiac surgery, this approach may be inappropriately aggressive, as these patients are often elderly, have other diseases that make heart operations more difficult and risky than usual, and in any case may have a reduced life expectancy from the disease necessitating the operation. As the most critical issue is to ensure that patients undergo their surgery uneventfully, an alternative is the use of intensive medical therapy to protect the heart. This multicentre study, based at Brisbane hospitals that perform large numbers of major operations, will follow up patients for complications, and outcome (including quality of life) will be assessed six months after the operation. We will address two important questions about the efficacy and cost of risk reduction strategies. First, in patients at higher levels of risk and with a positive stress test, could a combination of medical therapy designed to protect the heart be as effective as current approaches, which include the performance of bypass surgery or coronary balloon angioplasty? Second, in patients identified as being at some risk - but low risk - are drugs sufficiently effective to avoid the need for further testing to quantify risk? As the population continues to age, the numbers of at risk patients undergoing major surgery will increase, and answers to these questions will provide important information to guide their management."},"children":[{"color":"#336699","name":"Prof Thomas Marwick","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0032377","middle_name":"Hugh","last_name":"Marwick","source_individual_id":"RMIS108223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Marwick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85383","size":1},{"color":"#336699","name":"Prof Jeffrey Lipman","data":{"first_name":"Jeffrey","title":"Prof","dw_individual_id":"DW0032130","middle_name":"","last_name":"Lipman","source_individual_id":"5012259","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jeffrey Lipman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85314","size":1},{"color":"#336699","name":"A/Pr John Atherton","data":{"first_name":"John","title":"A/Pr","dw_individual_id":"DW0029226","middle_name":"J","last_name":"Atherton","source_individual_id":"RMIS2362369","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr John Atherton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84578","size":1},{"color":"#336699","name":"Prof Philip Walker","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0022791","middle_name":"John","last_name":"Walker","source_individual_id":"RMIS1116934","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Philip Walker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82875","size":1},{"color":"#336699","name":"Prof Bala Venkatesh","data":{"first_name":"Bala","title":"Prof","dw_individual_id":"DW0016832","middle_name":"","last_name":"Venkatesh","source_individual_id":"RMIS5223868","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Bala Venkatesh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81276","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6378","size":1},{"color":"#FF4D4D","name":"Does immunosuppression affect the post-transplantation hepatic fibrogenic response?","data":{"media_summary":"","end_year":2007,"keywords":["Cirrhosis","Hepatic stellate cell","Immunosuppression","Liver"],"nhmrc_grant_id":351466,"application_year":2004,"health_keywords":["Immunosuppression","Liver cirrhosis","Liver transplantation"],"scientific_title":"Does immunosuppression affect the post-transplantation hepatic fibrogenic response?","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gastroenterology and Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Darrell Crawford","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351466","simplified_title":"The role of immunosuppression in scar formation following liver transplantation.","sub_type":"Standard Project Grant","total_budget":"360000","source_system":"Liver transplantation is often the only treatment option for patients who progress to end-stage liver disease after initial treatment has failed. Unfortunately, re-emergence of disease is common and patients often develop fibrosis and cirrhosis (scarring of the liver) in the donor organ. In some cases it has been observed that this scarring often develops rapidly, sometimes in a year or less following transplantation. Re-transplantation is often required. This differs from the usual progression of cirrhosis pre-transplant which often takes years or decades to develop. While essential to prevent rejection of the transplanted organ, immunosuppression is not without side effects. To date, few studies have examined the effect of immunosuppressive agents on the development of hepatic fibrosis and the key fibrosis effector cell type, the hepatic stellate cell. These reports have shown that one of the most commonly used immunosuppressant agents (FK-506) may adversely influence fibrosis progression while rapamycin may prevent fibrosis progression. However little is known regarding the mechanisms through which this occurs. We propose to examine the effect of four different immunosuppressants on fibrosis development both in vitro and in vivo to determine whether scar development or scar breakdown pathways are altered post-immunosuppression. If the factors driving the fibrogenesis in the transplanted organ can be elucidated it may then be possible to develop therapeutic strategies to tackle the problem. This may result in a reduced need for re-transplantation which has obvious benefits to the transplant patient but would also reduce the numbers of donor organs required."},"children":[{"color":"#336699","name":"Dr Kim Bridle","data":{"first_name":"Kim","title":"Dr","dw_individual_id":"DW0017903","middle_name":"R","last_name":"Bridle","source_individual_id":"RMIS2353158","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Kim Bridle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81571","size":1},{"color":"#336699","name":"Dr Linda Fletcher","data":{"first_name":"Linda","title":"Dr","dw_individual_id":"DW0013042","middle_name":"M","last_name":"Fletcher","source_individual_id":"5014660","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Linda Fletcher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80225","size":1},{"color":"#336699","name":"Prof Darrell Crawford","data":{"first_name":"Darrell","title":"Prof","dw_individual_id":"DW0006770","middle_name":"Henry Gordon","last_name":"Crawford","source_individual_id":"5012156","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Darrell Crawford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78535","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6377","size":1},{"color":"#FF4D4D","name":"Identification of oncogenes from myeloid leukaemias by retroviral expression cloning","data":{"media_summary":"","end_year":2007,"keywords":["growth factor","leukaemia","monocyte/macrophage differentiation","oncogene","retroviral gene transfer"],"nhmrc_grant_id":351463,"application_year":2004,"health_keywords":["drug target","myeloid leukaemia","myeloproliferative disorders of the haemopoietic system"],"scientific_title":"Identification of oncogenes from myeloid leukaemias by retroviral expression cloning","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Thomas Gonda","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351463","simplified_title":"A new approach for identifying cancer-causing genes involved in leukaemia","sub_type":"Standard Project Grant","total_budget":"552000","source_system":"The success rates for treatment of most myeloid leukaemias remain relatively poor, with 5-year survival rates of 40-50% overall. Thus there is a clear need for improvements in diagnosis and particularly treatment. An important and relatively new approach for doing this is to target the specific molecular and genetic alterations that lead to these diseases. This requires the identification of these alterations, particularly the oncogenes ('cancer genes') that cause or contribute to the various forms of myeloid leukaemia. However in many cases (up to 50%), the key oncogenes involved in have not and-or cannot be identified using current methods. This project aims to develop and apply a powerful technique called 'retroviral expression cloning' for the identification of oncogenes involved in myeloid leukaemia. In essence our approach is to identify oncogenes from myeloid leukaemia samples on the basis of their function - that is, by virtue of their ability to induce dysregulated or uncontrolled growth of blood-derived cells in culture."},"children":[{"color":"#336699","name":"Prof Richard D'Andrea","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0018543","middle_name":"J","last_name":"D'Andrea","source_individual_id":"RMIS11290","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Richard D'Andrea"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81748","size":1},{"color":"#336699","name":"Prof Thomas Gonda","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0007535","middle_name":"John","last_name":"Gonda","source_individual_id":"5014863","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Thomas Gonda"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78737","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6376","size":1},{"color":"#FF4D4D","name":"How do flaviviruses modulate interferon response","data":{"media_summary":"","end_year":2007,"keywords":["Flavivirus infection","Flavivirus-host interactions","Interfeon modulation","Replicon","signal transduction"],"nhmrc_grant_id":351455,"application_year":2004,"health_keywords":["Flavivirus infection","Viral pathogenesis","Virus-host interactions","interferon response"],"scientific_title":"How do flaviviruses modulate interferon response","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351455","simplified_title":"How do flaviviruses battle antiviral response","sub_type":"Standard Project Grant","total_budget":"457500","source_system":"Several members of the Flaviviridae family are major pathogens of humans including dengue (DEN), yellow fever (YF), tick-borne encephalitis (TBE), Murray valley encephalitis (MVE), Japanese encephalitis (JE), and hepatitis C virus (HCV). An Australian flavivirus Kunjin (KUN), however, appears to be naturally attenuated and does not cause an overt disease in humans. In contrast, genetically and antigenically closely related to KUN, New York strain of West Nile virus (NY WN) has already caused ~500 deaths and over 20,000 registered infections since its emergence in North America in 1999, including 223 deaths and 9122 infections in 2003 alone. Recent studies with DEN indicated that flaviviruses may interfere with early steps of IFN-signalling pathway. The type I Interferon (IFN) response is the first line of defence against viral infections and many viruses have developed different strategies to counteract this response in order to ensure their survival in the infected host. In this grant we seek to exploit our extensive understanding of the molecular biology of KUN virus and the contrasting behaviour of KUN and NY WN viruses to gain an understanding of the role of flavivirus-mediated suppression of host anti-viral IFN response in virus-host relationships and its importance in determining virus virulence."},"children":[{"color":"#336699","name":"Dr Wenjun Liu","data":{"first_name":"Wenjun","title":"Dr","dw_individual_id":"DW0043838","middle_name":"","last_name":"Liu","source_individual_id":"RMIS2346721","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Wenjun Liu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88361","size":1},{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1},{"color":"#336699","name":"Prof Roy Hall","data":{"first_name":"Roy","title":"Prof","dw_individual_id":"DW0025278","middle_name":"A","last_name":"Hall","source_individual_id":"RMIS16831","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roy Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83509","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6374","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2009,"keywords":["cell and molecular biology"],"nhmrc_grant_id":351448,"application_year":2004,"start_year":2005,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Alpha Yap","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/351448","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"595500","source_system":""},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6373","size":1},{"color":"#FF4D4D","name":"Preserving Junctions: regulating cadherins by Rho and Myosin 2.","data":{"media_summary":"","end_year":2007,"keywords":["Actin cytoskeleton","Cadherin adhesion molecules","Epithelial morphogenesis","Myosin"],"nhmrc_grant_id":351447,"application_year":2004,"health_keywords":["Cancer","Epithelial inflammation","Gastrointestinal disease","Kidney disease"],"scientific_title":"Preserving Junctions: regulating cadherins by Rho and Myosin 2.","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Alpha Yap","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351447","simplified_title":"The essential role of myosin 2 in adherens junction integrity.","sub_type":"Standard Project Grant","total_budget":"425500","source_system":"This project studies the molecular mechanisms responsible for holding cells together in normal tissues. Such cell-to-cell adhesion is mediated by the cadherin family of molecules, which reside at the surfaces of cells. Cadherins allow cells to recognize one another and, upon recognition, adhere to one another. By this means populations of individual cells can be linked together into cohesive populations (i.e. the tissues or organs of the body). The importance of cadherin adhesion is exemplified by the well-documented observation that disruption of cadherin adhesion contributes to many important diseases, including inflammation of epithelia and cancers. Thus understanding the mechanisms by which cadherins hold cells together is necessary for us to understand the molecular basis of commondisease. Characteristically, cadherins accumulate in structures called adherens junctions, and preserving those junctions is important both for tissues to organize and also to prevent tumor progression. Despite this, we know very little about how junctions are preserved in epithelia. The research to be conducted in this grant will examine exactly this problem. It builds upon recent findings from my lab which indicate that the motor molecule, myosin 2 plays an essential role in preserving junctions. Furthermore, we will test the role for signaling pathways within cells to control the activity of myosin 2 at junctions. This research will provide important novel insights into the cellular mechanisms that couple cells into tissues, and how they may be disrupted in diesase."},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6372","size":1},{"color":"#FF4D4D","name":"Dissecting pain pathways with conopeptides","data":{"media_summary":"","end_year":2009,"keywords":["Chronic and neuropathic pain","Conotoxins and toxinology","Ligand-gated ion channels, adrenergic receptors an","NMR and structure-activity relationships","Neuropharmacology, neurophysiology and molecular n"],"nhmrc_grant_id":351446,"application_year":2004,"start_year":2005,"scientific_title":"Dissecting pain pathways with conopeptides","node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Richard Lewis","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/351446","simplified_title":"Improving our understanding of chronic pain using conopeptides","sub_type":"Program Grant","total_budget":"7614296.06","source_system":"A major obstacle to the development of safer and more effective pain treatments is the poorly defined nature of the different pathways involved in chronic pain. The applicant team bring together a unique set of research expertise in using neurotoxins to define, at the molecular level, how the nervous system functions. The applicants also share a common interest in understanding and improving treatments for pain, especially chronic pain which continues to remain poorly managed Through a focus on pain research, the Program will significantly enhance the scope of existing multidisciplinary collaborations between the Cis Lewis Alewood, Adams and Christie, which have already made a considerable impact in the fields of pharmacology and neuroscience. The CIs also have considerable experience in the development of pain therapeutics, having discovered two conopeptides now under commercial development with AMRAD (AM336) and Xenome Ltd (Xen2174). This Program will discover and use highly selective conopeptides such as these to dissect the pharmacology of peripheral pain pathways and their projections into the central nervous system, and to identify and characterise new targets amenable to drug intervention. The long-term goal of the Program is to discover new targets in pain pathways and develop conopeptides that act on these targets in animal models of chronic pain. These molecules will be optimised within the Program to the point where they can be considered for pre-clinical development in collaboration with commercial partners."},"children":[{"color":"#336699","name":"Prof Macdonald Christie","data":{"first_name":"Macdonald","title":"Prof","dw_individual_id":"DW0035875","middle_name":"James","last_name":"Christie","source_individual_id":"5012593","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Macdonald Christie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86297","size":1},{"color":"#336699","name":"Prof Paul Alewood","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0035049","middle_name":"F","last_name":"Alewood","source_individual_id":"5013158","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Alewood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86082","size":1},{"color":"#336699","name":"Prof Richard Lewis","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0014455","middle_name":"J","last_name":"Lewis","source_individual_id":"5015973","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Lewis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80612","size":1},{"color":"#336699","name":"Prof David Adams","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0000022","middle_name":"John","last_name":"Adams","source_individual_id":"RMIS8271","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Adams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76652","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6371","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2008,"keywords":["caveolae","endocytosis","muscle cell biology","plasma membrane","signal transduction"],"nhmrc_grant_id":351441,"application_year":2004,"start_year":2005,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/351441","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"516250","source_system":""},"children":[{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6370","size":1},{"color":"#FF4D4D","name":"Immunological therapies for cancer and autoimmunity","data":{"media_summary":"","end_year":2009,"keywords":["Autoimmunity","Graft v Host disease","Immunotherapy","Tumour immunology"],"nhmrc_grant_id":351439,"application_year":2004,"start_year":2005,"scientific_title":"Immunological therapies for cancer and autoimmunity","node_source":"NHMRC","node_type":"Grant","field_of_research":"Transplantation Immunology","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ian Frazer","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/351439","simplified_title":"Utilising immunoregulation for treatment of disease","sub_type":"Program Grant","total_budget":"4928323.52","source_system":"The programme team comprises a group of leading scientists with a history of successful investigation into the mechanisms and treatment of diseases in which the immune system plays a role in their development. These include cancers of the cervix and blood system, and autoimmune diseases such as rheumatoid arthritis and type 1 diabetes. Working together, the team have made discoveries that have led to testing and clinical development of new treatments for these diseases. In this programme, the team aims to discover mechanisms regulating the immune response, and to exploit this knowledge to define new ways of switching on or off, specific immune responses. We will particularly seek to develop novel vaccines for chronic infections and autoimmune diseases, and to improve the safety of bone marrow transplantation."},"children":[{"color":"#336699","name":"Prof Ranjeny Thomas","data":{"first_name":"Ranjeny","title":"Prof","dw_individual_id":"DW0045826","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS4352","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ranjeny Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88853","size":1},{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1},{"color":"#336699","name":"Prof Geoff Hill","data":{"first_name":"Geoff","title":"Prof","dw_individual_id":"DW0007868","middle_name":"Roger","last_name":"Hill","source_individual_id":"RMIS534437","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Geoff Hill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78822","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6369","size":1},{"color":"#FF4D4D","name":"Understanding the role of the olfactory ensheathing cell in the olfactory sensory system","data":{"media_summary":"","end_year":2007,"keywords":["axon guidance","neuron-glia interactions","olfactory ensheathing cell","olfactory system"],"nhmrc_grant_id":351435,"application_year":2004,"health_keywords":["brain damage","brain development","brain growth"],"scientific_title":"Understanding the role of the olfactory ensheathing cell in the olfactory sensory system","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr James St John","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351435","simplified_title":"Understanding how the system of smell is generated","sub_type":"Standard Project Grant","total_budget":"494000","source_system":"The olfactory (smell) system is a unique part of the nervous system; nerve cells are generated throughout life and it can regenerate even after injury. It therefore provides an excellent model for examining the growth, development and maintenance of nerve cells. This project will examine how one specialized type of cell, the olfactory ensheathing cell, helps the nerve cells to grow and regenerate. Information we obtain about how this system develops and regenerates may be useful in treating brain disorders and spinal injuries In the current project we will examine how olfactory nerve cells interact with the ensheathing cells. We will use transgenic mice in which the different cells are marked by separate colours which will allow us to easily identify the cells and see where they grow. In addition, we will also examine the behaviour of live cells as they are growing. In the past all attempts to understand how nerve cell connections are formed in the olfactory system have used dead tissue that has been permanently preserved. In this project we have the unique opportunity to visualise living nerve cells to enable us to determine how the cells interact with the ensheathing cells. The advantage of this approach is that it allows us to identify important interactions as they occur, rather than attempting to decipher them after they have occurred. An analogy would be watching a football game live and observing how goals were scored and appreciating the performance of individual players versus trying to guess from the final score how the game was played and who the key performers were. These experiments will provide important information about how the olfactory ensheathing and nerve cells grow and regenerate."},"children":[{"color":"#336699","name":"Prof Peter Mombaerts","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0032651","middle_name":"","last_name":"Mombaerts","source_individual_id":"RMIS3124863","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Peter Mombaerts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85453","size":1},{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1},{"color":"#336699","name":"Dr James St John","data":{"first_name":"James","title":"Dr","dw_individual_id":"DW0004781","middle_name":"A","last_name":"St John","source_individual_id":"RMIS5210245","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr James St John"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77995","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6368","size":1},{"color":"#FF4D4D","name":"Deciphering the molecular steps leading to the potentiation of neuronal exocytosis by arachidonic acid","data":{"media_summary":"","end_year":2007,"keywords":["Arachidonic acid","Cell biology","Exocytosis","Hormone and peptide secretion","SNARE"],"nhmrc_grant_id":351434,"application_year":2004,"health_keywords":["Adrenaline and noradenaline secretion","Hormone secretion","Neurodegenerative diseases"],"scientific_title":"Deciphering the molecular steps leading to the potentiation of neuronal exocytosis by arachidonic acid","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Membrane Biology","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Frederic Meunier","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351434","simplified_title":"Unraveled role of arachidonic acid during exocytosis","sub_type":"Standard Project Grant","total_budget":"273000","source_system":"Release of hormones and neurotransmitters relies on a process called exocytosis which involves SNARE proteins: syntaxin1A and SNAP-25 on the target plasma membrane and VAMP on the vesicular membrane. Availability of the t-SNARE on the plasma membrane is believed to play a major role in controlling the amount of exocytosis. Syntaxin1A bound to Munc18 constitute an 'unproductive-reserve' pool of closed Syntaxin that cannot interact with SNAP-25. Intracellular messengers capable of releasing Syntaxin1A from Munc18 thereby making it available to interact with SNAP-25, are foreseen to play a major role in potentiating exocytosis - a process with ramification for memory and learning. We have identified arachidonic acid, a lipidic messenger which fullfil this role. For the first time we are in a position to manipulate at the molecular level different pools of SNARE proteins with direct implications for our understanding of the mechanism of secretion. Very few models are currently available to understand how learning and memory occur in the brain. Our research points to a new direction: the amount of 'active' and 'unproductive-reserve' pools of SNARE proteins present on the plasma membrane of neurosecretory cells are in dynamic equilibrium and arachidonic acid, a second messenger capable of trans-synaptic action, can modify this equilibrium resulting in an increase of the amount of 'active' SNARE thereby potentiating the amount of transmitter-hormone released by exocytosis. Importantly, this research lays the basis for a dynamic view of the secretory mechanism with important implications for treatment of diseases such as diabetes and neurodegenerative diseases. Our hope is that by understanding at the molecular level how secretory cells regulate the amount of their secretion, we will be in a position to modify these parameters in order to counteract illnesses of the nervous system."},"children":[{"color":"#336699","name":"Prof Frederic Meunier","data":{"first_name":"Frederic","title":"Prof","dw_individual_id":"DW0020864","middle_name":"A","last_name":"Meunier","source_individual_id":"5016455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frederic Meunier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82341","size":1},{"color":"#336699","name":"Prof Jennifer Martin","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0008922","middle_name":"Louise","last_name":"Martin","source_individual_id":"5022915","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jennifer Martin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79117","size":1},{"color":"#336699","name":"Prof Philip Poronnik","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0004031","middle_name":"","last_name":"Poronnik","source_individual_id":"RMIS7101816","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Philip Poronnik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77792","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6367","size":1},{"color":"#FF4D4D","name":"The PDZ scaffold NHERF-1; a novel regulator of astrocyte function?","data":{"media_summary":"","end_year":2007,"keywords":["amino acid trasport","astrocytes","glutamate","neurological disease","scaffold protein"],"nhmrc_grant_id":351412,"application_year":2004,"health_keywords":["epilepsy","hydrocephaly","hypoxia","ischaemia"],"scientific_title":"The PDZ scaffold NHERF-1; a novel regulator of astrocyte function?","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Philip Poronnik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351412","simplified_title":"NHERF in astrocytes","sub_type":"Standard Project Grant","total_budget":"444500","source_system":"Astrocytes are a vital cell type in the human brain. They provide nutrients to neurons, remove toxic chemicals such as glutamate (a neurotransmitter), as well as stabilising the levels of molecules such as water and ions such as sodium, bicarbonate and potassium. Astrocytes perform all these tasks by means of specialised protein molecules called transporters that are embedded in their cell membranes. These transporters are not uniformly distributed; they are positioned in those parts of the astrocyte membranes where the particular biological job has to be performed. How are they targeted to, and retained in these places? We have preliminary data suggesting that a specialised protein called NHERF-1, can bind a group of these proteins, called glutamate transporters, thereby anchoring them to the skeleton of the cell. If we are correct then we should be able to manipulate this interaction, both in live brain tissues, and in simple cell culture systems, using a variety of physiological and molecular biology techniques. If we are correct in our hypothesis, then our findings will have immense value in trying to reduce damage that occurs in human brains in conditions such as strokes, where a breakdown in the control of glutamate around neurons causes extensive and irreversible brain damage."},"children":[{"color":"#336699","name":"Prof David Pow","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0021533","middle_name":"Vaughan","last_name":"Pow","source_individual_id":"RMIS4392155","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Pow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82534","size":1},{"color":"#336699","name":"A/Pr Chris Yun","data":{"first_name":"Chris","title":"A/Pr","dw_individual_id":"DW0017300","middle_name":"C","last_name":"Yun","source_individual_id":"RMIS3118999","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Chris Yun"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81405","size":1},{"color":"#336699","name":"Prof Philip Poronnik","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0004031","middle_name":"","last_name":"Poronnik","source_individual_id":"RMIS7101816","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Philip Poronnik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77792","size":1},{"color":"#336699","name":"Prof Stefan Broer","data":{"first_name":"Stefan","title":"Prof","dw_individual_id":"DW0000554","middle_name":"","last_name":"Broer","source_individual_id":"5018671","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stefan Broer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76808","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6366","size":1},{"color":"#FF4D4D","name":"The ClC-5 Cl- channel, a key regulatory role in albumin uptake by the proximal tubule","data":{"media_summary":"","end_year":2007,"keywords":["albumin uptake","chloride channel","proteinuria","proximal tubule","ubiquitination"],"nhmrc_grant_id":351411,"application_year":2004,"health_keywords":["hypertension","progressive renal disease","proteinuria"],"scientific_title":"The ClC-5 Cl- channel, a key regulatory role in albumin uptake by the proximal tubule","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Philip Poronnik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351411","simplified_title":"ClC-5 and albumin uptake","sub_type":"Standard Project Grant","total_budget":"510500","source_system":"The clinical association between protein loss in the urine and retention of salt, resulting in high blood pressure and progressive decline in kidney function, is well known. Under normal conditions, the kidneys filter 180 litres of water and reabsorb 1.7 kg of salt per day, a function which is principally performed by the kidney tubules in the kidney. Similarly the kidney tubule cells reabsorb and break down up to 3 grams of albumin per day. In the past, it has been considered that excessive protein loss in the urine is primarily due to problems in the filtering units of the kidneys, rather than due to abnormalities in the reabsorption of protein in the kidney tubules. However, we consider that common abnormalities in the processes within the kidney tubules that regulate both the reabsorption of salt and the excretion of acid may result in concomitant high blood pressure and increased protein loss in the kidney. Thus the overall aim of the project is to investigate the mechanisms by which the complex responsible for protein uptake determines the interrelationship between protein reabsorption and catabolism and the ion transporting proteins in the membrane of the proximal tubule. This project will comprehensively characterise the mechanisms of protein uptake in kidney tubule cells. The exact nature of the interaction of the proteins involved in performing the salt reabsorption and ensuring correct catabolism of protein uptake with the actual protein uptake mechanism will be determined. As persistent proteinuria is the most important predictor of tubulointerstitial pathology and progressive decline in renal function in almost all renal disease, the understanding of the precise mechanism by which this occurs is essential in the design of renoprotective therapies."},"children":[{"color":"#336699","name":"Prof Carol Pollock","data":{"first_name":"Carol","title":"Prof","dw_individual_id":"DW0039130","middle_name":"A","last_name":"Pollock","source_individual_id":"5017027","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Carol Pollock"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87145","size":1},{"color":"#336699","name":"Prof William Guggino","data":{"first_name":"William","title":"Prof","dw_individual_id":"DW0007639","middle_name":"B","last_name":"Guggino","source_individual_id":"RMIS3111046","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof William Guggino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78768","size":1},{"color":"#336699","name":"Prof Philip Poronnik","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0004031","middle_name":"","last_name":"Poronnik","source_individual_id":"RMIS7101816","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Philip Poronnik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77792","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6365","size":1},{"color":"#FF4D4D","name":"Targeted drug delivery by topical application","data":{"media_summary":"Transdermal kinetics","end_year":2007,"keywords":["Drug targeting","Formulation design","Skin permeability","Skin risk assessment","Transdermal delivery"],"nhmrc_grant_id":351410,"application_year":2004,"health_keywords":["Drug binding and distribution","Skin delivery system design","Structure-activity relationships","Topical exposure risk assessment","Transdermal kinetics"],"scientific_title":"Targeted drug delivery by topical application","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Michael Roberts","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351410","simplified_title":"Topical Drug Delivery","sub_type":"Standard Project Grant","total_budget":"537000","source_system":"Drugs are applied to the skin for the treatment of a wide range of conditions, including both local (eg. inflammation, muscle pain, eczema, psoriasis and other dermatological conditions) and systemic (eg. angina, hormone replacement, nicotine withdrawal) therapies. Advances in molecular biology technology has also led to the development of a range of large molecular weight peptide and protein based therapeutic agents for which transdermal delivery offers the most cost-effective and practical solution if appropriate delivery systems can be identified. In addition, unwanted skin absorption also occurs following exposure to environmental occupational chemicals, and those applied deliberately to the skin such as insecticides, sunscreens and cosmetics. This study continues our work in seeking to define the relationship between the chemical structure of agents, the types of formulations and solvents in which they are applied or come into contact with the skin and their penetration, distribution and retention in the various layers of the skin and underlying tissues. Of great significance to both the pharmaceutical industry and risk assessment regulatory bodies will be the further development of our work into important areas relating to the ability to predict the likely behaviour of a solute following contact with the skin from the aspect of both optimising drug delivery systems and the accuracy of risk assessment procedures. We will also be continuing our work examining techniques to facilitate drug transport through the skin using physical techniques such as iontophoresis and the design of formulations to specifically target larger pores in the skin such as hair follicles as a means of improving delivery rates and increasing the range of solutes, particularly those of large molecular weight, likely to be considered as potential drug candidates."},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1},{"color":"#336699","name":"Yuri Anissimov","data":{"first_name":"Yuri","title":"","dw_individual_id":"DW0011472","middle_name":"","last_name":"Anissimov","source_individual_id":"RMIS3110670","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Yuri Anissimov"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79814","size":1},{"color":"#336699","name":"Sheree Cross","data":{"first_name":"Sheree","title":"","dw_individual_id":"DW0001098","middle_name":"","last_name":"Cross","source_individual_id":"RMIS40999","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Sheree Cross"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76971","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6364","size":1},{"color":"#FF4D4D","name":"RNA trafficking in oligodendrocytes and neurons","data":{"media_summary":"","end_year":2007,"keywords":["RNA trafficking","heterogeneous nuclear ribonucleoproteins","long-term potentiation","memory","myelin basic protein mRNA"],"nhmrc_grant_id":351409,"application_year":2004,"health_keywords":["demyelination","memory loss","nervous system development"],"scientific_title":"RNA trafficking in oligodendrocytes and neurons","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Ross Smith","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351409","simplified_title":"Transport of RNA in cells","sub_type":"Standard Project Grant","total_budget":"439500","source_system":"Control of the use of DNA, gene expression, is vital to all living organisms, especially in development and disease. The information in the genes is transferred to an intermediate molecule, mRNA, in a process called transcription. The genetic information in the mRNA is subsequently used, in the process called translation, to make the protein encoded by the original gene. The switching on and off of DNA appears to be most frequently controlled at the transcription step but recently it has become apparent that there are many post-transcriptional events that govern how efficiently the genetic information is ultimately converted to protein molecules. In this project we will investigate the molecular mechanisms of several proteins, heterogeneous nuclear ribonucleoproteins (hnRNPs), that appear to play regulatory roles in many of these steps. These proteins appear to affect the longevity and replication of cells, the important chemical changes that take place in RNA after it is transcribed and before it is translated, the movement of the modifed RNAs through the cell and the efficiency of translation. Because of these central functions they are involved in development of tissues such as the brain, and in diseases including lung, skin and brain cancers, and rheumatoid arthritis. In this project we will focus on two RNA molecules, one vital for myelination in the central nervous system and the other for memory."},"children":[{"color":"#336699","name":"Prof Ross Smith","data":{"first_name":"Ross","title":"Prof","dw_individual_id":"DW0045515","middle_name":"William","last_name":"Smith","source_individual_id":"RMIS6441","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ross Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88776","size":1},{"color":"#336699","name":"A/Pr Joseph Rothnagel","data":{"first_name":"Joseph","title":"A/Pr","dw_individual_id":"DW0009982","middle_name":"A","last_name":"Rothnagel","source_individual_id":"5017267","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Joseph Rothnagel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79410","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6363","size":1},{"color":"#FF4D4D","name":"Effective management of acute whiplash injuries requires a pragmatic approach: An RCT with stratified treatments","data":{"media_summary":"whiplash related disorders","end_year":2007,"keywords":["clincial trial","multidisciplinary","physiotherapy","psychology","whiplash injuries"],"nhmrc_grant_id":351408,"application_year":2004,"health_keywords":["early intervention","health economics","injury rehabilitation and management","post-traumatic stress","whiplash related disorders"],"scientific_title":"Effective management of acute whiplash injuries requires a pragmatic approach: An RCT with stratified treatments","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Gwendolen Jull","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351408","simplified_title":"A clinical trial investigating individualised treatments for persons with an acute whiplash injury","sub_type":"Standard Project Grant","total_budget":"382550","source_system":"Whiplash injuries from a motor vehicle crash continue to incur substantial personal and financial costs to the community and the insurance industry. The current approaches to an acute whiplash injury in Australia and internationally have failed to lessen the rate of how many people develop chronic neck pain. Between 40 and 60% still have pain 6 months after injury. Motor Accident Insurance Commission (Qld) figures indicate that 20% of patients with chronic whiplash account for 60% of the costs. Transition from an acute to a chronic condition must be prevented. A new direction in management in the acute stage is urgently required as once the pain has become chronic, it is difficult to help. This research will conduct a novel randomised controlled trial for acute whiplash. It will test individually prescribed multi-professional management against usual care with the aim to lessen the numbers who go on to develop chronic pain. It will be the first clinical trial that acknowledges from the outset that the whiplash injuries and affects people in different ways. Our previous research with acute whiplash patients has documented the variations in presentation from physical, physiological and psychological perspectives. In this trial, management will be prescribed as directed by measurable pain, muscle and psychological impairments in the individual, rather than regard all patients as the same as in other trials. This trial will offer individualised treatments; medical, physiotherapy and-or psychological using an empirically derived treatment algorithm. Cost-effectiveness of the program will be evaluated against that incurred during usual care. It is predicted that early multi-professional management will be less expensive in the long term than existing approaches. This RCT stands to extend knowledge in the management of whiplash associated disorders (WAD)."},"children":[{"color":"#336699","name":"Prof Justin Kenardy","data":{"first_name":"Justin","title":"Prof","dw_individual_id":"DW0037727","middle_name":"Alastair","last_name":"Kenardy","source_individual_id":"RMIS53308","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Justin Kenardy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86768","size":1},{"color":"#336699","name":"Prof Luke Connelly","data":{"first_name":"Luke","title":"Prof","dw_individual_id":"DW0030066","middle_name":"Brian","last_name":"Connelly","source_individual_id":"5012629","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Luke Connelly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84790","size":1},{"color":"#336699","name":"A/Pr Elaine Beller","data":{"first_name":"Elaine","title":"A/Pr","dw_individual_id":"DW0029399","middle_name":"Margaret","last_name":"Beller","source_individual_id":"RMIS1207844","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Elaine Beller"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84621","size":1},{"color":"#336699","name":"Prof Michele Sterling","data":{"first_name":"Michele","title":"Prof","dw_individual_id":"DW0028165","middle_name":"","last_name":"Sterling","source_individual_id":"5017714","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michele Sterling"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84271","size":1},{"color":"#336699","name":"A/Pr Milton Cohen","data":{"first_name":"Milton","title":"A/Pr","dw_individual_id":"DW0024184","middle_name":"","last_name":"Cohen","source_individual_id":"5031565","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Milton Cohen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83208","size":1},{"color":"#336699","name":"E/Pr Gwendolen Jull","data":{"first_name":"Gwendolen","title":"E/Pr","dw_individual_id":"DW0019981","middle_name":"A","last_name":"Jull","source_individual_id":"RMIS5215","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"E/Pr Gwendolen Jull"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82087","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6362","size":1},{"color":"#FF4D4D","name":"Investigations in multiple sclerosis patients with coexistent autoimmune thyroid disease","data":{"media_summary":"","end_year":2007,"keywords":["autoimmune diseases","molecular mechanisms","multiple sclerosis","myelin proteins","neurology"],"nhmrc_grant_id":351404,"application_year":2004,"health_keywords":["Graves' disease","autoimmune disease","hypothyroidism","multiple sclerosis"],"scientific_title":"Investigations in multiple sclerosis patients with coexistent autoimmune thyroid disease","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Autoimmunity","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Dr Judith Greer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/351404","simplified_title":"Investigations in people with multiple autoimmune diseases","sub_type":"Standard Project Grant","total_budget":"557100","source_system":"Multiple sclerosis (MS) is a common chronic neurological disease affecting over one million people around the world. MS is generally thought to be an autoimmune disease, in which a person's own immune cells start to attack components of the brain and spinal cord. However, it is thought that the same components are not attacked in all patients, and that the pathway that leads to MS varies from one person to another. Therefore, in order to develop successful treatment strategies for MS, it will be necessary to look for patterns in the clinical symptoms and signs and other features of a person's MS that may give clues as to which particular pathway is leading to disease in that person. Some people who develop MS also develop other autoimmune diseases, or have these other diseases before they develop MS, or have other family members who have other autoimmune diseases. We have recently found that people who have the same combination of coexistent MS and autoimmune thyroid disease (AITD) show similar clinical signs of MS, and tend to have damage (lesions) to the same areas of their nervous system. This suggests that these people may have the same underlying pathways leading to the development of MS, and that they may be a very informative group in which to look for immune or genetic abnormalities that might explain why they develop MS. This project will investigate people who have both MS and AITD and other members of their families to see if we can work out what the links are between having the same combination of autoimmune diseases and developing lesions in particular parts of the nervous system. It will provide information on the pathways that lead to the development of MS, and information obtained from this study may eventually be of use in developing more specific therapeutic agents, by tailoring therapies to specific people with MS, depending on the clinical and immunological profile of that person."},"children":[{"color":"#336699","name":"Dr Judith Greer","data":{"first_name":"Judith","title":"Dr","dw_individual_id":"DW0036976","middle_name":"M","last_name":"Greer","source_individual_id":"RMIS24768","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Judith Greer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86571","size":1},{"color":"#336699","name":"Prof Michael Pender","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0009604","middle_name":"P","last_name":"Pender","source_individual_id":"RMIS18293","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Pender"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79308","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6361","size":1},{"color":"#FF4D4D","name":"New statistical approaches to the identification of genes contributing to complex traits.","data":{"media_summary":"","end_year":2009,"keywords":["Disease gene mapping","Genetic association","Genetic linkage","epigenetics"],"nhmrc_grant_id":339477,"application_year":2004,"start_year":2006,"scientific_title":"New statistical approaches to the identification of genes contributing to complex traits.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Quantitative Genetics","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Jackie Wicks","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/339477","simplified_title":"New statistical approaches to the identification of genes contributing to complex traits.","sub_type":"Australian Research Training ECF (Part-time)","total_budget":"76917.5","source_system":""},"children":[{"color":"#336699","name":"Dr Jackie Wicks","data":{"first_name":"Jackie","title":"Dr","dw_individual_id":"DW0017087","middle_name":"","last_name":"Wicks","source_individual_id":"RMIS2356996","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Jackie Wicks"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81337","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6114","size":1},{"color":"#FF4D4D","name":"Functional Significance of ATM-dependent phosphorylation of Mre11","data":{"media_summary":"","end_year":2007,"keywords":["Gene Expression","Genetic Disease","Phosphorylation","Radiation Biology","Signal Transduction"],"nhmrc_grant_id":339444,"application_year":2004,"health_keywords":["Biochemistry and molecular biology","Chromosomal Disorders","Gene expression","Genetic Disease"],"scientific_title":"Functional Significance of ATM-dependent phosphorylation of Mre11","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/339444","simplified_title":"Role of ATM in radiation response","sub_type":"Standard Project Grant","total_budget":"211500","source_system":"The aim of the project is to investigate the response of human cells to radiation damage to DNA. Radiation causes double strand breaks in DNA which are responsible for its carcinogenic activity. Several rare syndromes have been described where there is a hypersensitivity to radiation and an increased risk of developing cancer. Cells from these patients have provided a useful means of understanding the basis of sensitivity to radiation and how this may be linked to diseases such as cancer. The intention here is to investigate some of the normal mechanisms of cellular response to radiation and determine why they are deficient in cells from individuals with these rare syndromes. We will focus on a protein, ATM, which is activated by radiation and on one of its substrates Mre11. Both molecules are involved in sensing and transmitting signals from DNA to cell cycle checkpoints. The expected outcome of this study is a greater understanding of the intricate set of signaling pathways that are activated in response to radiation damage. In addition it is expected that a detailed knowledge of these pathways and what goes wrong in specific disease states will be of assistance in understanding risk of developing cancer. Finally this information will also be useful in the design of novel compounds for the prevention and-or treatment of cancer."},"children":[{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1},{"color":"#336699","name":"Dr Shaun Scott","data":{"first_name":"Shaun","title":"Dr","dw_individual_id":"DW0016131","middle_name":"P","last_name":"Scott","source_individual_id":"RMIS2362895","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Shaun Scott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81070","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6103","size":1},{"color":"#FF4D4D","name":"Functional Role of Aprataxin: Mutated in Ataxia with Oculomotor Apraxia","data":{"media_summary":"Genetic Disease","end_year":2007,"keywords":["Cell Biology","DNA damage","DNA repair","Disease Gene","Molecular Genetics"],"nhmrc_grant_id":339443,"application_year":2004,"health_keywords":["Basic Science","Cell Survival","Chromosomal Disorders","Gene expression","Genetic Disease"],"scientific_title":"Functional Role of Aprataxin: Mutated in Ataxia with Oculomotor Apraxia","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/339443","simplified_title":"Investigation of stress response protein","sub_type":"Standard Project Grant","total_budget":"276000","source_system":"The proposal is designed to investigate the role of a novel protein called Aprataxin in the cellular response to genotoxic stress. Aprataxin is mutated in a human genetic disorder, ataxia with oculomotor apraxia type 1 (AOA1). These individuals have a progressive loss of motor function and have difficulties with eye movement and focus. It is not clear why the loss of the Aprataxin protein is manifested by neurodegenerative changes and little effect on other tissues. We have demonstrated that cells from AOA1 patients are more sensitive to agents that cause breaks in DNA and we have shown that Aprataxin associates with proteins required to repair these breaks. The aim here is to investigate in detail the role of Aprataxin in DNA repair. We have also shown that Aprataxin is localized to different regions of the nucleus and will investigate the significance of this in relation to the response to genotoxic stress. A greater understanding of how this protein functions in the cell is likely to provide important information on why it is Aprataxin is so important in the brain. In the longer term this information may assist in the treatment of spinocerebellar ataxia syndromes."},"children":[{"color":"#336699","name":"A/Pr Nuri Gueven","data":{"first_name":"Nuri","title":"A/Pr","dw_individual_id":"DW0037013","middle_name":"","last_name":"Gueven","source_individual_id":"RMIS3058711","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Nuri Gueven"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86581","size":1},{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6102","size":1},{"color":"#FF4D4D","name":"Australasian Kidney trials (AKT) Network","data":{"media_summary":"","end_year":2010,"keywords":["Chronic Renal Disease","Clinical Trial","Evidence based medicine","Nephrology"],"nhmrc_grant_id":338800,"application_year":2004,"start_year":2006,"scientific_title":"Australasian Kidney trials (AKT) Network","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Carmel Hawley","higher_grant_type":"NHMRC Enabling Grants","purl":"http://purl.org/au-research/grants/nhmrc/338800","simplified_title":"Australasian Kidney trials (AKT) Network","sub_type":"Clinical Trials Resources","total_budget":"1290000","source_system":"The Australasian Kidney Trials Network will facilitate well-conducted clinical research and foster collaboration between leading researchers in kidney disease. The Networks focus will be to answer important questions about prevention and treatment of kidney disease to improve health and quality of life outcomes. The Network will be at the forefront of knowledge creation and address complex economic, technological and social needs relating to the patient care and the translation of research into clinical practice."},"children":[{"color":"#336699","name":"A/Pr Elaine Beller","data":{"first_name":"Elaine","title":"A/Pr","dw_individual_id":"DW0029399","middle_name":"Margaret","last_name":"Beller","source_individual_id":"RMIS1207844","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Elaine Beller"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84621","size":1},{"color":"#336699","name":"A/Pr Carmel Hawley","data":{"first_name":"Carmel","title":"A/Pr","dw_individual_id":"DW0025392","middle_name":"Mary","last_name":"Hawley","source_individual_id":"5012539","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Carmel Hawley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83535","size":1},{"color":"#336699","name":"Prof Wendy Hoy","data":{"first_name":"Wendy","title":"Prof","dw_individual_id":"DW0013767","middle_name":"Elizabeth","last_name":"Hoy","source_individual_id":"RMIS3725","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wendy Hoy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80407","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6092","size":1},{"color":"#FF4D4D","name":"Organization and function of primate auditory cortex","data":{"media_summary":"word deafness","end_year":2007,"keywords":["auditory system","brain mapping","cerebral cortex","communication","hearing"],"nhmrc_grant_id":334094,"application_year":2004,"health_keywords":["aphasia","auditory agnosia","cochlear prosthesis","communication","word deafness"],"scientific_title":"Organization and function of primate auditory cortex","start_year":2005,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Matthew Spitzer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/334094","simplified_title":"Organization and function of brain areas involved in perception of sound","sub_type":"Standard Project Grant","total_budget":"271671","source_system":"The conscious perception of speech and other sounds depends on processing within a brain region known as the auditory cortex. Compared to other brain areas, relatively little is known about the organization and function of this structure. Recent studies have proposed that the auditory cortex may be anatomically subdivided into functional modules, each of which is specialized for processing different types of information. However, the evidence for multiple processing streams is fragmentary, and not entirely consistent. The proposed experiments will combine anatomical and physiological approaches to evaluate the functional organization of auditory cortex in the primate brain. We will map the electrical responses of single brain cells to various complex sounds across the brain surface, and inject dyes to label pathways linking brain areas to one another. The data will allow us to determine whether specific subdivisions of the auditory cortex are specialized for processing different types of infomation, and whether specific subdivisions are linked together to form processing streams specialized for sound recognition and space perception. The results will advance our understanding of the neuronal processing involved in the perception of sound, with possible implications for speech perception. This will help to understand the consequences of brain damage, and may inform the development of hearing aids and artificial voice recognition systems. In addition, this study will help to develop a primate model for studying brain mechanisms of sound recognition that should be useful in research on cochlear implants."},"children":[{"color":"#336699","name":"Prof Marcello Rosa","data":{"first_name":"Marcello","title":"Prof","dw_individual_id":"DW0033498","middle_name":"G. P.","last_name":"Rosa","source_individual_id":"RMIS6051","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Marcello Rosa"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85672","size":1},{"color":"#336699","name":"Prof Dexter Irvine","data":{"first_name":"Dexter","title":"Prof","dw_individual_id":"DW0025708","middle_name":"Robert","last_name":"Irvine","source_individual_id":"RMIS8519","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Dexter Irvine"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83618","size":1},{"color":"#336699","name":"Matthew Spitzer","data":{"first_name":"Matthew","title":"","dw_individual_id":"DW0016366","middle_name":"","last_name":"Spitzer","source_individual_id":"RMIS2303331","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Matthew Spitzer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81144","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/6013","size":1},{"color":"#FF4D4D","name":"Process evaluation of the training of Aboriginal health workers in rurual communities in basic oral health care","data":{"media_summary":"","end_year":2009,"keywords":["Indigenous health","evaluation","oral health","training"],"nhmrc_grant_id":326239,"application_year":2004,"start_year":2005,"scientific_title":"Process evaluation of the training of Aboriginal health workers in rurual communities in basic oral health care","node_source":"NHMRC","node_type":"Grant","field_of_research":"Primary Health Care","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr David Walker","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/326239","simplified_title":"Process evaluation of the training of Aboriginal health workers in rurual communities in basic oral health care","sub_type":"Public Health Postgraduate Scholarship","total_budget":"146122.47","source_system":""},"children":[{"color":"#336699","name":"Dr David Walker","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0034516","middle_name":"John","last_name":"Walker","source_individual_id":"RMIS3391773","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr David Walker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85943","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5939","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2010,"keywords":["G protein-coupled receptors","arrestins","cell signalling","desensitisation"],"nhmrc_grant_id":317814,"application_year":2004,"start_year":2005,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Walter Thomas","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/317814","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"751976","source_system":"I am a cell physiologist committed to understanding how receptors and their signals impact on the health and disease of the heart and blood vessels."},"children":[{"color":"#336699","name":"Prof Walter Thomas","data":{"first_name":"Walter","title":"Prof","dw_individual_id":"DW0028371","middle_name":"Glen","last_name":"Thomas","source_individual_id":"RMIS225046","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Walter Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84337","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5854","size":1},{"color":"#FF4D4D","name":"An ethnographic study of the meaning of cancer to Aboriginal Women","data":{"media_summary":"","end_year":2005,"keywords":["Aboriginal Women","Cancer","Palliative"],"nhmrc_grant_id":311231,"application_year":2003,"start_year":2004,"scientific_title":"An ethnographic study of the meaning of cancer to Aboriginal Women","node_source":"NHMRC","node_type":"Grant","field_of_research":"Indigenous Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Mrs Deborah Prior","higher_grant_type":"SRDC - People","purl":"http://purl.org/au-research/grants/nhmrc/311231","simplified_title":"An ethnographic study of the meaning of cancer to Aboriginal Women","sub_type":"Public Health Scholarship - Palliative Care","total_budget":"26477.93","source_system":"The impetus for development of the palliative care movement was the plight of cancer patients, which is why my study aims to explore and interpret what cancer means to Aboriginal women and how experiences and perception of the disease impacts on their attitudes toward treatment options. In my thesis I hope to build a critique of Aboriginal womens perceptions of cancer that will inform health care services of socio-cultural issues that should be considered in developing and providing culturally supportive care."},"children":[{"color":"#336699","name":"Mrs Deborah Prior","data":{"first_name":"Deborah","title":"Mrs","dw_individual_id":"DW0004084","middle_name":"M","last_name":"Prior","source_individual_id":"RMIS2958125","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mrs Deborah Prior"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77807","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5768","size":1},{"color":"#FF4D4D","name":"A novel one-step approach in the early diagnosis of prostate cancer","data":{"media_summary":"","end_year":2005,"keywords":["Diagnostic assay","Early detection","Molecular markers","Prostate cancer","Urology"],"nhmrc_grant_id":311217,"application_year":2003,"start_year":2004,"scientific_title":"A novel one-step approach in the early diagnosis of prostate cancer","node_source":"NHMRC","node_type":"Grant","field_of_research":"Diagnostic Applications","research_area":"Clinical Medicine and Science","for_category":"BIOTECHNOLOGY","cia_name":"Prof Robert ('Frank') Gardiner","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/311217","simplified_title":"Prostate cell ertrieval from ejaculate in prostate cancer diagnosis","sub_type":"Development Grant","total_budget":"102150","source_system":"In order to avoid the invasiveness and imprecision of current prostate cancer detection, this programme is directed to developing a non-invasive and repeatable, accurate approach. This research project is designed to optimise retrieval of prostate cells from ejaculate and to compare two methods for profiling selected genetic changes to diagnose prostate cancer. The refinement of techniques, outlined in the application, is essential before proceeding to a clinical trial."},"children":[{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1},{"color":"#336699","name":"Prof Robert 'Frank' Gardiner","data":{"first_name":"Robert 'Frank'","title":"Prof","dw_individual_id":"DW0019135","middle_name":"Alexander","last_name":"Gardiner","source_individual_id":"RMIS6050429","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Robert 'Frank' Gardiner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81883","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5767","size":1},{"color":"#FF4D4D","name":"Biological membrane transporters: Delivery of an oligonucleotide inhibitor of vascular endothelial growth factor (VEGF)","data":{"media_summary":"","end_year":2005,"keywords":["Charged dendritic systems","Drug Delivery","Drug Design","Lipophilic dendrimers","Oligonucleotide delivery"],"nhmrc_grant_id":311216,"application_year":2003,"start_year":2004,"scientific_title":"Biological membrane transporters: Delivery of an oligonucleotide inhibitor of vascular endothelial growth factor (VEGF)","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmaceutical Sciences and Pharmacy","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Istvan TOTH","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/311216","simplified_title":"Oligonucleotide Delivery","sub_type":"Development Grant","total_budget":"99750","source_system":"Choroidal neovascularisation, which is the most severe form of Age Related Macular Degeneration, is the major cause of blindness in the developed world. Gene therapy could be a cure for this disease if the problems associated with the delivery of DNA could be addressed. Our project involves a highly novel strategy for gene delivery involving ion pair formation of lipophilic dendrimers (tree-like compounds with positive charges on the surface). We will develop new DNA-dendrimer complexes and test them in a well established animal model for neovascularisation. Successful completion of this project might offer a potential therapy for choroidal neovascularisation, with a good chance of entering into human clinical trials."},"children":[{"color":"#336699","name":"Prof Elizabeth Rakoczy","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0044981","middle_name":"Piroska","last_name":"Rakoczy","source_individual_id":"5020121","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Elizabeth Rakoczy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88645","size":1},{"color":"#336699","name":"Prof Istvan Toth","data":{"first_name":"Istvan","title":"Prof","dw_individual_id":"DW0034329","middle_name":"","last_name":"Toth","source_individual_id":"RMIS17214","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Istvan Toth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85883","size":1},{"color":"#336699","name":"Dr Joanne Blanchfield","data":{"first_name":"Joanne","title":"Dr","dw_individual_id":"DW0029492","middle_name":"T","last_name":"Blanchfield","source_individual_id":"5011312","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Joanne Blanchfield"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84646","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5766","size":1},{"color":"#FF4D4D","name":"New technologies for hierarchial shotgun sequencing of recalcitrant and repetitive DNA","data":{"media_summary":"","end_year":2006,"keywords":["Bioinformatics","DNA sequencing","Human genome project"],"nhmrc_grant_id":311213,"application_year":2003,"start_year":2005,"scientific_title":"New technologies for hierarchial shotgun sequencing of recalcitrant and repetitive DNA","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Technologies: Transformation, Site-directed Mutagenesis, etc.","research_area":"Basic Science","for_category":"BIOTECHNOLOGY","cia_name":"Dr KEITH MITCHELSON","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/311213","simplified_title":"Sequencing of recalcitrant and repetitive DNA","sub_type":"Development Grant","total_budget":"79750","source_system":"Many repetitive regions of genomes are difficult to sequence and to assemble. Sequencing Aided by Mutation (SAM) is a new sequencing technology, which overcomes many of the difficulties that hinder current sequencing methods. SAM involves forming randomly mutated copies of the target DNA. These copies can then be sequenced and new mathematical tools permit the original target sequence to be revealed from the mutant copies. Here the technology will be developed to aid sequencing of long repetitive DNA fragments in genomes."},"children":[{"color":"#336699","name":"Dr Keith Mitchelson","data":{"first_name":"Keith","title":"Dr","dw_individual_id":"DW0038586","middle_name":"R","last_name":"Mitchelson","source_individual_id":"RMIS2779025","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Keith Mitchelson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87000","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5765","size":1},{"color":"#FF4D4D","name":"The role of hedgehog signalling in the regulation of chondocyte and osteoblast differntiation in the developing bone.","data":{"media_summary":"","end_year":2005,"keywords":["Bone development","Hedgehog signalling","Stem cells","TF expression","in vitro differentiation"],"nhmrc_grant_id":301299,"application_year":2003,"start_year":2004,"scientific_title":"The role of hedgehog signalling in the regulation of chondocyte and osteoblast differntiation in the developing bone.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Stephen Rodda","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301299","simplified_title":"The role of hedgehog signalling in the regulation of chondocyte and osteoblast differntiation in the developing bone.","sub_type":"CJ Martin Biomedical ECF","total_budget":"191131.64","source_system":""},"children":[{"color":"#336699","name":"Stephen Rodda","data":{"first_name":"Stephen","title":"","dw_individual_id":"DW0027644","middle_name":"","last_name":"Rodda","source_individual_id":"RMIS2639361","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Stephen Rodda"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84136","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5530","size":1},{"color":"#FF4D4D","name":"Causal pathways to mental health: a longitudinal investigation","data":{"media_summary":"","end_year":2007,"keywords":["causality","longitudinal study","mental illness","pathway"],"nhmrc_grant_id":301298,"application_year":2003,"start_year":2004,"scientific_title":"Causal pathways to mental health: a longitudinal investigation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Rosa Alati","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301298","simplified_title":"Causal pathways to mental health: a longitudinal investigation","sub_type":"Public Health (Australia) ECF","total_budget":"266500","source_system":""},"children":[{"color":"#336699","name":"A/Pr Rosa Alati","data":{"first_name":"Rosa","title":"A/Pr","dw_individual_id":"DW0005759","middle_name":"","last_name":"Alati","source_individual_id":"RMIS2639340","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Rosa Alati"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78272","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5529","size":1},{"color":"#FF4D4D","name":"Seclusion: Perceptions of Aboriginal and Torres Strait Islander People","data":{"media_summary":"","end_year":2004,"keywords":["aboriginal health","mental health","psychiatry","seclusion"],"nhmrc_grant_id":301295,"application_year":2003,"start_year":2004,"scientific_title":"Seclusion: Perceptions of Aboriginal and Torres Strait Islander People","node_source":"NHMRC","node_type":"Grant","field_of_research":"Indigenous Health","research_area":"Clinical Medicine and Science","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Mr Derek Chong","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/301295","simplified_title":"Seclusion: Perceptions of Aboriginal and Torres Strait Islander People","sub_type":"Training Scholarship for Aboriginal Health Research","total_budget":"25853","source_system":""},"children":[{"color":"#336699","name":"Mr Derek Chong","data":{"first_name":"Derek","title":"Mr","dw_individual_id":"DW0029940","middle_name":"J","last_name":"Chong","source_individual_id":"RMIS2667900","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mr Derek Chong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84751","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5528","size":1},{"color":"#FF4D4D","name":"Role of adipocytokines in obesity realted disorders of pregnancy","data":{"media_summary":"","end_year":2006,"keywords":["adipocytokines","obesity","pregnancy"],"nhmrc_grant_id":301290,"application_year":2003,"start_year":2005,"scientific_title":"Role of adipocytokines in obesity realted disorders of pregnancy","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Leonie Callaway","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/301290","simplified_title":"Role of adipocytokines in obesity realted disorders of pregnancy","sub_type":"Medical Postgraduate Scholarship","total_budget":"23894.5","source_system":""},"children":[{"color":"#336699","name":"Prof Leonie Callaway","data":{"first_name":"Leonie","title":"Prof","dw_individual_id":"DW0018070","middle_name":"Kaye","last_name":"Callaway","source_individual_id":"5013749","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Leonie Callaway"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81618","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5527","size":1},{"color":"#FF4D4D","name":"Interactions between GH and prolactin signalling pathways and G-protein coupled receptors in reproductive tissue","data":{"media_summary":"","end_year":2007,"keywords":["Corpus luteum","SOCS","breast","growth hormone","prolactin"],"nhmrc_grant_id":301289,"application_year":2003,"start_year":2004,"scientific_title":"Interactions between GH and prolactin signalling pathways and G-protein coupled receptors in reproductive tissue","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Johanna BARCLAY","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/301289","simplified_title":"Interactions between GH and prolactin signalling pathways and G-protein coupled receptors in reproductive tissue","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"68106","source_system":""},"children":[{"color":"#336699","name":"Dr Johanna Barclay","data":{"first_name":"Johanna","title":"Dr","dw_individual_id":"DW0005945","middle_name":"L","last_name":"Barclay","source_individual_id":"RMIS2658990","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Johanna Barclay"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78322","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5526","size":1},{"color":"#FF4D4D","name":"Control of intercellular movement by cadherin-regulated cytoskeletal dynamics","data":{"media_summary":"","end_year":2007,"keywords":["E-cadherin","action","cell locomotion and adhesion","myosin","tumorigenesis"],"nhmrc_grant_id":301288,"application_year":2003,"start_year":2004,"scientific_title":"Control of intercellular movement by cadherin-regulated cytoskeletal dynamics","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Madhavi Maddugoda","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/301288","simplified_title":"Control of intercellular movement by cadherin-regulated cytoskeletal dynamics","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"73514.95","source_system":""},"children":[{"color":"#336699","name":"Madhavi Maddugoda","data":{"first_name":"Madhavi","title":"","dw_individual_id":"DW0020568","middle_name":"","last_name":"Maddugoda","source_individual_id":"RMIS2658956","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Madhavi Maddugoda"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82257","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5525","size":1},{"color":"#FF4D4D","name":"A Lifestyle and Education programme for Type 2 Diabetes in an Indigenous Australian Community","data":{"media_summary":"","end_year":2006,"keywords":["Aboriginal","Type 2 Diabetes mellitus","cardiovascular","education"],"nhmrc_grant_id":301287,"application_year":2003,"start_year":2004,"scientific_title":"A Lifestyle and Education programme for Type 2 Diabetes in an Indigenous Australian Community","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Lionel Chan","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/301287","simplified_title":"A Lifestyle and Education programme for Type 2 Diabetes in an Indigenous Australian Community","sub_type":"Medical Postgraduate Scholarship","total_budget":"74844.92","source_system":""},"children":[{"color":"#336699","name":"Dr Lionel Chan","data":{"first_name":"Lionel","title":"Dr","dw_individual_id":"DW0041541","middle_name":"C K","last_name":"Chan","source_individual_id":"RMIS2658916","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Lionel Chan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87780","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5524","size":1},{"color":"#FF4D4D","name":"A laboratory, field and hsopital study of the effects of artemether on S japonicum infection","data":{"media_summary":"","end_year":2008,"keywords":["artemether","praziquantel","prophylaxis","schistosomiasis","treatment"],"nhmrc_grant_id":301285,"application_year":2003,"start_year":2004,"scientific_title":"A laboratory, field and hsopital study of the effects of artemether on S japonicum infection","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Mr Darren Gray","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/301285","simplified_title":"A laboratory, field and hsopital study of the effects of artemether on S japonicum infection","sub_type":"Public Health Postgraduate Scholarship","total_budget":"73710.99","source_system":""},"children":[{"color":"#336699","name":"Dr Darren Gray","data":{"first_name":"Darren","title":"Dr","dw_individual_id":"DW0025164","middle_name":"James","last_name":"Gray","source_individual_id":"5020033","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Darren Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83474","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5523","size":1},{"color":"#FF4D4D","name":"Regulation and Function in TLR9 in Macrophages","data":{"media_summary":"","end_year":2007,"keywords":["CSF-1","CpG DNA","Macrophage"],"nhmrc_grant_id":301282,"application_year":2003,"start_year":2004,"scientific_title":"Regulation and Function in TLR9 in Macrophages","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Miss Angela Trieu","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/301282","simplified_title":"Regulation and Function in TLR9 in Macrophages","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"73512.89","source_system":""},"children":[{"color":"#336699","name":"Angela Trieu","data":{"first_name":"Angela","title":"","dw_individual_id":"DW0010725","middle_name":"","last_name":"Trieu","source_individual_id":"RMIS2658884","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Angela Trieu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79613","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5522","size":1},{"color":"#FF4D4D","name":"Inflammatory pH and peripheral analgesia","data":{"media_summary":"","end_year":2007,"keywords":["immune","inflammation","opioid","pH","pain"],"nhmrc_grant_id":301281,"application_year":2003,"start_year":2004,"scientific_title":"Inflammatory pH and peripheral analgesia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Irina Vetter","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/301281","simplified_title":"Inflammatory pH and peripheral analgesia","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"92722.74","source_system":""},"children":[{"color":"#336699","name":"Dr Irina Vetter","data":{"first_name":"Irina","title":"Dr","dw_individual_id":"DW0040232","middle_name":"","last_name":"Vetter","source_individual_id":"RMIS2658802","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Irina Vetter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87422","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5521","size":1},{"color":"#FF4D4D","name":"Clinical and molecular aspects of innate immunity and inflammatiion in Chronic Suppurative Lung Diseases (CSLD)","data":{"media_summary":"","end_year":2006,"keywords":["bronchiectasis","chronic bronchitis","cystic fibrosis","innate immunity","tuberculosis"],"nhmrc_grant_id":301280,"application_year":2003,"start_year":2004,"scientific_title":"Clinical and molecular aspects of innate immunity and inflammatiion in Chronic Suppurative Lung Diseases (CSLD)","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Samuel Kim","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/301280","simplified_title":"Clinical and molecular aspects of innate immunity and inflammatiion in Chronic Suppurative Lung Diseases (CSLD","sub_type":"Medical Postgraduate Scholarship","total_budget":"82390.12","source_system":""},"children":[{"color":"#336699","name":"Samuel Kim","data":{"first_name":"Samuel","title":"","dw_individual_id":"DW0025983","middle_name":"","last_name":"Kim","source_individual_id":"RMIS2659140","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Samuel Kim"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83707","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5520","size":1},{"color":"#FF4D4D","name":"Role of Fibroblast Growth Factor 1 (FGF1) in the regulation of human adipogenesis","data":{"media_summary":"","end_year":2006,"keywords":["FGF","adipose","differentiation","obesity"],"nhmrc_grant_id":301278,"application_year":2003,"start_year":2004,"scientific_title":"Role of Fibroblast Growth Factor 1 (FGF1) in the regulation of human adipogenesis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Miss Felicity Newell","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/301278","simplified_title":"Role of Fibroblast Growth Factor 1 (FGF1) in the regulation of human adipogenesis","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"51907.42","source_system":""},"children":[{"color":"#336699","name":"Felicity Newell","data":{"first_name":"Felicity","title":"","dw_individual_id":"DW0003639","middle_name":"","last_name":"Newell","source_individual_id":"RMIS2658761","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Felicity Newell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77665","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5519","size":1},{"color":"#FF4D4D","name":"Functions of Scabies Mite inactivated protease paralogues","data":{"media_summary":"","end_year":2007,"keywords":["inactive proteases","sarcoptes scabiei","vaccine"],"nhmrc_grant_id":301277,"application_year":2003,"start_year":2004,"scientific_title":"Functions of Scabies Mite inactivated protease paralogues","node_source":"NHMRC","node_type":"Grant","field_of_research":"Molecular Evolution","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Charlene Willis","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/301277","simplified_title":"Functions of Scabies Mite inactivated protease paralogues","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"73514.95","source_system":""},"children":[{"color":"#336699","name":"Dr Charlene Willis","data":{"first_name":"Charlene","title":"Dr","dw_individual_id":"DW0017140","middle_name":"","last_name":"Willis","source_individual_id":"RMIS2658729","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Charlene Willis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81353","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5518","size":1},{"color":"#FF4D4D","name":"Therapeutic and diagnostic applications of low power lasers on enamel and dentine","data":{"media_summary":"","end_year":2006,"keywords":["diagnostic","erosion","laser","therapaeutic"],"nhmrc_grant_id":301275,"application_year":2003,"start_year":2004,"scientific_title":"Therapeutic and diagnostic applications of low power lasers on enamel and dentine","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dentistry not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"DENTISTRY","cia_name":"Dr Jelena Vlacic","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/301275","simplified_title":"Therapeutic and diagnostic applications of low power lasers on enamel and dentine","sub_type":"Dental Postgraduate Research Scholarship","total_budget":"74844.92","source_system":""},"children":[{"color":"#336699","name":"Jelena Vlacic","data":{"first_name":"Jelena","title":"","dw_individual_id":"DW0046038","middle_name":"","last_name":"Vlacic","source_individual_id":"RMIS2659020","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Jelena Vlacic"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88915","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5517","size":1},{"color":"#FF4D4D","name":"The impact of stressful life events and anxiety symptoms on health status, mood state, quality of life & health care...","data":{"media_summary":"","end_year":2009,"keywords":["Ageing","Anxiety","Health","Risk factors","Stressful life events"],"nhmrc_grant_id":301270,"application_year":2003,"start_year":2004,"scientific_title":"The impact of stressful life events and anxiety symptoms on health status, mood state, quality of life & health care...","node_source":"NHMRC","node_type":"Grant","field_of_research":"Developmental Psychology and Ageing","research_area":"Public Health","for_category":"PSYCHOLOGY","cia_name":"Dr Natasha Koloski","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301270","simplified_title":"The impact of stressful life events and anxiety symptoms on health status, mood state, quality of life & health care...","sub_type":"Public Health (Australia) ECF","total_budget":"294530","source_system":""},"children":[{"color":"#336699","name":"Dr Natasha Koloski","data":{"first_name":"Natasha","title":"Dr","dw_individual_id":"DW0008432","middle_name":"A","last_name":"Koloski","source_individual_id":"5015771","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Natasha Koloski"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78977","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5516","size":1},{"color":"#FF4D4D","name":"Disarming Deadly Viruses: High Throughput Protease Screening using Massive Peptide Libraries","data":{"media_summary":"","end_year":2008,"keywords":["Infectious diseases","Medicianl chemistry","Protease","Protease Inhibitors","Screening"],"nhmrc_grant_id":301267,"application_year":2003,"start_year":2004,"scientific_title":"Disarming Deadly Viruses: High Throughput Protease Screening using Massive Peptide Libraries","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biotechnology not elsewhere classified","research_area":"Basic Science","for_category":"BIOTECHNOLOGY","cia_name":"Dr Bronwyn Battersby","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301267","simplified_title":"Massive Peptide Libraries for Disarming Deadly Viruses","sub_type":"Industry ECF","total_budget":"405625","source_system":"Viral diseases affect millions of people worldwide with mortality rates as high as 50%. Viral enzymes help liberate proteins essential for viral replication. The rapid identification of the activity and specificity of these viral enzymes is important to combat outbreaks of viral disease and has become possible through biomedical device technology developed by the industry partner. With just 17 new drugs approved by the FDA in 2002, the proposed program has the potential to deliver new drugs quickly and efficiently, and this will be of benefit to viral disease sufferers worldwide."},"children":[{"color":"#336699","name":"Dr Bronwyn Battersby","data":{"first_name":"Bronwyn","title":"Dr","dw_individual_id":"DW0000272","middle_name":"J","last_name":"Battersby","source_individual_id":"RMIS2025240","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Bronwyn Battersby"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76728","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5515","size":1},{"color":"#FF4D4D","name":"Exploring the structure activity relationships of novel trypsin inhibitor SFTI-1 with implications as cancer therapeutic","data":{"media_summary":"","end_year":2008,"keywords":["Enzyme inhibitors as pharmacological agents","cancer"],"nhmrc_grant_id":301266,"application_year":2003,"start_year":2004,"scientific_title":"Exploring the structure activity relationships of novel trypsin inhibitor SFTI-1 with implications as cancer therapeutic","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides","research_area":"Clinical Medicine and Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Dr Norelle Daly","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301266","simplified_title":"Exploring the therapeutic potential of a sunflower seed product as an anti-cancer agent","sub_type":"Industry ECF","total_budget":"360312.5","source_system":"A novel peptide isolated from sunflower seeds has recently been shown to interact with an enzyme implicated in the growth of cancers and in particular prostate cancer. The proposed research involves developing this peptide as a therapeutic by performing a thorough analysis of the important features involved in its exciting anti-cancer activity."},"children":[{"color":"#336699","name":"Prof Norelle Daly","data":{"first_name":"Norelle","title":"Prof","dw_individual_id":"DW0012604","middle_name":"L","last_name":"Daly","source_individual_id":"RMIS2275307","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Norelle Daly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80117","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5514","size":1},{"color":"#FF4D4D","name":"Genetic study on activation of adult neural stem cells after iscemic stroke","data":{"media_summary":"","end_year":2008,"keywords":["Adult neural stem cells","Genetic analysis","Neural progenitor cells","Neurogenesis","Stroke"],"nhmrc_grant_id":301265,"application_year":2003,"start_year":2004,"scientific_title":"Genetic study on activation of adult neural stem cells after iscemic stroke","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Li Li","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301265","simplified_title":"Genetic study on activation of adult neural stem cells after iscemic stroke","sub_type":"Peter Doherty Biomedical ECF","total_budget":"314562.5","source_system":""},"children":[{"color":"#336699","name":"Dr Li Li","data":{"first_name":"Li","title":"Dr","dw_individual_id":"DW0032083","middle_name":"","last_name":"Li","source_individual_id":"RMIS2639459","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Li Li"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85299","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5513","size":1},{"color":"#FF4D4D","name":"Communication ouctomes of preterm children: prevalence and description","data":{"media_summary":"","end_year":2008,"keywords":["cognition","communication","prematurity"],"nhmrc_grant_id":301263,"application_year":2003,"start_year":2004,"scientific_title":"Communication ouctomes of preterm children: prevalence and description","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Hearing and Speech","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Alison Holm","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301263","simplified_title":"Communication ouctomes of preterm children: prevalence and description","sub_type":"Australian Research Training ECF (Part-time)","total_budget":"134500","source_system":""},"children":[{"color":"#336699","name":"Alison Holm","data":{"first_name":"Alison","title":"","dw_individual_id":"DW0043100","middle_name":"","last_name":"Holm","source_individual_id":"RMIS2508514","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Alison Holm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88169","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5512","size":1},{"color":"#FF4D4D","name":"Population pharmacokinetic and pharmacodynamic modelling of the newer immunosuppressant drugs","data":{"media_summary":"","end_year":2008,"keywords":["Dosage prediction","Immunosuppressants","Pharmacodynamics","Pharmacokinetics","Tacrolimus"],"nhmrc_grant_id":301259,"application_year":2003,"start_year":2004,"scientific_title":"Population pharmacokinetic and pharmacodynamic modelling of the newer immunosuppressant drugs","node_source":"NHMRC","node_type":"Grant","field_of_research":"Therapies and Therapeutic Technology","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Dr Christine Staatz","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301259","simplified_title":"Population pharmacokinetic and pharmacodynamic modelling of the newer immunosuppressant drugs","sub_type":"Neil Hamilton Fairley Clinical ECF","total_budget":"329107.27","source_system":""},"children":[{"color":"#336699","name":"Dr Christine Staatz","data":{"first_name":"Christine","title":"Dr","dw_individual_id":"DW0028116","middle_name":"E","last_name":"Staatz","source_individual_id":"RMIS680289","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Christine Staatz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84257","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5510","size":1},{"color":"#FF4D4D","name":"Molecular mapping of integrins, chemokine receptors and cytohesin-1","data":{"media_summary":"","end_year":2006,"keywords":["chemokine","cytohesin","integrin","plasma membrane","signal transduction"],"nhmrc_grant_id":301258,"application_year":2003,"start_year":2004,"scientific_title":"Molecular mapping of integrins, chemokine receptors and cytohesin-1","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Kim Yap-Weber","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301258","simplified_title":"Molecular mapping of integrins, chemokine receptors and cytohesin-1","sub_type":"Howard Florey Centenary ECF","total_budget":"175163.97","source_system":""},"children":[{"color":"#336699","name":"Kim Yap-Weber","data":{"first_name":"Kim","title":"","dw_individual_id":"DW0011244","middle_name":"","last_name":"Yap-Weber","source_individual_id":"RMIS2638952","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Kim Yap-Weber"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79759","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5509","size":1},{"color":"#FF4D4D","name":"Matching between codon usage and tRNA abundance determines the expression of targeting genes in mammalian cells","data":{"media_summary":"","end_year":2007,"keywords":["Codon usage","Gene expression","Mammalian cells","Targetin genes","tRNA abudnance"],"nhmrc_grant_id":301256,"application_year":2003,"start_year":2004,"scientific_title":"Matching between codon usage and tRNA abundance determines the expression of targeting genes in mammalian cells","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Kong-Nan Zhao","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301256","simplified_title":"Codon usage, tRNA abundance and targeting gene expression","sub_type":"Industry ECF","total_budget":"358500","source_system":"This proposal is about optimal production of protein drugs (biopharmaceuticals), using genetic engineering in the laboratory and gene therapy in patients. It will explore the science behind a novel observation that the optimal way to use the genetic code to encode proteins for production varies from cell to cell in the lab, and from tissue to tissue in patients. If successful, a simple test can be used to decide the optimal genetic code for a specific application."},"children":[{"color":"#336699","name":"Dr Kong-Nan Zhao","data":{"first_name":"Kong-Nan","title":"Dr","dw_individual_id":"DW0023208","middle_name":"","last_name":"Zhao","source_individual_id":"RMIS108496","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Kong-Nan Zhao"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82979","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5508","size":1},{"color":"#FF4D4D","name":"Development and application of a pressure-sensing electropalatograph for the assessment and treatment of speech disorder","data":{"media_summary":"","end_year":2004,"keywords":["Motor control","Rehabilitation","Speech","Speech pathology"],"nhmrc_grant_id":301246,"application_year":2003,"start_year":2004,"scientific_title":"Development and application of a pressure-sensing electropalatograph for the assessment and treatment of speech disorder","node_source":"NHMRC","node_type":"Grant","field_of_research":"Therapies and Therapeutic Technology","research_area":"Health Services Research","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Bruce Murdoch","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/301246","simplified_title":"Development and application of an advanced speech assessment and treatment tool.","sub_type":"Development Grant","total_budget":"200750","source_system":"A multidisciplinary team of researchers aim to develop a unique, advanced, computer-based speech device that speech pathologists can use to assess and treat a variety of speech disorders. The device will record the location, timing and pressure of tongue contacts against the roof of the mouth (palate) during speech using innovative sensors embedded in an artificial plate placed over the roof of the mouth. State-of-the-art 3D graphics will be used to display tongue-to-palate contacts to both speech pathologist and patient."},"children":[{"color":"#336699","name":"Dr Dion Scott","data":{"first_name":"Dion","title":"Dr","dw_individual_id":"DW0045329","middle_name":"H","last_name":"Scott","source_individual_id":"RMIS1748490","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Dion Scott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88725","size":1},{"color":"#336699","name":"Dr Justine Goozee","data":{"first_name":"Justine","title":"Dr","dw_individual_id":"DW0019273","middle_name":"V","last_name":"Goozee","source_individual_id":"RMIS1113109","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Justine Goozee"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81911","size":1},{"color":"#336699","name":"Prof Bruce Murdoch","data":{"first_name":"Bruce","title":"Prof","dw_individual_id":"DW0015136","middle_name":"Ernest","last_name":"Murdoch","source_individual_id":"RMIS15270","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Bruce Murdoch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80802","size":1},{"color":"#336699","name":"Dr Martin Veidt","data":{"first_name":"Martin","title":"Dr","dw_individual_id":"DW0010825","middle_name":"","last_name":"Veidt","source_individual_id":"RMIS143154","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Martin Veidt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79642","size":1},{"color":"#336699","name":"Prof Ian Meyers","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0003388","middle_name":"A","last_name":"Meyers","source_individual_id":"RMIS618355","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ian Meyers"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77601","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5507","size":1},{"color":"#FF4D4D","name":"Phase 1 clinical trial of autologous dendritic cells to induce antigen-specific tolerance","data":{"media_summary":"","end_year":2004,"keywords":["Clinical trial","Dentritic cell","Rheumatoid arthritis","Tolerance","Vaccine"],"nhmrc_grant_id":301244,"application_year":2003,"start_year":2004,"scientific_title":"Phase 1 clinical trial of autologous dendritic cells to induce antigen-specific tolerance","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ranjeny Thomas","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/301244","simplified_title":"A dendritic cell vaccine to suppress the immune response to an antigen","sub_type":"Development Grant","total_budget":"165125","source_system":"We have previously generated modified dendritic cells in mice with the ability to suppress immune responses once they have started. This project will develop the dendritic cell vaccine as a platform technology for human clinical use. We aim to demonstrate, in a phase I clinical trial, the capacity of modified human autologous dendritic cells to suppress the immune response to a model antigen in a group of healthy volunteers and a group of patients with rheumatoid arthritis taking drugs for their disease"},"children":[{"color":"#336699","name":"Prof Ranjeny Thomas","data":{"first_name":"Ranjeny","title":"Prof","dw_individual_id":"DW0045826","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS4352","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ranjeny Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88853","size":1},{"color":"#336699","name":"Dr Paul Kubler","data":{"first_name":"Paul","title":"Dr","dw_individual_id":"DW0002748","middle_name":"","last_name":"Kubler","source_individual_id":"RMIS2594135","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Paul Kubler"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77419","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5506","size":1},{"color":"#FF4D4D","name":"A novel method for the early detection of cardiovascular disease through the direct measurement of tissue wall elasticit","data":{"media_summary":"","end_year":2004,"keywords":["Cardiovascular physiology","Cardiovascular risk","Diagnostic imaging","Outcomes assessment","Preventive medicine"],"nhmrc_grant_id":301240,"application_year":2003,"start_year":2004,"scientific_title":"A novel method for the early detection of cardiovascular disease through the direct measurement of tissue wall elasticit","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Thomas Marwick","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/301240","simplified_title":"A novel method for the early detection of cardiovascular disease","sub_type":"Development Grant","total_budget":"196000","source_system":"Changes in the structure and function of blood vessels are an early stage in the development of arterial disease. A simple means of assessing this damage will allow for early detection of arterial disease and will provide a tool for monitoring outcomes of treatment and preventive medicine. We have developed a novel method for measuring vessel wall displacement throughout the cardiac cycle. This study aims to provide proof of principle data through the validation of these measurements against the physical properties of the vessel and application of the technique to a clinical setting."},"children":[{"color":"#336699","name":"Prof Thomas Marwick","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0032377","middle_name":"Hugh","last_name":"Marwick","source_individual_id":"RMIS108223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Marwick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85383","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5505","size":1},{"color":"#FF4D4D","name":"Cranio-Cervical Dynamometry in the Rehabilitation of Neck Pain","data":{"media_summary":"","end_year":2004,"keywords":["Exercise Therapy","Musculoskeletal Pain","Neck","Rehabilitation"],"nhmrc_grant_id":301239,"application_year":2003,"start_year":2004,"scientific_title":"Cranio-Cervical Dynamometry in the Rehabilitation of Neck Pain","node_source":"NHMRC","node_type":"Grant","field_of_research":"Therapies and Therapeutic Technology","research_area":"Clinical Medicine and Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Gwendolen Jull","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/301239","simplified_title":"A New Device for Exercise Treatment of Neck Pain","sub_type":"Development Grant","total_budget":"110632.5","source_system":"Research has demonstrated that exercising particular neck muscles in a specific manner is effective in reducing painful neck symptoms. A device has been developed to quantify the performance of specific neck muscles, permitting more precise rehabilitative exercise, tailored to an individuals abilities and needs. The effectiveness of this device in the rehabilitation of chronic neck pain will be tested in a clinical trial against other commonly used forms of neck exercise."},"children":[{"color":"#336699","name":"E/Pr Gwendolen Jull","data":{"first_name":"Gwendolen","title":"E/Pr","dw_individual_id":"DW0019981","middle_name":"A","last_name":"Jull","source_individual_id":"RMIS5215","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"E/Pr Gwendolen Jull"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82087","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5504","size":1},{"color":"#FF4D4D","name":"Molecular Mechanisms of Neuronal Cell Death in the Adult","data":{"media_summary":"","end_year":2008,"keywords":["neurodegenerative","neuronal cell death"],"nhmrc_grant_id":301226,"application_year":2003,"start_year":2004,"scientific_title":"Molecular Mechanisms of Neuronal Cell Death in the Adult","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Elizabeth Coulson","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301226","simplified_title":"Molecular Mechanisms of Neuronal Cell Death in the Adult","sub_type":"RD Wright Biomedical CDF","total_budget":"444500","source_system":""},"children":[{"color":"#336699","name":"A/Pr Elizabeth Coulson","data":{"first_name":"Elizabeth","title":"A/Pr","dw_individual_id":"DW0006736","middle_name":"J","last_name":"Coulson","source_individual_id":"5014079","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Elizabeth Coulson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78524","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5503","size":1},{"color":"#FF4D4D","name":"Membrane Proteins within the Mouse Transcriptone: Annotation of their Organisation and Subcellular Localisation","data":{"media_summary":"","end_year":2008,"keywords":["Bioinformatics","Gene Annotation","Membrane Proteins","Membrane Transport","Subcellular Localisation"],"nhmrc_grant_id":301215,"application_year":2003,"start_year":2004,"scientific_title":"Membrane Proteins within the Mouse Transcriptone: Annotation of their Organisation and Subcellular Localisation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Rohan Teasdale","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301215","simplified_title":"Membrane Proteins within the Mouse Transcriptone: Annotation of their Organisation and Subcellular Localisation","sub_type":"RD Wright Biomedical CDF","total_budget":"421375","source_system":""},"children":[{"color":"#336699","name":"A/Pr Rohan Teasdale","data":{"first_name":"Rohan","title":"A/Pr","dw_individual_id":"DW0040022","middle_name":"D","last_name":"Teasdale","source_individual_id":"5017848","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Rohan Teasdale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87368","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5502","size":1},{"color":"#FF4D4D","name":"Heterogeneous nuclear ribonucleoprotein role in alternative RNA splicing and human disease","data":{"media_summary":"proteomics","end_year":2006,"keywords":["Cancer","Intrcellular gene expression","RNA metabolism","RNA-binding proteins","mRNA"],"nhmrc_grant_id":301212,"application_year":2003,"health_keywords":["biochemistry and molecular biology","cancer biology","cellular transformation","gene expression","proteomics"],"scientific_title":"Heterogeneous nuclear ribonucleoprotein role in alternative RNA splicing and human disease","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Ross Smith","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301212","simplified_title":"Proteins that alter the use of genetic information in normal and cancer cells","sub_type":"Standard Project Grant","total_budget":"254250","source_system":"Control of the use of DNA, gene expression, is vital to all living organisms, especially in development and disease. The information in the genes of DNA is transferred to an intermediate molecule, mRNA, in a process called transcription. The genetic information in the mRNA is subsequently used, in the process called translation, to make the protein encoded by the original gene. The switching on and off of DNA appears to be most frequently controlled at the transcription step but recently it has become apparent that there are many post-transcriptional events that govern how efficiently the genetic information is ultimately converted to protein molecules. An important step is the cutting out of parts (introns) of the RNA molecule that is copied from DNA, and splicing of the retained sections (exons). During this process the RNA may also lose one or more of its exons. As a result of this variable retention of exons a single gene may produce many isoforms of the protein it encodes. By this mechanism the roughly 30,000 genes in the human genome can give rise to potentially hundreds of thousands of proteins. RNA splicing connects to cancer in two ways. First, changes in the concentrations of the proteins that control splicing may change the isoforms, resulting in changes that lead to uncontrolled cell proliferation. Secondly, DNA mutations that affect the splicing process can also vary the ratios of the isoforms produced from a gene: if this occurs in a protein that is involved in the growth of cells this too may lead to cancer. In this project we will study the molecular mechanism of this alternative splicing, and particularly a group of proteins that generally favour the excision of some exons, with a focus on cancer cells. Recent publications have highlighted the potential for the therapeutic use of drugs that target the splicing apparatus: it is anticipated that studies of alternative splicing will underpin development of new therapeutic agents."},"children":[{"color":"#336699","name":"Prof Ross Smith","data":{"first_name":"Ross","title":"Prof","dw_individual_id":"DW0045515","middle_name":"William","last_name":"Smith","source_individual_id":"RMIS6441","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ross Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88776","size":1},{"color":"#336699","name":"A/Pr Joseph Rothnagel","data":{"first_name":"Joseph","title":"A/Pr","dw_individual_id":"DW0009982","middle_name":"A","last_name":"Rothnagel","source_individual_id":"5017267","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Joseph Rothnagel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79410","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5501","size":1},{"color":"#FF4D4D","name":"TLR9 And The Response To Foreign DNA","data":{"media_summary":"vaccination","end_year":2006,"keywords":["immune regulation","innate immunity","macrophage","macrophage activation"],"nhmrc_grant_id":301211,"application_year":2003,"health_keywords":["allergy","autoimmunity","cancer therapy","infectious disease","vaccination"],"scientific_title":"TLR9 And The Response To Foreign DNA","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Katryn Stacey","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301211","simplified_title":"How immune cells detect foreign DNA","sub_type":"Standard Project Grant","total_budget":"465750","source_system":"This project is based upon the observation that the mammalian immune system can distinguish between its own genetic material (DNA) and the DNA of infectious agents such as bacteria. This has implications for understanding how the immune system copes with infection, and also for design of new therapies and vaccines. Our central aim is to define how the recognition system for foreign DNA works. The cells that respond most vigorously to foreign DNA are large white blood cells called macrophages. We are investigating how a key protein that is required for these responses functions and what genes it turns on. The type of immune responses initiated by foreign DNA may be useful in treatment of allergies and cancer, and for improving vaccinations."},"children":[{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1},{"color":"#336699","name":"Dr Katryn Stacey","data":{"first_name":"Katryn","title":"Dr","dw_individual_id":"DW0028117","middle_name":"Jane","last_name":"Stacey","source_individual_id":"5017656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katryn Stacey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84258","size":1},{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5500","size":1},{"color":"#FF4D4D","name":"Regulation Of Macrophage Function And Gene Expression By The Th2-Promoting Stimulus, ES-62","data":{"media_summary":"nematode infections","end_year":2006,"keywords":["Th2 differentiation","anti-inflammatory","inflammation","macrophage activation","microarray"],"nhmrc_grant_id":301210,"application_year":2003,"health_keywords":["T cell subsets","allergy","inflammation","macrophage activation","nematode infections"],"scientific_title":"Regulation Of Macrophage Function And Gene Expression By The Th2-Promoting Stimulus, ES-62","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Matthew Sweet","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301210","simplified_title":"How immune cells detect foreign organisms","sub_type":"Standard Project Grant","total_budget":"465750","source_system":"White blood cells are responsible for co-ordinating the immune response against foreign micro-organisms. Macrophages are a particular type of white blood cell that attempt to destroy microbes during the initial stages of an infection, but also release toxic substances that are responsible for pathology and side effects during many immune responses. This project aims to address how macrophages are involved in a particular type of immune response that develops when individuals are susceptible to certain diseases including asthma and diseases associated with intracellular infections. We are identifying genes expressed in macrophages during these immune responses that are likely to be involved in susceptibility to such diseases."},"children":[{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1},{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5499","size":1},{"color":"#FF4D4D","name":"Regulation of Neural Cell Production in the Normal and Diseased Brain","data":{"media_summary":"","end_year":2008,"keywords":["Nervous system development","Neurogenetics","Neurological diseases","Regeneration","Stem Cell Therapy"],"nhmrc_grant_id":301204,"application_year":2003,"start_year":2004,"scientific_title":"Regulation of Neural Cell Production in the Normal and Diseased Brain","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Perry Bartlett","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/301204","simplified_title":"Control of nerve cell production","sub_type":"Program Grant","total_budget":"6888658.32","source_system":"Members of this team are at the forefront of research into the molecular control of nerve cell production and function in the developing and adult brain. They were responsible, often through collaboration, for many of the major discoveries demonstrating that stem cells in the brain of adult animals can generate new nerve cells; this revolutionised our concept of the brain and opened-up the possibility of therapeutic repair of neural damage through stimulation of a patient?s own stem cells. Discovering the molecular mechanisms controlling this process is the goal of the present program. In order to achieve this aim we have formed a team on the basis of considerable past success, as well as future requirements. The team members have the complementary skills to assess all aspects of the problem, including crucial functional and clinical expertise. By combining resources we will position ourselves at the very forefront of the international competition to discover and to evaluate clinically the molecular mechanisms underlying neural repair and regeneration. This is of enormous significance in determining how we best treat stroke, injury and other neurodegenerative diseases in the next 10 years, and will lead to the development of new therapeutics of immense value. The team will use innovative approaches such as cell-sorting to obtain pure populations of stem cells and their progeny in order to identify new therapeutic targets; these will then be validated in animal models of neurological disease. Since team members have previously been involved in progressing molecular discovery to clinical trials, we are also in a good position to exploit these discoveries in partnership with the biopharmaceutical industry."},"children":[{"color":"#336699","name":"Prof Pankaj Sah","data":{"first_name":"Pankaj","title":"Prof","dw_individual_id":"DW0033583","middle_name":"","last_name":"Sah","source_individual_id":"5017304","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Pankaj Sah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85693","size":1},{"color":"#336699","name":"Prof Seong-Seng Tan","data":{"first_name":"Seong-Seng","title":"Prof","dw_individual_id":"DW0028290","middle_name":"","last_name":"Tan","source_individual_id":"5017816","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Seong-Seng Tan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84311","size":1},{"color":"#336699","name":"Prof Trevor Kilpatrick","data":{"first_name":"Trevor","title":"Prof","dw_individual_id":"DW0025980","middle_name":"John","last_name":"Kilpatrick","source_individual_id":"5012199","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Trevor Kilpatrick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83706","size":1},{"color":"#336699","name":"Prof Perry Bartlett","data":{"first_name":"Perry","title":"Prof","dw_individual_id":"DW0011651","middle_name":"Francis","last_name":"Bartlett","source_individual_id":"5013357","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Perry Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79864","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5498","size":1},{"color":"#FF4D4D","name":"Understanding and Influencing Physical Activity to Improve Population Health","data":{"media_summary":"","end_year":2008,"keywords":["Measurment and descriptive epidemiology","Physical activity and population health outcomes","behavioural theories","interventions to influence activity","models and determinants"],"nhmrc_grant_id":301200,"application_year":2003,"start_year":2004,"scientific_title":"Understanding and Influencing Physical Activity to Improve Population Health","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Promotion","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Neville Owen","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/301200","simplified_title":"How can people be helped to exercise regularly so as to improve their health?","sub_type":"Program Grant","total_budget":"4668376.12","source_system":"Three of Australia's leading researchers on physical activity and population health will use new NHMRC program grant funding to consolidate and extend their already internationally-recognised studies. Doing regular physical activity is very important for maintaining good health. It helps to prevent weight gain, type 2 diabetes, heart disease and breast and colon cancer. Unfortunately, most Australian adults are not active enough for health benefits. Rates of overweight and obesity are increasing rapidly; more than 50% of Australian adults are above the healthy weight range. Rates of type 2 diabetes have doubled in the past 20 years. New ideas and practical tools are therefore needed to tackle these serious diseases of inactivity. To this end, Professors Neville Owen, Adrian Bauman and Wendy Brown will bring together innovative and practically useful scientific approaches drawn from psychology, epidemiology and exercise physiology. The approach is interdisciplinary _ it combines theories and methods from their individual disciplines in an innovative manner, within a public health framework. Their research to date has developed better methods for measuring peoples exercise habits and has provided new insights into how personal, social and environmental circumstances can make people less active. They have also shown how to design and deliver wide-reaching programs for different social groups and evaluated their effectiveness. Their new research program will build on and significantly extend these ideas and approaches into new areas.For example, they will develop new measures of incidental physical activity and sedentary behaviour and will develop and test new, complex community interventions.Their new program will involve in-depth study of some of the most challenging researchproblems in an important and under-researched area of public health. They will further combine their disciplines and the skills of their research team in new, creative and practical ways, to answer important research questions about physical activity and population health. These ideas and approaches will be used to identify practical ways to help more people to be more physically active."},"children":[{"color":"#336699","name":"Prof Adrian Bauman","data":{"first_name":"Adrian","title":"Prof","dw_individual_id":"DW0035294","middle_name":"E","last_name":"Bauman","source_individual_id":"5012367","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Adrian Bauman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86147","size":1},{"color":"#336699","name":"Prof Wendy Brown","data":{"first_name":"Wendy","title":"Prof","dw_individual_id":"DW0023824","middle_name":"J","last_name":"Brown","source_individual_id":"RMIS1714084","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wendy Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83116","size":1},{"color":"#336699","name":"Prof Neville Owen","data":{"first_name":"Neville","title":"Prof","dw_individual_id":"DW0003812","middle_name":"Gordon","last_name":"Owen","source_individual_id":"5016815","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Neville Owen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77725","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5497","size":1},{"color":"#FF4D4D","name":"The role of Patched/Hedgehog signalling in common human cancer.","data":{"media_summary":"","end_year":2006,"keywords":["conditional gene targeting","medulloblastoma","mutation analysis","skin cancer","transgenic animals"],"nhmrc_grant_id":301198,"application_year":2003,"health_keywords":["basal cell carcinoma","cancer genetics","genetic disorders","medulloblastoma"],"scientific_title":"The role of Patched/Hedgehog signalling in common human cancer.","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301198","simplified_title":"Molecular genetics of common skin and brain cancer","sub_type":"Standard Project Grant","total_budget":"495750","source_system":"Mutations in the patched -hedgehog pathway are responsible for most of the common skin cancer basal cell carcinoma and some of the brain tumour medulloblastoma. Despite this knowledge we still do not know which cell in the skin gives rise to the basal cell carcinoma, and which cell in the brain gives rise to medulloblastoma. This application describes an approach using animal models to answer these questions and therefore further our understanding of how a normal cell becomes a tumour cell. In addition this proposal extends out current studies to examine new gene family members in large tumour collections."},"children":[{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5496","size":1},{"color":"#FF4D4D","name":"C3/C5 Convertase Inhibitors As A New Class Of Anti-Inflammatory Drugs","data":{"media_summary":"sepsis","end_year":2006,"keywords":["C5a and C3a","Complement","Immunoinflammatory Drugs","Protease Inhibitor","serine proteases"],"nhmrc_grant_id":301178,"application_year":2003,"health_keywords":["Inflammation","arthritis","asthma","ischemia-reperfusion","sepsis"],"scientific_title":"C3/C5 Convertase Inhibitors As A New Class Of Anti-Inflammatory Drugs","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301178","simplified_title":"Retarding The Biosynthesis of Human Plasma Proteins That Cause Inflammatory Diseases","sub_type":"Standard Project Grant","total_budget":"465750","source_system":"Many serious inflammatory diseases, such as arthritis, septic shock, lung shock, heart disease, atherosclerosis, multiple sclerosis, are poorly controlled with currently available drugs. There is a great deal of evidence that naturally occuring Complement proteins in human blood are involved in exacerbating these and many other human diseases, yet there are no good drugs available to counteract their effects. Three complement proteins known as C3a, C5a and MAC (membrane attack complex) are thought to be particularly pivotal components of the complement system synthesized by the human body early in the development of inflammatory and immune diseases. New compounds that could block the formation of human C3a, C5a and MAC are expected : (a) To lead us to a better understanding of how these proteins act on immune cells and of their respective roles in the immune response to infection and injury, and (b) To enable the rapid development of an entirely new class of drugs for treating autoimmune and inflammatory diseases. No Complement-based drugs are yet available in man. In other NHMRC funded work we have developed compounds (antagonists) that selectively block the actions of human C3a or C5a, and shown that they are effective antiinflammatory agents in rat models of a number of inflammatory diseases. In this project we will design and develop small molecules that block the enzymes (C3-C5 convertases) that make C3a, C5a and other complement proteins including MAC. We expect that such inhibitors will be even more effective antinflammatory drugs because they will block formation of multiple complement proteins that each have proinflammatory activity. We will demonstrate selective effects of the new compounds on components of complement, and test them in rat models of inflammatory diseases. We expect C3-C5 convertase inhibitors to be a completely new type of anti-inflammatory drug, treating disease processes rather than symptoms like current drugs."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"Prof Stephen Taylor","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0010587","middle_name":"M","last_name":"Taylor","source_individual_id":"RMIS41211","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79577","size":1},{"color":"#336699","name":"John Abbenante","data":{"first_name":"John","title":"","dw_individual_id":"DW0005696","middle_name":"","last_name":"Abbenante","source_individual_id":"RMIS34220","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"John Abbenante"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78255","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5495","size":1},{"color":"#FF4D4D","name":"The role of MC1R polymorphism in skin cancer risk phenotypes","data":{"media_summary":"Skin colour","end_year":2006,"keywords":["G-protein coupled receptors","Melanocortin-1","Melanocyte","Pigmentation","Signalling pathways"],"nhmrc_grant_id":301173,"application_year":2003,"health_keywords":["Freckle","Melanoma","Moles","Skin Cancer","Skin colour"],"scientific_title":"The role of MC1R polymorphism in skin cancer risk phenotypes","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Richard Sturm","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301173","simplified_title":"Regulation of human pigmentation","sub_type":"Standard Project Grant","total_budget":"480750","source_system":"Sunsmart campaigns are a unifying element in the lives of many Australians who wish to ensure protection against the damaging effects of ultraviolet rays in sunlight. Indeed, Australians have the highest incidence of UV-induced melanoma in the world. Although it is evident that lighter skin colours are more susceptible to sun damage, the relationship between sun exposure, skin type and melanoma formation is less clear. An essential first step in understanding the complex interactions that give rise to melanoma, and in identifying individuals that have a high susceptibility, is to reduce phenotypic analyses to genotypic classifications. As pigmentation phenotype is a factor of central importance in determining an individuals risk for melanoma, characterisation of the genes underlying the physical qualities of human eye, hair and skin colour will give a more direct and accurate genotypic assessment of risk. Results from an epidemiology study of melanoma patients in Queensland have identified a number of genetic changes within the melanocyte stimulating hormone receptor (MC1R) gene that associate with skin, hair and eye colour as well as with incidence of melanoma. Further investigation of MC1R gene alleles which segregate with skin and hair colours will provide the beginning for a whole new genotype-based classification of skin colour and melanoma risk, and will significantly contribute to our understanding of what makes some individuals highly susceptible to melanoma while others are not. Indeed, MC1R polymorphisms may numerically be the most important melanoma predisposition gene yet identified, exerting its effects as one of those common genes of small effect which may account for much more of the case load in melanoma than rarer genes of large effect. Studies such as this will enable powerful genotyping methods to be employed in identification of those individuals at highest risk for melanoma and other skin cancers."},"children":[{"color":"#336699","name":"A/Pr Richard Sturm","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0045672","middle_name":"Alan","last_name":"Sturm","source_individual_id":"5017777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Sturm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88811","size":1},{"color":"#336699","name":"Dr Richard Newton","data":{"first_name":"Richard","title":"Dr","dw_individual_id":"DW0021126","middle_name":"A","last_name":"Newton","source_individual_id":"RMIS2383493","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Richard Newton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82414","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5494","size":1},{"color":"#FF4D4D","name":"Structure, function and cellular trafficking of the flavivirus NS1 protein","data":{"media_summary":"","end_year":2006,"keywords":["flavivirus","molecular biology","mutagenesis","protein trafficking","virus replication"],"nhmrc_grant_id":301165,"application_year":2003,"health_keywords":["arbovirus diseases","vaccines","virus replication"],"scientific_title":"Structure, function and cellular trafficking of the flavivirus NS1 protein","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Roy Hall","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301165","simplified_title":"Studies on the structure, function and cellular distribution of a protein that is required for flavivirus replication","sub_type":"Standard Project Grant","total_budget":"496500","source_system":"Flaviviruses are spread mainly by mosquitoes or ticks and include globally important pathogens such as yellow fever, dengue, Japanese encephalitis and West Nile. This proposal seeks to elucidate the precise function of a component of the virus ( the NS1 protein) essential for its infection cycle. We will analyse the structure and function of this protein and its role in viral disease. A complete understanding of the replication cycle of these viruses will shed further light on how they have evolved to replicate in animal cells and provide valuable information for the design of safe, new generation antiviral drugs and vaccines."},"children":[{"color":"#336699","name":"Prof Roy Hall","data":{"first_name":"Roy","title":"Prof","dw_individual_id":"DW0025278","middle_name":"A","last_name":"Hall","source_individual_id":"RMIS16831","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roy Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83509","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5493","size":1},{"color":"#FF4D4D","name":"Coordinate expression of virulence factors in pathogenic Escherichia coli","data":{"media_summary":"urinary tract infection","end_year":2006,"keywords":["Escherichia coli","adhesion mechanisms","gene regulation","pathogenesis","vaccine development"],"nhmrc_grant_id":301163,"application_year":2003,"health_keywords":["bacterial pathogenicity","bacterial virulence factors","biofilm contamination on instruments and implants","enteric infections","urinary tract infection"],"scientific_title":"Coordinate expression of virulence factors in pathogenic Escherichia coli","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Mark Schembri","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301163","simplified_title":"Virulence gene expression in pathogenic E. coli","sub_type":"New Investigator Grant","total_budget":"239250","source_system":"Escherichia coli is a versatile pathogen capable of causing a range of disease types including diarrhoea, dysentery, haemolytic uremic syndrome, bladder and kidney infections, septicaemia, pneumoniae and meningitis. Infections due to pathogenic E. coli may be limited to mucosal surfaces or can disseminate throughout the body. Amongst the different classes of pathogenic E. coli, diarrheagenic strains (namely enterotoxigenic and enteroinvasive E. coli) are responsible for the death of an estimated one million humans per year, mainly in third world countries. The majority (80%) of urinary tract infections (UTIs) in humans are caused by E. coli and in Australia alone there are about 250,000 cases per year. It is estimated that one in four women and one in twenty men will develop a urinary tract infection in their lifetime. Pathogenic E. coli strains are normally equipped with multiple virulence factors and there is mounting evidence that the expression of such factors is finely orchestrated by mutual regulatory cross-talk. For example, expression of flagella (which provide motility) and adhesins (which provide attachment) are fundamentally counteracting phenotypes, yet the molecular and genetic mechanisms that coordinate their expression are unknown. I plan to examine inter-system cross-regulation of bacterial surface structures (namely adhesins, autoaggregaters, capsules and flagella). The aim is to understand on the molecular level how microorganisms orchestrate expression of virulence factors and will have consequences for our understanding of microbial pathogenicity. The strategy outlined may lead to new routes for strain attenuation and perhaps a method for vaccine strain construction. The research will be performed in collaboration with international high profile partners."},"children":[{"color":"#336699","name":"Prof Mark Schembri","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0016088","middle_name":"A","last_name":"Schembri","source_individual_id":"5017368","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Schembri"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81054","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5492","size":1},{"color":"#FF4D4D","name":"Role of the Nuclear Growth Hormone Receptor in Cell Proliferation and Function","data":{"media_summary":"growth hormone treatment","end_year":2006,"keywords":["cell proliferation","cytokine receptor","growth hormone","nuclear transport","transcriptional regulation"],"nhmrc_grant_id":301159,"application_year":2003,"health_keywords":["ageing","cell cycle regulation","childhood growth","endocrine tumours","growth hormone treatment"],"scientific_title":"Role of the Nuclear Growth Hormone Receptor in Cell Proliferation and Function","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael WATERS","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301159","simplified_title":"How does the growth hormone receptor in the cell nucleus regulate cell division and cell function ?","sub_type":"Standard Project Grant","total_budget":"477750","source_system":"In addition to final height, growth hormone regulates many tissues in the body, and through these, regulates metabolism, body composition, vitality and aspects of ageing. However, there is some evidence that GH can also promote cancer, notably colon and blood cell cancers. Our discovery of the receptor for growth hormone in the cell nucleus, notably in many cancers, has led us to investigate the role of the nuclear GH receptor. We have found that targeting this receptor to the nucleus allows the cell to divide without the need for the normal factors which initiate cell division and survival. We have also found that a part of the GH receptor acts as a gene activator, and have identified some of the nuclear proteins which bind to the receptor and make this so. This proposal aims to establish the link between the nuclear GH receptor and cell division, both mechanistically, and in live animals. We also plan to establish if nuclear localizing the receptor artificially results in cancer formation. The outcome would provide an index of risk from current GH therapy, and could lead to a new cancer therapy."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5491","size":1},{"color":"#FF4D4D","name":"Selectivity and mode of action of rho-conopeptide TIA: A novel inhibitor of alpha1-adrenoceptors.","data":{"media_summary":"Peripheral vascular disease","end_year":2006,"keywords":["Adrenergic receptors","Conotoxins","Molecular modelling","Protein structure","Structure-activity relationships"],"nhmrc_grant_id":301147,"application_year":2003,"health_keywords":["Benign prostatic hyperplasia","Cardiovascular disease","Drug design","Neuropharmacology","Peripheral vascular disease"],"scientific_title":"Selectivity and mode of action of rho-conopeptide TIA: A novel inhibitor of alpha1-adrenoceptors.","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Richard Lewis","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301147","simplified_title":"Novel peptide inhibitors of a G protein-coupled receptor","sub_type":"Standard Project Grant","total_budget":"399300","source_system":"A major obstacle to the development of safer and more effective treatments for cardivascular diseases and benign prostatic hyperplasia is the inability to find small molecules with sufficient specificity to be safe and effective. The applicant team brings together a unique set of complementary research interests and skills in using conotoxins to define, at the molecular level, how rho-conotoxins act at the alpha1-adrenoceptor, a major drug target for cardiovascualr and related diseases. Rho-conotoxins are novel peptide inhibitors of the alpha1-adrenoceptor that appear to act at an undescribed allosteric site. This Project will use rho-conotoxins and analogues to characterise structurally and functionally how and where this class of conopepides act. The structure activity relationship for rho-conotoxins will be established to guide the development of subtype specific inhibitors. Pairwise interactins between the alpha1-adrenoceptorand TIA will be used to dock TIA onto a homolgy model of the alpha1-adrenoceptor. The long-term goal of the project is to develop new and safer treatments for cardiovascular and related disorders."},"children":[{"color":"#336699","name":"Prof Paul Alewood","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0035049","middle_name":"F","last_name":"Alewood","source_individual_id":"5013158","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Alewood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86082","size":1},{"color":"#336699","name":"Prof Richard Lewis","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0014455","middle_name":"J","last_name":"Lewis","source_individual_id":"5015973","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Lewis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80612","size":1},{"color":"#336699","name":"Prof David Adams","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0000022","middle_name":"John","last_name":"Adams","source_individual_id":"RMIS8271","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Adams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76652","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5490","size":1},{"color":"#FF4D4D","name":"Investigation Of COX-2 Regulation Of Bone Turnover And Mechanically Induced Bone Formation By Genetic overexpression.","data":{"media_summary":"osteoporosis","end_year":2006,"keywords":["bone","cyclooxygenase","gene expression","osteoblast","osteoclast"],"nhmrc_grant_id":301143,"application_year":2003,"health_keywords":["Bone growth and fracture repair","age related skeletal disorders","bone formation","bone resorption","osteoporosis"],"scientific_title":"Investigation Of COX-2 Regulation Of Bone Turnover And Mechanically Induced Bone Formation By Genetic overexpression.","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Mark Forwood","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301143","simplified_title":"Understanding the role of prostaglandin enzymes in bone physiology by increasing their production above normal.","sub_type":"Standard Project Grant","total_budget":"440750","source_system":"This project is important because it uses novel experimental models to advance our knowledge of prostaglandin biology in normal and pathological bone remodelling, and the response of the skeleton to increased physical activity. We expect that a genetic modification in mice to increase the normal production of key prostaglandin enzymes, cyclooxygenase-2 (COX-2), in bone cells will increase the number of cells that remove bone (osteoclasts), and increase bone loss and the rate of bone turnover when compared to normal mice. We believe this will occur via the effect of prostaglandins on expression of genes that control osteoclast formation. This will be tested by examining the structure of the skeleton, and the expression of certain genes, in transgenic mice at different ages from 2-8 months. These effects may be exacerbated in conditions of increased bone turnover, such as postmenopausal bone loss. This will be tested by examining the bone structure and gene expression in adult mice following removal of their ovaries. Due to the role of COX-2 in adaptation of bone to mechanical loading, we also expect the load-bearing skeleton to be more sensitive to increased weight-bearing activity. We will investigate this hypothesis by applying mechanical loads to the tibiae of mice in a controlled manner and then analysing the bone structure. Knowledge of specific pathways by which bone formation can be stimulated is important for developing novel approaches to induction and augmentation of osteogenesis in skeletal diseases associated with ageing or disability, or for maintenance of new bone around implants. The discovery that COX-2 is a key enzyme in mechanotransduction and osteoclastogenesis in bone, and a pharmacological target for modulating inflammation, has considerable clinical significance. Exploiting this knowledge requires precise knowledge of the role of this enzyme in bone remodelling and adaptation and our experiments will contribute significantly to that knowledge"},"children":[{"color":"#336699","name":"Dr Alan Cassady","data":{"first_name":"Alan","title":"Dr","dw_individual_id":"DW0029837","middle_name":"Ian","last_name":"Cassady","source_individual_id":"RMIS24493","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Alan Cassady"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84725","size":1},{"color":"#336699","name":"Prof Mark Forwood","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0007324","middle_name":"R","last_name":"Forwood","source_individual_id":"RMIS18701","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mark Forwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78676","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5489","size":1},{"color":"#FF4D4D","name":"LPS-regulated SNAREs and control of cytokine secretion in macrophages.","data":{"media_summary":"","end_year":2006,"keywords":["SNARE proteins","cell biology","cellular immunology","cytokine secretion","macrophage activation"],"nhmrc_grant_id":301137,"application_year":2003,"health_keywords":["infectiocute inflammation","inflammation, cirrhosis, arthritis, psoriasis, wound healing","inflammatory bowel disease","inflammatory mediators"],"scientific_title":"LPS-regulated SNAREs and control of cytokine secretion in macrophages.","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301137","simplified_title":"Regulation of SNAREs and cytokine secretion.","sub_type":"Standard Project Grant","total_budget":"470750","source_system":"TNF(tumour necrosis factor alpha) is a potent proinflammatory cytokine secreted by immune activated macrophages. TNF has essential roles in host defense, tumour killing and energy metabolism. Excessive secretion of TNF in acute and chronic inflammatory conditions, such as septic shock, Crohn s disease, rheumatoid arthritis and in cancer has many severe, even fatal, consequences. Improved anti-TNF therapeutics are needed for clinical management in all of these conditions. Our studies are focused on investigating how macrophages synthesize and secrete TNF, with the ultimate goal of characterizing the molecules and vesicles in the TNF secretory pathway. Our recent findings show the expression of SNARE proteins, part of the vesicle docking and fusion machinery, is regulated in concert with cytokine secretion and other trafficking changes in activated macrophages. We identified the proteins Syntaxin4, Munc-18c and SNAP-23 as the specific t-SNARE complex that regulates TNF delivery to the cell surface. In the proposed studies we will investigate how SNAREs are regulated during macrophage activation by studying their gene expression and protein modifications. We have developed a single-cell assay to measure TNF trafficking in macrophages; this allows the identification of molecules with roles in TNF secretion and it will be used in a series of experiments to identify the specific v-SNARE proteins that partner the t-SNARE for TNF delivery. Finally we will use live cell imaging to investigate how and where TNF is delivered to the macrophage cell surface and membrane fractionation to examine a role for membrane microdomains in organizing SNARE-mediated TNF secretion. Manipulation of SNAREs, using data generated by these studies, holds potential for the development of new anti-TNF therapies."},"children":[{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5488","size":1},{"color":"#FF4D4D","name":"Efficacy and mechanisms of exercise training in diastolic heart failure","data":{"media_summary":"","end_year":2005,"keywords":["Echocardiography","Exercise test","Exercise therapy","Heart failure","Ventricular dysfunction"],"nhmrc_grant_id":301136,"application_year":2003,"health_keywords":["Diastolic dysfunction","Echocardiography","Heart failure","Ventricular dysfunction"],"scientific_title":"Efficacy and mechanisms of exercise training in diastolic heart failure","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Thomas Marwick","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301136","simplified_title":"Exercise training in diastolic heart failure","sub_type":"Standard Project Grant","total_budget":"385250","source_system":"Heart failure is modern epidemic which presents a significant public health burden, due to a high mortality, frequent hospital admissions and impaired functional capacity. Although the typical heart failure patient presents with a reduced contractile function, many patients have typical heart failure symptoms but with normal contraction. The problem in these patients seems to relate to the heart's ability to fill with blood, and this entity is known as diastolic heart failure (DHF). This syndrome is most frequently due to ischemic or hypertensive heart disease, and most commonly occurs in the elderly. The optimal management of DHF is not well defined, although some drug trials are currently in progress. A number of studies have shown exercise training to improve functional capacity by 15-20% in typical heart failure. However, training has not so far been trialled in DHF. In this multicenter, multi-disciplinary study, we will study a training and control group to determine whether exercise capacity and DHF symptoms are responsive to exercise training. This work will teach us about the optimum exercise prescription, in terms of the duration and nature of training, as well as the safety and effectiveness of exercise training. By using a number of sensitive measurements of heart and vessel function (in which our group has special expertise), we will identify whether exercise training exerts its effect through improvement in vascular function and myocardial properties. If successful, the clinical implications of this study are that; 1. Exercise training will be adopted to improve functional capacity and symptoms of DHF 2. The merits of aerobic and strength training will be identified in DHF 3. Abnormal blood vessel function will be identified as a major and reversible contributor to DHF"},"children":[{"color":"#336699","name":"A/Pr David Prior","data":{"first_name":"David","title":"A/Pr","dw_individual_id":"DW0039183","middle_name":"L","last_name":"Prior","source_individual_id":"5017038","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr David Prior"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87158","size":1},{"color":"#336699","name":"Prof Thomas Marwick","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0032377","middle_name":"Hugh","last_name":"Marwick","source_individual_id":"RMIS108223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Marwick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85383","size":1},{"color":"#336699","name":"Prof David Hare","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0019461","middle_name":"L","last_name":"Hare","source_individual_id":"RMIS184069","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Hare"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81954","size":1},{"color":"#336699","name":"Dr Brian Haluska","data":{"first_name":"Brian","title":"Dr","dw_individual_id":"DW0019419","middle_name":"Andrew","last_name":"Haluska","source_individual_id":"RMIS2365824","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Brian Haluska"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81942","size":1},{"color":"#336699","name":"Prof Jeff Coombes","data":{"first_name":"Jeff","title":"Prof","dw_individual_id":"DW0018387","middle_name":"Scott","last_name":"Coombes","source_individual_id":"RMIS159442","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jeff Coombes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81708","size":1},{"color":"#336699","name":"Prof Dominic Leung","data":{"first_name":"Dominic","title":"Prof","dw_individual_id":"DW0002927","middle_name":"","last_name":"Leung","source_individual_id":"5015944","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Dominic Leung"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77479","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5487","size":1},{"color":"#FF4D4D","name":"Identification and origin of neuronal precursors in the adult mouse hippocampus","data":{"media_summary":"stroke","end_year":2006,"keywords":["Cell proliferation","Neural stem cells","Neurobiology","Neurogenesis","Neurotrophic factor and growth factors"],"nhmrc_grant_id":301134,"application_year":2003,"health_keywords":["brain cell culture","cortical plasticity","nervous system repair","neurodegeneration","stroke"],"scientific_title":"Identification and origin of neuronal precursors in the adult mouse hippocampus","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Rodney Rietze","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301134","simplified_title":"Identification of Hippocampal Precursors","sub_type":"New Investigator Grant","total_budget":"284250","source_system":"It is now clear that new neurons continue to be generated under normal conditions in at least 2 regions of the adult mammalian brain: the olfactory bulb (smell centre) and the hippocampus (organ responsible for memory and learning). These new neurons replace those lost as part of aging and, as such, are vital to normal brain function. Recently, these results have been extended to show that various insults, such as stroke, can cause the proliferation of precursor cells in the adult brain, which ultimately results in the addition of new nerve cells that go on to repair the pathological damage. Although the production of new nerve cells under normal conditions and following damage is highly significant, we still know surprisingly little about the nature of the precursor population which produces these cells and even less about their regulation. For the most part, this has been due to our inability to identify and isolate the brain stem cell. Thus, over the last 5 years I have adapted cell sorting techniques - which are normally used to separate blood cells to isolate populations of cells from the brains of adult mice. As a result of my work, we are now in the position to sort for a population of stem cells that are known to give rise to new brain cells in the adult olfactory bulb. This work will be extended to identify and characterise the precursor population that resides in the hippocampus. The identification of this hippocampal precursor population will thus provide the foundation for developing new approaches for the treatment of diseases such as stroke"},"children":[{"color":"#336699","name":"Rodney Rietze","data":{"first_name":"Rodney","title":"","dw_individual_id":"DW0004241","middle_name":"","last_name":"Rietze","source_individual_id":"RMIS1220749","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Rodney Rietze"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77852","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5486","size":1},{"color":"#FF4D4D","name":"Treatment of virally-induced cancers by RNA Interference.","data":{"media_summary":"","end_year":2006,"keywords":["RNA interference","cancer","oncogenes","papillamvirus","post transcritional gene silencing"],"nhmrc_grant_id":301121,"application_year":2003,"health_keywords":["cancer","cervical cancer","viral-induced cancers"],"scientific_title":"Treatment of virally-induced cancers by RNA Interference.","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Nigel McMillan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301121","simplified_title":"Can we turn off genes that cause cancer?","sub_type":"Standard Project Grant","total_budget":"389250","source_system":"Cancers require certain mutations and the over expression of genes to cause disease. Each cancer has a unique set of gene changes thus making it difficult to treat. However, it has become clear that the normal control mechanisms of many cancers are still intact but are repressed by the over expression of these oncogenes (or cancer genes). By turning off these oncogenes we can restore normal control to the cell and the cancer will die normally. We will use a new method of gene targeting called RNA interference to turn off oncogenes. RNA interference involves treatment of cells with a small peice of genetic material that provides the cell with an identity pattern of the gene to be eliminated. The cell takes the pattern and turms off the genes expression. As long as the pattern only turns off the cancer gene all other genes will remain normal. We will test this using cervical cancer as a model as all these cancers are caused by infection with a virus that carries 2 oncogenes. It is these virus oncogenes that cause the cancer and therefore we know the exact target genes that need to be turned off. Most importantly these genes are not present in normal cells making it safe to target them by RNA interference. We have gathered an expert group of investigators with experience in cervical cancer and cancer genetics to address this problem. If successful we will have proven this new technique can work against cervical cancer and this method could then be applied to any cancer. We would then be able to start human trials. Cervical cancer kills over 300 women in Australia each year, is the leading cause of cancer death in Aboriginal women, is 2nd most common cancer of women in the world and is the leading cancer killer worldwide in women under 50."},"children":[{"color":"#336699","name":"Dr Graham Leggatt","data":{"first_name":"Graham","title":"Dr","dw_individual_id":"DW0037982","middle_name":"R","last_name":"Leggatt","source_individual_id":"RMIS13401","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Graham Leggatt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86840","size":1},{"color":"#336699","name":"Prof Nigel Mcmillan","data":{"first_name":"Nigel","title":"Prof","dw_individual_id":"DW0032535","middle_name":"Alan John","last_name":"Mcmillan","source_individual_id":"5016394","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nigel Mcmillan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85423","size":1},{"color":"#336699","name":"A/Pr Nicholas Saunders","data":{"first_name":"Nicholas","title":"A/Pr","dw_individual_id":"DW0021953","middle_name":"A","last_name":"Saunders","source_individual_id":"5017363","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nicholas Saunders"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82651","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5485","size":1},{"color":"#FF4D4D","name":"Proteolytic cleavage of the p75 neurotrophin receptor mediates cell death","data":{"media_summary":"","end_year":2006,"keywords":["cell death/ apoptosis","metalloprotease","p75 neurotrophin receptor","presenilin","signalling"],"nhmrc_grant_id":301119,"application_year":2003,"health_keywords":["Alzheimer's disease","Stroke","nerve trauma","neurodegenerative disease"],"scientific_title":"Proteolytic cleavage of the p75 neurotrophin receptor mediates cell death","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Elizabeth Coulson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301119","simplified_title":"Proteolytic cleavage regulates nerve cell survival","sub_type":"New Investigator Grant","total_budget":"238500","source_system":"The p75 neutrotophin receptor (p75NTR) is a major inducer of nerve cell death, and is active in a wide range of neurodegenerative conditions, including Alzheimer's disease, motor neuron disease, multiple sclerosis, stroke and nerve trauma. This study aims to understand and to characterise the events that regulate this receptor. In particular, we will investigate the role that cleavage or controlled breakdown of the receptor plays in mediating its cell death activity. A fundamental aspect of this proposal is determining whether cleavage is due to presenilin-dependent activity, given that presenilin mutations have been demonstrated in most familial Alzheimer s disease cases. While this will increase our understanding of one of factors contributing to Alzheimer's disease, it also has much broader implications. A wide range of pharmaceuticals which regulate presenilin cleavage are already being developed and clinically tested for their efficacy in the treatment of Alzheimer s disease. Should our research demonstrate that p75NTR cleavage is the key process that regulates neuronal degeneration it will have major ramifications for approaches to the treatment of other p75NTR-associated neurodegenerative conditions."},"children":[{"color":"#336699","name":"A/Pr Elizabeth Coulson","data":{"first_name":"Elizabeth","title":"A/Pr","dw_individual_id":"DW0006736","middle_name":"J","last_name":"Coulson","source_individual_id":"5014079","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Elizabeth Coulson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78524","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5484","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2008,"keywords":["Ras Protein","microlocalization","plasma membrane","signal transduction"],"nhmrc_grant_id":301107,"application_year":2003,"start_year":2004,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof John Hancock","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301107","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"638750","source_system":""},"children":[{"color":"#336699","name":"Prof John Hancock","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0037089","middle_name":"F","last_name":"Hancock","source_individual_id":"RMIS11500","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Hancock"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86600","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5483","size":1},{"color":"#FF4D4D","name":"Cognitive impairments and post traumatic stress symptoms in children with traumatic brain injury: A longitudinal study","data":{"media_summary":"","end_year":2006,"keywords":["cognitive function assessment","longitudinal study","paediatric","post traumatic stress disorder","traumatic brain injury"],"nhmrc_grant_id":301103,"application_year":2003,"health_keywords":["children's mental health and adjustment","post-traumatic stress disorder (PTSD)","psychological and psychosocial adjustment","traumatic brain injury"],"scientific_title":"Cognitive impairments and post traumatic stress symptoms in children with traumatic brain injury: A longitudinal study","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Health, Clinical and Counselling Psychology","research_area":"Clinical Medicine and Science","for_category":"PSYCHOLOGY","cia_name":"Prof Justin Kenardy","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301103","simplified_title":"Cognitive and psychological problems in children with traumatic brain injury","sub_type":"Standard Project Grant","total_budget":"482250","source_system":"Traumatic brain injury in children is common with more than 2000 new cases a year in Queensland and Victoria alone. Many children who experience a brain injury go on to have long-term difficulties such as significant educational and social problems. Post-traumatic stress occurs in children following traumatic physical injury. However it is not clear to what extent this is so for children who have received a traumatic brain injury. Furthermore, when there is a traumatic brain injury and traumatic stress, it is not clear how these interact, how they influence long-term outcomes, and what factors such as pre-injury functioning and family support and distress mediate outcomes. These issues are very important since effective rehabilitation of children following traumatic brain injury is essential to maximise long-term functioning and minimise disability. To be effective, rehabilitation must be guided by the knowledge about key factors that determine the recovery process. This study aims to provide answers to these questions by following two cohorts of children (aged 6-14) over 18 months after receiving a traumatic brain injury. In total 240 children will be recruited from Brisbane and Melbourne hospitals. They will be assessed at three, six, twelve and eighteen months post-injury using measures of cognitive, psychological and social functioning. Information on parent distress and behaviours will also be obtained. The information obtained will provide the basis for the development of a specific rehabilitation strategy for children with traumatic brain injury, including information on strategies to help prevent any confounding impact of post-traumatic stress on recovery."},"children":[{"color":"#336699","name":"Prof Justin Kenardy","data":{"first_name":"Justin","title":"Prof","dw_individual_id":"DW0037727","middle_name":"Alastair","last_name":"Kenardy","source_individual_id":"RMIS53308","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Justin Kenardy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86768","size":1},{"color":"#336699","name":"Prof Nicholas Bellamy","data":{"first_name":"Nicholas","title":"Prof","dw_individual_id":"DW0035335","middle_name":"","last_name":"Bellamy","source_individual_id":"RMIS3691361","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Nicholas Bellamy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86158","size":1},{"color":"#336699","name":"Prof Vicki Anderson","data":{"first_name":"Vicki","title":"Prof","dw_individual_id":"DW0029167","middle_name":"Anne","last_name":"Anderson","source_individual_id":"RMIS168398","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Vicki Anderson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84564","size":1},{"color":"#336699","name":"Dr Lynne Mckinlay","data":{"first_name":"Lynne","title":"Dr","dw_individual_id":"DW0014881","middle_name":"","last_name":"Mckinlay","source_individual_id":"RMIS2406855","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Lynne Mckinlay"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80725","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5482","size":1},{"color":"#FF4D4D","name":"Dissecting the molecular mechanisms driving cell migration during neurulation triggered by the netrin receptor, neogenin","data":{"media_summary":"neural tube defects","end_year":2006,"keywords":["control of cell movement","developmental neurobiology","molecular mechanism","neural stem cell","neuronal migration"],"nhmrc_grant_id":301099,"application_year":2003,"health_keywords":["CNS repair after injury","cell signalling","migration","nervous system development","neural tube defects"],"scientific_title":"Dissecting the molecular mechanisms driving cell migration during neurulation triggered by the netrin receptor, neogenin","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Helen Cooper","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301099","simplified_title":"The molecular processes underlying the formation of the embryonic brain triggered by the receptor, neogenin","sub_type":"Standard Project Grant","total_budget":"432750","source_system":"In humans, abnormalities in brain and spinal cord formation during early embryogenesis result in congenital syndromes such as spina bifida and anencephaly. These defects occur at a rate of 1-1000 pregnancies and are therefore a major contributor to pre- and perinatal deaths. In the early embryo, the brain and spinal cord begin as a hollow tube of cells (the neural tube) that subsequently expands into the complex structures seen at birth. It is known that the neural tube is formed by a complex process in which early neural cells migrate toward the midline of the embryo and subsequently coalesce. This project seeks to determine the function of one molecular signaling pathway (the neogenin pathway) that has been implicated in driving these cell migration events. We will initially use the frog, Xenopus laevis, as our embryonic model since the developmental processes that form the Xenopus neural tube closely parallel those ocurring in the human embryo. This model will allow us to identify the molecules in the neogenin signaling pathway. We will also create mice that carry a mutation in the neogenin gene so that we can study neogenin function in the mammal. We anticipate that these studies will provide important insights into the development of the central nervous system and also into the aberrant molecular processes underlying neural tube defects in man."},"children":[{"color":"#336699","name":"A/Pr Helen Cooper","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0018393","middle_name":"M","last_name":"Cooper","source_individual_id":"RMIS222363","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Helen Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81710","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5481","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2008,"keywords":["NEURAL CELL-DEATH","NEURAL STEM CELLS","NEURONAL REPAIR AND REGENERATION","NEUROTROPHOPHIC GROWTH FACTORS"],"nhmrc_grant_id":301097,"application_year":2003,"start_year":2008,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Perry Bartlett","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301097","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"54748.12","source_system":""},"children":[{"color":"#336699","name":"Prof Perry Bartlett","data":{"first_name":"Perry","title":"Prof","dw_individual_id":"DW0011651","middle_name":"Francis","last_name":"Bartlett","source_individual_id":"5013357","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Perry Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79864","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5480","size":1},{"color":"#FF4D4D","name":"Design and Synthesis of peptide - based drugs for multiple sclerosis","data":{"media_summary":"","end_year":2006,"keywords":["NMR spectroscopy","drug design","multiple sclerosis","myelin proteins","protein engineering"],"nhmrc_grant_id":301093,"application_year":2003,"health_keywords":["central nervous system demyelination and inflammation","multiple sclerosis","novel therapeutic agents for T-cell autoimmune diseases"],"scientific_title":"Design and Synthesis of peptide - based drugs for multiple sclerosis","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Prof David Craik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301093","simplified_title":"New drugs for multiple sclerosis","sub_type":"Standard Project Grant","total_budget":"351000","source_system":"Multiple sclerosis (MS) is an inflammatory disease of the central nervous system that affects ~1 million young adults worldwide. It is a debilitating disease for which there is currently no cure. The most effective treatment available, interferon-b (IFN-b) is useful for the treatment of some forms of the disease, reducing the relapse rate, that is the frequency of attacks or exacerbations of the disease, and delaying the time to onset of sustained progression of the disability. This treatment may, however, cause adverse side effects, result in the development of antibodies that neutralise its function and is prohibitively expensive. In addition it does not slow the sustained progression of the disease in 20-40% of patients with the two most common types of MS and does not appear to directly affect deterioration of the protective layer around neurons, myelin. There is clearly a need for the development of therapeutics that address these issues and the drug leads to be developed in this project may help to overcome some of these shortfalls. While the immune system of a healthy individual is able to distinguish between foreign molecules and its own molecules, in MS the immune system fails to do this. An immune response against important proteins that form part of the protective myelin layer around neurons occurs. This means that the integrity of the protective layer is compromised. The peptide-based drugs that we plan to develop in this project are designed to interfere with the interaction between these important myelin proteins and their immune system targets. This will leave the myelin proteins to carry out their normal physiological roles and should therefore significantly slow, if not halt, progression of the disease. Given the prevalence of MS such a development could have a profound impact on the health and quality of life of many individuals and their families, and has the potential to substantially reduce the economic burden of this disease on the community."},"children":[{"color":"#336699","name":"Prof David Craik","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0041813","middle_name":"James","last_name":"Craik","source_individual_id":"5011504","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof David Craik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87851","size":1},{"color":"#336699","name":"Prof Claude Bernard","data":{"first_name":"Claude","title":"Prof","dw_individual_id":"DW0029436","middle_name":"C","last_name":"Bernard","source_individual_id":"RMIS118720","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Claude Bernard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84631","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5479","size":1},{"color":"#FF4D4D","name":"Histone hyperacetylation affects G2/M cell cycle transition","data":{"media_summary":"","end_year":2006,"keywords":["Mitosis","cell cycle checkpoint","centromere","histone acetylation"],"nhmrc_grant_id":301086,"application_year":2003,"health_keywords":["ant-cancer therapy","cancer","drug targets"],"scientific_title":"Histone hyperacetylation affects G2/M cell cycle transition","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Brian Gabrielli","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301086","simplified_title":"Disrupting chromosome structure affects mitosis.","sub_type":"Standard Project Grant","total_budget":"302250","source_system":"The mechanisms controlling cell growth are often disrupted in cancers. We have identified on such growth control mechanism. When normal body cells are treated with a particular family of drugs known as histone deacetylase inhibitors, they react by stopping proliferating, but will resume normal growth when the drug is removed. However, we have found that similarly treated tumour cells are killed by these drugs. The difference between the normal and tumour cells is the functionality of a particular growth control. The identification of how this growth control mechanism operates in normal cells, and defining the defect in tumour cells has the potential to identify new targets for more specific and potent anti-cancer drugs. The increased specificity, i.e. destruction of only the tumour cells while have little or no effect on the surround normal body tissue, would be extremely beneficial as one of the drawbacks to conventional anti-cancer treatments is their unwanted normal tissue toxicities. This is cause of the many debilitating side effects associated with chemo and radiotherapy which can limit the clinical effectiveness of these treatments."},"children":[{"color":"#336699","name":"A/Pr Brian Gabrielli","data":{"first_name":"Brian","title":"A/Pr","dw_individual_id":"DW0007391","middle_name":"G","last_name":"Gabrielli","source_individual_id":"5014734","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Brian Gabrielli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78693","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5478","size":1},{"color":"#FF4D4D","name":"What regulates G2 phase?","data":{"media_summary":"","end_year":2006,"keywords":["Mitosis","UV radiation","cell cycle checkpoint","skin"],"nhmrc_grant_id":301085,"application_year":2003,"health_keywords":["UV radiation","cancer","growth control","skin cancer"],"scientific_title":"What regulates G2 phase?","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Brian Gabrielli","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301085","simplified_title":"Control of progression through mitosis","sub_type":"Standard Project Grant","total_budget":"465750","source_system":"The mechanisms controlling cell growth are often disrupted in cancers. Here we will investigate a fundamental mechanism that ensures that every daughter cells receives identical copies of DNA. This control mechanism also appears to have a key role in protecting the cells that continuously repopulate the epidermal layer ofthe skin that are target for ultraviolet radiation induced mutation that lead to skin cancers. This mechanism is inoperative in cells derived from skin cancers, indicating that mutation of components of this mechanism must have occurred. These mutations, and the loss of this normally protective control mechanism are likely to contribute to either an increased risk of skin cancer, or to the increased malignant spread of the diseases."},"children":[{"color":"#336699","name":"Heather Beamish","data":{"first_name":"Heather","title":"","dw_individual_id":"DW0023541","middle_name":"","last_name":"Beamish","source_individual_id":"RMIS1214247","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Heather Beamish"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83053","size":1},{"color":"#336699","name":"A/Pr Brian Gabrielli","data":{"first_name":"Brian","title":"A/Pr","dw_individual_id":"DW0007391","middle_name":"G","last_name":"Gabrielli","source_individual_id":"5014734","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Brian Gabrielli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78693","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5477","size":1},{"color":"#FF4D4D","name":"The role of CD4+ T cells in the tumour killing by CD8+ memory T cells.","data":{"media_summary":"","end_year":2006,"keywords":["Cancer Vaccine","Cytotoxic T Cells","Memory CTL","Regulatory T cells"],"nhmrc_grant_id":301084,"application_year":2003,"health_keywords":["Anti-tumour Vaccine","Cancer","Cellular Immunity","Memory T-cells"],"scientific_title":"The role of CD4+ T cells in the tumour killing by CD8+ memory T cells.","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Tumour Immunology","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Dr Germain Fernando","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301084","simplified_title":"Mechanisms of Cancer Elimination.","sub_type":"Standard Project Grant","total_budget":"303000","source_system":"It has been observed that human cancers grow in spite of the presence of tumour antigen specific memory CD8+ tumour killer T cells in the body. These memory killer cells are unable to kill the cancer. Our research work in a mouse model indicates that the CD8+ T cells can be activated to kill cancers if cancer antigen specific CD4+ T helper cells are activated. The mechanism how this happens is not clear. The role of regulatory or suppressor CD4+ T cells are also not known. In this proposal we wish to study the mechanism of how CD8+ memory T cells get activated to cancer killer cells by the CD4+ T helper cells. This information will help us to design better immunotherapies for cancer patients."},"children":[{"color":"#336699","name":"Dr Germain Fernando","data":{"first_name":"Germain","title":"Dr","dw_individual_id":"DW0030659","middle_name":"J","last_name":"Fernando","source_individual_id":"5014600","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Germain Fernando"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84967","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5476","size":1},{"color":"#FF4D4D","name":"Development of a novel therapy for the treatment of epidermal squamous cell carcinoma","data":{"media_summary":"","end_year":2006,"keywords":["E2F","cell cycle","epithelial differentiation","proliferation","squamous cell carcinoma"],"nhmrc_grant_id":301075,"application_year":2003,"health_keywords":["head and neck cancer","skin cancer","solid tumours"],"scientific_title":"Development of a novel therapy for the treatment of epidermal squamous cell carcinoma","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Nicholas Saunders","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301075","simplified_title":"Development of novel treatments for skin cancer","sub_type":"Standard Project Grant","total_budget":"432750","source_system":"Squamous cell carcinomas (SCC) are the most common life-threatening form of skin cancer in Australia. SCCs commonly arise in areas of the body that have been exposed to excessive amounts of UV irradiation. The cells of the skin from which SCCs are derived are called keratinocytes. UV irradiation causes lesions within these cells such that their growth and maturation are disrupted leading to deregulated growth and maturation and hence tumour formation. We have previously identified a protein, E2F, that is central to this process and whose inhibition leads to decreased cancer cell growth. During the course of these studies we noted that the deregulation of E2F could also lead to the disruption of keratinocyte maturation. This led us to propose that the inhibition of E2F in SCCs may result in both decreased cancer cell growth as well as the reinstatement of a normal maturation process. this would make E2F inhibitors a very attractive therapeutic for treating SCC. In the present study we aim to explore the ability and the mechanism by which E2F modulates keratinocyte proliferation and maturation. This will be done in vitro as well as in animal models of SCC. These studies will be required in order to take the E2F inhibitors into clinical trials."},"children":[{"color":"#336699","name":"A/Pr Nicholas Saunders","data":{"first_name":"Nicholas","title":"A/Pr","dw_individual_id":"DW0021953","middle_name":"A","last_name":"Saunders","source_individual_id":"5017363","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nicholas Saunders"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82651","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5475","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2008,"keywords":["gene expression","genetic engineering and enzyme technology","genetic technolgies","immunology","preventative medicine"],"nhmrc_grant_id":301069,"application_year":2003,"start_year":2004,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301069","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"602500","source_system":""},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5474","size":1},{"color":"#FF4D4D","name":"Flavivirus RNA Replication and Virus Assembly","data":{"media_summary":"","end_year":2006,"keywords":["Flavivirus Kunjin","Flavivirus replication complex","Kunjin Virus assembly","Kunjin virus RNA replication","RNA encapsidation"],"nhmrc_grant_id":301066,"application_year":2003,"health_keywords":["Australian encephalitis and related flavivirus infections","Targets for design of antiviral therapies","Virus replication"],"scientific_title":"Flavivirus RNA Replication and Virus Assembly","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301066","simplified_title":"Flavivirus replication and assembly","sub_type":"Standard Project Grant","total_budget":"465750","source_system":"Flaviviruses are the agents of many mosquito-transmitted infections such as encephalitis and dengue. Hepatitis C virus is a member of the same virus family. Using Australian flavivirus Kunjin as a model and advanced techniques in molecular biology, biochemistry and electron micriscopy, the research at SASVRC has established international leadership in the area of flavivirus RNA replication and ultrastructure of virus-infected cells. The objectives of this application are to advance further our understanding of how the flavivirus RNA replication complex synthesizes RNA and how this RNA is specifically packaged to produce infectious virus. To achieve these goals we will employ state-of-the-art molecular biology techniques based on manipulations with infectious complementary DNA copy of Kunjin virus RNA. The intimate understanding of these mechanisms in flavivirus replication should facilitate the design of efficient antiviral drugs by specifically targeting unique events in RNA replication and-or packaging. This may assist in the development of antiviral drugs for treatment of infections caused by other higly pathogenic flaviviruses in Australia, such as dengue, Japanese encephalitis and Murray Valley encephalitis, and in the rest of the wirld such as New York strain of West Nile virus as well as the related heptitis C virus. Understanding the mechanisms of Kunjin virus replication and assembly will also aid in the further development of this virus as a safe vaccine vector against other viruses, e.g. HIV, and diseases such as cancer."},"children":[{"color":"#336699","name":"Dr Wenjun Liu","data":{"first_name":"Wenjun","title":"Dr","dw_individual_id":"DW0043838","middle_name":"","last_name":"Liu","source_individual_id":"RMIS2346721","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Wenjun Liu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88361","size":1},{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5473","size":1},{"color":"#FF4D4D","name":"The role of Crim1, a novel TGFb superfamily modulator, in early vertebrate patterning, vascular and renal development.","data":{"media_summary":"vascular disease","end_year":2006,"keywords":["embryonic development","kidney","knockout mice","vascular development","zebrafish"],"nhmrc_grant_id":301056,"application_year":2003,"health_keywords":["chronic renal failure","fetal development","kidney disease","renal disease","vascular disease"],"scientific_title":"The role of Crim1, a novel TGFb superfamily modulator, in early vertebrate patterning, vascular and renal development.","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301056","simplified_title":"The role of a novel protein in development of the kidney and blood vessels.","sub_type":"Standard Project Grant","total_budget":"501300","source_system":"The transforming growth factor (TGF) beta superfamily is a large group of secreted growth factors who play many different roles in normal development of tissues such as the brain, skeleton, heart, kidney, eyes, teeth and limbs. One of the groups within the superfamily, the bone morphogenetic proteins (BMPs), are being used in clinical trials to assist in regrowing bones after fracture. These molecules are also of interest for clinical reasons as growth factors within this family can also be deleterious, with their overexpression leading to conditions such as renal fibrosis and cataract. The activity of these growth factors is regulated by many other proteins, including protein antagonists which bind and inactivate them. It is therefore possible that by understanding these antagonists, we can find new ways of altering TGF beta superfamily activity. We have previously identified a novel protein, Crim1, which we have now shown can bind to TGF superfamily members and can reduce their secretion. We believe that Crim1 plays a role in the patterning of the central nervous system, the development of the blood vessels and the kidneys by regulating the TGFbeta superfamily. In this grant we will be investigating what the effect of disruption to Crim1 is on these organ systems and working out which members of the TGFbeta superfamily it is affecting to cause these effects. To do this, we will knock out the gene in zebrafish and characterise the defects found in a mouse line in which the gene has been disrupted. This may be important in developing new ways of activating or inactiviating these growth factors in a number of clinical conditions."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5472","size":1},{"color":"#FF4D4D","name":"Tropisetron: molecular mechanisms of action at the 5-HT3 receptor and the glycine receptor","data":{"media_summary":"","end_year":2006,"keywords":["ion channels","molecular neuroscience","molecular pharmacology","patch-clamping","receptor structure and function"],"nhmrc_grant_id":301053,"application_year":2003,"health_keywords":["analgesia","anti-emetic","chemotherapy treatment effects"],"scientific_title":"Tropisetron: molecular mechanisms of action at the 5-HT3 receptor and the glycine receptor","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Peripheral Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Joseph Lynch","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301053","simplified_title":"Molecular mechanism of action of an anti-emetic drug","sub_type":"Standard Project Grant","total_budget":"371800","source_system":"Tropisetron and related drugs are used clinically to combat chemotherapy-induced nausea and vomiting. These drugs are termed '5-HT3 antagonists' because they block the activity of 5-HT3 receptor ion channels, which are found in parts of the brain that control the vomit reflex. Tropisetron also has potent effects on the glycine receptor chloride channel, which inhibits the nervous system. Depending on the concentration used, tropisetron can either increase or decrease the activity of the glycine receptor. If a drug can be found to selectively increase glycine receptor activity, it may be useful as an analgesic. In this project, we aim to understand the molecular mechanisms by which tropisetron interacts with the 5-HT3 receptor and the glycine receptor. This may help to identify novel analgesic drugs and more selective anti-emetic drugs."},"children":[{"color":"#336699","name":"Prof Joseph Lynch","data":{"first_name":"Joseph","title":"Prof","dw_individual_id":"DW0032228","middle_name":"W","last_name":"Lynch","source_individual_id":"5016080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Joseph Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85342","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5471","size":1},{"color":"#FF4D4D","name":"Cortactin: molecular regulation of cadherin activity and epithelial morphogenesis.","data":{"media_summary":"Kidney disease","end_year":2006,"keywords":["Adhesion mechanisms","Cancer","Cortactin","E-cadherin","Epithelial morphogenesis"],"nhmrc_grant_id":301052,"application_year":2003,"health_keywords":["Cancer","Epithelial Neoplasms, malignant","Epithelial function","Gastrointestinal disease","Kidney disease"],"scientific_title":"Cortactin: molecular regulation of cadherin activity and epithelial morphogenesis.","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Alpha Yap","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301052","simplified_title":"Cortactin and cadherin-dependent morphogenesis","sub_type":"Standard Project Grant","total_budget":"239250","source_system":"Interactions between cells and their neighbouring cells control many important processes in the body. The adhesion molecule E-cadherin is a major protein that controls how cells interact with one another in many epithelial tissues (e.g. breast, lung, gut). These tissues are the source of many common diseases, particular cancer and inflammation. E-cadherin is essential for these tissues to form normally, and loss of E-cadherin function contributes to disease in these tissues (especially common cancers, such as breast and lung). Understanding how E-cadherin controls normal cell function in these tissues will therefore provide key insights into how disease arises. In this study we will investigate how a protein which binds to E-cadherin, cortactin, contributes to the biological effect of E-cadherin in supporting tissue architecture. Understanding the fundamental elements of how cortactin works with E-cadherin will provide invaluable information into how cells recognize one another in health, and fail to adequately recognize each other in common diseases."},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5470","size":1},{"color":"#FF4D4D","name":"Fetal Intrapartum Pulse Oximetry: a Multicentre Randomised Controlled Trial (the FOREMOST trial)","data":{"media_summary":"oxygen saturation","end_year":2004,"keywords":["Oxygen saturation","clinical trial","fetal","obsterics","operative delivery"],"nhmrc_grant_id":301050,"application_year":2003,"health_keywords":["fetal distress","labour","non-reassuring fetal status","opeartive delivery","oxygen saturation"],"scientific_title":"Fetal Intrapartum Pulse Oximetry: a Multicentre Randomised Controlled Trial (the FOREMOST trial)","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Obstetrics and Gynaecology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Paul Colditz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301050","simplified_title":"Trial of fetal pulse oximetry during labour","sub_type":"Standard Project Grant","total_budget":"146950","source_system":"Current methods of monitoring the well-being of the unborn baby during labour often result in concern about the unborn baby's health. This leads to delivery by caesarean section, forceps , or vacuum. These babies are usually found to be healthy once born, meaning that the operation was unnecessry. In this study, when an unborn baby appears to be distressed, half of the study participants will be allocated to continue with the current monitororing of the baby's heartbeat. The other half will have a new form of monitoring in labour, fetal oxgyen saturation monitoring, added. We will then determine whether the new form of monitoring makes a differnce in the number of times women need to have a caesarean section, forceps, or vacuum delivery. It is important to do this research BEFORE the new form of monitoring becomes used routinely. This Australian research is leading the world in letting the health consumer (women) know whether the new monitoring method is effective in practice and ensuring that there are no unforeseen adverse events."},"children":[{"color":"#336699","name":"Prof Fung Yee Chan","data":{"first_name":"Fung Yee","title":"Prof","dw_individual_id":"DW0041537","middle_name":"","last_name":"Chan","source_individual_id":"RMIS194284","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Fung Yee Chan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87778","size":1},{"color":"#336699","name":"Prof Shaun Brennecke","data":{"first_name":"Shaun","title":"Prof","dw_individual_id":"DW0023770","middle_name":"P","last_name":"Brennecke","source_individual_id":"RMIS3360","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Shaun Brennecke"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83105","size":1},{"color":"#336699","name":"Prof Christine East","data":{"first_name":"Christine","title":"Prof","dw_individual_id":"DW0012848","middle_name":"Elizabeth","last_name":"East","source_individual_id":"5014470","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Christine East"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80181","size":1},{"color":"#336699","name":"A/Pr James King","data":{"first_name":"James","title":"A/Pr","dw_individual_id":"DW0008384","middle_name":"","last_name":"King","source_individual_id":"RMIS3017695","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr James King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78968","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5469","size":1},{"color":"#FF4D4D","name":"Genetic programs induced by the nuclear hormone receptor PPARdelta in muscle: control of lipid and energy homeostasis","data":{"media_summary":"Obesity","end_year":2006,"keywords":["Fatty Acid and Lipid Metabolism","Gene Regulation","Microarrays and Expression Profiling","Skeletal Muscle","Steroid (and Nuclear) Hormone Receptors"],"nhmrc_grant_id":301041,"application_year":2003,"health_keywords":["Biological Sciences","Cardiovascular Disease","Dyslipidaemia","Endocrine Diseases and Diabetes","Obesity"],"scientific_title":"Genetic programs induced by the nuclear hormone receptor PPARdelta in muscle: control of lipid and energy homeostasis","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301041","simplified_title":"Understanding how receptors regulate lipid and energy metabolism in skeletal muscle","sub_type":"Standard Project Grant","total_budget":"432750","source_system":"Lipid homeostasis is regulated by dietary intake, de novo synthesis and catabolism. Lipid disease is associated with hyperinsulinemia, and anomalous levels of the lipid triad, i.e. low HDL-cholesterol, high LDL-cholesterol and elevated triglycerides. Increased incidence of cardiovascular disease has been linked to dyslipidemias associated with diet and lifestyle. Diabetes, atherosclerosis, and obesity are comorbidities with these lipid disorders. HDLs have a defensive role in the prevention of dyslipidemia by mediating cholesterol efflux from tissues. In contrast, the LDLs accumulate in the arterial wall leading to atherosclerosis. Physiological maintenance of lipid homeostasis requires a dynamic balance between metabolic signalling cascades, diet, lifestyle etc. PPPARs are nuclear hormone receptors that function as fatty acid activated transcription factors that regulate lipid and cholesterol homeostasis. PPARs are bona fide targets for the development of therapeutic compounds useful in the treatment of lipid disorders. PPAR delta is abundantly expressed in skeletal muscle, a major mass peripheral tissue that accounts for ~40% of total body weight. Muscle is a major site of glucose metabolism and, fatty acid oxidation. Furthermore, it is an important regulator of cholesterol homeostasis and HDL levels. Consequently, it has a significant role in insulin sensitivity, the blood lipid profile and lipid metabolism. Understanding the functional role of PPAR delta in skeletal muscle, a peripheral tissue that accounts for 40% of total body weight is of paramount importance in understanding whole body lipid homeostasis. Understsanding these receptors may provide a pharmaceutical solution for the prevention of hyper-lipidemia--cholesterolemia, and atherogenic disease. Moreover, it may lead to the identification of agents that influence a major mass tissue in terms of lipid absorption, and increased fatty acid oxidation, and consequently normalize the blood lipid profile."},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5468","size":1},{"color":"#FF4D4D","name":"Understanding the mechanism of action and pathophysiological function of the NOR1 and Nur77 orphan nuclear receptors","data":{"media_summary":"Muscle Disease","end_year":2006,"keywords":["Co-factor Binding Sites","Gene Regulation","Muscle","Steroid (Nuclear) Hormone Receptors","Transcription"],"nhmrc_grant_id":301040,"application_year":2003,"health_keywords":["Biological Sciences","Cancer Biology","Leukemia","Leukemia and Apoptosis","Muscle Disease"],"scientific_title":"Understanding the mechanism of action and pathophysiological function of the NOR1 and Nur77 orphan nuclear receptors","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301040","simplified_title":"Understanding how nuclear hormone receptors control gene expression","sub_type":"Standard Project Grant","total_budget":"269250","source_system":"Nuclear hormone receptors (NRs) function as ligand-hormone activated transcription factors that regulate gene expression involved in reproduction, development and metabolism. Dysfunctional hormonal signalling, and inappropriate NR function results in reproductive disorders, inflammation, cancer, diabetes, and cardiovascular disease. The significance of NRs in disease is underscored by the range of pharmacopoeia developed for the treatment of NR associated disorders. Orphan NRs belong to the superfamily on the basis of their sequence identity, however, the endogenous signaling molecules which bind to these proteins are unknown. The orphan NRs Nur77, NURR1, and NOR1, functions as stress response genes which are induced by a wide range of physiological stimuli Furthermore, the NR4A subgroup of receptors has been implicated in carcinogenesis, neurological disorders; inflammation, diabetes and atherogenesis. The objective of this proposal is to examine the molecular mechanisms that control the regulation of gene expression by the orphan nuclear receptors, Nur77 and NOR-1. Furthermore, we will investigate the pathophysiological function of NOR-1 and Nur77 in muscle. Nur77 and NOR-1 are expressed in skeletal muscle. This major mass tissue accounts for ~40% of total body weight and, is a major site of glucose and fat metabolism. Consequently, this peripheral tissue plays a significant role in insulin sensitivity, and the blood lipid profile. Furthermore, a collaboration with industry has identified NOR-1 as an insulin responsive gene in muscle, which becomes hyper-sensitive to insulin induction in diabetic patients. Additionally, we have exciting evidence that the anti-neoplastic purine anti-metabolite, 6-mercaptopurine activates the NR4A subgroup. Nur77 and NOR-1 represent an exciting challenge, and unlocking the molecular mechanisms that NOR-1-dependent transcription provides the opportunity for identifying novel signaling pathways, and therapeutics."},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5467","size":1},{"color":"#FF4D4D","name":"Foot orthotics in the treatment of patellofemoral pain syndrome: A randomised control trial in primary care","data":{"media_summary":"physiotherapy","end_year":2006,"keywords":["evidence based practice","physiotherapy","primary health care","randomised controlled trial","rehabilitation"],"nhmrc_grant_id":301037,"application_year":2003,"health_keywords":["exercise therapy","injury","musculoskeletal pain","physical activity","physiotherapy"],"scientific_title":"Foot orthotics in the treatment of patellofemoral pain syndrome: A randomised control trial in primary care","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Bill (Guglielmo) Vicenzino","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301037","simplified_title":"A clinical study of orthotic prescription for patellofemoral pain in primary care.","sub_type":"Standard Project Grant","total_budget":"192625","source_system":"Musculoskeletal conditions account for the third leading cause of health systems expenditure in Australia. Patellofemoral pain syndrome or pain about the knee cap is such a condition and is often treated in primary care. Both the individual and community are affected by this condition with an estimated 1 in 4 suffers still having problems and pain up to 20 years after first being afflicted. Importantly it interferes with activities such as walking, jogging, gym classes and aerobics, which are often prescribed to prevent serious conditions of the heart, diabetes and obesity. Hence it negatively impacts on the health and well being of our nation. Two popular treatment options that are commonly prescribed for the management of patellofemoral pain syndrome are physiotherapy and foot orthotics. To date there is some evidence supporting physiotherapy, especially current best practice methods such as a combined program of therapeutic exercise, manual therapy and kneecap taping. There is a lack of evidence for the use of orthotics in treating patellofemoral pain syndrome. This project will conduct a randomised clinical trial to evaluate the relative benefits of orthotics as the sole treatment of patellofemoral pain syndrome and also when combined with physiotherapy. Factors associated with predicting the results of orthotic therapy will be studied to see if there are any tests that a health care practitioner can perform to provide information early on in a consultation regarding possible treatment outcomes. A cost-benefit analysis will also be conducted to calculate the relative economic merits of the treatments. A tangible outcome of this project will be the development of clinical guidelines for the most effective method of treating patellofemoral pain syndrome in primary health care."},"children":[{"color":"#336699","name":"Prof Guglielmo Vicenzino","data":{"first_name":"Guglielmo","title":"Prof","dw_individual_id":"DW0046019","middle_name":"Tarcisio","last_name":"Vicenzino","source_individual_id":"5018115","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Guglielmo Vicenzino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88911","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5465","size":1},{"color":"#FF4D4D","name":"A telehealth application for the assessment and treatment of disordered speech in Parkinson's disease","data":{"media_summary":"Speech Intelligibility","end_year":2007,"keywords":["Access to health care","Dysarthria","Parkinson's Disease","Speech pathology","Telemedicine"],"nhmrc_grant_id":301029,"application_year":2003,"health_keywords":["Health services accessibility","Parkinson's Disease","Rehabilitation","Rural and remote health","Speech Intelligibility"],"scientific_title":"A telehealth application for the assessment and treatment of disordered speech in Parkinson's disease","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Hearing and Speech","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Deborah Theodoros","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301029","simplified_title":"Assessing and treating disordered speech in Parkinson's disease online","sub_type":"Standard Project Grant","total_budget":"362875","source_system":"People with Parkinson's disease frequently develop soft, indistinct, and monotonous speech that significantly affects the person's ability to communicate with his or her family, and the community in general. To date, the most effective treatment for the speech disturbance seen in persons with Parkinson's disease is the Lee Silverman Voice Treatment (LSVT ) program that focuses on improving the individual's vocal loudness and quality, resulting in improved speech intelligibility. For many people with this disease, accessing this effective treatment for their speech disorder is very difficult due to their physical disabilities, the distances they are required to travel, and the availability of speech pathologists. This project aims to overcome these access issues through the development of a telehealth system that will enable speech pathologists to assess and treat people with Parkinson's disease who have a speech disorder across the Internet using videoconferencing. It is intended that this research will ultimately enable people with Parkinson's disease to be treated within their own home or local community."},"children":[{"color":"#336699","name":"Prof Elizabeth Ward","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0040334","middle_name":"Celeste","last_name":"Ward","source_individual_id":"RMIS15276","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Ward"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87452","size":1},{"color":"#336699","name":"Prof Richard Wootton","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0023093","middle_name":"","last_name":"Wootton","source_individual_id":"5018481","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Wootton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82948","size":1},{"color":"#336699","name":"Prof Deborah Theodoros","data":{"first_name":"Deborah","title":"Prof","dw_individual_id":"DW0022512","middle_name":"Gale","last_name":"Theodoros","source_individual_id":"RMIS15273","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Deborah Theodoros"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82794","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5464","size":1},{"color":"#FF4D4D","name":"Molecular and cellular mechanisms of axon guidance in the vertebrate nervous system","data":{"media_summary":"","end_year":2006,"keywords":["axon","development","guidance","neurobiology"],"nhmrc_grant_id":301026,"application_year":2003,"health_keywords":["brain damage","brain growth","peripheral nerve injury"],"scientific_title":"Molecular and cellular mechanisms of axon guidance in the vertebrate nervous system","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Brian Key","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301026","simplified_title":"Axon navigation during development","sub_type":"Standard Project Grant","total_budget":"447750","source_system":"There are, at least, two major obstacles that have to be overcome in the design of therapies to assist the repair of injured brain tissue. First, the nerve cells that are damaged have to be encouraged to regrow - typically this regrowth is inhibited in the brain; and second, this regrowth has to be directed so that the correct connections are re-established. This project will begin to unravel some of the mechanisms that nerve cells use to wire up together during development. This information can be used to assist in trying to modulate and facilitate directed regrowth following injury."},"children":[{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5463","size":1},{"color":"#FF4D4D","name":"Assessing Cardiovascular Disease (CVD) Risk in Aboriginal People","data":{"media_summary":"","end_year":2004,"keywords":["Aboriginal","Epidemiology","cardiovascular disease","risk assessment"],"nhmrc_grant_id":301024,"application_year":2003,"health_keywords":["Aboriginal health","cardiovascular diseases","cardiovascular risk factors","epidemiological, clinical and physical assessments"],"scientific_title":"Assessing Cardiovascular Disease (CVD) Risk in Aboriginal People","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Zhiqiang Wang","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301024","simplified_title":"Assessing Cardiovascular Disease (CVD) Risk in Aboriginal People","sub_type":"Standard Project Grant","total_budget":"73550","source_system":"Aboriginal Australians have higher death rates from cardiovascular disease (CVD) than other Australians, with rates in young and middle aged people increased 15-fold or more. A multi-factor approach, which considers all the risk factors, is the best strategy to identify and reduce CVD risk. The first step for selection of risk-reduction therapy in an individual is to assess his-her risk status and the benefit of intervention. Several risk assessment tools, incorporating traditional risk factors, have been developed from Western populations. They would be most appropriately applied to individuals who resemble the study sample; their validity in Aboriginal Australians has not been evaluated and no risk prediction formulae have been developed specifically for Aboriginal people. Recent reports suggest that a variety of other non-traditional risk factors also influence CVD risk, including markers of central fat deposition, inflammation, nutrition, alcohol use and early growth. Given the disadvantaged circumstances of many Aboriginal people, it is likely that some of the factors are influencing their CVD risk. The applicants have collected baseline risk factor data on volunteers in one Aboriginal community and followed their course, including CVD deaths and CVD hospitalisations, for more than a decade. From this baseline information, which goes beyond traditional risk markers, and from additional measures like birthweight, and markers of inflammation and nutrition assayed in retrieved serum, we will develop a variety of models for predicting a CVD risk in this group. We will also lay plans to evaluate these tools in other Aboriginal groups. A better understanding of the causes of CVD in this population is important to influence public health policy for CVD prevention. The models will be helpful health education tools at the community level and will allow therapeutic or lifestyle intervention in individuals to be targeted at their individual risk profile."},"children":[{"color":"#336699","name":"A/Pr Zhiqiang Wang","data":{"first_name":"Zhiqiang","title":"A/Pr","dw_individual_id":"DW0028670","middle_name":"","last_name":"Wang","source_individual_id":"5019801","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Zhiqiang Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84425","size":1},{"color":"#336699","name":"Prof Wendy Hoy","data":{"first_name":"Wendy","title":"Prof","dw_individual_id":"DW0013767","middle_name":"Elizabeth","last_name":"Hoy","source_individual_id":"RMIS3725","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wendy Hoy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80407","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5462","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2008,"keywords":["Electrophysiology","Ion channel","Pain","Protein structure-function","Receptor"],"nhmrc_grant_id":301023,"application_year":2003,"start_year":2004,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Joseph Lynch","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301023","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"583750","source_system":""},"children":[{"color":"#336699","name":"Prof Joseph Lynch","data":{"first_name":"Joseph","title":"Prof","dw_individual_id":"DW0032228","middle_name":"W","last_name":"Lynch","source_individual_id":"5016080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Joseph Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85342","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5461","size":1},{"color":"#FF4D4D","name":"Control of blood vessel development by SOX transcription factors","data":{"media_summary":"","end_year":2006,"keywords":["Developmental genes","Embryonic development","Knockout mice","Murine models","Transcription factors"],"nhmrc_grant_id":301018,"application_year":2003,"health_keywords":["Defects in embryonic development","Genetics","Peripheral vascular disease"],"scientific_title":"Control of blood vessel development by SOX transcription factors","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Peter Koopman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/301018","simplified_title":"Factors controlling blood vessel development","sub_type":"Standard Project Grant","total_budget":"495750","source_system":"Cardiovascular disease is Australia s greatest health problem, with an estimated 3 million Australians suffering a spectrum of conditions from hypertension through to heart failure. Improper development of blood vessels in the embryo can compromise survival of the embryo, and predispose patients to vascular disease after birth. The growth of new blood vessels (angiogenesis) is also an important factor in the ability of solid tumours to grow during the progression of cancer. It is therefore of fundamental importance in the health sciences to gain an understanding of how blood vessels form and regenerate. We discovered a gene, Sox18, that appears to regulate blood vessel development by controlling the formation and-or properties of endothelial cells, which line the blood vessels and make them impermeable. Our research so far indicates that MICE WITH DEFECTS IN SOX18 DIE FROM VASCULAR DEFECTS, underlining the importance of this gene. THIS PROJECT IS CONCERNED WITH FINDING OUT HOW SOX18 WORKS - exactly what goes wrong in mice lacking this gene, whether Sox18 can influence endothelial cell behaviour in cell culture, how Sox18 comes to be active in endothelial cells, what genes are switched on by Sox18, and what genes Sox18 co-operates with in its role in endothelial cells. The answers to these questions will not only provide fundamental basic information about how blood vessels development is controlled, but also sow the seeds for possible future therapies in which blood vessel development could be stimulated (eg in wound healing) or suppressed (eg in tumour progression) by drug treatments."},"children":[{"color":"#336699","name":"Prof Peter Koopman","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0043570","middle_name":"A","last_name":"Koopman","source_individual_id":"5015773","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Koopman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88298","size":1},{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5459","size":1},{"color":"#FF4D4D","name":"Mucosal bacterial pathogens in inflammatory bowel diseases","data":{"media_summary":"","end_year":2008,"keywords":["Bioinformatics","Enteric bacteria","Inflammatory bowel diseases","Molecular cloning"],"nhmrc_grant_id":301013,"application_year":2003,"start_year":2004,"scientific_title":"Mucosal bacterial pathogens in inflammatory bowel diseases","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Microbiology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Timothy Florin","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/301013","simplified_title":"Mucosal bacterial pathogens in inflammatory bowel diseases","sub_type":"Practitioner Fellowship","total_budget":"226500","source_system":""},"children":[{"color":"#336699","name":"Prof Timothy Florin","data":{"first_name":"Timothy","title":"Prof","dw_individual_id":"DW0013048","middle_name":"H","last_name":"Florin","source_individual_id":"5014662","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Timothy Florin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80228","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5458","size":1},{"color":"#FF4D4D","name":"Neuroanatomical dynamics of attention in stroke patients and healthy individuals: A magnetic stimulation investigation","data":{"media_summary":"","end_year":2008,"keywords":["Crossmodal Interactions","Parietal Lobe","Selective Attention","Transcranial Magnetic Stimulation","Unilateral Neglect"],"nhmrc_grant_id":299958,"application_year":2003,"health_keywords":["Extinction","Neurological Rehabilitation","Stroke"],"scientific_title":"Neuroanatomical dynamics of attention in stroke patients and healthy individuals: A magnetic stimulation investigation","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)","research_area":"Clinical Medicine and Science","for_category":"PSYCHOLOGY","cia_name":"Prof Jason Mattingley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/299958","simplified_title":"Brain processes underlying attention in stroke patients and in healthy individuals: A magnetic stimulation study","sub_type":"Standard Project Grant","total_budget":"360363","source_system":"Mechanisms of selective attention are of central importance in guiding human behaviour. The brain uses attention to enhance the processing of information that is behaviourally relevant, and to suppress irrelevant information. The operation of attention within sensory modalities (vision, touch, hearing) has been studied for many decades; however, little is known about how attention combines information between different senses. An understanding of 'crossmodal' attention is important for many reasons. First, real events in the environment provide inputs simultaneously from different locations to multiple senses, and these inputs must be integrated to yield coherent perception. Second, the most basic aspects of human perception depend upon attention; the brain implements selective mechanisms in order to filter the immense quantities of information that constantly bombard our sensory receptors. Finally, many neurological disorders are characterised by impairments of attention; these syndromes are debilitating for the patients themselves, and also place a heavy burden on caregivers and the healthcare system. This project will examine mechanisms of attention in healthy individuals and in stroke patients with attentional deficits. In all experiments, we will employ a new technique in neuroscience called 'transcranial magnetic stimulation' (TMS). TMS enables the safe and reversible stimulation of brain activity in humans. In the current project, we will use TMS with two broad objectives: (i) to determine the key brain areas involved in crossmodal attention in healthy individuals, and (ii) to treat attentional deficits that occur within and between the senses in stroke patients ('magnetic stimulation rehabilitation'). This research will provide important insights into the brain mechanisms that govern selective attention in the healthy brain, and will help guide future methods for managing and treating neurological disorders in which deficits of attention are prominent."},"children":[{"color":"#336699","name":"Prof Jason Mattingley","data":{"first_name":"Jason","title":"Prof","dw_individual_id":"DW0020682","middle_name":"Brett","last_name":"Mattingley","source_individual_id":"RMIS123930","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jason Mattingley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82287","size":1},{"color":"#336699","name":"Dr Chris Chambers","data":{"first_name":"Chris","title":"Dr","dw_individual_id":"DW0018156","middle_name":"","last_name":"Chambers","source_individual_id":"RMIS2459829","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Chris Chambers"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81645","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5358","size":1},{"color":"#FF4D4D","name":"Addressing Multiple Risk Factors in Primary Health and Community Care settings: A Cluster-Randomised Trial","data":{"media_summary":"Physical activity","end_year":2007,"keywords":["Lifestyle factors","Preventative Medicine","Primary health care","Public Health"],"nhmrc_grant_id":290519,"application_year":2003,"health_keywords":["Diabetes (type 2)","Diet","Hypertension","Osteoarthritis","Physical activity"],"scientific_title":"Addressing Multiple Risk Factors in Primary Health and Community Care settings: A Cluster-Randomised Trial","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Preventive Medicine","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Elizabeth Eakin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/290519","simplified_title":"Linking General Practice and Community Care to Promote Health Behaviour Change","sub_type":"Standard Project Grant","total_budget":"765984.36","source_system":"The proposed study will evaluate an intervention designed to assist patients with chronic medical conditions to make lifestyle changes that will benefit their health and reduce the complications associated with their conditions. The study targets patients in a disadvantaged Southeast Qld community and is led by researchers from QUT's Centre for Public Health Research in collaboration with local-, state-, and national-level health service organizations. The health behaviour intervention model emphasises the following: a) a partnership between general practice and community care resources, b) a more coherent (ie, less fragmented) and sustained inter-sectoral effort, c) an approach that is responsive to the needs of individual consumers, their families and the community."},"children":[{"color":"#336699","name":"Prof Christopher Del Mar","data":{"first_name":"Christopher","title":"Prof","dw_individual_id":"DW0041984","middle_name":"B","last_name":"Del Mar","source_individual_id":"RMIS2365573","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Christopher Del Mar"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87888","size":1},{"color":"#336699","name":"Prof Elizabeth Eakin","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0036429","middle_name":"G","last_name":"Eakin","source_individual_id":"5014455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Elizabeth Eakin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86445","size":1},{"color":"#336699","name":"Prof Nicholas Graves","data":{"first_name":"Nicholas","title":"Prof","dw_individual_id":"DW0025161","middle_name":"","last_name":"Graves","source_individual_id":"5012570","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nicholas Graves"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83472","size":1},{"color":"#336699","name":"Prof Brian Oldenburg","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0015341","middle_name":"Frederick","last_name":"Oldenburg","source_individual_id":"RMIS7111213","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Oldenburg"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80864","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5235","size":1},{"color":"#FF4D4D","name":"A tiered series of early interventions for young adults with emerging alcohol. tobacco and marijuana problems","data":{"media_summary":"","end_year":2008,"keywords":["Substance abuse"],"nhmrc_grant_id":277023,"application_year":2003,"start_year":2004,"scientific_title":"A tiered series of early interventions for young adults with emerging alcohol. tobacco and marijuana problems","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health, Clinical and Counselling Psychology","research_area":"Health Services Research","for_category":"PSYCHOLOGY","cia_name":"A/Pr Adrian Kelly","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/277023","simplified_title":"A tiered series of early interventions for young adults with emerging alcohol, tobacco and marijuana problems","sub_type":"Clinical CDF","total_budget":"445123.75","source_system":""},"children":[{"color":"#336699","name":"A/Pr Adrian Kelly","data":{"first_name":"Adrian","title":"A/Pr","dw_individual_id":"DW0037701","middle_name":"B","last_name":"Kelly","source_individual_id":"RMIS1090709","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Adrian Kelly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86764","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5026","size":1},{"color":"#FF4D4D","name":"Hormonal regulation of growth: clinical and molecular mechanisms","data":{"media_summary":"","end_year":2006,"keywords":["Growth hormone","Paediatrics","Signal transduction","Transcription","sex steroids"],"nhmrc_grant_id":276434,"application_year":2003,"start_year":2004,"scientific_title":"Hormonal regulation of growth: clinical and molecular mechanisms","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Gary Leong","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/276434","simplified_title":"Hormonal regulation of growth: clinical and molecular mechanisms","sub_type":"Health Professional Research ECF","total_budget":"111270","source_system":""},"children":[{"color":"#336699","name":"Dr Gary Leong","data":{"first_name":"Gary","title":"Dr","dw_individual_id":"DW0020356","middle_name":"Martin","last_name":"Leong","source_individual_id":"RMIS1096296","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Gary Leong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82200","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5015","size":1},{"color":"#FF4D4D","name":"Anabolic Bone Gene Pathways","data":{"media_summary":"","end_year":2006,"keywords":["bone anabolic pathway","osteoblast","transgenic animals","vitamin D"],"nhmrc_grant_id":276415,"application_year":2003,"health_keywords":["age-related skeletal disorders","bone formation","fragility fracture","osteoporosis"],"scientific_title":"Anabolic Bone Gene Pathways","start_year":2004,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Edith Gardiner","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/276415","simplified_title":"Anabolic Bone Gene Pathways","sub_type":"Standard Project Grant","total_budget":"496500","source_system":"Osteoporosis is a major health burden resulting from bone fractures in older men and women due to progressive loss of bone and weakening of the skeleton. Although there are currently therapies to reduce bone loss, no current treatment effectively reconstructs lost bone. In this project, which is designed to identify new genes that may in the future be targeted by drugs to reverse osteoporosis, we have identified specific sets of genes that appear to work together to increase bone formation. This proposal is aimed at characterising these genes and the ways in which they work to determine whether they may be good targets for new osteoporosis treatments. We will examine the patterns of these genes in bone. We will also use cell cultures in which bone forming cells develop and function, to determine when the genes are expressed and how they function. We will test the ability of the candidate genes to cause an increase in the amount of bone forming activity in these cell cultures. An increase in bone formation may be caused by an increase in the number bone-forming cells, an increase in the activity of the cells, a decrease in cell death, or a combination of these changes. Each possibility will be tested. This research is important because of the need for new osteoporosis therapies to repair weakened bones. The knowledge resulting from this proposal has the potential to provide an important contribution to skeletal health and thus aged health worldwide."},"children":[{"color":"#336699","name":"Prof John Eisman","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0042239","middle_name":"Allan","last_name":"Eisman","source_individual_id":"5011503","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Eisman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87956","size":1},{"color":"#336699","name":"A/Pr Edith Gardiner","data":{"first_name":"Edith","title":"A/Pr","dw_individual_id":"DW0013168","middle_name":"M","last_name":"Gardiner","source_individual_id":"RMIS218068","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Edith Gardiner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80255","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/5009","size":1},{"color":"#FF4D4D","name":"Discovery and characterisation of inhibitors for human hematopoietic prostaglandin D2 synthase","data":{"media_summary":"","end_year":2006,"keywords":["Inhibitor screening","docking","ligand discovery","prostaglandin","protein"],"nhmrc_grant_id":268076,"application_year":2003,"start_year":2004,"scientific_title":"Discovery and characterisation of inhibitors for human hematopoietic prostaglandin D2 synthase","node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Jack Flanagan","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/268076","simplified_title":"Discovery and characterisation of inhibitors for human hematopoietic prostaglandin D2 synthase","sub_type":"Howard Florey Centenary ECF","total_budget":"171000","source_system":""},"children":[{"color":"#336699","name":"Dr Jack Flanagan","data":{"first_name":"Jack","title":"Dr","dw_individual_id":"DW0030695","middle_name":"Urquhart","last_name":"Flanagan","source_individual_id":"RMIS4453914","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Jack Flanagan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84971","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4946","size":1},{"color":"#FF4D4D","name":"Equipment Grant","data":{"media_summary":"","end_year":2004,"keywords":["Equipment Grant"],"nhmrc_grant_id":264651,"application_year":2003,"start_year":2004,"scientific_title":"Equipment Grant","node_source":"NHMRC","node_type":"Grant","field_of_research":"n-a","research_area":"Not Applicable","for_category":"N-A","cia_name":"Mrs Deb Ford","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/264651","simplified_title":"Equipment Grant","sub_type":"Equipment Grant","total_budget":"704074","source_system":""},"children":[{"color":"#336699","name":"Mrs Deb Ford","data":{"first_name":"Deb","title":"Mrs","dw_individual_id":"DW0042438","middle_name":"","last_name":"Ford","source_individual_id":"RMIS2960571","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mrs Deb Ford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88007","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4883","size":1},{"color":"#FF4D4D","name":"Equipment Grant","data":{"media_summary":"","end_year":2004,"keywords":["Equipment Grant"],"nhmrc_grant_id":264516,"application_year":2003,"start_year":2004,"scientific_title":"Equipment Grant","node_source":"NHMRC","node_type":"Grant","field_of_research":"n-a","research_area":"Not Applicable","for_category":"N-A","cia_name":"Ms Donna Hannan","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/264516","simplified_title":"Equipment Grant","sub_type":"Equipment Grant","total_budget":"630071","source_system":""},"children":[{"color":"#336699","name":"Ms Donna Hannan","data":{"first_name":"Donna","title":"Ms","dw_individual_id":"DW0013489","middle_name":"T","last_name":"Hannan","source_individual_id":"RMIS3586","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Donna Hannan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80343","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4820","size":1},{"color":"#FF4D4D","name":"A collaborative research-based program of education, intervention and scientific discovery in Type 2 Diabetes","data":{"media_summary":"","end_year":2008,"keywords":["Cardiovascular disease","Health education","Health promotion","Obesity","Type 2 diabetes"],"nhmrc_grant_id":264418,"application_year":2003,"start_year":2004,"scientific_title":"A collaborative research-based program of education, intervention and scientific discovery in Type 2 Diabetes","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof John Prins","higher_grant_type":"NHMRC Partnerships","purl":"http://purl.org/au-research/grants/nhmrc/264418","simplified_title":"The Diabetes Health Research Program","sub_type":"Health Research Partnership in Type 2 Diabetes","total_budget":"750000","source_system":""},"children":[{"color":"#336699","name":"Prof Johannes Prins","data":{"first_name":"Johannes","title":"Prof","dw_individual_id":"DW0039181","middle_name":"Bernhard","last_name":"Prins","source_individual_id":"RMIS7041737","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Johannes Prins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87157","size":1},{"color":"#336699","name":"Prof Thomas Marwick","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0032377","middle_name":"Hugh","last_name":"Marwick","source_individual_id":"RMIS108223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Marwick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85383","size":1},{"color":"#336699","name":"Dr David James","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0019873","middle_name":"","last_name":"James","source_individual_id":"RMIS2467850","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr David James"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82058","size":1},{"color":"#336699","name":"Prof Andrew Hills","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0013659","middle_name":"P","last_name":"Hills","source_individual_id":"RMIS504615","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Andrew Hills"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80386","size":1},{"color":"#336699","name":"Prof Jennifer Batch","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0005996","middle_name":"Anne","last_name":"Batch","source_individual_id":"RMIS41785","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Batch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78337","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4816","size":1},{"color":"#FF4D4D","name":"Burden of disease&cost effectiveness of intervention options:informing policy choices & health system reform in Thailand","data":{"media_summary":"","end_year":2009,"keywords":["Cause of death","Cost effectivness","Health outcomes","Health risk behaviours","Health sevice decision making"],"nhmrc_grant_id":301199,"application_year":2002,"start_year":2004,"scientific_title":"Burden of disease&cost effectiveness of intervention options:informing policy choices & health system reform in Thailand","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Alan Lopez","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/301199","simplified_title":"Burden of disease&cost effectiveness of intervention options:informing policy choices & health system reform in Thailand","sub_type":"International Collaborative Research Grant","total_budget":"787978","source_system":"This research project aims to improve the scientific basis for health services provision in Thailand by filling important gaps in knowledge about the causes of disease and the possibility of effectively intervening to reduce them. Since the accuracy of the routine death registration system in Thailand is unknown, it cannot be confidently used to guide policy. The team will evaluate how accurately causes of death are being recorded, both in urban and rural areas. It will also calculate how much disease and injury in Thailand is being caused by major risk factors, such as tobacco and unsafe sex. Using this information the team will evaluate the effectiveness of the major interventions to reduces diseases and injuries from risk factors that are affordable and applicable in the Thai context."},"children":[{"color":"#336699","name":"Prof Yawarat Porapakkham","data":{"first_name":"Yawarat","title":"Prof","dw_individual_id":"DW0027391","middle_name":"","last_name":"Porapakkham","source_individual_id":"RMIS2526775","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Yawarat Porapakkham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84073","size":1},{"color":"#336699","name":"Prof Wiput Phoolcharoen","data":{"first_name":"Wiput","title":"Prof","dw_individual_id":"DW0027347","middle_name":"","last_name":"Phoolcharoen","source_individual_id":"RMIS2521208","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wiput Phoolcharoen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84065","size":1},{"color":"#336699","name":"Prof Alan Lopez","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0026372","middle_name":"Donald","last_name":"Lopez","source_individual_id":"5012116","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alan Lopez"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83819","size":1},{"color":"#336699","name":"Prof Eric Vos","data":{"first_name":"Eric","title":"Prof","dw_individual_id":"DW0022749","middle_name":"Theo","last_name":"Vos","source_individual_id":"5012185","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Eric Vos"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82861","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4806","size":1},{"color":"#FF4D4D","name":"Study of HPV 6 L1 virus like paticles as Therapeutic vaccine for genital warts and recurrent respiratory papillomatosis.","data":{"media_summary":"","end_year":2008,"keywords":["AES","Check Inclusion/ exclusion criteria","DTH test","Physical Examination","study material"],"nhmrc_grant_id":264429,"application_year":2002,"start_year":2004,"scientific_title":"Study of HPV 6 L1 virus like paticles as Therapeutic vaccine for genital warts and recurrent respiratory papillomatosis.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ian Frazer","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/264429","simplified_title":"Study of HPV 6 L1 virus like paticles as Therapeutic vaccine for genital warts and recurrent respiratory papillomatosis.","sub_type":"International Collaborative Research Grant","total_budget":"615608","source_system":"This project will examine the effectiveness of a vaccine designed to prevent tumours and cancers associated with papillomarvirus infection as treatment for existing infections, and will look for predictors of a favourable outcome from treatment."},"children":[{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1},{"color":"#336699","name":"Dr Jieqiang Lu","data":{"first_name":"Jieqiang","title":"Dr","dw_individual_id":"DW0014555","middle_name":"","last_name":"Lu","source_individual_id":"RMIS2514596","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Jieqiang Lu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80636","size":1},{"color":"#336699","name":"Prof Bobei Chen","data":{"first_name":"Bobei","title":"Prof","dw_individual_id":"DW0006529","middle_name":"","last_name":"Chen","source_individual_id":"RMIS2514599","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Bobei Chen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78471","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4795","size":1},{"color":"#FF4D4D","name":"Protein targeting and signal transition","data":{"media_summary":"","end_year":2004,"keywords":["proteins"],"nhmrc_grant_id":264422,"application_year":2002,"start_year":2003,"scientific_title":"Protein targeting and signal transition","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Not Applicable","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Helen Cooper","higher_grant_type":"NHMRC Block Funding","purl":"http://purl.org/au-research/grants/nhmrc/264422","simplified_title":"Protein targeting and signal transition","sub_type":"Transfer from BFI Grant","total_budget":"168164.38","source_system":""},"children":[{"color":"#336699","name":"A/Pr Helen Cooper","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0018393","middle_name":"M","last_name":"Cooper","source_individual_id":"RMIS222363","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Helen Cooper"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81710","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4794","size":1},{"color":"#FF4D4D","name":"Central Nervous System and neurogenetics","data":{"media_summary":"","end_year":2004,"keywords":["central nervous system","neurogenetics"],"nhmrc_grant_id":264421,"application_year":2002,"start_year":2003,"scientific_title":"Central Nervous System and neurogenetics","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Not Applicable","for_category":"CLINICAL SCIENCES","cia_name":"Prof Perry Bartlett","higher_grant_type":"NHMRC Block Funding","purl":"http://purl.org/au-research/grants/nhmrc/264421","simplified_title":"Central Nervous System and neurogenetics","sub_type":"Transfer from BFI Grant","total_budget":"227835.61","source_system":""},"children":[{"color":"#336699","name":"Prof Perry Bartlett","data":{"first_name":"Perry","title":"Prof","dw_individual_id":"DW0011651","middle_name":"Francis","last_name":"Bartlett","source_individual_id":"5013357","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Perry Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79864","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4793","size":1},{"color":"#FF4D4D","name":"enhance understanding of the immunological mechanisms involved in asthma and will examine new approaches to preventing","data":{"media_summary":"","end_year":2007,"keywords":["Asthma","airway epithelium","airway inflammation","allergy","dendritic cells"],"nhmrc_grant_id":254524,"application_year":2002,"start_year":2003,"scientific_title":"enhance understanding of the immunological mechanisms involved in asthma and will examine new approaches to preventing","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof John Upham","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/254524","simplified_title":"enhance understanding of the immunological mechanisms involved in asthma and will examine new approaches to preventing","sub_type":"Practitioner Fellowship","total_budget":"408712.5","source_system":""},"children":[{"color":"#336699","name":"Prof John Upham","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0045963","middle_name":"W","last_name":"Upham","source_individual_id":"5018030","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Upham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88900","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4647","size":1},{"color":"#FF4D4D","name":"Building capacity for physical activity research in population health","data":{"media_summary":"","end_year":2009,"keywords":["behavioural theories, models and determinants","environmental and policy initiatves","interventions to influence activity","measurement and descriptive epidemiology","physical activity and population health outcomes"],"nhmrc_grant_id":252977,"application_year":2002,"start_year":2003,"scientific_title":"Building capacity for physical activity research in population health","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Promotion","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Neville Owen","higher_grant_type":"Capacity","purl":"http://purl.org/au-research/grants/nhmrc/252977","simplified_title":"Improving Australian research on exercise","sub_type":"Population Health Capacity Building Grant","total_budget":"2118560","source_system":"The program will focus on the 'diseases of inactivity' and will look at factors like obtaining accurate statistics on rates of inactivity and better statistics on which social groups are least active. It will look at:  the types of activity that are best for different people;  what the best types of exercise programs are;  the types of information campaigns that will be most effective; and  how community amenities and local environments might be used to help people to be active in ways that are more convenient and enjoyable."},"children":[{"color":"#336699","name":"Prof Adrian Bauman","data":{"first_name":"Adrian","title":"Prof","dw_individual_id":"DW0035294","middle_name":"E","last_name":"Bauman","source_individual_id":"5012367","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Adrian Bauman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86147","size":1},{"color":"#336699","name":"Prof Stewart Trost","data":{"first_name":"Stewart","title":"Prof","dw_individual_id":"DW0028465","middle_name":"Graeme","last_name":"Trost","source_individual_id":"5050183","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stewart Trost"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84362","size":1},{"color":"#336699","name":"Prof Wendy Brown","data":{"first_name":"Wendy","title":"Prof","dw_individual_id":"DW0023824","middle_name":"J","last_name":"Brown","source_individual_id":"RMIS1714084","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wendy Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83116","size":1},{"color":"#336699","name":"Prof Neville Owen","data":{"first_name":"Neville","title":"Prof","dw_individual_id":"DW0003812","middle_name":"Gordon","last_name":"Owen","source_individual_id":"5016815","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Neville Owen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77725","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4586","size":1},{"color":"#FF4D4D","name":"Novel genes and protein in non-alcoholic fatty liver disease: potential basis of a serum-based assessment of disease sta","data":{"media_summary":"","end_year":2004,"keywords":["diagnostic assay","fatty acids","fibrosis","health status","liver"],"nhmrc_grant_id":252974,"application_year":2002,"start_year":2003,"scientific_title":"Novel genes and protein in non-alcoholic fatty liver disease: potential basis of a serum-based assessment of disease sta","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Clinical Medicine and Science","for_category":"","cia_name":"A/Pr Peter Wilce","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/252974","simplified_title":"Development of serum-based methods for the assessment of non-alcoholic fatty liver disease","sub_type":"Development Grant","total_budget":"200000","source_system":"The most common cause of elevated liver function tests is non-alcoholic fatty liver disease (NAFLD). NALFD is a spectrum of disease ranging from steatosis, to non-alcoholic steatohepatitis (NASH), a condition associated with the development of fibrosis in the majority of individuals. Approximately 20% and 3% of adults are affected with NAFLD and NASH, respectively, and NAFLD is expected to become the next major liver epidemic facing the western world, far exceeding the prevalence of chronic infection with the hepatitis C virus. We obtained liver biopsies from patients with NAFLD, 80% of whom had NASH, and determined the expression profile analysis of each subject using 19,200 element microarrays. Our data demonstrates the concordant differential expression of 130 genes, in subjects with NAFLD that were categorizes into 6 major metabolic and regulatory pathways. Many of these genes represented uncharacterised genes. Utilising an extensive bioinformatics approach we have been able to define the genes and their protein product. The use of these proteins as a diagnostic tool for the detection of NAFLD forms the basis of a provisional patent application. However, measurements of protein levels in tissue and sera from patients with NAFLD are needed for the development of a diagnostic method. Such information would also provide significant insight into the pathogenesis of NAFLD. The AIMS are: 1) Production of antibodies against proteins encoded by candidate genes  Expression profile of candidate genes 3) Expression of proteins encoded by candidate genes in patients with NAFLD"},"children":[{"color":"#336699","name":"Prof Elizabeth Powell","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0044903","middle_name":"Ellen","last_name":"Powell","source_individual_id":"RMIS13575","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Powell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88622","size":1},{"color":"#336699","name":"Peter Wilce","data":{"first_name":"Peter","title":"","dw_individual_id":"DW0011061","middle_name":"","last_name":"Wilce","source_individual_id":"RMIS34632","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Peter Wilce"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79708","size":1},{"color":"#336699","name":"Paul Kroon","data":{"first_name":"Paul","title":"","dw_individual_id":"DW0008467","middle_name":"","last_name":"Kroon","source_individual_id":"RMIS39791","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Paul Kroon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78988","size":1},{"color":"#336699","name":"A/Pr Julie Jonsson","data":{"first_name":"Julie","title":"A/Pr","dw_individual_id":"DW0002506","middle_name":"R","last_name":"Jonsson","source_individual_id":"5015557","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Julie Jonsson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77348","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4585","size":1},{"color":"#FF4D4D","name":"Inhibitors of bacterial protein synthesis - a new class of antibiotics","data":{"media_summary":"","end_year":2004,"keywords":["DNA replication","antibiotics","protein-protein interactions","rational drug design"],"nhmrc_grant_id":252972,"application_year":2002,"start_year":2003,"scientific_title":"Inhibitors of bacterial protein synthesis - a new class of antibiotics","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biotechnology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"BIOTECHNOLOGY","cia_name":"Prof Paul Alewood","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/252972","simplified_title":"Development of a new drugs for bacterial infections","sub_type":"Development Grant","total_budget":"120000","source_system":"Pioneering work by CSIRO scientists has identified specific peptide motifs in the DNA replication machinery of bacteria that are critical for the correct functioning of the organism. In collaboration with CI Alewood potent (Kd ~ nM) lead compounds that inhibit bacterial DNA replication have been designed and synthesised. Through the application of a number of novel bioinformatics approaches to the analysis of the complete genome sequences of bacteria, the key sites of interaction of a number of protein families (DNA synthesis and repair enzymes) with the beta subunit of bacterial DNA Polymerase III have been identified. The nature of the sites, and preliminary experimental data, suggests that the approach will be generally applicable to all species of bacteria. In addition a wide range of novel assays for the identification of inhibitors of the interaction of proteins with the beta subunit have been developed. In this proposal we wish to demonstrate that our in vitro nanomolar inhibitors of the beta subunit can inhibit bacterial cell growth. The development program proposes to develop methods and strategies to gain bacterial cell entry of inhibitors of the interaction of proteins with the beta subunit of bacterial DNA Polymerase III. Proof of concept will be demonstrated by inhibition of bacterial cell growth. Stable compounds with good binding characteristics and able to be taken up by cells will be developed based on structure-function assay results, structural studies and modelling of inhibitors bound to the target. Antimicrobial activity of compounds will be demonstrated in standard FDA approved NCLLS (National Centre of Clinical Laboratory Standards USA) tests. Spectrum of activity will be demonstrated by testing compounds against bacterial species representative of the range of pathogenic organisms in standard FDA assays."},"children":[{"color":"#336699","name":"Prof Paul Alewood","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0035049","middle_name":"F","last_name":"Alewood","source_individual_id":"5013158","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Alewood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86082","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4584","size":1},{"color":"#FF4D4D","name":"Developing Anti-Inflammatory Drugs Based On Inhibition Of A Human Enzyme","data":{"media_summary":"","end_year":2004,"keywords":["anti-inflammatory","drug development","phospholipase A2"],"nhmrc_grant_id":252968,"application_year":2002,"start_year":2003,"scientific_title":"Developing Anti-Inflammatory Drugs Based On Inhibition Of A Human Enzyme","node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Stephen Taylor","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/252968","simplified_title":"Towards a clinical trial of anti-inflammatory drugs discovered by blocking enzymes","sub_type":"Development Grant","total_budget":"160000","source_system":"Human secretory phospholipases A2 have been associated with inflammatory diseases for many years, yet very few truly potent inhibitors of the human enzymes sPLA2 (isoforms IIa, V or X) are known due to a range of problems relating to the lipid nature of substrates, unavailability of enzymes, enzyme assays that do not correlate with in vivo data. Although there remains controversy about which enzyme is responsible in vivo for degrading membrane phospholipids to inflammatory mediators like arachidonate, PAF, prostaglandins, leukotrienes, etc. there is a consensus that blockade of phospholipid metabolism would represent a major advance on NSAIDs as antiinflammatory agents. No sPLA2-IIa inhibitor is available yet in man. We aim to create an attractive data package showing proof of concept for a potent new type of antiinflammatory drug. This data will give us an improved negotiating position in our commercialisation of a new drug with potential multi-billion dollar markets as diverse as arthritis, asthma, reperfusion injury, organ transplantation and many other currently intractable human ailments"},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"Prof Stephen Taylor","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0010587","middle_name":"M","last_name":"Taylor","source_individual_id":"RMIS41211","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79577","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4583","size":1},{"color":"#FF4D4D","name":"The role of innate immune response in the genetic susceptibility to inflammatory bowel disease.","data":{"media_summary":"","end_year":2008,"keywords":["Biochemistry and Cell Biology","Cell development incl cell division & apoptosis","Genetics"],"nhmrc_grant_id":252961,"application_year":2002,"start_year":2003,"scientific_title":"The role of innate immune response in the genetic susceptibility to inflammatory bowel disease.","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Health Services Research","for_category":"","cia_name":"Dr Georgia Hume","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/252961","simplified_title":"The role of innate immune response in the genetic susceptibility to inflammatory bowel disease.","sub_type":"Medical Postgraduate Scholarship","total_budget":"96459.98","source_system":""},"children":[{"color":"#336699","name":"Georgia Hume","data":{"first_name":"Georgia","title":"","dw_individual_id":"DW0008034","middle_name":"","last_name":"Hume","source_individual_id":"RMIS1980906","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Georgia Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78873","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4582","size":1},{"color":"#FF4D4D","name":"The functional role of phosphoprotein p120 catenin (p120ctn) in E-cadherin adhesive activity","data":{"media_summary":"","end_year":2004,"keywords":["Cell-cell adhesion","E-cadherin","RhoGTPases","p120ctn"],"nhmrc_grant_id":252956,"application_year":2002,"start_year":2003,"scientific_title":"The functional role of phosphoprotein p120 catenin (p120ctn) in E-cadherin adhesive activity","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Miss Marita Goodwin","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/252956","simplified_title":"The functional role of phosphoprotein p120 catenin (p120ctn) in E-cadherin adhesive activity","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"29816.82","source_system":""},"children":[{"color":"#336699","name":"Marita Goodwin","data":{"first_name":"Marita","title":"","dw_individual_id":"DW0036906","middle_name":"","last_name":"Goodwin","source_individual_id":"RMIS1983726","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Marita Goodwin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86555","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4581","size":1},{"color":"#FF4D4D","name":"Cellular plasticity and artificial blood vessels","data":{"media_summary":"","end_year":2005,"keywords":["Artificial artery","Peritoneal cavity","myofibroblast","plasticity"],"nhmrc_grant_id":252954,"application_year":2002,"start_year":2003,"scientific_title":"Cellular plasticity and artificial blood vessels","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biotechnology not elsewhere classified","research_area":"Basic Science","for_category":"BIOTECHNOLOGY","cia_name":"Mr Christopher Daly","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/252954","simplified_title":"Cellular plasticity and artificial blood vessels","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"61287.18","source_system":""},"children":[{"color":"#336699","name":"Mr Christopher Daly","data":{"first_name":"Christopher","title":"Mr","dw_individual_id":"DW0036143","middle_name":"Denis","last_name":"Daly","source_individual_id":"RMIS1983674","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mr Christopher Daly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86369","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4580","size":1},{"color":"#FF4D4D","name":"Are Cardiac conditions in older women managed appropriately?","data":{"media_summary":"","end_year":2006,"keywords":["Cardiovascular disease","Older People","evidence-based clinical practice","longitudinal study","womens health"],"nhmrc_grant_id":252952,"application_year":2002,"start_year":2003,"scientific_title":"Are Cardiac conditions in older women managed appropriately?","node_source":"NHMRC","node_type":"Grant","field_of_research":"Preventive Medicine","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Ms Lindy Humphreyes-Reid","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/252952","simplified_title":"Are Cardiac conditions in older women managed appropriately?","sub_type":"Public Health Postgraduate Scholarship","total_budget":"90890.36","source_system":""},"children":[{"color":"#336699","name":"Lindy Humphreyes-Reid","data":{"first_name":"Lindy","title":"","dw_individual_id":"DW0031446","middle_name":"","last_name":"Humphreyes-Reid","source_individual_id":"RMIS1983734","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Lindy Humphreyes-Reid"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85140","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4579","size":1},{"color":"#FF4D4D","name":"The role of childrens development characteristicsin the causation of injury","data":{"media_summary":"","end_year":2005,"keywords":["Child Behaviour","Injury Prevention"],"nhmrc_grant_id":252948,"application_year":2002,"start_year":2003,"scientific_title":"The role of childrens development characteristicsin the causation of injury","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Anneliese Spinks","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/252948","simplified_title":"The role of childrens development characteristicsin the causation of injury","sub_type":"Public Health Postgraduate Scholarship","total_budget":"60980","source_system":""},"children":[{"color":"#336699","name":"Dr Anneliese Spinks","data":{"first_name":"Anneliese","title":"Dr","dw_individual_id":"DW0022271","middle_name":"B","last_name":"Spinks","source_individual_id":"RMIS1983711","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Anneliese Spinks"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82746","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4578","size":1},{"color":"#FF4D4D","name":"Reducing cigarette smoking among young women","data":{"media_summary":"","end_year":2006,"keywords":["Behavioural Science","Intervention research","Tobacco Control","Womens Health"],"nhmrc_grant_id":252946,"application_year":2002,"start_year":2003,"scientific_title":"Reducing cigarette smoking among young women","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Promotion","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Ms Liane McDermott","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/252946","simplified_title":"Reducing cigarette smoking among young women","sub_type":"Public Health Postgraduate Scholarship","total_budget":"61553.42","source_system":""},"children":[{"color":"#336699","name":"Liane Mcdermott","data":{"first_name":"Liane","title":"","dw_individual_id":"DW0032450","middle_name":"","last_name":"Mcdermott","source_individual_id":"RMIS1983701","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Liane Mcdermott"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85400","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4577","size":1},{"color":"#FF4D4D","name":"Molecular genetic studies in familial and sporadic hyperthyroidism.","data":{"media_summary":"","end_year":2006,"keywords":["Familial","Genetics","Hyperparathyroidism","Primary","Sporadic"],"nhmrc_grant_id":252942,"application_year":2002,"start_year":2003,"scientific_title":"Molecular genetic studies in familial and sporadic hyperthyroidism.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Janet Warner","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/252942","simplified_title":"Molecular genetic studies in familial and sporadic hyperthyroidism.","sub_type":"Medical Postgraduate Scholarship","total_budget":"88314.52","source_system":""},"children":[{"color":"#336699","name":"Janet Warner","data":{"first_name":"Janet","title":"","dw_individual_id":"DW0010949","middle_name":"","last_name":"Warner","source_individual_id":"RMIS1983462","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Janet Warner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79687","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4576","size":1},{"color":"#FF4D4D","name":"Ataxia-Telangiectasia Mutated (ATM) Antisense cDNA Radiosensitisation of Gliomas using new lentiviral vectors.","data":{"media_summary":"","end_year":2008,"keywords":["Ataxia-Telangiectasia Mutated (ATM)","Glioma","Lentivirus","Radiosensitisation"],"nhmrc_grant_id":252941,"application_year":2002,"start_year":2003,"scientific_title":"Ataxia-Telangiectasia Mutated (ATM) Antisense cDNA Radiosensitisation of Gliomas using new lentiviral vectors.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Therapy","research_area":"Basic Science","for_category":"BIOTECHNOLOGY","cia_name":"Dr Teong Chuah","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/252941","simplified_title":"Ataxia-Telangiectasia Mutated (ATM) Antisense cDNA Radiosensitisation of Gliomas using new lentiviral vectors.","sub_type":"Medical Postgraduate Scholarship","total_budget":"44329.48","source_system":""},"children":[{"color":"#336699","name":"Dr Teong Chuah","data":{"first_name":"Teong","title":"Dr","dw_individual_id":"DW0029949","middle_name":"L","last_name":"Chuah","source_individual_id":"RMIS681560","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Teong Chuah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84756","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4575","size":1},{"color":"#FF4D4D","name":"Effects of nuclear receptor ligands on insulin resistance in human adipose tissue.","data":{"media_summary":"","end_year":2004,"keywords":["Human adipose tissue","Insulin resistance","Nuclear receptor"],"nhmrc_grant_id":252940,"application_year":2002,"start_year":2003,"scientific_title":"Effects of nuclear receptor ligands on insulin resistance in human adipose tissue.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Su Mien Yeoh","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/252940","simplified_title":"Effects of nuclear receptor ligands on insulin resistance in human adipose tissue.","sub_type":"Medical Postgraduate Scholarship","total_budget":"57921","source_system":""},"children":[{"color":"#336699","name":"Su Mien Yeoh","data":{"first_name":"Su Mien","title":"","dw_individual_id":"DW0034897","middle_name":"","last_name":"Yeoh","source_individual_id":"RMIS1433528","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Su Mien Yeoh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86045","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4574","size":1},{"color":"#FF4D4D","name":"Assessment of bilateral oedema by bioelectrical impedance analysis","data":{"media_summary":"","end_year":2006,"keywords":["assessment of tissue oedema","bioelectrical impedance analysis","chronic vascular disease","lymphoedema","quantification of tissue fluid"],"nhmrc_grant_id":252936,"application_year":2002,"start_year":2003,"scientific_title":"Assessment of bilateral oedema by bioelectrical impedance analysis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Instruments and Techniques","research_area":"Clinical Medicine and Science","for_category":"OTHER PHYSICAL SCIENCES","cia_name":"A/Pr Leigh Ward","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/252936","simplified_title":"Development and verification of a method for quantifying bilateral oedema","sub_type":"Development Grant","total_budget":"180000","source_system":"Swelling of tissue due to fluid accumulation, known as oedema, is one of the earliest signs of diseases such as kidney failure, burn injury or lymphedema. All of these are not uncommon conditions. Lymphedema, for example, is a common sequela of radiotherapy or surgery in the treatment of malignancies such as breast, uterine, and prostatic carcinoma. It is reported to occur in up to 40% of patients depending on the type of surgery and whether or not the patient received radiotherapy. It is estimated that at any time 100000 women are suffering from post- mastectomy lymphedema in Australia alone. Treatment of breast cancer alone therefore, given the incidence of the disease, produces a large at-risk population. Add to this other causes of oedema and the magnitude of the problem becomes clearly apparent. The presence of chronic oedema is often a disfiguring and disabling disorder, usually accompanied by pain, recurrent infection, reduced mobility and impaired function. In acute oedema the problem often resolves with recovery from the underlying pathology. In chronic oedema, progression may be arrested by early intervention including complex physical therapy (exercise regimen, compression bandaging, and massage) which is effective in reducing limb volume, in improving the quality of life, function and body image of patients. Although the assessment of oedema is clearly of clinical importance, relatively few objective and accurate techniques for its measurement exist. Research conducted over the past decade by the applicants has pioneered the Use of Bioelectrical Impedance Analysis for the assessment of lymphedema. This study aims to translate this basic research into clinical practice. Sensitivity and specificity studies will establish normative and threshold values for impedance measurements that can be used as presumptive indicators of oedema. User friendly technology and equipment suitable for clinical use will be developed which should improve treatment therapies."},"children":[{"color":"#336699","name":"Brian Thomas","data":{"first_name":"Brian","title":"","dw_individual_id":"DW0045811","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS1745699","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Brian Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88847","size":1},{"color":"#336699","name":"A/Pr Leigh Ward","data":{"first_name":"Leigh","title":"A/Pr","dw_individual_id":"DW0034575","middle_name":"C","last_name":"Ward","source_individual_id":"RMIS410070","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Leigh Ward"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85959","size":1},{"color":"#336699","name":"A/Pr Bruce Cornish","data":{"first_name":"Bruce","title":"A/Pr","dw_individual_id":"DW0030109","middle_name":"H","last_name":"Cornish","source_individual_id":"RMIS454240","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Bruce Cornish"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84799","size":1},{"color":"#336699","name":"Mrs Hildegard Reul-Hirche","data":{"first_name":"Hildegard","title":"Mrs","dw_individual_id":"DW0015835","middle_name":"","last_name":"Reul-Hirche","source_individual_id":"RMIS1745696","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mrs Hildegard Reul-Hirche"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80990","size":1},{"color":"#336699","name":"Dr Ian Bunce","data":{"first_name":"Ian","title":"Dr","dw_individual_id":"DW0000630","middle_name":"H","last_name":"Bunce","source_individual_id":"RMIS1745693","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Ian Bunce"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76831","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4573","size":1},{"color":"#FF4D4D","name":"The involvement of syndecan 4 and fibroblast growth factor 2 in the anabolic actions of parathyroid hormone","data":{"media_summary":"","end_year":2007,"keywords":["HSPG","bone formation","fibro blast growth factor","parathryoid hormone","syndecan-4"],"nhmrc_grant_id":252934,"application_year":2002,"start_year":2003,"scientific_title":"The involvement of syndecan 4 and fibroblast growth factor 2 in the anabolic actions of parathyroid hormone","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Dr Liza Raggatt","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252934","simplified_title":"The involvement of syndecan 4 and fibroblast growth factor 2 in the anabolic actions of parathyroid hormone","sub_type":"Peter Doherty Biomedical ECF","total_budget":"267518.71","source_system":""},"children":[{"color":"#336699","name":"Dr Liza Raggatt","data":{"first_name":"Liza","title":"Dr","dw_individual_id":"DW0015741","middle_name":"J","last_name":"Raggatt","source_individual_id":"RMIS4437738","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Liza Raggatt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80966","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4572","size":1},{"color":"#FF4D4D","name":"Structue and function of the Prion Protein -Function and Misfunction","data":{"media_summary":"","end_year":2006,"keywords":["Copper","NMR","Prion","Protein folding","Protein structure"],"nhmrc_grant_id":252927,"application_year":2002,"start_year":2003,"scientific_title":"Structue and function of the Prion Protein -Function and Misfunction","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Christopher Jones","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252927","simplified_title":"Structue and function of the Prion Protein -Function and Misfunction","sub_type":"CJ Martin Biomedical ECF","total_budget":"359497.56","source_system":""},"children":[{"color":"#336699","name":"Dr Christopher Jones","data":{"first_name":"Christopher","title":"Dr","dw_individual_id":"DW0025817","middle_name":"E","last_name":"Jones","source_individual_id":"RMIS705920","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Christopher Jones"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83651","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4570","size":1},{"color":"#FF4D4D","name":"Gene therapy for all aspects of vein-graft disease","data":{"media_summary":"","end_year":2008,"keywords":["Atherosclerosis","By-pass graft","Gene transfer","Restenosis","Vascular biology"],"nhmrc_grant_id":252926,"application_year":2002,"start_year":2003,"scientific_title":"Gene therapy for all aspects of vein-graft disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Anita Thomas","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252926","simplified_title":"Gene therapy for all aspects of vein-graft disease","sub_type":"CJ Martin Biomedical ECF","total_budget":"335624.58","source_system":""},"children":[{"color":"#336699","name":"Dr Anita Thomas","data":{"first_name":"Anita","title":"Dr","dw_individual_id":"DW0034250","middle_name":"C","last_name":"Thomas","source_individual_id":"RMIS1952190","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Anita Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85865","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4569","size":1},{"color":"#FF4D4D","name":"Induction of Smooth Muscle Differentiation in Bone Marrow Stromal Stem Cells","data":{"media_summary":"","end_year":2007,"keywords":["differentiation","gene expression","smooth muscle cells","stem cells"],"nhmrc_grant_id":252925,"application_year":2002,"start_year":2003,"scientific_title":"Induction of Smooth Muscle Differentiation in Bone Marrow Stromal Stem Cells","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Nathalie Worth","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252925","simplified_title":"Induction of Smooth Muscle Differentiation in Bone Marrow Stromal Stem Cells","sub_type":"CJ Martin Biomedical ECF","total_budget":"323644.48","source_system":""},"children":[{"color":"#336699","name":"Nathalie Worth","data":{"first_name":"Nathalie","title":"","dw_individual_id":"DW0028935","middle_name":"","last_name":"Worth","source_individual_id":"RMIS1952317","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Nathalie Worth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84501","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4568","size":1},{"color":"#FF4D4D","name":"Molecular pathways coupling phagocytosis to pro-inflammatory and anti-inflammatory signalling","data":{"media_summary":"","end_year":2008,"keywords":["Inflammation","Innate immunity","Macrophage","Phagocytosis"],"nhmrc_grant_id":252924,"application_year":2002,"start_year":2003,"scientific_title":"Molecular pathways coupling phagocytosis to pro-inflammatory and anti-inflammatory signalling","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr David Sester","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252924","simplified_title":"Molecular pathways coupling phagocytosis to pro-inflammatory and anti-inflammatory signalling","sub_type":"CJ Martin Biomedical ECF","total_budget":"196049.94","source_system":""},"children":[{"color":"#336699","name":"David Sester","data":{"first_name":"David","title":"","dw_individual_id":"DW0027883","middle_name":"","last_name":"Sester","source_individual_id":"RMIS1396741","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Sester"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84195","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4567","size":1},{"color":"#FF4D4D","name":"Characterization of the genetic pathways involved in the differentiation of the regenerative phenotype of peridontal fib","data":{"media_summary":"","end_year":2005,"keywords":["Fibroblast heterogeneity","Genetic pathways","Growth factors","Progenitor cell differentiation","Tissue engineering"],"nhmrc_grant_id":252923,"application_year":2002,"start_year":2003,"scientific_title":"Characterization of the genetic pathways involved in the differentiation of the regenerative phenotype of peridontal fib","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dental Therapy","research_area":"Clinical Medicine and Science","for_category":"DENTISTRY","cia_name":"Prof Saso Ivanovski","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252923","simplified_title":"Characterization of the genetic pathways involved in the differentiation of the regenerative phenotype of peridontal fib","sub_type":"Health Professional Research ECF","total_budget":"108375","source_system":""},"children":[{"color":"#336699","name":"Prof Saso Ivanovski","data":{"first_name":"Saso","title":"Prof","dw_individual_id":"DW0025722","middle_name":"","last_name":"Ivanovski","source_individual_id":"5015450","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Saso Ivanovski"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83623","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4566","size":1},{"color":"#FF4D4D","name":"Cellular and Molecular mechanisms of host resistance against oropharyngeal candidiasis","data":{"media_summary":"","end_year":2005,"keywords":["T lymphocytes","candida albicans","cytokines","immunity","phagocytic cells"],"nhmrc_grant_id":252921,"application_year":2002,"start_year":2003,"scientific_title":"Cellular and Molecular mechanisms of host resistance against oropharyngeal candidiasis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Camile Farah","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252921","simplified_title":"Cellular and Molecular mechanisms of host resistance against oropharyngeal candidiasis","sub_type":"Health Professional Research ECF","total_budget":"126000","source_system":""},"children":[{"color":"#336699","name":"A/Pr Camile Farah","data":{"first_name":"Camile","title":"A/Pr","dw_individual_id":"DW0030619","middle_name":"S","last_name":"Farah","source_individual_id":"RMIS706067","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Camile Farah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84955","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4564","size":1},{"color":"#FF4D4D","name":"Reducing Ischaemic Neurodegeneration by the Stimulation of Glutamate Transport","data":{"media_summary":"","end_year":2007,"keywords":["Opthalmology and Vision Science"],"nhmrc_grant_id":252915,"application_year":2002,"start_year":2003,"scientific_title":"Reducing Ischaemic Neurodegeneration by the Stimulation of Glutamate Transport","node_source":"NHMRC","node_type":"Grant","field_of_research":"Ophthalmology and Vision Science","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Nigel Barnett","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252915","simplified_title":"Reducing Ischaemic Neurodegeneration by the Stimulation of Glutamate Transport","sub_type":"RD Wright Biomedical CDF","total_budget":"435500","source_system":""},"children":[{"color":"#336699","name":"A/Pr Nigel Barnett","data":{"first_name":"Nigel","title":"A/Pr","dw_individual_id":"DW0011632","middle_name":"L","last_name":"Barnett","source_individual_id":"5013343","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nigel Barnett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79858","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4563","size":1},{"color":"#FF4D4D","name":"Movement Control: Function and Dysfunction","data":{"media_summary":"","end_year":2006,"keywords":["Neurological Diseases"],"nhmrc_grant_id":252914,"application_year":2002,"start_year":2003,"scientific_title":"Movement Control: Function and Dysfunction","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Basic Science","for_category":"","cia_name":"Prof Richard Carson","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252914","simplified_title":"Movement Control: Function and Dysfunction","sub_type":"RD Wright Biomedical CDF","total_budget":"300500","source_system":""},"children":[{"color":"#336699","name":"Prof Richard Carson","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0041489","middle_name":"G","last_name":"Carson","source_individual_id":"5013819","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Carson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87761","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4562","size":1},{"color":"#FF4D4D","name":"Molecular genetics of cystic fibrosis","data":{"media_summary":"","end_year":2005,"keywords":["cDNA micro-arrays","cell transfection","modifier genes","pathogen response","transgenic mice"],"nhmrc_grant_id":252906,"application_year":2002,"health_keywords":["bacterial pathogen","cystic fibrosis","inflammation"],"scientific_title":"Molecular genetics of cystic fibrosis","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252906","simplified_title":"Molecular genetics of cystic fibrosis","sub_type":"Standard Project Grant","total_budget":"598125","source_system":"Cystic fibrosis is a life-threatening disease of the lungs and digestive system. It is the most common single gene disorder of Caucasian populations and most of the moratility is caused by the presence of chronic lung infections, most notably with the bacterial pathogen, Pseudomonas aeruginosa. Despite the cystic fibrosis gene being discovered over 10 years ago we still have no clear indication as to how defects in the CF gene cause susceptibility to bacterial infections, and result in the inflammation of the lung. Our studies address this issue by examining thechanges of gene expression in response to infection with Pseudomonas aeruginosa and therefore provide us with routes to therapies which are targetted against CF gene mediated inflammation."},"children":[{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1},{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4561","size":1},{"color":"#FF4D4D","name":"Virtual Screening in Structure-Based Drug Design for Malaria","data":{"media_summary":"","end_year":2005,"keywords":["DRUG DESIGN AND SYNTHESIS","ENZYME INHIBITION","ENZYMOLOGY","PURINE METABOLISM","X-RAY CRYSTALLOGRAPHY"],"nhmrc_grant_id":252900,"application_year":2002,"health_keywords":["INFECTION CONTROL","MALARIA","PARASITIC DISEASE"],"scientific_title":"Virtual Screening in Structure-Based Drug Design for Malaria","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Enzymes","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Luke Guddat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252900","simplified_title":"Computer based screening and synthesis of anti-malarial compounds","sub_type":"Standard Project Grant","total_budget":"285000","source_system":"Malaria continues to be one of the most serious health problems in the world today with approximately 300 million people affected and 1.5 million recorded deaths per year. The most deadly and widespread parasite responsible for this disease is Plasmodium falciparum. Because of the parasite's increasing resistance to traditional medication, there is an urgent need to develop more effective treatments. Two approaches are feasible: vaccines and new drugs. Both will probably be necessary to combat the spread and consequences of malaria. We are approaching this problem by targeting an enzyme which is essential for the survival of the parasite. All protozoan parasites make their purine nucleotides (the building blocks of DNA and RNA) by purine base salvage. Unlike humans, they cannot make purines from simple precursor molecules. The key enzyme in the salvage pathway is hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT). Our plan is to capitalize on knowledge of the precise structure of HGXPRT and the increased power of computers to determine which chemicals are able to bind tightly and specifically to the active site of the enzyme. We will then test the ability of these compounds to inhibit purified human and Plasmodium enzymes and their ability to inhibit the growth of the malarial parasite in red cells. Chemical synthesis will be used to improve the effectiveness of these compounds."},"children":[{"color":"#336699","name":"A/Pr Craig Williams","data":{"first_name":"Craig","title":"A/Pr","dw_individual_id":"DW0046287","middle_name":"Mckenzie","last_name":"Williams","source_individual_id":"RMIS1751840","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Craig Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88988","size":1},{"color":"#336699","name":"A/Pr Luke Guddat","data":{"first_name":"Luke","title":"A/Pr","dw_individual_id":"DW0031041","middle_name":"William","last_name":"Guddat","source_individual_id":"RMIS1125097","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Luke Guddat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85040","size":1},{"color":"#336699","name":"E/Pr John De Jersey","data":{"first_name":"John","title":"E/Pr","dw_individual_id":"DW0018611","middle_name":"","last_name":"De Jersey","source_individual_id":"5014269","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"E/Pr John De Jersey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4560","size":1},{"color":"#FF4D4D","name":"Virulence and oxidative stress in Streptococcus pneumoniae","data":{"media_summary":"","end_year":2003,"keywords":["Gene regulation","Oxidative stress","Streptococcus pneumoniae","pathogenesis","psaA"],"nhmrc_grant_id":252886,"application_year":2002,"health_keywords":["bacterial virulence factors","respiratory tract infection","streptococcal disease"],"scientific_title":"Virulence and oxidative stress in Streptococcus pneumoniae","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Michael Jennings","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252886","simplified_title":"How the pathogenic bacterium, Streptococcus pneumoniae, is affected by conditions of oxidative stress in the host.","sub_type":"Standard Project Grant","total_budget":"110125","source_system":"Streptococcus pneumoniae is an important human pathogen that causes pneumonia, meningitis and bacteraemia as well as otitis media in young children. It is a cause of high morbidity and mortality around the world. S. pneumoniae grows by fermentative metabolism, a characteristic of anaerobic organisms, but it is able to adapt towards oxygen in the environment. This adaptive ability enables S. pneumoniae to live under conditions of high oxygen tension (eg. the upper respiratory tract) or under almost anaerobic conditions (eg. the middle ear) in the human body. The emergence of antibiotic resistant pneumococci and limitations of current vaccines has led to increased interest in understanding the molecular mechanisms of pathogenesis of this bacterium. Of particular interest has been the pneumococcal surface antigen PsaA, which has been shown to be a protective immunogen in mice. It has also been shown that psaA mutants exhibit massively reduced virulence in mice in intranasal and intraperitoneal challenge models. Taken together, these data have led to the suggestion that PsaA might be an effective vaccine antigen or antimicrobial target. We postulate that PsaA is involved in the oxidative stress response and virulence under aerobic conditions and have devised a study to determine the procise role of this protein in disease caused by Streptococcus pneumoniae."},"children":[{"color":"#336699","name":"Prof James Paton","data":{"first_name":"James","title":"Prof","dw_individual_id":"DW0027246","middle_name":"C","last_name":"Paton","source_individual_id":"RMIS7494","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof James Paton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84042","size":1},{"color":"#336699","name":"Prof Michael Jennings","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0025768","middle_name":"P","last_name":"Jennings","source_individual_id":"RMIS449244","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Jennings"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83637","size":1},{"color":"#336699","name":"Prof Alastair Mcewan","data":{"first_name":"Alastair","title":"Prof","dw_individual_id":"DW0014843","middle_name":"G","last_name":"Mcewan","source_individual_id":"5016339","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alastair Mcewan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80715","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4559","size":1},{"color":"#FF4D4D","name":"Multi-copper oxidase mediated iron uptake in Ps. aeruginosa and other pathogenic bacteria: mechanism and role in disease","data":{"media_summary":"","end_year":2003,"keywords":["Iron uptake","Multi-copper oxidase","Pseudomonas aeruginosa","ferroxidse","pathoggensis"],"nhmrc_grant_id":252885,"application_year":2002,"health_keywords":["Cystic fibrosis","Pseudomonas aeruginosa","nosocomial Infection"],"scientific_title":"Multi-copper oxidase mediated iron uptake in Ps. aeruginosa and other pathogenic bacteria: mechanism and role in disease","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alastair McEwan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252885","simplified_title":"A study of the mechanism and role of a new iron uptake pathway in bacteria that cause disease.","sub_type":"Standard Project Grant","total_budget":"73500","source_system":"Iron is essential for the growth of bacteria. One of the mechanisms used by humans (and other animals) to defend against bacteria that cause disease is to trap iron by binding it to a set of iron binding proteins eg. transferrin. In this way there is no free iron in the system, so bacteria that survive in humans have had to evolve specific mechanisms to remove the iron form these host proteins. The mechanisms of iron uptake in pathogenic bacteria have been studied extensively, and the iron uptake systems are considered to be important of virulence factors (bacterial factors essential for causing disease). Humans and other higher organisms like Yeast have an iron uptake system that uses multi copper oxidase proteins (MCOs). These proteins have a ferroxidase activity, which converts iron from a protein bound insoluable form Fe (III) to a soluble form Fe(II), allowing it to be released from iron binding proteins. We have searched the genomes of many bacteria for a similar system and have discovered that many bacteria have MCOs. We wanted to test the idea that the bacteria MCOs we have identified may be involved in iron uptkae. If so, it would represent a huge step forward in understanding this important process and could lead to products for prevention or better treatment of infectious disease. We chose the disease causing bacterium Pseudomonas aeruginosa for our study. We have shown that the MCO has ferroxidase activity (Fe(III)>Fe(II), we have made a mutation in the MCO gene had have shown that the bacterium lacking MCO will not grow under certain conditions. These conditions are consistent with a defect in iron uptake. We have identified but not characterised several other key compnents of this iron uptake system. In the proposed work we wish to investigate all of the components of this iron uptake system in this important pathogen, and to initiate studies in other bacteria pathogens."},"children":[{"color":"#336699","name":"Prof Michael Jennings","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0025768","middle_name":"P","last_name":"Jennings","source_individual_id":"RMIS449244","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Jennings"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83637","size":1},{"color":"#336699","name":"Prof Alastair Mcewan","data":{"first_name":"Alastair","title":"Prof","dw_individual_id":"DW0014843","middle_name":"G","last_name":"Mcewan","source_individual_id":"5016339","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alastair Mcewan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80715","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4558","size":1},{"color":"#FF4D4D","name":"Migration and differentiation of dendritic cells and monocytes in inflammatory arthritis.","data":{"media_summary":"","end_year":2004,"keywords":["cell migration","dendritic cell","monocyte","osteoclast","rheumatoid arthritis"],"nhmrc_grant_id":252879,"application_year":2002,"health_keywords":["autoimmunity","immunotherapy","rheumatoid arthritis"],"scientific_title":"Migration and differentiation of dendritic cells and monocytes in inflammatory arthritis.","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Autoimmunity","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ranjeny Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252879","simplified_title":"Traffic of dendritic cells in arthritis","sub_type":"Standard Project Grant","total_budget":"280000","source_system":"Dendritic cells and monocytes are of critical importance to the development and persistence of inflammatory disease in rheumatoid arthritis. Blocking this process at key strategic intervention points is a major focus of research to improve disease treatment. These studies examine the critical processes and molecules that control the entry of these cells to the joint in mice, and the derivation of cells that contribute directly to bone damage in the disease."},"children":[{"color":"#336699","name":"Prof Ranjeny Thomas","data":{"first_name":"Ranjeny","title":"Prof","dw_individual_id":"DW0045826","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS4352","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ranjeny Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88853","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4557","size":1},{"color":"#FF4D4D","name":"A transgenic analysis of the physiologic roles of signalling domains in the growth hormone receptor","data":{"media_summary":"dwarfism","end_year":2004,"keywords":["growth","growth hormone receptor","knock in","metabolism","signalling domain"],"nhmrc_grant_id":252877,"application_year":2002,"health_keywords":["acromegaly","ageing","cardiac insufficiency","diabetes","dwarfism"],"scientific_title":"A transgenic analysis of the physiologic roles of signalling domains in the growth hormone receptor","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael WATERS","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252877","simplified_title":"How does growth hormone promote growth and regulate metabolism ?","sub_type":"Standard Project Grant","total_budget":"262500","source_system":"The key hormone promoting growth postnatally is growth hormone (GH), and it acts through the growth hormone receptor to initiate a variety of signals which regulate gene expression. In addition to its role in growth, GH is an importnat metabolic regulator in starvation. It also appears to play a significant role in the ageing process, since mice lacking the GH receptor live 50% longer than normal mice. Although the signalling systems used by the GH receptor are reasonably well defined in vitro, we have no idea which signals are used to control postnatal growth, metabolism and ageing in the live animal. With NHMRC support, we have been creating mice with individual signalling domains of the GH receptor deleted. This proposal aims to use these mice to determine how the GH receptor brings about its actions of promoting postnatal growth, regulating metabolism and altering lifespan. In particular, through the use of gene arrays, we intend to define the key genes regulated in these processes. This would provide potential therapeutic targets for drug development to individually alter these key processes."},"children":[{"color":"#336699","name":"A/Pr Peter Noakes","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0038807","middle_name":"G","last_name":"Noakes","source_individual_id":"5016732","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Noakes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87053","size":1},{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4556","size":1},{"color":"#FF4D4D","name":"Effect of liver pathophysiology on hepatic pharmacokinetics","data":{"media_summary":"liver resection","end_year":2005,"keywords":["cirrhosis","liver disease","liver resection","modelling","pharmacokinetics"],"nhmrc_grant_id":252871,"application_year":2002,"health_keywords":["Liver disease","Minimising adverse effects of drugs","Optimal therapeutics","liver function","liver resection"],"scientific_title":"Effect of liver pathophysiology on hepatic pharmacokinetics","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Michael Roberts","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252871","simplified_title":"Pharmacokinetics in liver disease","sub_type":"Standard Project Grant","total_budget":"457500","source_system":"The liver is the main organ in the body for the metabolism and biliary excretion of natural and foreign solutes. Various liver diseases such as cirrhosis, alcoholic liver disease, diet and drug induced fatty livers can affect the uptake and metabolism of drugs and their suitability- dosing needs. Some liver diseases such as fatty livers are very common but how rapidly drugs are metabolised in these patients is not well described. The work is important as it may help us better design new drugs and better choose which drugs to give and, if so, in what doses. In addition, many liver diseases require a biopsy for a definite diagnosis of the likely function of the liver. Estimation of liver function is particularly important in estimating whether there will be sufficient reserve on resection of a cancer or deciding if a liver transplant is needed. The liver is also a very complex organ which can trap or breakdown solutes by a range of different systems. Also of importance is how those diseases affect drug disposition in the liver given that an altered hepatic drug disposition may affect systemic response to the drugs and their metabolites. This work seeks to answer these questions."},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1},{"color":"#336699","name":"Prof Darrell Crawford","data":{"first_name":"Darrell","title":"Prof","dw_individual_id":"DW0006770","middle_name":"Henry Gordon","last_name":"Crawford","source_individual_id":"5012156","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Darrell Crawford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78535","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4555","size":1},{"color":"#FF4D4D","name":"Human hepatic insulin resistance.","data":{"media_summary":"Insulin signalling","end_year":2005,"keywords":["Free fatty acids","Hepatic glucose metabolism","Hormone signalling","Insulin resistance","Obesity"],"nhmrc_grant_id":252869,"application_year":2002,"health_keywords":["Adiposity and obesity","Fatty acids","Glucose homeostasis","Hepatic insulin resistance","Insulin signalling"],"scientific_title":"Human hepatic insulin resistance.","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Hepatology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Graeme Macdonald","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252869","simplified_title":"Insulin action and signalling in human liver - the effects of obesity, free fatty acids and adiponectin.","sub_type":"Standard Project Grant","total_budget":"220500","source_system":"Obesity is an important cause of disease, including liver disease. Obesity-associated liver disease occurs when the liver becoming resistance to the effects of insulin, the hormone that controls blood sugar (glucose). In muscle and fat, insulin causes glucose to be taken into the tissues and stored. Glucose is made in the liver and the actions of insulin here are to turn off the release of glucose into the circulation and increase uptake and storage of glucose. Insulin resistance occurs in a number of situations but the most important of these is obesity, particularly when there is accumulation of fat inside the abdominal cavity. Although the liver has a central role in co-ordinating the bodies response to insulin, the mechanisms of insulin resistance in human liver are unknown. One prominent hypothesis is that fat molecules released by intra-abdominal fat deposits are responsible. Intra-abdominal fat stores are important because fatty acids from these deposits can travel directly to the liver with the blood supply from the gut. However the precise effects of these on insulin action in the liver are unknown. Fat tissue is actively involved in the regulation of metabolism and releases a number of regulatory proteins. One of these, adiponectin, appears to have an important role in improving insulin sensitivity in the liver. The production of adiponectin decreases as obesity increases, providing another link between obesity and insulin resistance in the liver. This project will examine insulin action and the signalling molecules responsible for this in human liver tissue. The project aims to determine the effect of obesity, particularly intra-abdominal fat deposits, on insulin responses in liver tissue. The studies also aim to confirm (or otherwise) the role of free fatty acids and adiponectin on insulin action in human liver. The data from these studies will contribute to our understanding of insulin resistance and obesity-related liver disease."},"children":[{"color":"#336699","name":"A/Pr Jonathan Whitehead","data":{"first_name":"Jonathan","title":"A/Pr","dw_individual_id":"DW0046246","middle_name":"P","last_name":"Whitehead","source_individual_id":"RMIS5218572","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jonathan Whitehead"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88973","size":1},{"color":"#336699","name":"A/Pr Graeme Macdonald","data":{"first_name":"Graeme","title":"A/Pr","dw_individual_id":"DW0043925","middle_name":"Alistair","last_name":"Macdonald","source_individual_id":"5016107","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Graeme Macdonald"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88380","size":1},{"color":"#336699","name":"Prof Johannes Prins","data":{"first_name":"Johannes","title":"Prof","dw_individual_id":"DW0039181","middle_name":"Bernhard","last_name":"Prins","source_individual_id":"RMIS7041737","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Johannes Prins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87157","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4554","size":1},{"color":"#FF4D4D","name":"CD44v3 and v6 as targets for anti-metastasis therapy","data":{"media_summary":"","end_year":2005,"keywords":["CD44","metastasis","monoclonal antibodies","recombinant peptides","therapy"],"nhmrc_grant_id":252864,"application_year":2002,"health_keywords":["cancer","metastasis","surgery","therapy"],"scientific_title":"CD44v3 and v6 as targets for anti-metastasis therapy","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Surgery","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Gotley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252864","simplified_title":"Targeting CD44 variants as cancer therapy","sub_type":"Standard Project Grant","total_budget":"220500","source_system":"Cancer metastasis remains the principal cause of treatment failure in malignant disease. Current therapies for metastases are generally non-specific, and can cause considerable systemic toxicity. The ideal target for metastasis therapy would be expressed by a broad range of tumours, but be restricted in expression in normal tissues. CD44 is a family of widely expressed cell-surface adhesion molecules and its members are implicated in a variety of physiological and pathological processes, including tumour progression and metastasis. CD44 has considerable molecular diversity and its broad range of known biological activities suggests that multiple domains in the molecule may confer different biological functions. The core CD44 molecule, termed CD44s, is the most commonly expressed CD44 molecule. CD44 variants (termed CD44v) are much more restricted in their expression in normal tissues, and hence may make specific targets for anti-metastasis therapy. We have shown that CD44 variants are expressed by colorectal tumours from the earliest stages of tumour development, and that theses variants are found to be expressed by colorectal hepatic metastases. We targeted two key domains in the variants and found that by inhibiting expression in these domains we showed complete abrogation of metastasis, and of primary tumour growth in mice. Hence these domains in the CD44 molecule are directly involved in cancer spread. We propose to develop a number of specific methods of targeting CD44 in order to prevent the spread of cancer. We have and will develop additional agents directed to these key domains in CD44. Targeting these domains has great potential as metastasis therapy."},"children":[{"color":"#336699","name":"A/Pr Andrew Barbour","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0035251","middle_name":"Paul","last_name":"Barbour","source_individual_id":"RMIS705983","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Andrew Barbour"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86137","size":1},{"color":"#336699","name":"Toni Antalis","data":{"first_name":"Toni","title":"","dw_individual_id":"DW0029179","middle_name":"","last_name":"Antalis","source_individual_id":"RMIS218549","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Toni Antalis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84567","size":1},{"color":"#336699","name":"Prof David Gotley","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0025141","middle_name":"C","last_name":"Gotley","source_individual_id":"RMIS5900","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Gotley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83464","size":1},{"color":"#336699","name":"Prof Jonathan Fawcett","data":{"first_name":"Jonathan","title":"Prof","dw_individual_id":"DW0018949","middle_name":"","last_name":"Fawcett","source_individual_id":"RMIS4512205","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jonathan Fawcett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81850","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4553","size":1},{"color":"#FF4D4D","name":"Mechanisms of CD44v2-10-mediated tumour metastasis.","data":{"media_summary":"","end_year":2005,"keywords":["CD44","cancer","cell adhesion","cell signalling","metastasis"],"nhmrc_grant_id":252863,"application_year":2002,"health_keywords":["cancer","metastasis","surgery","therapy"],"scientific_title":"Mechanisms of CD44v2-10-mediated tumour metastasis.","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Surgery","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Gotley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252863","simplified_title":"Role of CD44 variant molecules in cancer metastasis","sub_type":"Standard Project Grant","total_budget":"441000","source_system":"Cancer metastasis remains the principal cause of treatment failure in malignant disease. Current therapies for metastases are generally non-specific, and can cause considerable systemic toxicity. The ideal target for metastasis therapy would be expressed by a broad range of tumours, but be restricted in expression in normal tissues. CD44 is a family of widely expressed cell-surface adhesion molecules and its members are implicated in a variety of physiological and pathological processes, including tumour progression and metastasis. CD44 has considerable molecular diversity and its broad range of known biological activities suggests that multiple domains in the molecule may confer different biological functions. The core CD44 molecule, termed CD44s, is the most commonly expressed CD44 molecule. CD44 variants (termed CD44v) are much more restricted in their expression in normal tissues, and hence may make specific targets for anti-metastasis therapy. We have shown that CD44 variants are expressed by colorectal tumours from the earliest stages of tumour development, and that theses variants are found to be expressed by colorectal hepatic metastases. We targeted two key domains in the variants and found that by inhibiting expression in these domains we showed complete abrogation of metastasis, and of primary tumour growth in mice. Hence these domains in the CD44 molecule are directly involved in cancer spread. We propose to investigate the mechanisms by which specificdomains in the CD44 variants actually cause tumour spread. Understanding of the various mechanisms involved in tumour spread, and targeting the functions of the domains has enormous potential as a therapeutic target."},"children":[{"color":"#336699","name":"A/Pr Andrew Barbour","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0035251","middle_name":"Paul","last_name":"Barbour","source_individual_id":"RMIS705983","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Andrew Barbour"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86137","size":1},{"color":"#336699","name":"Toni Antalis","data":{"first_name":"Toni","title":"","dw_individual_id":"DW0029179","middle_name":"","last_name":"Antalis","source_individual_id":"RMIS218549","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Toni Antalis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84567","size":1},{"color":"#336699","name":"Prof David Gotley","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0025141","middle_name":"C","last_name":"Gotley","source_individual_id":"RMIS5900","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Gotley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83464","size":1},{"color":"#336699","name":"Prof Jonathan Fawcett","data":{"first_name":"Jonathan","title":"Prof","dw_individual_id":"DW0018949","middle_name":"","last_name":"Fawcett","source_individual_id":"RMIS4512205","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jonathan Fawcett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81850","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4552","size":1},{"color":"#FF4D4D","name":"Immunoregulatory immune responses to a peripherally presented tumour antigen","data":{"media_summary":"","end_year":2004,"keywords":["Epithelium","Peripheral Tolerance","Tumour immunology","Viral oncogenesis"],"nhmrc_grant_id":252855,"application_year":2002,"health_keywords":["Autoimmunity","Cervical cancer","Skin cancer"],"scientific_title":"Immunoregulatory immune responses to a peripherally presented tumour antigen","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Tumour Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ian Frazer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252855","simplified_title":"How tumours persuade the immune system to ignore them","sub_type":"Standard Project Grant","total_budget":"219750","source_system":"Tumours express proteins which the body can recognise as foreign. However, the recognition process often goes wrong, leaving the body's defences against infection unable to respond to the tumour. This lack of response may become permanent, and the tumour may then be protected by the immune system. We have a model system, based on cervical cancer, in which we can determine the reasons why tumour tolerance can occur, and explore ways of overcoming the tolerance"},"children":[{"color":"#336699","name":"Prof Ranjeny Thomas","data":{"first_name":"Ranjeny","title":"Prof","dw_individual_id":"DW0045826","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS4352","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ranjeny Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88853","size":1},{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1},{"color":"#336699","name":"Dr Graham Leggatt","data":{"first_name":"Graham","title":"Dr","dw_individual_id":"DW0037982","middle_name":"R","last_name":"Leggatt","source_individual_id":"RMIS13401","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Graham Leggatt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86840","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4551","size":1},{"color":"#FF4D4D","name":"Molecular pathogenesis of amino acid neurotransmission in human chronic alcoholism","data":{"media_summary":"","end_year":2005,"keywords":["Amino Acids","Human Brain","Neurotransmitter","Pathogenesis","Pharmacology - Receptors"],"nhmrc_grant_id":252848,"application_year":2002,"health_keywords":["Alcoholism","Cirrhosis","Pathology - Neuropathology"],"scientific_title":"Molecular pathogenesis of amino acid neurotransmission in human chronic alcoholism","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Peter Dodd","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252848","simplified_title":"The mechanism causing alcoholic brain damage","sub_type":"Standard Project Grant","total_budget":"378750","source_system":"Brain damage resulting from long-term alcohol abuse is localized to discrete regions of the brain, and may selectively affect certain specific functions of nerve cells. It appears that alcoholism affects processes which control the excitability in discrete regions of the brain, and hence can cause them to be over-stimulated. It is known that if brain cells are excessively stimulated for long periods, they are in danger of being killed. This study will determine how the tissue s capacity to process glutamate, the brain s major natural excitant, is altered in the regions which are selectively damaged in alcoholics. How these processes are affected by heredity, and by diseases commonly associated with alcoholism such as cirrhosis of the liver, will also be explored. An understanding of how selective brain damage occurs in alcoholics will help us to devise new drug therapies to combat and prevent it. As well, selective brain damage is found in a great many neurological diseases, so this study will provide a model which may help to dene general processes which give rise to localised neurological damage"},"children":[{"color":"#336699","name":"A/Pr Peter Dodd","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0001312","middle_name":"R","last_name":"Dodd","source_individual_id":"RMIS34635","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Dodd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77036","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4550","size":1},{"color":"#FF4D4D","name":"A molecular approach to constructing the olfactory system","data":{"media_summary":"","end_year":2005,"keywords":["axon","development","guidance","olfactory"],"nhmrc_grant_id":252829,"application_year":2002,"health_keywords":["brain damage","brain development","brain growth","peripheral nerve injury"],"scientific_title":"A molecular approach to constructing the olfactory system","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Brian Key","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252829","simplified_title":"Guiding olfactory axons to their targets","sub_type":"Standard Project Grant","total_budget":"440250","source_system":"The olfactory (smell) system is a unique part of the nervous system; nerve cells are generated throughout life and it can regenerate even after injury. It therefore provides an excellent model for examining the growth, development and maintenance of nerve cells. This project will examine the effects on the organisation of the olfactory system when some guidance signals are altered. Information we obtain about how this system develops and regenerates may be useful in treating brain disorders and spinal injuries In the current project we will examine the effects of specific nerve cell guidance molecules by generating transgenic mice that produce these molecules only in the olfactory system. We can then determine what changes occur to the nerve cells when these extra molecules are produced. The results of these experiments will provide important information on the the initial growth and targeting of these nerve cells which may have implications for regeneration of these as well as other nerve cells."},"children":[{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4548","size":1},{"color":"#FF4D4D","name":"Regulation of hedgehog signalling through intracellular trafficking events","data":{"media_summary":"","end_year":2005,"keywords":["abnormal development","cell biology","cholesterol","protein localisation","protein trafficking"],"nhmrc_grant_id":252827,"application_year":2002,"health_keywords":["basal cell carcinoma","developmental disorders","inherited disorders","skin cancer"],"scientific_title":"Regulation of hedgehog signalling through intracellular trafficking events","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Carol Wicking","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252827","simplified_title":"Analysis of hedgehog signalling in a mammalian cell system","sub_type":"Standard Project Grant","total_budget":"220500","source_system":"The hedgehog signalling cascade plays a role in forming almost every organ of the body during development of an embryo. Perturbation of the function of key members of this pathway during embryonic development often results in death in utero or severe childhood abnormalities. In addition, disruption to this pathway also results in a range of cancers, most notably the extremely common skin cancer basal cell carcinoma. In this proposal we aim to investigate in detail the regulatory mechanisms which operate to ensure that this complex pathway of interacting molecules functions correctly during embryonic development. By understanding how this regulation occurs we will gain valuable insight into how disruption of this pathway results in such a range of disease, as well as into how agents which modulate this pathway may potentially act in a therapeutic setting."},"children":[{"color":"#336699","name":"A/Pr Carol Wicking","data":{"first_name":"Carol","title":"A/Pr","dw_individual_id":"DW0028805","middle_name":"A","last_name":"Wicking","source_individual_id":"RMIS2473798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Carol Wicking"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84461","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4547","size":1},{"color":"#FF4D4D","name":"Role of protease activated receptors type 2 (PAR2) during inflammation of airways and intestine","data":{"media_summary":"Inflammation","end_year":2005,"keywords":["Airways","Electrolyte transport","Epithelium","Intestine","Protease activated receptors"],"nhmrc_grant_id":252823,"application_year":2002,"health_keywords":["Airways","Bowel disease","Crohn's disease","Diarrhea","Inflammation"],"scientific_title":"Role of protease activated receptors type 2 (PAR2) during inflammation of airways and intestine","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Physiology","research_area":"Clinical Medicine and Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof Karl Kunzelmann","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252823","simplified_title":"Role of protease receptors during inflammation of airways and intestine","sub_type":"Standard Project Grant","total_budget":"235500","source_system":"Epithelial cells lining the airways and the intestine contain receptors that are activated by proteases, which are protein cleaving enzymes. Activation of the subtype 2 of these receptors (PAR2) has been shown to cause salt and water transport in intestinal cells in culture. Little is known about the effects of PAR2-activation in the native airways and intestinal tissues. These tissues will be studied in the present project. A large increase in PAR2 is found in various diseases which are paralleled by a strong inflammation. Thus, PAR2 is likely to play a central role in intestinal diseases such as acute infectious diarrhea and chronic inflammatory bowel disease. PAR2 may also participate in the severe diarrhea frequently observed in patients with intestinal tumors. Similarly, inflammatory mediators released during airway infections are likely to act on PAR2, causing inappropriate secretion and a running nose. Most importantly, PAR2 are found in large excess in the airways of asthma patients. Since nothing is known about the impact of these receptors on fluid and electrolyte transport in the airways it appears timely and highly relevant to study the function of PAR2 in the airway epithelium. We will assess PAR2 mediated responses in human nasal biopsies. A more detailed analysis of the intracellular processes will be done in mouse trachea. We will further study the function of PAR2 in the intestinal epithelium. Activation of the ion transport via PAR2 will be examined in the mouse distal colon and in human rectal biopsies. We will utilize techniques such as Ussing chamber and patch clamp recordings to analyze the transport processes. The results should gain new inside into the role of PAR2 during inflammatory diseases of the airways and the intestine such as asthma and chronic inflammatory bowel diseases."},"children":[{"color":"#336699","name":"Prof Daniel Markovich","data":{"first_name":"Daniel","title":"Prof","dw_individual_id":"DW0038289","middle_name":"","last_name":"Markovich","source_individual_id":"5016201","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Daniel Markovich"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86917","size":1},{"color":"#336699","name":"Karl Kunzelmann","data":{"first_name":"Karl","title":"","dw_individual_id":"DW0014297","middle_name":"","last_name":"Kunzelmann","source_individual_id":"RMIS414873","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Karl Kunzelmann"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80561","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4546","size":1},{"color":"#FF4D4D","name":"Examination of delivery of family-centred care(FCC) in Australia, England & the Nordic countries: an ongoing project","data":{"media_summary":"","end_year":2002,"keywords":["health care evaluation","rehabilitation","stroke outcomes"],"nhmrc_grant_id":252818,"application_year":2002,"start_year":2002,"scientific_title":"Examination of delivery of family-centred care(FCC) in Australia, England & the Nordic countries: an ongoing project","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Leigh Tooth","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/252818","simplified_title":"Examination of delivery of family-centred care(FCC) in Australia, England & the Nordic countries: an ongoing project","sub_type":"Travelling Award for Research Training - Scholarship","total_budget":"13163","source_system":""},"children":[{"color":"#336699","name":"Dr Leigh Tooth","data":{"first_name":"Leigh","title":"Dr","dw_individual_id":"DW0010698","middle_name":"Rhonda","last_name":"Tooth","source_individual_id":"RMIS1112435","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Leigh Tooth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79606","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4545","size":1},{"color":"#FF4D4D","name":"P.gingivalis GroEL and HSP60 specific T cells in periodontal and cardiovascular diseases","data":{"media_summary":"","end_year":2005,"keywords":["Cardiovascular disease","Cross-reactivity","Heat Shock Protein","Immune response","Periodontal disease"],"nhmrc_grant_id":252813,"application_year":2002,"health_keywords":["Association","Cardiovascular disease","Mechanism","Periodontal disease"],"scientific_title":"P.gingivalis GroEL and HSP60 specific T cells in periodontal and cardiovascular diseases","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Dentistry not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"DENTISTRY","cia_name":"Prof Gregory Seymour","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252813","simplified_title":"A novel mechanism for the association between gum disease and heart disease","sub_type":"Standard Project Grant","total_budget":"619500","source_system":"Cardiovascular diseases are the major cause of death in adults in most developed and many developing countries. In recent years there has been accumulating evidence that chronic infections such as Helicobacter pylori and Chlamydia pneumoniae are associated with cardiovascular diseases. Chronic inflammatory periodontal diseases are among the most common chronic infections with over one million Australians at risk of losing their teeth. Poor dental health and in particular chronic periodontitis is now consistently being associated with a number of other diseases and conditions including cardiovascular disease. In some studies the relationship between periodontal disease and cardiovascular disease is stronger than that for other risk factors such as smoking and high cholesterol. Periodontitis results from the inflammatory response to dental plaque. One of the major pathogens identified in dental plaque is P.gingivalis. Heat shock proteins (HSP) are expressed by cells on exposure to various forms of stress including temperature and injury. They participate in physiological processes such as the assembly, transport and protection of proteins from breakdown. There is a remarkable conservation in the structure of heat shock genes and HSP across species. Many pathogens including P.gingivalis bear antigens that are similar to human HSPand cross reactivity during infection may result in disease such as atherosclerosis. This study aims to test the hypothesis that cross reactivity between the bacterial antigens and HSP may explain the mechanism of the association between periodontal disease and cardiovascular disease. This would have a significant impact on the treatment of both periodontal and cardiovascular disease."},"children":[{"color":"#336699","name":"Gregory Seymour","data":{"first_name":"Gregory","title":"","dw_individual_id":"DW0045362","middle_name":"","last_name":"Seymour","source_individual_id":"RMIS9783","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Gregory Seymour"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88735","size":1},{"color":"#336699","name":"Prof Philip Walker","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0022791","middle_name":"John","last_name":"Walker","source_individual_id":"RMIS1116934","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Philip Walker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82875","size":1},{"color":"#336699","name":"Erica Gemmell","data":{"first_name":"Erica","title":"","dw_individual_id":"DW0013197","middle_name":"","last_name":"Gemmell","source_individual_id":"RMIS9786","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Erica Gemmell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80264","size":1},{"color":"#336699","name":"Dr Mary Cullinan","data":{"first_name":"Mary","title":"Dr","dw_individual_id":"DW0012574","middle_name":"P","last_name":"Cullinan","source_individual_id":"RMIS222537","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Mary Cullinan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80103","size":1},{"color":"#336699","name":"Prof Malcolm West","data":{"first_name":"Malcolm","title":"Prof","dw_individual_id":"DW0005385","middle_name":"J","last_name":"West","source_individual_id":"5018261","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Malcolm West"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78171","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4544","size":1},{"color":"#FF4D4D","name":"Agonists and Antagonists Of The Human Complement C3a Receptor","data":{"media_summary":"sepsis","end_year":2005,"keywords":["Agonists and Antagonists","C3a and C5a","Human Complement","Immunoinflammatory Drugs","NMR structure"],"nhmrc_grant_id":252812,"application_year":2002,"health_keywords":["arthritis","asthma","inflammation","ischemia-reperfusion","sepsis"],"scientific_title":"Agonists and Antagonists Of The Human Complement C3a Receptor","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252812","simplified_title":"Towards New Antiinflammatory Drugs Based On Human Immune Defence","sub_type":"Standard Project Grant","total_budget":"473250","source_system":"Many serious inflammatory diseases, such as arthritis, septic shock, lung shock, heart disease, atherosclerosis, multiple sclerosis, are poorly controlled with currently available drugs. There is a great deal of evidence that naturally occuring Complement proteins in human blood are involved in exacerbating these and many other human diseases, yet there are no good drugs available to counteract their effects. One of the most important complement proteins is known as C3a. It is called an anaphylatoxin and is thought to be a pivotal component of the complement system synthesized by the human body early on in the development of inflammatory and immune diseases. New compounds that could stimulate or block the activity of C3a are expected : (a) To lead us to a better understanding of how C3a binds to its receptors on immune cells and its role in the immune response to infection and injury, and (b) To enable the rapid development of an entirely new class of drugs for treating autoimmune and inflammatory diseases. No Complement-based drugs are yet available. It is not yet possible to examine detailed structures of the receptors on cells that interact with complement proteins. However it is possible to determine and analyse three dimensional structures of small molecules that can bind to human immune cells, and mimic or block effects of human C3a on cells, rat tissues, and in whole rats. We will identify and improve such small molecules by optimising their binding to immune cells, by tailoring them to selectively block or mimic just the effects of C3a, and by making them pharmacologically stable for administration (preferably by mouth) to rats (and humans). We will then test them in rats for potential future development into a completely new type of anti-inflammatory drug, one that treats inflammatory disease processes rather than just the symptoms like most current antiinflammatory drugs."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"Prof Stephen Taylor","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0010587","middle_name":"M","last_name":"Taylor","source_individual_id":"RMIS41211","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79577","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4543","size":1},{"color":"#FF4D4D","name":"Design and Development Of Small Molecules To Regulate Protease Activated Receptor Type 2","data":{"media_summary":"","end_year":2005,"keywords":["Antagonists","Inflammation","Peptidomimetics","Pharmacology","Protease Activated Receptors"],"nhmrc_grant_id":252811,"application_year":2002,"health_keywords":["arthritis","asthma","cancer","pancreatitis"],"scientific_title":"Design and Development Of Small Molecules To Regulate Protease Activated Receptor Type 2","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Enzymes","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252811","simplified_title":"New antiinflammatory drugs that regulate receptors on surfaces of cells","sub_type":"Standard Project Grant","total_budget":"439500","source_system":"A new class of proteins have been discovered on the surface of cells. These are activated by enzymes known as proteases and are therefore called Protease Activated Receptors (PARs). PARs appear to be very important 'sensors' of proteases outside cells, becoming activated in response to very low concentrations of proteases. This suggest that proteases may exert some of their biological effects through these receptors, which are now implicated in a growing number of diseases (e.g. thrombosis, cardiovascular disorders, asthma, inflammatory bowel disease, Crohn's disease, pancreatitis, stomach and colon cancer, arthritis, and there may also be a role in wound healing). We are working towards dissecting the roles for one of these receptors (PAR2) in disease by developing small molecules for selective binding to this receptor. We will particularly distinguish between compounds that can activate (agonists) or deactivate (antagonists) the receptor. These experiments will involve computer-assisted compound design, structural comparisons between small molecules with activity and those without, and cellular studies designed to measure affinity, activation and deactivation of PAR2. The outcome will be a series of small molecules that bind tightly to the PAR2 receptor and have a well defined function (antagonist, agonist, partial agonist). While the above studies are in progress some peptides that are known to activate this receptor will be examined in rodent models of human disease (airways inflammation, pancreatitis, stomach and colon cancer, arthritis). Studies like this have been very revealing for us in the past (Nature 1999, 398, 156-160 A protective role for protease-activated receptors in the airways). Then the designed and developed compounds will also be examined for signs of therapeutic potential. The work will provide a better understanding of how this receptor works and a clearer picture of the role of this receptor in human disease."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"A/Pr Thomas Cocks","data":{"first_name":"Thomas","title":"A/Pr","dw_individual_id":"DW0030010","middle_name":"M","last_name":"Cocks","source_individual_id":"RMIS113782","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Thomas Cocks"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84779","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4542","size":1},{"color":"#FF4D4D","name":"Trafficking of E-cadherin in epithelial cells.","data":{"media_summary":"","end_year":2005,"keywords":["adhesion molecules","cell biology","membrane transport","protein targeting signals","transport vesicles"],"nhmrc_grant_id":252809,"application_year":2002,"health_keywords":["epithelial function","human polycystic kidney disease","tumour metastasis and invasion","tumour suppressor genes"],"scientific_title":"Trafficking of E-cadherin in epithelial cells.","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252809","simplified_title":"E-cadherin Trafficking.","sub_type":"Standard Project Grant","total_budget":"441000","source_system":"E-cadherin is one of the major proteins responsible for mediating cell-to-cell adhesion in the body. During development, E-cadherin is essential for establishing the cellular architecture of epithelial organs and for maintaining epithelial function in the adult. In this context, E-cadherin acts to establish and maintain the polarity of epithelial cells. E-cadherin is also a powerful tumour suppressor and the loss of E-cadherin expression or function is a primary event in metastasis and cancer invasion. Proteins at the surface of epithelial cells must be sorted and trafficked, or transported, to different membrane domains. E-cadherin, for instance, must be trafficked to the lateral domain of cells in order to function in cell-cell adhesion. We recently discovered that cell surface E-cadherin is re-internalized and recycled back to the surface via a pathway that is poised to contribute to the regulation of cell adhesion. Our proposed studies aim to reveal how newly-synthesized E-cadherin and recycling E-cadherin are trafficked, which molecules and which vesicle carriers accomplish this transport. E-cadherin has specific amino acids that act as targeting signals for its sorting and trafficking; we have recently identified one such signal and will now seek the signal responsible for its endocytosis. Using specifically engineered mutants of E-cadherin we will also study other proteins that interact with E-cadherin during its trafficking for sorting and regulation. One of these is polycystin, a protein that is mutated in a common inherited kidney disease. Insights into this disease and normal kidney epithelial function will emerge from this work. A growing understanding of E-cadherin function and regulation is essential for the health of epithelial organs and for controlling and preventing cancer."},"children":[{"color":"#336699","name":"A/Pr Rohan Teasdale","data":{"first_name":"Rohan","title":"A/Pr","dw_individual_id":"DW0040022","middle_name":"D","last_name":"Teasdale","source_individual_id":"5017848","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Rohan Teasdale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87368","size":1},{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4541","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2007,"keywords":["Skin Disorders"],"nhmrc_grant_id":252807,"application_year":2002,"start_year":2003,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Richard Sturm","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252807","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"572000","source_system":""},"children":[{"color":"#336699","name":"A/Pr Richard Sturm","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0045672","middle_name":"Alan","last_name":"Sturm","source_individual_id":"5017777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Sturm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88811","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4540","size":1},{"color":"#FF4D4D","name":"Functional analysis of candidate sex-determining and gonadal development genes","data":{"media_summary":"","end_year":2004,"keywords":["Developmental genes","Differential gene expression","Embryonic development","Murine models","Sex determination"],"nhmrc_grant_id":252788,"application_year":2002,"health_keywords":["Embryonic development","Organogenesis","Sex reversal"],"scientific_title":"Functional analysis of candidate sex-determining and gonadal development genes","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Josephine Bowles","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252788","simplified_title":"Genes that control sexual development in embryos","sub_type":"Standard Project Grant","total_budget":"503500","source_system":"This project is aimed at finding and studying the genes that control whether an embryo develops as a male or a female, and the genes that are responsible for proper development of the gonads, organs that control an individual's sexual development. It is thought that a genetic chain of events is important for gonadal development, and we aim to find the missing links of that chain and to work out how they fit together, as well as how genetic defects can lead to disorders of sexual development. Defects in sexual development in the human embryo not only result in some of the most common forms of birth defects but also have profound physiological and psychosexual ramifications for the afflicted individuals. A fuller understanding of the causes of these defects will lead to improved patient management."},"children":[{"color":"#336699","name":"Prof Peter Koopman","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0043570","middle_name":"A","last_name":"Koopman","source_individual_id":"5015773","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Koopman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88298","size":1},{"color":"#336699","name":"Dr Josephine Bowles","data":{"first_name":"Josephine","title":"Dr","dw_individual_id":"DW0035494","middle_name":"","last_name":"Bowles","source_individual_id":"RMIS30122","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Josephine Bowles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86197","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4539","size":1},{"color":"#FF4D4D","name":"Are cardiac conditions in older women managed appropriately?","data":{"media_summary":"Population based record-linkage","end_year":2005,"keywords":["Cardiovascular disease","Evidence based clinical practice","Longitudinal study","Older people","Women's health"],"nhmrc_grant_id":252786,"application_year":2002,"health_keywords":["Angina","Coronary heart disease","Evidence based health care","Older persons and heart failure","Population based record-linkage"],"scientific_title":"Are cardiac conditions in older women managed appropriately?","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Preventive Medicine","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Annette Dobson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252786","simplified_title":"Are cardiac conditions in older women managed appropriately?","sub_type":"Standard Project Grant","total_budget":"289492.5","source_system":"Cardiac conditions, including heart attach, heart failure, angina and high blood pressure are very common among older Australians. They account for large proportions of deaths, morbidity and health care costs. For most of these conditions there are highly effective treatments, however there is evidence that these are not as well used as they should be. Also, for women, diagnosis may be delayed due to perceptions that heart disease is a problem mainly among men. The project is based on the Australian Longitudinal Study on Women's Health which includes more than 10,000 women, over half living in rural and remote areas. Women with cardiac conditions will be surveyed about their medical care. This information, together with data they have provided over the last 6 years (and Medicare data if the women have given their consent), will be compared with best practice guidelines established by NHMRC and the Heart Foundation. In this way the project will examine the adequacy of medical care among older women in sufficient detail to make actionable recommendations to health authorities for where improvements are needed."},"children":[{"color":"#336699","name":"Prof Annette Dobson","data":{"first_name":"Annette","title":"Prof","dw_individual_id":"DW0036318","middle_name":"J","last_name":"Dobson","source_individual_id":"5011952","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Annette Dobson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86411","size":1},{"color":"#336699","name":"Prof Andrew Wilson","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0011115","middle_name":"Andrew","last_name":"Wilson","source_individual_id":"5018407","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Andrew Wilson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79722","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4538","size":1},{"color":"#FF4D4D","name":"Structural and diffusion tensor neuroimaging in twins concordant and discordant for psychosis.","data":{"media_summary":"","end_year":2005,"keywords":["Quantitative Structural Neuroimaging (MRI and DTI)","biological markers","twins research"],"nhmrc_grant_id":252777,"application_year":2002,"health_keywords":["bipolar affective disorder","psychosis","schizophrenia"],"scientific_title":"Structural and diffusion tensor neuroimaging in twins concordant and discordant for psychosis.","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Mental Health","research_area":"Clinical Medicine and Science","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Bryan Mowry","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252777","simplified_title":"Psychotic twins and neuroimaging","sub_type":"Standard Project Grant","total_budget":"477375","source_system":"Measures from specialised brain scans i.e. MRI's (Magnetic Resonance Imaging) have suggested that several areas in the brain are different in those individuals who suffer from psychosis compared to those who don't. Evaluations of these brain differences have helped us better understand the nature of these illnesses. For example, frontal lobe dysfunction has been linked with the loss of ability to plan and organize information, seen in those who have schizophrenia. These measures may also help clarify the relationship between the genetic and environmental factors contributing to the development of these disorders. One of the best ways to investigate this relationship is the use of a twin study design. The Australian study of twins with psychosis will recruit dizygotic (DZ) and monozygotic (MZ) twin pairs in which at least one twin is affected by a psychotic disorder, plus control twin pairs matched for age, sex and zygosity. Measures derived from MRI scans will be collected in an attempt to further define specific brain regions reported to be different in psychosis. In addition Diffusion Tensor Imaging (DTI) will be used to visualize white matter tracts in the brain. The twin study design will allow us to differentiate genetic and environmental factors associated with these brain measures and help evaluate the potential for these measures to genetically define sub-groups of individuals with psychotic disorders. The identification of these subgroups would facilitate the search for susceptibility genes. Additionally, this study will help clarify the possible clinical overlap between affective (i.e. bipolar affective disorder) and non-affective (i.e. schizophrenia) psychotic disorders. The information obtained from this study has the potential to greatly improve our understanding of caustive factors in psychosis, which may also lead to earlier diagnosis and treatment, thereby improving prognosis."},"children":[{"color":"#336699","name":"Prof Bryan Mowry","data":{"first_name":"Bryan","title":"Prof","dw_individual_id":"DW0044411","middle_name":"J","last_name":"Mowry","source_individual_id":"5016586","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bryan Mowry"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88510","size":1},{"color":"#336699","name":"Prof Christos Pantelis","data":{"first_name":"Christos","title":"Prof","dw_individual_id":"DW0038956","middle_name":"","last_name":"Pantelis","source_individual_id":"RMIS105799","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Christos Pantelis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87091","size":1},{"color":"#336699","name":"A/Pr Jonathan Chalk","data":{"first_name":"Jonathan","title":"A/Pr","dw_individual_id":"DW0029859","middle_name":"B","last_name":"Chalk","source_individual_id":"RMIS1706143","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jonathan Chalk"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84730","size":1},{"color":"#336699","name":"Prof Stephen Wood","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0023081","middle_name":"J","last_name":"Wood","source_individual_id":"RMIS105802","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Wood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82945","size":1},{"color":"#336699","name":"Dominique Hannah","data":{"first_name":"Dominique","title":"","dw_individual_id":"DW0019446","middle_name":"","last_name":"Hannah","source_individual_id":"RMIS1727508","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dominique Hannah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81950","size":1},{"color":"#336699","name":"A/Pr Stephen Rose","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0009965","middle_name":"E","last_name":"Rose","source_individual_id":"5017273","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Stephen Rose"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79404","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4537","size":1},{"color":"#FF4D4D","name":"Molecular characterization of E-cadherin-activated Rac signaling","data":{"media_summary":"","end_year":2005,"keywords":["Adhesion signaling","E-cadherin","PI3-kinase","Rac","Rho-GTPases"],"nhmrc_grant_id":252776,"application_year":2002,"health_keywords":["Cancer","Epithelial inflammation","Gastrointestinal disease","Kidney disease"],"scientific_title":"Molecular characterization of E-cadherin-activated Rac signaling","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Alpha Yap","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252776","simplified_title":"E-cadherin signaling","sub_type":"Standard Project Grant","total_budget":"220500","source_system":"Interactions between cells and their neighbouring cells control many important processes in the body. The adhesion molecule, E-cadherin, is a major protein that controls interactions between cells in epithelial tissues (e.g. breast, lung, gut). E-cadherin is essential for these tissues to form normally, and loss of E-cadherin function contributes to the progression of many human cancers (especially common cancers such as breast and lung). Understanding how E-cadherin controls normal epithelial cell function will therefore provide key insights into the bases for tumor progression. In this study we will examine how E-cadherin signals to the interior of cells. We have recently discovered a new signaling pathway that is turned on when E-cadherin is activated. Understanding the fundamental elements of this signaling pathway will provide invaluable insights into how cells recognize one another during health and disease."},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4536","size":1},{"color":"#FF4D4D","name":"Physiological mechanisms of efficacy of cervical flexor muscle retraining","data":{"media_summary":"","end_year":2005,"keywords":["Clinical treatment trials","Neck pain","Physiological mechanisms of efficacy","Therapeutic exercise"],"nhmrc_grant_id":252771,"application_year":2002,"health_keywords":["Management and prevention of neck pain","Mechanisms of effect of therapeutic exercise","Musculoskeletal disorders of the cervical spine"],"scientific_title":"Physiological mechanisms of efficacy of cervical flexor muscle retraining","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Gwendolen Jull","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252771","simplified_title":"Mechanisms of effect of retaining the neck muscles of neck pain patients","sub_type":"Standard Project Grant","total_budget":"264750","source_system":"Neck pain is a significant problem in society and its frequency is beginning to match the proportions of back pain, probably reflecting our increasingly sedentary lifestyles. Several problems have been identified in the muscle system in persons who suffer from neck pain. Therapeutic exercise has been found to have benefit in preventing and relieving pain and improving the neck function. Currently there are several, quite different methods of exercise and there is controversy regarding how therapeutic exercise works. It has been argued that parameters such as changes in muscle strength, endurance, joint position sense or muscle coordination may be responsible for the clinical efficacy. It is difficult to disentangle the effective component of exercise strategies and thus prescribe the most effective exercise strategies. This series of experiments will evaluate the physiological factors that change with a specific exercise intervention and to compare different exercise modalities in order to identify the most effective means to induce these changes. Cervical muscle training, using a proven exercise intervention strategy for chronic neck pain and headache, has been chosen as the model to investigate these questions. This exercise strategy has been chosen not only because it has been shown to be effective, but also because it does not conform to contemporary rationales for strength or endurance training. Thus while effective in relieving pain, it is unlikely to produce changes in these parameters. Thus other mechanisms are likely to be responsible for the clinical change. This research stands to make a significant contribution to exercise therapeutics by identifying the effective components of different exercise methods and investigating the pain relieving effects of the specific exercise. This knowledge will lead to the construction of a research based exercise program for neck pain patients, rather than have the current situation of often arbitrary choice of exercise."},"children":[{"color":"#336699","name":"Prof Guglielmo Vicenzino","data":{"first_name":"Guglielmo","title":"Prof","dw_individual_id":"DW0046019","middle_name":"Tarcisio","last_name":"Vicenzino","source_individual_id":"5018115","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Guglielmo Vicenzino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88911","size":1},{"color":"#336699","name":"Prof Paul Hodges","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0043077","middle_name":"W","last_name":"Hodges","source_individual_id":"RMIS222953","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Hodges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88164","size":1},{"color":"#336699","name":"E/Pr Gwendolen Jull","data":{"first_name":"Gwendolen","title":"E/Pr","dw_individual_id":"DW0019981","middle_name":"A","last_name":"Jull","source_individual_id":"RMIS5215","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"E/Pr Gwendolen Jull"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82087","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4535","size":1},{"color":"#FF4D4D","name":"Molecular genetics of macrophage activation.","data":{"media_summary":"","end_year":2005,"keywords":["differentiation","genetics","lipopolysaccharide","macrophage","transcription"],"nhmrc_grant_id":252765,"application_year":2002,"health_keywords":["cancer","genetics","inflammation"],"scientific_title":"Molecular genetics of macrophage activation.","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof David Hume","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252765","simplified_title":"Inherited variation in the innate immune response.","sub_type":"Standard Project Grant","total_budget":"425250","source_system":"This project concerns the basic biology of white blood cells called macrophages. Macrophages are required for the immediate defence against infection, as well as wound repair and normal turnover of tissues, but they can also produce toxic products that cause illness, especially in inflammatory diseases and cancer. We are attempting to use the availability of mouse genome information to produce a complete picture of the way that macrophages respond to a challenge from a potential disease-causing microorganism, and the influence of genetic differences between individuals."},"children":[{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1},{"color":"#336699","name":"Prof Sean Grimmond","data":{"first_name":"Sean","title":"Prof","dw_individual_id":"DW0007616","middle_name":"M","last_name":"Grimmond","source_individual_id":"5014956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sean Grimmond"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78759","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4534","size":1},{"color":"#FF4D4D","name":"Regulation of endosome function by the AAA-ATPase Vps4","data":{"media_summary":"","end_year":2005,"keywords":["endosome","membrane traffic","protein sorting","receptor down-regulation","virus budding"],"nhmrc_grant_id":252750,"application_year":2002,"health_keywords":["AIDS","cancer","nutrition"],"scientific_title":"Regulation of endosome function by the AAA-ATPase Vps4","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Alan Munn","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252750","simplified_title":"Understanding Vps4 - a protein with a dual role in suppression of tumours and AIDS virus infection","sub_type":"Standard Project Grant","total_budget":"220500","source_system":"Cells respond to many signals from the environment. Some signals tell cells to grow and divide and other signals tell cells to rest. These signals are usually in balance in healthy cells. To prevent cells from growing and dividing in an uncontrolled manner and forming a cancer, there are mechanisms to turn off signals for growth. One mechanism is to destroy the proteins responsible for growth signalling. This involves flipping (by a process called multivesicular body, or MVB, sorting) the signalling protein from one side of the membrane where signalling occurs to the other side where signalling cannot occur and where the signalling protein can be degraded. Interestingly, it has recently been discovered that some viruses (including the AIDS virus) use the same MVB sorting mechanisms to escape from infected cells. Instead of undergoing MVB sorting into an internal compartment and getting degraded, however, the virus is able to use the same mechanism to flip out of the cell. How MVB sorting occurs is not known, but the mechanism has been conserved through evolution and even microbes like yeast can perform MVB sorting of proteins. We are investigating a component of the MVB sorting mechanism known as Vps4 which is present in both human cells and in yeast cells. Since the human Vps4 and yeast Vps4 seem to function in the same way, and since powerful molecular genetic approaches can be used in yeast to elucidate how proteins function (some of which are not possible with human cells), we are using yeast to investigate Vps4 function. Once we understand how the yeast Vps4 works, we will be able to test if human Vps4 works the same way. Understanding the MVB sorting mechanism will give us information on how cells prevent uncontrolled growth and division and may also help us find ways of preventing AIDS infection."},"children":[{"color":"#336699","name":"Dr Alan Munn","data":{"first_name":"Alan","title":"Dr","dw_individual_id":"DW0038670","middle_name":"Leslie","last_name":"Munn","source_individual_id":"RMIS1725772","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Alan Munn"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87019","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4533","size":1},{"color":"#FF4D4D","name":"Molecular basis of dengue virus-induced fusion","data":{"media_summary":"","end_year":2005,"keywords":["antiviral agents","dengue virus","envelope protein","membrane fusion","protein structure"],"nhmrc_grant_id":252739,"application_year":2002,"health_keywords":["antiviral drug","dengue fever","infectious disease","vaccine"],"scientific_title":"Molecular basis of dengue virus-induced fusion","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Paul Young","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252739","simplified_title":"Understanding how dengue virus enters cells","sub_type":"Standard Project Grant","total_budget":"410250","source_system":"Dengue viruses are transmitted by mosquitoes and cause major epidemics in more than 100 countries in tropical and subtropical regions. Infection with Dengue viruses cause Dengue fever or its more severe and sometimes fatal form, Dengue hemmorrhagic fever-Dengue shock syndrome (DHF-DSS). Up to 100 million people are infected annually making Dengue virus one of the most important and frequent mosquito-borne viral diseases worldwide. Over the past two decades, the incidence of Dengue virus infection has increased steadily. More than 40% of the world's population is at risk of infection and this number is expected to increase as more people travel. This proposal focuses on the way dengue virus enters cells, specifically the mechanism used by viral proteins to mediate fusion of the viral membrane with that of the host cell. A clearer understanding of the molecular basis of this process should provide potential targets for new drugs that can bind and block this process. In addition, we will also use this information in the design and generation of new vaccine candidates."},"children":[{"color":"#336699","name":"Prof Bostjan Kobe","data":{"first_name":"Bostjan","title":"Prof","dw_individual_id":"DW0031827","middle_name":"","last_name":"Kobe","source_individual_id":"5011436","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bostjan Kobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85237","size":1},{"color":"#336699","name":"Prof Paul Young","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0005625","middle_name":"R","last_name":"Young","source_individual_id":"RMIS20614","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78234","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4530","size":1},{"color":"#FF4D4D","name":"Structural biology","data":{"media_summary":"","end_year":2007,"keywords":["molecular biology","treatments"],"nhmrc_grant_id":252736,"application_year":2002,"start_year":2003,"scientific_title":"Structural biology","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Basic Science","for_category":"","cia_name":"Prof Bostjan Kobe","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252736","simplified_title":"Structural biology","sub_type":"Research Fellowship","total_budget":"453000","source_system":""},"children":[{"color":"#336699","name":"Prof Bostjan Kobe","data":{"first_name":"Bostjan","title":"Prof","dw_individual_id":"DW0031827","middle_name":"","last_name":"Kobe","source_individual_id":"5011436","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bostjan Kobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85237","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4529","size":1},{"color":"#FF4D4D","name":"Structure and Gene Regulation of Human Glutathione Transferase GSTT1-1","data":{"media_summary":"","end_year":2005,"keywords":["Enzyme regulation","Enzyme structure","Promotor analysis","Xenobiotic & drug metabolism: glutathione transferases"],"nhmrc_grant_id":252735,"application_year":2002,"health_keywords":["Cancer susceptibility","Drug resistamce in cancer","Neurodegenerative diseases","Occupational health"],"scientific_title":"Structure and Gene Regulation of Human Glutathione Transferase GSTT1-1","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Toxicology (incl. Clinical Toxicology)","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Ricarda Thier","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252735","simplified_title":"Glutathione Transferase GSTT1","sub_type":"New Investigator Grant","total_budget":"250500","source_system":"Glutathione transferases (GSTs) play a critical role cellular detoxification system. They belong to the phase II enzymes of the xenobiotic metabolism and conjugate a wide range of drugs and chemicals with glutathione to increase water solubility and thereby enhancing their elimination. The conjugation with glutathione is considered an important detoxification route for most chemicals. However, it has been shown that in many cases this pathway leads to metabolites that are more toxic than the initial chemical or drug. The gene deletion of the particular human GSTT1 gene results in total loss of this particular enzyme activity in all tissues of homozygous null genotype individuals. This phenotype is called non-conjugator . Non-conjugators seem to have a higher risk to develop certain cancer types, e.g. urinary bladder cancer or brain tumours, while they seem to be less susceptible for others, e.g. liver. Occupational exposure to chemicals is of relevance in such relationships because the GSTT1 enzyme metabolises a wide range of industrial chemicals including solvents but also monomers used in the production of rubbers and other polymers. In addition, GSTT1 seems to influence the efficay of cancer chemotherapy by inactivating certain anti-cancer drugs, eg. BCNU, that is predominantly use in treatment of brain tumours. The aims of this study include the characterisation of the tissue-specific activity and the influence of xenobiotics on the protein levels of this enzyme. The study leads to a better understanding of the etiology of exposure related cancers and of the mechanisms of resistance to cancer chemotherapy. Such knowledge allows the development of concepts for the optimisation of efficacy and minimisation of side effects in chemotherapy."},"children":[{"color":"#336699","name":"Dr Ricarda Thier","data":{"first_name":"Ricarda","title":"Dr","dw_individual_id":"DW0028359","middle_name":"","last_name":"Thier","source_individual_id":"RMIS1086167","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Ricarda Thier"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84330","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4528","size":1},{"color":"#FF4D4D","name":"Structure, function and regulation of human cytosolic sulfotransferases","data":{"media_summary":"","end_year":2005,"keywords":["Drug conjugation","Molecular pharmacology","Structure-activity relationships","Toxicology","Xenobiotic metabolism"],"nhmrc_grant_id":252734,"application_year":2002,"health_keywords":["Drug metabolism and xenobiotics","Drug toxicity","Pharmacology - toxicology","Sulfation"],"scientific_title":"Structure, function and regulation of human cytosolic sulfotransferases","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Toxicology (incl. Clinical Toxicology)","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Mick McManus","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252734","simplified_title":"The role of sulfotransferases in drug and chemical metabolism","sub_type":"Standard Project Grant","total_budget":"265500","source_system":"The sulfotransferase family of enzymes serve an important role in the metabolism of drugs and foreign chemicals. They also metabolise a range of chemicals that are normally present in the body such as hormones and substances that are involved in brain function (neurotransmitters). Observations from clinical studies suggest that differences in sulfotransferases activities may be a causal factor in the incidence of certain types of cancer and neurodegenerative diseases. Recent advances in understanding the molecular biology of these enzymes have shown us that multiple forms of sulfotransferase existed within the body. In this area my laboratory has been at the forefront of the cloning and characterisation of these enzymes. Indeed, we were the first laboratory to clone the major human sulfotransferase (SULT1A3) responsible for the metabolism of brain neurotransmitters. We have also used new technology to determine the shape of this important enzyme. At the time of writing my laboratory has characterised a total seven human sulfotransferases but unlike SULT1A3, our knowledge of the functional significance of the other six sulfotransferase is poorly understood. Further, our knowledge of what regulates the amount of sulfotransferase in different tissues is practically nonexistent. The thrust of this project is to extend our studies on the physiological function of these enzymes and also through the use of molecular biology techniques understand what controls the level of their expression in different human tissues. This knowledge will provide a basis for understanding the role of sulfotransferases play in drug and chemical metabolism. It will also aid our understanding of their role in hormone and neurotransmitter metabolism and help determine whether they are involved in such diseases as cancer and neurodegenerative diseases."},"children":[{"color":"#336699","name":"Prof Mick Mcmanus","data":{"first_name":"Mick","title":"Prof","dw_individual_id":"DW0020792","middle_name":"","last_name":"Mcmanus","source_individual_id":"RMIS1086175","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mick Mcmanus"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82320","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4527","size":1},{"color":"#FF4D4D","name":"A multiple antigen lipophilic adjuvant carrier (MALAC) system","data":{"media_summary":"","end_year":2003,"keywords":["Adjuvant carrier system","Drug Delivery","Enhanced immunogenicity","Lipoamino acids","Multiple-antigen-lipophilic-adjuvant-carrier (MALAC)"],"nhmrc_grant_id":252733,"application_year":2002,"health_keywords":["Group A Streptococcal Peptide Vaccine","Immunisation","Oral Vaccination","Safe and Controlled Vaccine Design"],"scientific_title":"A multiple antigen lipophilic adjuvant carrier (MALAC) system","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmaceutical Sciences and Pharmacy","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Istvan TOTH","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252733","simplified_title":"A novel immunoadjuvant system","sub_type":"Standard Project Grant","total_budget":"141500","source_system":"We have developed a Multiple-Antigen-Lipophilic-Adjuvant-Carrier (MALAC) system, based on the incorporation of lipoamino acids into a poly-functional core that provides an excellent means for enhancing the antigenicity of a potential peptide vaccine. A system is used for generating antibodies without the use of any conventional adjuvant. The system comprises two or more different antigens and one or more lipid anchor. The key of this system is a novel carrier construct, which is non-toxic and non-immunogenic. The system contains variables, which allow optimising its structural configuration. A small library of poly-functional MALAC system will be synthesised in a controlled step-by-step way combining solution or solid phase techniques, where the exact chemical structure (and the order of the different immunological peptide sequences) of the construct is pre-determined. The antigenicity and the protection against disease will be compared with antigenicity and protection generated using conventional vaccine carriers. We also aim to exploit the particulate-forming properties of the lipo-peptide amphiphiles, to form micro-particulate oral antigens, exploiting the phenomenon of particulate uptake from the GI tract by the GALT or other intestinal sites. The MALAC constructs will be administered orally followed by the measurement of the serum IgG. Vaccination via the oral route is highly desirable, since it can overcome many of the disadvantages inherent in administration by injection - e.g. poor patient acceptability, requirement of skilled medical personnel, risk of HIV and other blood-born diseases, restricted availability and sometimes, stimulation of the wrong type of immunity. Development of vaccines for oral administration make them much more widely available, permitting self-administration and improving the operation of Public-Health vaccination programs, particularly in developing countries."},"children":[{"color":"#336699","name":"Prof Istvan Toth","data":{"first_name":"Istvan","title":"Prof","dw_individual_id":"DW0034329","middle_name":"","last_name":"Toth","source_individual_id":"RMIS17214","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Istvan Toth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85883","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4526","size":1},{"color":"#FF4D4D","name":"preclinical","data":{"media_summary":"","end_year":2007,"keywords":["Pharmacology","Treatments"],"nhmrc_grant_id":252720,"application_year":2002,"start_year":2003,"scientific_title":"preclinical","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Ronald Dickinson","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252720","simplified_title":"preclinical","sub_type":"Research Fellowship","total_budget":"707250","source_system":""},"children":[{"color":"#336699","name":"Prof Ronald Dickinson","data":{"first_name":"Ronald","title":"Prof","dw_individual_id":"DW0036292","middle_name":"G","last_name":"Dickinson","source_individual_id":"RMIS8307","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ronald Dickinson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86406","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4525","size":1},{"color":"#FF4D4D","name":"Implementation and evaluation of a diabetes intervention program in indigenous Australian Communities.","data":{"media_summary":"","end_year":2005,"keywords":["health education","indigenous health","lifestyle factors","primary health care"],"nhmrc_grant_id":252719,"application_year":2002,"health_keywords":["diabetes (type 2)","life-skills development","primary health care in indigenous communities"],"scientific_title":"Implementation and evaluation of a diabetes intervention program in indigenous Australian Communities.","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Indigenous Health","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Joanne Shaw","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252719","simplified_title":"The impact of a lifestyle change program in Aboriginal people with Type 2 diabetes.","sub_type":"Standard Project Grant","total_budget":"173625","source_system":"Approximately 700,000 Australians have type 2 diabetes (also termed maturity-onset diabetes or non-insulin dependent diabetes), which is a condition associated with reduced lifespan, eye disease, heart disease, renal disease, stroke, and foot complications leading to amputation. Indigenous Australians are at particularly high risk, with over 30% of adults affected by this condition in a number of communities, associated with significant morbidity and mortality. Early diagnosis, healthy lifestyle modification and tight control of the blood sugar levels, blood pressure and cholesterol are the keys to preventing the complications of diabetes. Self-management is central to success, and education, support and encouragement play an important role. This research project incorporates an education program that has been developed in partnership with the indigenous health team at Cherbourg. Particular strengths include the emphasis on family involvement and community support. The central role of the indigenous health team will ensure continuity of benefit to the community. If proven to be effective, the program could be used as a model for interventions in other community settings to reduce the burden from type 2 diabetes in the indigenous Australian population."},"children":[{"color":"#336699","name":"A/Pr Joanne Shaw","data":{"first_name":"Joanne","title":"A/Pr","dw_individual_id":"DW0039647","middle_name":"T.E.","last_name":"Shaw","source_individual_id":"RMIS13660","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Joanne Shaw"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87282","size":1},{"color":"#336699","name":"Prof Cindy Shannon","data":{"first_name":"Cindy","title":"Prof","dw_individual_id":"DW0033749","middle_name":"Anne-Maree","last_name":"Shannon","source_individual_id":"RMIS383276","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Cindy Shannon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85739","size":1},{"color":"#336699","name":"Prof Stewart Trost","data":{"first_name":"Stewart","title":"Prof","dw_individual_id":"DW0028465","middle_name":"Graeme","last_name":"Trost","source_individual_id":"5050183","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stewart Trost"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84362","size":1},{"color":"#336699","name":"Prof Wendy Brown","data":{"first_name":"Wendy","title":"Prof","dw_individual_id":"DW0023824","middle_name":"J","last_name":"Brown","source_individual_id":"RMIS1714084","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wendy Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83116","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4524","size":1},{"color":"#FF4D4D","name":"Genetic analysis of type 2 diabetes in indigenous Australian   pedigrees.","data":{"media_summary":"","end_year":2005,"keywords":["Linkage analysis","Medical genetics","Mutation detection","Susceptibility genes","Type 2 Diabetes"],"nhmrc_grant_id":252717,"application_year":2002,"health_keywords":["Indigenous Health","Medical genetics","Type 2 Diabetes"],"scientific_title":"Genetic analysis of type 2 diabetes in indigenous Australian   pedigrees.","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"GENETICS","cia_name":"A/Pr Joanne Shaw","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252717","simplified_title":"Genetic analysis of type 2 diabetes in indigenous Australian   pedigrees.","sub_type":"Standard Project Grant","total_budget":"502500","source_system":"Type 2 diabetes is a major world health problem. With 300 million people expected to be affected worldwide by 2025 it is a major economic burden. It is a leading cause of kidney failure, blindness, heart attacks, strokes and amputations. Over 7% of the general Australian population have type 2 diabetes, whilst up to 30% of the population in some indigenous communities are affected by this condition. Very few Australians have not been touched in some way by the shadow of diabetes. The precise cause of diabetes is unknown, however we do know that it tends to run in families, indicating that inherited tendency is important. This research program will find genes which cause diabetes by searching for them in indigenous Australian pedigrees in which many of the family members are affected by diabetes. Finding the genes which cause diabetes will have significant impact in at least three major ways. Firstly, it will increase our understanding of the disease process. Secondly, it will be possible to develop tests to identify people at risk of diabetes at a very early stage so that therapy can be introduced and complications averted. Thirdly, it will be possible to develop new and more effective approaches for the prevention and treatment of type 2 diabetes."},"children":[{"color":"#336699","name":"A/Pr Joanne Shaw","data":{"first_name":"Joanne","title":"A/Pr","dw_individual_id":"DW0039647","middle_name":"T.E.","last_name":"Shaw","source_individual_id":"RMIS13660","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Joanne Shaw"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87282","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4523","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2007,"keywords":["Kidney"],"nhmrc_grant_id":252713,"application_year":2002,"start_year":2003,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/252713","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"643687.5","source_system":""},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4522","size":1},{"color":"#FF4D4D","name":"A randomised control trial of physiotherapy and corticosteroid injections of lateral epicondylalgia in primary care.","data":{"media_summary":"primary health care","end_year":2005,"keywords":["evidence based practice","musculoskeletal pain","physical therapy","primary health care","randomised clinical trial"],"nhmrc_grant_id":252710,"application_year":2002,"health_keywords":["corticosteroid injection research","lateral epicondylalgia (tennis elbow, epicondylitis)","musculoskeletal injury (overuse)","physiotherapy","primary health care"],"scientific_title":"A randomised control trial of physiotherapy and corticosteroid injections of lateral epicondylalgia in primary care.","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Bill (Guglielmo) Vicenzino","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252710","simplified_title":"A clinical study of physiotherapy and injections for tennis elbow in primary health care setting.","sub_type":"Standard Project Grant","total_budget":"193775","source_system":"Musculoskeletal conditions account for the third leading cause of health systems expenditure in Australia. Lateral epicondylalgia (tennis elbow) is such a condition and is often treated in primary care. Both the individual and community are affected by this condition: 7 per 1000 patients seeing their medical doctor have this condition. Most are not tennis related. On average 10-30% of sufferers take 12 weeks off work. The condition may last 6-48 months and it tends to become stubborn to treatment and recurs often. Two popular treatment options that are commonly prescribed for the management of lateral epicondylalgia are physiotherapy and corticosteroid injections. To date there is little evidence supporting physiotherapy, especially current best practice methods such as manual therapy and therapeutic exercise. The lack of evidence is largely due to a small number of studies of physiotherapy, most of which are of poor quality and of treatments that are currently deemed to be less than optimal. A larger number of studies of corticosteroid injections have shown that corticosteroid injections are beneficial in the short term (3-6 weeks), but not over 12 months where they are associated with greater recurrence rates. Manual therapy has been shown to have short term pain relieving effects and therapeutic exercise exerts long standing improvements in this condition. It is proposed that the addition of manual therapy to therapeutic exercise will have superior short- and long-term effects. This project will conduct a randomised clinical trial to evaluate this proposition and also the factors associated with success, failure or recurrence rates. A cost-benefit analysis will also be conducted to calculate the relative economic merits of the treatments. A tangible outcome of this project will be the development of clinical guidelines for the most effective method of treating lateral epicondylalgia in primary health care."},"children":[{"color":"#336699","name":"Prof Guglielmo Vicenzino","data":{"first_name":"Guglielmo","title":"Prof","dw_individual_id":"DW0046019","middle_name":"Tarcisio","last_name":"Vicenzino","source_individual_id":"5018115","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Guglielmo Vicenzino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88911","size":1},{"color":"#336699","name":"Prof Peter Brooks","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0035559","middle_name":"M","last_name":"Brooks","source_individual_id":"5013624","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Brooks"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86210","size":1},{"color":"#336699","name":"E/Pr Gwendolen Jull","data":{"first_name":"Gwendolen","title":"E/Pr","dw_individual_id":"DW0019981","middle_name":"A","last_name":"Jull","source_individual_id":"RMIS5215","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"E/Pr Gwendolen Jull"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82087","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4521","size":1},{"color":"#FF4D4D","name":"Genetic programs regulated by the nuclear hormone receptor, LXR, in muscle: control of cholesterol and lipid metabolism","data":{"media_summary":"Obesity","end_year":2005,"keywords":["Expression Profiling and Gene Arrays","Gene Regulation","Nuclear Hormone Receptors","Skeletal Muscle Metabolism","Steroid Receptors"],"nhmrc_grant_id":252702,"application_year":2002,"health_keywords":["Biological Science","Cardiovascular disease","Dyslipidemia","Endocrine diseases and Diabetes","Obesity"],"scientific_title":"Genetic programs regulated by the nuclear hormone receptor, LXR, in muscle: control of cholesterol and lipid metabolism","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/252702","simplified_title":"Understanding how cholesterol regulates lipid metabolism in skeletal muscle","sub_type":"Standard Project Grant","total_budget":"425250","source_system":"The heightened occurrence of cardiovascular disease has been linked to disorders in lipid metabolism. Obesity, insulin resistance, and atherosclerosis are prevalent diseases associated with these dyslipidemias. Lipid homeostasis is regulated by dietary intake, de novo synthesis and catabolism. Disorders of lipid metabolism are associated with cardiovascular disease, insulin resistance-diabetes, obesity and hypertension. Raised levels of serum TGs, and low high density lipoprotein (HDL) cholesterol levels are characteristic of lipotoxic diseases. HDLs have a defensive role in the prevention of atherogenic dyslipidemia by mediating cholesterol efflux from peripheral tissues through the hormone -dependent ATP-binding cassette (ABC) transporters back to the liver for excretion and elimination. Agents that raise the levels of high density lipoprotein cholesterol (HDLc) through cholesterol efflux provide a pharmaceutical solution for the prevention of hypercholesterolemia, atherogenic and cardiovascular disease. These hormone dependent cholesterol and lipid effluxing proteins are regulated by a protein named LXR. Understanding the functional role of LXR in skeletal muscle, a peripheral tissue that accounts for 40% of total body weight is of paramount importance in understanding whole body cholesterol homeostasis and lipid metabolism. Furthermore, LXR and LXR target genes that facilitate cholesterol efflux and consequently raise HDLc levels are important pharmaceutical targets. Identification of novel LXR targets in skeletal muscle, which has a significant role in insulin sensitivity and the blood lipid profile provides an additional platform for therapeutic intervention."},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4520","size":1},{"color":"#FF4D4D","name":"The role of plasma membrane microdomains in cellualar function","data":{"media_summary":"","end_year":2007,"keywords":["Caveolae","Plasma Membrane","Ras","Signal Transduction"],"nhmrc_grant_id":252701,"application_year":2002,"start_year":2003,"scientific_title":"The role of plasma membrane microdomains in cellualar function","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof John Hancock","higher_grant_type":"Programs","purl":"http://purl.org/au-research/grants/nhmrc/252701","simplified_title":"Plasma membrane structure and function","sub_type":"Program Grant","total_budget":"4083868.8","source_system":"The planned research program relates to novel hypotheses regarding the role of cell surface domains in organising signalling pathways at the cell surface. The proposal will involve identifying the domains and molecules involved in specific signalling pathways and dissecting the formation and function of surface structures called caveolae. The findings will have huge importance for therapeutic strategies aimed at combating the cellular changes associated with cell transformation in cancer and other human diseases."},"children":[{"color":"#336699","name":"Prof John Hancock","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0037089","middle_name":"F","last_name":"Hancock","source_individual_id":"RMIS11500","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Hancock"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86600","size":1},{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4519","size":1},{"color":"#FF4D4D","name":"Fetal wound healing; an ovine model for scarless wound recovery in burns patients","data":{"media_summary":"","end_year":2003,"keywords":["Burns","Children","Skin","Trauma","Wound healing"],"nhmrc_grant_id":243706,"application_year":2002,"start_year":2003,"scientific_title":"Fetal wound healing; an ovine model for scarless wound recovery in burns patients","node_source":"NHMRC","node_type":"Grant","field_of_research":"Surgery","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr John Fraser","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/243706","simplified_title":"Fetal wound healing; an ovine model for scarless wound recovery in burns patients","sub_type":"Medical Postgraduate Scholarship","total_budget":"28432","source_system":""},"children":[{"color":"#336699","name":"Prof John Fraser","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0007344","middle_name":"Francis","last_name":"Fraser","source_individual_id":"5011410","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Fraser"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78686","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4340","size":1},{"color":"#FF4D4D","name":"A cluster-randomised trial of a health behaviour intervention linking general practice and community care","data":{"media_summary":"","end_year":2008,"keywords":["Primary Health Care"],"nhmrc_grant_id":242227,"application_year":2002,"start_year":2003,"scientific_title":"A cluster-randomised trial of a health behaviour intervention linking general practice and community care","node_source":"NHMRC","node_type":"Grant","field_of_research":"Primary Health Care","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Elizabeth Eakin","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/242227","simplified_title":"A cluster-randomised trial of a health behaviour intervention linking general practice and community care","sub_type":"Population Health CDF","total_budget":"435500","source_system":""},"children":[{"color":"#336699","name":"Prof Elizabeth Eakin","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0036429","middle_name":"G","last_name":"Eakin","source_individual_id":"5014455","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Elizabeth Eakin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86445","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4333","size":1},{"color":"#FF4D4D","name":"Investigation of Cancer Predisposition in Heterozygous Carriers of the ATM","data":{"media_summary":"","end_year":2007,"keywords":["Cancer","Cre/lox mice","DNA damage","genetic disease","ionizing radiation"],"nhmrc_grant_id":241925,"application_year":2002,"health_keywords":["Cancer","ataxia-telangiectasia","immunodeficiency","neurodegenerative disease"],"scientific_title":"Investigation of Cancer Predisposition in Heterozygous Carriers of the ATM","start_year":2003,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/241925","simplified_title":"Cancer susceptibility in ataxia-telangiectasia","sub_type":"Standard Project Grant","total_budget":"822750","source_system":"Individuals with the human genetic disorder ataxia-telangiectasia are prone to cancer development and so also are their parents and relatives (carriers) who have one defective copy of the gene. This is a multisystem disease that is also characterized by neurodegeneration, immunodeficiency, infertility and extreme sensitivity to radiation. This project is designed to generate a mouse model of this disease to investigate cancer susceptibility in carriers of the defective gene. The specific mutation to be introduced into the mouse has been described in a patient with breast cancer and it has been shown to interfere with the normal function of the ATM protein. The mouse model is expected to reflect closely the human disease and will provide the opportunity to monitor heterozygous carriers for the development of cancer. This model is expected to confirm the observations in humans and provide a resource to understand susceptibility to develop cancer. The model will also address the issue of exposure to low dose radiation and risk of developing cancer."},"children":[{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4311","size":1},{"color":"#FF4D4D","name":"Understanding the neuropathology of Down Syndrome and identification of molecular targets for therapeutic interventions","data":{"media_summary":"","end_year":2008,"keywords":["RT-PCR","down syndrome","genomics","interneurons","patch-clamp whole cell recording"],"nhmrc_grant_id":237028,"application_year":2002,"start_year":2003,"scientific_title":"Understanding the neuropathology of Down Syndrome and identification of molecular targets for therapeutic interventions","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Dr Randal Moldrich","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/237028","simplified_title":"Understanding the neuropathology of Down Syndrome and identification of molecular","sub_type":"CJ Martin Biomedical ECF","total_budget":"521576.44","source_system":""},"children":[{"color":"#336699","name":"Dr Randal Moldrich","data":{"first_name":"Randal","title":"Dr","dw_individual_id":"DW0020936","middle_name":"Xavier","last_name":"Moldrich","source_individual_id":"RMIS1945684","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Randal Moldrich"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82360","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/4256","size":1},{"color":"#FF4D4D","name":"Evaluation of an Integrated Strategy to Promote the Health of People with Chronic or Recurring Mental Disorders","data":{"media_summary":"","end_year":2008,"keywords":["Chronic or recurring mental disorders","Health Promotion Intervention","Indigenous health","Primary Health Care","Rural and Remote Health"],"nhmrc_grant_id":219327,"application_year":2002,"start_year":2003,"scientific_title":"Evaluation of an Integrated Strategy to Promote the Health of People with Chronic or Recurring Mental Disorders","node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Kavanagh","higher_grant_type":"NHMRC Partnerships","purl":"http://purl.org/au-research/grants/nhmrc/219327","simplified_title":"Evaluation of an Integrated Strategy to Promote the Health of People with Chronic or Recurring Mental Disorders","sub_type":"Health Research Partnership in Mental Health","total_budget":"2500000","source_system":""},"children":[{"color":"#336699","name":"Prof Christopher Del Mar","data":{"first_name":"Christopher","title":"Prof","dw_individual_id":"DW0041984","middle_name":"B","last_name":"Del Mar","source_individual_id":"RMIS2365573","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Christopher Del Mar"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87888","size":1},{"color":"#336699","name":"Prof Helen Bartlett","data":{"first_name":"Helen","title":"Prof","dw_individual_id":"DW0040986","middle_name":"P","last_name":"Bartlett","source_individual_id":"5013364","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Helen Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87634","size":1},{"color":"#336699","name":"Dr Lindsay Oades","data":{"first_name":"Lindsay","title":"Dr","dw_individual_id":"DW0032923","middle_name":"G","last_name":"Oades","source_individual_id":"RMIS2071857","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Lindsay Oades"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85534","size":1},{"color":"#336699","name":"Prof Ernest Hunter","data":{"first_name":"Ernest","title":"Prof","dw_individual_id":"DW0025657","middle_name":"","last_name":"Hunter","source_individual_id":"RMIS226584","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ernest Hunter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83608","size":1},{"color":"#336699","name":"Prof Frank Deane","data":{"first_name":"Frank","title":"Prof","dw_individual_id":"DW0024469","middle_name":"P","last_name":"Deane","source_individual_id":"RMIS116580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Frank Deane"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83280","size":1},{"color":"#336699","name":"Prof Mark Oakley Browne","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0021191","middle_name":"A","last_name":"Oakley Browne","source_individual_id":"5016755","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Mark Oakley Browne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82431","size":1},{"color":"#336699","name":"A/Pr Patricia Nagel","data":{"first_name":"Patricia","title":"A/Pr","dw_individual_id":"DW0021057","middle_name":"May","last_name":"Nagel","source_individual_id":"5012262","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Patricia Nagel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82398","size":1},{"color":"#336699","name":"Prof Graham Martin","data":{"first_name":"Graham","title":"Prof","dw_individual_id":"DW0008917","middle_name":"Edward","last_name":"Martin","source_individual_id":"RMIS3037699","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Graham Martin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79115","size":1},{"color":"#336699","name":"Prof David Kavanagh","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0008308","middle_name":"J","last_name":"Kavanagh","source_individual_id":"RMIS41345","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Kavanagh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78938","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3992","size":1},{"color":"#FF4D4D","name":"Development of a diagnostic test for bipolar disorder (BD)","data":{"media_summary":"","end_year":2004,"keywords":["Bipolar Disorder","Interhemispheric switching","Manic-depression","Neural rhythms","Perceptual rivalry"],"nhmrc_grant_id":252904,"application_year":2001,"start_year":2003,"scientific_title":"Development of a diagnostic test for bipolar disorder (BD)","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof John Pettigrew","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/252904","simplified_title":"Manic depression diagnosis","sub_type":"Development Grant","total_budget":"140330","source_system":"A unique test that monitors the rate of switching between the hemispheres of the brain in response to visual stimuli has been devised. A patent application covers an apparatus and test to measure the switching rate between the hemispheres and the way in which such measurements can be used as a means to diagnose bipolar disorder (BD). BD, also called manic depression, is a form of depression that currently affects over six million people worldwide with about three million in the USA alone. The condition has phases of mania and depression and periods of remittance. Full cycles of BD can occur as many as three times a year and for many patients, this is a lifelong condition. BD is effectively treated, once it is diagnosed. It is estimated that 20% of sufferers go undiagnosed and many more are misdiagnosed. The cost of mis- or non-diagnosis is measured by suicides, the financial burden on society with health care, loss of productivity etc, effects on family and associates, crime, etc. Diagnosis to date is achieved mainly by subjective means such as questionnaires. These instruments do not conclusively separate BD from other forms of depression and schizophrenia, for which treatment is quite different. Nor do they allow for factors such as substance abuse and other medical conditions that the patient may be suffering. BD is hereditary with the slow hemispheric switch rate being an indicator of the genetic trait. This phenomenon allows for an objective test for BD, even if an individual has not had an episode of BD. The slow switch allows relatively easy separation of a BD patient from those exhibiting symptoms that may have other causes."},"children":[{"color":"#336699","name":"John Pettigrew","data":{"first_name":"John","title":"","dw_individual_id":"DW0015559","middle_name":"","last_name":"Pettigrew","source_individual_id":"RMIS31384","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"John Pettigrew"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80922","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3969","size":1},{"color":"#FF4D4D","name":"Methodology for population health research: training and innovation in longitudinal studies","data":{"media_summary":"","end_year":2007,"keywords":["Longitudinal study","biostatistical methods","population health","record linkage","social research"],"nhmrc_grant_id":252834,"application_year":2001,"start_year":2002,"scientific_title":"Methodology for population health research: training and innovation in longitudinal studies","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Gail Williams","higher_grant_type":"Capacity","purl":"http://purl.org/au-research/grants/nhmrc/252834","simplified_title":"Methodology for longitudinal population health research","sub_type":"Population Health Capacity Building Grant","total_budget":"1963750","source_system":"This proposal builds on the applicants' experience with existing cohort studies to identify, evaluate and address areas of methodological concern, particularly with longitudinal studies. The group's ability to develop robust longitudinal methods in relation to these concerns will have the potential for both increasing knowledge of the determinants of population health and increasing their ability to attract trainee biostatisticians, an identified area of need in the country as a whole. The grant will help position Australia at the cutting edge of research skills and methodology involved with longitudinal studies. Longitudinal studies provide a powerful means of collecting information about the health of populations. This grant will use multi-disciplinary approaches to develop innovative methods for designing longitudinal studies, collecting and analysing data and communicating results to improve people's health."},"children":[{"color":"#336699","name":"Prof Philip Schluter","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0039558","middle_name":"John","last_name":"Schluter","source_individual_id":"RMIS1697880","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Philip Schluter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87260","size":1},{"color":"#336699","name":"Prof Annette Dobson","data":{"first_name":"Annette","title":"Prof","dw_individual_id":"DW0036318","middle_name":"J","last_name":"Dobson","source_individual_id":"5011952","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Annette Dobson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86411","size":1},{"color":"#336699","name":"David Purdie","data":{"first_name":"David","title":"","dw_individual_id":"DW0033272","middle_name":"","last_name":"Purdie","source_individual_id":"RMIS5967","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Purdie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85621","size":1},{"color":"#336699","name":"Prof Adele Green","data":{"first_name":"Adele","title":"Prof","dw_individual_id":"DW0030993","middle_name":"C","last_name":"Green","source_individual_id":"RMIS3935","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Adele Green"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85033","size":1},{"color":"#336699","name":"Prof Alan Lopez","data":{"first_name":"Alan","title":"Prof","dw_individual_id":"DW0026372","middle_name":"Donald","last_name":"Lopez","source_individual_id":"5012116","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alan Lopez"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83819","size":1},{"color":"#336699","name":"Prof Gail Williams","data":{"first_name":"Gail","title":"Prof","dw_individual_id":"DW0017119","middle_name":"Marilyn","last_name":"Williams","source_individual_id":"RMIS28497","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gail Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81346","size":1},{"color":"#336699","name":"Prof Jackob Najman","data":{"first_name":"Jackob","title":"Prof","dw_individual_id":"DW0003590","middle_name":"Moses","last_name":"Najman","source_individual_id":"5016639","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jackob Najman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77655","size":1},{"color":"#336699","name":"Dr Chris Bain","data":{"first_name":"Chris","title":"Dr","dw_individual_id":"DW0000195","middle_name":"J","last_name":"Bain","source_individual_id":"5013299","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Chris Bain"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76709","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3968","size":1},{"color":"#FF4D4D","name":"Improving first trimester screening by combining rapid MF-PCR of PAP smears with nuchal ultrasound scanning","data":{"media_summary":"","end_year":2004,"keywords":["First trimester prenatal diagnosis","Fluorescent PCR","Non-invasive testing","Nuchal screening","PAP smear sampling"],"nhmrc_grant_id":252756,"application_year":2001,"start_year":2002,"scientific_title":"Improving first trimester screening by combining rapid MF-PCR of PAP smears with nuchal ultrasound scanning","node_source":"NHMRC","node_type":"Grant","field_of_research":"Diagnostic Applications","research_area":"Clinical Medicine and Science","for_category":"BIOTECHNOLOGY","cia_name":"Dr Ian Findlay","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/252756","simplified_title":"Improving first trimester prenatal diagnosis screening - rapid prenatal screening for everyone","sub_type":"Development Grant","total_budget":"206809.63","source_system":"Genetic defects are the major cause of embryonic and foetal death as well as being responsible for a large proportion of childhood disabilities. Although many are detected by the ~50,000 prenatal tests currently performed annually in Australia, these methods are only offered to high risk mothers because they are invasive (~1% risk of miscarriage), and-or expensive. A rapid, low cost, less invasive and safer alternative prenatal diagnostic method such as PAP smears that could be offered to all mothers regardless of risk is therefore of immense value both to mothers and to the health care system. This proposal enhances first trimester screening by improving prenatal diagnosis from PAP smears. Although normally taken to detect cancer, these smears contain significant numbers of foetal cells. We will investigate: the best way and time to obtain these cells, the best way to remove the cells from any contamination, improvements in genetic diagnosis of these cells using a technique known as MF-PCR which is rapidly revolutionising conventional prenatal diagnosis. By automating these procedures, they will become less expensive and more accessible to all mothers regardless of risk. We will also compare these procedures with alternative first trimester screening techniques such as nuchal translucency to determine the value of both tests singly and in combination. This research should provide a safe, reliable and accurate method allowing inexpensive prenatal screening to be available for all pregnancies. General screening programmes using this new test, particularly if combined with nuchal translucency programmes, would result in a dramatic reduction in affected babies with major implications to families and the health care system."},"children":[{"color":"#336699","name":"Dr Ian Findlay","data":{"first_name":"Ian","title":"Dr","dw_individual_id":"DW0042373","middle_name":"","last_name":"Findlay","source_individual_id":"RMIS510603","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Ian Findlay"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87992","size":1},{"color":"#336699","name":"Prof Fung Yee Chan","data":{"first_name":"Fung Yee","title":"Prof","dw_individual_id":"DW0041537","middle_name":"","last_name":"Chan","source_individual_id":"RMIS194284","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Fung Yee Chan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87778","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3967","size":1},{"color":"#FF4D4D","name":"Optimising Cognitive Screening in General Practice","data":{"media_summary":"","end_year":2005,"keywords":["ageing","cognitive impairment","memory"],"nhmrc_grant_id":252704,"application_year":2001,"start_year":2003,"scientific_title":"Optimising Cognitive Screening in General Practice","node_source":"NHMRC","node_type":"Grant","field_of_research":"Learning, Memory, Cognition and Language","research_area":"Clinical Medicine and Science","for_category":"PSYCHOLOGY","cia_name":"Prof Michael Humphreys","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/252704","simplified_title":"Memory Screening in General Practice","sub_type":"Development Grant","total_budget":"300550","source_system":"Within the next 5 - 10 years it is likely that sophisticated combination pharmacotherapy for Alzheimer's disease will become available. Once intervention agents are available that affect the underlying disease process, it will be critical to accurately identify those patients who are in the earliest stages of cognitive decline. That is, failure to detect cognitive decline at an early stage will reduce the effectiveness of the intervention and be costly to the individual and society. At the same time, the probability of falsely identifying an individual as having Alzheimer's disease needs to be reduced in order to avoid unnecessary testing, anxiety and distress, and expense. A sophisticated and highly flexible testing system to detect the earliest stages of memory impairment will be developed. The test will be administered over the web in a general practitioner's surgery enabling the collection of normative data on the population of greatest interest (elderly patients seeing their doctor). Voice recognition technology will be used in order to insure a user friendly environment. Stringent procedures to protect privacy will be employed. The test will be inexpensive and easy to take and will allow valid retesting so that it can be used as part of the routine health screening for the elderly. This will be a far more sensitive and specific indicator of the cognitive decline found in most neurodegenerative disorders such as Alzheimer's disease, and will enable general practitioners to be more confident in assessing their older patients. It will also reduce costly referrals by more accurately identifying those patients at risk. It is expected that the test will find acceptance amongst patients and their doctors and become a routine part of normal health screening for the elderly."},"children":[{"color":"#336699","name":"Prof Christopher Del Mar","data":{"first_name":"Christopher","title":"Prof","dw_individual_id":"DW0041984","middle_name":"B","last_name":"Del Mar","source_individual_id":"RMIS2365573","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Christopher Del Mar"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87888","size":1},{"color":"#336699","name":"Prof Gerard Byrne","data":{"first_name":"Gerard","title":"Prof","dw_individual_id":"DW0023904","middle_name":"James","last_name":"Byrne","source_individual_id":"5013745","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gerard Byrne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83133","size":1},{"color":"#336699","name":"Prof Michael Humphreys","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0008036","middle_name":"S","last_name":"Humphreys","source_individual_id":"RMIS1713125","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Humphreys"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78874","size":1},{"color":"#336699","name":"A/Pr Gerald Tehan","data":{"first_name":"Gerald","title":"A/Pr","dw_individual_id":"DW0004968","middle_name":"","last_name":"Tehan","source_individual_id":"RMIS1713135","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Gerald Tehan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78047","size":1},{"color":"#336699","name":"Prof Nancy Pachana","data":{"first_name":"Nancy","title":"Prof","dw_individual_id":"DW0003819","middle_name":"Ann","last_name":"Pachana","source_individual_id":"RMIS1713128","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Nancy Pachana"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77727","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3966","size":1},{"color":"#FF4D4D","name":"Checkpoint restart: coordinating completion of DNA repair with cell cycle progression.","data":{"media_summary":"","end_year":2005,"keywords":["Cdc25","Cell cycle","Chk1","DNA damage","G2 checkpoint"],"nhmrc_grant_id":220001,"application_year":2001,"start_year":2002,"scientific_title":"Checkpoint restart: coordinating completion of DNA repair with cell cycle progression.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Nicole den Elzen","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/220001","simplified_title":"Checkpoint restart: coordinating completion of DNA repair with cell cycle progression.","sub_type":"Peter Doherty Biomedical ECF","total_budget":"247956.54","source_system":""},"children":[{"color":"#336699","name":"Nicole Den Elzen","data":{"first_name":"Nicole","title":"","dw_individual_id":"DW0018651","middle_name":"","last_name":"Den Elzen","source_individual_id":"RMIS2535654","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Nicole Den Elzen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81777","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3941","size":1},{"color":"#FF4D4D","name":"Equipment Grant 2002","data":{"media_summary":"","end_year":2003,"keywords":["None"],"nhmrc_grant_id":219353,"application_year":2001,"start_year":2003,"scientific_title":"Equipment Grant 2002","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Not Applicable","for_category":"","cia_name":"Ms Donna Hannan","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/219353","simplified_title":"Equipment Grant 2002","sub_type":"Equipment Grant","total_budget":"636383","source_system":""},"children":[{"color":"#336699","name":"Ms Donna Hannan","data":{"first_name":"Donna","title":"Ms","dw_individual_id":"DW0013489","middle_name":"T","last_name":"Hannan","source_individual_id":"RMIS3586","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Donna Hannan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80343","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3870","size":1},{"color":"#FF4D4D","name":"Medical end of life decisions: Attitudes and Practices in 6 European Countries","data":{"media_summary":"","end_year":2004,"keywords":["Attitudes","Bioethics","Biomedical Ethics","Human values"],"nhmrc_grant_id":219324,"application_year":2001,"start_year":2002,"scientific_title":"Medical end of life decisions: Attitudes and Practices in 6 European Countries","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Public Health","for_category":"","cia_name":"Prof Colleen Cartwright","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/219324","simplified_title":"Medical end of life decisions: Attitudes and Practices in 6 European Countries","sub_type":"Aust/EU Collaborative Research Grant","total_budget":"153300","source_system":"Not Available - Grant Title - Medical end-of-life decisions: attitudes and practices in 6 European countries"},"children":[{"color":"#336699","name":"Prof Colleen Cartwright","data":{"first_name":"Colleen","title":"Prof","dw_individual_id":"DW0000754","middle_name":"Maria","last_name":"Cartwright","source_individual_id":"RMIS117540","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Colleen Cartwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76873","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3860","size":1},{"color":"#FF4D4D","name":"How well do health & community services help older people with neurodegenerative disorders & their family care givers?","data":{"media_summary":"","end_year":2006,"keywords":["Carers","Dementia","Health Services Research","Multiple sclerosis","Parkinson's Disease"],"nhmrc_grant_id":219304,"application_year":2001,"start_year":2003,"scientific_title":"How well do health & community services help older people with neurodegenerative disorders & their family care givers?","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health and Community Services","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Annette Dobson","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/219304","simplified_title":"How well do health & community services help older people with neurodegenerative disorders & their family care givers?","sub_type":"Research Into Ageing","total_budget":"124705","source_system":""},"children":[{"color":"#336699","name":"Prof Christina Lee","data":{"first_name":"Christina","title":"Prof","dw_individual_id":"DW0043712","middle_name":"","last_name":"Lee","source_individual_id":"5012167","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Christina Lee"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88330","size":1},{"color":"#336699","name":"Prof Annette Dobson","data":{"first_name":"Annette","title":"Prof","dw_individual_id":"DW0036318","middle_name":"J","last_name":"Dobson","source_individual_id":"5011952","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Annette Dobson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86411","size":1},{"color":"#336699","name":"Prof Gerard Byrne","data":{"first_name":"Gerard","title":"Prof","dw_individual_id":"DW0023904","middle_name":"James","last_name":"Byrne","source_individual_id":"5013745","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Gerard Byrne"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83133","size":1},{"color":"#336699","name":"Prof Andrew Wilson","data":{"first_name":"Andrew","title":"Prof","dw_individual_id":"DW0011115","middle_name":"Andrew","last_name":"Wilson","source_individual_id":"5018407","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Andrew Wilson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79722","size":1},{"color":"#336699","name":"Dr Leigh Tooth","data":{"first_name":"Leigh","title":"Dr","dw_individual_id":"DW0010698","middle_name":"Rhonda","last_name":"Tooth","source_individual_id":"RMIS1112435","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Leigh Tooth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79606","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3853","size":1},{"color":"#FF4D4D","name":"Centre of Clinical Research Excellence in Cardiovascular Disease and Metabolic Disorders","data":{"media_summary":"","end_year":2007,"keywords":["Cardiovascular Disease","Diabetes Mellitus","Hypertension","Insulin Resistance","Nephrology"],"nhmrc_grant_id":219285,"application_year":2001,"start_year":2003,"scientific_title":"Centre of Clinical Research Excellence in Cardiovascular Disease and Metabolic Disorders","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Thomas Marwick","higher_grant_type":"Centre for Research Excellence","purl":"http://purl.org/au-research/grants/nhmrc/219285","simplified_title":"Centre of Clinical Research Excellence in Cardiovascular Disease and Metabolic Disorders","sub_type":"Centre of Clinical Excellence","total_budget":"2000000","source_system":"Cardiovascular complications are the main cause of morbidity in a number of metabolic diseases, including diabetes and renal failure. The Centre's objective is to bring together six successful clinical research groups in cardiovascular and metabolic disorders in collaboration with specialists in telemedicine, to address the interface between these diseases and to train a group of clinical researchers skilled in multi-disciplinary research. The planned research includes mechanistic studies as well as interventional studies that will be translated to clinical practice."},"children":[{"color":"#336699","name":"A/Pr Joanne Shaw","data":{"first_name":"Joanne","title":"A/Pr","dw_individual_id":"DW0039647","middle_name":"T.E.","last_name":"Shaw","source_individual_id":"RMIS13660","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Joanne Shaw"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87282","size":1},{"color":"#336699","name":"Prof Johannes Prins","data":{"first_name":"Johannes","title":"Prof","dw_individual_id":"DW0039181","middle_name":"Bernhard","last_name":"Prins","source_individual_id":"RMIS7041737","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Johannes Prins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87157","size":1},{"color":"#336699","name":"Prof Thomas Marwick","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0032377","middle_name":"Hugh","last_name":"Marwick","source_individual_id":"RMIS108223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Marwick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85383","size":1},{"color":"#336699","name":"A/Pr Elaine Beller","data":{"first_name":"Elaine","title":"A/Pr","dw_individual_id":"DW0029399","middle_name":"Margaret","last_name":"Beller","source_individual_id":"RMIS1207844","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Elaine Beller"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84621","size":1},{"color":"#336699","name":"Prof Michael Stowasser","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022365","middle_name":"","last_name":"Stowasser","source_individual_id":"5017746","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Michael Stowasser"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82770","size":1},{"color":"#336699","name":"Prof Jeff Coombes","data":{"first_name":"Jeff","title":"Prof","dw_individual_id":"DW0018387","middle_name":"Scott","last_name":"Coombes","source_individual_id":"RMIS159442","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jeff Coombes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81708","size":1},{"color":"#336699","name":"Prof David Johnson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0013969","middle_name":"Wayne","last_name":"Johnson","source_individual_id":"RMIS14680","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Johnson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80471","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3847","size":1},{"color":"#FF4D4D","name":"Equipment Grant","data":{"media_summary":"","end_year":2002,"keywords":["Equipment Grant"],"nhmrc_grant_id":219234,"application_year":2001,"start_year":2002,"scientific_title":"Equipment Grant","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Not Applicable","for_category":"","cia_name":"Ms Donna Hannan","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/219234","simplified_title":"Equipment Grant","sub_type":"Equipment Grant","total_budget":"292292","source_system":""},"children":[{"color":"#336699","name":"Ms Donna Hannan","data":{"first_name":"Donna","title":"Ms","dw_individual_id":"DW0013489","middle_name":"T","last_name":"Hannan","source_individual_id":"RMIS3586","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Donna Hannan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80343","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3804","size":1},{"color":"#FF4D4D","name":"Group Triple P - Positive Parenting Program for Indigenous Families in Community & Health Settings in Far North QLD","data":{"media_summary":"","end_year":2004,"keywords":["Child Behaviour","Indigenous Parenting","Positive Parenting","Prevention and Early intervention","Primary Care"],"nhmrc_grant_id":219215,"application_year":2001,"start_year":2003,"scientific_title":"Group Triple P - Positive Parenting Program for Indigenous Families in Community & Health Settings in Far North QLD","node_source":"NHMRC","node_type":"Grant","field_of_research":"Indigenous Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Matthew Sanders","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/219215","simplified_title":"Group Triple P - Positive Parenting Program for Indigenous Families : A Pilot","sub_type":"Mental Health Services Evaluation","total_budget":"90000","source_system":""},"children":[{"color":"#336699","name":"Prof Matthew Sanders","data":{"first_name":"Matthew","title":"Prof","dw_individual_id":"DW0033612","middle_name":"","last_name":"Sanders","source_individual_id":"RMIS15843","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Matthew Sanders"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85704","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3802","size":1},{"color":"#FF4D4D","name":"Effect of a personalised oral health education programme on clinical and molecular risk factors for at-risk populations","data":{"media_summary":"","end_year":2006,"keywords":["At risk population","General health","Health promotion","Oral health","Risk factors"],"nhmrc_grant_id":219194,"application_year":2001,"start_year":2003,"scientific_title":"Effect of a personalised oral health education programme on clinical and molecular risk factors for at-risk populations","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dental Therapy","research_area":"Clinical Medicine and Science","for_category":"DENTISTRY","cia_name":"Dr Mary Cullinan","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/219194","simplified_title":"Can oral health education lead to an improvement in both oral and general health","sub_type":"Oral Health Research","total_budget":"149900","source_system":"Recently, a number of studies have shown that poor oral health may impact on general health. However, for many Australians on low incomes, the only dental care they receive is of an emergency nature due to the long waiting lists in the public sector. The current study proposes to look at whether an oral health education program delivered by allied oral health professionals will result in a significant improvement in oral health which in turn will lead to better oral and general health outcomes in a low socio-economic community"},"children":[{"color":"#336699","name":"Dr Paul Wood","data":{"first_name":"Paul","title":"Dr","dw_individual_id":"DW0046378","middle_name":"F","last_name":"Wood","source_individual_id":"RMIS1548224","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Paul Wood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/89013","size":1},{"color":"#336699","name":"Gregory Seymour","data":{"first_name":"Gregory","title":"","dw_individual_id":"DW0045362","middle_name":"","last_name":"Seymour","source_individual_id":"RMIS9783","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Gregory Seymour"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88735","size":1},{"color":"#336699","name":"Dr Trevor Holcombe","data":{"first_name":"Trevor","title":"Dr","dw_individual_id":"DW0043090","middle_name":"Francis","last_name":"Holcombe","source_individual_id":"RMIS1548221","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Trevor Holcombe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88167","size":1},{"color":"#336699","name":"Dr Mary Cullinan","data":{"first_name":"Mary","title":"Dr","dw_individual_id":"DW0012574","middle_name":"P","last_name":"Cullinan","source_individual_id":"RMIS222537","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Mary Cullinan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80103","size":1},{"color":"#336699","name":"Prof David Kavanagh","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0008308","middle_name":"J","last_name":"Kavanagh","source_individual_id":"RMIS41345","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Kavanagh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78938","size":1},{"color":"#336699","name":"Prof Malcolm West","data":{"first_name":"Malcolm","title":"Prof","dw_individual_id":"DW0005385","middle_name":"J","last_name":"West","source_individual_id":"5018261","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Malcolm West"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78171","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3786","size":1},{"color":"#FF4D4D","name":"Case-control study to promote oral health in asthmatic children:Natural dietary strategies to conserve teeth erosion","data":{"media_summary":"","end_year":2007,"keywords":["Asthma","Diet","Saliva","Teeth","Wear"],"nhmrc_grant_id":219193,"application_year":2001,"start_year":2003,"scientific_title":"Case-control study to promote oral health in asthmatic children:Natural dietary strategies to conserve teeth erosion","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Clinical Medicine and Science","for_category":"","cia_name":"A/Pr William Young","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/219193","simplified_title":"Tooth conservation in asthmatic children by diet","sub_type":"Oral Health Research","total_budget":"112500.02","source_system":"Asthmatic children are at risk of dental corrosion, from medications that shut off saliva. Saliva protects teeth from acids in soft drinks and stomach-acid reflux. Dentist, William George Young and Nutritionist, Peter Davies, at the University of Queensland study childrens teeth, diet and lifestyles for the best natural methods to promote oral health. They will counsel parents and children on diets that conserve the teeth from dental erosion and decay by salivary stimulation. Patients need to self-manage their asthma and diets to avoid negative outcomes and costs in acute medical and dental therapy for these two chronic conditions."},"children":[{"color":"#336699","name":"Prof Peter Davies","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0018572","middle_name":"Sw","last_name":"Davies","source_individual_id":"5014241","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Davies"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81758","size":1},{"color":"#336699","name":"A/Pr William Young","data":{"first_name":"William","title":"A/Pr","dw_individual_id":"DW0005627","middle_name":"G","last_name":"Young","source_individual_id":"RMIS47577","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr William Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78236","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3785","size":1},{"color":"#FF4D4D","name":"Intervention strategies for the prevention of early childhood caries","data":{"media_summary":"","end_year":2006,"keywords":["Early childhood caries","Streptococcus mutans","chlorhexidine","dental caries","paediatric dentistry"],"nhmrc_grant_id":219191,"application_year":2001,"start_year":2002,"scientific_title":"Intervention strategies for the prevention of early childhood caries","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dentistry not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"DENTISTRY","cia_name":"A/Pr Wan Kim Seow","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/219191","simplified_title":"Preventive strategies for early childhood caries","sub_type":"Oral Health Research","total_budget":"125000","source_system":"Rampant dental decay in young children remains an important challenge for preventive dentistry. Although it is a preventable disease, the prevalence is high in many disadvantaged communities. The study will examine a few intervention programs to determine their effectiveness in preventing early childhood decay. These include brushing the teeth with a safe, dental antibacterial gel compared to traditional oral hygiene methods. Brushing with antibacterial gels at crucial times during the establishment of the oral flora is likely to prevent decay-causing bacteria from colonising a childs mouth, so that the risk of dental decay is reduced, not only during childhood, but possibly extending to adulthood as well."},"children":[{"color":"#336699","name":"Prof W. Kim Seow","data":{"first_name":"W. Kim","title":"Prof","dw_individual_id":"DW0010175","middle_name":"","last_name":"Seow","source_individual_id":"5019953","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof W. Kim Seow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79460","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3781","size":1},{"color":"#FF4D4D","name":"Reversing the Trend: Promoting Physical Activity and Healthly lifestyle among Young Torres Strait Islanders","data":{"media_summary":"","end_year":2005,"keywords":["Physical activity","Young People"],"nhmrc_grant_id":219123,"application_year":2001,"start_year":2002,"scientific_title":"Reversing the Trend: Promoting Physical Activity and Healthly lifestyle among Young Torres Strait Islanders","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Public Health","for_category":"","cia_name":"Dr Melissa Haswell-Elkins","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/219123","simplified_title":"Reversing the Trend: Promoting Physical Activity and Healthly lifestyle among Young Torres Strait Islanders","sub_type":"RAWG - Diabetes and Related Disorders","total_budget":"154004.25","source_system":""},"children":[{"color":"#336699","name":"Dr David Jenkins","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0037542","middle_name":"G","last_name":"Jenkins","source_individual_id":"RMIS41788","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr David Jenkins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86723","size":1},{"color":"#336699","name":"Prof Cindy Shannon","data":{"first_name":"Cindy","title":"Prof","dw_individual_id":"DW0033749","middle_name":"Anne-Maree","last_name":"Shannon","source_individual_id":"RMIS383276","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Cindy Shannon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85739","size":1},{"color":"#336699","name":"Prof Doune Macdonald","data":{"first_name":"Doune","title":"Prof","dw_individual_id":"DW0020537","middle_name":"","last_name":"Macdonald","source_individual_id":"RMIS3112983","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Doune Macdonald"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82247","size":1},{"color":"#336699","name":"A/Pr Melissa Haswell-Elkins","data":{"first_name":"Melissa","title":"A/Pr","dw_individual_id":"DW0019509","middle_name":"Ruth","last_name":"Haswell-Elkins","source_individual_id":"RMIS1289414","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Melissa Haswell-Elkins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81966","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3730","size":1},{"color":"#FF4D4D","name":"The NHMRC Clinical Practice Improvement Network for Early Psychosis","data":{"media_summary":"","end_year":2005,"keywords":[" Psychosis","Clinical Practice Guidelines","Cost Effectiveness","Early Intervention","Evaluation Studies"],"nhmrc_grant_id":219117,"application_year":2001,"start_year":2002,"scientific_title":"The NHMRC Clinical Practice Improvement Network for Early Psychosis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Stanley Catts","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/219117","simplified_title":"The NHMRC Clinical Practice Improvement Network for Early Psychosis","sub_type":"Mental Health Early Psychosis Program","total_budget":"400000","source_system":""},"children":[{"color":"#336699","name":"Dr Brian O'Toole","data":{"first_name":"Brian","title":"Dr","dw_individual_id":"DW0033019","middle_name":"Ignatius","last_name":"O'Toole","source_individual_id":"5019962","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Brian O'Toole"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85556","size":1},{"color":"#336699","name":"Prof Vaughan Carr","data":{"first_name":"Vaughan","title":"Prof","dw_individual_id":"DW0018106","middle_name":"James","last_name":"Carr","source_individual_id":"RMIS79758","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Vaughan Carr"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81631","size":1},{"color":"#336699","name":"Prof Stanley Catts","data":{"first_name":"Stanley","title":"Prof","dw_individual_id":"DW0000773","middle_name":"Victor","last_name":"Catts","source_individual_id":"RMIS575747","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stanley Catts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76879","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3729","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2004,"keywords":["Neurology"],"nhmrc_grant_id":215209,"application_year":2001,"start_year":2002,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Perry Bartlett","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/215209","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"149625","source_system":""},"children":[{"color":"#336699","name":"Prof Perry Bartlett","data":{"first_name":"Perry","title":"Prof","dw_individual_id":"DW0011651","middle_name":"Francis","last_name":"Bartlett","source_individual_id":"5013357","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Perry Bartlett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79864","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3644","size":1},{"color":"#FF4D4D","name":"Do people's environments influence their habitual physical activity?","data":{"media_summary":"Risk factors for cardiovascular disease","end_year":2003,"keywords":["Behavioural epidemiology","Cardiovascular risk","Environmental influences","Physical activity","Sedentary behaviour"],"nhmrc_grant_id":213114,"application_year":2001,"health_keywords":["Environmental influences","Locational and social disadvantage","Physical inactivity","Population health","Risk factors for cardiovascular disease"],"scientific_title":"Do people's environments influence their habitual physical activity?","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Promotion","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Neville Owen","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/213114","simplified_title":"Environmental influences on physical activity","sub_type":"Standard Project Grant","total_budget":"196650","source_system":"People seem to prefer to drive to the corner shop rather than walking. Or, they will drive the car to work instead of walking to the bus or train. Or, they send off e-mails instead of walking down the corridor at work. The result is that people are not using up the energy that they should and they get fatter. The average weight of many groups of Australians has gone up by several kilograms in the past 10 years. Active people not only have healthier weights. They are less likely to get heart disease, diabetes and some cancers. But too many people do no exercise at all. Only about 10% of Australians adults do fitness and sporting activities three or more times a week. More than half do not walk, cycle or do anything moderately active on any regular basis. To get people to be regularly active and to stay active, promoting deliberate 'exercise' is not the answer. Making it easier for people to choose to be more active as they go about their daily lives will be more effective. Road transport researchers and geographers have a lot to offer to health researchers. They have found that where there are footpaths and cycle ways, where shops and businesses are close by or where the roads make it easy and safe to get from place to place, people are much more likely to walk or ride bikes. We can now use large, complex computerised databases (called Geographic Information Systems) to put together this type of information on peoples' local environments. We will combine these 'geographic' data with other information from surveys on people's physical activity, exercise and transport habits. Starting our research in this way, we will be able to work out whether there are factors in people's local environments that really do make them less active. Governments, health planners and local councils will use this information to find ways to create communities that are more activity-friendly. This will have real health benefits."},"children":[{"color":"#336699","name":"Prof Graeme Hugo","data":{"first_name":"Graeme","title":"Prof","dw_individual_id":"DW0037413","middle_name":"J","last_name":"Hugo","source_individual_id":"5015378","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Graeme Hugo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86693","size":1},{"color":"#336699","name":"Prof Adrian Bauman","data":{"first_name":"Adrian","title":"Prof","dw_individual_id":"DW0035294","middle_name":"E","last_name":"Bauman","source_individual_id":"5012367","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Adrian Bauman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86147","size":1},{"color":"#336699","name":"Prof Neville Owen","data":{"first_name":"Neville","title":"Prof","dw_individual_id":"DW0003812","middle_name":"Gordon","last_name":"Owen","source_individual_id":"5016815","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Neville Owen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77725","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3627","size":1},{"color":"#FF4D4D","name":"Human arylamine N-acetyltransferase regulation and function - effect of genetic poymorphisms.","data":{"media_summary":"","end_year":2004,"keywords":["Drug metabolism","Drug toxicity","Enzyme polymorphism"],"nhmrc_grant_id":212066,"application_year":2001,"health_keywords":["Drug metabolism","Metabolic polymorphisms","acetylation","enzymes"],"scientific_title":"Human arylamine N-acetyltransferase regulation and function - effect of genetic poymorphisms.","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Rod Minchin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/212066","simplified_title":"How is the enzyme arylamine N-acetyltransferase controlled in humans","sub_type":"Standard Project Grant","total_budget":"421980","source_system":"How we handle chemicals that enter our bodies depends on a series of enzymes that are responsible for breaking down the chemicals and eliminating them. The activity of many of these enzymes varies between individuals so our responses to chemicals and drugs is different for each individual. Some of the enzymes vary because of inherited mutations, but others vary because of the diets we eat and the environment in which we live. This project will investigate a major enzyme called acetlytransferase that has been implicated as a risk factor in diseases such as cancer, asthma, liver cirrhossis and adverse drug reactions. We plan to look at the enzyme in cells and determine what environmental factors contribute to its variation between individuals, and how this impacts on the genetic mutations that have been found in its gene. From these studies, we will have a much better undersanding of how different people metabolise foreign chemicals, and should be able to predict those most at risk of certain diseases."},"children":[{"color":"#336699","name":"Prof Rodney Minchin","data":{"first_name":"Rodney","title":"Prof","dw_individual_id":"DW0026778","middle_name":"F","last_name":"Minchin","source_individual_id":"5016513","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Rodney Minchin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83936","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3609","size":1},{"color":"#FF4D4D","name":"An economic analysis of Australian aged care residential facilities: expenditure and health outcome determinandts","data":{"media_summary":"","end_year":2004,"keywords":["Elderly","Health outcomes","Helath care expenditure","Nursing Homes","Quality"],"nhmrc_grant_id":210366,"application_year":2001,"start_year":2002,"scientific_title":"An economic analysis of Australian aged care residential facilities: expenditure and health outcome determinandts","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health Economics","research_area":"Health Services Research","for_category":"ECONOMICS","cia_name":"Ms Susan Gargett","higher_grant_type":"SRDC - People","purl":"http://purl.org/au-research/grants/nhmrc/210366","simplified_title":"economic analysis of Australian aged care residential facilities:","sub_type":"Public Health Scholarship - Ageing","total_budget":"59357","source_system":""},"children":[{"color":"#336699","name":"Dr Susan Gargett","data":{"first_name":"Susan","title":"Dr","dw_individual_id":"DW0001723","middle_name":"","last_name":"Gargett","source_individual_id":"RMIS1367035","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Susan Gargett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77141","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3499","size":1},{"color":"#FF4D4D","name":"Fostering people-Health Partnership: A computer delivered problem based learning course for primary health care workers","data":{"media_summary":"","end_year":2006,"keywords":["Evaluation of Health Outcomes","Health Education","Health Policy Evaluation","Health and Support Services"],"nhmrc_grant_id":210365,"application_year":2001,"start_year":2002,"scientific_title":"Fostering people-Health Partnership: A computer delivered problem based learning course for primary health care workers","node_source":"NHMRC","node_type":"Grant","field_of_research":"Primary Health Care","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Mr Jared Dart","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/210365","simplified_title":"Community Based Education","sub_type":"Medical Postgraduate Scholarship","total_budget":"69309.45","source_system":""},"children":[{"color":"#336699","name":"A/Pr Jared Dart","data":{"first_name":"Jared","title":"A/Pr","dw_individual_id":"DW0001175","middle_name":"","last_name":"Dart","source_individual_id":"RMIS1366780","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jared Dart"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76988","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3498","size":1},{"color":"#FF4D4D","name":"Using IMET (n of 1) methodology as a management tool in clinical practice.","data":{"media_summary":"","end_year":2006,"keywords":["chronic conditions","concordance","consumer perspectives","n of 1 (Single patient) trial","prescribing"],"nhmrc_grant_id":210364,"application_year":2001,"start_year":2002,"scientific_title":"Using IMET (n of 1) methodology as a management tool in clinical practice.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Jane Nikles","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/210364","simplified_title":"Using IMET (n of 1) methodology as a management tool in clinical practice.","sub_type":"Medical Postgraduate Scholarship","total_budget":"94701.2","source_system":""},"children":[{"color":"#336699","name":"Dr Jane Nikles","data":{"first_name":"Jane","title":"Dr","dw_individual_id":"DW0021162","middle_name":"","last_name":"Nikles","source_individual_id":"5023242","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Jane Nikles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82422","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3497","size":1},{"color":"#FF4D4D","name":"Changes in insulin sensitivity and signalling in human adipose tissue and skeletal muscle during pregnancy.","data":{"media_summary":"","end_year":2004,"keywords":["glucose uptake","insulin signalling","pregnancy"],"nhmrc_grant_id":210363,"application_year":2001,"start_year":2002,"scientific_title":"Changes in insulin sensitivity and signalling in human adipose tissue and skeletal muscle during pregnancy.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides","research_area":"Basic Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Dr Anthony Russell","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/210363","simplified_title":"Changes in insulin sensitivity and signalling in human adipose tissue and skeletal muscle during pregnancy.","sub_type":"Medical Postgraduate Scholarship","total_budget":"56417.5","source_system":""},"children":[{"color":"#336699","name":"A/Pr Anthony Russell","data":{"first_name":"Anthony","title":"A/Pr","dw_individual_id":"DW0010015","middle_name":"William","last_name":"Russell","source_individual_id":"5017298","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Anthony Russell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79417","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3496","size":1},{"color":"#FF4D4D","name":"An investigation of family influences on dietary management of Type 2 Diabetes Mellitus by urban Indigenous women with","data":{"media_summary":"","end_year":2006,"keywords":["Ethnography","Family","Indigenous health","Nutrition","Type 2 Diabetes"],"nhmrc_grant_id":210358,"application_year":2001,"start_year":2002,"scientific_title":"An investigation of family influences on dietary management of Type 2 Diabetes Mellitus by urban Indigenous women with","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nutrition and Dietetics","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Ms Wendy Foley","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/210358","simplified_title":"An investigation of family influences on dietary management of Type 2 Diabetes Mellitus by urban Indigenous women with","sub_type":"Training Scholarship for Aboriginal Health Research","total_budget":"98528.66","source_system":""},"children":[{"color":"#336699","name":"Ms Wendy Foley","data":{"first_name":"Wendy","title":"Ms","dw_individual_id":"DW0019033","middle_name":"L","last_name":"Foley","source_individual_id":"RMIS1389896","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Wendy Foley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81865","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3495","size":1},{"color":"#FF4D4D","name":"The role of obesity and nutrition in chronic hepatitis C and fatty liver disease","data":{"media_summary":"","end_year":2004,"keywords":["diet","hepatitis","obesity","steatosis","treatment"],"nhmrc_grant_id":210356,"application_year":2001,"start_year":2002,"scientific_title":"The role of obesity and nutrition in chronic hepatitis C and fatty liver disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nutrition and Dietetics","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Ingrid Hickman","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/210356","simplified_title":"The role of obesity and nutrition in chronic hepatitis C and fatty liver disease","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"59828.99","source_system":""},"children":[{"color":"#336699","name":"Dr Ingrid Hickman","data":{"first_name":"Ingrid","title":"Dr","dw_individual_id":"DW0043028","middle_name":"J","last_name":"Hickman","source_individual_id":"5015215","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Ingrid Hickman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88150","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3494","size":1},{"color":"#FF4D4D","name":"The plasma membrane Ca2+ - ATPase in tumorigenic and non-tumorigenic mammary gland epithelial cells","data":{"media_summary":"","end_year":2006,"keywords":["Cancer","PMCA","calcium","calcium efflux"],"nhmrc_grant_id":210355,"application_year":2001,"start_year":2002,"scientific_title":"The plasma membrane Ca2+ - ATPase in tumorigenic and non-tumorigenic mammary gland epithelial cells","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Won Lee","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/210355","simplified_title":"The plasma membrane Ca2+ - ATPase in tumorigenic and non-tumorigenic mammary gland epithelial cells","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"88658.18","source_system":""},"children":[{"color":"#336699","name":"Dr Won Jae Lee","data":{"first_name":"Won Jae","title":"Dr","dw_individual_id":"DW0032026","middle_name":"","last_name":"Lee","source_individual_id":"5030421","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Won Jae Lee"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85284","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3493","size":1},{"color":"#FF4D4D","name":"Protein sorting in polarised cells","data":{"media_summary":"","end_year":2005,"keywords":["bioinformatics","epithelial cells","protein trafficking"],"nhmrc_grant_id":210354,"application_year":2001,"start_year":2002,"scientific_title":"Protein sorting in polarised cells","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Mr Kevin Miranda","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/210354","simplified_title":"Protein sorting in polarised cells","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"39277.44","source_system":""},"children":[{"color":"#336699","name":"Kevin Miranda","data":{"first_name":"Kevin","title":"","dw_individual_id":"DW0003422","middle_name":"","last_name":"Miranda","source_individual_id":"RMIS1469631","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Kevin Miranda"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77613","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3492","size":1},{"color":"#FF4D4D","name":"Mechanisms of dendritic cell - T Cell Interaction in Immune Tolerance","data":{"media_summary":"","end_year":2004,"keywords":["NfkappaB (RelB)","autoimmune disease","dendritic cells","immunotherapeutics","regulatory T cells"],"nhmrc_grant_id":210350,"application_year":2001,"start_year":2002,"scientific_title":"Mechanisms of dendritic cell - T Cell Interaction in Immune Tolerance","node_source":"NHMRC","node_type":"Grant","field_of_research":"Autoimmunity","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Angus Thompson","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/210350","simplified_title":"Mechanisms of dendritic cell - T Cell Interaction in Immune Tolerance","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"44732.59","source_system":""},"children":[{"color":"#336699","name":"Angus Thompson","data":{"first_name":"Angus","title":"","dw_individual_id":"DW0005007","middle_name":"","last_name":"Thompson","source_individual_id":"RMIS681789","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Angus Thompson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78058","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3491","size":1},{"color":"#FF4D4D","name":"Impaired self-awareness & employment outcome following acquired brain injury: Evaluation of an employment rehabilitation","data":{"media_summary":"","end_year":2006,"keywords":["Acquired brain injury","Employment outcomes","Executive functioning","Impaired self-awareness","Rehabilitation intervention"],"nhmrc_grant_id":210347,"application_year":2001,"start_year":2002,"scientific_title":"Impaired self-awareness & employment outcome following acquired brain injury: Evaluation of an employment rehabilitation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Dr Tamara Ownsworth","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/210347","simplified_title":"Impaired self-awareness & employment outcome following acquired brain injury: Evaluation of an employment rehabilitation","sub_type":"Public Health (Australia) ECF","total_budget":"214230.38","source_system":""},"children":[{"color":"#336699","name":"A/Pr Tamara Ownsworth","data":{"first_name":"Tamara","title":"A/Pr","dw_individual_id":"DW0027173","middle_name":"L","last_name":"Ownsworth","source_individual_id":"5016830","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Tamara Ownsworth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84022","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3489","size":1},{"color":"#FF4D4D","name":"Determination of the cellular and molecular mechanisms of axon growth and guidance in the embryonic vertebrate brain","data":{"media_summary":"","end_year":2004,"keywords":["axon guidance","development","xenopus embryo"],"nhmrc_grant_id":210344,"application_year":2001,"start_year":2002,"scientific_title":"Determination of the cellular and molecular mechanisms of axon growth and guidance in the embryonic vertebrate brain","node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Simon Kinder","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/210344","simplified_title":"Determination of the cellular and molecular mechanisms of axon growth and guidance in the embryonic vertebrate brain","sub_type":"Peter Doherty Biomedical ECF","total_budget":"165769.04","source_system":""},"children":[{"color":"#336699","name":"Simon Kinder","data":{"first_name":"Simon","title":"","dw_individual_id":"DW0031772","middle_name":"","last_name":"Kinder","source_individual_id":"RMIS1365996","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Simon Kinder"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85217","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3488","size":1},{"color":"#FF4D4D","name":"Structural and biochemical determination of beta-catenin nuclear import.","data":{"media_summary":"","end_year":2006,"keywords":["Beta-catenin","Crystallography","Nuclear import","Nucleoporins","Wnt signalling"],"nhmrc_grant_id":210342,"application_year":2001,"start_year":2002,"scientific_title":"Structural and biochemical determination of beta-catenin nuclear import.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Jade Forwood","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/210342","simplified_title":"Structural and biochemical determination of beta-catenin nuclear import.","sub_type":"CJ Martin Biomedical ECF","total_budget":"280884.25","source_system":""},"children":[{"color":"#336699","name":"A/Pr Jade Forwood","data":{"first_name":"Jade","title":"A/Pr","dw_individual_id":"DW0001631","middle_name":"K","last_name":"Forwood","source_individual_id":"5011282","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Jade Forwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77119","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3487","size":1},{"color":"#FF4D4D","name":"Anatomical substrates of cortical function and plasticity","data":{"media_summary":"","end_year":2006,"keywords":["Neurological diseases","Neurosciences"],"nhmrc_grant_id":210341,"application_year":2001,"start_year":2002,"scientific_title":"Anatomical substrates of cortical function and plasticity","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Basic Science","for_category":"","cia_name":"Dr Guy Elston","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/210341","simplified_title":"Anatomical substrates of cortical function and plasticity","sub_type":"RD Wright Biomedical CDF","total_budget":"402750","source_system":""},"children":[{"color":"#336699","name":"Guy Elston","data":{"first_name":"Guy","title":"","dw_individual_id":"DW0042265","middle_name":"","last_name":"Elston","source_individual_id":"RMIS224199","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Guy Elston"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87969","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3486","size":1},{"color":"#FF4D4D","name":"Expression profiling and defining gene pathways: a genomic based approach to defining angiogenic growth factor function","data":{"media_summary":"","end_year":2006,"keywords":["Angiogenesis","Microarray Expression profiling","Organogenesis","Tumour suppression","genomics"],"nhmrc_grant_id":210339,"application_year":2001,"start_year":2002,"scientific_title":"Expression profiling and defining gene pathways: a genomic based approach to defining angiogenic growth factor function","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Basic Science","for_category":"","cia_name":"A/Pr Sean Grimmond","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/210339","simplified_title":"Expression profiling and defining gene pathways: a genomic based approach to defining angiogenic growth factor function","sub_type":"RD Wright Biomedical CDF","total_budget":"425000","source_system":""},"children":[{"color":"#336699","name":"Prof Sean Grimmond","data":{"first_name":"Sean","title":"Prof","dw_individual_id":"DW0007616","middle_name":"M","last_name":"Grimmond","source_individual_id":"5014956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sean Grimmond"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78759","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3485","size":1},{"color":"#FF4D4D","name":"Effects of parental obesity on physical activity and the hypothesised social and environmental determinants","data":{"media_summary":"","end_year":2003,"keywords":["public health"],"nhmrc_grant_id":210335,"application_year":2001,"start_year":2002,"scientific_title":"Effects of parental obesity on physical activity and the hypothesised social and environmental determinants","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Public Health","for_category":"","cia_name":"Dr Stewart Trost","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/210335","simplified_title":"Effects of parental obesity on physical activity and the hypothesised social and environmental determinants","sub_type":"Population Health CDF","total_budget":"142625","source_system":""},"children":[{"color":"#336699","name":"Prof Stewart Trost","data":{"first_name":"Stewart","title":"Prof","dw_individual_id":"DW0028465","middle_name":"Graeme","last_name":"Trost","source_individual_id":"5050183","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stewart Trost"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84362","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3484","size":1},{"color":"#FF4D4D","name":"Statistical analysis of the transition to widowhood:","data":{"media_summary":"","end_year":2004,"keywords":["Ageing","Composite variables","Longitudinal study","Multiple imputation","Widowhood"],"nhmrc_grant_id":210317,"application_year":2001,"start_year":2002,"scientific_title":"Statistical analysis of the transition to widowhood:","node_source":"NHMRC","node_type":"Grant","field_of_research":"Applied Statistics","research_area":"Public Health","for_category":"STATISTICS","cia_name":"Ms Nadine Smith","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/210317","simplified_title":"Statistical analysis of the transition to widowhood:","sub_type":"Public Health Postgraduate Scholarship","total_budget":"59357","source_system":""},"children":[{"color":"#336699","name":"Ms Nadine Smith","data":{"first_name":"Nadine","title":"Ms","dw_individual_id":"DW0028042","middle_name":"","last_name":"Smith","source_individual_id":"RMIS1408822","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Nadine Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84233","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3483","size":1},{"color":"#FF4D4D","name":"Uncoupled Reseach Fellowship","data":{"media_summary":"","end_year":2006,"keywords":["Genetic disease","Lymphoma","Molecular genetics","Radiosensitivity","Signal Transduction"],"nhmrc_grant_id":210315,"application_year":2001,"start_year":2002,"scientific_title":"Uncoupled Reseach Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Martin Lavin","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/210315","simplified_title":"Uncoupled Reseach Fellowship","sub_type":"Research Fellowship","total_budget":"690000","source_system":""},"children":[{"color":"#336699","name":"Prof Martin Lavin","data":{"first_name":"Martin","title":"Prof","dw_individual_id":"DW0026168","middle_name":"F","last_name":"Lavin","source_individual_id":"RMIS4377719","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Martin Lavin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83769","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3482","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2006,"keywords":["Cytokine","Gene array","Growth hormone receptor","Transgenic","signalling"],"nhmrc_grant_id":210313,"application_year":2001,"start_year":2002,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael WATERS","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/210313","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"610500","source_system":""},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3481","size":1},{"color":"#FF4D4D","name":"Alternative splicing of GLI1 and its role in tumourigenesis","data":{"media_summary":"","end_year":2004,"keywords":["RNA-binding proteins","mRNA expression","oncogene","post-transcriptional regulation of gene expression","pre-mRNA splicing"],"nhmrc_grant_id":210312,"application_year":2001,"health_keywords":["basal cell carcinoma","cancer predisposition","molecular basis of disease"],"scientific_title":"Alternative splicing of GLI1 and its role in tumourigenesis","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Joseph Rothnagel","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210312","simplified_title":"Understanding the regulation of cancer genes","sub_type":"Standard Project Grant","total_budget":"392640","source_system":"Gene expression involves the transfer of information from DNA to proteins and is mediated by a third molecule called messenger RNA (mRNA). The process is tightly controlled since unregulated gene expression is harmful and can result in diseases such as developmental disorders and cancer. The genetic information in DNA is first copied to an RNA molecule in a process called transcription. This RNA molecule then undergoes a series of maturation steps before the information it carries can be translated into a protein. One of these maturation steps involves the removal of sequences (called introns) that do not contain protein coding information from the sequences (called exons) that will be present in the mature mRNA. Some genes contain no introns while others contain 20 or more, which are dispersed throughout the gene. The removal of intron sequences from immature RNA molecules is called splicing and is carried out by a macromolecular complex that recognises the intron sequences, cuts them out of the RNA and then rejoins the RNA to make a contiguous sequence. This process has to be precise otherwise spurious sequences will be present in the mRNA, which will result in the production of abnormal proteins. In addition, for some genes mRNAs are produced that have differences in a portion of their sequence. These alternative sequences are generated by the inclusion or exclusion of alternative exons. Because, RNA splicing is critical to the production of mature mRNAs and because it can generate sequence diversity it is tightly regulated. We have recently found that expression of a cancer gene (called GLI1) is regulated in part by the use of alternative GLI1 mRNAs. Moreover, we found that the expression of one of these alternative GLI1 mRNAs is associated with skin cancer. In this project we will investigate the molecular mechanisms that regulate alternative splicing in GLI1 and identify whether changes in these mechanisms result in cancer."},"children":[{"color":"#336699","name":"Prof Ross Smith","data":{"first_name":"Ross","title":"Prof","dw_individual_id":"DW0045515","middle_name":"William","last_name":"Smith","source_individual_id":"RMIS6441","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ross Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88776","size":1},{"color":"#336699","name":"A/Pr Joseph Rothnagel","data":{"first_name":"Joseph","title":"A/Pr","dw_individual_id":"DW0009982","middle_name":"A","last_name":"Rothnagel","source_individual_id":"5017267","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Joseph Rothnagel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79410","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3480","size":1},{"color":"#FF4D4D","name":"Glycosylation of pili in pathogenic Neisseria: function in disease and potential as a vaccine antigen","data":{"media_summary":"","end_year":2003,"keywords":["Neisseria gonorrhoeae","Neisseria meningitidis","Type 4 fimbriae (pili)","Virulence factor","glycosylation"],"nhmrc_grant_id":210310,"application_year":2001,"health_keywords":["gonorrhoea","meningitis","pelvic inflamatory disease"],"scientific_title":"Glycosylation of pili in pathogenic Neisseria: function in disease and potential as a vaccine antigen","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Michael Jennings","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210310","simplified_title":"How and why bacteria responsible for meningitis and gonorrhoeae modify surface proteins by the addition of sugars.","sub_type":"Standard Project Grant","total_budget":"150880","source_system":"Disease caused by Group B Neisseria meningitidis and Neisseria gonorrhoeae remain a significant health problem worldwide. There are currently no vaccines available for either of these bacteria. A surface structure found on these bacteria, called pili, are key in host colonisation and disease. Genetics and structural studies have identified that the protein subunits, which make up pili, are glycosylated - modified by the addition of sugars. The role of glycosylation in the disease process is not known. It is possible that the glycosylation of pili is required for attachment to host cells or perhaps in evasion of the immune system. In our current studies, we have identified and analysed a number of genes involved in pili glycosylation, in bacteria which make structre that are know. We have also identified a series of new genes we believe are also involved in glycosylation. Some of these genes are involved in the biosynthesis of unknown structures and are common in bacteria isolated from patients with meningitis. We will identify these stuctures and characterise bacteria in which these genes have been inactivated so that we can examine the role of pili glycosylation in colonisation and disease. This study has the potential to yield important new information about the process of colonisation and disease, and also has the potential to facilitate novel approaches in vaccine development."},"children":[{"color":"#336699","name":"Prof Michael Jennings","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0025768","middle_name":"P","last_name":"Jennings","source_individual_id":"RMIS449244","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Jennings"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83637","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3479","size":1},{"color":"#FF4D4D","name":"Heterogeneous nuclear ribonucleoprotein A2-dependent mRNA trafficking in the cytoplasm of cells.","data":{"media_summary":"","end_year":2004,"keywords":["cytoplasmic mRNA trafficking","heterogeneous nuclear ribonucleoproteins","myelin basic protein","neurons","protein targeting"],"nhmrc_grant_id":210308,"application_year":2001,"health_keywords":["cancer","multiple sclerosis","nervous system development","rheumatoid arthritis"],"scientific_title":"Heterogeneous nuclear ribonucleoprotein A2-dependent mRNA trafficking in the cytoplasm of cells.","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Ross Smith","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210308","simplified_title":"RNA transport in the cytoplasm of cells.","sub_type":"Standard Project Grant","total_budget":"346650","source_system":"Control of the use of DNA, gene expression, is vital to all living organisms, especially in development and disease. The information in the genes of DNA is transferred to an intermediate molecule, mRNA, in a process called transcription. The genetic information in the mRNA is subsequently used to make the protein encoded by the original gene. The switching on and off of DNA appears to be most frequently controlled at the transcription step but recently it has become apparent that there are many post-transcriptional events that govern how efficiently the genetic information is ultimately converted to protein molecules. The RNA molecules may be confined to a small region of the cell, resulting in the localization of the protein produced from it; the RNA may be rapidly degraded or stabilized; and the efficiency of production of the protein from its RNA precursor may be modulated by other molecules. It had previously been shown that the mRNA encoding a protein that is an essential structural component of central nervous system myelin is selectively transported to the regions in the cell where the myelin is made. We have identified the molecule that recognises this RNA as a protein called hnRNP A2 and shown how it selects the RNA molecules that have to be transported from the myriad of RNA moleclues in the cell at any given time. hnRNP A2 was previously thought to be confined to the nuclei of cells, but we have shown that it is also present outside the nucleus and is involved in RNA transport in a variety of cell types. hnRNP A2 appears to be directly involved in rheumatoid arthritis, lung cancer and other cancers. It has been proposed as a diagnostic test for cancer as elevated intracellular levels and circulating antibodies against this protein appear before the cancerous cells are visible under the microscope. The major aim of the proposed project is to explore the molecular mechanism by which hnRNP A2 transports RNA molecules in cells."},"children":[{"color":"#336699","name":"Prof Ross Smith","data":{"first_name":"Ross","title":"Prof","dw_individual_id":"DW0045515","middle_name":"William","last_name":"Smith","source_individual_id":"RMIS6441","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ross Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88776","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3478","size":1},{"color":"#FF4D4D","name":"Engineering subtype selective inhibitors of voltage-sensitive sodium channels","data":{"media_summary":"","end_year":2004,"keywords":["electrophysiology","molecular pharmacology","peptide structure activity relationships","sodium channel therapeutics"],"nhmrc_grant_id":210307,"application_year":2001,"health_keywords":["epilepsy","neuropathic pain","stroke"],"scientific_title":"Engineering subtype selective inhibitors of voltage-sensitive sodium channels","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Proteins and Peptides","research_area":"Clinical Medicine and Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Prof Richard Lewis","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210307","simplified_title":"Developing selective inhibitors of sodium channels","sub_type":"Standard Project Grant","total_budget":"406980","source_system":"During efforts to find new inhibitors of voltage sensitive sodium channels (VSSCs), we have discovered two new families of mu-conotoxins from Australian Conus tulipa and C. striatus that inhibit neuronal and muscle forms of the tetrodotoxin-sensitive (TTX-S) sodium channel. From these and related analogues we have identified a number of selective and highly potent inhibitors of VSSCs, opening the possibility of producing the first subtype selective TTX-S inhibitors useful in diseases such as epilepsy and stroke. These analogues also showed high selectivity for TTX-S sodium channels over a TTX-resistant (TTX-R) subtype hPN3, a key channel involved in the transmission of neuropathic pain that we recently cloned from human dorsal root ganglia. Given that TTX-S and TTX-R sodium channels have the same overall structure but differ at a relatively small number of key positions likely to affect mu-conotoxin binding, we believe it is possible to reverse engineer mu-conotoxin pharmacology in favour of the TTX-R form. This project will engineer subtype specific inhibitors of sodium channels in nerves through an understanding of how and wheremu-conotoxin bind to the sodium channel. Our long-term goal is to produce sodium channel drug candidates using m-conotoxins as templates for the development of subtype selective inhibitors of TTX-S and TTX-R sodium channels. The results of this study are designed to maximise the potential of this class of peptides as leads to the development of a new classes of therapeutics for pain, epilepsy and stroke."},"children":[{"color":"#336699","name":"Prof Paul Alewood","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0035049","middle_name":"F","last_name":"Alewood","source_individual_id":"5013158","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Alewood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86082","size":1},{"color":"#336699","name":"Prof Richard Lewis","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0014455","middle_name":"J","last_name":"Lewis","source_individual_id":"5015973","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Lewis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80612","size":1},{"color":"#336699","name":"Prof David Adams","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0000022","middle_name":"John","last_name":"Adams","source_individual_id":"RMIS8271","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Adams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76652","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3477","size":1},{"color":"#FF4D4D","name":"Evaluation of Family WellBeing empowerment program: a follow-up study","data":{"media_summary":"","end_year":2002,"keywords":["Australian Indigenous, family support, follow-up study","Control factor, Indigenous health, follow-up evaluation","Follow-up evaluation, Indigenous, family empowerment"],"nhmrc_grant_id":210303,"application_year":2001,"health_keywords":["Social and emotional wellbeing, control, coping skills","Social determinants of health, Control factor","Stress, mastery training, problem-solving skills"],"scientific_title":"Evaluation of Family WellBeing empowerment program: a follow-up study","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Indigenous Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Komla Tsey","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210303","simplified_title":"Evaluation of Family WellBeing empowerment program: a follow-up study","sub_type":"Standard Project Grant","total_budget":"82940","source_system":"Although relative powerlessnes resulting from colonisation has long been recognised as a major factor shaping Indigenous health, it is difficult to find tested and validated empowerment programs in the Indigenous health literature. The current project will follow-up a previous evaluation of a Family WellBeing empowerment training course which was implemented in Alice Springs in 1998-9. The aim is to find out the extent to which course participants have been able to sustain the high levels of personal empowerment demonstrated at the time of the original evaluation on the medium-long term basis. Among other things, this study will provide valuable insights and understandings about the pathways and conditions under which individuals and groups of people might use personal empowerment skills, especially better analytical and problem-solving skills to achieve greater control in life."},"children":[{"color":"#336699","name":"Prof Komla Tsey","data":{"first_name":"Komla","title":"Prof","dw_individual_id":"DW0045925","middle_name":"","last_name":"Tsey","source_individual_id":"RMIS1122536","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Komla Tsey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88886","size":1},{"color":"#336699","name":"Prof Ernest Hunter","data":{"first_name":"Ernest","title":"Prof","dw_individual_id":"DW0025657","middle_name":"","last_name":"Hunter","source_individual_id":"RMIS226584","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ernest Hunter"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83608","size":1},{"color":"#336699","name":"Prof Yvonne Cadet-James","data":{"first_name":"Yvonne","title":"Prof","dw_individual_id":"DW0018055","middle_name":"Lorraine","last_name":"Cadet-James","source_individual_id":"RMIS682305","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Yvonne Cadet-James"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81616","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3476","size":1},{"color":"#FF4D4D","name":"Pathways to Mental Health and Obesity in Young Adults: A Longitudinal Study","data":{"media_summary":"Young People","end_year":2004,"keywords":["Depression","Drug Abuse","Longitudinal Study","Obesity","Youth"],"nhmrc_grant_id":210298,"application_year":2001,"health_keywords":["Mental Illness","Obesity","Socioeconomic Variations in Health Status","Sociology, Medical","Young People"],"scientific_title":"Pathways to Mental Health and Obesity in Young Adults: A Longitudinal Study","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Jackob Najman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210298","simplified_title":"Pathways to Mental Health and Obesity in Young Adults: A Longitudinal Study","sub_type":"Standard Project Grant","total_budget":"698510","source_system":"While the health of the population has been gradually improving, there are some health problems which are increasing. The mental health of young people is one such area. Based on data relating to youth suicide, substance abuse, cigarette smoking by females and behavioural or mental health problems in the young, there has been evidence of a marked increase in some important health problems faced by the young. Little is known about the causes of these problems and even less is known about the reasons for the increase. Based on the available evidence, 20-25% of young persons manifest a mental health problem. A second area of marked health deterioration concerns youth (and adult) obesity. Existing research points to the accumulation of cardiovascular risk factors associated with obesity from a very early age. Over 10% of youth are obese and a substantially higher proportion are overweight. There is evidence that the rate of obesity has been substantially increasing. Again little is known about the factors that contribute to obesity or the causes of the increase in the rates of obesity in the population. This proposal is for a 21-year follow-up of a sample of youth first enrolled when their mothers attended for their first obstetrical visit. Using a substantial body of existing data, we propose to examine the changes in levels of mental health and obesity and to identify the factors which contribute to these changes. This study involves the largest Australian cohort ever assembled for such research. The main questions asked in this study concern the impact of the mother's social and economic circumstances, her physical health and well-being, her use of addictive substances (including alcohol, cigarettes, illicit drugs) on the youth's health. We will also examine the association between early indicators of mental health and well-being and subsequent youth health and development."},"children":[{"color":"#336699","name":"A/Pr Michael O'Callaghan","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0044590","middle_name":"James","last_name":"O'Callaghan","source_individual_id":"RMIS1119732","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Michael O'Callaghan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88543","size":1},{"color":"#336699","name":"Ms Margaret Andersen","data":{"first_name":"Margaret","title":"Ms","dw_individual_id":"DW0035089","middle_name":"","last_name":"Andersen","source_individual_id":"RMIS1119737","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Margaret Andersen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86093","size":1},{"color":"#336699","name":"Prof Gail Williams","data":{"first_name":"Gail","title":"Prof","dw_individual_id":"DW0017119","middle_name":"Marilyn","last_name":"Williams","source_individual_id":"RMIS28497","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gail Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81346","size":1},{"color":"#336699","name":"Dr William Bor","data":{"first_name":"William","title":"Dr","dw_individual_id":"DW0006156","middle_name":"","last_name":"Bor","source_individual_id":"RMIS1099638","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr William Bor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78373","size":1},{"color":"#336699","name":"Prof Jackob Najman","data":{"first_name":"Jackob","title":"Prof","dw_individual_id":"DW0003590","middle_name":"Moses","last_name":"Najman","source_individual_id":"5016639","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jackob Najman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77655","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3475","size":1},{"color":"#FF4D4D","name":"Mothers' History of Mental Health Impairment and its Impact during Mid-Life","data":{"media_summary":"WOMEN'S MENTAL HEALTH","end_year":2004,"keywords":["ANXIETY","DEPRESSION","LONGITUDINAL STUDY","MENOPAUSE","WOMEN'S HEALTH"],"nhmrc_grant_id":210297,"application_year":2001,"health_keywords":["MENTAL ILLNESS","QUALITY OF LIFE","WELL WOMEN","WOMEN'S HEALTH","WOMEN'S MENTAL HEALTH"],"scientific_title":"Mothers' History of Mental Health Impairment and its Impact during Mid-Life","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Public Health","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Prof Jackob Najman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210297","simplified_title":"Mothers' History of Mental Health Impairment and its Impact during Mid-Life","sub_type":"Standard Project Grant","total_budget":"421580","source_system":"There have been few specific studies of the health of women in mid-life. In mid-life, mental health impairment and health problems associated with biological and social transitions (e.g. menopause) are major concerns. National estimates indicate that between 15% and 20% of women in the mid-life age range have experienced a mental illness in the past year. The proportion of women experiencing a combination of emotional and physical symptoms, frequently associated with the menopause, is likely to be somewhat higher. This proposal involves merging information collected initially from 1981 onwards, with data on the mother's mental and physical health, to be collected in this follow-up. Women in this study (8556) were enrolled at their first obstetrical visit and they have been followed up shortly after the birth, when the child was 6 months, 5 years and 14 years. On each occasion extensive information has been obtained on the mother's mental and physical health, as well as on the child's health and development. This study will examine the chronicity of the mother's mental health symptoms over a 21-year period, and assess the association between her early mental health, the child's health and her current health status. This is the only large Australian cohort study to have followed a sample of women for 21 years. It will permit us to understand more of how women's health changes over time and the factors associated with these changes. It will provide the first large-scale study of factors influencing women's health transition through the menopause."},"children":[{"color":"#336699","name":"A/Pr Michael O'Callaghan","data":{"first_name":"Michael","title":"A/Pr","dw_individual_id":"DW0044590","middle_name":"James","last_name":"O'Callaghan","source_individual_id":"RMIS1119732","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Michael O'Callaghan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88543","size":1},{"color":"#336699","name":"Ms Margaret Andersen","data":{"first_name":"Margaret","title":"Ms","dw_individual_id":"DW0035089","middle_name":"","last_name":"Andersen","source_individual_id":"RMIS1119737","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Margaret Andersen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86093","size":1},{"color":"#336699","name":"Prof Gail Williams","data":{"first_name":"Gail","title":"Prof","dw_individual_id":"DW0017119","middle_name":"Marilyn","last_name":"Williams","source_individual_id":"RMIS28497","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gail Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81346","size":1},{"color":"#336699","name":"Dr William Bor","data":{"first_name":"William","title":"Dr","dw_individual_id":"DW0006156","middle_name":"","last_name":"Bor","source_individual_id":"RMIS1099638","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr William Bor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78373","size":1},{"color":"#336699","name":"Prof Jackob Najman","data":{"first_name":"Jackob","title":"Prof","dw_individual_id":"DW0003590","middle_name":"Moses","last_name":"Najman","source_individual_id":"5016639","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jackob Najman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77655","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3474","size":1},{"color":"#FF4D4D","name":"Molecular cell biology of hNP22: role in alcohol dependence","data":{"media_summary":"","end_year":2004,"keywords":["drug dependence","gene expression","molecular neuroscience"],"nhmrc_grant_id":210295,"application_year":2001,"health_keywords":["addiction","alcoholism","brain cell damage"],"scientific_title":"Molecular cell biology of hNP22: role in alcohol dependence","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Peter Wilce","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210295","simplified_title":"A novel gene associated with alcoholism","sub_type":"Standard Project Grant","total_budget":"346320","source_system":"We used a differential screening procedure to detect changes in gene expression in the human alcoholic brain and described a novel gene, which we named hNP22, with increased expression in the superior frontal cortex of the alcoholic cases. This is the first report of a novel alcohol-responsive gene isolated from the human brain. We now propose to further explore the hNP22 gene, its product and its regulation in human brain tissue, and in a variety of experimental systems. We will determine how protein expression correlates with the level of alcohol consumption. We will use animal and cell culture models to determine the response of the gene to various stimuli. We will express the recombinant protein to determine its function. It is likely that the gene product may be a component in an important signal pathway within neuronal cells and thus may represent a novel target for therapeutic intervention."},"children":[{"color":"#336699","name":"Peter Wilce","data":{"first_name":"Peter","title":"","dw_individual_id":"DW0011061","middle_name":"","last_name":"Wilce","source_individual_id":"RMIS34632","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Peter Wilce"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79708","size":1},{"color":"#336699","name":"Paul Kroon","data":{"first_name":"Paul","title":"","dw_individual_id":"DW0008467","middle_name":"","last_name":"Kroon","source_individual_id":"RMIS39791","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Paul Kroon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78988","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3473","size":1},{"color":"#FF4D4D","name":"Genetic Programs Induced by Growth Hormone","data":{"media_summary":"Dwarfism","end_year":2004,"keywords":["Clustering","Expression profiling","Gene array","Growth Hormone","IGF-1"],"nhmrc_grant_id":210278,"application_year":2001,"health_keywords":["Acromegaly","Ageing","Cardiac Insufficiency","Diabetes","Dwarfism"],"scientific_title":"Genetic Programs Induced by Growth Hormone","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael WATERS","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210278","simplified_title":"Discovering How Growth Hormone Regulates Tissue Metabolism at the Genetic Level.","sub_type":"Standard Project Grant","total_budget":"421980","source_system":"Growth hormone is responsible for normal postnatal growth, is an important metabolic regulator in starvation, and has many useful therapeutic applications, including forms of cardiac insufficiency, Crohns disease and, it is thought, amelioration of ageing. The means whereby GH brings about these changes are not known, although we do know a considerable amount about how the individual domains within the GH receptor signal. What we do not know is which genes are regulated by GH in these processes, and how this will change the state of the cell. We propose here to use the new technique of gene arrays to uncover the programs, or groups of genes, which GH regulates to change important cellular processes. When used in conjunction with cells expressing GH receptor mutants which are unable to signal to defined pathways, we will be able to know which functional families genes are regulated, and how they are regulated. This information will enable us to know how GH regulates cell growth and metabolism, and therfore to understand what goes wrong when GH or its mediator, IGF-1 , are abnormal. We can also use this information to validate small molecules designed to mimic GH through activating its receptor, to be certain that they are acting in the same way as GH."},"children":[{"color":"#336699","name":"A/Pr Rohan Teasdale","data":{"first_name":"Rohan","title":"A/Pr","dw_individual_id":"DW0040022","middle_name":"D","last_name":"Teasdale","source_individual_id":"5017848","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Rohan Teasdale"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87368","size":1},{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3472","size":1},{"color":"#FF4D4D","name":"Transcriptional regulation of the c-fms (CSF-1R) gene in macrophages.","data":{"media_summary":"","end_year":2004,"keywords":["CSF-1","differentiation","macrophage","transcription"],"nhmrc_grant_id":210273,"application_year":2001,"health_keywords":["cancer","genetics","inflammation"],"scientific_title":"Transcriptional regulation of the c-fms (CSF-1R) gene in macrophages.","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof David Hume","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210273","simplified_title":"Gene regulation in macrophages.","sub_type":"Standard Project Grant","total_budget":"422310","source_system":"This project concerns the basic biology of large white blood cells called macrophages. Macrophages are required for the immediate defence against infection, wound repair and normal turnover of tissues, but they can also produce toxic products that cause illness, especially in inflammatory diseases and cancer. We are studying a gene that is normally only produced in macrophages, but appears abnormally in many cancer cells. Our aim is understand at a molecular level exactly how the gene is controlled, and why it appears in tumours."},"children":[{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3471","size":1},{"color":"#FF4D4D","name":"Building best practice in child protection at the intersection of child protection and adult mental health services","data":{"media_summary":"","end_year":2004,"keywords":["best practice","services research","social research"],"nhmrc_grant_id":210272,"application_year":2001,"health_keywords":["child maltreatment","mental health","mental health services"],"scientific_title":"Building best practice in child protection at the intersection of child protection and adult mental health services","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Health and Community Services","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Yvonne Darlington","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210272","simplified_title":"Building best practice in child protection at the intersection of child protection and adult mental health services","sub_type":"Standard Project Grant","total_budget":"294590","source_system":"This research is an investigation of child protection practices with families where at least one parent has been diagnosed with a serious mental illness (affective or non-affective psychosis), and where child abuse or neglect has been substantiated or children are at risk of significant harm. It is specifically concerned to understand processes of interagency collaboration between workers in state government child protection and mental health service systems. The research has several aims. These are, first, to identify and examine the current practices of child protection and mental health workers where protective concerns have been identified in relation to children whose parent-s have been diagnosed with a mental illness. Practice will be examined at the assessment, child protection follow-up and post-order phases. Second, to identify and examine any barriers to effective collaboration between child protection and mental health organisations; and third, to develop inductively derived descriptions of 'best practice' in relation to these cases. The research will be conducted in four stages, including a survey of child protection and mental health workers, tracking of cases through the child protection system, in-depth interviews with child protection workers, mental health workers and parents, and group discussions with highly experienced child protection and mental health workers. The expected outcomes of the study are: the development of child protection practice guidelines for working with families where children have been harmed or at risk of harm by a parent who has a mental illness, including practice guidelines for interagency collaboration in this field; and identification of supervisional, training, administrative and policy responses to this issue."},"children":[{"color":"#336699","name":"Dr Judith Feeney","data":{"first_name":"Judith","title":"Dr","dw_individual_id":"DW0036569","middle_name":"A","last_name":"Feeney","source_individual_id":"RMIS1112030","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Judith Feeney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86484","size":1},{"color":"#336699","name":"Yvonne Darlington","data":{"first_name":"Yvonne","title":"","dw_individual_id":"DW0036158","middle_name":"","last_name":"Darlington","source_individual_id":"RMIS1112027","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Yvonne Darlington"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86377","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3470","size":1},{"color":"#FF4D4D","name":"Osteoclast- specific gene regulation","data":{"media_summary":"","end_year":2004,"keywords":["Control of gene expression","Macrophage biology","Osteoclast biology","Transcription factor","Transgenic animals"],"nhmrc_grant_id":210261,"application_year":2001,"health_keywords":["Arthritis","Inflammation","Osteoporosis"],"scientific_title":"Osteoclast- specific gene regulation","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Alan Cassady","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210261","simplified_title":"Bone cell regulation","sub_type":"Standard Project Grant","total_budget":"226650","source_system":"Osteoporosis is a pathological loss of bone that affects many Australians. It occurs because of an excessive release of calcium from bone that is caused by the overactivity of the cells that break down bone, osteoclasts. We have studied two genes that are involved in the way these cells work and by a close examination of the the way they are regulated we hope to understand how osteoclasts are derived and how their activity is controlled. In particular we will look at two newly dicovered osteoclast regulators called PPAR-gamma and PPAR-delta. These offer the opportunity for the development in the future of new, alternative drugs for the treatment of osteoporosis."},"children":[{"color":"#336699","name":"Dr Alan Cassady","data":{"first_name":"Alan","title":"Dr","dw_individual_id":"DW0029837","middle_name":"Ian","last_name":"Cassady","source_individual_id":"RMIS24493","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Alan Cassady"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84725","size":1},{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3469","size":1},{"color":"#FF4D4D","name":"Role of synaptogenesis in developmental motoneuron cell death","data":{"media_summary":"neurotransmission","end_year":2004,"keywords":["developmental neurobiology","motor neuron disease","neuromuscular junction","neuronal death","synaptic mechanisms"],"nhmrc_grant_id":210256,"application_year":2001,"health_keywords":["motor neuron disease","nervous system development","neuromuscular diseases","neuronal cell death","neurotransmission"],"scientific_title":"Role of synaptogenesis in developmental motoneuron cell death","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Peripheral Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Peter Noakes","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210256","simplified_title":"The development of central and peripheral connections with motoneurons are key determinants for motoneuron viability","sub_type":"Standard Project Grant","total_budget":"361650","source_system":"Naturally occurring cell death is an important and necessary event that shapes the developing embryo. It occurs in all organs of the developing body. In the nervous system about 50% of all neurons die at a time when they are making contact with one another or with their target organs. The underlying mechanisms that drive programmed neuronal cell death are not known. One possibility is that the formation of neuronal contacts (synapses) with other neurons and target cells determines the fate of a neuron. The connections of motor neurons with muscle during this period of developmental neuronal cell death is the best model to examine this phenomenon. In this grant we are in an exciting position to be able to address what causes neuronal cell death, as we have a number of mice that lack key molecules needed for the formation of specializations that allow neuronal contacts to be made between motor neurons and their muscle, and with other neurons within the spinal cord. By examining the function of motor neurons, counting them and screening for molecular changes in these mice, we will be able to dissect out the mechanism of how a motor neurons' fate is determined during the period of programmed cell death. The outcomes of this research will enable us to understand how the nervous system is shaped during development and will increase our knowledge about the basis of adult neurodegenerative diseases. For example, the pathology of Alzheimer's is characterised by a breakdown in neuronal connections that ultimately result in neuronal death and a loss of thought processes (cognition)."},"children":[{"color":"#336699","name":"A/Pr Peter Noakes","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0038807","middle_name":"G","last_name":"Noakes","source_individual_id":"5016732","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Noakes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87053","size":1},{"color":"#336699","name":"Dr Mark Bellingham","data":{"first_name":"Mark","title":"Dr","dw_individual_id":"DW0035336","middle_name":"C","last_name":"Bellingham","source_individual_id":"5013441","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Mark Bellingham"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86159","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3468","size":1},{"color":"#FF4D4D","name":"Anatomical substrates for primate executive cortical function","data":{"media_summary":"","end_year":2004,"keywords":["central nervous system","cognition","primates"],"nhmrc_grant_id":210250,"application_year":2001,"health_keywords":["Alzheimers disease","Schizophrenia","dementia"],"scientific_title":"Anatomical substrates for primate executive cortical function","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Guy Elston","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210250","simplified_title":"The mind - brain connection: a closeup look at circuits","sub_type":"New Investigator Grant","total_budget":"362820","source_system":"When studying the brain, many have been tempted to look for similarities in organization of cells and circuitry in different regions involved in various processes. While, at a first approximation, this may be a reasonable approach to understand how the brain works, it also ignores what makes the brain so complex: the diversity in its structure. In the late 19th, and early 20th, centuries, pioneering anatomists seized on the diversity in structure of the human brain. The study of cortical circuitry that underlies the diversity in cortical processing reached a zenith and there was a renaissance in understanding of brain function. These researchers were, however, limited by techniques available to them at the time. With the advent of new methodologies which allowed scientists to explore individual connections between cells (synapses), to probe structure and transmission across synapses, and to record from live neurones, new and exciting discoveries were made. However, these methodologies are highly time consuming and studies became necessarily more focussed. As a result, there was a tendency in the later half of the 20th century to extrapolate findings from one cortical area to cortex in general. Even more precarious, anatomical and functional findings in highly specialized sensory cortex of one species were projected to other distantly related species. Such thinking lead to a dark age in neuroscience. It became widely accepted that there exists a canonical circuit. Consequently, differences in function between different cortical areas were attributed solely to the source of their projections. The central thesis of this project is to study aspects of cell structure and cortical circuitry in the prefrontal lobe. We hope that the project will provide another step in the pathway that leads to understanding the mind."},"children":[{"color":"#336699","name":"Guy Elston","data":{"first_name":"Guy","title":"","dw_individual_id":"DW0042265","middle_name":"","last_name":"Elston","source_individual_id":"RMIS224199","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Guy Elston"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87969","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3467","size":1},{"color":"#FF4D4D","name":"Induction of antigen-specific tolerance through inhibition of RelB function in dendritic cells","data":{"media_summary":"","end_year":2004,"keywords":["RelB","arthritis","dendritic cells","immunotherapy","regulation"],"nhmrc_grant_id":210237,"application_year":2001,"health_keywords":["Autoimmunity","Immunotherapy","Rheumatoid arthritis"],"scientific_title":"Induction of antigen-specific tolerance through inhibition of RelB function in dendritic cells","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Autoimmunity","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ranjeny Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210237","simplified_title":"Re-education of the immune system in autoimmune arthritis","sub_type":"Standard Project Grant","total_budget":"421980","source_system":"This proposal builds on preliminary data showing the possibility that responses of the immune system to antigens can be suppressed by modifying cells known as dendritic cells using an inhibitory drug. The drug appears to be able to control the ability of dendritic cells to educate the immune system about antigens. When antigens presented continuously are harmful to the immune system, they produce diseases such as rheumatoid arthritis and allergies. The experiments to be undertaken specifically look at means to prevent and reverse diseases like rheumatoid arthritis through the use of dendritic cells."},"children":[{"color":"#336699","name":"Prof Ranjeny Thomas","data":{"first_name":"Ranjeny","title":"Prof","dw_individual_id":"DW0045826","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS4352","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ranjeny Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88853","size":1},{"color":"#336699","name":"Dr Brendan O'Sullivan","data":{"first_name":"Brendan","title":"Dr","dw_individual_id":"DW0015384","middle_name":"John","last_name":"O'Sullivan","source_individual_id":"RMIS1088861","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Brendan O'Sullivan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80879","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3466","size":1},{"color":"#FF4D4D","name":"Effects of hypoxia and reactive oxygen species on neuronal excitability of intrinsic cardiac ganglia","data":{"media_summary":"","end_year":2002,"keywords":["Cardiovascular control","Electrophysiology","Intracardiac ganglia","Intracellular calcium","Ion channels"],"nhmrc_grant_id":210233,"application_year":2001,"health_keywords":["Cardiac arrhythmias","Cardiac ischaemia","Coronary heart disease","Ischaemia-reperfusion"],"scientific_title":"Effects of hypoxia and reactive oxygen species on neuronal excitability of intrinsic cardiac ganglia","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof David Adams","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210233","simplified_title":"Hypoxia and neural control of the heart","sub_type":"Standard Project Grant","total_budget":"70000","source_system":"Neural control of the heart is mediated by intrinsic cardiac neurones which respond to chemical substances such as neurotransmitters released from nerve fibres innervating the heart and vasoactive substances released into the coronary ciruculation. Prolonged periods of myocardial ischaemia (hypoxia) and post ischaemic reperfusion (oxygen-derived free radicals) influence the electrical activity of the intrinsic cardiac nervous system. The involvement of membrane electrical phenomena in general, and ion-selective pores (ion channels) in particular, and the action of hypoxia and oxygen-derived free readicals on their function will be studied in isolated neurones dissociated from neonatal and adult rat intrinsic cardiac ganglia. The characterization of ion channels modulated by hypoxia and reactive oxygen species will be monitored using electrical and fluorescence techniques. The opening of ion channels in the cell membrane by changes in either voltage or the intracellular calcium ion concentration leads to an electrical response. The goal of the research is to elucidate the mechanisms underlying the effects of ischaemia and ischaemia-reperfusion on neuronal excitability in mammalian cardiac ganglia, thus regulation of the heart rate. Development of therapeutic strategies to prevent ischaemia and reperfusion injuries in coronary heart disease and improvement of cardiac protection during surgery are potential outcomes of this research."},"children":[{"color":"#336699","name":"Dr Ronald Hogg","data":{"first_name":"Ronald","title":"Dr","dw_individual_id":"DW0037317","middle_name":"C","last_name":"Hogg","source_individual_id":"RMIS543447","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Ronald Hogg"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86668","size":1},{"color":"#336699","name":"Prof David Adams","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0000022","middle_name":"John","last_name":"Adams","source_individual_id":"RMIS8271","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Adams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76652","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3465","size":1},{"color":"#FF4D4D","name":"Development of quantitative tools for assessment of regional cardiac function by echocardiography","data":{"media_summary":"","end_year":2004,"keywords":["Echocardiography","Exercise test","Ventricular dysfunction - Left"],"nhmrc_grant_id":210218,"application_year":2001,"health_keywords":["Coronary artery disease","Echocardiography","Ventricular dysfunction - Left","Viable myocardium"],"scientific_title":"Development of quantitative tools for assessment of regional cardiac function by echocardiography","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Thomas Marwick","higher_grant_type":"NHMRC Development Grants","purl":"http://purl.org/au-research/grants/nhmrc/210218","simplified_title":"A new technique for measurement of regional cardiac function","sub_type":"Development Grant","total_budget":"209430","source_system":"The application of ultrasound imaging to the assessment of cardiac function (echocardiography) is an invaluable tool for the assessment of patients with known or suspected cardiac problems. The assessment of contraction in each region of the heart is probably the most important of the reasons for doing this test, as regional function is disturbed in patients with coronary artery disease, which is one of the most common causes of death in Australia. The problem is that this analysis is currently completely subjective, and the reliability of the tool is based upon the availability of an experienced observer. This is particularly a problem in rural Australia, as most specialists with expertise in this modality work in the capital cities, and especially a problem in Queensland, where fewer than half of the population live in the capital. The cardiac imaging group at the University of Queensland have been working in collaboration with GE-Vingmed Ultrasound to develop a quantitative technique for the assessment of regional cardiac function since 1997. This collaboration has been the source of a number of published papers and presentations at international meetings. Our group is considered to be a world leader in the field and our industry partner is clearly the most focused of its competitors in addressing this problem. This submission seeks to address several remaining problems. The data thus far addressed function during stress, when the condition of most patients is similar. Tissue velocities are more variable at rest, and a more sophisticated approach is required to accurately measure the lower velocities in the resting state. This research plan seeks support for the development of a new, high frame-rate acquisition that would facilitate the examination of velocities relative to each other, so that translational motion of the heart does not influence the reading. This new method would then be validated against other techniques for assessing function and disease."},"children":[{"color":"#336699","name":"Dr Kjell Kristoffersen","data":{"first_name":"Kjell","title":"Dr","dw_individual_id":"DW0043611","middle_name":"","last_name":"Kristoffersen","source_individual_id":"RMIS1148776","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Kjell Kristoffersen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88307","size":1},{"color":"#336699","name":"Prof Thomas Marwick","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0032377","middle_name":"Hugh","last_name":"Marwick","source_individual_id":"RMIS108223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Marwick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85383","size":1},{"color":"#336699","name":"Mr Gunnar Hansen","data":{"first_name":"Gunnar","title":"Mr","dw_individual_id":"DW0013494","middle_name":"","last_name":"Hansen","source_individual_id":"RMIS1148779","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mr Gunnar Hansen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80346","size":1},{"color":"#336699","name":"A/Pr Stephen Rose","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0009965","middle_name":"E","last_name":"Rose","source_individual_id":"5017273","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Stephen Rose"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79404","size":1},{"color":"#336699","name":"Prof Bjorn Olstad","data":{"first_name":"Bjorn","title":"Prof","dw_individual_id":"DW0003783","middle_name":"","last_name":"Olstad","source_individual_id":"RMIS1148773","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Bjorn Olstad"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77719","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3462","size":1},{"color":"#FF4D4D","name":"Importance of the transmural distribution of viable myocardium to outcome of patients after revascularization","data":{"media_summary":"","end_year":2004,"keywords":["Echocardiography","Exercise test","Thalium SPECT","Ventricular dysfunction - Left","Viable myocardium"],"nhmrc_grant_id":210217,"application_year":2001,"health_keywords":["Echocardiography","Heart failure","Ventricular dysfunction - Left","Viable myocardium"],"scientific_title":"Importance of the transmural distribution of viable myocardium to outcome of patients after revascularization","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Thomas Marwick","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210217","simplified_title":"Patterns of viable myocardium in patients with coronary artery disease","sub_type":"Standard Project Grant","total_budget":"268800","source_system":"After a heart attack, up to 50% of tissue showing reduced function can recover if blood supply is returned to normal with bypass surgery or balloon angioplasty. Because these procedures may be risky in cardiac patients, the investigators have used various imaging approaches including radionuclide and ultrasound techniques to predict regions where function will recover after intervention. The results of these tests may be discordant because they assess separate attributes of cardiac muscle, and selection of patients for intervention on the basis of recovery of regional function ignores some other aspects that may be important. These include avoidance of heart enlargement, improvement of exercise capacity, and avoidance of heart rhythm disturbances and even other heart attacks. In this study, the investigators seek to define the importance of the proportion and site of live (viable) myocardium to the parameters listed above. A new magnetic resonance technique will be used to identify whether radionuclide and ultrasound techniques assess different parts of the heart wall. The relative importance of these sites will be identified by comparing the outcome of patients who have live tissue in the inner half, compared with the outer half of the heart wall. This study will involve 180 patients who will undergo testing with magnetic resonance and radionuclide imaging. A subgroup will undergo dobutamine echocardiography. Their responses over follow-up will be assessed by accurate evaluation of heart size, exercise response, heart rhythm abnormalities and clinical events."},"children":[{"color":"#336699","name":"Dr Julie Mundy","data":{"first_name":"Julie","title":"Dr","dw_individual_id":"DW0032740","middle_name":"A","last_name":"Mundy","source_individual_id":"RMIS227426","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Julie Mundy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85479","size":1},{"color":"#336699","name":"Prof Thomas Marwick","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0032377","middle_name":"Hugh","last_name":"Marwick","source_individual_id":"RMIS108223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Marwick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85383","size":1},{"color":"#336699","name":"Dr Frederick Khafagi","data":{"first_name":"Frederick","title":"Dr","dw_individual_id":"DW0020095","middle_name":"A","last_name":"Khafagi","source_individual_id":"RMIS1083954","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Frederick Khafagi"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82126","size":1},{"color":"#336699","name":"A/Pr Stephen Rose","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0009965","middle_name":"E","last_name":"Rose","source_individual_id":"5017273","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Stephen Rose"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79404","size":1},{"color":"#336699","name":"Dr Richard Lim","data":{"first_name":"Richard","title":"Dr","dw_individual_id":"DW0008671","middle_name":"","last_name":"Lim","source_individual_id":"RMIS1083959","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Richard Lim"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79050","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3461","size":1},{"color":"#FF4D4D","name":"A Novel Physiological Role for Cytochrome P450 Enzymes in the Brain?","data":{"media_summary":"","end_year":2004,"keywords":["anxiety","cytochrome P450","hippocampus","molecular toxicology"],"nhmrc_grant_id":210215,"application_year":2001,"health_keywords":["anxiety disorders","drug development","polymorphic drug metabolism","polymorphic enzymes"],"scientific_title":"A Novel Physiological Role for Cytochrome P450 Enzymes in the Brain?","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Toxicology (incl. Clinical Toxicology)","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"A/Pr ELIZABETH GILLAM","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210215","simplified_title":"A Novel Role for","sub_type":"Standard Project Grant","total_budget":"210990","source_system":"The cytochrome P450 enzymes in human liver have been traditionally regarded as drug metabolising enzymes. However, it is now becoming clear that they are distributed in other tissues in the body and that they may serve important and diverse roles in normal physiology. Little is known about their functions in the brain. We have identified a reaction catalysed by these enzymes that generates a chemical found in the brain normally, whose levels are elevated under stress and which, when given to animals, is anxiogenic. This points to a possible involvement of P450 enzymes in a hitherto unexplored branch of the stress response. Importantly, it may lead to the development of novel drugs that block the P450 and therefore block production of the anxiogenic chemical. This proposal is designed to explore the basic biology underlying this system."},"children":[{"color":"#336699","name":"Prof Elizabeth Gillam","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0036843","middle_name":"Maree Jeffery","last_name":"Gillam","source_individual_id":"RMIS37024","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Gillam"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86545","size":1},{"color":"#336699","name":"Peter Wilce","data":{"first_name":"Peter","title":"","dw_individual_id":"DW0011061","middle_name":"","last_name":"Wilce","source_individual_id":"RMIS34632","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Peter Wilce"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79708","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3460","size":1},{"color":"#FF4D4D","name":"Glucose, glucose transporters and blastocyst formation in the mouse","data":{"media_summary":"maternal nutrition program","end_year":2004,"keywords":["Blastocyst formation","epithelial biogenesis","glucose as a signal for gene expression","glucose transporter expression","glucose transporter targeting"],"nhmrc_grant_id":210194,"application_year":2001,"health_keywords":["IVF","diabetes mellitus","embryology","infertility","maternal nutrition program"],"scientific_title":"Glucose, glucose transporters and blastocyst formation in the mouse","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Reproduction","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Peter Kaye","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210194","simplified_title":"Why glucose is required for normal embryonic development?","sub_type":"Standard Project Grant","total_budget":"281650","source_system":"Embryo-based biotechnologies have the potential to improve human reproductive health, notably in treating infertility by In vitro fertilisation (IVF). They are also central to the future use of embryonic stem cells for human tissue replacement. This project investigates the molecular mechanisms controlling one of the earliest differentiations in the growth of the embryo. Using the mouse as an experimental model it will investigate the importance of several factors in the changes which set up the placenta and fetus as seperate tissues in the very early embryo. A key focus is the supply of glucose to the newly fertilised embryo and how important this glucose supply is for the survival of the embryo. Moreover there is great interest in the possibility that metabolic events in utero can contribute to the development of diseases in later life, notably, coronary heart diease, stroke, high blood pressure and non-insulin dependent diabetes. The results from these studies will contribute to our understanding of why some couples are infertile, lead to improved management of infertility by diet and invitro fertilisation procedures. It will also be of benefit in dietary advice to women with diabetes mellitus, seeking to have children. The adenoviral strategy for gene delivery into early mouse embryos may in the long term also find wide clinical application in the treatment of genetic defects at the very earliest stages in development and as such is of enormous potential benefit in the management of both animal and human reproduction."},"children":[{"color":"#336699","name":"Dr Marie Pantaleon","data":{"first_name":"Marie","title":"Dr","dw_individual_id":"DW0003844","middle_name":"","last_name":"Pantaleon","source_individual_id":"RMIS178225","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Marie Pantaleon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77737","size":1},{"color":"#336699","name":"A/Pr Peter Kaye","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0002568","middle_name":"L","last_name":"Kaye","source_individual_id":"RMIS3156936","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Kaye"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77370","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3459","size":1},{"color":"#FF4D4D","name":"Evaluating the Active Communication Education program for older people with hearing impairment","data":{"media_summary":"","end_year":2004,"keywords":["audiology","aural rehabilitation","gerontology"],"nhmrc_grant_id":210190,"application_year":2001,"health_keywords":["ageing","hearing impairment","presbycusis"],"scientific_title":"Evaluating the Active Communication Education program for older people with hearing impairment","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Hearing and Speech","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Louise Hickson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210190","simplified_title":"Communication education for older people with hearing impairment: When hearing aids are not the answer","sub_type":"Standard Project Grant","total_budget":"240550","source_system":"Hearing loss is one of the most prevalent disabilities in older people and as the Australian population ages, the number of people with hearing loss will also increase. Hearing loss can lead to social isolation and depression and has a profound effect on quality of life. Hearing aids are often seen as the panacea for hearing loss in older people but approximately 35% of people who have obtained a hearing aid use it infrequently or not at all. Even those who do use the hearing aid frequently may still have difficulty hearing in everyday situations. In addition, there are many older people with a hearing impairment who do not want a hearing aid. Cost is often cited as a factor but reasons such as cosmetic appearance and attitude towards hearing loss are also major reasons for not using hearing aids. Hearing is just one element of successful communication. The ability to communicate despite the presence of a hearing impairment is the focus of a new intervention, the Active Communication Education (ACE) program. Participants develop problem-solving strategies to help with communication in everyday life. The program uses a positive approach aimed at enabling older people themselves to try new solutions to old problems. The aim of this project is to evaluate the effectiveness of ACE for a range of older people with hearing impairment: those who are already using hearing aids, and those who have not sought a hearing aid. Some of the questions answered in this study are: Does the ACE program improve communication and quality of life for older people with hearing impairment? Do some people respond better to ACE , and if so, why? Are there long term effects of ACE? A simple low cost and effective program such as ACEwill have a major impact on the social and psychological health of older people."},"children":[{"color":"#336699","name":"Prof Linda Worrall","data":{"first_name":"Linda","title":"Prof","dw_individual_id":"DW0046389","middle_name":"Elizabeth","last_name":"Worrall","source_individual_id":"RMIS28004","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Linda Worrall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/89016","size":1},{"color":"#336699","name":"Prof Louise Hickson","data":{"first_name":"Louise","title":"Prof","dw_individual_id":"DW0025478","middle_name":"","last_name":"Hickson","source_individual_id":"5032562","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Louise Hickson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83559","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3458","size":1},{"color":"#FF4D4D","name":"Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2006,"keywords":["Abnormal embryogenesis","Birth defects","Craniofacial development","Molecular genetics","Signal transduction"],"nhmrc_grant_id":210181,"application_year":2001,"start_year":2002,"scientific_title":"Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Carol Wicking","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/210181","simplified_title":"Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"504500","source_system":""},"children":[{"color":"#336699","name":"A/Pr Carol Wicking","data":{"first_name":"Carol","title":"A/Pr","dw_individual_id":"DW0028805","middle_name":"A","last_name":"Wicking","source_individual_id":"RMIS2473798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Carol Wicking"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84461","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3457","size":1},{"color":"#FF4D4D","name":"Contractile and relaxant effects of b2- and b1-adrenoceptors in human heart: blockade by a third generation b-blocker","data":{"media_summary":"","end_year":2004,"keywords":["beta-adrenceptor subtypes","myocardial contractility","pharmacology"],"nhmrc_grant_id":210177,"application_year":2001,"health_keywords":["atrial fibrillation","cardiac failure","cardiomyopathy","pharmacological intervention"],"scientific_title":"Contractile and relaxant effects of b2- and b1-adrenoceptors in human heart: blockade by a third generation b-blocker","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Peter Molenaar","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210177","simplified_title":"Consequences of stimulation and blockade of b-adrenoceptors in the human heart: an investigation of mechanisms","sub_type":"Standard Project Grant","total_budget":"136320","source_system":"The force and the duration of each heart beat can be modified in disease states affecting the heart. They can also be modified by chemicals which occur naturally in the body. Two of the most important naturally occurring chemicals which affect the function of the heart are (-)-noradrenaline and (-)-adrenaline. These chemicals and others which have been synthesized and optimized can also be used therapeutically. They work by activating proteins which occur on the cell surface, called b-adrenoceptors. When activated, b-adrenoceptors cause an increase in the force of each heart beat and a reduction in the duration of each heart beat. This may be an advantage in conditions where the heart beat is too long. In this study we propose to map the biochemical pathways through which b-adrenoceptors affect each heart beat. The therapeutic management of heart failure has been revolutionized by the use of compounds which block b-adrenoceptors. One such drug, carvedilol is currently used in this country. The way in which it works may not be fully understood. In preliminary experiments we have identified a novel mechanism for carvedilol directly in human heart in which it may work and contribute to it's beneficial effects in the management of heart failure. Our studies will focus on this finding."},"children":[{"color":"#336699","name":"A/Pr Peter Molenaar","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0020938","middle_name":"","last_name":"Molenaar","source_individual_id":"RMIS221171","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Molenaar"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82361","size":1},{"color":"#336699","name":"Prof Malcolm West","data":{"first_name":"Malcolm","title":"Prof","dw_individual_id":"DW0005385","middle_name":"J","last_name":"West","source_individual_id":"5018261","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Malcolm West"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78171","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3456","size":1},{"color":"#FF4D4D","name":"Pharmacokinetic and pharmacodynamic studies of the newer immunosuppressants","data":{"media_summary":"","end_year":2004,"keywords":["clinical pharmacology","computer-based decision support","drug clearance and interactions","pharmacokinetics","transplantation"],"nhmrc_grant_id":210173,"application_year":2001,"health_keywords":["benefits of testing to identify future potential illness","clinical pharmacology/ therapeutic drug monitoring","drug therapy","transplant recipients"],"scientific_title":"Pharmacokinetic and pharmacodynamic studies of the newer immunosuppressants","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Susan Tett","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210173","simplified_title":"Better ways to use new immunosuppressant drugs","sub_type":"Standard Project Grant","total_budget":"406650","source_system":"After an organ transplant (such as a liver or kidney transplant), people need to take medicines continually to stop their immune systems from rejecting their new organ. This treatment with immunosuppressant drugs is vital for long-term success of the graft. These drugs are designed to prevent rejection in patients who have received organ transplants (e.g. kidney, liver) and are also being used to treat a variety of autoimmune diseases, including rheumatoid arthritis. However, too many people are losing transplanted organs, or not achieving remission from their autoimmune diseases, or are experiencing significant illness and sometimes death from over immunosuppression (infection or side effects) because these drugs are not being used in the best way. The quality and duration of life of increasing numbers of Australians is being affected by lack of understanding and application of some basic principles about dosing regimens for these drugs. The aim of this project is to accurately define the best way to dose these newer immunosuppressant drugs in Australian populations, before they become more widely used ."},"children":[{"color":"#336699","name":"A/Pr Peter Pillans","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0044840","middle_name":"I","last_name":"Pillans","source_individual_id":"RMIS3112671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Pillans"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88604","size":1},{"color":"#336699","name":"Prof Susan Tett","data":{"first_name":"Susan","title":"Prof","dw_individual_id":"DW0040037","middle_name":"Elizabeth","last_name":"Tett","source_individual_id":"5011655","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Susan Tett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87372","size":1},{"color":"#336699","name":"Prof Stephen Duffull","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0036379","middle_name":"B","last_name":"Duffull","source_individual_id":"5014415","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Stephen Duffull"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86429","size":1},{"color":"#336699","name":"Mr Paul Taylor","data":{"first_name":"Paul","title":"Mr","dw_individual_id":"DW0022474","middle_name":"James","last_name":"Taylor","source_individual_id":"5017860","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Mr Paul Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82790","size":1},{"color":"#336699","name":"Prof Stephen Lynch","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0014580","middle_name":"V","last_name":"Lynch","source_individual_id":"RMIS5846","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80640","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3455","size":1},{"color":"#FF4D4D","name":"Urotensin-II in human heart: investigation of mechanisms involved in cardiac function","data":{"media_summary":"","end_year":2004,"keywords":["Pharmacology","Urotensin-II","cardiac contraction","cardiac failure","signalling pathways"],"nhmrc_grant_id":210172,"application_year":2001,"health_keywords":["cardiomyopathy","cardiovascular disease","pharmacological intervention"],"scientific_title":"Urotensin-II in human heart: investigation of mechanisms involved in cardiac function","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Fraser Russell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210172","simplified_title":"Urotensin-II: its role in human heart","sub_type":"New Investigator Grant","total_budget":"255990","source_system":"The normal function of the body is maintained by naturally occurring compounds. Some for example affect the heart, fine tuning it to make it beat faster or slower, or beat with greater or less force when required in different situations in health and disease. We were the first to show just recently that a small protein which occurs naturally in the body, called urotensin-II can affect the way the heart beats. We showed that extremely tiny amounts increase the force of the heart beat. Our findings indicate that urotensin-II is the most potent heart stimulator identified to date. In patients with heart failure, short term stimulation of heart contraction is beneficial, supplying the heart and other organs with vital oxygen and nutrients. However, in the long term excessive stimulation causes worsening of the patients condition. Very little is currently known about the way in which urotensin-II alters heart function. The goal of our study is to understand the mechanism involved in urotensin-II mediated effects on the heart. This will involve identifying the location of urotensin-II and its receptors in the heart, and determining what signalling changes occur after the interaction of urotensin-II with its receptors. Urotensin-II must first be cleaved from a larger drug. We will determine where in the heart this cleavage occurs and whether the process is crucial to the ability of urotensin-II to stimulate contraction of the heart. Since stimulators of heart contraction are detrimental to patients with heart failure in the long term, we will determine whether these patients have more urotensin-II in their blood than patients who do not have heart failure. If the levels of urotensin-II are higher in heart failure patients, it may indicate a need to interfere with the interaction of urotensin-II with its receptors."},"children":[{"color":"#336699","name":"Dr Fraser Russell","data":{"first_name":"Fraser","title":"Dr","dw_individual_id":"DW0045208","middle_name":"Donald","last_name":"Russell","source_individual_id":"RMIS1114929","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Fraser Russell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88699","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3454","size":1},{"color":"#FF4D4D","name":"The role of plasma membrane microdomains in regulating Ras-dependent Raf activation","data":{"media_summary":"","end_year":2002,"keywords":["Lipid Rafts","Plasma membrane microdomains","Raf-1 activation","Ras signalling"],"nhmrc_grant_id":210164,"application_year":2001,"health_keywords":["Acute leukaemia","Cancer biology","Colon cancer"],"scientific_title":"The role of plasma membrane microdomains in regulating Ras-dependent Raf activation","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof John Hancock","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210164","simplified_title":"Interactions between Ras proteins and the cell membrane","sub_type":"Standard Project Grant","total_budget":"216100","source_system":"In human cancers one or more of the signaling pathways leading from growth factor receptors at the cell surface to the nucleus where cell division is initiated are subverted. For example, a protein called Ras, that regulates a series of major signaling pathways, is mutated in 25% of all human tumours. This leaves Ras and the signaling pathways permanently switched on causing uncontrolled cell proliferation. Our previous work has demonstrated that Ras must be attached to the inner surface of the cell membrane in order to function properly. This project now seeks to understand exactly how Ras attaches to and interacts with specific sites in the plasma membrane. Its is becoming clear that different isoforms of Ras, called H-, N- and K-ras have different functions in the cell which may in turn result from their different sites of attachment to the cell membrane. This is important because by understanding the precise micro-environment in which the different Ras proteins operate and how they activate subsequent proteins in their signaling networks we will be in a good position to design drugs that selectively compromise the function of each specific Ras isoform. A highly relevant example is provided by K-ras which is mutated in 90% of all pancreatic cancers and 50% of all colon cancers. Clearly the clinical impact of a drug that could selectively neutralise K-Ras function in these tumours is potentially enormous."},"children":[{"color":"#336699","name":"Prof John Hancock","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0037089","middle_name":"F","last_name":"Hancock","source_individual_id":"RMIS11500","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Hancock"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86600","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3451","size":1},{"color":"#FF4D4D","name":"BRCA1, PML and telomere maintenance","data":{"media_summary":"","end_year":2004,"keywords":["Acute promyelocytic leukaemia gene PML","Breast cancer susceptibility gene BRCA1","Chromosome stability","Molecular biology of cancer","Telomeres"],"nhmrc_grant_id":210162,"application_year":2001,"health_keywords":["Breast cancer","Genetic predisposition to cancer","Tumour suppressor genes","Tumourigenesis"],"scientific_title":"BRCA1, PML and telomere maintenance","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Melissa Brown","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210162","simplified_title":"Understanding how abnormalities in chromosome ends contribute to breast cancer","sub_type":"Standard Project Grant","total_budget":"226320","source_system":"Breast cancer affects approximately one in ten women and is therefore a major health problem. In order to improve the diagnosis, treatment and prognosis of this disease, it is critical to understand the molecular defects which contribute to disease initiation and progression. Over the last twenty years significant progress has been made in this regard, however there still remain a considerable number of unanswered questions. For example, it is not yet clear which are the most critical molecules contributing to this disease and thus which are the best targets for therapeutic intervention. In this proposal, we aim to study two molecules. The first is called BRCA1 and is particularly important in inherited susceptibility to breast cancer. The second is called PML and, although originally described as a leukaemia-associated gene, it has since been implicated in a number of cancers. Specifically, we aim to investigate the possibility that PML and BRCA1 work together to protect against cancer and that they do this by regulating the ends of chromosomes, that is, the telomeres."},"children":[{"color":"#336699","name":"Prof Melissa Brown","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0041312","middle_name":"A","last_name":"Brown","source_individual_id":"RMIS511711","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Melissa Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87712","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3450","size":1},{"color":"#FF4D4D","name":"Iron metabolism and the cirrhotic liver:studies on iron absorption and hepatic iron kinetics","data":{"media_summary":"","end_year":2004,"keywords":["Hepatic Ferrokinetics","Iron absorption in cholestatic and hepatocellular cirrhosis","Pathophysiology of iron overload in liver cirrhosis"],"nhmrc_grant_id":210159,"application_year":2001,"health_keywords":["Cirrhosis","Liver disease","Liver transplantation"],"scientific_title":"Iron metabolism and the cirrhotic liver:studies on iron absorption and hepatic iron kinetics","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gastroenterology and Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Darrell Crawford","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210159","simplified_title":"Iron and the cirrhotic liver","sub_type":"Standard Project Grant","total_budget":"256980","source_system":"Patients with liver disease awaiting liver transplantation often have excess iron in the liver that aggravates the existing liver disease. We have shown that patients with cholestatic liver disease, (due to poor bile excretion), do not have much iron in the liver compared to those patients with hepatocellular cirrhosis, (where the liver cells are damaged). Why this is so is unknown. Iron is normally absorbed from the diet by with the help of special molecules in the small intestine, carried in the blood to the liver where it is used by the cells. We would like to study how the proteins that transport iron in the intestine function and see if this is a different in disease. We would also like to examine exactly which molecules are important in depositing iron in the liver in patients with cirrhosis. We will work on animal models of liver disease as well as humans. We will treat animals so that they have liver disease that resembles human subjects with cirrhosis. These treatments include (1) feeding the animals carbon-tetrachloride, a toxin which damages the liver cells and therefore causes hepatocellular liver injury, and (2) tying the bile duct which stops the flow of bile and this results in cholestatic liver injury. It is known which proteins takes iron into the normal liver cells but no one knows which molecules transport the iron in liver disease. We think they may be different, because when the liver becomes diseased, scarring occurs this results in cirrhosis. Molecules that could easily enter liver cells may now be too big to pass through the openings. These studies are important since they will suggest new treatments to patients with liver disease who are awaiting a liver transplant and the treatment will probably differ depending on which type of liver disease the patient has."},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1},{"color":"#336699","name":"E/Pr Lawrie Powell","data":{"first_name":"Lawrie","title":"E/Pr","dw_individual_id":"DW0039158","middle_name":"William","last_name":"Powell","source_individual_id":"5012157","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"E/Pr Lawrie Powell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87152","size":1},{"color":"#336699","name":"Dr Linda Fletcher","data":{"first_name":"Linda","title":"Dr","dw_individual_id":"DW0013042","middle_name":"M","last_name":"Fletcher","source_individual_id":"5014660","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Linda Fletcher"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80225","size":1},{"color":"#336699","name":"Prof Darrell Crawford","data":{"first_name":"Darrell","title":"Prof","dw_individual_id":"DW0006770","middle_name":"Henry Gordon","last_name":"Crawford","source_individual_id":"5012156","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Darrell Crawford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78535","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3449","size":1},{"color":"#FF4D4D","name":"Extracellular acidosis and pH-modulating drugs as novel therapies for neuroprotection in hypoxia/ischemia in the newborn","data":{"media_summary":"neonatal brain injury","end_year":2004,"keywords":["Asphyxia","Perinatal asphyxia","hypoxia-ischaemia-reperfusion injury to the developing brain","neuropharmacology","neuroprotection"],"nhmrc_grant_id":210156,"application_year":2001,"health_keywords":["birth asphyxia","brain asphyxia","hypoxic-ischaemic encephalopathy","infant, newborn","neonatal brain injury"],"scientific_title":"Extracellular acidosis and pH-modulating drugs as novel therapies for neuroprotection in hypoxia/ischemia in the newborn","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Paul Colditz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210156","simplified_title":"Low pH protects nerve cells from a lack of oxygen in the newborn","sub_type":"Standard Project Grant","total_budget":"452310","source_system":"Approximately 4 out of every 1000 babies suffer severe perinatal asphyxia (a period of a shortage of oxygen) during the birth process which carries with it a high risk of brain damage or death. Those babies surviving with a severe disability cost Australia $500,000,000 per annum in lifelong costs. With currently available methods, the presence of asphyxia is difficult to detect and hence prevention is often not possible. At present, there are no effective medications to treat asphyxia-related brain damage in babies. This study brings together a multi-disciplinary team driven by the clinical need to develop suitable strategies for neuroprotection in the developing brain. We will investigate the neuroprotective properties of the clinically relevant factor of acidosis and determine how acidosis influences neuroprotectant drugs. In the future, it is envisaged that this study will lead to rationally-based clinical trials aimed at improving neurodevelopmental outcomes for babies who suffer asphyxia and for infants who are victims of near-drowning or head trauma."},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1},{"color":"#336699","name":"Dr Christopher Burke","data":{"first_name":"Christopher","title":"Dr","dw_individual_id":"DW0018010","middle_name":"","last_name":"Burke","source_individual_id":"RMIS67619","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Christopher Burke"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81604","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1},{"color":"#336699","name":"Prof Peter Gluckman","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0001826","middle_name":"D","last_name":"Gluckman","source_individual_id":"RMIS67624","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Peter Gluckman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77168","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3448","size":1},{"color":"#FF4D4D","name":"HPV and cervical carcinoma: Signaling and clinical responses to interferons","data":{"media_summary":"","end_year":2004,"keywords":["Stat1","cervical carcinoma","interferon signaling","papilloma virus","regulation of gene expression"],"nhmrc_grant_id":210149,"application_year":2001,"health_keywords":["cancer","cervical carcinoma","viral warts"],"scientific_title":"HPV and cervical carcinoma: Signaling and clinical responses to interferons","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Nigel McMillan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210149","simplified_title":"How the wart virus prevents interferons from working on virus infected or cervical cancer cells","sub_type":"Standard Project Grant","total_budget":"534480","source_system":"Cervical carcinoma and its treatment continues to be an important health concern in Australia. The interferons comprise an elaborate system of natural substances produced in the body, one of whose functions is to prevent cancer cells from developing. The interferons have been widely used to treat human diseases including viral infections and cancers caused by the wart virus. However, results of recent work indicates that viruses like the wart virus, HPV, have developed ways of inhibiting its effectiveness. We have found that cervical carcinoma cells and virally infected cells resist the direct anti-cancer and anti-viral effects of interferons because they have abnormalities in their ability to respond to interferon. We have made good progress in understanding why these cells do not respond to the interferons. In particular they show a deficiency in the activity of cell proteins required to transmit the interferon signal inside the cells. The current proposal will allow us to gain a greater understanding of the processes inside cells that are taken over by the wart viral proteins and the reasons for its abnormality in interferon resistant cancer cells. We will determine whether the levels of certain genes in clinical samples from patients relates to their response to interferon treatment. This may allow us to establish a test to predict which patients will respond to interferon therapy, saving patients from ineffective treatment, side effects and cost. This study will have a broad significance to many human diseases where abnormalities in interferon signaling occur and will help to bring about the necessary changes in cell properties to overcome the abnormalities, restore the responses and improve the application of interferons to treat infectious diseases and perhaps other cancers as well."},"children":[{"color":"#336699","name":"A/Pr Stephen Ralph","data":{"first_name":"Stephen","title":"A/Pr","dw_individual_id":"DW0044982","middle_name":"J","last_name":"Ralph","source_individual_id":"RMIS2453271","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Stephen Ralph"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88646","size":1},{"color":"#336699","name":"Prof Nigel Mcmillan","data":{"first_name":"Nigel","title":"Prof","dw_individual_id":"DW0032535","middle_name":"Alan John","last_name":"Mcmillan","source_individual_id":"5016394","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nigel Mcmillan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85423","size":1},{"color":"#336699","name":"Prof Laimonis Laimins","data":{"first_name":"Laimonis","title":"Prof","dw_individual_id":"DW0020238","middle_name":"A.","last_name":"Laimins","source_individual_id":"RMIS442280","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Laimonis Laimins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82168","size":1},{"color":"#336699","name":"Dr David Jardine","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0013909","middle_name":"","last_name":"Jardine","source_individual_id":"RMIS1094804","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr David Jardine"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80452","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3447","size":1},{"color":"#FF4D4D","name":"Effective immunotherapy for HPV associated cervical cancer precursor lesions","data":{"media_summary":"","end_year":2004,"keywords":["Epithelial immunology","Immunotherapy","Papillomavirus","Viral Immunology"],"nhmrc_grant_id":210148,"application_year":2001,"health_keywords":["Cervical cancer prevention","Cervical cancer treatment","Tumour immunology"],"scientific_title":"Effective immunotherapy for HPV associated cervical cancer precursor lesions","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Immunology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ian Frazer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210148","simplified_title":"Treating abnormal PAP smears immunologically","sub_type":"Standard Project Grant","total_budget":"482640","source_system":"Vaccines to prevent cervical cancer are currently being developed. These will be used to prevent infection with the causal virus, papillomavirus. However, there are very many people world wide who already have papillomavirus infection, which could turn into cancer at any point over the next 30 years. Therefore, there is a need for a vaccine that could be given along with the preventative vaccine, which would treat existing infections. This study addresses the characteristics of the immune response required to treat existing papillomavirus infections, since this is not currently known."},"children":[{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3446","size":1},{"color":"#FF4D4D","name":"Defining the role of EphA5 in olfactory axon growth, guidance and fasciculation","data":{"media_summary":"","end_year":2004,"keywords":["Eph receptors","axon guidance","ephrin","olfactory neuron","olfactory system"],"nhmrc_grant_id":210146,"application_year":2001,"health_keywords":["brain damage","brain development","brain growth","peripheral nerve injury"],"scientific_title":"Defining the role of EphA5 in olfactory axon growth, guidance and fasciculation","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr James St John","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210146","simplified_title":"Nerve cell guidance molecules in the olfactory system","sub_type":"Standard Project Grant","total_budget":"256320","source_system":"The olfactory (smell) system is a unique part of the nervous system; nerve cells are generated throughout life and it can regenerate even after injury. It therefore provides an excellent model for examining the growth, development and maintenance of nerve cells. This project will examine the effects on the organisation of the olfactory system when some guidance signals are altered. Information we obtain about how this system develops and regenerates may be useful in treating brain disorders and spinal injuries In the current project we will examine the effects of specific nerve cell guidance molecules by generating transgenic mice that produce these molecules only in the olfactory system. We can then determine what changes occur to the nerve cells when these extra molecules are produced. In addition, we will also examine the behaviour of live cells as they are growing. In the past all attempts to understand how nerve cell connections are formed in the olfactory system have used dead tissue that has been permanently preserved. In this project we have the unique opportunity to visualise living nerve cells to enable us to determine how the cells react to the guidance signals. The advantage of this approach is that it allows us to identify important interactions as they occur, rather than attempting to decipher them after they have occurred. An analogy would be watching a football game live and observing how goals were scored and appreciating the performance of individual players versus trying to guess from the final score how the game was played and who the key performers were. The results of these experiments will provide important information on the regeneration of olfactory nerve cells, as well as on the initial growth and targeting of these nerve cells."},"children":[{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1},{"color":"#336699","name":"Dr James St John","data":{"first_name":"James","title":"Dr","dw_individual_id":"DW0004781","middle_name":"A","last_name":"St John","source_individual_id":"RMIS5210245","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr James St John"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77995","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3445","size":1},{"color":"#FF4D4D","name":"Optimising immunity towards cancers by vaccination.","data":{"media_summary":"","end_year":2004,"keywords":["CTL activation","cancer vaccine","immunotherapy","tumour immunology"],"nhmrc_grant_id":210112,"application_year":2001,"health_keywords":["anti-tumour vaccine","cervical carcinoma","vaccine development","vaccine efficacy"],"scientific_title":"Optimising immunity towards cancers by vaccination.","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Tumour Immunology","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Dr Germain Fernando","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210112","simplified_title":"How to make better vaccines against cancers.","sub_type":"Standard Project Grant","total_budget":"211320","source_system":"In this project we will be studying the mechanisms of how an efficient anti cancer vaccine could be generated. We will be using cervical cancer associated human papillomavirus type 16 E7 protein as the model protein in an experimental vaccine model in mice. The results obtained from this project not only able us to design better vaccines against cervical cancers in women but against many other cancers and viruses."},"children":[{"color":"#336699","name":"Dr Germain Fernando","data":{"first_name":"Germain","title":"Dr","dw_individual_id":"DW0030659","middle_name":"J","last_name":"Fernando","source_individual_id":"5014600","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Germain Fernando"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84967","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3443","size":1},{"color":"#FF4D4D","name":"Investigation of the role of the Renin-Angiotensin System in hepatic fibrosis.","data":{"media_summary":"primary biliary cirrhosis","end_year":2004,"keywords":["angiotensin","hepatic fibrosis","hepatitis C"],"nhmrc_grant_id":210109,"application_year":2001,"health_keywords":["hepatic fibrosis","hepatitis C","hepatocellular cancer","liver transplantation","primary biliary cirrhosis"],"scientific_title":"Investigation of the role of the Renin-Angiotensin System in hepatic fibrosis.","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Julie Jonsson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210109","simplified_title":"Investigation of the role of the Renin-Angiotensin System in liver fibrosis.","sub_type":"Standard Project Grant","total_budget":"246990","source_system":"Hepatic fibrosis is a common response to chronic liver injury, during which the normal liver architecture is distorted by scar tissue. Hepatic fibrosis can lead to cirrhosis and liver transplantation may be required for patients with liver failure and hepatocellular carcinoma. The chronic liver injury may result from a number of causes including alcohol, persistent viral infections and metabolic disorders. The mechanisms causing fibrosis in liver are similar to those causing fibrosis in other organs such as kidney and heart. In those organs, the renin-angiotensin system has been shown to contribute to the progression of fibrosis. This system has not been investigated in hepatic fibrosis. We have recently shown in patients with chronic hepatitis C (HCV), that those patients who are genetically pre-disposed to produce higher levels of angiotensin have more liver fibrosis. This application will investigate the role of the renin-angiotensin system in hepatic fibrosis and whether using currently available drugs to inhibit this system can decrease the rate of progression of fibrosis in liver. Liver failure due to chronic HCV infection is currently the leading indication for liver transplantation in Australia. For those patients who fail to respond to anti-viral therapy, there are currently no approved therapeutic options designed to delay or reverse the progression of fibrosis. Based on current known numbers of HCV patients it has been estimated that by the year 2020, over 2000 HCV patients will require a liver transplant each year in Queensland alone. Currently the number of donor livers available allows about 50 transplants per year. Thus there is a desperate need for therapeutic treatments that will delay or reverse the progression of hepatic fibrosis. A successful conclusion to this study will provide a clinically useful treatment strategy that can delay the progression of hepatic fibrosis and thus prevent the need for liver transplantation in many patients."},"children":[{"color":"#336699","name":"Prof Elizabeth Powell","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0044903","middle_name":"Ellen","last_name":"Powell","source_individual_id":"RMIS13575","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Powell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88622","size":1},{"color":"#336699","name":"A/Pr Andrew Clouston","data":{"first_name":"Andrew","title":"A/Pr","dw_individual_id":"DW0030002","middle_name":"Donald","last_name":"Clouston","source_individual_id":"RMIS228640","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Andrew Clouston"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84776","size":1},{"color":"#336699","name":"A/Pr Julie Jonsson","data":{"first_name":"Julie","title":"A/Pr","dw_individual_id":"DW0002506","middle_name":"R","last_name":"Jonsson","source_individual_id":"5015557","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Julie Jonsson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77348","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3442","size":1},{"color":"#FF4D4D","name":"Molecular Characterization of SV40 infection","data":{"media_summary":"viral-induced cancer/oncogenesis","end_year":2002,"keywords":["cell biology","endoplasmic reticulum","membrane transport","plasma membrane","virus entry and replication"],"nhmrc_grant_id":210101,"application_year":2001,"health_keywords":["cancer","gene therapy","viral infection","viral replication","viral-induced cancer/oncogenesis"],"scientific_title":"Molecular Characterization of SV40 infection","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210101","simplified_title":"How viruses enter cells","sub_type":"Standard Project Grant","total_budget":"75440","source_system":"Viral disease is a major health hazard in the modern world. SV40 is a relatively simple virus which must enter mammalian cells in order to replicate. As it does so, it causes the infected cell to divide and hence triggers tumour formation in the host. This proposal is aimed at understanding how SV40 enters cells, and then passes to the nucleus where it replicates. Most viruses have hijacked existing pathways into cells. For example, some viruses have used the pathway by which cells take up nutrients from the external medium. However, we have shown that SV40 uses a completely novel pathway involving surface pits called caveolae. The subsequent steps in the pathway are unknown and have been difficult to study. We have discovered a number of agents which inhibit infection by SV40. In this proposal we will characterise the infectious entry pathway by investigating exactly where in the cell these agents work. We will then isolate the virus from within the cell and attempt to reconstitute part of the viral entry pathway in vitro. These studies will provide insights into the entry pathway of the virus which may lead to new therapeutic strategies to combat viral disease. In addition, study of this pathway, leading from the cell surface to the nucleus, may provide new avenues for drug delivery and-or gene targetting."},"children":[{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3441","size":1},{"color":"#FF4D4D","name":"Functional Characterization of Caveolae and Caveolins","data":{"media_summary":"","end_year":2002,"keywords":["cell biology","cholesterol","development","membrane signaling","membrane transport"],"nhmrc_grant_id":210100,"application_year":2001,"health_keywords":["cancer","defects in embryonic development","lipid disorder","lysosomal Storage Diseases"],"scientific_title":"Functional Characterization of Caveolae and Caveolins","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/210100","simplified_title":"Cell signalling through lipid domains","sub_type":"Standard Project Grant","total_budget":"140660","source_system":"This project aims to study the cellular machinery that allows a cell to respond to its external environment. Specifically, this project focusses on the function of a family of membrane proteins, called caveolins, which are the major protein components of caveolae small pits which cover the surface of many mammalian cells. Caveolins are believed to regulate signalling from the external environment to the cell interior and loss of this regulation leads to uncontrolled growth leading to cancer. Signalling from the cell surface relies on organisation of signalling components into modules. Our studies suggest that these modules are dependent on specific lipid molecules which form discrete patches, called lipid rafts, on the cell surface. We have hypothesised that caveolins control the lipid molecules associated with lipid rafts and so, indirectly, control signalling pathways. In particular, we have shown that caveolin is important in the regulation of cellular cholesterol, a vital molecule involved in maintaining the function of lipid raft domains. As numerous human diseases are associated with cholesterol imbalance, studies of caveolins can give fundamental new insights into this process, and the previously unidentified links between the cellular lipid balance and signal transduction. This project aims to use mutant caveolin molecules to disrupt caveolin function and so determine the role of caveolin in lipid regulation and in signal transduction. We will then use a lower vertebrate model system, which is amenable to experimental manipulation, to determine the role of caveolins and rafts in the development of the whole embryo."},"children":[{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3440","size":1},{"color":"#FF4D4D","name":"Structural characterisation and pharmacology of ion channel toxins from spider venoms.","data":{"media_summary":"","end_year":2007,"keywords":["ion channels","mass spectrometry","molecular pharmacology","protein biochemistry","spider toxins"],"nhmrc_grant_id":194470,"application_year":2001,"start_year":2002,"scientific_title":"Structural characterisation and pharmacology of ion channel toxins from spider venoms.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Lachlan Rash","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/194470","simplified_title":"Structural characterisation and pharmacology of ion channel toxins from spider venoms.","sub_type":"INSERM Exchange ECF","total_budget":"223206.8","source_system":""},"children":[{"color":"#336699","name":"Dr Lachlan Rash","data":{"first_name":"Lachlan","title":"Dr","dw_individual_id":"DW0027509","middle_name":"D","last_name":"Rash","source_individual_id":"RMIS1373336","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Lachlan Rash"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84101","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3184","size":1},{"color":"#FF4D4D","name":"Body Mass Index and Mortality in Aboriginal Australians in Northern Territory: A Cohort Study","data":{"media_summary":"weight disorders","end_year":2003,"keywords":["Aboriginal","Mortality","cardiovascular risk","nutrition","obesity"],"nhmrc_grant_id":193316,"application_year":2001,"health_keywords":["Aboriginal health","body weight changes","epidemiology","health status","weight disorders"],"scientific_title":"Body Mass Index and Mortality in Aboriginal Australians in Northern Territory: A Cohort Study","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Zhiqiang Wang","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/193316","simplified_title":"Body Mass Index and Mortality in Aboriginal Australians","sub_type":"Standard Project Grant","total_budget":"136220","source_system":"The ultimate goal of this study is to define a healthy weight range for Aboriginal people. To fulfil this goal, we will investigate the health implications of body weight and weight change in Aboriginal communities. We will assess the association between body weight (as measured by body mass index) and the risk of death by examining how the death rate changes with body weight. The findings will have important implications for health professionals to provide adequate advice to Aboriginal Australians, and for Aboriginal people to adopt a healthy life style in relation to body weight. Due to the differences in body shape and physiological and environmental factors between Aborigines and other populations, the optimal body weight obtained from other populations may not be applicable to Aboriginal communities. Do males and females have different optimal body weights? Do old and young people have different optimal body weights? This study will provide evidence for answering various questions like these. Individuals with different characteristics may have different optimal body weight values. Such information is useful for the development and modification of dietary guidelines for Aboriginal Australians. The results on the health impact of weight change are important for guiding weight control programs in Aboriginal communities."},"children":[{"color":"#336699","name":"A/Pr Zhiqiang Wang","data":{"first_name":"Zhiqiang","title":"A/Pr","dw_individual_id":"DW0028670","middle_name":"","last_name":"Wang","source_individual_id":"5019801","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Zhiqiang Wang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84425","size":1},{"color":"#336699","name":"Prof Wendy Hoy","data":{"first_name":"Wendy","title":"Prof","dw_individual_id":"DW0013767","middle_name":"Elizabeth","last_name":"Hoy","source_individual_id":"RMIS3725","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wendy Hoy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80407","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3118","size":1},{"color":"#FF4D4D","name":"Control of Ca2+ release in excitation-contraction coupling and its modulation by membrane cholesterol.","data":{"media_summary":"","end_year":2008,"keywords":["Ca2+ release","muscle"],"nhmrc_grant_id":191231,"application_year":2001,"start_year":2002,"scientific_title":"Control of Ca2+ release in excitation-contraction coupling and its modulation by membrane cholesterol.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Dr Bradley Launikonis","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/191231","simplified_title":"Control of Ca2+ release in excitation-contraction coupling and its modulation by membrane cholesterol.","sub_type":"CJ Martin Biomedical ECF","total_budget":"367547.5","source_system":""},"children":[{"color":"#336699","name":"Dr Bradley Launikonis","data":{"first_name":"Bradley","title":"Dr","dw_individual_id":"DW0014380","middle_name":"S","last_name":"Launikonis","source_individual_id":"5015864","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Bradley Launikonis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80584","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/3095","size":1},{"color":"#FF4D4D","name":"The functional basis of direction selectivity in the retina","data":{"media_summary":"","end_year":2004,"keywords":["Central nervous system","Neural systems","Patch clamping","Retinal neurophysiology","Synaptic physiology"],"nhmrc_grant_id":179837,"application_year":2001,"health_keywords":["Neurology","Ophthalmology","Retinal degeneration"],"scientific_title":"The functional basis of direction selectivity in the retina","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Ophthalmology and Vision Science","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Vaney","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/179837","simplified_title":"How does the eye know which way an object is moving?","sub_type":"Standard Project Grant","total_budget":"376320","source_system":"Motion is an everday visual experience, and in this project we are attempting to explain how our brains are able to detect the direction in which an object is moving. Surprisingly this is first accomplished within the retina, the light-sensitive system of neurons at the back of the eye. Thus the eyes are able to tell the brain in which direction an object is moving. So the question becomes, how do the eyes do it? We know that there is a special class of neurons, the direction-selective ganglion cells, which are able to detect the direction of image motion. The activity of these cells is increased by excitatory connections and reduced by so-called inhibitory connections. This project aims to identify the neural origin of the inhibitory connections, and discover how the excitation and inhibition work together to compute the direction of motion."},"children":[{"color":"#336699","name":"Prof David Vaney","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0028555","middle_name":"I","last_name":"Vaney","source_individual_id":"RMIS52594","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Vaney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84390","size":1},{"color":"#336699","name":"William Taylor","data":{"first_name":"William","title":"","dw_individual_id":"DW0028330","middle_name":"","last_name":"Taylor","source_individual_id":"RMIS1007412","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"William Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84323","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2993","size":1},{"color":"#FF4D4D","name":"The influence of the therapeutic alliance on the success of behavioural interventions in general practice: the case of w","data":{"media_summary":"","end_year":2003,"keywords":["Ambulatory computer-assisted device","Obesity","Therapeutic alliance"],"nhmrc_grant_id":210319,"application_year":2000,"start_year":2002,"scientific_title":"The influence of the therapeutic alliance on the success of behavioural interventions in general practice: the case of w","node_source":"NHMRC","node_type":"Grant","field_of_research":"Primary Health Care","research_area":"Clinical Medicine and Science","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Kelly Shaw","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/210319","simplified_title":"The influence of the therapeutic alliance on the success of behavioural interventions in general practice: the case of w","sub_type":"Primary Health Care Scholarship","total_budget":"56573.49","source_system":""},"children":[{"color":"#336699","name":"Kelly Shaw","data":{"first_name":"Kelly","title":"","dw_individual_id":"DW0010207","middle_name":"","last_name":"Shaw","source_individual_id":"RMIS3901453","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Kelly Shaw"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79466","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2976","size":1},{"color":"#FF4D4D","name":"Practitioner Fellowship 168111","data":{"media_summary":"","end_year":2005,"nhmrc_grant_id":168111,"application_year":2000,"start_year":2001,"scientific_title":"Practitioner Fellowship 168111","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Basic Science","for_category":"","cia_name":"A/Pr Elizabeth Powell","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/168111","simplified_title":"Practitioner Fellowship 168111","sub_type":"Practitioner Fellowship","total_budget":"263125","source_system":""},"children":[{"color":"#336699","name":"Prof Elizabeth Powell","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0044903","middle_name":"Ellen","last_name":"Powell","source_individual_id":"RMIS13575","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Elizabeth Powell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88622","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2919","size":1},{"color":"#FF4D4D","name":"Methylation in lung cancer","data":{"media_summary":"","end_year":2006,"keywords":["Lung cancer","Methylation"],"nhmrc_grant_id":162107,"application_year":2000,"start_year":2001,"scientific_title":"Methylation in lung cancer","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical and Health Sciences not elsewhere classified","research_area":"Basic Science","for_category":"OTHER MEDICAL AND HEALTH SCIENCES","cia_name":"Dr Maree Colosimo","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/162107","simplified_title":"Methylation in lung cancer","sub_type":"Medical Postgraduate Scholarship","total_budget":"83656.26","source_system":""},"children":[{"color":"#336699","name":"Maree Colosimo","data":{"first_name":"Maree","title":"","dw_individual_id":"DW0012417","middle_name":"","last_name":"Colosimo","source_individual_id":"RMIS681698","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Maree Colosimo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80060","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2852","size":1},{"color":"#FF4D4D","name":"Physiology and pathophysiology of trunk control mechanisms","data":{"media_summary":"","end_year":2005,"nhmrc_grant_id":157203,"application_year":2000,"start_year":2001,"scientific_title":"Physiology and pathophysiology of trunk control mechanisms","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Clinical Medicine and Science","for_category":"","cia_name":"Prof Paul Hodges","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/157203","simplified_title":"Physiology and pathophysiology of trunk control mechanisms","sub_type":"Research Fellowship","total_budget":"484676.35","source_system":""},"children":[{"color":"#336699","name":"Prof Paul Hodges","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0043077","middle_name":"W","last_name":"Hodges","source_individual_id":"RMIS222953","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Hodges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88164","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2737","size":1},{"color":"#FF4D4D","name":"Physiology and pathophysiology of trunk control mechanisms","data":{"media_summary":"Urinary incontinence","end_year":2005,"keywords":["Electromyography","Low back pain","Postural control","Respiratory muscles","Spine biomechanics"],"nhmrc_grant_id":157085,"application_year":2000,"health_keywords":["Asthma","Chronic respiratory disease","Low back pain","Physiotherapy","Urinary incontinence"],"scientific_title":"Physiology and pathophysiology of trunk control mechanisms","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Motor Control","research_area":"Basic Science","for_category":"HUMAN MOVEMENT AND SPORTS SCIENCE","cia_name":"Prof Paul Hodges","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/157085","simplified_title":"Control of the trunk in health and disease","sub_type":"Standard Project with Research Fellowship","total_budget":"168958.36","source_system":"The overall aim of this series of experiments is to understand how the spine is controlled and how this changes in disease. Altered control has been identified in people with low back pain, yet we still know very little about the normal mechanisms for protection and support of the spine. Back pain is a common affliction that affects about 5% of Australians each year and is the most common and expensive work-related injury in western society. An understanding of normal control and the mechanism of dysfunction is critical for identification of risk factors and development of strategies for rehabilitation and prevention. The experiments are divided into two series. The first series addresses normal spinal control. The questions to be asked deal with how the brain copes with the challenge of using trunk muscles for breathing and spinal control at the same time, how the activity of the trunk muscles is affected by input from sensory receptors in the joints, ligaments and muscles of the spine, and whether intra-abdominal pressure can support the trunk. The second series deals with clinical populations. The first aim is to identify whether people with respiratory diseases use trunk muscles for spinal control and breathing at the same time. If they cannot, we predict that they will be more prone to low back pain. We will test this in a large study of incidence of low back pain in people with and without respiratory disease. The second study will investigate the pelvic floor muscles which are important for continence and assist with spinal control. We will investigate whether people with incontinence have poor spinal control and whether this leads to back pain. The final experiment will identify whether people with low back pain interpret sensory information from the spine differently. By answering these questions we hope to intervene in the enormous personal, social and economic consequences of LBP which affects between 60-90% of the population at some stage in their life."},"children":[{"color":"#336699","name":"Prof Paul Hodges","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0043077","middle_name":"W","last_name":"Hodges","source_individual_id":"RMIS222953","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Hodges"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88164","size":1},{"color":"#336699","name":"Prof Stephen Lord","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0038138","middle_name":"R","last_name":"Lord","source_individual_id":"RMIS5224","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Lord"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86883","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2713","size":1},{"color":"#FF4D4D","name":"Molecular mechanisms linking proteinuria and sodium retention","data":{"media_summary":"","end_year":2003,"keywords":["megalin","proteinuria","proximal tubule","sodium -hydrogen exchange"],"nhmrc_grant_id":153931,"application_year":2000,"health_keywords":["hypertension","progressive renal disease","proteinuria"],"scientific_title":"Molecular mechanisms linking proteinuria and sodium retention","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Philip Poronnik","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/153931","simplified_title":"Control of protein and sodium handling in the kidney","sub_type":"Standard Project Grant","total_budget":"211527.54","source_system":"The clinical association between protein loss in the urine and retention of salt, resulting in high blood pressure and progressive decline in kidney function, is well known. Under normal conditions, the kidneys filter 180 litres of water and reabsorb 1.7 kg of salt per day, a function which is principally performed by the kidney tubules in the kidney. Similarly the kidney tubule cells reabsorb and break down up to 3 grams of albumin per day. In the past, it has been considered that excessive protein loss in the urine is primarily due to problems in the filtering units of the kidneys, rather than due to abnormalities in the reabsorption of protein in the kidney tubules. However, we consider that common abnormalities in the processes within the kidney tubules that regulate both the reabsorption of salt and the excretion of acid may result in concomitant high blood pressure and increased protein loss in the kidney. Thus the overall aim of the project is to investigate the interrelationship between protein reabsorption and catabolism and Na+ reabsorption in the human kidney tubule. The project uses the combined methods of cultured human kidney tubules, biochemical and molecular biology techniques which are unavailable in other laboratories in Australia (and internationally). This project will comprehensively characterise the mechanisms of protein uptake and salt reabsorption in human kidney tubule cells when exposed to both normal and high concentrations of protein. The exact nature of the interaction of protein uptake with salt reabsorption and hence high blood pressure will be determined. As both hypertension and persistent proteinuria are the most important predictors of tubulointerstitial pathology and progressive decline in renal function in almost all renal disease, the understanding of the precise interaction between these two factors is essential in the design of renoprotective therapies."},"children":[{"color":"#336699","name":"Prof Carol Pollock","data":{"first_name":"Carol","title":"Prof","dw_individual_id":"DW0039130","middle_name":"A","last_name":"Pollock","source_individual_id":"5017027","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Carol Pollock"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87145","size":1},{"color":"#336699","name":"Prof Philip Poronnik","data":{"first_name":"Philip","title":"Prof","dw_individual_id":"DW0004031","middle_name":"","last_name":"Poronnik","source_individual_id":"RMIS7101816","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Philip Poronnik"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77792","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2662","size":1},{"color":"#FF4D4D","name":"The role of integrins in inner ear hair cell differentiation","data":{"media_summary":"","end_year":2006,"keywords":["differentiation","hair cells","integrins","signal transduction","stereocilia"],"nhmrc_grant_id":148939,"application_year":2000,"start_year":2001,"scientific_title":"The role of integrins in inner ear hair cell differentiation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Anna Reynolds","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/148939","simplified_title":"The role of integrins in inner ear hair cell differentiation","sub_type":"CJ Martin Biomedical ECF","total_budget":"218646.82","source_system":""},"children":[{"color":"#336699","name":"Dr Anna Reynolds","data":{"first_name":"Anna","title":"Dr","dw_individual_id":"DW0045056","middle_name":"J","last_name":"Reynolds","source_individual_id":"5030459","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Anna Reynolds"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88666","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2558","size":1},{"color":"#FF4D4D","name":"A Pharmacogenetic approach to the treatment of opioid dependence using the D2 dopamine recetor gene","data":{"media_summary":"","end_year":2005,"keywords":["A1 allele","Dependence","Dopamine","Heroin","Pharmacogenetic"],"nhmrc_grant_id":143250,"application_year":2000,"start_year":2002,"scientific_title":"A Pharmacogenetic approach to the treatment of opioid dependence using the D2 dopamine recetor gene","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Clinical Medicine and Science","for_category":"","cia_name":"Prof Ross Young","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/143250","simplified_title":"Does a genetic resk for drug dependence influence antibepressant response in heroin dependent individuals?","sub_type":"NIDS Project - National Illicit Drugs Strategy 26","total_budget":"140373","source_system":""},"children":[{"color":"#336699","name":"Prof Ernest Noble","data":{"first_name":"Ernest","title":"Prof","dw_individual_id":"DW0015276","middle_name":"","last_name":"Noble","source_individual_id":"RMIS1212391","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ernest Noble"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80841","size":1},{"color":"#336699","name":"A/Pr Bruce Lawford","data":{"first_name":"Bruce","title":"A/Pr","dw_individual_id":"DW0014385","middle_name":"R","last_name":"Lawford","source_individual_id":"RMIS1212388","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Bruce Lawford"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80585","size":1},{"color":"#336699","name":"Prof Ross Young","data":{"first_name":"Ross","title":"Prof","dw_individual_id":"DW0005626","middle_name":"Mcdonald","last_name":"Young","source_individual_id":"5012569","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ross Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78235","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2353","size":1},{"color":"#FF4D4D","name":"Ongoing Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2004,"nhmrc_grant_id":143148,"application_year":2000,"start_year":2001,"scientific_title":"Ongoing Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Clinical Medicine and Science","for_category":"","cia_name":"Dr Peter Molenaar","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143148","simplified_title":"Ongoing Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"407090.48","source_system":""},"children":[{"color":"#336699","name":"A/Pr Peter Molenaar","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0020938","middle_name":"","last_name":"Molenaar","source_individual_id":"RMIS221171","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Molenaar"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82361","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2352","size":1},{"color":"#FF4D4D","name":"Ongoing uncoupled research fellowship","data":{"media_summary":"","end_year":2002,"nhmrc_grant_id":143147,"application_year":2000,"start_year":2001,"scientific_title":"Ongoing uncoupled research fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Basic Science","for_category":"","cia_name":"Prof Ronald Dickinson","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143147","simplified_title":"Ongoing uncoupled research fellowship","sub_type":"Research Fellowship","total_budget":"242865.37","source_system":""},"children":[{"color":"#336699","name":"Prof Ronald Dickinson","data":{"first_name":"Ronald","title":"Prof","dw_individual_id":"DW0036292","middle_name":"G","last_name":"Dickinson","source_individual_id":"RMIS8307","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ronald Dickinson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86406","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2351","size":1},{"color":"#FF4D4D","name":"Ongoing Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2003,"nhmrc_grant_id":143146,"application_year":2000,"start_year":2001,"scientific_title":"Ongoing Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Clinical Medicine and Science","for_category":"","cia_name":"Dr Janet Wanstall","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143146","simplified_title":"Ongoing Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"300354.98","source_system":""},"children":[{"color":"#336699","name":"Janet Wanstall","data":{"first_name":"Janet","title":"","dw_individual_id":"DW0005302","middle_name":"","last_name":"Wanstall","source_individual_id":"RMIS7727","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Janet Wanstall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78146","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2350","size":1},{"color":"#FF4D4D","name":"Ongoing Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2004,"nhmrc_grant_id":143145,"application_year":2000,"start_year":2001,"scientific_title":"Ongoing Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Basic Science","for_category":"","cia_name":"Prof David Vaney","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143145","simplified_title":"Ongoing Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"455332.35","source_system":""},"children":[{"color":"#336699","name":"Prof David Vaney","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0028555","middle_name":"I","last_name":"Vaney","source_individual_id":"RMIS52594","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Vaney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84390","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2349","size":1},{"color":"#FF4D4D","name":"Ongoing Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2002,"nhmrc_grant_id":143144,"application_year":2000,"start_year":2001,"scientific_title":"Ongoing Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Basic Science","for_category":"","cia_name":"Prof David Pow","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143144","simplified_title":"Ongoing Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"71851.95","source_system":""},"children":[{"color":"#336699","name":"Prof David Pow","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0021533","middle_name":"Vaughan","last_name":"Pow","source_individual_id":"RMIS4392155","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Pow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82534","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2348","size":1},{"color":"#FF4D4D","name":"Ongoing Uncoupled Research Fellowship","data":{"media_summary":"","end_year":2004,"nhmrc_grant_id":143143,"application_year":2000,"start_year":2001,"scientific_title":"Ongoing Uncoupled Research Fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Clinical Medicine and Science","for_category":"","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143143","simplified_title":"Ongoing Uncoupled Research Fellowship","sub_type":"Research Fellowship","total_budget":"448604.1","source_system":""},"children":[{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2347","size":1},{"color":"#FF4D4D","name":"Ongoing uncoupled research fellowship","data":{"media_summary":"","end_year":2004,"nhmrc_grant_id":143141,"application_year":2000,"start_year":2001,"scientific_title":"Ongoing uncoupled research fellowship","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Basic Science","for_category":"","cia_name":"A/Pr Peter Dodd","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143141","simplified_title":"Ongoing uncoupled research fellowship","sub_type":"Research Fellowship","total_budget":"454487.55","source_system":""},"children":[{"color":"#336699","name":"A/Pr Peter Dodd","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0001312","middle_name":"R","last_name":"Dodd","source_individual_id":"RMIS34635","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Dodd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77036","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2345","size":1},{"color":"#FF4D4D","name":"Regulations of G protein signalling on the golgi complex","data":{"media_summary":"","end_year":2005,"nhmrc_grant_id":143138,"application_year":2000,"start_year":2001,"scientific_title":"Regulations of G protein signalling on the golgi complex","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Basic Science","for_category":"","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143138","simplified_title":"Regulations of G protein signalling on the golgi complex","sub_type":"Research Fellowship","total_budget":"565758.03","source_system":""},"children":[{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2344","size":1},{"color":"#FF4D4D","name":"Targeted delivery by topical application","data":{"media_summary":"","end_year":2005,"nhmrc_grant_id":143137,"application_year":2000,"start_year":2001,"scientific_title":"Targeted delivery by topical application","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Clinical Medicine and Science","for_category":"","cia_name":"Prof Michael Roberts","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143137","simplified_title":"Targeted delivery by topical application","sub_type":"Research Fellowship","total_budget":"696716.79","source_system":""},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2343","size":1},{"color":"#FF4D4D","name":"Structure-function analysis of nuclear receptor & cofactor action: evidence for a role in muscle","data":{"media_summary":"","end_year":2005,"nhmrc_grant_id":143136,"application_year":2000,"start_year":2001,"scientific_title":"Structure-function analysis of nuclear receptor & cofactor action: evidence for a role in muscle","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Clinical Medicine and Science","for_category":"","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143136","simplified_title":"Structure-function analysis of nuclear receptor & cofactor action: evidence for a role in muscle","sub_type":"Research Fellowship","total_budget":"565758.03","source_system":""},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2342","size":1},{"color":"#FF4D4D","name":"Outcome and Process Evaluation of an Ergonomics Program Intervention to Prevent Occupational Musculoskeletal Injuries","data":{"media_summary":"","end_year":2002,"keywords":["Ergonomics","Manual Tasks","Occupational Musculoskeletal Disorders","Program Evaluation","Randomised Control Trial"],"nhmrc_grant_id":143135,"application_year":2000,"start_year":2001,"scientific_title":"Outcome and Process Evaluation of an Ergonomics Program Intervention to Prevent Occupational Musculoskeletal Injuries","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Public Health","for_category":"","cia_name":"Dr Robin Burgess-Limerick","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/143135","simplified_title":"Preventing Occupational Musculoskeletal Injuries","sub_type":"Translational Grants In Injury","total_budget":"106377","source_system":""},"children":[{"color":"#336699","name":"Prof Leon Straker","data":{"first_name":"Leon","title":"Prof","dw_individual_id":"DW0045660","middle_name":"M","last_name":"Straker","source_individual_id":"5017739","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Leon Straker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88807","size":1},{"color":"#336699","name":"Roxanne Egeskov","data":{"first_name":"Roxanne","title":"","dw_individual_id":"DW0042233","middle_name":"","last_name":"Egeskov","source_individual_id":"RMIS881562","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Roxanne Egeskov"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87953","size":1},{"color":"#336699","name":"Prof Clare Pollock","data":{"first_name":"Clare","title":"Prof","dw_individual_id":"DW0033213","middle_name":"M","last_name":"Pollock","source_individual_id":"RMIS4635814","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Clare Pollock"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85608","size":1},{"color":"#336699","name":"Robin Burgess-Limerick","data":{"first_name":"Robin","title":"","dw_individual_id":"DW0029687","middle_name":"","last_name":"Burgess-Limerick","source_individual_id":"RMIS386967","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Robin Burgess-Limerick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84687","size":1},{"color":"#336699","name":"Prof Wendy Brown","data":{"first_name":"Wendy","title":"Prof","dw_individual_id":"DW0023824","middle_name":"J","last_name":"Brown","source_individual_id":"RMIS1714084","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Wendy Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83116","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2341","size":1},{"color":"#FF4D4D","name":"Increasing resilience and reducing risk for depression in adolescents: universal control trial","data":{"media_summary":"","end_year":2002,"keywords":["adolescents","cognitive-behavioural therapy","depression","prevention","suicide"],"nhmrc_grant_id":143134,"application_year":2000,"start_year":2001,"scientific_title":"Increasing resilience and reducing risk for depression in adolescents: universal control trial","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Public Health","for_category":"","cia_name":"Dr Jeanie Sheffield","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/143134","simplified_title":"Increasing resilience and reducing risk for depression in adolescents","sub_type":"Youth Suicide","total_budget":"300000","source_system":""},"children":[{"color":"#336699","name":"Dr Nicholas Kowalenko","data":{"first_name":"Nicholas","title":"Dr","dw_individual_id":"DW0043598","middle_name":"Mark","last_name":"Kowalenko","source_individual_id":"RMIS4574640","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Nicholas Kowalenko"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88303","size":1},{"color":"#336699","name":"Ms Ann Wignall","data":{"first_name":"Ann","title":"Ms","dw_individual_id":"DW0040444","middle_name":"","last_name":"Wignall","source_individual_id":"RMIS880147","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Ann Wignall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87480","size":1},{"color":"#336699","name":"Dr Jeanie Sheffield","data":{"first_name":"Jeanie","title":"Dr","dw_individual_id":"DW0033772","middle_name":"K","last_name":"Sheffield","source_individual_id":"RMIS222805","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Jeanie Sheffield"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85745","size":1},{"color":"#336699","name":"Prof Susan Spence","data":{"first_name":"Susan","title":"Prof","dw_individual_id":"DW0022261","middle_name":"Hilary","last_name":"Spence","source_individual_id":"RMIS29798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Susan Spence"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82741","size":1},{"color":"#336699","name":"Prof Ronald Rapee","data":{"first_name":"Ronald","title":"Prof","dw_individual_id":"DW0009816","middle_name":"Michael","last_name":"Rapee","source_individual_id":"RMIS495764","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ronald Rapee"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79364","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2340","size":1},{"color":"#FF4D4D","name":"Development of an artificial blood vessel","data":{"media_summary":"","end_year":2005,"nhmrc_grant_id":143133,"application_year":2000,"start_year":2001,"scientific_title":"Development of an artificial blood vessel","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Clinical Medicine and Science","for_category":"","cia_name":"Prof Julie Campbell","higher_grant_type":"NHMRC Research Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143133","simplified_title":"Development of an artificial blood vessel","sub_type":"Research Fellowship","total_budget":"681716.79","source_system":""},"children":[{"color":"#336699","name":"Prof Julie Campbell","data":{"first_name":"Julie","title":"Prof","dw_individual_id":"DW0000708","middle_name":"H","last_name":"Campbell","source_individual_id":"RMIS330901","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Julie Campbell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76860","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2339","size":1},{"color":"#FF4D4D","name":"The diagnosis of conductive hearing loss secondary to otitis media with effusion in children","data":{"media_summary":"","end_year":2006,"keywords":["chronic otitis media","conductive hearing","systematic reviews"],"nhmrc_grant_id":143130,"application_year":2000,"start_year":2002,"scientific_title":"The diagnosis of conductive hearing loss secondary to otitis media with effusion in children","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Jennifer Doust","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/143130","simplified_title":"The diagnosis of conductive hearing loss secondary to otitis media with effusion in children","sub_type":"Public Health Postgraduate Scholarship","total_budget":"85464.76","source_system":""},"children":[{"color":"#336699","name":"Jennifer Doust","data":{"first_name":"Jennifer","title":"","dw_individual_id":"DW0030450","middle_name":"","last_name":"Doust","source_individual_id":"RMIS540342","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Jennifer Doust"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84902","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2338","size":1},{"color":"#FF4D4D","name":"Gene Therapy for Oral Lichen Planus","data":{"media_summary":"","end_year":2003,"keywords":["Animal Model","Gene Therapy","Oral Lichen Planus","Treatment"],"nhmrc_grant_id":143125,"application_year":2000,"start_year":2001,"scientific_title":"Gene Therapy for Oral Lichen Planus","node_source":"NHMRC","node_type":"Grant","field_of_research":"Clinical Pharmacology and Therapeutics","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Philip Sugerman","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143125","simplified_title":"Gene Therapy for Oral Lichen Planus","sub_type":"Industry ECF","total_budget":"245250","source_system":""},"children":[{"color":"#336699","name":"Philip Sugerman","data":{"first_name":"Philip","title":"","dw_individual_id":"DW0016502","middle_name":"","last_name":"Sugerman","source_individual_id":"RMIS13895","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Philip Sugerman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81183","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2337","size":1},{"color":"#FF4D4D","name":"The role of insulin-like growth factors in renal diseases.","data":{"media_summary":"","end_year":2004,"keywords":["Growth Factors","Mechanism","Renal disease","Treatment"],"nhmrc_grant_id":143114,"application_year":2000,"start_year":2001,"scientific_title":"The role of insulin-like growth factors in renal diseases.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Miss Catherine Cheung","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/143114","simplified_title":"The role of insulin-like growth factors in renal diseases.","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"67872.82","source_system":""},"children":[{"color":"#336699","name":"Miss Catherine Cheung","data":{"first_name":"Catherine","title":"Miss","dw_individual_id":"DW0018217","middle_name":"Wy","last_name":"Cheung","source_individual_id":"RMIS681412","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Miss Catherine Cheung"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81667","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2336","size":1},{"color":"#FF4D4D","name":"Relationship between Periodontal disease and Rheumatoid Arthritis","data":{"media_summary":"","end_year":2001,"keywords":["Clinical Research","Gene Polymorphisms","Peridontal disease","Rheumatoid Arthritis"],"nhmrc_grant_id":143111,"application_year":2000,"start_year":2001,"scientific_title":"Relationship between Periodontal disease and Rheumatoid Arthritis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dentistry not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"DENTISTRY","cia_name":"Dr Faustino Mercado","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/143111","simplified_title":"Relationship between Periodontal disease and Rheumatoid Arthritis","sub_type":"Dental Postgraduate Research Scholarship","total_budget":"7995","source_system":""},"children":[{"color":"#336699","name":"Dr Faustino Mercado","data":{"first_name":"Faustino","title":"Dr","dw_individual_id":"DW0026707","middle_name":"","last_name":"Mercado","source_individual_id":"RMIS681691","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Faustino Mercado"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83914","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2335","size":1},{"color":"#FF4D4D","name":"The role of T cell expression of receptor-activator NFkB ligand (RANKL) in the pathogenesis of rheuatoid arthritis bone","data":{"media_summary":"","end_year":2005,"keywords":["Bone erosion","Osteoclasts","RANKL","Rheumatoid arthritis","T cell subsets"],"nhmrc_grant_id":143109,"application_year":2000,"start_year":2001,"scientific_title":"The role of T cell expression of receptor-activator NFkB ligand (RANKL) in the pathogenesis of rheuatoid arthritis bone","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Clinical Medicine and Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Allison Pettit","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143109","simplified_title":"The role of T cell expression of receptor-activator NFkB ligand (RANKL) in the pathogenesis of rheuatoid arthritis bone","sub_type":"CJ Martin Biomedical ECF","total_budget":"235026.2","source_system":""},"children":[{"color":"#336699","name":"Dr Allison Pettit","data":{"first_name":"Allison","title":"Dr","dw_individual_id":"DW0015560","middle_name":"Robyn","last_name":"Pettit","source_individual_id":"5016963","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Allison Pettit"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80923","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2334","size":1},{"color":"#FF4D4D","name":"The molecular basis of primary pulmonary hypertension: role of mutations in the bone morphogenetic protein type II recep","data":{"media_summary":"","end_year":2005,"keywords":["growth factors","knockout mice","lung hypertension","signal transduction","vascular biology"],"nhmrc_grant_id":143108,"application_year":2000,"start_year":2001,"scientific_title":"The molecular basis of primary pulmonary hypertension: role of mutations in the bone morphogenetic protein type II recep","node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Trina Jeffery","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143108","simplified_title":"The molecular basis of primary pulmonary hypertension: role of mutations in the bone morphogenetic protein type II recep","sub_type":"CJ Martin Biomedical ECF","total_budget":"186796.11","source_system":""},"children":[{"color":"#336699","name":"Trina Jeffery","data":{"first_name":"Trina","title":"","dw_individual_id":"DW0013926","middle_name":"","last_name":"Jeffery","source_individual_id":"RMIS680687","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Trina Jeffery"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80458","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2333","size":1},{"color":"#FF4D4D","name":"Molecular Genetic Analysis of Placental Development in the Mouse","data":{"media_summary":"","end_year":2007,"keywords":["Endothelial Cells","Placenta","Transcription Factors","Trophoblast","Vasculogenesis"],"nhmrc_grant_id":143107,"application_year":2000,"start_year":2001,"scientific_title":"Molecular Genetic Analysis of Placental Development in the Mouse","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Kallayanee Chawengsaksophak","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/143107","simplified_title":"Molecular Genetic Analysis of Placental Development in the Mouse","sub_type":"CJ Martin Biomedical ECF","total_budget":"324169.53","source_system":""},"children":[{"color":"#336699","name":"Kallayanee Chawengsaksophak","data":{"first_name":"Kallayanee","title":"","dw_individual_id":"DW0012267","middle_name":"","last_name":"Chawengsaksophak","source_individual_id":"RMIS680457","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Kallayanee Chawengsaksophak"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80017","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2332","size":1},{"color":"#FF4D4D","name":"The role of Sox8 in sex determination and human disease","data":{"media_summary":"","end_year":2003,"keywords":["Developmental biology","Molecular genetics","Sex determination","Sox genes","Transcription factors"],"nhmrc_grant_id":143101,"application_year":2000,"health_keywords":["ATR-16 syndrome","Sex determination","Sexual development"],"scientific_title":"The role of Sox8 in sex determination and human disease","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Peter Koopman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143101","simplified_title":"Study of a novel gene in sex determination and disease","sub_type":"Standard Project Grant","total_budget":"211527.54","source_system":"We have discovered a new gene called Sox8. This gene is very closely related to another gene, Sox9, that is known to be a critical factor in determining whether an embryo develops as a male or female by specifying whether the embryo makes testes or ovaries. We have found that Sox8, like Sox9, is active in the cell type in fetal testes known to be important for the development of maleness, at around the time when the male-female decision is being made. We therefore believe that Sox8 is an important part of the genetic chain of events leading to normal male development. We aim to study how Sox8 exerts its effects on male development. We have also found that in humans, Sox8 is located in a chromosomal region associated with a developmental disease syndrome characterized by mental retardation, facial defects and anomalies of male sexual development. Sox8 is active in mouse embryos in all the tissues affected by the human disease. We believe defects in SOX8 in humans are largely responsible for this disease, called ATR-16 syndrome. We will test whether patients with ATR-16 have defects involving SOX8 in their DNA in order to test this theory. In summary, we believe we have found a new human disease gene which will further our understanding of how developmental diseases arise in the embryo. In addition, this work will shed light on the process of sexual development, a significant healthcare problem in view of the fact that defects in sexual development are among the most common forms of birth defects."},"children":[{"color":"#336699","name":"Prof Peter Koopman","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0043570","middle_name":"A","last_name":"Koopman","source_individual_id":"5015773","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Koopman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88298","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2331","size":1},{"color":"#FF4D4D","name":"Functional characterisation of Pendrin: the anion transporter causing Pendred Syndrome","data":{"media_summary":"thyroid goitre","end_year":2003,"keywords":["Functional characterisation","Membrane physiology","anion transport","molecular biology","mutation analyses"],"nhmrc_grant_id":143096,"application_year":2000,"health_keywords":["Pendred Syndrome","congenital deafness","hearing loss","ion transport defect","thyroid goitre"],"scientific_title":"Functional characterisation of Pendrin: the anion transporter causing Pendred Syndrome","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"A/Pr Daniel Markovich","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143096","simplified_title":"Characterisation of the protein responsible for Pendred Syndrome","sub_type":"Standard Project Grant","total_budget":"211527.54","source_system":"Mutations in the human pendrin protein cause progressive hearing loss from an early age in Pendred syndrome. Using techniques of molecular and cellular biology, we intend to test the effects of Pendred-causing mutations on the function of pendrin expressed in frog and cultured mammalian cells. Our approach will enable us to determine how pendrin functions in both the normal and diseased states, which is currently unknown. This will allow us to consider ways of correcting the ion channel defect associated with the Pendred syndrome."},"children":[{"color":"#336699","name":"Prof Daniel Markovich","data":{"first_name":"Daniel","title":"Prof","dw_individual_id":"DW0038289","middle_name":"","last_name":"Markovich","source_individual_id":"5016201","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Daniel Markovich"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86917","size":1},{"color":"#336699","name":"Dr Paul Dawson","data":{"first_name":"Paul","title":"Dr","dw_individual_id":"DW0018598","middle_name":"Anthony","last_name":"Dawson","source_individual_id":"RMIS449839","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Paul Dawson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81766","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2330","size":1},{"color":"#FF4D4D","name":"TRAFFICKING OF MEMBRANE SULFATE TRANSPORTERS IN THE KIDNEY","data":{"media_summary":"Sulphate metabolism disorder","end_year":2003,"keywords":["Epithelial trafficking","Phosphorylation and glycosylation","Post-transcriptional regulation","Protein-protein interactions","Renal sulphate membrane transporters"],"nhmrc_grant_id":143094,"application_year":2000,"health_keywords":["Cartilage/bone disorder","Hypersulphaturia","Hyposulphataemia","Renal reabsorption disorder","Sulphate metabolism disorder"],"scientific_title":"TRAFFICKING OF MEMBRANE SULFATE TRANSPORTERS IN THE KIDNEY","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Daniel Markovich","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143094","simplified_title":"CELL BIOLOGY OF KIDNEY SULFATE PROTEINS","sub_type":"Standard Project Grant","total_budget":"211527.54","source_system":"Many diseases such as diabetes, cystic fibrosis, Alzheimer's and Parkinson's, results from a defect in the intracellular trafficking of specific membrane proteins. One important family of membrane proteins are the renal sulphate transporters, NaSi-1 and sat-1. They are two important proteins that control body sulphate homeostasis. Sulphate in the body is essential for cell matrix formation and cartilage-bone development and growth. Trafficking defects in these proteins can lead to changes in serum sulphate levels, which results in softening of the bones, insufficient cartilage development, and changes in many metabolic processes. Using techniques of molecular and cellular biology, we aim to identify the precise the mechanisms that control the trafficking of these proteins in cells. This will enable us to determine how these proteins functions in both the normal and diseased states, which is currently unknown."},"children":[{"color":"#336699","name":"Prof Daniel Markovich","data":{"first_name":"Daniel","title":"Prof","dw_individual_id":"DW0038289","middle_name":"","last_name":"Markovich","source_individual_id":"5016201","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Daniel Markovich"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86917","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2329","size":1},{"color":"#FF4D4D","name":"Charged lipophilic dendrimers: Delivery of oligonucleotides with therapeutic potential","data":{"media_summary":"Gene Therapy","end_year":2003,"keywords":["Charged dendritic systems","Drug Delivery","Lipophilic dendrimers","Oligonucleotide delivery"],"nhmrc_grant_id":143090,"application_year":2000,"health_keywords":["Anti Angiogenesis","Choroidal Neovascularisation","Drug Delivery","Eye Disease","Gene Therapy"],"scientific_title":"Charged lipophilic dendrimers: Delivery of oligonucleotides with therapeutic potential","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmaceutical Sciences and Pharmacy","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Istvan TOTH","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143090","simplified_title":"Targeted DNA delivery","sub_type":"Standard Project Grant","total_budget":"422036.72","source_system":"Choroidal neovascularisation, which is the most severe form of Age Related Macular Degeneration (AMD) is the major cause of blindness in the developed world. The disease usually affects people above the age of 75-80. With an ageing population, reaching 3.5 million (over 65) in Australia by year of 2020, AMD is quickly becoming a significant socio-economic problem. Gene therapy could be a cure for the above disease. Currently, there are large numbers of antisense oligonucleotides that have the potential to be developed as new medicines. However, a lack of absorption-cellular uptake and poor in vivo stability are major hurdles that must first be overcome, before any of these compounds will reach the clinic. Synthetic DNA delivery agents are of interest for gene therapy as an alternative to viral vectors, since they carry potentially fewer risks in terms of immuneresponse and propagation. Gene transfer with synthetic compounds is a growing field of research and the largest family of such agents is based on positively charged lipids which are able to self-associate and to form complexes (salts) with DNA conferring a compacted state on the plasmid. Our project will address these major issues through a highly novel strategy involving ion pair formation of lipophilic dendrimer (tree-like compounds with positive charges on the surface) constructs. This multidisciplinary approach has the potential to develop and test new DNA-dendrimer complexes and test them in a well established animal model for neovascularisation. Successful completion of this project might offer a potential therapy for choroidal neovascularisation, with a good chance of entering into human clinical trials by year 2004."},"children":[{"color":"#336699","name":"Prof Elizabeth Rakoczy","data":{"first_name":"Elizabeth","title":"Prof","dw_individual_id":"DW0044981","middle_name":"Piroska","last_name":"Rakoczy","source_individual_id":"5020121","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Elizabeth Rakoczy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88645","size":1},{"color":"#336699","name":"Prof Istvan Toth","data":{"first_name":"Istvan","title":"Prof","dw_individual_id":"DW0034329","middle_name":"","last_name":"Toth","source_individual_id":"RMIS17214","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Istvan Toth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85883","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2328","size":1},{"color":"#FF4D4D","name":"Conditional knockout of the murine patched gene for the study of skin differentiation and cancer.","data":{"media_summary":"","end_year":2003,"keywords":["genetics of skin cancer","molecular genetics of human disease","mouse models"],"nhmrc_grant_id":143073,"application_year":2000,"health_keywords":["basal cell carcinoma","developmental anomalies","medulloblastoma"],"scientific_title":"Conditional knockout of the murine patched gene for the study of skin differentiation and cancer.","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143073","simplified_title":"A mouse model for skin cancer.","sub_type":"Standard Project Grant","total_budget":"423564.26","source_system":"Basal cell carcinoma (BCC) is the most common cancer in Australia. We recently isolated the BCC gene, Patched (PTCH) from analysis of patients with Naevoid Basal Cell Carcinoma Syndrome (NBCCS). Individuals with NBCCS have a wide variety of developmental defects in addition to a cancer predisposition which includes medulloblastoma, rhabdomyosarcoma and ovarian fibroma as well as multiple BCCs. This application proposes the generation of an animal model for skin development and cancer by selectively removing patched gene function from specific cell of the skin. In doing this we will be able to determine the exact role of this gene in skin development, and how mutation causes common skin cancer."},"children":[{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2327","size":1},{"color":"#FF4D4D","name":"The downstream targets of Patched/Hedgehog signalling.","data":{"media_summary":"","end_year":2003,"keywords":["genetics of skin cancer","genomic approaches to gene expression analysis","molecular genetics of human disease","transgenesis"],"nhmrc_grant_id":143072,"application_year":2000,"health_keywords":["developmental anomalies","medulloblastoma","skin cancer"],"scientific_title":"The downstream targets of Patched/Hedgehog signalling.","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143072","simplified_title":"The downstream targets of Patched/Hedgehog signalling.","sub_type":"Standard Project Grant","total_budget":"423055.08","source_system":"The patched-hedgehog gene pathway is disturbed in common human cancer, including basal cell carcinoma of the skin, medulloblastoma, rhabdomyosarcoma and ovarian fibroma. This application proposes to look at the genes turned off and on by the patched gene. By identifying these genes and examining their function we will identify the exact genetic disturbance which results in a large proportion of common human cancer. Once we find these genes this opens up the possibilities of designing drugs which specifically block the action of the geneticdefect and thereby treating the tumours."},"children":[{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2326","size":1},{"color":"#FF4D4D","name":"Host resistance and protection against oral candidasis","data":{"media_summary":"Pathology, Oral","end_year":2003,"keywords":["Cellular immunity","Cytokine production","Lymphocyte differentiation","Phagocytic cells"],"nhmrc_grant_id":143067,"application_year":2000,"health_keywords":["Biological Phenomena, Cell Phenomena and Immunity","Candidiasis","Immunity, Cellular","Immunity, Natural","Pathology, Oral"],"scientific_title":"Host resistance and protection against oral candidasis","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Dentistry not elsewhere classified","research_area":"Basic Science","for_category":"DENTISTRY","cia_name":"A/Pr Robert Ashman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143067","simplified_title":"Causes of oral candidasis","sub_type":"Standard Project Grant","total_budget":"196527.54","source_system":"Candida albicans is an important opportunistic pathogen, that is widely represented in general medical and dental practice, as well as in the hospital environment. Clinical observations indicate that defects in innate immunity predispose patients to disseminated infection, whereas a weakened cell-mediated immune response is commonly associated with chronic oral infections. Animal models of both chronic and acute oral candidiasis have been developed and characterised by the applicants, and these have clearly implicated T cells in the process of recovery from primary infection. The models will now be used to analyse the effector mechanisms that lead to clearance of the yeast from the oral cavity, with a particular focus on the role of phagocytic cells, and their interaction with T cells. The acute model will be used to identify immunological variables that can act as markers of protection, and the effectiveness of therapeutic manipulations will be evaluated in the chronic model, with the ultimate aim of developing a protective vaccine for human infections."},"children":[{"color":"#336699","name":"A/Pr Robert Ashman","data":{"first_name":"Robert","title":"A/Pr","dw_individual_id":"DW0029217","middle_name":"Brian","last_name":"Ashman","source_individual_id":"5013239","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Robert Ashman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84574","size":1},{"color":"#336699","name":"Prof Robert Clancy","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0024135","middle_name":"L","last_name":"Clancy","source_individual_id":"RMIS106413","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Robert Clancy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83195","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2325","size":1},{"color":"#FF4D4D","name":"Cell type specification in developing CNS: functional analysis of Sox14","data":{"media_summary":"","end_year":2003,"keywords":["CNS development","CNS function","Developmental genetics","Gene targeting","Neurological disease"],"nhmrc_grant_id":143064,"application_year":2000,"health_keywords":["Motor control","Neurodegeneration","Neurological disease"],"scientific_title":"Cell type specification in developing CNS: functional analysis of Sox14","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurogenetics","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Peter Koopman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143064","simplified_title":"CNS Cell type specification by Sox14","sub_type":"Standard Project Grant","total_budget":"468055.08","source_system":"The central nervous system (CNS) is the most complex organ in the body. The vast majority of nerve cells in the CNS are classified as 'interneurons'. These cells relay sensory information and motor commands within the CNS. Abnormal functioning of interneurons is likely to be the underlying cause of some, if not many, human nervous system diseases. However, very little is known of the precise anatomy and function of interneurons, which genes control their development, and how these functions are maintained in the adult. This has been largely due to a lack of efficient and reliable methods to identify and study interneurons. We have previously discovered that a gene termed Sox14 is active in distinct interneuron groups in the embryonic brain and spinal cord. Sox14 is a member of the Sox gene family, many of which act as genetic switches to control cell and tissue development. We found that Sox14 has been extremely well conserved throughout evolution and is active in similar interneuron groups in a number of animal species. These studies led us to hypothesise that Sox14 controls a critical molecular step in the generation of certain interneurons that may be involved in reflexes, locomotion or motor coordination. In this project, we will investigate both the role of Sox14 in interneuron development and the functions of interneurons in which this gene is active. We will do so by combining modern molecular and genetic techniques with physiological approaches. This project will reveal critical molecular steps in CNS development and determine the functions of a specific group of interneurons. To this end, we will generate mouse strains in which a specific group of interneurons are genetically marked and can be manipulated during development. We envisage that these mice with 'modified brain circuits' will become unique resources for future investigations of selected interneuron types and their functions."},"children":[{"color":"#336699","name":"Prof Peter Koopman","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0043570","middle_name":"A","last_name":"Koopman","source_individual_id":"5015773","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Koopman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88298","size":1},{"color":"#336699","name":"Toshiya Yamada","data":{"first_name":"Toshiya","title":"","dw_individual_id":"DW0017254","middle_name":"","last_name":"Yamada","source_individual_id":"RMIS133491","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Toshiya Yamada"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81394","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2324","size":1},{"color":"#FF4D4D","name":"Transcriptional control of blood vessel development by Sox18","data":{"media_summary":"","end_year":2003,"keywords":["Developmental biology","Endothelial cells","Molecular genetics","Sox genes","Transcription factors"],"nhmrc_grant_id":143061,"application_year":2000,"health_keywords":["Angiogenesis","Vascular disease","Wound healing"],"scientific_title":"Transcriptional control of blood vessel development by Sox18","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Peter Koopman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143061","simplified_title":"Control of blood vessel development","sub_type":"Standard Project Grant","total_budget":"468564.26","source_system":"Blood vessels play an essential role in maintaining the supply of nutrients to every organ and tissue in the body. Improper development of blood vessels in the embryo can compromise survival of the embryo, and defects in the ability of blood vessels to grow, regenerate and adapt to change during adult life can be life-threatening. The growth of new blood vessels (angiogenesis) is also an important factor in the ability of solid tumours to grow during the progression of cancer. It is therefore of fundamental importance in the health sciences to gain an understanding of how blood vessels form and regenerate. As a result of our collaborative research efforts, we have discovered a gene, Sox18, that appears to regulate blood vessel development by controlling the formation and-or behaviour of endothelial cells, which line the blood vessels and make them impermeable. Our research so far indicates that MICE WITH DEFECTS IN SOX18 DIE FROM VASCULAR DEFECTS, underlining the importance of this gene. THIS PROJECT IS CONCERNED WITH FINDING OUT HOW SOX18 WORKS - exactly what goes wrong in mice lacking this gene, whether Sox18 can influence endothelial cell behaviour in cell culture, how Sox18 comes to be active in endothelial cells, what genes are switched on by Sox18, and what genes Sox18 co-operates with in its role in endothelial cells. The answers to these questions will not only provide fundamental basic information about how blood vessels development is controlled, but also sow the seeds for possible future therapies in which blood vessel development could be stimulated (eg in wound healing) or suppressed (eg in tumour progression) through pharmaceutical intervention."},"children":[{"color":"#336699","name":"Prof Peter Koopman","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0043570","middle_name":"A","last_name":"Koopman","source_individual_id":"5015773","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Koopman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88298","size":1},{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1},{"color":"#336699","name":"Jane Olsson","data":{"first_name":"Jane","title":"","dw_individual_id":"DW0009454","middle_name":"","last_name":"Olsson","source_individual_id":"RMIS221670","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Jane Olsson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79265","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2323","size":1},{"color":"#FF4D4D","name":"Adaptive change and ethanol dependence","data":{"media_summary":"","end_year":2003,"keywords":["alcohol dependence","gene expression","glutamate receptors","molecular neuroscience"],"nhmrc_grant_id":143059,"application_year":2000,"health_keywords":["addiction","alcoholism","drugs of dependence"],"scientific_title":"Adaptive change and ethanol dependence","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Peter Wilce","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143059","simplified_title":"What changes take place in the brain during the development of alcohol dependence","sub_type":"Standard Project Grant","total_budget":"361527.54","source_system":"Ethanol abuse, alcoholism and the medical complications of excessive drinking are now major health problems worldwide. The alcohol dependence syndrome is characterised by tolerance and physical dependence ( the presence of a withdrawal syndrome). Ethanol withdrawal, in addition, to being a health hazard in itself, can act as a negative reinforcer to promote continued ethanol consumption. Alcohol dependence can be considered to result from adaptive changes produced by the chronic presence of ethanol in the brain. In this research programme we will learn more about the adaptive changes in the NMDA receptors, the major excitatory receptors in the brain. Current psychopharmacologic management of human alcoholism is limited and suboptimal. We will explore the efficacy of drugs to control behaviours and withdrawal-induced brain cell death. Effective treatment of the syndrome is crucial since withdrawal induces changes, which increases the severity of subsequent withdrawal episodes and its associated brain damage. The outcomes of this research will be a better understand of the underlying changes involved in ethanol dependence and better therapies to ameliorate the withdrawal syndrome."},"children":[{"color":"#336699","name":"Dr John Leah","data":{"first_name":"John","title":"Dr","dw_individual_id":"DW0020311","middle_name":"","last_name":"Leah","source_individual_id":"RMIS1698144","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr John Leah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82185","size":1},{"color":"#336699","name":"Peter Wilce","data":{"first_name":"Peter","title":"","dw_individual_id":"DW0011061","middle_name":"","last_name":"Wilce","source_individual_id":"RMIS34632","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Peter Wilce"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79708","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2322","size":1},{"color":"#FF4D4D","name":"Genetic dissection of the biogenesis and function of type IV fimbriae of Pseudomonas aeruginosa","data":{"media_summary":"","end_year":2003,"keywords":["Pseudomonas aeruginosa","fimbriae","host colonisation","infection"],"nhmrc_grant_id":143054,"application_year":2000,"health_keywords":["burns patients","cystic fibrosis","immunocompromised patients","nosocomial infections"],"scientific_title":"Genetic dissection of the biogenesis and function of type IV fimbriae of Pseudomonas aeruginosa","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof John Mattick","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143054","simplified_title":"Pseduomonas aeruginosa infections","sub_type":"Standard Project Grant","total_budget":"407545.9","source_system":"Pseudomonas aeruginosa is a common bacterium which causes serious life-threatening infections of individuals with cystic fibrosis, AIDS or who have suffered severe burns or are undergoing cancer chemotherapy. This pathogen, and a number of other important infectious bacteria use surface filaments, called fimbriae, like grappling hooks to attach to the cells of the body and to move across host tissues. These fimbriae are produced in response to environmental conditions, and are assembled by a process that is also used in the export of toxins and other pathogenic molecules. This project will characterise genes which specify and control this system, as a means to design better treatments against such bacteria, many of which are resistant to antibiotic treatment."},"children":[{"color":"#336699","name":"A/Pr Cynthia Whitchurch","data":{"first_name":"Cynthia","title":"A/Pr","dw_individual_id":"DW0017067","middle_name":"B","last_name":"Whitchurch","source_individual_id":"5018278","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Cynthia Whitchurch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81332","size":1},{"color":"#336699","name":"Prof John Mattick","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0014777","middle_name":"Stanley","last_name":"Mattick","source_individual_id":"5016273","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Mattick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80700","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2321","size":1},{"color":"#FF4D4D","name":"Design and Evaluation of Inhibitors of Phospholipases A2 as Anti-Inflammatory Drugs","data":{"media_summary":"structure","end_year":2003,"keywords":["anti-inflammatory","design","enzyme","inhibitor","protease"],"nhmrc_grant_id":143049,"application_year":2000,"health_keywords":["arthritis","drug","inflammation","protease","structure"],"scientific_title":"Design and Evaluation of Inhibitors of Phospholipases A2 as Anti-Inflammatory Drugs","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Stephen Taylor","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143049","simplified_title":"Rational Design of New Anti-Inflammatory Drugs","sub_type":"Standard Project Grant","total_budget":"317545.9","source_system":"There are at least 16 types of enzymes called phospholipases A2 (PLA2). They are found in venoms of snakes, bees, lizards, cone snails, etc and act as toxic and digestive agents. PLA2 enzymes are also found in cells and tissues of mammals where they carry out a wide range of digestive, maintenance, immune defence, and cell signalling functions. The human pancreas secretes one form of PLA2 into the gut to aid digestion. Human immune cells (macrophages, thymocytes, spleen leukocytes, platelets) use other forms of PLA2 in the inflammatory immune response to kill infectious foreign agents like viruses and bacteria. One form of PLA2, known as type IIa, is the main bacteria-killing ingredient of human tears and it is also a chief component of fluid from the joints of patients with arthritis. Type IIa PLA2 is present in abnormally high levels in blood from humans with arthritis, burns, sepsis, ARDS, atherosclerosis, Crohn's disease, malaria, cancer and other chronic illnesses. These high levels can cause injury, tissue damage and pain due to too much inflammation and treatments are needed to stop or decrease effects of this enzyme . For these reasons this and related enzymes are thought to be potential targets for drugs which would act by blocking the functions of such an enzyme. Our group has been using computers to design new chemicals that can selectively fit into this enzyme and stick very tightly. We are determining the three dimensional structures of these chemicals in the enzyme to learn how to make them bind even more tightly. This information is allowing us to synthesize new selective drugs that stop PLA2 from promoting the development of disease. We propose to continue these studies towards developing powerful new antiinflammatory drugs that block the enzyme, and to demonstrate possible benefits of these drugs by testing them in animal models of arthritis, sepsis, adult respiratory distress syndrome (ARDS), period pain, malaria, and cancer."},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1},{"color":"#336699","name":"Prof Stephen Taylor","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0010587","middle_name":"M","last_name":"Taylor","source_individual_id":"RMIS41211","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79577","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2320","size":1},{"color":"#FF4D4D","name":"A vaccine to break tolerance to cervical carcinoma oncoprotein","data":{"media_summary":"","end_year":2003,"keywords":["Cancer Vaccine","T cell immunotherapy","dendritic cells","peripheral tolerance","transgenic mouse"],"nhmrc_grant_id":143044,"application_year":2000,"health_keywords":["Cancer","Immunotherapy","Vaccine"],"scientific_title":"A vaccine to break tolerance to cervical carcinoma oncoprotein","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Tumour Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof ROBERT TINDLE","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143044","simplified_title":"Overcoming immune response non-reactivity in cervical cancer","sub_type":"Standard Project Grant","total_budget":"212036.72","source_system":"Evidence that cervical cancer is caused by Human Papillomavirus is compelling. Once the virus enters the cells of the cervix, it produces a protein named E7 which functions to make the cells cancerous. Cervical cancer is the fifth commonest cause of death in women in Australia, and the major killer of women world-wide. The E7 protein is the ideal target for a vaccine since it occurs only in the tumour cells. Cervical tumour cells are killed by specialised immune system cells termed CTLs which recognised fragments of the E7 molecule on their surface, bound to 'self' MHC molecules. Our laboratory has developed several mouse models of human cervical cancer, and has worked out which parts of the E7 protein are important in developing an appropriate immune response to control tumour growth. However a major finding is that the E7 molecules render the CTL cell population incapable of making an appropriate response to kill the tumour cells. We believe that this process, termed 'tolerance induction' can be overcome by using a novel approach as follows. Specialised antigen presenting cells , termed 'dendritic cells' (DCs) will be isolated and made to produce E7 protein by infecting them with a geneticlly modified virus (Adenovirus) which expresses E7 and specialised DC activators molecules, but is incapable of itself replicating. The dendritic cells will be re-introduced into the host as a vaccine, and will present the E7 to the immune system in such a way that tolerance will be broken. In other words the vaccine recipient will again be able to make a CTL immune response to the E7 protein in their tumours, and so be able to kill the tumour cells."},"children":[{"color":"#336699","name":"Prof Robert Tindle","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0028412","middle_name":"W","last_name":"Tindle","source_individual_id":"RMIS388145","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Robert Tindle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84347","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2319","size":1},{"color":"#FF4D4D","name":"Japanese encephalitis virus in Australasia: molecular studies of isolates and consequences of immunisation.","data":{"media_summary":"vector and vertebrate host ecology","end_year":2003,"keywords":["Immunisation","Japanese encephalitis virus","Quasi-species","antibody-dependent enhancement","mosquito transmission"],"nhmrc_grant_id":143043,"application_year":2000,"health_keywords":["Immunisation","emerging diseases","encephalitis","spread of mosquito-borne disease","vector and vertebrate host ecology"],"scientific_title":"Japanese encephalitis virus in Australasia: molecular studies of isolates and consequences of immunisation.","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof John MacKenzie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143043","simplified_title":"Japanese encpehalitis virus in Australasia: will immunisation strategies be successful for population protection.","sub_type":"Standard Project Grant","total_budget":"212036.72","source_system":"Japanese encephalitis (JE) virus is a mosquito-transmitted virus of Asia. Infection causes clinical disease in about 1 in 50 people infected, and of these, about 25% will die from a fatal encephalitis (inflammation of the brain), and a further 50% will have lifelong severe disabilities. There are over 50,000 cases annually in Asia, with about 12,000 fatalities.The virus normally circulates between mosquitoes and water birds and between mosquitoes and pigs. The World Health Organization has recognised JE as one of the most important mosquito-borne viruses because of its propensity to spread and to colonise new areas. The virus first appeared in northern Australia in the Torres Strait in 1995, causing three clinical cases of whom 2 died, and returned again in 1998, with a further case in the Torres Strait and the first case to occur on mainland Australia in Cape York. Both of these patients recovered. The virus returned again to the Torres Strait in 2000, but so far without causing human disease. We have shown that the virus is established in Papua New Guinea (PNG), where it is spreading rapidly, and our results suggest that PNG was the source of the virus causing the outbreaks in 1995 and 1998. It is believed that JE virus will almost certainly become established in Australia within the next few years. The aims of this project are to explore the consequences of JE becoming established and specifically: (a) the use of inactivated JE vaccine to protect at-risk populations and whether the vaccine will provide sufficient protection or whether it will lead to enhanced infection with indigenous flaviviruses such as Murray Valley encephalitis virus; and (b) the possibility of emergence of genetic variants with increased transmissibility, virulence, and altered neutralisation epitopes."},"children":[{"color":"#336699","name":"Prof Peter Mcminn","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0044201","middle_name":"C","last_name":"Mcminn","source_individual_id":"RMIS182718","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Peter Mcminn"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88455","size":1},{"color":"#336699","name":"Prof Roy Hall","data":{"first_name":"Roy","title":"Prof","dw_individual_id":"DW0025278","middle_name":"A","last_name":"Hall","source_individual_id":"RMIS16831","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roy Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83509","size":1},{"color":"#336699","name":"Prof John Mackenzie","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0008814","middle_name":"","last_name":"Mackenzie","source_individual_id":"RMIS218589","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mackenzie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79086","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2318","size":1},{"color":"#FF4D4D","name":"Molecular interactions of novel conotoxin inhibitors of the noradrenaline transporter","data":{"media_summary":"","end_year":2003,"keywords":["electrophysiology","molecular pharmacology","peptide inhibitors of noradrenaline transport","structure function relationships","uptake1"],"nhmrc_grant_id":143038,"application_year":2000,"health_keywords":["cardiovascular disease","mood disorders","neurotransmission"],"scientific_title":"Molecular interactions of novel conotoxin inhibitors of the noradrenaline transporter","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Richard Lewis","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143038","simplified_title":"How does a novel class of conotoxin inhibit the transport of noradrenaline into nerves","sub_type":"Standard Project Grant","total_budget":"392036.72","source_system":"A novel class of conotoxins (chi-conotoxins) has been discovered in the venom of an Australian cone snails, Conus marmoreus. Chi-conotoxins are the first peptide inhibitors of the noradrenaline transporter. From binding studies, it appears they act at a new site, remote from the site of action of antidepressants. This project is aimed at understanding how and where this novel class of peptide binds to the transporter. The results of this study are designed to maximise the potential of these patented peptides to be used as leads to the development of a new class of therapeutic for controlling the adverse effects of inadequate noradrenaline balance."},"children":[{"color":"#336699","name":"Prof Paul Alewood","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0035049","middle_name":"F","last_name":"Alewood","source_individual_id":"5013158","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Paul Alewood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86082","size":1},{"color":"#336699","name":"Prof Richard Lewis","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0014455","middle_name":"J","last_name":"Lewis","source_individual_id":"5015973","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Lewis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80612","size":1},{"color":"#336699","name":"Prof David Adams","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0000022","middle_name":"John","last_name":"Adams","source_individual_id":"RMIS8271","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Adams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76652","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2317","size":1},{"color":"#FF4D4D","name":"Identification of critical regulatory elements in the BRCA1 gene","data":{"media_summary":"","end_year":2003,"keywords":["BRCA1","Gene regulation","Mutation analysis","Transgenics","Tumour suppressor genes"],"nhmrc_grant_id":143037,"application_year":2000,"health_keywords":["Breast cancer","Molecular basis of disease","Molecular diagnostics"],"scientific_title":"Identification of critical regulatory elements in the BRCA1 gene","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Melissa Brown","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143037","simplified_title":"Understanding which molecular abnormalities contribute to breast cancer","sub_type":"Standard Project Grant","total_budget":"227036.72","source_system":"Breast cancer affects approximately one in ten women and is therefore a major health problem. In order to improve the diagnosis, treatment and prognosis of this disease, it is critical to understand the molecular defects that contribute to disease initiation and progression. Over the last twenty years significant progress has been made in this regard, however there still remain a considerable number of unanswered questions. For example, it is not yet clear precisely what contribution each of these genes makes. This is largely due to limitations in current mutation detection strategies and an incomplete understanding of all of the genetic elements for which disruption can lead to loss of gene function. This propsal aims to identify all of the genetic elements critical for the expression of an important breast cancer gene called BRCA1. Furthermore, it aims to determine the status of these elements in breast cancer patients, thus expanding our knowledge of the actual contribution disruption of this gene makes to this disease."},"children":[{"color":"#336699","name":"Prof Melissa Brown","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0041312","middle_name":"A","last_name":"Brown","source_individual_id":"RMIS511711","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Melissa Brown"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87712","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2316","size":1},{"color":"#FF4D4D","name":"The biosynthesis of Mycobactin T, a virulence factor from Mycobacterium tuberculosis.","data":{"media_summary":"","end_year":2003,"keywords":["Enzymology","Mycobacterium tuberculosis","Mycobactin biosynthesis","Non-ribosomal peptide synthase","Protein expression and Purification"],"nhmrc_grant_id":143031,"application_year":2000,"health_keywords":["Antibiotic","Drug Target","Drug resistance","Tuberculosis"],"scientific_title":"The biosynthesis of Mycobactin T, a virulence factor from Mycobacterium tuberculosis.","start_year":2002,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Enzymes","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof James De VOSS","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143031","simplified_title":"How is Mycobactin T, a virulence enhancing molecule from Mycobacterium tuberculosis, made?","sub_type":"Standard Project Grant","total_budget":"211527.54","source_system":"Mycobacterium tuberculosis is the causative agent of tuberculosis. The drug isoniazid led to a dramatic and sustained decline in mortality due to tuberculosis. This led to it being described in medical literature in 1988 as a disappearing disease which was now fairly easy to treat. However, the advent of HIV and the rapid rise of multidrug resistant M. tuberculosis led to dramatic changes. The risk that an HIV infected individual will develop active tuberculosis is 7% per year, compared to a lifetime risk of 10% for an immunocompetent person. Similarly, the prevalence of drug resistant strains of M. tuberculosis is over 5% in many regions, including SE asia. Mycobacterial infections are regarded as the leading cause of morbidity and mortality world wide and WHO estimates that 30 million deaths will occur in the next decade due to these infections. Clearly, new drugs are required to combat the rising menace of this organism. The aim of this project is to detail the unique metabolic pathways in M. tuberculosis that produce Mycobactin T, essential to the virulence of this organism. Mycobactin T helps the bacteria obtain iron, an essential nutrient. These factors make the mycobaction pathway an ideal drug target and an understanding of its biochemistry is essential to its eventual exploitation for intervention in M. tuberculosis infections. We hypothesise that it may already provide the unknown site of action of a clinically employed, antituberculosis drug para-aminosalicylate (PAS). This project will i) fully define the structure of mycobactin T; ii) clone and overexpress key genes which catalyse the first three steps of mycobactin formation; iii) purify and characterise the overexpressed proteins with respect to their biochemical function; iv) examine the interaction of PAS with the proteins likely to be targeted by this antimycobacterial agent. The results of this work will provide the basis for the development of future anti-tuberculosis drugs."},"children":[{"color":"#336699","name":"Prof James De Voss","data":{"first_name":"James","title":"Prof","dw_individual_id":"DW0018621","middle_name":"J","last_name":"De Voss","source_individual_id":"RMIS58959","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof James De Voss"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81771","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2315","size":1},{"color":"#FF4D4D","name":"A genetic study of schizophrenia in the Brahmin of Tamil Nadu","data":{"media_summary":"","end_year":2003,"keywords":["Linkage (genetics)","Linkage disequilibrium","Population isolate","Psychiatric Phenomenology","Schizophrenia"],"nhmrc_grant_id":143027,"application_year":2000,"health_keywords":["Schizophrenia - Aetiology","Schizophrenia - Diagnosis","Schizophrenia - Genetics"],"scientific_title":"A genetic study of schizophrenia in the Brahmin of Tamil Nadu","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Bryan Mowry","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143027","simplified_title":"A study of schizophrenia in a genetically distinct population of southern India","sub_type":"Standard Project Grant","total_budget":"267226.72","source_system":"The cause of schizophrenia is unknown, but there is good evidence that genes play a role. Geneticists do not fully understand how it is inherited, but it is very complex, and several interacting genes as well as environmental factors are probably involved. Societies such as Australia are genetically diverse because people from many different ethnic groups have intermarried. To detect susceptibility genes in this type of population, we must study very large patient samples. Alternatively, we can study genetically homogenous patient samples, found in isolated gene-pool populations. One such population is the Brahmin people in Tamil Nadu, a south-eastern state of India. The Brahmin are descended from the Aryan peoples who migrated into southern India 2000 years ago. In the Hindu caste system, Brahmin are the highly educated priest class, and enjoy a privileged position in society. Traditionally, marriages among the Brahmin of Tamil Nadu have been prearranged, with a preference for first-cousin marriages. As well as this cultural and historical evidence, genetic marker studies confirm that this population is a suitable genetic isolate. In this project, genetic material (DNA) will be collected from Brahmin schizophrenic patients and their families. Diagnostic data, detailed family data, and blood samples will be gathered from 90-100 extended families, each containing two or more ill individuals. Analysis of their genetic code will enable a search for possible schizophrenia susceptibility genes and a systematic search for a mutation. If found, this will greatly improve our understanding of schizophrenia, and stimulate the search for similar genes in other samples world-wide, including Australia where schizophrenia costs $3 billion annually in terms of treatment and lost jobs. If schizophrenia genes can be found, it may be possible to find better treatments that correct the basic causes of the illness and identify factors that protect against the illness."},"children":[{"color":"#336699","name":"Prof Bryan Mowry","data":{"first_name":"Bryan","title":"Prof","dw_individual_id":"DW0044411","middle_name":"J","last_name":"Mowry","source_individual_id":"5016586","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bryan Mowry"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88510","size":1},{"color":"#336699","name":"Dr Rangaswamy Thara","data":{"first_name":"Rangaswamy","title":"Dr","dw_individual_id":"DW0028354","middle_name":"","last_name":"Thara","source_individual_id":"RMIS51648","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Rangaswamy Thara"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84327","size":1},{"color":"#336699","name":"Dr Derek Nancarrow","data":{"first_name":"Derek","title":"Dr","dw_individual_id":"DW0026955","middle_name":"J","last_name":"Nancarrow","source_individual_id":"RMIS7763","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Derek Nancarrow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83977","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2314","size":1},{"color":"#FF4D4D","name":"A prospective study of traumatic stress in children involved in motor vehicle accidents","data":{"media_summary":"","end_year":2003,"keywords":["Children","Motor vehicle accidents","Prospective methods","Traumatic stress"],"nhmrc_grant_id":143021,"application_year":2000,"health_keywords":["Acute and chronic anxiety reactions","Children's mental health and adjustment","Post traumatic stress disorder"],"scientific_title":"A prospective study of traumatic stress in children involved in motor vehicle accidents","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Mental Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Justin Kenardy","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143021","simplified_title":"PTSD in children involved in motor vehicle accidents","sub_type":"Standard Project Grant","total_budget":"185889.18","source_system":"Motor vehicle accidents (MVAs) are relatively frequent major life trauma that represent significant life threatening experiences. Not surprisingly evidence suggests that MVAs represent a frequent trigger for the development of post traumatic stress disorder (PTSD), although studies have typically focussed upon adult survivors. Local statistics indicate a significant proportion of children will experience a MVA of sufficient severity to warrant attendance at hospital. This project is of significance because it will provide badly needed information about the prevalence and course of emotional and behavioural problems in children following exposure to a serious MVA. More broadly the study should provide valuable information on post-traumatic stress responses in children. Furthermore, it will enable us to identify the factors that place children at particular risk of developing psychological problems following a MVA. This will provide information to help design of interventions to prevent the development of PTSD and other forms of psychopathology following MVAs. Such data will also permit identification of those children who are at particular risk of psychological morbidity after MVA trauma and for whom preventive interventions are most likely to be beneficial."},"children":[{"color":"#336699","name":"Prof Justin Kenardy","data":{"first_name":"Justin","title":"Prof","dw_individual_id":"DW0037727","middle_name":"Alastair","last_name":"Kenardy","source_individual_id":"RMIS53308","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Justin Kenardy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86768","size":1},{"color":"#336699","name":"Prof Susan Spence","data":{"first_name":"Susan","title":"Prof","dw_individual_id":"DW0022261","middle_name":"Hilary","last_name":"Spence","source_individual_id":"RMIS29798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Susan Spence"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82741","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2313","size":1},{"color":"#FF4D4D","name":"Development of an artificial blood vessel","data":{"media_summary":"vascular prosthesis","end_year":2005,"keywords":["artificial artery","cardiovascular","cell differentiation","myofibroblast","vascular smooth muscle"],"nhmrc_grant_id":143019,"application_year":2000,"health_keywords":["atherosclerosis","coronary artery bypass","haemodialysis access fistula","vascular graft","vascular prosthesis"],"scientific_title":"Development of an artificial blood vessel","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Julie Campbell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143019","simplified_title":"Development of an artificial blood vessel","sub_type":"Standard Project with Research Fellowship","total_budget":"512443.44","source_system":"Atherosclerosis (hardening of the arteries) is the principal cause of heart attack, stroke and blockage of blood flow to the lower limbs. However, to date none of the biological or synthetic grafts used to bypass the narrowed regions of arteries is ideal. We have shown that lengths of silicone tubing placed into the peritoneal cavity of rats or rabbits becomes covered within 2 weeks by a capsule of granulation tissue (smooth-muscle-like cells and collagen) and mesothelial (endothelial-like) cells. The silicone tubing can be removed and the tissue turned inside out such that the endothelial-like cells now line the inside of the tube of living tissue, which resembles a blood vessel. These artificial blood vessels will be grown in the peritoneal cavity of rabbits, then grafted into the right carotid artery to replace a length of removed vessel. Their long-term (3,6,9 and 12 months) patency, reactivity, tensile strength and resistance to clot development will be assessed. Their susceptibility to atherosclerotic plaque development and blockage (as compared with natural carotid artery) will be examined in rabbits fed a cholesterol-enriched diet. Changes in gene expression as the artificial artery progressively develops will be examined, as will the potential to genetically manipulate the artificial artery to improve its functioning. Finally, attempts will be made to grow the vessels entirely in vitro. This novel vascular graft may open new options in the field of arterial reconstructive surgery for replacing or bypassing diseased vessels or as an access vessel for haemodialysis patients with end stage renal failure. This study will also provide new information on the biology of cells found in the peritoneal cavity and their alternative pathways for differentiation."},"children":[{"color":"#336699","name":"Prof Julie Campbell","data":{"first_name":"Julie","title":"Prof","dw_individual_id":"DW0000708","middle_name":"H","last_name":"Campbell","source_individual_id":"RMIS330901","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Julie Campbell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76860","size":1},{"color":"#336699","name":"Gordon Campbell","data":{"first_name":"Gordon","title":"","dw_individual_id":"DW0000705","middle_name":"","last_name":"Campbell","source_individual_id":"RMIS14178","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Gordon Campbell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76859","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2312","size":1},{"color":"#FF4D4D","name":"Structural characterisation of phosphopeptide recognition by FHA domains","data":{"media_summary":"leukemia","end_year":2003,"keywords":["NMR spectroscopy","X-ray crystallography","protein phosphorylation","protein structure","protein-protein interaction"],"nhmrc_grant_id":143013,"application_year":2000,"health_keywords":["Li-Fraumeni syndrome","Nijmegen breakage syndrome","ataxia-telangiectasia","cancer","leukemia"],"scientific_title":"Structural characterisation of phosphopeptide recognition by FHA domains","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Bostjan Kobe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143013","simplified_title":"Studies of interactions resulting in cellular signalling","sub_type":"Standard Project Grant","total_budget":"257036.72","source_system":"Cells require numerous signalling pathways to keep various cellular processes coordinated and under control. One of the most important aspects of signalling is formation of complexes involving two or more different proteins. One of the recently identified players in the formation of these signalling complexes is the so-called forkhead-associated (FHA) module, FHA modules are protein sequences of ~130 amino acids that appear as a part of signalling proteins and bind to specific sequences on signalling protein partners. Many proteins containing FHA modules are important for the repair of damaged DNA and the stability of chromosomes. The aim of our studies is to understand the molecular and atomic details of how FHA modules bind their partners. This is the first step towards designing therapeutic agents against various forms of cancer where DNA is damaged."},"children":[{"color":"#336699","name":"Prof Bostjan Kobe","data":{"first_name":"Bostjan","title":"Prof","dw_individual_id":"DW0031827","middle_name":"","last_name":"Kobe","source_individual_id":"5011436","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bostjan Kobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85237","size":1},{"color":"#336699","name":"A/Pr Helen Blanchard","data":{"first_name":"Helen","title":"A/Pr","dw_individual_id":"DW0017776","middle_name":"","last_name":"Blanchard","source_individual_id":"5013502","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Helen Blanchard"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81542","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2311","size":1},{"color":"#FF4D4D","name":"Regulators of G protein signalling on the Golgi complex","data":{"media_summary":"leukemia","end_year":2005,"keywords":["G proteins","Golgi complex","cell biology","macrophages","signal transduction"],"nhmrc_grant_id":143007,"application_year":2000,"health_keywords":["cancer","diabetes","inflammation","kidney disease","leukemia"],"scientific_title":"Regulators of G protein signalling on the Golgi complex","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/143007","simplified_title":"Regulation of cell signalling","sub_type":"Standard Project with Research Fellowship","total_budget":"666116.8","source_system":"The secretion of proteins from cells involves a host of regulatory and signalling proteins. G proteins, signal transducers, located on the Golgi membranes, participate in the budding of transport vesicles in the secretory pathway. A newly-discovered family of Regulators of G Protein Signalling (RGS) proteins perform the critical function of turning off signals generated by G proteins. RGS proteins are powerful, but as yet, ill-defined regulatory molecules. In this study we will identify and characterize RGS proteins in macrophages that are located on Golgi membranes and help to regulate cytokine secretion and other immune functions. More detailed studies on selected RGS proteins will include mutational analysis of functional domains within the proteins and identification of other proteins that interact with RGS proteins. Overall these studies will lead us to understand how specific RGS proteins interact with G proteins and other molecules to regulate signalling in the secretory pathway. Anomalies in cell signalling have severe consequences in a variety of diseases and can cause cancer. Similarly, abnormal secretion in cells contributes to inflammation, diabetes and other disease processes. Information forthcoming from our studies on RGS proteins will have wide-reaching implications and the potential to reveal new targets for therapeutics in these diseases."},"children":[{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2310","size":1},{"color":"#FF4D4D","name":"The identification of genes involved in mammalian craniofacial development and disease","data":{"media_summary":"","end_year":2003,"keywords":["craniofacial development","gene expression analysis","human embryonic development"],"nhmrc_grant_id":142993,"application_year":2000,"health_keywords":["defects in embryonic development","developmental syndromes","facial dysmorphology"],"scientific_title":"The identification of genes involved in mammalian craniofacial development and disease","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Carol Wicking","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142993","simplified_title":"Genes involved in development of the mammalian face","sub_type":"Standard Project Grant","total_budget":"408055.08","source_system":"Birth defects arising from abnormal development of the embryo are a major cause of infant mortality and childhood disabilities. On average 3-4% of liveborn babies have a major congenital abnormality, and of the 15-20% of pregnancies which spontaneously abort, many are due to chromosomal or other developmental anomalies. A common feature of many developmental disorders is dysmorphology of the face, suggesting that genes important in patterning the face are also important in the development of other organ systems. During development of the embryo many of the features of the face derive from a series of swellings termed the pharyngeal arches. The complex processes which determine how the face develops are in a large part controlled by the co-ordinated expression of a large number of genes in the first two of the five pharyngeal arch pairs. While we know some of the genes involved in these processes, the precise mechanisms of craniofacial development are relatively poorly understood. In this project we propose a large scale approach to identifying genes involved in development of the mammalian face and to further delineating their role in development and human disease. This approach takes advantage of state of the art genomic technologies available at the IMB and through existing collaborations overseas. In collaboration with Dr Bento Soares (University of Iowa) we have constructed a library containing all of the genes which are expressed in the first two pairs of pharyngeal arches in the developing mouse embryo. Using an approach designed to eliminate all those genes which are expressed in all or most tissues of the body and play a general role in the body's metabolism, we will select for those genes which play a specific and important role in embryonic development. We will then isolate the human counterparts of these genes and more thoroughly investigate their role in embryonic development and disease."},"children":[{"color":"#336699","name":"A/Pr Carol Wicking","data":{"first_name":"Carol","title":"A/Pr","dw_individual_id":"DW0028805","middle_name":"A","last_name":"Wicking","source_individual_id":"RMIS2473798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Carol Wicking"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84461","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2309","size":1},{"color":"#FF4D4D","name":"Central control of stress-induced changes in immune function.","data":{"media_summary":"","end_year":2003,"keywords":["Hypothalamic-pituitary-adrenal axis","Infection","Neuroendocrinology","Neuroimmune interactions","Stress"],"nhmrc_grant_id":142990,"application_year":2000,"health_keywords":["Brain pathways mediating stress and immune interactions","Effects of stress on infection","Neural substrates for therapeutic intervention of stress","Psychological stress"],"scientific_title":"Central control of stress-induced changes in immune function.","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Kathryn Buller","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142990","simplified_title":"How stress can make you sick.","sub_type":"Standard Project Grant","total_budget":"411724.12","source_system":"LONG-TERM STRESS CAN ALTER OUR BRAIN'S ATTEMPTS TO FIGHT INFECTION Long-term stress is often blamed for causing illness but precisely how this occurs is now only beginning to be realised. It is especially disturbing that long-term stress can increase one's susceptibility to infections. Stress can alter the way our brain can help deal with assaults by bacteria and viruses. Normally, at the start of an infection, we release a hormone called cortisol from our adrenal glands. A low level of cortisol in our body is beneficial because it can prevent the infection from taking hold in our body and spreading. However if we are chronically stressed our brains tell the adrenal glands to secrete excessive amounts of cortisol over long periods of time and this imbalance can actually hinder the ability of one's immune system to fight an infection. The unfortunate consequence is that the infection is more likely to win the battle and spread to cause further havoc. The present study will identify which areas of the brain are important in driving the secretion of cortisol during infection and how long-term stress can influence those areas. Because we might be exposed to long-term psychological stress that is repeated regularly or irregularly we will determine which pattern of stress has the greatest effect. An investigation into how the brain operates during long-term stress and infection will help us develop ways to prevent stress from disrupting our immune systems."},"children":[{"color":"#336699","name":"Dr Kathryn Buller","data":{"first_name":"Kathryn","title":"Dr","dw_individual_id":"DW0006311","middle_name":"Marie","last_name":"Buller","source_individual_id":"5013676","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Kathryn Buller"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78421","size":1},{"color":"#336699","name":"Prof Trevor Day","data":{"first_name":"Trevor","title":"Prof","dw_individual_id":"DW0001209","middle_name":"A","last_name":"Day","source_individual_id":"5014239","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Trevor Day"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76996","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2308","size":1},{"color":"#FF4D4D","name":"Functional analysis of human MC1R polymorphisms in directing melanocyte phenotype","data":{"media_summary":"Skin colour","end_year":2003,"keywords":["G-protein coupled receptors","Melanocortin-1 receptor","Melanocyte","Pigmentation","Tyrosinase"],"nhmrc_grant_id":142988,"application_year":2000,"health_keywords":["Freckles","Hair colour","Melanoma","Moles","Skin colour"],"scientific_title":"Functional analysis of human MC1R polymorphisms in directing melanocyte phenotype","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"A/Pr Richard Sturm","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142988","simplified_title":"Role of MC1R gene polymorphisms in human pigmentation","sub_type":"Standard Project Grant","total_budget":"361527.54","source_system":"Sunsmart campaigns are a unifying element in the lives of many Australians who wish to ensure protection against the damaging effects of ultraviolet rays in sunlight. Indeed, Australians have the highest incidence of UV-induced melanoma in the world. Although it is evident that lighter skin colours are more susceptible to sun damage, the relationship between sun exposure, skin type and melanoma formation is less clear. An essential first step in understanding the complex interactions that give rise to melanoma, and in identifying individuals that have a high susceptibility, is to reduce phenotypic analyses to genotypic classifications. As pigmentation phenotype is a factor of central importance in determining an individuals risk for melanoma, characterisation of the genes underlying the physical qualities of human eye, hair and skin colour will give a more direct and accurate genotypic assessment of risk. Results from an epidemiology study of melanoma patients in Queensland have identified a number of genetic changes within the melanocyte stimulating hormone receptor (MC1R) gene that associate with skin, hair and eye colour as well as with incidence of melanoma. Further investigation of MC1R gene alleles which segregate with skin and hair colours will provide the beginning for a whole new genotype-based classification of skin colour and melanoma risk, and will significantly contribute to our understanding of what makes some individuals highly susceptible to melanoma while others are not. Indeed, MC1R polymorphisms may numerically be the most important melanoma predisposition gene yet identified, exerting its effects as one of those common genes of small effect which may account for much more of the case load in melanoma than rarer genes of large effect. Studies such as this will enable powerful genotyping methods to be employed in identification of those individuals at highest risk for melanoma and other skin cancers."},"children":[{"color":"#336699","name":"A/Pr Richard Sturm","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0045672","middle_name":"Alan","last_name":"Sturm","source_individual_id":"5017777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Sturm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88811","size":1},{"color":"#336699","name":"A/Pr Neil Box","data":{"first_name":"Neil","title":"A/Pr","dw_individual_id":"DW0011937","middle_name":"","last_name":"Box","source_individual_id":"RMIS450565","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Neil Box"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79937","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2307","size":1},{"color":"#FF4D4D","name":"Molecular analyses of flavivirus RNA replication, encapsidation, and complementation","data":{"media_summary":"","end_year":2003,"keywords":["Complementation of defective viral RNAs","Flavivirus RNA replication using Kunjin virus as a model","Flavivirus replication complex","Protein-protein and protein-RNA interactions","RNA encapsidation"],"nhmrc_grant_id":142983,"application_year":2000,"health_keywords":["Australian encephalitis and related flavivirus infections","Targets for design of antiviral therapies","Virus replication"],"scientific_title":"Molecular analyses of flavivirus RNA replication, encapsidation, and complementation","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142983","simplified_title":"Analyses of how flavivirus RNA is amplified and assembled into infectious virus","sub_type":"Standard Project with Research Fellowship","total_budget":"602545.9","source_system":"Flaviviruses are the agents of many mosquito-transmitted infections such as encephalitis and dengue. Hepatitis C virus is a member of the same virus family. Using Australian flavivirus Kunjin as a model and advanced techniques in molecular biology, biochemistry and electron micriscopy, the Flavivirus Research Unit at SASVRC has established itself as an international leader in the area of flavivirus RNA replication and ultrastructure of virus-infected cells. The objectives of this application are to advance further our understanding of how the flavivirus RNA replication complex is assembled, how it synthesizes RNA and how this RNA is specifically packaged to produce infectious virus. To achieve these goals we will employ state-of-the-art molecular biology techniques based on manipulations with infectious complementary DNA copy of Kunjin virus RNA. The intimate understanding of these mechanisms in flavivirus replication should facilitate the design of efficient antiviral drugs by specifically targeting unique events in RNA replication and-or packaging. This may assist in the development of antiviral drugs for treatment of infections caused by other higly pathogenic flaviviruses in Australia, such as dengue, Japanese encephalitis and Murray Valley encephalitis, as well as of the related heptitis C virus."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2306","size":1},{"color":"#FF4D4D","name":"Effect of prostaglandin E2 on the periodontium and alveolar bone formation","data":{"media_summary":"","end_year":2003,"keywords":["Alveolar bone","Insulin-like growth factor-1","Periodontal disease","Prostaglandin E2","Transforming growth factor beta 1"],"nhmrc_grant_id":142979,"application_year":2000,"health_keywords":["Alveolar bone and cementum formation","Developing therapy for periodontitis and bone loss","Periodontal disease"],"scientific_title":"Effect of prostaglandin E2 on the periodontium and alveolar bone formation","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Dentistry not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"DENTISTRY","cia_name":"Dr Anne Symons","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142979","simplified_title":"Role of prostaglandin E2 on the hard and soft tissues which support tooth roots in the jaws","sub_type":"Standard Project Grant","total_budget":"211527.54","source_system":"Dental disease affecting the supporting structures of teeth (the periodontium), is prevalent in our society. Periodontal disease results in destruction of bone around teeth, loosening of teeth, compromised chewing function, and tooth loss. Over the last twenty years reports into the effects of prostaglandin E2 (PGE2) on the skeleton have been divided and controversial. While historically PGE2 has been reported to promote bone resorption, more recently it has been demonstrated that when PGE is placed in contact with mandibular bone, adjacent to erupted teeth, new bone and cementum formation occurs. The ability of PGE2 to induce new bone formation indicates a potential use for PGE2 in the management of bone loss associated with periodontal diseases, and the formation of new bone around dental implants, and around teeth following orthodontic movement. Growth factors are active in healing and have valuable applications in augmenting wound repair. Osseous and dental tissues are rich in growth factors, and these factors are involved with the regulation of bone metabolism as well as tissue repair, thus the action of PGE2 on the periodontium is most likely regulated via these factors. Since regeneration of the periodontium is a fundamental goal of dentistry, any treatment which leads to predictable formation of new connective tissues and their long term stability would be a major clinical advance."},"children":[{"color":"#336699","name":"Prof Laurence Walsh","data":{"first_name":"Laurence","title":"Prof","dw_individual_id":"DW0040305","middle_name":"J","last_name":"Walsh","source_individual_id":"RMIS12116","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Laurence Walsh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87441","size":1},{"color":"#336699","name":"Dr Anne Symons","data":{"first_name":"Anne","title":"Dr","dw_individual_id":"DW0039972","middle_name":"L","last_name":"Symons","source_individual_id":"RMIS12110","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Anne Symons"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87357","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2305","size":1},{"color":"#FF4D4D","name":"Genomic and proteomic dissection of the molecular basis of kidney development.","data":{"media_summary":"renal disease","end_year":2003,"keywords":["Wilms' tumour suppressor protein","developmental genetics","gene regulation","kidney development","molecular biology"],"nhmrc_grant_id":142978,"application_year":2000,"health_keywords":["Denys Drash syndrome","Wilms' tumour","mesangial sclerosis","nephron endowment","renal disease"],"scientific_title":"Genomic and proteomic dissection of the molecular basis of kidney development.","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142978","simplified_title":"Finding out what genes give you a kidney","sub_type":"Standard Project Grant","total_budget":"454582.62","source_system":"The number of nephrons present in the human adult kidney can vary by threefold. This is likely to be due to slight variations in the rate of nephron formation during development. Evidence is mounting that a reduced number of nephrons can predispose to renal failure later in life in response to stresses such as hypertension or substance abuse. 80,000 new cases of end stage renal failure occur each year in the US, with 25% of these related to hypertension and therefore possibly linked to a low nephron number. While it is known that the kidney arises through a series of reciprocal inductive events between the metanephric mesenchyme and the ureteric bud, a better understanding of the molecular basis of these events is needed to understand what dictates nephron endowment. The Wilms tumour suppressor protein WT1 is not only mutated in some cases of the childhood kidney cancer, Wilms tumour, but is also critical for the normal development of the metanephros, as demonstrated by knockout experiments in mice. One of the earliest genes expressed in the metanephric mesenchyme, WT1 is thought to prevent this tissue from dying before differentiation, directing it to form the kidney and, postnatally, regulating normal podocyte function. Although known to be a nuclear regulatory protein, the genes directly regulated by WT1 have not been clearly or convincingly delineated. This study aims to directly screen for changes to gene expression and protein production levels induced by WT1. To do so, an array approach unique in its use of a specific array set derived from developing kidney will be used. In concert, additional specific clone sets derived from mouse kidney prior and post the commencement of nephron formation will be constructed and analysed. As WT1 is a nuclear protein involved in splicing, this study will involve a parallel investigation at a proteomic level of changes in spliceosomal proteins in response to changes in WT1."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2304","size":1},{"color":"#FF4D4D","name":"The role of Crim-1 in lens development and eye disease.","data":{"media_summary":"nuclear sclerosis of the lens","end_year":2003,"keywords":["TGFbeta superfamily members","developmental genetics","lens development","molecular biology","transgenesis and gene knockouts"],"nhmrc_grant_id":142977,"application_year":2000,"health_keywords":["aftercataract","cataracts","eye disease","lens development","nuclear sclerosis of the lens"],"scientific_title":"The role of Crim-1 in lens development and eye disease.","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Ophthalmology and Vision Science","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142977","simplified_title":"The role of a novel gene in diseases of the lens","sub_type":"Standard Project Grant","total_budget":"196527.54","source_system":"We have recently isolated a novel gene (Crim1) and shown it to be strongly expressed during eye development. Its protein structure indicates that it may act to regulate the activities of two growth factor families, the TGF superfamily and the insulin-IGFs. These growth factors effect the behaviour of many cell types that influence events in normal and pathological development. For example in the eye lens, TGF 1 can induce cataractous changes in epithelial cells and early differentiating fibres; however, TGF signalling appears to be required for events in late stages of fibre cell maturation. Cataract is the leading cause of blindness and arises when lens cell architecture is disrupted and-or proteins aggregate abnormally. In humans, following ocular trauma, eye surgery, or in association with other diseases, cataracts can develop. These cataracts feature the development of subcapsular fibrotic plaques which obscure vision. We have shown that lenses cultured in the presence of TGF can mimic production of these plaques suggesting that these cataracts result from inappropriate activation of TGF . TGF is expressed in the lens and is abundant in the ocular media that bathes the lens. Thus, it appears that complex regulation of TGF bioavailability is required; epithelial cells and young fibre cells need to be protected from its cataractogenic effects, whereas older fibres require TGF signalling for maturation and-or survival. The expression pattern of Crim1 in the lens is consistent with it having a key role in inhibiting TGF in the lens. Thus, we hypothesise that Crim1 plays important roles in the lens, possibly via the modulation of members of the TGF superfamily and insulin-IGFs. We predict that Crim1 acts to maintain the lens epithelial phenotype and facilitate events in early fibre differentiation. If so, this may have implications for devising molecular strategies for preventing or slowing diseases, such as the various forms of human cataract."},"children":[{"color":"#336699","name":"Prof Frank Lovicu","data":{"first_name":"Frank","title":"Prof","dw_individual_id":"DW0043889","middle_name":"James","last_name":"Lovicu","source_individual_id":"5016055","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Frank Lovicu"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88374","size":1},{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1},{"color":"#336699","name":"Prof Johnston Mcavoy","data":{"first_name":"Johnston","title":"Prof","dw_individual_id":"DW0008972","middle_name":"William","last_name":"Mcavoy","source_individual_id":"RMIS3721859","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Johnston Mcavoy"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79132","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2303","size":1},{"color":"#FF4D4D","name":"Structure-function analysis of nuclear receptor and cofactor action: evidence for a role in muscle.","data":{"media_summary":"Rhabdomyosarcoma","end_year":2005,"keywords":["Differentiation","Nuclear Receptor Coactivators and Corepressors","Protein-Protein Interactions","Structure-Function Analysis of Nuclear Receptors","Transcriptional Coregulators and Development"],"nhmrc_grant_id":142971,"application_year":2000,"health_keywords":["Basic Science","Biological Sciences","Endocrine disorders","Myopathy","Rhabdomyosarcoma"],"scientific_title":"Structure-function analysis of nuclear receptor and cofactor action: evidence for a role in muscle.","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142971","simplified_title":"Hormonal Control of Muscle Differentiation","sub_type":"Standard Project with Research Fellowship","total_budget":"692040.16","source_system":"Hormone receptors have critical roles in almost all aspects of physiology by transducing the effects of hormones into metabolic responses. There are ~45 orphan hormone receptors encoded by distinct genes in humans, since all receptors are important in the treatment of human disease, the plethora of orphan receptors has been the catalyst for the development of a new paradigm, reverse endocrinology. Reverse endocrinology is the process whereby the orphan hormone receptor is used to search for a previously unknown hormone, and metabolic pathway. We are interested in the orphan hormone receptors, Rev-erbA and RVR, orphan members of the receptor superfamily. Rev-erb alpha expression is regulated by fibrates, widely used hypolipidemic drugs, and the circadian cycle. Rev-erbs mediate the regulation of lipid metabolism and peroxisomal beta oxidation. Furthermore, Rev-erbs are acutely induced during brain seizures, postulated to regulate cerebellar plasticity, and involved in growth control. In view of these critical regulatory roles, and the success of reverse endocrinology to date, we intend to complete the structural analysis of the Rev-erb and RVR as a tool to identify the hormone that binds this receptor. Hormone receptors recruit proteins called nuclear receptor cofactors, that function as regulators of gene expression. The cofactors regulate gene expression and development. Furthermore these cofactors, when misregulated result in the onset of disease and carcinogenesis, which underscores the need for achieving a high resolution view of their function in many tissues. Along these lines, we are interested in exmining the function of these cofactors in muscle. Understanding the molecular role of the NR cofactors during muscle differentiation will be a critical step toward elucidating the dysregulation-function of these proteins in muscle diseases, such as rhabdomyosarcoma and inflammatory myopathy that have cofactor deficiency."},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2302","size":1},{"color":"#FF4D4D","name":"Role of the Growth Hormone Binding Protein as a Transcriptional Activator","data":{"media_summary":"","end_year":2003,"keywords":["Hormone signalling","growth hormone","nuclear receptor","nuclear trafficking","transcriptional activation"],"nhmrc_grant_id":142960,"application_year":2000,"health_keywords":["Ageing","Cancer","Dwarfism"],"scientific_title":"Role of the Growth Hormone Binding Protein as a Transcriptional Activator","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael WATERS","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142960","simplified_title":"Gene Activation by the Extracellular Part of the Growth Hormone Receptor","sub_type":"Standard Project Grant","total_budget":"387226.72","source_system":"Growth hormone is an important hormone therapeutic for treating dwarfism. Recently, many new therapeutic applications for growth hormone have been discovered, particularly in relation to its role as an anabolic agent. These include post surgery recovery, enhanced bone fracture healing, Crohns disease, dilated cardiomyopathy, infertility and of course, ageing. This proposal examines a novel way that GH could work, that is by sending the extracellular part of its receptor (GHBP) to the nucleus, where it can directly activate gene readout. This would have the effect of augmenting the normal action of GH to regulate gene readout. We have exciting preliminary data which makes us think this may be a new mechanism for hormone activation of genes. The level of GHBP in the nucleus is regulated, and if a defect in export of the GHBP occurred, this would lead to accumulation of nuclear GHBP and stimulate cell proliferation. This may be important in cancer cell proliferation, since we find nuclear GHBP in cancers."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2301","size":1},{"color":"#FF4D4D","name":"Role of Conformational Change in Activation of the Growth Hormone Receptor","data":{"media_summary":"","end_year":2003,"keywords":["conformational change","cytokine signalling","growth hormone","receptor dimerization","structure-function"],"nhmrc_grant_id":142959,"application_year":2000,"health_keywords":["Ageing","Cancer","Dwarfism","Obesity"],"scientific_title":"Role of Conformational Change in Activation of the Growth Hormone Receptor","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Michael WATERS","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142959","simplified_title":"How Does the Growth Hormone Receptor Initiate Signalling ?","sub_type":"Standard Project Grant","total_budget":"242545.9","source_system":"Growth hormone is an important hormone therapeutic for treating dwarfism. Recently, many new therapeutic applications for growth hormone have been discovered, particularly in relation to its role as an anabolic agent. These include post surgery recovery, enhanced bone fracture healing, Crohns disease, dilated cardiomyopathy, infertility and of course, ageing. This project seeks to find out how growth hormone sends its signal into the target cell through its surface receptor. It is believed that the primary event in signalling is the ability of the hormone to bring two receptors together (receptor dimerization). However, it may be that the receptor already is dimerized, and the role of the hormone is to induce a specific change in shape of the receptor, which transfers the signal of hormone binding into the cell to initiate signalling to the genome. We have good evidence that a specific shape change is required for activation of an important signalling pathway by growth hormone, and the closely structurally related receptor for erythropoietin is already dimerized before hormone binds. We want to find out exactly how the shape change acts, and whether the receptor is predimerized. This information is vital for designing small orally active mimics of growth hormone which could be of great value as an anabolic supplement for the frail elderly."},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2300","size":1},{"color":"#FF4D4D","name":"Prostaglandin G/H synthase-2 (PGHS-2) is a key regulator of skeletal adaptation and remodelling","data":{"media_summary":"","end_year":2003,"keywords":["bone adaptation","bone remodelling","cyclooxygenase-2","fracture healing","mechanical stress"],"nhmrc_grant_id":142958,"application_year":2000,"health_keywords":["age-related skeletal disorders","fracture repair","osteoarthritis","osteoporosis"],"scientific_title":"Prostaglandin G/H synthase-2 (PGHS-2) is a key regulator of skeletal adaptation and remodelling","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Orthopaedics","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Mark Forwood","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142958","simplified_title":"Prostaglandin enzymes mediate normal bone turnover and adaptation.","sub_type":"Standard Project Grant","total_budget":"301018.36","source_system":"Knowledge of the biology underlying bone formation is important for developing novel approaches to stimulate new bone formation in skeletal diseases associated with ageing or disability, or for maintenance of new bone around orthopaedic or dental implants. The discovery that a prostaglandin enzyme (PGHS-2) is a key factor in activity-related bone formation and normal bone turnover, as well as a pharmacological target for reducing inflammation, has considerable clinical significance. Specific inhibition of PGHS-2 by recent anti-inflammatory drugs avoids formation of gastric ulcers, but their influence on normal bone remodelling and fracture repair is not known and must be investigated. Many such inhibitors are in advanced clinical trials, but their effect on bone metabolism has not been published. This project is important because it employs novel experimental models to advance our knowledge of prostaglandin biology in skeletal adaptation, and elucidates important clinical consequences for specific inhibition of PGHS-2 in the skeleton. This project will investigate the regulation of prostaglandin production by PGHS enzymes following mechanical loading in vivo. It will use cell, molecular and histochemical techniques to determine if the genes that regulate the enzymes are influenced by mechanical stimuli, and if they are dependent on other molecules, associated with structural proteins (stress fibres) within the cell. It will investigate if inhibition of PGHS-2 by antiinflammatory drugs or stress-fibre inhibitors, depresses normal bone turnover and healing responses. The outcome of these experiments could indicate new approaches to stimulate bone formation, preserve bone mass, or minimise adverse skeletal effects of anti-inflammatory treatments related to orthopaedic or dental procedures."},"children":[{"color":"#336699","name":"Dr Alan Cassady","data":{"first_name":"Alan","title":"Dr","dw_individual_id":"DW0029837","middle_name":"Ian","last_name":"Cassady","source_individual_id":"RMIS24493","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Alan Cassady"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84725","size":1},{"color":"#336699","name":"Prof Mark Forwood","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0007324","middle_name":"R","last_name":"Forwood","source_individual_id":"RMIS18701","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mark Forwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78676","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2299","size":1},{"color":"#FF4D4D","name":"Manipulation of tubulointerstitial nitric oxide and cytokine","data":{"media_summary":"renal interstitial scarring","end_year":2003,"keywords":["angiotensin II","nitric oxide","progressive chronic renal failure","renal growth factors","tubulointerstitial scarring"],"nhmrc_grant_id":142956,"application_year":2000,"health_keywords":["chronic cyclosporin nephropathy","diabetic nephropathy","ischaemic nephrosclerosis","progressive chronic renal failure","renal interstitial scarring"],"scientific_title":"Manipulation of tubulointerstitial nitric oxide and cytokine","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Johnson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142956","simplified_title":"Preventing chronic kidney failure by blocking multiple factors causing scarring","sub_type":"Standard Project Grant","total_budget":"211527.54","source_system":"Chronic kidney disease affects 1 in 250 people. Unfortunately, effective treatments are not available and so 1500 Australians commence dialysis on an artifical kidney machine every year. The main determinant of chronic kidney failure is scarring and damage to kidney tubules, which in many cases progresses to end-stage kidney failure, even if the original cause of the kidney injury is removed. Kidney scarring and damage appears to be caused by both decreases in protective factors and increases in damaging factors (called cytokines). These different factors interact with each other such that attempts to treat kidney disease by blocking a single type of cytokine is ineffective because of compensation by other cytokines. This project looks at the role of a kidney protective factor called nitric oxide (NO) in preventing scarring in human kidney cells grown in tissue culture. In three different models of human kidney disease, we will specifically focus on how the protective effects of NO are influenced by, and in turn influnce the actions of other cytokines. Armed with the knowledge of how these agents interact with each other, trials will be undertaken to prevent scarring and damage to kidney cells using a combination of agents which will simultaneously increase NO levels and block one or more injurious cytokines. The success of such a combined approach will go a long way towards developing new and effective treatment strategies for people with chronic kidney disease."},"children":[{"color":"#336699","name":"A/Pr Glenda Gobe","data":{"first_name":"Glenda","title":"A/Pr","dw_individual_id":"DW0042655","middle_name":"Carolyn","last_name":"Gobe","source_individual_id":"5012448","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Glenda Gobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88060","size":1},{"color":"#336699","name":"Prof Zoltan Endre","data":{"first_name":"Zoltan","title":"Prof","dw_individual_id":"DW0042272","middle_name":"H","last_name":"Endre","source_individual_id":"RMIS30819","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Zoltan Endre"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87972","size":1},{"color":"#336699","name":"Dr David Vesey","data":{"first_name":"David","title":"Dr","dw_individual_id":"DW0034467","middle_name":"Alan","last_name":"Vesey","source_individual_id":"RMIS387799","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr David Vesey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85922","size":1},{"color":"#336699","name":"Prof David Johnson","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0013969","middle_name":"Wayne","last_name":"Johnson","source_individual_id":"RMIS14680","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Johnson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80471","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2298","size":1},{"color":"#FF4D4D","name":"CTL avidity as a determinant of the mature, antigen-specific immune repertoire","data":{"media_summary":"","end_year":2003,"keywords":["CTL","Cell-mediated immunity","TCR","tetramer technology"],"nhmrc_grant_id":142952,"application_year":2000,"health_keywords":["CTL activation","Cervical Cancer","HPV"],"scientific_title":"CTL avidity as a determinant of the mature, antigen-specific immune repertoire","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Graham Leggatt","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142952","simplified_title":"Controlling CTL avidity","sub_type":"Standard Project Grant","total_budget":"241527.54","source_system":"Killer T lymphocytes are a diverse population which vary in their ability to recognise infected cells. This study aims to determine whether vaccine dose and frequency impact on the generation of highly sensitive killer T cells. This study will improve our basic knowledge of killer T lymphocyte selection during infection and have application to improved methods of vaccination."},"children":[{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1},{"color":"#336699","name":"Dr Graham Leggatt","data":{"first_name":"Graham","title":"Dr","dw_individual_id":"DW0037982","middle_name":"R","last_name":"Leggatt","source_individual_id":"RMIS13401","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Graham Leggatt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86840","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2297","size":1},{"color":"#FF4D4D","name":"Neural Rhythms and Bipolar Disorder","data":{"media_summary":"Suicide Prevention","end_year":2002,"keywords":["Bipolar disorder","Interhemispheric switching","Manic-Depression","Neural rhythms","Perceptual rivalry"],"nhmrc_grant_id":142951,"application_year":2000,"health_keywords":["Depression","Early diagnosis and prevention of bipolar disorder","Early intervention in psychosis","Schizophrenia","Suicide Prevention"],"scientific_title":"Neural Rhythms and Bipolar Disorder","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof John Pettigrew","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142951","simplified_title":"Brain Rhythms and Manic-Depression","sub_type":"Standard Project Grant","total_budget":"98302.09","source_system":"New research with scanning techniques has confirmed older ideas about the complementary functions of the two hemispheres of the human brain. One major contrast between the two hemispheres concerns their cognitive and emotional styles. The left hemisphere plans and confidently smooths over discrepancies that do not fit the plan while the right hemisphere looks at all possibilities and cautiously highlights the discrepancies. This research project studies the switch between the two hemispheres that alternately activates these contrasting, but equally valid, viewpoints. The switch is studied directly by optical recording from animal brains. The switch can also be studied in humans using a recent discovery from our laboratory:- that the perceptual rivalries are mediated by a hemispheric switch mechanism. Perceptual rivalry is a phenomenon where continuous, but ambiguous, stimulation leads to a back-and-forth alternation of complementary percepts, a phenomenon that fascinated Salvador Dali and is featured in many of his paintings. The nature of the perceptual switch during rivalry has been debated for centuries. New experiments link perceptual rivalry to the switch of attention between the hemispheres. Using perceptual rivalry as an indirect way to monitor hemispheric switching in humans, we discovered a remarkable feature. The back-and-forth switching process of perceptual rivalry is significantly slower in subjects with bipolar disorder (manic depression), even when they are between episodes and their mood is normal. The timing of the switching process is very stable in an individual, and appears to be similar in identical twins. The speed of the switch mechanism may therefore be inherited. Altered neural rhythms may underly the predisposition, known to run in familes, from which bipolar disorder can be triggered. The aim of the project is to test these propositions about the basis of this common disorder, affecting 1-2% of the population.."},"children":[{"color":"#336699","name":"John Pettigrew","data":{"first_name":"John","title":"","dw_individual_id":"DW0015559","middle_name":"","last_name":"Pettigrew","source_individual_id":"RMIS31384","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"John Pettigrew"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80922","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2296","size":1},{"color":"#FF4D4D","name":"Modulating retinal glutamate transport in health and disease","data":{"media_summary":"","end_year":2003,"keywords":["Excitotoxicity","Glutamate","Glutamate transporter","Retina"],"nhmrc_grant_id":142943,"application_year":2000,"health_keywords":["Central retinal artery occlusion","Central retinal vein occlusion","Glaucoma","Stroke"],"scientific_title":"Modulating retinal glutamate transport in health and disease","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Nigel Barnett","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142943","simplified_title":"Modulating retinal glutamate transport in health and disease","sub_type":"Standard Project Grant","total_budget":"256527.54","source_system":"Damage can occur to nervous tissues like the retina and brain when there is a reduction in the blood supply. This can occur as a result of a blood clot, stroke or the eye disease, glaucoma. These conditions often result in blindness. Much of the neuronal damage is due to the release of an excess of glutamate. Glutamate is a chemical (neurotransmitter) that nerves use to communicate with each other, but it is toxic to nerves when present at high concentrations. This project will investigate the mechanisms that regulate the concentration of glutamate in the retina. If these mechanisms could be made to work more efficiently, they may prevent the build-up of the glutamate and therefore prevent damage to the nerve cells. Understanding these mechanisms will aid in the development of an effective treatment to prevent blindness when there is a blockage of the blood supply to the retina."},"children":[{"color":"#336699","name":"A/Pr Nigel Barnett","data":{"first_name":"Nigel","title":"A/Pr","dw_individual_id":"DW0011632","middle_name":"L","last_name":"Barnett","source_individual_id":"5013343","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nigel Barnett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79858","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2295","size":1},{"color":"#FF4D4D","name":"Functional characterization of a signaling complex between receptor protein tyrosine phosphatase-k and E-cadherin.","data":{"media_summary":"","end_year":2003,"keywords":["Cell adhesion","Cell signaling","E-cadherin","Receptor tyrosine phosphatase","Tyrosine phosphorylation"],"nhmrc_grant_id":142942,"application_year":2000,"health_keywords":["Breast disease","Cancer biology","Kidney disease","Wound healing"],"scientific_title":"Functional characterization of a signaling complex between receptor protein tyrosine phosphatase-k and E-cadherin.","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Alpha Yap","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142942","simplified_title":"Receptor tyrosine phosphatase-E-cadherin signal complex","sub_type":"Standard Project Grant","total_budget":"227036.72","source_system":"Contact between cells in the body controls many aspects of cellular function, including cell adhesion, cell movenments, and the architecture of organs. These contacts involve many different kinds of molecules, such as adhesion molecules, proteins that link the cell surface to the cytoskeleton, and many signaling molecules that participate in cellular recognition. It has become increasingly clear that these different molecules interact with one another and that these interactions are functionally important. In this proposal we will study the association between a signaling molecule, the receptor tyrosine phosphatase RPTPk, and a cell-cell adhesion molecule, E-cadherin. RPTPk removes phosphate molecules from tyrosines, an important event that controls many signaling processes; E-cadherin is a major adhesion molecule responsible for cell-cell contact and patterning, and whose dysfunction is involved in tumor invasion. My collaborators and I have recently demonstrated that RPTPk and E-cadherin bind to one another, but the function of this association is unclear. I will test the general hypothesis that these molecules form a signaling complex, that can regulate both the activity of RPTPk and the adhesive function of E-cadherin to ultimately control the way in which cells associate with one another. This work will make an important contribution to our understanding of how cells signal to one another, and provide insights into how cell-cell adhesion and recognition may be perturbed in disease conditions, such as tumor progression."},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2294","size":1},{"color":"#FF4D4D","name":"Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial","data":{"media_summary":"","end_year":2002,"keywords":["fetal","obstetrics","operative delivery","oxygen saturation"],"nhmrc_grant_id":142936,"application_year":2000,"health_keywords":["fetal distress","labour","operative delivery","oxygen saturation"],"scientific_title":"Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Obstetrics and Gynaecology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Paul Colditz","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142936","simplified_title":"Trial of fetal pulse oximetry during labour","sub_type":"Standard Project Grant","total_budget":"246001.27","source_system":"Current methods of monitoring the well-being of the unborn baby during labour often result in concern about the unborn baby's health. This leads to delivery by caesarean section, forceps, or vacuum. These babies are usually found to be healthy once born, meaning that the operation was unnecessary. In this study, when an unborn baby appears to be distressed, half of the study participants will be allocated to continue with the current monitoring of the baby's heartbeat. The other half will have a new form of monitoring in labour, fetal oxygen saturation monitoring, added. We will then determine whether the new form of monitoring makes a difference in the number of times women need to have a caesarean section, forceps, or vacuum delivery. It is important to do this research BEFORE the new form of monitoring becomes used routinely. This Australian research is leading the world in letting the health consumer (women) know whether the now monitoring method is effective in practice and ensuring that there are no unforeseen adverse events."},"children":[{"color":"#336699","name":"Prof Fung Yee Chan","data":{"first_name":"Fung Yee","title":"Prof","dw_individual_id":"DW0041537","middle_name":"","last_name":"Chan","source_individual_id":"RMIS194284","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Fung Yee Chan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87778","size":1},{"color":"#336699","name":"Prof Shaun Brennecke","data":{"first_name":"Shaun","title":"Prof","dw_individual_id":"DW0023770","middle_name":"P","last_name":"Brennecke","source_individual_id":"RMIS3360","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Shaun Brennecke"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83105","size":1},{"color":"#336699","name":"Prof Christine East","data":{"first_name":"Christine","title":"Prof","dw_individual_id":"DW0012848","middle_name":"Elizabeth","last_name":"East","source_individual_id":"5014470","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Christine East"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80181","size":1},{"color":"#336699","name":"A/Pr James King","data":{"first_name":"James","title":"A/Pr","dw_individual_id":"DW0008384","middle_name":"","last_name":"King","source_individual_id":"RMIS3017695","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr James King"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78968","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2293","size":1},{"color":"#FF4D4D","name":"The Identification of a Novel NIDDM Susceptibility Gene Localised to Human Chromosome 12q","data":{"media_summary":"","end_year":2003,"keywords":["Linkage analysis","Non-Insulin Dependent Diabetes Mellitus","Positional cloning"],"nhmrc_grant_id":142935,"application_year":2000,"health_keywords":["Genetics of complex diseases","Insulin resistance","Non-Insulin Dependent Diabetes Mellitus"],"scientific_title":"The Identification of a Novel NIDDM Susceptibility Gene Localised to Human Chromosome 12q","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Joanne Shaw","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142935","simplified_title":"Genetics of Adult-Onset Diabetes","sub_type":"Standard Project Grant","total_budget":"438055.08","source_system":"Non-insulin dependent diabetes mellitus (adult-onset diabetes) is very common in Australia and is a major public health problem. It is a leading cause of kidney failure, blindness, heart attacks, strokes and amputations. Over 3% of the Australian population have adult-onset diabetes, and very few Australians have not been touched in some way by the shadow of diabetes. The precise cause of diabetes is unknown, however we do know that it tends to run in families, indicating that an inherited tendency is important. By finding genes which cause diabetes we have the opportunity to unravel much of the mystery of this condition. This research program will find genes which cause diabetes by searching for them in large pedigrees in which many family members are affected by diabetes. Finding the genes which cause diabetes will have a significant impact in at least three major ways. Firstly, it will increase our understanding of the disease process. Secondly, it will be possible to develop tests to identify people at risk of diabetes at a very early stage so that therapy can be introduced and complications averted. Thirdly, it will be possible to develop new and more effective approaches for the prevention and treatment of diabetes."},"children":[{"color":"#336699","name":"A/Pr Joanne Shaw","data":{"first_name":"Joanne","title":"A/Pr","dw_individual_id":"DW0039647","middle_name":"T.E.","last_name":"Shaw","source_individual_id":"RMIS13660","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Joanne Shaw"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87282","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2292","size":1},{"color":"#FF4D4D","name":"Early Identification of Infants Who Will Benefit From Neural Rescue Treatment","data":{"media_summary":"","end_year":2003,"keywords":["cerebral edema","electrical impedance","hypoxic-ischemic encephalopathy","perinatal asphyxia"],"nhmrc_grant_id":142932,"application_year":2000,"health_keywords":["cerebral palsy","neonatal brain injury","neonatal cerebral edema"],"scientific_title":"Early Identification of Infants Who Will Benefit From Neural Rescue Treatment","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Barbara Lingwood","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142932","simplified_title":"Early Detection of Infants With Treatable Brain Injury","sub_type":"Standard Project Grant","total_budget":"206320.45","source_system":"Lack of oxygen supply before, during or immediately after birth can lead to severe disability or death. This occurs in about 1 in every 500 births and is one of the most important but unsolved problems in pediatrics. The costs (financial and other) to both the individuals involved, and the community in general, is very high. However the outlook for those affected by this condition is improving. Recent research has focused on the development of neural rescue therapies, which may decrease the extent of disabilities suffered by these children. The same treatments may also be helpful in children following near drowning and head trauma. Neural rescue therapies must be applied less than 24 hours following the event which has caused the reduction in oxygen supply. Thus, before these treatments can be tested, it is necessary to find a way to quickly tell which babies may benefit from the treatments. This study will trial a new method which is inexpensive and can be used without moving the baby away from its incubator. This technique involves a new application of an established technology to detect the redistribution of water within the brain one of the earliest signs of impending brain cell death. The research team consists of medical personnel from the intensive care nurseries of both the Royal Women's Hospital and the Mater Mother s Hospital, as well as scientific staff experienced in the use of this technology. If this technique is effective, it will enable babies to receive maximum benefit from new treatments and reduce long-term difficulties suffered by these children and their families."},"children":[{"color":"#336699","name":"Dr Barbara Lingwood","data":{"first_name":"Barbara","title":"Dr","dw_individual_id":"DW0043819","middle_name":"Elizabeth","last_name":"Lingwood","source_individual_id":"5016005","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Barbara Lingwood"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88355","size":1},{"color":"#336699","name":"A/Pr Peter Gray","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0042730","middle_name":"Hamilton","last_name":"Gray","source_individual_id":"5014946","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Gray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88078","size":1},{"color":"#336699","name":"A/Pr Leigh Ward","data":{"first_name":"Leigh","title":"A/Pr","dw_individual_id":"DW0034575","middle_name":"C","last_name":"Ward","source_individual_id":"RMIS410070","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Leigh Ward"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85959","size":1},{"color":"#336699","name":"Mr Kimble Dunster","data":{"first_name":"Kimble","title":"Mr","dw_individual_id":"DW0024650","middle_name":"Robert","last_name":"Dunster","source_individual_id":"RMIS410075","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mr Kimble Dunster"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83327","size":1},{"color":"#336699","name":"Prof Paul Colditz","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0006654","middle_name":"Bernard","last_name":"Colditz","source_individual_id":"RMIS23314","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Colditz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78507","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2291","size":1},{"color":"#FF4D4D","name":"Inter-rater reliability and predictive validity of a new functional capacity evaluation for chronic back pain","data":{"media_summary":"workers compensation","end_year":2003,"keywords":["back pain","disability evaluation","inter observer evaluation","predictive value of tests","work capacity evaluation"],"nhmrc_grant_id":142931,"application_year":2000,"health_keywords":["chronic back pain","evaluation for return to work","occupational rehabilitation","work disability","workers compensation"],"scientific_title":"Inter-rater reliability and predictive validity of a new functional capacity evaluation for chronic back pain","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Rehabilitation and Therapy: Occupational and Physical","research_area":"Public Health","for_category":"CLINICAL SCIENCES","cia_name":"Prof Jenny Strong","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142931","simplified_title":"Consistency and predictive value of recommendations made from functional capacity evaluation on clients with back pain","sub_type":"Standard Project Grant","total_budget":"105794.18","source_system":"Back pain costs the Australian community tens of billions of dollars. Back pain is one of the main causes of work injury and lost time from work. The longer a person is off work, the harder it is to get them back to work. Workers' compensation systems around Australia aim at getting the injured worker with back pain back to work as soon as possible. One of the difficulties in this process is determining what the person with back pain can physically do in the workplace. An evaluation technique, called functional capacity evaluation (known as FCE), is one method used to find out what the person with back pain physically can and cannot do. In a FCE, a trained health professional such as an occupational therapist, observes the person performing a range of physical activities like the ones he or she may have to perform in a job. The therapist closely observes the person performing activities such as lifting, carrying, kneeling, crouching, balancing, and walking and notes any limitations in the person's ability to complete the activities. The therapist makes comments about what difficulties the person may have on the job and recommendations about how these could be reduced or eliminated. The information gained from these evaluations can be valuable for the treating doctor in deciding whether the person is ready to go back to work and what duties the person can and cannot do on the job. Because of such value they provide, FCE is commonly used in rehabilitation programs endorsed by workers' compensation systems around Australia. This widespread use and endorsement of FCE occurs despite limited research on the soundness of the ratings made from these evaluations. There is a need to see whether recommendations made from FCEs are consistent between therapists (i.e. reliable) and to see if the FCE accurately predicts the person's physical capacity for work. This research will examine these issues with injured workers with back pain."},"children":[{"color":"#336699","name":"Ms Elizabeth Gibson","data":{"first_name":"Elizabeth","title":"Ms","dw_individual_id":"DW0030880","middle_name":"A","last_name":"Gibson","source_individual_id":"RMIS22367","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Elizabeth Gibson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85005","size":1},{"color":"#336699","name":"Dr Heather Podlich","data":{"first_name":"Heather","title":"Dr","dw_individual_id":"DW0015623","middle_name":"M","last_name":"Podlich","source_individual_id":"RMIS409586","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Heather Podlich"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80941","size":1},{"color":"#336699","name":"Prof Jenny Strong","data":{"first_name":"Jenny","title":"Prof","dw_individual_id":"DW0010483","middle_name":"-","last_name":"Strong","source_individual_id":"RMIS22364","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jenny Strong"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79549","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2290","size":1},{"color":"#FF4D4D","name":"G2 phase cdk2/cyclin A co-ordinates multiple pathways in G2/M progression","data":{"media_summary":"","end_year":2003,"keywords":["G2 checkpoint control","cell cycle regulation","mitosis","protein kinase pathways"],"nhmrc_grant_id":142923,"application_year":2000,"health_keywords":["cancer","chemotherapy","hyperproliferative diseases"],"scientific_title":"G2 phase cdk2/cyclin A co-ordinates multiple pathways in G2/M progression","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Brian Gabrielli","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142923","simplified_title":"Co-ordination of mutliple signals involved in cell division","sub_type":"Standard Project Grant","total_budget":"302036.72","source_system":"Cell growth is a tightly regulated process that ensures the exact duplication of the entire genomic DNA followed by division of the cell into two identical daughter cells. If this strict ordering of events is in any way disrupted, the resultant daughter cells would have a different complement of DNA from their parent cell, essentially mutant cells. The cell has established a mechanism to ensure the correct ordering of these crucial events, known as the cell cycle, and mechanisms that can respond to disruptions in this ordering and halt the normal cell cycle mechanism until the fault is rectified. These are the checkpoint controls. Checkpoint controls also respond to environmental stresses such as toxins that can damage the DNA to produce mutations. In diseases such as cancer, these checkpoint mechanisms are often faulty, allowing the cells to accumulate DNA mutations which can ultimately result in the cells becoming the aggresive, malignant tumours associated with the worst forms of this disease. Thus a detailed understanding of the cellular mechanisms involved in normal cell cycle and checkpoint control is important in not only defining the causes of these diseases at a molecular level, but may ultimately provide molecular targets for drugs that specifically destroy cancer cells by targeting the faulty checkpoint control. This proposal will investigate one component of the cell cycle mechanism, cdk2-cyclin A, which also has a major role in checkpoint control, to determine its exact role in both these important cellular growth controls."},"children":[{"color":"#336699","name":"A/Pr Brian Gabrielli","data":{"first_name":"Brian","title":"A/Pr","dw_individual_id":"DW0007391","middle_name":"G","last_name":"Gabrielli","source_individual_id":"5014734","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Brian Gabrielli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78693","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2289","size":1},{"color":"#FF4D4D","name":"Molecular and cellular mechanisms of axon growth and guidance in the vertebrate nervous system","data":{"media_summary":"","end_year":2003,"keywords":["axon growth","axon guidance","axon tracts","development","growth cone"],"nhmrc_grant_id":142919,"application_year":2000,"health_keywords":["brain disease","brain lesion","nerve regeneration"],"scientific_title":"Molecular and cellular mechanisms of axon growth and guidance in the vertebrate nervous system","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Brian Key","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142919","simplified_title":"Axon growth in embryos","sub_type":"Standard Project Grant","total_budget":"467545.9","source_system":"There are millions of nerve cells in the vertebrate brain, each forming very precise and specific connections within neural circuits. During development of the embryo most of these cells are wired together. A Telstra technician will use the different colours of telephone cables to correctly connect them. Likewise, the growing processes of nerve cells in the brain use specific markers or labels as cues to establish the correct wiring. The aim of the present project is to characterize the specific role of some of these labels on nerve cells during development. This project will provide new fundamental knowledge about how brain cells are wired together during development of the embryo. This knowledge is essential for establishing strategies to enhance repair of brain cells following ischemic, excitotoxic or mechanical injury."},"children":[{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2288","size":1},{"color":"#FF4D4D","name":"Targeted delivery by topical application","data":{"media_summary":"transdermal kinetics","end_year":2005,"keywords":["drug targeting","skin permeability","skin risk assessment","topical drug delivery","transdermal delivery"],"nhmrc_grant_id":142914,"application_year":2000,"health_keywords":["drug delivery system design","formulation optimisation","skin permeability","topical absorption risk assessment","transdermal kinetics"],"scientific_title":"Targeted delivery by topical application","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmaceutical Sciences and Pharmacy","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Michael Roberts","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142914","simplified_title":"Topical drug delivery","sub_type":"Standard Project with Research Fellowship","total_budget":"815902.72","source_system":"Drugs are applied to the skin for the treatment of a wide range of conditions including both local (inflammation, pain, eczema, psoriasis) and systemic (angina, nicotine withdrawl, hormone replacement therapy) therapies. Unwanted skin absorption also occurs following exposure to environmental and occupational chemicals, including those applied deliberately to the skin such as insectisides, sunscreens and cosmetics. This study seeks to examine the relationship between the chemical structure of agents, the types of formulations in which they are applied and their penetration into the various layers of the skin and underlying tissues. We intend to further our research into important areas relating to the ability to predict the likely behaviour of a solute which comes into contact with the skin from the aspect of optimising both topical drug delivery systems and risk assessment procedures. We will also be examining techniques of facilitating drug transport through the skin using (i) the knowledge gained of the mechanisms by which vehicles act on the skin, (ii) the synthesis of ester and amide lipophilic prodrugs and (iii) physical techniques such as iontophoresis, whereby small electrical currents are applied to charged drug species on the outside of the skin."},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2287","size":1},{"color":"#FF4D4D","name":"Kunjin virus replicon-based vaccine vectors: new developments and applications","data":{"media_summary":"","end_year":2003,"keywords":["Chimeric fowlpox-Kujnin replicon vaccine vectors","Kunjin virus replicon-based vaccine vectors","Recombinant Kunjin virus-like particles","Respiratory synsytial virus vaccine"],"nhmrc_grant_id":142911,"application_year":2000,"health_keywords":["Antiviral immunity","Respiratory syncytial virus vaccine","Vaccine vectors"],"scientific_title":"Kunjin virus replicon-based vaccine vectors: new developments and applications","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Alexander Khromykh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142911","simplified_title":"Development of novel vaccine vectors based on self-replicating RNA of the flavivirus Kunjin","sub_type":"Standard Project Grant","total_budget":"227036.72","source_system":"The project is aimed towards further development of a unique gene expression and delivery system based on self-replicating RNA (replicon) of the nonvirulent Australian flavivirus Kunjin (KUN). A number of improvements in the design of KUN replicon vectors aimed to increase their efficiency and to optimize them for production of heterologous gene products with desired terminal sequences are proposed. Also proposed are improvements in the current KUN replicon packaging system and development of new packaging systems for production of large amounts of virus-like particles (VLPs) containing KUN replicon RNA enclosed in KUN coat proteins for use as potential vaccines. The vaccine potentials of the curent and newly developed KUN vectors and VLPs will be evaluated in mice using respiratory syncytial virus as a model. An entirely new direction proposed in this application is generation of chimeric fowlpox virus-KUN replicon vectors which will combine the advantages of both systems and may result in the generation of an ultimate vaccine vector."},"children":[{"color":"#336699","name":"Prof Alexander Khromykh","data":{"first_name":"Alexander","title":"Prof","dw_individual_id":"DW0043491","middle_name":"A","last_name":"Khromykh","source_individual_id":"RMIS12877","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Alexander Khromykh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88276","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2286","size":1},{"color":"#FF4D4D","name":"E2F inhibitors as anticancer agents for squamous cell carcinoma","data":{"media_summary":"","end_year":2003,"keywords":["cell cycle regulators","epithelial growth and differentiation","neoplastic development","squamous carcinoma development"],"nhmrc_grant_id":142906,"application_year":2000,"health_keywords":["Head and neck cancers","developmental therapeutics","skin cancers","squamous carcinoma"],"scientific_title":"E2F inhibitors as anticancer agents for squamous cell carcinoma","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Nicholas Saunders","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142906","simplified_title":"development of novel anticancer agents","sub_type":"Standard Project Grant","total_budget":"257036.72","source_system":"Squamous cell carcinoma of the head and neck is one of the six most frequent causes of cancer death worldwide. these tumours are currently treated with surgery, radiotherapy and chemotherapy. Although these treatments are associated with a five year survival rate of between 40% and 60% there is a critical need for more effective and less destructive treatments. In this application we will extend on our earlier work in which we identified the protein E2F1 as being a major contributor to tumour development. In normal cells, E2F1 is required for the regulated growth of head and neck cells. However, we found that in head and neck tumours, E2F1 is overactive and contributes to the dergulated growth of the tumour. In this project we will test our newly developed inhibitors of E2F1 on various tumour cells derived from head and neck cancers to see how effective they are at stopping tumour cell growth. Furthermore we will test these compounds in animal models of head and neck cancer to determine whether they will be useful therapeutic agents for treatment of human cancer. Early results on tumour cell lines look very promising."},"children":[{"color":"#336699","name":"A/Pr Nicholas Saunders","data":{"first_name":"Nicholas","title":"A/Pr","dw_individual_id":"DW0021953","middle_name":"A","last_name":"Saunders","source_individual_id":"5017363","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nicholas Saunders"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82651","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2285","size":1},{"color":"#FF4D4D","name":"Peripheral mechanims of analgesia in inflammatory pain","data":{"media_summary":"","end_year":2003,"keywords":["Endorphin","Opioid Pharmacology","POMC","Pain","Peripheral Analgesia"],"nhmrc_grant_id":142905,"application_year":2000,"health_keywords":["aids","immunosuppression","pain"],"scientific_title":"Peripheral mechanims of analgesia in inflammatory pain","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Peter Cabot","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142905","simplified_title":"Peripheral mechanisms of analgesia","sub_type":"New Investigator Grant","total_budget":"181018.36","source_system":"This proposal will explore for the first time the interaction between the peripheral nervous system and the immune system and the effect on pain. Our preliminary studies highlight the direct interaction between the immune system and the nervous system as having an integral role in the control of pain in inflammation. Indeed these studies emphasis the impact of a compromised immune system on this inflammatory pain."},"children":[{"color":"#336699","name":"Dr Peter Cabot","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0012135","middle_name":"John","last_name":"Cabot","source_individual_id":"RMIS21604","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Peter Cabot"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79981","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2284","size":1},{"color":"#FF4D4D","name":"A Phase 1b trial of specific immunotherapy for recurrent respiratory papillomatosis","data":{"media_summary":"","end_year":2002,"keywords":["immunotherapy","papillomavirus","therapy","vaccines","warts"],"nhmrc_grant_id":142902,"application_year":2000,"health_keywords":["papillomavirus infection","respiratory papillomatosis","warts"],"scientific_title":"A Phase 1b trial of specific immunotherapy for recurrent respiratory papillomatosis","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Ian Frazer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/142902","simplified_title":"Treating warts with a vaccine","sub_type":"Standard Project Grant","total_budget":"141208.36","source_system":"This project will determine whether immunisation can be used to effectively treat an existing infection. To date, immunisation has only been used to prevent infection, but there are many chronic infections where intervention might help the body's defences to to a better job and clear the chronic infection. In this study, we will work out whether this approach can be applied to a virus infection ( papillomavirus) which is associated with cancer. We will test immunisation against a chronic and lifethreatening disorder in which warts grow in the respirarory tract, as there is currently no satisfactory treatment for this. If the project is successful we may also learn which blood tests are likely to predict the outcome of immunisation to treat infection."},"children":[{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2283","size":1},{"color":"#FF4D4D","name":"Travelling award for Research Training Scholarship","data":{"media_summary":"","end_year":2002,"keywords":["Effectiveness","Health environment","Health management","Teamwork","personal construct theory / psychology"],"nhmrc_grant_id":7203,"application_year":2000,"start_year":2002,"scientific_title":"Travelling award for Research Training Scholarship","node_source":"NHMRC","node_type":"Grant","field_of_research":"Health and Community Services","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Ms Sharon Mickan","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/7203","simplified_title":"Travelling award for Research Training Scholarship","sub_type":"Travelling Award for Research Training - Scholarship","total_budget":"7300","source_system":""},"children":[{"color":"#336699","name":"Ms Sharon Mickan","data":{"first_name":"Sharon","title":"Ms","dw_individual_id":"DW0014983","middle_name":"M","last_name":"Mickan","source_individual_id":"RMIS705930","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Sharon Mickan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80759","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2152","size":1},{"color":"#FF4D4D","name":"Cellular and molecular mechanisms of development and regeneration in the olfactory system","data":{"media_summary":"","end_year":2002,"keywords":["axon guidance","cell adhesion molecules","development","regeneration"],"nhmrc_grant_id":114169,"application_year":1999,"health_keywords":["neuronal disease","neuronal injury","spinal cord injury"],"scientific_title":"Cellular and molecular mechanisms of development and regeneration in the olfactory system","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Brian Key","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/114169","simplified_title":"Development of the olfactory nervous system","sub_type":"Standard Project Grant","total_budget":"345773.25","source_system":"During development of the fetal brain, cells are wired together. The correct wiring patterns are essential for normal function of the brain. Growth and formation of new connections decreases after birth. For this reason, the repair of the damaged adult nervous system is limited. However, there is one region in the nervous system that exhibits continual growth and repair throughout life. This is the nerve that is responsible for smell and connects the nose to the brain. The aim of this study is to identify the processes that permit continual growth within this region of the nervous system."},"children":[{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/2006","size":1},{"color":"#FF4D4D","name":"The role of cholesterol in patched/hedgehog signalling during mammalian development.","data":{"media_summary":"","end_year":2002,"keywords":["Caveolae","Cholesterol homeostasis","Immunofluorescence and electron microscopy","Patched/hedgehog signalling","Protein localisation"],"nhmrc_grant_id":102610,"application_year":1999,"health_keywords":["Basal cell carcinoma","Holoprosencephaly","Naevoid basal cell carcinoma syndrome","Smith-Lemli Opitz syndrome"],"scientific_title":"The role of cholesterol in patched/hedgehog signalling during mammalian development.","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Carol Wicking","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102610","simplified_title":"The role of cholesterol in development of the mammalian embryo.","sub_type":"Standard Project Grant","total_budget":"198660.01","source_system":"Fluctuations in levels of cholesterol during development of the mammalian embryo have been shown to have catastrophic affects leading to gross deformities particularly in terms of brain and facial development. The requirement of the developing embryo for cholesterol has been linked to the patched-hedgehog signalling pathway which we have previously shown to be central to mammalian development as well as tumour formation. In particular, the patched protein which is responsible for regulating signalling through this complex cascade of protein interactions has a domain similar to that which in other proteins has been shown to detect and respond to intracellular levels of cholesterol. The patched protein binds to hedgehog at the surface of the cell and mediates the transduction of the the hedgehog signal into the cell. By analogy to the role of sterol sensing domains in other proteins, we hypothesise that this domain in patched detects fluctuations in intracellular cholesterol levels which in turn alter trafficking of patched to the cell surface where it can participate in the hedgehog receptor complex. This hypothesis is supported by our preliminary data which suggests that patched is normally localised both at the cell surface and intracellularly. We are proposing a series of experiments to test our hypothesis, most of which deal with determing the localisation of patched in a cell culure system exposed to agents aimed at varying the intracellular levels of cholesterol. Subcellular localisation of patched will be analysed by immunofluorescence, electron microscopy and immunoblotting analysis. We will also test the ability of patched to aggregate at the cell surface with other molecules important in receiving and sending the hedgehog signal. The experiments in this proposal are likely to give the first clues as to the function of the sterol sensing domain in patched and its role in mediating the vital link between cholesterol and embryonic development."},"children":[{"color":"#336699","name":"A/Pr Carol Wicking","data":{"first_name":"Carol","title":"A/Pr","dw_individual_id":"DW0028805","middle_name":"A","last_name":"Wicking","source_individual_id":"RMIS2473798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Carol Wicking"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84461","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1779","size":1},{"color":"#FF4D4D","name":"Neuroendocrine functions of PrRP, a novel hypothalamic peptide","data":{"media_summary":"","end_year":2002,"keywords":["Prolactin-releasing peptide","hypothalamus","luteinising hormone","pituitary gland","prolactin"],"nhmrc_grant_id":102607,"application_year":1999,"health_keywords":["amenorrhoea","hyperprolactinaemia","hypogonadotrophic hypogonadism"],"scientific_title":"Neuroendocrine functions of PrRP, a novel hypothalamic peptide","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Jon Curlewis","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102607","simplified_title":"A new hormone produced by the brain","sub_type":"Standard Project Grant","total_budget":"183928.12","source_system":"This project investigates the role of a newly discovered chemical (peptide) that is found in a part of the brain called the hypothalamus which regulates the activity of the pituitary gland. The hypothalamus and pituitary gland work together to control many of the body?s essential processes such as growth, metabolism and reproduction. Some human diseases are caused by abnormalities of the hypothalamus and pituitary gland while many other diseases affect the functions of these glands, leading to widespread complications such as weight loss, wasting, abnormal immune responses, infertility or failure of lactation. While many of the hormones and chemicals of the hypothalamus and pituitary gland have been extensively studied, recent advances in molecular biology have led to the discovery of new chemicals that may have important regulatory functions. One of these newly discovered substances which was named Prolactin-Releasing Peptide or PrRP is the topic of this project. PrRP will be tested in a series of experiments in animals in order to determine how important it is in regulating the pituitary gland, particularly in stress and during lactation which are conditions when PrRP could be secreted. It is hoped that this research will lead to a more detailed understanding of how the reproductive and endocrine system are controlled in humans and to new methods for the manipulation of these systems under normal and disease conditions."},"children":[{"color":"#336699","name":"Jon Curlewis","data":{"first_name":"Jon","title":"","dw_individual_id":"DW0006826","middle_name":"","last_name":"Curlewis","source_individual_id":"RMIS40202","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Jon Curlewis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78554","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1778","size":1},{"color":"#FF4D4D","name":"MOLECULAR STRUCTURE-FUNCTION RELATIONSHIPS OF THE NORADRENALINE TRANSPORTER & DRUG ACTION","data":{"media_summary":"","end_year":2002,"keywords":["Antidepressants","Cocaine","Noradrenaline","Noradrenaline transporter","Site-directed mutagenesis"],"nhmrc_grant_id":102605,"application_year":1999,"health_keywords":["Cocaine antagonists","Depression","Schizophrenia"],"scientific_title":"MOLECULAR STRUCTURE-FUNCTION RELATIONSHIPS OF THE NORADRENALINE TRANSPORTER & DRUG ACTION","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Lesley Bryan-Lluka","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102605","simplified_title":"STRUCTURE AND FUNCTION OF THE NORADRENALINE TRANSPORTER: USE TO DESIGN ANTI-COCAINE DRUGS","sub_type":"Standard Project Grant","total_budget":"188912.18","source_system":"The transmission of impulses by nerves is dependent on the release of chemicals, termed neurotransmitters, from the nerve. The neurotransmitter causes its effects and then its action is usually terminated by membrane proteins that transport the chemical back into the nerve. These proteins are termed 'transporters'. In the brain, psychostimulants such as cocaine and also drugs that are used in the therapy of conditions such as depression block the activity of the transporters for the neurotransmitters, noradrenaline, serotonin and dopamine. Recently, the structures of the transporter proteins have been determined using molecular biology techniques. The focus of this project is to determine the parts of the noradrenaline transporter protein structure that are important in determining its functions, utilising the knowledge that we now have about its molecular structure. This will lead to exciting advances in understanding the function of the noradrenaline transporter and these advances should ultimately lead to the development of more effective antidepressant drugs and of drugs to prevent the effects of psychostimulants such as cocaine."},"children":[{"color":"#336699","name":"Dr Lesley Bryan-Lluka","data":{"first_name":"Lesley","title":"Dr","dw_individual_id":"DW0000609","middle_name":"J","last_name":"Bryan-Lluka","source_individual_id":"RMIS1729153","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Lesley Bryan-Lluka"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76824","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1777","size":1},{"color":"#FF4D4D","name":"Characterisation of HiaNm, a novel outer membrane from Neisseria meningitidis; vaccine potential and functional studies","data":{"media_summary":"","end_year":2002,"keywords":["ADHESION","MEMBRANE PROTEIN","NEISSERIA MENINGITIDIS","VACCINE"],"nhmrc_grant_id":102599,"application_year":1999,"health_keywords":["Fulminant meningococcal septicaemia","Meninigitis","Vaccine"],"scientific_title":"Characterisation of HiaNm, a novel outer membrane from Neisseria meningitidis; vaccine potential and functional studies","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Michael Jennings","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102599","simplified_title":"A study of a protein from the bacterium causing meningococcal meningitis; a new vaccine candidate.","sub_type":"Standard Project Grant","total_budget":"356685.22","source_system":"Meningococcal meningitis is a devastating illness which mostly affects children under 5 years. The clinical presentation is of a rapidly progressing disease with high rates of morbidity and mortality. This disease is caused by a bacterium, Neisseria meningitidis (the meningococcus). Vaccines are available against serogroup A and C strains of N. meningitidis, but not for group B strains, which cause the majority of disease in industrialised countries. We have recently identified a gene (designated hiaNm) which encodes a new protein which is located on the surface of the bacterium, in the outer membrane. There has been an enormous body of work done on the immunology, biochemistry and genetics of all components of the outer membrane of Neisseria meningitidis. Therefore the discovery of this novel protein provides an exciting opportunity to take a new direction in vaccine development. For an effective vaccine, the target molecule must be present in most strains; we have already shown that the hiaNm gene is present in all strains examined. In this proposal we describe a study of the vaccine potential and biological function of the hiaNm gene product HiaNm. We will express the protein at high levels, immunise mice, and produce antibodies against HiaNm to discover whether they can protect mice against meningococcal disease. At the completion of this set of experiments we will be in an excellent position to assess the potential for the further development of HiaNm as a component of a meningococcal vaccine."},"children":[{"color":"#336699","name":"Prof Michael Jennings","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0025768","middle_name":"P","last_name":"Jennings","source_individual_id":"RMIS449244","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Jennings"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83637","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1776","size":1},{"color":"#FF4D4D","name":"The Melanoma Susceptibility Gene Product p16 Functions in a UV-induced Cell Cycle Checkpoint in Human Skin","data":{"media_summary":"","end_year":2002,"keywords":["DNA damage","cell cycle control","checkpoint function","ultraviolet radiation"],"nhmrc_grant_id":102596,"application_year":1999,"health_keywords":["melanoma","skin cancer","sun exposure"],"scientific_title":"The Melanoma Susceptibility Gene Product p16 Functions in a UV-induced Cell Cycle Checkpoint in Human Skin","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Development (incl. Cell Division and Apoptosis)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Brian Gabrielli","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102596","simplified_title":"Normal Function of a Gene Linking UV Exposure and Melanoma","sub_type":"Standard Project Grant","total_budget":"204131.69","source_system":"The contribution of the ultraviolet component of sunlight to skin cancer generally, and melanoma in particular, is widely acknowledged. However, the actual mechanism by which ultraviolet radiation changes the normal skin melanocytes, the pigmented skin cells, into cancerous melanomas is unclear. Several years ago, a gene was identified that was found to be mutated in a high proportion of sporadic melanomas, and was also found to be mutated in a proportion of families with a predisposition to developing melanoma. This melanoma susceptibility gene, p16, can act to block cells growth, thus loss of this gene function in disease could lead to uncontrolled cell growth, a hallmark of cancer. This proposal investiagtes the role of p16 in responses of normal skin cells to ultraviolet radiation. We will examine the increased levels of p16 detected in skin after exposure to low doses of ultraviolet radiation and attempt to define the growth responses of these cells to the increased p16 levels. This project will help to establish the normal role of p16 in cellular responses to ultraviolet radiation, and may also identify novel targets for diagnosis, prevention or treatment of melanoma."},"children":[{"color":"#336699","name":"A/Pr Brian Gabrielli","data":{"first_name":"Brian","title":"A/Pr","dw_individual_id":"DW0007391","middle_name":"G","last_name":"Gabrielli","source_individual_id":"5014734","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Brian Gabrielli"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78693","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1775","size":1},{"color":"#FF4D4D","name":"Probing central and peripheral calcium channel sybtypes with novel omega conotoxins","data":{"media_summary":"","end_year":2002,"keywords":["calcium channels","electrophysiology","omega conotoxins","peptide synthesis","structure-function activity"],"nhmrc_grant_id":102585,"application_year":1999,"health_keywords":["neurotransmission","pain","stroke therapy"],"scientific_title":"Probing central and peripheral calcium channel sybtypes with novel omega conotoxins","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Richard Lewis","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102585","simplified_title":"New conotoxins that discriminate between peripheral and central calcium channels","sub_type":"Standard Project Grant","total_budget":"383168.79","source_system":"New toxins including omega-conotoxin CVID have been discovered from fish eating cone snails found on the Great Barrier Reef. These toxins discriminate between ion channel receptors on nerve cells that allow calcium ions to enter the cell and nerve transmission to continue. Of great importance is the fact that CVID specifically and potently blocks nerves that transmit pain responses. This project is involved with understanding the nolecular basis for this action with the goal of underpinning the design of even more selective agents that will ameliorate pain while reducing side effects."},"children":[{"color":"#336699","name":"Prof Richard Lewis","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0014455","middle_name":"J","last_name":"Lewis","source_individual_id":"5015973","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Lewis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80612","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1774","size":1},{"color":"#FF4D4D","name":"Development of Specific Inhibitors of Parasitic Enzymes","data":{"media_summary":"","end_year":2002,"keywords":["Parasitic infections","crystallography","medicinal chemistry","peptidomimetics","protease inhibitors"],"nhmrc_grant_id":102582,"application_year":1999,"health_keywords":["Parasitic infections","Schistosomiasis","malaria"],"scientific_title":"Development of Specific Inhibitors of Parasitic Enzymes","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Parasitology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr John Abbenante","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102582","simplified_title":"New drug treatment strategies for parasitic infections","sub_type":"Standard Project Grant","total_budget":"199413.38","source_system":"Parasitic diseases such as malaria, schistosomiasis, filariasis, leishmaniasis, and american trypanosomiasis (Chaga?s disease) are a significant public health issue, especially in tropical and subtropical regions of the world. In children, they cause death or impaired growth and in adults debilitating chronic illness. These parasitic infections are increasingly being recognized as responsible for chronic illness in many industrialized countries as well. There are no vaccines currently available for the treatment of any of the human parasitic infections. In addition, the drugs that are currently used are becoming less effective because of the spread of drug resistant strains. Schistosomiasis, is the second most prevalent parasitic disease, after malaria, and is a leading cause of severe morbidity and death in many parts of the world. The disease is caused by flatworms or blood flukes, the eggs of which indirectly cause damage to the liver and spleen of infected individuals. These parasites feed on human red blood cells and use hemoglobin as their major food source. Our collaborative team (Brindley, Abbenante, Fairlie) has identified two enzymes that these flatworms need to use to eat red blood cells. This project aims to develop compounds that will stop these enzymes from functioning. These compounds will be tested to see whether they can cause the parasites to die of starvation. If successful these new compounds can be used as drugs to treat the disease and the general strategy can be applied to other blood-feeding parasites."},"children":[{"color":"#336699","name":"John Abbenante","data":{"first_name":"John","title":"","dw_individual_id":"DW0005696","middle_name":"","last_name":"Abbenante","source_individual_id":"RMIS34220","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"John Abbenante"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78255","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1773","size":1},{"color":"#FF4D4D","name":"Molecular genetics of gonadal development","data":{"media_summary":"","end_year":2002,"keywords":["Expression cloning","Gonadal development","Organogenesis","Sex determination","Sex-determining genes"],"nhmrc_grant_id":102579,"application_year":1999,"health_keywords":["Gonadal dysgenesis","Hermaphroditism","Sex reversal"],"scientific_title":"Molecular genetics of gonadal development","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetic Development (incl. Sex Determination)","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Dr Josephine Bowles","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102579","simplified_title":"Genes that control sexual development in embryos","sub_type":"Standard Project Grant","total_budget":"253887.36","source_system":"Defects in sexual development in the human embryo result in some of the most common forms of birth defects, which have profound physiological and psychosexual ramifications for the afflicted individuals. A fuller understanding of the causes of these defects may lead to improved counseling and perhaps also therapeutic possibilities. This project is aimed at finding and studying the genes that control whether an embryo develops as a male or a female, and the genes that are responsible for proper development of the gonads, organs that control an individual's sexual development. It is thought that a genetic chain of events is important for gonadal development, and we aim to find the missing links of that chain and to work out how they fit together."},"children":[{"color":"#336699","name":"Dr Josephine Bowles","data":{"first_name":"Josephine","title":"Dr","dw_individual_id":"DW0035494","middle_name":"","last_name":"Bowles","source_individual_id":"RMIS30122","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Josephine Bowles"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86197","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1772","size":1},{"color":"#FF4D4D","name":"Investigation into the roles of a novel vertebrate gene, S52, in CNS development and pathogenesis","data":{"media_summary":"","end_year":2002,"keywords":["CNS development","Developmental genetics","Gene isolation","Gene targeting","Neurological disease"],"nhmrc_grant_id":102578,"application_year":1999,"health_keywords":["Congenital diseases","Motor neuron disease","Neurological diesases","Spastic Paraplegia Type 4 (SPG4)"],"scientific_title":"Investigation into the roles of a novel vertebrate gene, S52, in CNS development and pathogenesis","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurogenetics","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102578","simplified_title":"Functional analysis of S52 in CNS development and pathogenesis","sub_type":"Standard Project Grant","total_budget":"272389.84","source_system":"Developmentally regulated genes when mutated or deleted can cause a variety of diseases including neurological diseases in humans. It is therefore important to understand the fundamental molecular genetics of development. We have discovered a novel human gene, termed S52, and its equivalent gene in the mouse. The predicted protein derived from these genes would indicate that S52 protein may interact with other proteins, possibly nerve growth factors, in the body to regulate normal development and possibly facilitate the survival of nerve cells in embryos. Strikingly, the worm C. elegans, an evoluationary very distant animal, also has a very similar gene to human. The fact that the protein has been so conserved throughout evolution supports the idea that S52 function is important in development. S52 mRNA is expressed in the developing brain, particularly in a special group of cells called the floor plate. Floor plate is a tissue that has ability to organize the patterning and differentiation of cells within the developing brain. S52 is also expressed in motor neurons in early stages of development and later in a subset of dorsal spinal cord neurons. We have mapped S52 to the short arm of human chromosome 2 (2p15-22). This region of chromosome 2 is linked to several human genetic diseases with neurological defects. Based on our preliminary data, we think S52 is not only important for normal brain development but may be mutated in a human neurological disease called Spastic Paraplegia Type 4 (SPG4) which is characterized by a degeneration of nerve cells in the spinal cord. The aim of this project is to further our understanding of the function of this gene and investigate its role in disease. This knowledge will contribute to an overall increase in our understanding of the molecular basis of brain development and neurological disease in humans."},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1},{"color":"#336699","name":"Toshiya Yamada","data":{"first_name":"Toshiya","title":"","dw_individual_id":"DW0017254","middle_name":"","last_name":"Yamada","source_individual_id":"RMIS133491","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Toshiya Yamada"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81394","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1771","size":1},{"color":"#FF4D4D","name":"Gene expression changes induced upon Beta3 integrin expression in human melanoma metastasis","data":{"media_summary":"","end_year":2002,"keywords":["Cell adhesion","Differential gene expression","Integrin","Tumour metastasis","Vertical growth phase melanoma"],"nhmrc_grant_id":102565,"application_year":1999,"health_keywords":["Melanoma","Skin cancer","Tumour invasiveness"],"scientific_title":"Gene expression changes induced upon Beta3 integrin expression in human melanoma metastasis","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Richard Sturm","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102565","simplified_title":"Genes induced in melanoma metastasis","sub_type":"Standard Project Grant","total_budget":"199413.38","source_system":"Diagnostic and prognostic markers for metastatic melanoma are essential to better understand the development of this cancer. One of the most effective markers so far found to correlate with invasiveness of tumour cells, and hence lethality of melanoma, is the Beta3 integrin molecule. When this protein is expressed on the surface of early stage melanoma cells, that in themselves are not able to form metastatic tumours, they convey upon the cells the ability to proceed from growing on the surface of the skin (radial growth phase) to allowing them to invade the skin (vertical growth phase). It is not clear how expression of Beta 3 allows this change in growth state to occur and this research program is designed to test if Beta 3 is the direct cause of gene expression changes mediating the metastatic transformation. To provide insight into the genetic changes induced in melanoma cells expressing the Beta3 protein a screen for genes that are either activated or repressed in the presence of Beta3 will be performed. Non-metastatic melanoma cells will be transduced with the Beta 3 gene and a molecular technique applied to these cells that can identify genetic differences which will allow the cloning of differentially expressed genes. The gene fragments that are identified will first provide clues as to what the genes are that maybe switched on or off to allow the tumour to grow beneath the skin. They will also form the basis of a Ometastatic melanoma gene panelO that can be tested for its diagnostic value of tumours. The utility and reproducibility of the gene panel will be confirmed by testing melanoma cell lines and tumour tissue. These experiments should lead to better diagnosis of metastatic melanoma and also possible new avenues to develop therapies for the disease."},"children":[{"color":"#336699","name":"A/Pr Richard Sturm","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0045672","middle_name":"Alan","last_name":"Sturm","source_individual_id":"5017777","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Richard Sturm"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88811","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1770","size":1},{"color":"#FF4D4D","name":"Neuroendocrine responses to psychological stress: unmasking the protective role of the prefrontal cortex.","data":{"media_summary":"","end_year":2002,"keywords":["central catecholamine systems","hypothalamic pituitary adrenal axis","limbic system","neuroendocrinology","stress"],"nhmrc_grant_id":102563,"application_year":1999,"health_keywords":["depression","hypertension","immunosupression","stress"],"scientific_title":"Neuroendocrine responses to psychological stress: unmasking the protective role of the prefrontal cortex.","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Central Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Trevor Day","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102563","simplified_title":"How the brain can protect you from stress.","sub_type":"Standard Project Grant","total_budget":"346153.94","source_system":"This project seeks to build up a picture of one of the mechanisms that the brain uses to protect our bodies from the potentially harmful effects of psychological stress. When we are subjected to psychological stress one of the consequences is the release of a hormone, corticosterone, into the blood-stream. This can be beneficial in the short-term as it helps our body redistribute its pattern of energy utilization in a way that helps in coping with an unexpected challenge. However, excessive secretion of corticosterone due to excessive exposure to psychological stress can damage your health. For example, it can make you more susceptible to infection and also accelerate the rate at which your brain ages. The brain possesses certain mechanisms which try to limit the release of corticosterone when you are subjected to psychological stress. Unfortunately these mechanisms are not quite up to doing the necessary job under the conditions in which we live today, i.e. a very high level of psychological stress is a common feature of modern life. Nevertheless we believe that if we can properly understand these protective mechanisms in the brain, it may be possible to develop drugs which can boost their efficiency. In the long term this could greatly reduce ill-health in our society."},"children":[{"color":"#336699","name":"Prof Trevor Day","data":{"first_name":"Trevor","title":"Prof","dw_individual_id":"DW0001209","middle_name":"A","last_name":"Day","source_individual_id":"5014239","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Trevor Day"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76996","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1769","size":1},{"color":"#FF4D4D","name":"Superoxide and the nitric oxide-peroxynitrite pathway in renal ischaemia-reperfusion injury","data":{"media_summary":"","end_year":2002,"keywords":["MRI and EPR","ischaemia-reperfusion injury","kidney","nitric oxide","superoxide"],"nhmrc_grant_id":102554,"application_year":1999,"health_keywords":["acute renal failure","ischaemic injury","renal transplantation"],"scientific_title":"Superoxide and the nitric oxide-peroxynitrite pathway in renal ischaemia-reperfusion injury","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Zoltan Endre","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102554","simplified_title":"Oxygen-derived chemicals injure the kidney during recovery from reduced blood flow","sub_type":"Standard Project Grant","total_budget":"202755.33","source_system":"Acute renal failure is common and has 50% mortality. Free radicals are vey reactive, unstable molecules that alter normal metabolic reactions. The study aims to determine the role of oxygen-derived free radicals and nitric oxide and their interaction in renal ischaemic injury. The balance between the positive effects of nitric oxide on blood flow and the damaging effects of by-products of the reaction of nitric oxide with superoxide radical (peroxynitrite) on renal tubules may determine the extent of cell damage and hence recovery from ischaemic and hypoxic renal injury. Modulation of these opposing forces may lead to strategies to protect and improve renal function in acute renal failure in man."},"children":[{"color":"#336699","name":"Prof Zoltan Endre","data":{"first_name":"Zoltan","title":"Prof","dw_individual_id":"DW0042272","middle_name":"H","last_name":"Endre","source_individual_id":"RMIS30819","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Zoltan Endre"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87972","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1768","size":1},{"color":"#FF4D4D","name":"The role of CD4+ T-helper cells in the generation, maintenance and activation of a long lasting anti-tumour CTL effect.","data":{"media_summary":"","end_year":2002,"keywords":["Anti-tumour Vaccines","Cytotoxic T cell memory","Tumour protection"],"nhmrc_grant_id":102553,"application_year":1999,"health_keywords":["Anti-tumour vaccines","Cancer prevention","Cervical Cancer","Women's Health"],"scientific_title":"The role of CD4+ T-helper cells in the generation, maintenance and activation of a long lasting anti-tumour CTL effect.","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Tumour Immunology","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Dr Germain Fernando","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102553","simplified_title":"How to induce a long lasting anti-tumour response.","sub_type":"Standard Project Grant","total_budget":"247383.49","source_system":"In this research project we will be studying the mechanisms how a long-lasting anti-cancer response could be achieved by vaccination. This information not only will help to design better vaccines against cancers, but also will help to design better vaccines against viral diseases."},"children":[{"color":"#336699","name":"Dr Germain Fernando","data":{"first_name":"Germain","title":"Dr","dw_individual_id":"DW0030659","middle_name":"J","last_name":"Fernando","source_individual_id":"5014600","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Germain Fernando"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84967","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1767","size":1},{"color":"#FF4D4D","name":"The role of keratin end-domains in filament biology","data":{"media_summary":"","end_year":2002,"keywords":["cytoskeleton","intermediate filaments","keratinocyte cell culture and transfection","kinesin","transgenic mice"],"nhmrc_grant_id":102549,"application_year":1999,"health_keywords":["epidermolysis bullosa","inherited disorders","skin related diseases"],"scientific_title":"The role of keratin end-domains in filament biology","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Joseph Rothnagel","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102549","simplified_title":"A study of keratin filament biology","sub_type":"Standard Project Grant","total_budget":"139235.24","source_system":"The skin is the largest organ in the body and is the main interface between the organism and the external environment. It protects us from UV radiation, microbial invasion and chemical attack. It is able to repair itself and in fact, is continually renewing itself. In this study, we propose to examine the biology of keratins and the filament networks they form. Keratins are the most abundant proteins present in the epidermis, the outer layer of the skin. Keratins form a cellular skeleton that reinforces skin cells to help them withstand mechanical trauma. Mutations in these proteins result in a much weaker skeleton and ultimately in disease. We will examine how the keratin building blocks are transported around the cell to where they are needed. We will also determine the effect of mutations in this transport process on the biology of the cell. These studies may provide important clues into certain inherited skin disorders."},"children":[{"color":"#336699","name":"A/Pr Joseph Rothnagel","data":{"first_name":"Joseph","title":"A/Pr","dw_individual_id":"DW0009982","middle_name":"A","last_name":"Rothnagel","source_individual_id":"5017267","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Joseph Rothnagel"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79410","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1766","size":1},{"color":"#FF4D4D","name":"Applications of C5a antagonists in vivo","data":{"media_summary":"","end_year":2002,"keywords":["C5a antagonists","complement C5a","immunoinflammatory disease"],"nhmrc_grant_id":102537,"application_year":1999,"health_keywords":["arthritis","immune complex disease","new class of anti-inflammatory drug","sepsis and ARDS"],"scientific_title":"Applications of C5a antagonists in vivo","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Basic Pharmacology","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Stephen Taylor","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102537","simplified_title":"Animal Testing of a New Class of Anti-Inflammatory Medicines","sub_type":"Standard Project Grant","total_budget":"214697.21","source_system":"Many serious inflammatory diseases, such as arthritis, septic shock, lung shock and heart disease are poorly controlled with currently available drugs. There is much evidence that a circulating hormone system called complement is involved with exacerbating these diseases, yet there are no drugs available to counteract its effects. One powerful component of the complement system, called C5a, causes inflammation and is suspected of causing tissue damage and suffering in these and many other immune diseases. An agent that could block the effects of C5a could be very useful clinically. There is no such drug available as yet. We have developed powerful agents which specifically block C5a in laboratory tests on isolated cells and tissues, and now propose to test their effectiveness in rats in which the above human disease conditions are mimicked. Our preliminary results are very promising, and we will conduct further testing to determine the scope of the actions of the new drugs. One of our new agents is orally active in rats, and we will determine how the blood levels of the drug relate to its beneficial effects. We are also planning to develop agents that are more effective when given by mouth. The results could lead to a new type of anti-inflammatory drug for humans suffering from a variety of diseases that are poorly treatable at present."},"children":[{"color":"#336699","name":"Prof Stephen Taylor","data":{"first_name":"Stephen","title":"Prof","dw_individual_id":"DW0010587","middle_name":"M","last_name":"Taylor","source_individual_id":"RMIS41211","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stephen Taylor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79577","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1764","size":1},{"color":"#FF4D4D","name":"Identification of risk factors associated with exposure to Australian bat lyssavirus","data":{"media_summary":"","end_year":2002,"keywords":["Australian bat lyssavirus","risk factors","sero-surveillance","vaccine studies in the natural host","virus detection and sequencing"],"nhmrc_grant_id":102528,"application_year":1999,"health_keywords":["epidemiology of infectious disease","lyssavirus encephalitis","zoonoses"],"scientific_title":"Identification of risk factors associated with exposure to Australian bat lyssavirus","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof John MacKenzie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102528","simplified_title":"Lyssavirus risk factors","sub_type":"Standard Project Grant","total_budget":"230344.68","source_system":"Australia is one of the few countries in the world known to be free of rabies. A dramatic impact on this status occurred in 1996. A flying fox in northern NSW was found to be infected with a rabies-like virus. Within 16 weeks of this discovery the first human case occurred. A further human case has now been reported. The newly discovered virus, named Australian bat lyssavirus (ABL) was found to be closely related to, but distinguishable from, rabies virus. Rabies virus is responsible for thousands of human infections each year, mainly in Asia and South Asia where it is endemic in urban dogs. In contrast, other rabies-like viruses have caused only a handful of human infections. Although the number of human cases of ABL is likely to remain low, each of the two known cases has aroused a great deal of public anxiety. The natural hosts appear to be various species of bats which collectively have a distribution along the entire northern and eastern coastlines. The number of potential exposures is therefore quite large and state health departments are devoting considerable resources to dealing with public concerns. This project will establish clearly defined risk factors for exposure to ABL and will allow health authorities to better manage expensive and limited vaccine and therapy resources."},"children":[{"color":"#336699","name":"Prof John Mackenzie","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0008814","middle_name":"","last_name":"Mackenzie","source_individual_id":"RMIS218589","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mackenzie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79086","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1763","size":1},{"color":"#FF4D4D","name":"Japanese encephalitis virus in northern Australia and Papua New Guinea:its ecology and risk to Australia.","data":{"media_summary":"vector and vertebrate host ecology","end_year":2002,"keywords":["Japanese encephalitis virus","emerging viruses","flaviviruses","mosquito transmission","virus surveillance"],"nhmrc_grant_id":102527,"application_year":1999,"health_keywords":["Public health and mosquito-borne disease","emerging diseases","encephalitis","spread of mosquito-borne disease","vector and vertebrate host ecology"],"scientific_title":"Japanese encephalitis virus in northern Australia and Papua New Guinea:its ecology and risk to Australia.","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof John MacKenzie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102527","simplified_title":"Studies to assess the risk of Japanese encephalitis virus entering, and spreading in northern Australia.","sub_type":"Standard Project Grant","total_budget":"292045.29","source_system":"Japanese encephalitis (JE) virus is a mosquito-transmitted virus of Asia. Infection causes clinical disease in about 1 in 50 people infected, and of these, about 25% will die from a fatal encephalitis (inflammation of the brain), and a further 50% will have lifelong severe disabilities. There are over 50,000 cases annually in Asia, with about 12,000 fatalities. However, many more cases may go unrecognised. The virus normally circulates between mosquitoes and water birds and between mosquitoes and pigs. The World Health Organization has recognised JE as one of the most important mosquito-borne viruses because of its propensity to spread and to colonise new areas. The virus first appeared in the Torres Strait of northern Australia in 1995, causing three clinical cases of whom 2 died. This was unexpected as the nearest known focus of virus activity was in Bali, over 3000km away. The virus returned again in 1998, with a further case in the Torres Strait and the first case to occur on mainland Australia in Cape York. Both of these patients recovered. We have shown that the virus is established in Papua New Guinea (PNG), where it is spreading rapidly, and our results suggest that PNG was the source of the virus causing the outbreaks in 1995 and 1998. This project is aimed at finding out more about JE virus in PNG, particularly as it relates to spread into northern Australia. The project also seeks to investigate the potential mosquito and animal hosts in Australia that might be involved if the virus becomes established in our wildlife in Cape York. Australia is already known to have suitable mosquito vector species and suitable animal hosts in water birds and feral pigs, but the ecology is not yet understood. Thus the overall aim is to provide information on which a sound risk assessment can be based."},"children":[{"color":"#336699","name":"Prof John Mackenzie","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0008814","middle_name":"","last_name":"Mackenzie","source_individual_id":"RMIS218589","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Mackenzie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79086","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1762","size":1},{"color":"#FF4D4D","name":"Study of papillomavirus DNA encapsidation and formation of infectious virions","data":{"media_summary":"","end_year":2002,"keywords":["Medical virology","Molecular virology","Papillomavirus viral structure","Viral immunology"],"nhmrc_grant_id":102525,"application_year":1999,"health_keywords":["Antibody neutralization assay","DNA encapsidation","DNA packaging cell line","Infectious virions"],"scientific_title":"Study of papillomavirus DNA encapsidation and formation of infectious virions","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Infectious Diseases","research_area":"Public Health","for_category":"CLINICAL SCIENCES","cia_name":"Dr Kong-Nan Zhao","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102525","simplified_title":"DNA packaging by papillomavirus","sub_type":"Standard Project Grant","total_budget":"214053.04","source_system":"Papillomavirus (PV) is a sexually-transmitted virus that is a major cause of cervical cancer. Our study will determine how PV is able to form new virus particles inside infected cells. This is a critical part of the virus life-cycle, and a better understanding of this process may allow it to be trageted by anti-viral treatments. In addition, we will develop a method to create non-harmful virus particles which we will use to study human immune responses to the virus."},"children":[{"color":"#336699","name":"Dr Kong-Nan Zhao","data":{"first_name":"Kong-Nan","title":"Dr","dw_individual_id":"DW0023208","middle_name":"","last_name":"Zhao","source_individual_id":"RMIS108496","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Kong-Nan Zhao"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82979","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1761","size":1},{"color":"#FF4D4D","name":"Genes controlling the development of lung disease in normal and cystic fibrosis mice.","data":{"media_summary":"","end_year":2002,"keywords":["gene therapy","genetic mapping","host/pathogen interaction","molecular genetics","transgenic/knockout animals"],"nhmrc_grant_id":102523,"application_year":1999,"health_keywords":["Pseudomonas infection","cystic fibrosis","gene therapy"],"scientific_title":"Genes controlling the development of lung disease in normal and cystic fibrosis mice.","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102523","simplified_title":"Genes controlling the development of lung disease in normal and cystic fibrosis mice.","sub_type":"Standard Project Grant","total_budget":"362582.98","source_system":"Patients with cystic fibrosis have a lethal predisposition to bacterial infection which causes irreversible lung disease. It is clear that even when patients carry the same mutation in the defective gene (CFTR), genetic background influences the course of the disease. Very little is known of the nature of these other genes and this proposal will identify those genes which influence the response of the CF lung to pathogens and in doing so may indicate novel therapeutic strategies."},"children":[{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1760","size":1},{"color":"#FF4D4D","name":"Mechanisms of macrophage activation by immunostimulatory DNA","data":{"media_summary":"vaccine","end_year":2002,"keywords":["CpG DNA","immunostimulatory DNA","lipopolysaccharide","macrophage activation","receptor"],"nhmrc_grant_id":102521,"application_year":1999,"health_keywords":["allergy","immunity","inflammation","sepsis","vaccine"],"scientific_title":"Mechanisms of macrophage activation by immunostimulatory DNA","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof David Hume","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102521","simplified_title":"How the immune system recognises foreign DNA","sub_type":"Standard Project Grant","total_budget":"230728.21","source_system":"This project is based upon the observation that the mammalian immune system can distinguish between its own genetic material (DNA) and the genes of infectious agents such as bacteria. This fact has implications for understanding how the immune system copes with infection, and also for design of new therapies and vaccines. Our central aim is to define exactly how this recognition system works. The cells that respond most vigorously to foreign DNA are large white blood cells called macrophages. We aim to find the macrophage protein which binds to foreign DNA and triggers the activation of the immune system. The type of immune responses initiated by foreign DNA may be useful in treatment of allergies and cancer and for improving vaccinations."},"children":[{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1759","size":1},{"color":"#FF4D4D","name":"The role of the microphthalmia transcription factor family in macrophage differentiation.","data":{"media_summary":"sepsis","end_year":2002,"keywords":["c-fms","differentiation","macrophage","microphthamia","transcription"],"nhmrc_grant_id":102520,"application_year":1999,"health_keywords":["arthritis","inflammation","leukaemia","osteoporosis","sepsis"],"scientific_title":"The role of the microphthalmia transcription factor family in macrophage differentiation.","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Gene Expression","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof David Hume","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102520","simplified_title":"Gene regulation in white blood cells.","sub_type":"Standard Project Grant","total_budget":"367193.44","source_system":"Macrophages are large white blood cells that are also found in all the tissues of the body. They are a major part of the front line defence against infection and malignancy, but they also cause much of the pathology of many diseases particularly those in which there is chronic inflammation. Macrophages, like all the cells of the blood, are produced from the bone marrow. In the process of macrophage production a suite of genes must be switched on so that the mature macrophage can carry out its functions. This project aims to understand the process of selective gene expression in macrophages. It is based upon the identification of four members of a gene family, called the microphthalmia gene family, as candidate master genes that control the overall process of macrophage production. We seek to understand how the products of genes interact."},"children":[{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1758","size":1},{"color":"#FF4D4D","name":"The Structural Basis of Direction Selectivity in the Retina","data":{"media_summary":"","end_year":2004,"keywords":["confocal microscopy","electron microscopy","information processing","neural circuit","retinal ganglion cell"],"nhmrc_grant_id":102519,"application_year":1999,"health_keywords":["neurology","ophthalmology","retinal degeneration"],"scientific_title":"The Structural Basis of Direction Selectivity in the Retina","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Sensory Systems","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof David Vaney","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102519","simplified_title":"Complex Information Processing by Simple Neuronal Circuits","sub_type":"Standard Project with Research Fellowship","total_budget":"401705.39","source_system":"The retina is part of the central nervous system and there are almost one hundred types of retinal neurons which process visual information before it is passed up the optic nerve to the brain. This project examines how some of these neurons are wired together to form a simple neuronal circuit that detects the direction of a moving object. The elucidation of the cellular mechanisms of direction selectivity will provide an important paradigm of complex processing by simple neuronal circuits, with direct relevance to information processing in other parts of the central nervous system. In particular, the project may provide strong evidence for two neuronal strategies that may be of general significance. First, information may be processed at a very local level, which would greatly increase the computational power of a single neuron. Second, neurons may make selective contact with only some processes of an input neuron, which would require novel mechanisms for producing the necessary specificity."},"children":[{"color":"#336699","name":"Prof David Vaney","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0028555","middle_name":"I","last_name":"Vaney","source_individual_id":"RMIS52594","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Vaney"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84390","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1757","size":1},{"color":"#FF4D4D","name":"The role of TAP and MHC class I expression in the response to melanoma immunotherapy using autolgous dendritic cells","data":{"media_summary":"","end_year":2002,"keywords":["TAP/MHC mutations","clinical trial","dendritic cell","immunotherapy","melanoma"],"nhmrc_grant_id":102515,"application_year":1999,"health_keywords":["immunotherapy","melanoma","tumours"],"scientific_title":"The role of TAP and MHC class I expression in the response to melanoma immunotherapy using autolgous dendritic cells","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Tumour Immunology","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ranjeny Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102515","simplified_title":"Reasons for response or failure to treatment of melanoma with a novel vaccine","sub_type":"Standard Project Grant","total_budget":"337811.62","source_system":"Treatment for patients with malignant melanoma whose disease has spread, or metastasised, to sites distant from the original melanoma is usually unsuccessful. At this stage of the disease there is no known curative treatment with conventional surgery, radiation or chemotherapy. Occasionally, however, melanoma in its early stages is successfully dealt with by the natural response of the immune system. In these cases, the immune system generates cancer-controlling killer T lymphocytes that enter the melanoma and kill the tumour cells. Killer T lymphocytes are generated by the lymph glands when the immune system is presented with melanoma cell components, or antigens, by specialised cells known as dendritic cells. This project consists of a clinical trial that aims to boost the natural ability of the immune system to generate killer cells by growing dendritic cells from the blood, mixing them with melanoma antigens, and then inject the mixture. When injected into the skin, dendritic cells quickly move to lymph glands to generate killer T lymphocytes. T lymphocytes can find their way to melanoma deposits all over the body. The reasons for response or non-response to the vaccination will particularly be assessed in this project."},"children":[{"color":"#336699","name":"Prof Ranjeny Thomas","data":{"first_name":"Ranjeny","title":"Prof","dw_individual_id":"DW0045826","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS4352","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ranjeny Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88853","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1756","size":1},{"color":"#FF4D4D","name":"Dendritic cell function, migration and modulation in a murine model of inflammatory arthritis","data":{"media_summary":"","end_year":2002,"keywords":["antigen induced arthritis","bone marrow chimera","chemotaxis and migration","dendritic cells"],"nhmrc_grant_id":102513,"application_year":1999,"health_keywords":["inflammatory disease","rheumatoid arthritis","vaccination immunology"],"scientific_title":"Dendritic cell function, migration and modulation in a murine model of inflammatory arthritis","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ranjeny Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102513","simplified_title":"Understanding the role that antigen presenting cells play in causing arthritis, and how suppress this","sub_type":"Standard Project Grant","total_budget":"201870.19","source_system":"Rheumatoid arthritis (RA) is a debilitating disease that affects the joints and other tissues. While it can often be controlled with drugs, complete remission off treatment is rare. Dendritic cells are the educators of the immune system. By displaying antigen to T cells they communicate the response that the immune system should make to foreign organisms, tumors and to self. Therefore, a communication failure may result in chronic inflammation, tumor growth or autoimmune disease, such as RA. In this proposal, we focus on the role of dendritic cells in a mouse model of RA and explore ways of using dendritic cells to turn off disease, that if successful may translate in humans to induction of remission."},"children":[{"color":"#336699","name":"Prof Ranjeny Thomas","data":{"first_name":"Ranjeny","title":"Prof","dw_individual_id":"DW0045826","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS4352","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ranjeny Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88853","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1755","size":1},{"color":"#FF4D4D","name":"Studies on the flavivirus nonstructural proteins and untranslated regions of the genome involved in virus replication","data":{"media_summary":"","end_year":2002,"keywords":["Infectious favivirus cDNA clones","flavivirus attenuation by site-directed mutatagenisis","flavivirus replication","structure/ function of nonstructural flavivirus proteins","structure/function of UTRs of the flavivirus RNA genome"],"nhmrc_grant_id":102511,"application_year":1999,"health_keywords":["Anti-viral drugs and attenuated flavivirus vaccines","Dengue, Japanese encephalitis, yellow fever","arthropod-transmitted diseases","flaviviruses"],"scientific_title":"Studies on the flavivirus nonstructural proteins and untranslated regions of the genome involved in virus replication","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Roy Hall","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102511","simplified_title":"Studies on flavivirus replication","sub_type":"Standard Project Grant","total_budget":"244277.17","source_system":"Flaviviruses cause potentially fatal diseases of global importance such as yellow fever, Japanese encephalitis (JE) and dengue haemorrhagic fever. Flavivirus disease is also important in Australia with recurrent outbreaks of dengue fever, Australian encephalitis and more recently JE in the northern regions of the continent. Effective vaccines are only available to yellow fever and JE and tick-borne encephalitis and are either live or killed preparations which are potentially hazardous and costly to produce. There are no therapeutic agents (antivirals) available against flavivirus diseases. To produce safe and cost effective vaccines against flaviviruses and to identify targets for antiviral agents, a more complete understanding of how these viruses replicate in the cell and cause disease is required. This investigation aims to define specific aspects of the flavivirus life cycle that are currently unknown."},"children":[{"color":"#336699","name":"Prof Roy Hall","data":{"first_name":"Roy","title":"Prof","dw_individual_id":"DW0025278","middle_name":"A","last_name":"Hall","source_individual_id":"RMIS16831","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Roy Hall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83509","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1754","size":1},{"color":"#FF4D4D","name":"An examination of the relationship between alcohol-related injury (ARI) and licensed premises","data":{"media_summary":"Intoxication","end_year":2001,"keywords":["Alcohol-related injury (assessment of incidence)","Police, and alcohol problems in licensed premises","Relationship between alcohol, injury and licensed premises"],"nhmrc_grant_id":102498,"application_year":1999,"health_keywords":["Acute alcohol problems","Alcohol and licensed premises","Alcohol-related injury","Injury","Intoxication"],"scientific_title":"An examination of the relationship between alcohol-related injury (ARI) and licensed premises","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Ann Roche","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102498","simplified_title":"Alcohol-related injury (ARI) stemming from licensed premises","sub_type":"Standard Project Grant","total_budget":"78686.62","source_system":"There is growing interest in acute alcohol-related problems, and especially injuries. These are often experienced by young people, frequently as a consequence of intoxication or drinking in unsafe settings. Little work has been undertaken in Australia to systematically examined alcohol-related injuries (ARIs). This study will examine ARIs, identify the frequency with which such problems present to a local hospital, record the nature of the injuries, details of the person sustaining it, and the drinking location. Characteristics of drinking locations and drinking settings, in particular licensed premises, will be examined to determine their association with ARIs. Then an intervention will be undertaken in conjunction with local police, to address the conditions of the drinking environment with the aim of reducing ARIs and other alcohol-related problems stemming from licensed premises. The intervention will form part of a randomised controlled trial where licensed premises, identified through monthly police data as hot spots, receive either an intervention or act as a control. In the following month, controls receive the intervention (a cross-over design). The intervention was established in 1998 by Gold Coast police and involves police, fire and liquor licensing officers undertaking an on-site inspection and taking prescribed actions. It is hypothesised that this action should result in a decreased level of ARIs being generated from premises which receive the intervention, compared to those that do not. This is an intersectoral, collaborative project aimed at improving community safety through a concerted effort by police, health and the licensees."},"children":[{"color":"#336699","name":"Prof Ann Roche","data":{"first_name":"Ann","title":"Prof","dw_individual_id":"DW0033473","middle_name":"","last_name":"Roche","source_individual_id":"RMIS37486","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ann Roche"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85666","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1753","size":1},{"color":"#FF4D4D","name":"SES and injury in children: a cohort study to identify and measure the effects of preventable mediating factors","data":{"media_summary":"","end_year":2002,"keywords":["Cohort studies","Conceptual and analytic modeling","Descriptive and risk factor epidemiology","Identying optimum points for public health intervention"],"nhmrc_grant_id":102497,"application_year":1999,"health_keywords":["Childhood injury","Health inequality","Injury prevention and control","Socioeconomic status"],"scientific_title":"SES and injury in children: a cohort study to identify and measure the effects of preventable mediating factors","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Roderick McClure","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102497","simplified_title":"Socio-economic status and injury in children","sub_type":"Standard Project Grant","total_budget":"360505.42","source_system":"While changing an individual or group SES is at best a long term and challenging social objective, proximal risk factors for injury can be more readily modified. Once the proximal risk factor differential across SES groups has been adequately delineated, then the possibility arises for targeted public health intervention to redress the SES differential in the incidence of injury. The sophistication of the proposed modeling will result in a good assessment of the best point to target."},"children":[{"color":"#336699","name":"Dr Roderick Mcclure","data":{"first_name":"Roderick","title":"Dr","dw_individual_id":"DW0032437","middle_name":"John","last_name":"Mcclure","source_individual_id":"5012518","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Roderick Mcclure"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85396","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1752","size":1},{"color":"#FF4D4D","name":"Do PACAP-containing neurons in the hypothalamus regulate reproductive hormone secretion?","data":{"media_summary":"","end_year":2002,"keywords":["PACAP","hypothalamus","luteinising hormone","pituitary gland","prolactin"],"nhmrc_grant_id":102491,"application_year":1999,"health_keywords":["amenorrhoea","anorexia nervosa","critical illness","hypogonadotrophic hypogonadism"],"scientific_title":"Do PACAP-containing neurons in the hypothalamus regulate reproductive hormone secretion?","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Jon Curlewis","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102491","simplified_title":"Control of reproductive hormone secretion by the brain","sub_type":"Standard Project Grant","total_budget":"182559.66","source_system":"This project investigates the role of a brain chemical called PACAP which is found in a part of the brain called the hypothalamus which regulates the reproductive system. The hypothalamus does this by controlling the secretion of several pituitary gland hormones, LH and prolactin, which in turn stimulate normal function of the ovaries or testes. Abnormal secretion of these hormones is seen in conditions such as anorexia nervosa, bulimia, stress, critical illness, aging and many others with the result that patients have low levels of steroids in their blood and inactive gonads, changes which in themselves lead to other health problems. Because these hormones are essential for normal reproduction, it is possible that PACAP may play an important role in regulating this process, both under normal conditions and in disease. It is hoped that this research will lead to a more detailed understanding of how the endocrine system is controlled in humans and to new methods for the manipulation of the reproductive axis, under normal and disease conditions."},"children":[{"color":"#336699","name":"Jon Curlewis","data":{"first_name":"Jon","title":"","dw_individual_id":"DW0006826","middle_name":"","last_name":"Curlewis","source_individual_id":"RMIS40202","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Jon Curlewis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78554","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1751","size":1},{"color":"#FF4D4D","name":"Regulation and Effect of the Growth Hormone, IGF-I, and IGF-Binding Protein Response to Acute Exercise","data":{"media_summary":"Regulation of the Stress Response","end_year":2002,"keywords":["Exercise Physiology","Growth Hormone","Insulin-like Growth Factor Binding Protein","Insulin-like Growth Factor-I","Metabolism"],"nhmrc_grant_id":102488,"application_year":1999,"health_keywords":["Diagnosis of Endocrine Disorders","Dope Detection in Sports/Health Prevention in Youth","Regulation of Anabolism/Catabolism","Regulation of Carbohydrate Metabolism/Diabetes","Regulation of the Stress Response"],"scientific_title":"Regulation and Effect of the Growth Hormone, IGF-I, and IGF-Binding Protein Response to Acute Exercise","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Ross Cuneo","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102488","simplified_title":"Regulation and Effect of the Growth Hormone Axis in Exercise","sub_type":"New Investigator Grant","total_budget":"367197.73","source_system":"The body's ability to respond to physiological stress is vital to survival. This series of studies aims to examine the hormonal responses to physical exercise. In studies recently completed to determine how to detect Growth Hormone (GH) abuse in the Olympics, we have discovered a new system of hormones that respond to exercise. These Insulin-like Growth Factors (IGF) and their IGF-Binding Proteins (IGF-BP) are normally controlled by GH. The IGF-IGF-BP system normally acts to control of many cellular and organ functions in many different tissues of the body. For example they stimulate protein accumulation and muscle growth, and have actions to control blood glucose in conditions like diabetes. Little is known about what regulates the production of the IGF and IGF-BPs in response to physical exercise. We aim to examine whether GH, either as an acute pulse as occurs naturally, or a direct effect of exercise that is not GH-mediated, is responsible for the increase in IGF and IGFBPs. This may uncover a new means of controlling this powerful hormonal system. In addition, we will examine whether GH or IGF-I, alone and together, influence the body's ability to respond to the stress of exercise (e.g., controlling fuel use, cardiovascular and kidney responses). Such information will allow greater understanding of this important hormonal system, so that in novel therapies may be developed for conditions such as normal ageing, the wasting states that accompany severe surgical or infectious stress, or conditions with abnormal blood glucose regulation such as diabetes. In addition, this information will permit greater sophistication in the detection of GH and related compounds in elite athletes. Unfortunately, GH is also being abused by non-elite athletes and high-school children. We believe our efforts will asist in the detection and prevention of these more general societal health issues."},"children":[{"color":"#336699","name":"Ross Cuneo","data":{"first_name":"Ross","title":"","dw_individual_id":"DW0030199","middle_name":"","last_name":"Cuneo","source_individual_id":"RMIS77841","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ross Cuneo"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84824","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1750","size":1},{"color":"#FF4D4D","name":"GPI anchored forms of the dengue virus NS1 protein: production and role in pathogenesis","data":{"media_summary":"","end_year":2002,"keywords":["dengue virus","glycosylphosphatidyl-inositol anchored protein","molecular pathogenesis","post-translational modification"],"nhmrc_grant_id":102484,"application_year":1999,"health_keywords":["dengue virus","haemorrhagic fever","pathogenesis"],"scientific_title":"GPI anchored forms of the dengue virus NS1 protein: production and role in pathogenesis","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Paul Young","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102484","simplified_title":"An unusual form of a dengue virus protein: its production and potential role in disease","sub_type":"Standard Project Grant","total_budget":"203448.44","source_system":"Dengue viruses are carried by mosquitoes and infect millions of people around the world, particularly in tropical countries of SE Asia, Central and South America, Africa and recently in Australia (North Queensland and NT). There is no vaccine or drug available for preventing or treating the infections, which are characterised by severe illness that involves inflammation and fevers that can sometimes be fatal. This study focuses on an unusual form of a dengue virus protein (called NS1) which we have identified. We plan to study the role that this protein plays in the more severe and often fatal forms of dengue infection (dengue haemorrhagic fever and dengue shock syndrome). In these more severe and life threatening forms of dengue the blood vessels of these patients become leaky. It is thought that this is caused by the secretion of certain chemicals (cytokines) from infected cells. We have shown that dengue infected human cells, which have the unusual form of NS1 protein on their surface, are capable of being activated by antibodies. Antibodies are proteins which are produced by the human body to fight infection. We aim to study whether cytokines are secreted from infected human blood cells activated in this way and whether these cytokines cause blood vessels to become leaky. We will also study how the virus produces this variant form of NS1 in the two host species that the virus infects; mosquito and human. These studies will increase our understanding of dengue virus infection and will provide valuable information concerning the role that this unusual form of the degue virus protein NS1 plays in the severe forms of dengue fever; dengue haemorrhagic fever and dengue shock syndrome."},"children":[{"color":"#336699","name":"Prof Paul Young","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0005625","middle_name":"R","last_name":"Young","source_individual_id":"RMIS20614","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78234","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1749","size":1},{"color":"#FF4D4D","name":"Design and Development of Inhibitors of the Dengue Virus Protease as Antiviral Drugs","data":{"media_summary":"","end_year":2002,"keywords":["Dengue","crystallography","inhibitor","protease"],"nhmrc_grant_id":102482,"application_year":1999,"health_keywords":["Dengue","Haemorrhagic Fever","Virus"],"scientific_title":"Design and Development of Inhibitors of the Dengue Virus Protease as Antiviral Drugs","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"A/Pr Paul Young","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102482","simplified_title":"Towards New Drugs For Dengue Virus Infections.","sub_type":"Standard Project Grant","total_budget":"362513.78","source_system":"Dengue viruses are carried by mosquitoes and infect millions of people around the world, particularly in tropical countries of SE Asia, Central and South America, Africa and recently in Australia (North Queensland and NT). There is no vaccine or drug available for preventing or treating the infections, which are characterised by severe illness that involves inflammation and fevers that can sometimes be fatal. This proposal focuses on a virus specific enzyme. This enzyme (called a protease) is essential for the virus to multiply and so it is a potential target for new drugs that can bind to it and block its function. We have produced and purified this viral enzyme in the laboratory and now propose to design, synthesize, and develop the first drugs for the treatment of humans infected with dengue virus. We plan to do this by examining the action of the enzyme, determining its three dimensional structure, and using computers and chemical methods to obtain very powerful blockers of enzyme action. These drug candidates will be tested against the enzyme, against cells infected with virus, and in rats to find out if they can be administered by mouth or by injection and if they have any toxic side effects. This project will provide valuable information about how to develop drugs to stop dengue fever and its associated illnesses."},"children":[{"color":"#336699","name":"Prof Paul Young","data":{"first_name":"Paul","title":"Prof","dw_individual_id":"DW0005625","middle_name":"R","last_name":"Young","source_individual_id":"RMIS20614","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Paul Young"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78234","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1748","size":1},{"color":"#FF4D4D","name":"Flavivirus replication - biogenesis, ultrastructure and roles of induced membranes","data":{"media_summary":"","end_year":2002,"keywords":["Assembly of flavivirus particles","Biogenesis of membranes induced by flavivirus infection","Flavivirus replication using Kunjin virus as a model","Helper system for replication of hepatitis C virus","Roles of flavivirus induced membranes"],"nhmrc_grant_id":102481,"application_year":1999,"health_keywords":["Australian encephalitis and related flavivirus infections","Creating a in vitro replication system for hepatitis C virus","Targets for design of antiviral chemotherapy"],"scientific_title":"Flavivirus replication - biogenesis, ultrastructure and roles of induced membranes","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Jason Mackenzie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102481","simplified_title":"Where and how the viruses causing Australian encephalitis and dengue multiply in cells","sub_type":"Standard Project Grant","total_budget":"334880.93","source_system":"Flaviviruses are the agents of many mosquito-transmitted infections such as encephalitis and dengue, and hepatitis C virus is a member of the same virus family. During virus multiplication in cells, new membrane structures are induced and these represent regions where the replication events occur. Using Kunjin virus, an agent of Australian encephalitis, as a model, and advanced techniques in biochemistry and electron microscopy, we have previously identified these membranes as the site of synthesis of the viral RNA or genetic material, and the viral proteins involved. These comprise the viral replication complex. The research will define the origin of these membranes, and how the components of the associated replication complex are assembled. Assembly of the virus particles in cells is also being analysed using similar technology. Hepatitis C virus cannot be reliably grown at present for research purposes in cultured cells, and we will attempt to develop a helper system to overcome the problem. An understanding of these processes, and how the viral RNA is copied into progeny RNA for new virus particles, may assist in the development of antiviral drugs for treatment of slow or persistent virus infections such as hepatitis C."},"children":[{"color":"#336699","name":"A/Pr Jason Mackenzie","data":{"first_name":"Jason","title":"A/Pr","dw_individual_id":"DW0038214","middle_name":"M","last_name":"Mackenzie","source_individual_id":"RMIS56171","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Jason Mackenzie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86904","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1747","size":1},{"color":"#FF4D4D","name":"Targeting alpha-conotoxin MII to inhibit neuronal nicotinic acetylcholine alpha3beta2 receptors of the CNS","data":{"media_summary":"","end_year":2002,"keywords":["Conotoxin","Drug Delivery","Liposaccharides","Oral absorption","Peptide delivery"],"nhmrc_grant_id":102477,"application_year":1999,"health_keywords":["Neuronal nicotinic acetylcholine receptor","Nicotine addiction","Oral drug administration"],"scientific_title":"Targeting alpha-conotoxin MII to inhibit neuronal nicotinic acetylcholine alpha3beta2 receptors of the CNS","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmaceutical Sciences and Pharmacy","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Istvan TOTH","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102477","simplified_title":"Delivering potent nicotinic antagonists to the brain","sub_type":"Standard Project Grant","total_budget":"218334.85","source_system":"Nicotinic acetylcholine receptors (nAChRs) play a central role in nerve signal transmission, neurite growth and development and are the representative model of the ligand-gated ion channel superfamily. Recent studies, including those from Dr Lewis' and A-Prof Alewood's laboratories, have identified alpha-conotoxin peptides which can discriminate among the different nAChRs, apparently by binding to the specific interfaces formed by different subunit combinations. Thus alpha-conotoxins are unique tools with which to identify and determine the physiological role, played by the different native neuronal nAChRs. Moreover, they are unusually stable peptides and can withstand enzyme and acid treatment. These findings have encouraged us to pursue the viability of alpha-conotoxin MII as a new and selective antagonist for the neuronal nictotinic receptor alpha3 beta2 which is involved in nicotine addiction. The challenge and major goal of this project is to deliver alpha-conotoxin MII efficiently into the brain. A-Prof Toth has developed a novel drug-delivery system for the oral administration of drugs and peptides, which in their unmodified form are poorly absorbed or biologically unstable. In this project alpha-conotoxin MII will be combined with a specifically designed lipopolysaccharide delivery system . The delivery system can be specifically tailored to transport a wide variety of peptides through the different biological barriers. The peptides can be conjugated to the delivery system in such a way as to release the peptide after it has been absorbed (prodrug), or to form a biologically stable and active novel molecule. The outcomes of this work will include the first delivery system of nicotinic antagonists to the brain and new knowledge concerning the importance of the neuronal nictotinic receptor alpha3 beta2 in nicotine addiction."},"children":[{"color":"#336699","name":"Prof Istvan Toth","data":{"first_name":"Istvan","title":"Prof","dw_individual_id":"DW0034329","middle_name":"","last_name":"Toth","source_individual_id":"RMIS17214","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Istvan Toth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85883","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1746","size":1},{"color":"#FF4D4D","name":"Effects of risk factor control on atherosclerosis, vasoreactivity and cardiac ischemia in patients on dialysis   ","data":{"media_summary":"","end_year":2002,"keywords":["Atherogenesis","Coronary disease - diagnosis","Coronary disease - drug therapy","Hyperlipidemia","Renal failure"],"nhmrc_grant_id":102471,"application_year":1999,"health_keywords":["Atherogenesis","Coronary disease - diagnosis","Renal failure"],"scientific_title":"Effects of risk factor control on atherosclerosis, vasoreactivity and cardiac ischemia in patients on dialysis   ","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Thomas Marwick","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102471","simplified_title":"Cardiac risk factors in renal failure","sub_type":"Standard Project Grant","total_budget":"212126.37","source_system":"End-stage renal failure is one of the commonest serious chronic diseases; in Australia, over 10,000 patients are in dialysis programs or have functioning transplants. The commonest cause of death in this patient group is coronary artery disease, and attempts are routinely made to identify patients with this problem, with the intent of controlling this risk by angioplasty or bypass surgery. Unfortunately, these procedures may be less effective than usual, because the process of artery narrowing is more aggressive in patients with renal disease. Moreover, this process may cause patients with negative testing for coronary disease at one point in time to develop coronary problems over follow-up. In this study, we propose to use a standard stress testing protocol to stratify the risk of coronary events in a group of at risk patients on dialysis. Those at highest risk will undergo bypass surgery, while those at intermediate and low risk will be randomized to usual care, or an aggressive treatment of atheroma with cholesterol reduction, folic acid supplementation (aiming to normalize homocysteine), blood pressure and blood sugar control. The effects of this approach will be followed by examination of biochemical markers of atherosclerosis, and imaging of arterial thickness and reactivity (reflecting tests of structure and function of the vasculature). We will also assess of the progression or reduction of abnormal cardiac stress responses, and the occurence of events at follow-up. Finally, follow-up data will be used to compare the predictive value of the 2 stress testing protocols. The results of this study will enhance our understanding of the importance of the atherosclerotic process in renal patients, and move the management approach for coronary disease in renal failure toward active risk factor control and away from revascularization."},"children":[{"color":"#336699","name":"Prof Thomas Marwick","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0032377","middle_name":"Hugh","last_name":"Marwick","source_individual_id":"RMIS108223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Marwick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85383","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1745","size":1},{"color":"#FF4D4D","name":"T cell apoptosis in multiple sclerosis and experimental autoimmune encephalomyelitis","data":{"media_summary":"","end_year":2002,"keywords":["Apoptosis","Experimental autoimmune encephalomyelitis","Multiple sclerosis","Neuroimmunology","T cell"],"nhmrc_grant_id":102468,"application_year":1999,"health_keywords":["Demyelinating disease","Multiple sclerosis","Nervous system"],"scientific_title":"T cell apoptosis in multiple sclerosis and experimental autoimmune encephalomyelitis","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael Pender","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102468","simplified_title":"T lymphocyte apoptosis in multiple sclerosis and an experimental model","sub_type":"Standard Project Grant","total_budget":"299950.17","source_system":"Multiple sclerosis is a disease of the nervous system and is a common cause of disability in young adults. There is increasing evidence that multiple sclerosis is caused by repeated attacks on the nervous system by the white blood cells (lymphocytes) of the body's own immune system. A major unanswered question in multiple sclerosis is why repeated immune attacks on the nervous system occur. I have recently proposed that the repeated nature of the immune attacks in multiple sclerosis results from a failure of the mechanism that switches off immune attacks on the nervous system in healthy individuals. In an animal model of multiple sclerosis we have shown that the lymphocytes attacking the nervous system rapidly commit suicide in the nervous system by a process known as apoptosis, and that this is associated with switching off of the immune attack and recovery from the disease. The present project aims to study further this process of lymphocyte suicide in experimental animals by determining whether the lymphocyte suicide is mediated through a death receptor molecule named Fas (CD95). The project will also investigate the process of lymphocyte suicide in white blood cells obtained from patients with multiple sclerosis to determine if this process is defective and to determine whether these patients have abnormalities in the Fas molecular pathway. This project will shed light on the question of why repeated immune attacks on the nervous system occur in multiple sclerosis, and has the potential to lead to the development of new treatments for multiple sclerosis."},"children":[{"color":"#336699","name":"Prof Michael Pender","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0009604","middle_name":"P","last_name":"Pender","source_individual_id":"RMIS18293","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Pender"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79308","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1744","size":1},{"color":"#FF4D4D","name":"Structural studies on SNARE proteins involved in insulin action","data":{"media_summary":"","end_year":2002,"keywords":["SNARE proteins","heterologous expression","protein structure","protein trafficking","vesicle transport"],"nhmrc_grant_id":102467,"application_year":1999,"health_keywords":["diabetes mellitus","hyperglycaemia","insulin resistance"],"scientific_title":"Structural studies on SNARE proteins involved in insulin action","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Martin","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102467","simplified_title":"Understanding how insulin regulates blood glucose","sub_type":"Standard Project Grant","total_budget":"308263.18","source_system":"Diabetes mellitus, a disease characterised by high blood glucose levels, is caused by a relative or absolute deficiency in the activity of insulin. The blood-glucose lowering action of insulin is a result of its ability to stimulate glucose uptake by fat and muscle cells. A major goal of Professor James' laboratory is to identify molecules that are involved in this insulin-regulated uptake of glucose. Professor James has identified and characterised the glucose transporter, GLUT4, a protein that is normally stored inside muscle and fat cells. In response to insulin stimulation, GLUT4 moves to the cell surface where it functions to transport glucose into the cell. Over the past 5 years Professor James laboratory has, in conjunction with other groups, discovered several key proteins that are involved in the insulin-regulated movement of GLUT4 within the cell. We plan to exploit the therapeutic potential of this biological system by obtaining high resolution three dimensional structures of these key proteins. The resulting structural information will allow us to develop compounds that modify the function of these key proteins. Such compounds could prove useful as novel therapeutic agents in the treatment of diabetes. The purpose of this proposal is to begin to implement this goal. By combining the knowledge and reagents coming out of the work on insulin-regulated glucose transport in Professor James' laboratory with the molecular and structural biology expertise in Dr Martin's, Dr Halliday's and Prof Craik's laboratories we are in a unique position to achieve this highly significant goal."},"children":[{"color":"#336699","name":"Prof Jennifer Martin","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0008922","middle_name":"Louise","last_name":"Martin","source_individual_id":"5022915","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jennifer Martin"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79117","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1743","size":1},{"color":"#FF4D4D","name":"Clinical correlates of the wish to hasten death among the terminally ill","data":{"media_summary":"palliative / hospice care","end_year":2001,"keywords":["cancer","consultation-liaison psychiatry","euthanasia","palliative care","terminal illness"],"nhmrc_grant_id":102464,"application_year":1999,"health_keywords":["cancer","depression / anxiety","doctor-patient communication","euthanasia","palliative / hospice care"],"scientific_title":"Clinical correlates of the wish to hasten death among the terminally ill","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Health Services Research","for_category":"CLINICAL SCIENCES","cia_name":"Prof Brian Kelly","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102464","simplified_title":"Factors associated with terminally ill patients' request for euthanasia","sub_type":"Standard Project Grant","total_budget":"131360.18","source_system":"There is little research that has directly examined the role of the health professional in a patient's wish to die and the implications of this for the support and development of services to provide care to a dying patient. The aim of this study is to examine factors in the health service, clinical care and social environment that influence the wish to hasten death among terminally ill patients. This is an issue of increasing importance in our community as legislative change is undertaken to enable assisted suicide in the terminally ill. In particular, there is very limited published research on these issues which have accessed a subject pool of patients who are based in services that specifically provide care for the terminally ill. A specific focus of this study is to examine the factors within the doctor-patient relationship that may influence a patient's wish to hasten death. The doctor's experience of subjective burden in caring for a dying patient, level of confidence in patient management and features of the doctor-patient relationhip will be assessed. This will essentially be an exploratory study which will attempt to establish methodologies that will help to increase an understanding of why some patients request euthanasia, thus leading to the establishment of sound management strategies, as well as contribute empirical data to the euthanasia debate."},"children":[{"color":"#336699","name":"Prof Brian Kelly","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0025923","middle_name":"","last_name":"Kelly","source_individual_id":"5015646","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Brian Kelly"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83688","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1741","size":1},{"color":"#FF4D4D","name":"Cytokine secretion: A model for protein trafficking.","data":{"media_summary":"","end_year":2002,"keywords":["Golgi complex","cytokine","cytoskeleton","protein secretion","vesicle trafficking"],"nhmrc_grant_id":102461,"application_year":1999,"health_keywords":["autoimmunity","cancer/cachexia","inflammation","septic shock"],"scientific_title":"Cytokine secretion: A model for protein trafficking.","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102461","simplified_title":"Cytokine secretion.","sub_type":"Standard Project Grant","total_budget":"204111.48","source_system":"TNF-a is an inflammatory cytokine with important roles in host defense, tumour regulation and energy homeostatis, however the oversecretion of TNF-a is also a major cause of septic shock, rheumatoid arthritis, Chron?s disease and the cachexia of cancer. TNF-a synthesis and its release from the surface of cells are relatively well understood. However little is known about its trafficking through the secretory pathway of cells. Understanding this process has the potential to provide new ways of controlling the secretion of TNF-a. In previous work we have characterized transport vesicles and cytoskeletal proteins involved in secretory pathways of epithelial cells. We now propose to focus on the characterization of transport vesicles, and the roles of actin and myosins involved in TNF-a secretion in macrophages. These studies will rely on introducing new technology to this line of research. Fluorescent tagged constructs of TNF-a will be expressed and viewed in living cells to analyse the secretory pathway and measure the transport of TNF-a from its site of accumulation in the Golgi complex to the cell surface. This work aims to identify membrane-bound vesicles and vesicle-associated proteins that target TNF-a for secretion. We will begin to investigate the role of actin and myosins, using drugs and microinjected peptides to block their function. Overall these studies will provide important cell biological information about protein trafficking in cells. Cytokine secretion is important in immunity and cancer, information important to both fields will be gained from these studies."},"children":[{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1739","size":1},{"color":"#FF4D4D","name":"Recycling of E-cadherin: implications for dynamic cell adhesion","data":{"media_summary":"","end_year":2002,"keywords":["Cell adhesion","Clathrin-coated vesicles","Endocytosis","Epithelial morphogenesis","Tissue patterning"],"nhmrc_grant_id":102460,"application_year":1999,"health_keywords":["Cancer of the colon","Embryonic development","Metastasis","Tumor progression"],"scientific_title":"Recycling of E-cadherin: implications for dynamic cell adhesion","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102460","simplified_title":"Trafficking of E-cadherin","sub_type":"Standard Project Grant","total_budget":"250494.87","source_system":"E-cadherin is one of the major proteins responsible for mediating cell-to-cell adhesion in the body. During embryonic development E-cadherin is essential for establishing the normal body pattern and the cellular architecture of many epithelial organs. Throughout life E-cadherin serves to maintain epithelial barriers, such as the lining of the digestive tract. E-cadherin has been clearly identified as a tumour suppressor molecule: loss of normal E-cadherin function leads to tumour metastasis and cancer invasion. It is therefore essential to understand the physiological function and regulation of E-cadherin in cells. E-cadherin is normally expressed on the surface of cells for adhesion to neighbouring cells. Recently, we found that cells can internalise and recycle this surface E-cadherin: even in mature epithelia, a proportion of the E-cadherin molecules appear to undergo constant movement in and out of the cell. It is likely that this mechanism participates in the dynamic remodelling of adhesive contacts between cells in organs such as the gastrointestinal tract and during wound healing. Corruption of this recycling mechanism could also potentially contribute to tumorigenesis. In this grant we propose to build upon this discovery by investigating molecular and cellular mechanisms that mediate E-cadherin recycling. We will characterize the cellular pathways by which E-cadherin is trafficked. The signaling pathways that regulate recycling will be analysed, since these may be perturbed in cancer and inflammation. Other molecules that interact with E-cadherin will be studied to determine whether they too recycle. The information from these studies will have broad implications for understanding the role of E-cadherin in healthy organs and in common cancers."},"children":[{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1738","size":1},{"color":"#FF4D4D","name":"A polyepitope HPV16 E7 DNA vaccine restricted through multiple class 1 haplotypes protects against E7-expressing tumour","data":{"media_summary":"","end_year":2002,"keywords":["Cancer vaccine","Cellular immunotherapy","Mice, transgenic","T-lymphocytes, cytotoxic"],"nhmrc_grant_id":102458,"application_year":1999,"health_keywords":["Cervical cancer","Immunotherapy","vaccine therapy"],"scientific_title":"A polyepitope HPV16 E7 DNA vaccine restricted through multiple class 1 haplotypes protects against E7-expressing tumour","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Tumour Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof ROBERT TINDLE","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102458","simplified_title":"A cervical cancer vaccine for the out-bred human population","sub_type":"Standard Project Grant","total_budget":"218244.4","source_system":"Evidence that cervical cancer is caused by Human Papillomavirus is compelling. Once the virus enters the cells of the cervix, it produces a protein named E7 which functions to make the cells cancerous. Cervical cancer is the 5th commonest cause of death in women in Australia, and the major killer of women world-wide.The disease is particularly severe in those women whose immune systems are impaired, indicating immunological control of the cancerous cells . Current therapies including surgical removal are frequently inadequate, and the r is no effective drug to combat the virus.These observations indicate that a vaccine is warranted, and that the E7 protein may be an ideal target for the vaccine. Cervical tumour cells are killed by specialised immune system cells named CTLs which recognise fragments of foreign antigen(E7) on their surface bound to selfMHC molecules. Our work has shown that multiple antigen fragments can be encoded and stitched together in a genetic vaccine which will stimulate CTLs to function in a number of 'self'molecule situations Our laboratory has developed several mouse models of human cervical cancer , and (along with others) has worked out which parts of the E7 protein are importatnt in developing an appropriate immune response to control tumour growth when given as a vaccine. One animal model consists of mice which are genetically engineered to produce several types of selfmolecules and also E7. Thes mice develop skin tumours as result of E7 expression. This system provides model of cervical epithelial tumours caused by E7 expression in women.Thus we can ask the questions o can we elicit CTL responses which function in the context of humanself ? o Will these CTL responses prevent the growth of E7-induced epithelial tumours? The OUTCOME of the project will be a vaccine which will prevent the establishment of cervical cancer which can progress directly into clinical trials in women bearing appropriate selfmolecules."},"children":[{"color":"#336699","name":"Prof Robert Tindle","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0028412","middle_name":"W","last_name":"Tindle","source_individual_id":"RMIS388145","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Robert Tindle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84347","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1737","size":1},{"color":"#FF4D4D","name":"Analysis of the C-terminal hypervariable region of Ras proteins","data":{"media_summary":"","end_year":2002,"keywords":["Lipid modifications","Plasma membrane","Ras proteins","Vesicular trafficking"],"nhmrc_grant_id":102457,"application_year":1999,"health_keywords":["Colon cancer","General Oncology","Leukaemia"],"scientific_title":"Analysis of the C-terminal hypervariable region of Ras proteins","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Protein Targeting and Signal Transduction","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof John Hancock","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102457","simplified_title":"A study of the biology of Ras proteins","sub_type":"Standard Project Grant","total_budget":"419241.16","source_system":"In human cancers one or more of the signaling pathways leading from growth factor receptors at the cell surface to the nucleus where cell division is initiated are subverted. For example, a protein called Ras, that regulates one major signaling pathway, is mutated in 90% of pancreatic cancers, 50% of colon cancers and 30% of acute leukaemias. This leaves Ras and the signaling pathway permanently switched on causing uncontrolled cell proliferation. The clinical impact of drugs that could neutralise Ras function in these tumours is potentially enormous. Our previous work demonstrated that Ras must be attached to the inner surface of the cell membrane in order to function properly. This project now seeks to understand exactly how Ras gets to and attaches to the cell membrane. Once we understand this mechanism drugs can be designed to block Ras getting to the membrane. Such drugs should neutralize the effect of Ras in tumours and control cell proliferation. In fact, our previous study has already led to the identification of the first generation of anti-Ras drugs that work on this principle."},"children":[{"color":"#336699","name":"Prof John Hancock","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0037089","middle_name":"F","last_name":"Hancock","source_individual_id":"RMIS11500","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Hancock"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86600","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1736","size":1},{"color":"#FF4D4D","name":"Taurine Transporters and Brain Taurine Homeostasis","data":{"media_summary":"","end_year":2002,"keywords":["brain","neurones","retina","taurine","transporters"],"nhmrc_grant_id":102448,"application_year":1999,"health_keywords":["brain development","epilepsy","macular degeneration","neurodegeneration"],"scientific_title":"Taurine Transporters and Brain Taurine Homeostasis","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Neurochemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof David Pow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102448","simplified_title":"Taurine Transporters in the Brain","sub_type":"Standard Project Grant","total_budget":"226034.27","source_system":"Taurine is a very abundant amino acid in the brains of all mammals. Some animals such as cats gain almost all their taurine from their diet; others such as rats make significant amounts of taurine themselves; humans lie somewhere between these two extremes. Despite the variation in sources of taurine it has been standard practise for well over a decade to include taurine in human infant milk formulae because lack of dietary taurine in kittens leads to epileptic fits and abnormalities in brain development, whilst in adult cats death of cells such as photoreceptors (in the eye) is also observed. Despite these observations we have very little knowledge as to what taurine does in the brain because we have no selective drugs to examine the site or sites of taurine action. We hypothesise that taurine might mediate its actions by modifying the intracellular and extracellular levels of other neurotransmiters, especially glutamate. We plan to examine the brains and retinas of adult cats and kittens which have been given a diet deficient in taurine. We will determine the levels of each of the main neurotransmitters in the brain, both as global assays of whole tissues and at the cellular level by immunocytochemistry. We will examine whether there are any compensatory changes in levels of expression of taurine transporters as the body becomes depleted of taurine (since taurine content of nerve cells will be regulated by uptake of taurine in the absence of endogenous synthesis). Expression of glutamate transporters will also be examined. By understanding the way that the major neurotransmiter systems respond to a reduction in taurine levels we hope to generate both descriptive and predictive models that define the roles of taurine in the mammalian nervous system and which may give insights into mechanisms of significant human disease processes including epilepsy and a series of conditions involving degeneration of photoreceptors."},"children":[{"color":"#336699","name":"Prof David Pow","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0021533","middle_name":"Vaughan","last_name":"Pow","source_individual_id":"RMIS4392155","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Pow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82534","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1734","size":1},{"color":"#FF4D4D","name":"A novel lipidic adjuvant carrier system for vaccination including vaccination via the oral route","data":{"media_summary":"Oral vaccination","end_year":2002,"keywords":["Adjuvant carrier system","Drug Delivery","Enhanced immunogenicity","Lipid-core-immunogen (LCI) system","Lipoamino acids"],"nhmrc_grant_id":102439,"application_year":1999,"health_keywords":["Foot and Mouth Disease Virus","Group A Streptococcal Peptide Vaccine","Immunisation","Nisseria Meningitidis","Oral vaccination"],"scientific_title":"A novel lipidic adjuvant carrier system for vaccination including vaccination via the oral route","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmaceutical Sciences and Pharmacy","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Istvan TOTH","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102439","simplified_title":"A novel adjuvant for vaccination","sub_type":"Standard Project Grant","total_budget":"214593.26","source_system":"We have developed a Lipid-Core-Peptide vaccine adjuvant system, based on the incorporation of lipoamino acids into poly-functional moiety that provides an excellent means for enhancing the antigenicity of a potential peptide-vaccine. As the system contains many variables, which allow substantial modifications to be made, we now wish to fully optimise its structural configuration. A library of spacer-lipoamino acid-poly-functional multiplier systems will be synthesised on solid phase. Model peptide epitopes will be synthesised on these different lipid-core systems and the antibody response will be compared with the response of the model peptide epitopes coupled to conventional vaccine carriers. The Lipid-Core Immunogen constructs including particulate systems will be administered orally as well, followed by measurement of the serum IgG response and the secretory IgA. This novel system can be used for any potential vaccine-peptide epitope and can open a new route to modern vaccination. The specific advantages of these kind of synthetic vaccines include the greater stability of the vaccine, reproducibility, eliminate the use of toxic conventional adjuvants. The key to this system is a novel carrier construct, which is non-toxic and not immunogenic. The system confers immunity with smaller risk of reaction, since it generates antibody production only against the infective microorganism. Vaccination via the oral route is highly desirable since it can overcome many of the disadvantages inherent in administration by injection - e.g. poor patient acceptability, requirement for skilled medical personnel, risk of HIV and other blood-borne diseases, restricted availability and, in cases, stimulation of the wrong type of immunity. Development of vaccines for oral administration will make them much more widely available, permitting self-administration by patients and markedly improving the operation of Public Health vaccination programs, particularly in developing countries."},"children":[{"color":"#336699","name":"Prof Istvan Toth","data":{"first_name":"Istvan","title":"Prof","dw_individual_id":"DW0034329","middle_name":"","last_name":"Toth","source_individual_id":"RMIS17214","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Istvan Toth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85883","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1732","size":1},{"color":"#FF4D4D","name":"Adolescent depression: Evaluation of a preventive intervention and identification of risk factors","data":{"media_summary":"","end_year":2002,"keywords":["Adolescent depression","Cognitive-behaviour therapy","Prevention","Risk and protective factors","School-based interventions"],"nhmrc_grant_id":102431,"application_year":1999,"health_keywords":["Adolescent depression","Adolescent mental health","Prevention"],"scientific_title":"Adolescent depression: Evaluation of a preventive intervention and identification of risk factors","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Mental Health","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Susan Spence","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102431","simplified_title":"Prevention of adolescent depression and identification of risk factors","sub_type":"Standard Project Grant","total_budget":"307313.33","source_system":"This project will evaluate the long-term effectiveness of a school-based program to prevent depression among adolescents. It also aims to identify factors that predict the onset of depression in those who do not receive the intervention. The intervention focuses on the training of interpersonal problem solving skills and enhancement of optimistic thinking styles within a classroom-based curriculum. This project extends the current research program of the applicant. The intervention has already been developed and implemented with 1600 young people, with the support of local education authorities. The evaluation uses well-researched measures and includes a control group of adolescents who do not receive the intervention. Around 5% of adolescents experience clinical levels of depression and an even larger percentage show subclinical levels. Depression results in many debilitating consequences such as impaired school, work and social functioning and is also a risk factor in adolescent suicide. The prevention of mental health problems is a priority for Commonwealth and State governments and yet there is minimal research to demonstrate the effectiveness of preventive interventions, particularly in the area of depression. If the present study demonstrates a positive outcome, it will provide important guidelines as to preventive materials that should be included in the school curriculum. It is predicted that: a) the intervention will be associated with lower levels of depression over the 4 year follow-up, particularly for adolescents who are assessed as showing mild symptoms of depression, poor problem solving skills or pessimistic cognitive style prior to intervention b) risk factors for the development of depression in adolescents who do not receive the intervention will include initial mild symptoms of depression, poor problem solving skills and pessimistic attributional style."},"children":[{"color":"#336699","name":"Prof Susan Spence","data":{"first_name":"Susan","title":"Prof","dw_individual_id":"DW0022261","middle_name":"Hilary","last_name":"Spence","source_individual_id":"RMIS29798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Susan Spence"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82741","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1731","size":1},{"color":"#FF4D4D","name":"The plasmalemmal calcium pump and vascular smooth muscle cell proliferation.","data":{"media_summary":"","end_year":2002,"keywords":["calcium","calcium pump","cellular signalling","pharmacology","signal transduction"],"nhmrc_grant_id":102426,"application_year":1999,"health_keywords":["cardiovascular disease","smooth muscle proliferation","vascular smooth muscle"],"scientific_title":"The plasmalemmal calcium pump and vascular smooth muscle cell proliferation.","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Cell Physiology","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"A/Pr Gregory Monteith","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102426","simplified_title":"A pump which removes calcium: is it important in the growth of smooth muscle?","sub_type":"New Investigator Grant","total_budget":"179593.2","source_system":"Excessive growth of smooth muscle cells can lead to adverse effects in our arteries. The level of calcium inside the muscle cells that line our arteries appears to regulate their growth. In these studies we will assess the changes in the synthesis (expression) of a pump which removes calcium from cells. We will also characterise the effects of modifiers of cell growth on the expression of the calcium pump. The effect of directly inhibiting the production of the calcium pump, on the growth of smooth muscle cells and the regulation of calcium will be determined for the first time."},"children":[{"color":"#336699","name":"Prof Gregory Monteith","data":{"first_name":"Gregory","title":"Prof","dw_individual_id":"DW0009187","middle_name":"Raymond","last_name":"Monteith","source_individual_id":"RMIS3112522","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gregory Monteith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79194","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1730","size":1},{"color":"#FF4D4D","name":"Peroxisome proliferator-activated receptors: A role in the promotion of mammary gland carcinogenesis by dietary fat.","data":{"media_summary":"","end_year":2002,"keywords":["Carcinogenesis, chemical","Dietary fat","Heterocyclic amine","Mammary gland cancer","Toxicology"],"nhmrc_grant_id":102422,"application_year":1999,"health_keywords":["High fat diet","Mammary gland cancer","women's health"],"scientific_title":"Peroxisome proliferator-activated receptors: A role in the promotion of mammary gland carcinogenesis by dietary fat.","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Toxicology (incl. Clinical Toxicology)","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"A/Pr Sarah Roberts-Thomson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102422","simplified_title":"The way in which a high fat diet may increase breast cancer incidence","sub_type":"New Investigator Grant","total_budget":"188702.04","source_system":"Breast cancer is a leading cause of death in Australian women. While some women have a hereditary predisposition to breast cancer, for most women a variety of factors are responsible for their disease. One thing that appears to be important as a cause of breast cancer is our diet. There are many components of the diet that may play a role. One important factor is the amount and type of fat that we consume. Just how dietary fat causes an increase in breast cancer is not known. What this project aims to achieve is an understanding of how dietary fat and breast cancer are related. If we can understand this then we can rationally design treatments or a preventative strategy."},"children":[{"color":"#336699","name":"Prof Sarah Roberts-Thomson","data":{"first_name":"Sarah","title":"Prof","dw_individual_id":"DW0004272","middle_name":"Jane","last_name":"Roberts-Thomson","source_individual_id":"RMIS5900691","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Sarah Roberts-Thomson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77861","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1729","size":1},{"color":"#FF4D4D","name":"Molecular analysis of the function of a muscle-specific caveolar protein","data":{"media_summary":"","end_year":2002,"keywords":["Caveolae","Cell biology","Membrane traffic","Muscle","Transverse tubules"],"nhmrc_grant_id":102419,"application_year":1999,"health_keywords":["Cholesterol regulation","Heart disease","Muscle disease","Muscular dystrophy"],"scientific_title":"Molecular analysis of the function of a muscle-specific caveolar protein","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Membrane Biology","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102419","simplified_title":"The role of a muscle membrane protein in muscular dystrophy","sub_type":"Standard Project with Research Fellowship","total_budget":"462528.29","source_system":"Muscular dystrophy is one of the most common and most debilitating inherited diseases in humans. Muscle from patients with muscular dystrophy is highly susceptible to damage leading to muscle wasting. In order to understand muscular dystrophy and to design therapeutic treatments, it is essential that researchers gain a detailed understanding of the workings of the muscle cell surface membrane. Caveolae are small pits which cover the entire surface of the muscle fibre. The major protein of muscle caveolae is caveolin-3, and mutations in this protein cause some forms of muscular dystrophy. This proposal aims to examine the function of this protein using a number of strategies. The caveolin-3 gene will be disrupted in mice to produce mice which lack this protein. The muscle from these mice will then be examined to see what effect the lack of this protein has on muscle function and whether this muscle is similar to that in patients with muscular dystrophy. The muscle from these mice will then be used to design treatments for the disease. In addition, we will search for proteins which work together with caveolin-3 in order to understand how the protein works in healthy and diseased muscle."},"children":[{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1727","size":1},{"color":"#FF4D4D","name":"The Characterisation of the Genetic basis of Paget's Disease of Bone","data":{"media_summary":"","end_year":2001,"keywords":["Genetic Analysis","Paget's Disease of Bone","Paget's Sarcoma"],"nhmrc_grant_id":102410,"application_year":1999,"health_keywords":["Paget's Disease of Bone","Paget's Sarcoma","Skeletal System and Disorders"],"scientific_title":"The Characterisation of the Genetic basis of Paget's Disease of Bone","start_year":2001,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Genetics","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Joanne Shaw","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102410","simplified_title":"Genetics of Paget's Disease of Bone","sub_type":"Standard Project Grant","total_budget":"266402.37","source_system":"Paget's disease is a bone disease in which the normal process of bone being formed and then broken down doesn't take place in the usual way. This results in bones that are enlarged, misshapen, dense and fragile. Paget's disease usually affects people of middle age or older. Although some cases are asymptomatic, Paget's disease is a major cause of bone pain and deformity. In Australia, 3-5% of people aged 40 years and over have Paget's disease. Paget's disease usually affects one of the long bones in the leg, the pelvic bone, the skull or the spine. One of the most serious complications of Paget's disease is the devlopment of bone cancer. A genetic predisposition is an important factor in the development of Paget's disease. At least a quarter of patients with Paget's disease have at least one close relative with the same condition. Although it is more than 100 years since Sir James Paget first described Paget's disease, the underlying cause remains unknown. We have identified a large family with over 200 members in which there are 35 subjects affected by Paget's disease. The pattern of inheritance in this family is consistent with an autosomal dominant disorder. We have identified a discrete genetic region that is linked with the inheritance of Paget's disease in this family, indicating that a suscpetibility gene for Paget's disease lies in this region. The research program outlined in this application will refine this localisation and will define and characterise this susceptibility gene for Paget's disease. This research program is of great clinical relevance as the identification of the causative gene will open up new approaches for the treatment and prevention of this disease."},"children":[{"color":"#336699","name":"A/Pr Joanne Shaw","data":{"first_name":"Joanne","title":"A/Pr","dw_individual_id":"DW0039647","middle_name":"T.E.","last_name":"Shaw","source_individual_id":"RMIS13660","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Joanne Shaw"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87282","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1726","size":1},{"color":"#FF4D4D","name":"What factors affect lesion distribution in multiple sclerosis and experimental autoimmune encephalomyelitis?","data":{"media_summary":"","end_year":2000,"keywords":["T cells and antibody","encephalomyelitis, allergic/immunology/pathology","magnetic resonance imaging and lesion localization","multiple sclerosis","myelin proteolipid protein"],"nhmrc_grant_id":102408,"application_year":1999,"health_keywords":["brainstem lesions","cerebellar lesions","disease progression","multiple sclerosis"],"scientific_title":"What factors affect lesion distribution in multiple sclerosis and experimental autoimmune encephalomyelitis?","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Judith Greer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/102408","simplified_title":"Why do lesions occur where they do in multiple sclerosis?","sub_type":"Bridging","total_budget":"56797.98","source_system":"Multiple sclerosis (MS) is a common neurological disease which affects about 10,000 people in Australia. In MS, a persons own immune system starts to attack specific parts of their brain and spinal cord, causing lesions that prevent nerve impulses from passing from the brain to other parts of the body. The symptoms that people with MS develop can vary from one person to another, depending on where in the brain or spinal cord the lesions occur. Some parts of the brain and spinal cord seem to be much more susceptible to this attack than others, and the question that this study will address is why do lesions occur where they do in MS? Some preliminary results strongly suggest that there is a link between carrying particular genes that control immune responses, having immune cells that can attack one particular protein in the nervous system called PLP, and developing lesions in parts of the brain that control balance. This will be investigated further, and we will also look for other links between immune cells that can attack other proteins and development of lesions in particular areas. If such links can be identified, they would be very important for improved diagnosis of MS and it would enable more specific treatments for MS to be developed. We will also use experimental models of MS to investigate the exact components within the nervous system and within the immune system that play a role in directing the attack to particular sites."},"children":[{"color":"#336699","name":"Dr Judith Greer","data":{"first_name":"Judith","title":"Dr","dw_individual_id":"DW0036976","middle_name":"M","last_name":"Greer","source_individual_id":"RMIS24768","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Judith Greer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86571","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1725","size":1},{"color":"#FF4D4D","name":"Statistical methods for the analysis of trends in coronary heart disease","data":{"media_summary":"","end_year":2001,"keywords":["Cardiovascular disease","Epidemiology","Statistical modelling"],"nhmrc_grant_id":100954,"application_year":1999,"health_keywords":["Coronary heart disease","Prevention","Risk factors"],"scientific_title":"Statistical methods for the analysis of trends in coronary heart disease","start_year":2000,"node_source":"NHMRC","node_type":"Grant","field_of_research":"Applied Statistics","research_area":"Public Health","for_category":"STATISTICS","cia_name":"Prof Annette Dobson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/100954","simplified_title":"Statistical methods for the analysis of trends in coronary heart disease","sub_type":"Standard Project Grant","total_budget":"112747.26","source_system":"Coronary heart disease is a leading cause of mortality, morbidity and medical costs in Australia. During the 1950's and 1960's, rates of coronary disease increased rapidly, then in the late 1960's they started to decline. This decrease has continued steadily for 30 years. While some other westernised countries have had this same experience, in Eastern Europe and in many developing countries coronary disease is increasing. There is a huge amount of evidence from experimental studies in animal and human subjects and population studies in many countries that the major determinants of coronary disease are high blood pressure, cigarette smoking and high cholesterol (and other lipids) as well as dietary factors, obesity and physical inactivity. Recently several large multicentre studies have found unexpectedly weaker associations between heart risk factors and disease rates. It is hypothesised that this is due to inappropriate analyses in which data from populations at different stages of the coronary epidemic have been combined. The aim of this study is to develop improved statistical methodology to help understand recent findings from large scale studies, such as the World Health Organization's MONICA Project, the US ARIC study and the Seven Countries study. It will provide new theoretical results and statistical software for their implementation. From a public health perspective the most important outcome will be clarification of recent apparently anomalous findings about the importance of established risk factors and effective treatments in reducing coronary disease at the population level."},"children":[{"color":"#336699","name":"Prof Annette Dobson","data":{"first_name":"Annette","title":"Prof","dw_individual_id":"DW0036318","middle_name":"J","last_name":"Dobson","source_individual_id":"5011952","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Annette Dobson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86411","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1699","size":1},{"color":"#FF4D4D","name":"The role of PMP-22 as an autoantigen in GBS 7 CIDP","data":{"media_summary":"","end_year":2001,"keywords":["NEUROPATHY","DEMYELINATION","AUTOIMMUNE","T LYMPHOCYTES"],"nhmrc_grant_id":8190,"application_year":1999,"start_year":2000,"scientific_title":"The role of PMP-22 as an autoantigen in GBS 7 CIDP","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Dr Alice-Ann Sullivan","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/8190","simplified_title":"The role of PMP-22 as an autoantigen in GBS 7 CIDP","sub_type":"Medical Postgraduate Scholarship","total_budget":"44819.09","source_system":""},"children":[{"color":"#336699","name":"Dr Alice-Ann Sullivan","data":{"first_name":"Alice-Ann","title":"Dr","dw_individual_id":"DW0010496","middle_name":"","last_name":"Sullivan","source_individual_id":"RMIS706201","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Alice-Ann Sullivan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79551","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1674","size":1},{"color":"#FF4D4D","name":"Insulin sensitivity & signalling in human adipose tissue & skeletal muscle:Effects of tumour necrosis factor t","data":{"media_summary":"","end_year":2002,"keywords":["INSULLIN SIGNALLING","GLUCOSE UPTAKE","HUMAN ADIPOSE TISSUE","SKELETAL MUSCLE"],"nhmrc_grant_id":8177,"application_year":1999,"start_year":2001,"scientific_title":"Insulin sensitivity & signalling in human adipose tissue & skeletal muscle:Effects of tumour necrosis factor t","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Trisha O'Moore-Sullivan","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/8177","simplified_title":"Insulin sensitivity & signalling in human adipose tissue & skeletal muscle:Effects of tumour necrosis factor t","sub_type":"Medical Postgraduate Scholarship","total_budget":"81937","source_system":""},"children":[{"color":"#336699","name":"Dr Trisha O'Moore-Sullivan","data":{"first_name":"Trisha","title":"Dr","dw_individual_id":"DW0009456","middle_name":"M","last_name":"O'Moore-Sullivan","source_individual_id":"RMIS1218754","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Trisha O'Moore-Sullivan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79267","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1666","size":1},{"color":"#FF4D4D","name":"Quantitation of echocardiographic assessment of regional myocardial function","data":{"media_summary":"","end_year":2002,"keywords":["NEW","CARDIAC","IMAGING"],"nhmrc_grant_id":8123,"application_year":1999,"start_year":2000,"scientific_title":"Quantitation of echocardiographic assessment of regional myocardial function","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr P Cain","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/8123","simplified_title":"Quantitation of echocardiographic assessment of regional myocardial function","sub_type":"Medical Postgraduate Scholarship","total_budget":"67926.28","source_system":""},"children":[{"color":"#336699","name":"Dr P Cain","data":{"first_name":"P","title":"Dr","dw_individual_id":"DW0012139","middle_name":"A","last_name":"Cain","source_individual_id":"RMIS706198","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr P Cain"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79984","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1642","size":1},{"color":"#FF4D4D","name":"THE INTERACTION BETWEEN THE HIV TAT PROTEIN AND PKR","data":{"media_summary":"","end_year":2002,"nhmrc_grant_id":7468,"application_year":1999,"start_year":2000,"scientific_title":"THE INTERACTION BETWEEN THE HIV TAT PROTEIN AND PKR","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Mrs Liliana Munoz","higher_grant_type":"CARG - People","purl":"http://purl.org/au-research/grants/nhmrc/7468","simplified_title":"THE INTERACTION BETWEEN THE HIV TAT PROTEIN AND PKR","sub_type":"ANCARD Scholarship","total_budget":"64736.01","source_system":""},"children":[{"color":"#336699","name":"Mrs Liliana Munoz","data":{"first_name":"Liliana","title":"Mrs","dw_individual_id":"DW0032742","middle_name":"B","last_name":"Munoz","source_individual_id":"RMIS706223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mrs Liliana Munoz"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85480","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1593","size":1},{"color":"#FF4D4D","name":"To examine the aggregation of AB into myeloid deposits and to better understand the formation of AB from APP","data":{"media_summary":"","end_year":2001,"keywords":["ALZHEIMER'S DISEASE","AMYLOID","SPECTROSCOPY"],"nhmrc_grant_id":7201,"application_year":1999,"start_year":2000,"scientific_title":"To examine the aggregation of AB into myeloid deposits and to better understand the formation of AB from APP","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and Cell Biology not elsewhere classified","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Sally-Ann Poulsen","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/7201","simplified_title":"To examine the aggregation of AB into myeloid deposits and to better understand the formation of AB from APP","sub_type":"CJ Martin Biomedical ECF","total_budget":"66729.68","source_system":""},"children":[{"color":"#336699","name":"A/Pr Sally-Ann Poulsen","data":{"first_name":"Sally-Ann","title":"A/Pr","dw_individual_id":"DW0004054","middle_name":"","last_name":"Poulsen","source_individual_id":"RMIS679447","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Sally-Ann Poulsen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77797","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1570","size":1},{"color":"#FF4D4D","name":"Defining a role for the retinoblastoma tumour suppressor (pRB) in muscle differentiation","data":{"media_summary":"","end_year":2003,"keywords":["SKELETAL MUSCLE","PRB","AKT/PROTEIN KINASE B","MEF2C","PHOSPHORYLATION"],"nhmrc_grant_id":7145,"application_year":1999,"start_year":2000,"scientific_title":"Defining a role for the retinoblastoma tumour suppressor (pRB) in muscle differentiation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Biochemistry: Other","research_area":"Basic Science","for_category":"MEDICAL BIOCHEMISTRY AND CLINICAL CHEMISTRY","cia_name":"Dr Peter Bailey","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/7145","simplified_title":"Defining a role for the retinoblastoma tumour suppressor (pRB) in muscle differentiation","sub_type":"CJ Martin Biomedical ECF","total_budget":"195894.39","source_system":""},"children":[{"color":"#336699","name":"Dr Peter Bailey","data":{"first_name":"Peter","title":"Dr","dw_individual_id":"DW0029264","middle_name":"J","last_name":"Bailey","source_individual_id":"RMIS706143","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Peter Bailey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84589","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1548","size":1},{"color":"#FF4D4D","name":"High resolution high quality digital time-lapse microscopy system","data":{"media_summary":"","end_year":2000,"nhmrc_grant_id":1528,"application_year":1999,"start_year":2000,"scientific_title":"High resolution high quality digital time-lapse microscopy system","node_source":"NHMRC","node_type":"Grant","field_of_research":"Not Applicable","research_area":"Not Applicable","for_category":"","cia_name":"Prof Brian Key","higher_grant_type":"NHMRC Infrastructure Grants","purl":"http://purl.org/au-research/grants/nhmrc/1528","simplified_title":"High resolution high quality digital time-lapse microsc opy system","sub_type":"Equipment Grant","total_budget":"146078","source_system":""},"children":[{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1418","size":1},{"color":"#FF4D4D","name":"Oral colonization of streptococcus mutans in children","data":{"media_summary":"","end_year":2003,"keywords":["DENTAL CARIES","ABORIGINAL HEALTH","PREVENTIVE DENTISTRY","PRETERM CHILDREN","STREPTOCOCCUS MUTANS"],"nhmrc_grant_id":997665,"application_year":1998,"start_year":1999,"scientific_title":"Oral colonization of streptococcus mutans in children","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Miss Annetta Wan","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/997665","simplified_title":"Oral colonization of streptococcus mutans in children","sub_type":"Gustav Nossal Scholarship","total_budget":"111109.42","source_system":""},"children":[{"color":"#336699","name":"Miss Annetta Wan","data":{"first_name":"Annetta","title":"Miss","dw_individual_id":"DW0028649","middle_name":"K L","last_name":"Wan","source_individual_id":"RMIS705944","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Miss Annetta Wan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84419","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1386","size":1},{"color":"#FF4D4D","name":"A Transgenic Analysis of the Basis for Growth Signalling by the Growth Hormone Receptor","data":{"media_summary":"","end_year":2003,"keywords":["GENE TARGETING","GROWTH HORMONE","SIGNALLING","RECEPTOR DOMAIN","MUTGENESIS"],"nhmrc_grant_id":997630,"application_year":1998,"start_year":1999,"scientific_title":"A Transgenic Analysis of the Basis for Growth Signalling by the Growth Hormone Receptor","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Miss Jennifer Rowland","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/997630","simplified_title":"A Transgenic Analysis of the Basis for Growth Signalling by the Growth Hormone Receptor","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"45816.15","source_system":""},"children":[{"color":"#336699","name":"Miss Jennifer Rowland","data":{"first_name":"Jennifer","title":"Miss","dw_individual_id":"DW0015981","middle_name":"","last_name":"Rowland","source_individual_id":"RMIS705853","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Miss Jennifer Rowland"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81026","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1380","size":1},{"color":"#FF4D4D","name":"Japanese encephalitis virus in the Torres Strait and northern Queensland","data":{"media_summary":"","end_year":2001,"keywords":["JAP ENCEPHALITIS","ECOLOGY, ZOONOSES","VERTEBRATE HOST","ARTHROPOD VECTOR","VIRUS DISPERSAL"],"nhmrc_grant_id":997595,"application_year":1998,"start_year":1999,"scientific_title":"Japanese encephalitis virus in the Torres Strait and northern Queensland","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Public Health","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Cheryl Johansen","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/997595","simplified_title":"Japanese encephalitis virus in the Torres Strait and northern Queensland","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"55048","source_system":""},"children":[{"color":"#336699","name":"Dr Cheryl Johansen","data":{"first_name":"Cheryl","title":"Dr","dw_individual_id":"DW0043313","middle_name":"A","last_name":"Johansen","source_individual_id":"RMIS705862","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Cheryl Johansen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88223","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1373","size":1},{"color":"#FF4D4D","name":"What makes effective teams: Using personal construct theory to investigate health environments","data":{"media_summary":"","end_year":2001,"keywords":["TEAMWORK","EFFECTIVENESS","PERSONAL CONSTRUCT","HEALTH ENVIRONMENT","HEALTH MANAGEMENT"],"nhmrc_grant_id":997557,"application_year":1998,"start_year":1999,"scientific_title":"What makes effective teams: Using personal construct theory to investigate health environments","node_source":"NHMRC","node_type":"Grant","field_of_research":"Environmental and Occupational Health and Safety","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Ms Sharon Mickan","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/997557","simplified_title":"What makes effective teams: Using personal construct theory to investigate health environments","sub_type":"Public Health Postgraduate Scholarship","total_budget":"57682.45","source_system":""},"children":[{"color":"#336699","name":"Ms Sharon Mickan","data":{"first_name":"Sharon","title":"Ms","dw_individual_id":"DW0014983","middle_name":"M","last_name":"Mickan","source_individual_id":"RMIS705930","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Ms Sharon Mickan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80759","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1361","size":1},{"color":"#FF4D4D","name":"Biomarkers of Dietary Intake","data":{"media_summary":"","end_year":2002,"keywords":["DIETARY INTAKE","SKIN CANCER PREVENTI"],"nhmrc_grant_id":997556,"application_year":1998,"start_year":1999,"scientific_title":"Biomarkers of Dietary Intake","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nutrition and Dietetics","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Sarah McNaughton","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/997556","simplified_title":"Biomarkers of Dietary Intake","sub_type":"Public Health Postgraduate Scholarship","total_budget":"81773.02","source_system":""},"children":[{"color":"#336699","name":"A/Pr Sarah Mcnaughton","data":{"first_name":"Sarah","title":"A/Pr","dw_individual_id":"DW0032538","middle_name":"A","last_name":"Mcnaughton","source_individual_id":"RMIS705957","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Sarah Mcnaughton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85425","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1360","size":1},{"color":"#FF4D4D","name":"The relative contribution of cognitive and genetic influences towards alcohol problems","data":{"media_summary":"","end_year":2001,"keywords":["ALCOHOL DEPENDENCE","COGNITIVE","GENETIC DISPOSITION","MEASRUREMENT"],"nhmrc_grant_id":997551,"application_year":1998,"start_year":1999,"scientific_title":"The relative contribution of cognitive and genetic influences towards alcohol problems","node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Jason Connor","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/997551","simplified_title":"The relative contribution of cognitive and genetic influences towards alcohol problems","sub_type":"Public Health Postgraduate Scholarship","total_budget":"58428.85","source_system":""},"children":[{"color":"#336699","name":"A/Pr Jason Connor","data":{"first_name":"Jason","title":"A/Pr","dw_individual_id":"DW0018369","middle_name":"Paul","last_name":"Connor","source_individual_id":"5014050","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Jason Connor"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81704","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1358","size":1},{"color":"#FF4D4D","name":"Interhemispheric switching in binocular rivalry and bipolar disorder","data":{"media_summary":"","end_year":2001,"keywords":["BIPOLAR DISORDER","HEMISPHERIC SWITCHIN","BINOCULAR RIVALRY","HEMISPHERIC ASYMMETR","MOOD"],"nhmrc_grant_id":997518,"application_year":1998,"start_year":1999,"scientific_title":"Interhemispheric switching in binocular rivalry and bipolar disorder","node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Steven Miller","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/997518","simplified_title":"Interhemispheric switching in binocular rivalry and bipolar disorder","sub_type":"Medical Postgraduate Scholarship","total_budget":"65901.49","source_system":""},"children":[{"color":"#336699","name":"Dr Steven Miller","data":{"first_name":"Steven","title":"Dr","dw_individual_id":"DW0026765","middle_name":"Mark","last_name":"Miller","source_individual_id":"RMIS705887","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Steven Miller"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83932","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1345","size":1},{"color":"#FF4D4D","name":"Molecular influences on COPD susceptibility, pathogeneis and treatment","data":{"media_summary":"","end_year":2001,"keywords":["COPD","GENETIC FACTORS"],"nhmrc_grant_id":997504,"application_year":1998,"start_year":1999,"scientific_title":"Molecular influences on COPD susceptibility, pathogeneis and treatment","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Ian Yang","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/997504","simplified_title":"Molecular influences on COPD susceptibility, pathogeneis and treatment","sub_type":"Medical Postgraduate Scholarship","total_budget":"65901.49","source_system":""},"children":[{"color":"#336699","name":"A/Pr Ian Yang","data":{"first_name":"Ian","title":"A/Pr","dw_individual_id":"DW0028973","middle_name":"Anthony","last_name":"Yang","source_individual_id":"RMIS57007","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Ian Yang"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84509","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1341","size":1},{"color":"#FF4D4D","name":"Role of caveolin-3 in muscle pathophysiology","data":{"media_summary":"","end_year":2000,"keywords":["MUSCULAR DYSTROPHY","CELLULAR PHYSIOLOGY"],"nhmrc_grant_id":997164,"application_year":1998,"start_year":1999,"scientific_title":"Role of caveolin-3 in muscle pathophysiology","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Mr Pierre-Francoise Mery","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/997164","simplified_title":"Role of caveolin-3 in muscle pathophysiology","sub_type":"INSERM Exchange ECF","total_budget":"54859.9","source_system":""},"children":[{"color":"#336699","name":"Mr Pierre-Francoise Mery","data":{"first_name":"Pierre-Francoise","title":"Mr","dw_individual_id":"DW0009109","middle_name":"","last_name":"Mery","source_individual_id":"RMIS676844","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mr Pierre-Francoise Mery"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79174","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1293","size":1},{"color":"#FF4D4D","name":"Anatomical substrates for functional diversity and plasticity in the adult primate cortex","data":{"media_summary":"","end_year":2002,"keywords":["PLASTICITY","RECEPTOR PROFILES","INHIBITION","EXCITION","NEURONAL MORPHOLOGY"],"nhmrc_grant_id":997161,"application_year":1998,"start_year":1999,"scientific_title":"Anatomical substrates for functional diversity and plasticity in the adult primate cortex","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Guy Elston","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/997161","simplified_title":"Anatomical substrates for functional diversity and plasticity in the adult primate cortex","sub_type":"CJ Martin Biomedical ECF","total_budget":"164194.56","source_system":""},"children":[{"color":"#336699","name":"Guy Elston","data":{"first_name":"Guy","title":"","dw_individual_id":"DW0042265","middle_name":"","last_name":"Elston","source_individual_id":"RMIS224199","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Guy Elston"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87969","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1292","size":1},{"color":"#FF4D4D","name":"Identification of best practice in health policyand planning for bilateral AID programs","data":{"media_summary":"","end_year":2001,"keywords":["AID","Health Policy","Sectoral Planning","Strategic Planning"],"nhmrc_grant_id":997153,"application_year":1998,"start_year":2001,"scientific_title":"Identification of best practice in health policyand planning for bilateral AID programs","node_source":"NHMRC","node_type":"Grant","field_of_research":"","research_area":"Health Services Research","for_category":"","cia_name":"A/Pr Peter Hill","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/997153","simplified_title":"Identification of best practice in health policyand planning for bilateral AID programs","sub_type":"Travelling Award for Research Training - Scholarship","total_budget":"19661","source_system":""},"children":[{"color":"#336699","name":"A/Pr Peter Hill","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0013658","middle_name":"Stewart","last_name":"Hill","source_individual_id":"5012306","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Hill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80385","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1291","size":1},{"color":"#FF4D4D","name":"Signalling cell death - structural basis of death effector/adaptor recruitment","data":{"media_summary":"","end_year":2005,"keywords":["MOLECULAR INTERACTIO","PROTEIN STRUCTURE","NMR","APOPTOSIS","DEATH DOMAIN"],"nhmrc_grant_id":997045,"application_year":1998,"start_year":1999,"scientific_title":"Signalling cell death - structural basis of death effector/adaptor recruitment","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Nervous System","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Justine Hill","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/997045","simplified_title":"Signalling cell death - structural basis of death effector/adaptor recruitment","sub_type":"CJ Martin Biomedical ECF","total_budget":"283768.28","source_system":""},"children":[{"color":"#336699","name":"Dr Justine Hill","data":{"first_name":"Justine","title":"Dr","dw_individual_id":"DW0013656","middle_name":"Maria","last_name":"Hill","source_individual_id":"RMIS706133","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Justine Hill"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80384","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1270","size":1},{"color":"#FF4D4D","name":"Predicting functional outcomes quality of life & healthcare utilisation following stroke & head injury","data":{"media_summary":"","end_year":2003,"keywords":["FUCTIONAL OUTCOME","OUTCOMES MEASUREMENT","LENGTH OF STAY","QUALITY OF LIFE","HEAD INJURY"],"nhmrc_grant_id":997032,"application_year":1998,"start_year":1999,"scientific_title":"Predicting functional outcomes quality of life & healthcare utilisation following stroke & head injury","node_source":"NHMRC","node_type":"Grant","field_of_research":"Epidemiology","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Leigh Tooth","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/997032","simplified_title":"Predicting functional outcomes quality of life & healthcare utilisation following stroke & head injury","sub_type":"Public Health (Australia) ECF","total_budget":"229336.94","source_system":""},"children":[{"color":"#336699","name":"Dr Leigh Tooth","data":{"first_name":"Leigh","title":"Dr","dw_individual_id":"DW0010698","middle_name":"Rhonda","last_name":"Tooth","source_individual_id":"RMIS1112435","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Leigh Tooth"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79606","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1265","size":1},{"color":"#FF4D4D","name":"Cardiovascular Disease","data":{"media_summary":"","end_year":2001,"keywords":["CARDIOLOGY"],"nhmrc_grant_id":993601,"application_year":1998,"start_year":1999,"scientific_title":"Cardiovascular Disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Thomas Marwick","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/993601","simplified_title":"Cardiovascular Disease","sub_type":"Eccles Award","total_budget":"533939.1","source_system":""},"children":[{"color":"#336699","name":"Prof Thomas Marwick","data":{"first_name":"Thomas","title":"Prof","dw_individual_id":"DW0032377","middle_name":"Hugh","last_name":"Marwick","source_individual_id":"RMIS108223","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Thomas Marwick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85383","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1224","size":1},{"color":"#FF4D4D","name":"Evaluating outcomes of assertive case management of heavy service users in integrated mental health","data":{"media_summary":"","end_year":2002,"keywords":["EVALUATION","HEAVY SERVICE USER","CASE-MANAGEMENT"],"nhmrc_grant_id":991755,"application_year":1998,"start_year":1999,"scientific_title":"Evaluating outcomes of assertive case management of heavy service users in integrated mental health","node_source":"NHMRC","node_type":"Grant","field_of_research":"Mental Health","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Peter Yellowlees","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991755","simplified_title":"Heavy service user intervention project","sub_type":"Special Investigation","total_budget":"210101.3","source_system":""},"children":[{"color":"#336699","name":"Peter Yellowlees","data":{"first_name":"Peter","title":"","dw_individual_id":"DW0046452","middle_name":"","last_name":"Yellowlees","source_individual_id":"RMIS42557","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Peter Yellowlees"},"class":"Researcher","self":"http://localhost:7474/db/data/node/89032","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1215","size":1},{"color":"#FF4D4D","name":"A controlled treatment trial of substance abuse in schizophrenia","data":{"media_summary":"","end_year":2002,"keywords":["SCHIZOPHRENIA","SUBSTANCE ABUSE","TREATMENT","PSYCHOSIS","COGNITIVE-BEHAVIOUR"],"nhmrc_grant_id":991754,"application_year":1998,"start_year":2001,"scientific_title":"A controlled treatment trial of substance abuse in schizophrenia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Kavanagh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991754","simplified_title":"Treatment of drug abuse in schizophrenia","sub_type":"Special Investigation","total_budget":"229221.29","source_system":""},"children":[{"color":"#336699","name":"Prof David Kavanagh","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0008308","middle_name":"J","last_name":"Kavanagh","source_individual_id":"RMIS41345","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Kavanagh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78938","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1214","size":1},{"color":"#FF4D4D","name":"Structural characterisation of nuclear localisation signal-receptor recognition","data":{"media_summary":"","end_year":2002,"keywords":["NUCLEAR PROTEIN IMPO","IMPORTIN","NUCLEAR LOCALISATION","CRYSTALLOGRAPHY","MOLECULAR RECOGNITIO"],"nhmrc_grant_id":991554,"application_year":1998,"start_year":1999,"scientific_title":"Structural characterisation of nuclear localisation signal-receptor recognition","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and clinical chemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Bostjan Kobe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991554","simplified_title":"Studies of the interactions between signals and receptors that determine protein localisation to the nucleus","sub_type":"Standard Project Grant","total_budget":"200510.19","source_system":""},"children":[{"color":"#336699","name":"Prof Bostjan Kobe","data":{"first_name":"Bostjan","title":"Prof","dw_individual_id":"DW0031827","middle_name":"","last_name":"Kobe","source_individual_id":"5011436","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bostjan Kobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85237","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1211","size":1},{"color":"#FF4D4D","name":"Human tartrate-resistant purple acid phosphatase: structure and function","data":{"media_summary":"","end_year":2001,"keywords":["OSTEOPOROSIS","HYDROXYL RADICALS","PEPTIDE INHIBITORS","X-RAY CRYSTALLOGRAPH","ACID PHOSPHATASE"],"nhmrc_grant_id":991511,"application_year":1998,"start_year":1999,"scientific_title":"Human tartrate-resistant purple acid phosphatase: structure and function","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and clinical chemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Susan Hamilton","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991511","simplified_title":"Studies on an enzyme which is a target for anti-osteoporotic drugs","sub_type":"Standard Project Grant","total_budget":"203056.52","source_system":""},"children":[{"color":"#336699","name":"Prof Susan Hamilton","data":{"first_name":"Susan","title":"Prof","dw_individual_id":"DW0007693","middle_name":"","last_name":"Hamilton","source_individual_id":"RMIS5888","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Susan Hamilton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78784","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1199","size":1},{"color":"#FF4D4D","name":"Influence of sulphation pattern of heparan sulphate on vascular pathologies","data":{"media_summary":"","end_year":2001,"keywords":["HEPARAN SULPHATE","ARTERY","N-SULPHOTRANSFERASE","SMOOTH MUSCLE CELLS","PROTEOGLYCAN"],"nhmrc_grant_id":991500,"application_year":1998,"start_year":1999,"scientific_title":"Influence of sulphation pattern of heparan sulphate on vascular pathologies","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Ian Hayward","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991500","simplified_title":"Heparan sulphate structure and function in arterial disease","sub_type":"Standard Project Grant","total_budget":"244727.07","source_system":""},"children":[{"color":"#336699","name":"Dr Ian Hayward","data":{"first_name":"Ian","title":"Dr","dw_individual_id":"DW0002111","middle_name":"P","last_name":"Hayward","source_individual_id":"RMIS7036","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Ian Hayward"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77250","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1195","size":1},{"color":"#FF4D4D","name":"Regulation and function of the transcription factor RelB in human dendritic cells","data":{"media_summary":"","end_year":2001,"keywords":["DENDRITIC CELLS","DIFFERENTIATION","ANTIGEN PRESENTATION","NFKAPPAB","CD40-LIGAND"],"nhmrc_grant_id":991488,"application_year":1998,"start_year":1999,"scientific_title":"Regulation and function of the transcription factor RelB in human dendritic cells","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ranjeny Thomas","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991488","simplified_title":"Control of antigen presenting cell differentiation","sub_type":"Standard Project Grant","total_budget":"199918.16","source_system":""},"children":[{"color":"#336699","name":"Prof Ranjeny Thomas","data":{"first_name":"Ranjeny","title":"Prof","dw_individual_id":"DW0045826","middle_name":"","last_name":"Thomas","source_individual_id":"RMIS4352","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ranjeny Thomas"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88853","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1191","size":1},{"color":"#FF4D4D","name":"Rational Design Of Novel Antiretroviral Drugs To Overcome Resistance","data":{"media_summary":"","end_year":2002,"nhmrc_grant_id":991293,"application_year":1998,"start_year":1999,"scientific_title":"Rational Design Of Novel Antiretroviral Drugs To Overcome Resistance","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/991293","simplified_title":"HIV AND RESISTANCE","sub_type":"ANCARD Project Grant","total_budget":"191943.61","source_system":""},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1157","size":1},{"color":"#FF4D4D","name":"The contribution of sexual experiences, abuse, dysfunction and satisfaction to health and well being","data":{"media_summary":"","end_year":2000,"keywords":["SEXUAL DYSFUNCTION","SEXUAL EXPERIENCES","RESPONSE BIAS","MENTAL HEALTH","SEXUAL ABUSE"],"nhmrc_grant_id":991272,"application_year":1998,"start_year":1999,"scientific_title":"The contribution of sexual experiences, abuse, dysfunction and satisfaction to health and well being","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Jackob Najman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991272","simplified_title":"The influence of sexual experiences, abuse dysfunction and satisfaction on general health","sub_type":"Public Health Project Grant","total_budget":"200239.15","source_system":""},"children":[{"color":"#336699","name":"Prof Jackob Najman","data":{"first_name":"Jackob","title":"Prof","dw_individual_id":"DW0003590","middle_name":"Moses","last_name":"Najman","source_individual_id":"5016639","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Jackob Najman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77655","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1152","size":1},{"color":"#FF4D4D","name":"Phase variation of LPS expression in Neisseria meningitidis; role in pathogenesis and vaccine development.","data":{"media_summary":"","end_year":2001,"keywords":["NEISSERIA MENINGITID","IMMUNOTYPE","GLYCOSYLTRANSFERASE","LIPOPOLYSACCHARIDE","PHASE VARIATION"],"nhmrc_grant_id":991266,"application_year":1998,"start_year":1999,"scientific_title":"Phase variation of LPS expression in Neisseria meningitidis; role in pathogenesis and vaccine development.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Michael Jennings","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991266","simplified_title":"A study on a component (LPS) of a bacteria which causes meningitis; its role in disease and vaccine potential.","sub_type":"Standard Project Grant","total_budget":"174161.8","source_system":""},"children":[{"color":"#336699","name":"Prof Michael Jennings","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0025768","middle_name":"P","last_name":"Jennings","source_individual_id":"RMIS449244","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Jennings"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83637","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1150","size":1},{"color":"#FF4D4D","name":"Cell mediated immunity in the early control of papillomavirus infection","data":{"media_summary":"","end_year":2001,"keywords":["PAPILLOMAVIRUS, HPV","VIRUS-LIKE PARTICLE","ANTIGEN PRESENTATION","CLASS I PATHWAY","VIRAL ANTIGEN PROCES"],"nhmrc_grant_id":991242,"application_year":1998,"start_year":1999,"scientific_title":"Cell mediated immunity in the early control of papillomavirus infection","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Clinical Medicine and Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Ian Frazer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991242","simplified_title":"How do papillomavirus and the human immune system play hide-and-seek game during infection?","sub_type":"Standard Project Grant","total_budget":"197108.89","source_system":""},"children":[{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1143","size":1},{"color":"#FF4D4D","name":"Sensitive assays for the early detection of prostatic cancer.","data":{"media_summary":"","end_year":2001,"keywords":["MARKERS OF MALIGNANC","PROSTATE CANCER","DIFFERENTIAL DISPLAY","TELOMERASE","EJACULATE"],"nhmrc_grant_id":991231,"application_year":1998,"start_year":1999,"scientific_title":"Sensitive assays for the early detection of prostatic cancer.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Robert ('Frank') Gardiner","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991231","simplified_title":"Early screening for detection of prostate cancer.","sub_type":"Standard Project Grant","total_budget":"279379.11","source_system":""},"children":[{"color":"#336699","name":"Prof Robert 'Frank' Gardiner","data":{"first_name":"Robert 'Frank'","title":"Prof","dw_individual_id":"DW0019135","middle_name":"Alexander","last_name":"Gardiner","source_individual_id":"RMIS6050429","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Robert 'Frank' Gardiner"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81883","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1141","size":1},{"color":"#FF4D4D","name":"A longitudinal study of the levels of intensity of palliative care received by cancer patients in Brisbane, Qu","data":{"media_summary":"","end_year":2001,"keywords":["LONGITUDINAL PROSPEC","PALLIATIVE CARE","QUALITY OF LIFE","PAIN AND SYMPTOM CON","QUALITATIVE AND QUAN"],"nhmrc_grant_id":991215,"application_year":1998,"start_year":1999,"scientific_title":"A longitudinal study of the levels of intensity of palliative care received by cancer patients in Brisbane, Qu","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Alexandra Clavarino","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991215","simplified_title":"A longitudinal study of palliative care received by cancer patients in Brisbane, Queensland.","sub_type":"Public Health Project Grant","total_budget":"180672.7","source_system":""},"children":[{"color":"#336699","name":"A/Pr Alexandra Clavarino","data":{"first_name":"Alexandra","title":"A/Pr","dw_individual_id":"DW0029981","middle_name":"","last_name":"Clavarino","source_individual_id":"RMIS31306","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Alexandra Clavarino"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84768","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1139","size":1},{"color":"#FF4D4D","name":"Would legalising physician-assisted suicide and euthanasia mean more, or fewer, incidences of these actions","data":{"media_summary":"","end_year":2000,"keywords":["END-OF-LIFE DECISION","EDUCATION PROGRAMS","DOCTOR/PATIENT COMMU","PALLIATIVE CARE","EUTHANASIA LEGISLATI"],"nhmrc_grant_id":991211,"application_year":1998,"start_year":1999,"scientific_title":"Would legalising physician-assisted suicide and euthanasia mean more, or fewer, incidences of these actions","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Gail Williams","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991211","simplified_title":"Euthanasia: will legislation increase or decrease it?","sub_type":"Public Health Project Grant","total_budget":"194467.92","source_system":""},"children":[{"color":"#336699","name":"Prof Gail Williams","data":{"first_name":"Gail","title":"Prof","dw_individual_id":"DW0017119","middle_name":"Marilyn","last_name":"Williams","source_individual_id":"RMIS28497","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Gail Williams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81346","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1138","size":1},{"color":"#FF4D4D","name":"Development of functional sympathetic synapses.","data":{"media_summary":"","end_year":2001,"keywords":["PURINOCEPTORS","EXCITATORY JUNCTION","NEUROTRANSMISSION","SYMPATHETIC VARICOSI"],"nhmrc_grant_id":991207,"application_year":1998,"start_year":1999,"scientific_title":"Development of functional sympathetic synapses.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Dr Nickolas Lavidis","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991207","simplified_title":"Development of functional connections between nerves and smooth muscle.","sub_type":"Standard Project Grant","total_budget":"261204.53","source_system":""},"children":[{"color":"#336699","name":"Dr Nickolas Lavidis","data":{"first_name":"Nickolas","title":"Dr","dw_individual_id":"DW0020288","middle_name":"Anastasios","last_name":"Lavidis","source_individual_id":"5015890","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Nickolas Lavidis"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82178","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1137","size":1},{"color":"#FF4D4D","name":"A multi-centre, randomised, controlled trial of BAL directed therapy in young children with cystic fibrosis.","data":{"media_summary":"","end_year":2003,"keywords":["RANDOMISED CONTROLLE","INFANTS AND YOUNG CH","CYSTIC FIBROSIS","BRONCHOALVEOLAR LAVA","LOWER RESPIRATORY IN"],"nhmrc_grant_id":991186,"application_year":1998,"start_year":1999,"scientific_title":"A multi-centre, randomised, controlled trial of BAL directed therapy in young children with cystic fibrosis.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Respiratory Diseases","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Claire Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991186","simplified_title":"A new cooperative approach to improve cystic fibrosis outcomes.","sub_type":"Epidemiology","total_budget":"547306.33","source_system":""},"children":[{"color":"#336699","name":"Prof Claire Wainwright","data":{"first_name":"Claire","title":"Prof","dw_individual_id":"DW0028616","middle_name":"Elizabeth","last_name":"Wainwright","source_individual_id":"RMIS6013","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Claire Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84407","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1129","size":1},{"color":"#FF4D4D","name":"Mechanisms and Regulation of Cadherin cell-cell adhesion.","data":{"media_summary":"","end_year":2001,"keywords":["CELL ADHESION","GROWTH FACTORS","CADHERIN ADHESION MO","CELL SIGNALLING","EPITHELIAL MORPHOGEN"],"nhmrc_grant_id":991170,"application_year":1998,"start_year":1999,"scientific_title":"Mechanisms and Regulation of Cadherin cell-cell adhesion.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and clinical chemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Alpha Yap","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991170","simplified_title":"Regulation of cell-cell adhesion.","sub_type":"Standard Project Grant","total_budget":"187269.58","source_system":""},"children":[{"color":"#336699","name":"Prof Alpha Yap","data":{"first_name":"Alpha","title":"Prof","dw_individual_id":"DW0034891","middle_name":"S.","last_name":"Yap","source_individual_id":"5018525","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Alpha Yap"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86044","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1127","size":1},{"color":"#FF4D4D","name":"Development of hybrid HPV/HIV VLPs, a novel vaccine to prevent both HIV and HPV infection","data":{"media_summary":"","end_year":2001,"nhmrc_grant_id":991146,"application_year":1998,"start_year":1999,"scientific_title":"Development of hybrid HPV/HIV VLPs, a novel vaccine to prevent both HIV and HPV infection","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Graham Leggatt","higher_grant_type":"NHMRC Strategic Awards","purl":"http://purl.org/au-research/grants/nhmrc/991146","simplified_title":"production of a vaccine to prevent both HIV and HPV infection","sub_type":"ANCARD Project Grant","total_budget":"183179.08","source_system":""},"children":[{"color":"#336699","name":"Dr Graham Leggatt","data":{"first_name":"Graham","title":"Dr","dw_individual_id":"DW0037982","middle_name":"R","last_name":"Leggatt","source_individual_id":"RMIS13401","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Graham Leggatt"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86840","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1122","size":1},{"color":"#FF4D4D","name":"Anatomical regional differences in regulation of human adipose cell number","data":{"media_summary":"","end_year":2002,"keywords":["ADIPOSE CELL NUMBER","PREADIPOCYTE DIFFERE","APOPTOSIS","FAT DISTRIBUTION"],"nhmrc_grant_id":991117,"application_year":1998,"start_year":1999,"scientific_title":"Anatomical regional differences in regulation of human adipose cell number","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof John Prins","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991117","simplified_title":"Regulation of adipose cell number","sub_type":"Standard Project Grant","total_budget":"218091.12","source_system":""},"children":[{"color":"#336699","name":"Prof Johannes Prins","data":{"first_name":"Johannes","title":"Prof","dw_individual_id":"DW0039181","middle_name":"Bernhard","last_name":"Prins","source_individual_id":"RMIS7041737","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Johannes Prins"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87157","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1116","size":1},{"color":"#FF4D4D","name":"How does papillomavirus regulate its late gene expression?","data":{"media_summary":"","end_year":2001,"keywords":["PAPILLOMAVIRUS","CAPSID PROTEIN","VIRUS LIFE CYCLE","TRANSLATION REGULATI","CERVICAL CANCER"],"nhmrc_grant_id":991041,"application_year":1998,"start_year":1999,"scientific_title":"How does papillomavirus regulate its late gene expression?","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Ian Frazer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991041","simplified_title":"Study the mechanisms by which papillomavirus turns on its coat protein production","sub_type":"Standard Project Grant","total_budget":"241069.87","source_system":""},"children":[{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1098","size":1},{"color":"#FF4D4D","name":"A genetic study of schizophrenia in the Iban of Sarawak","data":{"media_summary":"","end_year":2001,"keywords":["SCHIZOPHRENIA","PSYCHIATRIC PHENOMEN","TRANSCULTURAL PSYCHI","ISOLATED POPULATION","GENETIC LINKAGE/DISE"],"nhmrc_grant_id":991035,"application_year":1998,"start_year":1999,"scientific_title":"A genetic study of schizophrenia in the Iban of Sarawak","node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Bryan Mowry","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991035","simplified_title":"Searching for schizophrenia genes among the Iban of Sarawak","sub_type":"Standard Project Grant","total_budget":"261961.53","source_system":""},"children":[{"color":"#336699","name":"Prof Bryan Mowry","data":{"first_name":"Bryan","title":"Prof","dw_individual_id":"DW0044411","middle_name":"J","last_name":"Mowry","source_individual_id":"5016586","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Bryan Mowry"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88510","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1096","size":1},{"color":"#FF4D4D","name":"Modelling solute and metabolite disposition kinetics in perfused liver","data":{"media_summary":"","end_year":2001,"keywords":["PHARMACOKINETICS","HEPATIC CLEARANCE","FIRST PASS EFFECT","DRUG DISPOSITION","LIVER PERFUSION"],"nhmrc_grant_id":991016,"application_year":1998,"start_year":1999,"scientific_title":"Modelling solute and metabolite disposition kinetics in perfused liver","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Michael Roberts","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/991016","simplified_title":"Solute and metabolite pharmacokinetics in liver","sub_type":"Standard Project Grant","total_budget":"404059.36","source_system":""},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1090","size":1},{"color":"#FF4D4D","name":"Structure and function of the ligand binding domain of the low-density lipoprotein receptor","data":{"media_summary":"","end_year":2001,"keywords":["LDL RECEPTOR","PROTEIN EXPRESSION","LIPOPROTEIN","PROTEIN STRUCTURE","NUCLEAR MAGNETIC RES"],"nhmrc_grant_id":990982,"application_year":1998,"start_year":1999,"scientific_title":"Structure and function of the ligand binding domain of the low-density lipoprotein receptor","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and clinical chemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Paul Kroon","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990982","simplified_title":"An analysis of the receptor for low-density lipoprotein","sub_type":"Standard Project Grant","total_budget":"211933.74","source_system":""},"children":[{"color":"#336699","name":"Paul Kroon","data":{"first_name":"Paul","title":"","dw_individual_id":"DW0008467","middle_name":"","last_name":"Kroon","source_individual_id":"RMIS39791","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Paul Kroon"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78988","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1082","size":1},{"color":"#FF4D4D","name":"Tumour-host organ interaction: mechanisms of encapsulation of hepatocellular cancers (HCC).","data":{"media_summary":"","end_year":2000,"keywords":["HEPATIC STELLATE CEL","HEPATOCELLULAR CANCE","ENCAPSULATION"],"nhmrc_grant_id":990951,"application_year":1998,"start_year":1999,"scientific_title":"Tumour-host organ interaction: mechanisms of encapsulation of hepatocellular cancers (HCC).","node_source":"NHMRC","node_type":"Grant","field_of_research":"Gastroenterology and Hepatology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Gotley","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990951","simplified_title":"Tumour-host organ interaction in liver cancer","sub_type":"Standard Project Grant","total_budget":"119099.42","source_system":""},"children":[{"color":"#336699","name":"Prof David Gotley","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0025141","middle_name":"C","last_name":"Gotley","source_individual_id":"RMIS5900","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Gotley"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83464","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1074","size":1},{"color":"#FF4D4D","name":"New Molecular Probes For The Complement System. Development of Potent Agonists and Antagonists of C5a.","data":{"media_summary":"","end_year":2001,"keywords":["ANTAGONIST","COMPLEMENT C5A","AMINO ACID","PEPTIDE","NMR STRUCTURE"],"nhmrc_grant_id":990753,"application_year":1998,"start_year":1999,"scientific_title":"New Molecular Probes For The Complement System. Development of Potent Agonists and Antagonists of C5a.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and clinical chemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof David Fairlie","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990753","simplified_title":"Regulating an Inflammatory Protein in Blood","sub_type":"Standard Project Grant","total_budget":"279043.11","source_system":""},"children":[{"color":"#336699","name":"Prof David Fairlie","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0030610","middle_name":"Paul","last_name":"Fairlie","source_individual_id":"RMIS20617","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Fairlie"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84952","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1035","size":1},{"color":"#FF4D4D","name":"Population pharmacokinetics, pharmacodynamics and dosage prediction for tacrolimus","data":{"media_summary":"","end_year":2001,"keywords":["DOSAGE PREDICTION","THERAPEUTIC DRUG MON","IMMUNOSUPPRESSANT DR"],"nhmrc_grant_id":990715,"application_year":1998,"start_year":1999,"scientific_title":"Population pharmacokinetics, pharmacodynamics and dosage prediction for tacrolimus","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Susan Tett","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990715","simplified_title":"Improved method of dosing an immunosuppressant drug, tacrolimus","sub_type":"Standard Project Grant","total_budget":"144711.51","source_system":""},"children":[{"color":"#336699","name":"Prof Susan Tett","data":{"first_name":"Susan","title":"Prof","dw_individual_id":"DW0040037","middle_name":"Elizabeth","last_name":"Tett","source_individual_id":"5011655","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Susan Tett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87372","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1020","size":1},{"color":"#FF4D4D","name":"Molecular mechanisms involved in the formation, maintenance and viability of synapses.","data":{"media_summary":"","end_year":2001,"keywords":["NEUROTROPHINS","SYNAPSE FORMATION","MOTOR NEURONS","NEURONAL DIFFERENTIA","TRK'S"],"nhmrc_grant_id":990656,"application_year":1998,"start_year":1999,"scientific_title":"Molecular mechanisms involved in the formation, maintenance and viability of synapses.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Peter Noakes","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990656","simplified_title":"Molecular mechanisms of how motor nerve connections are maintained at the site of nerve-muscle contact.","sub_type":"Standard Project Grant","total_budget":"213613.88","source_system":""},"children":[{"color":"#336699","name":"A/Pr Peter Noakes","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0038807","middle_name":"G","last_name":"Noakes","source_individual_id":"5016732","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Noakes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87053","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1006","size":1},{"color":"#FF4D4D","name":"Physiological factors controlling the voltage-dependence of the olfactory cyclic AMP-gated ion channel","data":{"media_summary":"","end_year":2001,"keywords":["ION CHANNEL","OLFACTORY","MOLECULAR STRUCTURE","PATCH CLAMP","LIGAND-GATED"],"nhmrc_grant_id":990634,"application_year":1998,"start_year":1999,"scientific_title":"Physiological factors controlling the voltage-dependence of the olfactory cyclic AMP-gated ion channel","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof Joseph Lynch","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990634","simplified_title":"Physiological regulation of the olfactory cAMP-gated ion channel","sub_type":"Standard Project Grant","total_budget":"199551.83","source_system":""},"children":[{"color":"#336699","name":"Prof Joseph Lynch","data":{"first_name":"Joseph","title":"Prof","dw_individual_id":"DW0032228","middle_name":"W","last_name":"Lynch","source_individual_id":"5016080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Joseph Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85342","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/1001","size":1},{"color":"#FF4D4D","name":"Functional analysis of hSlit2, a human homolog of the Drosophila slit gene, in CNS and kidney development","data":{"media_summary":"","end_year":2001,"keywords":["KIDNEY DEVELOPMENT","CNS DEVELOPMENT","HUMAN GENETICS","GENE ISOLATION","GENE TARGETING"],"nhmrc_grant_id":990605,"application_year":1998,"start_year":1999,"scientific_title":"Functional analysis of hSlit2, a human homolog of the Drosophila slit gene, in CNS and kidney development","node_source":"NHMRC","node_type":"Grant","field_of_research":"Foetal Development and Medicine","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990605","simplified_title":"Understanding the function of the hSlit2 gene in neural and kidney development","sub_type":"Standard Project Grant","total_budget":"343443.66","source_system":""},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/994","size":1},{"color":"#FF4D4D","name":"Molecular regulation of GLUT4 trafficking","data":{"media_summary":"","end_year":2001,"keywords":["SECRETION","PROTEIN TRAFFICKING","GLUCOSE TRANSPORT","INSULIN ACTION","CELL BIOLOGY"],"nhmrc_grant_id":990558,"application_year":1998,"start_year":1999,"scientific_title":"Molecular regulation of GLUT4 trafficking","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof David James","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990558","simplified_title":"GLUT4 trafficking","sub_type":"Standard Project Grant","total_budget":"230705.43","source_system":""},"children":[{"color":"#336699","name":"Prof David James","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0019872","middle_name":"E","last_name":"James","source_individual_id":"RMIS8321","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David James"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82057","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/984","size":1},{"color":"#FF4D4D","name":"Energy expenditure and growth of body compartments in infants.","data":{"media_summary":"","end_year":2000,"keywords":["ENERGY EXPENDITURE","ENERGY REQUIREMENT","BODY COMPARTMENTS","INFANT FEEDING","INFANT NUTRITION AND"],"nhmrc_grant_id":990555,"application_year":1998,"start_year":1999,"scientific_title":"Energy expenditure and growth of body compartments in infants.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nutrition and Dietetics","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Ross Shepherd","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990555","simplified_title":"Energy expenditure and body composition in growing infants.","sub_type":"Public Health Project Grant","total_budget":"186899.1","source_system":""},"children":[{"color":"#336699","name":"Prof Ross Shepherd","data":{"first_name":"Ross","title":"Prof","dw_individual_id":"DW0010228","middle_name":"W","last_name":"Shepherd","source_individual_id":"5017505","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ross Shepherd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79472","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/983","size":1},{"color":"#FF4D4D","name":"Randomised controlled trial of an intervention to improve the health of adults with intellectual disability.","data":{"media_summary":"","end_year":2001,"keywords":["INTELLECTUAL DISABIL","GENERAL PRACTICE","HEALTH OUTCOMES","ADULTS","HEALTH ASSESSMENT"],"nhmrc_grant_id":990537,"application_year":1998,"start_year":1999,"scientific_title":"Randomised controlled trial of an intervention to improve the health of adults with intellectual disability.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"A/Pr Nicholas Lennox","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990537","simplified_title":"An intervention aimed at improving the health of adults with an intellectual disability.","sub_type":"Public Health Project Grant","total_budget":"188518.74","source_system":""},"children":[{"color":"#336699","name":"Prof Nicholas Lennox","data":{"first_name":"Nicholas","title":"Prof","dw_individual_id":"DW0032044","middle_name":"Gordon","last_name":"Lennox","source_individual_id":"5015941","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nicholas Lennox"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85287","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/980","size":1},{"color":"#FF4D4D","name":"Molecular characterisation of caveolae formation and function","data":{"media_summary":"","end_year":2001,"keywords":["PLASMA MEMBRANE","CAVEOLAE","ENDOCYTOSIS","GOLGI COMPLEX","MEMBRANE TRAFFIC"],"nhmrc_grant_id":990484,"application_year":1998,"start_year":1999,"scientific_title":"Molecular characterisation of caveolae formation and function","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and clinical chemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990484","simplified_title":"Caveolae formation and function","sub_type":"Standard Project Grant","total_budget":"325732.25","source_system":""},"children":[{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/972","size":1},{"color":"#FF4D4D","name":"Structural, functional and genetic characterisation of human sulfotransferases","data":{"media_summary":"","end_year":2001,"keywords":["SULFOTRANSFERASES","HETEROCYCLIC AMINES","HUMAN","CARCINOGENESIS","CDNA"],"nhmrc_grant_id":990394,"application_year":1998,"start_year":1999,"scientific_title":"Structural, functional and genetic characterisation of human sulfotransferases","node_source":"NHMRC","node_type":"Grant","field_of_research":"Toxicology (incl. Clinical Toxicology)","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Mick McManus","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990394","simplified_title":"Functional characterisation of human enzymes that metabolise foreign chemicals","sub_type":"Standard Project Grant","total_budget":"360524.92","source_system":""},"children":[{"color":"#336699","name":"Prof Mick Mcmanus","data":{"first_name":"Mick","title":"Prof","dw_individual_id":"DW0020792","middle_name":"","last_name":"Mcmanus","source_individual_id":"RMIS1086175","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mick Mcmanus"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82320","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/950","size":1},{"color":"#FF4D4D","name":"Determinants of effective immunotherapy for epithelial tumours","data":{"media_summary":"","end_year":2001,"keywords":["TUMOUR IMMUNOTHERAPY","AUTOIMMUNITY","CTL FUNCTION","CERVICAL CANCER","SKIN IMMUNOLOGY"],"nhmrc_grant_id":990345,"application_year":1998,"start_year":1999,"scientific_title":"Determinants of effective immunotherapy for epithelial tumours","node_source":"NHMRC","node_type":"Grant","field_of_research":"Tumour Immunology","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Prof Ian Frazer","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990345","simplified_title":"Treating cancers effectively with vaccines","sub_type":"Standard Project Grant","total_budget":"348128.87","source_system":""},"children":[{"color":"#336699","name":"Prof Ian Frazer","data":{"first_name":"Ian","title":"Prof","dw_individual_id":"DW0042479","middle_name":"H","last_name":"Frazer","source_individual_id":"5014710","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Ian Frazer"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/934","size":1},{"color":"#FF4D4D","name":"Identification of an Insulin-Specific Signal Transduction Pathway in Adipocytes","data":{"media_summary":"","end_year":2001,"keywords":["CELL BIOLOGY","ELECTROPHORESIS","INSULIN ACTION","SIGNAL TRANSDUCTION","PROTEIN PHOSPHORYLAT"],"nhmrc_grant_id":990333,"application_year":1998,"start_year":1999,"scientific_title":"Identification of an Insulin-Specific Signal Transduction Pathway in Adipocytes","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof David James","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990333","simplified_title":"Insulin Action in Muscle and Fat Cells","sub_type":"Standard Project Grant","total_budget":"197567.54","source_system":""},"children":[{"color":"#336699","name":"Prof David James","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0019872","middle_name":"E","last_name":"James","source_individual_id":"RMIS8321","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David James"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82057","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/930","size":1},{"color":"#FF4D4D","name":"Immunological consequences of epithelial expression of a viral oncoprotein associated with cervical carcinoma","data":{"media_summary":"","end_year":2001,"keywords":["HUMAN PAPILLOMAVIRUS","IMMUNOLOGICAL TOLERA","EPITHELIUM","TUMOUR","CYTOTOXIC T-CELLS"],"nhmrc_grant_id":990299,"application_year":1998,"start_year":1999,"scientific_title":"Immunological consequences of epithelial expression of a viral oncoprotein associated with cervical carcinoma","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof ROBERT TINDLE","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990299","simplified_title":"Immune response to tumour antigen in skin","sub_type":"Standard Project Grant","total_budget":"195176.48","source_system":""},"children":[{"color":"#336699","name":"Prof Robert Tindle","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0028412","middle_name":"W","last_name":"Tindle","source_individual_id":"RMIS388145","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Robert Tindle"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84347","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/920","size":1},{"color":"#FF4D4D","name":"Correlation between ganglioside-specific immune responses and disease progression in multiple sclerosis","data":{"media_summary":"","end_year":2001,"keywords":["AUTOIMMUNITY","NEUROIMMUNOLOGY","T LYMPHOCYTE","GANGLIOSIDE"],"nhmrc_grant_id":990291,"application_year":1998,"start_year":1999,"scientific_title":"Correlation between ganglioside-specific immune responses and disease progression in multiple sclerosis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Prof Michael Pender","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990291","simplified_title":"Autoreactivity to gangliosides in multiple sclerosis","sub_type":"Standard Project Grant","total_budget":"233472.77","source_system":""},"children":[{"color":"#336699","name":"Prof Michael Pender","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0009604","middle_name":"P","last_name":"Pender","source_individual_id":"RMIS18293","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Pender"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79308","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/918","size":1},{"color":"#FF4D4D","name":"CHILD SEXUAL ABUSE : EVALUATION OF A MULTIMODAL TREATMENT PROGRAMME","data":{"media_summary":"","end_year":2001,"keywords":["CHILD SEXUAL ABUSE","TREATMENT EVALUATION","FAMILY VIOLENCE"],"nhmrc_grant_id":990201,"application_year":1998,"start_year":1999,"scientific_title":"CHILD SEXUAL ABUSE : EVALUATION OF A MULTIMODAL TREATMENT PROGRAMME","node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychology not elsewhere classified","research_area":"Public Health","for_category":"PSYCHOLOGY","cia_name":"Prof Barry Nurcombe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990201","simplified_title":"CHILD SEXUAL ABUSE : MULTIMODAL TREATMENT","sub_type":"Public Health Project Grant","total_budget":"312066.55","source_system":""},"children":[{"color":"#336699","name":"Barry Nurcombe","data":{"first_name":"Barry","title":"","dw_individual_id":"DW0032917","middle_name":"","last_name":"Nurcombe","source_individual_id":"RMIS6092","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Barry Nurcombe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85532","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/895","size":1},{"color":"#FF4D4D","name":"The role of the human papillomavirus in alpha-6 integrin activation and cell growth.","data":{"media_summary":"","end_year":2001,"keywords":["CANCER-CAUSING VIRUS","KERATINOCYTE","RAS SIGNALLING PATHW","INTEGRIN","VIRUS RECEPTOR"],"nhmrc_grant_id":990198,"application_year":1998,"start_year":1999,"scientific_title":"The role of the human papillomavirus in alpha-6 integrin activation and cell growth.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Nigel McMillan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990198","simplified_title":"What happens when the cervical cancer-causing virus binds to cells?","sub_type":"Standard Project Grant","total_budget":"233967.48","source_system":""},"children":[{"color":"#336699","name":"Prof Nigel Mcmillan","data":{"first_name":"Nigel","title":"Prof","dw_individual_id":"DW0032535","middle_name":"Alan John","last_name":"Mcmillan","source_individual_id":"5016394","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Nigel Mcmillan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85423","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/893","size":1},{"color":"#FF4D4D","name":"Protein targeting in the brain: mRNA transport in oligodendrocytes and neurons.","data":{"media_summary":"","end_year":2001,"keywords":["MYELIN BASIC PROTEIN","PROTEIN TARGETING","MULTIPLE SCLEROSIS","CYTOPLASMIC MRNA TRA","HETEROGENEOUS NUCLEA"],"nhmrc_grant_id":990189,"application_year":1998,"start_year":1999,"scientific_title":"Protein targeting in the brain: mRNA transport in oligodendrocytes and neurons.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and clinical chemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Ross Smith","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990189","simplified_title":"RNA transport in brain cells.","sub_type":"Standard Project Grant","total_budget":"224105.7","source_system":""},"children":[{"color":"#336699","name":"Prof Ross Smith","data":{"first_name":"Ross","title":"Prof","dw_individual_id":"DW0045515","middle_name":"William","last_name":"Smith","source_individual_id":"RMIS6441","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ross Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88776","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/891","size":1},{"color":"#FF4D4D","name":"A transgenic analysis of the basis for growth signalling by the growth hormone receptor","data":{"media_summary":"","end_year":2001,"keywords":["GROWTH HORMONE","RECEPTOR DOMAIN","MUTAGENESIS","SIGNALLING","GENE TARGETING"],"nhmrc_grant_id":990179,"application_year":1998,"start_year":1999,"scientific_title":"A transgenic analysis of the basis for growth signalling by the growth hormone receptor","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael WATERS","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990179","simplified_title":"What part of the growth hormone receptor signals growth in vivo ?","sub_type":"Standard Project Grant","total_budget":"209455.89","source_system":""},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/888","size":1},{"color":"#FF4D4D","name":"Analysis and correction of the host response defect in cystic fibrosis G551D mice.","data":{"media_summary":"","end_year":2001,"keywords":["KNOCKOUT MICE","MICRO-ARRAY ANALYSIS","HOST RESPONSE","GENE THERAPY","CYSTIC FIBROSIS"],"nhmrc_grant_id":990175,"application_year":1998,"start_year":1999,"scientific_title":"Analysis and correction of the host response defect in cystic fibrosis G551D mice.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990175","simplified_title":"Probing the nature of the CF cell for the development of clinical endpoints and novel therapeutic strategies.","sub_type":"Standard Project Grant","total_budget":"397347.56","source_system":""},"children":[{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/886","size":1},{"color":"#FF4D4D","name":"Mechanism of activation of c-Raf-1","data":{"media_summary":"","end_year":2001,"keywords":["RAS PROTEINS","SIGNAL TRANSDUCTION","RAF SERINE/THREONINE","14-3-3 PROTEINS","CAVEOLAE"],"nhmrc_grant_id":990123,"application_year":1998,"start_year":1999,"scientific_title":"Mechanism of activation of c-Raf-1","node_source":"NHMRC","node_type":"Grant","field_of_research":"Oncology and Carcinogenesis","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof John Hancock","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990123","simplified_title":"How the signaling protein Raf is activated","sub_type":"Standard Project Grant","total_budget":"536601.44","source_system":""},"children":[{"color":"#336699","name":"Prof John Hancock","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0037089","middle_name":"F","last_name":"Hancock","source_individual_id":"RMIS11500","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Hancock"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86600","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/874","size":1},{"color":"#FF4D4D","name":"Drug action in experimental pulmonary hypertension: studies on pulmonary vascular function and structure","data":{"media_summary":"","end_year":2003,"keywords":["NITRIC OXIDE DONORS","VASOACTIVE DRUGS","PULMONARY BLOOD VESS","PULMONARY HYPERTENSI","5-HYDROXYTRYPTAMINE"],"nhmrc_grant_id":990093,"application_year":1998,"start_year":1999,"scientific_title":"Drug action in experimental pulmonary hypertension: studies on pulmonary vascular function and structure","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Janet Wanstall","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990093","simplified_title":"Drugs for Pulmonary Hypertension","sub_type":"Standard Project with Research Fellowship","total_budget":"724619.75","source_system":""},"children":[{"color":"#336699","name":"Janet Wanstall","data":{"first_name":"Janet","title":"","dw_individual_id":"DW0005302","middle_name":"","last_name":"Wanstall","source_individual_id":"RMIS7727","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Janet Wanstall"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78146","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/868","size":1},{"color":"#FF4D4D","name":"Analysis of COUP-TF II, an orphan nuclear receptor: Evidence for a functional role in differentiation","data":{"media_summary":"","end_year":2001,"keywords":["NUCLEAR RECEPTORS","TRANSCRIPTION","PROTEIN-PROTEIN INTE","CELL CYCLE","DIFFERENTIATION & DE"],"nhmrc_grant_id":990087,"application_year":1998,"start_year":1999,"scientific_title":"Analysis of COUP-TF II, an orphan nuclear receptor: Evidence for a functional role in differentiation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/990087","simplified_title":"Regulation of Differentiation by Nuclear Receptors","sub_type":"Standard Project Grant","total_budget":"183179.08","source_system":""},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/867","size":1},{"color":"#FF4D4D","name":"Molecular mechanisms of tumourigenesis: structure and function of the human patched gene","data":{"media_summary":"","end_year":2002,"keywords":["PATCHED/HEDGEHOG","MUTATION ANALYSIS","STRUCTURE/FUNCTION","NBCCS","TUMOUR SUPPRESSOR"],"nhmrc_grant_id":987762,"application_year":1997,"start_year":1998,"scientific_title":"Molecular mechanisms of tumourigenesis: structure and function of the human patched gene","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Genetics","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Carol Wicking","higher_grant_type":"Career Development Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/987762","simplified_title":"Molecular mechanisms of tumourigenesis: structure and function of the human patched gene","sub_type":"RD Wright Award","total_budget":"274075.85","source_system":""},"children":[{"color":"#336699","name":"A/Pr Carol Wicking","data":{"first_name":"Carol","title":"A/Pr","dw_individual_id":"DW0028805","middle_name":"A","last_name":"Wicking","source_individual_id":"RMIS2473798","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Carol Wicking"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84461","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/840","size":1},{"color":"#FF4D4D","name":"Structural characterisation of intracellular copper transporting proteins","data":{"media_summary":"","end_year":2001,"keywords":["COPPER HOMEOSTASIS","MENKES ATPASE","METAL TRANSPORT"],"nhmrc_grant_id":987465,"application_year":1997,"start_year":1998,"scientific_title":"Structural characterisation of intracellular copper transporting proteins","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and clinical chemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Christopher Jones","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/987465","simplified_title":"Structural characterisation of intracellular copper transporting proteins","sub_type":"Dora Lush Biomedical Postgraduate Scholarship","total_budget":"62937.56","source_system":""},"children":[{"color":"#336699","name":"Dr Christopher Jones","data":{"first_name":"Christopher","title":"Dr","dw_individual_id":"DW0025817","middle_name":"E","last_name":"Jones","source_individual_id":"RMIS705920","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Christopher Jones"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83651","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/790","size":1},{"color":"#FF4D4D","name":"Mechanisms of axon growth in the vertebrate nervous system.","data":{"media_summary":"","end_year":2002,"keywords":["AXON GUIDANCE","AXON GROWTH","OLFACTORY","DEVELOPMENT","TYROSINE KINASE"],"nhmrc_grant_id":987164,"application_year":1997,"start_year":1998,"scientific_title":"Mechanisms of axon growth in the vertebrate nervous system.","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr James St.John","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/987164","simplified_title":"Mechanisms of axon growth in the vertebrate nervous system.","sub_type":"Peter Doherty Biomedical ECF","total_budget":"217980.05","source_system":""},"children":[{"color":"#336699","name":"Dr James St John","data":{"first_name":"James","title":"Dr","dw_individual_id":"DW0004781","middle_name":"A","last_name":"St John","source_individual_id":"RMIS5210245","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr James St John"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77995","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/761","size":1},{"color":"#FF4D4D","name":"Bacterial DNA and DNA vaccines as regulators of macrophage function and as a therapeutic approach to Leishmani","data":{"media_summary":"","end_year":2003,"keywords":["MACROPHAGES","LEISHMANIA","BACTERIAL DNA","DNA VACCINES","INTERLUKINS"],"nhmrc_grant_id":987038,"application_year":1997,"start_year":1998,"scientific_title":"Bacterial DNA and DNA vaccines as regulators of macrophage function and as a therapeutic approach to Leishmani","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Dr Matthew Sweet","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/987038","simplified_title":"Bacterial DNA and DNA vaccines as regulators of macrophage function and as a therapeutic approach to Leishmani","sub_type":"CJ Martin Biomedical ECF","total_budget":"265362.43","source_system":""},"children":[{"color":"#336699","name":"A/Pr Matthew Sweet","data":{"first_name":"Matthew","title":"A/Pr","dw_individual_id":"DW0028255","middle_name":"J","last_name":"Sweet","source_individual_id":"5017818","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Matthew Sweet"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84300","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/737","size":1},{"color":"#FF4D4D","name":"Investigation of nuclear co-repressors their role and function during mamalian development and differentiation","data":{"media_summary":"","end_year":2002,"keywords":["CO-REPRESSORS","NUCLEAR RECEPTORS","TRANSCRIPTION","DEVELOPMENT","NCOR / SMRT"],"nhmrc_grant_id":987011,"application_year":1997,"start_year":1998,"scientific_title":"Investigation of nuclear co-repressors their role and function during mamalian development and differentiation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Michael Downes","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/987011","simplified_title":"Investigation of nuclear co-repressors their role and function during mamalian development and differentiation","sub_type":"CJ Martin Biomedical ECF","total_budget":"164691.16","source_system":""},"children":[{"color":"#336699","name":"Dr Michael Downes","data":{"first_name":"Michael","title":"Dr","dw_individual_id":"DW0012791","middle_name":"R","last_name":"Downes","source_individual_id":"RMIS706055","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Michael Downes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80163","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/730","size":1},{"color":"#FF4D4D","name":"Inactivation of the patched tumour suppressor gene in the skin of transgenic mice","data":{"media_summary":"","end_year":2000,"keywords":["SKIN CANCER","MOUSE MODEL","NBCCS","PATCHED GENE"],"nhmrc_grant_id":981824,"application_year":1997,"start_year":1998,"scientific_title":"Inactivation of the patched tumour suppressor gene in the skin of transgenic mice","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981824","simplified_title":"Inactivation of the patched tumour suppressor gene in the skin of transgenic mice","sub_type":"Standard Project Grant","total_budget":"164967.95","source_system":""},"children":[{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/674","size":1},{"color":"#FF4D4D","name":"Structure-function analysis of the patched tumour suppressor gene product","data":{"media_summary":"","end_year":2000,"keywords":["PATCHED","NBCCS","MUTATION MODELLING","STRUCTURE/FUNCTION","HEDGEHOG"],"nhmrc_grant_id":981823,"application_year":1997,"start_year":1998,"scientific_title":"Structure-function analysis of the patched tumour suppressor gene product","node_source":"NHMRC","node_type":"Grant","field_of_research":"Genetics not elsewhere classified","research_area":"Basic Science","for_category":"GENETICS","cia_name":"Prof Brandon Wainwright","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981823","simplified_title":"Structure-function analysis of the patched tumour suppressor gene product","sub_type":"Standard Project Grant","total_budget":"322284.62","source_system":""},"children":[{"color":"#336699","name":"Prof Brandon Wainwright","data":{"first_name":"Brandon","title":"Prof","dw_individual_id":"DW0010876","middle_name":"J","last_name":"Wainwright","source_individual_id":"RMIS3708556","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brandon Wainwright"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79662","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/673","size":1},{"color":"#FF4D4D","name":"Mechanisms of cell survival in renal proximal and distaltubules - role of bcl-2","data":{"media_summary":"","end_year":2000,"keywords":["KIDNEY","TUBULE","APOPTOSIS","BCL-2","GROWTH FACTORS"],"nhmrc_grant_id":981822,"application_year":1997,"start_year":1998,"scientific_title":"Mechanisms of cell survival in renal proximal and distaltubules - role of bcl-2","node_source":"NHMRC","node_type":"Grant","field_of_research":"Nephrology and Urology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Glenda Gobe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981822","simplified_title":"An investigation of how the bcl-2 gene family improves survival of kidney cells induced to die","sub_type":"Standard Project Grant","total_budget":"157186.59","source_system":""},"children":[{"color":"#336699","name":"A/Pr Glenda Gobe","data":{"first_name":"Glenda","title":"A/Pr","dw_individual_id":"DW0042655","middle_name":"Carolyn","last_name":"Gobe","source_individual_id":"5012448","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Glenda Gobe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88060","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/672","size":1},{"color":"#FF4D4D","name":"Amino acid neurotransmission in humkan chronic alcoholism","data":{"media_summary":"","end_year":2002,"keywords":["AMINO ACIDS","NEUROTRANSMITTER","ALCOHOLISM","HUMAN BRAIN","NEUROPATHOLOGY"],"nhmrc_grant_id":981723,"application_year":1997,"start_year":1998,"scientific_title":"Amino acid neurotransmission in humkan chronic alcoholism","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Peter Dodd","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981723","simplified_title":"How alcoholism causes damage to the human brain","sub_type":"Standard Project with Research Fellowship","total_budget":"762521.72","source_system":""},"children":[{"color":"#336699","name":"A/Pr Peter Dodd","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0001312","middle_name":"R","last_name":"Dodd","source_individual_id":"RMIS34635","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Dodd"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77036","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/661","size":1},{"color":"#FF4D4D","name":"Genetics and biochemistry of pili glycosylation in pathogenic neisseria","data":{"media_summary":"","end_year":2000,"keywords":["NEISSERIA MENINGITID","NEISSERIA GONORRHOEA","PILI","GLYCOSYLATION","PHASE VARIATION"],"nhmrc_grant_id":981423,"application_year":1997,"start_year":1998,"scientific_title":"Genetics and biochemistry of pili glycosylation in pathogenic neisseria","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Bacteriology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Michael Jennings","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981423","simplified_title":"The role of sugar modifications of surface proteins in bacteria causing meningitis and gonorrhoeae","sub_type":"Standard Project Grant","total_budget":"167680.95","source_system":""},"children":[{"color":"#336699","name":"Prof Michael Jennings","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0025768","middle_name":"P","last_name":"Jennings","source_individual_id":"RMIS449244","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Jennings"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83637","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/620","size":1},{"color":"#FF4D4D","name":"The immunopathogenesis of oral lichen planus","data":{"media_summary":"","end_year":2000,"keywords":["LICHEN PLANUS","T CELL RECEPTOR","STRESS PROTEINS","CYTOKINES","PATHOGENESIS"],"nhmrc_grant_id":957352,"application_year":1994,"start_year":1995,"scientific_title":"The immunopathogenesis of oral lichen planus","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Clinical Medicine and Science","for_category":"IMMUNOLOGY","cia_name":"Dr Philip Sugerman","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/957352","simplified_title":"The immunopathogenesis of oral lichen planus","sub_type":"CJ Martin Biomedical ECF","total_budget":"304858.83","source_system":""},"children":[{"color":"#336699","name":"Philip Sugerman","data":{"first_name":"Philip","title":"","dw_individual_id":"DW0016502","middle_name":"","last_name":"Sugerman","source_individual_id":"RMIS13895","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Philip Sugerman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81183","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/24","size":1},{"color":"#FF4D4D","name":"Progression of atherosclerosis: involvement of mural thrombi and bone marrow cells","data":{"media_summary":"","end_year":2000,"keywords":["ATHEROSCLEROSIS","MURAL THROMBI","SMOOTH MUSCLE CELLS","MYOFIBROBLASTS","BONE MARROW"],"nhmrc_grant_id":961223,"application_year":1995,"start_year":1996,"scientific_title":"Progression of atherosclerosis: involvement of mural thrombi and bone marrow cells","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Julie Campbell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/961223","simplified_title":"Bone marrow, mural thrombi and atherosclerosis progression","sub_type":"Standard Project with Research Fellowship","total_budget":"801598.72","source_system":""},"children":[{"color":"#336699","name":"Prof Julie Campbell","data":{"first_name":"Julie","title":"Prof","dw_individual_id":"DW0000708","middle_name":"H","last_name":"Campbell","source_individual_id":"RMIS330901","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Julie Campbell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76860","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/46","size":1},{"color":"#FF4D4D","name":"Comparative physiology of binocular vision","data":{"media_summary":"","end_year":2000,"keywords":["VISUAL CORTEX","OPTICAL MAPPING","OCULAR DOMINANCE","PLASTICITY","COLUMNAR ORGANISATIO"],"nhmrc_grant_id":961231,"application_year":1995,"start_year":1996,"scientific_title":"Comparative physiology of binocular vision","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof John Pettigrew","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/961231","simplified_title":"Functional circuits of the brain","sub_type":"Extended","total_budget":"584897.19","source_system":""},"children":[{"color":"#336699","name":"John Pettigrew","data":{"first_name":"John","title":"","dw_individual_id":"DW0015559","middle_name":"","last_name":"Pettigrew","source_individual_id":"RMIS31384","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"John Pettigrew"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80922","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/50","size":1},{"color":"#FF4D4D","name":"Studies of the mechanisms of relapse of experimental autoimmune encephalomyelitis","data":{"media_summary":"","end_year":2000,"keywords":["ENCEPHALOMYELITIS","NEUROIMMUNOLOGY","T LYMPHOCYTE","CYTOKINES","MULTIPLE SCLEROSIS"],"nhmrc_grant_id":961253,"application_year":1995,"start_year":1996,"scientific_title":"Studies of the mechanisms of relapse of experimental autoimmune encephalomyelitis","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Pamela McCombe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/961253","simplified_title":"The causes of ongoing disease in an animal model of multiple sclerosis","sub_type":"Standard Project with Research Fellowship","total_budget":"703597.33","source_system":""},"children":[{"color":"#336699","name":"Prof Pamela Mccombe","data":{"first_name":"Pamela","title":"Prof","dw_individual_id":"DW0032439","middle_name":"Ann","last_name":"Mccombe","source_individual_id":"RMIS5883","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Pamela Mccombe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85397","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/51","size":1},{"color":"#FF4D4D","name":"National Research Centre for Environmental Toxicology","data":{"media_summary":"","end_year":2001,"nhmrc_grant_id":963301,"application_year":1995,"start_year":1996,"scientific_title":"National Research Centre for Environmental Toxicology","node_source":"NHMRC","node_type":"Grant","field_of_research":"Toxicology (incl. Clinical Toxicology)","research_area":"Not Applicable","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Michael Moore","higher_grant_type":"NHMRC Block Funding","purl":"http://purl.org/au-research/grants/nhmrc/963301","simplified_title":"National Research Centre for Environmental Toxicology","sub_type":"Research Unit Grant","total_budget":"4301904.53","source_system":""},"children":[{"color":"#336699","name":"Michael Moore","data":{"first_name":"Michael","title":"","dw_individual_id":"DW0009200","middle_name":"","last_name":"Moore","source_individual_id":"RMIS6227","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Michael Moore"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79201","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/54","size":1},{"color":"#FF4D4D","name":"Function of the natural resistance associated macrophage protein (nramp)","data":{"media_summary":"","end_year":2001,"keywords":["NRAMP","MACROPHAGE","DISEASE RESISTANCE","ARTHRITIS"],"nhmrc_grant_id":967351,"application_year":1995,"start_year":1996,"scientific_title":"Function of the natural resistance associated macrophage protein (nramp)","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cellular Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Dr Katryn Stacey","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/967351","simplified_title":"Function of the natural resistance associated macrophage protein (nramp)","sub_type":"CJ Martin Biomedical ECF","total_budget":"261358.15","source_system":""},"children":[{"color":"#336699","name":"Dr Katryn Stacey","data":{"first_name":"Katryn","title":"Dr","dw_individual_id":"DW0028117","middle_name":"Jane","last_name":"Stacey","source_individual_id":"5017656","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Dr Katryn Stacey"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84258","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/90","size":1},{"color":"#FF4D4D","name":"Targeted drug delivery by topical application","data":{"media_summary":"","end_year":2000,"keywords":["TOPICAL DRUG DELIVER","DRUG TARGETING","SKIN PERMEABILITY","TRANSDERMAL DELIVERY","SKIN RISK ASSESSMENT"],"nhmrc_grant_id":971047,"application_year":1996,"start_year":1997,"scientific_title":"Targeted drug delivery by topical application","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Michael Roberts","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/971047","simplified_title":"Topical drug delivery","sub_type":"Standard Project with Research Fellowship","total_budget":"945929.65","source_system":""},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/144","size":1},{"color":"#FF4D4D","name":"Nuclear hormone receptor regulation of muscle differentiation","data":{"media_summary":"","end_year":2000,"keywords":["STEROID RECEPTORS","ORPHAN RECEPTORS","DIFFERENTIATION","TRANSCRIPTION","DEVELOPMENT"],"nhmrc_grant_id":971070,"application_year":1996,"start_year":1997,"scientific_title":"Nuclear hormone receptor regulation of muscle differentiation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof George Muscat","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/971070","simplified_title":"Hormonal control of differentiation","sub_type":"Standard Project with Research Fellowship","total_budget":"569841.16","source_system":""},"children":[{"color":"#336699","name":"Prof George Muscat","data":{"first_name":"George","title":"Prof","dw_individual_id":"DW0026936","middle_name":"E.O","last_name":"Muscat","source_individual_id":"RMIS5658","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof George Muscat"},"class":"Researcher","self":"http://localhost:7474/db/data/node/83974","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/145","size":1},{"color":"#FF4D4D","name":"Evaluation of community based intervention progrm for the bereaved","data":{"media_summary":"","end_year":2000,"keywords":["BEREAVEMENT","CAPACITY BUILDING","EMPOWERMENT","GRIEF INTERVENTION","INNOVATION DIFFUSION"],"nhmrc_grant_id":974318,"application_year":1996,"start_year":1997,"scientific_title":"Evaluation of community based intervention progrm for the bereaved","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Dr Judith Murray","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/974318","simplified_title":"Evaluation of community based intervention progrm for the bereaved","sub_type":"Public Health (Australia) ECF","total_budget":"219950.13","source_system":""},"children":[{"color":"#336699","name":"Dr Judith Murray","data":{"first_name":"Judith","title":"Dr","dw_individual_id":"DW0021040","middle_name":"A","last_name":"Murray","source_individual_id":"RMIS110193","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Judith Murray"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82391","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/184","size":1},{"color":"#FF4D4D","name":"Neurotransmitter-induced pharmaco- and electromechanical coupling in the arteriolar wall","data":{"media_summary":"","end_year":2003,"keywords":["MICROCIRCULATION","VASOCONSTRICTION","NEUROTRANSMITTER","PHARMACOMECHANICAL","ELECTROMECHANICAL"],"nhmrc_grant_id":977325,"application_year":1996,"start_year":1997,"scientific_title":"Neurotransmitter-induced pharmaco- and electromechanical coupling in the arteriolar wall","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Dr Dianna Gould","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/977325","simplified_title":"Neurotransmitter-induced pharmaco- and electromechanical coupling in the arteriolar wall","sub_type":"CJ Martin Biomedical ECF","total_budget":"268339.36","source_system":""},"children":[{"color":"#336699","name":"Dr Dianna Gould","data":{"first_name":"Dianna","title":"Dr","dw_individual_id":"DW0036922","middle_name":"J","last_name":"Gould","source_individual_id":"RMIS706116","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Dianna Gould"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86559","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/210","size":1},{"color":"#FF4D4D","name":"The molecular genetics of the sex chromosome genes UTY and UTX","data":{"media_summary":"","end_year":2002,"keywords":["SPERMATOGENESIS","DEVELOPMENT","TRANSGENICS","INFERTILITY"],"nhmrc_grant_id":977327,"application_year":1996,"start_year":1997,"scientific_title":"The molecular genetics of the sex chromosome genes UTY and UTX","node_source":"NHMRC","node_type":"Grant","field_of_research":"Reproduction","research_area":"Basic Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"A/Pr Sean Grimmond","higher_grant_type":"Early Career Fellowships","purl":"http://purl.org/au-research/grants/nhmrc/977327","simplified_title":"The molecular genetics of the sex chromosome genes UTY and UTX","sub_type":"CJ Martin Biomedical ECF","total_budget":"252325.25","source_system":""},"children":[{"color":"#336699","name":"Prof Sean Grimmond","data":{"first_name":"Sean","title":"Prof","dw_individual_id":"DW0007616","middle_name":"M","last_name":"Grimmond","source_individual_id":"5014956","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Sean Grimmond"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78759","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/212","size":1},{"color":"#FF4D4D","name":"Immunopathology of oral candida albicans infection","data":{"media_summary":"","end_year":2000,"keywords":["ORAL","CANDIDA","ALBICANS","INFECTION"],"nhmrc_grant_id":978004,"application_year":1996,"start_year":1997,"scientific_title":"Immunopathology of oral candida albicans infection","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dentistry not elsewhere classified","research_area":"Basic Science","for_category":"DENTISTRY","cia_name":"Dr Camile Farah","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/978004","simplified_title":"Immunopathology of oral candida albicans infection","sub_type":"Dental Postgraduate Research Scholarship","total_budget":"88234.01","source_system":""},"children":[{"color":"#336699","name":"A/Pr Camile Farah","data":{"first_name":"Camile","title":"A/Pr","dw_individual_id":"DW0030619","middle_name":"S","last_name":"Farah","source_individual_id":"RMIS706067","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Camile Farah"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84955","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/246","size":1},{"color":"#FF4D4D","name":"Cost-effectiveness of screening and treatment of renal disease","data":{"media_summary":"","end_year":2000,"keywords":["ACEI","RENAL PROTECTION","ECONOMICS","INTERVENTION","SCREENING"],"nhmrc_grant_id":978501,"application_year":1996,"start_year":1997,"scientific_title":"Cost-effectiveness of screening and treatment of renal disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Indigenous Health","research_area":"Health Services Research","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Mr Philip Baker","higher_grant_type":"NHMRC Postgraduate Scholarships","purl":"http://purl.org/au-research/grants/nhmrc/978501","simplified_title":"Cost-effectiveness of screening and treatment of renal disease","sub_type":"Training Scholarship for Aboriginal Health Research","total_budget":"61043.88","source_system":""},"children":[{"color":"#336699","name":"Mr Philip Baker","data":{"first_name":"Philip","title":"Mr","dw_individual_id":"DW0017554","middle_name":"R A","last_name":"Baker","source_individual_id":"RMIS975047","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Mr Philip Baker"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81484","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/277","size":1},{"color":"#FF4D4D","name":"Molecular and cellular mechanisms of axon guidance in the vertebrate nervous system","data":{"media_summary":"","end_year":2000,"keywords":["AXON GUIDANCE","AXON GROWTH","GROWTH CONES","CELL ADHESION","DEVELOPMENT"],"nhmrc_grant_id":980705,"application_year":1997,"start_year":1998,"scientific_title":"Molecular and cellular mechanisms of axon guidance in the vertebrate nervous system","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof Brian Key","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/980705","simplified_title":"What guides growing nerves in the brain?","sub_type":"Standard Project Grant","total_budget":"399600.12","source_system":""},"children":[{"color":"#336699","name":"Prof Brian Key","data":{"first_name":"Brian","title":"Prof","dw_individual_id":"DW0020093","middle_name":"","last_name":"Key","source_individual_id":"RMIS68076","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Brian Key"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82124","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/465","size":1},{"color":"#FF4D4D","name":"Modulation of human cardiac function by B-adrenoceptor and endothelin receptor systems","data":{"media_summary":"","end_year":2002,"keywords":["B2-ADRENOCEPTOR","NON-CONVENTIONAL","ATYPICAL B-ADREN","ENDOTHELIN RECEPTORS","HUMAN HEART"],"nhmrc_grant_id":980744,"application_year":1997,"start_year":1998,"scientific_title":"Modulation of human cardiac function by B-adrenoceptor and endothelin receptor systems","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Peter Molenaar","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/980744","simplified_title":"Effects of cardiostimulants on human heart","sub_type":"Standard Project with Research Fellowship","total_budget":"505315.96","source_system":""},"children":[{"color":"#336699","name":"A/Pr Peter Molenaar","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0020938","middle_name":"","last_name":"Molenaar","source_individual_id":"RMIS221171","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Molenaar"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82361","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/474","size":1},{"color":"#FF4D4D","name":"The role of reactivity of ACYL glucuronides in the dispostion of acidic drugs","data":{"media_summary":"","end_year":2002,"keywords":["GLUCURONIDATION","CHEMICAL REACTIVITY","ACIDIC DRUGS","COVALENT BINDING","DRUG HYPERSENSITIVIT"],"nhmrc_grant_id":981186,"application_year":1997,"start_year":1998,"scientific_title":"The role of reactivity of ACYL glucuronides in the dispostion of acidic drugs","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Ronald Dickinson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981186","simplified_title":"Understanding side effects of acidic drugs","sub_type":"Standard Project with Research Fellowship","total_budget":"844383.92","source_system":""},"children":[{"color":"#336699","name":"Prof Ronald Dickinson","data":{"first_name":"Ronald","title":"Prof","dw_individual_id":"DW0036292","middle_name":"G","last_name":"Dickinson","source_individual_id":"RMIS8307","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Ronald Dickinson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86406","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/572","size":1},{"color":"#FF4D4D","name":"Modulation of WT1 activity by protein-protein and protein-RNA interactions","data":{"media_summary":"","end_year":2000,"keywords":["TRANSCRIPTION FACTOR","RNA BINDING","PROTEIN ASSOCIATIONS","WT1 PROTEINS","POST-TRANSCRIPTION"],"nhmrc_grant_id":981189,"application_year":1997,"start_year":1998,"scientific_title":"Modulation of WT1 activity by protein-protein and protein-RNA interactions","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and clinical chemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Melissa Little","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981189","simplified_title":"Investigating the function of WT1 complexes with RNA and other proteins","sub_type":"Standard Project Grant","total_budget":"122372.58","source_system":""},"children":[{"color":"#336699","name":"Prof Melissa Little","data":{"first_name":"Melissa","title":"Prof","dw_individual_id":"DW0038091","middle_name":"Helen","last_name":"Little","source_individual_id":"5012687","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Melissa Little"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86868","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/573","size":1},{"color":"#FF4D4D","name":"Physiological rehabilitation of disordered speech following traumatic brain injury","data":{"media_summary":"","end_year":2000,"keywords":["DYSARTHRIA","HEAD INJURY","REHABILITATION","SPEECH DISORDER","BRAIN INJURY"],"nhmrc_grant_id":981194,"application_year":1997,"start_year":1998,"scientific_title":"Physiological rehabilitation of disordered speech following traumatic brain injury","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurology and Neuromuscular Diseases","research_area":"Clinical Medicine and Science","for_category":"NEUROSCIENCES","cia_name":"Prof Bruce Murdoch","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981194","simplified_title":"Treatment of disordered speech following traumatic brain injury","sub_type":"Special Initiative Grant","total_budget":"169338.18","source_system":""},"children":[{"color":"#336699","name":"Prof Bruce Murdoch","data":{"first_name":"Bruce","title":"Prof","dw_individual_id":"DW0015136","middle_name":"Ernest","last_name":"Murdoch","source_individual_id":"RMIS15270","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Bruce Murdoch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80802","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/574","size":1},{"color":"#FF4D4D","name":"Transcriptional regulation of the macrophage colony-stimulating factor receptor (c-fms) gene","data":{"media_summary":"","end_year":2000,"keywords":["C-FMS","MACROPHAGE","TRANSCRIPTION","PU.1","DIFFERENTIATION"],"nhmrc_grant_id":981197,"application_year":1997,"start_year":1998,"scientific_title":"Transcriptional regulation of the macrophage colony-stimulating factor receptor (c-fms) gene","node_source":"NHMRC","node_type":"Grant","field_of_research":"Haematology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Hume","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981197","simplified_title":"Macrophage differentiation","sub_type":"Standard Project Grant","total_budget":"306431.3","source_system":""},"children":[{"color":"#336699","name":"David Hume","data":{"first_name":"David","title":"","dw_individual_id":"DW0013804","middle_name":"","last_name":"Hume","source_individual_id":"RMIS29671","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"David Hume"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80420","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/576","size":1},{"color":"#FF4D4D","name":"The efficacy of an early childhood sun protection program for mothers","data":{"media_summary":"","end_year":2000,"keywords":["SUN PROTECTION","EARLY CHILDHOOD","SKIN CANCER","INFANTS"],"nhmrc_grant_id":981200,"application_year":1997,"start_year":1998,"scientific_title":"The efficacy of an early childhood sun protection program for mothers","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof John Lowe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981200","simplified_title":"Helping mothers protect their young child","sub_type":"Public Health Project Grant","total_budget":"193946.4","source_system":""},"children":[{"color":"#336699","name":"Prof John Lowe","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0032211","middle_name":"B","last_name":"Lowe","source_individual_id":"RMIS31303","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof John Lowe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85337","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/577","size":1},{"color":"#FF4D4D","name":"Molecular structure and function of the olfactory cyclic nucleotide-gated channel","data":{"media_summary":"","end_year":2000,"keywords":["ION CHANNEL","LIGAND-GATED","PATCH-CLAMP","RECEPTOR STRUCTURE","OLFACTORY"],"nhmrc_grant_id":981202,"application_year":1997,"start_year":1998,"scientific_title":"Molecular structure and function of the olfactory cyclic nucleotide-gated channel","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof Joseph Lynch","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981202","simplified_title":"How the structure of the olfactory ion channel is related to its function","sub_type":"Standard Project Grant","total_budget":"127956.35","source_system":""},"children":[{"color":"#336699","name":"Prof Joseph Lynch","data":{"first_name":"Joseph","title":"Prof","dw_individual_id":"DW0032228","middle_name":"W","last_name":"Lynch","source_individual_id":"5016080","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Joseph Lynch"},"class":"Researcher","self":"http://localhost:7474/db/data/node/85342","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/578","size":1},{"color":"#FF4D4D","name":"Immunocytochemical analysis of amino acid transporters in developing brains","data":{"media_summary":"","end_year":2002,"keywords":["GLUTAMATE","TRANSPORTER","GLYCINE","NITRIC OXIDE","NMDA"],"nhmrc_grant_id":981203,"application_year":1997,"start_year":1998,"scientific_title":"Immunocytochemical analysis of amino acid transporters in developing brains","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"Prof David Pow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981203","simplified_title":"Understanding how the brain regulates amino acid neurotransmitters","sub_type":"Standard Project with Research Fellowship","total_budget":"457850.53","source_system":""},"children":[{"color":"#336699","name":"Prof David Pow","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0021533","middle_name":"Vaughan","last_name":"Pow","source_individual_id":"RMIS4392155","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Pow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82534","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/579","size":1},{"color":"#FF4D4D","name":"Surface to nucleus transport of oncogenic dna viruses","data":{"media_summary":"","end_year":2000,"keywords":["ENDOCYTOSIS","VIRUS","SV40","MEMBRANE_TRANSPORT","NUCLEUS"],"nhmrc_grant_id":981206,"application_year":1997,"start_year":1998,"scientific_title":"Surface to nucleus transport of oncogenic dna viruses","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Virology","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof Robert Parton","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981206","simplified_title":"Characterisation of virus entry into animal cells","sub_type":"Standard Project Grant","total_budget":"268808.33","source_system":""},"children":[{"color":"#336699","name":"Prof Robert Parton","data":{"first_name":"Robert","title":"Prof","dw_individual_id":"DW0027233","middle_name":"Glenn","last_name":"Parton","source_individual_id":"5016875","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Robert Parton"},"class":"Researcher","self":"http://localhost:7474/db/data/node/84038","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/580","size":1},{"color":"#FF4D4D","name":"Human leukaemia inhibitory factor (hLIF): a potential anti-atherosclerotic / anti-restenotic agent","data":{"media_summary":"","end_year":2000,"keywords":["ATHEROSCLEROSIS","RESTENOSIS","LIPOPROTEIN","LIF","CYTOKINE"],"nhmrc_grant_id":981209,"application_year":1997,"start_year":1998,"scientific_title":"Human leukaemia inhibitory factor (hLIF): a potential anti-atherosclerotic / anti-restenotic agent","node_source":"NHMRC","node_type":"Grant","field_of_research":"Cardiology (incl. Cardiovascular Diseases)","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Julie Campbell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981209","simplified_title":"Novel cytokine protects against vascular disease","sub_type":"Standard Project Grant","total_budget":"153171.33","source_system":""},"children":[{"color":"#336699","name":"Prof Julie Campbell","data":{"first_name":"Julie","title":"Prof","dw_individual_id":"DW0000708","middle_name":"H","last_name":"Campbell","source_individual_id":"RMIS330901","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Julie Campbell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76860","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/581","size":1},{"color":"#FF4D4D","name":"The role of growth hormone in periodontal regeneration","data":{"media_summary":"","end_year":2000,"keywords":["GROWTH FACTORS","GROWTH HORMONE","PERIODONTAL DISEASE","TISSUE REGENERATION"],"nhmrc_grant_id":981211,"application_year":1997,"start_year":1998,"scientific_title":"The role of growth hormone in periodontal regeneration","node_source":"NHMRC","node_type":"Grant","field_of_research":"Dentistry not elsewhere classified","research_area":"Basic Science","for_category":"DENTISTRY","cia_name":"Prof Peter Bartold","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981211","simplified_title":"Growth hormone and regeneration","sub_type":"Standard Project Grant","total_budget":"304075.11","source_system":""},"children":[{"color":"#336699","name":"Prof Mark Bartold","data":{"first_name":"Mark","title":"Prof","dw_individual_id":"DW0005985","middle_name":"","last_name":"Bartold","source_individual_id":"RMIS5803397","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mark Bartold"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78334","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/582","size":1},{"color":"#FF4D4D","name":"Corticotrope dysfunction in cushing's syndrome, obesity and other pituitary disorders","data":{"media_summary":"","end_year":2000,"keywords":["ADRENOCORTICOTROPIN","NALOXONE","PITUITARY DISEASE","CORTICOTROPE","CORTISOL"],"nhmrc_grant_id":981218,"application_year":1997,"start_year":1998,"scientific_title":"Corticotrope dysfunction in cushing's syndrome, obesity and other pituitary disorders","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"A/Pr Richard Jackson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981218","simplified_title":"Abnormalities of pituitary acth secretion in disease states","sub_type":"Standard Project Grant","total_budget":"180828.98","source_system":""},"children":[{"color":"#336699","name":"A/Pr Richard Jackson","data":{"first_name":"Richard","title":"A/Pr","dw_individual_id":"DW0019858","middle_name":"V","last_name":"Jackson","source_individual_id":"RMIS9549","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Richard Jackson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82054","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/583","size":1},{"color":"#FF4D4D","name":"Functional role of glutamate transporters in normal and ischaemic retinas","data":{"media_summary":"","end_year":2000,"keywords":["RETINA","GLUTAMATE","ISCHAEMIA","IMMUNOHISTOCHEMISTRY","TRANSPORTERS"],"nhmrc_grant_id":981222,"application_year":1997,"start_year":1998,"scientific_title":"Functional role of glutamate transporters in normal and ischaemic retinas","node_source":"NHMRC","node_type":"Grant","field_of_research":"Ophthalmology and Vision Science","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Nigel Barnett","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981222","simplified_title":"Understanding the mechanisms of neuronal damage when retinal blood supply is reduced","sub_type":"Standard Project Grant","total_budget":"172978.99","source_system":""},"children":[{"color":"#336699","name":"A/Pr Nigel Barnett","data":{"first_name":"Nigel","title":"A/Pr","dw_individual_id":"DW0011632","middle_name":"L","last_name":"Barnett","source_individual_id":"5013343","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Nigel Barnett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/79858","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/584","size":1},{"color":"#FF4D4D","name":"Assessment of concussion and its sequelae in contact sport","data":{"media_summary":"","end_year":2000,"keywords":["CONCUSSION","HEAD INJURY","FOOTBALL","NEUROPSYCHOLOGY","SPORTS MEDICINE"],"nhmrc_grant_id":981227,"application_year":1997,"start_year":1998,"scientific_title":"Assessment of concussion and its sequelae in contact sport","node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychology not elsewhere classified","research_area":"Public Health","for_category":"PSYCHOLOGY","cia_name":"Prof Laurence Geffen","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981227","simplified_title":"Management of concussion in contact sport","sub_type":"Public Health Project Grant","total_budget":"193805.52","source_system":""},"children":[{"color":"#336699","name":"Prof Laurence Geffen","data":{"first_name":"Laurence","title":"Prof","dw_individual_id":"DW0007442","middle_name":"B","last_name":"Geffen","source_individual_id":"RMIS1122829","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Laurence Geffen"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78711","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/585","size":1},{"color":"#FF4D4D","name":"Molecular genetics of skeletogenesis: the Sox9 gene in development and disease","data":{"media_summary":"","end_year":2000,"keywords":["SOX9","DEVELOPMENT, MAMMALI","COLLAGEN, TYPE II","MOLECULAR GENETICS","CAMPOMELIC DYSPLASIA"],"nhmrc_grant_id":981236,"application_year":1997,"start_year":1998,"scientific_title":"Molecular genetics of skeletogenesis: the Sox9 gene in development and disease","node_source":"NHMRC","node_type":"Grant","field_of_research":"Foetal Development and Medicine","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Peter Koopman","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981236","simplified_title":"Molecular genetics of skeletal development","sub_type":"Standard Project Grant","total_budget":"291443.85","source_system":""},"children":[{"color":"#336699","name":"Prof Peter Koopman","data":{"first_name":"Peter","title":"Prof","dw_individual_id":"DW0043570","middle_name":"A","last_name":"Koopman","source_individual_id":"5015773","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Peter Koopman"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88298","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/586","size":1},{"color":"#FF4D4D","name":"Noradrenaline and serotonin transporter regulation: implications for therapy of depression","data":{"media_summary":"","end_year":2000,"keywords":["AMINE TRANSPORTERS","GENE REGULATION","NORADRENALINE","DEPRESSION","SEROTONIN"],"nhmrc_grant_id":981242,"application_year":1997,"start_year":1998,"scientific_title":"Noradrenaline and serotonin transporter regulation: implications for therapy of depression","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Dr Lesley Bryan-Lluka","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981242","simplified_title":"Molecular biology of transporter proteins: leads for more specific therapy of depression","sub_type":"Standard Project Grant","total_budget":"159468.26","source_system":""},"children":[{"color":"#336699","name":"Dr Lesley Bryan-Lluka","data":{"first_name":"Lesley","title":"Dr","dw_individual_id":"DW0000609","middle_name":"J","last_name":"Bryan-Lluka","source_individual_id":"RMIS1729153","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Dr Lesley Bryan-Lluka"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76824","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/587","size":1},{"color":"#FF4D4D","name":"A controlled trial of emotional cue exposure for relapse prevention in alcohol abuse","data":{"media_summary":"","end_year":2000,"keywords":["ALCOHOL ABUSE","MODERATION DRINKING","CUE EXPOSURE","TREATMENT","COGNITIVE-BEHAVIOUR"],"nhmrc_grant_id":981245,"application_year":1997,"start_year":1998,"scientific_title":"A controlled trial of emotional cue exposure for relapse prevention in alcohol abuse","node_source":"NHMRC","node_type":"Grant","field_of_research":"Psychiatry","research_area":"Clinical Medicine and Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof David Kavanagh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981245","simplified_title":"Prevention of relapse in treatment of alcohol abuse by exposure to risk situations","sub_type":"Standard Project Grant","total_budget":"188781.26","source_system":""},"children":[{"color":"#336699","name":"Prof David Kavanagh","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0008308","middle_name":"J","last_name":"Kavanagh","source_individual_id":"RMIS41345","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Kavanagh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78938","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/588","size":1},{"color":"#FF4D4D","name":"Synaptic development in the abscence of b2-laminin, agrin and rapsyn","data":{"media_summary":"","end_year":2000,"keywords":["NEUROMUSCULAR","SYNAPSE FORMATION","RAPSYN","B2-LAMININ","AGRIN"],"nhmrc_grant_id":981252,"application_year":1997,"start_year":1998,"scientific_title":"Synaptic development in the abscence of b2-laminin, agrin and rapsyn","node_source":"NHMRC","node_type":"Grant","field_of_research":"Neurosciences not elsewhere classified","research_area":"Basic Science","for_category":"NEUROSCIENCES","cia_name":"A/Pr Peter Noakes","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981252","simplified_title":"Role of synaptic molecules in the formation and function of nerve muscle connections","sub_type":"Standard Project Grant","total_budget":"147117.95","source_system":""},"children":[{"color":"#336699","name":"A/Pr Peter Noakes","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0038807","middle_name":"G","last_name":"Noakes","source_individual_id":"5016732","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Peter Noakes"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87053","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/589","size":1},{"color":"#FF4D4D","name":"Characterisation of human sulfotransferases involved in drug and xenobiotic metabolism","data":{"media_summary":"","end_year":2000,"keywords":["SULFOTRANSFERASES","HUMAN","CLONING","XENOBIOTICS","HYBRIDISATION"],"nhmrc_grant_id":981256,"application_year":1997,"start_year":1998,"scientific_title":"Characterisation of human sulfotransferases involved in drug and xenobiotic metabolism","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Mick McManus","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981256","simplified_title":"Characterisation of enzymes that metabolise foreign_chemicals","sub_type":"Standard Project Grant","total_budget":"307080.82","source_system":""},"children":[{"color":"#336699","name":"Prof Mick Mcmanus","data":{"first_name":"Mick","title":"Prof","dw_individual_id":"DW0020792","middle_name":"","last_name":"Mcmanus","source_individual_id":"RMIS1086175","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Mick Mcmanus"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82320","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/590","size":1},{"color":"#FF4D4D","name":"Expression and regulation of the early pregnancy factor gene(s)","data":{"media_summary":"","end_year":2000,"keywords":["RT-PCR","IN SITU HYBRIDISATIO","MOUSE EMBRYO","GENE REGULATION","HEAT SHOCK PROTEINS"],"nhmrc_grant_id":981258,"application_year":1997,"start_year":1998,"scientific_title":"Expression and regulation of the early pregnancy factor gene(s)","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and clinical chemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Dr Alice Cavanagh","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981258","simplified_title":"Expression and regulation of the early pregnancy factor gene(s)","sub_type":"Standard Project Grant","total_budget":"146388.43","source_system":""},"children":[{"color":"#336699","name":"Alice Cavanagh","data":{"first_name":"Alice","title":"","dw_individual_id":"DW0006458","middle_name":"","last_name":"Cavanagh","source_individual_id":"RMIS20795","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Alice Cavanagh"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78455","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/591","size":1},{"color":"#FF4D4D","name":"Cell-type specification in the cns: functional analysis of sox14","data":{"media_summary":"","end_year":2000,"keywords":["DEVELOPMENTAL BIOLOG","MOLECULAR GENETICS","VERTEBRATE CNS","SOX GENES"],"nhmrc_grant_id":981261,"application_year":1997,"start_year":1998,"scientific_title":"Cell-type specification in the cns: functional analysis of sox14","node_source":"NHMRC","node_type":"Grant","field_of_research":"Foetal Development and Medicine","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Dr Toshiya Yamada","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981261","simplified_title":"Sox14 and cns development","sub_type":"Standard Project Grant","total_budget":"141915.75","source_system":""},"children":[{"color":"#336699","name":"Toshiya Yamada","data":{"first_name":"Toshiya","title":"","dw_individual_id":"DW0017254","middle_name":"","last_name":"Yamada","source_individual_id":"RMIS133491","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Toshiya Yamada"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81394","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/592","size":1},{"color":"#FF4D4D","name":"Human and mouse renal sulphate transporters: gene structure, function and regulation","data":{"media_summary":"","end_year":2000,"keywords":["RENAL REABSORPTION","SULPHATE TRANSPORT","PROTEIN REGULATION","GENE CLONING","PHOSPHORYLATION"],"nhmrc_grant_id":981275,"application_year":1997,"start_year":1998,"scientific_title":"Human and mouse renal sulphate transporters: gene structure, function and regulation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"A/Pr Daniel Markovich","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981275","simplified_title":"Molecular characterization of genes encoding human and mouse Na/sulphate cotransporters","sub_type":"Standard Project Grant","total_budget":"296219.74","source_system":""},"children":[{"color":"#336699","name":"Prof Daniel Markovich","data":{"first_name":"Daniel","title":"Prof","dw_individual_id":"DW0038289","middle_name":"","last_name":"Markovich","source_individual_id":"5016201","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Daniel Markovich"},"class":"Researcher","self":"http://localhost:7474/db/data/node/86917","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/594","size":1},{"color":"#FF4D4D","name":"The development of cytokine mimetics","data":{"media_summary":"","end_year":2000,"keywords":["PROTEIN ENGINEERING","PROTEIN SYNTHESIS","PROTEIN THERAPEUTICS","MOLECULAR DESIGN"],"nhmrc_grant_id":981279,"application_year":1997,"start_year":1998,"scientific_title":"The development of cytokine mimetics","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and clinical chemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"A/Pr Mark Smythe","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981279","simplified_title":"New strategies towards protein therapeutics","sub_type":"Standard Project Grant","total_budget":"164967.95","source_system":""},"children":[{"color":"#336699","name":"A/Pr Mark Smythe","data":{"first_name":"Mark","title":"A/Pr","dw_individual_id":"DW0045518","middle_name":"Leslie","last_name":"Smythe","source_individual_id":"5023110","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"A/Pr Mark Smythe"},"class":"Researcher","self":"http://localhost:7474/db/data/node/88779","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/595","size":1},{"color":"#FF4D4D","name":"The development of small peptide inhibitors of cell adhesion, effective in reperfusion injury","data":{"media_summary":"","end_year":2000,"keywords":["REPERFUSION INJURY","CELL ADHESION","PHAGE DISPLAY","INHIBITORS"],"nhmrc_grant_id":981283,"application_year":1997,"start_year":1998,"scientific_title":"The development of small peptide inhibitors of cell adhesion, effective in reperfusion injury","node_source":"NHMRC","node_type":"Grant","field_of_research":"Transplantation Immunology","research_area":"Basic Science","for_category":"IMMUNOLOGY","cia_name":"Prof Jonathon Fawcett","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981283","simplified_title":"Developing new drugs to improve the preservation of transplant organs","sub_type":"Standard Project Grant","total_budget":"141915.75","source_system":""},"children":[{"color":"#336699","name":"Prof Jonathan Fawcett","data":{"first_name":"Jonathan","title":"Prof","dw_individual_id":"DW0018949","middle_name":"","last_name":"Fawcett","source_individual_id":"RMIS4512205","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jonathan Fawcett"},"class":"Researcher","self":"http://localhost:7474/db/data/node/81850","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/596","size":1},{"color":"#FF4D4D","name":"IGFs, growth hormone and prolactin in preimplantation development","data":{"media_summary":"","end_year":2000,"keywords":["CHAPERONIN 10","EPF","PRE/PERIIMPLANTATION","AUTO/PARACRINE","RECEPTORS"],"nhmrc_grant_id":981285,"application_year":1997,"start_year":1998,"scientific_title":"IGFs, growth hormone and prolactin in preimplantation development","node_source":"NHMRC","node_type":"Grant","field_of_research":"Reproduction","research_area":"Basic Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"A/Pr Peter Kaye","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981285","simplified_title":"Actions of growth hormones in early pregnancy","sub_type":"Standard Project Grant","total_budget":"166761.24","source_system":""},"children":[{"color":"#336699","name":"A/Pr Peter Kaye","data":{"first_name":"Peter","title":"A/Pr","dw_individual_id":"DW0002568","middle_name":"L","last_name":"Kaye","source_individual_id":"RMIS3156936","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"A/Pr Peter Kaye"},"class":"Researcher","self":"http://localhost:7474/db/data/node/77370","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/597","size":1},{"color":"#FF4D4D","name":"Morphological characterisation of the southwest pacific malaria vectors","data":{"media_summary":"","end_year":2000,"keywords":["MALARIA","VECTORS","ANOPHELES","TAXONOMY"],"nhmrc_grant_id":981288,"application_year":1997,"start_year":1998,"scientific_title":"Morphological characterisation of the southwest pacific malaria vectors","node_source":"NHMRC","node_type":"Grant","field_of_research":"Public Health and Health Services not elsewhere classified","research_area":"Public Health","for_category":"PUBLIC HEALTH AND HEALTH SERVICES","cia_name":"Prof Joan Bryan","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981288","simplified_title":"Naming and describing the SW pacific malaria carriers","sub_type":"Public Health Project Grant","total_budget":"198209.12","source_system":""},"children":[{"color":"#336699","name":"Joan Bryan","data":{"first_name":"Joan","title":"","dw_individual_id":"DW0006288","middle_name":"","last_name":"Bryan","source_individual_id":"RMIS228086","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Joan Bryan"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78411","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/598","size":1},{"color":"#FF4D4D","name":"G protein signalling on the golgi complex","data":{"media_summary":"","end_year":2000,"keywords":["PROTEIN SECRETION","VESICLE TRAFFICKING","G PROTEINS","EPITHELIAL CELLS","SIGNAL TRANSDUCTION"],"nhmrc_grant_id":981297,"application_year":1997,"start_year":1998,"scientific_title":"G protein signalling on the golgi complex","node_source":"NHMRC","node_type":"Grant","field_of_research":"Biochemistry and clinical chemistry","research_area":"Basic Science","for_category":"BIOCHEMISTRY AND CELL BIOLOGY","cia_name":"Prof Jennifer Stow","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981297","simplified_title":"G protein signalling on the golgi complex","sub_type":"Standard Project Grant","total_budget":"320847.88","source_system":""},"children":[{"color":"#336699","name":"Prof Jennifer Stow","data":{"first_name":"Jennifer","title":"Prof","dw_individual_id":"DW0004860","middle_name":"Lea","last_name":"Stow","source_individual_id":"RMIS42387","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Jennifer Stow"},"class":"Researcher","self":"http://localhost:7474/db/data/node/78016","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/601","size":1},{"color":"#FF4D4D","name":"M3G: further studies of its CNS pharmacology","data":{"media_summary":"","end_year":2000,"keywords":["MORHINE-3-GLUCURONID","MORPHINE","ANALGESIC TOLERANCE","MICRODIALYSIS","RECEPTOR BINDING"],"nhmrc_grant_id":981304,"application_year":1997,"start_year":1998,"scientific_title":"M3G: further studies of its CNS pharmacology","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Maree Smith","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981304","simplified_title":"Studies of the rate of entry of morphine-3-glucuronide into the brain and its mechanism of action","sub_type":"Standard Project Grant","total_budget":"145567.28","source_system":""},"children":[{"color":"#336699","name":"Prof Maree Smith","data":{"first_name":"Maree","title":"Prof","dw_individual_id":"DW0022204","middle_name":"T","last_name":"Smith","source_individual_id":"5011570","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Maree Smith"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82728","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/602","size":1},{"color":"#FF4D4D","name":"Neuropeptide and conopeptide modulation of synaptic function in mammalian parasympathetic ganglia","data":{"media_summary":"","end_year":2000,"keywords":["NICOTINIC RECEPTOR","SYNAPSE","ELECTROPHYSIOLOGY","INTRACELLULAR CALCIU","CARDIAC GANGLIA"],"nhmrc_grant_id":981308,"application_year":1997,"start_year":1998,"scientific_title":"Neuropeptide and conopeptide modulation of synaptic function in mammalian parasympathetic ganglia","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Physiology not elsewhere classified","research_area":"Basic Science","for_category":"MEDICAL PHYSIOLOGY","cia_name":"Prof David Adams","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981308","simplified_title":"Peptide modulation of ganglionic transmission in the heart","sub_type":"Standard Project Grant","total_budget":"164967.95","source_system":""},"children":[{"color":"#336699","name":"Prof David Adams","data":{"first_name":"David","title":"Prof","dw_individual_id":"DW0000022","middle_name":"John","last_name":"Adams","source_individual_id":"RMIS8271","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof David Adams"},"class":"Researcher","self":"http://localhost:7474/db/data/node/76652","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/603","size":1},{"color":"#FF4D4D","name":"An exploration of the developmental course of inter- and intra-limb coordination","data":{"media_summary":"","end_year":2000,"keywords":["PHYSIOTHERAPY","COORDINATION","DOWN SYNDROME","CLUMSY","MOVEMENT"],"nhmrc_grant_id":981311,"application_year":1997,"start_year":1998,"scientific_title":"An exploration of the developmental course of inter- and intra-limb coordination","node_source":"NHMRC","node_type":"Grant","field_of_research":"Paediatrics","research_area":"Basic Science","for_category":"PAEDIATRICS AND REPRODUCTIVE MEDICINE","cia_name":"Prof Richard Carson","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981311","simplified_title":"Coordinating research into movement disorders","sub_type":"Standard Project Grant","total_budget":"118882.77","source_system":""},"children":[{"color":"#336699","name":"Prof Richard Carson","data":{"first_name":"Richard","title":"Prof","dw_individual_id":"DW0041489","middle_name":"G","last_name":"Carson","source_individual_id":"5013819","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof Richard Carson"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87761","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/604","size":1},{"color":"#FF4D4D","name":"Treatment of recurrent malignant melanoma by limb infusion of cytotoxic drugs and other techniques","data":{"media_summary":"","end_year":2000,"keywords":["CYTOTOXIC","MALIGNANT MELANOMA","LIMB PERFUSION","CLINICAL RESPONSE","PHARMACOKINETICS"],"nhmrc_grant_id":981314,"application_year":1997,"start_year":1998,"scientific_title":"Treatment of recurrent malignant melanoma by limb infusion of cytotoxic drugs and other techniques","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Clinical Medicine and Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Michael Roberts","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981314","simplified_title":"Cytotoxic limb infusion pharmacokinetics","sub_type":"Standard Project Grant","total_budget":"285967.76","source_system":""},"children":[{"color":"#336699","name":"Prof Michael Roberts","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0039362","middle_name":"Stephen","last_name":"Roberts","source_individual_id":"RMIS41002","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Roberts"},"class":"Researcher","self":"http://localhost:7474/db/data/node/87206","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/605","size":1},{"color":"#FF4D4D","name":"The role of type 4 fimbriae in host colonisation by Pseudomonas aeruginosa","data":{"media_summary":"","end_year":2000,"keywords":["PSEUDOMONAS AERUGINO","FIMBRIAE","INFECTION","HOST COLONISATION","INHIBITORS"],"nhmrc_grant_id":981319,"application_year":1997,"start_year":1998,"scientific_title":"The role of type 4 fimbriae in host colonisation by Pseudomonas aeruginosa","node_source":"NHMRC","node_type":"Grant","field_of_research":"Medical Infection Agents (incl. Prions)","research_area":"Basic Science","for_category":"MEDICAL MICROBIOLOGY","cia_name":"Prof John Mattick","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981319","simplified_title":"Infection by pseudomonas aeruginosa","sub_type":"Standard Project Grant","total_budget":"320910.86","source_system":""},"children":[{"color":"#336699","name":"Prof John Mattick","data":{"first_name":"John","title":"Prof","dw_individual_id":"DW0014777","middle_name":"Stanley","last_name":"Mattick","source_individual_id":"5016273","node_source":"NHMRC","node_type":"Researcher","source_system":"RGMS","full_name":"Prof John Mattick"},"class":"Researcher","self":"http://localhost:7474/db/data/node/80700","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/606","size":1},{"color":"#FF4D4D","name":"Effects of drugs on airway inflammation","data":{"media_summary":"","end_year":2000,"keywords":["AIRWAY INFLAMMATION","ASTHMA DRUGS","MEDIATORS","PLASMA EXUDATION","MICROVASCULAR LEAK"],"nhmrc_grant_id":981322,"application_year":1997,"start_year":1998,"scientific_title":"Effects of drugs on airway inflammation","node_source":"NHMRC","node_type":"Grant","field_of_research":"Pharmacology not elsewhere classified","research_area":"Basic Science","for_category":"PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","cia_name":"Prof Stella O'Donnell","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981322","simplified_title":"Drugs and airway inflammation","sub_type":"Standard Project Grant","total_budget":"136331.98","source_system":""},"children":[{"color":"#336699","name":"Prof Stella O'Donnell","data":{"first_name":"Stella","title":"Prof","dw_individual_id":"DW0021226","middle_name":"R","last_name":"O'Donnell","source_individual_id":"RMIS421166","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Stella O'Donnell"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82443","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/607","size":1},{"color":"#FF4D4D","name":"Regulation of gene expression by growth hormone","data":{"media_summary":"","end_year":2000,"keywords":["GROWTH HORMONE","TRANSCRIPTION FACTOR","PROMOTER","ADIPOGENESIS","IGF 1"],"nhmrc_grant_id":981323,"application_year":1997,"start_year":1998,"scientific_title":"Regulation of gene expression by growth hormone","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael WATERS","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981323","simplified_title":"How does growth hormone regulate genes?","sub_type":"Standard Project Grant","total_budget":"176719.48","source_system":""},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/608","size":1},{"color":"#FF4D4D","name":"Structure-function studies on the growth hormone receptor","data":{"media_summary":"","end_year":2000,"keywords":["GROWTH HORMONE","RECEPTOR","SIGNALLING","DIMERIZATION","CONFORMATIONAL CHANG"],"nhmrc_grant_id":981324,"application_year":1997,"start_year":1998,"scientific_title":"Structure-function studies on the growth hormone receptor","node_source":"NHMRC","node_type":"Grant","field_of_research":"Endocrinology","research_area":"Basic Science","for_category":"CLINICAL SCIENCES","cia_name":"Prof Michael WATERS","higher_grant_type":"NHMRC Project Grants","purl":"http://purl.org/au-research/grants/nhmrc/981324","simplified_title":"How does the growth hormone receptor send its signal?","sub_type":"Standard Project Grant","total_budget":"317778.22","source_system":""},"children":[{"color":"#336699","name":"Prof Michael Waters","data":{"first_name":"Michael","title":"Prof","dw_individual_id":"DW0022867","middle_name":"J","last_name":"Waters","source_individual_id":"RMIS47580","node_source":"NHMRC","node_type":"Researcher","source_system":"RMIS","full_name":"Prof Michael Waters"},"class":"Researcher","self":"http://localhost:7474/db/data/node/82896","size":1}],"class":"Grant","self":"http://localhost:7474/db/data/node/609","size":1}],"class":"Institution","self":"http://localhost:7474/db/data/node/22","size":1}